<?xml version="1.0" encoding="UTF-8" ?>
<terminology>
	<namespace>
		<name>MED-RT</name>
		<code>2.16.840.1.113883.6.345</code>
		<version>2026.03.02</version>
		<authority>Apelon, Inc.</authority>
	</namespace>
	<referencedNamespace>
		<name>RxNorm</name>
		<code>2.16.840.1.113883.6.88</code>
		<version>2026.02.02.25AB</version>
		<authority>National Library of Medicine</authority>
	</referencedNamespace>
	<referencedNamespace>
		<name>MeSH</name>
		<code>2.16.840.1.113883.6.177</code>
		<version>2026_2026.01.01</version>
		<authority>National Library of Medicine</authority>
	</referencedNamespace>
	<referencedNamespace>
		<name>SNOMED CT US Edition</name>
		<code>2.16.840.1.113883.6.96</code>
		<version>2025.09.25AA</version>
		<authority>National Library of Medicine</authority>
	</referencedNamespace>
	<proptype type="C">
		<namespace>MED-RT</namespace>
		<name>CTY</name>
	</proptype>
	<proptype type="C">
		<namespace>MED-RT</namespace>
		<name>NUI</name>
	</proptype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<inverse_name>Child Of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<inverse_name>Synonym Of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<inverse_name>MoA_of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<inverse_name>PE_of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<inverse_name>may_be_treated_by</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<inverse_name>[Inv] CI_with</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<inverse_name>SC_of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<inverse_name>may_be_prevented_by</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<inverse_name>PK_of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<inverse_name>[Inv] CI_PE</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<inverse_name>[Inv] CI_ChemClass</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<inverse_name>diagnosed_with</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<inverse_name>TC_of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<inverse_name>[Inv] CI_MoA</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<inverse_name>induced_by</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>has_active_metabolites</name>
		<inverse_name>active_metabolites_of</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<inverse_name>metabolism_at_site</inverse_name>
	</assntype>
	<assntype type="C">
		<namespace>MED-RT</namespace>
		<name>effect_may_be_inhibited_by</name>
		<inverse_name>may_inhibit_effect_of</inverse_name>
	</assntype>
	<qualtype type="CA">
		<namespace>MED-RT</namespace>
		<name>Authority</name>
	</qualtype>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular or Molecular Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nuclear Export Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Unknown Cellular or Molecular Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic and Biological Factor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Structure Molecule Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tubulin Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta Tubulin Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Viral Envelope Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fusion Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fusion Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Menin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Fusion Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Fusion Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV 1 Post-attachment Fusion Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Viral Envelope Wrapping Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Viral Envelope Wrapping Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Surface Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Capsid Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic Factor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amyloid Beta-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TFPI Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tissue Factor Pathway Inhibitor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Soluble Antigen Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Soluble Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Lymphocyte Stimulator-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B Lymphocyte Stimulator-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BLyS-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17A-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17A-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-6-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGF-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Surface Antigen Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Surface Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD33-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Zaire EBOV GP-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD30-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TSLP Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thymic Stromal Lymphopoietin Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Signaling Lymphocytic Activation Molecule Family member 7-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD319-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLAMF7-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Receptor-1-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PD-1-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selectin Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P-Selectin Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T-Lymphocyte Antigen 4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CTLA 4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T-Lymphocyte Antigen-4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CTLA4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T Lymphocyte Antigen 4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CTLA-4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T Lymphocyte Antigen-4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycoprotein 100 Peptide-HLA-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gp100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gp100 Peptide-HLA-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PD-L1-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Ligand-1-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD22-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD86-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD52-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD4-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD11a-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Claudin-18.2-directed Cytolytic Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Claudin 18.2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CLDN18.2-directed Cytolytic Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CLDN 18.2-directed Cytolytic Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Claudin18.2-directed Cytolytic Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD80-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD38-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Surface Glycolipid Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GD2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycolipid Disialoganglioside (GD2)-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycolipid Disialoganglioside-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR-2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IFNγ Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCMA-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B Cell Maturation Antigen-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4R alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4R alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4 Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activation Gene-3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>LAG-3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activation Gene 3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 5 Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL5 Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-5 Receptor alpha-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-IL-5 Receptor alpha mAb Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antigen Neutralization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Venom Neutralization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bacterial Toxin Neutralization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anthrax Protective Antigen-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bacterial Neurotoxin Neutralization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endogenous Antigen Neutralization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Virus Neutralization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody-Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IgE-directed Antibody Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Biological Response Modifiers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PD-L1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Ligand-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-6 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 31 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-31 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-31 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL31 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-31R alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL31R alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-12 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL12 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 12 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-12 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGF Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic Adjuvants</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adjuvants, Immunologic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-13 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 13 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-13 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 13 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17A Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17A Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-23 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 23 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL23 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-23 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Inactivators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement 1 Inactivators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement 5 Inactivators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Classical Complement Pathway Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Classical Complement Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Factor B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement C5 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alternative Complement Pathway Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Factor D Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Humoral and Cellular Immune Response Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Expression Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Alterations</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Editing or Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Editing</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Transduction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Transduction or Replacement</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Replacement</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Beta-globin Gene Transfer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>β-globin Gene Transfer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Transcription Modulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SMN2 Splicing Modifiers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival Motor Neuron 2 Splicing Modifiers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival of Motor Neuron 2 Splicing Modifiers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Translation Modulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Biological Macromolecular Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Structural Macromolecules</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzymatic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sigma Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transcription Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aryl Hydrocarbon Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>AhR agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases (UGT) Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases-1A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP-Glucuronosyltransferase 1A1 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A1 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP glucuronosyltransferase family 1 member A1 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2B6 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2B6 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2C9 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C9 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2E1 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 1A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 1A2 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A2 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C19 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2C19 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2D6 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2D6 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A5 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A5 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A4 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A4 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2C8 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C8 Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor alpha Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR alpha Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome-Proliferator Receptor alpha (PPAR-alpha) Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-alpha Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-beta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR beta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor beta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor delta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-delta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR delta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor gamma Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR gamma Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-gamma Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Farnesoid X Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Steroid Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticosteroid Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucocorticoid Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sex Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestational Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatic Glucagon Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor β Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRβ Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>THR-β Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>THR-beta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor-beta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor-β Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor beta Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Steroid Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Estrogen Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progesterone Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Progesterone Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Progesterone Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Steroid Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aldosterone Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aldosterone Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sex Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestational Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estradiol Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucocorticoid Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRF Type 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticotropin Releasing Factor Type 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticotropin-releasing Factor Type 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRF1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRF 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia Inducible Factor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIF Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIF PH Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIF-2 alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIF-2α Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor 2 alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia Inducible Factor- 2 alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Membrane Fusion Complex Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Synaptic Fusion Complex Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Release Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytokine Receptor Superfamily Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor alpha Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF-a Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF-alpha Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Activator of Nuclear Factor-kappa B Ligand Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RANK Ligand Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RANKL Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor beta Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF-beta Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF-b Receptor Blocking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17 RA Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor A Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17RA Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17RA Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17RA Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17 Receptor A Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17 RA Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17RA Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17RA Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17RA Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17RA Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17RA Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor A Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17 Receptor A Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17 RA Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17 RA Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD123 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD25-directed Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thrombopoietin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thrombopoietin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chemokine Receptor Type 4 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CXC Chemokine Receptor 4 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CXCR-4 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CXCR4 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-15 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL15R Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 15 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 15 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL15 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 15R Interactions </name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-15 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-15 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 15 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 15 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-15 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL15 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chemokine Co-receptor 5 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCR5 Co-receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chemokine Co-receptor 5 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCR5 Co-receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCR5 Co-receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL1 Receptor Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL1 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL1 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL36 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 36 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-36 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-36 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-36RAs</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4R Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-4 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4R Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-4 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4R alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4 Receptor alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4R alpha Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ATP-Binding Cassette (ABC) Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Salt Export Pump Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BSEP Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BSEP Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Salt Export Pump Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCRP Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Cancer Resistance Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCRP Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Cancer Resistance Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P-Glycoprotein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P-Glycoprotein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P-Glycoprotein Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Multidrug Resistance-Associated Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MRP2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ABCC2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Multidrug Resistance-Associated Protein 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Activity Modifying Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Activity Modifying Protein Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amylin Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Activin Signaling Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Activity Modifying Protein Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>G-Protein-linked Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>G-Protein-linked Receptor-Effector Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EP2 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin EP2 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E2 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostacyclin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pituitary Hormones Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pituitary Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pituitary Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V1B Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V1A Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA B Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 3 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NK3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium-Sensing Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Calcium-sensing Receptor Sensitivity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Calcium-sensing Receptor Sensitivity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lysophospholipid Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lysosphingolipid Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>S1P Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sphingosine 1-Phosphate Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sphingosine 1-Phosphate Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>S1P Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melatonin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melatonin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypothalmic Hormone Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypothalamic Hormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypothalamic Hormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bradykinin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bradykinin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bradykinin B2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PAR Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PAR-1 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PAR-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Substance P Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NK 1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Substance P Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NK 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P2Y12 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine D2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopaminergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocortin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocortin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MCR Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MC4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocortin 4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin II Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin II Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin II Type I Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Type 1 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin II Type 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Type 1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin II Type I Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement 5a Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>C5aR Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement 5a Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>C5aR Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Smoothened Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Smoothened Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Secretin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Secretin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Secretin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 (GLP-1) Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-1 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 (GLP-1) Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-2 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 (GLP-2) Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-2 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 (GLP-2) Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-4 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT4 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT4 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 4 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 4 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-4 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1D Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1d Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1d Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1D Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1d Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1D Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1b Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1B Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1B Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1B Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1b Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1b Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-2c Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 2C Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-2C Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 2c Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-2c Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-2C Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5-Hydroxytryptamine-1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1 Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1a Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT1a Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5-Hydroxytryptamine-1a Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1a Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT1a Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H3 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H3 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H2 Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H2 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H2 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H1 Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H1 Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H1 Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine Receptor Inverse Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H3 Receptor Inverse Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine-3 Receptor Inverse Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Receptor Inverse Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonists and Opioid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonists/Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonists and Opioid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Full Opioid Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>mu-Opioid Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid mu-Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>KOR Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid kappa Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Competitive Opioid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive Opioid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-competitive Opioid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Beta-adrenergic Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Beta-adrenergic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-2 Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta2-Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-1 Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta1-Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alpha-adrenergic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-1 Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha1-Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-2 Adrenergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha2-Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-2 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha2-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-2 Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha1-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-1 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-1 Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta3-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-3 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-3 Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-2 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta2-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-2 Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-1 Adrenergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-1 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta1-Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Secretagogue Receptor Interactions </name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ghrelin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Secretagogue Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ghrelin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathormone Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathormone Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathormone Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Neuromuscular Nicotinic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Cholinergic Nicotinic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Full Cholinergic Nicotinic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Ganglionic Nicotinic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Neuromuscular Nicotinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Competitive Cholinergic Nicotinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-competitive Cholinergic Nicotinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive Cholinergic Nicotinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Ganglionic Nicotinic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Type I interferon Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Type I IFN Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fc Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FcRn Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neonatal FcRn Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neonatal Fc Receptor Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurotransmitter Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Uptake Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Uptake Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ACh Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VMAT Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VMAT Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Uptake Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 31 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CGPR Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Protein Kinase Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor alpha Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PDGFR alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor alpha Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Keratinocyte Growth Factor Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Keratinocyte Growth Factor Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Keratinocyte Growth Factor Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EGFR Family Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Family Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Receptor Family Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Family Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Epidermal Growth Factor Receptor Family Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EGFR Family Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Receptor Family Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EGFR Family Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Family Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Family Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Family Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER Receptor Family Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Family Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Epidermal Growth Factor Receptor Family Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Epidermal Growth Factor Receptor Family Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-2/Neu/cerbB2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-2/Neu/cerbB2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2/Neu/cerbB2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2/Neu/cerbB2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-2 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EGFR Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER-1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EGFR Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatotropin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatotropin Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Macrophage Colony Stimulating Factor Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin-like Growth Factor-1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IGF-1R Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IGF Type 1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IGF-1 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IGF-1R Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin-like Growth Factor-1 Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor beta Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PDGFR beta Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor beta Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ion Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCN Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Cation Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cation Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCN Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Cation Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cation Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCN Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Cation Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cation Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Openers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>L-Calcium Channel Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-Calcium Channel Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T-Calcium Channel Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Voltage-gated Calcium Channel Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ligand-Gated Ion Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ionotropic Glutamate Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ionotropic Glutamate Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-methyl-D-aspartate Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NMDA Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Competitive NMDA Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Competitive N-methyl-D-aspartate Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive N-methyl-D-aspartate Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive NMDA Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-methyl-D-aspartate Receptor Glycine Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NMDA Receptor Glycine Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive NMDA Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive N-methyl-D-aspartate Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kainate Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>AMPA Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thermoreceptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRPM8 Thermoreceptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transient Receptor Potential Melastatin 8 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Positive Modulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycine Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycine Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycine Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5HT-3 Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5HT-3 Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5HT-3 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activation Potentiators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Blockers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Agonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ion Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLC9 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Antiporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NHE Interactions </name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Solute Carrier 9 Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLC9 A3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Antiporter 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NHE3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Potassium Exchanging ATPase Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Na-K ATPase Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Na-K Exchanging ATPase Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cation Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Cation Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OCT2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Cation Transporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urate Transporter-1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLC22A12 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RST Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urate Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter 4-like Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>URAT1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uric Acid Transporter-1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Solute Carrier Family 22 Member 12 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uric Acid Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>URAT-1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OAT4L Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MATE1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MATE-2K Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MATE2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MATE2-K Inhibitiors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Cation Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OCT1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proton Pump Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proton Pump Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>M2 Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anion Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OAT1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporting Polypeptide 2B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OATP2B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OATP1B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporting Polypeptide 1B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OATP1B3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporting Polypeptide 1B3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OAT3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Symporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SGLT Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Cotransporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Symporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Cotransporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Symporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Transporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Symporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Cotransporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SGLT2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Symporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Cotransporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Transporter 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Symporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Cotransporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Cotransporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SGLT1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Symporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Transporter 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NTCP Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Taurocholate Co-transporting Polypeptide Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Bile Acid Cotransporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Apical Sodium Bile Acid Transporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IBAT Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ASBT Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ileal Sodium Bile Acid Cotransporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ileal Bile Acid Transporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NTCP Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Potassium Chloride Symporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Potassium Chloride Symporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Chloride Symporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Chloride Symporter Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monosaccharide Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Integrin Receptor Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Integrin Receptor Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Function-Associated Antigen-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>LFA-1 Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Physiochemical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radiopharmaceutical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Particle Emitting Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Ray Emitting Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Positron Emitting Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioligand Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Imaging Contrast Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Magnetic Resonance Contrast Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radiocontrast Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>X-Ray Contrast Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ultrasound Contrast Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fluorescence Contrast Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Irrigation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Demulcent Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Photoabsorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Photoabsorbtion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ultraviolet A Radiation Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Absorbs Ultraviolet A Radiation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Absorbs UVA Radiation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Absorbs UVB Radiation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ultraviolet B Radiation Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Absorbs Ultraviolet B Radiation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Redox Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxidation-Reduction Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reduction-Oxidation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reduction Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Free Radical Scavenging</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Free Radical Scavenging Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Disulfide Reduction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cystine Disulfide Reduction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxidation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Osmotic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stool Bulking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GI Bulking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Contents Bulking Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metal Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metal Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iron Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iron Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Siderophore Iron Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plutonium Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plutonium Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lead Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lead Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphate Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphate Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphate Chelating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Digoxin Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile-acid Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HbS Polymerization Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hemoglobin S Polymerization Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Heparin Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ammonia Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ammonium Ion Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Ion Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Binding Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transthyretin Stabilizers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ion Exchange Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Ion Exchange Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Magnesium Ion Exchange Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Surfactant Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ionophoric Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Donors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfate Donors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alkylating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sclerosing Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stains</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dyes</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Electrolyte Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acid-Base Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alkalinizing Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrogen Ion Scavengers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrogen Ion Scavenging Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrogen Ion Donor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acidifying Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrogen Ion Donors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methyl Donors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methylating Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydroxylase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phenylalanine Hydroxylase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Indirect Lipase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ANGPTL3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiopoietin-like 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antithrombin Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antithrombin 3 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antithrombin III Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lyase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Guanylate Cyclase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Guanylate Cyclase Stimulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ligase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CPS1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthase 1 (CPS1) Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl-Phosphate Synthetase 1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl-Phosphate Synthase 1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoylphosphate Synthase 1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthase 1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthetase 1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoylphosphate Synthetase 1 Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyruvate Kinase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plasminogen Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tissue Plasminogen Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GTP Phosphohydrolase Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease Activators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Steroid Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sex Hormone Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestin Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-alpha Reductase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenal Steroid Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucocorticoid Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetyl Aldehyde Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gamma Secretase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Direct Renin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protein Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>APOC-III RNA Antisense Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>APOC3 RNA Antisense Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydroxyphenylpyruvate Dioxygenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucosyl Transferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucosylceramide Synthase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Methyltransferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Methytransferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ubiquitin Ligase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>E3 Ubiquitin Ligase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucan Synthase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iodide Peroxidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Peroxidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase II Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>COX-2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Xanthine Oxidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Triphosphate-Citrate Lyase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ACL Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ATP Citrate Lyase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbonic Anhydrase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dephosphorylation Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytidine Deaminase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytidine Analog Deaminase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alcohol Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase-2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IDH2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipoxygenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-Lipoxygenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oligonucleotide Telomerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histone Deacetylase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histone Deacetylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anaplastic Lymphoma Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protein Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ROS1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Agammaglobulinaemia Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bruton's Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BTK Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Janus Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tyrosine Kinase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TYK2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proline-rich Tyrosine Kinase-2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proline-rich Tyrosine Kinase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyk2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PYK2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>JAK3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>JAK-3 Protein Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>JAK-3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>JAK3 Protein Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Janus Kinase 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stem Cell Factor (KIT) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stem Cell Factor (KIT) Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fibroblast Growth Factor Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FGFR Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PDGFR Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RET Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Rearranged during Transfection (RET) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MET Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mesenchymal Epithelial Transition Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bcr-Abl Tyrosine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bcr-Abl Tyrosine Kinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurotrophic Factor Receptor (RET) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>fms-Like Tyrosine Kinase 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FLT3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Feline McDonough Sarcoma-like Receptor Tyrosine Kinase 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FMS-related Receptor Tyrosine Kinase 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FMS-like Receptor Tyrosine Kinase 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PTK2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FAK Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Focal Adhesion Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Rho Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serine/Threonine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Division Protein Kinase 6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CDK 6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name> Cyclin-dependent Kinase 6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BRAF Serine/Threonine Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>mTOR Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mammalian Target of Rapamycin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAP Kinase Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mitogen-Activated Protein Kinase Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MEK-1 Protein Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MEK1 Protein Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAP Kinase Kinase 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAP Kinase Kinase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MEK-2 Protein Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MEK2 Protein Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Division Protein Kinase 4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name> Cyclin-dependent Kinase 4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CDK 4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Type II RAF Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRKs Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Kinases Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRKB Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Kinase B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRKC Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Kinase C Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Kinase A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRKA Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV pUL97 Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus pUL97 Kinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphatidylinositol 3-Kinases Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3Ks Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide-3-Kinases Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide 3-Kinases Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide-3-Kinase delta Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3Kδ Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphatidylinositol 3-Kinase delta Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3K delta Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide 3-Kinase delta Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3K-alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PIK3CA Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3K-α Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3K alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphatidylinositol 3-Kinase alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3K α Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide 3-Kinase alpha Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PI3Kα Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Lactamase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta Lactamase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuraminidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methyltransferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Squalene Monooxygenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Squalene Epoxidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tryptophan Hydroxylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Phosphorylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thymidine Phosphorylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases (UGT) Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT2B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-2B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases-2B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT2B7 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-2B7 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-2B7 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT2B15 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-2B15 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-2B15 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases-1A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-1A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-1A4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-1A6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-1A9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferase-1A3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT1A3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>UGT-1A3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Para-Aminobenzoic Acid Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PABA Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antithrombins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Farnesyltransferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FTIs</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Integrase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Integrase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Integrase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanin Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAOI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase-B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAO-B Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAOI-B</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAOI-A</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAO-A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase-A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcineurin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>COMT Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol O-Methyltransferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol-O-Methyltransferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol-O-Methyl Transferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol O-Methyl Transferase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uncouplers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase V Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 5 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase V Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 3 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase III Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase III Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase IV Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase IV Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11βHSD Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11-beta Hydroxysteroid Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11β Hydroxysteroid Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11 beta-Hydroxysteroid Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11beta-Hydroxysteroid Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11-beta-Hydroxysteroid Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11beta-HSD Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11beta-HSD1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11βHSD-1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>11β Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proprotein Convertase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PCSK9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enkephalinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Protease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Protease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metalloprotease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metalloendopeptidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neprilysin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proteasome Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proteasome Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proteosome Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DPP-4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase 4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl-Peptidase IV Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase IV Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gliptins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase-4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin Converting Enzyme Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin-converting Enzyme Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cysteine Proteinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serine Proteinase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tissue Plasminogen Activator Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TPA Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kallikrein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thrombin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plasmin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Trypsin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCV NS3/4A Protease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus NS3/4A Protease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endonuclease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polymerase Acidic Endonuclease Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PARP Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly (ADP-Ribose) Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly ADP-Ribose Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly (ADP Ribose) Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly(ADP-Ribose) Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly ADP Ribose Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PARP Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decarboxylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet Activating Factor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet Glycoprotein IIb/IIIA Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet Glycoprotein 2b/3A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PBP inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>penicillin binding protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transpepsidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transpeptidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ADP Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Diphosphate Receptor Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2B6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2B6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A5 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A5 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP11A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 11A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 11A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 17A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP17A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 17A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 1A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP1A1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C8 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2C8 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2C9 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2A6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2D6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2D6 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C19 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2C19 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP11B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 11B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 11B1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 1A2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sterol Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydroxymethylglutaryl-CoA Reductase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HMG-CoA Reductase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HMG-CoA Reductase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ergosterol Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fatty Acid Synthetase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Synthase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin K Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin K Epoxide Reductase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catecholamine Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catecholamine Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DOPA Decarboxylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydroxyphenylalanine Decarboxylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha Glucosidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Glucosidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alpha-glucosidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dehydropeptidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydropeptidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Gyrase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 2 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Gyrase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 4 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Terminase Complex Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folic Acid Metabolism Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folic Acid Metabolic Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folic Acid Antagonists</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ribonucleotide Reductase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Synthesis Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Deaminase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydroorotate Dehydrogenase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thymidylate Synthetase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reverse Transcriptase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Nucleoside Reverse Transcriptase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Reverse Transcriptase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA Synthetase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA-dependent RNA Polymerase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA Replicase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiac Myosin Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Factor Xa Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Activated Factor X Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Activated Factor 10 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Factor 10a Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>14-alpha Demethylase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epoxide Hydrolase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IDH1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase-1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 1 Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Stabilizers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Reactivators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Reactivators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Inducers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Membrane Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fatty Acid Transporter Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Microsomal Triglyceride Transfer Protein Interactions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Microsomal Triglyceride Transfer Protein Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MTTP Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Clinical Kinetics</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kinetics</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Order</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Zero Order</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>First Order</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Clearance</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Half-Life</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Compartments</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>1-Compartment</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>2-Compartment</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>3-Compartment</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Elimination</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Route of Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fecal Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Milk Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatic Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Clinically Unimportant Route of Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Umbilical Lint Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tear Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Skin Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hair Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Saliva Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sweat Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nail Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Site of Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatic Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Intestinal Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plasma Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzymatic Pathway of Metabolism</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfotransferases</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Esterases</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-acetyl transferases</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochromes</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glutathione s-transferases</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine oxidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epoxide hydrolases</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucuronosyl transferases</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thiopurine methyltransferase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Co-methyltransferase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatic hydroxylation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Affected by gastric pH</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enhanced by acidity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased by acidity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Affected by food/other nutrients</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased by food</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased by food</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Affected by concomitant drug administration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Affected by intestinal surface area</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Absorption Half-Life</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Distribution</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Volume of distribution</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Site of relative exclusion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Site of concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pharmaceutical and Biological Preparations</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Preparations by FDA Established Pharmacologic Class</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibody or Antibody Fragment</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Receptor-1 Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PD-1 Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycolipid Disialoganglioside (GD2)-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GD2-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycolipid Disialoganglioside-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Claudin 18.2-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CLDN 18.2-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CLDN18.2-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Claudin-18.2-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Claudin18.2-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Radiotherapeutic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD20-directed, Radiotherapeutic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunoglobulin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acquired Passive Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Passively Acquired Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunoglobulin G</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-5 Receptor alpha-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-IL-5 Receptor alpha mAb</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL5 Receptor alpha-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 5 Receptor alpha-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-IgE Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-IgE</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased IgE Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunoglobulin G</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amyloid Beta-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD20-directed, Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD38-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T-Lymphocyte Antigen 4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T Lymphocyte Antigen 4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T Lymphocyte Antigen-4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CTLA4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxic T-Lymphocyte Antigen-4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CTLA-4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CTLA 4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immune System Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunostimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immune Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Molecule Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cytokine Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Antibody Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunoglobulin G Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased IgG Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Hemagglutinin Inhibition Antibody Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Kinin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Bradykinin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lipid Derived Immunologically Active Molecule Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Eicosanoid Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Leukotriene Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prostaglandin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thromboxane Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Activating Factor Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Complement Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Adhesion Factor Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Biogenic Amine Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Serotonin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Kallidin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Molecule Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Adhesion Factor Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Complement Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Antibody Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lipid Derived Immunologically Active Molecule Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Eicosanoid Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prostaglandin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Leukotriene Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thromboxane Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Activating Factor Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Kallidin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Biogenic Amine Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Serotonin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cytokine Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Kinin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Bradykinin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acquired Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acquired Active Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Actively Acquired Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Humoral Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell-mediated Immunity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunity, Cellular</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Molecule Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lipid Derived Immunologically Active Molecule Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Eicosanoid Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prostaglandin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Leukotriene Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thromboxane Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Activating Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Complement Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cytokine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Kallidin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Antibody Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Kinin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Bradykinin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Adhesion Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Biogenic Amine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased T Lymphocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD22-directed Antibody-Drug Conjugate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD22-directed Immunoconjugate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific HER2-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RSV Anti-F Protein Monoclonal Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RSV Anti-F Protein Monoclonal (mAb)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Humanized Monoclonal Antibody Fragment</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antivenin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD33-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD33-directed Immunoconjugate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD33-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Receptor Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Blocker (Antibody)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Receptor Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD30-directed Antibody-drug Conjugate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD30-directed Immunoconjugate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Zaire Ebolavirus Glycoprotein-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Zaire EBOV GP-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLAMF7-directed Immunostimulatory Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Signaling Lymphocytic Activation Molecule Family member 7-directed Immunostimulatory Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD319-directed Immunostimulatory Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD52-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD52-directed, Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD52-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anthrax Protective Antigen-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Stimulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Medullary Respiratory Drive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Surfactant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alveolar Surface Tension Reduction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>LTRA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Antagonist (LTRA)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CFTR Potentiator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mast Cell Stabilizer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Release</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Expectorant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Respiratory Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Nasal and Sinus Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Pharyngeal Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Tracheo-Bronchial Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Respiratory Secretion Viscosity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-narcotic Antitussive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonnarcotic Antitussive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antitussive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antitussive Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Tracheobronchial Stretch Receptor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antihistaminic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antihistamine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucolytic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous HSC-Based Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous HSC Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hemoglobin Function Restoration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Imaging Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gadolinium-based Contrast Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhalation Diagnostic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diagnostic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diagnostic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Paramagnetic Contrast Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Contrast Agent for Ultrasound Imaging</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radiographic Contrast Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Optical Imaging Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diagnostic Dye</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarized Contrast Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ion Channel or Pump Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-type Calcium Channel Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydropyridine Calcium Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Cation Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCN Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cation Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I(h) Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nicotinic Cholinergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nicotinic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nicotine Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Cholinergic Nicotinic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Nicotine Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Nicotinic Cholinergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Nicotinic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid A Receptor Positive Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Positive Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive NMDA Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive N-methyl-D-aspartate (NMDA) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium-sparing Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diuretic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Diuresis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Diuresis at Loop of Henle</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid (GABA)-ergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABAergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA-ergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid-ergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA-A Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA-A Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid A Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid-A Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid A Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid-A Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuroactive Steroid GABA A Receptor Positive Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive AMPA Glutamate Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-competitive AMPA Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive AMPA Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-competitive AMPA Glutamate Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autonomic Ganglionic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Ganglionic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transient Receptor Potential Melastatin 8 Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRPM8 Thermoreceptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proton Pump Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium-competitive Acid Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-methyl-D-aspartate (NMDA) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N-methyl-D-aspartate Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NMDA Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nondepolarizing Neuromuscular Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Contraction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Nondepolarizing Blockade</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Blockade</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Depolarizing Blockade</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Depolarizing Neuromuscular Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nervous System Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticholinergic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticholinergic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ergotamine Derivative</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscarinic Anticholinesterase Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscarinic Anticholinergic Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscarinic Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Typical Antipsychotic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antipsychotic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antipsychotic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tricyclic Antidepressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TCA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tricyclic Antidepressant (TCA)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidepressive Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidepressive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidepressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Receptor Binder</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kappa Opioid Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>KOR Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist and Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Opioid Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Inhibitor (MAOI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAOI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAOI-B</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAO-B Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Type B (MAO-B) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Type B Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin and Norepinephrine Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SNRI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mood Stabilizer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimanic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimanic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetylcholinesterase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ergot-derived Dopamine Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopaminergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminoketone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Release Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ergot Derivative</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscarinic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Atypical Antipsychotic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Reactivator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Norepinephrine Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SNRI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 3 (5HT-3) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 3 (5-HT3) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 3 (5HT3) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Reuptake Inhibitor (SSRI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Serotonin Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SSRI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Serotonin Reuptake Inhibitor (SSRI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NDRI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine and Norepinephrine Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine-Norepinephrine Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine-Dopamine Reuptake Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNRI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin (5-HT) 2C Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin (5-HT) 2c Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-2C Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-2c Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 2c Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 2C Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-2c Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-2C Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Depressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Depression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>General Anesthesia</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Emesis Suppression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Analgesia</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anorectic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Appetite Suppression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonergot Dopamine Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melatonin Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic Amine Anorectic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amphetamine Anorectic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catecholamine-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catecholamine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic-like Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-1 Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-1 Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central alpha-2 Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central a-2 Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective alpha2-Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-2 Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-3 Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-3 Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta3-Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta3-Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Bladder Contractility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-2 Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta2-Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta2-Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-2 Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Releasing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phenothiazine-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phenothiazine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phenothiazine Derivative</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>D2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine-2 (D2) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine-2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiepileptic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Stimulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CNS Stimulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Appetite Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1B and 5HT-1D Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1B/5HT-1D Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1b and 1d Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1B/1D Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin (5-HT) 1b/1d Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1B and Serotonin-1D Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1b and 5HT-1d Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1b and Serotonin-1d Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1b/1d Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin (5-HT) 1B/1D Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-1b/5HT-1d Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1B and 1D Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematology Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thrombopoietin Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Megakaryocyte Maturation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thrombopoiesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Erythropoiesis-stimulating Agent (ESA)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Erythropoiesis-stimulating Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ESA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Erythroid Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hemoglobin S Polymerization Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HbS Polymerization Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-inhibitor Coagulant Complex</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reversed Anticoagulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reversed Anti-coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticoagulation Reversal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reversed Anti-coagulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reversed Anticoagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-coagulation Activity Reversal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-coagulation Reversal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticoagulation Activity Reversal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Serum Albumin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Intravascular Volume</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Oncotic Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Unfractionated Heparin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Direct Thrombin Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticoagulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-coagulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Coagulation Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prothrombin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Heparin Reversal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin K Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Factor VIII Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor VIII Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor VIII Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thrombolytic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thrombolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematopoietic Stem Cell Mobilizer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Hematopoietic Stem Cell Mobilization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antifibrinolytic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Fibrinolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antifibrinolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Low Molecular Weight Heparin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Low Molecular Weight Heparin (LMWH)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>LMWH</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Warfarin Reversal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prothrombin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Factor D Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Classical Complement Pathway Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Classical Complement Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement Factor B Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement C5 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tissue Factor Pathway Inhibitor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TFPI Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet Aggregation Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Aggregation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 (PAR-1) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PAR-1 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Antihemophilic Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Procoagulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pro-coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Procoagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pro-coagulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Aggregation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Endothelial Coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor IX Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrin Polymerization Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor X Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plasma Volume Expander</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet Reducing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-reducing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Megakaryocyte Maturation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood Viscosity Reducer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Blood Viscosity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antithrombin-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased RNA Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood Coagulation Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Erythroid Maturation Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Activated Factor X Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Factor Xa Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Factor 10a Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Activated Factor 10 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Blood Coagulation Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-infective</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuraminidase Inhibitor (NAI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NAI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuraminidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Macrolide Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimicrobial Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus pUL97 Kinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV pUL97 Kinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 NNRTI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor (HIV-1 NNRTI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonnucleoside Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Nucleoside Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonnucleoside Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Nucleoside Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiparasitic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiparasitic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiparasitic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ectoparasiticide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anthelmintic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antihelminthic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antihelminthic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antihelminthic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pediculicide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pediculocide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antileishmanial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiprotozoal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiprotozoal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Fusion Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 FI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Fusion Inhibitor (HIV-1 FI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Fusion Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Entry Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Post-attachment Fusion Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Post-attachment Entry Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue Antiviral</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Antiviral</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HBV Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatits B Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HBV NRTI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiviral</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiviral Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HSV Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Herpes Simplex Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HSV Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog HSV DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue HSV DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog VZV DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue Varicella Zoster Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue VZV DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue Herpes Zoster Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VZV Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Herpes Zoster Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VZV Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Varicella Zoster Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Varicella Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Varicella Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor (HIV NRTI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV NRTI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue Herpesvirus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Herpesvirus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpesvirus Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV Nucleoside Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV Nucleoside Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibacterial Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCR5 Co-receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chemokine Co-receptor 5 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PCSK9 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human alpha-1 Proteinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neprilysin Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin Converting Enzyme Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human C1 Esterase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Vascular Permeability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Capillary Permeability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proteasome Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Plasma Kallikrein Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase 4 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase IV Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl-Peptidase IV Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase-4 (DPP-4) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DPP-4 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase-4 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus NS3/4A Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCV NS3/4A Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polyene Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 INSTI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Integrase Strand Transfer Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV INSTI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (HIV-1 INSTI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Integrase Strand Transfer Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tetracycline-class Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tetracycline Class Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ketolide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penem Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polymyxin Class Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polymyxin-class Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monobactam Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tetracycline-class Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lincosamide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimycobacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimycobacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimycobacterial Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Rifamycin Antimycobacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diarylquinoline Antimycobacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amphenicol-class Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amphenicols</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pleuromutilin Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fluoroquinolone Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methylated Sulfonamide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methylated Sulfonamides</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Rifamycin Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Macrolide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycopeptide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cephalosporin Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penicillin-class Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penicillin Class Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipopeptide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitrofuran Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipoglycopeptide Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipoglycopeptides</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA Synthetase Inhibitor Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxazolidinone Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polyene Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antifungal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Azole Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipid-based Polyene Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Triterpenoid Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Echinocandin Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzylamine Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allylamine Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCV NS5A Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus NS5A Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitroimidazole Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiprotozoal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimalarial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimalarial Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimalarial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antimalarial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Quinolone Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Influenza A M2 Protein Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>M2 Proton Pump Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiseptic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiseptic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiseptic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Viral Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adeno-associated Virus Vector</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Viruses, Genetically-modified</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adeno-associated Virus Vector-based Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenovirus Vector-Based Gene Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidote</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin K</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin K-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidotes, Deterrents, and Toxicologic Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidote for Acetaminophen Overdose</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glutathione Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decorporation Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folate Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folate Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B6 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B 6 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B6 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B 6 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carnitine Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carnitine Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Stimulating Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D2 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D2 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>C-type Natriuretic Peptide Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone-Related Peptide Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone-Related Peptide Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D3 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D3 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholecystokinin (CCK) Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholecystokinin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCK Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCK Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholecystokinin (CCK) Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progesterone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progesterone-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>l-Thyroxine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>l-Thyroxine-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T4</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>l-Thyroxine (T4)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcitonin-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcitonin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenocorticotropic Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid-class Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leptin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leptin Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide 2 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-2 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amylin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amylin Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Secretin-class Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Secretin Class Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin D Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxytocic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Uterine Smooth Muscle Contraction or Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticosteroid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Growth Hormone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRH Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRH Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Hormone (GHRH) Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRF Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRF Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Hormone Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Hormone Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Factor (GHRF) Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Factor (GHRF) Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Hormone (GHRH) Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Factor Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Factor Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GHRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E1 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E1 (PGE1) Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin-1 (PGE1) Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PGE1 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E1 (PGE1) Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PGE1 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin-1 (PGE1) Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin-1 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin-1 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestin-containing Intrauterine System (IUS)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestin-containing IUS</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestin-containing Intrauterine System</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovum Fertilization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>l-Triiodothyronine-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T3</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>l-Triiodothyronine (T3)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>l-Triiodothyronine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allergen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Standardized Pollen Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Release</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Fungal Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Food Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Pollen Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized House Dust Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal and Animal Specific Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Standardized Animal Skin Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cells, Epidermal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Animal Skin Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Feather Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Standardized Animal Hair Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Insect Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Insect Venom Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Animal Dander Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Plant Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Plant Fiber Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Standardized Insect Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Standardized Insect Venom Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Animal Hair Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Bacterial Allergenic Extract</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Chemical Allergen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Standardized Chemical Allergen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Related Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antisense Oligonucleotide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-sense Oligonucleotide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>APOC-III-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased RNA Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transthyretin-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TTR-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ALAS1-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminolevulinate Synthase 1-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histone Deacetylase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HDAC Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histone Deacetylase (HDAC) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alkylating Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Short interfering RNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Small Interfering RNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>siRNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Silencing RNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Microtubule Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Microtubule Inhibition</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Metabolic Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus (HCV) Nucleotide Analog NS5B Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCV Nucleotide Analog NS5B Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folate Analogue Metabolic Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Folate Analog Metabolic Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus DNA Terminase Complex Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV DNA Terminase Complex Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimetabolite</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimetabolite Immunosuppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic Suppression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immune Suppression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immune System Suppression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunosuppression</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Molecule Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytokine Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Biogenic Amine Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Serotonin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipid Derived Immunologically Active Molecule Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Activating Factor Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Eicosanoid Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostaglandin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Thromboxane Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Leukotriene Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Kinin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Bradykinin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Adhesion Factor Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Kallidin Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Antibody Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Complement Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Molecule Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Adhesion Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Complement Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipid Derived Immunologically Active Molecule Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Eicosanoid Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Thromboxane Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Leukotriene Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostaglandin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Activating Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Kallidin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Kinin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Bradykinin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytokine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Biogenic Amine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Histamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Serotonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Antibody Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Molecule Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Antibody Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipid Derived Immunologically Active Molecule Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Activating Factor Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Eicosanoid Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Leukotriene Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostaglandin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Thromboxane Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Complement Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Kinin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Bradykinin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytokine Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Biogenic Amine Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Serotonin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Kallidin Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Adhesion Factor Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Purine Antimetabolite</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased DNA Replication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anthracycline Topoisomerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tubulin Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vinca Alkaloid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tubulin Inhibiting Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Mitosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SMN2-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival Motor Neuron-2-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival of Motor Neuron 2-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival Motor Neuron 2-directed RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival of Motor Neuron 2 Splicing Modifier</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SMN2 Splicing Modifier</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Survival Motor Neuron 2 Splicing Modifier</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platinum-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platinum-based Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platinum-containing Compounds</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 2D6 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2D6 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcineurin Inhibitor Immunosuppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase-5 (PDE-5) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase-5 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PDE-5 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 5 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase V Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta-Lactamase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta Lactamase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase III Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucosylceramide Synthase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thymidine Phosphorylase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenal Steroid Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Dehydropeptidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Farnesyltransferase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbonic Anhydrase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 17A1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP17 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP17A1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 17A1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase-2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IDH2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CYP450 3A Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catecholamine Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decarboxylase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methyltransferase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly ADP Ribose Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly (ADP Ribose) Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly ADP-Ribose Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly (ADP-Ribose) Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PARP Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poly(ADP-Ribose) Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PARP Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Xanthine Oxidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tryptophan Hydroxylase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocyte Pigment Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanin Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Depigmenting Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocyte Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renin Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxaborole Antifungal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-alpha Reductase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-Lipoxygenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cortisol Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Glucosidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oligonucleotide Telomerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>4-Hydroxyphenylpyruvate Dioxygenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydroxyphenylpyruvate Dioxygenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>COMT Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol O-Methyl Transferase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol-O-Methyltransferase (COMT) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol-O-Methyltransferase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol O-Methyltransferase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catechol-O-Methyl Transferase (COMT) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIF Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia Inducible Factor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIF PH Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polymerase Acidic Endonuclease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PA Endonuclease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-steroidal Antiinflammatory Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-steroidal Anti-inflammatory Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Anti-inflammatory Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Antiinflammatory Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NSAID</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-steroidal Anti-inflammatory Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Antiinflammatory Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Non-steroidal Antiinflammatory Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Anti-inflammatory Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 4 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase IV Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ACL Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Triphosphate-Citrate Lyase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ATP Citrate Lyase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aldehyde Dehydrogenase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Intestinal Lipase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase-1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IDH1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nuclear Export Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Janus Kinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tyrosine Kinase 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TYK2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Rho Kinase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EGFR Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER1 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor (EGFR) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mammalian Target of Rapamycin Inhibitor Immunosuppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>mTOR Inhibitor Immunosuppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR-2 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor-2 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR2 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor 2 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2/neu Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ErbB2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HER2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gamma Secretase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatic Amino Acid Decarboxylation Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatic Amino Acid Decarboxylation Inhibitors</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydroxymethylglutaryl-CoA Reductase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HMG-CoA Reductase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiac Myosin Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selectin Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methylxanthine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methylxanthine-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Stabilizer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phenylalanine Hydroxylase Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthetase 1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoylphosphate Synthetase 1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthase 1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoylphosphate Synthase 1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CPS1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl-Phosphate Synthase 1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl-Phosphate Synthetase 1 Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthase 1 (CPS1) Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Soluble Guanylate Cyclase Stimulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protease Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Guanylate Cyclase-C Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyruvate Kinase Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Processed Thymus Tissue-based Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated BCG Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Calmette-Guerin (BCG) Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Macrophage Proliferation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Cellular Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor-derived Autologous T Cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Autologous T Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MAGE-A4-directed Genetically Modified Autologous T Cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCMA-directed Genetically Modified Autologous T-cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B Cell Maturation Antigen-directed Genetically Modified Autologous T-cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCMA-directed Genetically Modified Autologous T Cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Cultured T Lymphocytes, Autologous</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T Lymphocytes, Cultured, Autologous, Genetically-modified</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Autologous Cultured T Lymphocytes</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cells, Cultured, Autologous</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Cultured Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cultured Cells, Autologous</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Cultured Cells, Autologous</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Autologous Cultured Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cells, Cultured, Autologous, Genetically-modified</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipid Emulsion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated BCG Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Calmette-Guerin Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Calmette-Guerin (BCG) Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Rubella Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Rotavirus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Japanese Encephalitis Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Poliovirus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Pneumococcal Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Syncytial Virus mRNA Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Syncytial Virus mRNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Rabies Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Yellow Fever Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Anthracis Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Corynebacterium Diphtheriae Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Influenza B Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Human Adenovirus Type 4 Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tick-Borne Encephalitis Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vaccines, Tick-Borne Encephalitis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Hepatitis A Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Vaccinia Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Rotavirus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Meningococcal Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Salmonella Typhi Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>COVID-19 messenger RNA Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>COVID-19 mRNA Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SARS-CoV-2 mRNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Herpes Zoster Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pneumococcal 21-valent Conjugate Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Bordetella Pertussis Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Salmonella Typhi Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Hepatitis B Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Human Papillomavirus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Haemophilus Influenzae B Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Influenza A Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Measles Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Chickenpox Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Varicella Zoster Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Clostridium Tetani Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Human Adenovirus Type 7 Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Mumps Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acellular Tissue Engineered Vessel</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antirheumatic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antirheumatic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antirheumatic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diagnostic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Skin Test Antigen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tuberculosis Skin Test</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H. pylori Diagnostic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H. Pylori Diagnostic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Helicobacter pylori Diagnostic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Helicobacter Pylori Diagnostic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Muscle Relaxant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscle Relaxant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Centrally-mediated Muscle Relaxation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Skeletal Muscle Relaxant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 12 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL12 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-12 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-12 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD19-directed CD3-directed T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19-directed CD3-directed BiTE</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E2 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin EP2 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>EP2 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone (GnRH) Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GnRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-15 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-15 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 15 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 15 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL15 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Secretagogue Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ghrelin Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostacyclin Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GIPR Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GIP Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor-beta Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>THR-β Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRβ Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor-β Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>THR-beta Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor beta Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor β Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Estrogen Receptor Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Estrogen Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SERM</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective Progesterone Receptor Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progesterone Agonist/Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed Progesterone Agonist and Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>AhR agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aryl Hydrocarbon Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium-sensing Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Sensing Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Farnesoid X Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>mu-Opioid Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid mu-Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor gamma (PPAR-gamma) Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor gamma Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-gamma Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor alpha Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-alpha Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor alpha (PPAR-alpha) Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor delta Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR-delta Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PPAR delta Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PGE-1 Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PGE1 Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E1 Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocortin Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MCR Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melanocortin 4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MC4 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide 1 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GLP-1 Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RANK Ligand (RANKL) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Activator of Nuclear Factor-kappa B Ligand Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RANKL Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RANK Ligand Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 13 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 13 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-13 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-13 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chemokine Receptor Type 4 Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCR4 Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CXCR-4 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CXC Chemokine Receptor 4 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CXCR4 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL5 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-5 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 5 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific BCMA-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD20-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD20-directed CD3-directed T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD20-directed CD3-directed T-Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD20-directed CD3 T-Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Activin Signaling Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 (IL-6) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-6 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 (IL6) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine-2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine-2 (H2) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4 Receptor alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4R alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-4R alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL4 Receptor alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-4 Receptor alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone (GnRH) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bradykinin B2 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neonatal Fc Receptor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>FcRn Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CGPR Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P2Y12 Platelet Aggregation Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P2Y12 Platelet Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hedgehog Pathway Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Insulin-like Growth Factor-1 Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IGF-1R Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aldosterone Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H1 Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine-1 Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Mineralocorticoid-Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Receptor Antagonist/Inverse Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine-3 Receptor Antagonist/Inverse Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H3 Receptor Antagonist/Inverse Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Substance P/Neurokinin-1 (NK-1) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Substance P/Neurokinin-1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-31 Receptor alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine-1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H1 Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-1 (IL-1) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 (IL1) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-36 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 36 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-36RA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-36 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL36 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGF Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Integrin Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Function-Associated Antigen-1 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>LFA-1 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NK3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 3 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Colony Stimulating Factor-1 Receptor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CSF1R Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Colony Stimulating Factor 1 Receptor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CSF-1R Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>C5aR Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Complement 5a Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRF Type 1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRF1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRF 1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticotropin-releasing Factor Type 1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticotropin Releasing Factor Type 1 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Adrenocorticotropic Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased ACTH Sectretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Progestin Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17RA Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17RA Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17 Receptor A Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17RA Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17 RA Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17RA Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor A Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17 RA Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TNF Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor (TNF) Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Receptor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin II Receptor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Receptor Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-23 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 23 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-23 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL23 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17A Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17A (IL17A) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17A Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A (IL-17A) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17A Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Type I interferon Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Type I IFN Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-6 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 (IL-6) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 (IL6) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific Glycoprotein 100 Peptide-HLA-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bispecific gp100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD123 Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-3 Receptor alpha-chain Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-3RA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sphingosine 1-phosphate Receptor Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Chemical Structure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tetracycline-class Drug</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Actinomycin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Actinomycin-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Barbiturate-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Barbiturate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aluminum Complex</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thiazolidinedione-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thiazolidinedione</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nicotinic Acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nicotinic Acid-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfone-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bismuth</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bismuth-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon beta</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon beta-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Medium-chain TG</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Medium-chain Triacylglycerol</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Medium-chain Triglyceride</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostacycline</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostacycline-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostacycline Vasodilator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostacycline-class Vasodilator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Venous Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penile Venous Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Venous Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Systemic Venous Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coronary Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coronary Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Systemic Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Systemic Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscular Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arteriolar Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscular Arterial Vasodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzothiazole</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Benzothiazole-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Porphyrin Precursor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiac Glycoside</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amino Acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aromatic Amino Acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amino Acid Hypertonic Solution</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thiazide Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thiazide-class Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Retinoid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Retinoid-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thalidomide Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thalidomide Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glinide-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glinide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glinides</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parenteral Iron Replacement Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parenteral Iron Replacement</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alkaloid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Hydroxy Acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyridone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrethroid-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrethroid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminosalicylate-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminosalicylate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitrate Vasodilator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitrate-class Vasodilator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Amide Local Anesthetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Local Anesthesia</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Semifluorinated Alkane</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Semifluorinated Alkane</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bisphosphonate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bisphosphonate-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Biguanide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Biguanide-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon alpha</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon alpha-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon alfa</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IFN alpha-2B</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon alfa-2B</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon alfa-2b</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ester Local Anesthetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Omega-3 Fatty Acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Omega-3 Fatty Acid-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Psoralen-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Psoralen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reducing and Complexing Thiol</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin monophosphoric acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic Pyranopterin Monophosphate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin monophoshic acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin phosphate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin phosphoric acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>cPMP</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin monophoshic acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin monophosphoric acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic Pyranopterin Monophosphate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>cPMP</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin phosphate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cyclic pyranopterin phosphoric acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Macrolide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Macrolide-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Steroid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Acid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Acid-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfonylurea-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfonylurea</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin or Mineral</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B Complex Member</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B12</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B12-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Provitamin D2 Compound</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Salt</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin C-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin C</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin A-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin A</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD4-directed Blocking Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bcl 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCL-2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Cell Lymphoma-2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Cell Lymphoma 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BCL 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Cell Lymphoma 2 Protein Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bcl-2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Cell Lymphoma-2 Protein Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cellular Death</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>BLyS-specific Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Lymphocyte Stimulator-specific Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B Lymphocyte Stimulator (BLyS)-specific Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B Lymphocyte Stimulator-specific Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B-Lymphocyte Stimulator (BLyS)-specific Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased B Lymphocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IFNγ Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Chimeric Antigen Receptor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective T Cell Costimulation Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T Lymphocyte Costimulation Activity Blockade</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PD-L1 Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Ligand-1 Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activation Gene-3 Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activation Gene 3 Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>LAG-3 Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monoclonal Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>mAb</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>moAb</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thymic Stromal Lymphopoietin Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TSLP Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD19 directed Cytolytic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lymphocyte Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased T Lymphocyte Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased B Lymphocyte Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lymphocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased B Lymphocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Menin Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Selective T Cell Costimulation Modulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T Lymphocyte Costimulation Activity Modulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytolytic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Membrane Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood Glucose Regulator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antihypoglycemic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Gluconeogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glycogenolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Cotransporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Symporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SGLT2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Transporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose-Sodium Cotransporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Symporter 2 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Tubular Transport Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Organic Ion Transport Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Organic Ion Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Organic Anion Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uricosuric Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Organic Cation Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Organic Ion Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Organic Anion Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Organic Cation Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucocutaneous Epithelial Cell Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Epithelial Proliferation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Platelet-derived Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Nerve Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leukocyte Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Myeloid Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Granulocytic Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Monocytic Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anesthetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Local Anesthetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>General Anesthetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Lysosomal alpha-Mannosidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endoglycosidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal Neutral Glycosphingolipid-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carboxypeptidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uric Acid Specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uric Acid-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal Cholesteryl Ester-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lysosomal beta Glucuronidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>beta Glucuronidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal Triacylglycerol-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sucrose-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal Glycogen-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glycogen-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glycosaminoglycan (GAG)-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal GAG-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal Glycosaminoglycan (GAG)-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal GAG-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tissue-nonspecific Alkaline Phosphatase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lysosomal N-terminal Tripeptidyl Peptidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tripeptidyl Peptidase-1</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tripeptidyl Peptidase I</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysozomal Glucocerebroside-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease 1 (rhDNase) Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease 1 Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease I (rhDNase) Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease 1</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human DNase I</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>rhDNase 1</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease I Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human DNase 1</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>rhDNase I</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease I</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Asparagine-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phenylalanine Metabolizing Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Collagen-specific Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiovascular Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pharmacologic Cardiac Stress Test Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dietary Cholesterol Absorption Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiarrhythmic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-arrhythmic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-arrhythmic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-arrhythmic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiarrhythmic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasodilator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Arteriolar Vasodilator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Acid Sequestrant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Catecholamine-depleting Sympatholytic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sympatholytic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Apolipoprotein B-100 Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Protein Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasoconstrictor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Venous Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Venous Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Systemic Venous Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscular Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Systemic Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coronary Arteriolar Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Muscular Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coronary Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Systemic Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arterial Vasoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Microsomal Triglyceride Transfer Protein Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>MTTP Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sclerosing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Sclerosing Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-anginal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antianginal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-anginal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-anginal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ANGPTL3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiopoietin-like 3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Dermal Fibroblast Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell (MSC) Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cells, Allogeneic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Pancreatic Islet Cellular Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cellularized Scaffold Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Chondrocyte Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Fibroblast Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Epidermal Keratinocyte Cell Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thiazide-like Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Osmotic Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Loop Diuretic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Physical or Chemical Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metal Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iron Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Binder</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lead Chelator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Demulcent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioactive Therapeutic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioligand Therapeutic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioactive alpha-Particle Emitting Therapeutic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha Particle-Emitting Radioactive Therapeutic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cystine Depleting Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper-containing Intrauterine Device (IUD)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper-containing Intrauterine Device</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper-containing IUD</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Photoactivated Radical Generator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Photosensitizing Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phosphate Binder</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitrogen Binding Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Binder</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Copper Absorption Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Copper Ion Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Photoenhancer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Methylating Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Disclosing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxidation-Reduction Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metabolic Alkalinizer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Releasing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transthyretin Stabilizer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Osmotic Laxative</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Large Intestinal Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Large Intestine Fluid/Electrolyte Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger 3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Solute Carrier Family 9 Member 3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLC9A3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>NHE3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Antiporter 3 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger 3 (NHE3) Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Calculi Dissolution Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calculi Dissolution Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cultured Cell Scaffold</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cultured Cells, Allogeneic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cells, Cultured, Allogeneic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cultured Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD25-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Apical Sodium Bile Acid Transporter Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IBAT Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>ASBT Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ileal Bile Acid Transporter Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ileal Sodium Bile Acid Cotransporter Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiemetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-emetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiemetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiemetic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-emetic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-emetic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidiarrheal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Large Intestine Fluid/Electrolyte Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Large Intestinal Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidiarrheal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidiarrheal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Large Intestine Fluid/Electrolyte Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Motility Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GI Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Esophageal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased LES Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Small Intestinal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Pyloric Sphincter Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sphincter of Odi Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased UES Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Gastric Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Anal Sphincter Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Large Intestinal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Gallbladder Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GI Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Biliary Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Gastric Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Esophageal Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Small Intestinal Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulant Laxative</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Large Intestine Fluid/Electrolyte Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytoprotective Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Preparations by Generic Ingredient</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>G [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>W [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>A [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>P [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>I [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>H [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>U [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>M [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>J [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>S [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>V [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>E [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>C [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Q [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>R [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>K [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Y [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>O [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Z [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>X [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>D [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>L [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>F [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>N [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>B [Preparations]</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactive Preparations by FDA Established Pharmacologic Class</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitroimidazole</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitroimidazole-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiviral</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Capsid Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Capsid Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lincosamide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lincosamide-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytidine Deaminase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytidine Analog Deaminase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Reuptake Inhibitor Anorectic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype D</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Butyrophenone-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Butyrophenone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inactivated Yersinia Pestis Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Influenza Neuraminidase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Agent for Positron Emission Tomography</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Synthesis Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Opioid Analgesic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Reuptake Inhibitor Anorectic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR-2-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor-2-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGFR 2-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Rifamycin Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thrombopoiesis Stimulating Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype E</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Kallikrein-Trypsin Inactivator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Proteolytic Enzyme</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cephamycin Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antiprotozoal</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Calcium Resorption Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Heparin Derivative</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bovine Intestinal Adenosine Deaminase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Reuptake Inhibitor Anorectic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-6-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL6-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 (IL-6)-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 (IL6)-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 6-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 NNRTI and NRTI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV-1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Natriuretic Peptide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD2-directed LFA-3/Fc Fusion Protein</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD2 Directed LFA-3/Fc Fusion Protein</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Death Inducer</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HCV Non-Nucleoside NS5B Palm Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PDGFR alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor Receptor alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor Receptor alpha (PDGFR-alpha) Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PDGFR-alpha Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Gal A Pharmacological Chaperone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Galactosidase A Pharmacological Chaperone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pharmacological Chaperone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Antithrombin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Acid Binding Resin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile-acid Binding Resin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic and beta-Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed alpha Adrenergic and beta Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha/beta Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed alpha-Adrenergic and beta-Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha Adrenergic and beta Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed alpha Adrenergic and beta Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha and beta Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha and beta Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic and beta-Adrenergic Receptor Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha Adrenergic and beta Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mixed alpha-Adrenergic and beta-Adrenergic Agonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Mumps Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Depigmenting Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Decongestant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD-11a Directed Humanized IgG1 Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD11a-directed Humanized IgG1 Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analog HSV DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HSV Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HSV Pyrophosphate Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analogue HSV DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analog Herpes Simplex Virus DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Interferon beta</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Receptor-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-2 Receptor-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Receptor-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL2 Receptor-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor-directed Cytotoxin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype A</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype C</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blocking Agent for Diagnostic Imaging</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urate Transporter 1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>URAT1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>URAT-1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>SLC22A12 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uric Acid Transporter-1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter 4-like Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Solute Carrier Family 22 Member 12 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uric Acid Transporter 1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urate Transporter-1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RST Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>OAT4L Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>VEGF-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Virus Vector</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin-4 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5-HT4 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin 4 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT4 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 4 (5-HT4) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>5HT-4 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 4 (5HT4) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 4 Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin subtype 4 (5HT-4) Receptor Antagonist</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iron Supplement</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iron-containing Supplement</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype G</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Protease Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV Protease Inhibitor (HIV PI)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>HIV PI</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Electrolytes</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Electrolyte</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Influenza A Virus Vaccine</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Multivitamin Preparation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CMV Pyrophosphate Analog DNA Polymerase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Oncolytic Viral Therapy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Secretion Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Secretion Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside Antimicrobial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Narcotic Antitussive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype F</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Streptogramin Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetaminophen-containing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetaminophen</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Locally-acting Aminosalicylate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Locally Acting Aminosalicylate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Recombinant Activated Protein C</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic and beta-Adrenergic Blocker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>alpha/beta-Adrenergic Blocking Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Agent for gamma-Scintigraphy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autologous Cultured Cell</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human CTLA-4/Fc-IgG1 Recombinant Fusion Protein</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 1 Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Releasing Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Intraocular Irrigating Solution</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B12 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B 12 Analog</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B 12 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin B12 Analogue</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype B</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Exchange Resin</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Activator</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Opener</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleotide Metabolic Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thioxanthene-class Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thioxanthene</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iodinated Contrast Agent for Radiographic Imaging</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17A-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A (IL-17A)-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17A (IL17A)-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL17A-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL 17A-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>IL-17A-directed Antibody</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Megakaryocyte Growth Factor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Skin Lightening Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD-3 Blocker Immunosuppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CD3 Blocker Immunosuppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Quinolone Antibacterial</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Decongestant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Human Anticoagulant Protein</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Receptor Inhibitor</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Physiological Effects</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Generalized Systemic Effects</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metabolic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vitamin Uptake and Modification Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Vitamin Uptake and Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Folic Acid Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Folate Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Vitamin Uptake and Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Carbohydrate Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Glucose Transport Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glucose Transport into Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucose Transport into Cells</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glucose Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Gluconeogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glycolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Polysaccharide Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mucopolysaccharide</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan Metabolism Decrease</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan Metabolism Increase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycogen Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycogenolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glycogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipid Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lipotropic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Triglyceride Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lipogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lipolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sterol Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sterol Synthesis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sterol Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sterol Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Elimination Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Elimination</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Elimination</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Synthesis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Absorption Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosphingolipid Synthesis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosphingolipid Synthesis Decrease</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycosphingolipid Synthesis Increase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peptide Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Ion Metabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Ion Synthesis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Organic Ion Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Organic Ion Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Amino Acid Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Uric Acid Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organic Ion Degradation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Organic Ion Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Organic Ion Degradation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metabolic Rate Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Metabolic Rate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Metabolic Rate</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inorganic Ion Absorption Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Inorganic Ion Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Appetite Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologically Active Molecule Production Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologically Active Molecule Degradation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunologically Active Molecule Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Structure Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Methylation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Methylation Increase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Methylation Decrease</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Organelle Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Membrane Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Membrane Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Membrane Synthesis &amp; Repair</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Membrane Synthesis &amp; Repair</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cell Wall Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Wall Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Wall Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Wall Synthesis &amp; Repair</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Wall Synthesis &amp; Repair</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cytoskeleton Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytoskeleton Synthesis &amp; Repair</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytoskeleton Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Proliferation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epithelial Proliferation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Epithelial Proliferation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelial Proliferation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Endothelial Proliferation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Endothelial Proliferation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Degradation/Digestion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Protein Degradation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Protein Breakdown</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Protein Breakdown</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lysosomal Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lysosomal Function</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lysosomal Function</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Communication Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Extracellular Communication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Signaling</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Extracellular Communication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Extracellular Communication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Intracellular Communication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Intracellular Communication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Intercellular Communication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Cycle Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Synthetic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Replication Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Replication Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased DNA Replication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA Replication Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased RNA Replication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased RNA Replication</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RNA Integrity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased RNA Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>DNA Integrity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased DNA Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased DNA Integrity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Translation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Protein Synthesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Transcription Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Transcription to RNA Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Transcription to RNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Transcription to RNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Post-transcriptional RNA Interaction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reverse Transcription to DNA Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Reverse Transcription to DNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Reverse Transcription to DNA</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Post Translation Protein Modification Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Protein Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Protein Modification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Growth Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Growth Phase Reduction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Growth Phase Arrest</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Synthetic Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Synthetic Phase Arrest</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Death Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cellular Death</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Division Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mitosis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Mitosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Meiosis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Meiosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Meiosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Motion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cellular Migration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Polymorphonuclear Leukocyte Migration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Fibroblast Migration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cellular Migration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Fibroblast Migration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Polymorphonuclear Leukocyte Migration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cellular Locomotion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cellular Locomotion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cellular Transport Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pinocytosis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Pinocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Pinocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Phagocytosis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Phagocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Phagocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endocytosis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Endocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Endocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Exocytosis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Exocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Exocytosis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Unknown Physiological Effect</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organ System Specific Effects</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endocrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Islet Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Pancreatic Somatostatin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Pancreatic Somatostatin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucagon Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glucagon Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Insulin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Insulin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pituitary Gland Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Luteinizing Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased LH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Growth Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Oxytocin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Growth Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased FSH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Follicle Stimulating Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prolactin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Vasopressin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Adrenocorticotropic Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased ACTH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Luteinizing Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased LH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Vasopressin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Follicle Stimulating Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased FSH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thyroid Stimulating Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased TSH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Oxytocin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prolactin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased TSH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Thyroid Stimulating Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Testicular Endocrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Dihydrotestosterone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased DHT Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Testosterone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Testosterone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Dihydrotestosterone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased DHT Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ovarian Endocrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Ovarian Progesterone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Ovarian Estrogen Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Ovarian Estrogen Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Ovarian Progesterone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Endocrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Erythropoetin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Erythropoetin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hypothalamic Endocrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PIF Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prolactin Inhibiting hormone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prolactin Inhibiting Factor Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PIF Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased PIF Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased PIF Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PIF Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased PIF Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased PIF Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prolactin Releasing Factor Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PRF Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PRF Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased PRF Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased PRF Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>PRF Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased PRF Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased PRF Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Corticotropin Releasing Hormone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRH Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRH Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased CRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased CRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CRH Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased CRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased CRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Somatostatin (SRIF) Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Somatostatin (SRIF) Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Somatostatin (SRIF) Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Somatostatin (SRIF) Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRH Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyrotropin Releasing Hormone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRH Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased TRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased TRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>TRH Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased TRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased TRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GNRH Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GnRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GnRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GnRH Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GnRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Hormone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRH Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRH Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GHRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GHRH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GHRH Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GHRH Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenal Cortical Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Mineralocorticoid Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glucocorticoid Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glucocorticoid Clearance</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucocorticoid Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucocorticoid Clearance</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Mineralocorticoid Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Gland Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Calcitonin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased PTH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Calcitonin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased PTH Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Placental Endocrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Placental Human Chorionic Gonadotropin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Placental HCG Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Placental HCG Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Placental Human Chorionic Gonadotropin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pineal Gland Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melatonin Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melatonin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Melatonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Melatonin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Melatonin Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Melatonin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Melatonin Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Adrenal Medullary Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Adrenal Norepinephrine Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Adrenal Epinephrine Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Adrenal Epinephrine Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Adrenal Norepinephrine Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Gland Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iodine Organification Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Iodine Organification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Iodine Organification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Thyroid Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thyroid Hormone Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Iodine Uptake Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Iodine Uptake</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Iodine Uptake</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Iodination Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Thyroid Hormone Iodination</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Thyroid Hormone Iodination</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiovascular Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiac Rhythm Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Atrial Depolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Conduction System Depolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lengthen Conduction System Depolarization Time</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Shorten Conduction System Depolarization Time</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nodal Repolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ventricular Depolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nodal Depolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Atrial Repolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Conduction System Repolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lengthen Conduction System Repolarization Time</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Shorten Conduction System Repolarization Time</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Delay Conduction System Repolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ventricular Repolarization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Alterations</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Vascular Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Vascular Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Permeability Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Vascular Permeability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Capillary Permeability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Growth Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Growth Increase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Angiogenesis Inhibition</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vascular Growth Decrease</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiac Contractility Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Negative Inotropy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Positive Inotropy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood Pressure Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Blood Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Blood Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiac Rate Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Negative Chronotropy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Positive Chronotropy</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal/Urological Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bladder Contractility Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Bladder Contractility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Urethra Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Urethra Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Urethra Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bladder Sphincter Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Bladder Sphincter Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Bladder Sphincter Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diuresis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Diuresis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidiuretic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Diuresis at Loop of Henle</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glomerular Filtration Pressure Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glomerular Filtration Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glomerular Filtration Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Collecting Duct Water Permeability Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Water Permeability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Water Permeability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Renal Ion Transport Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Ion Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule K+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Urea Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Ion Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule HCO3- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Na+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct SO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Ca++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule H+ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule PO4-- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Cl- Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Urea Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Mg++ Excretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dermatologic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Astringent Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sunscreening Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Skin Barrier Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dermal Regeneration Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Emollient Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antipruritic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sebaceous Gland Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sebaceous Gland Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sebaceous Gland Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sebaceous Gland Quantity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sebaceous Gland Quantity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiperspirant Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Keratin Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Skin Keratinization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Keratolytic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Exfoliant Acitivity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Skin Keratinization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hair Follicle Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Hair Growth</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Hair Growth</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Musculoskeletal Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Contraction Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Contraction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Permeability Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Permeability Alteration Increase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Permeability Alteration Decrease</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Collagen Formation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Collagen Formation Inhibition</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Collagen Formation Promotion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Metabolic Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Anabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Catabolism Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Formation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Formation Inhibition</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Formation Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Resorption Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Resorption Inhibition</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bone Resorption Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bronchial Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bronchodilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bronchoconstriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GI Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GI Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Gastric Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Pyloric Sphincter Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Small Intestinal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Esophageal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Anal Sphincter Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Large Intestinal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased UES Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased LES Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Gallbladder Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sphincter of Odi Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cervical Smooth Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cervical Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cervical Smooth Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uterine Smooth Muscle Contraction or Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Uterine Smooth Muscle Contraction or Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Digestive/GI System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Secretion Volume Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cholagogue Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Choleretic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bile Secretion Composition Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Bile Iron Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastric Mucous Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Gastric Mucous Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Gastric Mucous Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Enzymatic Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Pancreatic Enzymatic Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Pancreatic Enzymatic Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Fluid/Electrolyte Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Pancreatic Fluid/Electrolyte Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Pancreatic Fluid/Electrolyte Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>GI Motility Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GI Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Esophageal Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Emesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Gastric Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Biliary Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Small Intestinal Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Small Intestine Fluid/Electrolyte Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Small Intestine Fluid/Electrolyte Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Small Intestine Fluid/Electrolyte Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Small Intestine Fluid/Electrolyte Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Small Intestine Fluid/Electrolyte Absorption Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Small Intestine Fluid/Electrolyte Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Small Intestine Fluid/Electrolyte Absorption</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastric Acid Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Gastric Acid Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulation Gastric Acid Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antacid</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Saliva Production Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Salivation Inhibition</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Salivation Stimulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cariostatic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Large Intestine Fluid/Electrolyte Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Large Intestine Fluid/Electrolyte Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Large Intestine Fluid/Electrolyte Absorption Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Digestive Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Fat Digestion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Enzymatic Replacement</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibition Carbohydrate Digestion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nervous System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Electrical Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Organized Electrical Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Organized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Disorganized Electrical Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Disorganized Electrical Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gamma Amino Butyric Acid (GABA) Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic GABA Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Brain Derived Neurotropic Factor Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Brain Derived Neurotropic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dynorphin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Dynorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle VIP Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Epinephrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Epinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Substance P Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Substance P Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Norepinephrine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glycine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Glycine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neurotensin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Neurotensin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dopamine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Dopamine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Serotonin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Aspartate Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Aspartate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endorphin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Endorphin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enkephalin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Enkephalin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nerve Growth Factor Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Nerve Growth Factor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Glutamate Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Glutamate Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Acetylcholine Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastrin Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Gastrin Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Histamine Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CCK Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord CCK Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peripheral Nervous System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sensory System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autonomic Nervous System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Autonomic Ganglionic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Ganglionic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parasympathetic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parasympathomimetic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Parasympatholytic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sympathetic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory/Pulmonary Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Secretion Viscosity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Respiratory Secretion Viscosity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Respiratory Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Tracheo-Bronchial Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Pharyngeal Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Nasal and Sinus Secretions</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Alveolar Surface Tension Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Tracheobronchial Stretch Receptor Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Tracheobronchial Stretch Receptor Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ventilatory Gas Flow Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Ventilatory Gas Flow</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Ventilatory Gas Flow</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Medullary Respiratory Center Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Medullary Respiratory Drive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Peripheral Carotid Chemoreceptor Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Respiratory Drive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Respiratory Drive</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory Mucosal Edema Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Respiratory Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Pharyngeal Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Nasal and Sinus Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Tracheo-Bronchial Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Respiratory Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Pharyngeal Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Nasal and Sinus Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Tracheo-Bronchial Mucosal Edema</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Reproductive System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Male Reproductive System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penile Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penile Erectile Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enhance Penile Erection</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Diminish Penile Erection</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Penile Development Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Penile Development</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Penile Development</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sperm Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sperm Death Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sperm Death</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Spermatogenesis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increase Spermatogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decrease Spermatogenesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sperm Motility Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Sperm Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Sperm Motility</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostatic Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostatic Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostatic Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prostatic Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Prostatic Size Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostatic Size</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prostatic Size</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Female Reproductive System Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Embryonic Implantation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Embryonic Implantation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Embryonic Implantation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Development Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Embryonic &amp; Fetal Development</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Embryonic &amp; Fetal Development</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ovum Fertilization Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Growth Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Embryonic &amp; Fetal Growth</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Embryonic &amp; Fetal Growth</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Viability Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Embryonic &amp; Fetal Viability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Embryonic &amp; Fetal Viability</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Milk Ejection</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Breast Milk Ejection</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Breast Milk Ejection</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Glandular Development Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Breast Glandular Development</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Breast Glandular Development</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Breast Milk Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Breast Milk Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Breast Milk Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uterine Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uterine Proliferative Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Uterine Proliferative Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Uterine Proliferative Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uterine Menstrual Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Uterine Menstrual Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Uterine Menstrual Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Uterine Secretory Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Uterine Secretory Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Uterine Secretory Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vaginal Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vaginal Secretion Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Vaginal Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Vaginal Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Vaginal Muscle Tone Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Vaginal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Vaginal Muscle Tone</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cervical Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cervical Dilation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Cervical Dilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Cervical Dilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ovarian Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ovarian Follicular Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovarian Follicular Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Ovarian Follicular Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ovulation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Ovulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ovarian Luteal Phase Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovarian Luteal Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Stimulate Ovarian Luteal Phase</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Special Sensory Systems Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Intraocular Fluid Pressure Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Intraocular Fluid Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Intraocular Aqueous Secretion</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Retinal Pigment Epithelium Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>RPE Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Retinal Pigment Epithelium Function</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased RPE Function</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ocular Smooth Muscle Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pupillary Dilation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Pupillary Constriction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hemic/Lymphatic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematologic Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood &amp; Lymphatic Fluid Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Intravascular Volume Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Intravascular Volume</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oxygen Carrying Capacity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Oxygen Carrying Capacity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Oxygen Carrying Capacity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Oncotic Pressure Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Oncotic Pressure</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hemostasis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Platelet Aggregation Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fibrinolysis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrinolysis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Endothelial Coagulation Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Endothelial Coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coagulation Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-coagulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticoagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Coagulation Activity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticoagulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coagulation Factor Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coagulation Factor Activity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Coagulation Factor Concentration Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Coagulation Factor Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor VII Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrin Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor IX Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Prothrombin Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrinogen Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor X Concentration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematological Cell Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Monocyte Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Monocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Mast Cell Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lymphocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased T Lymphocyte Activation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activity Modulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>T Lymphocyte Activity Modulation</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematopoietic Stem Cell Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Hematopoietic Stem Cell Mobilization</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Erythrocyte Function Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hemorrheologic Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Blood Viscosity</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematological Cell Quantity Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematological Cell Destruction Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Hematological Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Erythroid Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lymphocyte Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased T Lymphocyte Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased B Lymphocyte Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Megakaryocte Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Myeloid Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Granulocytic Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Monocytic Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Hematological Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Megakaryocte Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Lymphocyte Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased T Lymphocyte Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased B Lymphocyte Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Erythroid Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Myeloid Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Monocytic Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Granulocytic Cell Destruction</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hematopoiesis Alteration</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Hematopoiesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Increased Megakaryocte Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Hematopoiesis</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Lymphocyte Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased B Lymphocyte Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased T Lymphocyte Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Megakaryocte Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Myeloid Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Granulocytic Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Monocytic Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Decreased Erythroid Cell Production</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Terminology Extensions for Classification</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Grain Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Virus-specific Hyperimmune Globulins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Poultry Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fish Proteins, Dietary</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Fruit Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Nut Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Shellfish Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Meat Proteins</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Current Non-smoker</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Therapeutic Categories</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antispasticity Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anxiolytics</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiparkinson Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Enzyme Replacements/Modifiers</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Otic Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anticonvulsants</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimyasthenic Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood Glucose Regulators</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Ophthalmic Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antineoplastic Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antineoplastic</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Analgesics</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Respiratory System Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Parathyroid)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Pituitary)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Thyroid)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>CNS Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Immunological Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Inflammatory Bowel Disease Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antimigraine Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiinfective</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-infective Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-infective</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Blood Products/Modifiers/Volume Expanders</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antidementia Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Cardiovascular Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dental and Oral Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Therapeutic Nutrients/Minerals/Electrolytes</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-inflammatory Agent</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antiinflammatory</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anti-inflammatory</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Bipolar Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Skeletal Muscle Relaxants</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Sedatives/Hypnotics</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Metabolic Bone Disease Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Antigout Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Agents</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Anesthetics</name>
		<status>A</status>
	</term>
	<term>
		<namespace>MED-RT</namespace>
		<name>Dermatological Agents</name>
		<status>A</status>
	</term>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular or Molecular Interactions [MoA]</name>
		<code>N0000000223</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000223</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular or Molecular Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nuclear Export Inhibitors [MoA]</name>
		<code>N0000194022</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194022</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nuclear Export Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Unknown Cellular or Molecular Interaction [MoA]</name>
		<code>N0000009915</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009915</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Unknown Cellular or Molecular Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologic and Biological Factor Interactions [MoA]</name>
		<code>N0000000254</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000254</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic and Biological Factor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Structure Molecule Interactions [MoA]</name>
		<code>N0000010255</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010255</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Structure Molecule Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tubulin Interactions [MoA]</name>
		<code>N0000010256</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010256</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tubulin Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta Tubulin Interactions [MoA]</name>
		<code>N0000010260</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010260</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta Tubulin Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Viral Envelope Interactions [MoA]</name>
		<code>N0000020089</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020089</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Viral Envelope Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fusion Protein Interactions [MoA]</name>
		<code>N0000175614</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175614</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fusion Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fusion Protein Inhibitors [MoA]</name>
		<code>N0000175615</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175615</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fusion Protein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Menin Inhibitors [MoA]</name>
		<code>N0000194140</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194140</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Menin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HIV Fusion Protein Inhibitors [MoA]</name>
		<code>N0000181002</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181002</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Fusion Protein Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Fusion Protein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</name>
		<code>N0000193807</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193807</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV 1 Post-attachment Fusion Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Viral Envelope Wrapping Protein Interactions [MoA]</name>
		<code>N0000193861</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193861</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Viral Envelope Wrapping Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Viral Envelope Wrapping Protein Inhibitors [MoA]</name>
		<code>N0000193860</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193860</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Viral Envelope Wrapping Protein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Surface Interactions [MoA]</name>
		<code>N0000009958</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009958</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Surface Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HIV Capsid Inhibitors [MoA]</name>
		<code>N0000194086</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194086</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Capsid Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologic Factor Interactions [MoA]</name>
		<code>N0000000082</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000082</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic Factor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody Interactions [MoA]</name>
		<code>N0000010226</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010226</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amyloid Beta-directed Antibody Interactions [MoA]</name>
		<code>N0000193950</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193950</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amyloid Beta-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER2-directed Antibody Interactions [MoA]</name>
		<code>N0000194138</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194138</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</name>
		<code>N0000194161</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194161</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TFPI Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tissue Factor Pathway Inhibitor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Soluble Antigen Interactions [MoA]</name>
		<code>N0000191501</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191501</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Soluble Antigen Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Soluble Protein Interactions [MoA]</name>
		<code>N0000191002</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191002</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Soluble Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</name>
		<code>N0000182636</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182636</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Lymphocyte Stimulator-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B Lymphocyte Stimulator-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BLyS-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A-directed Antibody Interactions [MoA]</name>
		<code>N0000191496</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191496</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17A-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17A-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17A-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6-directed Antibody Interactions [MoA]</name>
		<code>N0000191003</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191003</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-6-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</name>
		<code>N0000178291</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178291</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGF-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Surface Antigen Interactions [MoA]</name>
		<code>N0000191502</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191502</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Surface Antigen Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Surface Protein Interactions [MoA]</name>
		<code>N0000020023</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020023</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Surface Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD33-directed Antibody Interactions [MoA]</name>
		<code>N0000175077</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175077</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD33-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</name>
		<code>N0000194037</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194037</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Zaire EBOV GP-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD30-directed Antibody Interactions [MoA]</name>
		<code>N0000182966</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182966</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD30-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thymic Stromal Lymphopoietin Blockers [MoA]</name>
		<code>N0000194011</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194011</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TSLP Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thymic Stromal Lymphopoietin Blockers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Antibody Interactions [MoA]</name>
		<code>N0000191422</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191422</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD2-directed Antibody Interactions [MoA]</name>
		<code>N0000175857</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175857</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD2-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>SLAMF7-directed Antibody Interactions [MoA]</name>
		<code>N0000192337</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192337</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Signaling Lymphocytic Activation Molecule Family member 7-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD319-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLAMF7-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD3-directed Antibody Interactions [MoA]</name>
		<code>N0000175617</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175617</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</name>
		<code>N0000191259</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191259</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Programmed Death Receptor-1-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PD-1-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Selectin Blockers [MoA]</name>
		<code>N0000194033</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194033</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selectin Blockers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P-Selectin Blockers [MoA]</name>
		<code>N0000194031</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194031</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P-Selectin Blockers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CTLA-4-directed Antibody Interactions [MoA]</name>
		<code>N0000182634</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182634</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T-Lymphocyte Antigen 4-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CTLA 4-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T-Lymphocyte Antigen-4-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CTLA4-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T Lymphocyte Antigen 4-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CTLA-4-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T Lymphocyte Antigen-4-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</name>
		<code>N0000193994</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193994</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycoprotein 100 Peptide-HLA-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gp100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gp100 Peptide-HLA-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</name>
		<code>N0000193336</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193336</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PD-L1-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Programmed Death Ligand-1-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD22-directed Antibody Interactions [MoA]</name>
		<code>N0000193616</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193616</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD22-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Antibody Interactions [MoA]</name>
		<code>N0000175078</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175078</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD20-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD86-directed Antibody Interactions [MoA]</name>
		<code>N0000182151</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182151</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD86-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD52-directed Antibody Interactions [MoA]</name>
		<code>N0000175079</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175079</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD52-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD4-directed Antibody Interactions [MoA]</name>
		<code>N0000193805</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193805</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD4-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD11a-directed Antibody Interactions [MoA]</name>
		<code>N0000175856</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175856</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD11a-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Claudin 18.2-directed Antibody Interactions [MoA]</name>
		<code>N0000194106</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194106</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Claudin-18.2-directed Cytolytic Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Claudin 18.2-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CLDN18.2-directed Cytolytic Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CLDN 18.2-directed Cytolytic Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Claudin18.2-directed Cytolytic Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD80-directed Antibody Interactions [MoA]</name>
		<code>N0000182150</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182150</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD80-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD38-directed Antibody Interactions [MoA]</name>
		<code>N0000192335</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192335</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD38-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Surface Glycolipid Interactions [MoA]</name>
		<code>N0000191498</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191498</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Surface Glycolipid Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</name>
		<code>N0000191499</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191499</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GD2-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycolipid Disialoganglioside (GD2)-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycolipid Disialoganglioside-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Receptor Interactions [MoA]</name>
		<code>N0000009949</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009949</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions [MoA]</name>
		<code>N0000191005</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191005</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR2-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR-2-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma Antagonists [MoA]</name>
		<code>N0000193855</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193855</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon gamma Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IFNγ Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>B Cell Maturation Antigen-directed Antibody Interactions [MoA]</name>
		<code>N0000194165</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194165</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCMA-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B Cell Maturation Antigen-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor alpha-directed Antibody Interactions [MoA]</name>
		<code>N0000193339</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193339</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 4 Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4R alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4R alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4 Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activation Gene-3 Antagonists [MoA]</name>
		<code>N0000194002</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194002</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Activation Gene-3 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>LAG-3 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Activation Gene 3 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</name>
		<code>N0000175621</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175621</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</name>
		<code>N0000193802</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193802</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-5 Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL5 Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-5 Receptor alpha-directed Antibody Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-IL-5 Receptor alpha mAb Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antigen Neutralization [MoA]</name>
		<code>N0000184008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antigen Neutralization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Venom Neutralization [MoA]</name>
		<code>N0000184010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Venom Neutralization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bacterial Toxin Neutralization [MoA]</name>
		<code>N0000184011</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184011</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bacterial Toxin Neutralization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</name>
		<code>N0000192702</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192702</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anthrax Protective Antigen-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bacterial Neurotoxin Neutralization [MoA]</name>
		<code>N0000184141</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184141</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bacterial Neurotoxin Neutralization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endogenous Antigen Neutralization [MoA]</name>
		<code>N0000184012</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184012</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endogenous Antigen Neutralization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Virus Neutralization [MoA]</name>
		<code>N0000184009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Virus Neutralization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody-Antibody Interactions [MoA]</name>
		<code>N0000175985</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175985</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody-Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>IgE-directed Antibody Interactions [MoA]</name>
		<code>N0000175792</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175792</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IgE-directed Antibody Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Biological Response Modifiers [MoA]</name>
		<code>N0000000247</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000247</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Biological Response Modifiers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Ligand-1 Antagonists [MoA]</name>
		<code>N0000193337</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193337</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PD-L1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Programmed Death Ligand-1 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 Antagonists [MoA]</name>
		<code>N0000191004</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191004</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-6 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-31 Receptor alpha Antagonists [MoA]</name>
		<code>N0000194122</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194122</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 31 Receptor alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-31 Receptor alpha Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-31 Receptor alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL31 Receptor alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-31R alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL31R alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-12 Antagonists [MoA]</name>
		<code>N0000192796</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192796</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-12 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL12 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 12 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-12 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Inhibitors [MoA]</name>
		<code>N0000193542</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193542</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGF Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologic Adjuvants [MoA]</name>
		<code>N0000000135</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000135</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic Adjuvants</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adjuvants, Immunologic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-13 Antagonists [MoA]</name>
		<code>N0000193986</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193986</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-13 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 13 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-13 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 13 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A Antagonists [MoA]</name>
		<code>N0000191494</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191494</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17A Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17A Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17A Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Antagonists [MoA]</name>
		<code>N0000191871</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191871</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-5 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon Inducers [MoA]</name>
		<code>N0000000157</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000157</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-23 Antagonists [MoA]</name>
		<code>N0000192798</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192798</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-23 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 23 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL23 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-23 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD19 Receptor Interactions [MoA]</name>
		<code>N0000193544</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193544</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Inactivators [MoA]</name>
		<code>N0000000192</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000192</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Inactivators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement 1 Inactivators [MoA]</name>
		<code>N0000000086</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000086</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement 1 Inactivators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement 5 Inactivators [MoA]</name>
		<code>N0000175441</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175441</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement 5 Inactivators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Inhibitors [MoA]</name>
		<code>N0000175974</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175974</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Classical Complement Pathway Inhibitors [MoA]</name>
		<code>N0000193990</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193990</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Classical Complement Pathway Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Classical Complement Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Factor B Inhibitors [MoA]</name>
		<code>N0000194112</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194112</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Factor B Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement C5 Inhibitors [MoA]</name>
		<code>N0000194110</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194110</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement C5 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alternative Complement Pathway Inhibitors [MoA]</name>
		<code>N0000194102</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194102</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alternative Complement Pathway Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Factor D Inhibitors [MoA]</name>
		<code>N0000194114</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194114</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Factor D Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Humoral and Cellular Immune Response Activators [MoA]</name>
		<code>N0000194153</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194153</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Humoral and Cellular Immune Response Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Expression Interactions [MoA]</name>
		<code>N0000193793</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193793</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Expression Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Alterations [MoA]</name>
		<code>N0000193791</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193791</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Alterations</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Editing or Modification [MoA]</name>
		<code>N0000193792</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193792</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Editing or Modification</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Modification</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Editing</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Transduction or Replacement [MoA]</name>
		<code>N0000193795</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193795</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Transduction</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Transduction or Replacement</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Replacement</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Beta-globin Gene Transfer [MoA]</name>
		<code>N0000193972</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193972</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Beta-globin Gene Transfer</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>β-globin Gene Transfer</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Transcription Modulation [MoA]</name>
		<code>N0000193794</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193794</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Transcription Modulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</name>
		<code>N0000194060</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194060</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SMN2 Splicing Modifiers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival Motor Neuron 2 Splicing Modifiers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival of Motor Neuron 2 Splicing Modifiers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Translation Modulation [MoA]</name>
		<code>N0000193796</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193796</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Translation Modulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Biological Macromolecular Activity [MoA]</name>
		<code>N0000000142</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000142</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Biological Macromolecular Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Structural Macromolecules [MoA]</name>
		<code>N0000000228</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000228</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Structural Macromolecules</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzymatic Activity [MoA]</name>
		<code>N0000000178</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000178</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzymatic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Interactions [MoA]</name>
		<code>N0000000085</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000085</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sigma Receptor Interactions [MoA]</name>
		<code>N0000182145</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182145</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sigma Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Interactions [MoA]</name>
		<code>N0000182146</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182146</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sigma-1 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Antagonists [MoA]</name>
		<code>N0000182148</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182148</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sigma-1 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Receptor Agonists [MoA]</name>
		<code>N0000182147</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182147</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sigma-1 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Transcription Factor Activity [MoA]</name>
		<code>N0000000242</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000242</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transcription Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aryl Hydrocarbon Receptor Agonists [MoA]</name>
		<code>N0000194019</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194019</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aryl Hydrocarbon Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>AhR agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases Inducers [MoA]</name>
		<code>N0000190117</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190117</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases (UGT) Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A Inducers [MoA]</name>
		<code>N0000194035</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194035</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases-1A Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A1 Inducers [MoA]</name>
		<code>N0000194036</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194036</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP-Glucuronosyltransferase 1A1 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A1 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP glucuronosyltransferase family 1 member A1 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 Inducers [MoA]</name>
		<code>N0000185505</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185505</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2B6 Inducers [MoA]</name>
		<code>N0000187064</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187064</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2B6 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2B6 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C9 Inducers [MoA]</name>
		<code>N0000185507</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185507</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2C9 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2C9 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2E1 Inducers [MoA]</name>
		<code>N0000193955</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193955</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2E1 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A Inducers [MoA]</name>
		<code>N0000191624</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191624</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 1A Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 1A Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A2 Inducers [MoA]</name>
		<code>N0000191266</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191266</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 1A2 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 1A2 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C19 Inducers [MoA]</name>
		<code>N0000185607</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185607</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2C19 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2C19 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2D6 Inducers [MoA]</name>
		<code>N0000191267</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191267</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2D6 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2D6 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A Inducers [MoA]</name>
		<code>N0000190118</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190118</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A5 Inducers [MoA]</name>
		<code>N0000191268</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191268</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A5 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A5 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A4 Inducers [MoA]</name>
		<code>N0000185506</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185506</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A4 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A4 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C8 Inducers [MoA]</name>
		<code>N0000187063</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187063</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2C8 Inducers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2C8 Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor Activity [MoA]</name>
		<code>N0000175374</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175374</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</name>
		<code>N0000194129</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194129</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</name>
		<code>N0000175375</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175375</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR alpha Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome-Proliferator Receptor alpha (PPAR-alpha) Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-alpha Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor beta Agonists [MoA]</name>
		<code>N0000175376</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175376</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-beta Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR beta Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor beta Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</name>
		<code>N0000175378</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175378</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor delta Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-delta Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR delta Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</name>
		<code>N0000175377</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175377</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR gamma Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-gamma Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Farnesoid X Receptor Agonists [MoA]</name>
		<code>N0000192560</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192560</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Farnesoid X Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Interactions [MoA]</name>
		<code>N0000000257</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000257</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormone Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Agonists [MoA]</name>
		<code>N0000000149</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000149</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Steroid Hormone Receptor Agonists [MoA]</name>
		<code>N0000000182</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000182</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Steroid Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Corticosteroid Hormone Receptor Agonists [MoA]</name>
		<code>N0000175450</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175450</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticosteroid Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Receptor Agonists [MoA]</name>
		<code>N0000000094</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000094</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mineralocorticoid Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucocorticoid Receptor Agonists [MoA]</name>
		<code>N0000000159</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000159</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucocorticoid Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sex Hormone Receptor Agonists [MoA]</name>
		<code>N0000000214</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000214</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sex Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Agonists [MoA]</name>
		<code>N0000000146</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000146</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progestational Hormone Receptor Agonists [MoA]</name>
		<code>N0000000185</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000185</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestational Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Agonists [MoA]</name>
		<code>N0000000100</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000100</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon Receptor Agonists [MoA]</name>
		<code>N0000193923</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193923</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatic Glucagon Receptor Agonists [MoA]</name>
		<code>N0000193924</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193924</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatic Glucagon Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor Agonists [MoA]</name>
		<code>N0000000237</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000237</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor beta Agonists [MoA]</name>
		<code>N0000194132</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194132</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor β Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRβ Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>THR-β Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>THR-beta Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor-beta Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor-β Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor beta Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</name>
		<code>N0000175654</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175654</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Agonists [MoA]</name>
		<code>N0000010266</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010266</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Modulators [MoA]</name>
		<code>N0000000255</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000255</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormone Receptor Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Steroid Receptor Modulators [MoA]</name>
		<code>N0000000172</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000172</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Steroid Receptor Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Selective Estrogen Receptor Modulators [MoA]</name>
		<code>N0000000168</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000168</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Estrogen Receptor Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Selective Progesterone Receptor Modulators [MoA]</name>
		<code>N0000191262</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191262</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progesterone Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Progesterone Receptor Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Progesterone Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Modulators [MoA]</name>
		<code>N0000000186</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000186</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Receptor Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormone Receptor Antagonists [MoA]</name>
		<code>N0000000221</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000221</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor Antagonists [MoA]</name>
		<code>N0000000222</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000222</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</name>
		<code>N0000175084</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175084</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Steroid Receptor Antagonists [MoA]</name>
		<code>N0000000162</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000162</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Steroid Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Receptor Antagonists [MoA]</name>
		<code>N0000000139</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000139</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mineralocorticoid Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aldosterone Antagonists [MoA]</name>
		<code>N0000011310</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000011310</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aldosterone Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aldosterone Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sex Hormone Receptor Antagonists [MoA]</name>
		<code>N0000000084</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000084</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sex Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progestational Hormone Receptor Antagonists [MoA]</name>
		<code>N0000000115</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000115</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestational Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Antagonists [MoA]</name>
		<code>N0000000243</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000243</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Antagonists [MoA]</name>
		<code>N0000000145</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000145</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estradiol Antagonists [MoA]</name>
		<code>N0000011319</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000011319</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estradiol Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucocorticoid Receptor Antagonists [MoA]</name>
		<code>N0000000110</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000110</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucocorticoid Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</name>
		<code>N0000194152</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194152</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRF Type 1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticotropin Releasing Factor Type 1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRF1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRF 1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Antagonists [MoA]</name>
		<code>N0000010267</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010267</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor Inhibitors [MoA]</name>
		<code>N0000194000</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194000</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia Inducible Factor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIF Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia-inducible Factor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</name>
		<code>N0000194079</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194079</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIF PH Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]</name>
		<code>N0000193998</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193998</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIF-2 alpha Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIF-2α Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia-inducible Factor 2 alpha Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia Inducible Factor- 2 alpha Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Membrane Fusion Complex Interactions [MoA]</name>
		<code>N0000009954</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009954</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Membrane Fusion Complex Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Synaptic Fusion Complex Interactions [MoA]</name>
		<code>N0000009953</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009953</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Synaptic Fusion Complex Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Release Inhibitors [MoA]</name>
		<code>N0000175770</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175770</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetylcholine Release Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytokine Receptor Superfamily Interactions [MoA]</name>
		<code>N0000000175</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000175</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytokine Receptor Superfamily Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Interactions [MoA]</name>
		<code>N0000190477</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190477</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Antagonists [MoA]</name>
		<code>N0000190478</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190478</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 6 Receptor Agonists [MoA]</name>
		<code>N0000190479</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190479</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Receptor Interactions [MoA]</name>
		<code>N0000009950</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009950</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</name>
		<code>N0000175451</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175451</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor Receptor Blocking Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF Receptor Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</name>
		<code>N0000175446</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175446</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF-a Receptor Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF-alpha Receptor Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RANK Ligand Blocking Activity [MoA]</name>
		<code>N0000187054</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187054</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Activator of Nuclear Factor-kappa B Ligand Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RANK Ligand Blocking Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RANKL Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</name>
		<code>N0000175447</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175447</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor beta Receptor Blocking Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF-beta Receptor Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF-b Receptor Blocking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor Interactions [MoA]</name>
		<code>N0000193277</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193277</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor A Interactions [MoA]</name>
		<code>N0000193278</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193278</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17 RA Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17 Receptor A Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17RA Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17RA Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17RA Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17 Receptor A Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17 RA Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17RA Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 17 Receptor A Antagonists [MoA]</name>
		<code>N0000193279</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193279</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17RA Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17RA Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17RA Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17RA Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17 Receptor A Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17 Receptor A Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17 RA Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17 RA Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Interactions [MoA]</name>
		<code>N0000010281</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010281</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Agonists [MoA]</name>
		<code>N0000175618</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175618</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD3 Receptor Antagonists [MoA]</name>
		<code>N0000175619</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175619</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD123 Interactions [MoA]</name>
		<code>N0000193865</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193865</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD123 Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Interactions [MoA]</name>
		<code>N0000010278</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010278</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Antagonists [MoA]</name>
		<code>N0000010279</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010279</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 2 Receptor Agonists [MoA]</name>
		<code>N0000010280</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010280</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Activators</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD25-directed Receptor Interactions [MoA]</name>
		<code>N0000177911</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177911</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD25-directed Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thrombopoietin Receptor Interactions [MoA]</name>
		<code>N0000175967</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175967</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thrombopoietin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thrombopoietin Receptor Agonists [MoA]</name>
		<code>N0000175968</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175968</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thrombopoietin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chemokine Receptor Type 4 Interactions [MoA]</name>
		<code>N0000193867</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193867</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chemokine Receptor Type 4 Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CXC Chemokine Receptor 4 Antagonists [MoA]</name>
		<code>N0000194105</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194105</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CXC Chemokine Receptor 4 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CXCR-4 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CXCR4 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-15 Receptor Interactions [MoA]</name>
		<code>N0000194120</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194120</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-15 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL15R Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 15 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 15 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL15 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 15R Interactions </to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-15 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-15 Receptor Agonists [MoA]</name>
		<code>N0000194119</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194119</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-15 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 15 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 15 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-15 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL15 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chemokine Co-receptor 5 Interactions [MoA]</name>
		<code>N0000175444</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175444</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chemokine Co-receptor 5 Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCR5 Co-receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chemokine Co-receptor 5 Antagonists [MoA]</name>
		<code>N0000175445</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175445</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chemokine Co-receptor 5 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCR5 Co-receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCR5 Co-receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Interactions [MoA]</name>
		<code>N0000175707</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175707</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL1 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Agonists [MoA]</name>
		<code>N0000175708</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175708</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL1 Receptor Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL1 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Activators</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 1 Receptor Antagonists [MoA]</name>
		<code>N0000175709</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175709</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL1 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL1 Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-36 Receptor Antagonists [MoA]</name>
		<code>N0000194040</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194040</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL36 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 36 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-36 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-36 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-36RAs</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor Interactions [MoA]</name>
		<code>N0000193340</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193340</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4R Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-4 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4R Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 4 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 4 Receptor alpha Antagonists [MoA]</name>
		<code>N0000193341</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193341</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 4 Receptor alpha Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-4 Receptor alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4 Receptor alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4R alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4 Receptor alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4R alpha Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</name>
		<code>N0000000215</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000215</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ATP-Binding Cassette (ABC) Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Salt Export Pump Interactions [MoA]</name>
		<code>N0000193846</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193846</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Salt Export Pump Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BSEP Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Salt Export Pump Inhibitors [MoA]</name>
		<code>N0000193845</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193845</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BSEP Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Salt Export Pump Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Cancer Resistance Protein Interactions [MoA]</name>
		<code>N0000190112</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190112</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCRP Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Cancer Resistance Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Cancer Resistance Protein Inhibitors [MoA]</name>
		<code>N0000190113</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190113</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCRP Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Cancer Resistance Protein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P-Glycoprotein Interactions [MoA]</name>
		<code>N0000000239</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000239</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P-Glycoprotein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P-Glycoprotein Inhibitors [MoA]</name>
		<code>N0000185503</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185503</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P-Glycoprotein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P-Glycoprotein Inducers [MoA]</name>
		<code>N0000191264</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191264</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P-Glycoprotein Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Multidrug Resistance-Associated Protein Interactions [MoA]</name>
		<code>N0000193961</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193961</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Multidrug Resistance-Associated Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Multidrug Resistance-Associated Protein 2 Inhibitors [MoA]</name>
		<code>N0000193960</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193960</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MRP2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ABCC2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Multidrug Resistance-Associated Protein 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Antagonists [MoA]</name>
		<code>N0000193953</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193953</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcitonin Gene-related Peptide Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Activity Modifying Proteins [MoA]</name>
		<code>N0000020061</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020061</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Activity Modifying Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Activity Modifying Protein Agonists [MoA]</name>
		<code>N0000020062</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020062</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Activity Modifying Protein Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amylin Agonists [MoA]</name>
		<code>N0000020064</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020064</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amylin Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Activin Signaling Inhibitors [MoA]</name>
		<code>N0000194101</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194101</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Activin Signaling Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Activity Modifying Protein Antagonists [MoA]</name>
		<code>N0000020063</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020063</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Activity Modifying Protein Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>G-Protein-linked Receptor Interactions [MoA]</name>
		<code>N0000000152</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000152</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>G-Protein-linked Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>G-Protein-linked Receptor-Effector Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Receptor Interactions [MoA]</name>
		<code>N0000000131</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000131</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Receptor Agonists [MoA]</name>
		<code>N0000000106</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000106</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E2 Receptor Agonists [MoA]</name>
		<code>N0000194042</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194042</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EP2 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin EP2 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin E2 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostacyclin Receptor Agonists [MoA]</name>
		<code>N0000020068</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020068</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostacyclin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Receptor Antagonists [MoA]</name>
		<code>N0000000108</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000108</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pituitary Hormones Receptor Interactions [MoA]</name>
		<code>N0000000141</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000141</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pituitary Hormones Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pituitary Hormone Receptor Agonists [MoA]</name>
		<code>N0000000165</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000165</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pituitary Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Agonists [MoA]</name>
		<code>N0000194046</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194046</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pituitary Hormone Receptor Antagonists [MoA]</name>
		<code>N0000000249</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000249</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pituitary Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Antagonists [MoA]</name>
		<code>N0000020044</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020044</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V3 Receptor Antagonists [MoA]</name>
		<code>N0000193180</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193180</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin V1B Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin V3 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V1 Receptor Antagonists [MoA]</name>
		<code>N0000193179</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193179</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin V1 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin V1A Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V2 Receptor Antagonists [MoA]</name>
		<code>N0000193178</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193178</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin V2 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Interactions [MoA]</name>
		<code>N0000175362</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175362</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Antagonists [MoA]</name>
		<code>N0000175364</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175364</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelin Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Agonists [MoA]</name>
		<code>N0000175363</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175363</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Interactions [MoA]</name>
		<code>N0000190997</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190997</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Orexin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Antagonists [MoA]</name>
		<code>N0000190998</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190998</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Orexin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Agonists [MoA]</name>
		<code>N0000190999</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190999</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Orexin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA B Receptor Interactions [MoA]</name>
		<code>N0000000204</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000204</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA B Agonists [MoA]</name>
		<code>N0000000116</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000116</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA B Modulators [MoA]</name>
		<code>N0000000251</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000251</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Receptor Modulators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA B Antagonists [MoA]</name>
		<code>N0000000229</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000229</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA B Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 3 Receptor Interactions [MoA]</name>
		<code>N0000194092</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194092</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurokinin 3 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 3 Receptor Antagonists [MoA]</name>
		<code>N0000194091</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194091</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NK3 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurokinin 3 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Receptor Interactions [MoA]</name>
		<code>N0000000218</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000218</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Receptor Agonists [MoA]</name>
		<code>N0000000194</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000194</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Interactions [MoA]</name>
		<code>N0000000124</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000124</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leukotriene Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Antagonists [MoA]</name>
		<code>N0000000083</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000083</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leukotriene Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium-Sensing Receptor Interactions [MoA]</name>
		<code>N0000020080</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020080</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium-Sensing Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Calcium-sensing Receptor Sensitivity [MoA]</name>
		<code>N0000020082</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020082</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Calcium-sensing Receptor Sensitivity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Calcium-sensing Receptor Sensitivity [MoA]</name>
		<code>N0000020081</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020081</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Calcium-sensing Receptor Sensitivity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lysophospholipid Receptor Interactions [MoA]</name>
		<code>N0000181812</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181812</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lysophospholipid Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lysosphingolipid Receptor Interactions [MoA]</name>
		<code>N0000181813</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181813</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lysosphingolipid Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sphingosine 1-Phosphate Receptor Interactions [MoA]</name>
		<code>N0000181814</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181814</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>S1P Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sphingosine 1-Phosphate Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</name>
		<code>N0000181815</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181815</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sphingosine 1-Phosphate Receptor Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>S1P Receptor Modulators</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melatonin Receptor Interactions [MoA]</name>
		<code>N0000000123</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000123</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melatonin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melatonin Receptor Agonists [MoA]</name>
		<code>N0000000250</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000250</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melatonin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypothalmic Hormone Interactions [MoA]</name>
		<code>N0000019992</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019992</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypothalmic Hormone Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypothalamic Hormone Receptor Agonists [MoA]</name>
		<code>N0000019993</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019993</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypothalamic Hormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypothalamic Hormone Receptor Antagonists [MoA]</name>
		<code>N0000019994</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019994</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypothalamic Hormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bradykinin Receptor Interactions [MoA]</name>
		<code>N0000182962</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182962</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bradykinin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bradykinin Receptor Antagonists [MoA]</name>
		<code>N0000182963</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182963</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bradykinin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bradykinin B2 Receptor Antagonists [MoA]</name>
		<code>N0000182964</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182964</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bradykinin B2 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor Interactions [MoA]</name>
		<code>N0000190993</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190993</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PAR Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease-activated Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 Interactions [MoA]</name>
		<code>N0000190994</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190994</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease-activated Receptor-1 Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PAR-1 Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 Antagonists [MoA]</name>
		<code>N0000190995</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190995</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease-activated Receptor-1 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PAR-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 1 Receptor Interactions [MoA]</name>
		<code>N0000010261</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010261</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurokinin 1 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Substance P Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NK 1 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 1 Antagonists [MoA]</name>
		<code>N0000010262</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010262</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Substance P Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurokinin 1 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NK 1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Interactions [MoA]</name>
		<code>N0000175787</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175787</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Antagonists [MoA]</name>
		<code>N0000175789</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175789</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P2Y12 Receptor Antagonists [MoA]</name>
		<code>N0000182143</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182143</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P2Y12 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Agonists [MoA]</name>
		<code>N0000175788</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175788</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Receptor Interactions [MoA]</name>
		<code>N0000000203</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000203</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Antagonists [MoA]</name>
		<code>N0000000230</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000230</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine D2 Antagonists [MoA]</name>
		<code>N0000175799</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175799</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine D2 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Agonists [MoA]</name>
		<code>N0000000117</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000117</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopaminergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanocortin Receptor Interactions [MoA]</name>
		<code>N0000193942</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193942</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocortin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanocortin Receptor Agonists [MoA]</name>
		<code>N0000194030</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194030</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocortin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MCR Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanocortin 4 Receptor Agonists [MoA]</name>
		<code>N0000193941</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193941</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MC4 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocortin 4 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Receptor Antagonists [MoA]</name>
		<code>N0000000070</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000070</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin II Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin II Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin 2 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</name>
		<code>N0000180999</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180999</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin II Type I Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin 2 Type 1 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin II Type 1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin 2 Type 1 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin II Type I Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement 5a Receptor Interactions [MoA]</name>
		<code>N0000193975</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193975</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement 5a Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>C5aR Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement 5a Receptor Antagonists [MoA]</name>
		<code>N0000193974</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193974</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement 5a Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>C5aR Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Smoothened Receptor Interactions [MoA]</name>
		<code>N0000184147</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184147</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Smoothened Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Smoothened Receptor Antagonists [MoA]</name>
		<code>N0000184148</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184148</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Smoothened Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Secretin Receptor Interactions [MoA]</name>
		<code>N0000020077</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020077</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Secretin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Secretin Receptor Agonists [MoA]</name>
		<code>N0000020078</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020078</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Secretin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Secretin Receptor Antagonists [MoA]</name>
		<code>N0000020079</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020079</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Secretin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid Receptor Interactions [MoA]</name>
		<code>N0000181007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cannabinoid Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid Receptor Agonists [MoA]</name>
		<code>N0000181008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cannabinoid Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid Receptor Antagonists [MoA]</name>
		<code>N0000181009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cannabinoid Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon Receptor Interactions [MoA]</name>
		<code>N0000010275</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010275</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</name>
		<code>N0000020057</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020057</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-1 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 (GLP-1) Antagonists [MoA]</name>
		<code>N0000020059</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020059</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 (GLP-1) Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</name>
		<code>N0000020058</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020058</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-1 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</name>
		<code>N0000190989</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190989</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-2 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</name>
		<code>N0000190990</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190990</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 (GLP-2) Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-2 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucagon-like Peptide-2 (GLP-2) Antagonists [MoA]</name>
		<code>N0000190991</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190991</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 (GLP-2) Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Receptor Interactions [MoA]</name>
		<code>N0000000198</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000198</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Antagonists [MoA]</name>
		<code>N0000000130</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000130</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 4 Receptor Antagonists [MoA]</name>
		<code>N0000175816</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175816</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-4 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT4 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT4 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 4 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 4 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 3 Receptor Antagonists [MoA]</name>
		<code>N0000175817</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175817</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT3 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT3 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-3 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 3 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 3 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Agonists [MoA]</name>
		<code>N0000000256</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000256</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 4 Receptor Agonists [MoA]</name>
		<code>N0000193870</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193870</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 4 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT4 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT4 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-4 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1d Receptor Agonists [MoA]</name>
		<code>N0000175764</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175764</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-1D Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-1d Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1d Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1D Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1d Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1D Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1b Receptor Agonists [MoA]</name>
		<code>N0000175763</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175763</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1b Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1B Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1B Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-1B Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-1b Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1b Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 2c Receptor Agonists [MoA]</name>
		<code>N0000185009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-2c Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 2C Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-2C Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 2c Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-2c Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-2C Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1 Receptor Agonists [MoA]</name>
		<code>N0000193868</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193868</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1 Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT1 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT1 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5-Hydroxytryptamine-1 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1 Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 1a Receptor Agonists [MoA]</name>
		<code>N0000193869</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193869</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1a Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT1a Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5-Hydroxytryptamine-1a Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1a Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT1a Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine Receptor Interactions [MoA]</name>
		<code>N0000000216</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000216</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine Receptor Antagonists [MoA]</name>
		<code>N0000000207</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000207</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Receptor Antagonists [MoA]</name>
		<code>N0000181003</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181003</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H3 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H3 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H3 Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H3 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H3 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine H2 Receptor Antagonists [MoA]</name>
		<code>N0000000151</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000151</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H2 Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H2 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H2 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H2 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine H1 Receptor Antagonists [MoA]</name>
		<code>N0000000190</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000190</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H1 Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H1 Receptor Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H1 Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H1 Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine Receptor Inverse Agonists [MoA]</name>
		<code>N0000194052</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194052</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine Receptor Inverse Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine H3 Receptor Inverse Agonists [MoA]</name>
		<code>N0000194051</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194051</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H3 Receptor Inverse Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine-3 Receptor Inverse Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H3 Receptor Inverse Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine Agonists [MoA]</name>
		<code>N0000000112</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000112</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Receptor Interactions [MoA]</name>
		<code>N0000000200</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000200</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Agonists [MoA]</name>
		<code>N0000000174</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000174</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonists [MoA]</name>
		<code>N0000175685</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175685</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonists and Opioid Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonists/Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonists and Opioid Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Full Opioid Agonists [MoA]</name>
		<code>N0000175684</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175684</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Full Opioid Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid mu-Receptor Agonists [MoA]</name>
		<code>N0000191866</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191866</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>mu-Opioid Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid mu-Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid kappa Receptor Agonists [MoA]</name>
		<code>N0000194007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>KOR Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid kappa Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Antagonists [MoA]</name>
		<code>N0000000154</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000154</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Competitive Opioid Antagonists [MoA]</name>
		<code>N0000175686</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175686</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Competitive Opioid Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive Opioid Antagonists [MoA]</name>
		<code>N0000175687</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175687</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Noncompetitive Opioid Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-competitive Opioid Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Receptor Interactions [MoA]</name>
		<code>N0000000097</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000097</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Muscarinic Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Antagonists [MoA]</name>
		<code>N0000000125</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000125</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Muscarinic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Agonists [MoA]</name>
		<code>N0000000104</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000104</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Muscarinic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Receptor Interactions [MoA]</name>
		<code>N0000000153</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000153</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Antagonists [MoA]</name>
		<code>N0000000092</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000092</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-Antagonists [MoA]</name>
		<code>N0000000161</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000161</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Beta-adrenergic Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Beta-adrenergic Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta2-Antagonists [MoA]</name>
		<code>N0000009924</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009924</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-2 Adrenergic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta2-Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta1-Antagonists [MoA]</name>
		<code>N0000009923</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009923</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-1 Adrenergic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta1-Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-Antagonists [MoA]</name>
		<code>N0000000099</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000099</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alpha-adrenergic Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha-Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha1-Antagonists [MoA]</name>
		<code>N0000009919</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009919</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-1 Adrenergic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha1-Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha2-Antagonists [MoA]</name>
		<code>N0000009920</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009920</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-2 Adrenergic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha2-Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha-2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Agonists [MoA]</name>
		<code>N0000000122</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000122</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha-Agonists [MoA]</name>
		<code>N0000000209</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000209</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha2-Agonists [MoA]</name>
		<code>N0000009918</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009918</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha-2 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha2-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-2 Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic alpha1-Agonists [MoA]</name>
		<code>N0000009917</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009917</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha1-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic alpha-1 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-1 Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta-Agonists [MoA]</name>
		<code>N0000000245</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000245</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta3-Agonists [MoA]</name>
		<code>N0000185007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta3-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-3 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-3 Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta2-Agonists [MoA]</name>
		<code>N0000009922</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009922</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-2 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta2-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-2 Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic beta1-Agonists [MoA]</name>
		<code>N0000009921</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009921</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-1 Adrenergic Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta-1 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic beta1-Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Secretagogue Receptor Interactions [MoA]</name>
		<code>N0000193787</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193787</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Secretagogue Receptor Interactions </to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ghrelin Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Secretagogue Receptor Agonists [MoA]</name>
		<code>N0000193786</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193786</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Secretagogue Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ghrelin Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathormone Receptor Interactions [MoA]</name>
		<code>N0000000068</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000068</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathormone Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathormone Receptor Agonists [MoA]</name>
		<code>N0000000158</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000158</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathormone Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathormone Receptor Antagonists [MoA]</name>
		<code>N0000000136</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000136</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathormone Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Interactions [MoA]</name>
		<code>N0000175368</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175368</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Receptor Interactions [MoA]</name>
		<code>N0000000199</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000199</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Nicotinic Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Agonists [MoA]</name>
		<code>N0000000143</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000143</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Nicotinic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</name>
		<code>N0000175717</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175717</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Neuromuscular Nicotinic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Partial Cholinergic Nicotinic Agonists [MoA]</name>
		<code>N0000175702</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175702</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Cholinergic Nicotinic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Full Cholinergic Nicotinic Agonists [MoA]</name>
		<code>N0000175701</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175701</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Full Cholinergic Nicotinic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Ganglionic Nicotinic Agonists [MoA]</name>
		<code>N0000175652</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175652</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Ganglionic Nicotinic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Antagonists [MoA]</name>
		<code>N0000000227</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000227</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Nicotinic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</name>
		<code>N0000175718</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175718</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Neuromuscular Nicotinic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Competitive Cholinergic Nicotinic Antagonists [MoA]</name>
		<code>N0000175703</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175703</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Competitive Cholinergic Nicotinic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive Cholinergic Nicotinic Antagonists [MoA]</name>
		<code>N0000175704</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175704</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-competitive Cholinergic Nicotinic Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Noncompetitive Cholinergic Nicotinic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</name>
		<code>N0000175653</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175653</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Ganglionic Nicotinic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Agonists [MoA]</name>
		<code>N0000175369</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175369</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Antagonists [MoA]</name>
		<code>N0000175370</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175370</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon Receptor Interactions [MoA]</name>
		<code>N0000193959</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193959</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Type I interferon Receptor Antagonists [MoA]</name>
		<code>N0000193968</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193968</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Type I interferon Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Type I IFN Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fc Receptor Interactions [MoA]</name>
		<code>N0000193996</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193996</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fc Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FcRn Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neonatal Fc Receptor Blockers [MoA]</name>
		<code>N0000194005</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194005</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neonatal FcRn Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neonatal Fc Receptor Blockers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurotransmitter Transporter Interactions [MoA]</name>
		<code>N0000000105</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000105</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurotransmitter Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Transporter Interactions [MoA]</name>
		<code>N0000000167</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000167</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Uptake Inhibitors [MoA]</name>
		<code>N0000000109</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000109</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Uptake Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Transporter Interactions [MoA]</name>
		<code>N0000000219</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000219</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Uptake Inhibitors [MoA]</name>
		<code>N0000000114</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000114</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Uptake Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Transporter Interactions [MoA]</name>
		<code>N0000009955</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009955</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetylcholine Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ACh Transporter Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter Interactions [MoA]</name>
		<code>N0000178332</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178332</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VMAT Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vesicular Monoamine Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter Antagonists [MoA]</name>
		<code>N0000178333</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178333</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VMAT Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vesicular Monoamine Transporter Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</name>
		<code>N0000190855</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190855</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vesicular Monoamine Transporter 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Transporter Interactions [MoA]</name>
		<code>N0000000234</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000234</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Uptake Inhibitors [MoA]</name>
		<code>N0000000102</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000102</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine Uptake Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin 31 Receptor Interactions [MoA]</name>
		<code>N0000194117</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194117</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 31 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</name>
		<code>N0000193918</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193918</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CGPR Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcitonin Gene-related Peptide Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Protein Kinase Interactions [MoA]</name>
		<code>N0000000213</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000213</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Protein Kinase Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin Receptor Interactions [MoA]</name>
		<code>N0000000240</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000240</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin Receptor Antagonists [MoA]</name>
		<code>N0000000071</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000071</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin Receptor Agonists [MoA]</name>
		<code>N0000000225</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000225</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor alpha Receptor Interactions [MoA]</name>
		<code>N0000000093</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000093</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor alpha Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</name>
		<code>N0000020028</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020028</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PDGFR alpha Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Keratinocyte Growth Factor Receptor Interactions [MoA]</name>
		<code>N0000020070</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020070</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Keratinocyte Growth Factor Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Keratinocyte Growth Factor Receptor Antagonists [MoA]</name>
		<code>N0000020072</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020072</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Keratinocyte Growth Factor Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Keratinocyte Growth Factor Receptor Agonists [MoA]</name>
		<code>N0000020071</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020071</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Keratinocyte Growth Factor Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER Receptor Family Interactions [MoA]</name>
		<code>N0000000067</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000067</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EGFR Family Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Family Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Receptor Family Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor Family Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Epidermal Growth Factor Receptor Family Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER Receptor Family Antagonists [MoA]</name>
		<code>N0000020006</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020006</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EGFR Family Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Receptor Family Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EGFR Family Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Family Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Family Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor Family Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER Receptor Family Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor Family Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Epidermal Growth Factor Receptor Family Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Epidermal Growth Factor Receptor Family Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER2/Neu/cerbB2 Antagonists [MoA]</name>
		<code>N0000020008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-2/Neu/cerbB2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-2/Neu/cerbB2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2/Neu/cerbB2 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2/Neu/cerbB2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-2 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER3 Antagonists [MoA]</name>
		<code>N0000020012</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020012</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER3 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-3 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER1 Antagonists [MoA]</name>
		<code>N0000020010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EGFR Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER-1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER1 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EGFR Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatotropin Receptor Interactions [MoA]</name>
		<code>N0000000077</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000077</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatotropin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatotropin Receptor Agonists [MoA]</name>
		<code>N0000000217</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000217</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatotropin Receptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</name>
		<code>N0000000081</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000081</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Macrophage Colony Stimulating Factor Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</name>
		<code>N0000000137</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000137</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin-like Growth Factor-1 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IGF-1R Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IGF Type 1 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IGF-1 Receptor Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</name>
		<code>N0000193927</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193927</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IGF-1R Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin-like Growth Factor-1 Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor beta Receptor Interactions [MoA]</name>
		<code>N0000000189</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000189</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor beta Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</name>
		<code>N0000020029</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020029</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PDGFR beta Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor beta Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ion Channel Interactions [MoA]</name>
		<code>N0000000193</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000193</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ion Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</name>
		<code>N0000191545</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191545</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCN Channel Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Cation Channel Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Channel Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cation Channel Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists [MoA]</name>
		<code>N0000191547</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191547</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Channel Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCN Channel Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Cation Channel Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cation Channel Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</name>
		<code>N0000191546</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191546</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Channel Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCN Channel Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Cation Channel Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cation Channel Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Interactions [MoA]</name>
		<code>N0000000211</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000211</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Openers [MoA]</name>
		<code>N0000182728</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182728</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Openers</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Activators</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Antagonists [MoA]</name>
		<code>N0000175448</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175448</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Agonists [MoA]</name>
		<code>N0000175449</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175449</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Interactions [MoA]</name>
		<code>N0000000140</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000140</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Antagonists [MoA]</name>
		<code>N0000000069</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000069</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Channel Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Channel Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>L-Calcium Channel Receptor Antagonists [MoA]</name>
		<code>N0000020065</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020065</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>L-Calcium Channel Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>N-Calcium Channel Receptor Antagonists [MoA]</name>
		<code>N0000020069</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020069</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-Calcium Channel Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>T-Calcium Channel Receptor Antagonists [MoA]</name>
		<code>N0000020066</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020066</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T-Calcium Channel Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Voltage-gated Calcium Channel Receptor Antagonists [MoA]</name>
		<code>N0000020067</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020067</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Voltage-gated Calcium Channel Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Agonists [MoA]</name>
		<code>N0000000259</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000259</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Channel Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ligand-Gated Ion Channel Interactions [MoA]</name>
		<code>N0000188380</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188380</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ligand-Gated Ion Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ionotropic Glutamate Receptor Interactions [MoA]</name>
		<code>N0000188381</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188381</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ionotropic Glutamate Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ionotropic Glutamate Receptor Antagonists [MoA]</name>
		<code>N0000020014</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020014</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ionotropic Glutamate Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>NMDA Receptor Antagonists [MoA]</name>
		<code>N0000020015</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020015</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-methyl-D-aspartate Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NMDA Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Competitive NMDA Receptor Antagonists [MoA]</name>
		<code>N0000181817</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181817</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Competitive NMDA Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Competitive N-methyl-D-aspartate Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive NMDA Receptor Antagonists [MoA]</name>
		<code>N0000181818</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181818</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Noncompetitive N-methyl-D-aspartate Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Noncompetitive NMDA Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>NMDA Receptor Glycine Antagonists [MoA]</name>
		<code>N0000181820</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181820</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-methyl-D-aspartate Receptor Glycine Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NMDA Receptor Glycine Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive NMDA Receptor Antagonists [MoA]</name>
		<code>N0000181819</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181819</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uncompetitive NMDA Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kainate Receptor Antagonists [MoA]</name>
		<code>N0000020017</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020017</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kainate Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>AMPA Receptor Antagonists [MoA]</name>
		<code>N0000020016</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020016</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>AMPA Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thermoreceptor Interactions [MoA]</name>
		<code>N0000194174</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194174</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thermoreceptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>TRPM8 Thermoreceptor Agonists [MoA]</name>
		<code>N0000194173</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194173</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRPM8 Thermoreceptor Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transient Receptor Potential Melastatin 8 Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Interactions [MoA]</name>
		<code>N0000000138</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000138</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA A Antagonists [MoA]</name>
		<code>N0000000074</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000074</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzodiazepine Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzodiazepine Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA A Agonists [MoA]</name>
		<code>N0000000196</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000196</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Agonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA A Modulators [MoA]</name>
		<code>N0000000118</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000118</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Modulators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GABA A Receptor Positive Modulators [MoA]</name>
		<code>N0000193997</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193997</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Positive Modulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycine Receptor Interactions [MoA]</name>
		<code>N0000000244</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000244</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycine Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycine Agonists [MoA]</name>
		<code>N0000000073</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000073</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycine Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycine Antagonists [MoA]</name>
		<code>N0000000119</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000119</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycine Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5HT-3 Receptor Interactions [MoA]</name>
		<code>N0000000095</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000095</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5HT-3 Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5HT-3 Agonists [MoA]</name>
		<code>N0000000188</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000188</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5HT-3 Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin 5HT-3 Antagonists [MoA]</name>
		<code>N0000000090</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000090</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5HT-3 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Interactions [MoA]</name>
		<code>N0000000156</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000156</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activation Potentiators [MoA]</name>
		<code>N0000184145</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184145</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Activation Potentiators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Antagonists [MoA]</name>
		<code>N0000000224</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000224</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activators [MoA]</name>
		<code>N0000175456</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175456</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Activators</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Activator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Agonists [MoA]</name>
		<code>N0000000078</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000078</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Interactions [MoA]</name>
		<code>N0000000180</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000180</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Channel Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Antagonists [MoA]</name>
		<code>N0000181004</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181004</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Channel Blockers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Channel Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Agonists [MoA]</name>
		<code>N0000182727</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182727</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Channel Agonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ion Transporter Interactions [MoA]</name>
		<code>N0000188370</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188370</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ion Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiporter Interactions [MoA]</name>
		<code>N0000188374</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188374</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger Interactions [MoA]</name>
		<code>N0000194058</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194058</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Exchanger Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLC9 Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Antiporter Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NHE Interactions </to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Solute Carrier 9 Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</name>
		<code>N0000194057</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194057</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Exchanger 3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLC9 A3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Antiporter 3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NHE3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</name>
		<code>N0000000238</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000238</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Potassium Exchanging ATPase Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Na-K ATPase Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Na-K Exchanging ATPase Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cation Transporter Interactions [MoA]</name>
		<code>N0000188372</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188372</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cation Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Cation Transporter Interactions [MoA]</name>
		<code>N0000187060</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187060</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Cation Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Cation Transporter 2 Inhibitors [MoA]</name>
		<code>N0000187061</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187061</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OCT2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Cation Transporter 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Urate Transporter 1 Inhibitors [MoA]</name>
		<code>N0000192340</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192340</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urate Transporter-1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLC22A12 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RST Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urate Transporter 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporter 4-like Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>URAT1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uric Acid Transporter-1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Solute Carrier Family 22 Member 12 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uric Acid Transporter 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>URAT-1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OAT4L Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</name>
		<code>N0000191423</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191423</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MATE1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</name>
		<code>N0000193932</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193932</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MATE-2K Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MATE2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MATE2-K Inhibitiors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Cation Transporter 1 Inhibitors [MoA]</name>
		<code>N0000191265</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191265</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Cation Transporter 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OCT1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proton Pump Interactions [MoA]</name>
		<code>N0000188373</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188373</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proton Pump Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proton Pump Inhibitors [MoA]</name>
		<code>N0000000147</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000147</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proton Pump Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>M2 Protein Inhibitors [MoA]</name>
		<code>N0000175542</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175542</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>M2 Protein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anion Transporter Interactions [MoA]</name>
		<code>N0000188371</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188371</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anion Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter Interactions [MoA]</name>
		<code>N0000000132</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000132</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter 1 Inhibitors [MoA]</name>
		<code>N0000190110</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190110</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporter 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OAT1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</name>
		<code>N0000190109</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190109</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OATP2B1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</name>
		<code>N0000190107</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190107</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OATP1B1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</name>
		<code>N0000190108</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190108</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OATP1B3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Anion Transporter 3 Inhibitors [MoA]</name>
		<code>N0000190111</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190111</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporter 3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OAT3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Symporter Interactions [MoA]</name>
		<code>N0000188375</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188375</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Symporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter Interactions [MoA]</name>
		<code>N0000188378</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188378</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter Inhibitors [MoA]</name>
		<code>N0000187056</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187056</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SGLT Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Cotransporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Symporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Transporter Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Cotransporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Symporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Transporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</name>
		<code>N0000187058</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187058</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Symporter 2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Cotransporter 2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SGLT2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Symporter 2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Transporter 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Cotransporter 2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Transporter 2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Transporter 1 Inhibitors [MoA]</name>
		<code>N0000187057</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187057</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Symporter 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Transporter 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Cotransporter 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Cotransporter 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SGLT1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Symporter 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Transporter 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Bile Acid Cotransporter Interactions [MoA]</name>
		<code>N0000193964</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193964</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NTCP Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Taurocholate Co-transporting Polypeptide Interactions</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Bile Acid Cotransporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ileal Bile Acid Transporter Inhibitors [MoA]</name>
		<code>N0000193958</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193958</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Apical Sodium Bile Acid Transporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IBAT Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ASBT Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ileal Sodium Bile Acid Cotransporter Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ileal Bile Acid Transporter Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors [MoA]</name>
		<code>N0000193965</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193965</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NTCP Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Potassium Chloride Symporter Interactions [MoA]</name>
		<code>N0000188377</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188377</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Potassium Chloride Symporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</name>
		<code>N0000181006</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181006</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Potassium Chloride Symporter Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Chloride Symporter Interactions [MoA]</name>
		<code>N0000188376</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188376</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Chloride Symporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Chloride Symporter Inhibitors [MoA]</name>
		<code>N0000181005</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181005</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Chloride Symporter Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monosaccharide Transporter Interactions [MoA]</name>
		<code>N0000188379</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188379</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monosaccharide Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Integrin Receptor Interactions [MoA]</name>
		<code>N0000175773</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175773</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Integrin Receptor Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Integrin Receptor Antagonists [MoA]</name>
		<code>N0000175774</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175774</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Integrin Receptor Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</name>
		<code>N0000192700</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192700</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Function-Associated Antigen-1 Antagonists</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>LFA-1 Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Physiochemical Activity [MoA]</name>
		<code>N0000000065</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000065</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Physiochemical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radiopharmaceutical Activity [MoA]</name>
		<code>N0000000205</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000205</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radiopharmaceutical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Particle Emitting Activity [MoA]</name>
		<code>N0000187052</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187052</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Particle Emitting Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>gamma-Ray Emitting Activity [MoA]</name>
		<code>N0000175868</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175868</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Ray Emitting Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Positron Emitting Activity [MoA]</name>
		<code>N0000175869</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175869</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Positron Emitting Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioligand Activity [MoA]</name>
		<code>N0000194016</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194016</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioligand Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Imaging Contrast Activity [MoA]</name>
		<code>N0000010257</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010257</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Imaging Contrast Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Magnetic Resonance Contrast Activity [MoA]</name>
		<code>N0000175862</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175862</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Magnetic Resonance Contrast Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>X-Ray Contrast Activity [MoA]</name>
		<code>N0000010258</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010258</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radiocontrast Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>X-Ray Contrast Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ultrasound Contrast Activity [MoA]</name>
		<code>N0000010259</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010259</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ultrasound Contrast Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fluorescence Contrast Activity [MoA]</name>
		<code>N0000193981</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193981</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fluorescence Contrast Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Irrigation [MoA]</name>
		<code>N0000175534</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175534</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Irrigation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Demulcent Activity [MoA]</name>
		<code>N0000175532</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175532</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Demulcent Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Photoabsorption [MoA]</name>
		<code>N0000010217</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010217</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Photoabsorption</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Photoabsorbtion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ultraviolet A Radiation Absorption [MoA]</name>
		<code>N0000010218</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010218</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ultraviolet A Radiation Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Absorbs Ultraviolet A Radiation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Absorbs UVA Radiation</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ultraviolet B Radiation Absorption [MoA]</name>
		<code>N0000010219</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010219</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Absorbs UVB Radiation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ultraviolet B Radiation Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Absorbs Ultraviolet B Radiation</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxidation-Reduction Activity [MoA]</name>
		<code>N0000175545</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175545</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Redox Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxidation-Reduction Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reduction-Oxidation Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Reduction Activity [MoA]</name>
		<code>N0000175547</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175547</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reduction Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Free Radical Scavenging Activity [MoA]</name>
		<code>N0000000170</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000170</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Free Radical Scavenging</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Free Radical Scavenging Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Disulfide Reduction [MoA]</name>
		<code>N0000175548</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175548</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Disulfide Reduction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cystine Disulfide Reduction [MoA]</name>
		<code>N0000175549</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175549</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cystine Disulfide Reduction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxidation Activity [MoA]</name>
		<code>N0000175546</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175546</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxidation Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Osmotic Activity [MoA]</name>
		<code>N0000010288</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010288</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Osmotic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stool Bulking Activity [MoA]</name>
		<code>N0000000075</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000075</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stool Bulking Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GI Bulking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastrointestinal Contents Bulking Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Binding Activity [MoA]</name>
		<code>N0000175355</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175355</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Binding Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chelating Activity [MoA]</name>
		<code>N0000000087</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000087</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metal Chelating Activity [MoA]</name>
		<code>N0000175472</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175472</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metal Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metal Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iron Chelating Activity [MoA]</name>
		<code>N0000000144</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000144</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iron Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iron Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Siderophore Iron Chelating Activity [MoA]</name>
		<code>N0000181001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Siderophore Iron Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Plutonium Chelating Activity [MoA]</name>
		<code>N0000020076</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020076</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plutonium Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plutonium Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lead Chelating Activity [MoA]</name>
		<code>N0000175962</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175962</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lead Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lead Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Chelating Activity [MoA]</name>
		<code>N0000175089</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175089</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Binding Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Copper Chelating Activity [MoA]</name>
		<code>N0000020075</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020075</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphate Chelating Activity [MoA]</name>
		<code>N0000020074</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020074</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphate Chelator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphate Binding Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphate Chelating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Digoxin Binding Activity [MoA]</name>
		<code>N0000184150</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184150</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Digoxin Binding Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile-acid Binding Activity [MoA]</name>
		<code>N0000175365</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175365</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile-acid Binding Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hemoglobin S Polymerization Inhibitors [MoA]</name>
		<code>N0000194028</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194028</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HbS Polymerization Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hemoglobin S Polymerization Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Heparin Binding Activity [MoA]</name>
		<code>N0000175981</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175981</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Heparin Binding Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ammonium Ion Binding Activity [MoA]</name>
		<code>N0000175806</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175806</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ammonia Binding Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ammonium Ion Binding Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Ion Binding Activity [MoA]</name>
		<code>N0000178377</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178377</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Ion Binding Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Binding Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Transthyretin Stabilizers [MoA]</name>
		<code>N0000194135</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194135</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transthyretin Stabilizers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ion Exchange Activity [MoA]</name>
		<code>N0000175356</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175356</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ion Exchange Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Ion Exchange Activity [MoA]</name>
		<code>N0000175357</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175357</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Ion Exchange Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Magnesium Ion Exchange Activity [MoA]</name>
		<code>N0000175834</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175834</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Magnesium Ion Exchange Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Surfactant Activity [MoA]</name>
		<code>N0000000079</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000079</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Surfactant Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ionophoric Activity [MoA]</name>
		<code>N0000181010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ionophoric Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Donors [MoA]</name>
		<code>N0000000120</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000120</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitric Oxide Donors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfate Donors [MoA]</name>
		<code>N0000009983</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009983</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfate Donors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alkylating Activity [MoA]</name>
		<code>N0000000236</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000236</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alkylating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sclerosing Activity [MoA]</name>
		<code>N0000020024</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020024</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sclerosing Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dyes [MoA]</name>
		<code>N0000175533</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175533</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stains</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dyes</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Electrolyte Activity [MoA]</name>
		<code>N0000000220</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000220</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Electrolyte Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acid-Base Activity [MoA]</name>
		<code>N0000000226</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000226</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acid-Base Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alkalinizing Activity [MoA]</name>
		<code>N0000009986</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009986</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alkalinizing Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrogen Ion Scavengers</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrogen Ion Scavenging Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acidifying Activity [MoA]</name>
		<code>N0000175833</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175833</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrogen Ion Donor Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acidifying Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrogen Ion Donors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methylating Activity [MoA]</name>
		<code>N0000175804</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175804</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methyl Donors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methylating Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Interactions [MoA]</name>
		<code>N0000000163</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000163</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Activators [MoA]</name>
		<code>N0000000231</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000231</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydroxylase Activators [MoA]</name>
		<code>N0000190481</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190481</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydroxylase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phenylalanine Hydroxylase Activators [MoA]</name>
		<code>N0000190482</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190482</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phenylalanine Hydroxylase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipase Activators [MoA]</name>
		<code>N0000193928</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193928</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Indirect Lipase Activators [MoA]</name>
		<code>N0000193925</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193925</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Indirect Lipase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiopoietin-like 3 Inhibitors [MoA]</name>
		<code>N0000193916</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193916</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ANGPTL3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiopoietin-like 3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antithrombin Activators [MoA]</name>
		<code>N0000009960</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009960</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antithrombin Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antithrombin 3 Activators [MoA]</name>
		<code>N0000175636</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175636</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antithrombin 3 Activators</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antithrombin III Activators</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lyase Activators [MoA]</name>
		<code>N0000185498</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185498</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lyase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Guanylate Cyclase Activators [MoA]</name>
		<code>N0000185499</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185499</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Guanylate Cyclase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Guanylate Cyclase Stimulators [MoA]</name>
		<code>N0000190484</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190484</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Guanylate Cyclase Stimulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ligase Activators [MoA]</name>
		<code>N0000184142</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184142</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ligase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</name>
		<code>N0000184143</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184143</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CPS1 Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthase 1 (CPS1) Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl-Phosphate Synthetase 1 Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl-Phosphate Synthase 1 Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoylphosphate Synthase 1 Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthase 1 Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthetase 1 Activators</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activators</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoylphosphate Synthetase 1 Activators</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyruvate Kinase Activators [MoA]</name>
		<code>N0000194009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyruvate Kinase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Plasminogen Activators [MoA]</name>
		<code>N0000000089</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000089</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plasminogen Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tissue Plasminogen Activators [MoA]</name>
		<code>N0000000241</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000241</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tissue Plasminogen Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GTP Phosphohydrolase Activators [MoA]</name>
		<code>N0000000252</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000252</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GTP Phosphohydrolase Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease Activators [MoA]</name>
		<code>N0000194171</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194171</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease Activators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Inhibitors [MoA]</name>
		<code>N0000000133</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000133</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Steroid Synthesis Inhibitors [MoA]</name>
		<code>N0000175920</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175920</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Steroid Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sex Hormone Synthesis Inhibitors [MoA]</name>
		<code>N0000175922</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175922</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sex Hormone Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen Synthesis Inhibitors [MoA]</name>
		<code>N0000175926</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175926</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aromatase Inhibitors [MoA]</name>
		<code>N0000175080</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175080</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progestin Synthesis Inhibitors [MoA]</name>
		<code>N0000175927</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175927</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestin Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Androgen Synthesis Inhibitors [MoA]</name>
		<code>N0000175925</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175925</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>5-alpha Reductase Inhibitors [MoA]</name>
		<code>N0000000126</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000126</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-alpha Reductase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenal Steroid Synthesis Inhibitors [MoA]</name>
		<code>N0000175921</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175921</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenal Steroid Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucocorticoid Synthesis Inhibitors [MoA]</name>
		<code>N0000175923</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175923</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucocorticoid Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Synthesis Inhibitors [MoA]</name>
		<code>N0000175924</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175924</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mineralocorticoid Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]</name>
		<code>N0000000183</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000183</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetyl Aldehyde Dehydrogenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gamma Secretase Inhibitors [MoA]</name>
		<code>N0000194116</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194116</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gamma Secretase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipase Inhibitors [MoA]</name>
		<code>N0000009916</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009916</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renin Inhibitors [MoA]</name>
		<code>N0000175899</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175899</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Direct Renin Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protein Synthesis Inhibitors [MoA]</name>
		<code>N0000000150</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000150</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protein Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>APOC-III RNA Antisense Inhibitor [MoA]</name>
		<code>N0000194143</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194143</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>APOC-III RNA Antisense Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>APOC3 RNA Antisense Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</name>
		<code>N0000175808</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175808</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucosyl Transferase Inhibitors [MoA]</name>
		<code>N0000020018</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020018</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucosyl Transferase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucosylceramide Synthase Inhibitors [MoA]</name>
		<code>N0000020019</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020019</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucosylceramide Synthase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Methyltransferase Inhibitors [MoA]</name>
		<code>N0000019995</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019995</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Methyltransferase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Methytransferase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ubiquitin Ligase Inhibitors [MoA]</name>
		<code>N0000020084</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020084</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ubiquitin Ligase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>E3 Ubiquitin Ligase Inhibitors [MoA]</name>
		<code>N0000020085</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020085</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>E3 Ubiquitin Ligase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucan Synthase Inhibitors [MoA]</name>
		<code>N0000020027</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020027</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucan Synthase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Synthesis Inhibitors [MoA]</name>
		<code>N0000175917</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175917</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iodide Peroxidase Inhibitors [MoA]</name>
		<code>N0000010276</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010276</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iodide Peroxidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Peroxidase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase Inhibitors [MoA]</name>
		<code>N0000000160</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000160</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclooxygenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase 2 Inhibitors [MoA]</name>
		<code>N0000008288</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008288</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclooxygenase II Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>COX-2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclooxygenase 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Xanthine Oxidase Inhibitors [MoA]</name>
		<code>N0000000206</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000206</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Xanthine Oxidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</name>
		<code>N0000193914</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193914</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ACL Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ATP Citrate Lyase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carbonic Anhydrase Inhibitors [MoA]</name>
		<code>N0000000235</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000235</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbonic Anhydrase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dephosphorylation Inhibitors [MoA]</name>
		<code>N0000009959</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009959</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dephosphorylation Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytidine Deaminase Inhibitors [MoA]</name>
		<code>N0000193993</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193993</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytidine Deaminase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytidine Analog Deaminase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alcohol Dehydrogenase Inhibitors [MoA]</name>
		<code>N0000000179</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000179</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alcohol Dehydrogenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</name>
		<code>N0000193614</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193614</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase-2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IDH2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipoxygenase Inhibitors [MoA]</name>
		<code>N0000000134</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000134</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipoxygenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>5-Lipoxygenase Inhibitors [MoA]</name>
		<code>N0000175955</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175955</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-Lipoxygenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oligonucleotide Telomerase Inhibitors [MoA]</name>
		<code>N0000194126</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194126</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oligonucleotide Telomerase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histone Deacetylase Inhibitors [MoA]</name>
		<code>N0000175071</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175071</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histone Deacetylase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histone Deacetylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kinase Inhibitors [MoA]</name>
		<code>N0000175082</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175082</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anaplastic Lymphoma Kinase Inhibitors [MoA]</name>
		<code>N0000194147</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194147</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anaplastic Lymphoma Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protein Kinase Inhibitors [MoA]</name>
		<code>N0000175076</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175076</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protein Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tyrosine Kinase Inhibitors [MoA]</name>
		<code>N0000020001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tyrosine Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</name>
		<code>N0000194093</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194093</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ROS1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bruton's Tyrosine Kinase Inhibitors [MoA]</name>
		<code>N0000193934</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193934</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Agammaglobulinaemia Tyrosine Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bruton's Tyrosine Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BTK Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Janus Kinase Inhibitors [MoA]</name>
		<code>N0000190857</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190857</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Janus Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tyrosine Kinase 2 Inhibitors [MoA]</name>
		<code>N0000194044</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194044</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tyrosine Kinase 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TYK2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proline-rich Tyrosine Kinase 2 Inhibitors [MoA]</name>
		<code>N0000194169</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194169</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proline-rich Tyrosine Kinase-2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proline-rich Tyrosine Kinase 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyk2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PYK2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Janus Kinase 3 Inhibitors [MoA]</name>
		<code>N0000194064</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194064</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>JAK3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>JAK-3 Protein Tyrosine Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>JAK-3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>JAK3 Protein Tyrosine Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Janus Kinase 3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Tyrosine Kinase Inhibitors [MoA]</name>
		<code>N0000020000</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020000</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Tyrosine Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stem Cell Factor (KIT) Receptor Inhibitors [MoA]</name>
		<code>N0000020034</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020034</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stem Cell Factor (KIT) Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stem Cell Factor (KIT) Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</name>
		<code>N0000194026</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194026</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fibroblast Growth Factor Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FGFR Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</name>
		<code>N0000020007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>VEGFR3 Inhibitors [MoA]</name>
		<code>N0000020033</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020033</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>VEGFR1 Inhibitors [MoA]</name>
		<code>N0000020031</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020031</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>VEGFR2 Inhibitors [MoA]</name>
		<code>N0000020032</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020032</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</name>
		<code>N0000020030</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020030</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PDGFR Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</name>
		<code>N0000020036</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020036</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Rearranged during Transfection (RET) Inhibitors [MoA]</name>
		<code>N0000193947</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193947</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RET Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Rearranged during Transfection (RET) Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mesenchymal Epithelial Transition Inhibitors [MoA]</name>
		<code>N0000193929</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193929</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MET Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mesenchymal Epithelial Transition Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</name>
		<code>N0000020009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bcr-Abl Tyrosine Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bcr-Abl Tyrosine Kinase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurotrophic Factor Receptor (RET) Inhibitors [MoA]</name>
		<code>N0000020037</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020037</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurotrophic Factor Receptor (RET) Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]</name>
		<code>N0000194085</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194085</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>fms-Like Tyrosine Kinase 3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FLT3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Feline McDonough Sarcoma-like Receptor Tyrosine Kinase 3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FMS-related Receptor Tyrosine Kinase 3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FMS-like Receptor Tyrosine Kinase 3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Focal Adhesion Kinase Inhibitors [MoA]</name>
		<code>N0000194167</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194167</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PTK2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FAK Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Focal Adhesion Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Rho Kinase Inhibitors [MoA]</name>
		<code>N0000193789</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193789</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Rho Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serine/Threonine Kinase Inhibitors [MoA]</name>
		<code>N0000193933</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193933</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serine/Threonine Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclin-dependent Kinase 6 Inhibitors [MoA]</name>
		<code>N0000193922</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193922</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Division Protein Kinase 6 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CDK 6 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name> Cyclin-dependent Kinase 6 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</name>
		<code>N0000175411</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175411</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BRAF Serine/Threonine Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>mTOR Inhibitors [MoA]</name>
		<code>N0000175624</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175624</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>mTOR Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mammalian Target of Rapamycin Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</name>
		<code>N0000193945</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193945</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAP Kinase Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mitogen-Activated Protein Kinase Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</name>
		<code>N0000193943</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193943</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MEK-1 Protein Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MEK1 Protein Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAP Kinase Kinase 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</name>
		<code>N0000193944</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193944</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAP Kinase Kinase 2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MEK-2 Protein Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MEK2 Protein Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclin-dependent Kinase 4 Inhibitors [MoA]</name>
		<code>N0000193921</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193921</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Division Protein Kinase 4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name> Cyclin-dependent Kinase 4 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CDK 4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Type II RAF Kinase Inhibitors [MoA]</name>
		<code>N0000194133</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194133</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Type II RAF Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Kinases Inhibitors [MoA]</name>
		<code>N0000193859</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193859</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRKs Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Kinases Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</name>
		<code>N0000194095</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194095</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRKB Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Kinase B Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</name>
		<code>N0000194096</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194096</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRKC Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Kinase C Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</name>
		<code>N0000194094</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194094</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Kinase A Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRKA Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</name>
		<code>N0000193977</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193977</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV pUL97 Kinase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus pUL97 Kinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide 3-Kinases Inhibitors [MoA]</name>
		<code>N0000194055</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194055</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphatidylinositol 3-Kinases Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3Ks Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphoinositide-3-Kinases Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphoinositide 3-Kinases Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide 3-Kinase delta Inhibitors [MoA]</name>
		<code>N0000194054</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194054</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphoinositide-3-Kinase delta Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3Kδ Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphatidylinositol 3-Kinase delta Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3K delta Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphoinositide 3-Kinase delta Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphoinositide 3-Kinase alpha Inhibitors [MoA]</name>
		<code>N0000194130</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194130</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3K-alpha Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PIK3CA Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3K-α Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3K alpha Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphatidylinositol 3-Kinase alpha Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3K α Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphoinositide 3-Kinase alpha Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PI3Kα Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta Lactamase Inhibitors [MoA]</name>
		<code>N0000000202</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000202</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Lactamase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta Lactamase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuraminidase Inhibitors [MoA]</name>
		<code>N0000175436</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175436</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuraminidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methyltransferase Inhibitors [MoA]</name>
		<code>N0000193931</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193931</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methyltransferase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Squalene Monooxygenase Inhibitors [MoA]</name>
		<code>N0000010265</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010265</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Squalene Monooxygenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Squalene Epoxidase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tryptophan Hydroxylase Inhibitors [MoA]</name>
		<code>N0000193302</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193302</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tryptophan Hydroxylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Phosphorylase Inhibitors [MoA]</name>
		<code>N0000191868</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191868</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrimidine Phosphorylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thymidine Phosphorylase Inhibitors [MoA]</name>
		<code>N0000191869</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191869</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thymidine Phosphorylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UDP Glucuronosyltransferases Inhibitors [MoA]</name>
		<code>N0000191269</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191269</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases (UGT) Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT2B Inhibitors [MoA]</name>
		<code>N0000191271</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191271</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT2B Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-2B Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases-2B Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT2B7 Inhibitors [MoA]</name>
		<code>N0000191273</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191273</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT2B7 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-2B7 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-2B7 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT2B15 Inhibitors [MoA]</name>
		<code>N0000191274</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191274</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT2B15 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-2B15 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-2B15 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A Inhibitors [MoA]</name>
		<code>N0000191270</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191270</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferases-1A Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A1 Inhibitors [MoA]</name>
		<code>N0000191272</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191272</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-1A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A4 Inhibitors [MoA]</name>
		<code>N0000191276</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191276</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A4 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-1A4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A6 Inhibitors [MoA]</name>
		<code>N0000191277</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191277</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-1A6 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A6 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A6 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A9 Inhibitors [MoA]</name>
		<code>N0000191278</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191278</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A9 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A9 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-1A9 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>UGT1A3 Inhibitors [MoA]</name>
		<code>N0000191275</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191275</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UDP Glucuronosyltransferase-1A3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT1A3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>UGT-1A3 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Para-Aminobenzoic Acid Inhibitors [MoA]</name>
		<code>N0000009946</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009946</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Para-Aminobenzoic Acid Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PABA Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antithrombins [MoA]</name>
		<code>N0000000107</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000107</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antithrombins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Farnesyltransferase Inhibitors [MoA]</name>
		<code>N0000193939</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193939</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Farnesyltransferase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FTIs</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Integrase Inhibitors [MoA]</name>
		<code>N0000000258</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000258</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Integrase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HIV Integrase Inhibitors [MoA]</name>
		<code>N0000000127</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000127</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Integrase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Integrase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanin Synthesis Inhibitors [MoA]</name>
		<code>N0000175850</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175850</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanin Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Inhibitors [MoA]</name>
		<code>N0000000184</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000184</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAOI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase-B Inhibitors [MoA]</name>
		<code>N0000175761</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175761</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase-B Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAO-B Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAOI-B</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase-A Inhibitors [MoA]</name>
		<code>N0000175760</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175760</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAOI-A</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAO-A Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase-A Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcineurin Inhibitors [MoA]</name>
		<code>N0000175458</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175458</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcineurin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Catechol O-Methyltransferase Inhibitors [MoA]</name>
		<code>N0000175756</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175756</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>COMT Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol O-Methyltransferase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol-O-Methyltransferase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol-O-Methyl Transferase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol O-Methyl Transferase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uncouplers [MoA]</name>
		<code>N0000000155</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000155</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uncouplers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase Inhibitors [MoA]</name>
		<code>N0000000128</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000128</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 5 Inhibitors [MoA]</name>
		<code>N0000020026</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020026</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase V Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase 5 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase V Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 3 Inhibitors [MoA]</name>
		<code>N0000175086</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175086</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase 3 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase III Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase III Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 4 Inhibitors [MoA]</name>
		<code>N0000182960</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182960</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase 4 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase IV Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase IV Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>11-beta Hydroxysteroid Dehydrogenase Inhibitors [MoA]</name>
		<code>N0000194061</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194061</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11βHSD Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11-beta Hydroxysteroid Dehydrogenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11β Hydroxysteroid Dehydrogenase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11 beta-Hydroxysteroid Dehydrogenase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11beta-Hydroxysteroid Dehydrogenase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11-beta-Hydroxysteroid Dehydrogenase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11beta-HSD Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA]</name>
		<code>N0000194062</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194062</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11beta-HSD1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11βHSD-1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>11β Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Urease Inhibitors [MoA]</name>
		<code>N0000175087</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175087</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urease Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease Inhibitors [MoA]</name>
		<code>N0000000076</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000076</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proprotein Convertase Inhibitors [MoA]</name>
		<code>N0000191729</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191729</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proprotein Convertase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>PCSK9 Inhibitors [MoA]</name>
		<code>N0000191730</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191730</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PCSK9 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enkephalinase Inhibitors [MoA]</name>
		<code>N0000000195</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000195</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enkephalinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HIV Protease Inhibitors [MoA]</name>
		<code>N0000000246</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000246</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Protease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Protease Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metalloprotease Inhibitors [MoA]</name>
		<code>N0000191725</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191725</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metalloprotease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metalloendopeptidase Inhibitors [MoA]</name>
		<code>N0000191726</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191726</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metalloendopeptidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neprilysin Inhibitors [MoA]</name>
		<code>N0000191727</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191727</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neprilysin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proteasome Inhibitors [MoA]</name>
		<code>N0000175075</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175075</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proteasome Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proteasome Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proteosome Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</name>
		<code>N0000175912</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175912</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DPP-4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase 4 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl-Peptidase IV Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase IV Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gliptins</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase-4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiotensin-converting Enzyme Inhibitors [MoA]</name>
		<code>N0000000181</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000181</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin Converting Enzyme Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin-converting Enzyme Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cysteine Proteinase Inhibitors [MoA]</name>
		<code>N0000000101</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000101</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cysteine Proteinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serine Proteinase Inhibitors [MoA]</name>
		<code>N0000000169</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000169</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serine Proteinase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tissue Plasminogen Activator Inhibitors [MoA]</name>
		<code>N0000010263</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010263</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tissue Plasminogen Activator Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TPA Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kallikrein Inhibitors [MoA]</name>
		<code>N0000184151</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184151</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kallikrein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thrombin Inhibitors [MoA]</name>
		<code>N0000009963</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009963</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thrombin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Plasmin Inhibitors [MoA]</name>
		<code>N0000010264</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010264</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plasmin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Trypsin Inhibitors [MoA]</name>
		<code>N0000000197</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000197</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Trypsin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HCV NS3/4A Protease Inhibitors [MoA]</name>
		<code>N0000182638</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182638</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCV NS3/4A Protease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus NS3/4A Protease Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endonuclease Inhibitors [MoA]</name>
		<code>N0000193851</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193851</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endonuclease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Polymerase Acidic Endonuclease Inhibitors [MoA]</name>
		<code>N0000193853</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193853</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polymerase Acidic Endonuclease Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amylase Inhibitors [MoA]</name>
		<code>N0000010274</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010274</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</name>
		<code>N0000191622</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191622</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PARP Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly (ADP-Ribose) Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly ADP-Ribose Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly (ADP Ribose) Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly(ADP-Ribose) Polymerase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly ADP Ribose Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PARP Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decarboxylase Inhibitors [MoA]</name>
		<code>N0000175844</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175844</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decarboxylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet Activating Factor Inhibitors [MoA]</name>
		<code>N0000009961</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009961</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet Activating Factor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</name>
		<code>N0000009962</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009962</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet Glycoprotein IIb/IIIA Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet Glycoprotein 2b/3A Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Transpeptidase Inhibitors [MoA]</name>
		<code>N0000010215</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010215</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PBP inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>penicillin binding protein Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transpepsidase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transpeptidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Diphosphate Receptor Inhibitors [MoA]</name>
		<code>N0000010334</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010334</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ADP Receptor Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Diphosphate Receptor Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 Inhibitors [MoA]</name>
		<code>N0000182136</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182136</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2B6 Inhibitors [MoA]</name>
		<code>N0000182139</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182139</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2B6 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2B6 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A Inhibitors [MoA]</name>
		<code>N0000190114</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190114</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A5 Inhibitors [MoA]</name>
		<code>N0000190115</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190115</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A5 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A5 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A4 Inhibitors [MoA]</name>
		<code>N0000182141</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182141</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A4 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A4 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 11A1 Inhibitors [MoA]</name>
		<code>N0000193984</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193984</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP11A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 11A1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 11A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 17A1 Inhibitors [MoA]</name>
		<code>N0000182632</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182632</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 17A1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP17A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 17A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A1 Inhibitors [MoA]</name>
		<code>N0000193954</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193954</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 1A1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 1A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP1A1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C8 Inhibitors [MoA]</name>
		<code>N0000187062</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187062</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2C8 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2C8 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C9 Inhibitors [MoA]</name>
		<code>N0000185504</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185504</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2C9 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2C9 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2A6 Inhibitors [MoA]</name>
		<code>N0000193937</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193937</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2A6 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2D6 Inhibitors [MoA]</name>
		<code>N0000182137</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182137</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2D6 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2D6 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2C19 Inhibitors [MoA]</name>
		<code>N0000182140</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182140</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2C19 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2C19 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 11B1 Inhibitors [MoA]</name>
		<code>N0000193936</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193936</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP11B1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 11B1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 11B1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 1A2 Inhibitors [MoA]</name>
		<code>N0000182138</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182138</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 1A2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 1A2 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sterol Synthesis Inhibitors [MoA]</name>
		<code>N0000009956</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009956</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sterol Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Synthesis Inhibitors [MoA]</name>
		<code>N0000175919</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175919</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholesterol Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</name>
		<code>N0000000121</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000121</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HMG-CoA Reductase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HMG-CoA Reductase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ergosterol Synthesis Inhibitors [MoA]</name>
		<code>N0000009957</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009957</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ergosterol Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fatty Acid Synthetase Inhibitors [MoA]</name>
		<code>N0000181000</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181000</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fatty Acid Synthetase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Synthase Inhibitors [MoA]</name>
		<code>N0000000173</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000173</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitric Oxide Synthase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin K Inhibitors [MoA]</name>
		<code>N0000175964</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175964</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin K Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin K Epoxide Reductase Inhibitors [MoA]</name>
		<code>N0000000164</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000164</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin K Epoxide Reductase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Catecholamine Synthesis Inhibitors [MoA]</name>
		<code>N0000175361</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175361</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catecholamine Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catecholamine Synthesis Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DOPA Decarboxylase Inhibitors [MoA]</name>
		<code>N0000175755</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175755</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DOPA Decarboxylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydroxyphenylalanine Decarboxylase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha Glucosidase Inhibitors [MoA]</name>
		<code>N0000000166</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000166</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha Glucosidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Glucosidase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alpha-glucosidase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dipeptidase Inhibitors [MoA]</name>
		<code>N0000175513</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175513</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dehydropeptidase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydropeptidase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Synthesis Inhibitors [MoA]</name>
		<code>N0000000233</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000233</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleic Acid Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase Inhibitors [MoA]</name>
		<code>N0000000176</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000176</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Gyrase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 2 Inhibitors [MoA]</name>
		<code>N0000020088</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020088</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase 2 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Gyrase Inhibitors [MoA]</name>
		<code>N0000020086</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020086</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Gyrase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 1 Inhibitors [MoA]</name>
		<code>N0000175890</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175890</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 4 Inhibitors [MoA]</name>
		<code>N0000020087</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020087</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase 4 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Terminase Complex Inhibitors [MoA]</name>
		<code>N0000193801</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193801</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Terminase Complex Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Folic Acid Metabolism Inhibitors [MoA]</name>
		<code>N0000000111</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000111</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folic Acid Metabolism Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folic Acid Metabolic Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folic Acid Antagonists</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitors [MoA]</name>
		<code>N0000000191</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000191</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydrofolate Reductase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ribonucleotide Reductase Inhibitors [MoA]</name>
		<code>N0000000212</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000212</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ribonucleotide Reductase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Polymerase Inhibitors [MoA]</name>
		<code>N0000020060</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020060</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Polymerase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Synthesis Inhibitors [MoA]</name>
		<code>N0000175074</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175074</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Synthesis Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Deaminase Inhibitors [MoA]</name>
		<code>N0000000187</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000187</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Deaminase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</name>
		<code>N0000185501</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185501</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydroorotate Dehydrogenase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thymidylate Synthetase Inhibitors [MoA]</name>
		<code>N0000000098</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000098</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thymidylate Synthetase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Reverse Transcriptase Inhibitors [MoA]</name>
		<code>N0000000103</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000103</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reverse Transcriptase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</name>
		<code>N0000009948</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009948</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</name>
		<code>N0000009947</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009947</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Reverse Transcriptase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RNA Synthetase Inhibitors [MoA]</name>
		<code>N0000175516</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175516</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA Synthetase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RNA Replicase Inhibitors [MoA]</name>
		<code>N0000191258</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191258</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA-dependent RNA Polymerase Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA Replicase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiac Myosin Inhibitors [MoA]</name>
		<code>N0000194048</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194048</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiac Myosin Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Factor Xa Inhibitors [MoA]</name>
		<code>N0000175635</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175635</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Factor Xa Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Activated Factor X Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Activated Factor 10 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Factor 10a Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>14-alpha Demethylase Inhibitors [MoA]</name>
		<code>N0000020025</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020025</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>14-alpha Demethylase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Epoxide Hydrolase Inhibitors [MoA]</name>
		<code>N0000192345</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192345</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epoxide Hydrolase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Inhibitors [MoA]</name>
		<code>N0000000177</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000177</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinesterase Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</name>
		<code>N0000193988</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193988</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IDH1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase-1 Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase 1 Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Stabilizers [MoA]</name>
		<code>N0000194078</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194078</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Stabilizers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Reactivators [MoA]</name>
		<code>N0000000208</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000208</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Reactivators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Reactivators [MoA]</name>
		<code>N0000000080</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000080</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinesterase Reactivators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Inducers [MoA]</name>
		<code>N0000190116</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190116</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Inducers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Membrane Transporter Interactions [MoA]</name>
		<code>N0000188367</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188367</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Membrane Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fatty Acid Transporter Interactions [MoA]</name>
		<code>N0000188368</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188368</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fatty Acid Transporter Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Microsomal Triglyceride Transfer Protein Interactions [MoA]</name>
		<code>N0000188369</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188369</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Microsomal Triglyceride Transfer Protein Interactions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</name>
		<code>N0000186778</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>MoA</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000186778</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Microsomal Triglyceride Transfer Protein Inhibitors</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MTTP Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Clinical Kinetics [PK]</name>
		<code>N0000000003</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000003</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Clinical Kinetics</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kinetics [PK]</name>
		<code>N0000000055</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000055</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kinetics</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Order [PK]</name>
		<code>N0000000056</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000056</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Order</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Zero Order [PK]</name>
		<code>N0000000058</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000058</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Zero Order</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>First Order [PK]</name>
		<code>N0000000057</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000057</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>First Order</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Clearance [PK]</name>
		<code>N0000000063</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000063</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Clearance</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Half-Life [PK]</name>
		<code>N0000000064</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000064</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Half-Life</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Compartments [PK]</name>
		<code>N0000000059</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000059</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Compartments</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>1-Compartment [PK]</name>
		<code>N0000000060</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000060</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>1-Compartment</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>2-Compartment [PK]</name>
		<code>N0000000061</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000061</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>2-Compartment</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>3-Compartment [PK]</name>
		<code>N0000000062</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000062</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>3-Compartment</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Elimination [PK]</name>
		<code>N0000000022</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000022</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Elimination</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Route of Excretion [PK]</name>
		<code>N0000000041</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000041</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Route of Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Excretion [PK]</name>
		<code>N0000000042</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000042</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fecal Excretion [PK]</name>
		<code>N0000000045</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000045</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fecal Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Milk Excretion [PK]</name>
		<code>N0000000046</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000046</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Milk Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatic Excretion [PK]</name>
		<code>N0000000043</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000043</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatic Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Excretion [PK]</name>
		<code>N0000000044</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000044</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Clinically Unimportant Route of Excretion [PK]</name>
		<code>N0000000047</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000047</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Clinically Unimportant Route of Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Umbilical Lint Excretion [PK]</name>
		<code>N0000000054</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000054</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Umbilical Lint Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tear Excretion [PK]</name>
		<code>N0000000049</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000049</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tear Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Skin Excretion [PK]</name>
		<code>N0000000051</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000051</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Skin Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hair Excretion [PK]</name>
		<code>N0000000052</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000052</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hair Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Saliva Excretion [PK]</name>
		<code>N0000000048</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000048</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Saliva Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sweat Excretion [PK]</name>
		<code>N0000000050</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000050</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sweat Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nail Excretion [PK]</name>
		<code>N0000000053</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000053</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nail Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metabolism [PK]</name>
		<code>N0000000023</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000023</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Site of Metabolism [PK]</name>
		<code>N0000000024</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000024</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Site of Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Metabolism [PK]</name>
		<code>N0000000027</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000027</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatic Metabolism [PK]</name>
		<code>N0000000026</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000026</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatic Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Intestinal Metabolism [PK]</name>
		<code>N0000000025</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000025</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Intestinal Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Metabolism [PK]</name>
		<code>N0000000028</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000028</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Plasma Metabolism [PK]</name>
		<code>N0000000029</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000029</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plasma Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzymatic Pathway of Metabolism [PK]</name>
		<code>N0000000030</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000030</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzymatic Pathway of Metabolism</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfotransferases [PK]</name>
		<code>N0000000036</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000036</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfotransferases</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Esterases [PK]</name>
		<code>N0000000032</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000032</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Esterases</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>N-acetyl transferases [PK]</name>
		<code>N0000000037</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000037</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-acetyl transferases</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochromes [PK]</name>
		<code>N0000000031</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000031</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochromes</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glutathione s-transferases [PK]</name>
		<code>N0000000035</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000035</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glutathione s-transferases</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoamine oxidase [PK]</name>
		<code>N0000000039</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000039</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine oxidase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Epoxide hydrolases [PK]</name>
		<code>N0000000033</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000033</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epoxide hydrolases</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucuronosyl transferases [PK]</name>
		<code>N0000000034</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000034</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucuronosyl transferases</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thiopurine methyltransferase [PK]</name>
		<code>N0000000038</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000038</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thiopurine methyltransferase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Co-methyltransferase [PK]</name>
		<code>N0000000040</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000040</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Co-methyltransferase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aromatic hydroxylation [PK]</name>
		<code>N0000008289</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008289</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatic hydroxylation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Absorption [PK]</name>
		<code>N0000000008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Affected by gastric pH [PK]</name>
		<code>N0000000012</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000012</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Affected by gastric pH</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enhanced by acidity [PK]</name>
		<code>N0000000013</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000013</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enhanced by acidity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased by acidity [PK]</name>
		<code>N0000000014</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000014</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased by acidity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Affected by food/other nutrients [PK]</name>
		<code>N0000000009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Affected by food/other nutrients</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased by food [PK]</name>
		<code>N0000000011</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000011</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased by food</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased by food [PK]</name>
		<code>N0000000010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased by food</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Affected by concomitant drug administration [PK]</name>
		<code>N0000000016</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000016</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Affected by concomitant drug administration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Affected by intestinal surface area [PK]</name>
		<code>N0000000015</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000015</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Affected by intestinal surface area</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Absorption Half-Life [PK]</name>
		<code>N0000000017</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000017</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Absorption Half-Life</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Distribution [PK]</name>
		<code>N0000000018</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000018</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Distribution</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Volume of distribution [PK]</name>
		<code>N0000000019</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000019</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Volume of distribution</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Site of relative exclusion [PK]</name>
		<code>N0000000021</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000021</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Site of relative exclusion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Site of concentration [PK]</name>
		<code>N0000000020</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PK</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000020</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Site of concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pharmaceutical and Biological Preparations</name>
		<code>N0000000001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000000001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pharmaceutical and Biological Preparations</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Preparations by FDA Established Pharmacologic Class</name>
		<code>N0000189939</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000189939</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Preparations by FDA Established Pharmacologic Class</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibody or Antibody Fragment [APC]</name>
		<code>N0000193872</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193872</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibody or Antibody Fragment</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Receptor-1 Blocking Antibody [EPC]</name>
		<code>N0000191260</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191260</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Programmed Death Receptor-1 Blocking Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PD-1 Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycolipid Disialoganglioside-directed Antibody [EPC]</name>
		<code>N0000191500</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191500</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycolipid Disialoganglioside (GD2)-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GD2-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycolipid Disialoganglioside-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Claudin 18.2-directed Cytolytic Antibody [EPC]</name>
		<code>N0000194107</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194107</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Claudin 18.2-directed Cytolytic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CLDN 18.2-directed Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CLDN18.2-directed Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Claudin-18.2-directed Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Claudin18.2-directed Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Radiotherapeutic Antibody [EPC]</name>
		<code>N0000175658</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175658</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD20-directed Radiotherapeutic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD20-directed, Radiotherapeutic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunoglobulin [EPC]</name>
		<code>N0000184164</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184164</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunoglobulin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Passively Acquired Immunity [PE]</name>
		<code>N0000183365</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183365</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acquired Passive Immunity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Passively Acquired Immunity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunoglobulin G [EPC]</name>
		<code>N0000184165</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184165</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunoglobulin G</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</name>
		<code>N0000193803</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193803</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-5 Receptor alpha-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-IL-5 Receptor alpha mAb</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL5 Receptor alpha-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 5 Receptor alpha-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-IgE [EPC]</name>
		<code>N0000175794</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175794</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-IgE Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-IgE</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased IgE Activity [PE]</name>
		<code>N0000175793</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175793</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased IgE Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunoglobulin G [EPC]</name>
		<code>N0000184163</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184163</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunoglobulin G</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amyloid Beta-directed Antibody [EPC]</name>
		<code>N0000193951</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193951</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amyloid Beta-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD20-directed Cytolytic Antibody [EPC]</name>
		<code>N0000175657</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175657</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD20-directed Cytolytic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD20-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD20-directed, Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD38-directed Cytolytic Antibody [EPC]</name>
		<code>N0000192336</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192336</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD38-directed Cytolytic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CTLA-4-directed Blocking Antibody [EPC]</name>
		<code>N0000182635</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182635</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T-Lymphocyte Antigen 4-directed Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T Lymphocyte Antigen 4-directed Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T Lymphocyte Antigen-4-directed Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CTLA4-directed Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxic T-Lymphocyte Antigen-4-directed Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CTLA-4-directed Blocking Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CTLA 4-directed Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologic Activity [PE]</name>
		<code>N0000175551</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175551</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immune System Stimulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic Stimulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunostimulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immune Stimulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Molecule Production [PE]</name>
		<code>N0000009359</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009359</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologically Active Molecule Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cytokine Production [PE]</name>
		<code>N0000009269</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009269</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cytokine Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Antibody Production [PE]</name>
		<code>N0000009088</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009088</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Antibody Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased IgG Production [PE]</name>
		<code>N0000185001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunoglobulin G Production</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased IgG Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Hemagglutinin Inhibition Antibody Production [PE]</name>
		<code>N0000186107</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000186107</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Hemagglutinin Inhibition Antibody Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Kinin Production [PE]</name>
		<code>N0000009369</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009369</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Kinin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Bradykinin Production [PE]</name>
		<code>N0000009120</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009120</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Bradykinin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</name>
		<code>N0000009378</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009378</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lipid Derived Immunologically Active Molecule Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Eicosanoid Production [PE]</name>
		<code>N0000009286</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009286</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Eicosanoid Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Leukotriene Production [PE]</name>
		<code>N0000009375</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009375</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Leukotriene Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prostaglandin Production [PE]</name>
		<code>N0000009528</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009528</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prostaglandin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thromboxane Production [PE]</name>
		<code>N0000009698</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009698</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thromboxane Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Activating Factor Production [PE]</name>
		<code>N0000009523</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009523</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Platelet Activating Factor Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Complement Production [PE]</name>
		<code>N0000009266</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009266</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Complement Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Adhesion Factor Production [PE]</name>
		<code>N0000009082</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009082</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Adhesion Factor Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Biogenic Amine Production [PE]</name>
		<code>N0000009356</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009356</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologically Active Biogenic Amine Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Serotonin Production [PE]</name>
		<code>N0000009587</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009587</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Serotonin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Production [PE]</name>
		<code>N0000009353</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009353</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Histamine Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Kallidin Production [PE]</name>
		<code>N0000009366</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009366</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Kallidin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Molecule Degradation [PE]</name>
		<code>N0000009358</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009358</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologically Active Molecule Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Adhesion Factor Degradation [PE]</name>
		<code>N0000009081</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009081</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Adhesion Factor Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Complement Degradation [PE]</name>
		<code>N0000009265</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009265</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Complement Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Antibody Degradation [PE]</name>
		<code>N0000009087</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009087</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Antibody Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</name>
		<code>N0000009377</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009377</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lipid Derived Immunologically Active Molecule Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Eicosanoid Degradation [PE]</name>
		<code>N0000009285</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009285</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Eicosanoid Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prostaglandin Degradation [PE]</name>
		<code>N0000009527</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009527</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prostaglandin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Leukotriene Degradation [PE]</name>
		<code>N0000009374</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009374</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Leukotriene Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thromboxane Degradation [PE]</name>
		<code>N0000009697</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009697</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thromboxane Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Activating Factor Degradation [PE]</name>
		<code>N0000009522</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009522</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Platelet Activating Factor Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Kallidin Degradation [PE]</name>
		<code>N0000009365</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009365</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Kallidin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Biogenic Amine Degradation [PE]</name>
		<code>N0000009355</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009355</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologically Active Biogenic Amine Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Degradation [PE]</name>
		<code>N0000009352</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009352</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Histamine Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Serotonin Degradation [PE]</name>
		<code>N0000009586</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009586</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Serotonin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cytokine Degradation [PE]</name>
		<code>N0000009268</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009268</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cytokine Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Kinin Degradation [PE]</name>
		<code>N0000009368</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009368</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Kinin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Bradykinin Degradation [PE]</name>
		<code>N0000009119</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009119</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Bradykinin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acquired Immunity [PE]</name>
		<code>N0000183363</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183363</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acquired Immunity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Actively Acquired Immunity [PE]</name>
		<code>N0000183364</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183364</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acquired Active Immunity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Actively Acquired Immunity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Humoral Immunity [PE]</name>
		<code>N0000185002</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185002</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Humoral Immunity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell-mediated Immunity [PE]</name>
		<code>N0000184306</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184306</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell-mediated Immunity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunity, Cellular</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Molecule Activity [PE]</name>
		<code>N0000009357</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009357</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologically Active Molecule Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</name>
		<code>N0000009376</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009376</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lipid Derived Immunologically Active Molecule Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Eicosanoid Activity [PE]</name>
		<code>N0000009284</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009284</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Eicosanoid Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prostaglandin Activity [PE]</name>
		<code>N0000009526</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009526</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prostaglandin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Leukotriene Activity [PE]</name>
		<code>N0000009373</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009373</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Leukotriene Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thromboxane Activity [PE]</name>
		<code>N0000009696</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009696</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thromboxane Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Activating Factor Activity [PE]</name>
		<code>N0000009521</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009521</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Platelet Activating Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Complement Activity [PE]</name>
		<code>N0000009264</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009264</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Complement Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cytokine Activity [PE]</name>
		<code>N0000009267</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009267</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cytokine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Kallidin Activity [PE]</name>
		<code>N0000009364</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009364</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Kallidin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Antibody Activity [PE]</name>
		<code>N0000009086</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009086</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Antibody Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Kinin Activity [PE]</name>
		<code>N0000009367</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009367</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Kinin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Bradykinin Activity [PE]</name>
		<code>N0000009118</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009118</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Bradykinin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Adhesion Factor Activity [PE]</name>
		<code>N0000009080</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009080</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Adhesion Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Immunologically Active Biogenic Amine Activity [PE]</name>
		<code>N0000009354</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009354</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Immunologically Active Biogenic Amine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Serotonin Activity [PE]</name>
		<code>N0000009585</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009585</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Serotonin Activity [PE]</name>
		<code>N0000009198</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009198</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Serotonin Activity [PE]</name>
		<code>N0000009142</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009142</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Serotonin Activity [PE]</name>
		<code>N0000009420</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009420</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Serotonin Activity [PE]</name>
		<code>N0000009638</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009638</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Serotonin Activity [PE]</name>
		<code>N0000009221</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009221</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Serotonin Activity [PE]</name>
		<code>N0000009244</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009244</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Serotonin Activity [PE]</name>
		<code>N0000009514</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009514</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Serotonin Activity [PE]</name>
		<code>N0000009582</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009582</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Serotonin Activity [PE]</name>
		<code>N0000009314</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009314</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Serotonin Activity [PE]</name>
		<code>N0000009110</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009110</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Serotonin Activity [PE]</name>
		<code>N0000009491</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009491</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Serotonin Activity [PE]</name>
		<code>N0000009686</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009686</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Serotonin Activity [PE]</name>
		<code>N0000009447</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009447</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Serotonin Activity [PE]</name>
		<code>N0000009662</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009662</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Serotonin Activity [PE]</name>
		<code>N0000009611</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009611</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Serotonin Activity [PE]</name>
		<code>N0000009169</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009169</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Activity [PE]</name>
		<code>N0000009351</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009351</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Histamine Activity [PE]</name>
		<code>N0000009508</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009508</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Histamine Activity [PE]</name>
		<code>N0000009308</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009308</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Histamine Activity [PE]</name>
		<code>N0000009577</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009577</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Histamine Activity [PE]</name>
		<code>N0000009104</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009104</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Histamine Activity [PE]</name>
		<code>N0000009485</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009485</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Histamine Activity [PE]</name>
		<code>N0000009680</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009680</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Histamine Activity [PE]</name>
		<code>N0000009192</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009192</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Histamine Activity [PE]</name>
		<code>N0000009136</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009136</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Histamine Activity [PE]</name>
		<code>N0000009632</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009632</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Histamine Activity [PE]</name>
		<code>N0000009414</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009414</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Histamine Activity [PE]</name>
		<code>N0000009215</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009215</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Histamine Activity [PE]</name>
		<code>N0000009238</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009238</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Histamine Activity [PE]</name>
		<code>N0000009441</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009441</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Histamine Activity [PE]</name>
		<code>N0000009605</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009605</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Histamine Activity [PE]</name>
		<code>N0000009163</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009163</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Histamine Activity [PE]</name>
		<code>N0000009656</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009656</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased T Lymphocyte Activation [PE]</name>
		<code>N0000182157</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182157</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased T Lymphocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD22-directed Immunoconjugate [EPC]</name>
		<code>N0000193617</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193617</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD22-directed Antibody-Drug Conjugate</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD22-directed Immunoconjugate</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bispecific HER2-directed Antibody [EPC]</name>
		<code>N0000194137</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194137</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific HER2-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</name>
		<code>N0000175623</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175623</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RSV Anti-F Protein Monoclonal Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RSV Anti-F Protein Monoclonal (mAb)</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Humanized Monoclonal Antibody Fragment [EPC]</name>
		<code>N0000191873</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191873</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Humanized Monoclonal Antibody Fragment</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antivenin [EPC]</name>
		<code>N0000184162</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184162</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antivenin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD33-directed Immunoconjugate [EPC]</name>
		<code>N0000175571</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175571</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD33-directed Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD33-directed Immunoconjugate</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD33-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Receptor Blocking Antibody [EPC]</name>
		<code>N0000175622</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175622</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-2 Receptor Blocking Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-2 Blocker (Antibody)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-2 Receptor Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor Blocking Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD30-directed Immunoconjugate [EPC]</name>
		<code>N0000182967</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182967</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD30-directed Antibody-drug Conjugate</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD30-directed Immunoconjugate</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</name>
		<code>N0000194038</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194038</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Zaire EBOV GP-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>SLAMF7-directed Immunostimulatory Antibody [EPC]</name>
		<code>N0000192338</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192338</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLAMF7-directed Immunostimulatory Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Signaling Lymphocytic Activation Molecule Family member 7-directed Immunostimulatory Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD319-directed Immunostimulatory Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD52-directed Cytolytic Antibody [EPC]</name>
		<code>N0000175659</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175659</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD52-directed Cytolytic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD52-directed, Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD52-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anthrax Protective Antigen-directed Antibody [EPC]</name>
		<code>N0000192703</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192703</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anthrax Protective Antigen-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Agent [APC]</name>
		<code>N0000193909</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193909</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Stimulant [EPC]</name>
		<code>N0000175716</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175716</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Stimulant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Medullary Respiratory Drive [PE]</name>
		<code>N0000009393</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009393</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Medullary Respiratory Drive</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Surfactant [EPC]</name>
		<code>N0000175778</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175778</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Surfactant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alveolar Surface Tension Reduction [PE]</name>
		<code>N0000008294</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008294</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alveolar Surface Tension Reduction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Receptor Antagonist [EPC]</name>
		<code>N0000175777</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175777</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>LTRA</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leukotriene Receptor Antagonist (LTRA)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leukotriene Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</name>
		<code>N0000184146</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184146</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CFTR Potentiator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mast Cell Stabilizer [EPC]</name>
		<code>N0000175630</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175630</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mast Cell Stabilizer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Release [PE]</name>
		<code>N0000175628</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175628</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Histamine Release</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Expectorant [EPC]</name>
		<code>N0000193956</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193956</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Expectorant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Respiratory Secretions [PE]</name>
		<code>N0000009560</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009560</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Respiratory Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Nasal and Sinus Secretions [PE]</name>
		<code>N0000009588</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009588</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Nasal and Sinus Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Pharyngeal Secretions [PE]</name>
		<code>N0000009452</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009452</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Pharyngeal Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Tracheo-Bronchial Secretions [PE]</name>
		<code>N0000009701</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009701</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Tracheo-Bronchial Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Respiratory Secretion Viscosity [PE]</name>
		<code>N0000008867</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008867</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Respiratory Secretion Viscosity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-narcotic Antitussive [EPC]</name>
		<code>N0000175796</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175796</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-narcotic Antitussive</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonnarcotic Antitussive</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antitussive Agent [TC]</name>
		<code>N0000178319</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178319</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antitussive</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antitussive Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</name>
		<code>N0000009010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Tracheobronchial Stretch Receptor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antihistamine [EPC]</name>
		<code>N0000175750</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175750</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antihistaminic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antihistamine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mucolytic [EPC]</name>
		<code>N0000175776</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175776</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucolytic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gene Therapy [APC]</name>
		<code>N0000194012</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194012</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gene Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</name>
		<code>N0000194087</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194087</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</name>
		<code>N0000193971</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193971</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous HSC-Based Gene Therapy</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous HSC Gene Therapy</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hemoglobin Function Restoration [PE]</name>
		<code>N0000193979</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193979</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hemoglobin Function Restoration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</name>
		<code>N0000194103</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194103</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Imaging Agent [APC]</name>
		<code>N0000193875</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193875</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Imaging Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gadolinium-based Contrast Agent [EPC]</name>
		<code>N0000183362</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183362</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gadolinium-based Contrast Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhalation Diagnostic Agent [EPC]</name>
		<code>N0000175866</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175866</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhalation Diagnostic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diagnostic Agent [TC]</name>
		<code>N0000178317</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178317</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diagnostic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diagnostic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Paramagnetic Contrast Agent [EPC]</name>
		<code>N0000180184</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180184</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Paramagnetic Contrast Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Agent [EPC]</name>
		<code>N0000177914</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177914</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioactive Diagnostic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Contrast Agent for Ultrasound Imaging [EPC]</name>
		<code>N0000175864</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175864</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Contrast Agent for Ultrasound Imaging</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radiographic Contrast Agent [EPC]</name>
		<code>N0000180185</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180185</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radiographic Contrast Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Optical Imaging Agent [EPC]</name>
		<code>N0000193983</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193983</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Optical Imaging Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diagnostic Dye [EPC]</name>
		<code>N0000175536</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175536</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diagnostic Dye</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarized Contrast Agent [EPC]</name>
		<code>N0000194089</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194089</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarized Contrast Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ion Channel or Pump Agent [APC]</name>
		<code>N0000193904</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193904</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ion Channel or Pump Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Agent [APC]</name>
		<code>N0000193892</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193892</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Channel Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>N-type Calcium Channel Antagonist [EPC]</name>
		<code>N0000175697</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175697</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-type Calcium Channel Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydropyridine Calcium Channel Blocker [EPC]</name>
		<code>N0000175421</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175421</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydropyridine Calcium Channel Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Channel Blocker [EPC]</name>
		<code>N0000175566</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175566</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Channel Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</name>
		<code>N0000191544</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191544</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Cation Channel Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCN Channel Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hyperpolarization-activated Cation Channel Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I(h) Channel Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Blocker [EPC]</name>
		<code>N0000192795</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192795</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine [EPC]</name>
		<code>N0000175694</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175694</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzodiazepine</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzodiazepine-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Nicotinic Agonist [EPC]</name>
		<code>N0000175706</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175706</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Nicotinic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nicotinic Cholinergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nicotinic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nicotine Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Partial Cholinergic Nicotinic Agonist [EPC]</name>
		<code>N0000175705</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175705</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Cholinergic Nicotinic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Nicotine Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Nicotinic Cholinergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Nicotinic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</name>
		<code>N0000194083</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194083</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid A Receptor Positive Modulator</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Positive Modulator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</name>
		<code>N0000181821</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181821</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uncompetitive NMDA Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uncompetitive N-methyl-D-aspartate (NMDA) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium Channel Blocker [EPC]</name>
		<code>N0000194141</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194141</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium Channel Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chloride Channel Activator [EPC]</name>
		<code>N0000175573</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175573</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chloride Channel Activator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium-sparing Diuretic [EPC]</name>
		<code>N0000175418</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175418</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium-sparing Diuretic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Diuresis [PE]</name>
		<code>N0000175359</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175359</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diuretic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Diuresis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Diuresis at Loop of Henle [PE]</name>
		<code>N0000175366</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175366</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Diuresis at Loop of Henle</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Ca++ Excretion [PE]</name>
		<code>N0000009381</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009381</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle SO4-- Excretion [PE]</name>
		<code>N0000009389</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009389</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle H+ Excretion [PE]</name>
		<code>N0000009383</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009383</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle K+ Excretion [PE]</name>
		<code>N0000009385</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009385</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Na+ Excretion [PE]</name>
		<code>N0000009387</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009387</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Cl- Excretion [PE]</name>
		<code>N0000009382</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009382</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle HCO3- Excretion [PE]</name>
		<code>N0000009384</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009384</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle Mg++ Excretion [PE]</name>
		<code>N0000009386</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009386</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Loop of Henle PO4-- Excretion [PE]</name>
		<code>N0000009388</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009388</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Loop of Henle PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal K+ Excretion [PE]</name>
		<code>N0000008859</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008859</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct K+ Excretion [PE]</name>
		<code>N0000008562</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008562</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle K+ Excretion [PE]</name>
		<code>N0000008693</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008693</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule K+ Excretion [PE]</name>
		<code>N0000008583</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008583</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule K+ Excretion [PE]</name>
		<code>N0000008846</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008846</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</name>
		<code>N0000175759</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175759</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid (GABA)-ergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABAergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA-ergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid-ergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</name>
		<code>N0000183360</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183360</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA-A Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA-A Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid A Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid-A Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid A Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GABA A Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>gamma-Aminobutyric Acid-A Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</name>
		<code>N0000194006</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194006</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuroactive Steroid GABA A Receptor Positive Modulator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</name>
		<code>N0000186106</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000186106</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Noncompetitive AMPA Glutamate Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-competitive AMPA Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Noncompetitive AMPA Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-competitive AMPA Glutamate Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autonomic Ganglionic Blocker [EPC]</name>
		<code>N0000175641</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175641</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autonomic Ganglionic Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Ganglionic Activity [PE]</name>
		<code>N0000175644</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175644</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Ganglionic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>TRPM8 Thermoreceptor Agonist [EPC]</name>
		<code>N0000194172</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194172</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transient Receptor Potential Melastatin 8 Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRPM8 Thermoreceptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proton Pump Inhibitor [EPC]</name>
		<code>N0000175525</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175525</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proton Pump Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium-competitive Acid Blocker [EPC]</name>
		<code>N0000194136</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194136</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium-competitive Acid Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>N-methyl-D-aspartate Receptor Antagonist [EPC]</name>
		<code>N0000175745</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175745</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-methyl-D-aspartate (NMDA) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N-methyl-D-aspartate Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NMDA Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Benzodiazepine Antagonist [EPC]</name>
		<code>N0000175680</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175680</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzodiazepine Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Blocker [EPC]</name>
		<code>N0000193962</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193962</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuromuscular Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nondepolarizing Neuromuscular Blocker [EPC]</name>
		<code>N0000175720</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175720</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nondepolarizing Neuromuscular Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Contraction [PE]</name>
		<code>N0000008953</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008953</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Contraction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Nondepolarizing Blockade [PE]</name>
		<code>N0000175732</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175732</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuromuscular Nondepolarizing Blockade</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Blockade [PE]</name>
		<code>N0000175731</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175731</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuromuscular Blockade</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Depolarizing Blockade [PE]</name>
		<code>N0000175733</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175733</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuromuscular Depolarizing Blockade</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Depolarizing Neuromuscular Blocker [EPC]</name>
		<code>N0000175719</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175719</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Depolarizing Neuromuscular Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nervous System Agent [APC]</name>
		<code>N0000193905</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193905</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nervous System Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Agonist/Antagonist [EPC]</name>
		<code>N0000175692</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175692</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Opioid Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Agonist/Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Opioid Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist/Antagonist [EPC]</name>
		<code>N0000175688</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175688</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Opioid Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Opioid Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist/Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Receptor Agonist [EPC]</name>
		<code>N0000175884</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175884</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anticholinergic [EPC]</name>
		<code>N0000175574</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175574</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticholinergic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticholinergic Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ergotamine Derivative [EPC]</name>
		<code>N0000175766</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175766</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ergotamine Derivative</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Antagonist [EPC]</name>
		<code>N0000175700</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175700</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscarinic Anticholinesterase Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscarinic Anticholinergic Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscarinic Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Muscarinic Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Typical Antipsychotic [EPC]</name>
		<code>N0000180182</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180182</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Typical Antipsychotic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antipsychotic Agent [TC]</name>
		<code>N0000178316</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178316</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antipsychotic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antipsychotic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tricyclic Antidepressant [EPC]</name>
		<code>N0000175752</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175752</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tricyclic Antidepressant</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TCA</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tricyclic Antidepressant (TCA)</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidepressive Agent [TC]</name>
		<code>N0000178314</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178314</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidepressive Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidepressive</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidepressant</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Agonist [EPC]</name>
		<code>N0000175690</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175690</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Receptor Binder</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kappa Opioid Receptor Agonist [EPC]</name>
		<code>N0000194001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kappa Opioid Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>KOR Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Partial Opioid Agonist [EPC]</name>
		<code>N0000175689</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175689</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Opioid Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist and Opioid Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Partial Opioid Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Opioid Agonist/Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Blocker [EPC]</name>
		<code>N0000175556</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175556</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Inhibitor [EPC]</name>
		<code>N0000175744</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175744</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase Inhibitor (MAOI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAOI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoamine Oxidase Type B Inhibitor [EPC]</name>
		<code>N0000175762</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175762</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAOI-B</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAO-B Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase Type B (MAO-B) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoamine Oxidase Type B Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</name>
		<code>N0000175749</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175749</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin and Norepinephrine Reuptake Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SNRI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mood Stabilizer [EPC]</name>
		<code>N0000175751</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175751</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mood Stabilizer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimanic Agent [TC]</name>
		<code>N0000178315</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178315</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimanic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimanic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</name>
		<code>N0000190856</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190856</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vesicular Monoamine Transporter 2 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Blocker [EPC]</name>
		<code>N0000175553</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175553</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Inhibitor [EPC]</name>
		<code>N0000175723</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175723</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetylcholinesterase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinesterase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ergot-derived Dopamine Receptor Agonist [EPC]</name>
		<code>N0000175767</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175767</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ergot-derived Dopamine Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopaminergic Agonist [EPC]</name>
		<code>N0000175580</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175580</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopaminergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aminoketone [EPC]</name>
		<code>N0000180855</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180855</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminoketone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Release Inhibitor [EPC]</name>
		<code>N0000175771</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175771</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetylcholine Release Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Tone [PE]</name>
		<code>N0000175735</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175735</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Acetylcholine Activity [PE]</name>
		<code>N0000008949</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008949</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ergot Derivative [EPC]</name>
		<code>N0000175827</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175827</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ergot Derivative</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sigma-1 Agonist [EPC]</name>
		<code>N0000182149</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182149</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sigma-1 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sigma-1 Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Muscarinic Agonist [EPC]</name>
		<code>N0000175840</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175840</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscarinic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Muscarinic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Atypical Antipsychotic [EPC]</name>
		<code>N0000175430</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175430</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Atypical Antipsychotic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinesterase Reactivator [EPC]</name>
		<code>N0000175742</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175742</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinesterase Reactivator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cannabinoid [EPC]</name>
		<code>N0000175782</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175782</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cannabinoid-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cannabinoid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Reuptake Inhibitor [EPC]</name>
		<code>N0000175695</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175695</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Norepinephrine Reuptake Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine Reuptake Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SNRI</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin-3 Receptor Antagonist [EPC]</name>
		<code>N0000175818</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175818</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 3 (5HT-3) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 3 (5-HT3) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-3 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 3 (5HT3) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT3 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-3 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 3 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 3 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT3 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Reuptake Inhibitor [EPC]</name>
		<code>N0000175696</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175696</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Reuptake Inhibitor (SSRI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Serotonin Reuptake Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SSRI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Serotonin Reuptake Inhibitor (SSRI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Reuptake Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</name>
		<code>N0000194049</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194049</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NDRI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine and Norepinephrine Reuptake Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine-Norepinephrine Reuptake Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine-Dopamine Reuptake Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNRI</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin-2c Receptor Agonist [EPC]</name>
		<code>N0000185010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin (5-HT) 2C Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin (5-HT) 2c Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-2C Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-2c Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 2c Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 2C Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-2c Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-2C Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Depressant [EPC]</name>
		<code>N0000175758</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175758</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Nervous System Depressant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000008501</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008501</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</name>
		<code>N0000008547</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008547</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Organized Electrical Activity [PE]</name>
		<code>N0000008524</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008524</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Organized Electrical Activity [PE]</name>
		<code>N0000008727</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008727</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Organized Electrical Activity [PE]</name>
		<code>N0000008445</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008445</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Organized Electrical Activity [PE]</name>
		<code>N0000008945</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008945</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Depression [PE]</name>
		<code>N0000175728</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175728</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Nervous System Depression</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>General Anesthesia [PE]</name>
		<code>N0000175975</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175975</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>General Anesthesia</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Emesis Suppression [PE]</name>
		<code>N0000009034</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009034</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Emesis Suppression</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Analgesia [PE]</name>
		<code>N0000175439</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175439</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Analgesia</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Appetite Suppression [PE]</name>
		<code>N0000175372</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175372</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anorectic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Appetite Suppression</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nonergot Dopamine Agonist [EPC]</name>
		<code>N0000175768</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175768</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonergot Dopamine Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melatonin Receptor Agonist [EPC]</name>
		<code>N0000175743</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175743</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melatonin Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic Agent [APC]</name>
		<code>N0000193910</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193910</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sympathomimetic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic Amine Anorectic [EPC]</name>
		<code>N0000175423</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175423</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sympathomimetic Amine Anorectic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Activity [PE]</name>
		<code>N0000175651</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175651</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sympathomimetic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic VIP Activity [PE]</name>
		<code>N0000009688</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009688</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic GABA Activity [PE]</name>
		<code>N0000009676</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009676</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Norepinephrine Activity [PE]</name>
		<code>N0000009684</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009684</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Gastrin Activity [PE]</name>
		<code>N0000009677</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009677</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Glycine Activity [PE]</name>
		<code>N0000009679</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009679</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Neurotensin Activity [PE]</name>
		<code>N0000009682</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009682</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Nerve Growth Factor Activity [PE]</name>
		<code>N0000009681</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009681</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Epinephrine Activity [PE]</name>
		<code>N0000009675</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009675</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Enkephalin Activity [PE]</name>
		<code>N0000009674</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009674</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Dynorphin Activity [PE]</name>
		<code>N0000009672</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009672</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Endorphin Activity [PE]</name>
		<code>N0000009673</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009673</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic CCK Activity [PE]</name>
		<code>N0000009669</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009669</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Acetylcholine Activity [PE]</name>
		<code>N0000009666</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009666</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Glutamate Activity [PE]</name>
		<code>N0000009678</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009678</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Substance P Activity [PE]</name>
		<code>N0000009687</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009687</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Nitric Oxide Activity [PE]</name>
		<code>N0000009683</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009683</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009668</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009668</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Aspartate Activity [PE]</name>
		<code>N0000009667</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009667</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Dopamine Activity [PE]</name>
		<code>N0000009671</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009671</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amphetamine Anorectic [EPC]</name>
		<code>N0000175425</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175425</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amphetamine Anorectic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Catecholamine [EPC]</name>
		<code>N0000175570</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175570</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catecholamine-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catecholamine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sympathomimetic-like Agent [EPC]</name>
		<code>N0000175769</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175769</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sympathomimetic-like Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Receptor Agonist [EPC]</name>
		<code>N0000175883</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175883</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Agonist [EPC]</name>
		<code>N0000175552</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175552</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-1 Adrenergic Agonist [EPC]</name>
		<code>N0000186105</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000186105</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-1 Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-1 Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central alpha-2 Adrenergic Agonist [EPC]</name>
		<code>N0000175554</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175554</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central alpha-2 Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central a-2 Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective alpha2-Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-2 Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta-Adrenergic Agonist [EPC]</name>
		<code>N0000175555</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175555</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta3-Adrenergic Agonist [EPC]</name>
		<code>N0000185008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-3 Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-3 Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta3-Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta3-Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Bladder Contractility [PE]</name>
		<code>N0000008420</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008420</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Bladder Contractility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta2-Adrenergic Agonist [EPC]</name>
		<code>N0000175779</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175779</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-2 Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta2-Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta2-Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-2 Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Releasing Agent [EPC]</name>
		<code>N0000192563</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192563</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine Releasing Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Norepinephrine Activity [PE]</name>
		<code>N0000009456</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009456</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000009196</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009196</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Norepinephrine Activity [PE]</name>
		<code>N0000009418</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009418</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Norepinephrine Activity [PE]</name>
		<code>N0000009636</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009636</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Norepinephrine Activity [PE]</name>
		<code>N0000009140</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009140</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Norepinephrine Activity [PE]</name>
		<code>N0000009219</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009219</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Norepinephrine Activity [PE]</name>
		<code>N0000009242</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009242</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Norepinephrine Activity [PE]</name>
		<code>N0000009445</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009445</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Norepinephrine Activity [PE]</name>
		<code>N0000009167</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009167</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Norepinephrine Activity [PE]</name>
		<code>N0000009609</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009609</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Norepinephrine Activity [PE]</name>
		<code>N0000009660</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009660</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000009512</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009512</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000009312</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009312</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000009108</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009108</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Norepinephrine Activity [PE]</name>
		<code>N0000009489</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009489</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000009580</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009580</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phenothiazine [EPC]</name>
		<code>N0000175746</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175746</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phenothiazine-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phenothiazine</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phenothiazine Derivative</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine-2 Receptor Antagonist [EPC]</name>
		<code>N0000175800</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175800</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>D2 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine-2 (D2) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine-2 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic Agent [EPC]</name>
		<code>N0000175753</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175753</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-epileptic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-epileptic Drug</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-epileptic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000008486</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008486</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Disorganized Electrical Activity [PE]</name>
		<code>N0000008430</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008430</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Disorganized Electrical Activity [PE]</name>
		<code>N0000008930</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008930</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Disorganized Electrical Activity [PE]</name>
		<code>N0000008532</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008532</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Disorganized Electrical Activity [PE]</name>
		<code>N0000008712</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008712</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Disorganized Electrical Activity [PE]</name>
		<code>N0000008509</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008509</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-epileptic Agent [TC]</name>
		<code>N0000178313</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178313</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-epileptic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiepileptic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-epileptic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Stimulant [EPC]</name>
		<code>N0000175739</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175739</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulant</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Nervous System Stimulant</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CNS Stimulant</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Stimulation [PE]</name>
		<code>N0000175729</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175729</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Nervous System Stimulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Appetite Stimulation [PE]</name>
		<code>N0000175373</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175373</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Appetite Stimulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</name>
		<code>N0000175765</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175765</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1B and 5HT-1D Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1B/5HT-1D Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1b and 1d Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1B/1D Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin (5-HT) 1b/1d Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-1B and Serotonin-1D Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1b and 5HT-1d Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-1b and Serotonin-1d Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1b/1d Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin (5-HT) 1B/1D Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-1b/5HT-1d Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 1B and 1D Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematology Agent [APC]</name>
		<code>N0000193901</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193901</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematology Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thrombopoietin Receptor Agonist [EPC]</name>
		<code>N0000175973</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175973</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thrombopoietin Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Megakaryocyte Maturation [PE]</name>
		<code>N0000175969</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175969</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Megakaryocyte Maturation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Production [PE]</name>
		<code>N0000175970</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175970</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thrombopoiesis</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Platelet Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Erythropoiesis-stimulating Agent [EPC]</name>
		<code>N0000175665</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175665</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Erythropoiesis-stimulating Agent (ESA)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Erythropoiesis-stimulating Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ESA</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Erythroid Cell Production [PE]</name>
		<code>N0000009319</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009319</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Erythroid Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hemoglobin S Polymerization Inhibitor [EPC]</name>
		<code>N0000194027</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194027</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hemoglobin S Polymerization Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HbS Polymerization Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-inhibitor Coagulant Complex [EPC]</name>
		<code>N0000184166</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184166</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-inhibitor Coagulant Complex</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Reversed Anticoagulation Activity [PE]</name>
		<code>N0000175982</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175982</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reversed Anticoagulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reversed Anti-coagulation Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticoagulation Reversal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reversed Anti-coagulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reversed Anticoagulation Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-coagulation Activity Reversal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-coagulation Reversal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticoagulation Activity Reversal</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Serum Albumin [EPC]</name>
		<code>N0000184174</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184174</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Serum Albumin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Intravascular Volume [PE]</name>
		<code>N0000009361</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009361</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Intravascular Volume</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Oncotic Pressure [PE]</name>
		<code>N0000009457</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009457</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Oncotic Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Unfractionated Heparin [EPC]</name>
		<code>N0000175474</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175474</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Unfractionated Heparin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Direct Thrombin Inhibitor [EPC]</name>
		<code>N0000175518</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175518</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Direct Thrombin Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-coagulant [EPC]</name>
		<code>N0000175980</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175980</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticoagulant</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-coagulant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Coagulation Factor Activity [PE]</name>
		<code>N0000008556</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008556</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Coagulation Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prothrombin Activity [PE]</name>
		<code>N0000193995</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193995</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prothrombin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Heparin Reversal Agent [EPC]</name>
		<code>N0000175983</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175983</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Heparin Reversal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin K Antagonist [EPC]</name>
		<code>N0000175476</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175476</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin K Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Factor VIII Activator [EPC]</name>
		<code>N0000175916</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175916</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Factor VIII Activator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor VIII Concentration [PE]</name>
		<code>N0000175915</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175915</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor VIII Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor VIII Activity [PE]</name>
		<code>N0000175914</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175914</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor VIII Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thrombolytic Agent [EPC]</name>
		<code>N0000175526</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175526</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thrombolytic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thrombolysis [PE]</name>
		<code>N0000009695</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009695</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thrombolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematopoietic Stem Cell Mobilizer [EPC]</name>
		<code>N0000178326</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178326</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematopoietic Stem Cell Mobilizer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Hematopoietic Stem Cell Mobilization [PE]</name>
		<code>N0000178324</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178324</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Hematopoietic Stem Cell Mobilization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antifibrinolytic Agent [EPC]</name>
		<code>N0000175634</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175634</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antifibrinolytic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Fibrinolysis [PE]</name>
		<code>N0000175632</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175632</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Fibrinolysis</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antifibrinolysis</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Low Molecular Weight Heparin [EPC]</name>
		<code>N0000175586</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175586</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Low Molecular Weight Heparin</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Low Molecular Weight Heparin (LMWH)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>LMWH</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Warfarin Reversal Agent [EPC]</name>
		<code>N0000175966</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175966</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Warfarin Reversal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prothrombin Activity [PE]</name>
		<code>N0000175965</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175965</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prothrombin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Inhibitor [EPC]</name>
		<code>N0000175575</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175575</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Factor D Inhibitor [EPC]</name>
		<code>N0000194113</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194113</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Factor D Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Classical Complement Pathway Inhibitor [EPC]</name>
		<code>N0000193991</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193991</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Classical Complement Pathway Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Classical Complement Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement Factor B Inhibitor [EPC]</name>
		<code>N0000194111</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194111</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement Factor B Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement C5 Inhibitor [EPC]</name>
		<code>N0000194109</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194109</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement C5 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</name>
		<code>N0000194160</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194160</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tissue Factor Pathway Inhibitor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TFPI Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet Aggregation Inhibitor [EPC]</name>
		<code>N0000175578</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175578</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet Aggregation Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Aggregation [PE]</name>
		<code>N0000008832</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008832</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Platelet Aggregation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease-activated Receptor-1 Antagonist [EPC]</name>
		<code>N0000190996</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190996</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease-activated Receptor-1 (PAR-1) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PAR-1 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease-activated Receptor-1 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Antihemophilic Factor [EPC]</name>
		<code>N0000184167</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184167</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Antihemophilic Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Activity [PE]</name>
		<code>N0000175979</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175979</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Procoagulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pro-coagulation Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Procoagulation Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pro-coagulation</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Platelet Aggregation [PE]</name>
		<code>N0000009524</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009524</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Platelet Aggregation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Endothelial Coagulation Activity [PE]</name>
		<code>N0000009292</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009292</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Endothelial Coagulation Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor Activity [PE]</name>
		<code>N0000009252</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009252</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor IX Activity [PE]</name>
		<code>N0000184153</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184153</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor IX Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrin Polymerization Activity [PE]</name>
		<code>N0000184155</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184155</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Fibrin Polymerization Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor X Activity [PE]</name>
		<code>N0000184154</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184154</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor X Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Plasma Volume Expander [EPC]</name>
		<code>N0000184175</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184175</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plasma Volume Expander</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-reducing Agent [EPC]</name>
		<code>N0000175638</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175638</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet Reducing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-reducing Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Production [PE]</name>
		<code>N0000175972</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175972</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Platelet Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Megakaryocyte Maturation [PE]</name>
		<code>N0000175971</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175971</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Megakaryocyte Maturation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood Viscosity Reducer [EPC]</name>
		<code>N0000175895</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175895</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood Viscosity Reducer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Blood Viscosity [PE]</name>
		<code>N0000175893</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175893</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Blood Viscosity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antithrombin-directed RNA Interaction [EPC]</name>
		<code>N0000194148</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194148</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antithrombin-directed RNA Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased RNA Integrity [PE]</name>
		<code>N0000008852</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008852</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased RNA Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood Coagulation Factor [EPC]</name>
		<code>N0000184168</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184168</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood Coagulation Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Erythroid Maturation Agent [EPC]</name>
		<code>N0000194025</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194025</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Erythroid Maturation Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Factor Xa Inhibitor [EPC]</name>
		<code>N0000175637</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175637</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Activated Factor X Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Factor Xa Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Factor 10a Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Activated Factor 10 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Blood Coagulation Factor [EPC]</name>
		<code>N0000184169</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184169</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Blood Coagulation Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-infective [APC]</name>
		<code>N0000193879</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193879</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-infective</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimicrobial [APC]</name>
		<code>N0000193882</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193882</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuraminidase Inhibitor [EPC]</name>
		<code>N0000175524</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175524</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuraminidase Inhibitor (NAI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NAI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuraminidase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Macrolide Antimicrobial [EPC]</name>
		<code>N0000175935</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175935</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Macrolide Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimicrobial Agent [TC]</name>
		<code>N0000178300</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178300</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimicrobial Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimicrobial</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</name>
		<code>N0000193976</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193976</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus pUL97 Kinase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV pUL97 Kinase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
		<code>N0000175463</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175463</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 NNRTI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor (HIV-1 NNRTI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Nucleoside Analog [EXT]</name>
		<code>N0000175460</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175460</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonnucleoside Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Nucleoside Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonnucleoside Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Nucleoside Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiparasitic [EPC]</name>
		<code>N0000175484</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175484</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiparasitic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiparasitic Agent [TC]</name>
		<code>N0000178302</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178302</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiparasitic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiparasitic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ectoparasiticide [EPC]</name>
		<code>N0000194050</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194050</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ectoparasiticide</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anthelmintic [EPC]</name>
		<code>N0000175481</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175481</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anthelmintic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antihelminthic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antihelminthic Agent [TC]</name>
		<code>N0000178298</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178298</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antihelminthic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antihelminthic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pediculicide [EPC]</name>
		<code>N0000181811</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181811</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pediculicide</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pediculocide</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antileishmanial [EPC]</name>
		<code>N0000190851</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190851</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antileishmanial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiprotozoal Agent [TC]</name>
		<code>N0000178303</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178303</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiprotozoal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiprotozoal</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</name>
		<code>N0000175616</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175616</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Fusion Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 FI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Fusion Inhibitor (HIV-1 FI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Entry Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]</name>
		<code>N0000193808</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193808</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Post-attachment Fusion Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Post-attachment Entry Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Antiviral [EPC]</name>
		<code>N0000175466</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175466</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue Antiviral</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog Antiviral</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
		<code>N0000175656</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175656</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HBV Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatits B Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HBV NRTI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog [EXT]</name>
		<code>N0000175459</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175459</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiviral Agent [TC]</name>
		<code>N0000178304</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178304</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiviral</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiviral Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000180187</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180187</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HSV Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HSV Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog HSV DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Simplex Virus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue HSV DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000180188</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180188</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog VZV DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue Varicella Zoster Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue VZV DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue Herpes Zoster Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VZV Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog Herpes Zoster Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VZV Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog Varicella Zoster Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Varicella Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Varicella Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
		<code>N0000175462</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175462</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor (HIV NRTI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV NRTI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000175468</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175468</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue Herpesvirus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog Herpesvirus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpesvirus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000175461</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175461</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV Nucleoside Analog DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide Antimicrobial [EPC]</name>
		<code>N0000175504</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175504</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfonamide Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide Antibacterial [EPC]</name>
		<code>N0000175503</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175503</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfonamide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibacterial Agent [TC]</name>
		<code>N0000178296</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178296</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibacterial Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibacterial</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CCR5 Co-receptor Antagonist [EPC]</name>
		<code>N0000175572</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175572</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCR5 Co-receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chemokine Co-receptor 5 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000175470</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175470</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyrophosphate Analog [EXT]</name>
		<code>N0000175469</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175469</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease Inhibitor [EPC]</name>
		<code>N0000175889</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175889</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Protease Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>PCSK9 Inhibitor [EPC]</name>
		<code>N0000191731</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191731</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PCSK9 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human alpha-1 Proteinase Inhibitor [EPC]</name>
		<code>N0000184171</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184171</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human alpha-1 Proteinase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neprilysin Inhibitor [EPC]</name>
		<code>N0000191728</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191728</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neprilysin Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiotensin Converting Enzyme Inhibitor [EPC]</name>
		<code>N0000175562</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175562</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin Converting Enzyme Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human C1 Esterase Inhibitor [EPC]</name>
		<code>N0000184172</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184172</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human C1 Esterase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Vascular Permeability [PE]</name>
		<code>N0000010252</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010252</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Vascular Permeability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Capillary Permeability [PE]</name>
		<code>N0000010253</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010253</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Capillary Permeability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proteasome Inhibitor [EPC]</name>
		<code>N0000175604</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175604</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proteasome Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Plasma Kallikrein Inhibitor [EPC]</name>
		<code>N0000192750</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192750</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Plasma Kallikrein Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</name>
		<code>N0000175913</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175913</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase 4 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase IV Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl-Peptidase IV Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase-4 (DPP-4) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DPP-4 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dipeptidyl Peptidase-4 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</name>
		<code>N0000182639</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182639</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus NS3/4A Protease Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCV NS3/4A Protease Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Polyene Antimicrobial [EPC]</name>
		<code>N0000175936</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175936</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polyene Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</name>
		<code>N0000175887</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175887</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 INSTI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Integrase Strand Transfer Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV INSTI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (HIV-1 INSTI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Integrase Strand Transfer Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tetracycline-class Antimicrobial [EPC]</name>
		<code>N0000175505</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175505</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tetracycline-class Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tetracycline Class Antimicrobial</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antibacterial [APC]</name>
		<code>N0000193880</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193880</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ketolide Antibacterial [EPC]</name>
		<code>N0000175492</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175492</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ketolide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Penem Antibacterial [EPC]</name>
		<code>N0000175496</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175496</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penem Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Polymyxin-class Antibacterial [EPC]</name>
		<code>N0000175499</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175499</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polymyxin Class Antibacterial</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polymyxin-class Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monobactam Antibacterial [EPC]</name>
		<code>N0000175493</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175493</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monobactam Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tetracycline-class Antibacterial [EPC]</name>
		<code>N0000175938</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175938</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tetracycline-class Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside Antibacterial [EPC]</name>
		<code>N0000175477</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175477</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminoglycoside Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lincosamide Antibacterial [EPC]</name>
		<code>N0000175443</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175443</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lincosamide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimycobacterial [EPC]</name>
		<code>N0000175483</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175483</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimycobacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimycobacterial Agent [TC]</name>
		<code>N0000178301</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178301</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimycobacterial</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimycobacterial Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Rifamycin Antimycobacterial [EPC]</name>
		<code>N0000175501</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175501</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Rifamycin Antimycobacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diarylquinoline Antimycobacterial [EPC]</name>
		<code>N0000186775</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000186775</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diarylquinoline Antimycobacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amphenicol-class Antibacterial [EPC]</name>
		<code>N0000175480</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175480</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amphenicol-class Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amphenicols [EXT]</name>
		<code>N0000175479</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175479</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amphenicols</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pleuromutilin Antibacterial [EPC]</name>
		<code>N0000175434</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175434</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pleuromutilin Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fluoroquinolone Antibacterial [EPC]</name>
		<code>N0000193223</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193223</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fluoroquinolone Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methylated Sulfonamide Antibacterial [EPC]</name>
		<code>N0000175511</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175511</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methylated Sulfonamide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methylated Sulfonamides [EXT]</name>
		<code>N0000175512</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175512</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methylated Sulfonamides</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Rifamycin Antibacterial [EPC]</name>
		<code>N0000175500</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175500</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Rifamycin Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Macrolide Antibacterial [EPC]</name>
		<code>N0000175431</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175431</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Macrolide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycopeptide Antibacterial [EPC]</name>
		<code>N0000175491</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175491</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycopeptide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cephalosporin Antibacterial [EPC]</name>
		<code>N0000175488</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175488</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cephalosporin Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</name>
		<code>N0000175489</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175489</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydrofolate Reductase Inhibitor Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Penicillin-class Antibacterial [EPC]</name>
		<code>N0000175497</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175497</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penicillin-class Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penicillin Class Antibacterial</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipopeptide Antibacterial [EPC]</name>
		<code>N0000175509</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175509</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipopeptide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitrofuran Antibacterial [EPC]</name>
		<code>N0000175494</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175494</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitrofuran Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipoglycopeptide Antibacterial [EPC]</name>
		<code>N0000191281</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191281</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipoglycopeptide Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipoglycopeptides [EXT]</name>
		<code>N0000191280</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191280</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipoglycopeptides</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RNA Synthetase Inhibitor Antibacterial [EPC]</name>
		<code>N0000175515</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175515</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA Synthetase Inhibitor Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxazolidinone Antibacterial [EPC]</name>
		<code>N0000175495</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175495</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxazolidinone Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antifungal [APC]</name>
		<code>N0000193881</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193881</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Polyene Antifungal [EPC]</name>
		<code>N0000175498</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175498</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polyene Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antifungal Agent [TC]</name>
		<code>N0000178297</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178297</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antifungal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antifungal</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog Antifungal [EPC]</name>
		<code>N0000175467</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175467</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Antifungal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue Antifungal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Azole Antifungal [EPC]</name>
		<code>N0000175487</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175487</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Azole Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipid-based Polyene Antifungal [EPC]</name>
		<code>N0000175510</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175510</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipid-based Polyene Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Triterpenoid Antifungal [EPC]</name>
		<code>N0000193966</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193966</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Triterpenoid Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Echinocandin Antifungal [EPC]</name>
		<code>N0000175507</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175507</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Echinocandin Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Benzylamine Antifungal [EPC]</name>
		<code>N0000175875</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175875</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzylamine Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allylamine Antifungal [EPC]</name>
		<code>N0000175874</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175874</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allylamine Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus NS5A Inhibitor [EPC]</name>
		<code>N0000191256</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191256</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCV NS5A Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus NS5A Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitroimidazole Antimicrobial [EPC]</name>
		<code>N0000175435</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175435</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitroimidazole Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiprotozoal [EPC]</name>
		<code>N0000175485</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175485</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiprotozoal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimalarial [EPC]</name>
		<code>N0000175482</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175482</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimalarial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimalarial Agent [TC]</name>
		<code>N0000178299</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178299</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimalarial Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimalarial</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</name>
		<code>N0000175934</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175934</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydrofolate Reductase Inhibitor Antimalarial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Quinolone Antimicrobial [EPC]</name>
		<code>N0000175937</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175937</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Quinolone Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</name>
		<code>N0000193857</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193857</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Influenza A M2 Protein Inhibitor [EPC]</name>
		<code>N0000175543</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175543</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Influenza A M2 Protein Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>M2 Proton Pump Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiseptic [EPC]</name>
		<code>N0000175486</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175486</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiseptic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiseptic Agent [TC]</name>
		<code>N0000178305</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178305</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiseptic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiseptic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Viral Therapy [APC]</name>
		<code>N0000194073</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194073</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Viral Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adeno-associated Virus Vector [EPC]</name>
		<code>N0000193790</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193790</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adeno-associated Virus Vector</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Viruses, Genetically-modified [EXT]</name>
		<code>N0000191722</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191722</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Viruses, Genetically-modified</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</name>
		<code>N0000194065</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194065</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adeno-associated Virus Vector-based Gene Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenovirus Vector-Based Gene Therapy [EPC]</name>
		<code>N0000194066</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194066</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenovirus Vector-Based Gene Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidote [EPC]</name>
		<code>N0000175429</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175429</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidote</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin K [EPC]</name>
		<code>N0000180191</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180191</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin K</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin K-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidotes, Deterrents, and Toxicologic Agents [TC]</name>
		<code>N0000178294</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178294</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidotes, Deterrents, and Toxicologic Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidote for Acetaminophen Overdose [EPC]</name>
		<code>N0000175961</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175961</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidote for Acetaminophen Overdose</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glutathione Concentration [PE]</name>
		<code>N0000175960</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175960</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glutathione Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decorporation Agent [EPC]</name>
		<code>N0000192801</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192801</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decorporation Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Folate Analog [EPC]</name>
		<code>N0000178369</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178369</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folate Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folate Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin B6 Analog [EPC]</name>
		<code>N0000192800</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192800</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B6 Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B 6 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B6 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B 6 Analog</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin [EPC]</name>
		<code>N0000175944</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175944</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carnitine Analog [EPC]</name>
		<code>N0000175903</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175903</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carnitine Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carnitine Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin Analog [EPC]</name>
		<code>N0000175453</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175453</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormone [APC]</name>
		<code>N0000193874</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193874</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Androgen [EPC]</name>
		<code>N0000175824</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175824</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Stimulating Hormone [EPC]</name>
		<code>N0000175949</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175949</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Stimulating Hormone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin D2 Analog [EPC]</name>
		<code>N0000175907</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175907</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D2 Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D2 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>C-type Natriuretic Peptide Analog [EPC]</name>
		<code>N0000193980</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193980</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>C-type Natriuretic Peptide Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone-Related Peptide Analog [EPC]</name>
		<code>N0000193453</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193453</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid Hormone-Related Peptide Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid Hormone-Related Peptide Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin D3 Analog [EPC]</name>
		<code>N0000175908</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175908</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D3 Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D3 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholecystokinin Analog [EPC]</name>
		<code>N0000175798</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175798</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholecystokinin (CCK) Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholecystokinin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCK Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCK Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholecystokinin (CCK) Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin Analog [EPC]</name>
		<code>N0000175454</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175454</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progesterone [EPC]</name>
		<code>N0000175601</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175601</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progesterone</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progesterone-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>l-Thyroxine [EPC]</name>
		<code>N0000175945</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175945</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>l-Thyroxine</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>l-Thyroxine-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T4</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>l-Thyroxine (T4)</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcitonin [EPC]</name>
		<code>N0000175942</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175942</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcitonin-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcitonin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone Analog [EPC]</name>
		<code>N0000180852</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180852</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid Hormone Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid Hormone Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenocorticotropic Hormone [EPC]</name>
		<code>N0000175941</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175941</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenocorticotropic Hormone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Hormone [EPC]</name>
		<code>N0000180851</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180851</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid-class Hormone</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid Hormone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin [EPC]</name>
		<code>N0000175838</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175838</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Leptin Analog [EPC]</name>
		<code>N0000190854</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190854</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leptin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leptin Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin D [EPC]</name>
		<code>N0000175952</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175952</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GLP-2 Analog [EPC]</name>
		<code>N0000190992</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190992</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide 2 Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-2 Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-2 Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amylin Analog [EPC]</name>
		<code>N0000177910</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177910</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amylin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amylin Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Secretin-class Hormone [EPC]</name>
		<code>N0000175813</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175813</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Secretin-class Hormone</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Secretin Class Hormone</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin D Analog [EPC]</name>
		<code>N0000175849</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175849</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin D Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen [EPC]</name>
		<code>N0000175825</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175825</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxytocic [EPC]</name>
		<code>N0000175828</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175828</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxytocic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</name>
		<code>N0000009705</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009705</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Uterine Smooth Muscle Contraction or Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Corticosteroid [EPC]</name>
		<code>N0000175576</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175576</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticosteroid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Analog [EPC]</name>
		<code>N0000175905</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175905</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Growth Hormone [EPC]</name>
		<code>N0000175606</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175606</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Growth Hormone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Factor Analog [EPC]</name>
		<code>N0000182144</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182144</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRH Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRH Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Hormone (GHRH) Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRF Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRF Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Hormone Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Hormone Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Factor (GHRF) Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Factor (GHRF) Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Hormone (GHRH) Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Factor Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Factor Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GHRH Activity [PE]</name>
		<code>N0000009327</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009327</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GHRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E1 Analog [EPC]</name>
		<code>N0000175785</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175785</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin E1 Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin E1 (PGE1) Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin-1 (PGE1) Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PGE1 Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin E1 (PGE1) Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PGE1 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin-1 (PGE1) Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin-1 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin-1 Analog</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progestin [EPC]</name>
		<code>N0000175602</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175602</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progestin-containing Intrauterine System [EPC]</name>
		<code>N0000175832</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175832</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestin-containing Intrauterine System (IUS)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestin-containing IUS</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestin-containing Intrauterine System</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovum Fertilization [PE]</name>
		<code>N0000175830</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175830</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Ovum Fertilization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>l-Triiodothyronine [EPC]</name>
		<code>N0000175946</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175946</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>l-Triiodothyronine-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T3</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>l-Triiodothyronine (T3)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>l-Triiodothyronine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Analog [EPC]</name>
		<code>N0000175904</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175904</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Analog</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allergen [APC]</name>
		<code>N0000193889</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193889</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allergen</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allergenic Extract [APC]</name>
		<code>N0000193890</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193890</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Standardized Pollen Allergenic Extract [EPC]</name>
		<code>N0000185006</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185006</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Standardized Pollen Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Histamine Release [PE]</name>
		<code>N0000175629</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175629</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Histamine Release</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Fungal Allergenic Extract [EPC]</name>
		<code>N0000185372</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185372</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Fungal Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Food Allergenic Extract [EPC]</name>
		<code>N0000185371</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185371</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Food Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Pollen Allergenic Extract [EPC]</name>
		<code>N0000185367</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185367</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Pollen Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized House Dust Allergenic Extract [EPC]</name>
		<code>N0000185374</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185374</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized House Dust Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Epidermal and Animal Specific Allergenic Extract [APC]</name>
		<code>N0000193899</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193899</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal and Animal Specific Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Standardized Animal Skin Allergenic Extract [EPC]</name>
		<code>N0000185004</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185004</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Standardized Animal Skin Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cells, Epidermal [EXT]</name>
		<code>N0000185377</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185377</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermis</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Cells</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cells, Epidermal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Animal Skin Allergenic Extract [EPC]</name>
		<code>N0000185364</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185364</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Animal Skin Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Feather Allergenic Extract [EPC]</name>
		<code>N0000185373</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185373</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Feather Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Standardized Animal Hair Allergenic Extract [EPC]</name>
		<code>N0000185003</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185003</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Standardized Animal Hair Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Insect Allergenic Extract [EPC]</name>
		<code>N0000185365</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185365</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Insect Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Insect Venom Allergenic Extract [EPC]</name>
		<code>N0000185366</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185366</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Insect Venom Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Animal Dander Allergenic Extract [EPC]</name>
		<code>N0000185368</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185368</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Animal Dander Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Plant Allergenic Extract [EPC]</name>
		<code>N0000185375</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185375</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Plant Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</name>
		<code>N0000185376</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185376</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Plant Fiber Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Standardized Insect Allergenic Extract [EPC]</name>
		<code>N0000185005</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185005</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Standardized Insect Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Standardized Insect Venom Allergenic Extract [EPC]</name>
		<code>N0000185021</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185021</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Standardized Insect Venom Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Animal Hair Allergenic Extract [EPC]</name>
		<code>N0000185363</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185363</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Animal Hair Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Bacterial Allergenic Extract [EPC]</name>
		<code>N0000185369</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185369</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Bacterial Allergenic Extract</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Non-Standardized Chemical Allergen [EPC]</name>
		<code>N0000185370</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185370</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-Standardized Chemical Allergen</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Standardized Chemical Allergen [EPC]</name>
		<code>N0000185508</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185508</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Standardized Chemical Allergen</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Related Agent [APC]</name>
		<code>N0000193906</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193906</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleic Acid Related Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antisense Oligonucleotide [EPC]</name>
		<code>N0000191626</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191626</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antisense Oligonucleotide</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-sense Oligonucleotide</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>APOC-III-directed RNA Interaction [EPC]</name>
		<code>N0000194144</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194144</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>APOC-III-directed RNA Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased RNA Degradation [PE]</name>
		<code>N0000194154</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194154</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased RNA Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Transthyretin-directed RNA Interaction [EPC]</name>
		<code>N0000193849</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193849</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transthyretin-directed RNA Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TTR-directed RNA Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</name>
		<code>N0000194024</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194024</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ALAS1-directed RNA Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminolevulinate Synthase 1-directed RNA Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histone Deacetylase Inhibitor [EPC]</name>
		<code>N0000175588</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175588</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histone Deacetylase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HDAC Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histone Deacetylase (HDAC) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alkylating Drug [EPC]</name>
		<code>N0000175558</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175558</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alkylating Drug</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Analog [EPC]</name>
		<code>N0000191809</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191809</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrimidine Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrimidine Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Small Interfering RNA [EPC]</name>
		<code>N0000193848</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193848</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Short interfering RNA</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Small Interfering RNA</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>siRNA</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Silencing RNA</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Microtubule Inhibitor [EPC]</name>
		<code>N0000175592</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175592</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Microtubule Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Microtubule Inhibition [PE]</name>
		<code>N0000175085</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175085</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Microtubule Inhibition</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Synthesis Inhibitor [APC]</name>
		<code>N0000193907</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193907</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleic Acid Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Metabolic Inhibitor [EPC]</name>
		<code>N0000175595</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175595</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Metabolic Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</name>
		<code>N0000191493</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191493</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus (HCV) Nucleotide Analog NS5B Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCV Nucleotide Analog NS5B Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RNA Polymerase Inhibitor [APC]</name>
		<code>N0000193946</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193946</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</name>
		<code>N0000193948</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193948</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Folate Analog Metabolic Inhibitor [EPC]</name>
		<code>N0000175584</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175584</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folate Analogue Metabolic Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Folate Analog Metabolic Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</name>
		<code>N0000193800</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193800</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus DNA Terminase Complex Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV DNA Terminase Complex Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyrimidine Synthesis Inhibitor [EPC]</name>
		<code>N0000185502</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185502</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrimidine Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimetabolite [EPC]</name>
		<code>N0000180853</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180853</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimetabolite</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimetabolite Immunosuppressant [EPC]</name>
		<code>N0000175613</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175613</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimetabolite Immunosuppressant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologic Activity [PE]</name>
		<code>N0000175550</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175550</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic Suppression</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immune Suppression</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immune System Suppression</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunosuppression</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Molecule Production [PE]</name>
		<code>N0000008665</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008665</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologically Active Molecule Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytokine Production [PE]</name>
		<code>N0000008573</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008573</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cytokine Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Biogenic Amine Production [PE]</name>
		<code>N0000008662</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008662</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologically Active Biogenic Amine Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Production [PE]</name>
		<code>N0000008659</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008659</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Histamine Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Serotonin Production [PE]</name>
		<code>N0000008895</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008895</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Serotonin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</name>
		<code>N0000008686</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008686</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lipid Derived Immunologically Active Molecule Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Activating Factor Production [PE]</name>
		<code>N0000008831</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008831</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Platelet Activating Factor Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Eicosanoid Production [PE]</name>
		<code>N0000008592</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008592</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Eicosanoid Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostaglandin Production [PE]</name>
		<code>N0000008836</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008836</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prostaglandin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Thromboxane Production [PE]</name>
		<code>N0000009006</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009006</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Thromboxane Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Leukotriene Production [PE]</name>
		<code>N0000008683</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008683</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Leukotriene Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Kinin Production [PE]</name>
		<code>N0000008677</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008677</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Kinin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Bradykinin Production [PE]</name>
		<code>N0000008424</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008424</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Bradykinin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Adhesion Factor Production [PE]</name>
		<code>N0000008386</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008386</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Adhesion Factor Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Kallidin Production [PE]</name>
		<code>N0000008674</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008674</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Kallidin Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Antibody Production [PE]</name>
		<code>N0000008392</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008392</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Antibody Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Complement Production [PE]</name>
		<code>N0000008570</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008570</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Complement Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Molecule Activity [PE]</name>
		<code>N0000008663</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008663</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologically Active Molecule Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Adhesion Factor Activity [PE]</name>
		<code>N0000008384</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008384</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Adhesion Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Complement Activity [PE]</name>
		<code>N0000008568</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008568</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Complement Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</name>
		<code>N0000008684</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008684</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lipid Derived Immunologically Active Molecule Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Eicosanoid Activity [PE]</name>
		<code>N0000008590</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008590</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Eicosanoid Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Thromboxane Activity [PE]</name>
		<code>N0000009004</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009004</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Thromboxane Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Leukotriene Activity [PE]</name>
		<code>N0000008681</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008681</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Leukotriene Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostaglandin Activity [PE]</name>
		<code>N0000008834</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008834</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prostaglandin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Activating Factor Activity [PE]</name>
		<code>N0000008829</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008829</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Platelet Activating Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Kallidin Activity [PE]</name>
		<code>N0000008672</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008672</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Kallidin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Kinin Activity [PE]</name>
		<code>N0000008675</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008675</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Kinin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Bradykinin Activity [PE]</name>
		<code>N0000008422</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008422</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Bradykinin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytokine Activity [PE]</name>
		<code>N0000008571</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008571</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cytokine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Biogenic Amine Activity [PE]</name>
		<code>N0000008660</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008660</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologically Active Biogenic Amine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Activity [PE]</name>
		<code>N0000008657</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008657</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Histamine Activity [PE]</name>
		<code>N0000008816</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008816</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Histamine Activity [PE]</name>
		<code>N0000008408</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008408</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Histamine Activity [PE]</name>
		<code>N0000008988</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008988</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Histamine Activity [PE]</name>
		<code>N0000008793</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008793</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Histamine Activity [PE]</name>
		<code>N0000008884</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008884</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Histamine Activity [PE]</name>
		<code>N0000008614</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008614</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Histamine Activity [PE]</name>
		<code>N0000008496</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008496</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Histamine Activity [PE]</name>
		<code>N0000008542</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008542</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Histamine Activity [PE]</name>
		<code>N0000008722</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008722</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Histamine Activity [PE]</name>
		<code>N0000008440</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008440</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Histamine Activity [PE]</name>
		<code>N0000008519</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008519</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Histamine Activity [PE]</name>
		<code>N0000008940</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008940</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Histamine Activity [PE]</name>
		<code>N0000008749</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008749</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Histamine Activity [PE]</name>
		<code>N0000008913</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008913</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Histamine Activity [PE]</name>
		<code>N0000008964</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008964</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Histamine Activity [PE]</name>
		<code>N0000008467</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008467</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Histamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Serotonin Activity [PE]</name>
		<code>N0000008893</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008893</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Serotonin Activity [PE]</name>
		<code>N0000008822</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008822</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Serotonin Activity [PE]</name>
		<code>N0000008890</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008890</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Serotonin Activity [PE]</name>
		<code>N0000008414</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008414</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Serotonin Activity [PE]</name>
		<code>N0000008799</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008799</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Serotonin Activity [PE]</name>
		<code>N0000008994</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008994</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Serotonin Activity [PE]</name>
		<code>N0000008620</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008620</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Serotonin Activity [PE]</name>
		<code>N0000008502</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008502</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Serotonin Activity [PE]</name>
		<code>N0000008728</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008728</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Serotonin Activity [PE]</name>
		<code>N0000008446</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008446</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Serotonin Activity [PE]</name>
		<code>N0000008548</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008548</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Serotonin Activity [PE]</name>
		<code>N0000008525</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008525</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Serotonin Activity [PE]</name>
		<code>N0000008946</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008946</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Serotonin Activity [PE]</name>
		<code>N0000008755</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008755</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Serotonin Activity [PE]</name>
		<code>N0000008473</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008473</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Serotonin Activity [PE]</name>
		<code>N0000008970</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008970</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Serotonin Activity [PE]</name>
		<code>N0000008919</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008919</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Serotonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Antibody Activity [PE]</name>
		<code>N0000008390</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008390</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Antibody Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Molecule Degradation [PE]</name>
		<code>N0000008664</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008664</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologically Active Molecule Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Antibody Degradation [PE]</name>
		<code>N0000008391</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008391</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Antibody Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</name>
		<code>N0000008685</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008685</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lipid Derived Immunologically Active Molecule Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Platelet Activating Factor Degradation [PE]</name>
		<code>N0000008830</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008830</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Platelet Activating Factor Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Eicosanoid Degradation [PE]</name>
		<code>N0000008591</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008591</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Eicosanoid Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Leukotriene Degradation [PE]</name>
		<code>N0000008682</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008682</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Leukotriene Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostaglandin Degradation [PE]</name>
		<code>N0000008835</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008835</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prostaglandin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Thromboxane Degradation [PE]</name>
		<code>N0000009005</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009005</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Thromboxane Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Complement Degradation [PE]</name>
		<code>N0000008569</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008569</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Complement Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Kinin Degradation [PE]</name>
		<code>N0000008676</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008676</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Kinin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Bradykinin Degradation [PE]</name>
		<code>N0000008423</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008423</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Bradykinin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytokine Degradation [PE]</name>
		<code>N0000008572</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008572</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cytokine Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</name>
		<code>N0000008661</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008661</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Immunologically Active Biogenic Amine Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Serotonin Degradation [PE]</name>
		<code>N0000008894</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008894</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Serotonin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Histamine Degradation [PE]</name>
		<code>N0000008658</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008658</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Histamine Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Kallidin Degradation [PE]</name>
		<code>N0000008673</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008673</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Kallidin Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Adhesion Factor Degradation [PE]</name>
		<code>N0000008385</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008385</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Adhesion Factor Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Purine Antimetabolite [EPC]</name>
		<code>N0000175712</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175712</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Purine Antimetabolite</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase Inhibitor [EPC]</name>
		<code>N0000175609</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175609</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</name>
		<code>N0000194142</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194142</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased DNA Replication [PE]</name>
		<code>N0000008577</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008577</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased DNA Replication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anthracycline Topoisomerase Inhibitor [EPC]</name>
		<code>N0000175414</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175414</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anthracycline Topoisomerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tubulin Agent [APC]</name>
		<code>N0000193911</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193911</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tubulin Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vinca Alkaloid [EPC]</name>
		<code>N0000175612</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175612</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vinca Alkaloid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tubulin Inhibiting Agent [EPC]</name>
		<code>N0000175848</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175848</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tubulin Inhibiting Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Mitosis [PE]</name>
		<code>N0000008732</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008732</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Mitosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</name>
		<code>N0000193222</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193222</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SMN2-directed RNA Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival Motor Neuron-2-directed RNA Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival of Motor Neuron 2-directed RNA Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival Motor Neuron 2-directed RNA Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</name>
		<code>N0000194059</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194059</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival of Motor Neuron 2 Splicing Modifier</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SMN2 Splicing Modifier</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Survival Motor Neuron 2 Splicing Modifier</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platinum-based Drug [EPC]</name>
		<code>N0000175413</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175413</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platinum-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platinum-based Drug</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platinum-containing Compounds [EXT]</name>
		<code>N0000175073</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175073</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platinum-containing Compounds</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Interaction [APC]</name>
		<code>N0000193898</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193898</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Inhibitor [APC]</name>
		<code>N0000193897</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193897</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 2D6 Inhibitor [EPC]</name>
		<code>N0000182135</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182135</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 2D6 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 2D6 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcineurin Inhibitor Immunosuppressant [EPC]</name>
		<code>N0000175457</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175457</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcineurin Inhibitor Immunosuppressant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 5 Inhibitor [EPC]</name>
		<code>N0000175599</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175599</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase-5 (PDE-5) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase-5 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PDE-5 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase 5 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase V Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>beta Lactamase Inhibitor [EPC]</name>
		<code>N0000175930</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175930</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta-Lactamase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta Lactamase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Urease Inhibitor [EPC]</name>
		<code>N0000175611</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175611</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urease Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 3 Inhibitor [EPC]</name>
		<code>N0000175598</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175598</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase III Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase 3 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucosylceramide Synthase Inhibitor [EPC]</name>
		<code>N0000175783</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175783</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucosylceramide Synthase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thymidine Phosphorylase Inhibitor [EPC]</name>
		<code>N0000191870</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191870</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thymidine Phosphorylase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclooxygenase Inhibitor [EPC]</name>
		<code>N0000175939</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175939</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclooxygenase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenal Steroid Synthesis Inhibitor [EPC]</name>
		<code>N0000175928</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175928</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenal Steroid Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Dehydropeptidase Inhibitor [EPC]</name>
		<code>N0000175514</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175514</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Dehydropeptidase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Farnesyltransferase Inhibitor [EPC]</name>
		<code>N0000193938</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193938</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Farnesyltransferase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carbonic Anhydrase Inhibitor [EPC]</name>
		<code>N0000175517</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175517</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbonic Anhydrase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 17A1 Inhibitor [EPC]</name>
		<code>N0000182633</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182633</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 17A1 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP17 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP17A1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 17A1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</name>
		<code>N0000193615</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193615</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase-2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase 2 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IDH2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytochrome P450 3A Inhibitor [EPC]</name>
		<code>N0000191001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CYP450 3A Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytochrome P450 3A Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Catecholamine Synthesis Inhibitor [EPC]</name>
		<code>N0000175569</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175569</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catecholamine Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decarboxylase Inhibitor [EPC]</name>
		<code>N0000175845</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175845</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decarboxylase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methyltransferase Inhibitor [EPC]</name>
		<code>N0000193930</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193930</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methyltransferase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</name>
		<code>N0000191623</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191623</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly ADP Ribose Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly (ADP Ribose) Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly ADP-Ribose Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly (ADP-Ribose) Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PARP Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poly(ADP-Ribose) Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PARP Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Xanthine Oxidase Inhibitor [EPC]</name>
		<code>N0000175698</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175698</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Xanthine Oxidase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Synthesis Inhibitor [EPC]</name>
		<code>N0000175918</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175918</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tryptophan Hydroxylase Inhibitor [EPC]</name>
		<code>N0000193303</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193303</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tryptophan Hydroxylase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanin Synthesis Inhibitor [EPC]</name>
		<code>N0000175854</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175854</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocyte Pigment Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanin Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Depigmenting Activity [PE]</name>
		<code>N0000175851</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175851</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Depigmenting Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanocyte Destruction [PE]</name>
		<code>N0000175852</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175852</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocyte Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renin Inhibitor [EPC]</name>
		<code>N0000175900</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175900</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renin Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxaborole Antifungal [EPC]</name>
		<code>N0000191279</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191279</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxaborole Antifungal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>5-alpha Reductase Inhibitor [EPC]</name>
		<code>N0000175836</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175836</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-alpha Reductase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aromatase Inhibitor [EPC]</name>
		<code>N0000175563</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175563</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>5-Lipoxygenase Inhibitor [EPC]</name>
		<code>N0000175956</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175956</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-Lipoxygenase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cortisol Synthesis Inhibitor [EPC]</name>
		<code>N0000193935</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193935</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cortisol Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Glucosidase Inhibitor [EPC]</name>
		<code>N0000175559</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175559</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Glucosidase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oligonucleotide Telomerase Inhibitor [EPC]</name>
		<code>N0000194125</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194125</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oligonucleotide Telomerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</name>
		<code>N0000175809</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175809</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>4-Hydroxyphenylpyruvate Dioxygenase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Catechol-O-Methyltransferase Inhibitor [EPC]</name>
		<code>N0000175757</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175757</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>COMT Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol O-Methyl Transferase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol-O-Methyltransferase (COMT) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol-O-Methyltransferase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol O-Methyltransferase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catechol-O-Methyl Transferase (COMT) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor Inhibitor [EPC]</name>
		<code>N0000193999</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193999</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia-inducible Factor Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIF Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia Inducible Factor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</name>
		<code>N0000194080</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194080</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIF PH Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Polymerase Acidic Endonuclease Inhibitor [EPC]</name>
		<code>N0000193852</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193852</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polymerase Acidic Endonuclease Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PA Endonuclease Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Anti-inflammatory Drug [EPC]</name>
		<code>N0000175722</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175722</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-steroidal Antiinflammatory Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-steroidal Anti-inflammatory Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonsteroidal Anti-inflammatory Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonsteroidal Antiinflammatory Drug</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NSAID</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-steroidal Anti-inflammatory Drug</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonsteroidal Antiinflammatory Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Non-steroidal Antiinflammatory Drug</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonsteroidal Anti-inflammatory Drug</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphodiesterase 4 Inhibitor [EPC]</name>
		<code>N0000182961</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182961</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase 4 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphodiesterase IV Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</name>
		<code>N0000193913</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193913</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ACL Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ATP Citrate Lyase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aldehyde Dehydrogenase Inhibitor [EPC]</name>
		<code>N0000175679</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175679</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aldehyde Dehydrogenase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Intestinal Lipase Inhibitor [EPC]</name>
		<code>N0000175591</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175591</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Intestinal Lipase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</name>
		<code>N0000193987</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193987</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase-1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Isocitrate Dehydrogenase 1 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IDH1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nuclear Export Inhibitor [EPC]</name>
		<code>N0000194021</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194021</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nuclear Export Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kinase Inhibitor [EPC]</name>
		<code>N0000175605</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175605</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kinase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Janus Kinase Inhibitor [EPC]</name>
		<code>N0000190858</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190858</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Janus Kinase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tyrosine Kinase 2 Inhibitor [EPC]</name>
		<code>N0000194043</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194043</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tyrosine Kinase 2 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TYK2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Rho Kinase Inhibitor [EPC]</name>
		<code>N0000193788</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193788</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Rho Kinase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Epidermal Growth Factor Receptor Antagonist [EPC]</name>
		<code>N0000175664</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175664</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EGFR Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER1 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor (EGFR) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epidermal Growth Factor Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>mTOR Inhibitor Immunosuppressant [EPC]</name>
		<code>N0000175625</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175625</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mammalian Target of Rapamycin Inhibitor Immunosuppressant</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>mTOR Inhibitor Immunosuppressant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</name>
		<code>N0000191009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR-2 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Receptor-2 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR2 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HER2/neu Receptor Antagonist [EPC]</name>
		<code>N0000175661</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175661</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2/neu Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ErbB2 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HER2 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gamma Secretase Inhibitor [EPC]</name>
		<code>N0000194115</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194115</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gamma Secretase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</name>
		<code>N0000175754</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175754</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatic Amino Acid Decarboxylation Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatic Amino Acid Decarboxylation Inhibitors</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>HMG-CoA Reductase Inhibitor [EPC]</name>
		<code>N0000175589</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175589</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HMG-CoA Reductase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiac Myosin Inhibitor [EPC]</name>
		<code>N0000194047</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194047</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiac Myosin Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Selectin Blocker [EPC]</name>
		<code>N0000194032</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194032</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selectin Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methylxanthine [EPC]</name>
		<code>N0000175790</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175790</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methylxanthine</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methylxanthine-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Stabilizer [EPC]</name>
		<code>N0000194077</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194077</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Stabilizer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Activator [APC]</name>
		<code>N0000193896</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193896</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Activator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phenylalanine Hydroxylase Activator [EPC]</name>
		<code>N0000190483</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190483</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phenylalanine Hydroxylase Activator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</name>
		<code>N0000184144</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184144</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthetase 1 Activator</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoylphosphate Synthetase 1 Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthase 1 Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoylphosphate Synthase 1 Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CPS1 Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl-Phosphate Synthase 1 Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl-Phosphate Synthetase 1 Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbamoyl Phosphate Synthase 1 (CPS1) Activator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Soluble Guanylate Cyclase Stimulator [EPC]</name>
		<code>N0000190485</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190485</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Soluble Guanylate Cyclase Stimulator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protease Activator [EPC]</name>
		<code>N0000194170</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194170</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protease Activator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Guanylate Cyclase-C Agonist [EPC]</name>
		<code>N0000185500</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185500</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Guanylate Cyclase-C Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyruvate Kinase Activator [EPC]</name>
		<code>N0000194008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyruvate Kinase Activator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunotherapy [APC]</name>
		<code>N0000194070</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194070</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Processed Thymus Tissue-based Immunotherapy [EPC]</name>
		<code>N0000194076</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194076</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Processed Thymus Tissue-based Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</name>
		<code>N0000183906</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183906</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated BCG Immunotherapy</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Bacillus Calmette-Guerin (BCG) Immunotherapy</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Macrophage Proliferation [PE]</name>
		<code>N0000183884</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183884</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Macrophage Proliferation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autologous Cellular Immunotherapy [EPC]</name>
		<code>N0000184997</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184997</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Cellular Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tumor-derived Autologous T Cell Immunotherapy [EPC]</name>
		<code>N0000194099</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194099</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor-derived Autologous T Cell Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Autologous T Cells [EPC]</name>
		<code>N0000193549</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193549</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Autologous T Cells</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</name>
		<code>N0000194123</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194123</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MAGE-A4-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</name>
		<code>N0000194067</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194067</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCMA-directed Genetically Modified Autologous T-cell Immunotherapy</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B Cell Maturation Antigen-directed Genetically Modified Autologous T-cell Immunotherapy</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCMA-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</name>
		<code>N0000193548</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193548</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Cultured T Lymphocytes, Autologous</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Autologous Cultured T Lymphocytes</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</name>
		<code>N0000194068</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194068</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cells, Cultured, Autologous [EXT]</name>
		<code>N0000184310</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184310</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cells, Cultured, Autologous</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Cultured Cells</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cultured Cells, Autologous</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cells, Cultured, Autologous, Genetically-modified [EXT]</name>
		<code>N0000193547</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193547</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Cultured Cells, Autologous</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Autologous Cultured Cells</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cells, Cultured, Autologous, Genetically-modified</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipid Emulsion [EPC]</name>
		<code>N0000191261</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191261</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipid Emulsion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vaccine [APC]</name>
		<code>N0000193912</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193912</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</name>
		<code>N0000183904</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183904</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated BCG Vaccine</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Bacillus Calmette-Guerin Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Bacillus Calmette-Guerin (BCG) Vaccine</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Rubella Virus Vaccine [EPC]</name>
		<code>N0000183909</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183909</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Rubella Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Rotavirus Vaccine [EPC]</name>
		<code>N0000183908</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183908</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Rotavirus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</name>
		<code>N0000183894</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183894</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Japanese Encephalitis Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Poliovirus Vaccine [EPC]</name>
		<code>N0000183898</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183898</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Poliovirus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Pneumococcal Vaccine [EPC]</name>
		<code>N0000183897</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183897</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Pneumococcal Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</name>
		<code>N0000194157</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194157</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Syncytial Virus mRNA Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Syncytial Virus mRNA [EXT]</name>
		<code>N0000194158</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194158</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Syncytial Virus mRNA</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Rabies Virus Vaccine [EPC]</name>
		<code>N0000183899</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183899</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Rabies Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</name>
		<code>N0000183912</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183912</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Yellow Fever Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</name>
		<code>N0000183903</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183903</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Bacillus Anthracis Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</name>
		<code>N0000183887</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183887</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Corynebacterium Diphtheriae Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Influenza B Virus Vaccine [EPC]</name>
		<code>N0000183893</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183893</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Influenza B Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Human Adenovirus Type 4 Vaccine [EPC]</name>
		<code>N0000183913</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183913</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Human Adenovirus Type 4 Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tick-Borne Encephalitis Vaccine [EPC]</name>
		<code>N0000194159</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194159</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tick-Borne Encephalitis Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vaccines, Tick-Borne Encephalitis [EXT]</name>
		<code>N0000194162</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194162</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vaccines, Tick-Borne Encephalitis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Hepatitis A Virus Vaccine [EPC]</name>
		<code>N0000183889</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183889</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Hepatitis A Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Vaccinia Virus Vaccine [EPC]</name>
		<code>N0000183917</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183917</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Vaccinia Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Rotavirus Vaccine [EPC]</name>
		<code>N0000183916</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183916</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Rotavirus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Meningococcal Vaccine [EPC]</name>
		<code>N0000183895</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183895</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Meningococcal Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Salmonella Typhi Vaccine [EPC]</name>
		<code>N0000183901</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183901</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Salmonella Typhi Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>COVID-19 mRNA Vaccine [EPC]</name>
		<code>N0000194097</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194097</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>COVID-19 messenger RNA Vaccine</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>COVID-19 mRNA Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>SARS-CoV-2 mRNA [EXT]</name>
		<code>N0000194098</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194098</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SARS-CoV-2 mRNA</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</name>
		<code>N0000183905</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183905</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Herpes Zoster Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</name>
		<code>N0000194168</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194168</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pneumococcal 21-valent Conjugate Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Bordetella Pertussis Vaccine [EPC]</name>
		<code>N0000183896</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183896</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Bordetella Pertussis Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Salmonella Typhi Vaccine [EPC]</name>
		<code>N0000183910</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183910</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Salmonella Typhi Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Hepatitis B Virus Vaccine [EPC]</name>
		<code>N0000183890</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183890</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Hepatitis B Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Human Papillomavirus Vaccine [EPC]</name>
		<code>N0000183891</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183891</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Human Papillomavirus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</name>
		<code>N0000183888</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183888</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Haemophilus Influenzae B Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Influenza A Virus Vaccine [EPC]</name>
		<code>N0000183892</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183892</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Influenza A Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Measles Virus Vaccine [EPC]</name>
		<code>N0000183907</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183907</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Measles Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</name>
		<code>N0000183911</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183911</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Chickenpox Virus Vaccine</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Varicella Zoster Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Clostridium Tetani Vaccine [EPC]</name>
		<code>N0000183900</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183900</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Clostridium Tetani Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Human Adenovirus Type 7 Vaccine [EPC]</name>
		<code>N0000183914</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183914</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Human Adenovirus Type 7 Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Mumps Virus Vaccine [EPC]</name>
		<code>N0000183918</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183918</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Mumps Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acellular Tissue Engineered Vessel [EPC]</name>
		<code>N0000194163</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194163</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acellular Tissue Engineered Vessel</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antirheumatic Agent [EPC]</name>
		<code>N0000175713</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175713</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antirheumatic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antirheumatic Agent [TC]</name>
		<code>N0000178308</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178308</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antirheumatic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antirheumatic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diagnostic Agent [APC]</name>
		<code>N0000193895</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193895</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diagnostic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Skin Test Antigen [EPC]</name>
		<code>N0000184316</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184316</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Skin Test Antigen</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tuberculosis Skin Test [EPC]</name>
		<code>N0000184315</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184315</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tuberculosis Skin Test</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Helicobacter pylori Diagnostic [EPC]</name>
		<code>N0000175886</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175886</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H. pylori Diagnostic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H. Pylori Diagnostic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Helicobacter pylori Diagnostic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Helicobacter Pylori Diagnostic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Muscle Relaxant [EPC]</name>
		<code>N0000175737</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175737</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Muscle Relaxant</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscle Relaxant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Centrally-mediated Muscle Relaxation [PE]</name>
		<code>N0000175730</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175730</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Centrally-mediated Muscle Relaxation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Skeletal Muscle Relaxant [EPC]</name>
		<code>N0000175738</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175738</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Skeletal Muscle Relaxant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Interaction [APC]</name>
		<code>N0000193888</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193888</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-12 Antagonist [EPC]</name>
		<code>N0000192797</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192797</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 12 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL12 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-12 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-12 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</name>
		<code>N0000191421</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191421</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific CD19-directed CD3-directed T Cell Engager</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19-directed CD3-directed BiTE</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Agonist [APC]</name>
		<code>N0000193886</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193886</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E2 Receptor Agonist [EPC]</name>
		<code>N0000194041</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194041</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin E2 Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin EP2 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>EP2 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</name>
		<code>N0000175655</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175655</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone (GnRH) Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GnRH Secretion [PE]</name>
		<code>N0000009332</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009332</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GnRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-15 Receptor Agonist [EPC]</name>
		<code>N0000194118</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194118</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-15 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-15 Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 15 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 15 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL15 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Secretagogue Receptor Agonist [EPC]</name>
		<code>N0000193785</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193785</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Secretagogue Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ghrelin Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostacyclin Receptor Agonist [EPC]</name>
		<code>N0000192339</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192339</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostacyclin Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</name>
		<code>N0000194015</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194015</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GIPR Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GIP Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Receptor beta Agonist [EPC]</name>
		<code>N0000194131</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194131</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor-beta Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>THR-β Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRβ Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor-β Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>THR-beta Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor beta Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Receptor β Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin-4 Receptor Agonist [EPC]</name>
		<code>N0000193871</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193871</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT4 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-4 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-4 Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT4 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen Agonist/Antagonist [EPC]</name>
		<code>N0000175826</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175826</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Estrogen Receptor Modulator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Estrogen Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Agonist/Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SERM</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progesterone Agonist/Antagonist [EPC]</name>
		<code>N0000191263</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191263</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective Progesterone Receptor Modulator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progesterone Agonist/Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed Progesterone Agonist and Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aryl Hydrocarbon Receptor Agonist [EPC]</name>
		<code>N0000194018</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194018</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>AhR agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aryl Hydrocarbon Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium-sensing Receptor Agonist [EPC]</name>
		<code>N0000175902</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175902</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium-sensing Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Sensing Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Farnesoid X Receptor Agonist [EPC]</name>
		<code>N0000192561</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192561</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Farnesoid X Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>mu-Opioid Receptor Agonist [EPC]</name>
		<code>N0000191867</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191867</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>mu-Opioid Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid mu-Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</name>
		<code>N0000194128</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194128</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator-activated Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</name>
		<code>N0000180186</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180186</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator Receptor gamma (PPAR-gamma) Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator Receptor gamma Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-gamma Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</name>
		<code>N0000175596</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175596</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator Receptor alpha Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-alpha Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator Receptor alpha (PPAR-alpha) Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peroxisome Proliferator Receptor delta Agonist [EPC]</name>
		<code>N0000194127</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194127</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peroxisome Proliferator Receptor delta Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR-delta Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PPAR delta Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adenosine Receptor Agonist [EPC]</name>
		<code>N0000178375</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178375</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adenosine Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostaglandin E1 Agonist [EPC]</name>
		<code>N0000180189</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180189</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PGE-1 Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PGE1 Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostaglandin E1 Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Agonist [EPC]</name>
		<code>N0000194045</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194045</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanocortin Receptor Agonist [EPC]</name>
		<code>N0000194029</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194029</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocortin Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MCR Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melanocortin 4 Receptor Agonist [EPC]</name>
		<code>N0000193940</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193940</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melanocortin 4 Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MC4 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GLP-1 Receptor Agonist [EPC]</name>
		<code>N0000178480</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178480</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide 1 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucagon-like Peptide-1 Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GLP-1 Receptor Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RANK Ligand Inhibitor [EPC]</name>
		<code>N0000187055</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187055</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RANK Ligand (RANKL) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Activator of Nuclear Factor-kappa B Ligand Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RANKL Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RANK Ligand Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-13 Antagonist [EPC]</name>
		<code>N0000193985</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193985</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 13 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 13 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-13 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-13 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chemokine Receptor Type 4 Interaction [EPC]</name>
		<code>N0000193866</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193866</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chemokine Receptor Type 4 Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCR4 Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CXC Chemokine Receptor 4 Antagonist [EPC]</name>
		<code>N0000194104</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194104</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CXCR-4 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CXC Chemokine Receptor 4 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CXCR4 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-5 Antagonist [EPC]</name>
		<code>N0000191872</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191872</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL5 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-5 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-5 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 5 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</name>
		<code>N0000194166</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194166</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific BCMA-directed CD3 T Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</name>
		<code>N0000194063</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194063</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific CD20-directed CD3 T Cell Engager</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific CD20-directed CD3-directed T Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific CD20-directed CD3-directed T-Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific CD20-directed CD3 T-Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Activin Signaling Inhibitor [EPC]</name>
		<code>N0000194100</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194100</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Activin Signaling Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Receptor Antagonist [APC]</name>
		<code>N0000193887</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193887</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin Receptor Antagonist [EPC]</name>
		<code>N0000178376</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178376</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasopressin V2 Receptor Antagonist [EPC]</name>
		<code>N0000193181</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193181</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasopressin V2 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Androgen Receptor Inhibitor [EPC]</name>
		<code>N0000175560</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175560</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Androgen Receptor Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 Receptor Antagonist [EPC]</name>
		<code>N0000190480</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190480</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6 (IL-6) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-6 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 (IL6) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endothelin Receptor Antagonist [EPC]</name>
		<code>N0000175581</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175581</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelin Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine-2 Receptor Antagonist [EPC]</name>
		<code>N0000175784</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175784</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine-2 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H2 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine-2 (H2) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-4 Receptor alpha Antagonist [EPC]</name>
		<code>N0000193342</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193342</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 4 Receptor alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4 Receptor alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4R alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-4R alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL4 Receptor alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-4 Receptor alpha Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</name>
		<code>N0000175839</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175839</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone (GnRH) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Estrogen Receptor Antagonist [EPC]</name>
		<code>N0000175582</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175582</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Estrogen Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bradykinin B2 Receptor Antagonist [EPC]</name>
		<code>N0000182965</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182965</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bradykinin B2 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Antagonist [EPC]</name>
		<code>N0000175691</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175691</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neonatal Fc Receptor Blocker [EPC]</name>
		<code>N0000194004</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194004</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neonatal Fc Receptor Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>FcRn Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</name>
		<code>N0000193917</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193917</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CGPR Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcitonin Gene-related Peptide Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P2Y12 Platelet Inhibitor [EPC]</name>
		<code>N0000182142</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182142</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P2Y12 Platelet Aggregation Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P2Y12 Platelet Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hedgehog Pathway Inhibitor [EPC]</name>
		<code>N0000184149</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184149</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hedgehog Pathway Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</name>
		<code>N0000193926</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193926</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Insulin-like Growth Factor-1 Receptor Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IGF-1R Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Orexin Receptor Antagonist [EPC]</name>
		<code>N0000191000</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191000</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Orexin Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aldosterone Antagonist [EPC]</name>
		<code>N0000175557</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175557</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aldosterone Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine-1 Receptor Inhibitor [EPC]</name>
		<code>N0000175519</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175519</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H1 Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine-1 Receptor Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</name>
		<code>N0000193970</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193970</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</name>
		<code>N0000194053</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194053</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine H3 Receptor Antagonist/Inverse Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine-3 Receptor Antagonist/Inverse Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H3 Receptor Antagonist/Inverse Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</name>
		<code>N0000175786</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175786</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Substance P/Neurokinin-1 (NK-1) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Substance P/Neurokinin-1 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-31 Receptor alpha Antagonist [EPC]</name>
		<code>N0000194121</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194121</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-31 Receptor alpha Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine-1 Receptor Antagonist [EPC]</name>
		<code>N0000175587</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175587</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine-1 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H1 Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-1 Receptor Antagonist [EPC]</name>
		<code>N0000175710</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175710</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-1 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-1 (IL-1) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 1 (IL1) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-36 Receptor Antagonist [EPC]</name>
		<code>N0000194039</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194039</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-36 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 36 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-36RA</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-36 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL36 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Inhibitor [EPC]</name>
		<code>N0000193543</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193543</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGF Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Integrin Receptor Antagonist [EPC]</name>
		<code>N0000175775</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175775</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Integrin Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</name>
		<code>N0000192701</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192701</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Function-Associated Antigen-1 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>LFA-1 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurokinin 3 Receptor Antagonist [EPC]</name>
		<code>N0000194090</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194090</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NK3 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurokinin 3 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</name>
		<code>N0000194108</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194108</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Colony Stimulating Factor-1 Receptor Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CSF1R Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Colony Stimulating Factor 1 Receptor Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CSF-1R Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Complement 5a Receptor Antagonist [EPC]</name>
		<code>N0000193973</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193973</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>C5aR Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Complement 5a Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</name>
		<code>N0000194151</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194151</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRF Type 1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRF1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRF 1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticotropin Releasing Factor Type 1 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Adrenocorticotropic Hormone Secretion [PE]</name>
		<code>N0000008382</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008382</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Adrenocorticotropic Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased ACTH Sectretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Progestin Antagonist [EPC]</name>
		<code>N0000175841</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175841</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Progestin Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17 Receptor A Antagonist [EPC]</name>
		<code>N0000193276</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193276</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17RA Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17RA Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17 Receptor A Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17RA Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17 RA Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17RA Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17 Receptor A Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17 RA Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tumor Necrosis Factor Blocker [EPC]</name>
		<code>N0000175610</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175610</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TNF Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor (TNF) Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor Receptor Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tumor Necrosis Factor Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiotensin 2 Receptor Blocker [EPC]</name>
		<code>N0000175561</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175561</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin II Receptor Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiotensin 2 Receptor Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Receptor Antagonist [EPC]</name>
		<code>N0000190119</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190119</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Receptor Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcitonin Gene-related Peptide Antagonist [EPC]</name>
		<code>N0000193952</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193952</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcitonin Gene-related Peptide Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-23 Antagonist [EPC]</name>
		<code>N0000192799</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192799</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-23 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 23 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-23 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL23 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A Antagonist [EPC]</name>
		<code>N0000191495</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191495</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17A Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17A (IL17A) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17A Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17A (IL-17A) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17A Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17A Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Type I interferon Receptor Antagonist [EPC]</name>
		<code>N0000193967</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193967</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Type I interferon Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Type I IFN Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6 Antagonist [EPC]</name>
		<code>N0000191006</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191006</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-6 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6 Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6 (IL-6) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 (IL6) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6 Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</name>
		<code>N0000193989</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193989</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific Glycoprotein 100 Peptide-HLA-directed CD3 T Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bispecific gp100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD123 Interaction [EPC]</name>
		<code>N0000193864</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193864</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD123 Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-3 Receptor alpha-chain Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-3RA Interaction</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sphingosine 1-phosphate Receptor Modulator [EPC]</name>
		<code>N0000181816</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000181816</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sphingosine 1-phosphate Receptor Modulator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Chemical Structure [APC]</name>
		<code>N0000193894</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193894</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Chemical Structure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tetracycline-class Drug [EPC]</name>
		<code>N0000175882</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175882</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tetracycline-class Drug</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Actinomycin [EPC]</name>
		<code>N0000180850</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180850</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Actinomycin</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Actinomycin-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Barbiturate [EPC]</name>
		<code>N0000175693</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175693</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Barbiturate-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Barbiturate</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aluminum Complex [EPC]</name>
		<code>N0000175801</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175801</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aluminum Complex</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium [EPC]</name>
		<code>N0000175901</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175901</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thiazolidinedione [EPC]</name>
		<code>N0000180190</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180190</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thiazolidinedione-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thiazolidinedione</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nicotinic Acid [EPC]</name>
		<code>N0000175594</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175594</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nicotinic Acid</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nicotinic Acid-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfone [EPC]</name>
		<code>N0000175881</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175881</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfone-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bismuth [EPC]</name>
		<code>N0000180183</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180183</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bismuth</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bismuth-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon beta [EPC]</name>
		<code>N0000191625</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191625</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon beta</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon beta-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Medium-chain Triglyceride [EPC]</name>
		<code>N0000194023</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194023</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Medium-chain TG</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Medium-chain Triacylglycerol</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Medium-chain Triglyceride</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostacycline [EPC]</name>
		<code>N0000175603</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175603</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostacycline</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostacycline-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostacycline Vasodilator [EPC]</name>
		<code>N0000175416</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175416</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostacycline Vasodilator</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostacycline-class Vasodilator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasodilation [PE]</name>
		<code>N0000009909</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009909</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Venous Vasodilation [PE]</name>
		<code>N0000009911</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009911</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Venous Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Penile Venous Vasodilation [PE]</name>
		<code>N0000009798</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009798</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penile Venous Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Venous Vasodilation [PE]</name>
		<code>N0000009818</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009818</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Venous Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Systemic Venous Vasodilation [PE]</name>
		<code>N0000009883</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009883</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Systemic Venous Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Arterial Vasodilation [PE]</name>
		<code>N0000008299</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008299</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coronary Arterial Vasodilation [PE]</name>
		<code>N0000008375</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008375</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coronary Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coronary Arteriolar Vasodilation [PE]</name>
		<code>N0000175381</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175381</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coronary Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Systemic Arterial Vasodilation [PE]</name>
		<code>N0000009940</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009940</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Systemic Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Systemic Arteriolar Vasodilation [PE]</name>
		<code>N0000175394</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175394</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Systemic Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arterial Vasodilation [PE]</name>
		<code>N0000008352</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008352</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cerebral Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arteriolar Vasodilation [PE]</name>
		<code>N0000175380</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175380</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cerebral Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Arteriolar Vasodilation [PE]</name>
		<code>N0000175379</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175379</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arteriolar Vasodilation [PE]</name>
		<code>N0000175383</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175383</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucosal Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arteriolar Vasodilation [PE]</name>
		<code>N0000175386</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175386</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oropharyngeal Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arteriolar Vasodilation [PE]</name>
		<code>N0000175385</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175385</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genitourinary Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arteriolar Vasodilation [PE]</name>
		<code>N0000175387</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175387</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arteriolar Vasodilation [PE]</name>
		<code>N0000175384</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175384</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Conjunctival Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Muscular Arteriolar Vasodilation [PE]</name>
		<code>N0000175388</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175388</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscular Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arteriolar Vasodilation [PE]</name>
		<code>N0000175382</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175382</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cutaneous Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arteriolar Vasodilation [PE]</name>
		<code>N0000175389</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175389</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Arteriolar Vasodilation [PE]</name>
		<code>N0000175390</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175390</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arteriolar Vasodilation [PE]</name>
		<code>N0000175392</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175392</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Efferent Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arteriolar Vasodilation [PE]</name>
		<code>N0000175391</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175391</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Afferent Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arteriolar Vasodilation [PE]</name>
		<code>N0000175393</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175393</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Splanchnic Arteriolar Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arterial Vasodilation [PE]</name>
		<code>N0000008377</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008377</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cutaneous Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arterial Vasodilation [PE]</name>
		<code>N0000009752</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009752</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucosal Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arterial Vasodilation [PE]</name>
		<code>N0000008372</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008372</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Conjunctival Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arterial Vasodilation [PE]</name>
		<code>N0000009835</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009835</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arterial Vasodilation [PE]</name>
		<code>N0000009059</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009059</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genitourinary Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arterial Vasodilation [PE]</name>
		<code>N0000009776</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009776</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oropharyngeal Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Arterial Vasodilation [PE]</name>
		<code>N0000009826</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009826</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arterial Vasodilation [PE]</name>
		<code>N0000009824</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009824</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Afferent Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arterial Vasodilation [PE]</name>
		<code>N0000009828</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009828</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Efferent Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arterial Vasodilation [PE]</name>
		<code>N0000009816</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009816</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arterial Vasodilation [PE]</name>
		<code>N0000009856</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009856</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Splanchnic Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Muscular Arterial Vasodilation [PE]</name>
		<code>N0000009754</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009754</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscular Arterial Vasodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Benzothiazole [EPC]</name>
		<code>N0000175740</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175740</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzothiazole</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Benzothiazole-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Porphyrin Precursor [EPC]</name>
		<code>N0000175846</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175846</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Porphyrin Precursor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan [EPC]</name>
		<code>N0000175837</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175837</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosaminoglycan</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiac Glycoside [EPC]</name>
		<code>N0000175568</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175568</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiac Glycoside</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amino Acid [EPC]</name>
		<code>N0000175780</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175780</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amino Acid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aromatic Amino Acid [EPC]</name>
		<code>N0000193220</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193220</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aromatic Amino Acid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amino Acid Hypertonic Solution [EPC]</name>
		<code>N0000175797</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175797</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amino Acid Hypertonic Solution</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thiazide Diuretic [EPC]</name>
		<code>N0000175419</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175419</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thiazide Diuretic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thiazide-class Diuretic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Retinoid [EPC]</name>
		<code>N0000175607</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175607</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Retinoid</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Retinoid-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thalidomide Analog [EPC]</name>
		<code>N0000184014</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184014</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thalidomide Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thalidomide Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glinide [EPC]</name>
		<code>N0000175428</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175428</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glinide-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glinide</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glinides [EXT]</name>
		<code>N0000177907</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177907</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glinides</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parenteral Iron Replacement [EPC]</name>
		<code>N0000177913</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177913</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parenteral Iron Replacement Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parenteral Iron Replacement</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alkaloid [EPC]</name>
		<code>N0000193949</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193949</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alkaloid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Hydroxy Acid [EPC]</name>
		<code>N0000175842</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175842</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Hydroxy Acid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyridone [EPC]</name>
		<code>N0000191420</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191420</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyridone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pyrethroid [EPC]</name>
		<code>N0000175847</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175847</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrethroid-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrethroid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aminosalicylate [EPC]</name>
		<code>N0000175781</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175781</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminosalicylate-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminosalicylate</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitrate Vasodilator [EPC]</name>
		<code>N0000175415</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175415</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitrate Vasodilator</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitrate-class Vasodilator</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Amide Local Anesthetic [EPC]</name>
		<code>N0000175682</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175682</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Amide Local Anesthetic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Local Anesthesia [PE]</name>
		<code>N0000175976</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175976</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Local Anesthesia</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Semifluorinated Alkane [EPC]</name>
		<code>N0000194071</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194071</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Semifluorinated Alkane</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Semifluorinated Alkane [EXT]</name>
		<code>N0000194072</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194072</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Semifluorinated Alkane</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bisphosphonate [EPC]</name>
		<code>N0000175579</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175579</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bisphosphonate</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bisphosphonate-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Biguanide [EPC]</name>
		<code>N0000175565</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175565</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Biguanide</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Biguanide-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon alpha [EPC]</name>
		<code>N0000175521</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175521</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon alpha</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon alpha-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon alfa</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon alfa-2b [EPC]</name>
		<code>N0000193982</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193982</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IFN alpha-2B</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon alfa-2B</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon alfa-2b</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ester Local Anesthetic [EPC]</name>
		<code>N0000175683</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175683</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ester Local Anesthetic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Omega-3 Fatty Acid [EPC]</name>
		<code>N0000175583</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175583</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Omega-3 Fatty Acid</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Omega-3 Fatty Acid-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Psoralen [EPC]</name>
		<code>N0000175879</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175879</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Psoralen-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Psoralen</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma [EPC]</name>
		<code>N0000175541</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175541</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon gamma</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon gamma-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Reducing and Complexing Thiol [EPC]</name>
		<code>N0000175898</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175898</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reducing and Complexing Thiol</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclic Pyranopterin Monophosphate [EPC]</name>
		<code>N0000193919</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193919</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin monophosphoric acid</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic Pyranopterin Monophosphate</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin monophoshic acid</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin phosphate</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin phosphoric acid</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>cPMP</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cyclic Pyranopterin Monophosphate [EXT]</name>
		<code>N0000193920</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193920</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin monophoshic acid</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin monophosphoric acid</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic Pyranopterin Monophosphate</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>cPMP</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin phosphate</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cyclic pyranopterin phosphoric acid</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Macrolide [EPC]</name>
		<code>N0000175877</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175877</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Macrolide</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Macrolide-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Steroid [EPC]</name>
		<code>N0000194034</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194034</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Steroid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Acid [EPC]</name>
		<code>N0000175802</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175802</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Acid</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Acid-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfonylurea [EPC]</name>
		<code>N0000175608</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175608</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfonylurea-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfonylurea</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin or Mineral [APC]</name>
		<code>N0000193877</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193877</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin or Mineral</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin B Complex Member [EPC]</name>
		<code>N0000175714</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175714</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B Complex Member</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin B12 [EPC]</name>
		<code>N0000175951</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175951</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B12</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B12-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Provitamin D2 Compound [EPC]</name>
		<code>N0000175909</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175909</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Provitamin D2 Compound</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Salt [EPC]</name>
		<code>N0000175600</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175600</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Salt</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin C [EPC]</name>
		<code>N0000193618</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193618</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin C-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin C</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin A [EPC]</name>
		<code>N0000175950</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175950</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin A-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin A</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologic Agent [APC]</name>
		<code>N0000193902</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193902</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD4-directed Blocking Antibody [EPC]</name>
		<code>N0000193806</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193806</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD4-directed Blocking Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>BCL-2 Inhibitor [EPC]</name>
		<code>N0000192515</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192515</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bcl 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCL-2 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Cell Lymphoma-2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Cell Lymphoma 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BCL 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Cell Lymphoma 2 Protein Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bcl-2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Cell Lymphoma-2 Protein Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cellular Death [PE]</name>
		<code>N0000009176</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009176</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cellular Death</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</name>
		<code>N0000182637</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182637</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>BLyS-specific Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Lymphocyte Stimulator-specific Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B Lymphocyte Stimulator (BLyS)-specific Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B Lymphocyte Stimulator-specific Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B-Lymphocyte Stimulator (BLyS)-specific Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased B Lymphocyte Activation [PE]</name>
		<code>N0000182156</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182156</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased B Lymphocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interferon gamma Blocker [EPC]</name>
		<code>N0000193856</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193856</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interferon gamma Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IFNγ Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Chimeric Antigen Receptor [EPC]</name>
		<code>N0000193546</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193546</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19-directed Chimeric Antigen Receptor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Selective T Cell Costimulation Blocker [EPC]</name>
		<code>N0000182830</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182830</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective T Cell Costimulation Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>T Lymphocyte Costimulation Activity Blockade [PE]</name>
		<code>N0000182829</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182829</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T Lymphocyte Costimulation Activity Blockade</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Programmed Death Ligand-1 Blocker [EPC]</name>
		<code>N0000193338</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193338</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PD-L1 Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Programmed Death Ligand-1 Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activation Gene-3 Blocker [EPC]</name>
		<code>N0000194003</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194003</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Activation Gene-3 Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Activation Gene 3 Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>LAG-3 Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD3-directed Antibody [EPC]</name>
		<code>N0000194084</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194084</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monoclonal Antibody [EPC]</name>
		<code>N0000193863</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193863</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monoclonal Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>mAb</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>moAb</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thymic Stromal Lymphopoietin Blocker [EPC]</name>
		<code>N0000194010</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194010</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thymic Stromal Lymphopoietin Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TSLP Blocker</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD19-directed Cytolytic Antibody [EPC]</name>
		<code>N0000194013</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194013</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19-directed Cytolytic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD19 directed Cytolytic Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Growth Factor [EPC]</name>
		<code>N0000175667</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175667</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lymphocyte Cell Production [PE]</name>
		<code>N0000009391</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009391</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lymphocyte Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased T Lymphocyte Production [PE]</name>
		<code>N0000009690</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009690</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased T Lymphocyte Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased B Lymphocyte Production [PE]</name>
		<code>N0000009114</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009114</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased B Lymphocyte Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lymphocyte Activation [PE]</name>
		<code>N0000178328</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178328</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lymphocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased B Lymphocyte Activation [PE]</name>
		<code>N0000182158</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182158</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased B Lymphocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Menin Inhibitor [EPC]</name>
		<code>N0000194139</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194139</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Menin Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin Agent [APC]</name>
		<code>N0000193903</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193903</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Selective T Cell Costimulation Modulator [EPC]</name>
		<code>N0000182159</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182159</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Selective T Cell Costimulation Modulator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>T Lymphocyte Costimulation Activity Modulation [PE]</name>
		<code>N0000182154</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182154</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T Lymphocyte Costimulation Activity Modulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytolytic Agent [EPC]</name>
		<code>N0000191548</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191548</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytolytic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Membrane Integrity [PE]</name>
		<code>N0000008476</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008476</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cell Membrane Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood Glucose Regulator [APC]</name>
		<code>N0000193891</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193891</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood Glucose Regulator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antihypoglycemic Agent [EPC]</name>
		<code>N0000190852</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190852</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antihypoglycemic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Gluconeogenesis [PE]</name>
		<code>N0000009340</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009340</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Gluconeogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glycogenolysis [PE]</name>
		<code>N0000009345</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009345</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glycogenolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</name>
		<code>N0000187059</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187059</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Cotransporter 2 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Symporter 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SGLT2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Transporter 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose-Sodium Cotransporter 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Transporter 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Glucose Symporter 2 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Tubular Transport Inhibitor [EPC]</name>
		<code>N0000194156</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194156</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Tubular Transport Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Organic Ion Transport Alteration [PE]</name>
		<code>N0000009831</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009831</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Organic Ion Transport Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Organic Ion Excretion [PE]</name>
		<code>N0000009556</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009556</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Organic Ion Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Organic Anion Excretion [PE]</name>
		<code>N0000009554</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009554</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Organic Anion Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uricosuric Activity [PE]</name>
		<code>N0000009896</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009896</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uricosuric Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Organic Cation Excretion [PE]</name>
		<code>N0000009555</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009555</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Organic Cation Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Organic Ion Excretion [PE]</name>
		<code>N0000008864</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008864</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Organic Ion Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Organic Anion Excretion [PE]</name>
		<code>N0000008862</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008862</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Organic Anion Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Organic Cation Excretion [PE]</name>
		<code>N0000008863</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008863</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Organic Cation Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Factor [APC]</name>
		<code>N0000193885</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193885</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</name>
		<code>N0000175671</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175671</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucocutaneous Epithelial Cell Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Epithelial Proliferation [PE]</name>
		<code>N0000175675</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175675</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Epithelial Proliferation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Platelet-derived Growth Factor [EPC]</name>
		<code>N0000175885</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175885</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Platelet-derived Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Nerve Growth Factor [EPC]</name>
		<code>N0000193854</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193854</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Nerve Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Leukocyte Growth Factor [EPC]</name>
		<code>N0000175666</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175666</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leukocyte Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Myeloid Cell Production [PE]</name>
		<code>N0000009451</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009451</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Myeloid Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Granulocytic Cell Production [PE]</name>
		<code>N0000009348</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009348</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Granulocytic Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Monocytic Cell Production [PE]</name>
		<code>N0000009426</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009426</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Monocytic Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anesthetic [APC]</name>
		<code>N0000193878</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193878</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anesthetic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Local Anesthetic [EPC]</name>
		<code>N0000175539</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175539</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Local Anesthetic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>General Anesthetic [EPC]</name>
		<code>N0000175681</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175681</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>General Anesthetic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme [APC]</name>
		<code>N0000193884</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193884</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </name>
		<code>N0000194082</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194082</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Lysosomal alpha-Mannosidase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endoglycosidase [EPC]</name>
		<code>N0000175531</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175531</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endoglycosidase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</name>
		<code>N0000175822</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175822</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal Neutral Glycosphingolipid-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carboxypeptidase [EPC]</name>
		<code>N0000184013</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184013</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carboxypeptidase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uric Acid-specific Enzyme [EPC]</name>
		<code>N0000175670</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175670</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uric Acid Specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uric Acid-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</name>
		<code>N0000192342</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192342</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal Cholesteryl Ester-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lysosomal beta Glucuronidase [EPC]</name>
		<code>N0000193804</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193804</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lysosomal beta Glucuronidase</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>beta Glucuronidase</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</name>
		<code>N0000192343</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192343</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal Triacylglycerol-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sucrose-specific Enzyme [EPC]</name>
		<code>N0000175819</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175819</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sucrose-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</name>
		<code>N0000175821</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175821</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal Glycogen-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Glycogen-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</name>
		<code>N0000175823</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175823</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Glycosaminoglycan (GAG)-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal GAG-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal Glycosaminoglycan (GAG)-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal GAG-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tissue-nonspecific Alkaline Phosphatase [EPC]</name>
		<code>N0000191865</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191865</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tissue-nonspecific Alkaline Phosphatase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</name>
		<code>N0000193414</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193414</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lysosomal N-terminal Tripeptidyl Peptidase</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tripeptidyl Peptidase-1</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tripeptidyl Peptidase I</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</name>
		<code>N0000175820</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175820</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysozomal Glucocerebroside-specific Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Deoxyribonuclease 1 [EPC]</name>
		<code>N0000175958</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175958</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Deoxyribonuclease 1 (rhDNase) Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Deoxyribonuclease 1 Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Deoxyribonuclease I (rhDNase) Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Deoxyribonuclease 1</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human DNase I</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>rhDNase 1</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Deoxyribonuclease I Enzyme</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human DNase 1</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>rhDNase I</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Deoxyribonuclease I</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Asparagine-specific Enzyme [EPC]</name>
		<code>N0000175669</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175669</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Asparagine-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phenylalanine Metabolizing Enzyme [EPC]</name>
		<code>N0000193858</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193858</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phenylalanine Metabolizing Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Collagen-specific Enzyme [EPC]</name>
		<code>N0000175843</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175843</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Collagen-specific Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiovascular Agent [APC]</name>
		<code>N0000193893</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193893</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiovascular Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pharmacologic Cardiac Stress Test Agent [EPC]</name>
		<code>N0000193963</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193963</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pharmacologic Cardiac Stress Test Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dietary Cholesterol Absorption Inhibitor [EPC]</name>
		<code>N0000175911</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175911</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dietary Cholesterol Absorption Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Absorption [PE]</name>
		<code>N0000008553</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008553</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cholesterol Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiarrhythmic [EPC]</name>
		<code>N0000175426</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175426</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiarrhythmic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-arrhythmic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-arrhythmic Agent [TC]</name>
		<code>N0000178311</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178311</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-arrhythmic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-arrhythmic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiarrhythmic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasodilator [EPC]</name>
		<code>N0000175940</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175940</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasodilator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Arteriolar Vasodilator [EPC]</name>
		<code>N0000175564</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175564</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Arteriolar Vasodilator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Acid Sequestrant [EPC]</name>
		<code>N0000180292</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180292</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Acid Sequestrant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Catecholamine-depleting Sympatholytic [EPC]</name>
		<code>N0000175640</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175640</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Catecholamine-depleting Sympatholytic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Activity [PE]</name>
		<code>N0000175650</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175650</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sympatholytic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Aspartate Activity [PE]</name>
		<code>N0000008975</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008975</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Glycine Activity [PE]</name>
		<code>N0000008987</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008987</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008976</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008976</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Nerve Growth Factor Activity [PE]</name>
		<code>N0000008989</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008989</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Dynorphin Activity [PE]</name>
		<code>N0000008980</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008980</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Neurotensin Activity [PE]</name>
		<code>N0000008990</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008990</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Nitric Oxide Activity [PE]</name>
		<code>N0000008991</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008991</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Acetylcholine Activity [PE]</name>
		<code>N0000008974</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008974</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic CCK Activity [PE]</name>
		<code>N0000008977</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008977</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Gastrin Activity [PE]</name>
		<code>N0000008985</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008985</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Glutamate Activity [PE]</name>
		<code>N0000008986</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008986</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Substance P Activity [PE]</name>
		<code>N0000008995</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008995</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Endorphin Activity [PE]</name>
		<code>N0000008981</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008981</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Epinephrine Activity [PE]</name>
		<code>N0000008983</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008983</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Enkephalin Activity [PE]</name>
		<code>N0000008982</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008982</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic VIP Activity [PE]</name>
		<code>N0000008996</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008996</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic GABA Activity [PE]</name>
		<code>N0000008984</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008984</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Dopamine Activity [PE]</name>
		<code>N0000008979</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008979</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Norepinephrine Activity [PE]</name>
		<code>N0000008992</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008992</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</name>
		<code>N0000191627</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191627</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Apolipoprotein B-100 Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Protein Synthesis [PE]</name>
		<code>N0000008841</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008841</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Protein Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasoconstrictor [EPC]</name>
		<code>N0000192562</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192562</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasoconstrictor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasoconstriction [PE]</name>
		<code>N0000009908</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009908</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Venous Vasoconstriction [PE]</name>
		<code>N0000009910</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009910</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Venous Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Venous Vasoconstriction [PE]</name>
		<code>N0000009817</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009817</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Venous Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Systemic Venous Vasoconstriction [PE]</name>
		<code>N0000009882</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009882</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Systemic Venous Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Arterial Vasoconstriction [PE]</name>
		<code>N0000008298</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008298</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arterial Vasoconstriction [PE]</name>
		<code>N0000009815</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009815</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pulmonary Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175405</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175405</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pulmonary Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175395</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175395</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Muscular Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175404</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175404</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscular Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175399</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175399</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucosal Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175400</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175400</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Conjunctival Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175402</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175402</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oropharyngeal Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175403</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175403</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175401</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175401</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genitourinary Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175398</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175398</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cutaneous Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175396</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175396</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cerebral Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175406</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175406</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175408</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175408</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Efferent Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175407</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175407</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Afferent Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175409</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175409</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Splanchnic Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Systemic Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175410</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175410</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Systemic Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coronary Arteriolar Vasoconstriction [PE]</name>
		<code>N0000175397</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175397</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coronary Arteriolar Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Splanchnic Arterial Vasoconstriction [PE]</name>
		<code>N0000009855</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009855</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Splanchnic Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Arterial Vasoconstriction [PE]</name>
		<code>N0000009825</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009825</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Afferent Arterial Vasoconstriction [PE]</name>
		<code>N0000009823</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009823</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Afferent Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Efferent Arterial Vasoconstriction [PE]</name>
		<code>N0000009827</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009827</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Efferent Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cerebral Arterial Vasoconstriction [PE]</name>
		<code>N0000008351</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008351</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cerebral Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Muscular Arterial Vasoconstriction [PE]</name>
		<code>N0000009753</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009753</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Muscular Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cutaneous Arterial Vasoconstriction [PE]</name>
		<code>N0000008376</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008376</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cutaneous Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coronary Arterial Vasoconstriction [PE]</name>
		<code>N0000008374</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008374</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coronary Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Systemic Arterial Vasoconstriction [PE]</name>
		<code>N0000009941</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009941</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Systemic Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mucosal Arterial Vasoconstriction [PE]</name>
		<code>N0000009751</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009751</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucosal Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Arterial Vasoconstriction [PE]</name>
		<code>N0000009834</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009834</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Conjunctival Arterial Vasoconstriction [PE]</name>
		<code>N0000008371</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008371</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Conjunctival Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oropharyngeal Arterial Vasoconstriction [PE]</name>
		<code>N0000009775</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009775</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oropharyngeal Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Arterial Vasoconstriction [PE]</name>
		<code>N0000009058</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009058</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genitourinary Arterial Vasoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</name>
		<code>N0000186779</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000186779</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Microsomal Triglyceride Transfer Protein Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>MTTP Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sclerosing Agent [EPC]</name>
		<code>N0000175814</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175814</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sclerosing Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Sclerosing Activity [PE]</name>
		<code>N0000009905</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009905</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Sclerosing Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-anginal [EPC]</name>
		<code>N0000175427</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175427</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-anginal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-anginal Agent [TC]</name>
		<code>N0000178310</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178310</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antianginal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-anginal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-anginal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Angiopoietin-like 3 Inhibitor [EPC]</name>
		<code>N0000193915</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193915</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ANGPTL3 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiopoietin-like 3 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Therapy [APC]</name>
		<code>N0000194069</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194069</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Dermal Fibroblast Cell Therapy [EPC]</name>
		<code>N0000194145</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194145</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Dermal Fibroblast Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy [EPC]</name>
		<code>N0000194164</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194164</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell (MSC) Therapy</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</name>
		<code>N0000184318</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184318</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy [EPC]</name>
		<code>N0000194081</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194081</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cells, Allogeneic [EXT]</name>
		<code>N0000185022</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185022</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cells, Allogeneic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Cells</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Pancreatic Islet Cellular Therapy [EPC]</name>
		<code>N0000194075</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194075</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Pancreatic Islet Cellular Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cellularized Scaffold Cell Therapy [EPC]</name>
		<code>N0000194074</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194074</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Cellularized Scaffold Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autologous Chondrocyte Cell Therapy [EPC]</name>
		<code>N0000194149</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194149</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Chondrocyte Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autologous Fibroblast Cell Therapy [EPC]</name>
		<code>N0000194150</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194150</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Fibroblast Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Epidermal Keratinocyte Cell Therapy [EPC]</name>
		<code>N0000194146</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194146</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Epidermal Keratinocyte Cell Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diuretic [APC]</name>
		<code>N0000193873</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193873</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diuretic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thiazide-like Diuretic [EPC]</name>
		<code>N0000175420</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175420</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thiazide-like Diuretic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Osmotic Diuretic [EPC]</name>
		<code>N0000175810</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175810</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Osmotic Diuretic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Loop Diuretic [EPC]</name>
		<code>N0000175590</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175590</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Loop Diuretic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Physical or Chemical Agent [APC]</name>
		<code>N0000193908</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193908</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Physical or Chemical Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metal Chelator [EPC]</name>
		<code>N0000175473</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175473</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metal Chelator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iron Chelator [EPC]</name>
		<code>N0000175522</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175522</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iron Chelator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Copper Chelator [EPC]</name>
		<code>N0000194014</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194014</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper Chelator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Binder [EPC]</name>
		<code>N0000175567</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175567</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Binder</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lead Chelator [EPC]</name>
		<code>N0000175963</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175963</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lead Chelator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Demulcent [EPC]</name>
		<code>N0000175535</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175535</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Demulcent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioactive Therapeutic Agent [EPC]</name>
		<code>N0000175872</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175872</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioactive Therapeutic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioligand Therapeutic Agent [EPC]</name>
		<code>N0000194017</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194017</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioligand Therapeutic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</name>
		<code>N0000187053</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187053</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioactive alpha-Particle Emitting Therapeutic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha Particle-Emitting Radioactive Therapeutic Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cystine Depleting Agent [EPC]</name>
		<code>N0000187051</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000187051</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cystine Depleting Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Copper-containing Intrauterine Device [EPC]</name>
		<code>N0000175831</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175831</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper-containing Intrauterine Device (IUD)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper-containing Intrauterine Device</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper-containing IUD</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Photoactivated Radical Generator [EPC]</name>
		<code>N0000175984</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175984</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Photoactivated Radical Generator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Photosensitizing Activity [PE]</name>
		<code>N0000009801</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009801</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Photosensitizing Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phosphate Binder [EPC]</name>
		<code>N0000175597</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175597</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phosphate Binder</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitrogen Binding Agent [EPC]</name>
		<code>N0000175807</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175807</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitrogen Binding Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Binder [EPC]</name>
		<code>N0000178378</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178378</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Binder</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Copper Absorption Inhibitor [EPC]</name>
		<code>N0000175530</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175530</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Copper Absorption Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Copper Ion Absorption [PE]</name>
		<code>N0000175529</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175529</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Copper Ion Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Photoenhancer [EPC]</name>
		<code>N0000175540</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175540</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Photoenhancer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Methylating Agent [EPC]</name>
		<code>N0000175805</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175805</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Methylating Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Disclosing Agent [EPC]</name>
		<code>N0000194020</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194020</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Disclosing Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxidation-Reduction Agent [EPC]</name>
		<code>N0000192516</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192516</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxidation-Reduction Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metabolic Alkalinizer [EPC]</name>
		<code>N0000175896</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175896</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metabolic Alkalinizer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Releasing Agent [EPC]</name>
		<code>N0000194124</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194124</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitric Oxide Releasing Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Nitric Oxide Activity [PE]</name>
		<code>N0000009455</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009455</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Nitric Oxide Activity [PE]</name>
		<code>N0000009444</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009444</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Nitric Oxide Activity [PE]</name>
		<code>N0000009659</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009659</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Nitric Oxide Activity [PE]</name>
		<code>N0000009166</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009166</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Nitric Oxide Activity [PE]</name>
		<code>N0000009608</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009608</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000009195</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009195</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Nitric Oxide Activity [PE]</name>
		<code>N0000009218</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009218</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Nitric Oxide Activity [PE]</name>
		<code>N0000009139</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009139</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Nitric Oxide Activity [PE]</name>
		<code>N0000009417</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009417</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Nitric Oxide Activity [PE]</name>
		<code>N0000009241</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009241</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Nitric Oxide Activity [PE]</name>
		<code>N0000009635</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009635</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000009511</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009511</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000009311</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009311</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000009107</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009107</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Nitric Oxide Activity [PE]</name>
		<code>N0000009488</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009488</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000009579</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009579</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Transthyretin Stabilizer [EPC]</name>
		<code>N0000194134</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194134</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transthyretin Stabilizer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Osmotic Laxative [EPC]</name>
		<code>N0000175811</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175811</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Osmotic Laxative</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Large Intestinal Motility [PE]</name>
		<code>N0000009371</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009371</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Large Intestinal Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</name>
		<code>N0000009726</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009726</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</name>
		<code>N0000194056</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194056</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Exchanger 3 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Solute Carrier Family 9 Member 3 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLC9A3 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>NHE3 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Antiporter 3 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sodium-Hydrogen Exchanger 3 (NHE3) Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calculi Dissolution Agent [EPC]</name>
		<code>N0000175835</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175835</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Calculi Dissolution Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calculi Dissolution Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Allogeneic Cultured Cell Scaffold [EPC]</name>
		<code>N0000184319</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184319</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Cultured Cell Scaffold</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cells, Cultured, Allogeneic [EXT]</name>
		<code>N0000184309</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184309</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cultured Cells, Allogeneic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cells, Cultured, Allogeneic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Allogeneic Cultured Cells</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytotoxin [EPC]</name>
		<code>N0000193862</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193862</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytotoxin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD25-directed Cytotoxin [EPC]</name>
		<code>N0000177912</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177912</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD25-directed Cytotoxin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Agent [APC]</name>
		<code>N0000193900</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>APC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193900</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastrointestinal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ileal Bile Acid Transporter Inhibitor [EPC]</name>
		<code>N0000193957</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193957</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Apical Sodium Bile Acid Transporter Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IBAT Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>ASBT Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ileal Bile Acid Transporter Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ileal Sodium Bile Acid Cotransporter Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiemetic [EPC]</name>
		<code>N0000178372</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178372</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiemetic</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-emetic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-emetic Agent [TC]</name>
		<code>N0000178371</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178371</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiemetic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiemetic Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-emetic</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-emetic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidiarrheal [EPC]</name>
		<code>N0000178374</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178374</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidiarrheal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</name>
		<code>N0000009727</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009727</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Large Intestinal Motility [PE]</name>
		<code>N0000008679</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008679</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Large Intestinal Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidiarrheal Agent [TC]</name>
		<code>N0000178373</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178373</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidiarrheal</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidiarrheal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</name>
		<code>N0000009870</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009870</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Motility Inhibitor [EPC]</name>
		<code>N0000190853</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000190853</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastrointestinal Motility Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GI Smooth Muscle Tone [PE]</name>
		<code>N0000008636</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008636</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GI Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Esophageal Muscle Tone [PE]</name>
		<code>N0000008628</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008628</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Esophageal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased LES Tone [PE]</name>
		<code>N0000008678</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008678</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased LES Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Small Intestinal Muscle Tone [PE]</name>
		<code>N0000008898</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008898</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Small Intestinal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Pyloric Sphincter Tone [PE]</name>
		<code>N0000008851</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008851</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Pyloric Sphincter Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sphincter of Odi Tone [PE]</name>
		<code>N0000008925</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008925</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sphincter of Odi Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased UES Tone [PE]</name>
		<code>N0000009012</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009012</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased UES Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Gastric Muscle Tone [PE]</name>
		<code>N0000008641</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008641</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Gastric Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Anal Sphincter Tone [PE]</name>
		<code>N0000008389</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008389</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Anal Sphincter Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Large Intestinal Muscle Tone [PE]</name>
		<code>N0000008680</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008680</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Large Intestinal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Gallbladder Tone [PE]</name>
		<code>N0000008639</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008639</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Gallbladder Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GI Motility [PE]</name>
		<code>N0000008635</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008635</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GI Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Biliary Motility [PE]</name>
		<code>N0000008419</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008419</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Biliary Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Gastric Motility [PE]</name>
		<code>N0000008640</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008640</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Gastric Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Esophageal Motility [PE]</name>
		<code>N0000008627</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008627</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Esophageal Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Small Intestinal Motility [PE]</name>
		<code>N0000008897</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008897</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Small Intestinal Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulant Laxative [EPC]</name>
		<code>N0000175812</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175812</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulant Laxative</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</name>
		<code>N0000009871</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009871</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytoprotective Agent [EPC]</name>
		<code>N0000180854</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180854</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytoprotective Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Preparations by Generic Ingredient</name>
		<code>N0000010582</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010582</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Preparations by Generic Ingredient</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>G [Preparations]</name>
		<code>N0000010589</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010589</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>G [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>W [Preparations]</name>
		<code>N0000010605</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010605</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>W [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>A [Preparations]</name>
		<code>N0000010583</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010583</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>A [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>P [Preparations]</name>
		<code>N0000010598</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010598</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>P [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>I [Preparations]</name>
		<code>N0000010591</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010591</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>I [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>H [Preparations]</name>
		<code>N0000010590</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010590</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>H [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>U [Preparations]</name>
		<code>N0000010603</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010603</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>U [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>M [Preparations]</name>
		<code>N0000010595</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010595</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>M [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>J [Preparations]</name>
		<code>N0000010592</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010592</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>J [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>S [Preparations]</name>
		<code>N0000010601</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010601</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>S [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>T [Preparations]</name>
		<code>N0000010602</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010602</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>V [Preparations]</name>
		<code>N0000010604</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010604</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>V [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>E [Preparations]</name>
		<code>N0000010587</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010587</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>E [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>C [Preparations]</name>
		<code>N0000010585</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010585</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>C [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Q [Preparations]</name>
		<code>N0000010599</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010599</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Q [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>R [Preparations]</name>
		<code>N0000010600</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010600</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>R [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>K [Preparations]</name>
		<code>N0000010593</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010593</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>K [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Y [Preparations]</name>
		<code>N0000010607</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010607</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Y [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>O [Preparations]</name>
		<code>N0000010597</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010597</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>O [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Z [Preparations]</name>
		<code>N0000010608</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010608</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Z [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>X [Preparations]</name>
		<code>N0000010606</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010606</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>X [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>D [Preparations]</name>
		<code>N0000010586</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010586</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>D [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>L [Preparations]</name>
		<code>N0000010594</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010594</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>L [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>F [Preparations]</name>
		<code>N0000010588</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010588</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>F [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>N [Preparations]</name>
		<code>N0000010596</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010596</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>N [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>B [Preparations]</name>
		<code>N0000010584</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010584</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>B [Preparations]</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactive Preparations by FDA Established Pharmacologic Class</name>
		<code>N0000193876</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193876</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactive Preparations by FDA Established Pharmacologic Class</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitroimidazole [EPC]</name>
		<code>N0000175878</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175878</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitroimidazole</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitroimidazole-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiviral [EPC]</name>
		<code>N0000193883</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193883</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiviral</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</name>
		<code>N0000194088</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194088</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Capsid Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Capsid Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lincosamide [EPC]</name>
		<code>N0000175876</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175876</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lincosamide</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lincosamide-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytidine Deaminase Inhibitor [EPC]</name>
		<code>N0000193992</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193992</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytidine Deaminase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytidine Analog Deaminase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Reuptake Inhibitor Anorectic [EPC]</name>
		<code>N0000175948</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175948</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Reuptake Inhibitor Anorectic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype D [EPC]</name>
		<code>N0000188983</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188983</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype D</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Butyrophenone [EPC]</name>
		<code>N0000175741</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175741</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Butyrophenone-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Butyrophenone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mineralocorticoid Receptor Antagonist [EPC]</name>
		<code>N0000193969</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193969</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mineralocorticoid Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inactivated Yersinia Pestis Vaccine [EPC]</name>
		<code>N0000183902</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183902</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inactivated Yersinia Pestis Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Influenza Neuraminidase Inhibitor [EPC]</name>
		<code>N0000175437</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175437</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Influenza Neuraminidase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</name>
		<code>N0000175871</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175871</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioactive Diagnostic Agent for Positron Emission Tomography</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Leukotriene Synthesis Inhibitor [EPC]</name>
		<code>N0000175577</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175577</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Leukotriene Synthesis Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Opioid Analgesic [EPC]</name>
		<code>N0000175440</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175440</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Opioid Analgesic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Reuptake Inhibitor Anorectic [EPC]</name>
		<code>N0000175947</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175947</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine Reuptake Inhibitor Anorectic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody [EPC]</name>
		<code>N0000191008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR-2-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Receptor-2-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGFR 2-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Rifamycin Antimicrobial [EPC]</name>
		<code>N0000175506</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175506</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Rifamycin Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thrombopoiesis Stimulating Agent [EPC]</name>
		<code>N0000178368</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178368</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thrombopoiesis Stimulating Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype E [EPC]</name>
		<code>N0000188984</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188984</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype E</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Kallikrein-Trypsin Inactivator [EPC]</name>
		<code>N0000184173</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184173</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Kallikrein-Trypsin Inactivator</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Proteolytic Enzyme [EPC]</name>
		<code>N0000191621</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191621</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Proteolytic Enzyme</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cephamycin Antibacterial [EPC]</name>
		<code>N0000175931</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175931</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cephamycin Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</name>
		<code>N0000175490</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175490</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydrofolate Reductase Inhibitor Antiprotozoal</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Calcium Resorption Inhibitor [EPC]</name>
		<code>N0000180856</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180856</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Calcium Resorption Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Heparin Derivative [EPC]</name>
		<code>N0000175860</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175860</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Heparin Derivative</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bovine Intestinal Adenosine Deaminase [EPC]</name>
		<code>N0000175471</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175471</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bovine Intestinal Adenosine Deaminase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Reuptake Inhibitor Anorectic [EPC]</name>
		<code>N0000175943</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175943</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Reuptake Inhibitor Anorectic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Antibody [EPC]</name>
		<code>N0000175873</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175873</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioactive Diagnostic Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sulfonamide [EPC]</name>
		<code>N0000175880</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175880</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfonamide</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sulfonamide-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-6-directed Antibody [EPC]</name>
		<code>N0000191007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-6-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL6-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6 (IL-6)-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-6-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6 (IL6)-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 6-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 6-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
		<code>N0000175464</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175464</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 NNRTI and NRTI</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV-1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Natriuretic Peptide [EPC]</name>
		<code>N0000175593</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175593</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Natriuretic Peptide</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</name>
		<code>N0000175859</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175859</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD2-directed LFA-3/Fc Fusion Protein</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD2 Directed LFA-3/Fc Fusion Protein</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Death Inducer [EPC]</name>
		<code>N0000184015</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184015</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Death Inducer</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</name>
		<code>N0000191257</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191257</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HCV Non-Nucleoside NS5B Palm Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet-derived Growth Factor Receptor alpha Antagonist [EPC]</name>
		<code>N0000193221</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193221</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PDGFR alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor Receptor alpha Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet-derived Growth Factor Receptor alpha (PDGFR-alpha) Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PDGFR-alpha Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Galactosidase A Pharmacological Chaperone [EPC]</name>
		<code>N0000193850</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193850</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Gal A Pharmacological Chaperone</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Galactosidase A Pharmacological Chaperone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pharmacological Chaperone [EXT]</name>
		<code>N0000193847</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193847</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pharmacological Chaperone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic [EPC]</name>
		<code>N0000175424</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175424</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Antithrombin [EPC]</name>
		<code>N0000184170</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184170</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Antithrombin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Acid Binding Resin [EPC]</name>
		<code>N0000175422</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175422</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Acid Binding Resin</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile-acid Binding Resin</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleoside Analog [EPC]</name>
		<code>N0000175465</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175465</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleoside Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic and beta-Adrenergic Agonist [EPC]</name>
		<code>N0000175699</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175699</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic and beta-Adrenergic Agonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed alpha Adrenergic and beta Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha/beta Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed alpha-Adrenergic and beta-Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha Adrenergic and beta Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed alpha Adrenergic and beta Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha and beta Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha and beta Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic and beta-Adrenergic Receptor Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha Adrenergic and beta Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mixed alpha-Adrenergic and beta-Adrenergic Agonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Mumps Virus Vaccine [EPC]</name>
		<code>N0000183915</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183915</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Mumps Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Depigmenting Agent [EPC]</name>
		<code>N0000175853</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175853</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Depigmenting Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic Decongestant [EPC]</name>
		<code>N0000175957</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175957</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic Decongestant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD11a-directed Humanized IgG1 Antibody [EPC]</name>
		<code>N0000175858</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175858</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD-11a Directed Humanized IgG1 Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD11a-directed Humanized IgG1 Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000180291</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180291</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Simplex Virus Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analog HSV DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HSV Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HSV Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analogue HSV DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pyrophosphate Analog Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Human Interferon beta [EPC]</name>
		<code>N0000175747</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175747</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Human Interferon beta</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-2 Receptor-directed Cytotoxin [EPC]</name>
		<code>N0000175660</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175660</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-2 Receptor-directed Cytotoxin</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-2 Receptor-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-2 Receptor-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL2 Receptor-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 2 Receptor-directed Cytotoxin</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype A [EPC]</name>
		<code>N0000188980</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188980</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype A</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype C [EPC]</name>
		<code>N0000188982</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188982</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype C</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</name>
		<code>N0000175954</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175954</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydrofolate Reductase Inhibitor Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blocking Agent for Diagnostic Imaging [EPC]</name>
		<code>N0000175861</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175861</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blocking Agent for Diagnostic Imaging</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside [EPC]</name>
		<code>N0000175929</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175929</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminoglycoside-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminoglycoside</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Urate Transporter 1 Inhibitor [EPC]</name>
		<code>N0000192341</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000192341</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urate Transporter 1 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>URAT1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>URAT-1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>SLC22A12 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uric Acid Transporter-1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Anion Transporter 4-like Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Solute Carrier Family 22 Member 12 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uric Acid Transporter 1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urate Transporter-1 Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RST Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>OAT4L Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Endothelial Growth Factor-directed Antibody [EPC]</name>
		<code>N0000178292</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178292</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>VEGF-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Endothelial Growth Factor-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Virus Vector [EPC]</name>
		<code>N0000193797</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193797</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Virus Vector</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin-4 Receptor Antagonist [EPC]</name>
		<code>N0000175815</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175815</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin-4 Receptor Antagonist</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5-HT4 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin 4 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT4 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 4 (5-HT4) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>5HT-4 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 4 (5HT4) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 4 Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin subtype 4 (5HT-4) Receptor Antagonist</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iron Supplement [EPC]</name>
		<code>N0000175523</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175523</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iron Supplement</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iron-containing Supplement</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype G [EPC]</name>
		<code>N0000188986</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188986</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype G</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</name>
		<code>N0000175520</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175520</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Immunodeficiency Virus Protease Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Protease Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV Protease Inhibitor (HIV PI)</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>HIV PI</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Electrolyte [EPC]</name>
		<code>N0000175803</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175803</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Electrolytes</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Electrolyte</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Live Attenuated Influenza A Virus Vaccine [EPC]</name>
		<code>N0000184007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Live Attenuated Influenza A Virus Vaccine</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Multivitamin Preparation [EPC]</name>
		<code>N0000175910</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175910</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Multivitamin Preparation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</name>
		<code>N0000180290</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000180290</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CMV Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genetically-modified Oncolytic Viral Therapy [EPC]</name>
		<code>N0000191724</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191724</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genetically-modified Oncolytic Viral Therapy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Secretion Inhibitor [EPC]</name>
		<code>N0000175585</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175585</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone Secretion Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Secretion Inhibitor</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aminoglycoside Antimicrobial [EPC]</name>
		<code>N0000175478</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175478</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aminoglycoside Antimicrobial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Narcotic Antitussive [EPC]</name>
		<code>N0000175795</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175795</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Narcotic Antitussive</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype F [EPC]</name>
		<code>N0000188985</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188985</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype F</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Streptogramin Antibacterial [EPC]</name>
		<code>N0000175502</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175502</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Streptogramin Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetaminophen [EPC]</name>
		<code>N0000177915</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000177915</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetaminophen-containing Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetaminophen</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Locally-acting Aminosalicylate [EPC]</name>
		<code>N0000175455</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175455</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Locally-acting Aminosalicylate</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Locally Acting Aminosalicylate</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Recombinant Activated Protein C [EPC]</name>
		<code>N0000175639</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175639</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Recombinant Activated Protein C</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>alpha-Adrenergic and beta-Adrenergic Blocker [EPC]</name>
		<code>N0000175953</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175953</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha-Adrenergic and beta-Adrenergic Blocker</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>alpha/beta-Adrenergic Blocking Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</name>
		<code>N0000175870</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175870</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Radioactive Diagnostic Agent for gamma-Scintigraphy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autologous Cultured Cell [EPC]</name>
		<code>N0000184317</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184317</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autologous Cultured Cell</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</name>
		<code>N0000175711</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175711</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human CTLA-4/Fc-IgG1 Recombinant Fusion Protein</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Topoisomerase 1 Inhibitor [EPC]</name>
		<code>N0000175891</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175891</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Topoisomerase 1 Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Releasing Agent [EPC]</name>
		<code>N0000175772</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175772</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetylcholine Releasing Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Acetylcholine Activity [PE]</name>
		<code>N0000009079</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009079</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000009178</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009178</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Acetylcholine Activity [PE]</name>
		<code>N0000009400</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009400</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Acetylcholine Activity [PE]</name>
		<code>N0000009122</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009122</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Acetylcholine Activity [PE]</name>
		<code>N0000009618</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009618</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Acetylcholine Activity [PE]</name>
		<code>N0000009201</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009201</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Acetylcholine Activity [PE]</name>
		<code>N0000009224</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009224</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000009494</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009494</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000009294</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009294</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000009090</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009090</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Acetylcholine Activity [PE]</name>
		<code>N0000009471</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009471</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000009563</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009563</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Acetylcholine Activity [PE]</name>
		<code>N0000009427</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009427</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Acetylcholine Activity [PE]</name>
		<code>N0000009149</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009149</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Acetylcholine Activity [PE]</name>
		<code>N0000009641</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009641</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Acetylcholine Activity [PE]</name>
		<code>N0000009591</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009591</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Intraocular Irrigating Solution [EPC]</name>
		<code>N0000175537</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175537</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Intraocular Irrigating Solution</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin B12 Analog [EPC]</name>
		<code>N0000175906</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175906</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B12 Analog</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B 12 Analog</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B 12 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin B12 Analogue</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Equine Botulinum Antitoxin, Serotype B [EPC]</name>
		<code>N0000188981</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188981</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Equine Botulinum Antitoxin, Serotype B</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Exchange Resin [EPC]</name>
		<code>N0000175417</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175417</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Exchange Resin</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Potassium Channel Opener [EPC]</name>
		<code>N0000182729</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182729</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Activator</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Potassium Channel Opener</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleotide Metabolic Inhibitor [EPC]</name>
		<code>N0000175888</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175888</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleotide Metabolic Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dihydrofolate Reductase Inhibitor [EPC]</name>
		<code>N0000175933</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175933</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dihydrofolate Reductase Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thioxanthene [EPC]</name>
		<code>N0000175748</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175748</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thioxanthene-class Agent</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thioxanthene</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iodinated Contrast Agent for Radiographic Imaging [EPC]</name>
		<code>N0000175867</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175867</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iodinated Contrast Agent for Radiographic Imaging</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Interleukin-17A-directed Antibody [EPC]</name>
		<code>N0000191497</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000191497</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17A-directed Antibody</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17A-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin-17A (IL-17A)-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Interleukin 17A (IL17A)-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL17A-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL 17A-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>IL-17A-directed Antibody</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Megakaryocyte Growth Factor [EPC]</name>
		<code>N0000175668</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175668</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Megakaryocyte Growth Factor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Skin Lightening Agent [EPC]</name>
		<code>N0000175855</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175855</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Skin Lightening Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CD3 Blocker Immunosuppressant [EPC]</name>
		<code>N0000175620</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175620</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD-3 Blocker Immunosuppressant</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CD3 Blocker Immunosuppressant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Quinolone Antibacterial [EPC]</name>
		<code>N0000175432</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175432</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Quinolone Antibacterial</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenergic Decongestant [EPC]</name>
		<code>N0000175791</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175791</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenergic Decongestant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Human Anticoagulant Protein [EPC]</name>
		<code>N0000188979</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000188979</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Human Anticoagulant Protein</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholinergic Receptor Inhibitor [EPC]</name>
		<code>N0000175932</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EPC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175932</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholinergic Receptor Inhibitor</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Physiological Effects [PE]</name>
		<code>N0000009802</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009802</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Physiological Effects</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Generalized Systemic Effects [PE]</name>
		<code>N0000009057</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009057</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Generalized Systemic Effects</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metabolic Activity Alteration [PE]</name>
		<code>N0000009748</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009748</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metabolic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vitamin Uptake and Modification Alteration [PE]</name>
		<code>N0000009932</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009932</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vitamin Uptake and Modification Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Vitamin Uptake and Modification [PE]</name>
		<code>N0000009934</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009934</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Vitamin Uptake and Modification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Folic Acid Modification [PE]</name>
		<code>N0000009935</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009935</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Folic Acid Modification</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Folate Modification</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Vitamin Uptake and Modification [PE]</name>
		<code>N0000009933</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009933</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Vitamin Uptake and Modification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Carbohydrate Metabolism Alteration [PE]</name>
		<code>N0000008327</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008327</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Carbohydrate Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Glucose Transport Alteration [PE]</name>
		<code>N0000008333</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008333</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Glucose Transport Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glucose Transport into Cells [PE]</name>
		<code>N0000009341</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009341</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glucose Transport into Cells</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucose Transport into Cells [PE]</name>
		<code>N0000008647</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008647</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glucose Transport into Cells</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glucose Metabolism Alteration [PE]</name>
		<code>N0000009061</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009061</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glucose Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycolysis [PE]</name>
		<code>N0000008652</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008652</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glycolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Gluconeogenesis [PE]</name>
		<code>N0000008646</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008646</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Gluconeogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glycolysis [PE]</name>
		<code>N0000009346</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009346</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glycolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Polysaccharide Metabolism Alteration [PE]</name>
		<code>N0000020040</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020040</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Polysaccharide Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan Metabolism Alteration [PE]</name>
		<code>N0000020041</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020041</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosaminoglycan Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mucopolysaccharide</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan Metabolism Decrease [PE]</name>
		<code>N0000020043</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020043</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosaminoglycan Metabolism Decrease</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosaminoglycan Metabolism Increase [PE]</name>
		<code>N0000020042</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020042</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosaminoglycan Metabolism Increase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycogen Metabolism Alteration [PE]</name>
		<code>N0000009064</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009064</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycogen Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycogenolysis [PE]</name>
		<code>N0000008651</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008651</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glycogenolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycogenesis [PE]</name>
		<code>N0000008650</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008650</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glycogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glycogenesis [PE]</name>
		<code>N0000009344</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009344</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glycogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipid Metabolism Alteration [PE]</name>
		<code>N0000009739</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009739</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipid Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lipotropic Activity Alteration [PE]</name>
		<code>N0000009740</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009740</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lipotropic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Triglyceride Metabolism Alteration [PE]</name>
		<code>N0000009895</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009895</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Triglyceride Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipogenesis [PE]</name>
		<code>N0000008687</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008687</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lipogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lipogenesis [PE]</name>
		<code>N0000009379</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009379</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lipogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lipolysis [PE]</name>
		<code>N0000009380</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009380</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lipolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lipolysis [PE]</name>
		<code>N0000008688</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008688</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lipolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sterol Metabolism Alteration [PE]</name>
		<code>N0000010222</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010222</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sterol Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sterol Synthesis Alteration [PE]</name>
		<code>N0000010223</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010223</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sterol Synthesis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sterol Synthesis [PE]</name>
		<code>N0000010225</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010225</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sterol Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sterol Synthesis [PE]</name>
		<code>N0000010224</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010224</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sterol Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Metabolism Alteration [PE]</name>
		<code>N0000008360</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008360</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholesterol Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Elimination Alteration [PE]</name>
		<code>N0000008359</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008359</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholesterol Elimination Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Elimination [PE]</name>
		<code>N0000008554</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008554</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cholesterol Elimination</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Elimination [PE]</name>
		<code>N0000009250</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009250</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cholesterol Elimination</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Synthesis Alteration [PE]</name>
		<code>N0000008361</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008361</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholesterol Synthesis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Synthesis [PE]</name>
		<code>N0000009251</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009251</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cholesterol Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Synthesis [PE]</name>
		<code>N0000008555</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008555</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cholesterol Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Secretion Alteration [PE]</name>
		<code>N0000010236</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010236</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholesterol Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cholesterol Secretion [PE]</name>
		<code>N0000010237</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010237</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cholesterol Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Secretion [PE]</name>
		<code>N0000010238</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010238</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cholesterol Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholesterol Absorption Alteration [PE]</name>
		<code>N0000008358</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008358</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholesterol Absorption Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cholesterol Absorption [PE]</name>
		<code>N0000009249</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009249</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cholesterol Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosphingolipid Synthesis Alteration [PE]</name>
		<code>N0000020020</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020020</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosphingolipid Synthesis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosphingolipid Synthesis Decrease [PE]</name>
		<code>N0000020022</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020022</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosphingolipid Synthesis Decrease</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycosphingolipid Synthesis Increase [PE]</name>
		<code>N0000020021</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020021</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycosphingolipid Synthesis Increase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peptide Metabolism Alteration [PE]</name>
		<code>N0000175959</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175959</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peptide Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Ion Metabolism Alteration [PE]</name>
		<code>N0000009772</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009772</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Ion Metabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Ion Synthesis Alteration [PE]</name>
		<code>N0000009773</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009773</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Ion Synthesis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Organic Ion Synthesis [PE]</name>
		<code>N0000009459</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009459</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Organic Ion Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Organic Ion Synthesis [PE]</name>
		<code>N0000008767</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008767</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Organic Ion Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Amino Acid Synthesis [PE]</name>
		<code>N0000010235</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010235</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Amino Acid Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Uric Acid Synthesis [PE]</name>
		<code>N0000009013</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009013</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Uric Acid Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organic Ion Degradation Alteration [PE]</name>
		<code>N0000009771</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009771</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organic Ion Degradation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Organic Ion Degradation [PE]</name>
		<code>N0000008766</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008766</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Organic Ion Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Organic Ion Degradation [PE]</name>
		<code>N0000009458</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009458</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Organic Ion Degradation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metabolic Rate Alteration [PE]</name>
		<code>N0000009749</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009749</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metabolic Rate Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Metabolic Rate [PE]</name>
		<code>N0000008707</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008707</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Metabolic Rate</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Metabolic Rate [PE]</name>
		<code>N0000009399</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009399</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Metabolic Rate</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inorganic Ion Absorption Alteration [PE]</name>
		<code>N0000175527</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175527</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inorganic Ion Absorption Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Inorganic Ion Absorption [PE]</name>
		<code>N0000175528</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175528</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Inorganic Ion Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Appetite Alteration [PE]</name>
		<code>N0000175371</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175371</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Appetite Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologic Activity Alteration [PE]</name>
		<code>N0000009073</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009073</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologically Active Molecule Production Alteration [PE]</name>
		<code>N0000009076</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009076</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologically Active Molecule Production Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologically Active Molecule Degradation Alteration [PE]</name>
		<code>N0000009075</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009075</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologically Active Molecule Degradation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunologically Active Molecule Activity Alteration [PE]</name>
		<code>N0000009074</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009074</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunologically Active Molecule Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Activity Alteration [PE]</name>
		<code>N0000008337</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008337</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Structure Alteration [PE]</name>
		<code>N0000008346</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008346</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Structure Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Alteration [PE]</name>
		<code>N0000019996</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019996</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Methylation [PE]</name>
		<code>N0000019997</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019997</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Methylation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Methylation Increase [PE]</name>
		<code>N0000019998</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019998</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Methylation Increase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Methylation Decrease [PE]</name>
		<code>N0000019999</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000019999</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Methylation Decrease</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Organelle Alteration [PE]</name>
		<code>N0000008335</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008335</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Organelle Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Membrane Alteration [PE]</name>
		<code>N0000008334</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008334</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Membrane Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Membrane Integrity [PE]</name>
		<code>N0000009172</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009172</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cell Membrane Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Membrane Synthesis &amp; Repair [PE]</name>
		<code>N0000009173</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009173</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cell Membrane Synthesis &amp; Repair</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Membrane Synthesis &amp; Repair [PE]</name>
		<code>N0000008477</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008477</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cell Membrane Synthesis &amp; Repair</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cell Wall Alteration [PE]</name>
		<code>N0000008336</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008336</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cell Wall Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Wall Integrity [PE]</name>
		<code>N0000009174</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009174</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cell Wall Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Wall Integrity [PE]</name>
		<code>N0000008478</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008478</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cell Wall Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cell Wall Synthesis &amp; Repair [PE]</name>
		<code>N0000009175</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009175</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cell Wall Synthesis &amp; Repair</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cell Wall Synthesis &amp; Repair [PE]</name>
		<code>N0000008479</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008479</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cell Wall Synthesis &amp; Repair</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cytoskeleton Alteration [PE]</name>
		<code>N0000008378</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008378</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cytoskeleton Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytoskeleton Synthesis &amp; Repair [PE]</name>
		<code>N0000008575</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008575</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cytoskeleton Synthesis &amp; Repair</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cytoskeleton Integrity [PE]</name>
		<code>N0000008574</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008574</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cytoskeleton Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Proliferation Alteration [PE]</name>
		<code>N0000175672</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175672</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Proliferation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Epithelial Proliferation Alteration [PE]</name>
		<code>N0000175673</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175673</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epithelial Proliferation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Epithelial Proliferation [PE]</name>
		<code>N0000175676</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175676</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Epithelial Proliferation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endothelial Proliferation Alteration [PE]</name>
		<code>N0000175674</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175674</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelial Proliferation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Endothelial Proliferation [PE]</name>
		<code>N0000175678</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175678</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Endothelial Proliferation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Endothelial Proliferation [PE]</name>
		<code>N0000175677</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175677</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Endothelial Proliferation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Degradation/Digestion Alteration [PE]</name>
		<code>N0000008341</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008341</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Degradation/Digestion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Protein Degradation Alteration [PE]</name>
		<code>N0000009814</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009814</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Protein Degradation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Protein Breakdown [PE]</name>
		<code>N0000008839</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008839</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Protein Breakdown</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Protein Breakdown [PE]</name>
		<code>N0000009531</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009531</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Protein Breakdown</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lysosomal Function Alteration [PE]</name>
		<code>N0000009741</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009741</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lysosomal Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lysosomal Function [PE]</name>
		<code>N0000009392</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009392</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lysosomal Function</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lysosomal Function [PE]</name>
		<code>N0000008700</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008700</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lysosomal Function</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Communication Alteration [PE]</name>
		<code>N0000008338</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008338</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Communication Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Extracellular Communication [PE]</name>
		<code>N0000010230</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010230</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Extracellular Communication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Extracellular Communication [PE]</name>
		<code>N0000010229</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010229</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cell Signaling</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Extracellular Communication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Growth Factor Activity [PE]</name>
		<code>N0000010233</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010233</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Extracellular Communication [PE]</name>
		<code>N0000010228</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010228</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Extracellular Communication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Growth Factor Activity [PE]</name>
		<code>N0000010232</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010232</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Intracellular Communication [PE]</name>
		<code>N0000010231</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010231</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Intracellular Communication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Intracellular Communication [PE]</name>
		<code>N0000008668</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008668</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Intracellular Communication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Intercellular Communication [PE]</name>
		<code>N0000008667</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008667</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Intercellular Communication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Cycle Alteration [PE]</name>
		<code>N0000008339</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008339</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Cycle Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Synthetic Activity Alteration [PE]</name>
		<code>N0000008347</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008347</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Synthetic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Replication Alteration [PE]</name>
		<code>N0000009766</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009766</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleic Acid Replication Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Replication Alteration [PE]</name>
		<code>N0000008380</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008380</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Replication Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased DNA Replication [PE]</name>
		<code>N0000009271</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009271</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased DNA Replication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RNA Replication Alteration [PE]</name>
		<code>N0000009822</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009822</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA Replication Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased RNA Replication [PE]</name>
		<code>N0000008853</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008853</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased RNA Replication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased RNA Replication [PE]</name>
		<code>N0000009545</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009545</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased RNA Replication</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>RNA Integrity Alteration [PE]</name>
		<code>N0000009821</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009821</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RNA Integrity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased RNA Integrity [PE]</name>
		<code>N0000009544</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009544</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased RNA Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>DNA Integrity Alteration [PE]</name>
		<code>N0000008379</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008379</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>DNA Integrity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased DNA Integrity [PE]</name>
		<code>N0000009270</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009270</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased DNA Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased DNA Integrity [PE]</name>
		<code>N0000008576</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008576</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased DNA Integrity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Translation Alteration [PE]</name>
		<code>N0000009894</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009894</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Translation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Protein Synthesis [PE]</name>
		<code>N0000009533</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009533</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Protein Synthesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nucleic Acid Transcription Alteration [PE]</name>
		<code>N0000009767</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009767</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nucleic Acid Transcription Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Transcription to RNA Alteration [PE]</name>
		<code>N0000009893</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009893</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Transcription to RNA Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Transcription to RNA [PE]</name>
		<code>N0000009011</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009011</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Transcription to RNA</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Transcription to RNA [PE]</name>
		<code>N0000009703</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009703</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Transcription to RNA</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Post-transcriptional RNA Interaction [PE]</name>
		<code>N0000194155</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000194155</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Post-transcriptional RNA Interaction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Reverse Transcription to DNA Alteration [PE]</name>
		<code>N0000009840</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009840</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reverse Transcription to DNA Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Reverse Transcription to DNA [PE]</name>
		<code>N0000008869</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008869</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Reverse Transcription to DNA</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Reverse Transcription to DNA [PE]</name>
		<code>N0000009561</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009561</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Reverse Transcription to DNA</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Post Translation Protein Modification Alteration [PE]</name>
		<code>N0000009810</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009810</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Post Translation Protein Modification Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Protein Modification [PE]</name>
		<code>N0000009532</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009532</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Protein Modification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Protein Modification [PE]</name>
		<code>N0000008840</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008840</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Protein Modification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Growth Phase Alteration [PE]</name>
		<code>N0000008343</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008343</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Growth Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Growth Phase Reduction [PE]</name>
		<code>N0000020013</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020013</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Growth Phase Reduction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Growth Phase Arrest [PE]</name>
		<code>N0000008344</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008344</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Growth Phase Arrest</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Synthetic Phase Alteration [PE]</name>
		<code>N0000008348</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008348</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Synthetic Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Synthetic Phase Arrest [PE]</name>
		<code>N0000008349</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008349</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Synthetic Phase Arrest</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Death Alteration [PE]</name>
		<code>N0000008340</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008340</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Death Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cellular Death [PE]</name>
		<code>N0000008480</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008480</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cellular Death</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Division Phase Alteration [PE]</name>
		<code>N0000008342</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008342</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Division Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mitosis Alteration [PE]</name>
		<code>N0000009750</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009750</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mitosis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Mitosis [PE]</name>
		<code>N0000009424</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009424</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Mitosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Meiosis Alteration [PE]</name>
		<code>N0000009744</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009744</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Meiosis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Meiosis [PE]</name>
		<code>N0000009396</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009396</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Meiosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Meiosis [PE]</name>
		<code>N0000008704</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008704</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Meiosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Motion Alteration [PE]</name>
		<code>N0000008345</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008345</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Motion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cellular Migration [PE]</name>
		<code>N0000009928</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009928</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cellular Migration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Polymorphonuclear Leukocyte Migration [PE]</name>
		<code>N0000010246</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010246</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Polymorphonuclear Leukocyte Migration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Fibroblast Migration [PE]</name>
		<code>N0000010248</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010248</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Fibroblast Migration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cellular Migration [PE]</name>
		<code>N0000009929</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009929</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cellular Migration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Fibroblast Migration [PE]</name>
		<code>N0000010249</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010249</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Fibroblast Migration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Polymorphonuclear Leukocyte Migration [PE]</name>
		<code>N0000010247</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010247</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Polymorphonuclear Leukocyte Migration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cellular Locomotion [PE]</name>
		<code>N0000009177</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009177</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cellular Locomotion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cellular Locomotion [PE]</name>
		<code>N0000008481</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008481</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cellular Locomotion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cellular Transport Alteration [PE]</name>
		<code>N0000008350</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008350</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cellular Transport Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pinocytosis Alteration [PE]</name>
		<code>N0000009804</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009804</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pinocytosis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Pinocytosis [PE]</name>
		<code>N0000008827</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008827</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Pinocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Pinocytosis [PE]</name>
		<code>N0000009519</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009519</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Pinocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Phagocytosis Alteration [PE]</name>
		<code>N0000009800</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009800</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Phagocytosis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Phagocytosis [PE]</name>
		<code>N0000008826</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008826</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Phagocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Phagocytosis [PE]</name>
		<code>N0000009518</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009518</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Phagocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endocytosis Alteration [PE]</name>
		<code>N0000009037</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009037</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endocytosis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Endocytosis [PE]</name>
		<code>N0000008596</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008596</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Endocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Endocytosis [PE]</name>
		<code>N0000009290</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009290</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Endocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Exocytosis Alteration [PE]</name>
		<code>N0000009043</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009043</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Exocytosis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Exocytosis [PE]</name>
		<code>N0000009323</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009323</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Exocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Exocytosis [PE]</name>
		<code>N0000008629</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008629</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Exocytosis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Unknown Physiological Effect [PE]</name>
		<code>N0000009925</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009925</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Unknown Physiological Effect</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organ System Specific Effects [PE]</name>
		<code>N0000009770</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009770</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organ System Specific Effects</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endocrine Activity Alteration [PE]</name>
		<code>N0000009036</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009036</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endocrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Islet Activity Alteration [PE]</name>
		<code>N0000009792</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009792</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pancreatic Islet Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Pancreatic Somatostatin Secretion [PE]</name>
		<code>N0000009470</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009470</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Pancreatic Somatostatin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Pancreatic Somatostatin Secretion [PE]</name>
		<code>N0000008778</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008778</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Pancreatic Somatostatin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucagon Secretion [PE]</name>
		<code>N0000008644</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008644</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glucagon Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glucagon Secretion [PE]</name>
		<code>N0000009338</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009338</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glucagon Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Insulin Secretion [PE]</name>
		<code>N0000009360</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009360</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Insulin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Insulin Secretion [PE]</name>
		<code>N0000008666</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008666</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Insulin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pituitary Gland Activity Alteration [PE]</name>
		<code>N0000009805</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009805</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pituitary Gland Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Luteinizing Hormone Secretion [PE]</name>
		<code>N0000009930</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009930</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Luteinizing Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased LH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Growth Hormone Secretion [PE]</name>
		<code>N0000008632</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008632</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Growth Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Oxytocin Secretion [PE]</name>
		<code>N0000008772</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008772</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Oxytocin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Growth Hormone Secretion [PE]</name>
		<code>N0000009326</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009326</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Growth Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Follicle Stimulating Hormone Secretion [PE]</name>
		<code>N0000008630</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008630</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased FSH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Follicle Stimulating Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prolactin Secretion [PE]</name>
		<code>N0000008833</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008833</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prolactin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Vasopressin Secretion [PE]</name>
		<code>N0000009018</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009018</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Vasopressin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Adrenocorticotropic Hormone Secretion [PE]</name>
		<code>N0000009078</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009078</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Adrenocorticotropic Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased ACTH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Luteinizing Hormone Secretion [PE]</name>
		<code>N0000009931</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009931</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Luteinizing Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased LH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Vasopressin Secretion [PE]</name>
		<code>N0000009709</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009709</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Vasopressin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Follicle Stimulating Hormone Secretion [PE]</name>
		<code>N0000009324</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009324</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Follicle Stimulating Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased FSH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thyroid Stimulating Hormone Secretion [PE]</name>
		<code>N0000009693</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009693</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thyroid Stimulating Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased TSH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Oxytocin Secretion [PE]</name>
		<code>N0000009464</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009464</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Oxytocin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prolactin Secretion [PE]</name>
		<code>N0000009525</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009525</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prolactin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Thyroid Stimulating Hormone Secretion [PE]</name>
		<code>N0000009001</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009001</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased TSH Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Thyroid Stimulating Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Testicular Endocrine Activity Alteration [PE]</name>
		<code>N0000009887</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009887</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Testicular Endocrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Dihydrotestosterone Secretion [PE]</name>
		<code>N0000009937</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009937</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Dihydrotestosterone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased DHT Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Testosterone Secretion [PE]</name>
		<code>N0000009694</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009694</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Testosterone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Testosterone Secretion [PE]</name>
		<code>N0000009002</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009002</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Testosterone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Dihydrotestosterone Secretion [PE]</name>
		<code>N0000009936</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009936</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Dihydrotestosterone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased DHT Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ovarian Endocrine Activity Alteration [PE]</name>
		<code>N0000009777</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009777</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ovarian Endocrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Ovarian Progesterone Secretion [PE]</name>
		<code>N0000009462</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009462</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Ovarian Progesterone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Ovarian Estrogen Secretion [PE]</name>
		<code>N0000009461</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009461</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Ovarian Estrogen Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Ovarian Estrogen Secretion [PE]</name>
		<code>N0000008769</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008769</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Ovarian Estrogen Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Ovarian Progesterone Secretion [PE]</name>
		<code>N0000008770</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008770</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Ovarian Progesterone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Endocrine Activity Alteration [PE]</name>
		<code>N0000009829</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009829</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Endocrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Erythropoetin Secretion [PE]</name>
		<code>N0000008626</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008626</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Erythropoetin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Erythropoetin Secretion [PE]</name>
		<code>N0000009320</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009320</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Erythropoetin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hypothalamic Endocrine Activity Alteration [PE]</name>
		<code>N0000009072</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009072</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hypothalamic Endocrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prolactin Inhibiting Factor Alteration [PE]</name>
		<code>N0000009784</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009784</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PIF Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prolactin Inhibiting hormone Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prolactin Inhibiting Factor Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>PIF Activity Alteration [PE]</name>
		<code>N0000009783</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009783</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PIF Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased PIF Activity [PE]</name>
		<code>N0000009465</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009465</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased PIF Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased PIF Activity [PE]</name>
		<code>N0000008773</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008773</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased PIF Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>PIF Secretion Alteration [PE]</name>
		<code>N0000009785</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009785</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PIF Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased PIF Secretion [PE]</name>
		<code>N0000008774</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008774</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased PIF Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased PIF Secretion [PE]</name>
		<code>N0000009466</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009466</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased PIF Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prolactin Releasing Factor Alteration [PE]</name>
		<code>N0000009787</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009787</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prolactin Releasing Factor Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PRF Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>PRF Activity Alteration [PE]</name>
		<code>N0000009786</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009786</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PRF Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased PRF Activity [PE]</name>
		<code>N0000009467</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009467</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased PRF Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased PRF Activity [PE]</name>
		<code>N0000008775</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008775</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased PRF Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>PRF Secretion Alteration [PE]</name>
		<code>N0000009788</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009788</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>PRF Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased PRF Secretion [PE]</name>
		<code>N0000009468</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009468</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased PRF Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased PRF Secretion [PE]</name>
		<code>N0000008776</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008776</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased PRF Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Corticotropin Releasing Hormone Alteration [PE]</name>
		<code>N0000008325</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008325</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Corticotropin Releasing Hormone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRH Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CRH Secretion Alteration [PE]</name>
		<code>N0000008326</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008326</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRH Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased CRH Secretion [PE]</name>
		<code>N0000009147</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009147</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased CRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased CRH Secretion [PE]</name>
		<code>N0000008451</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008451</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased CRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CRH Activity Alteration [PE]</name>
		<code>N0000008324</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008324</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CRH Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased CRH Activity [PE]</name>
		<code>N0000008450</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008450</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased CRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased CRH Activity [PE]</name>
		<code>N0000009146</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009146</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased CRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Alteration [PE]</name>
		<code>N0000009849</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009849</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Activity Alteration [PE]</name>
		<code>N0000009848</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009848</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Somatostatin (SRIF) Activity [PE]</name>
		<code>N0000008922</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008922</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Somatostatin (SRIF) Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Somatostatin (SRIF) Activity [PE]</name>
		<code>N0000009614</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009614</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Somatostatin (SRIF) Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Somatostatin Secretion Alteration [PE]</name>
		<code>N0000009850</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009850</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Somatostatin Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Somatostatin (SRIF) Secretion [PE]</name>
		<code>N0000008923</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008923</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Somatostatin (SRIF) Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Somatostatin (SRIF) Secretion [PE]</name>
		<code>N0000009615</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009615</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Somatostatin (SRIF) Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyrotropin Releasing Hormone Alteration [PE]</name>
		<code>N0000009885</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009885</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRH Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyrotropin Releasing Hormone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>TRH Secretion Alteration [PE]</name>
		<code>N0000009886</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009886</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRH Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased TRH Secretion [PE]</name>
		<code>N0000009692</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009692</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased TRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased TRH Secretion [PE]</name>
		<code>N0000009000</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009000</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased TRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>TRH Activity Alteration [PE]</name>
		<code>N0000009884</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009884</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>TRH Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased TRH Activity [PE]</name>
		<code>N0000009691</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009691</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased TRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased TRH Activity [PE]</name>
		<code>N0000008999</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008999</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased TRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gonadotropin Releasing Hormone Alteration [PE]</name>
		<code>N0000009051</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009051</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GNRH Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gonadotropin Releasing Hormone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GnRH Activity Alteration [PE]</name>
		<code>N0000009050</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009050</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GnRH Activity [PE]</name>
		<code>N0000009331</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009331</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GnRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GnRH Activity [PE]</name>
		<code>N0000008637</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008637</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GnRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GnRH Secretion Alteration [PE]</name>
		<code>N0000009052</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009052</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GnRH Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GnRH Secretion [PE]</name>
		<code>N0000008638</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008638</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GnRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Growth Hormone Releasing Hormone Alteration [PE]</name>
		<code>N0000009046</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009046</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Growth Hormone Releasing Hormone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRH Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GHRH Secretion Alteration [PE]</name>
		<code>N0000009047</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009047</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRH Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GHRH Secretion [PE]</name>
		<code>N0000009328</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009328</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GHRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GHRH Secretion [PE]</name>
		<code>N0000008634</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008634</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GHRH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GHRH Activity Alteration [PE]</name>
		<code>N0000009045</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009045</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GHRH Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GHRH Activity [PE]</name>
		<code>N0000008633</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008633</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GHRH Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenal Cortical Activity Alteration [PE]</name>
		<code>N0000008291</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008291</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenal Cortical Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Mineralocorticoid Secretion [PE]</name>
		<code>N0000008731</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008731</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Mineralocorticoid Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glucocorticoid Secretion [PE]</name>
		<code>N0000009339</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009339</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glucocorticoid Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glucocorticoid Clearance [PE]</name>
		<code>N0000009938</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009938</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glucocorticoid Clearance</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucocorticoid Secretion [PE]</name>
		<code>N0000008645</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008645</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glucocorticoid Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glucocorticoid Clearance [PE]</name>
		<code>N0000009939</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009939</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glucocorticoid Clearance</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Mineralocorticoid Secretion [PE]</name>
		<code>N0000009423</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009423</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Mineralocorticoid Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parathyroid Gland Activity Alteration [PE]</name>
		<code>N0000009794</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009794</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parathyroid Gland Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Calcitonin Secretion [PE]</name>
		<code>N0000008452</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008452</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Calcitonin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased PTH Secretion [PE]</name>
		<code>N0000008777</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008777</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased PTH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Calcitonin Secretion [PE]</name>
		<code>N0000009148</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009148</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Calcitonin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased PTH Secretion [PE]</name>
		<code>N0000009469</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009469</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased PTH Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Placental Endocrine Activity Alteration [PE]</name>
		<code>N0000009806</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009806</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Placental Endocrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Placental Human Chorionic Gonadotropin Secretion [PE]</name>
		<code>N0000008828</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008828</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Placental Human Chorionic Gonadotropin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Placental HCG Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Placental Human Chorionic Gonadotropin Secretion [PE]</name>
		<code>N0000009520</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009520</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Placental HCG Secretion</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Placental Human Chorionic Gonadotropin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pineal Gland Activity Alteration [PE]</name>
		<code>N0000009803</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009803</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pineal Gland Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melatonin Alteration [PE]</name>
		<code>N0000009746</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009746</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melatonin Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melatonin Activity Alteration [PE]</name>
		<code>N0000009745</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009745</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melatonin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Melatonin Activity [PE]</name>
		<code>N0000009397</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009397</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Melatonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Melatonin Activity [PE]</name>
		<code>N0000008705</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008705</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Melatonin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Melatonin Secretion Alteration [PE]</name>
		<code>N0000009747</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009747</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Melatonin Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Melatonin Secretion [PE]</name>
		<code>N0000008706</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008706</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Melatonin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Melatonin Secretion [PE]</name>
		<code>N0000009398</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009398</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Melatonin Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Adrenal Medullary Activity Alteration [PE]</name>
		<code>N0000008292</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008292</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Adrenal Medullary Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Adrenal Norepinephrine Secretion [PE]</name>
		<code>N0000009084</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009084</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Adrenal Norepinephrine Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Adrenal Epinephrine Secretion [PE]</name>
		<code>N0000009083</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009083</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Adrenal Epinephrine Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Adrenal Epinephrine Secretion [PE]</name>
		<code>N0000008387</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008387</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Adrenal Epinephrine Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Adrenal Norepinephrine Secretion [PE]</name>
		<code>N0000008388</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008388</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Adrenal Norepinephrine Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Gland Activity Alteration [PE]</name>
		<code>N0000009889</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009889</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Gland Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iodine Organification Alteration [PE]</name>
		<code>N0000009733</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009733</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iodine Organification Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Iodine Organification [PE]</name>
		<code>N0000009362</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009362</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Iodine Organification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Iodine Organification [PE]</name>
		<code>N0000008670</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008670</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Iodine Organification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Secretion Alteration [PE]</name>
		<code>N0000009891</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009891</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Thyroid Hormone Secretion [PE]</name>
		<code>N0000009008</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009008</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Thyroid Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thyroid Hormone Secretion [PE]</name>
		<code>N0000009700</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009700</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thyroid Hormone Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Iodine Uptake Alteration [PE]</name>
		<code>N0000009734</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009734</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Iodine Uptake Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Iodine Uptake [PE]</name>
		<code>N0000008671</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008671</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Iodine Uptake</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Iodine Uptake [PE]</name>
		<code>N0000009363</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009363</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Iodine Uptake</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Thyroid Hormone Iodination Alteration [PE]</name>
		<code>N0000009890</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009890</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Thyroid Hormone Iodination Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Thyroid Hormone Iodination [PE]</name>
		<code>N0000009007</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009007</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Thyroid Hormone Iodination</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Thyroid Hormone Iodination [PE]</name>
		<code>N0000009699</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009699</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Thyroid Hormone Iodination</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiovascular Activity Alteration [PE]</name>
		<code>N0000008331</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008331</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiovascular Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiac Rhythm Alteration [PE]</name>
		<code>N0000008330</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008330</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiac Rhythm Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Atrial Depolarization [PE]</name>
		<code>N0000008302</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008302</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Atrial Depolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Conduction System Depolarization [PE]</name>
		<code>N0000008369</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008369</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Conduction System Depolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lengthen Conduction System Depolarization Time [PE]</name>
		<code>N0000010283</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010283</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lengthen Conduction System Depolarization Time</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Shorten Conduction System Depolarization Time [PE]</name>
		<code>N0000010284</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010284</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Shorten Conduction System Depolarization Time</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nodal Repolarization [PE]</name>
		<code>N0000009764</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009764</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nodal Repolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ventricular Depolarization [PE]</name>
		<code>N0000009913</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009913</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ventricular Depolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nodal Depolarization [PE]</name>
		<code>N0000009763</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009763</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nodal Depolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Atrial Repolarization [PE]</name>
		<code>N0000008303</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008303</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Atrial Repolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Conduction System Repolarization [PE]</name>
		<code>N0000008370</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008370</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Conduction System Repolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lengthen Conduction System Repolarization Time [PE]</name>
		<code>N0000010285</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010285</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lengthen Conduction System Repolarization Time</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Shorten Conduction System Repolarization Time [PE]</name>
		<code>N0000010286</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010286</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Shorten Conduction System Repolarization Time</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Delay Conduction System Repolarization [PE]</name>
		<code>N0000010287</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010287</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Delay Conduction System Repolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ventricular Repolarization [PE]</name>
		<code>N0000009914</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009914</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ventricular Repolarization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Alterations [PE]</name>
		<code>N0000020002</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020002</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Alterations</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Tone Alteration [PE]</name>
		<code>N0000009906</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009906</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000010269</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010269</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Vascular Smooth Muscle Tone [PE]</name>
		<code>N0000010270</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010270</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Vascular Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Vascular Smooth Muscle Tone [PE]</name>
		<code>N0000010271</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010271</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Vascular Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Permeability Alteration [PE]</name>
		<code>N0000010250</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010250</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Permeability Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Vascular Permeability [PE]</name>
		<code>N0000010251</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010251</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Vascular Permeability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Capillary Permeability [PE]</name>
		<code>N0000010254</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010254</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Capillary Permeability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Growth Alteration [PE]</name>
		<code>N0000020003</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020003</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Growth Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Growth Increase [PE]</name>
		<code>N0000020004</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020004</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Growth Increase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vascular Growth Decrease [PE]</name>
		<code>N0000020005</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020005</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Angiogenesis Inhibition</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vascular Growth Decrease</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiac Contractility Alteration [PE]</name>
		<code>N0000008328</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008328</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiac Contractility Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Negative Inotropy [PE]</name>
		<code>N0000009757</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009757</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Negative Inotropy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Positive Inotropy [PE]</name>
		<code>N0000009809</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009809</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Positive Inotropy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood Pressure Alteration [PE]</name>
		<code>N0000178476</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178476</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood Pressure Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Blood Pressure [PE]</name>
		<code>N0000178478</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178478</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Blood Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Blood Pressure [PE]</name>
		<code>N0000178477</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178477</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Blood Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiac Rate Alteration [PE]</name>
		<code>N0000008329</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008329</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiac Rate Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Negative Chronotropy [PE]</name>
		<code>N0000009756</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009756</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Negative Chronotropy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Positive Chronotropy [PE]</name>
		<code>N0000009808</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009808</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Positive Chronotropy</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal/Urological Activity Alteration [PE]</name>
		<code>N0000009832</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009832</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal/Urological Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bladder Contractility Alteration [PE]</name>
		<code>N0000008305</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008305</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bladder Contractility Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Bladder Contractility [PE]</name>
		<code>N0000009116</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009116</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Bladder Contractility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Urethra Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000009975</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009975</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Urethra Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Urethra Smooth Muscle Tone [PE]</name>
		<code>N0000009976</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009976</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Urethra Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Urethra Smooth Muscle Tone [PE]</name>
		<code>N0000009977</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009977</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Urethra Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bladder Sphincter Tone Alteration [PE]</name>
		<code>N0000008306</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008306</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bladder Sphincter Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Bladder Sphincter Tone [PE]</name>
		<code>N0000009117</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009117</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Bladder Sphincter Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Bladder Sphincter Tone [PE]</name>
		<code>N0000008421</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008421</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Bladder Sphincter Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diuresis Alteration [PE]</name>
		<code>N0000175358</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175358</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diuresis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Diuresis [PE]</name>
		<code>N0000175360</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175360</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Diuresis</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidiuretic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Diuresis at Loop of Henle [PE]</name>
		<code>N0000175367</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175367</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Diuresis at Loop of Henle</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle PO4-- Excretion [PE]</name>
		<code>N0000008696</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008696</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Na+ Excretion [PE]</name>
		<code>N0000008695</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008695</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Ca++ Excretion [PE]</name>
		<code>N0000008689</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008689</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle H+ Excretion [PE]</name>
		<code>N0000008691</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008691</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle HCO3- Excretion [PE]</name>
		<code>N0000008692</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008692</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Cl- Excretion [PE]</name>
		<code>N0000008690</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008690</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle Mg++ Excretion [PE]</name>
		<code>N0000008694</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008694</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Loop of Henle SO4-- Excretion [PE]</name>
		<code>N0000008697</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008697</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Loop of Henle SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glomerular Filtration Pressure Alteration [PE]</name>
		<code>N0000009060</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009060</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glomerular Filtration Pressure Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glomerular Filtration Pressure [PE]</name>
		<code>N0000008643</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008643</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glomerular Filtration Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glomerular Filtration Pressure [PE]</name>
		<code>N0000009337</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009337</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glomerular Filtration Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Collecting Duct Water Permeability Alteration [PE]</name>
		<code>N0000008368</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008368</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Collecting Duct Water Permeability Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Water Permeability [PE]</name>
		<code>N0000008567</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008567</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct Water Permeability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Water Permeability [PE]</name>
		<code>N0000009263</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009263</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct Water Permeability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Renal Ion Transport Alteration [PE]</name>
		<code>N0000009830</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009830</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Renal Ion Transport Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Ion Excretion [PE]</name>
		<code>N0000009550</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009550</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Ion Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal K+ Excretion [PE]</name>
		<code>N0000009551</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009551</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct K+ Excretion [PE]</name>
		<code>N0000009258</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009258</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule K+ Excretion [PE]</name>
		<code>N0000009277</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009277</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule K+ Excretion [PE]</name>
		<code>N0000009538</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009538</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule K+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Na+ Excretion [PE]</name>
		<code>N0000009553</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009553</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Na+ Excretion [PE]</name>
		<code>N0000009540</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009540</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Na+ Excretion [PE]</name>
		<code>N0000009279</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009279</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Na+ Excretion [PE]</name>
		<code>N0000009260</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009260</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal H+ Excretion [PE]</name>
		<code>N0000009548</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009548</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct H+ Excretion [PE]</name>
		<code>N0000009256</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009256</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule H+ Excretion [PE]</name>
		<code>N0000009275</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009275</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule H+ Excretion [PE]</name>
		<code>N0000009536</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009536</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Mg++ Excretion [PE]</name>
		<code>N0000009552</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009552</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Mg++ Excretion [PE]</name>
		<code>N0000009259</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009259</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Mg++ Excretion [PE]</name>
		<code>N0000009539</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009539</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Mg++ Excretion [PE]</name>
		<code>N0000009278</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009278</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal PO4-- Excretion [PE]</name>
		<code>N0000009557</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009557</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct PO4-- Excretion [PE]</name>
		<code>N0000009261</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009261</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule PO4-- Excretion [PE]</name>
		<code>N0000009280</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009280</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule PO4-- Excretion [PE]</name>
		<code>N0000009541</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009541</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Urea Excretion [PE]</name>
		<code>N0000010240</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010240</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Urea Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal HCO3- Excretion [PE]</name>
		<code>N0000009549</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009549</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct HCO3- Excretion [PE]</name>
		<code>N0000009257</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009257</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule HCO3- Excretion [PE]</name>
		<code>N0000009276</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009276</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule HCO3- Excretion [PE]</name>
		<code>N0000009537</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009537</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal SO4-- Excretion [PE]</name>
		<code>N0000009558</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009558</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct SO4-- Excretion [PE]</name>
		<code>N0000009262</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009262</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule SO4-- Excretion [PE]</name>
		<code>N0000009281</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009281</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule SO4-- Excretion [PE]</name>
		<code>N0000009542</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009542</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Ca++ Excretion [PE]</name>
		<code>N0000009546</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009546</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Ca++ Excretion [PE]</name>
		<code>N0000009273</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009273</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Ca++ Excretion [PE]</name>
		<code>N0000009534</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009534</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Ca++ Excretion [PE]</name>
		<code>N0000009254</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009254</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Renal Cl- Excretion [PE]</name>
		<code>N0000009547</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009547</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Renal Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Distal Tubule Cl- Excretion [PE]</name>
		<code>N0000009274</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009274</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Distal Tubule Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Collecting Duct Cl- Excretion [PE]</name>
		<code>N0000009255</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009255</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Collecting Duct Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Proximal Tubule Cl- Excretion [PE]</name>
		<code>N0000009535</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009535</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Proximal Tubule Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Ion Excretion [PE]</name>
		<code>N0000008858</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008858</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Ion Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal HCO3- Excretion [PE]</name>
		<code>N0000008857</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008857</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct HCO3- Excretion [PE]</name>
		<code>N0000008561</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008561</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule HCO3- Excretion [PE]</name>
		<code>N0000008845</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008845</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule HCO3- Excretion [PE]</name>
		<code>N0000008582</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008582</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule HCO3- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Na+ Excretion [PE]</name>
		<code>N0000008861</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008861</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Na+ Excretion [PE]</name>
		<code>N0000008564</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008564</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Na+ Excretion [PE]</name>
		<code>N0000008848</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008848</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Na+ Excretion [PE]</name>
		<code>N0000008585</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008585</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule Na+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal SO4-- Excretion [PE]</name>
		<code>N0000008866</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008866</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule SO4-- Excretion [PE]</name>
		<code>N0000008587</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008587</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule SO4-- Excretion [PE]</name>
		<code>N0000008850</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008850</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct SO4-- Excretion [PE]</name>
		<code>N0000008566</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008566</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct SO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Ca++ Excretion [PE]</name>
		<code>N0000008854</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008854</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Ca++ Excretion [PE]</name>
		<code>N0000008579</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008579</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Ca++ Excretion [PE]</name>
		<code>N0000008842</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008842</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Ca++ Excretion [PE]</name>
		<code>N0000008558</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008558</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct Ca++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal H+ Excretion [PE]</name>
		<code>N0000008856</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008856</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule H+ Excretion [PE]</name>
		<code>N0000008581</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008581</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct H+ Excretion [PE]</name>
		<code>N0000008560</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008560</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule H+ Excretion [PE]</name>
		<code>N0000008844</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008844</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule H+ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal PO4-- Excretion [PE]</name>
		<code>N0000008865</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008865</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct PO4-- Excretion [PE]</name>
		<code>N0000008565</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008565</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule PO4-- Excretion [PE]</name>
		<code>N0000008849</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008849</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule PO4-- Excretion [PE]</name>
		<code>N0000008586</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008586</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule PO4-- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Cl- Excretion [PE]</name>
		<code>N0000008855</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008855</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Cl- Excretion [PE]</name>
		<code>N0000008580</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008580</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Cl- Excretion [PE]</name>
		<code>N0000008559</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008559</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Cl- Excretion [PE]</name>
		<code>N0000008843</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008843</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule Cl- Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Urea Excretion [PE]</name>
		<code>N0000010239</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010239</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Urea Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Renal Mg++ Excretion [PE]</name>
		<code>N0000008860</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008860</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Renal Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Distal Tubule Mg++ Excretion [PE]</name>
		<code>N0000008584</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008584</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Distal Tubule Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Proximal Tubule Mg++ Excretion [PE]</name>
		<code>N0000008847</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008847</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Proximal Tubule Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Collecting Duct Mg++ Excretion [PE]</name>
		<code>N0000008563</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008563</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Collecting Duct Mg++ Excretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dermatologic Activity Alteration [PE]</name>
		<code>N0000009020</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009020</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dermatologic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Astringent Activity [PE]</name>
		<code>N0000008301</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008301</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Astringent Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sunscreening Activity [PE]</name>
		<code>N0000009881</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009881</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sunscreening Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Skin Barrier Activity [PE]</name>
		<code>N0000010282</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010282</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Skin Barrier Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dermal Regeneration Activity [PE]</name>
		<code>N0000020073</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020073</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dermal Regeneration Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Emollient Activity [PE]</name>
		<code>N0000009035</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009035</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Emollient Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antipruritic Activity [PE]</name>
		<code>N0000008297</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008297</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antipruritic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sebaceous Gland Alteration [PE]</name>
		<code>N0000009978</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009978</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sebaceous Gland Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sebaceous Gland Activity [PE]</name>
		<code>N0000009981</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009981</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sebaceous Gland Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sebaceous Gland Activity [PE]</name>
		<code>N0000009982</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009982</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sebaceous Gland Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sebaceous Gland Quantity [PE]</name>
		<code>N0000009980</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009980</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sebaceous Gland Quantity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sebaceous Gland Quantity [PE]</name>
		<code>N0000009979</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009979</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sebaceous Gland Quantity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiperspirant Activity [PE]</name>
		<code>N0000008296</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008296</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiperspirant Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Keratin Alteration [PE]</name>
		<code>N0000009973</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009973</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Keratin Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Skin Keratinization [PE]</name>
		<code>N0000009735</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009735</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Skin Keratinization</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Keratolytic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Exfoliant Acitivity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Skin Keratinization [PE]</name>
		<code>N0000009974</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009974</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Skin Keratinization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hair Follicle Alteration [PE]</name>
		<code>N0000178320</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178320</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hair Follicle Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Hair Growth [PE]</name>
		<code>N0000178321</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178321</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Hair Growth</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Hair Growth [PE]</name>
		<code>N0000178322</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178322</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Hair Growth</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Musculoskeletal Activity Alteration [PE]</name>
		<code>N0000009755</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009755</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Musculoskeletal Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Contraction Alteration [PE]</name>
		<code>N0000009879</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009879</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Striated Muscle Contraction Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Contraction [PE]</name>
		<code>N0000009645</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009645</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Contraction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Alteration [PE]</name>
		<code>N0000008373</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008373</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Connective Tissue Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Permeability Alteration [PE]</name>
		<code>N0000020051</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020051</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Connective Tissue Permeability Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Permeability Alteration Increase [PE]</name>
		<code>N0000020052</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020052</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Connective Tissue Permeability Alteration Increase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Connective Tissue Permeability Alteration Decrease [PE]</name>
		<code>N0000020053</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020053</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Connective Tissue Permeability Alteration Decrease</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Collagen Formation Alteration [PE]</name>
		<code>N0000008365</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008365</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Collagen Formation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Collagen Formation Inhibition [PE]</name>
		<code>N0000008366</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008366</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Collagen Formation Inhibition</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Collagen Formation Promotion [PE]</name>
		<code>N0000008367</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008367</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Collagen Formation Promotion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Tone Alteration [PE]</name>
		<code>N0000175734</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175734</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Striated Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Tone [PE]</name>
		<code>N0000175736</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175736</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Metabolic Alteration [PE]</name>
		<code>N0000009876</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009876</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Striated Muscle Metabolic Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Anabolism Alteration [PE]</name>
		<code>N0000009877</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009877</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Striated Muscle Anabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Striated Muscle Catabolism Alteration [PE]</name>
		<code>N0000009878</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009878</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Striated Muscle Catabolism Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Alteration [PE]</name>
		<code>N0000008308</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008308</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Formation Alteration [PE]</name>
		<code>N0000008309</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008309</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Formation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Formation Inhibition [PE]</name>
		<code>N0000008310</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008310</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Formation Inhibition</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Formation Stimulation [PE]</name>
		<code>N0000008311</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008311</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Formation Stimulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Resorption Alteration [PE]</name>
		<code>N0000008312</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008312</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Resorption Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Resorption Inhibition [PE]</name>
		<code>N0000008313</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008313</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Resorption Inhibition</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bone Resorption Stimulation [PE]</name>
		<code>N0000008314</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008314</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bone Resorption Stimulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000010268</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010268</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000009838</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009838</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bronchial Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000008320</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008320</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bronchial Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bronchodilation [PE]</name>
		<code>N0000008322</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008322</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bronchodilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bronchoconstriction [PE]</name>
		<code>N0000008321</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008321</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bronchoconstriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GI Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000009049</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009049</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GI Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GI Smooth Muscle Tone [PE]</name>
		<code>N0000009330</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009330</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GI Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Gastric Muscle Tone [PE]</name>
		<code>N0000009335</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009335</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Gastric Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Pyloric Sphincter Tone [PE]</name>
		<code>N0000009543</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009543</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Pyloric Sphincter Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Small Intestinal Muscle Tone [PE]</name>
		<code>N0000009590</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009590</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Small Intestinal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Esophageal Muscle Tone [PE]</name>
		<code>N0000009322</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009322</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Esophageal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Anal Sphincter Tone [PE]</name>
		<code>N0000009085</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009085</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Anal Sphincter Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Large Intestinal Muscle Tone [PE]</name>
		<code>N0000009372</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009372</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Large Intestinal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased UES Tone [PE]</name>
		<code>N0000009704</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009704</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased UES Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased LES Tone [PE]</name>
		<code>N0000009370</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009370</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased LES Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Gallbladder Tone [PE]</name>
		<code>N0000009333</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009333</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Gallbladder Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sphincter of Odi Tone [PE]</name>
		<code>N0000009617</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009617</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sphincter of Odi Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cervical Smooth Muscle Tone Alteration [PE]</name>
		<code>N0000008355</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008355</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cervical Smooth Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cervical Smooth Muscle Tone [PE]</name>
		<code>N0000009248</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009248</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cervical Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cervical Smooth Muscle Tone [PE]</name>
		<code>N0000008552</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008552</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cervical Smooth Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uterine Smooth Muscle Contraction or Tone [PE]</name>
		<code>N0000009901</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009901</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uterine Smooth Muscle Contraction or Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</name>
		<code>N0000009014</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009014</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Uterine Smooth Muscle Contraction or Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Digestive/GI System Activity Alteration [PE]</name>
		<code>N0000009022</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009022</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Digestive/GI System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Secretion Alteration [PE]</name>
		<code>N0000008304</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008304</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Secretion Volume Alteration [PE]</name>
		<code>N0000020054</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020054</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Secretion Volume Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cholagogue Activity [PE]</name>
		<code>N0000008356</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008356</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cholagogue Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Choleretic Activity [PE]</name>
		<code>N0000008357</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008357</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Choleretic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bile Secretion Composition Alteration [PE]</name>
		<code>N0000020055</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020055</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bile Secretion Composition Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Bile Iron Secretion [PE]</name>
		<code>N0000020056</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000020056</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Bile Iron Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gastric Mucous Secretion Alteration [PE]</name>
		<code>N0000009055</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009055</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastric Mucous Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Gastric Mucous Secretion [PE]</name>
		<code>N0000009869</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009869</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Gastric Mucous Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Gastric Mucous Secretion [PE]</name>
		<code>N0000009725</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009725</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Gastric Mucous Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Secretion Alteration [PE]</name>
		<code>N0000009793</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009793</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pancreatic Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Enzymatic Secretion Alteration [PE]</name>
		<code>N0000009790</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009790</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pancreatic Enzymatic Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Pancreatic Enzymatic Secretion [PE]</name>
		<code>N0000009728</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009728</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Pancreatic Enzymatic Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Pancreatic Enzymatic Secretion [PE]</name>
		<code>N0000009872</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009872</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Pancreatic Enzymatic Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Fluid/Electrolyte Secretion Alteration [PE]</name>
		<code>N0000009791</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009791</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pancreatic Fluid/Electrolyte Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Pancreatic Fluid/Electrolyte Secretion [PE]</name>
		<code>N0000009729</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009729</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Pancreatic Fluid/Electrolyte Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</name>
		<code>N0000009873</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009873</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>GI Motility Alteration [PE]</name>
		<code>N0000009048</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009048</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>GI Motility Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GI Motility [PE]</name>
		<code>N0000009329</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009329</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GI Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Esophageal Motility [PE]</name>
		<code>N0000009321</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009321</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Esophageal Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Emesis [PE]</name>
		<code>N0000009033</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009033</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Emesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Gastric Motility [PE]</name>
		<code>N0000009334</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009334</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Gastric Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Biliary Motility [PE]</name>
		<code>N0000009115</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009115</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Biliary Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Small Intestinal Motility [PE]</name>
		<code>N0000009589</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009589</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Small Intestinal Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Small Intestine Fluid/Electrolyte Alteration [PE]</name>
		<code>N0000009846</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009846</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Small Intestine Fluid/Electrolyte Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Small Intestine Fluid/Electrolyte Secretion Alteration [PE]</name>
		<code>N0000009847</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009847</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Small Intestine Fluid/Electrolyte Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</name>
		<code>N0000009875</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009875</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Small Intestine Fluid/Electrolyte Secretion [PE]</name>
		<code>N0000009731</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009731</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Small Intestine Fluid/Electrolyte Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</name>
		<code>N0000009845</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009845</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Small Intestine Fluid/Electrolyte Absorption Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</name>
		<code>N0000009874</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009874</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</name>
		<code>N0000009730</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009730</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gastric Acid Alteration [PE]</name>
		<code>N0000009054</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009054</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastric Acid Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Gastric Acid Secretion [PE]</name>
		<code>N0000009724</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009724</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Gastric Acid Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulation Gastric Acid Secretion [PE]</name>
		<code>N0000009868</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009868</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulation Gastric Acid Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antacid [PE]</name>
		<code>N0000008295</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008295</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antacid</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Saliva Production Alteration [PE]</name>
		<code>N0000009841</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009841</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Saliva Production Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Salivation Inhibition [PE]</name>
		<code>N0000009842</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009842</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Salivation Inhibition</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Salivation Stimulation [PE]</name>
		<code>N0000009843</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009843</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Salivation Stimulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cariostatic Activity [PE]</name>
		<code>N0000008332</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008332</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cariostatic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Large Intestine Fluid/Electrolyte Alteration [PE]</name>
		<code>N0000009737</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009737</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Large Intestine Fluid/Electrolyte Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</name>
		<code>N0000009738</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009738</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Large Intestine Fluid/Electrolyte Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</name>
		<code>N0000009736</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009736</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Large Intestine Fluid/Electrolyte Absorption Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Digestive Alteration [PE]</name>
		<code>N0000009021</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009021</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Digestive Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Fat Digestion [PE]</name>
		<code>N0000009723</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009723</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Fat Digestion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pancreatic Enzymatic Replacement [PE]</name>
		<code>N0000009789</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009789</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pancreatic Enzymatic Replacement</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibition Carbohydrate Digestion [PE]</name>
		<code>N0000009722</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009722</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibition Carbohydrate Digestion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nervous System Activity Alteration [PE]</name>
		<code>N0000009759</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009759</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nervous System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Electrical Activity Alteration [PE]</name>
		<code>N0000009027</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009027</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Electrical Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Organized Electrical Activity Alteration [PE]</name>
		<code>N0000009774</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009774</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Organized Electrical Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Organized Electrical Activity [PE]</name>
		<code>N0000009460</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009460</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Organized Electrical Activity [PE]</name>
		<code>N0000009446</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009446</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Organized Electrical Activity [PE]</name>
		<code>N0000009168</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009168</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Organized Electrical Activity [PE]</name>
		<code>N0000009661</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009661</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Organized Electrical Activity [PE]</name>
		<code>N0000009610</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009610</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000009197</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009197</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Organized Electrical Activity [PE]</name>
		<code>N0000009419</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009419</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Organized Electrical Activity [PE]</name>
		<code>N0000009141</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009141</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Organized Electrical Activity [PE]</name>
		<code>N0000009637</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009637</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Organized Electrical Activity [PE]</name>
		<code>N0000009220</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009220</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Organized Electrical Activity [PE]</name>
		<code>N0000009243</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009243</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000009513</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009513</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000009109</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009109</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Organized Electrical Activity [PE]</name>
		<code>N0000009490</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009490</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Organized Electrical Activity [PE]</name>
		<code>N0000009685</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009685</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000009313</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009313</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000009581</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009581</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Organized Electrical Activity [PE]</name>
		<code>N0000008768</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008768</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000008821</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008821</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000008889</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008889</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000008413</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008413</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Organized Electrical Activity [PE]</name>
		<code>N0000008798</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008798</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Organized Electrical Activity [PE]</name>
		<code>N0000008993</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008993</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Organized Electrical Activity [PE]</name>
		<code>N0000008619</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008619</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Organized Electrical Activity [PE]</name>
		<code>N0000008754</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008754</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Organized Electrical Activity [PE]</name>
		<code>N0000008969</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008969</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</name>
		<code>N0000008472</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008472</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Organized Electrical Activity [PE]</name>
		<code>N0000008918</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008918</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Organized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Disorganized Electrical Activity Alteration [PE]</name>
		<code>N0000009024</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009024</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Disorganized Electrical Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Disorganized Electrical Activity [PE]</name>
		<code>N0000009272</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009272</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Disorganized Electrical Activity [PE]</name>
		<code>N0000009431</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009431</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Disorganized Electrical Activity [PE]</name>
		<code>N0000009595</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009595</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Disorganized Electrical Activity [PE]</name>
		<code>N0000009153</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009153</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Disorganized Electrical Activity [PE]</name>
		<code>N0000009646</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009646</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000009182</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009182</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Disorganized Electrical Activity [PE]</name>
		<code>N0000009205</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009205</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Disorganized Electrical Activity [PE]</name>
		<code>N0000009622</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009622</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Disorganized Electrical Activity [PE]</name>
		<code>N0000009126</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009126</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Disorganized Electrical Activity [PE]</name>
		<code>N0000009404</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009404</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Disorganized Electrical Activity [PE]</name>
		<code>N0000009228</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009228</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000009498</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009498</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000009567</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009567</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000009298</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009298</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000009094</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009094</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sympathetic Disorganized Electrical Activity [PE]</name>
		<code>N0000009670</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009670</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sympathetic Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Disorganized Electrical Activity [PE]</name>
		<code>N0000009475</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009475</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Disorganized Electrical Activity [PE]</name>
		<code>N0000008578</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008578</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Disorganized Electrical Activity [PE]</name>
		<code>N0000008739</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008739</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Disorganized Electrical Activity [PE]</name>
		<code>N0000008457</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008457</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Disorganized Electrical Activity [PE]</name>
		<code>N0000008903</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008903</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Disorganized Electrical Activity [PE]</name>
		<code>N0000008954</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008954</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000008806</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008806</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000008398</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008398</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sympathetic Disorganized Electrical Activity [PE]</name>
		<code>N0000008978</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008978</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sympathetic Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Disorganized Electrical Activity [PE]</name>
		<code>N0000008783</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008783</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000008874</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008874</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Disorganized Electrical Activity [PE]</name>
		<code>N0000008604</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008604</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Disorganized Electrical Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Activity Alteration [PE]</name>
		<code>N0000175724</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175724</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Nervous System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</name>
		<code>N0000009761</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009761</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</name>
		<code>N0000009053</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009053</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased GABA Activity [PE]</name>
		<code>N0000009325</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009325</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System GABA Activity [PE]</name>
		<code>N0000009188</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009188</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum GABA Activity [PE]</name>
		<code>N0000009211</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009211</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex GABA Activity [PE]</name>
		<code>N0000009234</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009234</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem GABA Activity [PE]</name>
		<code>N0000009132</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009132</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord GABA Activity [PE]</name>
		<code>N0000009628</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009628</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain GABA Activity [PE]</name>
		<code>N0000009410</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009410</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System GABA Activity [PE]</name>
		<code>N0000009437</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009437</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle GABA Activity [PE]</name>
		<code>N0000009652</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009652</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle GABA Activity [PE]</name>
		<code>N0000009601</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009601</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle GABA Activity [PE]</name>
		<code>N0000009159</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009159</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System GABA Activity [PE]</name>
		<code>N0000009504</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009504</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System GABA Activity [PE]</name>
		<code>N0000009304</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009304</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System GABA Activity [PE]</name>
		<code>N0000009100</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009100</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic GABA Activity [PE]</name>
		<code>N0000009481</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009481</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System GABA Activity [PE]</name>
		<code>N0000009573</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009573</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased GABA Activity [PE]</name>
		<code>N0000008631</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008631</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System GABA Activity [PE]</name>
		<code>N0000008492</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008492</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex GABA Activity [PE]</name>
		<code>N0000008538</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008538</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord GABA Activity [PE]</name>
		<code>N0000008936</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008936</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum GABA Activity [PE]</name>
		<code>N0000008515</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008515</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain GABA Activity [PE]</name>
		<code>N0000008718</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008718</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem GABA Activity [PE]</name>
		<code>N0000008436</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008436</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System GABA Activity [PE]</name>
		<code>N0000008745</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008745</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle GABA Activity [PE]</name>
		<code>N0000008463</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008463</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle GABA Activity [PE]</name>
		<code>N0000008909</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008909</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle GABA Activity [PE]</name>
		<code>N0000008960</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008960</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System GABA Activity [PE]</name>
		<code>N0000008812</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008812</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System GABA Activity [PE]</name>
		<code>N0000008610</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008610</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System GABA Activity [PE]</name>
		<code>N0000008880</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008880</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System GABA Activity [PE]</name>
		<code>N0000008404</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008404</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic GABA Activity [PE]</name>
		<code>N0000008789</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008789</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic GABA Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Brain Derived Neurotropic Factor Activity Alteration [PE]</name>
		<code>N0000008315</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008315</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Brain Derived Neurotropic Factor Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008425</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008425</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008484</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008484</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008428</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008428</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008507</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008507</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008710</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008710</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008530</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008530</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008928</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008928</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008804</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008804</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008602</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008602</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008872</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008872</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008396</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008396</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008781</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008781</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008737</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008737</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008951</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008951</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008901</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008901</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000008455</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008455</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009121</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009121</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009496</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009496</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009296</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009296</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009565</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009565</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009092</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009092</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009473</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009473</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009429</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009429</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009643</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009643</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009593</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009593</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009151</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009151</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009180</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009180</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009620</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009620</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009226</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009226</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009124</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009124</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009402</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009402</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Brain Derived Neurotropic Activity [PE]</name>
		<code>N0000009203</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009203</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Brain Derived Neurotropic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dynorphin Activity Alteration [PE]</name>
		<code>N0000009026</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009026</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dynorphin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Dynorphin Activity [PE]</name>
		<code>N0000008589</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008589</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</name>
		<code>N0000008808</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008808</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Dynorphin Activity [PE]</name>
		<code>N0000008606</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008606</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Dynorphin Activity [PE]</name>
		<code>N0000008876</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008876</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Dynorphin Activity [PE]</name>
		<code>N0000008785</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008785</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Dynorphin Activity [PE]</name>
		<code>N0000008400</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008400</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Dynorphin Activity [PE]</name>
		<code>N0000008488</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008488</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Dynorphin Activity [PE]</name>
		<code>N0000008714</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008714</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Dynorphin Activity [PE]</name>
		<code>N0000008511</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008511</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Dynorphin Activity [PE]</name>
		<code>N0000008432</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008432</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Dynorphin Activity [PE]</name>
		<code>N0000008534</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008534</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Dynorphin Activity [PE]</name>
		<code>N0000008932</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008932</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Dynorphin Activity [PE]</name>
		<code>N0000008741</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008741</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Dynorphin Activity [PE]</name>
		<code>N0000008905</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008905</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Dynorphin Activity [PE]</name>
		<code>N0000008459</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008459</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Dynorphin Activity [PE]</name>
		<code>N0000008956</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008956</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Dynorphin Activity [PE]</name>
		<code>N0000009283</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009283</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Dynorphin Activity [PE]</name>
		<code>N0000009500</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009500</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Dynorphin Activity [PE]</name>
		<code>N0000009096</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009096</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Dynorphin Activity [PE]</name>
		<code>N0000009477</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009477</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Dynorphin Activity [PE]</name>
		<code>N0000009300</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009300</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Dynorphin Activity [PE]</name>
		<code>N0000009569</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009569</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Dynorphin Activity [PE]</name>
		<code>N0000009433</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009433</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Dynorphin Activity [PE]</name>
		<code>N0000009597</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009597</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Dynorphin Activity [PE]</name>
		<code>N0000009155</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009155</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Dynorphin Activity [PE]</name>
		<code>N0000009648</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009648</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Dynorphin Activity [PE]</name>
		<code>N0000009184</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009184</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Dynorphin Activity [PE]</name>
		<code>N0000009128</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009128</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Dynorphin Activity [PE]</name>
		<code>N0000009406</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009406</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Dynorphin Activity [PE]</name>
		<code>N0000009230</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009230</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Dynorphin Activity [PE]</name>
		<code>N0000009207</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009207</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Dynorphin Activity [PE]</name>
		<code>N0000009624</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009624</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Dynorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nitric Oxide Activity Alteration [PE]</name>
		<code>N0000009762</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009762</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nitric Oxide Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Nitric Oxide Activity [PE]</name>
		<code>N0000008763</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008763</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000008499</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008499</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Nitric Oxide Activity [PE]</name>
		<code>N0000008443</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008443</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Nitric Oxide Activity [PE]</name>
		<code>N0000008545</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008545</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Nitric Oxide Activity [PE]</name>
		<code>N0000008943</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008943</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Nitric Oxide Activity [PE]</name>
		<code>N0000008522</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008522</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Nitric Oxide Activity [PE]</name>
		<code>N0000008725</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008725</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Nitric Oxide Activity [PE]</name>
		<code>N0000008752</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008752</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Nitric Oxide Activity [PE]</name>
		<code>N0000008967</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008967</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Nitric Oxide Activity [PE]</name>
		<code>N0000008916</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008916</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Nitric Oxide Activity [PE]</name>
		<code>N0000008470</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008470</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000008819</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008819</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000008617</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008617</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000008411</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008411</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Nitric Oxide Activity [PE]</name>
		<code>N0000008796</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008796</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</name>
		<code>N0000008887</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008887</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration [PE]</name>
		<code>N0000009907</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009907</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased VIP Activity [PE]</name>
		<code>N0000009015</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009015</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System VIP Activity [PE]</name>
		<code>N0000008824</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008824</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System VIP Activity [PE]</name>
		<code>N0000008892</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008892</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System VIP Activity [PE]</name>
		<code>N0000008416</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008416</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic VIP Activity [PE]</name>
		<code>N0000008801</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008801</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System VIP Activity [PE]</name>
		<code>N0000008622</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008622</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System VIP Activity [PE]</name>
		<code>N0000008504</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008504</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord VIP Activity [PE]</name>
		<code>N0000008948</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008948</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex VIP Activity [PE]</name>
		<code>N0000008550</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008550</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem VIP Activity [PE]</name>
		<code>N0000008448</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008448</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain VIP Activity [PE]</name>
		<code>N0000008730</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008730</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum VIP Activity [PE]</name>
		<code>N0000008527</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008527</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System VIP Activity [PE]</name>
		<code>N0000008757</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008757</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle VIP Activity [PE]</name>
		<code>N0000008475</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008475</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle VIP Activity [PE]</name>
		<code>N0000008921</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008921</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle VIP Activity [PE]</name>
		<code>N0000008972</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008972</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased VIP Activity [PE]</name>
		<code>N0000009706</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009706</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System VIP Activity [PE]</name>
		<code>N0000009516</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009516</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System VIP Activity [PE]</name>
		<code>N0000009316</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009316</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System VIP Activity [PE]</name>
		<code>N0000009112</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009112</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic VIP Activity [PE]</name>
		<code>N0000009493</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009493</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System VIP Activity [PE]</name>
		<code>N0000009584</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009584</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System VIP Activity [PE]</name>
		<code>N0000009200</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009200</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem VIP Activity [PE]</name>
		<code>N0000009144</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009144</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain VIP Activity [PE]</name>
		<code>N0000009422</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009422</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord VIP Activity [PE]</name>
		<code>N0000009640</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009640</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex VIP Activity [PE]</name>
		<code>N0000009246</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009246</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum VIP Activity [PE]</name>
		<code>N0000009223</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009223</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System VIP Activity [PE]</name>
		<code>N0000009449</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009449</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle VIP Activity [PE]</name>
		<code>N0000009613</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009613</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle VIP Activity [PE]</name>
		<code>N0000009664</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009664</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle VIP Activity [PE]</name>
		<code>N0000009171</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009171</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle VIP Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Epinephrine Activity Alteration [PE]</name>
		<code>N0000009042</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009042</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Epinephrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Epinephrine Activity [PE]</name>
		<code>N0000008623</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008623</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Epinephrine Activity [PE]</name>
		<code>N0000008811</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008811</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Epinephrine Activity [PE]</name>
		<code>N0000008609</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008609</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Epinephrine Activity [PE]</name>
		<code>N0000008879</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008879</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Epinephrine Activity [PE]</name>
		<code>N0000008403</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008403</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Epinephrine Activity [PE]</name>
		<code>N0000008788</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008788</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Epinephrine Activity [PE]</name>
		<code>N0000008744</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008744</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Epinephrine Activity [PE]</name>
		<code>N0000008462</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008462</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Epinephrine Activity [PE]</name>
		<code>N0000008959</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008959</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Epinephrine Activity [PE]</name>
		<code>N0000008908</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008908</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Epinephrine Activity [PE]</name>
		<code>N0000008491</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008491</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Epinephrine Activity [PE]</name>
		<code>N0000008935</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008935</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Epinephrine Activity [PE]</name>
		<code>N0000008435</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008435</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Epinephrine Activity [PE]</name>
		<code>N0000008514</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008514</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Epinephrine Activity [PE]</name>
		<code>N0000008717</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008717</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Epinephrine Activity [PE]</name>
		<code>N0000008537</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008537</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Epinephrine Activity [PE]</name>
		<code>N0000009317</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009317</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Epinephrine Activity [PE]</name>
		<code>N0000009503</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009503</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Epinephrine Activity [PE]</name>
		<code>N0000009099</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009099</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Epinephrine Activity [PE]</name>
		<code>N0000009480</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009480</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Epinephrine Activity [PE]</name>
		<code>N0000009303</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009303</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Epinephrine Activity [PE]</name>
		<code>N0000009572</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009572</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Epinephrine Activity [PE]</name>
		<code>N0000009436</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009436</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Epinephrine Activity [PE]</name>
		<code>N0000009651</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009651</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Epinephrine Activity [PE]</name>
		<code>N0000009158</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009158</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Epinephrine Activity [PE]</name>
		<code>N0000009600</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009600</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Epinephrine Activity [PE]</name>
		<code>N0000009187</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009187</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Epinephrine Activity [PE]</name>
		<code>N0000009233</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009233</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Epinephrine Activity [PE]</name>
		<code>N0000009210</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009210</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Epinephrine Activity [PE]</name>
		<code>N0000009409</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009409</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Epinephrine Activity [PE]</name>
		<code>N0000009627</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009627</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Epinephrine Activity [PE]</name>
		<code>N0000009131</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009131</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Epinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Substance P Activity Alteration [PE]</name>
		<code>N0000009880</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009880</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Substance P Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Substance P Activity [PE]</name>
		<code>N0000008973</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008973</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Substance P Activity [PE]</name>
		<code>N0000008503</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008503</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Substance P Activity [PE]</name>
		<code>N0000008947</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008947</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Substance P Activity [PE]</name>
		<code>N0000008729</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008729</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Substance P Activity [PE]</name>
		<code>N0000008526</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008526</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Substance P Activity [PE]</name>
		<code>N0000008549</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008549</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Substance P Activity [PE]</name>
		<code>N0000008447</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008447</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Substance P Activity [PE]</name>
		<code>N0000008756</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008756</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Substance P Activity [PE]</name>
		<code>N0000008474</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008474</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Substance P Activity [PE]</name>
		<code>N0000008971</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008971</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Substance P Activity [PE]</name>
		<code>N0000008920</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008920</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Substance P Activity [PE]</name>
		<code>N0000008823</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008823</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Substance P Activity [PE]</name>
		<code>N0000008621</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008621</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Substance P Activity [PE]</name>
		<code>N0000008415</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008415</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Substance P Activity [PE]</name>
		<code>N0000008800</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008800</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Substance P Activity [PE]</name>
		<code>N0000008891</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008891</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Substance P Activity [PE]</name>
		<code>N0000009665</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009665</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Substance P Activity [PE]</name>
		<code>N0000009448</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009448</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Substance P Activity [PE]</name>
		<code>N0000009663</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009663</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Substance P Activity [PE]</name>
		<code>N0000009170</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009170</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Substance P Activity [PE]</name>
		<code>N0000009612</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009612</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Substance P Activity [PE]</name>
		<code>N0000009199</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009199</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Substance P Activity [PE]</name>
		<code>N0000009143</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009143</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Substance P Activity [PE]</name>
		<code>N0000009639</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009639</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Substance P Activity [PE]</name>
		<code>N0000009245</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009245</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Substance P Activity [PE]</name>
		<code>N0000009421</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009421</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Substance P Activity [PE]</name>
		<code>N0000009222</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009222</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Substance P Activity [PE]</name>
		<code>N0000009515</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009515</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Substance P Activity [PE]</name>
		<code>N0000009583</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009583</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Substance P Activity [PE]</name>
		<code>N0000009111</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009111</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Substance P Activity [PE]</name>
		<code>N0000009492</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009492</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Substance P Activity [PE]</name>
		<code>N0000009315</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009315</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Substance P Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Norepinephrine Activity Alteration [PE]</name>
		<code>N0000009765</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009765</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Norepinephrine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Norepinephrine Activity [PE]</name>
		<code>N0000008764</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008764</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000008500</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008500</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Norepinephrine Activity [PE]</name>
		<code>N0000008546</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008546</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Norepinephrine Activity [PE]</name>
		<code>N0000008944</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008944</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Norepinephrine Activity [PE]</name>
		<code>N0000008726</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008726</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Norepinephrine Activity [PE]</name>
		<code>N0000008523</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008523</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Norepinephrine Activity [PE]</name>
		<code>N0000008444</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008444</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000008820</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008820</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000008618</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008618</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000008888</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008888</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Norepinephrine Activity [PE]</name>
		<code>N0000008412</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008412</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Norepinephrine Activity [PE]</name>
		<code>N0000008797</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008797</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Norepinephrine Activity [PE]</name>
		<code>N0000008753</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008753</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Norepinephrine Activity [PE]</name>
		<code>N0000008917</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008917</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Norepinephrine Activity [PE]</name>
		<code>N0000008471</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008471</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Norepinephrine Activity [PE]</name>
		<code>N0000008968</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008968</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Norepinephrine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glycine Activity Alteration [PE]</name>
		<code>N0000009063</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009063</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glycine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glycine Activity [PE]</name>
		<code>N0000009343</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009343</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Glycine Activity [PE]</name>
		<code>N0000009507</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009507</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Glycine Activity [PE]</name>
		<code>N0000009576</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009576</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Glycine Activity [PE]</name>
		<code>N0000009307</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009307</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Glycine Activity [PE]</name>
		<code>N0000009103</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009103</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Glycine Activity [PE]</name>
		<code>N0000009484</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009484</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Glycine Activity [PE]</name>
		<code>N0000009440</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009440</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Glycine Activity [PE]</name>
		<code>N0000009604</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009604</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Glycine Activity [PE]</name>
		<code>N0000009162</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009162</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Glycine Activity [PE]</name>
		<code>N0000009655</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009655</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Glycine Activity [PE]</name>
		<code>N0000009191</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009191</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Glycine Activity [PE]</name>
		<code>N0000009237</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009237</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Glycine Activity [PE]</name>
		<code>N0000009135</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009135</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Glycine Activity [PE]</name>
		<code>N0000009413</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009413</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Glycine Activity [PE]</name>
		<code>N0000009214</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009214</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Glycine Activity [PE]</name>
		<code>N0000009631</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009631</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glycine Activity [PE]</name>
		<code>N0000008649</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008649</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Glycine Activity [PE]</name>
		<code>N0000008748</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008748</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Glycine Activity [PE]</name>
		<code>N0000008466</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008466</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Glycine Activity [PE]</name>
		<code>N0000008963</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008963</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Glycine Activity [PE]</name>
		<code>N0000008912</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008912</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Glycine Activity [PE]</name>
		<code>N0000008495</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008495</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Glycine Activity [PE]</name>
		<code>N0000008939</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008939</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Glycine Activity [PE]</name>
		<code>N0000008439</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008439</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Glycine Activity [PE]</name>
		<code>N0000008721</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008721</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Glycine Activity [PE]</name>
		<code>N0000008518</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008518</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Glycine Activity [PE]</name>
		<code>N0000008541</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008541</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Glycine Activity [PE]</name>
		<code>N0000008815</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008815</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Glycine Activity [PE]</name>
		<code>N0000008407</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008407</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Glycine Activity [PE]</name>
		<code>N0000008792</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008792</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Glycine Activity [PE]</name>
		<code>N0000008613</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008613</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Glycine Activity [PE]</name>
		<code>N0000008883</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008883</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Glycine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neurotensin Activity Alteration [PE]</name>
		<code>N0000009760</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009760</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neurotensin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Neurotensin Activity [PE]</name>
		<code>N0000008762</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008762</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Neurotensin Activity [PE]</name>
		<code>N0000008751</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008751</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Neurotensin Activity [PE]</name>
		<code>N0000008915</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008915</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Neurotensin Activity [PE]</name>
		<code>N0000008966</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008966</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Neurotensin Activity [PE]</name>
		<code>N0000008469</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008469</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Neurotensin Activity [PE]</name>
		<code>N0000008498</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008498</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Neurotensin Activity [PE]</name>
		<code>N0000008442</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008442</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Neurotensin Activity [PE]</name>
		<code>N0000008521</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008521</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Neurotensin Activity [PE]</name>
		<code>N0000008544</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008544</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Neurotensin Activity [PE]</name>
		<code>N0000008724</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008724</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Neurotensin Activity [PE]</name>
		<code>N0000008942</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008942</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Neurotensin Activity [PE]</name>
		<code>N0000008818</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008818</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Neurotensin Activity [PE]</name>
		<code>N0000008616</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008616</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Neurotensin Activity [PE]</name>
		<code>N0000008410</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008410</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Neurotensin Activity [PE]</name>
		<code>N0000008795</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008795</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Neurotensin Activity [PE]</name>
		<code>N0000008886</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008886</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Neurotensin Activity [PE]</name>
		<code>N0000009454</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009454</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Neurotensin Activity [PE]</name>
		<code>N0000009443</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009443</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Neurotensin Activity [PE]</name>
		<code>N0000009658</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009658</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Neurotensin Activity [PE]</name>
		<code>N0000009607</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009607</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Neurotensin Activity [PE]</name>
		<code>N0000009165</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009165</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Neurotensin Activity [PE]</name>
		<code>N0000009194</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009194</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Neurotensin Activity [PE]</name>
		<code>N0000009138</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009138</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Neurotensin Activity [PE]</name>
		<code>N0000009634</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009634</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Neurotensin Activity [PE]</name>
		<code>N0000009416</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009416</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Neurotensin Activity [PE]</name>
		<code>N0000009240</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009240</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Neurotensin Activity [PE]</name>
		<code>N0000009217</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009217</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Neurotensin Activity [PE]</name>
		<code>N0000009510</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009510</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Neurotensin Activity [PE]</name>
		<code>N0000009310</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009310</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Neurotensin Activity [PE]</name>
		<code>N0000009106</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009106</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Neurotensin Activity [PE]</name>
		<code>N0000009487</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009487</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Neurotensin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System [PE]</name>
		<code>N0000009562</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009562</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dopamine Activity Alteration [PE]</name>
		<code>N0000009025</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009025</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dopamine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Dopamine Activity [PE]</name>
		<code>N0000008588</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008588</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Dopamine Activity [PE]</name>
		<code>N0000008487</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008487</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Dopamine Activity [PE]</name>
		<code>N0000008510</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008510</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Dopamine Activity [PE]</name>
		<code>N0000008431</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008431</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Dopamine Activity [PE]</name>
		<code>N0000008713</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008713</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Dopamine Activity [PE]</name>
		<code>N0000008931</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008931</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Dopamine Activity [PE]</name>
		<code>N0000008533</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008533</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Dopamine Activity [PE]</name>
		<code>N0000008740</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008740</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Dopamine Activity [PE]</name>
		<code>N0000008955</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008955</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Dopamine Activity [PE]</name>
		<code>N0000008458</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008458</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Dopamine Activity [PE]</name>
		<code>N0000008904</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008904</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Dopamine Activity [PE]</name>
		<code>N0000008807</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008807</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Dopamine Activity [PE]</name>
		<code>N0000008605</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008605</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Dopamine Activity [PE]</name>
		<code>N0000008875</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008875</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Dopamine Activity [PE]</name>
		<code>N0000008399</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008399</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Dopamine Activity [PE]</name>
		<code>N0000008784</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008784</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Dopamine Activity [PE]</name>
		<code>N0000009282</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009282</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Dopamine Activity [PE]</name>
		<code>N0000009183</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009183</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Dopamine Activity [PE]</name>
		<code>N0000009127</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009127</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Dopamine Activity [PE]</name>
		<code>N0000009405</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009405</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Dopamine Activity [PE]</name>
		<code>N0000009206</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009206</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Dopamine Activity [PE]</name>
		<code>N0000009229</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009229</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Dopamine Activity [PE]</name>
		<code>N0000009623</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009623</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Dopamine Activity [PE]</name>
		<code>N0000009499</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009499</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Dopamine Activity [PE]</name>
		<code>N0000009095</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009095</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Dopamine Activity [PE]</name>
		<code>N0000009476</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009476</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Dopamine Activity [PE]</name>
		<code>N0000009299</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009299</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Dopamine Activity [PE]</name>
		<code>N0000009568</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009568</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Dopamine Activity [PE]</name>
		<code>N0000009432</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009432</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Dopamine Activity [PE]</name>
		<code>N0000009154</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009154</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Dopamine Activity [PE]</name>
		<code>N0000009596</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009596</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Dopamine Activity [PE]</name>
		<code>N0000009647</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009647</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Dopamine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Serotonin Activity Alteration [PE]</name>
		<code>N0000009844</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009844</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Serotonin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Aspartate Activity Alteration [PE]</name>
		<code>N0000008300</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008300</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Aspartate Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Aspartate Activity [PE]</name>
		<code>N0000008393</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008393</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Aspartate Activity [PE]</name>
		<code>N0000008736</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008736</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Aspartate Activity [PE]</name>
		<code>N0000008454</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008454</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Aspartate Activity [PE]</name>
		<code>N0000008950</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008950</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Aspartate Activity [PE]</name>
		<code>N0000008900</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008900</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Aspartate Activity [PE]</name>
		<code>N0000008803</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008803</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Aspartate Activity [PE]</name>
		<code>N0000008395</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008395</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Aspartate Activity [PE]</name>
		<code>N0000008780</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008780</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Aspartate Activity [PE]</name>
		<code>N0000008601</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008601</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Aspartate Activity [PE]</name>
		<code>N0000008871</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008871</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Aspartate Activity [PE]</name>
		<code>N0000008483</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008483</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Aspartate Activity [PE]</name>
		<code>N0000008506</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008506</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Aspartate Activity [PE]</name>
		<code>N0000008927</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008927</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Aspartate Activity [PE]</name>
		<code>N0000008427</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008427</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Aspartate Activity [PE]</name>
		<code>N0000008709</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008709</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Aspartate Activity [PE]</name>
		<code>N0000008529</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008529</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Aspartate Activity [PE]</name>
		<code>N0000009089</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009089</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Aspartate Activity [PE]</name>
		<code>N0000009428</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009428</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Aspartate Activity [PE]</name>
		<code>N0000009592</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009592</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Aspartate Activity [PE]</name>
		<code>N0000009150</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009150</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Aspartate Activity [PE]</name>
		<code>N0000009642</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009642</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Aspartate Activity [PE]</name>
		<code>N0000009495</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009495</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Aspartate Activity [PE]</name>
		<code>N0000009295</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009295</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Aspartate Activity [PE]</name>
		<code>N0000009091</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009091</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Aspartate Activity [PE]</name>
		<code>N0000009472</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009472</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Aspartate Activity [PE]</name>
		<code>N0000009564</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009564</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Aspartate Activity [PE]</name>
		<code>N0000009179</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009179</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Aspartate Activity [PE]</name>
		<code>N0000009123</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009123</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Aspartate Activity [PE]</name>
		<code>N0000009401</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009401</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Aspartate Activity [PE]</name>
		<code>N0000009202</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009202</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Aspartate Activity [PE]</name>
		<code>N0000009225</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009225</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Aspartate Activity [PE]</name>
		<code>N0000009619</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009619</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Aspartate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endorphin Activity Alteration [PE]</name>
		<code>N0000009038</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009038</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endorphin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Endorphin Activity [PE]</name>
		<code>N0000009291</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009291</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Endorphin Activity [PE]</name>
		<code>N0000009501</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009501</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Endorphin Activity [PE]</name>
		<code>N0000009097</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009097</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Endorphin Activity [PE]</name>
		<code>N0000009478</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009478</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Endorphin Activity [PE]</name>
		<code>N0000009570</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009570</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Endorphin Activity [PE]</name>
		<code>N0000009301</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009301</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Endorphin Activity [PE]</name>
		<code>N0000009434</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009434</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Endorphin Activity [PE]</name>
		<code>N0000009598</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009598</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Endorphin Activity [PE]</name>
		<code>N0000009649</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009649</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Endorphin Activity [PE]</name>
		<code>N0000009156</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009156</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Endorphin Activity [PE]</name>
		<code>N0000009185</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009185</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Endorphin Activity [PE]</name>
		<code>N0000009407</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009407</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Endorphin Activity [PE]</name>
		<code>N0000009625</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009625</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Endorphin Activity [PE]</name>
		<code>N0000009208</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009208</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Endorphin Activity [PE]</name>
		<code>N0000009231</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009231</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Endorphin Activity [PE]</name>
		<code>N0000009129</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009129</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Endorphin Activity [PE]</name>
		<code>N0000008597</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008597</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Endorphin Activity [PE]</name>
		<code>N0000008489</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008489</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Endorphin Activity [PE]</name>
		<code>N0000008933</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008933</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Endorphin Activity [PE]</name>
		<code>N0000008433</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008433</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Endorphin Activity [PE]</name>
		<code>N0000008715</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008715</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Endorphin Activity [PE]</name>
		<code>N0000008535</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008535</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Endorphin Activity [PE]</name>
		<code>N0000008512</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008512</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Endorphin Activity [PE]</name>
		<code>N0000008742</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008742</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Endorphin Activity [PE]</name>
		<code>N0000008957</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008957</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Endorphin Activity [PE]</name>
		<code>N0000008460</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008460</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Endorphin Activity [PE]</name>
		<code>N0000008906</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008906</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Endorphin Activity [PE]</name>
		<code>N0000008809</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008809</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Endorphin Activity [PE]</name>
		<code>N0000008607</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008607</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Endorphin Activity [PE]</name>
		<code>N0000008401</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008401</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Endorphin Activity [PE]</name>
		<code>N0000008786</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008786</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Endorphin Activity [PE]</name>
		<code>N0000008877</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008877</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Endorphin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enkephalin Activity Alteration [PE]</name>
		<code>N0000009041</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009041</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enkephalin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enkephalin Activity [PE]</name>
		<code>N0000009293</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009293</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Enkephalin Activity [PE]</name>
		<code>N0000009186</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009186</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Enkephalin Activity [PE]</name>
		<code>N0000009232</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009232</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Enkephalin Activity [PE]</name>
		<code>N0000009626</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009626</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Enkephalin Activity [PE]</name>
		<code>N0000009130</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009130</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Enkephalin Activity [PE]</name>
		<code>N0000009209</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009209</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Enkephalin Activity [PE]</name>
		<code>N0000009408</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009408</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Enkephalin Activity [PE]</name>
		<code>N0000009502</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009502</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Enkephalin Activity [PE]</name>
		<code>N0000009479</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009479</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Enkephalin Activity [PE]</name>
		<code>N0000009571</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009571</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Enkephalin Activity [PE]</name>
		<code>N0000009098</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009098</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Enkephalin Activity [PE]</name>
		<code>N0000009302</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009302</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Enkephalin Activity [PE]</name>
		<code>N0000009435</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009435</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Enkephalin Activity [PE]</name>
		<code>N0000009650</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009650</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Enkephalin Activity [PE]</name>
		<code>N0000009157</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009157</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Enkephalin Activity [PE]</name>
		<code>N0000009599</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009599</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enkephalin Activity [PE]</name>
		<code>N0000008599</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008599</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</name>
		<code>N0000008810</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008810</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Enkephalin Activity [PE]</name>
		<code>N0000008787</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008787</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Enkephalin Activity [PE]</name>
		<code>N0000008878</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008878</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Enkephalin Activity [PE]</name>
		<code>N0000008608</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008608</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Enkephalin Activity [PE]</name>
		<code>N0000008402</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008402</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Enkephalin Activity [PE]</name>
		<code>N0000008490</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008490</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Enkephalin Activity [PE]</name>
		<code>N0000008934</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008934</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Enkephalin Activity [PE]</name>
		<code>N0000008536</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008536</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Enkephalin Activity [PE]</name>
		<code>N0000008513</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008513</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Enkephalin Activity [PE]</name>
		<code>N0000008434</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008434</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Enkephalin Activity [PE]</name>
		<code>N0000008716</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008716</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Enkephalin Activity [PE]</name>
		<code>N0000008743</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008743</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Enkephalin Activity [PE]</name>
		<code>N0000008461</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008461</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Enkephalin Activity [PE]</name>
		<code>N0000008958</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008958</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Enkephalin Activity [PE]</name>
		<code>N0000008907</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008907</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Enkephalin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nerve Growth Factor Activity Alteration [PE]</name>
		<code>N0000009758</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009758</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nerve Growth Factor Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Nerve Growth Factor Activity [PE]</name>
		<code>N0000008761</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008761</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000008817</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008817</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000008615</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008615</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000008409</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008409</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Nerve Growth Factor Activity [PE]</name>
		<code>N0000008794</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008794</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000008885</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008885</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Nerve Growth Factor Activity [PE]</name>
		<code>N0000008750</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008750</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Nerve Growth Factor Activity [PE]</name>
		<code>N0000008914</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008914</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Nerve Growth Factor Activity [PE]</name>
		<code>N0000008965</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008965</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Nerve Growth Factor Activity [PE]</name>
		<code>N0000008468</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008468</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000008497</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008497</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Nerve Growth Factor Activity [PE]</name>
		<code>N0000008441</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008441</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Nerve Growth Factor Activity [PE]</name>
		<code>N0000008543</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008543</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Nerve Growth Factor Activity [PE]</name>
		<code>N0000008520</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008520</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Nerve Growth Factor Activity [PE]</name>
		<code>N0000008723</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008723</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Nerve Growth Factor Activity [PE]</name>
		<code>N0000008941</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008941</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Nerve Growth Factor Activity [PE]</name>
		<code>N0000009453</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009453</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Nerve Growth Factor Activity [PE]</name>
		<code>N0000009442</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009442</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Nerve Growth Factor Activity [PE]</name>
		<code>N0000009164</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009164</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Nerve Growth Factor Activity [PE]</name>
		<code>N0000009606</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009606</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Nerve Growth Factor Activity [PE]</name>
		<code>N0000009657</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009657</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000009193</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009193</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Nerve Growth Factor Activity [PE]</name>
		<code>N0000009239</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009239</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Nerve Growth Factor Activity [PE]</name>
		<code>N0000009415</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009415</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Nerve Growth Factor Activity [PE]</name>
		<code>N0000009633</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009633</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Nerve Growth Factor Activity [PE]</name>
		<code>N0000009137</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009137</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Nerve Growth Factor Activity [PE]</name>
		<code>N0000009216</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009216</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000009509</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009509</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000009105</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009105</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Nerve Growth Factor Activity [PE]</name>
		<code>N0000009486</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009486</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000009578</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009578</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Nerve Growth Factor Activity [PE]</name>
		<code>N0000009309</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009309</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Nerve Growth Factor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Glutamate Activity Alteration [PE]</name>
		<code>N0000009062</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009062</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Glutamate Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Glutamate Activity [PE]</name>
		<code>N0000008648</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008648</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Glutamate Activity [PE]</name>
		<code>N0000008494</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008494</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Glutamate Activity [PE]</name>
		<code>N0000008720</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008720</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Glutamate Activity [PE]</name>
		<code>N0000008517</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008517</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Glutamate Activity [PE]</name>
		<code>N0000008540</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008540</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Glutamate Activity [PE]</name>
		<code>N0000008938</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008938</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Glutamate Activity [PE]</name>
		<code>N0000008438</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008438</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Glutamate Activity [PE]</name>
		<code>N0000008814</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008814</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Glutamate Activity [PE]</name>
		<code>N0000008612</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008612</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Glutamate Activity [PE]</name>
		<code>N0000008882</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008882</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Glutamate Activity [PE]</name>
		<code>N0000008406</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008406</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Glutamate Activity [PE]</name>
		<code>N0000008791</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008791</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Glutamate Activity [PE]</name>
		<code>N0000008747</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008747</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Glutamate Activity [PE]</name>
		<code>N0000008465</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008465</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Glutamate Activity [PE]</name>
		<code>N0000008962</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008962</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Glutamate Activity [PE]</name>
		<code>N0000008911</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008911</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Glutamate Activity [PE]</name>
		<code>N0000009342</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009342</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Glutamate Activity [PE]</name>
		<code>N0000009190</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009190</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Glutamate Activity [PE]</name>
		<code>N0000009236</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009236</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Glutamate Activity [PE]</name>
		<code>N0000009630</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009630</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Glutamate Activity [PE]</name>
		<code>N0000009134</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009134</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Glutamate Activity [PE]</name>
		<code>N0000009412</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009412</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Glutamate Activity [PE]</name>
		<code>N0000009213</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009213</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Glutamate Activity [PE]</name>
		<code>N0000009506</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009506</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Glutamate Activity [PE]</name>
		<code>N0000009102</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009102</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Glutamate Activity [PE]</name>
		<code>N0000009483</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009483</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Glutamate Activity [PE]</name>
		<code>N0000009575</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009575</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Glutamate Activity [PE]</name>
		<code>N0000009306</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009306</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Glutamate Activity [PE]</name>
		<code>N0000009439</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009439</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Glutamate Activity [PE]</name>
		<code>N0000009654</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009654</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Glutamate Activity [PE]</name>
		<code>N0000009161</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009161</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Glutamate Activity [PE]</name>
		<code>N0000009603</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009603</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Glutamate Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Acetylcholine Activity Alteration [PE]</name>
		<code>N0000008290</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008290</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Acetylcholine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Acetylcholine Activity [PE]</name>
		<code>N0000008383</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008383</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000008482</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008482</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Acetylcholine Activity [PE]</name>
		<code>N0000008708</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008708</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Acetylcholine Activity [PE]</name>
		<code>N0000008426</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008426</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Acetylcholine Activity [PE]</name>
		<code>N0000008505</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008505</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Acetylcholine Activity [PE]</name>
		<code>N0000008528</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008528</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Acetylcholine Activity [PE]</name>
		<code>N0000008926</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008926</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Acetylcholine Activity [PE]</name>
		<code>N0000008735</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008735</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Acetylcholine Activity [PE]</name>
		<code>N0000008899</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008899</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</name>
		<code>N0000008453</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008453</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000008802</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008802</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000008394</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008394</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Acetylcholine Activity [PE]</name>
		<code>N0000008779</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008779</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000008870</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008870</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Acetylcholine Activity [PE]</name>
		<code>N0000008600</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008600</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Acetylcholine Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gastrin Activity Alteration [PE]</name>
		<code>N0000009056</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009056</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastrin Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Gastrin Activity [PE]</name>
		<code>N0000009336</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009336</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System Gastrin Activity [PE]</name>
		<code>N0000009438</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009438</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle Gastrin Activity [PE]</name>
		<code>N0000009160</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009160</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle Gastrin Activity [PE]</name>
		<code>N0000009602</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009602</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle Gastrin Activity [PE]</name>
		<code>N0000009653</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009653</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System Gastrin Activity [PE]</name>
		<code>N0000009189</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009189</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex Gastrin Activity [PE]</name>
		<code>N0000009235</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009235</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain Gastrin Activity [PE]</name>
		<code>N0000009411</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009411</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum Gastrin Activity [PE]</name>
		<code>N0000009212</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009212</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem Gastrin Activity [PE]</name>
		<code>N0000009133</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009133</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord Gastrin Activity [PE]</name>
		<code>N0000009629</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009629</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System Gastrin Activity [PE]</name>
		<code>N0000009505</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009505</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System Gastrin Activity [PE]</name>
		<code>N0000009305</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009305</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System Gastrin Activity [PE]</name>
		<code>N0000009101</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009101</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Gastrin Activity [PE]</name>
		<code>N0000009482</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009482</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System Gastrin Activity [PE]</name>
		<code>N0000009574</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009574</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Gastrin Activity [PE]</name>
		<code>N0000008642</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008642</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System Gastrin Activity [PE]</name>
		<code>N0000008493</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008493</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain Gastrin Activity [PE]</name>
		<code>N0000008719</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008719</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex Gastrin Activity [PE]</name>
		<code>N0000008539</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008539</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum Gastrin Activity [PE]</name>
		<code>N0000008516</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008516</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord Gastrin Activity [PE]</name>
		<code>N0000008937</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008937</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem Gastrin Activity [PE]</name>
		<code>N0000008437</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008437</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System Gastrin Activity [PE]</name>
		<code>N0000008746</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008746</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle Gastrin Activity [PE]</name>
		<code>N0000008961</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008961</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle Gastrin Activity [PE]</name>
		<code>N0000008910</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008910</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle Gastrin Activity [PE]</name>
		<code>N0000008464</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008464</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System Gastrin Activity [PE]</name>
		<code>N0000008813</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008813</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System Gastrin Activity [PE]</name>
		<code>N0000008405</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008405</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Gastrin Activity [PE]</name>
		<code>N0000008790</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008790</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System Gastrin Activity [PE]</name>
		<code>N0000008881</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008881</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System Gastrin Activity [PE]</name>
		<code>N0000008611</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008611</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System Gastrin Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Histamine Activity Alteration [PE]</name>
		<code>N0000009071</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009071</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Histamine Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>CCK Activity Alteration [PE]</name>
		<code>N0000008323</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008323</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CCK Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased CCK Activity [PE]</name>
		<code>N0000008449</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008449</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Central Nervous System CCK Activity [PE]</name>
		<code>N0000008485</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008485</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Central Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebellum CCK Activity [PE]</name>
		<code>N0000008508</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008508</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebellum CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Midbrain CCK Activity [PE]</name>
		<code>N0000008711</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008711</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Midbrain CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cerebral Cortex CCK Activity [PE]</name>
		<code>N0000008531</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008531</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cerebral Cortex CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Spinal Cord CCK Activity [PE]</name>
		<code>N0000008929</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008929</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Spinal Cord CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Brain Stem CCK Activity [PE]</name>
		<code>N0000008429</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008429</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Brain Stem CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Muscular System CCK Activity [PE]</name>
		<code>N0000008738</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008738</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Muscular System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Striated Muscle CCK Activity [PE]</name>
		<code>N0000008952</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008952</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Striated Muscle CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Smooth Muscle CCK Activity [PE]</name>
		<code>N0000008902</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008902</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Smooth Muscle CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cardiac Muscle CCK Activity [PE]</name>
		<code>N0000008456</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008456</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cardiac Muscle CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Nervous System CCK Activity [PE]</name>
		<code>N0000008805</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008805</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sensory-Somatic Nervous System CCK Activity [PE]</name>
		<code>N0000008873</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008873</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sensory-Somatic Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Autonomic Nervous System CCK Activity [PE]</name>
		<code>N0000008397</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008397</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Autonomic Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic CCK Activity [PE]</name>
		<code>N0000008782</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008782</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Enteric Nervous System CCK Activity [PE]</name>
		<code>N0000008603</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008603</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Enteric Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased CCK Activity [PE]</name>
		<code>N0000009145</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009145</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Nervous System CCK Activity [PE]</name>
		<code>N0000009497</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009497</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Enteric Nervous System CCK Activity [PE]</name>
		<code>N0000009297</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009297</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Enteric Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sensory-Somatic Nervous System CCK Activity [PE]</name>
		<code>N0000009566</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009566</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sensory-Somatic Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Nervous System CCK Activity [PE]</name>
		<code>N0000009093</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009093</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic CCK Activity [PE]</name>
		<code>N0000009474</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009474</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Muscular System CCK Activity [PE]</name>
		<code>N0000009430</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009430</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Muscular System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cardiac Muscle CCK Activity [PE]</name>
		<code>N0000009152</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009152</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cardiac Muscle CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Smooth Muscle CCK Activity [PE]</name>
		<code>N0000009594</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009594</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Smooth Muscle CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Striated Muscle CCK Activity [PE]</name>
		<code>N0000009644</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009644</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Striated Muscle CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Central Nervous System CCK Activity [PE]</name>
		<code>N0000009181</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009181</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Central Nervous System CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Midbrain CCK Activity [PE]</name>
		<code>N0000009403</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009403</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Midbrain CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebellum CCK Activity [PE]</name>
		<code>N0000009204</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009204</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebellum CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Brain Stem CCK Activity [PE]</name>
		<code>N0000009125</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009125</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Brain Stem CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cerebral Cortex CCK Activity [PE]</name>
		<code>N0000009227</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009227</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cerebral Cortex CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Spinal Cord CCK Activity [PE]</name>
		<code>N0000009621</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009621</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Spinal Cord CCK Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peripheral Nervous System Activity Alteration [PE]</name>
		<code>N0000175725</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175725</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peripheral Nervous System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sensory System Activity Alteration [PE]</name>
		<code>N0000175727</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175727</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sensory System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Neuromuscular Activity Alteration [PE]</name>
		<code>N0000175726</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175726</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Neuromuscular Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autonomic Nervous System Activity Alteration [PE]</name>
		<code>N0000175642</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175642</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autonomic Nervous System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Autonomic Ganglionic Activity Alteration [PE]</name>
		<code>N0000175643</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175643</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Autonomic Ganglionic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Autonomic Ganglionic Activity [PE]</name>
		<code>N0000175645</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175645</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Autonomic Ganglionic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Parasympathetic Activity Alteration [PE]</name>
		<code>N0000175646</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175646</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parasympathetic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Parasympathetic Activity [PE]</name>
		<code>N0000175649</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175649</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Parasympathetic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parasympathomimetic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Parasympathetic Activity [PE]</name>
		<code>N0000175648</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175648</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Parasympatholytic Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Parasympathetic Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sympathetic Activity Alteration [PE]</name>
		<code>N0000175647</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175647</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sympathetic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory/Pulmonary Activity Alteration [PE]</name>
		<code>N0000009839</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009839</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory/Pulmonary Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Secretion Alteration [PE]</name>
		<code>N0000009836</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009836</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Secretion Viscosity Alteration [PE]</name>
		<code>N0000009837</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009837</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Secretion Viscosity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Respiratory Secretion Viscosity [PE]</name>
		<code>N0000009559</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009559</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Respiratory Secretion Viscosity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Respiratory Secretions [PE]</name>
		<code>N0000008868</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008868</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Respiratory Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Tracheo-Bronchial Secretions [PE]</name>
		<code>N0000009009</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009009</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Tracheo-Bronchial Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Pharyngeal Secretions [PE]</name>
		<code>N0000008760</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008760</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Pharyngeal Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Nasal and Sinus Secretions [PE]</name>
		<code>N0000008896</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008896</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Nasal and Sinus Secretions</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Alveolar Surface Tension Alteration [PE]</name>
		<code>N0000008293</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008293</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Alveolar Surface Tension Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Tracheobronchial Stretch Receptor Alteration [PE]</name>
		<code>N0000009892</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009892</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Tracheobronchial Stretch Receptor Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Tracheobronchial Stretch Receptor Activity [PE]</name>
		<code>N0000009702</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009702</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Tracheobronchial Stretch Receptor Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ventilatory Gas Flow Alteration [PE]</name>
		<code>N0000009912</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009912</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ventilatory Gas Flow Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Ventilatory Gas Flow [PE]</name>
		<code>N0000009710</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009710</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Ventilatory Gas Flow</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Ventilatory Gas Flow [PE]</name>
		<code>N0000009019</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009019</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Ventilatory Gas Flow</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Medullary Respiratory Center Activity Alteration [PE]</name>
		<code>N0000009743</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009743</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Medullary Respiratory Center Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Medullary Respiratory Drive [PE]</name>
		<code>N0000008701</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008701</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Medullary Respiratory Drive</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Peripheral Carotid Chemoreceptor Alteration [PE]</name>
		<code>N0000009799</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009799</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Peripheral Carotid Chemoreceptor Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Peripheral Respiratory Drive [PE]</name>
		<code>N0000008825</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008825</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Peripheral Respiratory Drive</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Peripheral Respiratory Drive [PE]</name>
		<code>N0000009517</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009517</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Peripheral Respiratory Drive</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory Mucosal Edema Alteration [PE]</name>
		<code>N0000009964</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009964</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory Mucosal Edema Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Respiratory Mucosal Edema [PE]</name>
		<code>N0000009965</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009965</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Respiratory Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Pharyngeal Mucosal Edema [PE]</name>
		<code>N0000009971</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009971</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Pharyngeal Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Nasal and Sinus Mucosal Edema [PE]</name>
		<code>N0000009972</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009972</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Nasal and Sinus Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Tracheo-Bronchial Mucosal Edema [PE]</name>
		<code>N0000009970</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009970</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Tracheo-Bronchial Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Respiratory Mucosal Edema [PE]</name>
		<code>N0000009966</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009966</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Respiratory Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Pharyngeal Mucosal Edema [PE]</name>
		<code>N0000009968</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009968</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Pharyngeal Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Nasal and Sinus Mucosal Edema [PE]</name>
		<code>N0000009967</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009967</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Nasal and Sinus Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Tracheo-Bronchial Mucosal Edema [PE]</name>
		<code>N0000009969</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009969</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Tracheo-Bronchial Mucosal Edema</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Reproductive System Activity Alteration [PE]</name>
		<code>N0000009833</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009833</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Reproductive System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Male Reproductive System Activity Alteration [PE]</name>
		<code>N0000009742</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009742</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Male Reproductive System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Penile Alteration [PE]</name>
		<code>N0000009795</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009795</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penile Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Penile Erectile Alteration [PE]</name>
		<code>N0000009797</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009797</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penile Erectile Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enhance Penile Erection [PE]</name>
		<code>N0000009040</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009040</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enhance Penile Erection</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Diminish Penile Erection [PE]</name>
		<code>N0000009023</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009023</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Diminish Penile Erection</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Penile Development Alteration [PE]</name>
		<code>N0000009796</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009796</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Penile Development Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Penile Development [PE]</name>
		<code>N0000009718</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009718</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Penile Development</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Penile Development [PE]</name>
		<code>N0000009864</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009864</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Penile Development</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sperm Alteration [PE]</name>
		<code>N0000009852</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009852</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sperm Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sperm Death Alteration [PE]</name>
		<code>N0000009989</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009989</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sperm Death Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sperm Death [PE]</name>
		<code>N0000009990</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009990</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sperm Death</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Spermatogenesis Alteration [PE]</name>
		<code>N0000009854</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009854</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Spermatogenesis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increase Spermatogenesis [PE]</name>
		<code>N0000009077</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009077</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increase Spermatogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decrease Spermatogenesis [PE]</name>
		<code>N0000008381</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008381</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decrease Spermatogenesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sperm Motility Alteration [PE]</name>
		<code>N0000009853</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009853</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sperm Motility Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Sperm Motility [PE]</name>
		<code>N0000008924</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008924</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Sperm Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Sperm Motility [PE]</name>
		<code>N0000009616</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009616</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Sperm Motility</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostatic Alteration [PE]</name>
		<code>N0000009811</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009811</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostatic Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostatic Secretion Alteration [PE]</name>
		<code>N0000009812</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009812</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostatic Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostatic Secretion [PE]</name>
		<code>N0000008837</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008837</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prostatic Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prostatic Secretion [PE]</name>
		<code>N0000009529</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009529</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prostatic Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Prostatic Size Alteration [PE]</name>
		<code>N0000009813</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009813</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Prostatic Size Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Prostatic Size [PE]</name>
		<code>N0000008838</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008838</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Prostatic Size</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prostatic Size [PE]</name>
		<code>N0000009530</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009530</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prostatic Size</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Female Reproductive System Activity Alteration [PE]</name>
		<code>N0000009044</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009044</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Female Reproductive System Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Alteration [PE]</name>
		<code>N0000009028</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009028</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Embryonic &amp; Fetal Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Embryonic Implantation Alteration [PE]</name>
		<code>N0000009032</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009032</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Embryonic Implantation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Embryonic Implantation [PE]</name>
		<code>N0000008595</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008595</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Embryonic Implantation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Embryonic Implantation [PE]</name>
		<code>N0000009289</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009289</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Embryonic Implantation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Development Alteration [PE]</name>
		<code>N0000009029</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009029</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Embryonic &amp; Fetal Development Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Embryonic &amp; Fetal Development [PE]</name>
		<code>N0000009860</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009860</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Embryonic &amp; Fetal Development</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Embryonic &amp; Fetal Development [PE]</name>
		<code>N0000009714</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009714</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Embryonic &amp; Fetal Development</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ovum Fertilization Alteration [PE]</name>
		<code>N0000175829</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175829</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ovum Fertilization Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Growth Alteration [PE]</name>
		<code>N0000009030</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009030</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Embryonic &amp; Fetal Growth Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Embryonic &amp; Fetal Growth [PE]</name>
		<code>N0000009287</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009287</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Embryonic &amp; Fetal Growth</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Embryonic &amp; Fetal Growth [PE]</name>
		<code>N0000008593</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008593</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Embryonic &amp; Fetal Growth</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Embryonic &amp; Fetal Viability Alteration [PE]</name>
		<code>N0000009031</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009031</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Embryonic &amp; Fetal Viability Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Embryonic &amp; Fetal Viability [PE]</name>
		<code>N0000009288</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009288</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Embryonic &amp; Fetal Viability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Embryonic &amp; Fetal Viability [PE]</name>
		<code>N0000008594</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008594</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Embryonic &amp; Fetal Viability</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Function Alteration [PE]</name>
		<code>N0000008316</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008316</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Milk Ejection [PE]</name>
		<code>N0000008318</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008318</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Milk Ejection</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Breast Milk Ejection [PE]</name>
		<code>N0000009712</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009712</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Breast Milk Ejection</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Breast Milk Ejection [PE]</name>
		<code>N0000009858</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009858</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Breast Milk Ejection</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Glandular Development Alteration [PE]</name>
		<code>N0000008317</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008317</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Glandular Development Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Breast Glandular Development [PE]</name>
		<code>N0000009711</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009711</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Breast Glandular Development</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Breast Glandular Development [PE]</name>
		<code>N0000009857</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009857</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Breast Glandular Development</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Breast Milk Secretion [PE]</name>
		<code>N0000008319</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008319</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Breast Milk Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Breast Milk Secretion [PE]</name>
		<code>N0000009713</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009713</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Breast Milk Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Breast Milk Secretion [PE]</name>
		<code>N0000009859</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009859</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Breast Milk Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uterine Function Alteration [PE]</name>
		<code>N0000009897</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009897</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uterine Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uterine Proliferative Phase Alteration [PE]</name>
		<code>N0000009899</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009899</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uterine Proliferative Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Uterine Proliferative Phase [PE]</name>
		<code>N0000009720</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009720</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Uterine Proliferative Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Uterine Proliferative Phase [PE]</name>
		<code>N0000009866</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009866</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Uterine Proliferative Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uterine Menstrual Phase [PE]</name>
		<code>N0000009898</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009898</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uterine Menstrual Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Uterine Menstrual Phase [PE]</name>
		<code>N0000009719</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009719</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Uterine Menstrual Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Uterine Menstrual Phase [PE]</name>
		<code>N0000009865</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009865</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Uterine Menstrual Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Uterine Secretory Phase Alteration [PE]</name>
		<code>N0000009900</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009900</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Uterine Secretory Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Uterine Secretory Phase [PE]</name>
		<code>N0000009721</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009721</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Uterine Secretory Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Uterine Secretory Phase [PE]</name>
		<code>N0000009867</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009867</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Uterine Secretory Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vaginal Function Alteration [PE]</name>
		<code>N0000009902</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009902</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vaginal Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vaginal Secretion Alteration [PE]</name>
		<code>N0000009904</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009904</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vaginal Secretion Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Vaginal Secretion [PE]</name>
		<code>N0000009708</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009708</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Vaginal Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Vaginal Secretion [PE]</name>
		<code>N0000009017</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009017</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Vaginal Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Vaginal Muscle Tone Alteration [PE]</name>
		<code>N0000009903</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009903</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Vaginal Muscle Tone Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Vaginal Muscle Tone [PE]</name>
		<code>N0000009016</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009016</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Vaginal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Vaginal Muscle Tone [PE]</name>
		<code>N0000009707</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009707</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Vaginal Muscle Tone</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cervical Function Alteration [PE]</name>
		<code>N0000008354</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008354</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cervical Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cervical Dilation Alteration [PE]</name>
		<code>N0000008353</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008353</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cervical Dilation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Cervical Dilation [PE]</name>
		<code>N0000009247</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009247</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Cervical Dilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Cervical Dilation [PE]</name>
		<code>N0000008551</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008551</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Cervical Dilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ovarian Function Alteration [PE]</name>
		<code>N0000009779</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009779</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ovarian Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ovarian Follicular Phase Alteration [PE]</name>
		<code>N0000009778</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009778</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ovarian Follicular Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovarian Follicular Phase [PE]</name>
		<code>N0000009715</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009715</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Ovarian Follicular Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Ovarian Follicular Phase [PE]</name>
		<code>N0000009861</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009861</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Ovarian Follicular Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ovulation Alteration [PE]</name>
		<code>N0000009781</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009781</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ovulation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovulation [PE]</name>
		<code>N0000009717</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009717</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Ovulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Ovulation [PE]</name>
		<code>N0000009863</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009863</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Ovulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ovarian Luteal Phase Alteration [PE]</name>
		<code>N0000009780</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009780</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ovarian Luteal Phase Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inhibit Ovarian Luteal Phase [PE]</name>
		<code>N0000009716</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009716</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inhibit Ovarian Luteal Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Stimulate Ovarian Luteal Phase [PE]</name>
		<code>N0000009862</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009862</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Stimulate Ovarian Luteal Phase</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Special Sensory Systems Activity Alteration [PE]</name>
		<code>N0000009851</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009851</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Special Sensory Systems Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Intraocular Fluid Pressure Alteration [PE]</name>
		<code>N0000009942</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009942</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Intraocular Fluid Pressure Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Intraocular Fluid Pressure [PE]</name>
		<code>N0000009943</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009943</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Intraocular Fluid Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Intraocular Aqueous Secretion [PE]</name>
		<code>N0000009944</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009944</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Intraocular Aqueous Secretion</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Retinal Pigment Epithelium Alteration [PE]</name>
		<code>N0000193799</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193799</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Retinal Pigment Epithelium Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>RPE Alteration</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Retinal Pigment Epithelium Function [PE]</name>
		<code>N0000193798</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193798</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Retinal Pigment Epithelium Function</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased RPE Function</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ocular Smooth Muscle Activity Alteration [PE]</name>
		<code>N0000009768</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009768</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ocular Smooth Muscle Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pupillary Dilation [PE]</name>
		<code>N0000009820</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009820</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pupillary Dilation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Pupillary Constriction [PE]</name>
		<code>N0000009819</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009819</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Pupillary Constriction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hemic/Lymphatic Activity Alteration [PE]</name>
		<code>N0000009069</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009069</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hemic/Lymphatic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematologic Activity Alteration [PE]</name>
		<code>N0000009065</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009065</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematologic Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</name>
		<code>N0000008307</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008307</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood &amp; Lymphatic Fluid Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Intravascular Volume Alteration [PE]</name>
		<code>N0000009732</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009732</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Intravascular Volume Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Intravascular Volume [PE]</name>
		<code>N0000008669</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008669</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Intravascular Volume</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oxygen Carrying Capacity Alteration [PE]</name>
		<code>N0000009782</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009782</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oxygen Carrying Capacity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Oxygen Carrying Capacity [PE]</name>
		<code>N0000008771</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008771</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Oxygen Carrying Capacity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Oxygen Carrying Capacity [PE]</name>
		<code>N0000009463</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009463</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Oxygen Carrying Capacity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Oncotic Pressure Alteration [PE]</name>
		<code>N0000009769</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009769</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Oncotic Pressure Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Oncotic Pressure [PE]</name>
		<code>N0000008765</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008765</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Oncotic Pressure</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hemostasis Alteration [PE]</name>
		<code>N0000009070</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009070</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hemostasis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Platelet Aggregation Alteration [PE]</name>
		<code>N0000009807</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009807</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Platelet Aggregation Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fibrinolysis Alteration [PE]</name>
		<code>N0000175631</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175631</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fibrinolysis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrinolysis [PE]</name>
		<code>N0000175633</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175633</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Fibrinolysis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Endothelial Coagulation Activity Alteration [PE]</name>
		<code>N0000009039</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009039</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Endothelial Coagulation Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Endothelial Coagulation Activity [PE]</name>
		<code>N0000008598</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008598</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Endothelial Coagulation Activity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coagulation Activity Alteration [PE]</name>
		<code>N0000175977</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175977</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coagulation Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Coagulation Activity [PE]</name>
		<code>N0000175978</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175978</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-coagulation</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-coagulation Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticoagulation Activity</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Coagulation Activity</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticoagulation</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coagulation Factor Alteration [PE]</name>
		<code>N0000008363</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008363</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coagulation Factor Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coagulation Factor Activity Alteration [PE]</name>
		<code>N0000008362</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008362</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coagulation Factor Activity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Coagulation Factor Concentration Alteration [PE]</name>
		<code>N0000008364</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008364</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Coagulation Factor Concentration Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Coagulation Factor Concentration [PE]</name>
		<code>N0000008557</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008557</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Coagulation Factor Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor Concentration [PE]</name>
		<code>N0000009253</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009253</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor VII Concentration [PE]</name>
		<code>N0000184156</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184156</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor VII Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrin Concentration [PE]</name>
		<code>N0000184160</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184160</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Fibrin Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor IX Concentration [PE]</name>
		<code>N0000184157</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184157</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor IX Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Prothrombin Concentration [PE]</name>
		<code>N0000184161</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184161</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Prothrombin Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Fibrinogen Concentration [PE]</name>
		<code>N0000184159</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184159</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Fibrinogen Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Coagulation Factor X Concentration [PE]</name>
		<code>N0000184158</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184158</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Coagulation Factor X Concentration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematological Cell Function Alteration [PE]</name>
		<code>N0000175626</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175626</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematological Cell Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Monocyte Function Alteration [PE]</name>
		<code>N0000183882</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183882</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Monocyte Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Monocyte Activation [PE]</name>
		<code>N0000183883</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000183883</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Monocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Mast Cell Function Alteration [PE]</name>
		<code>N0000175627</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175627</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Mast Cell Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Function Alteration [PE]</name>
		<code>N0000178327</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178327</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lymphocyte Activation [PE]</name>
		<code>N0000178329</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178329</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lymphocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased T Lymphocyte Activation [PE]</name>
		<code>N0000182155</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182155</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased T Lymphocyte Activation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Lymphocyte Activity Modulation [PE]</name>
		<code>N0000182152</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182152</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Lymphocyte Activity Modulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>T Lymphocyte Activity Modulation [PE]</name>
		<code>N0000182153</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000182153</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>T Lymphocyte Activity Modulation</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematopoietic Stem Cell Function Alteration [PE]</name>
		<code>N0000178323</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178323</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematopoietic Stem Cell Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Hematopoietic Stem Cell Mobilization [PE]</name>
		<code>N0000178325</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178325</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Hematopoietic Stem Cell Mobilization</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Erythrocyte Function Alteration [PE]</name>
		<code>N0000193978</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193978</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Erythrocyte Function Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hemorrheologic Alteration [PE]</name>
		<code>N0000175892</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175892</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hemorrheologic Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Blood Viscosity [PE]</name>
		<code>N0000175894</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000175894</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Blood Viscosity</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematological Cell Quantity Alteration [PE]</name>
		<code>N0000009067</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009067</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematological Cell Quantity Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematological Cell Destruction Alteration [PE]</name>
		<code>N0000009066</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009066</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematological Cell Destruction Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Hematological Cell Destruction [PE]</name>
		<code>N0000008655</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008655</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Hematological Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Erythroid Cell Destruction [PE]</name>
		<code>N0000008624</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008624</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Erythroid Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lymphocyte Cell Destruction [PE]</name>
		<code>N0000008698</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008698</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lymphocyte Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased T Lymphocyte Destruction [PE]</name>
		<code>N0000008997</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008997</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased T Lymphocyte Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased B Lymphocyte Destruction [PE]</name>
		<code>N0000008417</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008417</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased B Lymphocyte Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Megakaryocte Cell Destruction [PE]</name>
		<code>N0000008702</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008702</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Megakaryocte Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Myeloid Cell Destruction [PE]</name>
		<code>N0000008758</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008758</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Myeloid Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Granulocytic Cell Destruction [PE]</name>
		<code>N0000008653</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008653</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Granulocytic Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Monocytic Cell Destruction [PE]</name>
		<code>N0000008733</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008733</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Monocytic Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Hematological Cell Destruction [PE]</name>
		<code>N0000009349</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009349</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Hematological Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Megakaryocte Cell Destruction [PE]</name>
		<code>N0000009394</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009394</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Megakaryocte Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Lymphocyte Cell Destruction [PE]</name>
		<code>N0000009390</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009390</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Lymphocyte Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased T Lymphocyte Destruction [PE]</name>
		<code>N0000009689</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009689</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased T Lymphocyte Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased B Lymphocyte Destruction [PE]</name>
		<code>N0000009113</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009113</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased B Lymphocyte Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Erythroid Cell Destruction [PE]</name>
		<code>N0000009318</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009318</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Erythroid Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Myeloid Cell Destruction [PE]</name>
		<code>N0000009450</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009450</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Myeloid Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Monocytic Cell Destruction [PE]</name>
		<code>N0000009425</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009425</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Monocytic Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Granulocytic Cell Destruction [PE]</name>
		<code>N0000009347</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009347</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Granulocytic Cell Destruction</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hematopoiesis Alteration [PE]</name>
		<code>N0000009068</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009068</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hematopoiesis Alteration</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Hematopoiesis [PE]</name>
		<code>N0000009350</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009350</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Hematopoiesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Increased Megakaryocte Cell Production [PE]</name>
		<code>N0000009395</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000009395</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Increased Megakaryocte Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Hematopoiesis [PE]</name>
		<code>N0000008656</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008656</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Hematopoiesis</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Lymphocyte Cell Production [PE]</name>
		<code>N0000008699</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008699</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Lymphocyte Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased B Lymphocyte Production [PE]</name>
		<code>N0000008418</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008418</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased B Lymphocyte Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased T Lymphocyte Production [PE]</name>
		<code>N0000008998</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008998</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased T Lymphocyte Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Megakaryocte Cell Production [PE]</name>
		<code>N0000008703</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008703</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Megakaryocte Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Myeloid Cell Production [PE]</name>
		<code>N0000008759</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008759</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Myeloid Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Granulocytic Cell Production [PE]</name>
		<code>N0000008654</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008654</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Granulocytic Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Monocytic Cell Production [PE]</name>
		<code>N0000008734</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008734</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Monocytic Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Decreased Erythroid Cell Production [PE]</name>
		<code>N0000008625</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>PE</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000008625</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Decreased Erythroid Cell Production</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Terminology Extensions for Classification [EXT]</name>
		<code>N0000193784</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>HC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193784</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Terminology Extensions for Classification</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Grain Proteins [EXT]</name>
		<code>N0000185016</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185016</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Grain Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Virus-specific Hyperimmune Globulins [EXT]</name>
		<code>N0000184152</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000184152</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Virus-specific Hyperimmune Globulins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Poultry Proteins [EXT]</name>
		<code>N0000185018</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185018</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Poultry Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fish Proteins, Dietary [EXT]</name>
		<code>N0000185014</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185014</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fish Proteins, Dietary</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Fruit Proteins [EXT]</name>
		<code>N0000185015</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185015</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Fruit Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Nut Proteins [EXT]</name>
		<code>N0000185019</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185019</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Nut Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Shellfish Proteins [EXT]</name>
		<code>N0000185020</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185020</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Shellfish Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Meat Proteins [EXT]</name>
		<code>N0000185017</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000185017</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Meat Proteins</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Current Non-smoker [EXT]</name>
		<code>N0000010308</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>EXT</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000010308</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Current Non-smoker</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Therapeutic Categories [TC]</name>
		<code>N0000178293</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178293</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Therapeutic Categories</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antispasticity Agents [TC]</name>
		<code>N0000193817</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193817</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antispasticity Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Gastrointestinal Agent [TC]</name>
		<code>N0000178370</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178370</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Gastrointestinal Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anxiolytics [TC]</name>
		<code>N0000193818</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193818</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anxiolytics</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antiparkinson Agents [TC]</name>
		<code>N0000193816</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193816</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiparkinson Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Enzyme Replacements/Modifiers [TC]</name>
		<code>N0000193824</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193824</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Enzyme Replacements/Modifiers</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Otic Agents [TC]</name>
		<code>N0000193841</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193841</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Otic Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anticonvulsants [TC]</name>
		<code>N0000193811</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193811</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anticonvulsants</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimyasthenic Agents [TC]</name>
		<code>N0000193815</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193815</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimyasthenic Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood Glucose Regulators [TC]</name>
		<code>N0000193820</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193820</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood Glucose Regulators</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Ophthalmic Agents [TC]</name>
		<code>N0000193840</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193840</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Ophthalmic Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antineoplastic Agent [TC]</name>
		<code>N0000178307</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178307</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antineoplastic Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antineoplastic</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Analgesics [TC]</name>
		<code>N0000193809</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193809</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Analgesics</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Respiratory System Agent [TC]</name>
		<code>N0000178318</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178318</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Respiratory System Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant [TC]</name>
		<code>N0000193836</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193836</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Suppressant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Parathyroid) [TC]</name>
		<code>N0000193832</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193832</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Suppressant (Parathyroid)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Pituitary) [TC]</name>
		<code>N0000193833</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193833</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Suppressant (Pituitary)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</name>
		<code>N0000193834</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193834</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Suppressant (Thyroid) [TC]</name>
		<code>N0000193835</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193835</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Suppressant (Thyroid)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Central Nervous System Agent [TC]</name>
		<code>N0000178312</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178312</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Central Nervous System Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>CNS Agent</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Immunological Agents [TC]</name>
		<code>N0000193837</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193837</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Immunological Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Inflammatory Bowel Disease Agents [TC]</name>
		<code>N0000193838</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193838</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Inflammatory Bowel Disease Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antimigraine Agents [TC]</name>
		<code>N0000193814</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193814</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antimigraine Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-infective Agent [TC]</name>
		<code>N0000178295</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178295</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiinfective</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-infective Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-infective</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Blood Products/Modifiers/Volume Expanders [TC]</name>
		<code>N0000193821</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193821</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Blood Products/Modifiers/Volume Expanders</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant [TC]</name>
		<code>N0000193826</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193826</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Stimulant</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</name>
		<code>N0000193828</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193828</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</name>
		<code>N0000193830</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193830</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</name>
		<code>N0000193831</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193831</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</name>
		<code>N0000193827</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193827</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins) [TC]</name>
		<code>N0000193829</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193829</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antidementia Agents [TC]</name>
		<code>N0000193812</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193812</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antidementia Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Cardiovascular Agent [TC]</name>
		<code>N0000178309</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178309</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Cardiovascular Agent</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dental and Oral Agents [TC]</name>
		<code>N0000193822</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193822</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dental and Oral Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</name>
		<code>N0000193844</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193844</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Therapeutic Nutrients/Minerals/Electrolytes</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anti-inflammatory Agent [TC]</name>
		<code>N0000178306</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000178306</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-inflammatory Agent</to_name>
			<preferred>true</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antiinflammatory</to_name>
			<preferred>false</preferred>
		</synonym>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Synonym</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anti-inflammatory</to_name>
			<preferred>false</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Bipolar Agents [TC]</name>
		<code>N0000193819</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193819</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Bipolar Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Skeletal Muscle Relaxants [TC]</name>
		<code>N0000193843</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193843</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Skeletal Muscle Relaxants</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Sedatives/Hypnotics [TC]</name>
		<code>N0000193842</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193842</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Sedatives/Hypnotics</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Metabolic Bone Disease Agents [TC]</name>
		<code>N0000193839</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193839</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Metabolic Bone Disease Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Antigout Agents [TC]</name>
		<code>N0000193813</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193813</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Antigout Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Genitourinary Agents [TC]</name>
		<code>N0000193825</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193825</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Genitourinary Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Anesthetics [TC]</name>
		<code>N0000193810</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193810</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Anesthetics</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<concept>
		<namespace>MED-RT</namespace>
		<name>Dermatological Agents [TC]</name>
		<code>N0000193823</code>
		<status>A</status>
		<property>
			<namespace>MED-RT</namespace>
			<name>CTY</name>
			<value>TC</value>
		</property>
		<property>
			<namespace>MED-RT</namespace>
			<name>NUI</name>
			<value>N0000193823</value>
		</property>
		<synonym>
			<namespace>MED-RT</namespace>
			<name>Preferred Term</name>
			<to_namespace>MED-RT</to_namespace>
			<to_name>Dermatological Agents</to_name>
			<preferred>true</preferred>
		</synonym>
	</concept>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitors [MoA]</to_name>
		<to_code>N0000194022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
		<to_code>N0000000254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular or Molecular Interactions [MoA]</from_name>
		<from_code>N0000000223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Membrane Transporter Interactions [MoA]</to_name>
		<to_code>N0000188367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone sodium sulfate</from_name>
		<from_code>1366962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular or Molecular Interactions [MoA]</to_name>
		<to_code>N0000000223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone</from_name>
		<from_code>3143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular or Molecular Interactions [MoA]</to_name>
		<to_code>N0000000223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kelp preparation</from_name>
		<from_code>285155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular or Molecular Interactions [MoA]</to_name>
		<to_code>N0000000223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ezetimibe</from_name>
		<from_code>341248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular or Molecular Interactions [MoA]</to_name>
		<to_code>N0000000223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agalsidase beta</from_name>
		<from_code>338817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular or Molecular Interactions [MoA]</to_name>
		<to_code>N0000000223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resorcinol</from_name>
		<from_code>35382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular or Molecular Interactions [MoA]</to_name>
		<to_code>N0000000223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selinexor</from_name>
		<from_code>2178390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitors [MoA]</to_name>
		<to_code>N0000194022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nuclear Export Inhibitor [EPC]</from_name>
		<from_code>N0000194021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitors [MoA]</to_name>
		<to_code>N0000194022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric subsulfate solution</from_name>
		<from_code>24912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecylenate</from_name>
		<from_code>314881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifarotene</from_name>
		<from_code>2205637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet cation</from_name>
		<from_code>1546369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antipyrine</from_name>
		<from_code>1001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Limosilactobacillus reuteri</from_name>
		<from_code>285156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>senna concentrate</from_name>
		<from_code>219860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus acidophilus</from_name>
		<from_code>6205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isotretinoin</from_name>
		<from_code>6064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin alfa</from_name>
		<from_code>4952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybate</from_name>
		<from_code>2387302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodinated glycerol</from_name>
		<from_code>27723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer free acid</from_name>
		<from_code>2710444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edaravone</from_name>
		<from_code>1921877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine</from_name>
		<from_code>3022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus crispatus</from_name>
		<from_code>2054188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate potassium chloride</from_name>
		<from_code>1789517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pregabalin</from_name>
		<from_code>187832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic</from_name>
		<from_code>1111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclosan</from_name>
		<from_code>10795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar extract</from_name>
		<from_code>90735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium perborate</from_name>
		<from_code>36702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fecal microbiota spores, live-brpk</from_name>
		<from_code>2636536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium permanganate</from_name>
		<from_code>8604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gotu kola extract</from_name>
		<from_code>319837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benznidazole</from_name>
		<from_code>18994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium undecylenate</from_name>
		<from_code>1744166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1a</from_name>
		<from_code>75917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin</from_name>
		<from_code>6398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (1500 MPA.S at 1%)</from_name>
		<from_code>1312606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>borage oil</from_name>
		<from_code>68905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentosan polysulphate sodium</from_name>
		<from_code>134413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 6000</from_name>
		<from_code>1314384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium benzoate</from_name>
		<from_code>56455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus delbrueckii subsp. bulgaricus</from_name>
		<from_code>100272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phensuximide</from_name>
		<from_code>33309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium fluoride f-18</from_name>
		<from_code>1311495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revakinagene taroretcel-lwey</from_name>
		<from_code>2708831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactobacillic acid</from_name>
		<from_code>2002583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil, light</from_name>
		<from_code>577312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha,alpha-dibromo-d-camphor</from_name>
		<from_code>1858362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (2000 CPS at 1%)</from_name>
		<from_code>1299925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lifileucel</from_name>
		<from_code>2675860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium perborate tetrahydrate</from_name>
		<from_code>2104324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revakinagene taroretcel</from_name>
		<from_code>2708830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acidulated phosphate fluoride</from_name>
		<from_code>236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine hydrochloride</from_name>
		<from_code>57555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlorofluoromethane</from_name>
		<from_code>38578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calamine</from_name>
		<from_code>106212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trypsin</from_name>
		<from_code>10890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadexomer iodine</from_name>
		<from_code>20012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirfenidone</from_name>
		<from_code>1592254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic trioxide</from_name>
		<from_code>18330</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypochlorite</from_name>
		<from_code>9881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine bitartrate</from_name>
		<from_code>81990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, bovine</from_name>
		<from_code>2264114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat's claw preparation</from_name>
		<from_code>285223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxybate</from_name>
		<from_code>2387308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine</from_name>
		<from_code>5933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecylenic acid</from_name>
		<from_code>10989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K3</from_name>
		<from_code>6728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose</from_name>
		<from_code>27244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon beta-1a</from_name>
		<from_code>1546168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fecal microbiota spores, live</from_name>
		<from_code>2636537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone</from_name>
		<from_code>3143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver sulfadiazine</from_name>
		<from_code>9793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felbamate</from_name>
		<from_code>24812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etretinate</from_name>
		<from_code>4182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alefacept</from_name>
		<from_code>299635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>helium</from_name>
		<from_code>5140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sennosides, USP</from_name>
		<from_code>36387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boric acid</from_name>
		<from_code>1700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin alfa</from_name>
		<from_code>1367075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursodiol</from_name>
		<from_code>11065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet</from_name>
		<from_code>4778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide acetate</from_name>
		<from_code>2176311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanidine</from_name>
		<from_code>50675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>birch triterpenes</from_name>
		<from_code>2675583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorine</from_name>
		<from_code>1310123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paraldehyde</from_name>
		<from_code>7909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sul hemipenthy</from_name>
		<from_code>259379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (5000 CPS at 1%)</from_name>
		<from_code>1307084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactase</from_name>
		<from_code>41397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium nitrate</from_name>
		<from_code>25544</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitotane</from_name>
		<from_code>7004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin hydrochloride</from_name>
		<from_code>82036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar</from_name>
		<from_code>2635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor oil</from_name>
		<from_code>1297880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plerixafor</from_name>
		<from_code>733003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous fluoride</from_name>
		<from_code>10030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Astragalus preparation</from_name>
		<from_code>319818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine maleate</from_name>
		<from_code>860647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perfluorohexyloctane</from_name>
		<from_code>2637547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormezanone</from_name>
		<from_code>2373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 1000</from_name>
		<from_code>1368863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sennoside A&amp;B, calcium salt</from_name>
		<from_code>267741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium oxybate</from_name>
		<from_code>2387307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine</from_name>
		<from_code>3409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide phosphate</from_name>
		<from_code>203178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanidine hydrochloride</from_name>
		<from_code>50676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Limosilactobacillus reuteri subsp. reuteri F275</from_name>
		<from_code>2668424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazinamide</from_name>
		<from_code>8987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crotamiton</from_name>
		<from_code>21766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine</from_name>
		<from_code>7895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextranomer</from_name>
		<from_code>22708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lacticaseibacillus rhamnosus GG</from_name>
		<from_code>602811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil</from_name>
		<from_code>6972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus helveticus</from_name>
		<from_code>1310845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactiplantibacillus plantarum</from_name>
		<from_code>1673942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobenzone</from_name>
		<from_code>17145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium aminobenzoate</from_name>
		<from_code>142141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levetiracetam</from_name>
		<from_code>114477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyacetone</from_name>
		<from_code>3430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlexanox</from_name>
		<from_code>46307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lasmiditan</from_name>
		<from_code>2256930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrogen</from_name>
		<from_code>7456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactic acid</from_name>
		<from_code>28393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenugreek seed meal</from_name>
		<from_code>282436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodoquinol</from_name>
		<from_code>3435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchiceine</from_name>
		<from_code>2174385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podofilox</from_name>
		<from_code>8463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine hydrochloride</from_name>
		<from_code>203197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica sinensis preparation</from_name>
		<from_code>328141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinamate</from_name>
		<from_code>24474</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin</from_name>
		<from_code>2399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 8000</from_name>
		<from_code>1307312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide</from_name>
		<from_code>41289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine</from_name>
		<from_code>3820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenol</from_name>
		<from_code>33290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus bifidus</from_name>
		<from_code>236855</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (4000 CPS at 1%)</from_name>
		<from_code>1307036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine hydrochloride</from_name>
		<from_code>82027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diroximel fumarate</from_name>
		<from_code>2261783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omega-3 fatty acids</from_name>
		<from_code>4301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea preparation</from_name>
		<from_code>228041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine succinate</from_name>
		<from_code>2054091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linolenic acid</from_name>
		<from_code>52071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1b</from_name>
		<from_code>72257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar pitch volatiles</from_name>
		<from_code>90732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin microsphere</from_name>
		<from_code>221175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamabrom</from_name>
		<from_code>54365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine hydrochloride</from_name>
		<from_code>203132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>devil's claw preparation</from_name>
		<from_code>236279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenugreek seed preparation</from_name>
		<from_code>360375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyllin copper complex</from_name>
		<from_code>82242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sulfate</from_name>
		<from_code>235959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine</from_name>
		<from_code>34347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clioquinol</from_name>
		<from_code>5942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium oxybate</from_name>
		<from_code>2387309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>witch hazel</from_name>
		<from_code>89821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parachlorophenol</from_name>
		<from_code>14982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine</from_name>
		<from_code>5470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>standardized enzyme lactase</from_name>
		<from_code>221165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentoxifylline</from_name>
		<from_code>8013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactiplantibacillus plantarum 299</from_name>
		<from_code>2706643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine</from_name>
		<from_code>4845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine hydrochloride</from_name>
		<from_code>82015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane</from_name>
		<from_code>42736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ingenol mebutate</from_name>
		<from_code>1242806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor (natural)</from_name>
		<from_code>1298738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin</from_name>
		<from_code>10753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide</from_name>
		<from_code>2176312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin carbamate</from_name>
		<from_code>20880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, human</from_name>
		<from_code>825006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milk thistle extract</from_name>
		<from_code>283579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>feverfew extract</from_name>
		<from_code>114203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer sodium</from_name>
		<from_code>2710445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane hydrochloride</from_name>
		<from_code>1294534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelaic acid</from_name>
		<from_code>18602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine</from_name>
		<from_code>8120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 4000</from_name>
		<from_code>1310594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 200</from_name>
		<from_code>1368864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginseng preparation</from_name>
		<from_code>325526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bexarotene</from_name>
		<from_code>233272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium lactate</from_name>
		<from_code>215247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate hydrochloride</from_name>
		<from_code>235398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus acidophilus BCMC 12130</from_name>
		<from_code>2639942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine codecarboxylate</from_name>
		<from_code>158387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethosuximide</from_name>
		<from_code>4135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trofinetide</from_name>
		<from_code>2632852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide acetate</from_name>
		<from_code>6573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc undecylenate</from_name>
		<from_code>89748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitroprusside</from_name>
		<from_code>9895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer</from_name>
		<from_code>2710434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heavy mineral oil</from_name>
		<from_code>258439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium oxybate</from_name>
		<from_code>9899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen peroxide</from_name>
		<from_code>5499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor</from_name>
		<from_code>1952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium undecylenate</from_name>
		<from_code>89746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone sodium sulfate</from_name>
		<from_code>1366962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine hydrochloride</from_name>
		<from_code>1426886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine hydrochloride</from_name>
		<from_code>236608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methsuximide</from_name>
		<from_code>47858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus</from_name>
		<from_code>6204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ligilactobacillus salivarius</from_name>
		<from_code>2110033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon</from_name>
		<from_code>11363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloperidone</from_name>
		<from_code>73178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloral hydrate</from_name>
		<from_code>2344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium fluoride</from_name>
		<from_code>9873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talc</from_name>
		<from_code>10323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liquefied phenol</from_name>
		<from_code>239351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl chloride</from_name>
		<from_code>4141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide</from_name>
		<from_code>3541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate</from_name>
		<from_code>4847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lacticaseibacillus rhamnosus</from_name>
		<from_code>100278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia spirit, aromatic</from_name>
		<from_code>317201</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lacticaseibacillus casei</from_name>
		<from_code>1592255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide fumarate</from_name>
		<from_code>51256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone tosylate</from_name>
		<from_code>2275731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous iodide</from_name>
		<from_code>1720256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone</from_name>
		<from_code>1827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxamniquine</from_name>
		<from_code>7778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin</from_name>
		<from_code>10528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous fluoride dihydrate</from_name>
		<from_code>1311371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone</from_name>
		<from_code>2275602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 20000</from_name>
		<from_code>1747569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
		<to_code>N0000009915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
		<from_code>N0000000254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
		<to_code>N0000010255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
		<from_code>N0000000254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Interactions [MoA]</to_name>
		<to_code>N0000020089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
		<from_code>N0000000254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
		<from_code>N0000000254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Capsid Inhibitors [MoA]</to_name>
		<to_code>N0000194086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
		<from_code>N0000000254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olaratumab</from_name>
		<from_code>1855735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
		<to_code>N0000000254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
		<to_code>N0000000254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
		<to_code>N0000000254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular Structure Molecule Interactions [MoA]</from_name>
		<from_code>N0000010255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
		<to_code>N0000010255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
		<to_code>N0000010255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
		<to_code>N0000010255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tubulin Interactions [MoA]</from_name>
		<from_code>N0000010256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin mesylate</from_name>
		<from_code>1045452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebendazole</from_name>
		<from_code>6672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine sulfate</from_name>
		<from_code>11203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine</from_name>
		<from_code>11202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin</from_name>
		<from_code>1045453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albendazole</from_name>
		<from_code>430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel protein-bound</from_name>
		<from_code>486610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel</from_name>
		<from_code>56946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Tubulin Interactions [MoA]</to_name>
		<to_code>N0000010260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Viral Envelope Interactions [MoA]</from_name>
		<from_code>N0000020089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Viral Envelope Interactions [MoA]</from_name>
		<from_code>N0000020089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Interactions [MoA]</to_name>
		<to_code>N0000193861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fusion Protein Interactions [MoA]</from_name>
		<from_code>N0000175614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luspatercept-aamt</from_name>
		<from_code>2262543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp-erzs</from_name>
		<from_code>2109054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein</from_name>
		<from_code>2631084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luspatercept</from_name>
		<from_code>2262544</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotatercept</from_name>
		<from_code>2678930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp</from_name>
		<from_code>2109055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl</from_name>
		<from_code>2631083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotatercept-csrk</from_name>
		<from_code>2678931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Interactions [MoA]</to_name>
		<to_code>N0000175614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fusion Protein Inhibitors [MoA]</from_name>
		<from_code>N0000175615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Menin Inhibitors [MoA]</to_name>
		<to_code>N0000194140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fusion Protein Inhibitors [MoA]</from_name>
		<from_code>N0000175615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000181002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab-cfor</from_name>
		<from_code>2716803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palivizumab</from_name>
		<from_code>194279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revumenib</from_name>
		<from_code>2698325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revumenib citrate</from_name>
		<from_code>2698326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfuvirtide</from_name>
		<from_code>139896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirsevimab-alip</from_name>
		<from_code>2642402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab</from_name>
		<from_code>2716802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirsevimab</from_name>
		<from_code>2642401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziftomenib</from_name>
		<from_code>2725985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Menin Inhibitors [MoA]</to_name>
		<to_code>N0000194140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Menin Inhibitor [EPC]</from_name>
		<from_code>N0000194139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Menin Inhibitors [MoA]</to_name>
		<to_code>N0000194140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revumenib</from_name>
		<from_code>2698325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Menin Inhibitors [MoA]</to_name>
		<to_code>N0000194140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HIV Fusion Protein Inhibitors [MoA]</from_name>
		<from_code>N0000181002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
		<to_code>N0000193807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfuvirtide</from_name>
		<from_code>139896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000181002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
		<from_code>N0000175616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Fusion Protein Inhibitors [MoA]</to_name>
		<to_code>N0000181002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
		<to_code>N0000193807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
		<to_code>N0000193807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab-uiyk</from_name>
		<from_code>2043313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
		<to_code>N0000193807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
		<to_code>N0000193807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Viral Envelope Wrapping Protein Interactions [MoA]</from_name>
		<from_code>N0000193861</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
		<to_code>N0000193860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
		<to_code>N0000193860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat monohydrate</from_name>
		<from_code>2055677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
		<to_code>N0000193860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir sodium</from_name>
		<from_code>2625652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
		<to_code>N0000193860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticovirimat monohydrate</from_name>
		<from_code>2055103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
		<to_code>N0000193860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
		<to_code>N0000193860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium hemi-pentahydrate</from_name>
		<from_code>1356127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium monohydrate</from_name>
		<from_code>1356128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid anhydrous</from_name>
		<from_code>1546014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chloride hexahydrate</from_name>
		<from_code>17611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronic acid</from_name>
		<from_code>1546406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chloride anhydrous</from_name>
		<from_code>1608145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronic acid</from_name>
		<from_code>236083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid</from_name>
		<from_code>77655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chloride</from_name>
		<from_code>46241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronate</from_name>
		<from_code>57230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium</from_name>
		<from_code>60334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronic acid</from_name>
		<from_code>115265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate</from_name>
		<from_code>42682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate tetrasodium</from_name>
		<from_code>1364894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronic acid</from_name>
		<from_code>1356715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronate</from_name>
		<from_code>46041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate</from_name>
		<from_code>73056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronate</from_name>
		<from_code>115264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronate sodium</from_name>
		<from_code>236916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronate disodium</from_name>
		<from_code>83153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronate disodium</from_name>
		<from_code>105443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium anhydrous</from_name>
		<from_code>1926958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronate sodium</from_name>
		<from_code>203152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate disodium</from_name>
		<from_code>9872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medronate disodium</from_name>
		<from_code>317599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronate</from_name>
		<from_code>11473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bone Surface Interactions [MoA]</to_name>
		<to_code>N0000009958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Capsid Inhibitors [MoA]</to_name>
		<to_code>N0000194086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</from_name>
		<from_code>N0000194088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Capsid Inhibitors [MoA]</to_name>
		<to_code>N0000194086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Factor Interactions [MoA]</from_name>
		<from_code>N0000000082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Factor Interactions [MoA]</from_name>
		<from_code>N0000000082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Factor Interactions [MoA]</from_name>
		<from_code>N0000000082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inactivators [MoA]</to_name>
		<to_code>N0000000192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Factor Interactions [MoA]</from_name>
		<from_code>N0000000082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral and Cellular Immune Response Activators [MoA]</to_name>
		<to_code>N0000194153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrolyzed casein (enzymatic; 1000 MW)</from_name>
		<from_code>1812932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform L), recombinant</from_name>
		<from_code>2588217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform M), recombinant</from_name>
		<from_code>2588218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 1, human</from_name>
		<from_code>1316105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanolin alcohols</from_name>
		<from_code>1426478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinutuximab</from_name>
		<from_code>1606274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</from_name>
		<from_code>1440973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben sodium</from_name>
		<from_code>1311574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazolidinylurea</from_name>
		<from_code>1310602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hemophilus B polysaccharide</from_name>
		<from_code>314656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lyme Disease Vaccine</from_name>
		<from_code>214177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-chloro-2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben calcium</from_name>
		<from_code>1867698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben</from_name>
		<from_code>34706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butylparaben</from_name>
		<from_code>1306937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b</from_name>
		<from_code>50937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A vaccine (inactivated) strain HM175</from_name>
		<from_code>798361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hepatitis A Vaccine, Inactivated</from_name>
		<from_code>253174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talimogene laherparepvec</from_name>
		<from_code>1721264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bronopol</from_name>
		<from_code>1114345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidurea</from_name>
		<from_code>1368885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Factor Interactions [MoA]</to_name>
		<to_code>N0000000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</to_name>
		<to_code>N0000194161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Soluble Antigen Interactions [MoA]</to_name>
		<to_code>N0000191501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody Interactions [MoA]</from_name>
		<from_code>N0000010226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Antibody Interactions [MoA]</to_name>
		<to_code>N0000175985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</from_name>
		<from_code>1801767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizanlizumab-tmca</from_name>
		<from_code>2262421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</from_name>
		<from_code>2180337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab</from_name>
		<from_code>2387844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</from_name>
		<from_code>2380836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/WUH4618/2021 antigen</from_name>
		<from_code>2605725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>marstacimab-hncq</from_name>
		<from_code>2697132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Austria/1359417/2021 antigen</from_name>
		<from_code>2605039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen</from_name>
		<from_code>2687714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen</from_name>
		<from_code>2719300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</from_name>
		<from_code>1664171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</from_name>
		<from_code>2379531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/9/2014 antigen</from_name>
		<from_code>1723997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain</from_name>
		<from_code>1005929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</from_name>
		<from_code>1664172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pozelimab-bbfg</from_name>
		<from_code>2663939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptinezumab</from_name>
		<from_code>2282660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, RIT-4385 strain</from_name>
		<from_code>2603501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/46/2015 antigen</from_name>
		<from_code>1942125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen</from_name>
		<from_code>2688113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</from_name>
		<from_code>1427171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H3N2) antigen</from_name>
		<from_code>1657131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</from_name>
		<from_code>1666425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin-blmf</from_name>
		<from_code>2387833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</from_name>
		<from_code>1794331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spesolimab-sbzo</from_name>
		<from_code>2610418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen</from_name>
		<from_code>2642276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/122/2022 (H3N2) antigen</from_name>
		<from_code>2675569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Iowa/06/2017 antigen</from_name>
		<from_code>2056523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</from_name>
		<from_code>1928290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein</from_name>
		<from_code>2468231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imdevimab</from_name>
		<from_code>2465249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab-dgnb</from_name>
		<from_code>2478646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen</from_name>
		<from_code>2605723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Darwin/7/2019 antigen</from_name>
		<from_code>2380838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</from_name>
		<from_code>2177290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen</from_name>
		<from_code>2561244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin antibodies Fab fragments</from_name>
		<from_code>203223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</from_name>
		<from_code>2380834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</from_name>
		<from_code>2380837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</from_name>
		<from_code>2048564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Michigan/01/2021 antigen</from_name>
		<from_code>2593400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/7/2009 (H1N1) antigen</from_name>
		<from_code>1657331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen</from_name>
		<from_code>2562555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pozelimab</from_name>
		<from_code>2663938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Panama/45/90 antigen</from_name>
		<from_code>2262062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</from_name>
		<from_code>1664339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Phuket/3073/2013 antigen</from_name>
		<from_code>1657228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarucizumab</from_name>
		<from_code>1716191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab-mwge</from_name>
		<from_code>2391551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen</from_name>
		<from_code>2694005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus</from_name>
		<from_code>1491862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1)</from_name>
		<from_code>2722594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, attenuated Schwarz strain</from_name>
		<from_code>2603499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</from_name>
		<from_code>1657224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ROTAVIRUS VACCINE, LIVE</from_name>
		<from_code>253199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</from_name>
		<from_code>2380835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Colorado/06/2017 antigen</from_name>
		<from_code>2054177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus antigen</from_name>
		<from_code>1657134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/60/2008 antigen</from_name>
		<from_code>1657226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vibrio cholerae CVD 103-HGR strain live antigen</from_name>
		<from_code>1812935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus strain CR 326F antigen, inactivated</from_name>
		<from_code>2274413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen</from_name>
		<from_code>2564395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Maryland/15/2016 antigen</from_name>
		<from_code>2048563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Victoria/705/2018 antigen</from_name>
		<from_code>2380575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</from_name>
		<from_code>1928528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen</from_name>
		<from_code>2479040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1)</from_name>
		<from_code>2722617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen</from_name>
		<from_code>2593854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</from_name>
		<from_code>1666421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</from_name>
		<from_code>1663632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</from_name>
		<from_code>1946964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</from_name>
		<from_code>2180338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</from_name>
		<from_code>2380574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 4</from_name>
		<from_code>2197293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</from_name>
		<from_code>2177291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>marstacimab</from_name>
		<from_code>2697133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizanlizumab</from_name>
		<from_code>2262279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>datopotamab deruxtecan</from_name>
		<from_code>2703033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Utah/9/2014 antigen</from_name>
		<from_code>1657133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</from_name>
		<from_code>2056525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</from_name>
		<from_code>1928289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spesolimab</from_name>
		<from_code>2610417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etesevimab</from_name>
		<from_code>2477854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</from_name>
		<from_code>1657222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen</from_name>
		<from_code>2686166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tick-borne encephalitis purified antigen</from_name>
		<from_code>2583637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen</from_name>
		<from_code>2708995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab</from_name>
		<from_code>2478335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>datopotamab deruxtecan-dlnk</from_name>
		<from_code>2703034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</from_name>
		<from_code>1657130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 7 vaccine live</from_name>
		<from_code>1099937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</from_name>
		<from_code>1663630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 1</from_name>
		<from_code>2197290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen</from_name>
		<from_code>2630221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen</from_name>
		<from_code>2641622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cholera Vaccine</from_name>
		<from_code>2427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Washington/02/2019 antigen</from_name>
		<from_code>2280293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab</from_name>
		<from_code>2391541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin</from_name>
		<from_code>2387834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 3</from_name>
		<from_code>2197292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1)</from_name>
		<from_code>2722424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</from_name>
		<from_code>2056521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casirivimab</from_name>
		<from_code>2465242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab</from_name>
		<from_code>2472152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 4 vaccine live</from_name>
		<from_code>1099933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 2</from_name>
		<from_code>2197291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen</from_name>
		<from_code>2717943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</from_name>
		<from_code>2379530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab-mtci</from_name>
		<from_code>2708340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen</from_name>
		<from_code>2605724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain</from_name>
		<from_code>1006250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</from_name>
		<from_code>1657127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen</from_name>
		<from_code>2641877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen</from_name>
		<from_code>2562554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen</from_name>
		<from_code>2607735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen</from_name>
		<from_code>2562553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H1N1) antigen</from_name>
		<from_code>1657128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hong Kong/259/2010 antigen</from_name>
		<from_code>1801603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen</from_name>
		<from_code>2645084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</from_name>
		<from_code>2280296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab-zykl</from_name>
		<from_code>2472151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen</from_name>
		<from_code>2605083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab</from_name>
		<from_code>2708333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen</from_name>
		<from_code>2720359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen</from_name>
		<from_code>2388136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptinezumab-jjmr</from_name>
		<from_code>2283045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody Interactions [MoA]</to_name>
		<to_code>N0000010226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lecanemab</from_name>
		<from_code>2626143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lecanemab-irmb</from_name>
		<from_code>2626142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donanemab</from_name>
		<from_code>2687966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amyloid Beta-directed Antibody [EPC]</from_name>
		<from_code>N0000193951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donanemab-azbt</from_name>
		<from_code>2687965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific HER2-directed Antibody [EPC]</from_name>
		<from_code>N0000194137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanidatamab</from_name>
		<from_code>2698198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</from_name>
		<from_code>N0000194160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</to_name>
		<to_code>N0000194161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab</from_name>
		<from_code>2708333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</to_name>
		<to_code>N0000194161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Soluble Antigen Interactions [MoA]</from_name>
		<from_code>N0000191501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
		<to_code>N0000191002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
		<from_code>N0000191002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
		<from_code>N0000191002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
		<from_code>N0000191002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
		<from_code>N0000191002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab</from_name>
		<from_code>2268307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
		<to_code>N0000191002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bamlanivimab</from_name>
		<from_code>2463114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
		<to_code>N0000191002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab vedotin-ejfv</from_name>
		<from_code>2268306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
		<to_code>N0000191002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab vedotin</from_name>
		<from_code>2277607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
		<to_code>N0000191002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</from_name>
		<from_code>1427020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 31 vaccine</from_name>
		<from_code>1596930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
		<from_code>N0000182637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</from_name>
		<from_code>1301887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab-xiiy</from_name>
		<from_code>2626348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 45 vaccine</from_name>
		<from_code>1596932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</from_name>
		<from_code>1301885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 33 vaccine</from_name>
		<from_code>1596931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab</from_name>
		<from_code>2626349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 58 vaccine</from_name>
		<from_code>1596934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belimumab</from_name>
		<from_code>1092437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 52 vaccine</from_name>
		<from_code>1596933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimekizumab</from_name>
		<from_code>2668041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimekizumab-bkzx</from_name>
		<from_code>2668080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-adcd</from_name>
		<from_code>2627648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab</from_name>
		<from_code>595060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-tnjn</from_name>
		<from_code>2700660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-bvzr</from_name>
		<from_code>2268037</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab</from_name>
		<from_code>253337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-maly</from_name>
		<from_code>2599041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-nwgd</from_name>
		<from_code>2712044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab-nuna</from_name>
		<from_code>2602351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-awwb</from_name>
		<from_code>2046138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab-eqrn</from_name>
		<from_code>2612673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000178291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Antigen Interactions [MoA]</from_name>
		<from_code>N0000191502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Antigen Interactions [MoA]</from_name>
		<from_code>N0000191502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
		<to_code>N0000191498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teplizumab-mzwv</from_name>
		<from_code>2621881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idecabtagene vicleucel</from_name>
		<from_code>2536430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus</from_name>
		<from_code>1427211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacituzumab govitecan</from_name>
		<from_code>2360232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacituzumab</from_name>
		<from_code>2360231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teclistamab</from_name>
		<from_code>2619426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teclistamab-cqyv</from_name>
		<from_code>2619425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacituzumab govitecan-hziy</from_name>
		<from_code>2360530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teplizumab</from_name>
		<from_code>2621880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</from_name>
		<from_code>854930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
		<to_code>N0000191502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD30-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blockers [MoA]</to_name>
		<to_code>N0000194011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selectin Blockers [MoA]</to_name>
		<to_code>N0000194033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD86-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD52-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD11a-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD80-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
		<from_code>N0000020023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</from_name>
		<from_code>854974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</from_name>
		<from_code>854964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360571</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polatuzumab vedotin-piiq</from_name>
		<from_code>2174091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</from_name>
		<from_code>854944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</from_name>
		<from_code>854938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</from_name>
		<from_code>854956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen</from_name>
		<from_code>1593127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen</from_name>
		<from_code>1601231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</from_name>
		<from_code>854940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</from_name>
		<from_code>854972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen</from_name>
		<from_code>1593130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen</from_name>
		<from_code>1601233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</from_name>
		<from_code>854966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</from_name>
		<from_code>854952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</from_name>
		<from_code>2685002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>798279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle</from_name>
		<from_code>1601236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polatuzumab vedotin</from_name>
		<from_code>2174090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen</from_name>
		<from_code>1601232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</from_name>
		<from_code>854954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</from_name>
		<from_code>854936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</from_name>
		<from_code>854970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</from_name>
		<from_code>854962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</from_name>
		<from_code>854934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tarlatamab-dlle</from_name>
		<from_code>2682955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tarlatamab</from_name>
		<from_code>2682954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-strf</from_name>
		<from_code>2700714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit anti-human T-lymphocyte globulin</from_name>
		<from_code>107044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</from_name>
		<from_code>854958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</from_name>
		<from_code>854948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolbetuximab-clzb</from_name>
		<from_code>2695870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group B vaccine</from_name>
		<from_code>1593128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</from_name>
		<from_code>854932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lymphocyte immune globulin, anti-thymocyte globulin, equine</from_name>
		<from_code>91601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</from_name>
		<from_code>854960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolbetuximab</from_name>
		<from_code>2695869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</from_name>
		<from_code>854950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</from_name>
		<from_code>854942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymocyte immunoglobulin, equine</from_name>
		<from_code>1427177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</from_name>
		<from_code>854968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</from_name>
		<from_code>854946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
		<to_code>N0000020023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD33-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000175571</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemtuzumab ozogamicin</from_name>
		<from_code>1294580</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</from_name>
		<from_code>N0000194038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab</from_name>
		<from_code>2472152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD30-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000182967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD30-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brentuximab vedotin</from_name>
		<from_code>1147320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD30-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thymic Stromal Lymphopoietin Blocker [EPC]</from_name>
		<from_code>N0000194010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blockers [MoA]</to_name>
		<to_code>N0000194011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tezepelumab</from_name>
		<from_code>2587789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blockers [MoA]</to_name>
		<to_code>N0000194011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
		<from_code>N0000191421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000194013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blinatumomab</from_name>
		<from_code>1597258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafasitamab</from_name>
		<from_code>2387211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loncastuximab tesirine-lpyl</from_name>
		<from_code>2540965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inebilizumab</from_name>
		<from_code>2373951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisocabtagene maraleucel</from_name>
		<from_code>2479136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexucabtagene autoleucel</from_name>
		<from_code>2387277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inebilizumab-cdon</from_name>
		<from_code>2373950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafasitamab-cxix</from_name>
		<from_code>2387334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loncastuximab tesirine</from_name>
		<from_code>2540964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obecabtagene autoleucel</from_name>
		<from_code>2698195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alefacept</from_name>
		<from_code>299635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elotuzumab</from_name>
		<from_code>1726104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</from_name>
		<from_code>N0000192338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teclistamab</from_name>
		<from_code>2619426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp</from_name>
		<from_code>2590743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elranatamab</from_name>
		<from_code>2644880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosunetuzumab</from_name>
		<from_code>2625122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tarlatamab-dlle</from_name>
		<from_code>2682955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talquetamab-tgvs</from_name>
		<from_code>2644448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tarlatamab</from_name>
		<from_code>2682954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000194063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elranatamab-bcmm</from_name>
		<from_code>2644881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab-gcpt</from_name>
		<from_code>2719477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab-bysp</from_name>
		<from_code>2637395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teplizumab</from_name>
		<from_code>2621880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000193989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab</from_name>
		<from_code>2719416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosunetuzumab-axgb</from_name>
		<from_code>2625125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talquetamab</from_name>
		<from_code>2644447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab</from_name>
		<from_code>2637392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teclistamab-cqyv</from_name>
		<from_code>2619425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000194166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teplizumab-mzwv</from_name>
		<from_code>2621881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab-gxbm</from_name>
		<from_code>2639781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
		<from_code>N0000191421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blinatumomab</from_name>
		<from_code>1597258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cemiplimab</from_name>
		<from_code>2058826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nivolumab-nvhy</from_name>
		<from_code>2700791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atezolizumab</from_name>
		<from_code>1792776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nivolumab-rmbw</from_name>
		<from_code>2596770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atezolizumab-tqjs</from_name>
		<from_code>2693883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dostarlimab-gxly</from_name>
		<from_code>2539968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nivolumab</from_name>
		<from_code>1597876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penpulimab</from_name>
		<from_code>2712542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dostarlimab</from_name>
		<from_code>2539967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pembrolizumab</from_name>
		<from_code>1547545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cemiplimab-rwlc</from_name>
		<from_code>2058825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab-ipdl</from_name>
		<from_code>2717512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab</from_name>
		<from_code>2669406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab-tpzi</from_name>
		<from_code>2669407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retifanlimab</from_name>
		<from_code>2632981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab-jsgr</from_name>
		<from_code>2677425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penpulimab-kcqx</from_name>
		<from_code>2712646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab</from_name>
		<from_code>2677426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pembrolizumab-pmph</from_name>
		<from_code>2723753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab</from_name>
		<from_code>2717511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retifanlimab-dlwr</from_name>
		<from_code>2632980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selectin Blockers [MoA]</from_name>
		<from_code>N0000194033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Selectin Blockers [MoA]</to_name>
		<to_code>N0000194031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selectin Blocker [EPC]</from_name>
		<from_code>N0000194032</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selectin Blockers [MoA]</to_name>
		<to_code>N0000194033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizanlizumab</from_name>
		<from_code>2262279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Selectin Blockers [MoA]</to_name>
		<to_code>N0000194031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipilimumab</from_name>
		<from_code>1094833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tremelimumab</from_name>
		<from_code>2619313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tremelimumab-actl</from_name>
		<from_code>2619312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000182635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000193989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp</from_name>
		<from_code>2590743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab-jsgr</from_name>
		<from_code>2677425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>durvalumab</from_name>
		<from_code>1919503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab-ipdl</from_name>
		<from_code>2717512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab</from_name>
		<from_code>2717511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avelumab</from_name>
		<from_code>1875534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab</from_name>
		<from_code>2677426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotuzumab ozogamicin</from_name>
		<from_code>1942950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxetumomab pasudotox</from_name>
		<from_code>2099295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxetumomab pasudotox-tdfk</from_name>
		<from_code>2099305</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD22-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000193617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab</from_name>
		<from_code>2637392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-131-tositumomab</from_name>
		<from_code>234449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab-xiiy</from_name>
		<from_code>2626348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosunetuzumab-axgb</from_name>
		<from_code>2625125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-arrx</from_name>
		<from_code>2472325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofatumumab</from_name>
		<from_code>712566</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tositumomab</from_name>
		<from_code>263010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosunetuzumab</from_name>
		<from_code>2625122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab</from_name>
		<from_code>2626349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab-ocsq</from_name>
		<from_code>2693449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-pvvr</from_name>
		<from_code>2273510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Radiotherapeutic Antibody [EPC]</from_name>
		<from_code>N0000175658</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-abbs</from_name>
		<from_code>2105824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab-bysp</from_name>
		<from_code>2637395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab</from_name>
		<from_code>1876366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000194063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obinutuzumab</from_name>
		<from_code>974779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab-gxbm</from_name>
		<from_code>2639781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab</from_name>
		<from_code>121191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belatacept</from_name>
		<from_code>1112973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD86-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
		<from_code>N0000182830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD86-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD86-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
		<from_code>N0000182159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD86-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alemtuzumab</from_name>
		<from_code>117055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD52-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD52-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD52-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab-uiyk</from_name>
		<from_code>2043313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD4-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD11a-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efalizumab</from_name>
		<from_code>356988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD11a-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000194107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolbetuximab</from_name>
		<from_code>2695869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belatacept</from_name>
		<from_code>1112973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD80-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD80-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
		<from_code>N0000182830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD80-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
		<from_code>N0000182159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD80-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000182150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daratumumab</from_name>
		<from_code>1721947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isatuximab-irfc</from_name>
		<from_code>2282019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000192336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isatuximab</from_name>
		<from_code>2282018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daratumumab-fihj</from_name>
		<from_code>2375130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Surface Glycolipid Interactions [MoA]</from_name>
		<from_code>N0000191498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp</from_name>
		<from_code>2590743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
		<to_code>N0000191498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp-tebn</from_name>
		<from_code>2590744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
		<to_code>N0000191498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naxitamab</from_name>
		<from_code>2474039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
		<to_code>N0000191498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinutuximab</from_name>
		<from_code>1606274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naxitamab</from_name>
		<from_code>2474039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
		<from_code>N0000191500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000191005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon gamma Antagonists [MoA]</to_name>
		<to_code>N0000193855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Cell Maturation Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 4 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Activation Gene-3 Antagonists [MoA]</to_name>
		<to_code>N0000194002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Receptor Interactions [MoA]</from_name>
		<from_code>N0000009949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisotumab vedotin-tftv</from_name>
		<from_code>2571093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histoplasmin</from_name>
		<from_code>5363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibeprenlimab</from_name>
		<from_code>2728380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romosozumab-aqqg</from_name>
		<from_code>2123180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibeprenlimab-szsi</from_name>
		<from_code>2728394</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teclistamab-cqyv</from_name>
		<from_code>2619425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylpenicilloyl polylysine</from_name>
		<from_code>19079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efalizumab</from_name>
		<from_code>356988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin, human</from_name>
		<from_code>91603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tezepelumab</from_name>
		<from_code>2587789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efgartigimod alfa</from_name>
		<from_code>2587717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teprotumumab-trbw</from_name>
		<from_code>2274802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tezepelumab-ekko</from_name>
		<from_code>2587790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus</from_name>
		<from_code>1426911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teclistamab</from_name>
		<from_code>2619426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab</from_name>
		<from_code>2626349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caplacizumab-yhdp</from_name>
		<from_code>2110604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PERTUSSIS VACCINE,ADSORBED</from_name>
		<from_code>402543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-131-tositumomab</from_name>
		<from_code>234449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mogamulizumab</from_name>
		<from_code>2054068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab-mrkz</from_name>
		<from_code>2668385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirvetuximab soravtansine</from_name>
		<from_code>2621548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E</from_name>
		<from_code>1986821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab</from_name>
		<from_code>2668384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanidatamab-hrii</from_name>
		<from_code>2698200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guselkumab</from_name>
		<from_code>1928588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rho(D) immune globulin, human</from_name>
		<from_code>1789837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilobelimab</from_name>
		<from_code>2639620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narsoplimab-wuug</from_name>
		<from_code>2732292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alemtuzumab</from_name>
		<from_code>117055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanidatamab</from_name>
		<from_code>2698198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab</from_name>
		<from_code>2669406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mumps Vaccine</from_name>
		<from_code>763656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amivantamab-vmjw</from_name>
		<from_code>2549198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romosozumab</from_name>
		<from_code>2123126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nipocalimab</from_name>
		<from_code>2712693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narsoplimab</from_name>
		<from_code>2732291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-arrx</from_name>
		<from_code>2472325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemivibart</from_name>
		<from_code>2677789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amivantamab-lpuj</from_name>
		<from_code>2729288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab</from_name>
		<from_code>2596773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisotumab vedotin</from_name>
		<from_code>2571094</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fremanezumab-vfrm</from_name>
		<from_code>2056690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvalent Crotalidae antivenin</from_name>
		<from_code>91596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab-xiiy</from_name>
		<from_code>2626348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teprotumumab</from_name>
		<from_code>2274803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab</from_name>
		<from_code>121191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nipocalimab-aahu</from_name>
		<from_code>2712692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab-tpzi</from_name>
		<from_code>2669407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E, recombinant</from_name>
		<from_code>1986820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emapalumab-lzsg</from_name>
		<from_code>2104603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps skin test antigen</from_name>
		<from_code>89854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisotumab</from_name>
		<from_code>2571095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab vedotin-tllv</from_name>
		<from_code>2714236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab vedotin</from_name>
		<from_code>2721996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>equine diphtheria antitoxin</from_name>
		<from_code>91602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dostarlimab-gxly</from_name>
		<from_code>2539968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galcanezumab-gnlm</from_name>
		<from_code>2058868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin</from_name>
		<from_code>1727875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-pvvr</from_name>
		<from_code>2273510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria antitoxin</from_name>
		<from_code>3510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotrovimab</from_name>
		<from_code>2550731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fremanezumab</from_name>
		<from_code>2056691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tositumomab</from_name>
		<from_code>263010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efgartigimod alfa-qvfc</from_name>
		<from_code>2639944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab-rmbw</from_name>
		<from_code>2596772</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab</from_name>
		<from_code>2714237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirvetuximab soravtansine-gynx</from_name>
		<from_code>2621549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amivantamab</from_name>
		<from_code>2549199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caplacizumab</from_name>
		<from_code>2110605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galcanezumab</from_name>
		<from_code>2058846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efgartigimod alfa-fcab</from_name>
		<from_code>2587719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emapalumab</from_name>
		<from_code>2104604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dostarlimab</from_name>
		<from_code>2539967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody-Receptor Interactions [MoA]</to_name>
		<to_code>N0000009949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emapalumab</from_name>
		<from_code>2104604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon gamma Antagonists [MoA]</to_name>
		<to_code>N0000193855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000194166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Cell Maturation Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000194165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Activation Gene-3 Blocker [EPC]</from_name>
		<from_code>N0000194003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Activation Gene-3 Antagonists [MoA]</to_name>
		<to_code>N0000194002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab</from_name>
		<from_code>2596773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Activation Gene-3 Antagonists [MoA]</to_name>
		<to_code>N0000194002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-2 Receptor Blocking Antibody [EPC]</from_name>
		<from_code>N0000175622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclizumab</from_name>
		<from_code>190353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basiliximab</from_name>
		<from_code>196102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benralizumab</from_name>
		<from_code>1989100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000193803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000193802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antigen Neutralization [MoA]</from_name>
		<from_code>N0000184008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antigen Neutralization [MoA]</from_name>
		<from_code>N0000184008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Toxin Neutralization [MoA]</to_name>
		<to_code>N0000184011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antigen Neutralization [MoA]</from_name>
		<from_code>N0000184008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endogenous Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antigen Neutralization [MoA]</from_name>
		<from_code>N0000184008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin</from_name>
		<from_code>1727875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human) - hipp</from_name>
		<from_code>2167145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - ifas</from_name>
		<from_code>2102433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - dira</from_name>
		<from_code>2706382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human) - klhw</from_name>
		<from_code>2196290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human)</from_name>
		<from_code>617615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - stwk</from_name>
		<from_code>2672094</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulin G, human</from_name>
		<from_code>1426680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - slra</from_name>
		<from_code>2123035</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulin G</from_name>
		<from_code>5666</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - kthm</from_name>
		<from_code>2726012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin, human</from_name>
		<from_code>91603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2 (equine)</from_name>
		<from_code>2101270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2</from_name>
		<from_code>2101271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Centruroides (scorpion) immune F(ab')2 (equine)</from_name>
		<from_code>1119986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venom Neutralization [MoA]</to_name>
		<to_code>N0000184010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bacterial Toxin Neutralization [MoA]</from_name>
		<from_code>N0000184011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bacterial Toxin Neutralization [MoA]</from_name>
		<from_code>N0000184011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Toxin Neutralization [MoA]</to_name>
		<to_code>N0000184011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anthrax Vaccine Adsorbed</from_name>
		<from_code>404774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Toxin Neutralization [MoA]</to_name>
		<to_code>N0000184011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bezlotoxumab</from_name>
		<from_code>1855048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Toxin Neutralization [MoA]</to_name>
		<to_code>N0000184011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bacillus anthracis strain V770-NP1-R antigens</from_name>
		<from_code>1368371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Toxin Neutralization [MoA]</to_name>
		<to_code>N0000184011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obiltoxaximab</from_name>
		<from_code>1746906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raxibacumab</from_name>
		<from_code>1366567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthrax Protective Antigen-directed Antibody [EPC]</from_name>
		<from_code>N0000192703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthrax immune globulin</from_name>
		<from_code>1722336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthrax immune globulin, human</from_name>
		<from_code>1722335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000192702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin A immune FAB2, equine</from_name>
		<from_code>1722696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin G immune FAB2, equine</from_name>
		<from_code>1722706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin D immune FAB2, equine</from_name>
		<from_code>1722700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulism immune globulin IV human</from_name>
		<from_code>544488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin E immune FAB2</from_name>
		<from_code>1722703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin A immune FAB2</from_name>
		<from_code>1722697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin B immune FAB2, equine</from_name>
		<from_code>1722683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin F immune FAB2</from_name>
		<from_code>1722705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin E immune FAB2, equine</from_name>
		<from_code>1722702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin B immune FAB2</from_name>
		<from_code>1722684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin C immune FAB2, equine</from_name>
		<from_code>1722698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin F immune FAB2, equine</from_name>
		<from_code>1722704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin D immune FAB2</from_name>
		<from_code>1722701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin C immune FAB2</from_name>
		<from_code>1722699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin G immune FAB2</from_name>
		<from_code>1722707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
		<to_code>N0000184141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rho(D) immune globulin, human</from_name>
		<from_code>1789837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endogenous Antigen Neutralization [MoA]</to_name>
		<to_code>N0000184012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine, inactivated</from_name>
		<from_code>845525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bebtelovimab</from_name>
		<from_code>2592360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 1 (Mahoney)</from_name>
		<from_code>763096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 2 (MEF-1)</from_name>
		<from_code>763098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytomegalovirus immune globulin</from_name>
		<from_code>22178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytomegalovirus immune globulin, human</from_name>
		<from_code>1997443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</from_name>
		<from_code>1300779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human vaccinia immune globulin</from_name>
		<from_code>597392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B immune globulin</from_name>
		<from_code>26744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 3 (Saukett)</from_name>
		<from_code>763100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Virus Neutralization [MoA]</to_name>
		<to_code>N0000184009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody-Antibody Interactions [MoA]</from_name>
		<from_code>N0000175985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>IgE-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicilloyl polylysine</from_name>
		<from_code>2667743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>IgE-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omalizumab-igec</from_name>
		<from_code>2725997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>IgE-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-IgE [EPC]</from_name>
		<from_code>N0000175794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>IgE-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omalizumab</from_name>
		<from_code>302379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>IgE-directed Antibody Interactions [MoA]</to_name>
		<to_code>N0000175792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
		<to_code>N0000193337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Antagonists [MoA]</to_name>
		<to_code>N0000191004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000194122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonists [MoA]</to_name>
		<to_code>N0000193986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonists [MoA]</to_name>
		<to_code>N0000191494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonists [MoA]</to_name>
		<to_code>N0000191871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon Inducers [MoA]</to_name>
		<to_code>N0000000157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Response Modifiers [MoA]</from_name>
		<from_code>N0000000247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19 Receptor Interactions [MoA]</to_name>
		<to_code>N0000193544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remestemcel-L</from_name>
		<from_code>2700765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil sodium</from_name>
		<from_code>266663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-n3</from_name>
		<from_code>612937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciltacabtagene autoleucel</from_name>
		<from_code>2594775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golimumab</from_name>
		<from_code>819300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1b</from_name>
		<from_code>72257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab-ilto</from_name>
		<from_code>2691309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remestemcel-L-rknd</from_name>
		<from_code>2700764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil</from_name>
		<from_code>31563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1a</from_name>
		<from_code>75917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-txid</from_name>
		<from_code>2700365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab</from_name>
		<from_code>2691310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Response Modifiers [MoA]</to_name>
		<to_code>N0000000247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab</from_name>
		<from_code>2717511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
		<to_code>N0000193337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avelumab</from_name>
		<from_code>1875534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
		<to_code>N0000193337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
		<from_code>N0000193338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
		<to_code>N0000193337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>durvalumab</from_name>
		<from_code>1919503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
		<to_code>N0000193337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab-ipdl</from_name>
		<from_code>2717512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
		<to_code>N0000193337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Antagonist [EPC]</from_name>
		<from_code>N0000191006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Antagonists [MoA]</to_name>
		<to_code>N0000191004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>siltuximab</from_name>
		<from_code>1535218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Antagonists [MoA]</to_name>
		<to_code>N0000191004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polaprezinc</from_name>
		<from_code>2179843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Antagonists [MoA]</to_name>
		<to_code>N0000191004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab</from_name>
		<from_code>2691310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000194122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-31 Receptor alpha Antagonist [EPC]</from_name>
		<from_code>N0000194121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000194122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 31 Receptor Interactions [MoA]</from_name>
		<from_code>N0000194117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000194122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-12 Antagonist [EPC]</from_name>
		<from_code>N0000192797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonists [MoA]</to_name>
		<to_code>N0000192796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>faricimab-svoa</from_name>
		<from_code>2591584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-mrbb</from_name>
		<from_code>2706479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-maly</from_name>
		<from_code>2599041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-nwgd</from_name>
		<from_code>2712044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-ayyh</from_name>
		<from_code>2696256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-adcd</from_name>
		<from_code>2627648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziv-aflibercept</from_name>
		<from_code>1304475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-yszy</from_name>
		<from_code>2715399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab-nuna</from_name>
		<from_code>2602351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>faricimab</from_name>
		<from_code>2591519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-boav</from_name>
		<from_code>2725885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab-eqrn</from_name>
		<from_code>2612673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab</from_name>
		<from_code>253337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brolucizumab</from_name>
		<from_code>2204915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brolucizumab-dbll</from_name>
		<from_code>2204916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab</from_name>
		<from_code>595060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-tnjn</from_name>
		<from_code>2700660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept</from_name>
		<from_code>1232150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
		<to_code>N0000193542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antirabies serum,equine</from_name>
		<from_code>485234</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus envelope glycoprotein</from_name>
		<from_code>2624742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole hydrochloride</from_name>
		<from_code>227227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole</from_name>
		<from_code>6371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole phosphate</from_name>
		<from_code>1535214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemannan</from_name>
		<from_code>1426875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel protein-bound</from_name>
		<from_code>486610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glatiramer acetate</from_name>
		<from_code>84375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein</from_name>
		<from_code>2624741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glatiramer</from_name>
		<from_code>214582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel</from_name>
		<from_code>56946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Adjuvants [MoA]</to_name>
		<to_code>N0000000135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lebrikizumab</from_name>
		<from_code>2693758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonists [MoA]</to_name>
		<to_code>N0000193986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-13 Antagonist [EPC]</from_name>
		<from_code>N0000193985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonists [MoA]</to_name>
		<to_code>N0000193986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tralokinumab</from_name>
		<from_code>2589225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonists [MoA]</to_name>
		<to_code>N0000193986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lebrikizumab-lbkz</from_name>
		<from_code>2693778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonists [MoA]</to_name>
		<to_code>N0000193986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tralokinumab-ldrm</from_name>
		<from_code>2589374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonists [MoA]</to_name>
		<to_code>N0000193986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-17A Antagonist [EPC]</from_name>
		<from_code>N0000191495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonists [MoA]</to_name>
		<to_code>N0000191494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secukinumab</from_name>
		<from_code>1599788</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonists [MoA]</to_name>
		<to_code>N0000191494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixekizumab</from_name>
		<from_code>1745099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonists [MoA]</to_name>
		<to_code>N0000191494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepolizumab</from_name>
		<from_code>1720597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonists [MoA]</to_name>
		<to_code>N0000191871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reslizumab</from_name>
		<from_code>1746889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonists [MoA]</to_name>
		<to_code>N0000191871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Antagonist [EPC]</from_name>
		<from_code>N0000191872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonists [MoA]</to_name>
		<to_code>N0000191871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>depemokimab-ulaa</from_name>
		<from_code>2729264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonists [MoA]</to_name>
		<to_code>N0000191871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>depemokimab</from_name>
		<from_code>2729265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonists [MoA]</to_name>
		<to_code>N0000191871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiquimod</from_name>
		<from_code>59943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon Inducers [MoA]</to_name>
		<to_code>N0000000157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon Inducers [MoA]</to_name>
		<to_code>N0000000157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab</from_name>
		<from_code>2668384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guselkumab</from_name>
		<from_code>1928588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risankizumab</from_name>
		<from_code>2166040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab</from_name>
		<from_code>2053436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab-mrkz</from_name>
		<from_code>2668385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab-asmn</from_name>
		<from_code>2053449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risankizumab-rzaa</from_name>
		<from_code>2166132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonists [MoA]</to_name>
		<to_code>N0000192798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axicabtagene ciloleucel</from_name>
		<from_code>1987398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19 Receptor Interactions [MoA]</to_name>
		<to_code>N0000193544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisagenlecleucel</from_name>
		<from_code>1986438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19 Receptor Interactions [MoA]</to_name>
		<to_code>N0000193544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inactivators [MoA]</from_name>
		<from_code>N0000000192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 1 Inactivators [MoA]</to_name>
		<to_code>N0000000086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inactivators [MoA]</from_name>
		<from_code>N0000000192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5 Inactivators [MoA]</to_name>
		<to_code>N0000175441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inactivators [MoA]</from_name>
		<from_code>N0000000192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sutimlimab-jome</from_name>
		<from_code>2591415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 1 Inactivators [MoA]</to_name>
		<to_code>N0000000086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sutimlimab</from_name>
		<from_code>2591404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 1 Inactivators [MoA]</to_name>
		<to_code>N0000000086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacopan</from_name>
		<from_code>2572100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5 Inactivators [MoA]</to_name>
		<to_code>N0000175441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitors [MoA]</from_name>
		<from_code>N0000175974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Classical Complement Pathway Inhibitors [MoA]</to_name>
		<to_code>N0000193990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitors [MoA]</from_name>
		<from_code>N0000175974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alternative Complement Pathway Inhibitors [MoA]</to_name>
		<to_code>N0000194102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crovalimab-akkz</from_name>
		<from_code>2686620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacincaptad pegol sodium</from_name>
		<from_code>2645107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narsoplimab</from_name>
		<from_code>2732291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iptacopan hydrochloride</from_name>
		<from_code>2671062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ravulizumab</from_name>
		<from_code>2107301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eculizumab</from_name>
		<from_code>591781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zilucoplan</from_name>
		<from_code>2672489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ravulizumab-cwvz</from_name>
		<from_code>2107316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danicopan</from_name>
		<from_code>2678952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacincaptad pegol</from_name>
		<from_code>2645108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zilucoplan sodium</from_name>
		<from_code>2672492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sutimlimab</from_name>
		<from_code>2591404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegcetacoplan</from_name>
		<from_code>2557372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crovalimab</from_name>
		<from_code>2686619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narsoplimab-wuug</from_name>
		<from_code>2732292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eculizumab-aagh</from_name>
		<from_code>2706334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sutimlimab-jome</from_name>
		<from_code>2591415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eculizumab-aeeb</from_name>
		<from_code>2706347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iptacopan</from_name>
		<from_code>2671061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pozelimab</from_name>
		<from_code>2663938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pozelimab-bbfg</from_name>
		<from_code>2663939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitors [MoA]</to_name>
		<to_code>N0000175974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Classical Complement Pathway Inhibitors [MoA]</from_name>
		<from_code>N0000193990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor B Inhibitors [MoA]</to_name>
		<to_code>N0000194112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Classical Complement Pathway Inhibitors [MoA]</from_name>
		<from_code>N0000193990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitors [MoA]</to_name>
		<to_code>N0000194110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000193991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Classical Complement Pathway Inhibitors [MoA]</to_name>
		<to_code>N0000193990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sutimlimab</from_name>
		<from_code>2591404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Classical Complement Pathway Inhibitors [MoA]</to_name>
		<to_code>N0000193990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Factor B Inhibitor [EPC]</from_name>
		<from_code>N0000194111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor B Inhibitors [MoA]</to_name>
		<to_code>N0000194112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iptacopan</from_name>
		<from_code>2671061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor B Inhibitors [MoA]</to_name>
		<to_code>N0000194112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement C5 Inhibitor [EPC]</from_name>
		<from_code>N0000194109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitors [MoA]</to_name>
		<to_code>N0000194110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crovalimab</from_name>
		<from_code>2686619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitors [MoA]</to_name>
		<to_code>N0000194110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alternative Complement Pathway Inhibitors [MoA]</from_name>
		<from_code>N0000194102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor D Inhibitors [MoA]</to_name>
		<to_code>N0000194114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Factor D Inhibitor [EPC]</from_name>
		<from_code>N0000194113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor D Inhibitors [MoA]</to_name>
		<to_code>N0000194114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danicopan</from_name>
		<from_code>2678952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor D Inhibitors [MoA]</to_name>
		<to_code>N0000194114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</from_name>
		<from_code>N0000194157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral and Cellular Immune Response Activators [MoA]</to_name>
		<to_code>N0000194153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Expression Interactions [MoA]</from_name>
		<from_code>N0000193793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Alterations [MoA]</to_name>
		<to_code>N0000193791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Expression Interactions [MoA]</from_name>
		<from_code>N0000193793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transcription Modulation [MoA]</to_name>
		<to_code>N0000193794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Expression Interactions [MoA]</from_name>
		<from_code>N0000193793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Translation Modulation [MoA]</to_name>
		<to_code>N0000193796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran</from_name>
		<from_code>2604578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen sodium</from_name>
		<from_code>2724362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran sodium</from_name>
		<from_code>2605574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplontersen sodium</from_name>
		<from_code>2671940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen</from_name>
		<from_code>2724361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplontersen</from_name>
		<from_code>2671939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Expression Interactions [MoA]</to_name>
		<to_code>N0000193793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Alterations [MoA]</from_name>
		<from_code>N0000193791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Alterations [MoA]</from_name>
		<from_code>N0000193791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delandistrogene moxeparvovec</from_name>
		<from_code>2641675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Alterations [MoA]</to_name>
		<to_code>N0000193791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viltolarsen</from_name>
		<from_code>2389840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Alterations [MoA]</to_name>
		<to_code>N0000193791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casimersen</from_name>
		<from_code>2480096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Alterations [MoA]</to_name>
		<to_code>N0000193791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delandistrogene moxeparvovec-rokl</from_name>
		<from_code>2641674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Alterations [MoA]</to_name>
		<to_code>N0000193791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidanacogene elaparvovec-dzkt</from_name>
		<from_code>2681020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etranacogene dezaparvovec</from_name>
		<from_code>2626727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etranacogene dezaparvovec-drlb</from_name>
		<from_code>2626768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Virus Vector [EPC]</from_name>
		<from_code>N0000193797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delandistrogene moxeparvovec-rokl</from_name>
		<from_code>2641674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risdiplam</from_name>
		<from_code>2390935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidanacogene elaparvovec</from_name>
		<from_code>2681011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delandistrogene moxeparvovec</from_name>
		<from_code>2641675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revakinagene taroretcel</from_name>
		<from_code>2708830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vosoritide</from_name>
		<from_code>2586354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revakinagene taroretcel-lwey</from_name>
		<from_code>2708831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exagamglogene autotemcel</from_name>
		<from_code>2671667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Editing or Modification [MoA]</to_name>
		<to_code>N0000193792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Transduction or Replacement [MoA]</from_name>
		<from_code>N0000193795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Beta-globin Gene Transfer [MoA]</to_name>
		<to_code>N0000193972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eladocagene exuparvovec-tneq</from_name>
		<from_code>2698765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elivaldogene autotemcel</from_name>
		<from_code>2612527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onasemnogene abeparvovec-brve</from_name>
		<from_code>2727303</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eladocagene exuparvovec</from_name>
		<from_code>2698762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zopapogene imadenovec</from_name>
		<from_code>2723361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atidarsagene autotemcel</from_name>
		<from_code>2677916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beremagene geperpavec</from_name>
		<from_code>2637758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onasemnogene abeparvovec</from_name>
		<from_code>2170226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onasemnogene abeparvovec-xioi</from_name>
		<from_code>2170225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beremagene geperpavec-svdt</from_name>
		<from_code>2637757</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec-rvox</from_name>
		<from_code>2641609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voretigene neparvovec</from_name>
		<from_code>1995537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zopapogene imadenovec-drba</from_name>
		<from_code>2723360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec</from_name>
		<from_code>2641610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transduction or Replacement [MoA]</to_name>
		<to_code>N0000193795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovotibeglogene autotemcel</from_name>
		<from_code>2671958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Beta-globin Gene Transfer [MoA]</to_name>
		<to_code>N0000193972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betibeglogene autotemcel</from_name>
		<from_code>2610349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Beta-globin Gene Transfer [MoA]</to_name>
		<to_code>N0000193972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</from_name>
		<from_code>N0000193971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Beta-globin Gene Transfer [MoA]</to_name>
		<to_code>N0000193972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Transcription Modulation [MoA]</from_name>
		<from_code>N0000193794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</to_name>
		<to_code>N0000194060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viltolarsen</from_name>
		<from_code>2389840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transcription Modulation [MoA]</to_name>
		<to_code>N0000193794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadofaragene firadenovec</from_name>
		<from_code>2644436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transcription Modulation [MoA]</to_name>
		<to_code>N0000193794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belzutifan</from_name>
		<from_code>2567226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transcription Modulation [MoA]</to_name>
		<to_code>N0000193794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadofaragene firadenovec-vncg</from_name>
		<from_code>2644435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Transcription Modulation [MoA]</to_name>
		<to_code>N0000193794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</from_name>
		<from_code>N0000194059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</to_name>
		<to_code>N0000194060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risdiplam</from_name>
		<from_code>2390935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</to_name>
		<to_code>N0000194060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Macromolecular Activity [MoA]</from_name>
		<from_code>N0000000142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biological Macromolecular Activity [MoA]</from_name>
		<from_code>N0000000142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>D-biotin</from_name>
		<from_code>314583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline</from_name>
		<from_code>2449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (bovine)</from_name>
		<from_code>1299929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine</from_name>
		<from_code>1091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, bovine</from_name>
		<from_code>1306129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutamic acid</from_name>
		<from_code>25916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hyaluronate</from_name>
		<from_code>42892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine fumarate</from_name>
		<from_code>360300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine hydrochloride</from_name>
		<from_code>476316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine, DL-</from_name>
		<from_code>1310540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fiber</from_name>
		<from_code>70727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine hydrochloride</from_name>
		<from_code>6538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutamine</from_name>
		<from_code>4885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine hydrochloride, DL-</from_name>
		<from_code>1593400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (shark)</from_name>
		<from_code>1358172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate A sodium</from_name>
		<from_code>476847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronic acid</from_name>
		<from_code>5463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alanine</from_name>
		<from_code>426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine</from_name>
		<from_code>193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alanine, DL-</from_name>
		<from_code>1546161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartic acid</from_name>
		<from_code>1169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine, DL-</from_name>
		<from_code>1729154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tyrosine</from_name>
		<from_code>10962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenine</from_name>
		<from_code>290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine aminobenzoate</from_name>
		<from_code>1010241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, porcine</from_name>
		<from_code>1306202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine tartrate</from_name>
		<from_code>1364375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine</from_name>
		<from_code>6536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate (shark)</from_name>
		<from_code>1789516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium</from_name>
		<from_code>1605114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine hydrochloride, (+)-</from_name>
		<from_code>1539210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-alanine</from_name>
		<from_code>61</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine, D-</from_name>
		<from_code>1742746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine hydrochloride</from_name>
		<from_code>1426681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine hydrochloride</from_name>
		<from_code>1311532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine</from_name>
		<from_code>2106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine acetate</from_name>
		<from_code>6537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine</from_name>
		<from_code>4919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine aspartate</from_name>
		<from_code>18254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butylparaben</from_name>
		<from_code>1306937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesterol</from_name>
		<from_code>2438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (porcine)</from_name>
		<from_code>1366974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine monohydrate</from_name>
		<from_code>1314248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine chloride</from_name>
		<from_code>1311519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfates</from_name>
		<from_code>2473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine hydrochloride</from_name>
		<from_code>89918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine</from_name>
		<from_code>42955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hylan G-F 20</from_name>
		<from_code>284637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biological Macromolecular Activity [MoA]</to_name>
		<to_code>N0000000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>24-homo-1,25-dihydroxyvitamin D3</from_name>
		<from_code>1423458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol anhydrous</from_name>
		<from_code>1855064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine</from_name>
		<from_code>296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous dextrose</from_name>
		<from_code>349730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose monohydrate</from_name>
		<from_code>1299920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergocalciferol</from_name>
		<from_code>4018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine phosphate disodium</from_name>
		<from_code>1306123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medium chain triglycerides</from_name>
		<from_code>1310578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose hydrous</from_name>
		<from_code>1297771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitriol</from_name>
		<from_code>1894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine monophosphate</from_name>
		<from_code>309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine triphosphate</from_name>
		<from_code>318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose</from_name>
		<from_code>4850</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitonin</from_name>
		<from_code>1311287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon calcitonin</from_name>
		<from_code>36118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-D-glucopyranose</from_name>
		<from_code>1442190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Structural Macromolecules [MoA]</to_name>
		<to_code>N0000000228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avalglucosidase alfa</from_name>
		<from_code>2565814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cipaglucosidase alfa-atga</from_name>
		<from_code>2667434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elapegademase-lvlr</from_name>
		<from_code>2059218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velaglucerase alfa</from_name>
		<from_code>901805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elapegademase</from_name>
		<from_code>2059219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucerase</from_name>
		<from_code>46049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-nvhy</from_name>
		<from_code>2700789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacrosidase</from_name>
		<from_code>214817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiglucerase</from_name>
		<from_code>84959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agalsidase alfa</from_name>
		<from_code>2691830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dornase alfa</from_name>
		<from_code>337623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegademase bovine</from_name>
		<from_code>59768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avalglucosidase alfa-ngpt</from_name>
		<from_code>2565813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taliglucerase alfa</from_name>
		<from_code>1291609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asfotase alfa</from_name>
		<from_code>1720259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylase / lipase / protease</from_name>
		<from_code>392491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaspargase</from_name>
		<from_code>34132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cipaglucosidase alfa</from_name>
		<from_code>2667433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Activity [MoA]</to_name>
		<to_code>N0000000178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma Receptor Interactions [MoA]</to_name>
		<to_code>N0000182145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
		<to_code>N0000009954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
		<to_code>N0000000175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
		<to_code>N0000193953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Proteins [MoA]</to_name>
		<to_code>N0000020061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Interactions [MoA]</to_name>
		<to_code>N0000175368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon Receptor Interactions [MoA]</to_name>
		<to_code>N0000193959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fc Receptor Interactions [MoA]</to_name>
		<to_code>N0000193996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 31 Receptor Interactions [MoA]</to_name>
		<to_code>N0000194117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Protein Kinase Interactions [MoA]</to_name>
		<to_code>N0000000213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Transporter Interactions [MoA]</to_name>
		<to_code>N0000188370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monosaccharide Transporter Interactions [MoA]</to_name>
		<to_code>N0000188379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interactions [MoA]</from_name>
		<from_code>N0000000085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Interactions [MoA]</to_name>
		<to_code>N0000175773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimegepant</from_name>
		<from_code>2282307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentagastrin</from_name>
		<from_code>7993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimegepant sulfate</from_name>
		<from_code>2282322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nesiritide</from_name>
		<from_code>19666</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobenguane I-131</from_name>
		<from_code>2053281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubrogepant</from_name>
		<from_code>2268216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifarotene</from_name>
		<from_code>2205637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin</from_name>
		<from_code>10753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbetapentane citrate</from_name>
		<from_code>283547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy polyethylene glycol-epoetin beta</from_name>
		<from_code>729596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palovarotene</from_name>
		<from_code>2663954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isotretinoin</from_name>
		<from_code>6064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alitretinoin</from_name>
		<from_code>81864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin microsphere</from_name>
		<from_code>221175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caramiphen edisylate</from_name>
		<from_code>133053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrotachysterol</from_name>
		<from_code>3429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bexarotene</from_name>
		<from_code>233272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caramiphen</from_name>
		<from_code>20191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebendazole</from_name>
		<from_code>6672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebelipase alfa</from_name>
		<from_code>1726975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbetapentane tannate</from_name>
		<from_code>221070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbetapentane</from_name>
		<from_code>20217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interactions [MoA]</to_name>
		<to_code>N0000000085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma Receptor Interactions [MoA]</from_name>
		<from_code>N0000182145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000182146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma-1 Receptor Interactions [MoA]</from_name>
		<from_code>N0000182146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma-1 Receptor Interactions [MoA]</from_name>
		<from_code>N0000182146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noscapine</from_name>
		<from_code>7533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrobromide</from_name>
		<from_code>102490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan tannate</from_name>
		<from_code>259262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrochloride</from_name>
		<from_code>267251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydroiodide</from_name>
		<from_code>539765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma-1 Agonist [EPC]</from_name>
		<from_code>N0000182149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan polistirex</from_name>
		<from_code>236146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000182147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aryl Hydrocarbon Receptor Agonists [MoA]</to_name>
		<to_code>N0000194019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UDP Glucuronosyltransferases Inducers [MoA]</to_name>
		<to_code>N0000190117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inducers [MoA]</to_name>
		<to_code>N0000185505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor Activity [MoA]</to_name>
		<to_code>N0000175374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesoid X Receptor Agonists [MoA]</to_name>
		<to_code>N0000192560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Interactions [MoA]</to_name>
		<to_code>N0000000257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transcription Factor Activity [MoA]</from_name>
		<from_code>N0000000242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Inhibitors [MoA]</to_name>
		<to_code>N0000194000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arimoclomol citrate</from_name>
		<from_code>2694282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adapalene</from_name>
		<from_code>60223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arimoclomol</from_name>
		<from_code>2694283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polaprezinc</from_name>
		<from_code>2179843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vadadustat</from_name>
		<from_code>2679296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transcription Factor Activity [MoA]</to_name>
		<to_code>N0000000242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aryl Hydrocarbon Receptor Agonist [EPC]</from_name>
		<from_code>N0000194018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aryl Hydrocarbon Receptor Agonists [MoA]</to_name>
		<to_code>N0000194019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapinarof</from_name>
		<from_code>2602286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aryl Hydrocarbon Receptor Agonists [MoA]</to_name>
		<to_code>N0000194019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UDP Glucuronosyltransferases Inducers [MoA]</from_name>
		<from_code>N0000190117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A Inducers [MoA]</to_name>
		<to_code>N0000194035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UDP Glucuronosyltransferases Inducers [MoA]</to_name>
		<to_code>N0000190117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inducers [MoA]</from_name>
		<from_code>N0000190116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UDP Glucuronosyltransferases Inducers [MoA]</to_name>
		<to_code>N0000190117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT1A Inducers [MoA]</from_name>
		<from_code>N0000194035</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inducers [MoA]</to_name>
		<to_code>N0000194036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inducers [MoA]</to_name>
		<to_code>N0000194036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2E1 Inducers [MoA]</to_name>
		<to_code>N0000193955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A Inducers [MoA]</to_name>
		<to_code>N0000191624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
		<to_code>N0000191267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inducers [MoA]</from_name>
		<from_code>N0000185505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inducers [MoA]</from_name>
		<from_code>N0000190116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inducers [MoA]</to_name>
		<to_code>N0000185505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relugolix</from_name>
		<from_code>2472778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemborexant</from_name>
		<from_code>2272403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
		<to_code>N0000187064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivosidenib</from_name>
		<from_code>2049873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enzalutamide</from_name>
		<from_code>1307298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
		<to_code>N0000185507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitisinone</from_name>
		<from_code>61805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2E1 Inducers [MoA]</to_name>
		<to_code>N0000193955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 1A Inducers [MoA]</from_name>
		<from_code>N0000191624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albendazole</from_name>
		<from_code>430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A Inducers [MoA]</to_name>
		<to_code>N0000191624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib</from_name>
		<from_code>1721560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib mesylate</from_name>
		<from_code>1721559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
		<to_code>N0000191266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enzalutamide</from_name>
		<from_code>1307298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavacamten</from_name>
		<from_code>2600867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirogacestat</from_name>
		<from_code>2670631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
		<to_code>N0000185607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
		<to_code>N0000191267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
		<to_code>N0000191267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
		<to_code>N0000191267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inducers [MoA]</from_name>
		<from_code>N0000190118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inducers [MoA]</to_name>
		<to_code>N0000191268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inducers [MoA]</from_name>
		<from_code>N0000190118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir dihydrochloride</from_name>
		<from_code>1606217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorasidenib</from_name>
		<from_code>2690647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brigatinib</from_name>
		<from_code>1921217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etravirine</from_name>
		<from_code>475969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir sodium</from_name>
		<from_code>2625652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relugolix</from_name>
		<from_code>2472778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib</from_name>
		<from_code>2183102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tovorafenib</from_name>
		<from_code>2682434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suzetrigine</from_name>
		<from_code>2704819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
		<to_code>N0000190118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavacamten</from_name>
		<from_code>2600867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivosidenib</from_name>
		<from_code>2049873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enzalutamide</from_name>
		<from_code>1307298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine acetate</from_name>
		<from_code>1482501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repotrectinib</from_name>
		<from_code>2670644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elafibranor</from_name>
		<from_code>2684941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib mesylate</from_name>
		<from_code>1721559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdafitinib</from_name>
		<from_code>2123125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omaveloxolone</from_name>
		<from_code>2631931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine</from_name>
		<from_code>1482502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib</from_name>
		<from_code>1721560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belzutifan</from_name>
		<from_code>2567226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flibanserin</from_name>
		<from_code>1665509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant</from_name>
		<from_code>2197878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitotane</from_name>
		<from_code>7004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
		<to_code>N0000185506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omaveloxolone</from_name>
		<from_code>2631931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
		<to_code>N0000187063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Activity [MoA]</from_name>
		<from_code>N0000175374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</to_name>
		<to_code>N0000194129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor Activity [MoA]</to_name>
		<to_code>N0000175374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
		<from_code>N0000194129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
		<from_code>N0000194129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor beta Agonists [MoA]</to_name>
		<to_code>N0000175376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
		<from_code>N0000194129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
		<to_code>N0000175378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
		<from_code>N0000194129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</to_name>
		<to_code>N0000194129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elafibranor</from_name>
		<from_code>2684941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</to_name>
		<to_code>N0000194129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate micronized</from_name>
		<from_code>221100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elafibranor</from_name>
		<from_code>2684941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate</from_name>
		<from_code>8703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troglitazone</from_name>
		<from_code>72610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
		<to_code>N0000175375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elafibranor</from_name>
		<from_code>2684941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
		<to_code>N0000175378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</from_name>
		<from_code>N0000194127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
		<to_code>N0000175378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>seladelpar</from_name>
		<from_code>2690869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
		<to_code>N0000175378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>seladelpar lysine</from_name>
		<from_code>2690868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
		<to_code>N0000175378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
		<from_code>N0000180186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troglitazone</from_name>
		<from_code>72610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elafibranor</from_name>
		<from_code>2684941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
		<to_code>N0000175377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
		<from_code>N0000192561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesoid X Receptor Agonists [MoA]</to_name>
		<to_code>N0000192560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obeticholic acid</from_name>
		<from_code>1798288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesoid X Receptor Agonists [MoA]</to_name>
		<to_code>N0000192560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Interactions [MoA]</from_name>
		<from_code>N0000000257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Interactions [MoA]</from_name>
		<from_code>N0000000257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Interactions [MoA]</from_name>
		<from_code>N0000000257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Steroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Agonists [MoA]</to_name>
		<to_code>N0000193923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000010266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone</from_name>
		<from_code>227518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriparatide acetate</from_name>
		<from_code>114260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart protamine, human</from_name>
		<from_code>352385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriparatide</from_name>
		<from_code>32915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin-releasing hormone</from_name>
		<from_code>10580</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sermorelin</from_name>
		<from_code>56188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afamelanotide acetate</from_name>
		<from_code>2278002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin</from_name>
		<from_code>28656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin acetate</from_name>
		<from_code>203147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afamelanotide</from_name>
		<from_code>2262250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human chorionic gonadotropin</from_name>
		<from_code>340705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melatonin</from_name>
		<from_code>6711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone, porcine</from_name>
		<from_code>1594665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lutropin alfa</from_name>
		<from_code>388084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sermorelin acetate</from_name>
		<from_code>58932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choriogonadotropin alfa</from_name>
		<from_code>283550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chorionic gonadotropin</from_name>
		<from_code>4986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parathyroid hormone</from_name>
		<from_code>1427222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sex Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000175450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000175450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deflazacort</from_name>
		<from_code>22396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluclorolone acetonide</from_name>
		<from_code>103447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluclorolone</from_name>
		<from_code>108091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vamorolone</from_name>
		<from_code>2669799</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoxycorticosterone</from_name>
		<from_code>3256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludrocortisone</from_name>
		<from_code>4452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoxycorticosterone pivalate</from_name>
		<from_code>22537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludrocortisone acetate</from_name>
		<from_code>165516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoxycorticosterone acetate</from_name>
		<from_code>258333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone pivalate</from_name>
		<from_code>25113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deflazacort</from_name>
		<from_code>22396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloticasone</from_name>
		<from_code>2719926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vamorolone</from_name>
		<from_code>2669799</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloprednol</from_name>
		<from_code>21285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone</from_name>
		<from_code>4458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide (11.beta.,16.alpha.(S))</from_name>
		<from_code>1367172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclesonide</from_name>
		<from_code>274964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000000159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone isocaproate</from_name>
		<from_code>75806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone (micronized)</from_name>
		<from_code>221168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methandriol</from_name>
		<from_code>6817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stanozolol</from_name>
		<from_code>10032</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyltestosterone</from_name>
		<from_code>6904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone decanoate</from_name>
		<from_code>37858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methandriol dipropionate</from_name>
		<from_code>235381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetholone</from_name>
		<from_code>7813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxandrolone</from_name>
		<from_code>7779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methandrostenolone</from_name>
		<from_code>6818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethynodrel</from_name>
		<from_code>7515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol</from_name>
		<from_code>6703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol acetate</from_name>
		<from_code>29451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyestradiol phosphate</from_name>
		<from_code>34120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinestradol</from_name>
		<from_code>35215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, B</from_name>
		<from_code>618365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol</from_name>
		<from_code>2539031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienestrol</from_name>
		<from_code>3368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol tetrasodium</from_name>
		<from_code>281876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, A</from_name>
		<from_code>253166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyestradiol</from_name>
		<from_code>34119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cohosh extract</from_name>
		<from_code>236665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorotrianisene</from_name>
		<from_code>2397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylstilbestrol</from_name>
		<from_code>3390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tibolone</from_name>
		<from_code>38260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, esterified (USP)</from_name>
		<from_code>214549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol</from_name>
		<from_code>25284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinestrol</from_name>
		<from_code>9066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Agonists [MoA]</to_name>
		<to_code>N0000000100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon Receptor Agonists [MoA]</from_name>
		<from_code>N0000193923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Glucagon Receptor Agonists [MoA]</to_name>
		<to_code>N0000193924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasiglucagon</from_name>
		<from_code>2535233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Agonists [MoA]</to_name>
		<to_code>N0000193923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retatrutide</from_name>
		<from_code>2722410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Agonists [MoA]</to_name>
		<to_code>N0000193923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor beta Agonists [MoA]</to_name>
		<to_code>N0000194132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroglobulin</from_name>
		<from_code>10565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium</from_name>
		<from_code>40144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine sodium</from_name>
		<from_code>142448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (beef)</from_name>
		<from_code>325521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine</from_name>
		<from_code>10814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (USP)</from_name>
		<from_code>10572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmetirom</from_name>
		<from_code>2677894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium anhydrous</from_name>
		<from_code>1372638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Receptor beta Agonist [EPC]</from_name>
		<from_code>N0000194131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor beta Agonists [MoA]</to_name>
		<to_code>N0000194132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmetirom</from_name>
		<from_code>2677894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor beta Agonists [MoA]</to_name>
		<to_code>N0000194132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin</from_name>
		<from_code>6384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin acetate</from_name>
		<from_code>236538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin</from_name>
		<from_code>28656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin acetate</from_name>
		<from_code>203147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin acetate</from_name>
		<from_code>203146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin hydrochloride</from_name>
		<from_code>204194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin</from_name>
		<from_code>50610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin acetate</from_name>
		<from_code>1294622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin</from_name>
		<from_code>50975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin diacetate tetrahydrate</from_name>
		<from_code>1298838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trelstar pamoate</from_name>
		<from_code>905060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide acetate</from_name>
		<from_code>203217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide mesylate</from_name>
		<from_code>2595041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide</from_name>
		<from_code>42375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin</from_name>
		<from_code>38782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin acetate</from_name>
		<from_code>204193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin pamoate</from_name>
		<from_code>338529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000175654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrem</from_name>
		<from_code>56570</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000010266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin (recombinant DNA origin)</from_name>
		<from_code>314845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000010266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin</from_name>
		<from_code>61148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000010266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin, E-coli derived</from_name>
		<from_code>259321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000010266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Modulators [MoA]</from_name>
		<from_code>N0000000255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Steroid Receptor Modulators [MoA]</to_name>
		<to_code>N0000000172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide</from_name>
		<from_code>42375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etrasimod arginine</from_name>
		<from_code>2668046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin alfa</from_name>
		<from_code>386938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix acetate</from_name>
		<from_code>259338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix</from_name>
		<from_code>35825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix acetate</from_name>
		<from_code>259264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin beta</from_name>
		<from_code>25357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone</from_name>
		<from_code>227518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide mesylate</from_name>
		<from_code>2595041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide acetate</from_name>
		<from_code>203217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etrasimod</from_name>
		<from_code>2668045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone, porcine</from_name>
		<from_code>1594665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix</from_name>
		<from_code>68147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin acetate</from_name>
		<from_code>203146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone Receptor Modulators [MoA]</to_name>
		<to_code>N0000000255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Receptor Modulators [MoA]</from_name>
		<from_code>N0000000172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Receptor Modulators [MoA]</from_name>
		<from_code>N0000000172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
		<to_code>N0000191262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Receptor Modulators [MoA]</from_name>
		<from_code>N0000000172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen</from_name>
		<from_code>10324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ospemifene</from_name>
		<from_code>1370971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene</from_name>
		<from_code>1441386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene acetate</from_name>
		<from_code>1442171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene citrate</from_name>
		<from_code>142431</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raloxifene hydrochloride</from_name>
		<from_code>166551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene</from_name>
		<from_code>2596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fulvestrant</from_name>
		<from_code>282357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene</from_name>
		<from_code>38409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene citrate</from_name>
		<from_code>49953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen citrate</from_name>
		<from_code>40137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raloxifene</from_name>
		<from_code>72143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
		<to_code>N0000000168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ulipristal acetate</from_name>
		<from_code>1005920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
		<to_code>N0000191262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000191263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
		<to_code>N0000191262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ulipristal</from_name>
		<from_code>1005921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
		<to_code>N0000191262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Steroid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix sodium</from_name>
		<from_code>2049847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linzagolix</from_name>
		<from_code>2621019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linzagolix choline</from_name>
		<from_code>2621020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix acetate</from_name>
		<from_code>259338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix</from_name>
		<from_code>68147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix</from_name>
		<from_code>35825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>degarelix</from_name>
		<from_code>475230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relugolix</from_name>
		<from_code>2472778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>degarelix acetate</from_name>
		<from_code>835863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix acetate</from_name>
		<from_code>259264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abarelix</from_name>
		<from_code>301739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sex Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminoglutethimide</from_name>
		<from_code>677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Steroid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mineralocorticoid Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldosterone Antagonists [MoA]</to_name>
		<to_code>N0000011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finerenone</from_name>
		<from_code>2562811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vamorolone</from_name>
		<from_code>2669799</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mineralocorticoid Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aldosterone Antagonist [EPC]</from_name>
		<from_code>N0000175557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldosterone Antagonists [MoA]</to_name>
		<to_code>N0000011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplerenone</from_name>
		<from_code>298869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldosterone Antagonists [MoA]</to_name>
		<to_code>N0000011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldosterone Antagonists [MoA]</to_name>
		<to_code>N0000011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin Antagonist [EPC]</from_name>
		<from_code>N0000175841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestational Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enzalutamide</from_name>
		<from_code>1307298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clascoterone</from_name>
		<from_code>2474340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darolutamide</from_name>
		<from_code>2180325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilutamide</from_name>
		<from_code>31805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apalutamide</from_name>
		<from_code>1999574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutamide</from_name>
		<from_code>4508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicalutamide</from_name>
		<from_code>83008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estradiol Antagonists [MoA]</to_name>
		<to_code>N0000011319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elacestrant</from_name>
		<from_code>2628469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fulvestrant</from_name>
		<from_code>282357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol</from_name>
		<from_code>6703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol acetate</from_name>
		<from_code>29451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elacestrant dihydrochloride</from_name>
		<from_code>2628473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imlunestrant tosylate</from_name>
		<from_code>2725911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imlunestrant</from_name>
		<from_code>2725912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crinecerfont</from_name>
		<from_code>2701386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegvisomant</from_name>
		<from_code>278739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Inhibitors [MoA]</from_name>
		<from_code>N0000194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000194079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Inhibitors [MoA]</from_name>
		<from_code>N0000194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]</to_name>
		<to_code>N0000193998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daprodustat</from_name>
		<from_code>2628210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Inhibitors [MoA]</to_name>
		<to_code>N0000194000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Inhibitors [MoA]</to_name>
		<to_code>N0000194000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vadadustat</from_name>
		<from_code>2679296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000194079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000194079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000194080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000194079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daprodustat</from_name>
		<from_code>2628210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000194079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belzutifan</from_name>
		<from_code>2567226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]</to_name>
		<to_code>N0000193998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Membrane Fusion Complex Interactions [MoA]</from_name>
		<from_code>N0000009954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Synaptic Fusion Complex Interactions [MoA]</to_name>
		<to_code>N0000009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
		<to_code>N0000009954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
		<to_code>N0000009954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
		<to_code>N0000009954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Synaptic Fusion Complex Interactions [MoA]</from_name>
		<from_code>N0000009953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type B</from_name>
		<from_code>2167673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
		<to_code>N0000175770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Interactions [MoA]</to_name>
		<to_code>N0000190477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000009950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 17 Receptor Interactions [MoA]</to_name>
		<to_code>N0000193277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Interactions [MoA]</to_name>
		<to_code>N0000010281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD123 Interactions [MoA]</to_name>
		<to_code>N0000193865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Interactions [MoA]</to_name>
		<to_code>N0000010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Interactions [MoA]</to_name>
		<to_code>N0000175967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
		<to_code>N0000193867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Interactions [MoA]</to_name>
		<to_code>N0000194120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Co-receptor 5 Interactions [MoA]</to_name>
		<to_code>N0000175444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000175707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
		<from_code>N0000000175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 4 Receptor Interactions [MoA]</to_name>
		<to_code>N0000193340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nogapendekin alfa inbakicept-pmln</from_name>
		<from_code>2682677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
		<to_code>N0000000175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotatercept-csrk</from_name>
		<from_code>2678931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
		<to_code>N0000000175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metreleptin</from_name>
		<from_code>1491625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
		<to_code>N0000000175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nogapendekin alfa inbakicept</from_name>
		<from_code>2682678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
		<to_code>N0000000175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotatercept</from_name>
		<from_code>2678930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
		<to_code>N0000000175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 6 Receptor Interactions [MoA]</from_name>
		<from_code>N0000190477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 6 Receptor Interactions [MoA]</from_name>
		<from_code>N0000190477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Agonists [MoA]</to_name>
		<to_code>N0000190479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-anoh</from_name>
		<from_code>2705421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-aazg</from_name>
		<from_code>2679427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarilumab</from_name>
		<from_code>1923319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-bavi</from_name>
		<from_code>2680283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab</from_name>
		<from_code>612865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab</from_name>
		<from_code>2391541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab-mwge</from_name>
		<from_code>2391551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Receptor Interactions [MoA]</from_name>
		<from_code>N0000009950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemannan</from_name>
		<from_code>1426875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000009950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brentuximab vedotin</from_name>
		<from_code>1147320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000009950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</from_name>
		<from_code>N0000175451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</from_name>
		<from_code>N0000175451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</from_name>
		<from_code>N0000175451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golimumab</from_name>
		<from_code>819300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclofenac</from_name>
		<from_code>16689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golimumab</from_name>
		<from_code>819300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-dssb</from_name>
		<from_code>2725498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-nxxp</from_name>
		<from_code>2723334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-bbdz</from_name>
		<from_code>2715382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-qbde</from_name>
		<from_code>2725562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-kyqq</from_name>
		<from_code>2725924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab</from_name>
		<from_code>993449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RANK Ligand Inhibitor [EPC]</from_name>
		<from_code>N0000187055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-bmwo</from_name>
		<from_code>2717851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-mobz</from_name>
		<from_code>2729308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-bnht</from_name>
		<from_code>2717527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Blocking Activity [MoA]</to_name>
		<to_code>N0000187054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</to_name>
		<to_code>N0000175447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 17 Receptor Interactions [MoA]</from_name>
		<from_code>N0000193277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 17 Receptor A Interactions [MoA]</to_name>
		<to_code>N0000193278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 17 Receptor A Interactions [MoA]</from_name>
		<from_code>N0000193278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 17 Receptor A Antagonists [MoA]</to_name>
		<to_code>N0000193279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brodalumab</from_name>
		<from_code>1872251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 17 Receptor A Interactions [MoA]</to_name>
		<to_code>N0000193278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brodalumab</from_name>
		<from_code>1872251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 17 Receptor A Antagonists [MoA]</to_name>
		<to_code>N0000193279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-17 Receptor A Antagonist [EPC]</from_name>
		<from_code>N0000193276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 17 Receptor A Antagonists [MoA]</to_name>
		<to_code>N0000193279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD3 Receptor Interactions [MoA]</from_name>
		<from_code>N0000010281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD3 Receptor Interactions [MoA]</from_name>
		<from_code>N0000010281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blinatumomab</from_name>
		<from_code>1597258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
		<from_code>N0000191421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab</from_name>
		<from_code>2637392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000193989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp</from_name>
		<from_code>2590743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp</from_name>
		<from_code>2109055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD123 Interactions [MoA]</to_name>
		<to_code>N0000193865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 2 Receptor Interactions [MoA]</from_name>
		<from_code>N0000010278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 2 Receptor Interactions [MoA]</from_name>
		<from_code>N0000010278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Agonists [MoA]</to_name>
		<to_code>N0000010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 2 Receptor Interactions [MoA]</from_name>
		<from_code>N0000010278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD25-directed Receptor Interactions [MoA]</to_name>
		<to_code>N0000177911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-2 Receptor Blocking Antibody [EPC]</from_name>
		<from_code>N0000175622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclizumab</from_name>
		<from_code>190353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basiliximab</from_name>
		<from_code>196102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 2 Receptor Agonists [MoA]</to_name>
		<to_code>N0000010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Interactions [MoA]</from_name>
		<from_code>N0000175967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lusutrombopag</from_name>
		<from_code>2054984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag choline</from_name>
		<from_code>2675185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag</from_name>
		<from_code>2045726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag maleate</from_name>
		<from_code>2045727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oprelvekin</from_name>
		<from_code>139994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romiplostim</from_name>
		<from_code>805452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemokine Receptor Type 4 Interactions [MoA]</from_name>
		<from_code>N0000193867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CXC Chemokine Receptor 4 Antagonists [MoA]</to_name>
		<to_code>N0000194105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>motixafortide acetate</from_name>
		<from_code>2664897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
		<to_code>N0000193867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
		<to_code>N0000193867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mogamulizumab</from_name>
		<from_code>2054068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
		<to_code>N0000193867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>motixafortide</from_name>
		<from_code>2664896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
		<to_code>N0000193867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CXC Chemokine Receptor 4 Antagonist [EPC]</from_name>
		<from_code>N0000194104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CXC Chemokine Receptor 4 Antagonists [MoA]</to_name>
		<to_code>N0000194105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CXC Chemokine Receptor 4 Antagonists [MoA]</to_name>
		<to_code>N0000194105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-15 Receptor Interactions [MoA]</from_name>
		<from_code>N0000194120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Agonists [MoA]</to_name>
		<to_code>N0000194119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-15 Receptor Agonist [EPC]</from_name>
		<from_code>N0000194118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Agonists [MoA]</to_name>
		<to_code>N0000194119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nogapendekin alfa inbakicept-pmln</from_name>
		<from_code>2682677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Agonists [MoA]</to_name>
		<to_code>N0000194119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemokine Co-receptor 5 Interactions [MoA]</from_name>
		<from_code>N0000175444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Co-receptor 5 Antagonists [MoA]</to_name>
		<to_code>N0000175445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CCR5 Co-receptor Antagonist [EPC]</from_name>
		<from_code>N0000175572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Co-receptor 5 Antagonists [MoA]</to_name>
		<to_code>N0000175445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Co-receptor 5 Antagonists [MoA]</to_name>
		<to_code>N0000175445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 1 Receptor Interactions [MoA]</from_name>
		<from_code>N0000175707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000175708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 1 Receptor Interactions [MoA]</from_name>
		<from_code>N0000175707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 1 Receptor Antagonists [MoA]</from_name>
		<from_code>N0000175709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canakinumab</from_name>
		<from_code>853491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilonacept</from_name>
		<from_code>763450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anakinra</from_name>
		<from_code>72435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-36 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spesolimab</from_name>
		<from_code>2610417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin 4 Receptor Interactions [MoA]</from_name>
		<from_code>N0000193340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 4 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000193341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
		<from_code>N0000193342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 4 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000193341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dupilumab</from_name>
		<from_code>1876376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin 4 Receptor alpha Antagonists [MoA]</to_name>
		<to_code>N0000193341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
		<from_code>N0000000215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Interactions [MoA]</to_name>
		<to_code>N0000193846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
		<from_code>N0000000215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Interactions [MoA]</to_name>
		<to_code>N0000190112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
		<from_code>N0000000215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Interactions [MoA]</to_name>
		<to_code>N0000000239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
		<from_code>N0000000215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug Resistance-Associated Protein Interactions [MoA]</to_name>
		<to_code>N0000193961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Membrane Transporter Interactions [MoA]</from_name>
		<from_code>N0000188367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicorandil</from_name>
		<from_code>31748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine hydrochloride</from_name>
		<from_code>235853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag</from_name>
		<from_code>2045726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag maleate</from_name>
		<from_code>2045727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine</from_name>
		<from_code>28863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
		<to_code>N0000000215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Salt Export Pump Interactions [MoA]</from_name>
		<from_code>N0000193846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
		<to_code>N0000193845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levacetylleucine</from_name>
		<from_code>2375522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
		<to_code>N0000193845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
		<to_code>N0000193845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
		<to_code>N0000193845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
		<to_code>N0000193845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
		<to_code>N0000193845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Breast Cancer Resistance Protein Interactions [MoA]</from_name>
		<from_code>N0000190112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lazertinib</from_name>
		<from_code>2691150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib mesylate</from_name>
		<from_code>1721559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir dihydrochloride</from_name>
		<from_code>1606217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relugolix</from_name>
		<from_code>2472778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmetirom</from_name>
		<from_code>2677894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vimseltinib</from_name>
		<from_code>2705378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirtobrutinib</from_name>
		<from_code>2629338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ledipasvir</from_name>
		<from_code>1591922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vadadustat</from_name>
		<from_code>2679296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutivacaftor</from_name>
		<from_code>2701430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>futibatinib</from_name>
		<from_code>2628190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levacetylleucine</from_name>
		<from_code>2375522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elacestrant</from_name>
		<from_code>2628469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zongertinib</from_name>
		<from_code>2721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sapropterin</from_name>
		<from_code>753340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib</from_name>
		<from_code>1721560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imlunestrant</from_name>
		<from_code>2725912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maribavir</from_name>
		<from_code>2586068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danicopan</from_name>
		<from_code>2678952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib</from_name>
		<from_code>1312397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ripretinib</from_name>
		<from_code>2369389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
		<to_code>N0000190113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P-Glycoprotein Interactions [MoA]</from_name>
		<from_code>N0000000239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P-Glycoprotein Interactions [MoA]</from_name>
		<from_code>N0000000239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inducers [MoA]</to_name>
		<to_code>N0000191264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirtobrutinib</from_name>
		<from_code>2629338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline</from_name>
		<from_code>2694828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticagrelor</from_name>
		<from_code>1116632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat tartrate</from_name>
		<from_code>1547219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vimseltinib</from_name>
		<from_code>2705378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relugolix</from_name>
		<from_code>2472778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir dihydrochloride</from_name>
		<from_code>1606217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neratinib</from_name>
		<from_code>1940643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat</from_name>
		<from_code>1547220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tucatinib</from_name>
		<from_code>2361285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>BCL-2 Inhibitor [EPC]</from_name>
		<from_code>N0000192515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venetoclax</from_name>
		<from_code>1747556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voclosporin</from_name>
		<from_code>2475166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vandetanib</from_name>
		<from_code>1098413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin anhydrous</from_name>
		<from_code>1546031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berotralstat</from_name>
		<from_code>2467540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flibanserin</from_name>
		<from_code>1665509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ripretinib</from_name>
		<from_code>2369389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tepotinib</from_name>
		<from_code>2477103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etravirine</from_name>
		<from_code>475969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotagliflozin</from_name>
		<from_code>2638675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline hydrochloride</from_name>
		<from_code>2059038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danicopan</from_name>
		<from_code>2678952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchiceine</from_name>
		<from_code>2174385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirabegron</from_name>
		<from_code>1300786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib tartrate</from_name>
		<from_code>2698561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maribavir</from_name>
		<from_code>2586068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suvorexant</from_name>
		<from_code>1547099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sapropterin</from_name>
		<from_code>753340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdafitinib</from_name>
		<from_code>2123125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imlunestrant</from_name>
		<from_code>2725912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remibrutinib</from_name>
		<from_code>2724365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemigatinib</from_name>
		<from_code>2359268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elacestrant</from_name>
		<from_code>2628469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutivacaftor</from_name>
		<from_code>2701430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>futibatinib</from_name>
		<from_code>2628190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levacetylleucine</from_name>
		<from_code>2375522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivacaftor</from_name>
		<from_code>1243041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ledipasvir</from_name>
		<from_code>1591922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vemurafenib</from_name>
		<from_code>1147220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abrocitinib</from_name>
		<from_code>2591476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
		<to_code>N0000185503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inducers [MoA]</to_name>
		<to_code>N0000191264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inducers [MoA]</to_name>
		<to_code>N0000191264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P-Glycoprotein Inducers [MoA]</to_name>
		<to_code>N0000191264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Multidrug Resistance-Associated Protein Interactions [MoA]</from_name>
		<from_code>N0000193961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug Resistance-Associated Protein 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptinezumab</from_name>
		<from_code>2282660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
		<to_code>N0000193953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
		<from_code>N0000193952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
		<to_code>N0000193953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atogepant</from_name>
		<from_code>2571813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
		<to_code>N0000193953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Activity Modifying Proteins [MoA]</from_name>
		<from_code>N0000020061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Activity Modifying Proteins [MoA]</from_name>
		<from_code>N0000020061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Activin Signaling Inhibitors [MoA]</to_name>
		<to_code>N0000194101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Activity Modifying Proteins [MoA]</from_name>
		<from_code>N0000020061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Antagonists [MoA]</to_name>
		<to_code>N0000020063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Activity Modifying Protein Agonists [MoA]</from_name>
		<from_code>N0000020062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Agonists [MoA]</to_name>
		<to_code>N0000020064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-aafi</from_name>
		<from_code>2057198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-fpgk</from_name>
		<from_code>2613761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-pbbk</from_name>
		<from_code>2602779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-jmdb</from_name>
		<from_code>2048018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-ayow</from_name>
		<from_code>2595942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-apgf</from_name>
		<from_code>2469333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
		<to_code>N0000020062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide acetate</from_name>
		<from_code>356773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Agonists [MoA]</to_name>
		<to_code>N0000020064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amylin Analog [EPC]</from_name>
		<from_code>N0000177910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Agonists [MoA]</to_name>
		<to_code>N0000020064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide</from_name>
		<from_code>139953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Agonists [MoA]</to_name>
		<to_code>N0000020064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Activin Signaling Inhibitor [EPC]</from_name>
		<from_code>N0000194100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Activin Signaling Inhibitors [MoA]</to_name>
		<to_code>N0000194101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotatercept</from_name>
		<from_code>2678930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Activin Signaling Inhibitors [MoA]</to_name>
		<to_code>N0000194101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormones Receptor Interactions [MoA]</to_name>
		<to_code>N0000000141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Interactions [MoA]</to_name>
		<to_code>N0000175362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Interactions [MoA]</to_name>
		<to_code>N0000190997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Receptor Interactions [MoA]</to_name>
		<to_code>N0000000204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Interactions [MoA]</to_name>
		<to_code>N0000194092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Interactions [MoA]</to_name>
		<to_code>N0000000124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium-Sensing Receptor Interactions [MoA]</to_name>
		<to_code>N0000020080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lysophospholipid Receptor Interactions [MoA]</to_name>
		<to_code>N0000181812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalmic Hormone Interactions [MoA]</to_name>
		<to_code>N0000019992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin Receptor Interactions [MoA]</to_name>
		<to_code>N0000182962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor Interactions [MoA]</to_name>
		<to_code>N0000190993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000010261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Interactions [MoA]</to_name>
		<to_code>N0000175787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin Receptor Interactions [MoA]</to_name>
		<to_code>N0000193942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Interactions [MoA]</to_name>
		<to_code>N0000193975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Interactions [MoA]</to_name>
		<to_code>N0000184147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin Receptor Interactions [MoA]</to_name>
		<to_code>N0000020077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Interactions [MoA]</to_name>
		<to_code>N0000181007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Interactions [MoA]</to_name>
		<to_code>N0000010275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Receptor Interactions [MoA]</to_name>
		<to_code>N0000000200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Interactions [MoA]</to_name>
		<to_code>N0000193787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
		<from_code>N0000000152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathormone Receptor Interactions [MoA]</to_name>
		<to_code>N0000000068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>angiotensin II acetate, human</from_name>
		<from_code>2204740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirzepatide</from_name>
		<from_code>2601723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp-tebn</from_name>
		<from_code>2590744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</from_name>
		<from_code>N0000194015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>angiotensin II</from_name>
		<from_code>1999003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp</from_name>
		<from_code>2590743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talquetamab-tgvs</from_name>
		<from_code>2644448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin acetate</from_name>
		<from_code>1733680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talquetamab</from_name>
		<from_code>2644447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retatrutide</from_name>
		<from_code>2722410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
		<to_code>N0000000152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Receptor Agonists [MoA]</from_name>
		<from_code>N0000000106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E2 Receptor Agonists [MoA]</to_name>
		<to_code>N0000194042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Receptor Agonists [MoA]</from_name>
		<from_code>N0000000106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacyclin Receptor Agonists [MoA]</to_name>
		<to_code>N0000020068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>unoprostone</from_name>
		<from_code>1546408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>latanoprost acid</from_name>
		<from_code>2675687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>misoprostol</from_name>
		<from_code>42331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selexipag</from_name>
		<from_code>1729002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil diolamine</from_name>
		<from_code>1927409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl unoprostone</from_name>
		<from_code>135313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinoprostone</from_name>
		<from_code>3478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>travoprost</from_name>
		<from_code>283809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimatoprost</from_name>
		<from_code>283810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omidenepag isopropyl</from_name>
		<from_code>2612690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omidenepag</from_name>
		<from_code>2612691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin E1 Agonist [EPC]</from_name>
		<from_code>N0000180189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil sodium</from_name>
		<from_code>342691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacyclin Receptor Agonist [EPC]</from_name>
		<from_code>N0000192339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafluprost</from_name>
		<from_code>1244607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>latanoprost</from_name>
		<from_code>43611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin E2 Receptor Agonist [EPC]</from_name>
		<from_code>N0000194041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E2 Receptor Agonists [MoA]</to_name>
		<to_code>N0000194042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omidenepag</from_name>
		<from_code>2612691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E2 Receptor Agonists [MoA]</to_name>
		<to_code>N0000194042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloprost</from_name>
		<from_code>40138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacyclin Receptor Agonists [MoA]</to_name>
		<to_code>N0000020068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selexipag</from_name>
		<from_code>1729002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacyclin Receptor Agonists [MoA]</to_name>
		<to_code>N0000020068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine</from_name>
		<from_code>1815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride anhydrous</from_name>
		<from_code>1375412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride</from_name>
		<from_code>267396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacetin</from_name>
		<from_code>8113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pituitary Hormones Receptor Interactions [MoA]</from_name>
		<from_code>N0000000141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pituitary Hormones Receptor Interactions [MoA]</from_name>
		<from_code>N0000000141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix</from_name>
		<from_code>68147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormones Receptor Interactions [MoA]</to_name>
		<to_code>N0000000141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix acetate</from_name>
		<from_code>259338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormones Receptor Interactions [MoA]</to_name>
		<to_code>N0000000141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pituitary Hormone Receptor Agonists [MoA]</from_name>
		<from_code>N0000000165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Agonists [MoA]</to_name>
		<to_code>N0000194046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrem</from_name>
		<from_code>56570</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin hexahydrate</from_name>
		<from_code>1653802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin (recombinant DNA origin)</from_name>
		<from_code>314845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticorelin ovine triflutate</from_name>
		<from_code>74670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin</from_name>
		<from_code>2890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticorelin ovine</from_name>
		<from_code>74671</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin</from_name>
		<from_code>61148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin, E-coli derived</from_name>
		<from_code>259321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Agonists [MoA]</to_name>
		<to_code>N0000194046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terlipressin</from_name>
		<from_code>57048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Agonists [MoA]</to_name>
		<to_code>N0000194046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pituitary Hormone Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crinecerfont</from_name>
		<from_code>2701386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pituitary Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atosiban</from_name>
		<from_code>59639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000178376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atosiban acetate</from_name>
		<from_code>2680385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin V2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolvaptan</from_name>
		<from_code>358257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Interactions [MoA]</from_name>
		<from_code>N0000175362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Interactions [MoA]</from_name>
		<from_code>N0000175362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Agonists [MoA]</to_name>
		<to_code>N0000175363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atrasentan</from_name>
		<from_code>2710449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan</from_name>
		<from_code>75207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan monohydrate</from_name>
		<from_code>498193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprocitentan</from_name>
		<from_code>2679059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambrisentan</from_name>
		<from_code>358274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macitentan</from_name>
		<from_code>1442132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Interactions [MoA]</from_name>
		<from_code>N0000190997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Interactions [MoA]</from_name>
		<from_code>N0000190997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Agonists [MoA]</to_name>
		<to_code>N0000190999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daridorexant hydrochloride</from_name>
		<from_code>2591496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daridorexant</from_name>
		<from_code>2591497</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000191000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suvorexant</from_name>
		<from_code>1547099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemborexant</from_name>
		<from_code>2272403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000190998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA B Receptor Interactions [MoA]</from_name>
		<from_code>N0000000204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA B Receptor Interactions [MoA]</from_name>
		<from_code>N0000000204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Modulators [MoA]</to_name>
		<to_code>N0000000251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA B Receptor Interactions [MoA]</from_name>
		<from_code>N0000000204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Antagonists [MoA]</to_name>
		<to_code>N0000000229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Receptor Interactions [MoA]</to_name>
		<to_code>N0000000204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kava preparation</from_name>
		<from_code>285228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Receptor Interactions [MoA]</to_name>
		<to_code>N0000000204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Receptor Interactions [MoA]</to_name>
		<to_code>N0000000204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Receptor Interactions [MoA]</to_name>
		<to_code>N0000000204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopamide</from_name>
		<from_code>2603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium oxybate</from_name>
		<from_code>2387309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem tartrate</from_name>
		<from_code>221183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium oxybate</from_name>
		<from_code>9899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
		<from_code>N0000175759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
		<from_code>N0000183360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zaleplon</from_name>
		<from_code>74667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baclofen</from_name>
		<from_code>1292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital</from_name>
		<from_code>38077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybate</from_name>
		<from_code>2387302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotiazepam</from_name>
		<from_code>2622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium oxybate</from_name>
		<from_code>2387307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxybate</from_name>
		<from_code>2387308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital sodium</from_name>
		<from_code>314874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Agonists [MoA]</to_name>
		<to_code>N0000000116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Modulators [MoA]</to_name>
		<to_code>N0000000251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Modulators [MoA]</to_name>
		<to_code>N0000000251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentylenetetrazole</from_name>
		<from_code>8015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Antagonists [MoA]</to_name>
		<to_code>N0000000229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumazenil</from_name>
		<from_code>4457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA B Antagonists [MoA]</to_name>
		<to_code>N0000000229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurokinin 3 Receptor Interactions [MoA]</from_name>
		<from_code>N0000194092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurokinin 3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fezolinetant</from_name>
		<from_code>2637134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elinzanetant</from_name>
		<from_code>2725511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000194091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotide gallium ga-68</from_name>
		<from_code>2199391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotride</from_name>
		<from_code>2199392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanreotide acetate</from_name>
		<from_code>236167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide diaspartate</from_name>
		<from_code>1364104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide pamoate</from_name>
		<from_code>1597818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide</from_name>
		<from_code>1364105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanreotide</from_name>
		<from_code>68092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide</from_name>
		<from_code>7617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide acetate</from_name>
		<from_code>221130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paltusotine hydrochloride</from_name>
		<from_code>2724364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paltusotine</from_name>
		<from_code>2724363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lutetium Lu 177 dotatate</from_name>
		<from_code>1999335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukotriene Receptor Interactions [MoA]</from_name>
		<from_code>N0000000124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast</from_name>
		<from_code>88249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast sodium</from_name>
		<from_code>115713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zafirlukast</from_name>
		<from_code>114970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-Sensing Receptor Interactions [MoA]</from_name>
		<from_code>N0000020080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-Sensing Receptor Interactions [MoA]</from_name>
		<from_code>N0000020080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
		<from_code>N0000175902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinacalcet</from_name>
		<from_code>407990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinacalcet hydrochloride</from_name>
		<from_code>384379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etelcalcetide</from_name>
		<from_code>1876119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etelcalcetide hydrochloride</from_name>
		<from_code>1876122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
		<to_code>N0000020081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lysophospholipid Receptor Interactions [MoA]</from_name>
		<from_code>N0000181812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lysosphingolipid Receptor Interactions [MoA]</to_name>
		<to_code>N0000181813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lysophospholipid Receptor Interactions [MoA]</to_name>
		<to_code>N0000181812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lysosphingolipid Receptor Interactions [MoA]</from_name>
		<from_code>N0000181813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Interactions [MoA]</to_name>
		<to_code>N0000181814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sphingosine 1-Phosphate Receptor Interactions [MoA]</from_name>
		<from_code>N0000181814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>siponimod</from_name>
		<from_code>2121085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
		<from_code>N0000181816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod hydrochloride</from_name>
		<from_code>2288235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod</from_name>
		<from_code>2288236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod lauryl sulfate</from_name>
		<from_code>2610292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod</from_name>
		<from_code>1012892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod hydrochloride</from_name>
		<from_code>1012891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ponesimod</from_name>
		<from_code>2532300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
		<to_code>N0000181815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melatonin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melatonin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramelteon</from_name>
		<from_code>596205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tasimelteon</from_name>
		<from_code>1490468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypothalmic Hormone Interactions [MoA]</from_name>
		<from_code>N0000019992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000019993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypothalmic Hormone Interactions [MoA]</from_name>
		<from_code>N0000019992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000019994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin acetate</from_name>
		<from_code>236538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000019993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trelstar pamoate</from_name>
		<from_code>905060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000019993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin</from_name>
		<from_code>38782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000019993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin pamoate</from_name>
		<from_code>338529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000019993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abarelix</from_name>
		<from_code>301739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypothalamic Hormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000019994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bradykinin Receptor Interactions [MoA]</from_name>
		<from_code>N0000182962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bradykinin Receptor Antagonists [MoA]</from_name>
		<from_code>N0000182963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icatibant</from_name>
		<from_code>1148138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icatibant acetate</from_name>
		<from_code>1294605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bradykinin B2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000182965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease-activated Receptor Interactions [MoA]</from_name>
		<from_code>N0000190993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Interactions [MoA]</to_name>
		<to_code>N0000190994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease-activated Receptor-1 Interactions [MoA]</from_name>
		<from_code>N0000190994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
		<to_code>N0000190995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar sulfate</from_name>
		<from_code>1537050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
		<to_code>N0000190995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease-activated Receptor-1 Antagonist [EPC]</from_name>
		<from_code>N0000190996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
		<to_code>N0000190995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar</from_name>
		<from_code>1537034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
		<to_code>N0000190995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurokinin 1 Receptor Interactions [MoA]</from_name>
		<from_code>N0000010261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant chloride hydrochloride</from_name>
		<from_code>2044416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elinzanetant</from_name>
		<from_code>2725511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant</from_name>
		<from_code>2044417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 1 Antagonists [MoA]</to_name>
		<to_code>N0000010262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Interactions [MoA]</from_name>
		<from_code>N0000175787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Interactions [MoA]</from_name>
		<from_code>N0000175787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Antagonists [MoA]</from_name>
		<from_code>N0000175789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyphylline</from_name>
		<from_code>3714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib</from_name>
		<from_code>2044896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>istradefylline</from_name>
		<from_code>2199015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyridamole</from_name>
		<from_code>3521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib disodium</from_name>
		<from_code>2055929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
		<from_code>N0000182142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel</from_name>
		<from_code>613391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel bisulfate</from_name>
		<from_code>236991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor tetrasodium</from_name>
		<from_code>1656051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor</from_name>
		<from_code>1656052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticagrelor</from_name>
		<from_code>1116632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel hydrochloride</from_name>
		<from_code>847020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000182143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine phosphate disodium</from_name>
		<from_code>1306123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine monophosphate</from_name>
		<from_code>309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regadenoson anhydrous</from_name>
		<from_code>1546015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine triphosphate</from_name>
		<from_code>318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Agonist [EPC]</from_name>
		<from_code>N0000178375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine</from_name>
		<from_code>296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regadenoson</from_name>
		<from_code>640062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonists [MoA]</to_name>
		<to_code>N0000175788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine hydrochloride</from_name>
		<from_code>282415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine sulfate</from_name>
		<from_code>621</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine</from_name>
		<from_code>620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa anhydrous</from_name>
		<from_code>1545982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levodopa</from_name>
		<from_code>6375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarbidopa</from_name>
		<from_code>2695774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foslevodopa</from_name>
		<from_code>2695775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa</from_name>
		<from_code>2019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine Antagonists [MoA]</from_name>
		<from_code>N0000000230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>periciazine</from_name>
		<from_code>8766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine</from_name>
		<from_code>10471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacetazine</from_name>
		<from_code>8338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol</from_name>
		<from_code>10804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine dimalonate</from_name>
		<from_code>236771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine</from_name>
		<from_code>8042</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine maleate</from_name>
		<from_code>71529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol hydrochloride</from_name>
		<from_code>236140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penfluridol</from_name>
		<from_code>7974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Antagonists [MoA]</to_name>
		<to_code>N0000000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluspirilene</from_name>
		<from_code>4507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dordaviprone hydrochloride</from_name>
		<from_code>2721193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dordaviprone</from_name>
		<from_code>2721194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone maleate</from_name>
		<from_code>236099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertindole</from_name>
		<from_code>41996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone</from_name>
		<from_code>3626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amisulpride</from_name>
		<from_code>46303</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine D2 Antagonists [MoA]</to_name>
		<to_code>N0000175799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide mesylate</from_name>
		<from_code>8048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopaminergic Agonist [EPC]</from_name>
		<from_code>N0000175580</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot-derived Dopamine Receptor Agonist [EPC]</from_name>
		<from_code>N0000175767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam mesylate</from_name>
		<from_code>203151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>armodafinil</from_name>
		<from_code>641465</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropinirole</from_name>
		<from_code>72302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam</from_name>
		<from_code>24853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piribedil</from_name>
		<from_code>8353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabergoline</from_name>
		<from_code>47579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibopamine</from_name>
		<from_code>51253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piribedil mesylate</from_name>
		<from_code>236380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotigotine</from_name>
		<from_code>616739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonergot Dopamine Agonist [EPC]</from_name>
		<from_code>N0000175768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropinirole hydrochloride</from_name>
		<from_code>236553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole</from_name>
		<from_code>746741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide</from_name>
		<from_code>8047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apomorphine</from_name>
		<from_code>1043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apomorphine hydrochloride</from_name>
		<from_code>71225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibopamine hydrochloride</from_name>
		<from_code>284157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole dihydrochloride</from_name>
		<from_code>236747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Agonists [MoA]</to_name>
		<to_code>N0000000117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Interactions [MoA]</from_name>
		<from_code>N0000193942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin Receptor Agonists [MoA]</to_name>
		<to_code>N0000194030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Agonists [MoA]</from_name>
		<from_code>N0000194030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin 4 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin Receptor Agonists [MoA]</to_name>
		<to_code>N0000194030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide</from_name>
		<from_code>2176312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin Receptor Agonists [MoA]</to_name>
		<to_code>N0000194030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>setmelanotide</from_name>
		<from_code>2469247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin 4 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin 4 Receptor Agonist [EPC]</from_name>
		<from_code>N0000193940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin 4 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan medoxomil</from_name>
		<from_code>1091642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan</from_name>
		<from_code>1091643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan kamedoxomil</from_name>
		<from_code>1294597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan medoxomil</from_name>
		<from_code>1091642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan</from_name>
		<from_code>1091643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000180999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement 5a Receptor Interactions [MoA]</from_name>
		<from_code>N0000193975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacopan</from_name>
		<from_code>2572100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement 5a Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Smoothened Receptor Interactions [MoA]</from_name>
		<from_code>N0000184147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sonidegib phosphate</from_name>
		<from_code>1659192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sonidegib</from_name>
		<from_code>1659191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vismodegib</from_name>
		<from_code>1242987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000184149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glasdegib maleate</from_name>
		<from_code>2105844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glasdegib</from_name>
		<from_code>2105845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Smoothened Receptor Antagonists [MoA]</to_name>
		<to_code>N0000184148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Secretin Receptor Interactions [MoA]</from_name>
		<from_code>N0000020077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin Receptor Agonists [MoA]</to_name>
		<to_code>N0000020078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Secretin Receptor Interactions [MoA]</from_name>
		<from_code>N0000020077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secretin</from_name>
		<from_code>9627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin Receptor Agonists [MoA]</to_name>
		<to_code>N0000020078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secretin acetate</from_name>
		<from_code>408108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin Receptor Agonists [MoA]</to_name>
		<to_code>N0000020078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid Receptor Interactions [MoA]</from_name>
		<from_code>N0000181007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000181008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid Receptor Interactions [MoA]</from_name>
		<from_code>N0000181007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid [EPC]</from_name>
		<from_code>N0000175782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000181008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000181008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
		<to_code>N0000181008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon Receptor Interactions [MoA]</from_name>
		<from_code>N0000010275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</to_name>
		<to_code>N0000020057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon Receptor Interactions [MoA]</from_name>
		<from_code>N0000010275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</to_name>
		<to_code>N0000190989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Interactions [MoA]</to_name>
		<to_code>N0000010275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Interactions [MoA]</to_name>
		<to_code>N0000010275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon Receptor Interactions [MoA]</to_name>
		<to_code>N0000010275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</from_name>
		<from_code>N0000020057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Antagonists [MoA]</to_name>
		<to_code>N0000020059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</from_name>
		<from_code>N0000020057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirzepatide</from_name>
		<from_code>2601723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</to_name>
		<to_code>N0000020057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirzepatide</from_name>
		<from_code>2601723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exenatide</from_name>
		<from_code>60548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lixisenatide</from_name>
		<from_code>1440051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albiglutide</from_name>
		<from_code>1534763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dulaglutide</from_name>
		<from_code>1551291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semaglutide</from_name>
		<from_code>1991302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liraglutide</from_name>
		<from_code>475968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retatrutide</from_name>
		<from_code>2722410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
		<to_code>N0000020058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</from_name>
		<from_code>N0000190989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</to_name>
		<to_code>N0000190990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</from_name>
		<from_code>N0000190989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-2 (GLP-2) Antagonists [MoA]</to_name>
		<to_code>N0000190991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teduglutide</from_name>
		<from_code>1364468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</to_name>
		<to_code>N0000190990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-2 Analog [EPC]</from_name>
		<from_code>N0000190992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</to_name>
		<to_code>N0000190990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone</from_name>
		<from_code>2672253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone hydrochloride</from_name>
		<from_code>2672254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin tartrate</from_name>
		<from_code>1791686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Antagonists [MoA]</from_name>
		<from_code>N0000000130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Antagonists [MoA]</from_name>
		<from_code>N0000000130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Antagonists [MoA]</to_name>
		<to_code>N0000000130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-4 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Agonists [MoA]</from_name>
		<from_code>N0000000256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Agonists [MoA]</from_name>
		<from_code>N0000000256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Agonists [MoA]</from_name>
		<from_code>N0000000256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Agonists [MoA]</from_name>
		<from_code>N0000000256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
		<to_code>N0000185009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Agonists [MoA]</from_name>
		<from_code>N0000000256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone</from_name>
		<from_code>1827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone</from_name>
		<from_code>2672253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertindole</from_name>
		<from_code>41996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone hydrochloride</from_name>
		<from_code>2672254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Agonists [MoA]</to_name>
		<to_code>N0000000256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 4 Receptor Agonists [MoA]</to_name>
		<to_code>N0000193870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
		<to_code>N0000175764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
		<to_code>N0000175763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride hemihydrate</from_name>
		<from_code>1597623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
		<to_code>N0000185009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-2c Receptor Agonist [EPC]</from_name>
		<from_code>N0000185010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
		<to_code>N0000185009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride anhydrous</from_name>
		<from_code>1808546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
		<to_code>N0000185009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin</from_name>
		<from_code>1300701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
		<to_code>N0000185009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride</from_name>
		<from_code>1300700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
		<to_code>N0000185009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin 1 Receptor Agonists [MoA]</from_name>
		<from_code>N0000193868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 1a Receptor Agonists [MoA]</to_name>
		<to_code>N0000193869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Inverse Agonists [MoA]</to_name>
		<to_code>N0000194052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Agonists [MoA]</to_name>
		<to_code>N0000000112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Antagonists [MoA]</from_name>
		<from_code>N0000000207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate, (R)-</from_name>
		<from_code>2622915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihistamine [EPC]</from_name>
		<from_code>N0000175750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant</from_name>
		<from_code>2197878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant hydrochloride</from_name>
		<from_code>2197879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H3 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline</from_name>
		<from_code>6821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline bromide</from_name>
		<from_code>91163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine resin complex</from_name>
		<from_code>314786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine</from_name>
		<from_code>33408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine hydrochloride</from_name>
		<from_code>82019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bampine hydrochloride</from_name>
		<from_code>236519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine hydrochloride</from_name>
		<from_code>1294532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine</from_name>
		<from_code>10849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcaftadine</from_name>
		<from_code>1000082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine tannate</from_name>
		<from_code>686390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine</from_name>
		<from_code>863035</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline phosphate</from_name>
		<from_code>866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine</from_name>
		<from_code>135391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bamipine lactate</from_name>
		<from_code>236530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine hydrochloride</from_name>
		<from_code>71534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine</from_name>
		<from_code>18603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen</from_name>
		<from_code>6146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine</from_name>
		<from_code>22696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine difumarate</from_name>
		<from_code>221094</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine hydrochloride</from_name>
		<from_code>236961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine hydrochloride</from_name>
		<from_code>203150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine hydrochloride</from_name>
		<from_code>236599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline</from_name>
		<from_code>865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loratadine</from_name>
		<from_code>28889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine besilate</from_name>
		<from_code>658552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene</from_name>
		<from_code>6822</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline hydrochloride</from_name>
		<from_code>81954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine</from_name>
		<from_code>4459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine hydrochloride</from_name>
		<from_code>236474</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine tannate</from_name>
		<from_code>1099727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene hydrochloride</from_name>
		<from_code>235721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine hydrochloride</from_name>
		<from_code>235824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine</from_name>
		<from_code>33283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine maleate</from_name>
		<from_code>48936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine</from_name>
		<from_code>39684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequitazine</from_name>
		<from_code>29528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine</from_name>
		<from_code>2354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine hydrochloride</from_name>
		<from_code>235725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine polistirex</from_name>
		<from_code>236792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide</from_name>
		<from_code>52151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceprometazine</from_name>
		<from_code>161203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenylpyraline hydrochloride</from_name>
		<from_code>203155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline sulfate</from_name>
		<from_code>2680384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine</from_name>
		<from_code>20610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine</from_name>
		<from_code>28144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terfenadine</from_name>
		<from_code>42330</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine tartrate</from_name>
		<from_code>221137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine citrate</from_name>
		<from_code>221141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen fumarate</from_name>
		<from_code>11404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine</from_name>
		<from_code>87636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate, (R)-</from_name>
		<from_code>2622915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desloratadine</from_name>
		<from_code>275635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astemizole</from_name>
		<from_code>42328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide tromethamine</from_name>
		<from_code>28859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine</from_name>
		<from_code>28627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bamipine</from_name>
		<from_code>18753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Receptor Inverse Agonists [MoA]</from_name>
		<from_code>N0000194052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H3 Receptor Inverse Agonists [MoA]</to_name>
		<to_code>N0000194051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant</from_name>
		<from_code>2197878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H3 Receptor Inverse Agonists [MoA]</to_name>
		<to_code>N0000194051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
		<from_code>N0000194053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine H3 Receptor Inverse Agonists [MoA]</to_name>
		<to_code>N0000194051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine Agonists [MoA]</to_name>
		<to_code>N0000000112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Receptor Interactions [MoA]</from_name>
		<from_code>N0000000200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Receptor Interactions [MoA]</from_name>
		<from_code>N0000000200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alphaprodine hydrochloride</from_name>
		<from_code>7433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Receptor Interactions [MoA]</to_name>
		<to_code>N0000000200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alphaprodine</from_name>
		<from_code>594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Receptor Interactions [MoA]</to_name>
		<to_code>N0000000200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonists [MoA]</from_name>
		<from_code>N0000000174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonists [MoA]</from_name>
		<from_code>N0000000174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone hydrochloride</from_name>
		<from_code>218337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difelikefalin</from_name>
		<from_code>2569089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol hydrochloride</from_name>
		<from_code>857492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oliceridine</from_name>
		<from_code>2392230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difelikefalin acetate</from_name>
		<from_code>2569090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl acetate hydrochloride</from_name>
		<from_code>82043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dezocine</from_name>
		<from_code>22713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oliceridine fumarate</from_name>
		<from_code>2392633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl</from_name>
		<from_code>237005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone</from_name>
		<from_code>6813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonists [MoA]</to_name>
		<to_code>N0000000174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist [EPC]</from_name>
		<from_code>N0000175689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine</from_name>
		<from_code>1819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine hydrochloride</from_name>
		<from_code>203841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonists [MoA]</to_name>
		<to_code>N0000175685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Full Opioid Agonists [MoA]</from_name>
		<from_code>N0000175684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Full Opioid Agonists [MoA]</from_name>
		<from_code>N0000175684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid kappa Receptor Agonists [MoA]</to_name>
		<to_code>N0000194007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil hydrochloride</from_name>
		<from_code>203203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone polistirex</from_name>
		<from_code>221107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil</from_name>
		<from_code>56795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene</from_name>
		<from_code>8785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol</from_name>
		<from_code>10689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil</from_name>
		<from_code>480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene hydrochloride</from_name>
		<from_code>71517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol hydrochloride</from_name>
		<from_code>82110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol hydrochloride</from_name>
		<from_code>857492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone hydrochloride</from_name>
		<from_code>203177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone</from_name>
		<from_code>3423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene napsylate</from_name>
		<from_code>8786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone</from_name>
		<from_code>6813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil</from_name>
		<from_code>480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil hydrochloride</from_name>
		<from_code>236540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil hydrochloride</from_name>
		<from_code>203203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil citrate</from_name>
		<from_code>58964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone hydrochloride</from_name>
		<from_code>218337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone bitartrate</from_name>
		<from_code>142439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone resin complex</from_name>
		<from_code>314667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil</from_name>
		<from_code>73032</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Opioid Agonists [MoA]</to_name>
		<to_code>N0000175684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone</from_name>
		<from_code>3423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone bitartrate</from_name>
		<from_code>142439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone hydrochloride</from_name>
		<from_code>2122776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone tannate</from_name>
		<from_code>597355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>mu-Opioid Receptor Agonist [EPC]</from_name>
		<from_code>N0000191867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone polistirex</from_name>
		<from_code>221107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine tosylate</from_name>
		<from_code>1876598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine</from_name>
		<from_code>1876597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone hydrochloride</from_name>
		<from_code>203177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone hydrochloride</from_name>
		<from_code>236931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone resin complex</from_name>
		<from_code>314667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
		<to_code>N0000191866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kappa Opioid Receptor Agonist [EPC]</from_name>
		<from_code>N0000194001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid kappa Receptor Agonists [MoA]</to_name>
		<to_code>N0000194007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difelikefalin</from_name>
		<from_code>2569089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid kappa Receptor Agonists [MoA]</to_name>
		<to_code>N0000194007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonists [MoA]</from_name>
		<from_code>N0000000154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonists [MoA]</from_name>
		<from_code>N0000000154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alvimopan</from_name>
		<from_code>480639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone</from_name>
		<from_code>7242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan L-malate</from_name>
		<from_code>2570387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnaltrexone</from_name>
		<from_code>29899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine</from_name>
		<from_code>1876597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine tosylate</from_name>
		<from_code>1876598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride</from_name>
		<from_code>203192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnaltrexone bromide</from_name>
		<from_code>979111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine hydrochloride</from_name>
		<from_code>203841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride dihydrate</from_name>
		<from_code>1010598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan</from_name>
		<from_code>2559612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dezocine</from_name>
		<from_code>22713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine</from_name>
		<from_code>1819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol</from_name>
		<from_code>1551777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene hydrochloride</from_name>
		<from_code>236069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene</from_name>
		<from_code>31479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol oxalate</from_name>
		<from_code>1593586</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alvimopan anhydrous</from_name>
		<from_code>1516803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonists [MoA]</to_name>
		<to_code>N0000000154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alvimopan anhydrous</from_name>
		<from_code>1516803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine hydrochloride</from_name>
		<from_code>203841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist [EPC]</from_name>
		<from_code>N0000175689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alvimopan</from_name>
		<from_code>480639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine</from_name>
		<from_code>1819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Opioid Antagonists [MoA]</to_name>
		<to_code>N0000175686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Receptor Interactions [MoA]</from_name>
		<from_code>N0000000097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Receptor Interactions [MoA]</from_name>
		<from_code>N0000000097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Interactions [MoA]</from_name>
		<from_code>N0000175368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide anhydrous</from_name>
		<from_code>1445143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium</from_name>
		<from_code>21232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperidolate</from_name>
		<from_code>59064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium</from_name>
		<from_code>1546438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Antagonists [MoA]</from_name>
		<from_code>N0000175370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solifenacin</from_name>
		<from_code>322167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine</from_name>
		<from_code>27084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium</from_name>
		<from_code>2689322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine hydrochloride</from_name>
		<from_code>142443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide, anhydrous</from_name>
		<from_code>2462023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperidolate hydrochloride</from_name>
		<from_code>102170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium</from_name>
		<from_code>69120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisotropine</from_name>
		<from_code>89780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine tartrate</from_name>
		<from_code>221174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine</from_name>
		<from_code>119565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium cation</from_name>
		<from_code>1546373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclidinium</from_name>
		<from_code>1303098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fesoterodine</from_name>
		<from_code>797195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine</from_name>
		<from_code>8718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline</from_name>
		<from_code>6821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine</from_name>
		<from_code>8352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopentolate</from_name>
		<from_code>3001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline bromide</from_name>
		<from_code>91163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclidinium bromide</from_name>
		<from_code>1303097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darifenacin</from_name>
		<from_code>136198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropicamide</from_name>
		<from_code>10869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umeclidinium bromide</from_name>
		<from_code>1487512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide monohydrate</from_name>
		<from_code>1298831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide monohydrate</from_name>
		<from_code>1309404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide mono</from_name>
		<from_code>1552007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide</from_name>
		<from_code>89784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium bromide</from_name>
		<from_code>2689321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umeclidinium</from_name>
		<from_code>1487514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate hydrochloride</from_name>
		<from_code>142437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide iodide</from_name>
		<from_code>6051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium bromide</from_name>
		<from_code>48212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trospium chloride</from_name>
		<from_code>38891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fesoterodine fumarate</from_name>
		<from_code>797196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revefenacin</from_name>
		<from_code>2102775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darifenacin hydrobromide</from_name>
		<from_code>485417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solifenacin succinate</from_name>
		<from_code>476588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide</from_name>
		<from_code>393575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octotropine methylbromide</from_name>
		<from_code>17945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trospium</from_name>
		<from_code>236778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropatepine hydrochloride</from_name>
		<from_code>236190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine hydrochloride</from_name>
		<from_code>235775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium</from_name>
		<from_code>7213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropatepine</from_name>
		<from_code>38876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopentolate hydrochloride</from_name>
		<from_code>106029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate</from_name>
		<from_code>4440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
		<to_code>N0000000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine</from_name>
		<from_code>8328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Agonist [EPC]</from_name>
		<from_code>N0000175840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine</from_name>
		<from_code>194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclidine hydrochloride</from_name>
		<from_code>2721767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine methylbromide</from_name>
		<from_code>27085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine hydrobromide</from_name>
		<from_code>235428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine chloride</from_name>
		<from_code>20814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline</from_name>
		<from_code>2694828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine hydrochloride</from_name>
		<from_code>235426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline</from_name>
		<from_code>44281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine</from_name>
		<from_code>27084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclidine</from_name>
		<from_code>2721766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDART</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline tartrate</from_name>
		<from_code>2694829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline hydrochloride anhydrous</from_name>
		<from_code>2698548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline hydrochloride</from_name>
		<from_code>260036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbachol</from_name>
		<from_code>1999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine nitrate</from_name>
		<from_code>103244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Agonists [MoA]</from_name>
		<from_code>N0000175369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
		<to_code>N0000000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Interactions [MoA]</from_name>
		<from_code>N0000000153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Antagonists [MoA]</to_name>
		<to_code>N0000000092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Interactions [MoA]</from_name>
		<from_code>N0000000153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Antagonists [MoA]</from_name>
		<from_code>N0000000092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Antagonists [MoA]</from_name>
		<from_code>N0000000092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium</from_name>
		<from_code>19685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Antagonists [MoA]</to_name>
		<to_code>N0000000092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium tosylate</from_name>
		<from_code>1737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Antagonists [MoA]</to_name>
		<to_code>N0000000092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic beta-Antagonists [MoA]</from_name>
		<from_code>N0000000161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic beta-Antagonists [MoA]</from_name>
		<from_code>N0000000161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amosulalol hydrochloride</from_name>
		<from_code>2667255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol</from_name>
		<from_code>1520</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepindolol</from_name>
		<from_code>29518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine chloride</from_name>
		<from_code>40165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amosulalol</from_name>
		<from_code>2667256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepindolol sulfate</from_name>
		<from_code>236904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine</from_name>
		<from_code>155080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talinolol</from_name>
		<from_code>37546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobunolol</from_name>
		<from_code>1813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tertatolol hydrochloride</from_name>
		<from_code>236374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadoxolol hydrochloride</from_name>
		<from_code>236178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol hydrochloride</from_name>
		<from_code>236883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobunolol hydrochloride</from_name>
		<from_code>227212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tertatolol</from_name>
		<from_code>37840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadoxolol</from_name>
		<from_code>31462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobetaxolol</from_name>
		<from_code>353497</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol</from_name>
		<from_code>31555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metipranolol hydrochloride</from_name>
		<from_code>314731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metipranolol</from_name>
		<from_code>10824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol hydrochloride</from_name>
		<from_code>142144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobetaxolol hydrochloride</from_name>
		<from_code>261718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Antagonists [MoA]</to_name>
		<to_code>N0000000161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol hydrochloride</from_name>
		<from_code>236806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol</from_name>
		<from_code>1817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bopindolol hydrogen malonate</from_name>
		<from_code>236903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol</from_name>
		<from_code>597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol</from_name>
		<from_code>7801</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol hydrochloride</from_name>
		<from_code>81947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carazolol</from_name>
		<from_code>20192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bopindolol</from_name>
		<from_code>19605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol hydrochloride</from_name>
		<from_code>203131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
		<to_code>N0000009924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol</from_name>
		<from_code>597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol</from_name>
		<from_code>7801</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobetaxolol hydrochloride</from_name>
		<from_code>261718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol hydrochloride</from_name>
		<from_code>236806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol hydrochloride</from_name>
		<from_code>142144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol</from_name>
		<from_code>1817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bopindolol hydrogen malonate</from_name>
		<from_code>236903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bopindolol</from_name>
		<from_code>19605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>practolol</from_name>
		<from_code>8620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobetaxolol</from_name>
		<from_code>353497</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol hydrochloride</from_name>
		<from_code>203131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>landiolol</from_name>
		<from_code>2712070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol hydrochloride</from_name>
		<from_code>81947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carazolol</from_name>
		<from_code>20192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol</from_name>
		<from_code>1520</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>landiolol hydrochloride</from_name>
		<from_code>2712069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
		<to_code>N0000009923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic alpha-Antagonists [MoA]</from_name>
		<from_code>N0000000099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic alpha-Antagonists [MoA]</from_name>
		<from_code>N0000000099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamsulosin</from_name>
		<from_code>77492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine hydrochloride</from_name>
		<from_code>133041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine</from_name>
		<from_code>220982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine hydrochloride</from_name>
		<from_code>71512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine mesylate</from_name>
		<from_code>227240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine</from_name>
		<from_code>8149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamsulosin hydrochloride</from_name>
		<from_code>236495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride</from_name>
		<from_code>235224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin</from_name>
		<from_code>37798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacetazine</from_name>
		<from_code>8338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapiprazole hydrochloride</from_name>
		<from_code>235757</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin</from_name>
		<from_code>49276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin hydrochloride</from_name>
		<from_code>203210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine</from_name>
		<from_code>8153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin mesylate</from_name>
		<from_code>39173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>periciazine</from_name>
		<from_code>8766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin</from_name>
		<from_code>8629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapiprazole</from_name>
		<from_code>22298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride anhydrous</from_name>
		<from_code>1299927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
		<to_code>N0000000099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamsulosin hydrochloride</from_name>
		<from_code>236495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin mesylate</from_name>
		<from_code>39173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amosulalol</from_name>
		<from_code>2667256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin hydrochloride</from_name>
		<from_code>46043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin</from_name>
		<from_code>49276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urapidil</from_name>
		<from_code>39230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amosulalol hydrochloride</from_name>
		<from_code>2667255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamsulosin</from_name>
		<from_code>77492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
		<to_code>N0000009919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atipamezole</from_name>
		<from_code>18475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atipamezole hydrochloride</from_name>
		<from_code>390043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
		<to_code>N0000009920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Agonists [MoA]</from_name>
		<from_code>N0000000122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Agonists [MoA]</from_name>
		<from_code>N0000000122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin</from_name>
		<from_code>23410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrate</from_name>
		<from_code>283561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnorepinephrine</from_name>
		<from_code>156240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine</from_name>
		<from_code>39684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnorepinephrine hydrochloride</from_name>
		<from_code>289080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-hydroxyamphetamine</from_name>
		<from_code>7839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyamphetamine hydrobromide</from_name>
		<from_code>82066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine sulfate</from_name>
		<from_code>82042</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine hydrochloride</from_name>
		<from_code>236481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin hydrochloride</from_name>
		<from_code>203156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine</from_name>
		<from_code>6756</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Agonists [MoA]</to_name>
		<to_code>N0000000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic alpha-Agonists [MoA]</from_name>
		<from_code>N0000000209</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic alpha-Agonists [MoA]</from_name>
		<from_code>N0000000209</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrozoline hydrochloride</from_name>
		<from_code>57983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin hydrochloride</from_name>
		<from_code>203156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octopamine hydrochloride</from_name>
		<from_code>1744461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine, DL-</from_name>
		<from_code>1657875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noradrenaline hydrochloride</from_name>
		<from_code>2256931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine</from_name>
		<from_code>7512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrate</from_name>
		<from_code>283561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine</from_name>
		<from_code>8163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine bitartrate</from_name>
		<from_code>221140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine</from_name>
		<from_code>39684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine</from_name>
		<from_code>8175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine hydrochloride</from_name>
		<from_code>8164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline hydrochloride</from_name>
		<from_code>82054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline hydrochloride</from_name>
		<from_code>106101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine hydrochloride</from_name>
		<from_code>3266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine</from_name>
		<from_code>134615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrozoline</from_name>
		<from_code>37935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine tannate</from_name>
		<from_code>221139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine hydrochloride</from_name>
		<from_code>91350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline</from_name>
		<from_code>7812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline</from_name>
		<from_code>7247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnorepinephrine hydrochloride</from_name>
		<from_code>289080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine tartrate</from_name>
		<from_code>39171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octopamine</from_name>
		<from_code>1311141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine bitartrate</from_name>
		<from_code>91167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline nitrate</from_name>
		<from_code>235810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine hydrochloride</from_name>
		<from_code>236961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine</from_name>
		<from_code>14845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin</from_name>
		<from_code>23410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha-Agonists [MoA]</to_name>
		<to_code>N0000000209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine hydrochloride</from_name>
		<from_code>236460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine hydrochloride</from_name>
		<from_code>91350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline</from_name>
		<from_code>39841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine</from_name>
		<from_code>134615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine</from_name>
		<from_code>40114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline hydrochloride</from_name>
		<from_code>54220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine</from_name>
		<from_code>48937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine</from_name>
		<from_code>28863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine</from_name>
		<from_code>14845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz</from_name>
		<from_code>5033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz acetate</from_name>
		<from_code>227225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine tartrate</from_name>
		<from_code>39171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine hydrochloride</from_name>
		<from_code>228054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine</from_name>
		<from_code>57258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guafacine hydrochloride</from_name>
		<from_code>862004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine hydrochloride</from_name>
		<from_code>235853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
		<to_code>N0000009918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine</from_name>
		<from_code>28863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine bitartrate</from_name>
		<from_code>91167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine tannate</from_name>
		<from_code>221139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline</from_name>
		<from_code>39841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-1 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000186105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine</from_name>
		<from_code>8163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine hydrochloride</from_name>
		<from_code>228054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine hydrochloride</from_name>
		<from_code>235853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine hydrochloride</from_name>
		<from_code>8164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline hydrochloride</from_name>
		<from_code>54220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine</from_name>
		<from_code>48937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
		<to_code>N0000009917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic beta-Agonists [MoA]</from_name>
		<from_code>N0000000245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta3-Agonists [MoA]</to_name>
		<to_code>N0000185007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic beta-Agonists [MoA]</from_name>
		<from_code>N0000000245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic beta-Agonists [MoA]</from_name>
		<from_code>N0000000245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine hydrochloride</from_name>
		<from_code>203121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine</from_name>
		<from_code>6066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine hydrochloride</from_name>
		<from_code>82033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrate</from_name>
		<from_code>283561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine</from_name>
		<from_code>3616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta-Agonists [MoA]</to_name>
		<to_code>N0000000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta3-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000185008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta3-Agonists [MoA]</to_name>
		<to_code>N0000185007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirabegron</from_name>
		<from_code>1300786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta3-Agonists [MoA]</to_name>
		<to_code>N0000185007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vibegron</from_name>
		<from_code>2472254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta3-Agonists [MoA]</to_name>
		<to_code>N0000185007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine hydrochloride</from_name>
		<from_code>102397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate</from_name>
		<from_code>236216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine hydrochloride</from_name>
		<from_code>105470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol</from_name>
		<from_code>25255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol sulfate</from_name>
		<from_code>142153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate dihydrate</from_name>
		<from_code>998038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitolterol mesylate</from_name>
		<from_code>47187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitolterol</from_name>
		<from_code>19499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bambuterol hydrochloride</from_name>
		<from_code>235862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levalbuterol</from_name>
		<from_code>237159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arformoterol</from_name>
		<from_code>304962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaproterenol</from_name>
		<from_code>7688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoterol</from_name>
		<from_code>4333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol HCl</from_name>
		<from_code>235447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olodaterol hydrochloride</from_name>
		<from_code>1546396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levalbuterol hydrochloride</from_name>
		<from_code>237160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol xinafoate</from_name>
		<from_code>72616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin</from_name>
		<from_code>23410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline hydrochloride</from_name>
		<from_code>54220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine mesylate</from_name>
		<from_code>6024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin hydrochloride</from_name>
		<from_code>203156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olodaterol</from_name>
		<from_code>1546059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arformoterol tartrate</from_name>
		<from_code>668284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bambuterol</from_name>
		<from_code>18751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol</from_name>
		<from_code>33767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline</from_name>
		<from_code>39841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol</from_name>
		<from_code>36117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol trifenatate</from_name>
		<from_code>1424883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol acetate</from_name>
		<from_code>221142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine</from_name>
		<from_code>9392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaproterenol sulfate</from_name>
		<from_code>6804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoterol hydrobromide</from_name>
		<from_code>203124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indacaterol</from_name>
		<from_code>1114326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levalbuterol tartrate</from_name>
		<from_code>487066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol</from_name>
		<from_code>435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine</from_name>
		<from_code>6023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol</from_name>
		<from_code>1424884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indacaterol maleate</from_name>
		<from_code>1114325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline</from_name>
		<from_code>10368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline sulfate</from_name>
		<from_code>10369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta2-Agonists [MoA]</to_name>
		<to_code>N0000009922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine</from_name>
		<from_code>7512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine</from_name>
		<from_code>3616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin</from_name>
		<from_code>23410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noradrenaline hydrochloride</from_name>
		<from_code>2256931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline</from_name>
		<from_code>39841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine, DL-</from_name>
		<from_code>1657875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline hydrochloride</from_name>
		<from_code>54220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine hydrochloride</from_name>
		<from_code>203121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin hydrochloride</from_name>
		<from_code>203156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic beta1-Agonists [MoA]</to_name>
		<to_code>N0000009921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Secretagogue Receptor Interactions [MoA]</from_name>
		<from_code>N0000193787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
		<to_code>N0000193786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macimorelin</from_name>
		<from_code>1999420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
		<to_code>N0000193786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macimorelin acetate</from_name>
		<from_code>1999419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
		<to_code>N0000193786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrogon</from_name>
		<from_code>2644503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
		<to_code>N0000193786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrogon-ghla</from_name>
		<from_code>2644513</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
		<to_code>N0000193786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Secretagogue Receptor Agonist [EPC]</from_name>
		<from_code>N0000193785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
		<to_code>N0000193786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathormone Receptor Interactions [MoA]</from_name>
		<from_code>N0000000068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathormone Receptor Interactions [MoA]</from_name>
		<from_code>N0000000068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathormone Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abaloparatide</from_name>
		<from_code>1921069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathormone Receptor Agonists [MoA]</to_name>
		<to_code>N0000000158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Interactions [MoA]</from_name>
		<from_code>N0000175368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Interactions [MoA]</from_name>
		<from_code>N0000175368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Interactions [MoA]</from_name>
		<from_code>N0000175368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Receptor Interactions [MoA]</from_name>
		<from_code>N0000000199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000000143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Receptor Interactions [MoA]</from_name>
		<from_code>N0000000199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000000227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000188380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Receptor Interactions [MoA]</to_name>
		<to_code>N0000000199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
		<from_code>N0000000143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
		<from_code>N0000000143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
		<from_code>N0000000143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
		<from_code>N0000000143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Ganglionic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Agonists [MoA]</from_name>
		<from_code>N0000175369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000000143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metocurine iodide</from_name>
		<from_code>203206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000000143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000000143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000000143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine</from_name>
		<from_code>10154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride dihydrate</from_name>
		<from_code>2397714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suxamethonium bromide</from_name>
		<from_code>121039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine iodide</from_name>
		<from_code>262295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride</from_name>
		<from_code>3565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varenicline tartrate</from_name>
		<from_code>636674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varenicline</from_name>
		<from_code>591622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
		<to_code>N0000175701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
		<from_code>N0000000227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
		<from_code>N0000000227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
		<from_code>N0000000227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
		<from_code>N0000000227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000000227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine</from_name>
		<from_code>6673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000000227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Antagonists [MoA]</from_name>
		<from_code>N0000175370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000000227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine hydrochloride</from_name>
		<from_code>91240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000000227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000000227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine</from_name>
		<from_code>10917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium besylate</from_name>
		<from_code>1219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium chloride</from_name>
		<from_code>49275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium bromide</from_name>
		<from_code>32521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium</from_name>
		<from_code>71535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium</from_name>
		<from_code>262100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium</from_name>
		<from_code>33742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium bromide</from_name>
		<from_code>66983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine chloride</from_name>
		<from_code>82115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium bromide</from_name>
		<from_code>228530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium</from_name>
		<from_code>30077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium</from_name>
		<from_code>1218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium cation</from_name>
		<from_code>1546399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium</from_name>
		<from_code>23651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium bromide</from_name>
		<from_code>7884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium chloride</from_name>
		<from_code>52796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallamine triethiodide</from_name>
		<from_code>4639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium bromide</from_name>
		<from_code>11153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium</from_name>
		<from_code>7883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium</from_name>
		<from_code>1218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium</from_name>
		<from_code>30077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium bromide</from_name>
		<from_code>228530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine chloride</from_name>
		<from_code>82115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium</from_name>
		<from_code>23651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium cation</from_name>
		<from_code>1546399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium chloride</from_name>
		<from_code>52796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium bromide</from_name>
		<from_code>7884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium</from_name>
		<from_code>7883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium bromide</from_name>
		<from_code>11153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallamine triethiodide</from_name>
		<from_code>4639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium besylate</from_name>
		<from_code>1219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine</from_name>
		<from_code>10917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium</from_name>
		<from_code>71535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium bromide</from_name>
		<from_code>32521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium chloride</from_name>
		<from_code>49275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium bromide</from_name>
		<from_code>66983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium</from_name>
		<from_code>33742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium</from_name>
		<from_code>262100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethaphan camsylate</from_name>
		<from_code>38680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
		<from_code>N0000175641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine</from_name>
		<from_code>6673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine hydrochloride</from_name>
		<from_code>91240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
		<to_code>N0000175653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varenicline</from_name>
		<from_code>591622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine</from_name>
		<from_code>8328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine</from_name>
		<from_code>194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamoylcholine</from_name>
		<from_code>1546387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine</from_name>
		<from_code>155080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine chloride</from_name>
		<from_code>20814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline</from_name>
		<from_code>44281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine hydrochloride</from_name>
		<from_code>235426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine chloride</from_name>
		<from_code>40165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline hydrochloride anhydrous</from_name>
		<from_code>2698548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine nitrate</from_name>
		<from_code>103244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Agonists [MoA]</to_name>
		<to_code>N0000175369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>profenamine</from_name>
		<from_code>4134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine</from_name>
		<from_code>8718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium</from_name>
		<from_code>7213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepenzolate bromide</from_name>
		<from_code>52560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octotropine methylbromide</from_name>
		<from_code>17945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepenzolate</from_name>
		<from_code>107770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethopropazine hydrochloride</from_name>
		<from_code>6541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barbital</from_name>
		<from_code>1325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide, anhydrous</from_name>
		<from_code>2462023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium</from_name>
		<from_code>69120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisotropine</from_name>
		<from_code>89780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium bromide</from_name>
		<from_code>48212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revefenacin</from_name>
		<from_code>2102775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium cation</from_name>
		<from_code>1546373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclidinium</from_name>
		<from_code>1303098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium tosylate</from_name>
		<from_code>2052857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine hydrochloride</from_name>
		<from_code>142443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umeclidinium</from_name>
		<from_code>1487514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barbital sodium</from_name>
		<from_code>235404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclidinium bromide</from_name>
		<from_code>1303097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium</from_name>
		<from_code>21232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropicamide</from_name>
		<from_code>10869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium</from_name>
		<from_code>1546438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umeclidinium bromide</from_name>
		<from_code>1487512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Antagonists [MoA]</to_name>
		<to_code>N0000175370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon Receptor Interactions [MoA]</from_name>
		<from_code>N0000193959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropeginterferon alfa-2b-njft</from_name>
		<from_code>2587060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon Receptor Interactions [MoA]</to_name>
		<to_code>N0000193959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropeginterferon alfa-2b</from_name>
		<from_code>2587059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon Receptor Interactions [MoA]</to_name>
		<to_code>N0000193959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anifrolumab-fnia</from_name>
		<from_code>2565276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Type I interferon Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anifrolumab</from_name>
		<from_code>2565265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fc Receptor Interactions [MoA]</from_name>
		<from_code>N0000193996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efgartigimod alfa-qvfc</from_name>
		<from_code>2639944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rozanolixizumab-noli</from_name>
		<from_code>2642273</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rozanolixizumab</from_name>
		<from_code>2642274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efgartigimod alfa</from_name>
		<from_code>2587717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nipocalimab</from_name>
		<from_code>2712693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
		<from_code>N0000194004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nipocalimab-aahu</from_name>
		<from_code>2712692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
		<to_code>N0000194005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
		<from_code>N0000000105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
		<from_code>N0000000105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
		<from_code>N0000000105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
		<from_code>N0000000105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter Interactions [MoA]</to_name>
		<to_code>N0000178332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
		<from_code>N0000000105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum oleoresin</from_name>
		<from_code>235787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butalbital</from_name>
		<from_code>19860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanol</from_name>
		<from_code>448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital</from_name>
		<from_code>8004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutethimide</from_name>
		<from_code>4903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcohol, x-ray exposed (1000 rad)</from_name>
		<from_code>1368126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital</from_name>
		<from_code>8134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barbital</from_name>
		<from_code>1325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethadione</from_name>
		<from_code>10827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Membrane Transporter Interactions [MoA]</from_name>
		<from_code>N0000188367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprobarbital</from_name>
		<from_code>17381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital sodium</from_name>
		<from_code>203085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital sodium</from_name>
		<from_code>91109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine</from_name>
		<from_code>60842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capsaicin</from_name>
		<from_code>1992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital sodium</from_name>
		<from_code>82077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dehydrated alcohol</from_name>
		<from_code>1310469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital</from_name>
		<from_code>477631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine mesylate</from_name>
		<from_code>60841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barbital sodium</from_name>
		<from_code>235404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
		<to_code>N0000000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Transporter Interactions [MoA]</from_name>
		<from_code>N0000000167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Transporter Interactions [MoA]</to_name>
		<to_code>N0000000167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrochloride</from_name>
		<from_code>267251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydroiodide</from_name>
		<from_code>539765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrobromide</from_name>
		<from_code>102490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan tannate</from_name>
		<from_code>259262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan polistirex</from_name>
		<from_code>236146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone hydrochloride</from_name>
		<from_code>1086768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin</from_name>
		<from_code>3634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran</from_name>
		<from_code>588250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin</from_name>
		<from_code>3332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone</from_name>
		<from_code>1086769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin hydrochloride</from_name>
		<from_code>142133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran hydrochloride</from_name>
		<from_code>30003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin hydrochloride</from_name>
		<from_code>236807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine Transporter Interactions [MoA]</from_name>
		<from_code>N0000000219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000194049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mazindol</from_name>
		<from_code>6664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol hydrochloride</from_name>
		<from_code>2121750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol</from_name>
		<from_code>2121751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>modafinil</from_name>
		<from_code>30125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
		<to_code>N0000009955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter Interactions [MoA]</from_name>
		<from_code>N0000178332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
		<to_code>N0000178333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiporter Interactions [MoA]</from_name>
		<from_code>N0000188374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter Interactions [MoA]</to_name>
		<to_code>N0000178332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter Antagonists [MoA]</from_name>
		<from_code>N0000178333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000190855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
		<to_code>N0000178333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine-depleting Sympatholytic [EPC]</from_name>
		<from_code>N0000175640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
		<to_code>N0000178333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
		<to_code>N0000178333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valbenazine</from_name>
		<from_code>1918219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000190855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000190856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000190855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valbenazine tosylate</from_name>
		<from_code>1923002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000190855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutetrabenazine</from_name>
		<from_code>1876905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000190855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrabenazine</from_name>
		<from_code>10390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000190855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Transporter Interactions [MoA]</from_name>
		<from_code>N0000000234</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
		<to_code>N0000000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netarsudil</from_name>
		<from_code>1992864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netarsudil mesylate</from_name>
		<from_code>1992863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin</from_name>
		<from_code>3634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran hydrochloride</from_name>
		<from_code>30003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin hydrochloride</from_name>
		<from_code>236807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mazindol</from_name>
		<from_code>6664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000194049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin hydrochloride</from_name>
		<from_code>142133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine hydrochloride</from_name>
		<from_code>142143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran</from_name>
		<from_code>588250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin</from_name>
		<from_code>3332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol</from_name>
		<from_code>2121751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol hydrochloride</from_name>
		<from_code>2121750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine</from_name>
		<from_code>38400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
		<to_code>N0000000102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubrogepant</from_name>
		<from_code>2268216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zavegepant</from_name>
		<from_code>2637955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atogepant</from_name>
		<from_code>2571813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zavegepant hydrochloride</from_name>
		<from_code>2637956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimegepant</from_name>
		<from_code>2282307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
		<to_code>N0000193918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor alpha Receptor Interactions [MoA]</to_name>
		<to_code>N0000000093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Keratinocyte Growth Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000020070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER Receptor Family Interactions [MoA]</to_name>
		<to_code>N0000000067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatotropin Receptor Interactions [MoA]</to_name>
		<to_code>N0000000077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000000081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000000137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
		<from_code>N0000000213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor beta Receptor Interactions [MoA]</to_name>
		<to_code>N0000000189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Protein Kinase Interactions [MoA]</to_name>
		<to_code>N0000000213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000000071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide, micronized</from_name>
		<from_code>217364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glulisine, human</from_name>
		<from_code>400008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, beef</from_name>
		<from_code>317235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin</from_name>
		<from_code>6809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, beef</from_name>
		<from_code>235280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nateglinide</from_name>
		<from_code>274332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, beef</from_name>
		<from_code>235282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, pork</from_name>
		<from_code>221108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro protamine, human</from_name>
		<from_code>314684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazamide</from_name>
		<from_code>10633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro</from_name>
		<from_code>86009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glimepiride</from_name>
		<from_code>25789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, human</from_name>
		<from_code>253181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, beef-pork</from_name>
		<from_code>235275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin degludec</from_name>
		<from_code>1670007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart-xjhz</from_name>
		<from_code>2720519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, pork</from_name>
		<from_code>221109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin hydrochloride</from_name>
		<from_code>235743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide sodium</from_name>
		<from_code>221173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, prompt zinc, pork</from_name>
		<from_code>235286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, human</from_name>
		<from_code>221110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, beef-pork</from_name>
		<from_code>317598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, beef-pork</from_name>
		<from_code>235281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, beef</from_name>
		<from_code>235278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide</from_name>
		<from_code>4815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart, human</from_name>
		<from_code>51428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, human</from_name>
		<from_code>253182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart-szjj</from_name>
		<from_code>2705729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro-aabc</from_name>
		<from_code>2376838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, human</from_name>
		<from_code>314683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohexamide</from_name>
		<from_code>173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, pork</from_name>
		<from_code>235279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide</from_name>
		<from_code>10635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, pork</from_name>
		<from_code>93108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glipizide</from_name>
		<from_code>4821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glargine-aglr</from_name>
		<from_code>2589006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, beef-pork</from_name>
		<from_code>314685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpropamide</from_name>
		<from_code>2404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, prompt zinc, beef-pork</from_name>
		<from_code>235283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repaglinide</from_name>
		<from_code>73044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart protamine, human</from_name>
		<from_code>352385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, beef</from_name>
		<from_code>314686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, prompt zinc, beef</from_name>
		<from_code>235284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, beef-pork</from_name>
		<from_code>314682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glargine</from_name>
		<from_code>274783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-derived Growth Factor alpha Receptor Interactions [MoA]</from_name>
		<from_code>N0000000093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</from_name>
		<from_code>N0000020030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olaratumab</from_name>
		<from_code>1855735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ripretinib</from_name>
		<from_code>2369389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Keratinocyte Growth Factor Receptor Interactions [MoA]</from_name>
		<from_code>N0000020070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Keratinocyte Growth Factor Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Keratinocyte Growth Factor Receptor Interactions [MoA]</from_name>
		<from_code>N0000020070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Keratinocyte Growth Factor Receptor Agonists [MoA]</to_name>
		<to_code>N0000020071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palifermin</from_name>
		<from_code>196319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Keratinocyte Growth Factor Receptor Agonists [MoA]</to_name>
		<to_code>N0000020071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER Receptor Family Interactions [MoA]</from_name>
		<from_code>N0000000067</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER Receptor Family Antagonists [MoA]</to_name>
		<to_code>N0000020006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER Receptor Family Antagonists [MoA]</from_name>
		<from_code>N0000020006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER Receptor Family Antagonists [MoA]</from_name>
		<from_code>N0000020006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER3 Antagonists [MoA]</to_name>
		<to_code>N0000020012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER Receptor Family Antagonists [MoA]</from_name>
		<from_code>N0000020006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER Receptor Family Antagonists [MoA]</to_name>
		<to_code>N0000020006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zenocutuzumab-zbco</from_name>
		<from_code>2699587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ado-trastuzumab emtansine</from_name>
		<from_code>1371041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertuzumab-zzxf</from_name>
		<from_code>2382597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fam-trastuzumab deruxtecan-nxki</from_name>
		<from_code>2267574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-dttb</from_name>
		<from_code>2289225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-dkst</from_name>
		<from_code>2103478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zongertinib</from_name>
		<from_code>2721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-zzxf</from_name>
		<from_code>2382599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>margetuximab-cmkb</from_name>
		<from_code>2473850</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib ditosylate</from_name>
		<from_code>481474</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab deruxtecan</from_name>
		<from_code>2267582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-anns</from_name>
		<from_code>2174802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-oysk</from_name>
		<from_code>2375543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertuzumab</from_name>
		<from_code>1298944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab</from_name>
		<from_code>224905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zenocutuzumab</from_name>
		<from_code>2699588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-qyyp</from_name>
		<from_code>2280730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>margetuximab</from_name>
		<from_code>2473851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-pkrb</from_name>
		<from_code>2107051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib</from_name>
		<from_code>480167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-strf</from_name>
		<from_code>2700714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
		<to_code>N0000020008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zenocutuzumab</from_name>
		<from_code>2699588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER3 Antagonists [MoA]</to_name>
		<to_code>N0000020012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zenocutuzumab-zbco</from_name>
		<from_code>2699587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER3 Antagonists [MoA]</to_name>
		<to_code>N0000020012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erlotinib</from_name>
		<from_code>337525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erlotinib hydrochloride</from_name>
		<from_code>477320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetuximab</from_name>
		<from_code>318341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gefitinib</from_name>
		<from_code>328134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>necitumumab</from_name>
		<from_code>1723738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panitumumab</from_name>
		<from_code>263034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER1 Antagonists [MoA]</to_name>
		<to_code>N0000020010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatotropin Receptor Interactions [MoA]</from_name>
		<from_code>N0000000077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatotropin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonapegsomatropin</from_name>
		<from_code>2569562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatotropin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonapegsomatropin-tcgd</from_name>
		<from_code>2569592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatotropin Receptor Agonists [MoA]</to_name>
		<to_code>N0000000217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efbemalenograstim alfa</from_name>
		<from_code>2670630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000000081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efbemalenograstim alfa-vuxw</from_name>
		<from_code>2670656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</to_name>
		<to_code>N0000000081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</from_name>
		<from_code>N0000000137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000193927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegvisomant</from_name>
		<from_code>278739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000000137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin</from_name>
		<from_code>1044584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000000137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin acetate</from_name>
		<from_code>1044583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
		<to_code>N0000000137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000193926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000193927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teprotumumab</from_name>
		<from_code>2274803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000193927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-derived Growth Factor beta Receptor Interactions [MoA]</from_name>
		<from_code>N0000000189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trapidil</from_name>
		<from_code>10735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</from_name>
		<from_code>N0000020030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000000193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</to_name>
		<to_code>N0000191545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000000193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000000193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000000193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ligand-Gated Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000188380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000000193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Interactions [MoA]</to_name>
		<to_code>N0000000156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000000193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine hydrochloride</from_name>
		<from_code>282415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proparacaine</from_name>
		<from_code>34905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proparacaine hydrochloride</from_name>
		<from_code>227778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine</from_name>
		<from_code>9386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine hydrochloride</from_name>
		<from_code>82093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine sulfate</from_name>
		<from_code>621</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acoltremon</from_name>
		<from_code>2716801</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Membrane Transporter Interactions [MoA]</from_name>
		<from_code>N0000188367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine</from_name>
		<from_code>620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel Interactions [MoA]</to_name>
		<to_code>N0000000193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</from_name>
		<from_code>N0000191545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists [MoA]</to_name>
		<to_code>N0000191547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</from_name>
		<from_code>N0000191545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
		<to_code>N0000191546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</from_name>
		<from_code>N0000191544</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
		<to_code>N0000191546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine</from_name>
		<from_code>1649480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
		<to_code>N0000191546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine hydrochloride</from_name>
		<from_code>1649479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
		<to_code>N0000191546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Interactions [MoA]</from_name>
		<from_code>N0000000211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Openers [MoA]</to_name>
		<to_code>N0000182728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Interactions [MoA]</from_name>
		<from_code>N0000000211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Interactions [MoA]</from_name>
		<from_code>N0000000211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Agonists [MoA]</to_name>
		<to_code>N0000175449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate ester</from_name>
		<from_code>1926479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide, micronized</from_name>
		<from_code>217364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil</from_name>
		<from_code>6984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohexamide</from_name>
		<from_code>173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate</from_name>
		<from_code>1651695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide</from_name>
		<from_code>4815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Interactions [MoA]</to_name>
		<to_code>N0000000211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide choline</from_name>
		<from_code>2711542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Openers [MoA]</to_name>
		<to_code>N0000182728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicorandil</from_name>
		<from_code>31748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Openers [MoA]</to_name>
		<to_code>N0000182728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ezogabine</from_name>
		<from_code>1112990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Openers [MoA]</to_name>
		<to_code>N0000182728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide</from_name>
		<from_code>3327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Openers [MoA]</to_name>
		<to_code>N0000182728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pinacidil</from_name>
		<from_code>33717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Openers [MoA]</to_name>
		<to_code>N0000182728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repaglinide</from_name>
		<from_code>73044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifampridine</from_name>
		<from_code>2106338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium tosylate</from_name>
		<from_code>1737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium</from_name>
		<from_code>19685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nateglinide</from_name>
		<from_code>274332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifampridine phosphate</from_name>
		<from_code>2106337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinide [EPC]</from_name>
		<from_code>N0000175428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfampridine</from_name>
		<from_code>897018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Blocker [EPC]</from_name>
		<from_code>N0000192795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Antagonists [MoA]</to_name>
		<to_code>N0000175448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Interactions [MoA]</from_name>
		<from_code>N0000000140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Interactions [MoA]</from_name>
		<from_code>N0000000140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Agonists [MoA]</to_name>
		<to_code>N0000000259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praziquantel</from_name>
		<from_code>8628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Interactions [MoA]</to_name>
		<to_code>N0000000140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Antagonists [MoA]</from_name>
		<from_code>N0000000069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Antagonists [MoA]</from_name>
		<from_code>N0000000069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Antagonists [MoA]</from_name>
		<from_code>N0000000069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Antagonists [MoA]</from_name>
		<from_code>N0000000069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Voltage-gated Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilvadipine</from_name>
		<from_code>53692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol glucuronide</from_name>
		<from_code>2704947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine hydrochloride</from_name>
		<from_code>153679</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terodiline hydrochloride</from_name>
		<from_code>235839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine butyrate</from_name>
		<from_code>977863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene</from_name>
		<from_code>3105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol</from_name>
		<from_code>6750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine</from_name>
		<from_code>233603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175566</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline hydrochloride</from_name>
		<from_code>236767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terodiline</from_name>
		<from_code>37815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol, (+)-</from_name>
		<from_code>1648123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine maleate</from_name>
		<from_code>2377031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline</from_name>
		<from_code>4327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine</from_name>
		<from_code>2376944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine</from_name>
		<from_code>135056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene sodium</from_name>
		<from_code>3106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Antagonists [MoA]</to_name>
		<to_code>N0000000069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine</from_name>
		<from_code>233603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barnidipine hydrochloride</from_name>
		<from_code>283819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil</from_name>
		<from_code>83213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etripamil</from_name>
		<from_code>2730302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine butyrate</from_name>
		<from_code>977863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacidipine</from_name>
		<from_code>28382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrendipine</from_name>
		<from_code>7441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine benzoate</from_name>
		<from_code>2184116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallopamil hydrochloride</from_name>
		<from_code>439837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil dihydrochloride</from_name>
		<from_code>83214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepirodipine</from_name>
		<from_code>39879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallopamil</from_name>
		<from_code>4648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziconotide acetate</from_name>
		<from_code>486126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>N-type Calcium Channel Antagonist [EPC]</from_name>
		<from_code>N0000175697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziconotide</from_name>
		<from_code>68503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine</from_name>
		<from_code>4459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine hydrochloride</from_name>
		<from_code>82019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil dihydrochloride</from_name>
		<from_code>83214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil</from_name>
		<from_code>83213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000188380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Interactions [MoA]</to_name>
		<to_code>N0000188381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000188380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thermoreceptor Interactions [MoA]</to_name>
		<to_code>N0000194174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000188380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Interactions [MoA]</to_name>
		<to_code>N0000000138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000188380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
		<from_code>N0000188380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Receptor Interactions [MoA]</to_name>
		<to_code>N0000000095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ionotropic Glutamate Receptor Interactions [MoA]</from_name>
		<from_code>N0000188381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ionotropic Glutamate Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ionotropic Glutamate Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kainate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ionotropic Glutamate Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>AMPA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifenprodil tartrate</from_name>
		<from_code>289912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifenprodil</from_name>
		<from_code>27403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butobarbital</from_name>
		<from_code>19874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>NMDA Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Competitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>NMDA Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>NMDA Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Glycine Antagonists [MoA]</to_name>
		<to_code>N0000181820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>NMDA Receptor Antagonists [MoA]</from_name>
		<from_code>N0000020015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate calcium</from_name>
		<from_code>152761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate</from_name>
		<from_code>82819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>memantine</from_name>
		<from_code>6719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone hydrochloride</from_name>
		<from_code>218337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>memantine hydrochloride</from_name>
		<from_code>236685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone</from_name>
		<from_code>6813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrobromide</from_name>
		<from_code>102490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrochloride</from_name>
		<from_code>267251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydroiodide</from_name>
		<from_code>539765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan polistirex</from_name>
		<from_code>236146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000181821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan tannate</from_name>
		<from_code>259262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000181819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perampanel</from_name>
		<from_code>1356552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>AMPA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000186106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>AMPA Receptor Antagonists [MoA]</to_name>
		<to_code>N0000020016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thermoreceptor Interactions [MoA]</from_name>
		<from_code>N0000194174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>TRPM8 Thermoreceptor Agonists [MoA]</to_name>
		<to_code>N0000194173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>TRPM8 Thermoreceptor Agonist [EPC]</from_name>
		<from_code>N0000194172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>TRPM8 Thermoreceptor Agonists [MoA]</to_name>
		<to_code>N0000194173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA A Receptor Interactions [MoA]</from_name>
		<from_code>N0000000138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA A Receptor Interactions [MoA]</from_name>
		<from_code>N0000000138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA A Receptor Interactions [MoA]</from_name>
		<from_code>N0000000138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zaleplon</from_name>
		<from_code>74667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Interactions [MoA]</to_name>
		<to_code>N0000000138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Interactions [MoA]</from_name>
		<from_code>N0000000156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Interactions [MoA]</to_name>
		<to_code>N0000000138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Interactions [MoA]</to_name>
		<to_code>N0000000138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Interactions [MoA]</to_name>
		<to_code>N0000000138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Interactions [MoA]</to_name>
		<to_code>N0000000138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine Antagonist [EPC]</from_name>
		<from_code>N0000175680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apalutamide</from_name>
		<from_code>1999574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumazenil</from_name>
		<from_code>4457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentylenetetrazole</from_name>
		<from_code>8015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Antagonists [MoA]</to_name>
		<to_code>N0000000074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam hydrochloride</from_name>
		<from_code>71484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baclofen</from_name>
		<from_code>1292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medazepam</from_name>
		<from_code>6680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine sulfate</from_name>
		<from_code>1549138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butobarbital</from_name>
		<from_code>19874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dehydrated alcohol</from_name>
		<from_code>1310469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexobarbital</from_name>
		<from_code>5302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolazepam</from_name>
		<from_code>1535252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zaleplon</from_name>
		<from_code>74667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanol</from_name>
		<from_code>448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine hexahydrate</from_name>
		<from_code>271743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stiripentol</from_name>
		<from_code>2054968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotiazepam</from_name>
		<from_code>2622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine hydrate</from_name>
		<from_code>67518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine adipate</from_name>
		<from_code>33746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcohol, x-ray exposed (1000 rad)</from_name>
		<from_code>1368126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine phosphate</from_name>
		<from_code>54749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nordazepam</from_name>
		<from_code>3155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolazepam hydrochloride</from_name>
		<from_code>1999183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lormetazepam</from_name>
		<from_code>28894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital</from_name>
		<from_code>38077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital sodium</from_name>
		<from_code>314874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quazepam</from_name>
		<from_code>35185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopamide</from_name>
		<from_code>2603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estazolam</from_name>
		<from_code>4077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
		<from_code>N0000183360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam</from_name>
		<from_code>4501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine citrate</from_name>
		<from_code>342992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate</from_name>
		<from_code>2353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrazepam</from_name>
		<from_code>7440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem tartrate</from_name>
		<from_code>221183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate dipotassium</from_name>
		<from_code>2607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine</from_name>
		<from_code>8340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
		<from_code>N0000175759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunitrazepam</from_name>
		<from_code>4460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Agonists [MoA]</to_name>
		<to_code>N0000000196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GABA A Modulators [MoA]</from_name>
		<from_code>N0000000118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lormetazepam</from_name>
		<from_code>28894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam maleate</from_name>
		<from_code>142441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate</from_name>
		<from_code>82819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quazepam</from_name>
		<from_code>35185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormethiazole</from_name>
		<from_code>2372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halazepam</from_name>
		<from_code>26412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estazolam</from_name>
		<from_code>4077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam</from_name>
		<from_code>4501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate</from_name>
		<from_code>2353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepic acid</from_name>
		<from_code>235408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexanolone</from_name>
		<from_code>2121777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrazepam</from_name>
		<from_code>7440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem tartrate</from_name>
		<from_code>221183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methaqualone</from_name>
		<from_code>6823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyprylon</from_name>
		<from_code>6910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunitrazepam</from_name>
		<from_code>4460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate calcium</from_name>
		<from_code>152761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate dipotassium</from_name>
		<from_code>2607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medazepam</from_name>
		<from_code>6680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam hydrochloride</from_name>
		<from_code>71484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomethiazole edisylate</from_name>
		<from_code>20802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethchlorvynol</from_name>
		<from_code>4118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butobarbital</from_name>
		<from_code>19874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metharbital</from_name>
		<from_code>6825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remimazolam besylate</from_name>
		<from_code>2383942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexobarbital</from_name>
		<from_code>5302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remimazolam</from_name>
		<from_code>2383941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromazepam</from_name>
		<from_code>1749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolazepam</from_name>
		<from_code>1535252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazepam</from_name>
		<from_code>8627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nordazepam</from_name>
		<from_code>3155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolazepam hydrochloride</from_name>
		<from_code>1999183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Modulators [MoA]</to_name>
		<to_code>N0000000118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
		<from_code>N0000194006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganaxolone</from_name>
		<from_code>2604689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
		<from_code>N0000194083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zuranolone</from_name>
		<from_code>2669905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
		<to_code>N0000193997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Agonists [MoA]</to_name>
		<to_code>N0000000073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycine Receptor Interactions [MoA]</from_name>
		<from_code>N0000000244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Antagonists [MoA]</to_name>
		<to_code>N0000000119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Interactions [MoA]</from_name>
		<from_code>N0000000156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Receptor Interactions [MoA]</to_name>
		<to_code>N0000000244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Agonists [MoA]</to_name>
		<to_code>N0000000073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Agonists [MoA]</to_name>
		<to_code>N0000000073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Agonists [MoA]</to_name>
		<to_code>N0000000073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycine Agonists [MoA]</to_name>
		<to_code>N0000000073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin 5HT-3 Receptor Interactions [MoA]</from_name>
		<from_code>N0000000095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Agonists [MoA]</to_name>
		<to_code>N0000000188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin 5HT-3 Receptor Interactions [MoA]</from_name>
		<from_code>N0000000095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
		<to_code>N0000000090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Interactions [MoA]</from_name>
		<from_code>N0000000156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
		<to_code>N0000184145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Interactions [MoA]</from_name>
		<from_code>N0000000156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Antagonists [MoA]</to_name>
		<to_code>N0000000224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Interactions [MoA]</from_name>
		<from_code>N0000000156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activators [MoA]</to_name>
		<to_code>N0000175456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Interactions [MoA]</from_name>
		<from_code>N0000000156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Agonists [MoA]</to_name>
		<to_code>N0000000078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxidectin</from_name>
		<from_code>1047072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Interactions [MoA]</to_name>
		<to_code>N0000000156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivermectin</from_name>
		<from_code>6069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Interactions [MoA]</to_name>
		<to_code>N0000000156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
		<to_code>N0000184145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
		<from_code>N0000184146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
		<to_code>N0000184145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivacaftor</from_name>
		<from_code>1243041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
		<to_code>N0000184145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutivacaftor</from_name>
		<from_code>2701430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
		<to_code>N0000184145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanzacaftor</from_name>
		<from_code>2701431</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
		<to_code>N0000184145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Antagonists [MoA]</to_name>
		<to_code>N0000000224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Antagonists [MoA]</to_name>
		<to_code>N0000000224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Antagonists [MoA]</to_name>
		<to_code>N0000000224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Antagonists [MoA]</to_name>
		<to_code>N0000000224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lubiprostone</from_name>
		<from_code>623033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activators [MoA]</to_name>
		<to_code>N0000175456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plecanatide</from_name>
		<from_code>1873752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activators [MoA]</to_name>
		<to_code>N0000175456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linaclotide</from_name>
		<from_code>1307404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activators [MoA]</to_name>
		<to_code>N0000175456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lormetazepam</from_name>
		<from_code>28894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activators [MoA]</to_name>
		<to_code>N0000175456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Activator [EPC]</from_name>
		<from_code>N0000175573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activators [MoA]</to_name>
		<to_code>N0000175456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Channel Interactions [MoA]</from_name>
		<from_code>N0000000180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Channel Interactions [MoA]</from_name>
		<from_code>N0000000180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Agonists [MoA]</to_name>
		<to_code>N0000182727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine</from_name>
		<from_code>6759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidocaine hydrochloride</from_name>
		<from_code>227221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephenytoin</from_name>
		<from_code>6757</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butacaine</from_name>
		<from_code>1829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine hydrochloride</from_name>
		<from_code>203185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine</from_name>
		<from_code>10391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide phosphate</from_name>
		<from_code>203178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rufinamide</from_name>
		<from_code>69036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine</from_name>
		<from_code>592464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride anhydrous</from_name>
		<from_code>1375412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine</from_name>
		<from_code>259453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine hydrochloride</from_name>
		<from_code>221126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate hydrochloride</from_name>
		<from_code>235398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrethrins</from_name>
		<from_code>8991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine hydrochloride</from_name>
		<from_code>106558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine</from_name>
		<from_code>35780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride anhydrous</from_name>
		<from_code>2198974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonordefrin</from_name>
		<from_code>132889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride monohydrate</from_name>
		<from_code>1298851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide monohydrochloride</from_name>
		<from_code>142145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine hydrochloride</from_name>
		<from_code>91188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate</from_name>
		<from_code>18889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacosamide</from_name>
		<from_code>623400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine</from_name>
		<from_code>8701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide</from_name>
		<from_code>42359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine</from_name>
		<from_code>23744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encainide</from_name>
		<from_code>42368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine hydrochloride</from_name>
		<from_code>2117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride</from_name>
		<from_code>267396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine hydrochloride</from_name>
		<from_code>259454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine hydrochloride</from_name>
		<from_code>91189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encainide hydrochloride</from_name>
		<from_code>281189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxcarbazepine</from_name>
		<from_code>32624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine</from_name>
		<from_code>40169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride</from_name>
		<from_code>236539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide</from_name>
		<from_code>3541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine</from_name>
		<from_code>1815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidocaine</from_name>
		<from_code>4171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Interactions [MoA]</to_name>
		<to_code>N0000000180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene</from_name>
		<from_code>8785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine acetate</from_name>
		<from_code>1482501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Channel Blocker [EPC]</from_name>
		<from_code>N0000194141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacemide</from_name>
		<from_code>33253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suzetrigine</from_name>
		<from_code>2704819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-sparing Diuretic [EPC]</from_name>
		<from_code>N0000175418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene napsylate</from_name>
		<from_code>8786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riluzole</from_name>
		<from_code>35623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine</from_name>
		<from_code>1482502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene hydrochloride</from_name>
		<from_code>71517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Antagonists [MoA]</to_name>
		<to_code>N0000181004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Transporter Interactions [MoA]</from_name>
		<from_code>N0000188370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiporter Interactions [MoA]</to_name>
		<to_code>N0000188374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Transporter Interactions [MoA]</from_name>
		<from_code>N0000188370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cation Transporter Interactions [MoA]</to_name>
		<to_code>N0000188372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Transporter Interactions [MoA]</from_name>
		<from_code>N0000188370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anion Transporter Interactions [MoA]</to_name>
		<to_code>N0000188371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Transporter Interactions [MoA]</from_name>
		<from_code>N0000188370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Symporter Interactions [MoA]</to_name>
		<to_code>N0000188375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper histidinate</from_name>
		<from_code>2732215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Transporter Interactions [MoA]</to_name>
		<to_code>N0000188370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Membrane Transporter Interactions [MoA]</from_name>
		<from_code>N0000188367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Transporter Interactions [MoA]</to_name>
		<to_code>N0000188370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiporter Interactions [MoA]</from_name>
		<from_code>N0000188374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Hydrogen Exchanger Interactions [MoA]</to_name>
		<to_code>N0000194058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiporter Interactions [MoA]</from_name>
		<from_code>N0000188374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor</from_name>
		<from_code>2199674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiporter Interactions [MoA]</to_name>
		<to_code>N0000188374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor hydrochloride</from_name>
		<from_code>2199673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiporter Interactions [MoA]</to_name>
		<to_code>N0000188374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Hydrogen Exchanger Interactions [MoA]</from_name>
		<from_code>N0000194058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</to_name>
		<to_code>N0000194057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor</from_name>
		<from_code>2199674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</to_name>
		<to_code>N0000194057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</from_name>
		<from_code>N0000194056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</to_name>
		<to_code>N0000194057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzonatate</from_name>
		<from_code>18993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium polystyrene sulfonate</from_name>
		<from_code>56512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitalin</from_name>
		<from_code>1923401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
		<to_code>N0000000238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000188372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter Interactions [MoA]</to_name>
		<to_code>N0000187060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000188372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Interactions [MoA]</to_name>
		<to_code>N0000188373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000187060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000187060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000192340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000187060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000187060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Cation Transporter Interactions [MoA]</from_name>
		<from_code>N0000187060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemigatinib</from_name>
		<from_code>2359268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir</from_name>
		<from_code>1433868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdafitinib</from_name>
		<from_code>2123125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givinostat</from_name>
		<from_code>2678889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arimoclomol</from_name>
		<from_code>2694283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vimseltinib</from_name>
		<from_code>2705378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib</from_name>
		<from_code>2479690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vandetanib</from_name>
		<from_code>1098413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000000132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000192340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lesinurad</from_name>
		<from_code>1731031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000192340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Urate Transporter 1 Inhibitor [EPC]</from_name>
		<from_code>N0000192341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000192340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir</from_name>
		<from_code>1433868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemigatinib</from_name>
		<from_code>2359268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risdiplam</from_name>
		<from_code>2390935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine</from_name>
		<from_code>28863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazemetostat</from_name>
		<from_code>2274378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib</from_name>
		<from_code>2479690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lofexidine hydrochloride</from_name>
		<from_code>235853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risdiplam</from_name>
		<from_code>2390935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib</from_name>
		<from_code>2479690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazemetostat</from_name>
		<from_code>2274378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
		<to_code>N0000193932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000191265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Interactions [MoA]</from_name>
		<from_code>N0000188373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitors [MoA]</from_name>
		<from_code>N0000000147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium</from_name>
		<from_code>283562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole</from_name>
		<from_code>40790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexlansoprazole</from_name>
		<from_code>816346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vonoprazan fumarate</from_name>
		<from_code>2604576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole</from_name>
		<from_code>283742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-competitive Acid Blocker [EPC]</from_name>
		<from_code>N0000194136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole sodium</from_name>
		<from_code>1294569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole sodium</from_name>
		<from_code>253191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole sodium</from_name>
		<from_code>1792108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole magnesium</from_name>
		<from_code>236486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole strontium</from_name>
		<from_code>1435522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vonoprazan</from_name>
		<from_code>2604577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole sodium</from_name>
		<from_code>226868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium trihydrate</from_name>
		<from_code>2688630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium dihydrate</from_name>
		<from_code>1601995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole</from_name>
		<from_code>114979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole (as pantoprazole sodium sesquihydrate)</from_name>
		<from_code>236632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexlansoprazole sesquihydrate</from_name>
		<from_code>2673463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitors [MoA]</to_name>
		<to_code>N0000000147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine</from_name>
		<from_code>620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Influenza A M2 Protein Inhibitor [EPC]</from_name>
		<from_code>N0000175543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine hydrochloride</from_name>
		<from_code>82093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine sulfate</from_name>
		<from_code>621</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine</from_name>
		<from_code>9386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine hydrochloride</from_name>
		<from_code>282415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M2 Protein Inhibitors [MoA]</to_name>
		<to_code>N0000175542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000188371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter Interactions [MoA]</to_name>
		<to_code>N0000000132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000000132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000000132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000000132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000000132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Organic Anion Transporter Interactions [MoA]</from_name>
		<from_code>N0000000132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter Interactions [MoA]</to_name>
		<to_code>N0000000132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter Interactions [MoA]</to_name>
		<to_code>N0000000132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probenecid</from_name>
		<from_code>8698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter Interactions [MoA]</to_name>
		<to_code>N0000000132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter Interactions [MoA]</to_name>
		<to_code>N0000000132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitisinone</from_name>
		<from_code>61805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Tubular Transport Inhibitor [EPC]</from_name>
		<from_code>N0000194156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabotegravir</from_name>
		<from_code>2475077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levacetylleucine</from_name>
		<from_code>2375522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000190110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maralixibat</from_name>
		<from_code>2571074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor</from_name>
		<from_code>2199674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole</from_name>
		<from_code>2691333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trofinetide</from_name>
		<from_code>2632852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voclosporin</from_name>
		<from_code>2475166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix sodium</from_name>
		<from_code>2049847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir dihydrochloride</from_name>
		<from_code>1606217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmetirom</from_name>
		<from_code>2677894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
		<to_code>N0000190107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole</from_name>
		<from_code>2691333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trofinetide</from_name>
		<from_code>2632852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voclosporin</from_name>
		<from_code>2475166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir dihydrochloride</from_name>
		<from_code>1606217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmetirom</from_name>
		<from_code>2677894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
		<to_code>N0000190108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pretomanid</from_name>
		<from_code>2198359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levacetylleucine</from_name>
		<from_code>2375522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Tubular Transport Inhibitor [EPC]</from_name>
		<from_code>N0000194156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabotegravir</from_name>
		<from_code>2475077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vadadustat</from_name>
		<from_code>2679296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitisinone</from_name>
		<from_code>61805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
		<to_code>N0000190111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter Interactions [MoA]</to_name>
		<to_code>N0000188378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Bile Acid Cotransporter Interactions [MoA]</to_name>
		<to_code>N0000193964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Interactions [MoA]</to_name>
		<to_code>N0000188377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Symporter Interactions [MoA]</from_name>
		<from_code>N0000188375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Interactions [MoA]</to_name>
		<to_code>N0000188376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Transporter Interactions [MoA]</from_name>
		<from_code>N0000188378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000187056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monosaccharide Transporter Interactions [MoA]</from_name>
		<from_code>N0000188379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter Interactions [MoA]</to_name>
		<to_code>N0000188378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Transporter Inhibitors [MoA]</from_name>
		<from_code>N0000187056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Transporter Inhibitors [MoA]</from_name>
		<from_code>N0000187056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 1 Inhibitors [MoA]</to_name>
		<to_code>N0000187057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapagliflozin</from_name>
		<from_code>1488564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin anhydrous</from_name>
		<from_code>1546031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin</from_name>
		<from_code>1373458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin pidolate</from_name>
		<from_code>1992674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin</from_name>
		<from_code>1992672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotagliflozin</from_name>
		<from_code>2638675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapagliflozin propanediol</from_name>
		<from_code>1486966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>empagliflozin</from_name>
		<from_code>1545653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bexagliflozin</from_name>
		<from_code>2627044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
		<to_code>N0000187058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Bile Acid Cotransporter Interactions [MoA]</from_name>
		<from_code>N0000193964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000193958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Bile Acid Cotransporter Interactions [MoA]</from_name>
		<from_code>N0000193964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors [MoA]</to_name>
		<to_code>N0000193965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ileal Bile Acid Transporter Inhibitor [EPC]</from_name>
		<from_code>N0000193957</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000193958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>odevixibat</from_name>
		<from_code>2563966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000193958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maralixibat chloride</from_name>
		<from_code>2571073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000193958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maralixibat</from_name>
		<from_code>2571074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000193958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>odevixibat sesquihydrate</from_name>
		<from_code>2563978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
		<to_code>N0000193958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Potassium Chloride Symporter Interactions [MoA]</from_name>
		<from_code>N0000188377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Chloride Symporter Interactions [MoA]</from_name>
		<from_code>N0000188376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethiazide</from_name>
		<from_code>89911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
		<to_code>N0000181005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Membrane Transporter Interactions [MoA]</from_name>
		<from_code>N0000188367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monosaccharide Transporter Interactions [MoA]</to_name>
		<to_code>N0000188379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrin Receptor Interactions [MoA]</from_name>
		<from_code>N0000175773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrin Receptor Antagonists [MoA]</from_name>
		<from_code>N0000175774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</to_name>
		<to_code>N0000192700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vedolizumab</from_name>
		<from_code>1538097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natalizumab-sztn</from_name>
		<from_code>2725169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natalizumab</from_name>
		<from_code>354770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonists [MoA]</to_name>
		<to_code>N0000175774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lifitegrast</from_name>
		<from_code>1801820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</to_name>
		<to_code>N0000192700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</from_name>
		<from_code>N0000192701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</to_name>
		<to_code>N0000192700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Irrigation [MoA]</to_name>
		<to_code>N0000175534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation-Reduction Activity [MoA]</to_name>
		<to_code>N0000175545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ionophoric Activity [MoA]</to_name>
		<to_code>N0000181010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfate Donors [MoA]</to_name>
		<to_code>N0000009983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physiochemical Activity [MoA]</from_name>
		<from_code>N0000000065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylating Activity [MoA]</to_name>
		<to_code>N0000175804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese gluconate</from_name>
		<from_code>52403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea</from_name>
		<from_code>11002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminobenzoic acid</from_name>
		<from_code>74</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium selenate</from_name>
		<from_code>36717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol, L-</from_name>
		<from_code>1742749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamide peroxide</from_name>
		<from_code>47686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea hydrochloride</from_name>
		<from_code>1862866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese dioxide</from_name>
		<from_code>29263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc oxide</from_name>
		<from_code>11423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>padimate-O</from_name>
		<from_code>32786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese monoxide</from_name>
		<from_code>1728312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium chloride</from_name>
		<from_code>2200142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octinoxate</from_name>
		<from_code>13369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avobenzone</from_name>
		<from_code>45045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chlorohydrate</from_name>
		<from_code>17610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese sulfate</from_name>
		<from_code>29268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenious acid</from_name>
		<from_code>36344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese</from_name>
		<from_code>6623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol</from_name>
		<from_code>9945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium</from_name>
		<from_code>9641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxate</from_name>
		<from_code>288262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminohippurate sodium</from_name>
		<from_code>203194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybenzone</from_name>
		<from_code>32673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octisalate</from_name>
		<from_code>91327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaliplatin</from_name>
		<from_code>32592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxylenol</from_name>
		<from_code>20877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physiochemical Activity [MoA]</to_name>
		<to_code>N0000000065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiopharmaceutical Activity [MoA]</from_name>
		<from_code>N0000000205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Particle Emitting Activity [MoA]</to_name>
		<to_code>N0000187052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiopharmaceutical Activity [MoA]</from_name>
		<from_code>N0000000205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>gamma-Ray Emitting Activity [MoA]</to_name>
		<to_code>N0000175868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiopharmaceutical Activity [MoA]</from_name>
		<from_code>N0000000205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiopharmaceutical Activity [MoA]</from_name>
		<from_code>N0000000205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioligand Activity [MoA]</to_name>
		<to_code>N0000194016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ipodate</from_name>
		<from_code>1911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inhalation Diagnostic Agent [EPC]</from_name>
		<from_code>N0000175866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane</from_name>
		<from_code>2571854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxidronate</from_name>
		<from_code>1306068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallous chloride Tl201</from_name>
		<from_code>91588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorodeoxyglucose F18</from_name>
		<from_code>1362737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-131</from_name>
		<from_code>1546415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate sodium</from_name>
		<from_code>9887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m disofenin</from_name>
		<from_code>37665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetate disodium</from_name>
		<from_code>259268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129</from_name>
		<from_code>2626219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium 67 citrate</from_name>
		<from_code>272758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotride</from_name>
		<from_code>2199392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane I-123</from_name>
		<from_code>1426874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Therapeutic Agent [EPC]</from_name>
		<from_code>N0000175872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fanolesomab</from_name>
		<from_code>1314371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-133</from_name>
		<from_code>259282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,chromated Cr-51 serum</from_name>
		<from_code>314299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m medronate</from_name>
		<from_code>1488818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobenguane I-131</from_name>
		<from_code>2053281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate</from_name>
		<from_code>5976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopanoic acid</from_name>
		<from_code>5967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium-111</from_name>
		<from_code>90540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium cation Sr-89</from_name>
		<from_code>2280602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iophendylate</from_name>
		<from_code>5968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>82 rubidium</from_name>
		<from_code>1546434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallous cation Tl-201</from_name>
		<from_code>1546370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotide gallium ga-68</from_name>
		<from_code>2199391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vipivotide tetraxetan</from_name>
		<from_code>2597054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamic acid I-125</from_name>
		<from_code>1546452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-123</from_name>
		<from_code>1361657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,iodinated I-131 serum</from_name>
		<from_code>314301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 chloride</from_name>
		<from_code>42987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenomethionine Se 75</from_name>
		<from_code>9133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pertechnetate Tc 99m</from_name>
		<from_code>10349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobenguane sulfate I-123</from_name>
		<from_code>1427223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodohippurate I131 sodium</from_name>
		<from_code>91540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline C-11</from_name>
		<from_code>1425419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia N-13</from_name>
		<from_code>1305558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc-99m sulfur colloid</from_name>
		<from_code>1423270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129, hyperpolarized</from_name>
		<from_code>2626220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetreotide</from_name>
		<from_code>1724429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoride ion F-18</from_name>
		<from_code>1546273</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m tilmanocept</from_name>
		<from_code>1373391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene diphosphonate</from_name>
		<from_code>29844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc-99m pyrophosphate</from_name>
		<from_code>1488368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyanocobalamin Co57</from_name>
		<from_code>91516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lutetium Lu 177 vipivotide tetraxetan</from_name>
		<from_code>2597053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromic phosphate P32</from_name>
		<from_code>121070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium 99m</from_name>
		<from_code>90650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89 chloride</from_name>
		<from_code>281890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m exametazime</from_name>
		<from_code>1431726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 oxyquinoline</from_name>
		<from_code>1314372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutemetamol F-18</from_name>
		<from_code>1486025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m sestamibi</from_name>
		<from_code>1482913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal sodium I 131</from_name>
		<from_code>82097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,iodinated I-125 serum</from_name>
		<from_code>317177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetapir F-18</from_name>
		<from_code>1427224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iocetamic acid</from_name>
		<from_code>183830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiopharmaceutical Activity [MoA]</to_name>
		<to_code>N0000000205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</from_name>
		<from_code>N0000187053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Particle Emitting Activity [MoA]</to_name>
		<to_code>N0000187052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radium Ra-223 cation</from_name>
		<from_code>1745075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Particle Emitting Activity [MoA]</to_name>
		<to_code>N0000187052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicisate dihydrochloride</from_name>
		<from_code>1306099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurpiridaz F-18</from_name>
		<from_code>2700762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetaben</from_name>
		<from_code>2571857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluciclovine</from_name>
		<from_code>2571859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flotufolastat F-18</from_name>
		<from_code>2637946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dotatate gallium GA-68</from_name>
		<from_code>1872044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat F-18</from_name>
		<from_code>2556616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurpiridaz</from_name>
		<from_code>2700763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flotufolastat</from_name>
		<from_code>2637947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoroestradiol F-18</from_name>
		<from_code>2372221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flortaucipir</from_name>
		<from_code>2571858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper oxodotreotide CU-64</from_name>
		<from_code>2396442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluciclovine F-18</from_name>
		<from_code>1796118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium GA-68 gozetotide</from_name>
		<from_code>2586016</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetaben f-18</from_name>
		<from_code>1492940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>82 rubidium</from_name>
		<from_code>1546434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicisate</from_name>
		<from_code>1306100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dotatate gallium ga-68</from_name>
		<from_code>676679</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetapir F-18</from_name>
		<from_code>1427224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Positron Emitting Activity [MoA]</to_name>
		<to_code>N0000175869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioligand Therapeutic Agent [EPC]</from_name>
		<from_code>N0000194017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioligand Activity [MoA]</to_name>
		<to_code>N0000194016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lutetium Lu 177 vipivotide tetraxetan</from_name>
		<from_code>2597053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioligand Activity [MoA]</to_name>
		<to_code>N0000194016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Contrast Activity [MoA]</from_name>
		<from_code>N0000010257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Contrast Activity [MoA]</from_name>
		<from_code>N0000010257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Contrast Activity [MoA]</from_name>
		<from_code>N0000010257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Contrast Activity [MoA]</from_name>
		<from_code>N0000010257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fluorescence Contrast Activity [MoA]</to_name>
		<to_code>N0000193981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafolacianine sodium</from_name>
		<from_code>2586858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate</from_name>
		<from_code>5973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurpiridaz F-18</from_name>
		<from_code>2700762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein</from_name>
		<from_code>25138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129, hyperpolarized</from_name>
		<from_code>2626220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethiodized oil</from_name>
		<from_code>4125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat</from_name>
		<from_code>2556617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate meglumine</from_name>
		<from_code>66895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate sodium</from_name>
		<from_code>66896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurpiridaz</from_name>
		<from_code>2700763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodixanol</from_name>
		<from_code>27729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopiclenol</from_name>
		<from_code>2618720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barium sulfate</from_name>
		<from_code>1331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein sodium</from_name>
		<from_code>57789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglic acid</from_name>
		<from_code>1426458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129</from_name>
		<from_code>2626219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafolacianine</from_name>
		<from_code>2586857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopromide</from_name>
		<from_code>27781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat F-18</from_name>
		<from_code>2556616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate lysine</from_name>
		<from_code>236477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodipamide</from_name>
		<from_code>5936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxilan</from_name>
		<from_code>27793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Contrast Activity [MoA]</to_name>
		<to_code>N0000010257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangafodipir</from_name>
		<from_code>236987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadofosveset trisodium</from_name>
		<from_code>1364289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadodiamide</from_name>
		<from_code>41144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hyperpolarized Contrast Agent [EPC]</from_name>
		<from_code>N0000194089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoterate meglumine</from_name>
		<from_code>1421151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadolinium cation (3+)</from_name>
		<from_code>1546429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopiclenol</from_name>
		<from_code>2618720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate dimeglumine</from_name>
		<from_code>68173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopentetate dimeglumine</from_name>
		<from_code>25486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129, hyperpolarized</from_name>
		<from_code>2626220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobutrol</from_name>
		<from_code>84990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate</from_name>
		<from_code>692620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate disodium</from_name>
		<from_code>637320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxides</from_name>
		<from_code>72901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadofosveset</from_name>
		<from_code>1364290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangafodipir trisodium, anhydrous</from_name>
		<from_code>221119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoteridol</from_name>
		<from_code>25483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese cation (2+)</from_name>
		<from_code>1546272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoversetamide</from_name>
		<from_code>228833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Paramagnetic Contrast Agent [EPC]</from_name>
		<from_code>N0000180184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate</from_name>
		<from_code>802624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
		<from_code>N0000183362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
		<to_code>N0000175862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barium sulfate</from_name>
		<from_code>1331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoic acid</from_name>
		<from_code>1546223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopromide</from_name>
		<from_code>27781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxilan</from_name>
		<from_code>27793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iomeprol</from_name>
		<from_code>2606484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate</from_name>
		<from_code>5973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate meglumine</from_name>
		<from_code>66895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethiodized oil</from_name>
		<from_code>4125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobitridol</from_name>
		<from_code>87639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate sodium</from_name>
		<from_code>66896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iso-sulfan blue</from_name>
		<from_code>27863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodixanol</from_name>
		<from_code>27729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamic acid</from_name>
		<from_code>1546451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X-Ray Contrast Activity [MoA]</to_name>
		<to_code>N0000010258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflutren</from_name>
		<from_code>283753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur hexafluoride</from_name>
		<from_code>1599276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
		<from_code>N0000175864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflexane</from_name>
		<from_code>1540828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin microspheres, human</from_name>
		<from_code>1370439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultrasound Contrast Activity [MoA]</to_name>
		<to_code>N0000010259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafolacianine</from_name>
		<from_code>2586857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fluorescence Contrast Activity [MoA]</to_name>
		<to_code>N0000193981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Optical Imaging Agent [EPC]</from_name>
		<from_code>N0000193983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fluorescence Contrast Activity [MoA]</to_name>
		<to_code>N0000193981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fluorescence Contrast Activity [MoA]</to_name>
		<to_code>N0000193981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluconolactone</from_name>
		<from_code>25842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Irrigation [MoA]</to_name>
		<to_code>N0000175534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Irrigation [MoA]</to_name>
		<to_code>N0000175534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calculi Dissolution Agent [EPC]</from_name>
		<from_code>N0000175835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Irrigation [MoA]</to_name>
		<to_code>N0000175534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (6 cps)</from_name>
		<from_code>1300454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2208 (100 MPA.S)</from_name>
		<from_code>1300444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2208 (3 MPA.S)</from_name>
		<from_code>1300446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 300</from_name>
		<from_code>8513</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 38 MPA.S at 2%)</from_name>
		<from_code>2257286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2208 (15000 MPA.S)</from_name>
		<from_code>1300445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl methylcellulose 2910</from_name>
		<from_code>1363586</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose</from_name>
		<from_code>27334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2906 (50 MPA.S)</from_name>
		<from_code>1297881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 400 MPA.S at 1%)</from_name>
		<from_code>1653793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2208 (4000 CPS)</from_name>
		<from_code>1300447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 400</from_name>
		<from_code>8514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl cellulose (type H)</from_name>
		<from_code>1811461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (50 MPA.S)</from_name>
		<from_code>1300453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (15000 MPA.S)</from_name>
		<from_code>1300451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (3 MPA.S)</from_name>
		<from_code>1300449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%)</from_name>
		<from_code>1371909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl methylcellulose 2208</from_name>
		<from_code>1363585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose</from_name>
		<from_code>2062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2906 (4000 mpa.s)</from_name>
		<from_code>1299222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium</from_name>
		<from_code>491498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl cellulose (1600000 WAMW)</from_name>
		<from_code>2048727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitutions per saccharide; 600 MPA.S at 2 %)</from_name>
		<from_code>1812763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 600 MPA.S at 2 %)</from_name>
		<from_code>2099296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (5 MPA.S)</from_name>
		<from_code>1300452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2208 (100000 MPA.S)</from_name>
		<from_code>1300448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 50-100 MPA.S at 1% )</from_name>
		<from_code>1597390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropylcellulose</from_name>
		<from_code>27291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Demulcent [EPC]</from_name>
		<from_code>N0000175535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (4000 MPA.S)</from_name>
		<from_code>1300455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose 2910 (15 MPA.S)</from_name>
		<from_code>1300450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose calcium</from_name>
		<from_code>1307734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent Activity [MoA]</to_name>
		<to_code>N0000175532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoabsorption [MoA]</from_name>
		<from_code>N0000010217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultraviolet A Radiation Absorption [MoA]</to_name>
		<to_code>N0000010218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoabsorption [MoA]</from_name>
		<from_code>N0000010217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultraviolet B Radiation Absorption [MoA]</to_name>
		<to_code>N0000010219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Flavin Mononucleotide</from_name>
		<from_code>4509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verteporfin</from_name>
		<from_code>118886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoactivated Radical Generator [EPC]</from_name>
		<from_code>N0000175984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoenhancer [EPC]</from_name>
		<from_code>N0000175540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxate</from_name>
		<from_code>288262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate</from_name>
		<from_code>1925821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihematoporphyrin ether</from_name>
		<from_code>23066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoabsorption [MoA]</to_name>
		<to_code>N0000010217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoctrizole</from_name>
		<from_code>1310510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultraviolet A Radiation Absorption [MoA]</to_name>
		<to_code>N0000010218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drometrizole</from_name>
		<from_code>1426903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultraviolet A Radiation Absorption [MoA]</to_name>
		<to_code>N0000010218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoctrizole</from_name>
		<from_code>1310510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultraviolet B Radiation Absorption [MoA]</to_name>
		<to_code>N0000010219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drometrizole</from_name>
		<from_code>1426903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ultraviolet B Radiation Absorption [MoA]</to_name>
		<to_code>N0000010219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxidation-Reduction Activity [MoA]</from_name>
		<from_code>N0000175545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reduction Activity [MoA]</to_name>
		<to_code>N0000175547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxidation-Reduction Activity [MoA]</from_name>
		<from_code>N0000175545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation Activity [MoA]</to_name>
		<to_code>N0000175546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation-Reduction Activity [MoA]</to_name>
		<to_code>N0000175545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxidation-Reduction Agent [EPC]</from_name>
		<from_code>N0000192516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation-Reduction Activity [MoA]</to_name>
		<to_code>N0000175545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reduction Activity [MoA]</from_name>
		<from_code>N0000175547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reduction Activity [MoA]</from_name>
		<from_code>N0000175547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reduction Activity [MoA]</to_name>
		<to_code>N0000175547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
		<from_code>N0000175961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reduction Activity [MoA]</to_name>
		<to_code>N0000175547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate</from_name>
		<from_code>39626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol,DL-alpha</from_name>
		<from_code>402899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A palmitate</from_name>
		<from_code>35406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, DL-</from_name>
		<from_code>2370134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>d-alpha-tocopheryl acetate</from_name>
		<from_code>1441649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbic acid</from_name>
		<from_code>1151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polaprezinc</from_name>
		<from_code>2179843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A myristate</from_name>
		<from_code>1813433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha tocopherol</from_name>
		<from_code>237099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl acid succinate,D-alpha</from_name>
		<from_code>314875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E DL-alpha</from_name>
		<from_code>220893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E d-alpha</from_name>
		<from_code>220892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, D-</from_name>
		<from_code>1426447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzoyl peroxide</from_name>
		<from_code>1418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dl-alpha tocopheryl acetate</from_name>
		<from_code>317841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E</from_name>
		<from_code>11256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol calcium succinate, DL-</from_name>
		<from_code>2598017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A</from_name>
		<from_code>11246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ascorbate</from_name>
		<from_code>267366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol linoleate, D-</from_name>
		<from_code>1427235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol acetate</from_name>
		<from_code>39625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitexin</from_name>
		<from_code>2684982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinol acetate</from_name>
		<from_code>35400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E acetate</from_name>
		<from_code>2531274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine</from_name>
		<from_code>4126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol acetate</from_name>
		<from_code>1046243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxygen</from_name>
		<from_code>7806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine anhydrous</from_name>
		<from_code>1545987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Free Radical Scavenging Activity [MoA]</to_name>
		<to_code>N0000000170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Disulfide Reduction [MoA]</from_name>
		<from_code>N0000175548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reducing and Complexing Thiol [EPC]</from_name>
		<from_code>N0000175898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine</from_name>
		<from_code>3022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystine Depleting Agent [EPC]</from_name>
		<from_code>N0000187051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine bitartrate</from_name>
		<from_code>81990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine hydrochloride</from_name>
		<from_code>1426886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiopronin</from_name>
		<from_code>6765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Disulfide Reduction [MoA]</to_name>
		<to_code>N0000175549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omega-3 fatty acids</from_name>
		<from_code>4301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation Activity [MoA]</to_name>
		<to_code>N0000175546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oil (containing omega-3 acids)</from_name>
		<from_code>2053495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation Activity [MoA]</to_name>
		<to_code>N0000175546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation Activity [MoA]</to_name>
		<to_code>N0000175546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Activity [MoA]</from_name>
		<from_code>N0000010288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic sodium phosphate, dihydrate</from_name>
		<from_code>1311286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic</from_name>
		<from_code>236719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate</from_name>
		<from_code>36709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icodextrin</from_name>
		<from_code>140480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactitol</from_name>
		<from_code>28395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium hydrogen phosphate dehydrate</from_name>
		<from_code>1311230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic</from_name>
		<from_code>235496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dried sodium phosphate</from_name>
		<from_code>1366977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate dihydrate</from_name>
		<from_code>314837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, monohydrate</from_name>
		<from_code>1311342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic, anhydrous</from_name>
		<from_code>349753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ion</from_name>
		<from_code>1318915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl starch 130-0.4</from_name>
		<from_code>1363352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium cation</from_name>
		<from_code>1311382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Diuretic [EPC]</from_name>
		<from_code>N0000175810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sodium phosphate</from_name>
		<from_code>2288215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dihydrate</from_name>
		<from_code>1311323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, anhydrous</from_name>
		<from_code>314838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate,monobasic,monohydrate</from_name>
		<from_code>221125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol</from_name>
		<from_code>6628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium cation</from_name>
		<from_code>1426853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dodecahydrate</from_name>
		<from_code>1311326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfate ion</from_name>
		<from_code>1426598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium cation</from_name>
		<from_code>1364429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dihydrogen phosphate dihydrate</from_name>
		<from_code>1311311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Activity [MoA]</to_name>
		<to_code>N0000010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (4000 CPS)</from_name>
		<from_code>1297402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malt soup extract</from_name>
		<from_code>91264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose</from_name>
		<from_code>6873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (100 CPS)</from_name>
		<from_code>1310583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stool Bulking Activity [MoA]</to_name>
		<to_code>N0000000075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Digoxin Binding Activity [MoA]</to_name>
		<to_code>N0000184150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin S Polymerization Inhibitors [MoA]</to_name>
		<to_code>N0000194028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Binding Activity [MoA]</to_name>
		<to_code>N0000175981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ammonium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000175806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000178377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transthyretin Stabilizers [MoA]</to_name>
		<to_code>N0000194135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Binding Activity [MoA]</from_name>
		<from_code>N0000175355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate malate</from_name>
		<from_code>1487143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric sulfate</from_name>
		<from_code>24913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-lactoglobulin (bovine)</from_name>
		<from_code>2722644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>attapulgite</from_name>
		<from_code>18516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated attapulgite</from_name>
		<from_code>133050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bezlotoxumab</from_name>
		<from_code>1855048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesna</from_name>
		<from_code>44</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate</from_name>
		<from_code>10156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bentoquatam</from_name>
		<from_code>134568</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Binding Activity [MoA]</to_name>
		<to_code>N0000175355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chelating Activity [MoA]</from_name>
		<from_code>N0000000087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelating Activity [MoA]</to_name>
		<to_code>N0000175472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chelating Activity [MoA]</from_name>
		<from_code>N0000000087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir</from_name>
		<from_code>2197842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane</from_name>
		<from_code>42736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prussian blue insoluble</from_name>
		<from_code>24902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium</from_name>
		<from_code>1903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium</from_name>
		<from_code>1368950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxyquinoline sulfate</from_name>
		<from_code>42836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxyquinoline</from_name>
		<from_code>110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium anhydrous</from_name>
		<from_code>1371967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane hydrochloride</from_name>
		<from_code>1294534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium monohydrate</from_name>
		<from_code>2001422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chelating Activity [MoA]</to_name>
		<to_code>N0000000087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelating Activity [MoA]</from_name>
		<from_code>N0000175472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelating Activity [MoA]</from_name>
		<from_code>N0000175472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelating Activity [MoA]</from_name>
		<from_code>N0000175472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelating Activity [MoA]</from_name>
		<from_code>N0000175472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelating Activity [MoA]</from_name>
		<from_code>N0000175472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Chelating Activity [MoA]</to_name>
		<to_code>N0000020075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelator [EPC]</from_name>
		<from_code>N0000175473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelating Activity [MoA]</to_name>
		<to_code>N0000175472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine hydrochloride</from_name>
		<from_code>235370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelating Activity [MoA]</to_name>
		<to_code>N0000175472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine tetrahydrochloride</from_name>
		<from_code>2611541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelating Activity [MoA]</to_name>
		<to_code>N0000175472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimercaprol</from_name>
		<from_code>3445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelating Activity [MoA]</to_name>
		<to_code>N0000175472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine</from_name>
		<from_code>10798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelating Activity [MoA]</to_name>
		<to_code>N0000175472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Iron Chelating Activity [MoA]</from_name>
		<from_code>N0000000144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Siderophore Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000181001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetic acid</from_name>
		<from_code>3690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferiprone</from_name>
		<from_code>11645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Iron Chelator [EPC]</from_name>
		<from_code>N0000175522</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelating Activity [MoA]</to_name>
		<to_code>N0000000144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate pentasodium</from_name>
		<from_code>314774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetic acid</from_name>
		<from_code>3690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate zinc trisodium</from_name>
		<from_code>408077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate calcium trisodium</from_name>
		<from_code>132879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate</from_name>
		<from_code>618371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetate disodium</from_name>
		<from_code>259268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plutonium Chelating Activity [MoA]</to_name>
		<to_code>N0000020076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetic acid</from_name>
		<from_code>3690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate calcium trisodium</from_name>
		<from_code>132879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetate disodium</from_name>
		<from_code>259268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate pentasodium</from_name>
		<from_code>314774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate zinc trisodium</from_name>
		<from_code>408077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lead Chelator [EPC]</from_name>
		<from_code>N0000175963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate</from_name>
		<from_code>618371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succimer</from_name>
		<from_code>3446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelating Activity [MoA]</to_name>
		<to_code>N0000175962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulose sodium phosphate</from_name>
		<from_code>342965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Binder [EPC]</from_name>
		<from_code>N0000175567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Chelating Activity [MoA]</to_name>
		<to_code>N0000175089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper Chelator [EPC]</from_name>
		<from_code>N0000194014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Chelating Activity [MoA]</to_name>
		<to_code>N0000020075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine</from_name>
		<from_code>10798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Chelating Activity [MoA]</to_name>
		<to_code>N0000020075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate</from_name>
		<from_code>1908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium creosotate</from_name>
		<from_code>317206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tricalcium phosphate</from_name>
		<from_code>47628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride dihydrate</from_name>
		<from_code>221068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate dibasic</from_name>
		<from_code>47627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride</from_name>
		<from_code>1901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer carbonate</from_name>
		<from_code>660890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glycerophosphate</from_name>
		<from_code>1909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium levulinate</from_name>
		<from_code>47624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate</from_name>
		<from_code>1919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate</from_name>
		<from_code>1925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glubionate</from_name>
		<from_code>25806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanthanum cation (3+)</from_name>
		<from_code>1546443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ion</from_name>
		<from_code>1316581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium lactate</from_name>
		<from_code>47622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric cation</from_name>
		<from_code>1546357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer</from_name>
		<from_code>214824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate anhydrous</from_name>
		<from_code>2106283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium acetate</from_name>
		<from_code>214342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate</from_name>
		<from_code>47613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride anhydrous</from_name>
		<from_code>1667640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucroferric oxyhydroxide</from_name>
		<from_code>1484283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer hydrochloride</from_name>
		<from_code>237125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium iodized</from_name>
		<from_code>317207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium</from_name>
		<from_code>1895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium amino acid chelate</from_name>
		<from_code>994438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphate Binder [EPC]</from_name>
		<from_code>N0000175597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pangamate</from_name>
		<from_code>1917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pantothenate</from_name>
		<from_code>1918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium hydroxide</from_name>
		<from_code>1910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate monohydrate</from_name>
		<from_code>1298846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Chelating Activity [MoA]</to_name>
		<to_code>N0000020074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Digoxin Binding Activity [MoA]</to_name>
		<to_code>N0000184150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid Sequestrant [EPC]</from_name>
		<from_code>N0000180292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile-acid Binding Activity [MoA]</to_name>
		<to_code>N0000175365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
		<from_code>N0000194027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin S Polymerization Inhibitors [MoA]</to_name>
		<to_code>N0000194028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxelotor</from_name>
		<from_code>2265678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin S Polymerization Inhibitors [MoA]</to_name>
		<to_code>N0000194028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Heparin Reversal Agent [EPC]</from_name>
		<from_code>N0000175983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Binding Activity [MoA]</to_name>
		<to_code>N0000175981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamines</from_name>
		<from_code>8826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Binding Activity [MoA]</to_name>
		<to_code>N0000175981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Binding Activity [MoA]</to_name>
		<to_code>N0000175981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine hydrochloride</from_name>
		<from_code>236471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Binding Activity [MoA]</to_name>
		<to_code>N0000175981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium benzoate</from_name>
		<from_code>56455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ammonium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000175806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrogen Binding Agent [EPC]</from_name>
		<from_code>N0000175807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ammonium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000175806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylbutyric acid</from_name>
		<from_code>1546447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ammonium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000175806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzoic acid</from_name>
		<from_code>18989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ammonium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000175806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylacetic acid</from_name>
		<from_code>33332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ammonium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000175806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patiromer</from_name>
		<from_code>1716203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000178377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patiromer sorbitex calcium</from_name>
		<from_code>2204723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000178377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Binder [EPC]</from_name>
		<from_code>N0000178378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000178377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium polystyrene sulfonate</from_name>
		<from_code>56512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Binding Activity [MoA]</to_name>
		<to_code>N0000178377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acoramidis</from_name>
		<from_code>2698312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transthyretin Stabilizers [MoA]</to_name>
		<to_code>N0000194135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin Stabilizer [EPC]</from_name>
		<from_code>N0000194134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transthyretin Stabilizers [MoA]</to_name>
		<to_code>N0000194135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Exchange Activity [MoA]</from_name>
		<from_code>N0000175356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Exchange Activity [MoA]</from_name>
		<from_code>N0000175356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prussian blue insoluble</from_name>
		<from_code>24902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium polystyrene sulfonate</from_name>
		<from_code>56512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluconolactone</from_name>
		<from_code>25842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium cation</from_name>
		<from_code>1426853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calculi Dissolution Agent [EPC]</from_name>
		<from_code>N0000175835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
		<to_code>N0000175834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol diacetate</from_name>
		<from_code>1427008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-100 stearate</from_name>
		<from_code>1367120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethicone 410</from_name>
		<from_code>1299921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beractant</from_name>
		<from_code>46967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peg-75 lanolin</from_name>
		<from_code>1363619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol monostearate</from_name>
		<from_code>1314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine stearate</from_name>
		<from_code>38625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-120 methyl glucose dioleate</from_name>
		<from_code>1309363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simethicone</from_name>
		<from_code>9796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SIMETHICONE-CELLULOSE</from_name>
		<from_code>283585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poractant alfa</from_name>
		<from_code>236381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol, (S)-</from_name>
		<from_code>1663407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium laureth sulfate</from_name>
		<from_code>1310569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine polypeptide oleate condensate</from_name>
		<from_code>38624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol propyl ether</from_name>
		<from_code>1947500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octoxynol-9</from_name>
		<from_code>54034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-6 lauramide</from_name>
		<from_code>1363617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-phenylpropanal propylene glycol acetal</from_name>
		<from_code>1947505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-40 sorbitan diisostearate</from_name>
		<from_code>1363615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calfactant</from_name>
		<from_code>232539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-4 dilaurate</from_name>
		<from_code>1363613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-8 dioleate</from_name>
		<from_code>1363621</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol</from_name>
		<from_code>34693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxychlorosene sodium</from_name>
		<from_code>221136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol 2-(2-methylbutyrate)</from_name>
		<from_code>1947503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dodecyl sulfate</from_name>
		<from_code>9871</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-40 stearate</from_name>
		<from_code>1314849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonoxynol-9</from_name>
		<from_code>53750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxychlorosene</from_name>
		<from_code>32680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant Activity [MoA]</to_name>
		<to_code>N0000000079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl nitrite</from_name>
		<from_code>742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetranitrate</from_name>
		<from_code>7992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Donors [MoA]</to_name>
		<to_code>N0000000120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendamustine hydrochloride</from_name>
		<from_code>1114693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid</from_name>
		<from_code>21183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide monohydrate</from_name>
		<from_code>2679071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, 1-stearyl ester</from_name>
		<from_code>1435636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium citrate sesquihydrate</from_name>
		<from_code>2049608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacarbazine</from_name>
		<from_code>3098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid monohydrate</from_name>
		<from_code>221079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>busulfan</from_name>
		<from_code>1828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipobroman</from_name>
		<from_code>8347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temozolomide</from_name>
		<from_code>37776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendamustine</from_name>
		<from_code>134547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine phosphate</from_name>
		<from_code>105556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptozocin</from_name>
		<from_code>10114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine</from_name>
		<from_code>4089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine phosphate sodium</from_name>
		<from_code>4090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan</from_name>
		<from_code>6718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carmustine</from_name>
		<from_code>2105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loncastuximab tesirine</from_name>
		<from_code>2540964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan flufenamide hydrochloride</from_name>
		<from_code>2531370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifosfamide</from_name>
		<from_code>5657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurbinectedin</from_name>
		<from_code>2374729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan flufenamide</from_name>
		<from_code>2531369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uracil mustard</from_name>
		<from_code>10996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trabectedin</from_name>
		<from_code>1716278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorambucil</from_name>
		<from_code>2346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan hydrochloride</from_name>
		<from_code>235857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loncastuximab tesirine-lpyl</from_name>
		<from_code>2540965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomustine</from_name>
		<from_code>6466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Activity [MoA]</to_name>
		<to_code>N0000000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine</from_name>
		<from_code>9061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine monohydrochloride</from_name>
		<from_code>82092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine</from_name>
		<from_code>24457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laureth-9 phosphate</from_name>
		<from_code>2373964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laureth-9</from_name>
		<from_code>236545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine oleate</from_name>
		<from_code>24460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine thenoate</from_name>
		<from_code>236213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polidocanol</from_name>
		<from_code>968170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine hydrochloride</from_name>
		<from_code>1311530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sclerosing Agent [EPC]</from_name>
		<from_code>N0000175814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Activity [MoA]</to_name>
		<to_code>N0000020024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green</from_name>
		<from_code>5775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal</from_name>
		<from_code>9471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Disclosing Agent [EPC]</from_name>
		<from_code>N0000194020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brilliant blue G</from_name>
		<from_code>1998867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green acid form</from_name>
		<from_code>2199577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal sodium I 131</from_name>
		<from_code>82097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein</from_name>
		<from_code>25138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trypan blue free acid</from_name>
		<from_code>1726081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal sodium</from_name>
		<from_code>1362690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigotindisulfonic acid</from_name>
		<from_code>1546441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein sodium</from_name>
		<from_code>57789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dyes [MoA]</to_name>
		<to_code>N0000175533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate, anhydrous</from_name>
		<from_code>267453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate anhydrous</from_name>
		<from_code>1657484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dodecahydrate</from_name>
		<from_code>1311326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate</from_name>
		<from_code>56466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate dibasic trihydrate</from_name>
		<from_code>2475957</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride anhydrous</from_name>
		<from_code>1311539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate</from_name>
		<from_code>29164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sodium phosphate</from_name>
		<from_code>2288215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate</from_name>
		<from_code>39954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic potassium phosphate</from_name>
		<from_code>55019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic, dodecahydrate</from_name>
		<from_code>1311345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate dihydrate</from_name>
		<from_code>2729665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride hexahydrate</from_name>
		<from_code>221118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic sodium phosphate, dihydrate</from_name>
		<from_code>1311286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic, monohydrate</from_name>
		<from_code>1311357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous zinc acetate</from_name>
		<from_code>1299637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium amino acid chelate</from_name>
		<from_code>486895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric oxide</from_name>
		<from_code>21837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium carbonate</from_name>
		<from_code>29155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibasic sodium phosphate heptahydrate</from_name>
		<from_code>221090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tribasic sodium phosphate</from_name>
		<from_code>36710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium gluconate</from_name>
		<from_code>89903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc chloride</from_name>
		<from_code>39937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate anhydrous</from_name>
		<from_code>1299928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pantothenate</from_name>
		<from_code>1918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper gluconate</from_name>
		<from_code>2839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glycerophosphate</from_name>
		<from_code>1909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium hydrogen phosphate dehydrate</from_name>
		<from_code>1311230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride tetrahydrate</from_name>
		<from_code>2003593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic anhydrous</from_name>
		<from_code>1307158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate</from_name>
		<from_code>1919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium levulinate</from_name>
		<from_code>47624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, monohydrate</from_name>
		<from_code>1311342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic, anhydrous</from_name>
		<from_code>349753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chloride</from_name>
		<from_code>8591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate</from_name>
		<from_code>36709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium,chelated</from_name>
		<from_code>259277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate, dihydrate</from_name>
		<from_code>1310463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium lactate</from_name>
		<from_code>47622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum magnesium silicate</from_name>
		<from_code>17614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium dihydrogen phosphate</from_name>
		<from_code>236560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric chloride</from_name>
		<from_code>21833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate</from_name>
		<from_code>58300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium citrate anhydrous</from_name>
		<from_code>1310549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium stearate</from_name>
		<from_code>1310567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dihydrate</from_name>
		<from_code>1311323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, anhydrous</from_name>
		<from_code>314838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate,monobasic,monohydrate</from_name>
		<from_code>221125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloride ion</from_name>
		<from_code>153974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartate magnesium hydrochloride</from_name>
		<from_code>1167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate</from_name>
		<from_code>58295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic</from_name>
		<from_code>235496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate dihydrate</from_name>
		<from_code>314837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bicarbonate</from_name>
		<from_code>34296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ion</from_name>
		<from_code>1318915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate</from_name>
		<from_code>56443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate, heptahydrate</from_name>
		<from_code>1311282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium acetate</from_name>
		<from_code>54987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glubionate</from_name>
		<from_code>25806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate</from_name>
		<from_code>47613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate, monobasic, anhydrous</from_name>
		<from_code>1426444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate</from_name>
		<from_code>34322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate anhydrous</from_name>
		<from_code>1792467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate anhydrous</from_name>
		<from_code>2106283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium gluconate</from_name>
		<from_code>52358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate trihydrate</from_name>
		<from_code>1440975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dihydrogen phosphate dihydrate</from_name>
		<from_code>1311311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, dibasic</from_name>
		<from_code>1482795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate</from_name>
		<from_code>142131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium zirconium cyclosilicate</from_name>
		<from_code>2047628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, tribasic, pentahydrate</from_name>
		<from_code>1313280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium glycinate</from_name>
		<from_code>476818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium</from_name>
		<from_code>6574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bicarbonate</from_name>
		<from_code>36676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibasic potassium phosphate</from_name>
		<from_code>55018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride</from_name>
		<from_code>6579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dried sodium phosphate</from_name>
		<from_code>1366977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate monohydrate</from_name>
		<from_code>1309410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic</from_name>
		<from_code>236719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium acetate tetrahydrate</from_name>
		<from_code>317246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium lactate</from_name>
		<from_code>56489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxytol</from_name>
		<from_code>473387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate dibasic trihydrate</from_name>
		<from_code>237119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Electrolyte Activity [MoA]</to_name>
		<to_code>N0000000220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acid-Base Activity [MoA]</from_name>
		<from_code>N0000000226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acid-Base Activity [MoA]</from_name>
		<from_code>N0000000226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc chloride</from_name>
		<from_code>39937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate anhydrous</from_name>
		<from_code>1792467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium gluconate</from_name>
		<from_code>89903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate</from_name>
		<from_code>34322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium gluconate</from_name>
		<from_code>52358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium chloride</from_name>
		<from_code>712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, dibasic</from_name>
		<from_code>1482795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate</from_name>
		<from_code>142131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate trihydrate</from_name>
		<from_code>1440975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate anhydrous</from_name>
		<from_code>1299928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium glycinate</from_name>
		<from_code>476818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium</from_name>
		<from_code>6574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, tribasic, pentahydrate</from_name>
		<from_code>1313280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bicarbonate</from_name>
		<from_code>36676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride tetrahydrate</from_name>
		<from_code>2003593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride</from_name>
		<from_code>6579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate monohydrate</from_name>
		<from_code>1309410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chloride</from_name>
		<from_code>8591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium acetate tetrahydrate</from_name>
		<from_code>317246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium lactate</from_name>
		<from_code>56489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium,chelated</from_name>
		<from_code>259277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate dibasic trihydrate</from_name>
		<from_code>237119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum magnesium silicate</from_name>
		<from_code>17614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate, anhydrous</from_name>
		<from_code>267453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citrate</from_name>
		<from_code>114200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate anhydrous</from_name>
		<from_code>1657484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate</from_name>
		<from_code>56466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate</from_name>
		<from_code>29164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate</from_name>
		<from_code>58300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride anhydrous</from_name>
		<from_code>1311539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate</from_name>
		<from_code>39954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium citrate anhydrous</from_name>
		<from_code>1310549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium stearate</from_name>
		<from_code>1310567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic potassium phosphate</from_name>
		<from_code>55019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate</from_name>
		<from_code>58295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloride ion</from_name>
		<from_code>153974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartate magnesium hydrochloride</from_name>
		<from_code>1167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate dihydrate</from_name>
		<from_code>2729665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bicarbonate</from_name>
		<from_code>34296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride hexahydrate</from_name>
		<from_code>221118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ion</from_name>
		<from_code>1318915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous zinc acetate</from_name>
		<from_code>1299637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium amino acid chelate</from_name>
		<from_code>486895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate</from_name>
		<from_code>56443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium carbonate</from_name>
		<from_code>29155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate, heptahydrate</from_name>
		<from_code>1311282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium acetate</from_name>
		<from_code>54987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acid-Base Activity [MoA]</to_name>
		<to_code>N0000000226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metabolic Alkalinizer [EPC]</from_name>
		<from_code>N0000175896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicarbonate ion</from_name>
		<from_code>1546277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tromethamine hydrochloride</from_name>
		<from_code>1311534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate anhydrous</from_name>
		<from_code>1374802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tromethamine</from_name>
		<from_code>10865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkalinizing Activity [MoA]</to_name>
		<to_code>N0000009986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium zirconium cyclosilicate</from_name>
		<from_code>2047628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calculi Dissolution Agent [EPC]</from_name>
		<from_code>N0000175835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racemethionine</from_name>
		<from_code>9100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluconolactone</from_name>
		<from_code>25842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactic acid</from_name>
		<from_code>28393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acidifying Activity [MoA]</to_name>
		<to_code>N0000175833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaine, anhydrous</from_name>
		<from_code>350374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylating Activity [MoA]</to_name>
		<to_code>N0000175804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaine hydrochloride</from_name>
		<from_code>81965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylating Activity [MoA]</to_name>
		<to_code>N0000175804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaine</from_name>
		<from_code>1512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylating Activity [MoA]</to_name>
		<to_code>N0000175804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylating Agent [EPC]</from_name>
		<from_code>N0000175805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylating Activity [MoA]</to_name>
		<to_code>N0000175804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interactions [MoA]</from_name>
		<from_code>N0000000163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interactions [MoA]</from_name>
		<from_code>N0000000163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interactions [MoA]</from_name>
		<from_code>N0000000163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Stabilizers [MoA]</to_name>
		<to_code>N0000194078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interactions [MoA]</from_name>
		<from_code>N0000000163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Reactivators [MoA]</to_name>
		<to_code>N0000000208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interactions [MoA]</from_name>
		<from_code>N0000000163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inducers [MoA]</to_name>
		<to_code>N0000190116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin sodium</from_name>
		<from_code>2109051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, human recombinant</from_name>
		<from_code>1300478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine mononitrate</from_name>
		<from_code>10456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal phosphate</from_name>
		<from_code>9004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>migalastat</from_name>
		<from_code>2054252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecobalamin</from_name>
		<from_code>29421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum magnesium silicate</from_name>
		<from_code>17614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride tetrahydrate</from_name>
		<from_code>2003593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate sodium dihydrate</from_name>
		<from_code>2611697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase</from_name>
		<from_code>5464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine hydrochloride</from_name>
		<from_code>235355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A</from_name>
		<from_code>11246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantothenic acid</from_name>
		<from_code>7891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucarpidase</from_name>
		<from_code>1242127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin hydrochloride</from_name>
		<from_code>1947247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerliponase alfa</from_name>
		<from_code>1922436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pantothenate</from_name>
		<from_code>1918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biotin</from_name>
		<from_code>1588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-qvfc</from_name>
		<from_code>2639946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitriol</from_name>
		<from_code>1894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine hydrochloride</from_name>
		<from_code>203164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 5-aminolevulinate</from_name>
		<from_code>337068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbic acid</from_name>
		<from_code>1151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese gluconate</from_name>
		<from_code>52403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc chloride</from_name>
		<from_code>39937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol-mknl</from_name>
		<from_code>2121417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A palmitate</from_name>
		<from_code>35406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-tqjs</from_name>
		<from_code>2693885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate anhydrous</from_name>
		<from_code>1299928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, ovine</from_name>
		<from_code>486164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panthenol triacetate, (+)-</from_name>
		<from_code>1426597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegvaliase</from_name>
		<from_code>2046360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium amino acid chelate</from_name>
		<from_code>486895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous zinc acetate</from_name>
		<from_code>1299637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol anhydrous</from_name>
		<from_code>1855064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine</from_name>
		<from_code>10454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinol acetate</from_name>
		<from_code>35400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium carbonate</from_name>
		<from_code>29155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate</from_name>
		<from_code>1925821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergocalciferol</from_name>
		<from_code>4018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racemethionine</from_name>
		<from_code>9100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate dihydrate</from_name>
		<from_code>2729665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride hexahydrate</from_name>
		<from_code>221118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine</from_name>
		<from_code>684879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-lpuj</from_name>
		<from_code>2729290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium molybdate</from_name>
		<from_code>17789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate</from_name>
		<from_code>39954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>androstenedione</from_name>
		<from_code>784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paricalcitol</from_name>
		<from_code>73710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythritol</from_name>
		<from_code>1369563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn</from_name>
		<from_code>2561249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxalactam</from_name>
		<from_code>7069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate anhydrous</from_name>
		<from_code>1657484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molybdenum</from_name>
		<from_code>7024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride anhydrous</from_name>
		<from_code>1311539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate</from_name>
		<from_code>29164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin acetate</from_name>
		<from_code>236302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium acetate tetrahydrate</from_name>
		<from_code>317246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine phosphoserinate</from_name>
		<from_code>236803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate dibasic trihydrate</from_name>
		<from_code>237119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, bovine</from_name>
		<from_code>578350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride</from_name>
		<from_code>6579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panthenol</from_name>
		<from_code>1044977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxercalciferol</from_name>
		<from_code>11516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene</from_name>
		<from_code>29365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>migalastat hydrochloride</from_name>
		<from_code>2054264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate monohydrate</from_name>
		<from_code>1309410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, tribasic, pentahydrate</from_name>
		<from_code>1313280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bentiromide</from_name>
		<from_code>18896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium</from_name>
		<from_code>6574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine pyrophosphate</from_name>
		<from_code>10459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium glycinate</from_name>
		<from_code>476818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene hydrate</from_name>
		<from_code>1299898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium latamoxef</from_name>
		<from_code>258330</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B6</from_name>
		<from_code>42954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate sodium</from_name>
		<from_code>1925820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A myristate</from_name>
		<from_code>1813433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate anhydrous</from_name>
		<from_code>1792467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin</from_name>
		<from_code>9346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium gluconate</from_name>
		<from_code>52358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-oysk</from_name>
		<from_code>2119708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate trihydrate</from_name>
		<from_code>1440975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-zzxf</from_name>
		<from_code>2382595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, dibasic</from_name>
		<from_code>1482795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate</from_name>
		<from_code>142131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone sodium</from_name>
		<from_code>236529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone</from_name>
		<from_code>8160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-ocsq</from_name>
		<from_code>2693451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate, heptahydrate</from_name>
		<from_code>1311282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegvaliase-pqpz</from_name>
		<from_code>2046361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>24-homo-1,25-dihydroxyvitamin D3</from_name>
		<from_code>1423458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ascorbate</from_name>
		<from_code>267366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin tetrabutyrate</from_name>
		<from_code>2106328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylbenzethonium chloride</from_name>
		<from_code>1796444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-nvhy</from_name>
		<from_code>2700789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin</from_name>
		<from_code>5514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantothenic acid, (+-)-</from_name>
		<from_code>2394646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine disulfide</from_name>
		<from_code>38041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>D-biotin</from_name>
		<from_code>314583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium stearate</from_name>
		<from_code>1310567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl aminolevulinate hydrochloride</from_name>
		<from_code>1300479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol</from_name>
		<from_code>2121416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartate magnesium hydrochloride</from_name>
		<from_code>1167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B12</from_name>
		<from_code>11248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate</from_name>
		<from_code>58295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate sodium anhydrous</from_name>
		<from_code>2279515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-fihj</from_name>
		<from_code>2375132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone piperazine</from_name>
		<from_code>236354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate</from_name>
		<from_code>58300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interactions [MoA]</to_name>
		<to_code>N0000000163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxylase Activators [MoA]</to_name>
		<to_code>N0000190481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipase Activators [MoA]</to_name>
		<to_code>N0000193928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lyase Activators [MoA]</to_name>
		<to_code>N0000185498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ligase Activators [MoA]</to_name>
		<to_code>N0000184142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyruvate Kinase Activators [MoA]</to_name>
		<to_code>N0000194009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GTP Phosphohydrolase Activators [MoA]</to_name>
		<to_code>N0000000252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activators [MoA]</from_name>
		<from_code>N0000000231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Activators [MoA]</to_name>
		<to_code>N0000194171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor X</from_name>
		<from_code>4262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen,I-125</from_name>
		<from_code>314623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegloticase</from_name>
		<from_code>1011650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase</from_name>
		<from_code>58939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa</from_name>
		<from_code>352374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase Clostridium histolyticum</from_name>
		<from_code>898492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptacog alfa activated</from_name>
		<from_code>253149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated</from_name>
		<from_code>1741397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonoctocog alfa</from_name>
		<from_code>1796377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor Xa (recombinant), inactivated-zhzo</from_name>
		<from_code>2045125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIIa</from_name>
		<from_code>4256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated-exei</from_name>
		<from_code>2275722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vericiguat</from_name>
		<from_code>2475830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine</from_name>
		<from_code>221060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human</from_name>
		<from_code>2264108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonacog alfa</from_name>
		<from_code>1300488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant residues 743-1636 deleted</from_name>
		<from_code>1300485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human-lans</from_name>
		<from_code>2643194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant antihemophilic factor VIII</from_name>
		<from_code>253151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII</from_name>
		<from_code>4271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine B-domain truncated recombinant</from_name>
		<from_code>1592899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa (activated), lyophilized</from_name>
		<from_code>353106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>andexanet alfa</from_name>
		<from_code>2045114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor VIIa (recombinant)-jncw</from_name>
		<from_code>2386863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII, human</from_name>
		<from_code>826070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simoctocog alfa</from_name>
		<from_code>1729084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasburicase</from_name>
		<from_code>283821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turoctocog alfa</from_name>
		<from_code>1737557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor XIII a-subunit (recombinant)</from_name>
		<from_code>1488293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII</from_name>
		<from_code>4257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activators [MoA]</to_name>
		<to_code>N0000000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydroxylase Activators [MoA]</from_name>
		<from_code>N0000190481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
		<to_code>N0000190482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenylalanine Hydroxylase Activator [EPC]</from_name>
		<from_code>N0000190483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
		<to_code>N0000190482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sapropterin dihydrochloride</from_name>
		<from_code>753341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
		<to_code>N0000190482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sepiapterin</from_name>
		<from_code>2723056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
		<to_code>N0000190482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sapropterin</from_name>
		<from_code>753340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
		<to_code>N0000190482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipase Activators [MoA]</from_name>
		<from_code>N0000193928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Indirect Lipase Activators [MoA]</to_name>
		<to_code>N0000193925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Indirect Lipase Activators [MoA]</from_name>
		<from_code>N0000193925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiopoietin-like 3 Inhibitors [MoA]</to_name>
		<to_code>N0000193916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiopoietin-like 3 Inhibitor [EPC]</from_name>
		<from_code>N0000193915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiopoietin-like 3 Inhibitors [MoA]</to_name>
		<to_code>N0000193916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab</from_name>
		<from_code>2478335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiopoietin-like 3 Inhibitors [MoA]</to_name>
		<to_code>N0000193916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antithrombin Activators [MoA]</from_name>
		<from_code>N0000009960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin 3 Activators [MoA]</to_name>
		<to_code>N0000175636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin Activators [MoA]</to_name>
		<to_code>N0000009960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lyase Activators [MoA]</from_name>
		<from_code>N0000185498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lyase Activators [MoA]</from_name>
		<from_code>N0000185498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linaclotide</from_name>
		<from_code>1307404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plecanatide</from_name>
		<from_code>1873752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Guanylate Cyclase-C Agonist [EPC]</from_name>
		<from_code>N0000185500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Activators [MoA]</to_name>
		<to_code>N0000185499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride trihydrate</from_name>
		<from_code>1309396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avanafil</from_name>
		<from_code>1291301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vericiguat</from_name>
		<from_code>2475830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vericiguat</from_name>
		<from_code>2475830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil</from_name>
		<from_code>306674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride</from_name>
		<from_code>307306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riociguat</from_name>
		<from_code>1439816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Soluble Guanylate Cyclase Stimulator [EPC]</from_name>
		<from_code>N0000190485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
		<to_code>N0000190484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ligase Activators [MoA]</from_name>
		<from_code>N0000184142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</to_name>
		<to_code>N0000184143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carglumic acid</from_name>
		<from_code>401713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</to_name>
		<to_code>N0000184143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</from_name>
		<from_code>N0000184144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</to_name>
		<to_code>N0000184143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat sulfate</from_name>
		<from_code>2595574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyruvate Kinase Activators [MoA]</to_name>
		<to_code>N0000194009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyruvate Kinase Activator [EPC]</from_name>
		<from_code>N0000194008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyruvate Kinase Activators [MoA]</to_name>
		<to_code>N0000194009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyruvate Kinase Activators [MoA]</to_name>
		<to_code>N0000194009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasminogen Activators [MoA]</from_name>
		<from_code>N0000000089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasminogen</from_name>
		<from_code>2557200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasminogen, human-tvmh</from_name>
		<from_code>2557201</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide, bovine lung</from_name>
		<from_code>1788946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide sodium</from_name>
		<from_code>1746523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide</from_name>
		<from_code>1311089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activators [MoA]</to_name>
		<to_code>N0000000241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dordaviprone</from_name>
		<from_code>2721194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Activators [MoA]</to_name>
		<to_code>N0000194171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Activator [EPC]</from_name>
		<from_code>N0000194170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Activators [MoA]</to_name>
		<to_code>N0000194171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dordaviprone hydrochloride</from_name>
		<from_code>2721193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Activators [MoA]</to_name>
		<to_code>N0000194171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000000183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitors [MoA]</to_name>
		<to_code>N0000194116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipase Inhibitors [MoA]</to_name>
		<to_code>N0000009916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitors [MoA]</to_name>
		<to_code>N0000175899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosyl Transferase Inhibitors [MoA]</to_name>
		<to_code>N0000020018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000019995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ubiquitin Ligase Inhibitors [MoA]</to_name>
		<to_code>N0000020084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</to_name>
		<to_code>N0000193914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dephosphorylation Inhibitors [MoA]</to_name>
		<to_code>N0000009959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytidine Deaminase Inhibitors [MoA]</to_name>
		<to_code>N0000193993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alcohol Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000000179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oligonucleotide Telomerase Inhibitors [MoA]</to_name>
		<to_code>N0000194126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Squalene Monooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000010265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000193302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrimidine Phosphorylase Inhibitors [MoA]</to_name>
		<to_code>N0000191868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UDP Glucuronosyltransferases Inhibitors [MoA]</to_name>
		<to_code>N0000191269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000175756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncouplers [MoA]</to_name>
		<to_code>N0000000155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>11-beta Hydroxysteroid Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000194061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitors [MoA]</to_name>
		<to_code>N0000175087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endonuclease Inhibitors [MoA]</to_name>
		<to_code>N0000193851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylase Inhibitors [MoA]</to_name>
		<to_code>N0000010274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Activating Factor Inhibitors [MoA]</to_name>
		<to_code>N0000009961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Diphosphate Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000010334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fatty Acid Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000181000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000000173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Inhibitors [MoA]</to_name>
		<to_code>N0000175964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
		<to_code>N0000000166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000175513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
		<to_code>N0000194048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epoxide Hydrolase Inhibitors [MoA]</to_name>
		<to_code>N0000192345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitors [MoA]</from_name>
		<from_code>N0000000133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imetelstat</from_name>
		<from_code>2685236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>josamycin</from_name>
		<from_code>6084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiabendazole</from_name>
		<from_code>10450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine hydrochloride</from_name>
		<from_code>81945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivosidenib</from_name>
		<from_code>2049873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testolactone</from_name>
		<from_code>10378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resveratrol</from_name>
		<from_code>1000492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin sodium</from_name>
		<from_code>267417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anastrozole</from_name>
		<from_code>84857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>6-aminocaproic acid</from_name>
		<from_code>99</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrosine</from_name>
		<from_code>266604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimecrolimus</from_name>
		<from_code>321952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantharidin</from_name>
		<from_code>1984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hemin</from_name>
		<from_code>5175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bedaquiline fumarate</from_name>
		<from_code>1364503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazemetostat hydrobromide</from_name>
		<from_code>2274379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarbidopa</from_name>
		<from_code>2695774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anakinra</from_name>
		<from_code>72435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin disodium</from_name>
		<from_code>258332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine</from_name>
		<from_code>569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazemetostat</from_name>
		<from_code>2274378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin</from_name>
		<from_code>2190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imetelstat sodium</from_name>
		<from_code>2685237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vigabatrin</from_name>
		<from_code>14851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine</from_name>
		<from_code>1886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bempedoic acid</from_name>
		<from_code>2282403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exemestane</from_name>
		<from_code>258494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethosuximide</from_name>
		<from_code>4135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bedaquiline</from_name>
		<from_code>1364504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>josamycin propionate</from_name>
		<from_code>28069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa</from_name>
		<from_code>2019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letrozole</from_name>
		<from_code>72965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol sulfate tosylate</from_name>
		<from_code>2265863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niclosamide</from_name>
		<from_code>7402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperonyl butoxide</from_name>
		<from_code>8345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine citrate</from_name>
		<from_code>20033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine monohydrochloride</from_name>
		<from_code>82092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus monohydrate</from_name>
		<from_code>484288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous tacrolimus</from_name>
		<from_code>235991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine monohydrate</from_name>
		<from_code>236112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin</from_name>
		<from_code>2015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin indanyl sodium</from_name>
		<from_code>56461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa anhydrous</from_name>
		<from_code>1545982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine</from_name>
		<from_code>9061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin phenyl sodium</from_name>
		<from_code>42580</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol</from_name>
		<from_code>2265702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine</from_name>
		<from_code>6704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sex Hormone Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sex Hormone Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminoglutethimide</from_name>
		<from_code>677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatase Inhibitor [EPC]</from_name>
		<from_code>N0000175563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testolactone</from_name>
		<from_code>10378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exemestane</from_name>
		<from_code>258494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letrozole</from_name>
		<from_code>72965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anastrozole</from_name>
		<from_code>84857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitors [MoA]</to_name>
		<to_code>N0000175080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finasteride</from_name>
		<from_code>25025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dutasteride</from_name>
		<from_code>228790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saw palmetto extract</from_name>
		<from_code>236344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dutasteride</from_name>
		<from_code>228790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenal Steroid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucocorticoid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenal Steroid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mineralocorticoid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenal Steroid Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrapone</from_name>
		<from_code>6923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat phosphate</from_name>
		<from_code>2286253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminoglutethimide</from_name>
		<from_code>677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000000183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirogacestat</from_name>
		<from_code>2670631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitors [MoA]</to_name>
		<to_code>N0000194116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gamma Secretase Inhibitor [EPC]</from_name>
		<from_code>N0000194115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitors [MoA]</to_name>
		<to_code>N0000194116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orlistat</from_name>
		<from_code>37925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipase Inhibitors [MoA]</to_name>
		<to_code>N0000009916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
		<from_code>N0000175591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipase Inhibitors [MoA]</to_name>
		<to_code>N0000009916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitors [MoA]</to_name>
		<to_code>N0000175899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitors [MoA]</to_name>
		<to_code>N0000175899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renin Inhibitor [EPC]</from_name>
		<from_code>N0000175900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitors [MoA]</to_name>
		<to_code>N0000175899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitors [MoA]</to_name>
		<to_code>N0000175899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitors [MoA]</to_name>
		<to_code>N0000175899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protein Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III RNA Antisense Inhibitor [MoA]</to_name>
		<to_code>N0000194143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium heptahydrate</from_name>
		<from_code>1666923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tavaborole</from_name>
		<from_code>1543173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oleandomycin</from_name>
		<from_code>7629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate, liposomal</from_name>
		<from_code>2059179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline</from_name>
		<from_code>21272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed dipotassium</from_name>
		<from_code>2699334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed monohydrate</from_name>
		<from_code>2590669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin hydrochloride</from_name>
		<from_code>1541465</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium hemipentahydrate</from_name>
		<from_code>2056898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline tosylate</from_name>
		<from_code>2059268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen sodium</from_name>
		<from_code>314633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omacetaxine</from_name>
		<from_code>1546446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxaborole Antifungal [EPC]</from_name>
		<from_code>N0000191279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline dihydrochloride</from_name>
		<from_code>2055907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed tromethamine anhydrous</from_name>
		<from_code>2604776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eteplirsen</from_name>
		<from_code>1810569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline hydrochloride</from_name>
		<from_code>2059038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate</from_name>
		<from_code>2640868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralatrexate</from_name>
		<from_code>662019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline sodium</from_name>
		<from_code>102758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen</from_name>
		<from_code>85763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfopristin</from_name>
		<from_code>229369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin liposomal</from_name>
		<from_code>2059180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium</from_name>
		<from_code>282443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denileukin diftitox-cxdl</from_name>
		<from_code>2700746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>APOC-III-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III RNA Antisense Inhibitor [MoA]</to_name>
		<to_code>N0000194143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plozasiran sodium</from_name>
		<from_code>2727337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III RNA Antisense Inhibitor [MoA]</to_name>
		<to_code>N0000194143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plozasiran</from_name>
		<from_code>2727175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III RNA Antisense Inhibitor [MoA]</to_name>
		<to_code>N0000194143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitisinone</from_name>
		<from_code>61805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucosyl Transferase Inhibitors [MoA]</from_name>
		<from_code>N0000020018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miglustat</from_name>
		<from_code>402316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat tartrate</from_name>
		<from_code>1547219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat</from_name>
		<from_code>1547220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucosylceramide Synthase Inhibitor [EPC]</from_name>
		<from_code>N0000175783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azacitidine</from_name>
		<from_code>1251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000019995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>decitabine</from_name>
		<from_code>15657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000019995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ubiquitin Ligase Inhibitors [MoA]</from_name>
		<from_code>N0000020084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>E3 Ubiquitin Ligase Inhibitors [MoA]</to_name>
		<to_code>N0000020085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bortezomib</from_name>
		<from_code>358258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ubiquitin Ligase Inhibitors [MoA]</to_name>
		<to_code>N0000020084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenalidomide</from_name>
		<from_code>342369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>E3 Ubiquitin Ligase Inhibitors [MoA]</to_name>
		<to_code>N0000020085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomalidomide</from_name>
		<from_code>1369713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>E3 Ubiquitin Ligase Inhibitors [MoA]</to_name>
		<to_code>N0000020085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rezafungin acetate</from_name>
		<from_code>2639156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp citrate</from_name>
		<from_code>2560215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp</from_name>
		<from_code>2560213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin sodium</from_name>
		<from_code>487070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rezafungin</from_name>
		<from_code>2639155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Triterpenoid Antifungal [EPC]</from_name>
		<from_code>N0000193966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucan Synthase Inhibitors [MoA]</to_name>
		<to_code>N0000020027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iodide Peroxidase Inhibitors [MoA]</to_name>
		<to_code>N0000010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclooxygenase Inhibitors [MoA]</from_name>
		<from_code>N0000000160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000008288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac sodium</from_name>
		<from_code>47364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate</from_name>
		<from_code>52364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suprofen</from_name>
		<from_code>10255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nepafenac</from_name>
		<from_code>298665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carprofen</from_name>
		<from_code>20343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylamide</from_name>
		<from_code>9518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine citrate</from_name>
		<from_code>203175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclofenac</from_name>
		<from_code>16689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac</from_name>
		<from_code>19737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexketoprofen</from_name>
		<from_code>237162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trolamine salicylate</from_name>
		<from_code>38866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexketoprofen trometamol</from_name>
		<from_code>233386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine</from_name>
		<from_code>3384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valdecoxib</from_name>
		<from_code>278567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000008288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000008288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rofecoxib</from_name>
		<from_code>232158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000008288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allopurinol</from_name>
		<from_code>519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>febuxostat</from_name>
		<from_code>73689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allopurinol sodium</from_name>
		<from_code>80566</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bempedoic acid</from_name>
		<from_code>2282403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</to_name>
		<to_code>N0000193914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</from_name>
		<from_code>N0000193913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</to_name>
		<to_code>N0000193914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methazolamide</from_name>
		<from_code>6826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dorzolamide</from_name>
		<from_code>60207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dorzolamide hydrochloride</from_name>
		<from_code>236065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brinzolamide</from_name>
		<from_code>194881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide choline</from_name>
		<from_code>2711542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide</from_name>
		<from_code>3327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichlorphenamide</from_name>
		<from_code>3353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
		<to_code>N0000000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytidine Deaminase Inhibitor [EPC]</from_name>
		<from_code>N0000193992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytidine Deaminase Inhibitors [MoA]</to_name>
		<to_code>N0000193993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alcohol Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000000179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enasidenib</from_name>
		<from_code>1940332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000193615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorasidenib</from_name>
		<from_code>2690647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorasidenib citrate</from_name>
		<from_code>2690648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoxygenase Inhibitors [MoA]</from_name>
		<from_code>N0000000134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000000134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zileuton</from_name>
		<from_code>40575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine</from_name>
		<from_code>3384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine citrate</from_name>
		<from_code>203175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000175955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imetelstat</from_name>
		<from_code>2685236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oligonucleotide Telomerase Inhibitors [MoA]</to_name>
		<to_code>N0000194126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oligonucleotide Telomerase Inhibitor [EPC]</from_name>
		<from_code>N0000194125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oligonucleotide Telomerase Inhibitors [MoA]</to_name>
		<to_code>N0000194126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panobinostat</from_name>
		<from_code>1603350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panobinostat lactate</from_name>
		<from_code>1603349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorinostat</from_name>
		<from_code>194337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belinostat</from_name>
		<from_code>1543543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givinostat</from_name>
		<from_code>2678889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
		<to_code>N0000175071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anaplastic Lymphoma Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000194147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</to_name>
		<to_code>N0000194055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobimetinib</from_name>
		<from_code>1722365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alectinib</from_name>
		<from_code>1727455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tepotinib hydrochloride</from_name>
		<from_code>2477104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ensartinib hydrochloride</from_name>
		<from_code>2712547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib citrate</from_name>
		<from_code>2595242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib dihydrochloride</from_name>
		<from_code>2479691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib</from_name>
		<from_code>2183102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duvelisib</from_name>
		<from_code>2058509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idelalisib</from_name>
		<from_code>1544460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralsetinib</from_name>
		<from_code>2394936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mobocertinib succinate</from_name>
		<from_code>2570737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vimseltinib</from_name>
		<from_code>2705378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mobocertinib</from_name>
		<from_code>2570736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lazertinib mesylate</from_name>
		<from_code>2691151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umbralisib</from_name>
		<from_code>2478439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infigratinib</from_name>
		<from_code>2550729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib</from_name>
		<from_code>1312397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib monohydrate</from_name>
		<from_code>1371319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribociclib succinate</from_name>
		<from_code>1873978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tepotinib</from_name>
		<from_code>2477103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib phosphate</from_name>
		<from_code>2633006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribociclib</from_name>
		<from_code>1873916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib hydrochloride</from_name>
		<from_code>2362259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib tosylate</from_name>
		<from_code>597744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quizartinib</from_name>
		<from_code>2643048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lazertinib</from_name>
		<from_code>2691150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palbociclib</from_name>
		<from_code>1601374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>futibatinib</from_name>
		<from_code>2628190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofarabine</from_name>
		<from_code>44151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib</from_name>
		<from_code>2479690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abemaciclib</from_name>
		<from_code>1946825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemigatinib</from_name>
		<from_code>2359268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib mesylate</from_name>
		<from_code>1721559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpelisib</from_name>
		<from_code>2169285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neratinib maleate</from_name>
		<from_code>1940642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib</from_name>
		<from_code>495881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ensartinib</from_name>
		<from_code>2712546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umbralisib tosylate</from_name>
		<from_code>2478438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quizartinib dihydrochloride</from_name>
		<from_code>2643049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib</from_name>
		<from_code>1721560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neratinib</from_name>
		<from_code>1940643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protein Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protein Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protein Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protein Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</to_name>
		<to_code>N0000193859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protein Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib</from_name>
		<from_code>1312397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib</from_name>
		<from_code>282388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temsirolimus</from_name>
		<from_code>657797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobimetinib</from_name>
		<from_code>1722365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrutinib</from_name>
		<from_code>1442981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selumetinib sulfate</from_name>
		<from_code>2361596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib tartrate</from_name>
		<from_code>2698561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib</from_name>
		<from_code>714438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib hydrochloride monohydrate</from_name>
		<from_code>2701416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afatinib</from_name>
		<from_code>1430438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ponatinib</from_name>
		<from_code>1364347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobimetinib fumarate</from_name>
		<from_code>1722380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus</from_name>
		<from_code>35302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib hydrochloride</from_name>
		<from_code>1804015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selumetinib</from_name>
		<from_code>2289380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nintedanib</from_name>
		<from_code>1592737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib</from_name>
		<from_code>1721560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copanlisib</from_name>
		<from_code>1945077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribociclib</from_name>
		<from_code>1873916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vemurafenib</from_name>
		<from_code>1147220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palbociclib</from_name>
		<from_code>1601374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gefitinib</from_name>
		<from_code>328134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abemaciclib</from_name>
		<from_code>1946825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacomitinib</from_name>
		<from_code>2058849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brigatinib</from_name>
		<from_code>1921217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erlotinib</from_name>
		<from_code>337525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasatinib</from_name>
		<from_code>475342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasatinib anhydrous</from_name>
		<from_code>1546019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entrectinib</from_name>
		<from_code>2197862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceritinib</from_name>
		<from_code>1535457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trametinib</from_name>
		<from_code>1425099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alectinib</from_name>
		<from_code>1727455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib</from_name>
		<from_code>480167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axitinib</from_name>
		<from_code>1242999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunitinib</from_name>
		<from_code>357977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midostaurin</from_name>
		<from_code>1919083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabozantinib</from_name>
		<from_code>1363268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idelalisib</from_name>
		<from_code>1544460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ruxolitinib</from_name>
		<from_code>1193326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trametinib dimethyl sulfoxide</from_name>
		<from_code>1425098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenvatinib</from_name>
		<from_code>1603296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib mesylate</from_name>
		<from_code>284924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib</from_name>
		<from_code>495881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neratinib</from_name>
		<from_code>1940643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>binimetinib</from_name>
		<from_code>2049122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacomitinib anhydrous</from_name>
		<from_code>2058848</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afatinib dimaleate</from_name>
		<from_code>1430441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunitinib malate</from_name>
		<from_code>616275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosutinib</from_name>
		<from_code>1307619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vandetanib</from_name>
		<from_code>1098413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protein Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</to_name>
		<to_code>N0000194093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bruton's Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Focal Adhesion Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000194167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritlecitinib tosylate</from_name>
		<from_code>2641596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ponatinib</from_name>
		<from_code>1364347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defactinib</from_name>
		<from_code>2714502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afatinib</from_name>
		<from_code>1430438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabozantinib</from_name>
		<from_code>1363268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib</from_name>
		<from_code>2183102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib</from_name>
		<from_code>2044896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ponatinib hydrochloride</from_name>
		<from_code>1364953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alectinib</from_name>
		<from_code>1727455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevabertinib</from_name>
		<from_code>2728187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acalabrutinib</from_name>
		<from_code>1986808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceritinib</from_name>
		<from_code>1535457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ripretinib</from_name>
		<from_code>2369389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunvozertinib</from_name>
		<from_code>2719226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fedratinib hydrochloride</from_name>
		<from_code>2197594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alectinib hydrochloride</from_name>
		<from_code>1727454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deucravacitinib</from_name>
		<from_code>2612087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanubrutinib</from_name>
		<from_code>2262435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brigatinib</from_name>
		<from_code>1921217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosutinib monohydrate</from_name>
		<from_code>1314319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vandetanib</from_name>
		<from_code>1098413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosutinib</from_name>
		<from_code>1307619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib adipate</from_name>
		<from_code>2716920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinone</from_name>
		<from_code>5509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afatinib dimaleate</from_name>
		<from_code>1430441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tivozanib</from_name>
		<from_code>2534233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fedratinib</from_name>
		<from_code>2197490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tucatinib</from_name>
		<from_code>2361285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib disodium</from_name>
		<from_code>2055929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritlecitinib</from_name>
		<from_code>2641595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdafitinib</from_name>
		<from_code>2123125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defactinib hydrochloride</from_name>
		<from_code>2714501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabozantinib s-malate</from_name>
		<from_code>1363267</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib</from_name>
		<from_code>2716919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib hydrochloride</from_name>
		<from_code>2183103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repotrectinib</from_name>
		<from_code>2670644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</to_name>
		<to_code>N0000194093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib</from_name>
		<from_code>2716919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</to_name>
		<to_code>N0000194093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanubrutinib</from_name>
		<from_code>2262435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bruton's Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remibrutinib</from_name>
		<from_code>2724365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bruton's Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirtobrutinib</from_name>
		<from_code>2629338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bruton's Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bruton's Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000190857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000194044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000190857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000194064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>upadacitinib</from_name>
		<from_code>2196092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fedratinib hydrochloride</from_name>
		<from_code>2197594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ruxolitinib phosphate</from_name>
		<from_code>1193325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib</from_name>
		<from_code>1357536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib citrate</from_name>
		<from_code>1358492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritlecitinib</from_name>
		<from_code>2641595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fedratinib</from_name>
		<from_code>2197490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ruxolitinib</from_name>
		<from_code>1193326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delgocitinib</from_name>
		<from_code>2721163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deucravacitinib</from_name>
		<from_code>2612087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baricitinib</from_name>
		<from_code>2047232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>momelotinib</from_name>
		<from_code>2665204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib phosphate</from_name>
		<from_code>2716557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritlecitinib tosylate</from_name>
		<from_code>2641596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>momelotinib dihydrochloride monohydrate</from_name>
		<from_code>2665205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abrocitinib</from_name>
		<from_code>2591476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000190857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase 2 Inhibitors [MoA]</from_name>
		<from_code>N0000194044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proline-rich Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000194169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000194043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000194044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deucravacitinib</from_name>
		<from_code>2612087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000194044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delgocitinib</from_name>
		<from_code>2721163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000194044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delgocitinib</from_name>
		<from_code>2721163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000194064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stem Cell Factor (KIT) Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000194026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
		<to_code>N0000020036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rearranged during Transfection (RET) Inhibitors [MoA]</to_name>
		<to_code>N0000193947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mesenchymal Epithelial Transition Inhibitors [MoA]</to_name>
		<to_code>N0000193929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurotrophic Factor Receptor (RET) Inhibitors [MoA]</to_name>
		<to_code>N0000020037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000020000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]</to_name>
		<to_code>N0000194085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entrectinib</from_name>
		<from_code>2197862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tivozanib</from_name>
		<from_code>2534233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nintedanib</from_name>
		<from_code>1592737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenvatinib mesylate</from_name>
		<from_code>1604346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gilteritinib fumarate</from_name>
		<from_code>2105823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tivozanib hydrochloride</from_name>
		<from_code>2534245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zongertinib</from_name>
		<from_code>2721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenvatinib</from_name>
		<from_code>1603296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midostaurin</from_name>
		<from_code>1919083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunitinib malate</from_name>
		<from_code>616275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gilteritinib</from_name>
		<from_code>2105806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axitinib</from_name>
		<from_code>1242999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dictamnine</from_name>
		<from_code>2685302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorlatinib</from_name>
		<from_code>2103164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repotrectinib</from_name>
		<from_code>2670644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nintedanib esylate</from_name>
		<from_code>1592736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunitinib</from_name>
		<from_code>357977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ripretinib</from_name>
		<from_code>2369389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stem Cell Factor (KIT) Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdafitinib</from_name>
		<from_code>2123125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000194026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>futibatinib</from_name>
		<from_code>2628190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000194026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</from_name>
		<from_code>N0000020007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR3 Inhibitors [MoA]</to_name>
		<to_code>N0000020033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</from_name>
		<from_code>N0000020007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR1 Inhibitors [MoA]</to_name>
		<to_code>N0000020031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</from_name>
		<from_code>N0000020007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR2 Inhibitors [MoA]</to_name>
		<to_code>N0000020032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab-eqrn</from_name>
		<from_code>2612673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab-nuna</from_name>
		<from_code>2602351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab</from_name>
		<from_code>595060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-tnjn</from_name>
		<from_code>2700660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-bvzr</from_name>
		<from_code>2268037</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab</from_name>
		<from_code>253337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-awwb</from_name>
		<from_code>2046138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fruquintinib</from_name>
		<from_code>2670179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib hydrochloride</from_name>
		<from_code>732187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-adcd</from_name>
		<from_code>2627648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib</from_name>
		<from_code>714438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-nwgd</from_name>
		<from_code>2712044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bevacizumab-maly</from_name>
		<from_code>2599041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fruquintinib</from_name>
		<from_code>2670179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR3 Inhibitors [MoA]</to_name>
		<to_code>N0000020033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fruquintinib</from_name>
		<from_code>2670179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR1 Inhibitors [MoA]</to_name>
		<to_code>N0000020031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</from_name>
		<from_code>N0000191009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR2 Inhibitors [MoA]</to_name>
		<to_code>N0000020032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramucirumab</from_name>
		<from_code>1535922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR2 Inhibitors [MoA]</to_name>
		<to_code>N0000020032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fruquintinib</from_name>
		<from_code>2670179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>VEGFR2 Inhibitors [MoA]</to_name>
		<to_code>N0000020032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib hydrochloride</from_name>
		<from_code>732187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib</from_name>
		<from_code>714438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</to_name>
		<to_code>N0000020030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axatilimab-csfr</from_name>
		<from_code>2691528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
		<to_code>N0000020036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</from_name>
		<from_code>N0000194108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
		<to_code>N0000020036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vimseltinib</from_name>
		<from_code>2705378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
		<to_code>N0000020036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axatilimab</from_name>
		<from_code>2691526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
		<to_code>N0000020036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib</from_name>
		<from_code>2183102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
		<to_code>N0000020036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rearranged during Transfection (RET) Inhibitors [MoA]</to_name>
		<to_code>N0000193947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralsetinib</from_name>
		<from_code>2394936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rearranged during Transfection (RET) Inhibitors [MoA]</to_name>
		<to_code>N0000193947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mesenchymal Epithelial Transition Inhibitors [MoA]</to_name>
		<to_code>N0000193929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tepotinib</from_name>
		<from_code>2477103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mesenchymal Epithelial Transition Inhibitors [MoA]</to_name>
		<to_code>N0000193929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib hydrochloride</from_name>
		<from_code>1804015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asciminib hydrochloride</from_name>
		<from_code>2584303</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib mesylate</from_name>
		<from_code>284924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib hydrochloride monohydrate</from_name>
		<from_code>2701416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asciminib</from_name>
		<from_code>2584304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosutinib</from_name>
		<from_code>1307619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib tartrate</from_name>
		<from_code>2698561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib</from_name>
		<from_code>282388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000020009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quizartinib</from_name>
		<from_code>2643048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]</to_name>
		<to_code>N0000194085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belumosudil</from_name>
		<from_code>2564025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rho Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000193788</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netarsudil</from_name>
		<from_code>1992864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netarsudil mesylate</from_name>
		<from_code>1992863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belumosudil mesylate</from_name>
		<from_code>2565692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclin-dependent Kinase 6 Inhibitors [MoA]</to_name>
		<to_code>N0000193922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclin-dependent Kinase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000193921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type II RAF Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000194133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capivasertib</from_name>
		<from_code>2669967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib</from_name>
		<from_code>2479690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclin-dependent Kinase 6 Inhibitors [MoA]</to_name>
		<to_code>N0000193922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000175411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitors [MoA]</to_name>
		<to_code>N0000175624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib</from_name>
		<from_code>1424911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tovorafenib</from_name>
		<from_code>2682434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encorafenib</from_name>
		<from_code>2049106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabrafenib mesylate</from_name>
		<from_code>1425222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vemurafenib</from_name>
		<from_code>1147220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000175411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temsirolimus</from_name>
		<from_code>657797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitors [MoA]</to_name>
		<to_code>N0000175624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus protein-bound</from_name>
		<from_code>2712352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitors [MoA]</to_name>
		<to_code>N0000175624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitors [MoA]</to_name>
		<to_code>N0000175624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus</from_name>
		<from_code>35302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitors [MoA]</to_name>
		<to_code>N0000175624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitors [MoA]</to_name>
		<to_code>N0000175624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</from_name>
		<from_code>N0000193945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selumetinib</from_name>
		<from_code>2289380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirdametinib</from_name>
		<from_code>2705551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avutometinib</from_name>
		<from_code>2714515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avutometinib potassium</from_name>
		<from_code>2714514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selumetinib</from_name>
		<from_code>2289380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirdametinib</from_name>
		<from_code>2705551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000193944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaciclib</from_name>
		<from_code>2479690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclin-dependent Kinase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000193921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tovorafenib</from_name>
		<from_code>2682434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type II RAF Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000194133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</from_name>
		<from_code>N0000193859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
		<to_code>N0000194095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</from_name>
		<from_code>N0000193859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
		<to_code>N0000194096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</from_name>
		<from_code>N0000193859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
		<to_code>N0000194094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>larotrectinib</from_name>
		<from_code>2105628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</to_name>
		<to_code>N0000193859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>larotrectinib sulfate</from_name>
		<from_code>2104548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</to_name>
		<to_code>N0000193859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib</from_name>
		<from_code>2716919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
		<to_code>N0000194095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repotrectinib</from_name>
		<from_code>2670644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
		<to_code>N0000194095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib adipate</from_name>
		<from_code>2716920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
		<to_code>N0000194095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib</from_name>
		<from_code>2716919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
		<to_code>N0000194096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repotrectinib</from_name>
		<from_code>2670644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
		<to_code>N0000194096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib adipate</from_name>
		<from_code>2716920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
		<to_code>N0000194096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repotrectinib</from_name>
		<from_code>2670644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
		<to_code>N0000194094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib</from_name>
		<from_code>2716919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
		<to_code>N0000194094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taletrectinib adipate</from_name>
		<from_code>2716920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
		<to_code>N0000194094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maribavir</from_name>
		<from_code>2586068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000193976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</to_name>
		<to_code>N0000193977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</from_name>
		<from_code>N0000194055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphoinositide 3-Kinase delta Inhibitors [MoA]</to_name>
		<to_code>N0000194054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</from_name>
		<from_code>N0000194055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphoinositide 3-Kinase alpha Inhibitors [MoA]</to_name>
		<to_code>N0000194130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inavolisib</from_name>
		<from_code>2695422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</to_name>
		<to_code>N0000194055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphoinositide 3-Kinase delta Inhibitors [MoA]</to_name>
		<to_code>N0000194054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inavolisib</from_name>
		<from_code>2695422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphoinositide 3-Kinase alpha Inhibitors [MoA]</to_name>
		<to_code>N0000194130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaborbactam</from_name>
		<from_code>1945213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam monohydrate</from_name>
		<from_code>2184136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>durlobactam</from_name>
		<from_code>2639089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam</from_name>
		<from_code>2184137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam</from_name>
		<from_code>37617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam sodium</from_name>
		<from_code>221167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam anhydrous</from_name>
		<from_code>2268500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitors [MoA]</to_name>
		<to_code>N0000000202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peramivir anhydrous</from_name>
		<from_code>1598096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir carboxylate</from_name>
		<from_code>1546279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir</from_name>
		<from_code>260101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir phosphate</from_name>
		<from_code>259275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanamivir</from_name>
		<from_code>69722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peramivir</from_name>
		<from_code>619693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitors [MoA]</to_name>
		<to_code>N0000175436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazemetostat</from_name>
		<from_code>2274378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000193930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revumenib citrate</from_name>
		<from_code>2698326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revumenib</from_name>
		<from_code>2698325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolnaftate</from_name>
		<from_code>10637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Squalene Monooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000010265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Squalene Monooxygenase Inhibitors [MoA]</to_name>
		<to_code>N0000010265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat</from_name>
		<from_code>1872382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000193302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat etiprate</from_name>
		<from_code>1872448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000193302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000193303</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000193302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat ethyl</from_name>
		<from_code>1872441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
		<to_code>N0000193302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Phosphorylase Inhibitors [MoA]</from_name>
		<from_code>N0000191868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
		<to_code>N0000191869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
		<from_code>N0000191870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
		<to_code>N0000191869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipiracil</from_name>
		<from_code>1670304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
		<to_code>N0000191869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipiracil hydrochloride</from_name>
		<from_code>1670303</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
		<to_code>N0000191869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UDP Glucuronosyltransferases Inhibitors [MoA]</from_name>
		<from_code>N0000191269</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B Inhibitors [MoA]</to_name>
		<to_code>N0000191271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UDP Glucuronosyltransferases Inhibitors [MoA]</from_name>
		<from_code>N0000191269</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A Inhibitors [MoA]</to_name>
		<to_code>N0000191270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UDP Glucuronosyltransferases Inhibitors [MoA]</to_name>
		<to_code>N0000191269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT2B Inhibitors [MoA]</from_name>
		<from_code>N0000191271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B7 Inhibitors [MoA]</to_name>
		<to_code>N0000191273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT2B Inhibitors [MoA]</from_name>
		<from_code>N0000191271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B15 Inhibitors [MoA]</to_name>
		<to_code>N0000191274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B7 Inhibitors [MoA]</to_name>
		<to_code>N0000191273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B7 Inhibitors [MoA]</to_name>
		<to_code>N0000191273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B7 Inhibitors [MoA]</to_name>
		<to_code>N0000191273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perampanel</from_name>
		<from_code>1356552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B7 Inhibitors [MoA]</to_name>
		<to_code>N0000191273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B15 Inhibitors [MoA]</to_name>
		<to_code>N0000191274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT2B15 Inhibitors [MoA]</to_name>
		<to_code>N0000191274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT1A Inhibitors [MoA]</from_name>
		<from_code>N0000191270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT1A Inhibitors [MoA]</from_name>
		<from_code>N0000191270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A4 Inhibitors [MoA]</to_name>
		<to_code>N0000191276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT1A Inhibitors [MoA]</from_name>
		<from_code>N0000191270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A6 Inhibitors [MoA]</to_name>
		<to_code>N0000191277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT1A Inhibitors [MoA]</from_name>
		<from_code>N0000191270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A9 Inhibitors [MoA]</to_name>
		<to_code>N0000191278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>UGT1A Inhibitors [MoA]</from_name>
		<from_code>N0000191270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A3 Inhibitors [MoA]</to_name>
		<to_code>N0000191275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib</from_name>
		<from_code>2183102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib tartrate</from_name>
		<from_code>2698561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib</from_name>
		<from_code>1312397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000191272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A4 Inhibitors [MoA]</to_name>
		<to_code>N0000191276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A4 Inhibitors [MoA]</to_name>
		<to_code>N0000191276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A6 Inhibitors [MoA]</to_name>
		<to_code>N0000191277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A6 Inhibitors [MoA]</to_name>
		<to_code>N0000191277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A9 Inhibitors [MoA]</to_name>
		<to_code>N0000191278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib</from_name>
		<from_code>1312397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A9 Inhibitors [MoA]</to_name>
		<to_code>N0000191278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A9 Inhibitors [MoA]</to_name>
		<to_code>N0000191278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A9 Inhibitors [MoA]</to_name>
		<to_code>N0000191278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perampanel</from_name>
		<from_code>1356552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A9 Inhibitors [MoA]</to_name>
		<to_code>N0000191278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag olamine</from_name>
		<from_code>735651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A3 Inhibitors [MoA]</to_name>
		<to_code>N0000191275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>UGT1A3 Inhibitors [MoA]</to_name>
		<to_code>N0000191275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacytine</from_name>
		<from_code>78902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfabenzamide</from_name>
		<from_code>37320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide acetate</from_name>
		<from_code>6573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapsone</from_name>
		<from_code>3108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfanilamide</from_name>
		<from_code>10184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfapyridine</from_name>
		<from_code>10188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide</from_name>
		<from_code>10169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole</from_name>
		<from_code>10193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide sodium</from_name>
		<from_code>82101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole sodium</from_name>
		<from_code>236084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
		<to_code>N0000009946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium,porcine</from_name>
		<from_code>235995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reviparin sodium</from_name>
		<from_code>75961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin</from_name>
		<from_code>60819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reviparin</from_name>
		<from_code>75960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin sodium</from_name>
		<from_code>152612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apixaban</from_name>
		<from_code>1364430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin</from_name>
		<from_code>152610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin sodium</from_name>
		<from_code>436195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin</from_name>
		<from_code>280611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin trifluoroacetate</from_name>
		<from_code>2380556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parnaparin</from_name>
		<from_code>69528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombins [MoA]</to_name>
		<to_code>N0000000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Farnesyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000193938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000193939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrase Inhibitors [MoA]</from_name>
		<from_code>N0000000258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raltegravir</from_name>
		<from_code>719872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir</from_name>
		<from_code>1433868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir sodium</from_name>
		<from_code>1433867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabotegravir</from_name>
		<from_code>2475077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raltegravir potassium</from_name>
		<from_code>1235585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabotegravir sodium</from_name>
		<from_code>2475076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Integrase Inhibitors [MoA]</to_name>
		<to_code>N0000000127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinone</from_name>
		<from_code>5509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequinol</from_name>
		<from_code>15080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobenzone</from_name>
		<from_code>17145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanin Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitors [MoA]</from_name>
		<from_code>N0000000184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitors [MoA]</from_name>
		<from_code>N0000000184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-A Inhibitors [MoA]</to_name>
		<to_code>N0000175760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydroiodide</from_name>
		<from_code>539765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine tannate</from_name>
		<from_code>1099727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrabenazine</from_name>
		<from_code>10390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine</from_name>
		<from_code>38400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan polistirex</from_name>
		<from_code>236146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol hydrochloride</from_name>
		<from_code>857492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine</from_name>
		<from_code>14845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol xinafoate</from_name>
		<from_code>72616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone hydrochloride</from_name>
		<from_code>1086768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa anhydrous</from_name>
		<from_code>1545982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate dihydrate</from_name>
		<from_code>998038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine hydrochloride</from_name>
		<from_code>91350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichloralphenazone</from_name>
		<from_code>22892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine hydrochloride</from_name>
		<from_code>3266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serdexmethylphenidate chloride</from_name>
		<from_code>2562177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine</from_name>
		<from_code>10849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine</from_name>
		<from_code>6756</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan tannate</from_name>
		<from_code>259262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarbidopa</from_name>
		<from_code>2695774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine dimesylate</from_name>
		<from_code>673579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate (1:1)</from_name>
		<from_code>317238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine sulfate</from_name>
		<from_code>82042</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone</from_name>
		<from_code>1086769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl</from_name>
		<from_code>237005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mazindol</from_name>
		<from_code>6664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa</from_name>
		<from_code>2019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol</from_name>
		<from_code>2121751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine</from_name>
		<from_code>8175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate</from_name>
		<from_code>104994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol</from_name>
		<from_code>25255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrobromide</from_name>
		<from_code>102490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod hydrochloride</from_name>
		<from_code>2288235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrochloride</from_name>
		<from_code>267251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine</from_name>
		<from_code>700810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serdexmethylphenidate</from_name>
		<from_code>2562176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol hydrochloride</from_name>
		<from_code>2121750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran hydrochloride</from_name>
		<from_code>30003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opicapone</from_name>
		<from_code>2362167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine hydrochloride</from_name>
		<from_code>236481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine bitartrate</from_name>
		<from_code>221140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol</from_name>
		<from_code>36117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod</from_name>
		<from_code>2288236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine hydrochloride</from_name>
		<from_code>71534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutetrabenazine</from_name>
		<from_code>1876905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl acetate hydrochloride</from_name>
		<from_code>82043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levodopa</from_name>
		<from_code>6375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate</from_name>
		<from_code>236216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foslevodopa</from_name>
		<from_code>2695775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran</from_name>
		<from_code>588250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
		<to_code>N0000000184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
		<from_code>N0000175762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
		<to_code>N0000175761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-A Inhibitors [MoA]</to_name>
		<to_code>N0000175760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase-A Inhibitors [MoA]</to_name>
		<to_code>N0000175760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous tacrolimus</from_name>
		<from_code>235991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voclosporin</from_name>
		<from_code>2475166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimecrolimus</from_name>
		<from_code>321952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitors [MoA]</to_name>
		<to_code>N0000175458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolcapone</from_name>
		<from_code>72937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000175756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entacapone</from_name>
		<from_code>60307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000175756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opicapone</from_name>
		<from_code>2362167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000175756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000175757</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
		<to_code>N0000175756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncouplers [MoA]</to_name>
		<to_code>N0000000155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitazoxanide</from_name>
		<from_code>31819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncouplers [MoA]</to_name>
		<to_code>N0000000155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncouplers [MoA]</to_name>
		<to_code>N0000000155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase Inhibitors [MoA]</from_name>
		<from_code>N0000000128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase Inhibitors [MoA]</from_name>
		<from_code>N0000000128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase Inhibitors [MoA]</from_name>
		<from_code>N0000000128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyridamole</from_name>
		<from_code>3521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyphylline</from_name>
		<from_code>3714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trapidil</from_name>
		<from_code>10735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide</from_name>
		<from_code>596724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofisopam</from_name>
		<from_code>38365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate hydrochloride</from_name>
		<from_code>142437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide hydrochloride</from_name>
		<from_code>236612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate</from_name>
		<from_code>4440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil</from_name>
		<from_code>136411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avanafil</from_name>
		<from_code>1291301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tadalafil</from_name>
		<from_code>358263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride trihydrate</from_name>
		<from_code>1309396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil citrate</from_name>
		<from_code>221161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riociguat</from_name>
		<from_code>1439816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride</from_name>
		<from_code>307306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil</from_name>
		<from_code>306674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
		<to_code>N0000020026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide</from_name>
		<from_code>596724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
		<from_code>N0000175598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone lactate</from_name>
		<from_code>155120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone</from_name>
		<from_code>52769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ensifentrine</from_name>
		<from_code>2687215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
		<to_code>N0000175086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000182961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotaverin</from_name>
		<from_code>23684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nerandomilast</from_name>
		<from_code>2725523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crisaborole</from_name>
		<from_code>1865953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ensifentrine</from_name>
		<from_code>2687215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roflumilast</from_name>
		<from_code>1091836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotaverine hydrochloride</from_name>
		<from_code>236960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apremilast</from_name>
		<from_code>1492727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000182960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>11-beta Hydroxysteroid Dehydrogenase Inhibitors [MoA]</from_name>
		<from_code>N0000194061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA]</to_name>
		<to_code>N0000194062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohydroxamic acid</from_name>
		<from_code>16728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitors [MoA]</to_name>
		<to_code>N0000175087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohydroxamic acid</from_name>
		<from_code>16728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitors [MoA]</to_name>
		<to_code>N0000175087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Urease Inhibitor [EPC]</from_name>
		<from_code>N0000175611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitors [MoA]</to_name>
		<to_code>N0000175087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proprotein Convertase Inhibitors [MoA]</to_name>
		<to_code>N0000191729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enkephalinase Inhibitors [MoA]</to_name>
		<to_code>N0000000195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metalloprotease Inhibitors [MoA]</to_name>
		<to_code>N0000191725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitors [MoA]</to_name>
		<to_code>N0000175075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cysteine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitors [MoA]</from_name>
		<from_code>N0000000076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl methylcellulose 2208</from_name>
		<from_code>1363585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium,porcine</from_name>
		<from_code>235995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchiceine</from_name>
		<from_code>2174385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirogacestat</from_name>
		<from_code>2670631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brensocatib</from_name>
		<from_code>2721880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl methylcellulose 2910</from_name>
		<from_code>1363586</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirmatrelvir</from_name>
		<from_code>2587892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirogacestat hydrobromide</from_name>
		<from_code>2670632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proprotein Convertase Inhibitors [MoA]</from_name>
		<from_code>N0000191729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitors [MoA]</to_name>
		<to_code>N0000191730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lerodalcibep-liga</from_name>
		<from_code>2729461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitors [MoA]</to_name>
		<to_code>N0000191730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>PCSK9 Inhibitor [EPC]</from_name>
		<from_code>N0000191731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitors [MoA]</to_name>
		<to_code>N0000191730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lerodalcibep</from_name>
		<from_code>2729426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitors [MoA]</to_name>
		<to_code>N0000191730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alirocumab</from_name>
		<from_code>1659152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitors [MoA]</to_name>
		<to_code>N0000191730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evolocumab</from_name>
		<from_code>1665684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitors [MoA]</to_name>
		<to_code>N0000191730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HIV Protease Inhibitors [MoA]</to_name>
		<to_code>N0000000246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metalloprotease Inhibitors [MoA]</from_name>
		<from_code>N0000191725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metalloendopeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000191726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abametapir</from_name>
		<from_code>2475532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metalloprotease Inhibitors [MoA]</to_name>
		<to_code>N0000191725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metalloendopeptidase Inhibitors [MoA]</from_name>
		<from_code>N0000191726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacubitrilat</from_name>
		<from_code>1860608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacubitril</from_name>
		<from_code>1656328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neprilysin Inhibitor [EPC]</from_name>
		<from_code>N0000191728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitors [MoA]</to_name>
		<to_code>N0000191727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixazomib</from_name>
		<from_code>1723735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitors [MoA]</to_name>
		<to_code>N0000175075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bortezomib</from_name>
		<from_code>358258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitors [MoA]</to_name>
		<to_code>N0000175075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proteasome Inhibitor [EPC]</from_name>
		<from_code>N0000175604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitors [MoA]</to_name>
		<to_code>N0000175075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixazomib citrate</from_name>
		<from_code>1723734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitors [MoA]</to_name>
		<to_code>N0000175075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carfilzomib</from_name>
		<from_code>1302966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitors [MoA]</to_name>
		<to_code>N0000175075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sitagliptin phosphate</from_name>
		<from_code>621590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sitagliptin</from_name>
		<from_code>593411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin hydrochloride dihydrate</from_name>
		<from_code>2643444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin</from_name>
		<from_code>857974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alogliptin benzoate</from_name>
		<from_code>1368000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin hydrochloride</from_name>
		<from_code>1043560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin anhydrous</from_name>
		<from_code>1546030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alogliptin</from_name>
		<from_code>1368001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sitagliptin hydrochloride</from_name>
		<from_code>2716481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linagliptin</from_name>
		<from_code>1100699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000175912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril</from_name>
		<from_code>39990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolaprilat</from_name>
		<from_code>1546379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat dihydrate</from_name>
		<from_code>2672730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril</from_name>
		<from_code>60245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril calcium</from_name>
		<from_code>259493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rescinnamine</from_name>
		<from_code>9259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinaprilat</from_name>
		<from_code>1546359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril hydrochloride</from_name>
		<from_code>259335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinoprilat</from_name>
		<from_code>1546393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramiprilat</from_name>
		<from_code>1546377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
		<to_code>N0000000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine Proteinase Inhibitors [MoA]</from_name>
		<from_code>N0000000169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activator Inhibitors [MoA]</to_name>
		<to_code>N0000010263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine Proteinase Inhibitors [MoA]</from_name>
		<from_code>N0000000169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine Proteinase Inhibitors [MoA]</from_name>
		<from_code>N0000000169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine Proteinase Inhibitors [MoA]</from_name>
		<from_code>N0000000169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasmin Inhibitors [MoA]</to_name>
		<to_code>N0000010264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine Proteinase Inhibitors [MoA]</from_name>
		<from_code>N0000000169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Trypsin Inhibitors [MoA]</to_name>
		<to_code>N0000000197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serine Proteinase Inhibitors [MoA]</from_name>
		<from_code>N0000000169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha 1-proteinase inhibitor, human</from_name>
		<from_code>991743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin</from_name>
		<from_code>280611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III, human</from_name>
		<from_code>221062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brensocatib</from_name>
		<from_code>2721880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin sodium</from_name>
		<from_code>436195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprotinin</from_name>
		<from_code>1056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serine Proteinase Inhibitors [MoA]</to_name>
		<to_code>N0000000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activator Inhibitors [MoA]</to_name>
		<to_code>N0000010263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Plasminogen Activator Inhibitors [MoA]</to_name>
		<to_code>N0000010263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
		<from_code>N0000184172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garadacimab-gxii</from_name>
		<from_code>2717168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecallantide</from_name>
		<from_code>658708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanadelumab</from_name>
		<from_code>2055641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berotralstat</from_name>
		<from_code>2467540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanadelumab-flyo</from_name>
		<from_code>2055640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebetralstat</from_name>
		<from_code>2717944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garadacimab</from_name>
		<from_code>2717169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kallikrein Inhibitors [MoA]</to_name>
		<to_code>N0000184151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin</from_name>
		<from_code>60819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Antithrombin [EPC]</from_name>
		<from_code>N0000184170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran etexilate mesylate</from_name>
		<from_code>1037041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin trifluoroacetate</from_name>
		<from_code>2380556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran</from_name>
		<from_code>1546356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran etexilate</from_name>
		<from_code>1037042</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desirudin</from_name>
		<from_code>114934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lepirudin</from_name>
		<from_code>237057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombin Inhibitors [MoA]</to_name>
		<to_code>N0000009963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranexamic acid</from_name>
		<from_code>10691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasmin Inhibitors [MoA]</to_name>
		<to_code>N0000010264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
		<from_code>N0000184171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Trypsin Inhibitors [MoA]</to_name>
		<to_code>N0000000197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha 1-proteinase inhibitor, human</from_name>
		<from_code>991743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Trypsin Inhibitors [MoA]</to_name>
		<to_code>N0000000197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
		<to_code>N0000182638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endonuclease Inhibitors [MoA]</from_name>
		<from_code>N0000193851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
		<to_code>N0000193853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir</from_name>
		<from_code>2197842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
		<to_code>N0000193853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</from_name>
		<from_code>N0000193852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
		<to_code>N0000193853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir marboxil</from_name>
		<from_code>2099995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
		<to_code>N0000193853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acarbose</from_name>
		<from_code>16681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylase Inhibitors [MoA]</to_name>
		<to_code>N0000010274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niraparib tosylate</from_name>
		<from_code>2637447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rucaparib</from_name>
		<from_code>1862579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niraparib</from_name>
		<from_code>1918231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niraparib tosylate monohydrate</from_name>
		<from_code>2640208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talazoparib</from_name>
		<from_code>2099704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rucaparib camsylate</from_name>
		<from_code>1862578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talazoparib tosylate</from_name>
		<from_code>2099703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olaparib</from_name>
		<from_code>1597582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000191622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decarboxylase Inhibitor [EPC]</from_name>
		<from_code>N0000175845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine</from_name>
		<from_code>569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine hydrochloride</from_name>
		<from_code>81945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Activating Factor Inhibitors [MoA]</from_name>
		<from_code>N0000009961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
		<to_code>N0000009962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine</from_name>
		<from_code>10594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Activating Factor Inhibitors [MoA]</to_name>
		<to_code>N0000009961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine hydrochloride</from_name>
		<from_code>97</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Activating Factor Inhibitors [MoA]</to_name>
		<to_code>N0000009961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
		<to_code>N0000009962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
		<to_code>N0000009962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
		<to_code>N0000009962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
		<to_code>N0000009962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talampicillin</from_name>
		<from_code>10322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temocillin</from_name>
		<from_code>37775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin sodium</from_name>
		<from_code>235750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpirome</from_name>
		<from_code>27130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V benzathine</from_name>
		<from_code>18926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotiam</from_name>
		<from_code>2188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftiofur sodium</from_name>
		<from_code>1370372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azidocillin</from_name>
		<from_code>18609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V calcium</from_name>
		<from_code>236517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefetamet</from_name>
		<from_code>20482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin sodium monohydrate</from_name>
		<from_code>1309402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin</from_name>
		<from_code>2181306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenethicillin</from_name>
		<from_code>33277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin</from_name>
		<from_code>8372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin magnesium</from_name>
		<from_code>235825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftiofur</from_name>
		<from_code>1311521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulopenem</from_name>
		<from_code>2717833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefovecin sodium</from_name>
		<from_code>1591924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole</from_name>
		<from_code>2691333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calteridol</from_name>
		<from_code>1424676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftiofur hydrochloride</from_name>
		<from_code>1311520</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefovecin</from_name>
		<from_code>1591901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole medocaril sodium</from_name>
		<from_code>2691334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulopenem etzadroxil</from_name>
		<from_code>2717834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin</from_name>
		<from_code>626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin</from_name>
		<from_code>4448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin</from_name>
		<from_code>26797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phenethicillin</from_name>
		<from_code>132907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotiam hydrochloride</from_name>
		<from_code>236202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talampicillin napsylate</from_name>
		<from_code>235836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpirome sulfate</from_name>
		<from_code>236104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calteridol calcium</from_name>
		<from_code>1424675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin hydrochloride</from_name>
		<from_code>42553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclacillin</from_name>
		<from_code>2968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbenicillin</from_name>
		<from_code>10168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefatrizine</from_name>
		<from_code>2179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azidocillin sodium</from_name>
		<from_code>236787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transpeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000010215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 11A1 Inhibitors [MoA]</to_name>
		<to_code>N0000193984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
		<to_code>N0000182632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000193954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2A6 Inhibitors [MoA]</to_name>
		<to_code>N0000193937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
		<to_code>N0000193936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
		<from_code>N0000182136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab</from_name>
		<from_code>2637392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bifonazole</from_name>
		<from_code>19295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat phosphate</from_name>
		<from_code>2286253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
		<to_code>N0000182136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pexidartinib</from_name>
		<from_code>2183102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
		<to_code>N0000182139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inhibitors [MoA]</from_name>
		<from_code>N0000190114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inhibitors [MoA]</from_name>
		<from_code>N0000190114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suvorexant</from_name>
		<from_code>1547099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirabegron</from_name>
		<from_code>1300786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine</from_name>
		<from_code>1102270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suzetrigine</from_name>
		<from_code>2704819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib</from_name>
		<from_code>1721560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crizotinib</from_name>
		<from_code>1148495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribociclib</from_name>
		<from_code>1873916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivacaftor</from_name>
		<from_code>1243041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirogacestat</from_name>
		<from_code>2670631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palbociclib</from_name>
		<from_code>1601374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine hydrochloride</from_name>
		<from_code>1102287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirtobrutinib</from_name>
		<from_code>2629338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceritinib</from_name>
		<from_code>1535457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat</from_name>
		<from_code>1547220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venetoclax</from_name>
		<from_code>1747556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inhibitor [EPC]</from_name>
		<from_code>N0000191001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilzabrutinib</from_name>
		<from_code>2722398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idelalisib</from_name>
		<from_code>1544460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat tartrate</from_name>
		<from_code>1547219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osimertinib mesylate</from_name>
		<from_code>1721559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tucatinib</from_name>
		<from_code>2361285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolvaptan</from_name>
		<from_code>358257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplerenone</from_name>
		<from_code>298869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
		<to_code>N0000190114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
		<to_code>N0000190115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline</from_name>
		<from_code>2694828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticagrelor</from_name>
		<from_code>1116632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine hydrochloride</from_name>
		<from_code>1649479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasatinib anhydrous</from_name>
		<from_code>1546019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavacamten</from_name>
		<from_code>2600867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lazertinib</from_name>
		<from_code>2691150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol</from_name>
		<from_code>1551777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berotralstat</from_name>
		<from_code>2467540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givinostat</from_name>
		<from_code>2678889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol oxalate</from_name>
		<from_code>1593586</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacopan</from_name>
		<from_code>2572100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchiceine</from_name>
		<from_code>2174385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib</from_name>
		<from_code>714438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxelotor</from_name>
		<from_code>2265678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maribavir</from_name>
		<from_code>2586068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib</from_name>
		<from_code>282388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin hydrochloride</from_name>
		<from_code>46043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perampanel</from_name>
		<from_code>1356552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubrogepant</from_name>
		<from_code>2268216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdafitinib</from_name>
		<from_code>2123125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine</from_name>
		<from_code>1649480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trofinetide</from_name>
		<from_code>2632852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finerenone</from_name>
		<from_code>2562811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
		<to_code>N0000182141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 11A1 Inhibitors [MoA]</to_name>
		<to_code>N0000193984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
		<to_code>N0000182632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abiraterone acetate</from_name>
		<from_code>1100071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
		<to_code>N0000182632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
		<from_code>N0000182633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
		<to_code>N0000182632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abiraterone</from_name>
		<from_code>1100072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
		<to_code>N0000182632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A1 Inhibitors [MoA]</to_name>
		<to_code>N0000193954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daprodustat</from_name>
		<from_code>2628210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib</from_name>
		<from_code>714438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmetirom</from_name>
		<from_code>2677894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirtobrutinib</from_name>
		<from_code>2629338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ripretinib</from_name>
		<from_code>2369389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perampanel</from_name>
		<from_code>1356552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abiraterone</from_name>
		<from_code>1100072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tucatinib</from_name>
		<from_code>2361285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selexipag</from_name>
		<from_code>1729002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
		<to_code>N0000187062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceritinib</from_name>
		<from_code>1535457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etravirine</from_name>
		<from_code>475969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regorafenib</from_name>
		<from_code>1312397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zafirlukast</from_name>
		<from_code>114970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutivacaftor</from_name>
		<from_code>2701430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avapritinib</from_name>
		<from_code>2272107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitisinone</from_name>
		<from_code>61805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivacaftor</from_name>
		<from_code>1243041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acoramidis</from_name>
		<from_code>2698312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib phosphate</from_name>
		<from_code>2716557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
		<to_code>N0000185504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2A6 Inhibitors [MoA]</to_name>
		<to_code>N0000193937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat tartrate</from_name>
		<from_code>1547219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib d-tartrate</from_name>
		<from_code>2715454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilotinib</from_name>
		<from_code>662281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pazopanib</from_name>
		<from_code>714438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirabegron</from_name>
		<from_code>1300786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat</from_name>
		<from_code>1547220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib</from_name>
		<from_code>282388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 2D6 Inhibitor [EPC]</from_name>
		<from_code>N0000182135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berotralstat</from_name>
		<from_code>2467540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panobinostat</from_name>
		<from_code>1603350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat</from_name>
		<from_code>1547220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abiraterone</from_name>
		<from_code>1100072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eliglustat tartrate</from_name>
		<from_code>1547219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
		<to_code>N0000182137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine acetate</from_name>
		<from_code>1482501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole</from_name>
		<from_code>283742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonafarnib</from_name>
		<from_code>2467553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirtobrutinib</from_name>
		<from_code>2629338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavacamten</from_name>
		<from_code>2600867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etravirine</from_name>
		<from_code>475969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine</from_name>
		<from_code>1482502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
		<to_code>N0000182140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cortisol Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000193935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
		<to_code>N0000193936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
		<to_code>N0000193936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
		<to_code>N0000193936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine hydrochloride</from_name>
		<from_code>236460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fezolinetant</from_name>
		<from_code>2637134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vemurafenib</from_name>
		<from_code>1147220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capmatinib</from_name>
		<from_code>2362165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osilodrostat</from_name>
		<from_code>2286252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pacritinib</from_name>
		<from_code>2595243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine</from_name>
		<from_code>57258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
		<to_code>N0000182138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sterol Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000009956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholesterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sterol Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000009956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholesterol Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursadiol</from_name>
		<from_code>2045735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholesterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin sodium</from_name>
		<from_code>221072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin sodium</from_name>
		<from_code>72875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin</from_name>
		<from_code>41127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin</from_name>
		<from_code>301542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin calcium</from_name>
		<from_code>323828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin</from_name>
		<from_code>596723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole nitrate</from_name>
		<from_code>236601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutrimazole</from_name>
		<from_code>61773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole nitrate</from_name>
		<from_code>56226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine</from_name>
		<from_code>31476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bifonazole</from_name>
		<from_code>19295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000009957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K Inhibitors [MoA]</from_name>
		<from_code>N0000175964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Inhibitors [MoA]</to_name>
		<to_code>N0000175964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K Antagonist [EPC]</from_name>
		<from_code>N0000175476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrosine</from_name>
		<from_code>266604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa</from_name>
		<from_code>2019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</from_name>
		<from_code>N0000175754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarbidopa</from_name>
		<from_code>2695774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
		<to_code>N0000175755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miglitol</from_name>
		<from_code>30009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
		<to_code>N0000000166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acarbose</from_name>
		<from_code>16681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
		<to_code>N0000000166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
		<from_code>N0000175559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
		<to_code>N0000000166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000175513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000175513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Dehydropeptidase Inhibitor [EPC]</from_name>
		<from_code>N0000175514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidase Inhibitors [MoA]</to_name>
		<to_code>N0000175513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Terminase Complex Inhibitors [MoA]</to_name>
		<to_code>N0000193801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ribonucleotide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000000103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000000233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine anhydrous</from_name>
		<from_code>1546005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladribine</from_name>
		<from_code>44157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine</from_name>
		<from_code>12574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetyldithranol</from_name>
		<from_code>38536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaliplatin</from_name>
		<from_code>32592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine hydrochloride</from_name>
		<from_code>236234</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthralin</from_name>
		<from_code>873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine</from_name>
		<from_code>24698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifapentine</from_name>
		<from_code>35617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine phosphate</from_name>
		<from_code>25102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin sulfate</from_name>
		<from_code>1621</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine</from_name>
		<from_code>10485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemtuzumab ozogamicin</from_name>
		<from_code>1294580</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azacitidine</from_name>
		<from_code>1251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite Immunosuppressant [EPC]</from_name>
		<from_code>N0000175613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>decitabine</from_name>
		<from_code>15657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofazimine</from_name>
		<from_code>2592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate sodium</from_name>
		<from_code>408142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolic acid</from_name>
		<from_code>7145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofarabine</from_name>
		<from_code>44151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidaxomicin</from_name>
		<from_code>1111103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifabutin</from_name>
		<from_code>55672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptozocin</from_name>
		<from_code>10114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxuridine</from_name>
		<from_code>4488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifaximin</from_name>
		<from_code>35619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran</from_name>
		<from_code>2604578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelarabine</from_name>
		<from_code>274771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate</from_name>
		<from_code>265323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eteplirsen</from_name>
		<from_code>1810569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin</from_name>
		<from_code>1622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idoxuridine</from_name>
		<from_code>5653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran sodium</from_name>
		<from_code>2605574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentostatin</from_name>
		<from_code>8011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000000233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitors [MoA]</from_name>
		<from_code>N0000000176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitors [MoA]</from_name>
		<from_code>N0000000176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000175890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitors [MoA]</from_name>
		<from_code>N0000000176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan</from_name>
		<from_code>51499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide</from_name>
		<from_code>4179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teniposide</from_name>
		<from_code>10362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finafloxacin</from_name>
		<from_code>1598641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide phosphate</from_name>
		<from_code>24614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valrubicin</from_name>
		<from_code>31435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan hydrochloride</from_name>
		<from_code>153329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone hydrochloride</from_name>
		<from_code>203129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>datopotamab deruxtecan-dlnk</from_name>
		<from_code>2703034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fleroxacin</from_name>
		<from_code>42322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone</from_name>
		<from_code>7005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>datopotamab deruxtecan</from_name>
		<from_code>2703033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitors [MoA]</to_name>
		<to_code>N0000000176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase 2 Inhibitors [MoA]</from_name>
		<from_code>N0000020088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000194142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin mesylate</from_name>
		<from_code>2709213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
		<to_code>N0000020088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fleroxacin</from_name>
		<from_code>42322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozenoxacin</from_name>
		<from_code>1994739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finafloxacin</from_name>
		<from_code>1598641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>besifloxacin</from_name>
		<from_code>819911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Gyrase Inhibitors [MoA]</to_name>
		<to_code>N0000020086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozenoxacin</from_name>
		<from_code>1994739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>besifloxacin</from_name>
		<from_code>819911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
		<to_code>N0000020087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
		<from_code>N0000193800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Terminase Complex Inhibitors [MoA]</to_name>
		<to_code>N0000193801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Terminase Complex Inhibitors [MoA]</to_name>
		<to_code>N0000193801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folic Acid Metabolism Inhibitors [MoA]</from_name>
		<from_code>N0000000111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium hemipentahydrate</from_name>
		<from_code>2056898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed monohydrate</from_name>
		<from_code>2590669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed dipotassium</from_name>
		<from_code>2699334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed tromethamine anhydrous</from_name>
		<from_code>2604776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralatrexate</from_name>
		<from_code>662019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
		<to_code>N0000000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed dipotassium</from_name>
		<from_code>2699334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed tromethamine anhydrous</from_name>
		<from_code>2604776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
		<from_code>N0000175934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralatrexate</from_name>
		<from_code>662019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil hydrochloride</from_name>
		<from_code>142428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate glucuronate</from_name>
		<from_code>38725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium heptahydrate</from_name>
		<from_code>1666923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate</from_name>
		<from_code>42333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium</from_name>
		<from_code>282443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed monohydrate</from_name>
		<from_code>2590669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium hemipentahydrate</from_name>
		<from_code>2056898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ribonucleotide Reductase Inhibitors [MoA]</to_name>
		<to_code>N0000000212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brincidofovir</from_name>
		<from_code>2599518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine liposome</from_name>
		<from_code>968804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir</from_name>
		<from_code>83171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir anhydrous</from_name>
		<from_code>1546007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>DNA Polymerase Inhibitors [MoA]</to_name>
		<to_code>N0000020060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Deaminase Inhibitors [MoA]</to_name>
		<to_code>N0000000187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Synthesis Inhibitors [MoA]</from_name>
		<from_code>N0000175074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000185501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine</from_name>
		<from_code>12574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelarabine</from_name>
		<from_code>274771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine hydrochloride</from_name>
		<from_code>236234</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azacitidine</from_name>
		<from_code>1251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofarabine</from_name>
		<from_code>44151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>decitabine</from_name>
		<from_code>15657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine</from_name>
		<from_code>24698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentostatin</from_name>
		<from_code>8011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine liposome</from_name>
		<from_code>968804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine phosphate</from_name>
		<from_code>25102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
		<to_code>N0000175074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyridamole</from_name>
		<from_code>3521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Deaminase Inhibitors [MoA]</to_name>
		<to_code>N0000000187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriflunomide</from_name>
		<from_code>1310520</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000185501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000185502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</to_name>
		<to_code>N0000185501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed dipotassium</from_name>
		<from_code>2699334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed tromethamine anhydrous</from_name>
		<from_code>2604776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium hemipentahydrate</from_name>
		<from_code>2056898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium</from_name>
		<from_code>282443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed monohydrate</from_name>
		<from_code>2590669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium heptahydrate</from_name>
		<from_code>1666923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000000098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reverse Transcriptase Inhibitors [MoA]</from_name>
		<from_code>N0000000103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reverse Transcriptase Inhibitors [MoA]</from_name>
		<from_code>N0000000103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000000103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000000103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etravirine</from_name>
		<from_code>475969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine hydrochloride</from_name>
		<from_code>1102287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine</from_name>
		<from_code>1102270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bictegravir sodium</from_name>
		<from_code>1999661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>didanosine</from_name>
		<from_code>3364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zalcitabine</from_name>
		<from_code>3363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stavudine</from_name>
		<from_code>59763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir anhydrous</from_name>
		<from_code>1546027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bictegravir</from_name>
		<from_code>1999660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil succinate</from_name>
		<from_code>1928942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir sulfate</from_name>
		<from_code>221052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil</from_name>
		<from_code>300195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zidovudine</from_name>
		<from_code>11413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide</from_name>
		<from_code>1721603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emtricitabine</from_name>
		<from_code>276237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
		<to_code>N0000009947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin diacetate</from_name>
		<from_code>236200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran sodium</from_name>
		<from_code>2605574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin</from_name>
		<from_code>30005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin</from_name>
		<from_code>42372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran</from_name>
		<from_code>2604578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin calcium</from_name>
		<from_code>221128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitors [MoA]</to_name>
		<to_code>N0000175516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remdesivir</from_name>
		<from_code>2284718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Replicase Inhibitors [MoA]</to_name>
		<to_code>N0000191258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiac Myosin Inhibitor [EPC]</from_name>
		<from_code>N0000194047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
		<to_code>N0000194048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavacamten</from_name>
		<from_code>2600867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
		<to_code>N0000194048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aficamten</from_name>
		<from_code>2731469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
		<to_code>N0000194048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivaroxaban</from_name>
		<from_code>1114195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin</from_name>
		<from_code>152610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban maleate</from_name>
		<from_code>1927955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edoxaban</from_name>
		<from_code>1599538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apixaban</from_name>
		<from_code>1364430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban</from_name>
		<from_code>1927851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin sodium</from_name>
		<from_code>152612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin</from_name>
		<from_code>280611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin sodium</from_name>
		<from_code>436195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Antithrombin [EPC]</from_name>
		<from_code>N0000184170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitors [MoA]</to_name>
		<to_code>N0000175635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole nitrate</from_name>
		<from_code>56226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole nitrate</from_name>
		<from_code>236601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
		<to_code>N0000020025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brivaracetam</from_name>
		<from_code>1739745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epoxide Hydrolase Inhibitors [MoA]</to_name>
		<to_code>N0000192345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzgalantamine gluconate</from_name>
		<from_code>2690626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demecarium bromide</from_name>
		<from_code>22482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivastigmine</from_name>
		<from_code>183379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel pamoate</from_name>
		<from_code>8985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium</from_name>
		<from_code>3752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium cation</from_name>
		<from_code>1546421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivastigmine tartrate</from_name>
		<from_code>994808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambenonium chloride</from_name>
		<from_code>624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donepezil</from_name>
		<from_code>135447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine</from_name>
		<from_code>9000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel</from_name>
		<from_code>8984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel tartrate</from_name>
		<from_code>2197593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurophate</from_name>
		<from_code>6027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine</from_name>
		<from_code>4637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malathion</from_name>
		<from_code>6606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>huperzine A</from_name>
		<from_code>2267703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine bromide</from_name>
		<from_code>9001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecothiopate</from_name>
		<from_code>89778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demecarium</from_name>
		<from_code>107771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrine</from_name>
		<from_code>10318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine hydrobromide</from_name>
		<from_code>860693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambenonium</from_name>
		<from_code>623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>echothiophate iodide</from_name>
		<from_code>3740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donepezil hydrochloride</from_name>
		<from_code>236559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium chloride</from_name>
		<from_code>3754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrine hydrochloride</from_name>
		<from_code>235972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzgalantamine</from_name>
		<from_code>2690627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitors [MoA]</to_name>
		<to_code>N0000000177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorasidenib citrate</from_name>
		<from_code>2690648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
		<from_code>N0000193987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivosidenib</from_name>
		<from_code>2049873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olutasidenib</from_name>
		<from_code>2623641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorasidenib</from_name>
		<from_code>2690647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
		<to_code>N0000193988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Stabilizer [EPC]</from_name>
		<from_code>N0000194077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Stabilizers [MoA]</to_name>
		<to_code>N0000194078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miglustat</from_name>
		<from_code>402316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Stabilizers [MoA]</to_name>
		<to_code>N0000194078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Reactivators [MoA]</from_name>
		<from_code>N0000000208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Reactivator [EPC]</from_name>
		<from_code>N0000175742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivators [MoA]</to_name>
		<to_code>N0000000080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Membrane Transporter Interactions [MoA]</from_name>
		<from_code>N0000188367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fatty Acid Transporter Interactions [MoA]</to_name>
		<to_code>N0000188368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxidectin</from_name>
		<from_code>1047072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Membrane Transporter Interactions [MoA]</to_name>
		<to_code>N0000188367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver</from_name>
		<from_code>2606543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Membrane Transporter Interactions [MoA]</to_name>
		<to_code>N0000188367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selinexor</from_name>
		<from_code>2178390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Membrane Transporter Interactions [MoA]</to_name>
		<to_code>N0000188367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fatty Acid Transporter Interactions [MoA]</from_name>
		<from_code>N0000188368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microsomal Triglyceride Transfer Protein Interactions [MoA]</to_name>
		<to_code>N0000188369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microsomal Triglyceride Transfer Protein Interactions [MoA]</from_name>
		<from_code>N0000188369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
		<to_code>N0000186778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
		<from_code>N0000186779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
		<to_code>N0000186778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
		<to_code>N0000186778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_MoA</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
		<to_code>N0000186778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinical Kinetics [PK]</from_name>
		<from_code>N0000000003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinetics [PK]</to_name>
		<to_code>N0000000055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinical Kinetics [PK]</from_name>
		<from_code>N0000000003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Elimination [PK]</to_name>
		<to_code>N0000000022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinical Kinetics [PK]</from_name>
		<from_code>N0000000003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Absorption [PK]</to_name>
		<to_code>N0000000008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinical Kinetics [PK]</from_name>
		<from_code>N0000000003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Distribution [PK]</to_name>
		<to_code>N0000000018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinetics [PK]</from_name>
		<from_code>N0000000055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Order [PK]</to_name>
		<to_code>N0000000056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinetics [PK]</from_name>
		<from_code>N0000000055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Clearance [PK]</to_name>
		<to_code>N0000000063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinetics [PK]</from_name>
		<from_code>N0000000055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Half-Life [PK]</to_name>
		<to_code>N0000000064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinetics [PK]</from_name>
		<from_code>N0000000055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Compartments [PK]</to_name>
		<to_code>N0000000059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Order [PK]</from_name>
		<from_code>N0000000056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zero Order [PK]</to_name>
		<to_code>N0000000058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Order [PK]</from_name>
		<from_code>N0000000056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>First Order [PK]</to_name>
		<to_code>N0000000057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Compartments [PK]</from_name>
		<from_code>N0000000059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>1-Compartment [PK]</to_name>
		<to_code>N0000000060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Compartments [PK]</from_name>
		<from_code>N0000000059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>2-Compartment [PK]</to_name>
		<to_code>N0000000061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Compartments [PK]</from_name>
		<from_code>N0000000059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>3-Compartment [PK]</to_name>
		<to_code>N0000000062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Elimination [PK]</from_name>
		<from_code>N0000000022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Route of Excretion [PK]</to_name>
		<to_code>N0000000041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Elimination [PK]</from_name>
		<from_code>N0000000022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metabolism [PK]</to_name>
		<to_code>N0000000023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Route of Excretion [PK]</from_name>
		<from_code>N0000000041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Route of Excretion [PK]</from_name>
		<from_code>N0000000041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fecal Excretion [PK]</to_name>
		<to_code>N0000000045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Route of Excretion [PK]</from_name>
		<from_code>N0000000041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Milk Excretion [PK]</to_name>
		<to_code>N0000000046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Route of Excretion [PK]</from_name>
		<from_code>N0000000041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Excretion [PK]</to_name>
		<to_code>N0000000043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Route of Excretion [PK]</from_name>
		<from_code>N0000000041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Excretion [PK]</to_name>
		<to_code>N0000000044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Route of Excretion [PK]</from_name>
		<from_code>N0000000041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Clinically Unimportant Route of Excretion [PK]</to_name>
		<to_code>N0000000047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin</from_name>
		<from_code>6809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol</from_name>
		<from_code>435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin hydrochloride</from_name>
		<from_code>235743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol sulfate</from_name>
		<from_code>142153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Excretion [PK]</to_name>
		<to_code>N0000000042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fecal Excretion [PK]</to_name>
		<to_code>N0000000045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fecal Excretion [PK]</to_name>
		<to_code>N0000000045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fecal Excretion [PK]</to_name>
		<to_code>N0000000045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fecal Excretion [PK]</to_name>
		<to_code>N0000000045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fecal Excretion [PK]</to_name>
		<to_code>N0000000045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Breast Milk Excretion [PK]</to_name>
		<to_code>N0000000046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Excretion [PK]</to_name>
		<to_code>N0000000043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Excretion [PK]</to_name>
		<to_code>N0000000043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Excretion [PK]</to_name>
		<to_code>N0000000043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Excretion [PK]</to_name>
		<to_code>N0000000043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Excretion [PK]</to_name>
		<to_code>N0000000043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Umbilical Lint Excretion [PK]</to_name>
		<to_code>N0000000054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tear Excretion [PK]</to_name>
		<to_code>N0000000049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Skin Excretion [PK]</to_name>
		<to_code>N0000000051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hair Excretion [PK]</to_name>
		<to_code>N0000000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Saliva Excretion [PK]</to_name>
		<to_code>N0000000048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sweat Excretion [PK]</to_name>
		<to_code>N0000000050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
		<from_code>N0000000047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nail Excretion [PK]</to_name>
		<to_code>N0000000053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metabolism [PK]</from_name>
		<from_code>N0000000023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Site of Metabolism [PK]</to_name>
		<to_code>N0000000024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metabolism [PK]</from_name>
		<from_code>N0000000023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzymatic Pathway of Metabolism [PK]</to_name>
		<to_code>N0000000030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Site of Metabolism [PK]</from_name>
		<from_code>N0000000024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Metabolism [PK]</to_name>
		<to_code>N0000000027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Site of Metabolism [PK]</from_name>
		<from_code>N0000000024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Site of Metabolism [PK]</from_name>
		<from_code>N0000000024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Intestinal Metabolism [PK]</to_name>
		<to_code>N0000000025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Site of Metabolism [PK]</from_name>
		<from_code>N0000000024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Metabolism [PK]</to_name>
		<to_code>N0000000028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Site of Metabolism [PK]</from_name>
		<from_code>N0000000024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasma Metabolism [PK]</to_name>
		<to_code>N0000000029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Metabolism [PK]</to_name>
		<to_code>N0000000027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol</from_name>
		<from_code>435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole sodium</from_name>
		<from_code>253191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glipizide</from_name>
		<from_code>4821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole magnesium</from_name>
		<from_code>236486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole</from_name>
		<from_code>114979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol sulfate</from_name>
		<from_code>142153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole</from_name>
		<from_code>40790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatic Metabolism [PK]</to_name>
		<to_code>N0000000026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Intestinal Metabolism [PK]</to_name>
		<to_code>N0000000025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>site_of_metabolism</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Intestinal Metabolism [PK]</to_name>
		<to_code>N0000000025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfotransferases [PK]</to_name>
		<to_code>N0000000036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Esterases [PK]</to_name>
		<to_code>N0000000032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-acetyl transferases [PK]</to_name>
		<to_code>N0000000037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochromes [PK]</to_name>
		<to_code>N0000000031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glutathione s-transferases [PK]</to_name>
		<to_code>N0000000035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine oxidase [PK]</to_name>
		<to_code>N0000000039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epoxide hydrolases [PK]</to_name>
		<to_code>N0000000033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucuronosyl transferases [PK]</to_name>
		<to_code>N0000000034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiopurine methyltransferase [PK]</to_name>
		<to_code>N0000000038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Co-methyltransferase [PK]</to_name>
		<to_code>N0000000040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
		<from_code>N0000000030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatic hydroxylation [PK]</to_name>
		<to_code>N0000008289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PK</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatic hydroxylation [PK]</to_name>
		<to_code>N0000008289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Absorption [PK]</from_name>
		<from_code>N0000000008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Affected by gastric pH [PK]</to_name>
		<to_code>N0000000012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Absorption [PK]</from_name>
		<from_code>N0000000008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Affected by food/other nutrients [PK]</to_name>
		<to_code>N0000000009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Absorption [PK]</from_name>
		<from_code>N0000000008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Affected by concomitant drug administration [PK]</to_name>
		<to_code>N0000000016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Absorption [PK]</from_name>
		<from_code>N0000000008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Affected by intestinal surface area [PK]</to_name>
		<to_code>N0000000015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Absorption [PK]</from_name>
		<from_code>N0000000008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Absorption Half-Life [PK]</to_name>
		<to_code>N0000000017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Affected by gastric pH [PK]</from_name>
		<from_code>N0000000012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enhanced by acidity [PK]</to_name>
		<to_code>N0000000013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Affected by gastric pH [PK]</from_name>
		<from_code>N0000000012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased by acidity [PK]</to_name>
		<to_code>N0000000014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Affected by food/other nutrients [PK]</from_name>
		<from_code>N0000000009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased by food [PK]</to_name>
		<to_code>N0000000011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Affected by food/other nutrients [PK]</from_name>
		<from_code>N0000000009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased by food [PK]</to_name>
		<to_code>N0000000010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Distribution [PK]</from_name>
		<from_code>N0000000018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Volume of distribution [PK]</to_name>
		<to_code>N0000000019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Distribution [PK]</from_name>
		<from_code>N0000000018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Site of relative exclusion [PK]</to_name>
		<to_code>N0000000021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Distribution [PK]</from_name>
		<from_code>N0000000018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Site of concentration [PK]</to_name>
		<to_code>N0000000020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pharmaceutical and Biological Preparations</from_name>
		<from_code>N0000000001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Preparations by FDA Established Pharmacologic Class</to_name>
		<to_code>N0000189939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pharmaceutical and Biological Preparations</from_name>
		<from_code>N0000000001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Preparations by Generic Ingredient</to_name>
		<to_code>N0000010582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pharmaceutical and Biological Preparations</from_name>
		<from_code>N0000000001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactive Preparations by FDA Established Pharmacologic Class</to_name>
		<to_code>N0000193876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibody or Antibody Fragment [APC]</to_name>
		<to_code>N0000193872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Agent [APC]</to_name>
		<to_code>N0000193909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gene Therapy [APC]</to_name>
		<to_code>N0000194012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Imaging Agent [APC]</to_name>
		<to_code>N0000193875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ion Channel or Pump Agent [APC]</to_name>
		<to_code>N0000193904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nervous System Agent [APC]</to_name>
		<to_code>N0000193905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hematology Agent [APC]</to_name>
		<to_code>N0000193901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-infective [APC]</to_name>
		<to_code>N0000193879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viral Therapy [APC]</to_name>
		<to_code>N0000194073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidote [EPC]</to_name>
		<to_code>N0000175429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hormone [APC]</to_name>
		<to_code>N0000193874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allergen [APC]</to_name>
		<to_code>N0000193889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Related Agent [APC]</to_name>
		<to_code>N0000193906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Interaction [APC]</to_name>
		<to_code>N0000193898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunotherapy [APC]</to_name>
		<to_code>N0000194070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipid Emulsion [EPC]</to_name>
		<to_code>N0000191261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vaccine [APC]</to_name>
		<to_code>N0000193912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acellular Tissue Engineered Vessel [EPC]</to_name>
		<to_code>N0000194163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [EPC]</to_name>
		<to_code>N0000175713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [APC]</to_name>
		<to_code>N0000193895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscle Relaxant [EPC]</to_name>
		<to_code>N0000175737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Interaction [APC]</to_name>
		<to_code>N0000193888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemical Structure [APC]</to_name>
		<to_code>N0000193894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin or Mineral [APC]</to_name>
		<to_code>N0000193877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunologic Agent [APC]</to_name>
		<to_code>N0000193902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytolytic Agent [EPC]</to_name>
		<to_code>N0000191548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Blood Glucose Regulator [APC]</to_name>
		<to_code>N0000193891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Tubular Transport Inhibitor [EPC]</to_name>
		<to_code>N0000194156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Factor [APC]</to_name>
		<to_code>N0000193885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anesthetic [APC]</to_name>
		<to_code>N0000193878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme [APC]</to_name>
		<to_code>N0000193884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiovascular Agent [APC]</to_name>
		<to_code>N0000193893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell Therapy [APC]</to_name>
		<to_code>N0000194069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diuretic [APC]</to_name>
		<to_code>N0000193873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Physical or Chemical Agent [APC]</to_name>
		<to_code>N0000193908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
		<to_code>N0000184319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytotoxin [EPC]</to_name>
		<to_code>N0000193862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by FDA Established Pharmacologic Class</from_name>
		<from_code>N0000189939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gastrointestinal Agent [APC]</to_name>
		<to_code>N0000193900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
		<to_code>N0000191260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
		<to_code>N0000191500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Radiotherapeutic Antibody [EPC]</to_name>
		<to_code>N0000175658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin [EPC]</to_name>
		<to_code>N0000184164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000193803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-IgE [EPC]</to_name>
		<to_code>N0000175794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody [EPC]</to_name>
		<to_code>N0000193951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000175657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000192336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Blocking Antibody [EPC]</to_name>
		<to_code>N0000182635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000193617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
		<to_code>N0000194137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
		<to_code>N0000175623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
		<to_code>N0000191873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antivenin [EPC]</to_name>
		<to_code>N0000184162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000175571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
		<to_code>N0000175622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD30-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000182967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
		<to_code>N0000194038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
		<to_code>N0000192338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD52-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000175659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibody or Antibody Fragment [APC]</from_name>
		<from_code>N0000193872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody [EPC]</to_name>
		<to_code>N0000192703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toripalimab</to_name>
		<to_code>2669406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pembrolizumab</to_name>
		<to_code>1547545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atezolizumab</to_name>
		<to_code>1792776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retifanlimab</to_name>
		<to_code>2632981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nivolumab</to_name>
		<to_code>1597876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dostarlimab</to_name>
		<to_code>2539967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
		<from_code>N0000191260</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tislelizumab</to_name>
		<to_code>2677426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
		<to_code>N0000191260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
		<to_code>N0000191260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
		<to_code>N0000191260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
		<from_code>N0000191500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
		<from_code>N0000191500</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dinutuximab</to_name>
		<to_code>1606274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
		<from_code>N0000191500</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naxitamab</to_name>
		<to_code>2474039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
		<to_code>N0000191500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
		<to_code>N0000191500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
		<to_code>N0000191500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000194107</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zolbetuximab</to_name>
		<to_code>2695869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Radiotherapeutic Antibody [EPC]</from_name>
		<from_code>N0000175658</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibritumomab tiuxetan</to_name>
		<to_code>262323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Radiotherapeutic Antibody [EPC]</to_name>
		<to_code>N0000175658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin [EPC]</from_name>
		<from_code>N0000184164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoglobulins</to_name>
		<to_code>M0011122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin [EPC]</from_name>
		<from_code>N0000184164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin [EPC]</from_name>
		<from_code>N0000184164</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B immune globulin</to_name>
		<to_code>26744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin [EPC]</from_name>
		<from_code>N0000184164</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Human immunoglobulin (substance)</to_name>
		<to_code>420084002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin [EPC]</from_name>
		<from_code>N0000184164</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing human immunoglobulin (medicinal product)</to_name>
		<to_code>333711001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin [EPC]</from_name>
		<from_code>N0000184164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin [EPC]</to_name>
		<to_code>N0000184164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin [EPC]</to_name>
		<to_code>N0000184164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin C immune FAB2, equine</from_name>
		<from_code>1722698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytomegalovirus immune globulin</from_name>
		<from_code>22178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin D immune FAB2</from_name>
		<from_code>1722701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin C immune FAB2</from_name>
		<from_code>1722699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - kthm</from_name>
		<from_code>2726012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - stwk</from_name>
		<from_code>2672094</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthrax immune globulin, human</from_name>
		<from_code>1722335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin B immune FAB2, equine</from_name>
		<from_code>1722683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthrax immune globulin</from_name>
		<from_code>1722336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rho(D) immune globulin, human</from_name>
		<from_code>1789837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulin G</from_name>
		<from_code>5666</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin F immune FAB2</from_name>
		<from_code>1722705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human) - klhw</from_name>
		<from_code>2196290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2</from_name>
		<from_code>2101271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human) - hipp</from_name>
		<from_code>2167145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - ifas</from_name>
		<from_code>2102433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin</from_name>
		<from_code>2387834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus</from_name>
		<from_code>1427211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulism immune globulin IV human</from_name>
		<from_code>544488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2 (equine)</from_name>
		<from_code>2101270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Centruroides (scorpion) immune F(ab')2 (equine)</from_name>
		<from_code>1119986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin E immune FAB2</from_name>
		<from_code>1722703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin A immune FAB2</from_name>
		<from_code>1722697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human)</from_name>
		<from_code>617615</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin-blmf</from_name>
		<from_code>2387833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - dira</from_name>
		<from_code>2706382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human vaccinia immune globulin</from_name>
		<from_code>597392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab</from_name>
		<from_code>2387844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin, human</from_name>
		<from_code>91603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin F immune FAB2, equine</from_name>
		<from_code>1722704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - slra</from_name>
		<from_code>2123035</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin G immune FAB2</from_name>
		<from_code>1722707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulin G, human</from_name>
		<from_code>1426680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin E immune FAB2, equine</from_name>
		<from_code>1722702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin B immune FAB2</from_name>
		<from_code>1722684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acquired Immunity [PE]</from_name>
		<from_code>N0000183363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytomegalovirus immune globulin, human</from_name>
		<from_code>1997443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin</from_name>
		<from_code>1727875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin A immune FAB2, equine</from_name>
		<from_code>1722696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin G immune FAB2, equine</from_name>
		<from_code>1722706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum neurotoxin D immune FAB2, equine</from_name>
		<from_code>1722700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B immune globulin</from_name>
		<from_code>26744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Passively Acquired Immunity [PE]</to_name>
		<to_code>N0000183365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>botulism immune globulin IV human</to_name>
		<to_code>544488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human vaccinia immune globulin</to_name>
		<to_code>597392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rho(D) immune globulin, human</to_name>
		<to_code>1789837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytomegalovirus immune globulin, human</to_name>
		<to_code>1997443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoglobulins</to_name>
		<to_code>M0011122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184165</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulin G, human</to_name>
		<to_code>1426680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Human immunoglobulin (substance)</from_name>
		<from_code>420084002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing human immunoglobulin (medicinal product)</from_name>
		<from_code>333711001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000193803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal, Humanized</to_name>
		<to_code>M0556300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000193803</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benralizumab</to_name>
		<to_code>1989100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000193803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000193803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-IgE [EPC]</from_name>
		<from_code>N0000175794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased IgE Activity [PE]</to_name>
		<to_code>N0000175793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-IgE [EPC]</from_name>
		<from_code>N0000175794</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Anti-immunoglobulin E antibody (substance)</to_name>
		<to_code>117194009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-IgE [EPC]</from_name>
		<from_code>N0000175794</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>omalizumab</to_name>
		<to_code>302379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antibody (product)</from_name>
		<from_code>768606008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-IgE [EPC]</to_name>
		<to_code>N0000175794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-IgE [EPC]</to_name>
		<to_code>N0000175794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omalizumab-igec</from_name>
		<from_code>2725997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased IgE Activity [PE]</to_name>
		<to_code>N0000175793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Antibody Activity [PE]</from_name>
		<from_code>N0000008390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased IgE Activity [PE]</to_name>
		<to_code>N0000175793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omalizumab</from_name>
		<from_code>302379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased IgE Activity [PE]</to_name>
		<to_code>N0000175793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ovine digoxin immune fab</to_name>
		<to_code>1745257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Immunoglobulin G (substance)</to_name>
		<to_code>29246005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit anti-human T-lymphocyte globulin</to_name>
		<to_code>107044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymocyte immunoglobulin, equine</to_name>
		<to_code>1427177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lymphocyte immune globulin, anti-thymocyte globulin, equine</to_name>
		<to_code>91601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunoglobulin G [EPC]</from_name>
		<from_code>N0000184163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoglobulins</to_name>
		<to_code>M0011122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunoglobulin (product)</from_name>
		<from_code>333710000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Immunoglobulin G [EPC]</to_name>
		<to_code>N0000184163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amyloid Beta-directed Antibody [EPC]</from_name>
		<from_code>N0000193951</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lecanemab-irmb</to_name>
		<to_code>2626142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amyloid Beta-directed Antibody [EPC]</from_name>
		<from_code>N0000193951</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lecanemab</to_name>
		<to_code>2626143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody [EPC]</to_name>
		<to_code>N0000193951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amyloid Beta-directed Antibody [EPC]</to_name>
		<to_code>N0000193951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175657</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ofatumumab</to_name>
		<to_code>712566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175657</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>obinutuzumab</to_name>
		<to_code>974779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175657</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rituximab</to_name>
		<to_code>121191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175657</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ocrelizumab</to_name>
		<to_code>1876366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175657</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ublituximab</to_name>
		<to_code>2626349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antibody (product)</from_name>
		<from_code>768606008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000175657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunosuppressant (substance)</from_name>
		<from_code>372823004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000175657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000175657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000192336</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000192336</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isatuximab</to_name>
		<to_code>2282018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000192336</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>daratumumab</to_name>
		<to_code>1721947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000192336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000192336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000192336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000182635</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipilimumab</to_name>
		<to_code>1094833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000182635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000182635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000182635</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tremelimumab</to_name>
		<to_code>2619313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Blocking Antibody [EPC]</to_name>
		<to_code>N0000182635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CTLA-4-directed Blocking Antibody [EPC]</to_name>
		<to_code>N0000182635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologic Activity [PE]</from_name>
		<from_code>N0000175551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000009359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologic Activity [PE]</from_name>
		<from_code>N0000175551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000009358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologic Activity [PE]</from_name>
		<from_code>N0000175551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologic Activity [PE]</from_name>
		<from_code>N0000175551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-txid</from_name>
		<from_code>2700365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penpulimab</from_name>
		<from_code>2712542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized</from_name>
		<from_code>2642139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nogapendekin alfa inbakicept-pmln</from_name>
		<from_code>2682677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized</from_name>
		<from_code>2642138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>durvalumab</from_name>
		<from_code>1919503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atezolizumab</from_name>
		<from_code>1792776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sipuleucel-T</from_name>
		<from_code>997261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deucravacitinib</from_name>
		<from_code>2612087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapinarof</from_name>
		<from_code>2602286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 1, human</from_name>
		<from_code>1316105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab</from_name>
		<from_code>2677426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus envelope glycoprotein</from_name>
		<from_code>2624742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efbemalenograstim alfa</from_name>
		<from_code>2670630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elotuzumab</from_name>
		<from_code>1726104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cemiplimab-rwlc</from_name>
		<from_code>2058825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab</from_name>
		<from_code>2669406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab-tpzi</from_name>
		<from_code>2669407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab</from_name>
		<from_code>2716802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avelumab</from_name>
		<from_code>1875534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein</from_name>
		<from_code>2636589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Activity Alteration [PE]</from_name>
		<from_code>N0000009073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cemiplimab</from_name>
		<from_code>2058826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, recombinant</from_name>
		<from_code>2636588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atezolizumab-tqjs</from_name>
		<from_code>2693883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efbemalenograstim alfa-vuxw</from_name>
		<from_code>2670656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipilimumab</from_name>
		<from_code>1094833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinutuximab</from_name>
		<from_code>1606274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab-cfor</from_name>
		<from_code>2716803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein</from_name>
		<from_code>2624741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talimogene laherparepvec</from_name>
		<from_code>1721264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nogapendekin alfa inbakicept</from_name>
		<from_code>2682678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab-jsgr</from_name>
		<from_code>2677425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penpulimab-kcqx</from_name>
		<from_code>2712646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologic Activity [PE]</to_name>
		<to_code>N0000175551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Kinin Production [PE]</to_name>
		<to_code>N0000009369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000009378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Complement Production [PE]</to_name>
		<to_code>N0000009266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000009082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Biogenic Amine Production [PE]</to_name>
		<to_code>N0000009356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Kallidin Production [PE]</to_name>
		<to_code>N0000009366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologically Active Molecule Production Alteration [PE]</from_name>
		<from_code>N0000009076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000009359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemannan</from_name>
		<from_code>1426875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000009359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosunetuzumab</from_name>
		<from_code>2625122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiquimod</from_name>
		<from_code>59943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosunetuzumab-axgb</from_name>
		<from_code>2625125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab</from_name>
		<from_code>2677426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tislelizumab-jsgr</from_name>
		<from_code>2677425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tarlatamab</from_name>
		<from_code>2682954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tarlatamab-dlle</from_name>
		<from_code>2682955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab</from_name>
		<from_code>2596773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab-rmbw</from_name>
		<from_code>2596772</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Production [PE]</to_name>
		<to_code>N0000009269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Antibody Production [PE]</from_name>
		<from_code>N0000009088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform S), recombinant</from_name>
		<from_code>2588219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</from_name>
		<from_code>1664339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Phuket/3073/2013 antigen</from_name>
		<from_code>1657228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Michigan/01/2021 antigen</from_name>
		<from_code>2593400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E</from_name>
		<from_code>1986821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hepatitis A Vaccine, Inactivated</from_name>
		<from_code>253174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus</from_name>
		<from_code>1491862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1)</from_name>
		<from_code>2722594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen</from_name>
		<from_code>2694005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</from_name>
		<from_code>1657224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mumps Vaccine</from_name>
		<from_code>763656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 52 vaccine</from_name>
		<from_code>1596933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b</from_name>
		<from_code>50937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/122/2022 (H3N2) antigen</from_name>
		<from_code>2675569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 31 vaccine</from_name>
		<from_code>1596930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bacillus anthracis strain V770-NP1-R antigens</from_name>
		<from_code>1368371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</from_name>
		<from_code>854942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Darwin/7/2019 antigen</from_name>
		<from_code>2380838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</from_name>
		<from_code>854950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group Y</from_name>
		<from_code>314725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</from_name>
		<from_code>2177290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen</from_name>
		<from_code>2688113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lyme Disease Vaccine</from_name>
		<from_code>214177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen</from_name>
		<from_code>1593127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen</from_name>
		<from_code>1601231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>798279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain</from_name>
		<from_code>1005929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</from_name>
		<from_code>854952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group C polysaccharide</from_name>
		<from_code>29503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histoplasmin</from_name>
		<from_code>5363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</from_name>
		<from_code>854956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</from_name>
		<from_code>854944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</from_name>
		<from_code>1666425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</from_name>
		<from_code>2380836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</from_name>
		<from_code>1801767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Austria/1359417/2021 antigen</from_name>
		<from_code>2605039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized</from_name>
		<from_code>2642139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</from_name>
		<from_code>2379531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen</from_name>
		<from_code>2687714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen</from_name>
		<from_code>2719300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</from_name>
		<from_code>1664171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</from_name>
		<from_code>854936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</from_name>
		<from_code>854970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus</from_name>
		<from_code>1426911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen</from_name>
		<from_code>2562554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen</from_name>
		<from_code>2641877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain</from_name>
		<from_code>1006250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group B vaccine</from_name>
		<from_code>1593128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen</from_name>
		<from_code>2605083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</from_name>
		<from_code>2280296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen</from_name>
		<from_code>2720359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein</from_name>
		<from_code>2636589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</from_name>
		<from_code>854948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H1N1) antigen</from_name>
		<from_code>1657128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen</from_name>
		<from_code>2645084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 58 vaccine</from_name>
		<from_code>1596934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen</from_name>
		<from_code>2641622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Washington/02/2019 antigen</from_name>
		<from_code>2280293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine, inactivated</from_name>
		<from_code>845525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</from_name>
		<from_code>854946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 2</from_name>
		<from_code>2197291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen</from_name>
		<from_code>2717943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 4 vaccine live</from_name>
		<from_code>1099933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 3</from_name>
		<from_code>2197292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</from_name>
		<from_code>1300779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anthrax Vaccine Adsorbed</from_name>
		<from_code>404774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</from_name>
		<from_code>854960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvalent Crotalidae antivenin</from_name>
		<from_code>91596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen</from_name>
		<from_code>1593130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen</from_name>
		<from_code>1601233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</from_name>
		<from_code>854966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</from_name>
		<from_code>2056525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 1 (Mahoney)</from_name>
		<from_code>763096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Utah/9/2014 antigen</from_name>
		<from_code>1657133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live, New York City Board of Health vaccinia strain</from_name>
		<from_code>798467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen</from_name>
		<from_code>2708995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 1</from_name>
		<from_code>2197290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</from_name>
		<from_code>1657130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</from_name>
		<from_code>854974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen</from_name>
		<from_code>2686166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</from_name>
		<from_code>854938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group W-135</from_name>
		<from_code>314724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, recombinant</from_name>
		<from_code>2636588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Maryland/15/2016 antigen</from_name>
		<from_code>2048563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</from_name>
		<from_code>1928528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen</from_name>
		<from_code>2479040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</from_name>
		<from_code>854962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Victoria/705/2018 antigen</from_name>
		<from_code>2380575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Colorado/06/2017 antigen</from_name>
		<from_code>2054177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</from_name>
		<from_code>N0000194157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus strain CR 326F antigen, inactivated</from_name>
		<from_code>2274413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</from_name>
		<from_code>1663632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</from_name>
		<from_code>1946964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 4</from_name>
		<from_code>2197293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 45 vaccine</from_name>
		<from_code>1596932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen</from_name>
		<from_code>2593854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen</from_name>
		<from_code>1601232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</from_name>
		<from_code>854954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Panama/45/90 antigen</from_name>
		<from_code>2262062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/7/2009 (H1N1) antigen</from_name>
		<from_code>1657331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live vaccinia virus</from_name>
		<from_code>833079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</from_name>
		<from_code>N0000194168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</from_name>
		<from_code>2048564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</from_name>
		<from_code>854932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen</from_name>
		<from_code>2562555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ROTAVIRUS VACCINE, LIVE</from_name>
		<from_code>253199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</from_name>
		<from_code>2380835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 3 (Saukett)</from_name>
		<from_code>763100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A vaccine (inactivated) strain HM175</from_name>
		<from_code>798361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, attenuated Schwarz strain</from_name>
		<from_code>2603499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein</from_name>
		<from_code>2468231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen</from_name>
		<from_code>2642276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</from_name>
		<from_code>1928290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</from_name>
		<from_code>854968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 2 (MEF-1)</from_name>
		<from_code>763098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Iowa/06/2017 antigen</from_name>
		<from_code>2056523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</from_name>
		<from_code>2380834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</from_name>
		<from_code>2380837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen</from_name>
		<from_code>2605723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen</from_name>
		<from_code>2561244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized</from_name>
		<from_code>2642138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, RIT-4385 strain</from_name>
		<from_code>2603501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/46/2015 antigen</from_name>
		<from_code>1942125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/9/2014 antigen</from_name>
		<from_code>1723997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</from_name>
		<from_code>1664172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</from_name>
		<from_code>854972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylpenicilloyl polylysine</from_name>
		<from_code>19079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</from_name>
		<from_code>1794331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</from_name>
		<from_code>854964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H3N2) antigen</from_name>
		<from_code>1657131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hemophilus B polysaccharide</from_name>
		<from_code>314656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</from_name>
		<from_code>854930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</from_name>
		<from_code>2180337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</from_name>
		<from_code>854934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PERTUSSIS VACCINE,ADSORBED</from_name>
		<from_code>402543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle</from_name>
		<from_code>1601236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/WUH4618/2021 antigen</from_name>
		<from_code>2605725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen</from_name>
		<from_code>2607735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</from_name>
		<from_code>1657127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</from_name>
		<from_code>2379530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen</from_name>
		<from_code>2605724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</from_name>
		<from_code>1427020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen</from_name>
		<from_code>2388136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen</from_name>
		<from_code>2562553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</from_name>
		<from_code>1301885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</from_name>
		<from_code>854958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hong Kong/259/2010 antigen</from_name>
		<from_code>1801603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cholera Vaccine</from_name>
		<from_code>2427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen</from_name>
		<from_code>2630221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform M), recombinant</from_name>
		<from_code>2588218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 33 vaccine</from_name>
		<from_code>1596931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1)</from_name>
		<from_code>2722424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</from_name>
		<from_code>2056521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform L), recombinant</from_name>
		<from_code>2588217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</from_name>
		<from_code>854940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</from_name>
		<from_code>1928289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360571</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 7 vaccine live</from_name>
		<from_code>1099937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</from_name>
		<from_code>1663630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</from_name>
		<from_code>1301887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
		<from_code>N0000194159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</from_name>
		<from_code>1657222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>equine diphtheria antitoxin</from_name>
		<from_code>91602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1)</from_name>
		<from_code>2722617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus antigen</from_name>
		<from_code>1657134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E, recombinant</from_name>
		<from_code>1986820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen</from_name>
		<from_code>2564395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/60/2008 antigen</from_name>
		<from_code>1657226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vibrio cholerae CVD 103-HGR strain live antigen</from_name>
		<from_code>1812935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</from_name>
		<from_code>2180338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</from_name>
		<from_code>2380574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</from_name>
		<from_code>2177291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</from_name>
		<from_code>1666421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria antitoxin</from_name>
		<from_code>3510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Production [PE]</to_name>
		<to_code>N0000009088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased IgG Production [PE]</from_name>
		<from_code>N0000185001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Hemagglutinin Inhibition Antibody Production [PE]</to_name>
		<to_code>N0000186107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microsporum audouinii allergenic extract</from_name>
		<from_code>1014395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western larch pollen extract</from_name>
		<from_code>2166614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP</from_name>
		<from_code>349980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Australian pine pollen extract</from_name>
		<from_code>852229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acrothecium robustum allergenic extract</from_name>
		<from_code>905088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian balsam</from_name>
		<from_code>33219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse dander extract</from_name>
		<from_code>2167548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat hair extract</from_name>
		<from_code>895503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cochliobolus spicifer allergenic extract</from_name>
		<from_code>995699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow hornet venom protein</from_name>
		<from_code>1297537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton tonsurans allergenic extract</from_name>
		<from_code>1098619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut pollen extract</from_name>
		<from_code>852577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broad leaved paperbark pollen extract</from_name>
		<from_code>903913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Utah juniper pollen extract</from_name>
		<from_code>852597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rough marshelder pollen extract</from_name>
		<from_code>852532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chinquapin oak pollen extract</from_name>
		<from_code>2167695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese black pine pollen extract</from_name>
		<from_code>900777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass smut allergenic extract</from_name>
		<from_code>852128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western white pine pollen extract</from_name>
		<from_code>900743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
		<from_code>N0000185369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humicola grisea allergenic extract</from_name>
		<from_code>1014391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck feather extract</from_name>
		<from_code>892851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine bush pollen extract</from_name>
		<from_code>851894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium expansum allergenic extract</from_name>
		<from_code>967111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylenediamine</from_name>
		<from_code>1362740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey feather extract</from_name>
		<from_code>1594963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf plantain pollen extract</from_name>
		<from_code>1484983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haematonectria haematococca allergenic extract</from_name>
		<from_code>852503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Platycladus orientalis pollen extract</from_name>
		<from_code>1360623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Callistemon citrinus pollen extract</from_name>
		<from_code>2171260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pinus cembroides pollen extract</from_name>
		<from_code>2590679</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken feather extract</from_name>
		<from_code>894934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>weakleaf bur ragweed pollen extract</from_name>
		<from_code>1117083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linden pollen extract</from_name>
		<from_code>852070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus lunatus allergenic extract</from_name>
		<from_code>852264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rocky Mountain juniper pollen extract</from_name>
		<from_code>852601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lombardy poplar pollen extract</from_name>
		<from_code>852348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Blatta orientalis preparation</from_name>
		<from_code>1346617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster skin extract</from_name>
		<from_code>852663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidurea</from_name>
		<from_code>1368885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hackberry pollen extract</from_name>
		<from_code>852324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bronopol</from_name>
		<from_code>1114345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitch pine pollen extract</from_name>
		<from_code>900758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus rubra pollen allergenic extract</from_name>
		<from_code>1426632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary grass pollen extract</from_name>
		<from_code>852697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Iris germanica var. florentina root extract</from_name>
		<from_code>1993233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger var. niger extract</from_name>
		<from_code>854082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor racemosus allergenic extract</from_name>
		<from_code>852687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lens scale pollen extract</from_name>
		<from_code>852096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>longleaf pine pollen extract</from_name>
		<from_code>1014360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burweed marshelder pollen extract</from_name>
		<from_code>852551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida tropicalis allergenic extract</from_name>
		<from_code>967033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Verticillium albo-atrum allergenic extract</from_name>
		<from_code>968467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white (mexican) dock pollen extract</from_name>
		<from_code>1014743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red alder pollen extract</from_name>
		<from_code>851914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European house dust mite allergenic extract</from_name>
		<from_code>1116979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epidermophyton floccosum allergenic extract</from_name>
		<from_code>995707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog flea allergenic extract</from_name>
		<from_code>886637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry birch pollen extract</from_name>
		<from_code>852144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white oak pollen extract</from_name>
		<from_code>852294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald-faced hornet venom protein</from_name>
		<from_code>1297525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit hair extract</from_name>
		<from_code>895527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California scrub oak pollen extract</from_name>
		<from_code>852802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Camelus bactrianus hair extract</from_name>
		<from_code>2590604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona cypress pollen extract</from_name>
		<from_code>852814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sheep sorrel pollen extract</from_name>
		<from_code>852213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosquito allergenic extract</from_name>
		<from_code>974741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Austrian pine pollen extract</from_name>
		<from_code>900750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lichtheimia corymbifera allergenic extract</from_name>
		<from_code>995727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burning bush pollen extract</from_name>
		<from_code>852593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allscale pollen extract</from_name>
		<from_code>897304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt grass pollen extract</from_name>
		<from_code>852329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ash pollen extract</from_name>
		<from_code>1484982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acremonium strictum allergenic extract</from_name>
		<from_code>905070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black oak pollen extract</from_name>
		<from_code>852260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pyrethrum cinerariifolium allergenic extract</from_name>
		<from_code>967970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hard maple pollen extract</from_name>
		<from_code>851874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shagbark hickory pollen extract</from_name>
		<from_code>852221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora tarda allergenic extract</from_name>
		<from_code>852404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>live oak pollen extract</from_name>
		<from_code>867311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whey protein hydrolysate</from_name>
		<from_code>2266754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nickel</from_name>
		<from_code>1311629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma destructiva allergenic extract</from_name>
		<from_code>966995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cootamundra wattle pollen extract</from_name>
		<from_code>895353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common wasp venom protein</from_name>
		<from_code>1297527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. circinelloides allergenic extract</from_name>
		<from_code>2101422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA</from_name>
		<from_code>350060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lambs quarters pollen extract</from_name>
		<from_code>852237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliocladium allergenic extract</from_name>
		<from_code>1192997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus globulus pollen extract</from_name>
		<from_code>852386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perennial rye grass pollen extract</from_name>
		<from_code>852819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pepper tree pollen extract</from_name>
		<from_code>852140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pollen extract</from_name>
		<from_code>897403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mexican tea pollen extract</from_name>
		<from_code>897391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Garrys oak pollen extract</from_name>
		<from_code>900987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glaucum allergenic extract</from_name>
		<from_code>1986792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit extract</from_name>
		<from_code>124323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rat skin extract</from_name>
		<from_code>895279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phanerodontia chrysosporium allergenic extract</from_name>
		<from_code>968114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English oak pollen extract</from_name>
		<from_code>1484984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arroyo willow pollen extract</from_name>
		<from_code>852170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Italian rye grass pollen extract</from_name>
		<from_code>1014340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt cedar pollen extract</from_name>
		<from_code>852806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem oak pollen extract</from_name>
		<from_code>1014766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bahia grass pollen extract</from_name>
		<from_code>852673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma harzianum allergenic extract</from_name>
		<from_code>968197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western juniper pollen extract</from_name>
		<from_code>852589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Quercus marilandica pollen extract</from_name>
		<from_code>1437222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated barley pollen extract</from_name>
		<from_code>1098118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western wheatgrass pollen extract</from_name>
		<from_code>852659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red cedar pollen extract</from_name>
		<from_code>852609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golden chain pollen extract</from_name>
		<from_code>1996102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazolidinylurea</from_name>
		<from_code>1310602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster hair extract</from_name>
		<from_code>1594965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast maple pollen extract</from_name>
		<from_code>851736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oneseed juniper pollen extract</from_name>
		<from_code>900108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow dander extract</from_name>
		<from_code>2166591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water oak pollen extract</from_name>
		<from_code>1013944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus glabra pollen extract</from_name>
		<from_code>2369372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides farinae</from_name>
		<from_code>852810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern sycamore pollen extract</from_name>
		<from_code>852746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocklebur pollen extract</from_name>
		<from_code>852025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated oat pollen extract</from_name>
		<from_code>852114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colonial bent grass pollen extract</from_name>
		<from_code>1484937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gray birch pollen extract</from_name>
		<from_code>852178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton schoenleinii allergenic extract</from_name>
		<from_code>968422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig dander</from_name>
		<from_code>2166593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>post oak pollen extract</from_name>
		<from_code>901011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium digitatum allergenic extract</from_name>
		<from_code>1427044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver maple pollen extract</from_name>
		<from_code>851866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>box elder maple pollen extract</from_name>
		<from_code>851740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red oak pollen extract</from_name>
		<from_code>852268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetracoccosporium paxianum allergenic extract</from_name>
		<from_code>968502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clioquinol</from_name>
		<from_code>5942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides pteronyssinus</from_name>
		<from_code>852826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat hair extract</from_name>
		<from_code>248123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tabanus nigrovittatus extract</from_name>
		<from_code>2590185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redwood pollen extract</from_name>
		<from_code>1014707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house fly allergenic extract</from_name>
		<from_code>350173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gambels oak pollen extract</from_name>
		<from_code>852276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plains cottonwood pollen extract</from_name>
		<from_code>867297</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broomweed pollen extract</from_name>
		<from_code>1094193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton fiber allergenic extract</from_name>
		<from_code>966925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern bayberry pollen extract</from_name>
		<from_code>867260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white poplar pollen extract</from_name>
		<from_code>852382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shortleaf pine pollen extract</from_name>
		<from_code>852709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pussy willow pollen extract</from_name>
		<from_code>852174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syringa vulgaris pollen extract</from_name>
		<from_code>2634236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>para grass pollen extract</from_name>
		<from_code>894750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat skin extract</from_name>
		<from_code>852252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pin oak pollen extract</from_name>
		<from_code>900999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date palm pollen extract</from_name>
		<from_code>852704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. lusitanicus allergenic extract</from_name>
		<from_code>2101473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neurospora intermedia allergenic extract</from_name>
		<from_code>867274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water birch pollen extract</from_name>
		<from_code>852166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>microsporum canis allergenic extract</from_name>
		<from_code>1014399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neurospora sitophila allergenic extract</from_name>
		<from_code>1098200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paper birch pollen extract</from_name>
		<from_code>899576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canada goldenrod pollen extract</from_name>
		<from_code>995743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog hair extract</from_name>
		<from_code>895542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black willow pollen extract</from_name>
		<from_code>852162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canadian bluegrass pollen extract</from_name>
		<from_code>1014731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sorghum bicolor pollen extract</from_name>
		<from_code>1311406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nux vomica extract</from_name>
		<from_code>314743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsam poplar pollen extract</from_name>
		<from_code>1014762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narrowleaf marshelder pollen extract</from_name>
		<from_code>1098130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse hair extract</from_name>
		<from_code>895515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white hickory pollen extract</from_name>
		<from_code>852193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris root allergenic extract</from_name>
		<from_code>1098353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow sweet clover pollen extract</from_name>
		<from_code>1014447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>groundsel pollen extract</from_name>
		<from_code>897332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microascus brevicaulis allergenic extract</from_name>
		<from_code>1192992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slash pine pollen extract</from_name>
		<from_code>900731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palo verde pollen extract</from_name>
		<from_code>852359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet vernal grass pollen extract</from_name>
		<from_code>851898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cheat grass pollen extract</from_name>
		<from_code>852225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European beech pollen extract</from_name>
		<from_code>1484981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pignut hickory pollen extract</from_name>
		<from_code>899650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesquite pollen extract</from_name>
		<from_code>852320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladosporium sphaerospermum allergenic extract</from_name>
		<from_code>867202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scrub pine pollen extract</from_name>
		<from_code>1013913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspen pollen extract</from_name>
		<from_code>852339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus nidulans allergenic extract</from_name>
		<from_code>1368357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amaranthus hybridus pollen extract</from_name>
		<from_code>1363561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tag alder pollen extract</from_name>
		<from_code>851902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California mugwort pollen extract</from_name>
		<from_code>892734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black carpenter ant allergenic extract</from_name>
		<from_code>2057909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow foxtail pollen extract</from_name>
		<from_code>1484974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wing scale pollen extract</from_name>
		<from_code>852074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white ash pollen extract</from_name>
		<from_code>852450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum allergenic extract</from_name>
		<from_code>2101722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow fescue grass pollen extract</from_name>
		<from_code>851918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>privet pollen extract</from_name>
		<from_code>852622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acer pseudoplatanus pollen extract</from_name>
		<from_code>1801702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clonostachys rosea f. rosea allergenic extract</from_name>
		<from_code>1426481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redberry juniper pollen extract</from_name>
		<from_code>900113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chinese elm pollen extract</from_name>
		<from_code>852844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tree of heaven pollen extract</from_name>
		<from_code>851890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern yellow jacket venom protein</from_name>
		<from_code>1297533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog skin extract</from_name>
		<from_code>852839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black walnut pollen extract</from_name>
		<from_code>852561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>european olive pollen extract</from_name>
		<from_code>852653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES</from_name>
		<from_code>350004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow birch pollen extract</from_name>
		<from_code>899550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue spruce pollen extract</from_name>
		<from_code>900704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German wasp venom protein</from_name>
		<from_code>1297531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose wheat smut allergenic extract</from_name>
		<from_code>968437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Koelers grass pollen extract</from_name>
		<from_code>852605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kapok tree fiber allergenic extract</from_name>
		<from_code>852315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shad scale pollen extract</from_name>
		<from_code>852087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red maple pollen extract</from_name>
		<from_code>851744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian olive pollen extract</from_name>
		<from_code>852367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosin</from_name>
		<from_code>1362931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium chrysogenum var. chrysogenum allergenic extract</from_name>
		<from_code>854130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian pepper tree pollen extract</from_name>
		<from_code>2632070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow pine pollen extract</from_name>
		<from_code>852716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard pollen extract</from_name>
		<from_code>852205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixocortol pivalate</from_name>
		<from_code>38336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat flea allergenic extract</from_name>
		<from_code>886638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</from_name>
		<from_code>1440973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cytisus scoparius flowering top extract</from_name>
		<from_code>2168418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium cladosporioides extract</from_name>
		<from_code>867198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white willow pollen extract</from_name>
		<from_code>1484986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pine pollen extract</from_name>
		<from_code>900754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>2102052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvet grass pollen extract</from_name>
		<from_code>852514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-chloro-2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow hair extract</from_name>
		<from_code>895488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Carya laciniosa pollen extract</from_name>
		<from_code>1305551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hypomyces perniciosus allergenic extract</from_name>
		<from_code>1192968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian thistle pollen extract</from_name>
		<from_code>852158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
		<from_code>N0000185374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia longifolia pollen extract</from_name>
		<from_code>853983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>winterfat pollen extract</from_name>
		<from_code>852613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green ash pollen extract</from_name>
		<from_code>852491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Brazilian pepper tree pollen extract</from_name>
		<from_code>2632068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit skin extract</from_name>
		<from_code>895195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white sweet clover pollen extract</from_name>
		<from_code>1014735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>queen palm pollen extract</from_name>
		<from_code>867353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Paecilomyces variotii allergenic extract</from_name>
		<from_code>966979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butylparaben</from_name>
		<from_code>1306937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium compactum allergenic extract</from_name>
		<from_code>999457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Solidago virgaurea pollen extract</from_name>
		<from_code>1309242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium camemberti allergenic extract</from_name>
		<from_code>966943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium italicum allergenic extract</from_name>
		<from_code>967960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black oak pollen extract</from_name>
		<from_code>1014721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osage orange pollen extract</from_name>
		<from_code>1098189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver birch pollen allergenic extract</from_name>
		<from_code>1306108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>1340182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern yellow jacket venom protein</from_name>
		<from_code>1297529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium sarciniforme allergenic extract</from_name>
		<from_code>968130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parakeet feather allergenic extract</from_name>
		<from_code>1192987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Colletotrichum coccodes allergenic extract</from_name>
		<from_code>1192729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed extract</from_name>
		<from_code>853406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black locust pollen extract</from_name>
		<from_code>867325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Indian wormwood sage pollen extract</from_name>
		<from_code>1006495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix repens pollen extract</from_name>
		<from_code>2533912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia pollen extract</from_name>
		<from_code>851732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alnus glutinosa bark extract</from_name>
		<from_code>1441543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ustilago maydis extract</from_name>
		<from_code>1427134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig skin extract</from_name>
		<from_code>852298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humulus lupulus pollen extract</from_name>
		<from_code>1740937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium roquefortii allergenic extract</from_name>
		<from_code>972365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Scotch pine pollen extract</from_name>
		<from_code>900764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western waterhemp pollen extract</from_name>
		<from_code>851934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet gum pollen extract</from_name>
		<from_code>852627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jute fiber allergenic extract</from_name>
		<from_code>852412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus amstelodami extract</from_name>
		<from_code>2101007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS</from_name>
		<from_code>350125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bulbous buttercup pollen extract</from_name>
		<from_code>1484985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS</from_name>
		<from_code>350075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton rubrum allergenic extract</from_name>
		<from_code>968413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS</from_name>
		<from_code>350081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vitis vinifera pollen extract</from_name>
		<from_code>2669695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alkali blite pollen extract</from_name>
		<from_code>852106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Calocedrus decurrens pollen extract</from_name>
		<from_code>2670160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saltbush pollen extract</from_name>
		<from_code>897316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fivehorn smotherweed pollen extract</from_name>
		<from_code>852124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>annual bluegrass pollen extract</from_name>
		<from_code>898404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English plantain pollen extract</from_name>
		<from_code>852742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German cockroach allergenic extract</from_name>
		<from_code>905276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bur oak pollen extract</from_name>
		<from_code>900991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog dander extract</from_name>
		<from_code>2167551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</from_name>
		<from_code>350160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cottonwood pollen extract</from_name>
		<from_code>852376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quackgrass pollen extract</from_name>
		<from_code>852343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European aspen pollen extract</from_name>
		<from_code>2166596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Leucanthemum vulgare pollen</from_name>
		<from_code>2102006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goose feather extract</from_name>
		<from_code>894783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sudan grass pollen extract</from_name>
		<from_code>1098455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>algal fungi allergenic extract</from_name>
		<from_code>966692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheasant feather extract</from_name>
		<from_code>1594964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula mucilaginosa allergenic extract</from_name>
		<from_code>967529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern white pine pollen extract</from_name>
		<from_code>852738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salsola tragus pollen extract</from_name>
		<from_code>1314927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanolin alcohols</from_name>
		<from_code>1426478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western black willow pollen extract</from_name>
		<from_code>1014755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme allergenic extract</from_name>
		<from_code>974527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary feather extract</from_name>
		<from_code>894961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thimerosal</from_name>
		<from_code>10472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf cattail pollen extract</from_name>
		<from_code>1232637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grain sorghum pollen extract</from_name>
		<from_code>1098438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse skin extract</from_name>
		<from_code>852693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton seed extract</from_name>
		<from_code>1309369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus repens allergenic extract</from_name>
		<from_code>1006310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia graminis allergenic extract</from_name>
		<from_code>999487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat pollen extract</from_name>
		<from_code>867361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>greasewood pollen extract</from_name>
		<from_code>852152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodgepole pine pollen extract</from_name>
		<from_code>898324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valley oak pollen extract</from_name>
		<from_code>1111024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt</from_name>
		<from_code>1310300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quaternium-15</from_name>
		<from_code>283678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast live oak pollen extract</from_name>
		<from_code>852302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mongolian gerbil skin allergenic extract</from_name>
		<from_code>895070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus var. oryzae protease</from_name>
		<from_code>1307040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobacco leaf allergenic extract</from_name>
		<from_code>852062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syncephalastrum racemosum allergenic extract</from_name>
		<from_code>968506</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass smut allergenic extract</from_name>
		<from_code>1014385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, CAMEL</from_name>
		<from_code>314336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dogfennel pollen extract</from_name>
		<from_code>867218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Malus domestica pollen extract</from_name>
		<from_code>2593689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Siberian elm pollen extract</from_name>
		<from_code>1299981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue beech pollen extract</from_name>
		<from_code>899611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver ragweed pollen extract</from_name>
		<from_code>852306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptomyces griseus allergenic extract</from_name>
		<from_code>1314592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitternut hickory pollen extract</from_name>
		<from_code>899645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Epicoccum nigrum allergenic extract</from_name>
		<from_code>852466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Periplaneta australasiae extract</from_name>
		<from_code>2590183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum extract</from_name>
		<from_code>852617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisal fiber allergenic extract</from_name>
		<from_code>851882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grama grass pollen extract</from_name>
		<from_code>852197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common cocklebur pollen extract</from_name>
		<from_code>902215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jack pine pollen extract</from_name>
		<from_code>1014690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut pollen extract</from_name>
		<from_code>852281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silk allergenic extract</from_name>
		<from_code>314455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfalfa pollen extract</from_name>
		<from_code>852634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common hazel pollen extract</from_name>
		<from_code>1484979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower pollen extract</from_name>
		<from_code>852509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated rye grass pollen extract</from_name>
		<from_code>1014774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Douglas fir pollen extract</from_name>
		<from_code>1098257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gliocladium viride extract</from_name>
		<from_code>2101008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white alder pollen extract</from_name>
		<from_code>851910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora betae allergenic extract</from_name>
		<from_code>852756</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Grindelia ciliata pollen extract</from_name>
		<from_code>2043451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rattus norvegicus hair preparation</from_name>
		<from_code>2471704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canis lupus familiaris hair extract</from_name>
		<from_code>854025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona ash pollen extract</from_name>
		<from_code>852496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creeping bentgrass pollen extract</from_name>
		<from_code>1094116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Strychnos nux-vomica seed extract</from_name>
		<from_code>1309678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben</from_name>
		<from_code>34706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dendryphiella vinosa allergenic extract</from_name>
		<from_code>995703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crested dogstail pollen extract</from_name>
		<from_code>1484980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig hair extract</from_name>
		<from_code>895507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American cockroach allergenic extract</from_name>
		<from_code>905258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylparaben</from_name>
		<from_code>29903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orchard grass pollen extract</from_name>
		<from_code>851878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apis mellifera preparation</from_name>
		<from_code>285219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Passalora fulva allergenic extract</from_name>
		<from_code>883442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American basswood pollen extract</from_name>
		<from_code>995754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora herbarum allergenic extract</from_name>
		<from_code>971198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poverty weed pollen extract</from_name>
		<from_code>852539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant wild rye pollen extract</from_name>
		<from_code>900148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow dock pollen extract</from_name>
		<from_code>852209</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia dealbata pollen extract</from_name>
		<from_code>2202946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American house dust mite allergenic extract</from_name>
		<from_code>1116977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Helminthosporium solani allergenic extract</from_name>
		<from_code>867232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Oregon ash pollen extract</from_name>
		<from_code>900045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western yellow jacket venom protein</from_name>
		<from_code>1297535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nettle pollen extract</from_name>
		<from_code>852046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>London planetree</from_name>
		<from_code>2166616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>littleseed canary grass pollen extract</from_name>
		<from_code>1098232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium solani allergenic extract</from_name>
		<from_code>867349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut pollen extract</from_name>
		<from_code>852569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Geotrichum candidum allergenic extract</from_name>
		<from_code>999463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharomyces cerevisiae allergenic extract</from_name>
		<from_code>350141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald cypress pollen extract</from_name>
		<from_code>995747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sydney golden wattle pollen extract</from_name>
		<from_code>895365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma exigua var. exigua allergenic extract</from_name>
		<from_code>867284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pale dock pollen extract</from_name>
		<from_code>1232604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix lutea pollen extract</from_name>
		<from_code>2590686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mountain cedar pollen extract</from_name>
		<from_code>852581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose barley smut allergenic extract</from_name>
		<from_code>968492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrolyzed casein (enzymatic; 1000 MW)</from_name>
		<from_code>1812932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American elm pollen extract</from_name>
		<from_code>852054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cricket allergenic extract</from_name>
		<from_code>973447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loblolly pine pollen extract</from_name>
		<from_code>900770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white mulberry pollen extract</from_name>
		<from_code>852669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Khuskia oryzae allergenic extract</from_name>
		<from_code>892338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella fujikuroi extract</from_name>
		<from_code>2043450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Schinus terebinthifolius pollen extract</from_name>
		<from_code>2590688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern cottonwood pollen extract</from_name>
		<from_code>852363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lawsonia inermis leaf extract</from_name>
		<from_code>1307699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella zeae allergenic extract</from_name>
		<from_code>1922751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedar elm pollen extract</from_name>
		<from_code>1014191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red mulberry pollen extract</from_name>
		<from_code>852680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black imported fire ant allergenic extract</from_name>
		<from_code>995738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia striiformis allergenic extract</from_name>
		<from_code>852311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>river birch pollen extract</from_name>
		<from_code>852148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitter dock pollen extract</from_name>
		<from_code>1014739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western sycamore pollen extract</from_name>
		<from_code>852750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red imported fire ant allergenic extract</from_name>
		<from_code>867341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM</from_name>
		<from_code>317581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stachybotrys chartarum allergenic extract</from_name>
		<from_code>968123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mulberry pollen extract</from_name>
		<from_code>899593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California juniper pollen extract</from_name>
		<from_code>852585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse hair extract</from_name>
		<from_code>1993210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fremont cottonwood pollen extract</from_name>
		<from_code>852355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased IgG Production [PE]</to_name>
		<to_code>N0000185001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Kinin Production [PE]</from_name>
		<from_code>N0000009369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Bradykinin Production [PE]</to_name>
		<to_code>N0000009120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Eicosanoid Production [PE]</to_name>
		<to_code>N0000009286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000009378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000009523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Production [PE]</from_name>
		<from_code>N0000009286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Leukotriene Production [PE]</to_name>
		<to_code>N0000009375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Production [PE]</from_name>
		<from_code>N0000009286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Production [PE]</to_name>
		<to_code>N0000009528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Production [PE]</from_name>
		<from_code>N0000009286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thromboxane Production [PE]</to_name>
		<to_code>N0000009698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>borage oil</from_name>
		<from_code>68905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Production [PE]</to_name>
		<to_code>N0000009528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oprelvekin</from_name>
		<from_code>139994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thromboxane Production [PE]</to_name>
		<to_code>N0000009698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000009082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000009082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000009082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000009082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000009082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Biogenic Amine Production [PE]</from_name>
		<from_code>N0000009356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Production [PE]</to_name>
		<to_code>N0000009587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Biogenic Amine Production [PE]</from_name>
		<from_code>N0000009356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tryptophan</from_name>
		<from_code>10898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Production [PE]</to_name>
		<to_code>N0000009587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylpenicilloyl polylysine</from_name>
		<from_code>19079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Production [PE]</to_name>
		<to_code>N0000009353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Degradation [PE]</to_name>
		<to_code>N0000009081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Complement Degradation [PE]</to_name>
		<to_code>N0000009265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Degradation [PE]</to_name>
		<to_code>N0000009087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000009377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Kallidin Degradation [PE]</to_name>
		<to_code>N0000009365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Biogenic Amine Degradation [PE]</to_name>
		<to_code>N0000009355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Degradation [PE]</to_name>
		<to_code>N0000009268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Kinin Degradation [PE]</to_name>
		<to_code>N0000009368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000009358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologically Active Molecule Degradation Alteration [PE]</from_name>
		<from_code>N0000009075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000009358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Eicosanoid Degradation [PE]</to_name>
		<to_code>N0000009285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000009377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Activating Factor Degradation [PE]</to_name>
		<to_code>N0000009522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Degradation [PE]</from_name>
		<from_code>N0000009285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Degradation [PE]</to_name>
		<to_code>N0000009527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Degradation [PE]</from_name>
		<from_code>N0000009285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Leukotriene Degradation [PE]</to_name>
		<to_code>N0000009374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Degradation [PE]</from_name>
		<from_code>N0000009285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thromboxane Degradation [PE]</to_name>
		<to_code>N0000009697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
		<from_code>N0000009355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Degradation [PE]</to_name>
		<to_code>N0000009352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
		<from_code>N0000009355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Degradation [PE]</to_name>
		<to_code>N0000009586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Degradation [PE]</to_name>
		<to_code>N0000009352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Degradation [PE]</to_name>
		<to_code>N0000009352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimecrolimus</from_name>
		<from_code>321952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Degradation [PE]</to_name>
		<to_code>N0000009268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Kinin Degradation [PE]</from_name>
		<from_code>N0000009368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000009119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acquired Immunity [PE]</from_name>
		<from_code>N0000183363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373</from_name>
		<from_code>2606073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705</from_name>
		<from_code>2688626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2)</from_name>
		<from_code>2691168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein</from_name>
		<from_code>2606074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2)</from_name>
		<from_code>2691192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5)</from_name>
		<from_code>2610326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5)</from_name>
		<from_code>2610243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601</from_name>
		<from_code>2666309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acquired Immunity [PE]</to_name>
		<to_code>N0000183363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Actively Acquired Immunity [PE]</from_name>
		<from_code>N0000183364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Actively Acquired Immunity [PE]</from_name>
		<from_code>N0000183364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen</from_name>
		<from_code>1601232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</from_name>
		<from_code>854954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 45 vaccine</from_name>
		<from_code>1596932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen</from_name>
		<from_code>2593854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 4</from_name>
		<from_code>2197293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</from_name>
		<from_code>1946964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</from_name>
		<from_code>1663632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus strain CR 326F antigen, inactivated</from_name>
		<from_code>2274413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Colorado/06/2017 antigen</from_name>
		<from_code>2054177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen</from_name>
		<from_code>2479040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</from_name>
		<from_code>854962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</from_name>
		<from_code>1928528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
		<from_code>N0000183899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine</from_name>
		<from_code>798444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Victoria/705/2018 antigen</from_name>
		<from_code>2380575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Maryland/15/2016 antigen</from_name>
		<from_code>2048563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis pertactin vaccine, inactivated</from_name>
		<from_code>1300184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
		<from_code>N0000183913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</from_name>
		<from_code>854938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, recombinant</from_name>
		<from_code>2636588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group W-135</from_name>
		<from_code>314724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen</from_name>
		<from_code>2686166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 1</from_name>
		<from_code>2197290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated</from_name>
		<from_code>1300182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</from_name>
		<from_code>1657130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</from_name>
		<from_code>854974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live, New York City Board of Health vaccinia strain</from_name>
		<from_code>798467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen</from_name>
		<from_code>2708995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 1 (Mahoney)</from_name>
		<from_code>763096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen</from_name>
		<from_code>1601233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen</from_name>
		<from_code>1593130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</from_name>
		<from_code>2056525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</from_name>
		<from_code>854966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Utah/9/2014 antigen</from_name>
		<from_code>1657133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chikungunya virus antigen, live attenuated LR2006 OPY1 strain</from_name>
		<from_code>2673238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
		<from_code>N0000183900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</from_name>
		<from_code>1300779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 3</from_name>
		<from_code>2197292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</from_name>
		<from_code>854960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anthrax Vaccine Adsorbed</from_name>
		<from_code>404774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
		<from_code>N0000183904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen</from_name>
		<from_code>2717943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 2</from_name>
		<from_code>2197291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 4 vaccine live</from_name>
		<from_code>1099933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</from_name>
		<from_code>854946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Washington/02/2019 antigen</from_name>
		<from_code>2280293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen</from_name>
		<from_code>2641622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 58 vaccine</from_name>
		<from_code>1596934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen</from_name>
		<from_code>2645084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H1N1) antigen</from_name>
		<from_code>1657128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</from_name>
		<from_code>854948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen</from_name>
		<from_code>2720359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 X-181 (H1N1), Inactivated</from_name>
		<from_code>1303850</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein</from_name>
		<from_code>2636589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen</from_name>
		<from_code>2605083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</from_name>
		<from_code>2280296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain</from_name>
		<from_code>1006250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E1</from_name>
		<from_code>2707121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group B vaccine</from_name>
		<from_code>1593128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaccinia virus strain New York City Board of Health live antigen</from_name>
		<from_code>1492300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen</from_name>
		<from_code>2562554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen</from_name>
		<from_code>2641877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</from_name>
		<from_code>854936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</from_name>
		<from_code>854970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized</from_name>
		<from_code>2642139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</from_name>
		<from_code>2379531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</from_name>
		<from_code>1664171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen</from_name>
		<from_code>2687714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen</from_name>
		<from_code>2719300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Austria/1359417/2021 antigen</from_name>
		<from_code>2605039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</from_name>
		<from_code>1801767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</from_name>
		<from_code>2380836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</from_name>
		<from_code>1666425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</from_name>
		<from_code>854944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</from_name>
		<from_code>854956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5)</from_name>
		<from_code>2664825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>798279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain</from_name>
		<from_code>1005929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group C polysaccharide</from_name>
		<from_code>29503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</from_name>
		<from_code>854952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen</from_name>
		<from_code>2688113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen</from_name>
		<from_code>1601231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen</from_name>
		<from_code>1593127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group Y</from_name>
		<from_code>314725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</from_name>
		<from_code>2177290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Darwin/7/2019 antigen</from_name>
		<from_code>2380838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</from_name>
		<from_code>854942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</from_name>
		<from_code>854950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bacillus anthracis strain V770-NP1-R antigens</from_name>
		<from_code>1368371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
		<from_code>N0000183894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 31 vaccine</from_name>
		<from_code>1596930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/122/2022 (H3N2) antigen</from_name>
		<from_code>2675569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus envelope glycoprotein</from_name>
		<from_code>2624742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 52 vaccine</from_name>
		<from_code>1596933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mumps Vaccine</from_name>
		<from_code>763656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</from_name>
		<from_code>1657224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen</from_name>
		<from_code>1804259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus</from_name>
		<from_code>1491862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen</from_name>
		<from_code>2694005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hepatitis A Vaccine, Inactivated</from_name>
		<from_code>253174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chikungunya virus antigen, recombinant Senegal strain 37997 capsid protein</from_name>
		<from_code>2707119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Michigan/01/2021 antigen</from_name>
		<from_code>2593400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Phuket/3073/2013 antigen</from_name>
		<from_code>1657228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</from_name>
		<from_code>1664339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform S), recombinant</from_name>
		<from_code>2588219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</from_name>
		<from_code>1666421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</from_name>
		<from_code>2177291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</from_name>
		<from_code>2180338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</from_name>
		<from_code>2380574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
		<from_code>N0000183898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen</from_name>
		<from_code>2564395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/60/2008 antigen</from_name>
		<from_code>1657226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vibrio cholerae CVD 103-HGR strain live antigen</from_name>
		<from_code>1812935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus antigen</from_name>
		<from_code>1657134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</from_name>
		<from_code>1657222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
		<from_code>N0000183917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</from_name>
		<from_code>1663630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</from_name>
		<from_code>1301887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 7 vaccine live</from_name>
		<from_code>1099937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E2</from_name>
		<from_code>2707122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360571</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</from_name>
		<from_code>1928289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</from_name>
		<from_code>854940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein</from_name>
		<from_code>2624741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
		<from_code>N0000183888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform L), recombinant</from_name>
		<from_code>2588217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</from_name>
		<from_code>2056521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 33 vaccine</from_name>
		<from_code>1596931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform M), recombinant</from_name>
		<from_code>2588218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen</from_name>
		<from_code>2630221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cholera Vaccine</from_name>
		<from_code>2427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
		<from_code>N0000183903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hong Kong/259/2010 antigen</from_name>
		<from_code>1801603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</from_name>
		<from_code>1301885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen</from_name>
		<from_code>2562553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chikungunya virus antigen, recombinant Senegal strain 37997</from_name>
		<from_code>2707120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</from_name>
		<from_code>854958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen</from_name>
		<from_code>2388136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</from_name>
		<from_code>1427020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen</from_name>
		<from_code>2605724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</from_name>
		<from_code>2379530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen</from_name>
		<from_code>2607735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</from_name>
		<from_code>1657127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
		<from_code>N0000183918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/WUH4618/2021 antigen</from_name>
		<from_code>2605725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle</from_name>
		<from_code>1601236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</from_name>
		<from_code>2180337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</from_name>
		<from_code>854934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis toxoid vaccine, inactivated</from_name>
		<from_code>1300186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
		<from_code>N0000183912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</from_name>
		<from_code>854930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
		<from_code>N0000183887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H3N2) antigen</from_name>
		<from_code>1657131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</from_name>
		<from_code>1427171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</from_name>
		<from_code>854964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</from_name>
		<from_code>1794331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated</from_name>
		<from_code>1300180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</from_name>
		<from_code>854972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</from_name>
		<from_code>1664172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/9/2014 antigen</from_name>
		<from_code>1723997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/46/2015 antigen</from_name>
		<from_code>1942125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
		<from_code>N0000183907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, RIT-4385 strain</from_name>
		<from_code>2603501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen</from_name>
		<from_code>2561244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized</from_name>
		<from_code>2642138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
		<from_code>N0000183909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen</from_name>
		<from_code>2605723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</from_name>
		<from_code>2380837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</from_name>
		<from_code>2380834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</from_name>
		<from_code>1928290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</from_name>
		<from_code>854968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Iowa/06/2017 antigen</from_name>
		<from_code>2056523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 2 (MEF-1)</from_name>
		<from_code>763098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen</from_name>
		<from_code>2642276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, attenuated Schwarz strain</from_name>
		<from_code>2603499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5)</from_name>
		<from_code>2664725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A vaccine (inactivated) strain HM175</from_name>
		<from_code>798361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 3 (Saukett)</from_name>
		<from_code>763100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ROTAVIRUS VACCINE, LIVE</from_name>
		<from_code>253199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</from_name>
		<from_code>2380835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</from_name>
		<from_code>854932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen</from_name>
		<from_code>2562555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live vaccinia virus</from_name>
		<from_code>833079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/7/2009 (H1N1) antigen</from_name>
		<from_code>1657331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</from_name>
		<from_code>2048564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Panama/45/90 antigen</from_name>
		<from_code>2262062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
		<from_code>N0000183914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actively Acquired Immunity [PE]</to_name>
		<to_code>N0000183364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1)</from_name>
		<from_code>2722617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 52 vaccine</from_name>
		<from_code>1596933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 58 vaccine</from_name>
		<from_code>1596934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein</from_name>
		<from_code>2468231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</from_name>
		<from_code>2685002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zopapogene imadenovec-drba</from_name>
		<from_code>2723360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</from_name>
		<from_code>1301887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 31 vaccine</from_name>
		<from_code>1596930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1)</from_name>
		<from_code>2722424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</from_name>
		<from_code>1301885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1)</from_name>
		<from_code>2722594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zopapogene imadenovec</from_name>
		<from_code>2723361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 45 vaccine</from_name>
		<from_code>1596932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 33 vaccine</from_name>
		<from_code>1596931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humoral Immunity [PE]</to_name>
		<to_code>N0000185002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Allium cepa bulb extract</from_name>
		<from_code>2695867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canadian bluegrass pollen extract</from_name>
		<from_code>1014731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nux vomica extract</from_name>
		<from_code>314743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narrowleaf marshelder pollen extract</from_name>
		<from_code>1098130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paper birch pollen extract</from_name>
		<from_code>899576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canada goldenrod pollen extract</from_name>
		<from_code>995743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog hair extract</from_name>
		<from_code>895542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon allergenic extract</from_name>
		<from_code>901382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rye allergenic extract</from_name>
		<from_code>892638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesquite pollen extract</from_name>
		<from_code>852320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris root allergenic extract</from_name>
		<from_code>1098353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber extract</from_name>
		<from_code>1305719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange allergenic extract</from_name>
		<from_code>892565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common carp allergenic extract</from_name>
		<from_code>901390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palo verde pollen extract</from_name>
		<from_code>852359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet vernal grass pollen extract</from_name>
		<from_code>851898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cheat grass pollen extract</from_name>
		<from_code>852225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European beech pollen extract</from_name>
		<from_code>1484981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow foxtail pollen extract</from_name>
		<from_code>1484974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum allergenic extract</from_name>
		<from_code>2101722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coccidioides immitis spherule</from_name>
		<from_code>1549330</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>privet pollen extract</from_name>
		<from_code>852622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sipuleucel-T</from_name>
		<from_code>997261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1)</from_name>
		<from_code>2722424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladosporium sphaerospermum allergenic extract</from_name>
		<from_code>867202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wormwood sage pollen extract</from_name>
		<from_code>852007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white fish allergenic extract</from_name>
		<from_code>901265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tag alder pollen extract</from_name>
		<from_code>851902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black walnut pollen extract</from_name>
		<from_code>852561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>european olive pollen extract</from_name>
		<from_code>852653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue spruce pollen extract</from_name>
		<from_code>900704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celery allergenic extract</from_name>
		<from_code>892372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haddock allergenic extract</from_name>
		<from_code>899428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tall oat grass pollen extract</from_name>
		<from_code>1006506</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redberry juniper pollen extract</from_name>
		<from_code>900113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylparaben</from_name>
		<from_code>19075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chinese elm pollen extract</from_name>
		<from_code>852844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantaloupe allergenic extract</from_name>
		<from_code>892517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coffea arabica seed extract</from_name>
		<from_code>2695791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow dander extract</from_name>
		<from_code>2166591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paprika allergenic extract</from_name>
		<from_code>899873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black olive allergenic extract</from_name>
		<from_code>974650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coffee bean allergenic extract</from_name>
		<from_code>891727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus allergenic extract</from_name>
		<from_code>999384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peach allergenic extract</from_name>
		<from_code>892575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry allergenic extract</from_name>
		<from_code>899734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redroot pigweed pollen extract</from_name>
		<from_code>851930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig dander</from_name>
		<from_code>2166593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>post oak pollen extract</from_name>
		<from_code>901011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver maple pollen extract</from_name>
		<from_code>851866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chickpea allergenic extract</from_name>
		<from_code>1011049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocklebur pollen extract</from_name>
		<from_code>852025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gray birch pollen extract</from_name>
		<from_code>852178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton schoenleinii allergenic extract</from_name>
		<from_code>968422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara preparation</from_name>
		<from_code>235940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quince extract</from_name>
		<from_code>1370761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clioquinol</from_name>
		<from_code>5942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat hair extract</from_name>
		<from_code>248123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sandbur ragweed pollen extract</from_name>
		<from_code>851955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date allergenic extract</from_name>
		<from_code>899742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein</from_name>
		<from_code>2468231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red oak pollen extract</from_name>
		<from_code>852268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg (chicken) allergenic extract</from_name>
		<from_code>904507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scallop allergenic extract</from_name>
		<from_code>899916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetracoccosporium paxianum allergenic extract</from_name>
		<from_code>968502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat skin extract</from_name>
		<from_code>852252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red currant allergenic extract</from_name>
		<from_code>972480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt allergenic extract</from_name>
		<from_code>1006510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1311644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water birch pollen extract</from_name>
		<from_code>852166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neurospora intermedia allergenic extract</from_name>
		<from_code>867274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English sole allergenic extract</from_name>
		<from_code>974140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white catfish allergenic extract</from_name>
		<from_code>971166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house fly allergenic extract</from_name>
		<from_code>350173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton fiber allergenic extract</from_name>
		<from_code>966925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shortleaf pine pollen extract</from_name>
		<from_code>852709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pussy willow pollen extract</from_name>
		<from_code>852174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern bayberry pollen extract</from_name>
		<from_code>867260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white poplar pollen extract</from_name>
		<from_code>852382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California scrub oak pollen extract</from_name>
		<from_code>852802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Camelus bactrianus hair extract</from_name>
		<from_code>2590604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona cypress pollen extract</from_name>
		<from_code>852814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt syrup</from_name>
		<from_code>1306883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-isopropyl-N-phenyl-4-phenylenediamine</from_name>
		<from_code>1363710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sheep sorrel pollen extract</from_name>
		<from_code>852213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosquito allergenic extract</from_name>
		<from_code>974741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Austrian pine pollen extract</from_name>
		<from_code>900750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lichtheimia corymbifera allergenic extract</from_name>
		<from_code>995727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-oxydiethylene-2-benzothiazole sulfenamide</from_name>
		<from_code>1363711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Verticillium albo-atrum allergenic extract</from_name>
		<from_code>968467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cumin allergenic extract</from_name>
		<from_code>901365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit hair extract</from_name>
		<from_code>895527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white oak pollen extract</from_name>
		<from_code>852294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald-faced hornet venom protein</from_name>
		<from_code>1297525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern ragweed pollen extract</from_name>
		<from_code>885750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Corylus americana nut oil</from_name>
		<from_code>1603849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hard maple pollen extract</from_name>
		<from_code>851874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shagbark hickory pollen extract</from_name>
		<from_code>852221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whey protein hydrolysate</from_name>
		<from_code>2266754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black-eyed pea allergenic extract</from_name>
		<from_code>899490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nickel</from_name>
		<from_code>1311629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>live oak pollen extract</from_name>
		<from_code>867311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>northern pike allergenic extract</from_name>
		<from_code>889602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard greens allergenic extract</from_name>
		<from_code>899452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sardine allergenic extract</from_name>
		<from_code>974129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra extract</from_name>
		<from_code>1370435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allscale pollen extract</from_name>
		<from_code>897304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ash pollen extract</from_name>
		<from_code>1484982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt grass pollen extract</from_name>
		<from_code>852329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green olive allergenic extract</from_name>
		<from_code>971379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pollen extract</from_name>
		<from_code>897403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perennial rye grass pollen extract</from_name>
		<from_code>852819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pepper tree pollen extract</from_name>
		<from_code>852140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Garrys oak pollen extract</from_name>
		<from_code>900987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-cyclohexyl-2-benzothiazosulfenamide</from_name>
		<from_code>1306886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glaucum allergenic extract</from_name>
		<from_code>1986792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit extract</from_name>
		<from_code>124323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut extract</from_name>
		<from_code>1372248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. circinelloides allergenic extract</from_name>
		<from_code>2101422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lambs quarters pollen extract</from_name>
		<from_code>852237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skin Test Antigen [EPC]</from_name>
		<from_code>N0000184316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA</from_name>
		<from_code>350060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bahia grass pollen extract</from_name>
		<from_code>852673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western juniper pollen extract</from_name>
		<from_code>852589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phanerodontia chrysosporium allergenic extract</from_name>
		<from_code>968114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broccoli allergenic extract</from_name>
		<from_code>899386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt cedar pollen extract</from_name>
		<from_code>852806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oyster, unspecified preparation</from_name>
		<from_code>1315121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carob allergenic extract</from_name>
		<from_code>904498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellowfin tuna allergenic extract</from_name>
		<from_code>2102488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Italian rye grass pollen extract</from_name>
		<from_code>1014340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potato allergenic extract</from_name>
		<from_code>892632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sour cherry allergenic extract</from_name>
		<from_code>1012134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western larch pollen extract</from_name>
		<from_code>2166614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acrothecium robustum allergenic extract</from_name>
		<from_code>905088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP</from_name>
		<from_code>349980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canyon ragweed pollen extract</from_name>
		<from_code>851942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenylguanidine</from_name>
		<from_code>1368170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broad leaved paperbark pollen extract</from_name>
		<from_code>903913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Utah juniper pollen extract</from_name>
		<from_code>852597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humicola grisea allergenic extract</from_name>
		<from_code>1014391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western white pine pollen extract</from_name>
		<from_code>900743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cochliobolus spicifer allergenic extract</from_name>
		<from_code>995699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow hornet venom protein</from_name>
		<from_code>1297537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat hair extract</from_name>
		<from_code>895503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pacific halibut allergenic extract</from_name>
		<from_code>882469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut pollen extract</from_name>
		<from_code>852577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken feather extract</from_name>
		<from_code>894934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben calcium</from_name>
		<from_code>1867698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kidney bean allergenic extract</from_name>
		<from_code>891637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pinus cembroides pollen extract</from_name>
		<from_code>2590679</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linden pollen extract</from_name>
		<from_code>852070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>banana allergenic extract</from_name>
		<from_code>891830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylenediamine</from_name>
		<from_code>1362740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut allergenic extract</from_name>
		<from_code>891633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley extract</from_name>
		<from_code>1370766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra extract</from_name>
		<from_code>1370787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary grass pollen extract</from_name>
		<from_code>852697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Iris germanica var. florentina root extract</from_name>
		<from_code>1993233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lens scale pollen extract</from_name>
		<from_code>852096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>longleaf pine pollen extract</from_name>
		<from_code>1014360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dark leaved mugwort pollen extract</from_name>
		<from_code>896246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1)</from_name>
		<from_code>2722594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burweed marshelder pollen extract</from_name>
		<from_code>852551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lombardy poplar pollen extract</from_name>
		<from_code>852348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango extract</from_name>
		<from_code>1426332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hackberry pollen extract</from_name>
		<from_code>852324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pineapple extract</from_name>
		<from_code>1492174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bronopol</from_name>
		<from_code>1114345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine allergenic extract</from_name>
		<from_code>1011412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western yellow jacket venom protein</from_name>
		<from_code>1297535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nettle pollen extract</from_name>
		<from_code>852046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>littleseed canary grass pollen extract</from_name>
		<from_code>1098232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldibromo glutaronitrile</from_name>
		<from_code>1307044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald cypress pollen extract</from_name>
		<from_code>995747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sydney golden wattle pollen extract</from_name>
		<from_code>895365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cauliflower allergenic extract</from_name>
		<from_code>899661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American house dust mite allergenic extract</from_name>
		<from_code>1116977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil allergenic extract</from_name>
		<from_code>899444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Oregon ash pollen extract</from_name>
		<from_code>900045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Helminthosporium solani allergenic extract</from_name>
		<from_code>867232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mountain cedar pollen extract</from_name>
		<from_code>852581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrolyzed casein (enzymatic; 1000 MW)</from_name>
		<from_code>1812932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American elm pollen extract</from_name>
		<from_code>852054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cricket allergenic extract</from_name>
		<from_code>973447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma exigua var. exigua allergenic extract</from_name>
		<from_code>867284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lime allergenic extract</from_name>
		<from_code>1011060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pale dock pollen extract</from_name>
		<from_code>1232604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix lutea pollen extract</from_name>
		<from_code>2590686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl-p-hydroxybenzoate</from_name>
		<from_code>1362892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lawsonia inermis leaf extract</from_name>
		<from_code>1307699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horseradish allergenic extract</from_name>
		<from_code>1011043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocean perch preparation</from_name>
		<from_code>2471431</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>careless weed pollen extract</from_name>
		<from_code>851926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Schinus terebinthifolius pollen extract</from_name>
		<from_code>2590688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM</from_name>
		<from_code>317581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mulberry pollen extract</from_name>
		<from_code>899593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse hair extract</from_name>
		<from_code>1993210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed allergenic extract</from_name>
		<from_code>901203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goat milk allergenic extract</from_name>
		<from_code>862475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fremont cottonwood pollen extract</from_name>
		<from_code>852355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red mulberry pollen extract</from_name>
		<from_code>852680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedar elm pollen extract</from_name>
		<from_code>1014191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango allergenic extract</from_name>
		<from_code>1011404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia striiformis allergenic extract</from_name>
		<from_code>852311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice allergenic extract</from_name>
		<from_code>895552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fig allergenic extract</from_name>
		<from_code>973880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green bell pepper allergenic extract</from_name>
		<from_code>862478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisal fiber allergenic extract</from_name>
		<from_code>851882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn grain extract</from_name>
		<from_code>1423924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grama grass pollen extract</from_name>
		<from_code>852197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grape extract</from_name>
		<from_code>253172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jack pine pollen extract</from_name>
		<from_code>1014690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basil allergenic extract</from_name>
		<from_code>899355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben sodium</from_name>
		<from_code>1311574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Malus domestica pollen extract</from_name>
		<from_code>2593689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver ragweed pollen extract</from_name>
		<from_code>852306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat gluten extract</from_name>
		<from_code>1370781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitternut hickory pollen extract</from_name>
		<from_code>899645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamb allergenic extract</from_name>
		<from_code>971849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Epicoccum nigrum allergenic extract</from_name>
		<from_code>852466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Douglas fir pollen extract</from_name>
		<from_code>1098257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gliocladium viride extract</from_name>
		<from_code>2101008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raspberry extract</from_name>
		<from_code>1370769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clam allergenic extract</from_name>
		<from_code>892539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silk allergenic extract</from_name>
		<from_code>314455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef allergenic extract</from_name>
		<from_code>892599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common hazel pollen extract</from_name>
		<from_code>1484979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfalfa pollen extract</from_name>
		<from_code>852634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated rye grass pollen extract</from_name>
		<from_code>1014774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower pollen extract</from_name>
		<from_code>852509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Strychnos nux-vomica seed extract</from_name>
		<from_code>1309678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herring allergenic extract</from_name>
		<from_code>899434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Concord grape allergenic extract</from_name>
		<from_code>901191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poppy seed allergenic extract</from_name>
		<from_code>1011017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rattus norvegicus hair preparation</from_name>
		<from_code>2471704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canis lupus familiaris hair extract</from_name>
		<from_code>854025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creeping bentgrass pollen extract</from_name>
		<from_code>1094116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Passalora fulva allergenic extract</from_name>
		<from_code>883442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American basswood pollen extract</from_name>
		<from_code>995754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poverty weed pollen extract</from_name>
		<from_code>852539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crested dogstail pollen extract</from_name>
		<from_code>1484980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig hair extract</from_name>
		<from_code>895507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zucchini extract</from_name>
		<from_code>1649134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American cockroach allergenic extract</from_name>
		<from_code>905258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint allergenic extract</from_name>
		<from_code>901313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic mackerel allergenic extract</from_name>
		<from_code>2198984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tuna allergenic extract</from_name>
		<from_code>892503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylparaben</from_name>
		<from_code>29903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apis mellifera preparation</from_name>
		<from_code>285219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean allergenic extract</from_name>
		<from_code>891668</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS</from_name>
		<from_code>350081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium roquefortii allergenic extract</from_name>
		<from_code>972365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western waterhemp pollen extract</from_name>
		<from_code>851934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS</from_name>
		<from_code>350125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bulbous buttercup pollen extract</from_name>
		<from_code>1484985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dill allergenic extract</from_name>
		<from_code>975763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</from_name>
		<from_code>350160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quackgrass pollen extract</from_name>
		<from_code>852343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European aspen pollen extract</from_name>
		<from_code>2166596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ditiocarb, zinc salt</from_name>
		<from_code>1427192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa bean allergenic extract</from_name>
		<from_code>891721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sudan grass pollen extract</from_name>
		<from_code>1098455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saltbush pollen extract</from_name>
		<from_code>897316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fivehorn smotherweed pollen extract</from_name>
		<from_code>852124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed extract</from_name>
		<from_code>1309391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disperse blue 106</from_name>
		<from_code>1368171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog dander extract</from_name>
		<from_code>2167551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit allergenic extract</from_name>
		<from_code>899424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safflower seed extract</from_name>
		<from_code>1440241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton seed extract</from_name>
		<from_code>1309369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus repens allergenic extract</from_name>
		<from_code>1006310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia graminis allergenic extract</from_name>
		<from_code>999487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula mucilaginosa allergenic extract</from_name>
		<from_code>967529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanolin alcohols</from_name>
		<from_code>1426478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme allergenic extract</from_name>
		<from_code>974527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avocado allergenic extract</from_name>
		<from_code>895582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary feather extract</from_name>
		<from_code>894961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thimerosal</from_name>
		<from_code>10472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg white (chicken) allergenic extract</from_name>
		<from_code>892616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt</from_name>
		<from_code>1310300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quaternium-15</from_name>
		<from_code>283678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast live oak pollen extract</from_name>
		<from_code>852302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus var. oryzae protease</from_name>
		<from_code>1307040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syncephalastrum racemosum allergenic extract</from_name>
		<from_code>968506</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dogfennel pollen extract</from_name>
		<from_code>867218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>greasewood pollen extract</from_name>
		<from_code>852152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat pollen extract</from_name>
		<from_code>867361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodgepole pine pollen extract</from_name>
		<from_code>898324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valley oak pollen extract</from_name>
		<from_code>1111024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon preparation</from_name>
		<from_code>1421430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red snapper allergenic extract</from_name>
		<from_code>889646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish allergenic extract</from_name>
		<from_code>974687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian pepper tree pollen extract</from_name>
		<from_code>2632070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow pine pollen extract</from_name>
		<from_code>852716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buckwheat allergenic extract</from_name>
		<from_code>899394</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat flea allergenic extract</from_name>
		<from_code>886638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</from_name>
		<from_code>1440973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixocortol pivalate</from_name>
		<from_code>38336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose wheat smut allergenic extract</from_name>
		<from_code>968437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sea scallop preparation</from_name>
		<from_code>1426396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red bell pepper allergenic extract</from_name>
		<from_code>901329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shad scale pollen extract</from_name>
		<from_code>852087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kapok tree fiber allergenic extract</from_name>
		<from_code>852315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>largemouth bass allergenic extract</from_name>
		<from_code>1098183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian olive pollen extract</from_name>
		<from_code>852367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hypomyces perniciosus allergenic extract</from_name>
		<from_code>1192968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Carya laciniosa pollen extract</from_name>
		<from_code>1305551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
		<from_code>N0000185374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pepper extract</from_name>
		<from_code>1313692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lime (citrus) extract</from_name>
		<from_code>1305725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>winterfat pollen extract</from_name>
		<from_code>852613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white willow pollen extract</from_name>
		<from_code>1484986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pine pollen extract</from_name>
		<from_code>900754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>2102052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-chloro-2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow hair extract</from_name>
		<from_code>895488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium camemberti allergenic extract</from_name>
		<from_code>966943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pisum sativum (pea) extract</from_name>
		<from_code>1426912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper allergenic extract</from_name>
		<from_code>899363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oregano allergenic extract</from_name>
		<from_code>1010965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit skin extract</from_name>
		<from_code>895195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix repens pollen extract</from_name>
		<from_code>2533912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Indian wormwood sage pollen extract</from_name>
		<from_code>1006495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ustilago maydis extract</from_name>
		<from_code>1427134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia pollen extract</from_name>
		<from_code>851732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alnus glutinosa bark extract</from_name>
		<from_code>1441543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humulus lupulus pollen extract</from_name>
		<from_code>1740937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>1340182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
		<from_code>N0000184997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Colletotrichum coccodes allergenic extract</from_name>
		<from_code>1192729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern yellow jacket venom protein</from_name>
		<from_code>1297529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium sarciniforme allergenic extract</from_name>
		<from_code>968130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black willow pollen extract</from_name>
		<from_code>852162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sorghum bicolor pollen extract</from_name>
		<from_code>1311406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsam poplar pollen extract</from_name>
		<from_code>1014762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse hair extract</from_name>
		<from_code>895515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya allergenic extract</from_name>
		<from_code>1011426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neurospora sitophila allergenic extract</from_name>
		<from_code>1098200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>microsporum canis allergenic extract</from_name>
		<from_code>1014399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1)</from_name>
		<from_code>2722617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow sweet clover pollen extract</from_name>
		<from_code>1014447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>groundsel pollen extract</from_name>
		<from_code>897332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white hickory pollen extract</from_name>
		<from_code>852193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slash pine pollen extract</from_name>
		<from_code>900731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microascus brevicaulis allergenic extract</from_name>
		<from_code>1192992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic aldehyde</from_name>
		<from_code>1368153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint preparation</from_name>
		<from_code>33093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pignut hickory pollen extract</from_name>
		<from_code>899650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet potato allergenic extract</from_name>
		<from_code>901307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pumpkin allergenic extract</from_name>
		<from_code>883459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black carpenter ant allergenic extract</from_name>
		<from_code>2057909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wing scale pollen extract</from_name>
		<from_code>852074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white ash pollen extract</from_name>
		<from_code>852450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef liver allergenic extract</from_name>
		<from_code>972689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow fescue grass pollen extract</from_name>
		<from_code>851918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scrub pine pollen extract</from_name>
		<from_code>1013913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus nidulans allergenic extract</from_name>
		<from_code>1368357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspen pollen extract</from_name>
		<from_code>852339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean allergenic extract</from_name>
		<from_code>901291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amaranthus hybridus pollen extract</from_name>
		<from_code>1363561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California mugwort pollen extract</from_name>
		<from_code>892734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog skin extract</from_name>
		<from_code>852839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES</from_name>
		<from_code>350004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow birch pollen extract</from_name>
		<from_code>899550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German wasp venom protein</from_name>
		<from_code>1297531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acer pseudoplatanus pollen extract</from_name>
		<from_code>1801702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clonostachys rosea f. rosea allergenic extract</from_name>
		<from_code>1426481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut allergenic extract</from_name>
		<from_code>891611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl cinnamal</from_name>
		<from_code>1311606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tree of heaven pollen extract</from_name>
		<from_code>851890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern yellow jacket venom protein</from_name>
		<from_code>1297533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast maple pollen extract</from_name>
		<from_code>851736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oneseed juniper pollen extract</from_name>
		<from_code>900108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water oak pollen extract</from_name>
		<from_code>1013944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley allergenic extract</from_name>
		<from_code>862453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus glabra pollen extract</from_name>
		<from_code>2369372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated barley pollen extract</from_name>
		<from_code>1098118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Quercus marilandica pollen extract</from_name>
		<from_code>1437222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated mushroom allergenic extract</from_name>
		<from_code>901369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western wheatgrass pollen extract</from_name>
		<from_code>852659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red cedar pollen extract</from_name>
		<from_code>852609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant allergenic extract</from_name>
		<from_code>972601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>honeydew melon allergenic extract</from_name>
		<from_code>899476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golden chain pollen extract</from_name>
		<from_code>1996102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn extract</from_name>
		<from_code>1323308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster hair extract</from_name>
		<from_code>1594965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley allergenic extract</from_name>
		<from_code>899877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic allergenic extract</from_name>
		<from_code>899414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazolidinylurea</from_name>
		<from_code>1310602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-MERCAPTOBENZOTHIAZOLE</from_name>
		<from_code>1306880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic preparation</from_name>
		<from_code>265647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium digitatum allergenic extract</from_name>
		<from_code>1427044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern sycamore pollen extract</from_name>
		<from_code>852746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides farinae</from_name>
		<from_code>852810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber allergenic extract</from_name>
		<from_code>899738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit allergenic extract</from_name>
		<from_code>813859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated oat pollen extract</from_name>
		<from_code>852114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colonial bent grass pollen extract</from_name>
		<from_code>1484937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides pteronyssinus</from_name>
		<from_code>852826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tabanus nigrovittatus extract</from_name>
		<from_code>2590185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redwood pollen extract</from_name>
		<from_code>1014707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>box elder maple pollen extract</from_name>
		<from_code>851740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed extract</from_name>
		<from_code>1310046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brown rice preparation</from_name>
		<from_code>1311040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shrimp allergenic extract</from_name>
		<from_code>892592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>para grass pollen extract</from_name>
		<from_code>894750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint flowering top extract</from_name>
		<from_code>2168421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pin oak pollen extract</from_name>
		<from_code>900999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. lusitanicus allergenic extract</from_name>
		<from_code>2101473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed allergenic extract</from_name>
		<from_code>901199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black sea bass allergenic extract</from_name>
		<from_code>2102474</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant ragweed pollen extract</from_name>
		<from_code>851998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date palm pollen extract</from_name>
		<from_code>852704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gambels oak pollen extract</from_name>
		<from_code>852276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plains cottonwood pollen extract</from_name>
		<from_code>867297</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cow milk allergenic extract</from_name>
		<from_code>892665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lobster allergenic extract</from_name>
		<from_code>892561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broomweed pollen extract</from_name>
		<from_code>1094193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syringa vulgaris pollen extract</from_name>
		<from_code>2634236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish extract</from_name>
		<from_code>1314656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red alder pollen extract</from_name>
		<from_code>851914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut allergenic extract</from_name>
		<from_code>891695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white (mexican) dock pollen extract</from_name>
		<from_code>1014743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epidermophyton floccosum allergenic extract</from_name>
		<from_code>995707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog flea allergenic extract</from_name>
		<from_code>886637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European house dust mite allergenic extract</from_name>
		<from_code>1116979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry birch pollen extract</from_name>
		<from_code>852144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsnip allergenic extract</from_name>
		<from_code>1011027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pyrethrum cinerariifolium allergenic extract</from_name>
		<from_code>967970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acremonium strictum allergenic extract</from_name>
		<from_code>905070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black oak pollen extract</from_name>
		<from_code>852260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parthenolide</from_name>
		<from_code>32941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora tarda allergenic extract</from_name>
		<from_code>852404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burning bush pollen extract</from_name>
		<from_code>852593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codfish allergenic extract</from_name>
		<from_code>892543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg allergenic extract</from_name>
		<from_code>891652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliocladium allergenic extract</from_name>
		<from_code>1192997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus globulus pollen extract</from_name>
		<from_code>852386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mexican tea pollen extract</from_name>
		<from_code>897391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rat skin extract</from_name>
		<from_code>895279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma destructiva allergenic extract</from_name>
		<from_code>966995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cootamundra wattle pollen extract</from_name>
		<from_code>895353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common wasp venom protein</from_name>
		<from_code>1297527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desert ragweed pollen extract</from_name>
		<from_code>851981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef liver preparation</from_name>
		<from_code>1330085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cucumis sativus fruit extract</from_name>
		<from_code>2700058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>licorice root extract</from_name>
		<from_code>235524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>swordfish allergenic extract</from_name>
		<from_code>901283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma harzianum allergenic extract</from_name>
		<from_code>968197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lima bean allergenic extract</from_name>
		<from_code>891641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cola acuminata seed extract</from_name>
		<from_code>1307595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tomato allergenic extract</from_name>
		<from_code>892499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English oak pollen extract</from_name>
		<from_code>1484984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leek allergenic extract</from_name>
		<from_code>1010932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arroyo willow pollen extract</from_name>
		<from_code>852170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cod, unspecified preparation</from_name>
		<from_code>1426437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem oak pollen extract</from_name>
		<from_code>1014766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carrot allergenic extract</from_name>
		<from_code>892368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1352501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger allergenic extract</from_name>
		<from_code>899420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>veal allergenic extract</from_name>
		<from_code>1012026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse dander extract</from_name>
		<from_code>2167548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian balsam</from_name>
		<from_code>33219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prairie sagebrush pollen extract</from_name>
		<from_code>867142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American lobster allergenic extract</from_name>
		<from_code>1997187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microsporum audouinii allergenic extract</from_name>
		<from_code>1014395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Australian pine pollen extract</from_name>
		<from_code>852229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat allergenic extract</from_name>
		<from_code>971932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oyster allergenic extract</from_name>
		<from_code>973274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chocolate allergenic extract</from_name>
		<from_code>1010915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rough marshelder pollen extract</from_name>
		<from_code>852532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chinquapin oak pollen extract</from_name>
		<from_code>2167695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
		<from_code>N0000185369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein allergenic extract</from_name>
		<from_code>862460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese black pine pollen extract</from_name>
		<from_code>900777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass smut allergenic extract</from_name>
		<from_code>852128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium expansum allergenic extract</from_name>
		<from_code>967111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geraniol</from_name>
		<from_code>1368875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck feather extract</from_name>
		<from_code>892851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine bush pollen extract</from_name>
		<from_code>851894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bean extract</from_name>
		<from_code>1370773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2'-dithiobisbenzothiazole</from_name>
		<from_code>1306112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit bush pollen extract</from_name>
		<from_code>851969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant extract</from_name>
		<from_code>1315116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brazil nut allergenic extract</from_name>
		<from_code>891514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton tonsurans allergenic extract</from_name>
		<from_code>1098619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trout allergenic extract</from_name>
		<from_code>882482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>weakleaf bur ragweed pollen extract</from_name>
		<from_code>1117083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus lunatus allergenic extract</from_name>
		<from_code>852264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion allergenic extract</from_name>
		<from_code>899466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2-bis(4-glycidyloxyphenyl)propane</from_name>
		<from_code>1368138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey feather extract</from_name>
		<from_code>1594963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haematonectria haematococca allergenic extract</from_name>
		<from_code>852503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf plantain pollen extract</from_name>
		<from_code>1484983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Platycladus orientalis pollen extract</from_name>
		<from_code>1360623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra root powder extract</from_name>
		<from_code>2711885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Callistemon citrinus pollen extract</from_name>
		<from_code>2171260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-tert-butylphenol-formaldehyde resin (low molecular weight)</from_name>
		<from_code>1427189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue crab preparation</from_name>
		<from_code>1315126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger var. niger extract</from_name>
		<from_code>854082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor racemosus allergenic extract</from_name>
		<from_code>852687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey allergenic extract</from_name>
		<from_code>975119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida tropicalis allergenic extract</from_name>
		<from_code>967033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Blatta orientalis preparation</from_name>
		<from_code>1346617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoeugenol</from_name>
		<from_code>1363706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rocky Mountain juniper pollen extract</from_name>
		<from_code>852601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidurea</from_name>
		<from_code>1368885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster skin extract</from_name>
		<from_code>852663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciltacabtagene autoleucel</from_name>
		<from_code>2594775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitch pine pollen extract</from_name>
		<from_code>900758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus rubra pollen allergenic extract</from_name>
		<from_code>1426632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>London planetree</from_name>
		<from_code>2166616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Geotrichum candidum allergenic extract</from_name>
		<from_code>999463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium solani allergenic extract</from_name>
		<from_code>867349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut pollen extract</from_name>
		<from_code>852569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet wormwood pollen extract</from_name>
		<from_code>2167819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharomyces cerevisiae allergenic extract</from_name>
		<from_code>350141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raspberry allergenic extract</from_name>
		<from_code>899906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant wild rye pollen extract</from_name>
		<from_code>900148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow dock pollen extract</from_name>
		<from_code>852209</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia dealbata pollen extract</from_name>
		<from_code>2202946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American chestnut allergenic extract</from_name>
		<from_code>891752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose barley smut allergenic extract</from_name>
		<from_code>968492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon allergenic extract</from_name>
		<from_code>899673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white mulberry pollen extract</from_name>
		<from_code>852669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loblolly pine pollen extract</from_name>
		<from_code>900770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic salmon allergenic extract</from_name>
		<from_code>900031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparagus allergenic extract</from_name>
		<from_code>891796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plum allergenic extract</from_name>
		<from_code>899470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cashew nut allergenic extract</from_name>
		<from_code>892526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella zeae allergenic extract</from_name>
		<from_code>1922751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Khuskia oryzae allergenic extract</from_name>
		<from_code>892338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella fujikuroi extract</from_name>
		<from_code>2043450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pekoe tea allergenic extract</from_name>
		<from_code>966696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape allergenic extract</from_name>
		<from_code>892317</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern cottonwood pollen extract</from_name>
		<from_code>852363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red imported fire ant allergenic extract</from_name>
		<from_code>867341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mung bean allergenic extract</from_name>
		<from_code>891647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stachybotrys chartarum allergenic extract</from_name>
		<from_code>968123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California juniper pollen extract</from_name>
		<from_code>852585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N,N'-diphenyl-4-phenylenediamine</from_name>
		<from_code>1363709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black imported fire ant allergenic extract</from_name>
		<from_code>995738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>river birch pollen extract</from_name>
		<from_code>852148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabbage allergenic extract</from_name>
		<from_code>899398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western sycamore pollen extract</from_name>
		<from_code>852750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitter dock pollen extract</from_name>
		<from_code>1014739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic cod allergenic extract</from_name>
		<from_code>900025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Periplaneta australasiae extract</from_name>
		<from_code>2590183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit peel extract</from_name>
		<from_code>1358897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum extract</from_name>
		<from_code>852617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut pollen extract</from_name>
		<from_code>852281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common cocklebur pollen extract</from_name>
		<from_code>902215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue beech pollen extract</from_name>
		<from_code>899611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Siberian elm pollen extract</from_name>
		<from_code>1299981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptomyces griseus allergenic extract</from_name>
		<from_code>1314592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apiospora montagnei allergenic extract</from_name>
		<from_code>1006258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watercress allergenic extract</from_name>
		<from_code>1011418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venison allergenic extract</from_name>
		<from_code>882488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxycitronellal</from_name>
		<from_code>1362893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc dibutyldithiocarbamate</from_name>
		<from_code>1426942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watermelon allergenic extract</from_name>
		<from_code>901258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora betae allergenic extract</from_name>
		<from_code>852756</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white alder pollen extract</from_name>
		<from_code>851910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape extract</from_name>
		<from_code>1307718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem artichoke extract</from_name>
		<from_code>1648701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben</from_name>
		<from_code>34706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Grindelia ciliata pollen extract</from_name>
		<from_code>2043451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bluefish allergenic extract</from_name>
		<from_code>892181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona ash pollen extract</from_name>
		<from_code>852496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avocado oil</from_name>
		<from_code>1311611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perch allergenic extract</from_name>
		<from_code>976711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora herbarum allergenic extract</from_name>
		<from_code>971198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic halibut allergenic extract</from_name>
		<from_code>2261370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dendryphiella vinosa allergenic extract</from_name>
		<from_code>995703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bay leaf extract</from_name>
		<from_code>1606480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orchard grass pollen extract</from_name>
		<from_code>851878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine carbamate</from_name>
		<from_code>2375923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watermelon preparation</from_name>
		<from_code>260014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS</from_name>
		<from_code>350075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton rubrum allergenic extract</from_name>
		<from_code>968413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strawberry allergenic extract</from_name>
		<from_code>892484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slender ragweed pollen extract</from_name>
		<from_code>851990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet gum pollen extract</from_name>
		<from_code>852627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Scotch pine pollen extract</from_name>
		<from_code>900764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus amstelodami extract</from_name>
		<from_code>2101007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway seed allergenic extract</from_name>
		<from_code>899637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jute fiber allergenic extract</from_name>
		<from_code>852412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage leaf allergenic extract</from_name>
		<from_code>1011627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cottonwood pollen extract</from_name>
		<from_code>852376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Leucanthemum vulgare pollen</from_name>
		<from_code>2102006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goose feather extract</from_name>
		<from_code>894783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>algal fungi allergenic extract</from_name>
		<from_code>966692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorquinaldol</from_name>
		<from_code>2407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alkali blite pollen extract</from_name>
		<from_code>852106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Calocedrus decurrens pollen extract</from_name>
		<from_code>2670160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut allergenic extract</from_name>
		<from_code>891658</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vitis vinifera pollen extract</from_name>
		<from_code>2669695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German cockroach allergenic extract</from_name>
		<from_code>905276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>annual bluegrass pollen extract</from_name>
		<from_code>898404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English plantain pollen extract</from_name>
		<from_code>852742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper preparation</from_name>
		<from_code>259314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bur oak pollen extract</from_name>
		<from_code>900991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse skin extract</from_name>
		<from_code>852693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burrobrush pollen extract</from_name>
		<from_code>852526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean extract</from_name>
		<from_code>2275721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvetleaf huckleberry allergenic extract</from_name>
		<from_code>2102487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crab allergenic extract</from_name>
		<from_code>892610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck allergenic extract</from_name>
		<from_code>972037</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiram</from_name>
		<from_code>10517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheasant feather extract</from_name>
		<from_code>1594964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western black willow pollen extract</from_name>
		<from_code>1014755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern white pine pollen extract</from_name>
		<from_code>852738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salsola tragus pollen extract</from_name>
		<from_code>1314927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pear preparation</from_name>
		<from_code>1367125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf cattail pollen extract</from_name>
		<from_code>1232637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grain sorghum pollen extract</from_name>
		<from_code>1098438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-cyclohexyl-N'-phenyl-1,4-phenylenediamine</from_name>
		<from_code>1427136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg extract</from_name>
		<from_code>1353217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mongolian gerbil skin allergenic extract</from_name>
		<from_code>895070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinach allergenic extract</from_name>
		<from_code>901317</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass smut allergenic extract</from_name>
		<from_code>1014385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, CAMEL</from_name>
		<from_code>314336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobacco leaf allergenic extract</from_name>
		<from_code>852062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut allergenic extract</from_name>
		<from_code>891687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brussels sprout allergenic extract</from_name>
		<from_code>899390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tuberculosis Skin Test [EPC]</from_name>
		<from_code>N0000184315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosin</from_name>
		<from_code>1362931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium chrysogenum var. chrysogenum allergenic extract</from_name>
		<from_code>854130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pistachio nut allergenic extract</from_name>
		<from_code>904606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squash allergenic extract</from_name>
		<from_code>975509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard pollen extract</from_name>
		<from_code>852205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cytisus scoparius flowering top extract</from_name>
		<from_code>2168418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-mercaptobenzothiazole</from_name>
		<from_code>1358845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>string bean allergenic extract</from_name>
		<from_code>891676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk (chicken) allergenic extract</from_name>
		<from_code>892620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Koelers grass pollen extract</from_name>
		<from_code>852605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red maple pollen extract</from_name>
		<from_code>851744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian thistle pollen extract</from_name>
		<from_code>852158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetramethylthiuram monosulfide</from_name>
		<from_code>1363713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamyl alcohol</from_name>
		<from_code>1362889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>northern quahog preparation</from_name>
		<from_code>1925437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia longifolia pollen extract</from_name>
		<from_code>853983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lettuce allergenic extract</from_name>
		<from_code>899448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green ash pollen extract</from_name>
		<from_code>852491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Brazilian pepper tree pollen extract</from_name>
		<from_code>2632068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flounder allergenic extract</from_name>
		<from_code>899746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium cladosporioides extract</from_name>
		<from_code>867198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvet grass pollen extract</from_name>
		<from_code>852514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Solidago virgaurea pollen extract</from_name>
		<from_code>1309242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium italicum allergenic extract</from_name>
		<from_code>967960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine extract</from_name>
		<from_code>1426364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra allergenic extract</from_name>
		<from_code>1011021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken allergenic extract</from_name>
		<from_code>892653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black oak pollen extract</from_name>
		<from_code>1014721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osage orange pollen extract</from_name>
		<from_code>1098189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast sage pollen extract</from_name>
		<from_code>852011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white sweet clover pollen extract</from_name>
		<from_code>1014735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Paecilomyces variotii allergenic extract</from_name>
		<from_code>966979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>queen palm pollen extract</from_name>
		<from_code>867353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil seed extract</from_name>
		<from_code>1426921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butylparaben</from_name>
		<from_code>1306937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipentamethylenethiuram disulfide</from_name>
		<from_code>1426773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pork allergenic extract</from_name>
		<from_code>892628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium compactum allergenic extract</from_name>
		<from_code>999457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed extract</from_name>
		<from_code>853406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black locust pollen extract</from_name>
		<from_code>867325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig skin extract</from_name>
		<from_code>852298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver birch pollen allergenic extract</from_name>
		<from_code>1306108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turnip allergenic extract</from_name>
		<from_code>883414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic halibut preparation</from_name>
		<from_code>1424920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parakeet feather allergenic extract</from_name>
		<from_code>1192987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cell-mediated Immunity [PE]</to_name>
		<to_code>N0000184306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Complement Activity [PE]</to_name>
		<to_code>N0000009264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Kallidin Activity [PE]</to_name>
		<to_code>N0000009364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Kinin Activity [PE]</to_name>
		<to_code>N0000009367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000009080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Biogenic Amine Activity [PE]</to_name>
		<to_code>N0000009354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea preparation</from_name>
		<from_code>228041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps skin test antigen</from_name>
		<from_code>89854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole phosphate</from_name>
		<from_code>1535214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zalcitabine</from_name>
		<from_code>3363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole hydrochloride</from_name>
		<from_code>227227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole</from_name>
		<from_code>6371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfuvirtide</from_name>
		<from_code>139896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antirabies serum,equine</from_name>
		<from_code>485234</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologically Active Molecule Activity Alteration [PE]</from_name>
		<from_code>N0000009074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000009357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Eicosanoid Activity [PE]</to_name>
		<to_code>N0000009284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000009376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000009521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Activity [PE]</from_name>
		<from_code>N0000009284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000009526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Activity [PE]</from_name>
		<from_code>N0000009284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Leukotriene Activity [PE]</to_name>
		<to_code>N0000009373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Eicosanoid Activity [PE]</from_name>
		<from_code>N0000009284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafluprost</from_name>
		<from_code>1244607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000009526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimatoprost</from_name>
		<from_code>283810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000009526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000009526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>misoprostol</from_name>
		<from_code>42331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000009526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000009526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000009521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000009521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epcoritamab</from_name>
		<from_code>2637392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talquetamab</from_name>
		<from_code>2644447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp</from_name>
		<from_code>2590743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab</from_name>
		<from_code>2719416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elranatamab</from_name>
		<from_code>2644880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elranatamab-bcmm</from_name>
		<from_code>2644881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiquimod</from_name>
		<from_code>59943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab-gcpt</from_name>
		<from_code>2719477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talquetamab-tgvs</from_name>
		<from_code>2644448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tebentafusp-tebn</from_name>
		<from_code>2590744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cytokine Activity [PE]</to_name>
		<to_code>N0000009267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5)</from_name>
		<from_code>2664725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, attenuated Schwarz strain</from_name>
		<from_code>2603499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ROTAVIRUS VACCINE, LIVE</from_name>
		<from_code>253199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</from_name>
		<from_code>2380835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 3 (Saukett)</from_name>
		<from_code>763100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A vaccine (inactivated) strain HM175</from_name>
		<from_code>798361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/7/2009 (H1N1) antigen</from_name>
		<from_code>1657331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live vaccinia virus</from_name>
		<from_code>833079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</from_name>
		<from_code>2048564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</from_name>
		<from_code>854932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen</from_name>
		<from_code>2562555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Panama/45/90 antigen</from_name>
		<from_code>2262062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen</from_name>
		<from_code>2605723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen</from_name>
		<from_code>2561244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</from_name>
		<from_code>2380834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</from_name>
		<from_code>2380837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen</from_name>
		<from_code>2642276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</from_name>
		<from_code>1928290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</from_name>
		<from_code>854968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 2 (MEF-1)</from_name>
		<from_code>763098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Iowa/06/2017 antigen</from_name>
		<from_code>2056523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein</from_name>
		<from_code>2468231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H3N2) antigen</from_name>
		<from_code>1657131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</from_name>
		<from_code>1427171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</from_name>
		<from_code>1794331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</from_name>
		<from_code>854964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/9/2014 antigen</from_name>
		<from_code>1723997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</from_name>
		<from_code>1664172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</from_name>
		<from_code>854972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, RIT-4385 strain</from_name>
		<from_code>2603501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/46/2015 antigen</from_name>
		<from_code>1942125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/WUH4618/2021 antigen</from_name>
		<from_code>2605725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PERTUSSIS VACCINE,ADSORBED</from_name>
		<from_code>402543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle</from_name>
		<from_code>1601236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</from_name>
		<from_code>2180337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</from_name>
		<from_code>854934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</from_name>
		<from_code>854930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen</from_name>
		<from_code>2562553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</from_name>
		<from_code>1301885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</from_name>
		<from_code>854958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hong Kong/259/2010 antigen</from_name>
		<from_code>1801603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</from_name>
		<from_code>1427020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</from_name>
		<from_code>2379530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen</from_name>
		<from_code>2605724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen</from_name>
		<from_code>2607735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</from_name>
		<from_code>1657127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 33 vaccine</from_name>
		<from_code>1596931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1)</from_name>
		<from_code>2722424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</from_name>
		<from_code>2056521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform M), recombinant</from_name>
		<from_code>2588218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen</from_name>
		<from_code>2630221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cholera Vaccine</from_name>
		<from_code>2427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</from_name>
		<from_code>1657222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360571</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 7 vaccine live</from_name>
		<from_code>1099937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</from_name>
		<from_code>1663630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</from_name>
		<from_code>1301887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</from_name>
		<from_code>1928289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform L), recombinant</from_name>
		<from_code>2588217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</from_name>
		<from_code>854940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</from_name>
		<from_code>1666421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria antitoxin</from_name>
		<from_code>3510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</from_name>
		<from_code>2180338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</from_name>
		<from_code>2380574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</from_name>
		<from_code>2177291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus antigen</from_name>
		<from_code>1657134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E, recombinant</from_name>
		<from_code>1986820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/60/2008 antigen</from_name>
		<from_code>1657226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vibrio cholerae CVD 103-HGR strain live antigen</from_name>
		<from_code>1812935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>equine diphtheria antitoxin</from_name>
		<from_code>91602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1)</from_name>
		<from_code>2722617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus</from_name>
		<from_code>1491862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1)</from_name>
		<from_code>2722594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen</from_name>
		<from_code>2694005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</from_name>
		<from_code>1657224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hepatitis A Vaccine, Inactivated</from_name>
		<from_code>253174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Michigan/01/2021 antigen</from_name>
		<from_code>2593400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E</from_name>
		<from_code>1986821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform S), recombinant</from_name>
		<from_code>2588219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</from_name>
		<from_code>1664339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Phuket/3073/2013 antigen</from_name>
		<from_code>1657228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</from_name>
		<from_code>854942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Darwin/7/2019 antigen</from_name>
		<from_code>2380838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</from_name>
		<from_code>854950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group Y</from_name>
		<from_code>314725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</from_name>
		<from_code>2177290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 31 vaccine</from_name>
		<from_code>1596930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bacillus anthracis strain V770-NP1-R antigens</from_name>
		<from_code>1368371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/122/2022 (H3N2) antigen</from_name>
		<from_code>2675569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 52 vaccine</from_name>
		<from_code>1596933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</from_name>
		<from_code>854956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</from_name>
		<from_code>854944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</from_name>
		<from_code>1666425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5)</from_name>
		<from_code>2664825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>798279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</from_name>
		<from_code>2685002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain</from_name>
		<from_code>1005929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</from_name>
		<from_code>854952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group C polysaccharide</from_name>
		<from_code>29503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen</from_name>
		<from_code>2688113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen</from_name>
		<from_code>1601231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen</from_name>
		<from_code>1593127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</from_name>
		<from_code>854936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</from_name>
		<from_code>854970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Austria/1359417/2021 antigen</from_name>
		<from_code>2605039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</from_name>
		<from_code>2379531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen</from_name>
		<from_code>2687714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen</from_name>
		<from_code>2719300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</from_name>
		<from_code>1664171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</from_name>
		<from_code>1801767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</from_name>
		<from_code>2380836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</from_name>
		<from_code>854948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H1N1) antigen</from_name>
		<from_code>1657128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen</from_name>
		<from_code>2645084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen</from_name>
		<from_code>2605083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</from_name>
		<from_code>2280296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen</from_name>
		<from_code>2720359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain</from_name>
		<from_code>1006250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group B vaccine</from_name>
		<from_code>1593128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen</from_name>
		<from_code>2562554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen</from_name>
		<from_code>2641877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 3</from_name>
		<from_code>2197292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</from_name>
		<from_code>1300779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anthrax Vaccine Adsorbed</from_name>
		<from_code>404774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</from_name>
		<from_code>854960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 2</from_name>
		<from_code>2197291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen</from_name>
		<from_code>2717943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 4 vaccine live</from_name>
		<from_code>1099933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine, inactivated</from_name>
		<from_code>845525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</from_name>
		<from_code>854946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 58 vaccine</from_name>
		<from_code>1596934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen</from_name>
		<from_code>2641622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Washington/02/2019 antigen</from_name>
		<from_code>2280293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen</from_name>
		<from_code>2686166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</from_name>
		<from_code>854938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group W-135</from_name>
		<from_code>314724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live, New York City Board of Health vaccinia strain</from_name>
		<from_code>798467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen</from_name>
		<from_code>2708995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 1</from_name>
		<from_code>2197290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</from_name>
		<from_code>1657130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</from_name>
		<from_code>854974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen</from_name>
		<from_code>1601233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen</from_name>
		<from_code>1593130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</from_name>
		<from_code>854966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</from_name>
		<from_code>2056525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 1 (Mahoney)</from_name>
		<from_code>763096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Utah/9/2014 antigen</from_name>
		<from_code>1657133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvalent Crotalidae antivenin</from_name>
		<from_code>91596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 45 vaccine</from_name>
		<from_code>1596932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen</from_name>
		<from_code>2593854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen</from_name>
		<from_code>1601232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</from_name>
		<from_code>854954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</from_name>
		<from_code>1663632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</from_name>
		<from_code>1946964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 4</from_name>
		<from_code>2197293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Colorado/06/2017 antigen</from_name>
		<from_code>2054177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus strain CR 326F antigen, inactivated</from_name>
		<from_code>2274413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Maryland/15/2016 antigen</from_name>
		<from_code>2048563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</from_name>
		<from_code>1928528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen</from_name>
		<from_code>2479040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</from_name>
		<from_code>854962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Victoria/705/2018 antigen</from_name>
		<from_code>2380575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Antibody Activity [PE]</to_name>
		<to_code>N0000009086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Kinin Activity [PE]</from_name>
		<from_code>N0000009367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Bradykinin Activity [PE]</to_name>
		<to_code>N0000009118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Biogenic Amine Activity [PE]</from_name>
		<from_code>N0000009354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Immunologically Active Biogenic Amine Activity [PE]</from_name>
		<from_code>N0000009354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Activity [PE]</to_name>
		<to_code>N0000009351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Serotonin Activity [PE]</from_name>
		<from_code>N0000009585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Serotonin Activity [PE]</from_name>
		<from_code>N0000009585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Serotonin Activity [PE]</from_name>
		<from_code>N0000009585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Muscular System Serotonin Activity [PE]</to_name>
		<to_code>N0000009447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone</from_name>
		<from_code>1827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine</from_name>
		<from_code>4637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone</from_name>
		<from_code>2672253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Activity Alteration [PE]</from_name>
		<from_code>N0000009844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol hydrochloride</from_name>
		<from_code>82110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine hydrobromide</from_name>
		<from_code>860693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol</from_name>
		<from_code>10689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone hydrochloride</from_name>
		<from_code>2672254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Serotonin Activity [PE]</to_name>
		<to_code>N0000009585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000009142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Midbrain Serotonin Activity [PE]</to_name>
		<to_code>N0000009420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Spinal Cord Serotonin Activity [PE]</to_name>
		<to_code>N0000009638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebellum Serotonin Activity [PE]</to_name>
		<to_code>N0000009221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Serotonin Activity [PE]</to_name>
		<to_code>N0000009244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran</from_name>
		<from_code>588250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone</from_name>
		<from_code>1086769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran hydrochloride</from_name>
		<from_code>30003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone hydrochloride</from_name>
		<from_code>1086768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000009142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000009142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000009142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000009142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000009142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sensory-Somatic Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Enteric Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Autonomic Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000009110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000009491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000009110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000009686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Parasympathetic Activity [PE]</from_name>
		<from_code>N0000175649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000009491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000009686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Serotonin Activity [PE]</from_name>
		<from_code>N0000009447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Striated Muscle Serotonin Activity [PE]</to_name>
		<to_code>N0000009662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Serotonin Activity [PE]</from_name>
		<from_code>N0000009447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Smooth Muscle Serotonin Activity [PE]</to_name>
		<to_code>N0000009611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Serotonin Activity [PE]</from_name>
		<from_code>N0000009447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cardiac Muscle Serotonin Activity [PE]</to_name>
		<to_code>N0000009169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Histamine Activity [PE]</from_name>
		<from_code>N0000009351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Peripheral Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000009508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Histamine Activity [PE]</from_name>
		<from_code>N0000009351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000009192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Histamine Activity [PE]</from_name>
		<from_code>N0000009351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Muscular System Histamine Activity [PE]</to_name>
		<to_code>N0000009441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Activity Alteration [PE]</from_name>
		<from_code>N0000009071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Activity [PE]</to_name>
		<to_code>N0000009351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Activity [PE]</to_name>
		<to_code>N0000009351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Enteric Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000009308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sensory-Somatic Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000009577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Autonomic Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000009104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000009485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000009680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Parasympathetic Activity [PE]</from_name>
		<from_code>N0000175649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000009485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000009680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Histamine Activity [PE]</to_name>
		<to_code>N0000009136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Spinal Cord Histamine Activity [PE]</to_name>
		<to_code>N0000009632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Midbrain Histamine Activity [PE]</to_name>
		<to_code>N0000009414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebellum Histamine Activity [PE]</to_name>
		<to_code>N0000009215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000009192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Histamine Activity [PE]</to_name>
		<to_code>N0000009238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Histamine Activity [PE]</from_name>
		<from_code>N0000009441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Smooth Muscle Histamine Activity [PE]</to_name>
		<to_code>N0000009605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Histamine Activity [PE]</from_name>
		<from_code>N0000009441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cardiac Muscle Histamine Activity [PE]</to_name>
		<to_code>N0000009163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Histamine Activity [PE]</from_name>
		<from_code>N0000009441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Striated Muscle Histamine Activity [PE]</to_name>
		<to_code>N0000009656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tremelimumab</from_name>
		<from_code>2619313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab-gcpt</from_name>
		<from_code>2719477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipilimumab</from_name>
		<from_code>1094833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axicabtagene ciloleucel</from_name>
		<from_code>1987398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</from_name>
		<from_code>1440973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisagenlecleucel</from_name>
		<from_code>1986438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab</from_name>
		<from_code>2719416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab-rmbw</from_name>
		<from_code>2596772</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrolyzed casein (enzymatic; 1000 MW)</from_name>
		<from_code>1812932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lymphocyte Activation [PE]</from_name>
		<from_code>N0000178328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relatlimab</from_name>
		<from_code>2596773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab-gxbm</from_name>
		<from_code>2639781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD22-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000193617</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inotuzumab ozogamicin</to_name>
		<to_code>1942950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD22-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000193617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoconjugates</to_name>
		<to_code>M0028142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000193617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD22-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000193617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific HER2-directed Antibody [EPC]</from_name>
		<from_code>N0000194137</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zanidatamab</to_name>
		<to_code>2698198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
		<to_code>N0000194137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antibody (substance)</from_name>
		<from_code>68498002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
		<to_code>N0000194137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antibody (product)</from_name>
		<from_code>768606008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
		<to_code>N0000194137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nirsevimab</to_name>
		<to_code>2642401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clesrovimab</to_name>
		<to_code>2716802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000175623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palivizumab</to_name>
		<to_code>194279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
		<to_code>N0000175623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antibody to Respiratory syncytial virus (substance)</from_name>
		<from_code>120709004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
		<to_code>N0000175623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
		<to_code>N0000175623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</from_name>
		<from_code>2685002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab</from_name>
		<from_code>2716802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palivizumab</from_name>
		<from_code>194279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab-cfor</from_name>
		<from_code>2716803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirsevimab</from_name>
		<from_code>2642401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized</from_name>
		<from_code>2642138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, recombinant</from_name>
		<from_code>2636588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</from_name>
		<from_code>2685002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirsevimab-alip</from_name>
		<from_code>2642402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein</from_name>
		<from_code>2636589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized</from_name>
		<from_code>2642139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palivizumab</from_name>
		<from_code>194279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Syncytial Virus Infections</to_name>
		<to_code>M0027589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Humanized Monoclonal Antibody Fragment [EPC]</from_name>
		<from_code>N0000191873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal, Humanized</to_name>
		<to_code>M0556300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Humanized Monoclonal Antibody Fragment [EPC]</from_name>
		<from_code>N0000191873</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idarucizumab</to_name>
		<to_code>1716191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunoglobulin fragment (substance)</from_name>
		<from_code>399798000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
		<to_code>N0000191873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
		<to_code>N0000191873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
		<to_code>N0000191873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
		<to_code>N0000191873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarucizumab</from_name>
		<from_code>1716191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal, Humanized</to_name>
		<to_code>M0556300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab</from_name>
		<from_code>1876366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal, Humanized</to_name>
		<to_code>M0556300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atezolizumab</from_name>
		<from_code>1792776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal, Humanized</to_name>
		<to_code>M0556300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal, Humanized</to_name>
		<to_code>M0556300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Antivenom (substance)</to_name>
		<to_code>398809003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus adamanteus antivenin</to_name>
		<to_code>885185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus atrox antivenin</to_name>
		<to_code>885187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Latrodectus mactans antivenin</to_name>
		<to_code>89887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus scutulatus antivenin</to_name>
		<to_code>885189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agkistrodon piscivorus antivenin</to_name>
		<to_code>885183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing antivenom (product)</to_name>
		<to_code>16131008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antivenin [EPC]</from_name>
		<from_code>N0000184162</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centruroides (scorpion) immune F(ab')2 (equine)</to_name>
		<to_code>1119986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antivenin [EPC]</to_name>
		<to_code>N0000184162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Centruroides (scorpion) immune F(ab')2 (equine)</from_name>
		<from_code>1119986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antivenins</to_name>
		<to_code>M0001517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD33-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000175571</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemtuzumab ozogamicin</to_name>
		<to_code>1294580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000175571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD33-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000175571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-2 Receptor Blocking Antibody [EPC]</from_name>
		<from_code>N0000175622</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>basiliximab</to_name>
		<to_code>196102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
		<to_code>N0000175622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
		<to_code>N0000175622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
		<to_code>N0000175622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
		<to_code>N0000175622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD30-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000182967</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brentuximab vedotin</to_name>
		<to_code>1147320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD30-directed Immunoconjugate [EPC]</from_name>
		<from_code>N0000182967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoconjugates</to_name>
		<to_code>M0028142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD30-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000182967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD30-directed Immunoconjugate [EPC]</to_name>
		<to_code>N0000182967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</from_name>
		<from_code>N0000194038</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ansuvimab</to_name>
		<to_code>2472152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
		<to_code>N0000194038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
		<to_code>N0000194038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
		<to_code>N0000194038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</from_name>
		<from_code>N0000192338</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elotuzumab</to_name>
		<to_code>1726104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</from_name>
		<from_code>N0000192338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
		<to_code>N0000192338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
		<to_code>N0000192338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
		<to_code>N0000192338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
		<to_code>N0000192338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD52-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000175659</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alemtuzumab</to_name>
		<to_code>117055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD52-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000175659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthrax Protective Antigen-directed Antibody [EPC]</from_name>
		<from_code>N0000192703</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>obiltoxaximab</to_name>
		<to_code>1746906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthrax Protective Antigen-directed Antibody [EPC]</from_name>
		<from_code>N0000192703</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raxibacumab</to_name>
		<to_code>1366567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody [EPC]</to_name>
		<to_code>N0000192703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthrax Protective Antigen-directed Antibody [EPC]</to_name>
		<to_code>N0000192703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Stimulant [EPC]</to_name>
		<to_code>N0000175716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant [EPC]</to_name>
		<to_code>N0000175778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</to_name>
		<to_code>N0000184146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mast Cell Stabilizer [EPC]</to_name>
		<to_code>N0000175630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Expectorant [EPC]</to_name>
		<to_code>N0000193956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-narcotic Antitussive [EPC]</to_name>
		<to_code>N0000175796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihistamine [EPC]</to_name>
		<to_code>N0000175750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Agent [APC]</from_name>
		<from_code>N0000193909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucolytic [EPC]</to_name>
		<to_code>N0000175776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Stimulant [EPC]</from_name>
		<from_code>N0000175716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Stimulant [EPC]</from_name>
		<from_code>N0000175716</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Respiratory stimulant (substance)</to_name>
		<to_code>418760000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Stimulant [EPC]</from_name>
		<from_code>N0000175716</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxapram</to_name>
		<to_code>3637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone</from_name>
		<from_code>7242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride dihydrate</from_name>
		<from_code>1010598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene</from_name>
		<from_code>31479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene hydrochloride</from_name>
		<from_code>236069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Medullary Respiratory Center Activity Alteration [PE]</from_name>
		<from_code>N0000009743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride</from_name>
		<from_code>203192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia spirit, aromatic</from_name>
		<from_code>317201</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Medullary Respiratory Drive [PE]</to_name>
		<to_code>N0000009393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>beractant</to_name>
		<to_code>46967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poractant alfa</to_name>
		<to_code>236381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Surfactant (substance)</to_name>
		<to_code>422248006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing surfactant (product)</to_name>
		<to_code>764306007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calfactant</to_name>
		<to_code>232539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Surfactant [EPC]</from_name>
		<from_code>N0000175778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Surfactant [EPC]</to_name>
		<to_code>N0000175778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beractant</from_name>
		<from_code>46967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poractant alfa</from_name>
		<from_code>236381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calfactant</from_name>
		<from_code>232539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alveolar Surface Tension Alteration [PE]</from_name>
		<from_code>N0000008293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alveolar Surface Tension Reduction [PE]</to_name>
		<to_code>N0000008294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175777</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with leukotriene receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372517002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175777</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>montelukast</to_name>
		<to_code>88249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175777</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zafirlukast</to_name>
		<to_code>114970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175777</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing leukotriene receptor antagonist (product)</to_name>
		<to_code>108616001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukotriene Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
		<from_code>N0000184146</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing cystic fibrosis transmembrane conductance regulator potentiator (product)</to_name>
		<to_code>764133002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
		<from_code>N0000184146</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deutivacaftor</to_name>
		<to_code>2701430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
		<from_code>N0000184146</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action (substance)</to_name>
		<to_code>736948000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
		<from_code>N0000184146</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivacaftor</to_name>
		<to_code>1243041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</to_name>
		<to_code>N0000184146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Respiratory system agent (substance)</from_name>
		<from_code>373272007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</to_name>
		<to_code>N0000184146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Stabilizer [EPC]</from_name>
		<from_code>N0000175630</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing mast cell stabilizer (product)</to_name>
		<to_code>108860003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Stabilizer [EPC]</from_name>
		<from_code>N0000175630</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cromolyn</to_name>
		<to_code>42612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Stabilizer [EPC]</from_name>
		<from_code>N0000175630</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nedocromil</to_name>
		<to_code>31563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Stabilizer [EPC]</from_name>
		<from_code>N0000175630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Stabilizer [EPC]</from_name>
		<from_code>N0000175630</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with mast cell stabilizer mechanism of action (substance)</to_name>
		<to_code>372553000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Stabilizer [EPC]</from_name>
		<from_code>N0000175630</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olopatadine</to_name>
		<to_code>135391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Function Alteration [PE]</from_name>
		<from_code>N0000175627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine</from_name>
		<from_code>39684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil sodium</from_name>
		<from_code>266663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol trifenatate</from_name>
		<from_code>1424883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remibrutinib</from_name>
		<from_code>2724365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine</from_name>
		<from_code>135391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide tromethamine</from_name>
		<from_code>28859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide</from_name>
		<from_code>52151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol</from_name>
		<from_code>1424884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil</from_name>
		<from_code>31563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Release [PE]</to_name>
		<to_code>N0000175628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Expectorant [EPC]</from_name>
		<from_code>N0000193956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Respiratory Secretions [PE]</to_name>
		<to_code>N0000009560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Expectorant [EPC]</from_name>
		<from_code>N0000193956</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Expectorant agent (substance)</to_name>
		<to_code>372849009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Expectorant [EPC]</from_name>
		<from_code>N0000193956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Expectorant [EPC]</from_name>
		<from_code>N0000193956</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaifenesin</to_name>
		<to_code>5032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Respiratory Secretions [PE]</from_name>
		<from_code>N0000009560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nasal and Sinus Secretions [PE]</to_name>
		<to_code>N0000009588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Respiratory Secretions [PE]</from_name>
		<from_code>N0000009560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Pharyngeal Secretions [PE]</to_name>
		<to_code>N0000009452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Respiratory Secretions [PE]</from_name>
		<from_code>N0000009560</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Tracheo-Bronchial Secretions [PE]</to_name>
		<to_code>N0000009701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metocurine iodide</from_name>
		<from_code>203206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Respiratory Secretions [PE]</to_name>
		<to_code>N0000009560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Respiratory Secretions [PE]</to_name>
		<to_code>N0000009560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Respiratory Secretions [PE]</to_name>
		<to_code>N0000009560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Secretion Alteration [PE]</from_name>
		<from_code>N0000009836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Respiratory Secretions [PE]</to_name>
		<to_code>N0000009560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium guaiacolsulfonate</from_name>
		<from_code>91275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Respiratory Secretions [PE]</to_name>
		<to_code>N0000009560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodinated glycerol</from_name>
		<from_code>27723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Tracheo-Bronchial Secretions [PE]</to_name>
		<to_code>N0000009701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucolytic [EPC]</from_name>
		<from_code>N0000175776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodinated glycerol</from_name>
		<from_code>27723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dornase alfa</from_name>
		<from_code>337623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Secretion Viscosity Alteration [PE]</from_name>
		<from_code>N0000009837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
		<from_code>N0000175958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
		<to_code>N0000008867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-narcotic Antitussive [EPC]</from_name>
		<from_code>N0000175796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-narcotic Antitussive [EPC]</from_name>
		<from_code>N0000175796</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benzonatate</to_name>
		<to_code>18993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-narcotic Antitussive [EPC]</from_name>
		<from_code>N0000175796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cough</to_name>
		<to_code>M0005255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-narcotic Antitussive [EPC]</from_name>
		<from_code>N0000175796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
		<to_code>N0000009010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antitussive agent (substance)</from_name>
		<from_code>372791003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-narcotic Antitussive [EPC]</to_name>
		<to_code>N0000175796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloperastine</from_name>
		<from_code>2104180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine hydrobromide</from_name>
		<from_code>235428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloperastine hydrochloride</from_name>
		<from_code>2104181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine</from_name>
		<from_code>27084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrochloride</from_name>
		<from_code>267251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan polistirex</from_name>
		<from_code>236146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noscapine</from_name>
		<from_code>7533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory System Agent [TC]</from_name>
		<from_code>N0000178318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan tannate</from_name>
		<from_code>259262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzonatate</from_name>
		<from_code>18993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Narcotic Antitussive [EPC]</from_name>
		<from_code>N0000175795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine methylbromide</from_name>
		<from_code>27085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrobromide</from_name>
		<from_code>102490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydroiodide</from_name>
		<from_code>539765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antitussive Agent [TC]</to_name>
		<to_code>N0000178319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzonatate</from_name>
		<from_code>18993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
		<to_code>N0000009010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tracheobronchial Stretch Receptor Alteration [PE]</from_name>
		<from_code>N0000009892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
		<to_code>N0000009010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihistamine [EPC]</from_name>
		<from_code>N0000175750</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing histamine receptor antagonist (product)</to_name>
		<to_code>6425004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihistamine [EPC]</from_name>
		<from_code>N0000175750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benztropine</to_name>
		<to_code>1424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihistamine [EPC]</from_name>
		<from_code>N0000175750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxylamine</to_name>
		<to_code>3642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihistamine [EPC]</from_name>
		<from_code>N0000175750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyzine</to_name>
		<to_code>5553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihistamine [EPC]</from_name>
		<from_code>N0000175750</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with histamine receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372806008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihistamine [EPC]</to_name>
		<to_code>N0000175750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucolytic [EPC]</from_name>
		<from_code>N0000175776</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine</to_name>
		<to_code>197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucolytic [EPC]</to_name>
		<to_code>N0000175776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Respiratory system agent (substance)</from_name>
		<from_code>373272007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucolytic [EPC]</to_name>
		<to_code>N0000175776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Therapy [APC]</from_name>
		<from_code>N0000194012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</to_name>
		<to_code>N0000194087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gene Therapy [APC]</from_name>
		<from_code>N0000194012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</to_name>
		<to_code>N0000193971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Genetically modified virus (substance)</from_name>
		<from_code>788108004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</to_name>
		<to_code>N0000194087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing genetically modified virus (product)</from_name>
		<from_code>1002248007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</to_name>
		<to_code>N0000194087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</from_name>
		<from_code>N0000193971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin Function Restoration [PE]</to_name>
		<to_code>N0000193979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</from_name>
		<from_code>N0000193971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</to_name>
		<to_code>N0000194103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hematopoietic factor (substance)</from_name>
		<from_code>17948008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</to_name>
		<to_code>N0000193971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betibeglogene autotemcel</from_name>
		<from_code>2610349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin Function Restoration [PE]</to_name>
		<to_code>N0000193979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovotibeglogene autotemcel</from_name>
		<from_code>2671958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin Function Restoration [PE]</to_name>
		<to_code>N0000193979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vadadustat</from_name>
		<from_code>2679296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin Function Restoration [PE]</to_name>
		<to_code>N0000193979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythrocyte Function Alteration [PE]</from_name>
		<from_code>N0000193978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin Function Restoration [PE]</to_name>
		<to_code>N0000193979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
		<to_code>N0000183362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhalation Diagnostic Agent [EPC]</to_name>
		<to_code>N0000175866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Paramagnetic Contrast Agent [EPC]</to_name>
		<to_code>N0000180184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive Diagnostic Agent [EPC]</to_name>
		<to_code>N0000177914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Contrast Agent for Ultrasound Imaging [EPC]</to_name>
		<to_code>N0000175864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiographic Contrast Agent [EPC]</to_name>
		<to_code>N0000180185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Dye [EPC]</to_name>
		<to_code>N0000175536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Imaging Agent [APC]</from_name>
		<from_code>N0000193875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarized Contrast Agent [EPC]</to_name>
		<to_code>N0000194089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
		<from_code>N0000183362</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadolinium cation (3+)</to_name>
		<to_code>1546429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
		<from_code>N0000183362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadobutrol</to_name>
		<to_code>M0239381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
		<from_code>N0000183362</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadobutrol</to_name>
		<to_code>84990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
		<to_code>N0000183362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing gadolinium and/or gadolinium compound (product)</from_name>
		<from_code>768763008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
		<to_code>N0000183362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Magnetic resonance imaging contrast media (product) [349360003]</from_name>
		<from_code>349360003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
		<to_code>N0000183362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Gadolinium and/or gadolinium compound (substance)</from_name>
		<from_code>767234009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
		<to_code>N0000183362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Magnetic resonance imaging contrast media (substance)</from_name>
		<from_code>419909004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
		<to_code>N0000183362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobutrol</from_name>
		<from_code>84990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadobutrol</to_name>
		<to_code>M0239381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobutrol</from_name>
		<from_code>84990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadobutrol</to_name>
		<to_code>M0239381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inhalation Diagnostic Agent [EPC]</from_name>
		<from_code>N0000175866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inhalation Diagnostic Agent [EPC]</from_name>
		<from_code>N0000175866</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>xenon-133</to_name>
		<to_code>259282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhalation Diagnostic Agent [EPC]</to_name>
		<to_code>N0000175866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic substance (substance)</from_name>
		<from_code>373782009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhalation Diagnostic Agent [EPC]</to_name>
		<to_code>N0000175866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Agent [APC]</from_name>
		<from_code>N0000193895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhalation Diagnostic Agent [EPC]</to_name>
		<to_code>N0000175866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflexane</from_name>
		<from_code>1540828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoic acid</from_name>
		<from_code>1546223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenomethionine Se 75</from_name>
		<from_code>9133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorodopa F-18</from_name>
		<from_code>2571853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Therapeutic Categories [TC]</from_name>
		<from_code>N0000178293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorodopa</from_name>
		<from_code>2571852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alogliptin</from_name>
		<from_code>1368001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin hexahydrate</from_name>
		<from_code>1653802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129, hyperpolarized</from_name>
		<from_code>2626220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamic acid</from_name>
		<from_code>1546451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m sestamibi</from_name>
		<from_code>1482913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate sodium</from_name>
		<from_code>66896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium 99m</from_name>
		<from_code>90650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dulaglutide</from_name>
		<from_code>1551291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium 67 citrate</from_name>
		<from_code>272758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regadenoson anhydrous</from_name>
		<from_code>1546015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-131</from_name>
		<from_code>1546415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein sodium</from_name>
		<from_code>57789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barium sulfate</from_name>
		<from_code>1331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pyrophosphate</from_name>
		<from_code>1364532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>empagliflozin</from_name>
		<from_code>1545653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadodiamide</from_name>
		<from_code>41144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadofosveset trisodium</from_name>
		<from_code>1364289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-hydroxyamphetamine</from_name>
		<from_code>7839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iso-sulfan blue</from_name>
		<from_code>27863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium-111</from_name>
		<from_code>90540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine carbamate</from_name>
		<from_code>2375923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglic acid</from_name>
		<from_code>1426458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotide gallium ga-68</from_name>
		<from_code>2199391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobutrol</from_name>
		<from_code>84990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxides</from_name>
		<from_code>72901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macimorelin acetate</from_name>
		<from_code>1999419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium GA-68 gozetotide</from_name>
		<from_code>2586016</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium pyrophosphate</from_name>
		<from_code>267798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pertechnetate Tc 99m</from_name>
		<from_code>10349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat</from_name>
		<from_code>2556617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine chloride</from_name>
		<from_code>40165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pyrophosphate decahydrate</from_name>
		<from_code>1944687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</from_name>
		<from_code>N0000175870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate</from_name>
		<from_code>5973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iocetamic acid</from_name>
		<from_code>183830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetapir F-18</from_name>
		<from_code>1427224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-129</from_name>
		<from_code>2626219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histoplasmin</from_name>
		<from_code>5363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine</from_name>
		<from_code>10917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopiclenol</from_name>
		<from_code>2618720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane</from_name>
		<from_code>2571854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicisate</from_name>
		<from_code>1306100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxilan</from_name>
		<from_code>27793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodipamide</from_name>
		<from_code>5936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate lysine</from_name>
		<from_code>236477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Helicobacter pylori Diagnostic [EPC]</from_name>
		<from_code>N0000175886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat F-18</from_name>
		<from_code>2556616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green acid form</from_name>
		<from_code>2199577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flotufolastat</from_name>
		<from_code>2637947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicisate dihydrochloride</from_name>
		<from_code>1306099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentagastrin</from_name>
		<from_code>7993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium</from_name>
		<from_code>1310124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyproline</from_name>
		<from_code>1311548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-123</from_name>
		<from_code>1361657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodohippurate I131 sodium</from_name>
		<from_code>91540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin</from_name>
		<from_code>2890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal sodium</from_name>
		<from_code>1362690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluciclovine</from_name>
		<from_code>2571859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyanocobalamin Co57</from_name>
		<from_code>91516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethiodized oil</from_name>
		<from_code>4125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein</from_name>
		<from_code>25138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetreotide</from_name>
		<from_code>1724429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopentetate dimeglumine</from_name>
		<from_code>25486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrophosphoric acid</from_name>
		<from_code>1546425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,iodinated I-125 serum</from_name>
		<from_code>317177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoversetamide</from_name>
		<from_code>228833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macimorelin</from_name>
		<from_code>1999420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 oxyquinoline</from_name>
		<from_code>1314372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flotufolastat F-18</from_name>
		<from_code>2637946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangafodipir</from_name>
		<from_code>236987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallous chloride Tl201</from_name>
		<from_code>91588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</from_name>
		<from_code>N0000175871</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate sodium</from_name>
		<from_code>9887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrapone</from_name>
		<from_code>6923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflutren</from_name>
		<from_code>283753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine chloride</from_name>
		<from_code>82115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,chromated Cr-51 serum</from_name>
		<from_code>314299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iophendylate</from_name>
		<from_code>5968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blocking Agent for Diagnostic Imaging [EPC]</from_name>
		<from_code>N0000175861</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodixanol</from_name>
		<from_code>27729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopanoic acid</from_name>
		<from_code>5967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate</from_name>
		<from_code>5976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetaben</from_name>
		<from_code>2571857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrophosphate</from_name>
		<from_code>1364533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese cation (2+)</from_name>
		<from_code>1546272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green</from_name>
		<from_code>5775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopromide</from_name>
		<from_code>27781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpropamide</from_name>
		<from_code>2404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobitridol</from_name>
		<from_code>87639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate disodium</from_name>
		<from_code>637320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafolacianine sodium</from_name>
		<from_code>2586858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyamphetamine hydrobromide</from_name>
		<from_code>82066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoteridol</from_name>
		<from_code>25483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>florbetaben f-18</from_name>
		<from_code>1492940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal</from_name>
		<from_code>9471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flortaucipir</from_name>
		<from_code>2571858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurpiridaz</from_name>
		<from_code>2700763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin hydrochloride</from_name>
		<from_code>204194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorodeoxyglucose F18</from_name>
		<from_code>1362737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m disofenin</from_name>
		<from_code>37665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetate disodium</from_name>
		<from_code>259268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin</from_name>
		<from_code>6384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trypan blue free acid</from_name>
		<from_code>1726081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicilloyl polylysine</from_name>
		<from_code>2667743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate dimeglumine</from_name>
		<from_code>68173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gozetotide</from_name>
		<from_code>2588949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ipodate</from_name>
		<from_code>1911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate</from_name>
		<from_code>692620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fanolesomab</from_name>
		<from_code>1314371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine</from_name>
		<from_code>155080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane I-123</from_name>
		<from_code>1426874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin acetate</from_name>
		<from_code>204193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate</from_name>
		<from_code>802624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur hexafluoride</from_name>
		<from_code>1599276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotride</from_name>
		<from_code>2199392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafolacianine</from_name>
		<from_code>2586857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium pyrophosphate</from_name>
		<from_code>1426658</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoterate meglumine</from_name>
		<from_code>1421151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate meglumine</from_name>
		<from_code>66895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-133</from_name>
		<from_code>259282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurpiridaz F-18</from_name>
		<from_code>2700762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regadenoson</from_name>
		<from_code>640062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Antibody [EPC]</from_name>
		<from_code>N0000175873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alogliptin benzoate</from_name>
		<from_code>1368000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>82 rubidium</from_name>
		<from_code>1546434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangafodipir trisodium, anhydrous</from_name>
		<from_code>221119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin diacetate tetrahydrate</from_name>
		<from_code>1298838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Agent [TC]</to_name>
		<to_code>N0000178317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Paramagnetic Contrast Agent [EPC]</from_name>
		<from_code>N0000180184</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadoteridol</to_name>
		<to_code>25483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Paramagnetic Contrast Agent [EPC]</from_name>
		<from_code>N0000180184</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadofosveset</to_name>
		<to_code>1364290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Paramagnetic Contrast Agent [EPC]</from_name>
		<from_code>N0000180184</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ferumoxides</to_name>
		<to_code>72901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Paramagnetic Contrast Agent [EPC]</from_name>
		<from_code>N0000180184</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadodiamide</to_name>
		<to_code>41144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Paramagnetic Contrast Agent [EPC]</from_name>
		<from_code>N0000180184</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese cation (2+)</to_name>
		<to_code>1546272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Paramagnetic Contrast Agent [EPC]</to_name>
		<to_code>N0000180184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Magnetic resonance imaging contrast media (product) [349360003]</from_name>
		<from_code>349360003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Paramagnetic Contrast Agent [EPC]</to_name>
		<to_code>N0000180184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Magnetic resonance imaging contrast media (substance)</from_name>
		<from_code>419909004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Paramagnetic Contrast Agent [EPC]</to_name>
		<to_code>N0000180184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dotatate gallium ga-68</to_name>
		<to_code>676679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Radioactive isotope (substance)</to_name>
		<to_code>89457008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium GA-68 gozetotide</to_name>
		<to_code>2586016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioflupane I-123</to_name>
		<to_code>1426874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper oxodotreotide CU-64</to_name>
		<to_code>2396442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iobenguane sulfate I-123</to_name>
		<to_code>1427223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pertechnetate Tc 99m</to_name>
		<to_code>10349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piflufolastat F-18</to_name>
		<to_code>2556616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flotufolastat F-18</to_name>
		<to_code>2637946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 chloride</to_name>
		<to_code>42987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 pentetate disodium</to_name>
		<to_code>259268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodide ion I-123</to_name>
		<to_code>1361657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamic acid I-125</to_name>
		<to_code>1546452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluorodeoxyglucose F18</to_name>
		<to_code>1362737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thallous cation Tl-201</to_name>
		<to_code>1546370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>florbetapir F-18</to_name>
		<to_code>1427224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>82 rubidium</to_name>
		<to_code>1546434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>florbetaben f-18</to_name>
		<to_code>1492940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flutemetamol F-18</to_name>
		<to_code>1486025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Diagnostic radioisotope (product)</to_name>
		<to_code>17600005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m sestamibi</to_name>
		<to_code>1482913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 oxyquinoline</to_name>
		<to_code>1314372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluciclovine F-18</to_name>
		<to_code>1796118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m exametazime</to_name>
		<to_code>1431726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluoroestradiol F-18</to_name>
		<to_code>2372221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m medronate</to_name>
		<to_code>1488818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dotatate gallium GA-68</to_name>
		<to_code>1872044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc-99m pyrophosphate</to_name>
		<to_code>1488368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluoride ion F-18</to_name>
		<to_code>1546273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m tilmanocept</to_name>
		<to_code>1373391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flurpiridaz F-18</to_name>
		<to_code>2700762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 pentetreotide</to_name>
		<to_code>1724429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonia N-13</to_name>
		<to_code>1305558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc-99m sulfur colloid</to_name>
		<to_code>1423270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Diagnostic Agent [EPC]</from_name>
		<from_code>N0000177914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline C-11</to_name>
		<to_code>1425419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive Diagnostic Agent [EPC]</to_name>
		<to_code>N0000177914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Agent [APC]</from_name>
		<from_code>N0000193895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive Diagnostic Agent [EPC]</to_name>
		<to_code>N0000177914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
		<from_code>N0000175864</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perflutren</to_name>
		<to_code>283753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
		<from_code>N0000175864</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Ultrasound contrast media (product) [356442006]</to_name>
		<to_code>356442006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
		<from_code>N0000175864</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfur hexafluoride</to_name>
		<to_code>1599276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
		<from_code>N0000175864</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perflexane</to_name>
		<to_code>1540828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
		<from_code>N0000175864</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin microspheres, human</to_name>
		<to_code>1370439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Contrast media (substance)</from_name>
		<from_code>385420005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Contrast Agent for Ultrasound Imaging [EPC]</to_name>
		<to_code>N0000175864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Contrast Agent for Ultrasound Imaging [EPC]</to_name>
		<to_code>N0000175864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioversol</to_name>
		<to_code>27792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopamidol</to_name>
		<to_code>5966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopromide</to_name>
		<to_code>27781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbon dioxide</to_name>
		<to_code>2034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodixanol</to_name>
		<to_code>27729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamic acid</to_name>
		<to_code>1546451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iohexol</to_name>
		<to_code>5956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iomeprol</to_name>
		<to_code>2606484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Optical Imaging Agent [EPC]</to_name>
		<to_code>N0000193983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diatrizoic acid</to_name>
		<to_code>1546223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barium sulfate</to_name>
		<to_code>1331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radiographic Contrast Agent [EPC]</from_name>
		<from_code>N0000180185</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethiodized oil</to_name>
		<to_code>4125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Contrast media (substance)</from_name>
		<from_code>385420005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiographic Contrast Agent [EPC]</to_name>
		<to_code>N0000180185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radiographic Contrast Agent [EPC]</to_name>
		<to_code>N0000180185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Optical Imaging Agent [EPC]</from_name>
		<from_code>N0000193983</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pafolacianine</to_name>
		<to_code>2586857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Optical Imaging Agent [EPC]</from_name>
		<from_code>N0000193983</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminolevulinic acid</to_name>
		<to_code>683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluorescein</to_name>
		<to_code>25138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trypan blue free acid</to_name>
		<to_code>1726081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indocyanine green</to_name>
		<to_code>5775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Diagnostic dye (substance)</to_name>
		<to_code>419148000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Dye [EPC]</from_name>
		<from_code>N0000175536</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indigotindisulfonic acid</to_name>
		<to_code>1546441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Agent [APC]</from_name>
		<from_code>N0000193895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Dye [EPC]</to_name>
		<to_code>N0000175536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diagnostic Dye [EPC]</to_name>
		<to_code>N0000175536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hyperpolarized Contrast Agent [EPC]</from_name>
		<from_code>N0000194089</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>xenon-129, hyperpolarized</to_name>
		<to_code>2626220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Magnetic resonance imaging contrast media (substance)</from_name>
		<from_code>419909004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarized Contrast Agent [EPC]</to_name>
		<to_code>N0000194089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Agent [APC]</to_name>
		<to_code>N0000193892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</to_name>
		<to_code>N0000191544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Channel Blocker [EPC]</to_name>
		<to_code>N0000192795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzodiazepine [EPC]</to_name>
		<to_code>N0000175694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonist [EPC]</to_name>
		<to_code>N0000175706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
		<to_code>N0000194083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000181821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium Channel Blocker [EPC]</to_name>
		<to_code>N0000194141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activator [EPC]</to_name>
		<to_code>N0000175573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium-sparing Diuretic [EPC]</to_name>
		<to_code>N0000175418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</to_name>
		<to_code>N0000175759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000186106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autonomic Ganglionic Blocker [EPC]</to_name>
		<to_code>N0000175641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>TRPM8 Thermoreceptor Agonist [EPC]</to_name>
		<to_code>N0000194172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitor [EPC]</to_name>
		<to_code>N0000175525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzodiazepine Antagonist [EPC]</to_name>
		<to_code>N0000175680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ion Channel or Pump Agent [APC]</from_name>
		<from_code>N0000193904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blocker [EPC]</to_name>
		<to_code>N0000193962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Agent [APC]</from_name>
		<from_code>N0000193892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
		<to_code>N0000175697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Agent [APC]</from_name>
		<from_code>N0000193892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydropyridine Calcium Channel Blocker [EPC]</to_name>
		<to_code>N0000175421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Agent [APC]</from_name>
		<from_code>N0000193892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Blocker [EPC]</to_name>
		<to_code>N0000175566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Channel Agent [APC]</to_name>
		<to_code>N0000193892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>N-type Calcium Channel Antagonist [EPC]</from_name>
		<from_code>N0000175697</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ziconotide</to_name>
		<to_code>68503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing calcium channel blocker (product)</from_name>
		<from_code>48698004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
		<to_code>N0000175697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with calcium channel blocker mechanism of action (substance)</from_name>
		<from_code>373304005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
		<to_code>N0000175697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
		<to_code>N0000175697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nicardipine</to_name>
		<to_code>7396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>felodipine</to_name>
		<to_code>4316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with dihydropyridine derivative structure and calcium channel blocker mechanism of action (substance)</to_name>
		<to_code>406769001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nifedipine</to_name>
		<to_code>7417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clevidipine</to_name>
		<to_code>233603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isradipine</to_name>
		<to_code>33910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nimodipine</to_name>
		<to_code>7426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amlodipine</to_name>
		<to_code>17767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nisoldipine</to_name>
		<to_code>7435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing calcium channel blocker (product)</from_name>
		<from_code>48698004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydropyridine Calcium Channel Blocker [EPC]</to_name>
		<to_code>N0000175421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine</from_name>
		<from_code>233603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine butyrate</from_name>
		<from_code>977863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydropyridines</to_name>
		<to_code>M0006414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175566</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>verapamil</to_name>
		<to_code>11170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175566</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diltiazem</to_name>
		<to_code>3443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175566</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amlodipine</to_name>
		<to_code>17767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175566</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcium channel blocker (product)</to_name>
		<to_code>48698004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Channel Blocker [EPC]</from_name>
		<from_code>N0000175566</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with calcium channel blocker mechanism of action (substance)</to_name>
		<to_code>373304005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</from_name>
		<from_code>N0000191544</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivabradine</to_name>
		<to_code>1649480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with calcium channel blocker mechanism of action (substance)</from_name>
		<from_code>373304005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</to_name>
		<to_code>N0000191544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Blocker [EPC]</from_name>
		<from_code>N0000192795</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with potassium channel blocker mechanism of action (substance)</to_name>
		<to_code>415152007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Blocker [EPC]</from_name>
		<from_code>N0000192795</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amifampridine</to_name>
		<to_code>2106338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Blocker [EPC]</from_name>
		<from_code>N0000192795</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing potassium channel blocker (product)</to_name>
		<to_code>415151000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Channel Blocker [EPC]</from_name>
		<from_code>N0000192795</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dalfampridine</to_name>
		<to_code>897018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing benzodiazepine (product)</to_name>
		<to_code>16047007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxazepam</to_name>
		<to_code>7781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlordiazepoxide</to_name>
		<to_code>2356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprazolam</to_name>
		<to_code>596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estazolam</to_name>
		<to_code>4077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temazepam</to_name>
		<to_code>10355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clorazepic acid</to_name>
		<to_code>235408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonazepam</to_name>
		<to_code>2598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Benzodiazepine (substance)</to_name>
		<to_code>372664007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobazam</to_name>
		<to_code>21241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flurazepam</to_name>
		<to_code>4501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diazepam</to_name>
		<to_code>3322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triazolam</to_name>
		<to_code>10767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midazolam</to_name>
		<to_code>6960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quazepam</to_name>
		<to_code>35185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine [EPC]</from_name>
		<from_code>N0000175694</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lorazepam</to_name>
		<to_code>6470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzodiazepine [EPC]</to_name>
		<to_code>N0000175694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzodiazepine [EPC]</to_name>
		<to_code>N0000175694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate</from_name>
		<from_code>2353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepic acid</from_name>
		<from_code>235408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam hydrochloride</from_name>
		<from_code>71484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam</from_name>
		<from_code>4501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quazepam</from_name>
		<from_code>35185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate dipotassium</from_name>
		<from_code>2607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estazolam</from_name>
		<from_code>4077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzodiazepines</to_name>
		<to_code>M0002356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175706</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with nicotinic receptor agonist mechanism of action (substance)</to_name>
		<to_code>712888001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Cholinergic Nicotinic Agonist [EPC]</to_name>
		<to_code>N0000175705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175706</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nicotine</to_name>
		<to_code>7407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175706</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing nicotinic receptor agonist (product)</to_name>
		<to_code>764140001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonist [EPC]</to_name>
		<to_code>N0000175706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Nicotinic Agonist [EPC]</to_name>
		<to_code>N0000175706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Cholinergic Nicotinic Agonist [EPC]</from_name>
		<from_code>N0000175705</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varenicline</to_name>
		<to_code>591622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
		<from_code>N0000194083</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zolpidem</to_name>
		<to_code>39993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000181821</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dextromethorphan</to_name>
		<to_code>3289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)</from_name>
		<from_code>406456001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000181821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000181821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with N-methyl-D-aspartate receptor antagonist mechanism of action (substance)</from_name>
		<from_code>414858002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000181821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Channel Blocker [EPC]</from_name>
		<from_code>N0000194141</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suzetrigine</to_name>
		<to_code>2704819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Channel Blocker [EPC]</from_name>
		<from_code>N0000194141</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with sodium channel blocker mechanism of action (substance)</to_name>
		<to_code>782436006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium Channel Blocker [EPC]</from_name>
		<from_code>N0000194141</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing sodium channel blocker (product)</to_name>
		<to_code>782817006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chloride Channel Activator [EPC]</from_name>
		<from_code>N0000175573</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lubiprostone</to_name>
		<to_code>623033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chloride Channel Activator [EPC]</to_name>
		<to_code>N0000175573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-sparing Diuretic [EPC]</from_name>
		<from_code>N0000175418</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiloride</to_name>
		<to_code>644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-sparing Diuretic [EPC]</from_name>
		<from_code>N0000175418</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamterene</to_name>
		<to_code>10763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-sparing Diuretic [EPC]</from_name>
		<from_code>N0000175418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-sparing Diuretic [EPC]</from_name>
		<from_code>N0000175418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-sparing Diuretic [EPC]</from_name>
		<from_code>N0000175418</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Potassium-sparing diuretic (substance)</to_name>
		<to_code>372753003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diuretic [APC]</from_name>
		<from_code>N0000193873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium-sparing Diuretic [EPC]</to_name>
		<to_code>N0000175418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis [PE]</from_name>
		<from_code>N0000175359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolvaptan</from_name>
		<from_code>358257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazamide</from_name>
		<from_code>10633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diuresis Alteration [PE]</from_name>
		<from_code>N0000175358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide, micronized</from_name>
		<from_code>217364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide-like Diuretic [EPC]</from_name>
		<from_code>N0000175420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethiazide</from_name>
		<from_code>89911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamabrom</from_name>
		<from_code>54365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol</from_name>
		<from_code>6628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Diuretic [EPC]</from_name>
		<from_code>N0000175810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide</from_name>
		<from_code>4815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xipamide</from_name>
		<from_code>11371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis [PE]</to_name>
		<to_code>N0000175359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle SO4-- Excretion [PE]</to_name>
		<to_code>N0000009389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle H+ Excretion [PE]</to_name>
		<to_code>N0000009383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle HCO3- Excretion [PE]</to_name>
		<to_code>N0000009384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle PO4-- Excretion [PE]</to_name>
		<to_code>N0000009388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
		<to_code>N0000175366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Ca++ Excretion [PE]</from_name>
		<from_code>N0000009546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
		<to_code>N0000009381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal SO4-- Excretion [PE]</from_name>
		<from_code>N0000009558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle SO4-- Excretion [PE]</to_name>
		<to_code>N0000009389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal H+ Excretion [PE]</from_name>
		<from_code>N0000009548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle H+ Excretion [PE]</to_name>
		<to_code>N0000009383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal K+ Excretion [PE]</from_name>
		<from_code>N0000009551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000009385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Na+ Excretion [PE]</from_name>
		<from_code>N0000009553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
		<to_code>N0000009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Cl- Excretion [PE]</from_name>
		<from_code>N0000009547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
		<to_code>N0000009382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal HCO3- Excretion [PE]</from_name>
		<from_code>N0000009549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle HCO3- Excretion [PE]</to_name>
		<to_code>N0000009384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Mg++ Excretion [PE]</from_name>
		<from_code>N0000009552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
		<to_code>N0000009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal PO4-- Excretion [PE]</from_name>
		<from_code>N0000009557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Loop of Henle PO4-- Excretion [PE]</to_name>
		<to_code>N0000009388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal K+ Excretion [PE]</from_name>
		<from_code>N0000008859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
		<to_code>N0000008562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal K+ Excretion [PE]</from_name>
		<from_code>N0000008859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000008693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal K+ Excretion [PE]</from_name>
		<from_code>N0000008859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal K+ Excretion [PE]</from_name>
		<from_code>N0000008859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Proximal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinaprilat</from_name>
		<from_code>1546359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal Ion Excretion [PE]</from_name>
		<from_code>N0000008858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolaprilat</from_name>
		<from_code>1546379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramiprilat</from_name>
		<from_code>1546377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril hydrochloride</from_name>
		<from_code>259335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinoprilat</from_name>
		<from_code>1546393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril calcium</from_name>
		<from_code>259493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril</from_name>
		<from_code>39990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat dihydrate</from_name>
		<from_code>2672730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril</from_name>
		<from_code>60245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal K+ Excretion [PE]</to_name>
		<to_code>N0000008859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
		<to_code>N0000008562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
		<to_code>N0000008562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
		<to_code>N0000008562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
		<to_code>N0000008562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
		<from_code>N0000175367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Loop of Henle K+ Excretion [PE]</to_name>
		<to_code>N0000008693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplerenone</from_name>
		<from_code>298869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
		<to_code>N0000008583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
		<from_code>N0000175759</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>baclofen</to_name>
		<to_code>1292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
		<from_code>N0000175759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</to_name>
		<to_code>N0000183360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
		<from_code>N0000175759</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with gamma-aminobutyric acid receptor agonist mechanism of action (substance)</to_name>
		<to_code>767566000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
		<from_code>N0000175759</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing gamma-aminobutyric acid receptor agonist (product)</to_name>
		<to_code>767568004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</to_name>
		<to_code>N0000175759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
		<from_code>N0000183360</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zaleplon</to_name>
		<to_code>74667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
		<from_code>N0000183360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
		<to_code>N0000194006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
		<from_code>N0000194006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganaxolone</to_name>
		<to_code>2604689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
		<from_code>N0000194006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zuranolone</to_name>
		<to_code>2669905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing gamma-aminobutyric acid receptor agonist (product)</from_name>
		<from_code>767568004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
		<to_code>N0000194006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with gamma-aminobutyric acid receptor agonist mechanism of action (substance)</from_name>
		<from_code>767566000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
		<to_code>N0000194006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000186106</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist mechanism of action (substance)</to_name>
		<to_code>782514006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000186106</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perampanel</to_name>
		<to_code>1356552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing glutamate receptor antagonist (product)</from_name>
		<from_code>414350003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000186106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000186106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
		<from_code>N0000175641</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with ganglion blocking mechanism of action (substance)</to_name>
		<to_code>373256004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
		<from_code>N0000175641</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecamylamine</to_name>
		<to_code>6673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
		<from_code>N0000175641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
		<to_code>N0000175644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
		<from_code>N0000175641</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing ganglion blocker (product)</to_name>
		<to_code>318945006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autonomic Ganglionic Blocker [EPC]</to_name>
		<to_code>N0000175641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
		<to_code>N0000175644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine</from_name>
		<from_code>6673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
		<to_code>N0000175644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autonomic Ganglionic Activity Alteration [PE]</from_name>
		<from_code>N0000175643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
		<to_code>N0000175644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine hydrochloride</from_name>
		<from_code>91240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
		<to_code>N0000175644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
		<to_code>N0000175644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>TRPM8 Thermoreceptor Agonist [EPC]</to_name>
		<to_code>N0000194172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lansoprazole</to_name>
		<to_code>17128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>omeprazole</to_name>
		<to_code>7646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)</to_name>
		<to_code>108665006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with hydrogen/potassium adenosine triphosphatase enzyme system inhibitor mechanism of action (substance)</to_name>
		<to_code>372525000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabeprazole</to_name>
		<to_code>114979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantoprazole</to_name>
		<to_code>40790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dexlansoprazole</to_name>
		<to_code>816346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole</to_name>
		<to_code>283742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proton Pump Inhibitor [EPC]</from_name>
		<from_code>N0000175525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium-competitive Acid Blocker [EPC]</to_name>
		<to_code>N0000194136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proton Pump Inhibitor [EPC]</to_name>
		<to_code>N0000175525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-competitive Acid Blocker [EPC]</from_name>
		<from_code>N0000194136</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with hydrogen/potassium adenosine triphosphatase enzyme system inhibitor mechanism of action (substance)</to_name>
		<to_code>372525000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium-competitive Acid Blocker [EPC]</from_name>
		<from_code>N0000194136</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)</to_name>
		<to_code>108665006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175745</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with N-methyl-D-aspartate receptor antagonist mechanism of action (substance)</to_name>
		<to_code>414858002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175745</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>memantine</to_name>
		<to_code>6719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175745</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)</to_name>
		<to_code>406456001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine Antagonist [EPC]</from_name>
		<from_code>N0000175680</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flumazenil</to_name>
		<to_code>4457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine Antagonist [EPC]</from_name>
		<from_code>N0000175680</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with benzodiazepine receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372906009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzodiazepine Antagonist [EPC]</from_name>
		<from_code>N0000175680</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing benzodiazepine receptor antagonist (product)</to_name>
		<to_code>96246003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzodiazepine Antagonist [EPC]</to_name>
		<to_code>N0000175680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Neuromuscular blocking agent (substance)</to_name>
		<to_code>373295003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>letibotulinumtoxinA</to_name>
		<to_code>2689280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abobotulinumtoxinA</to_name>
		<to_code>860168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing neuromuscular blocker (product)</to_name>
		<to_code>87586001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nondepolarizing Neuromuscular Blocker [EPC]</to_name>
		<to_code>N0000175720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>botulinum toxin type A</to_name>
		<to_code>1712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000193962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depolarizing Neuromuscular Blocker [EPC]</to_name>
		<to_code>N0000175719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vecuronium cation</to_name>
		<to_code>1546399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisatracurium</to_name>
		<to_code>319864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atracurium</to_name>
		<to_code>1218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing nondepolarizing neuromuscular blocker (product)</to_name>
		<to_code>59594008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rocuronium</to_name>
		<to_code>68139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Nondepolarizing agent (substance)</to_name>
		<to_code>372790002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175720</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vecuronium</to_name>
		<to_code>71535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nondepolarizing Neuromuscular Blocker [EPC]</to_name>
		<to_code>N0000175720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium chloride</from_name>
		<from_code>49275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium</from_name>
		<from_code>33742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium</from_name>
		<from_code>262100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine hydrochloride</from_name>
		<from_code>236460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine</from_name>
		<from_code>10917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suxamethonium bromide</from_name>
		<from_code>121039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride</from_name>
		<from_code>3565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium</from_name>
		<from_code>1218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine chloride</from_name>
		<from_code>82115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Striated Muscle Contraction Alteration [PE]</from_name>
		<from_code>N0000009879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium</from_name>
		<from_code>23651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium cation</from_name>
		<from_code>1546399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine iodide</from_name>
		<from_code>262295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium bromide</from_name>
		<from_code>66983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium besylate</from_name>
		<from_code>1219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium chloride</from_name>
		<from_code>52796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium</from_name>
		<from_code>71535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metocurine iodide</from_name>
		<from_code>203206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene sodium</from_name>
		<from_code>3106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baclofen</from_name>
		<from_code>1292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride dihydrate</from_name>
		<from_code>2397714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium bromide</from_name>
		<from_code>7884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium</from_name>
		<from_code>7883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallamine triethiodide</from_name>
		<from_code>4639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium</from_name>
		<from_code>30077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium bromide</from_name>
		<from_code>32521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene</from_name>
		<from_code>3105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skeletal Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine</from_name>
		<from_code>57258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium bromide</from_name>
		<from_code>11153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium bromide</from_name>
		<from_code>228530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine</from_name>
		<from_code>10154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Contraction [PE]</to_name>
		<to_code>N0000008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium cation</from_name>
		<from_code>1546399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium</from_name>
		<from_code>1218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium bromide</from_name>
		<from_code>11153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium</from_name>
		<from_code>68139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium</from_name>
		<from_code>7883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium bromide</from_name>
		<from_code>7884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium besylate</from_name>
		<from_code>1219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blockade [PE]</from_name>
		<from_code>N0000175731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium bromide</from_name>
		<from_code>32521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium</from_name>
		<from_code>71535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
		<to_code>N0000175732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Blockade [PE]</from_name>
		<from_code>N0000175731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
		<to_code>N0000175733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Activity Alteration [PE]</from_name>
		<from_code>N0000175726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Blockade [PE]</to_name>
		<to_code>N0000175731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride dihydrate</from_name>
		<from_code>2397714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
		<to_code>N0000175733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
		<to_code>N0000175733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride</from_name>
		<from_code>3565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
		<to_code>N0000175733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine</from_name>
		<from_code>10154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
		<to_code>N0000175733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175719</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Depolarizing agent (substance)</to_name>
		<to_code>373250005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175719</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylcholine</to_name>
		<to_code>10154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
		<from_code>N0000175719</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing depolarizing neuromuscular blocker (product)</to_name>
		<to_code>22587006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depolarizing Neuromuscular Blocker [EPC]</to_name>
		<to_code>N0000175719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Receptor Agonist [EPC]</to_name>
		<to_code>N0000175884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anticholinergic [EPC]</to_name>
		<to_code>N0000175574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergotamine Derivative [EPC]</to_name>
		<to_code>N0000175766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonist [EPC]</to_name>
		<to_code>N0000175700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Typical Antipsychotic [EPC]</to_name>
		<to_code>N0000180182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tricyclic Antidepressant [EPC]</to_name>
		<to_code>N0000175752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist [EPC]</to_name>
		<to_code>N0000175690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta-Adrenergic Blocker [EPC]</to_name>
		<to_code>N0000175556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitor [EPC]</to_name>
		<to_code>N0000175744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000175749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mood Stabilizer [EPC]</to_name>
		<to_code>N0000175751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</to_name>
		<to_code>N0000190856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Adrenergic Blocker [EPC]</to_name>
		<to_code>N0000175553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitor [EPC]</to_name>
		<to_code>N0000175723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
		<to_code>N0000175767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopaminergic Agonist [EPC]</to_name>
		<to_code>N0000175580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminoketone [EPC]</to_name>
		<to_code>N0000180855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitor [EPC]</to_name>
		<to_code>N0000175771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergot Derivative [EPC]</to_name>
		<to_code>N0000175827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Agonist [EPC]</to_name>
		<to_code>N0000182149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
		<to_code>N0000175840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Atypical Antipsychotic [EPC]</to_name>
		<to_code>N0000175430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivator [EPC]</to_name>
		<to_code>N0000175742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid [EPC]</to_name>
		<to_code>N0000175782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000175695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-3 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000175696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000194049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
		<to_code>N0000185010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depressant [EPC]</to_name>
		<to_code>N0000175758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonergot Dopamine Agonist [EPC]</to_name>
		<to_code>N0000175768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Agonist [EPC]</to_name>
		<to_code>N0000175743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic Agent [APC]</to_name>
		<to_code>N0000193910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenothiazine [EPC]</to_name>
		<to_code>N0000175746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine-2 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [EPC]</to_name>
		<to_code>N0000175753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulant [EPC]</to_name>
		<to_code>N0000175739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nervous System Agent [APC]</from_name>
		<from_code>N0000193905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
		<to_code>N0000175765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175692</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>butorphanol</to_name>
		<to_code>1841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175692</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nalbuphine</to_name>
		<to_code>7238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with opioid receptor antagonist mechanism of action (substance)</from_name>
		<from_code>372656001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing opioid receptor agonist (product)</from_name>
		<from_code>360204007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
		<from_code>404642006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing opioid receptor antagonist (product)</from_name>
		<from_code>14103001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175688</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentazocine</to_name>
		<to_code>8001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175688</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing opioid receptor partial agonist (product)</to_name>
		<to_code>85063003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175688</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with opioid receptor partial antagonist mechanism of action (substance)</to_name>
		<to_code>771374006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175688</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with opioid receptor partial agonist mechanism of action (substance)</to_name>
		<to_code>373711007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with acetylcholine receptor agonist mechanism of action (substance)</to_name>
		<to_code>421148003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varenicline</to_name>
		<to_code>591622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pilocarpine</to_name>
		<to_code>8328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcholine</to_name>
		<to_code>194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbamoylcholine</to_name>
		<to_code>1546387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacholine</to_name>
		<to_code>155080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceclidine</to_name>
		<to_code>2721766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing acetylcholine receptor agonist (product)</to_name>
		<to_code>420383004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175884</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cevimeline</to_name>
		<to_code>44281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Receptor Agonist [EPC]</to_name>
		<to_code>N0000175884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>umeclidinium</to_name>
		<to_code>1487514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benztropine</to_name>
		<to_code>1424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atropine</to_name>
		<to_code>1223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium</to_name>
		<to_code>7213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methscopolamine</to_name>
		<to_code>89785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with acetylcholine receptor antagonist mechanism of action (substance)</to_name>
		<to_code>373246003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium cation</to_name>
		<to_code>1546373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revefenacin</to_name>
		<to_code>2102775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dicyclomine</to_name>
		<to_code>3361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aclidinium</to_name>
		<to_code>1303098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropicamide</to_name>
		<to_code>10869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scopolamine</to_name>
		<to_code>9601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycopyrronium</to_name>
		<to_code>1546438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clidinium</to_name>
		<to_code>21232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiotropium</to_name>
		<to_code>69120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anticholinergic [EPC]</from_name>
		<from_code>N0000175574</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing acetylcholine receptor antagonist (product)</to_name>
		<to_code>14601000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anticholinergic [EPC]</to_name>
		<to_code>N0000175574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anticholinergic [EPC]</to_name>
		<to_code>N0000175574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergotamine Derivative [EPC]</from_name>
		<from_code>N0000175766</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergotamine</to_name>
		<to_code>4025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergotamine Derivative [EPC]</from_name>
		<from_code>N0000175766</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dihydroergotamine</to_name>
		<to_code>3418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergotamine Derivative [EPC]</from_name>
		<from_code>N0000175766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing ergotamine (medicinal product)</from_name>
		<from_code>32647002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergotamine Derivative [EPC]</to_name>
		<to_code>N0000175766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergotamine Derivative [EPC]</to_name>
		<to_code>N0000175766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Ergotamine (substance)</from_name>
		<from_code>395975005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergotamine Derivative [EPC]</to_name>
		<to_code>N0000175766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamines</to_name>
		<to_code>M0007665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing muscarinic receptor antagonist (product)</to_name>
		<to_code>26244009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trospium</to_name>
		<to_code>236778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homatropine</to_name>
		<to_code>27084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solifenacin</to_name>
		<to_code>322167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with muscarinic receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372679000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>darifenacin</to_name>
		<to_code>136198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxybutynin</to_name>
		<to_code>32675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolterodine</to_name>
		<to_code>119565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atropine</to_name>
		<to_code>1223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycopyrronium</to_name>
		<to_code>1546438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
		<from_code>N0000175700</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flavoxate</to_name>
		<to_code>4440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonist [EPC]</to_name>
		<to_code>N0000175700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Antagonist [EPC]</to_name>
		<to_code>N0000175700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Typical Antipsychotic [EPC]</from_name>
		<from_code>N0000180182</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimozide</to_name>
		<to_code>8331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Typical Antipsychotic [EPC]</from_name>
		<from_code>N0000180182</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molindone</to_name>
		<to_code>7019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Typical Antipsychotic [EPC]</from_name>
		<from_code>N0000180182</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haloperidol</to_name>
		<to_code>5093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Typical Antipsychotic [EPC]</from_name>
		<from_code>N0000180182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Typical Antipsychotic [EPC]</from_name>
		<from_code>N0000180182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Typical Antipsychotic [EPC]</from_name>
		<from_code>N0000180182</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiothixene</to_name>
		<to_code>10510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anti-psychotic agent (substance)</from_name>
		<from_code>372482001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Typical Antipsychotic [EPC]</to_name>
		<to_code>N0000180182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol hydrochloride</from_name>
		<from_code>236140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penfluridol</from_name>
		<from_code>7974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan</from_name>
		<from_code>2559612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine</from_name>
		<from_code>8042</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan L-malate</from_name>
		<from_code>2570387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine dimalonate</from_name>
		<from_code>236771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromperidol decanoate</from_name>
		<from_code>186024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline</from_name>
		<from_code>2694828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Agent [TC]</from_name>
		<from_code>N0000178312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol</from_name>
		<from_code>10804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloperidone</from_name>
		<from_code>73178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromperidol</from_name>
		<from_code>19777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>periciazine</from_name>
		<from_code>8766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone tosylate</from_name>
		<from_code>2275731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertindole</from_name>
		<from_code>41996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone</from_name>
		<from_code>2275602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline tartrate</from_name>
		<from_code>2694829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluspirilene</from_name>
		<from_code>4507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antipsychotic Agent [TC]</to_name>
		<to_code>N0000178316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amitriptyline</to_name>
		<to_code>704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desipramine</to_name>
		<to_code>3247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomipramine</to_name>
		<to_code>2597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nortriptyline</to_name>
		<to_code>7531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimipramine</to_name>
		<to_code>10834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protriptyline</to_name>
		<to_code>8886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxepin</to_name>
		<to_code>3638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Tricyclic antidepressant (substance)</to_name>
		<to_code>373253007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxapine</to_name>
		<to_code>722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tricyclic Antidepressant [EPC]</from_name>
		<from_code>N0000175752</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipramine</to_name>
		<to_code>5691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tricyclic Antidepressant [EPC]</to_name>
		<to_code>N0000175752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Affective Disorders, Psychotic</to_name>
		<to_code>M0000522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heterocyclic Compounds, 3-Ring</to_name>
		<to_code>M0010294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin</from_name>
		<from_code>3332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine hydrochloride</from_name>
		<from_code>142143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine</from_name>
		<from_code>60842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin hydrochloride</from_name>
		<from_code>142133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone</from_name>
		<from_code>1086769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone</from_name>
		<from_code>2672253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin hydrochloride</from_name>
		<from_code>236807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine mesylate</from_name>
		<from_code>60841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone hydrochloride</from_name>
		<from_code>2672254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone hydrochloride</from_name>
		<from_code>1086768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin</from_name>
		<from_code>3634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zuranolone</from_name>
		<from_code>2669905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tryptophan</from_name>
		<from_code>10898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Agent [TC]</from_name>
		<from_code>N0000178312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexanolone</from_name>
		<from_code>2121777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidepressive Agent [TC]</to_name>
		<to_code>N0000178314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole</from_name>
		<from_code>746741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone</from_name>
		<from_code>1827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin</from_name>
		<from_code>3332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin hydrochloride</from_name>
		<from_code>236807</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole dihydrochloride</from_name>
		<from_code>236747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin hydrochloride</from_name>
		<from_code>142133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine,DL-</from_name>
		<from_code>236948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine</from_name>
		<from_code>8156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kava preparation</from_name>
		<from_code>285228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin</from_name>
		<from_code>3634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder</to_name>
		<to_code>M0006033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxymorphone</to_name>
		<to_code>7814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxycodone</to_name>
		<to_code>7804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meperidine</to_name>
		<to_code>6754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing opioid receptor agonist (product)</to_name>
		<to_code>360204007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tapentadol</to_name>
		<to_code>787390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydromorphone</to_name>
		<to_code>3423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with opioid receptor agonist mechanism of action (substance)</to_name>
		<to_code>404642006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tramadol</to_name>
		<to_code>10689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000194001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine</to_name>
		<to_code>7052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dihydrocodeine</to_name>
		<to_code>23088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propoxyphene</to_name>
		<to_code>8785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sufentanil</to_name>
		<to_code>56795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine anhydrous</to_name>
		<to_code>1545976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>loperamide</to_name>
		<to_code>6468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levorphanol</to_name>
		<to_code>6378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fentanyl</to_name>
		<to_code>4337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfentanil</to_name>
		<to_code>480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone</to_name>
		<to_code>5489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methadone</to_name>
		<to_code>6813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remifentanil</to_name>
		<to_code>73032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Agonist [EPC]</from_name>
		<from_code>N0000175690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Partial Opioid Agonist [EPC]</to_name>
		<to_code>N0000175689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Agonist [EPC]</to_name>
		<to_code>N0000175690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kappa Opioid Receptor Agonist [EPC]</from_name>
		<from_code>N0000194001</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>difelikefalin</to_name>
		<to_code>2569089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
		<from_code>404642006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000194001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Analgesic (substance)</from_name>
		<from_code>373265006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000194001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing opioid receptor agonist (product)</from_name>
		<from_code>360204007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000194001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist [EPC]</from_name>
		<from_code>N0000175689</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with opioid receptor partial agonist mechanism of action (substance)</to_name>
		<to_code>373711007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist [EPC]</from_name>
		<from_code>N0000175689</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>buprenorphine</to_name>
		<to_code>1819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Partial Opioid Agonist [EPC]</from_name>
		<from_code>N0000175689</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing opioid receptor partial agonist (product)</to_name>
		<to_code>85063003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>timolol anhydrous</to_name>
		<to_code>1546004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>landiolol</to_name>
		<to_code>2712070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing beta adrenergic receptor antagonist (product)</to_name>
		<to_code>33252009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nadolol</to_name>
		<to_code>7226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoprolol</to_name>
		<to_code>6918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nebivolol</to_name>
		<to_code>31555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propranolol</to_name>
		<to_code>8787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acebutolol</to_name>
		<to_code>149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esmolol</to_name>
		<to_code>49737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvedilol</to_name>
		<to_code>20352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with beta adrenergic receptor antagonist mechanism of action (substance)</to_name>
		<to_code>373254001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>betaxolol</to_name>
		<to_code>1520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carteolol</to_name>
		<to_code>2116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levobunolol</to_name>
		<to_code>1813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bisoprolol</to_name>
		<to_code>19484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atenolol</to_name>
		<to_code>1202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>labetalol</to_name>
		<to_code>6185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175556</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pindolol</to_name>
		<to_code>8332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta-Adrenergic Blocker [EPC]</to_name>
		<to_code>N0000175556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta-Adrenergic Blocker [EPC]</to_name>
		<to_code>N0000175556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenelzine</to_name>
		<to_code>8123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocarboxazid</to_name>
		<to_code>6011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with monoamine oxidase inhibitor mechanism of action (substance)</to_name>
		<to_code>373281001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rasagiline</to_name>
		<to_code>134748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tranylcypromine</to_name>
		<to_code>10734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selegiline</to_name>
		<to_code>9639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Type B Inhibitor [EPC]</to_name>
		<to_code>N0000175762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175744</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing monoamine oxidase inhibitor (product)</to_name>
		<to_code>71770007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoamine Oxidase Inhibitor [EPC]</to_name>
		<to_code>N0000175744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
		<from_code>N0000175762</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with monoamine oxidase B inhibitor mechanism of action (substance)</to_name>
		<to_code>373242001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
		<from_code>N0000175762</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing monoamine oxidase B inhibitor (product)</to_name>
		<to_code>356844002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
		<from_code>N0000175762</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safinamide</to_name>
		<to_code>1922448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
		<from_code>N0000175762</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selegiline</to_name>
		<to_code>9639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action (substance)</to_name>
		<to_code>767560006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venlafaxine</to_name>
		<to_code>39786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desvenlafaxine</to_name>
		<to_code>734064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levomilnacipran</to_name>
		<to_code>1433212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milnacipran</to_name>
		<to_code>588250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing norepinephrine reuptake inhibitor and serotonin reuptake inhibitor (product)</to_name>
		<to_code>767562003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175749</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>duloxetine</to_name>
		<to_code>72625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valproic acid</to_name>
		<to_code>11118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lithium cation</to_name>
		<to_code>1546265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbamazepine</to_name>
		<to_code>2002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lamotrigine</to_name>
		<to_code>28439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mood Stabilizer [EPC]</from_name>
		<from_code>N0000175751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mood Disorders</to_name>
		<to_code>M0029642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Psychotropic agent (substance)</from_name>
		<from_code>418183005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mood Stabilizer [EPC]</to_name>
		<to_code>N0000175751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Agent [TC]</from_name>
		<from_code>N0000178312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimanic Agent [TC]</to_name>
		<to_code>N0000178315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mood Disorders</to_name>
		<to_code>M0029642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mood Disorders</to_name>
		<to_code>M0029642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mood Disorders</to_name>
		<to_code>M0029642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mood Disorders</to_name>
		<to_code>M0029642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mood Disorders</to_name>
		<to_code>M0029642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000190856</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with vesicular monoamine transporter 2 inhibitor mechanism of action (substance)</to_name>
		<to_code>733726005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000190856</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrabenazine</to_name>
		<to_code>10390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000190856</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vesicular monoamine transporter 2 inhibitor (product)</to_name>
		<to_code>764136005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000190856</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valbenazine</to_name>
		<to_code>1918219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Central nervous system agent (substance)</from_name>
		<from_code>372752008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</to_name>
		<to_code>N0000190856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxazosin</to_name>
		<to_code>49276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentolamine</to_name>
		<to_code>8153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvedilol</to_name>
		<to_code>20352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxybenzamine</to_name>
		<to_code>8149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dapiprazole</to_name>
		<to_code>22298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>17300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing alpha adrenergic receptor antagonist (product)</to_name>
		<to_code>67440007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with alpha adrenergic receptor antagonist mechanism of action (substance)</to_name>
		<to_code>373275009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terazosin</to_name>
		<to_code>37798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prazosin</to_name>
		<to_code>8629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamsulosin</to_name>
		<to_code>77492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Blocker [EPC]</from_name>
		<from_code>N0000175553</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silodosin</to_name>
		<to_code>720825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Adrenergic Blocker [EPC]</to_name>
		<to_code>N0000175553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rivastigmine</to_name>
		<to_code>183379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>donepezil</to_name>
		<to_code>135447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridostigmine</to_name>
		<to_code>9000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with acetylcholinesterase inhibitor mechanism of action (substance)</to_name>
		<to_code>771384007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing acetylcholinesterase inhibitor (product)</to_name>
		<to_code>789250004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malathion</to_name>
		<to_code>6606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galantamine</to_name>
		<to_code>4637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>neostigmine</to_name>
		<to_code>7315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ecothiopate</to_name>
		<to_code>89778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Inhibitor [EPC]</from_name>
		<from_code>N0000175723</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edrophonium cation</to_name>
		<to_code>1546421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Inhibitor [EPC]</to_name>
		<to_code>N0000175723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot-derived Dopamine Receptor Agonist [EPC]</from_name>
		<from_code>N0000175767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot-derived Dopamine Receptor Agonist [EPC]</from_name>
		<from_code>N0000175767</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pergolide</to_name>
		<to_code>8047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with dopamine receptor agonist mechanism of action (substance)</from_name>
		<from_code>418222008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
		<to_code>N0000175767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
		<to_code>N0000175767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing dopamine receptor agonist (product)</from_name>
		<from_code>384952006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
		<to_code>N0000175767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopaminergic Agonist [EPC]</from_name>
		<from_code>N0000175580</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing dopamine receptor agonist (product)</to_name>
		<to_code>384952006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopaminergic Agonist [EPC]</from_name>
		<from_code>N0000175580</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apomorphine</to_name>
		<to_code>1043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopaminergic Agonist [EPC]</from_name>
		<from_code>N0000175580</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with dopamine receptor agonist mechanism of action (substance)</to_name>
		<to_code>418222008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopaminergic Agonist [EPC]</to_name>
		<to_code>N0000175580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoketone [EPC]</from_name>
		<from_code>N0000180855</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Aminoketone phenylethylamine derivative (substance)</to_name>
		<to_code>406780001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoketone [EPC]</from_name>
		<from_code>N0000180855</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bupropion</to_name>
		<to_code>42347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminoketone [EPC]</to_name>
		<to_code>N0000180855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>botulinum toxin type A</to_name>
		<to_code>1712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with acetylcholinesterase inhibitor mechanism of action (substance)</to_name>
		<to_code>771384007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing acetylcholinesterase inhibitor (product)</to_name>
		<to_code>789250004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abobotulinumtoxinA</to_name>
		<to_code>860168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>letibotulinumtoxinA</to_name>
		<to_code>2689280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
		<from_code>N0000175771</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimabotulinumtoxinB</to_name>
		<to_code>860178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Neuromuscular blocking agent (substance)</from_name>
		<from_code>373295003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitor [EPC]</to_name>
		<to_code>N0000175771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing neuromuscular blocker (product)</from_name>
		<from_code>87586001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Acetylcholine Release Inhibitor [EPC]</to_name>
		<to_code>N0000175771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Striated Muscle Tone Alteration [PE]</from_name>
		<from_code>N0000175734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene</from_name>
		<from_code>3105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene sodium</from_name>
		<from_code>3106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skeletal Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Tone [PE]</to_name>
		<to_code>N0000175735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Acetylcholine Activity [PE]</from_name>
		<from_code>N0000008735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot Derivative [EPC]</from_name>
		<from_code>N0000175827</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing ergot alkaloid (product)</to_name>
		<to_code>350623006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot Derivative [EPC]</from_name>
		<from_code>N0000175827</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabergoline</to_name>
		<to_code>47579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot Derivative [EPC]</from_name>
		<from_code>N0000175827</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bromocriptine</to_name>
		<to_code>1760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot Derivative [EPC]</from_name>
		<from_code>N0000175827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot Derivative [EPC]</from_name>
		<from_code>N0000175827</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Ergot alkaloid (substance)</to_name>
		<to_code>32824001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ergot Derivative [EPC]</from_name>
		<from_code>N0000175827</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylergonovine</to_name>
		<to_code>6883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ergot Derivative [EPC]</to_name>
		<to_code>N0000175827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide</from_name>
		<from_code>8047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabergoline</from_name>
		<from_code>47579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot alkaloids</from_name>
		<from_code>4023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide mesylate</from_name>
		<from_code>8048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergot Alkaloids</to_name>
		<to_code>M0007656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma-1 Agonist [EPC]</from_name>
		<from_code>N0000182149</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing sigma-1 receptor agonist (product)</to_name>
		<to_code>764143004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma-1 Agonist [EPC]</from_name>
		<from_code>N0000182149</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dextromethorphan</to_name>
		<to_code>3289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sigma-1 Agonist [EPC]</from_name>
		<from_code>N0000182149</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with sigma-1 receptor agonist mechanism of action (substance)</to_name>
		<to_code>764142009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sigma-1 Agonist [EPC]</to_name>
		<to_code>N0000182149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Agonist [EPC]</from_name>
		<from_code>N0000175840</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>xanomeline</to_name>
		<to_code>2694828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinergic Muscarinic Agonist [EPC]</from_name>
		<from_code>N0000175840</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bethanechol</to_name>
		<to_code>19257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with acetylcholine receptor agonist mechanism of action (substance)</from_name>
		<from_code>421148003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
		<to_code>N0000175840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing acetylcholine receptor agonist (product)</from_name>
		<from_code>420383004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
		<to_code>N0000175840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
		<to_code>N0000175840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ziprasidone</to_name>
		<to_code>115698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cariprazine</to_name>
		<to_code>1667655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lurasidone</to_name>
		<to_code>1040028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risperidone</to_name>
		<to_code>35636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clozapine</to_name>
		<to_code>2626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quetiapine</to_name>
		<to_code>51272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olanzapine</to_name>
		<to_code>61381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brexpiprazole</to_name>
		<to_code>1658314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimavanserin</to_name>
		<to_code>1791685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iloperidone</to_name>
		<to_code>73178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lumateperone</to_name>
		<to_code>2275602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asenapine</to_name>
		<to_code>784649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paliperidone</to_name>
		<to_code>679314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Atypical Antipsychotic [EPC]</from_name>
		<from_code>N0000175430</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aripiprazole</to_name>
		<to_code>89013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anti-psychotic agent (substance)</from_name>
		<from_code>372482001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Atypical Antipsychotic [EPC]</to_name>
		<to_code>N0000175430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloperidone</from_name>
		<from_code>73178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromperidol</from_name>
		<from_code>19777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol hydrochloride</from_name>
		<from_code>236140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penfluridol</from_name>
		<from_code>7974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol</from_name>
		<from_code>10804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromperidol decanoate</from_name>
		<from_code>186024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia Spectrum and Other Psychotic Disorders</to_name>
		<to_code>M0029660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Reactivator [EPC]</from_name>
		<from_code>N0000175742</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing cholinesterase reactivator (product)</to_name>
		<to_code>350077009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Reactivator [EPC]</from_name>
		<from_code>N0000175742</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with cholinesterase reactivator mechanism of action (substance)</to_name>
		<to_code>372629003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholinesterase Reactivator [EPC]</from_name>
		<from_code>N0000175742</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralidoxime</to_name>
		<to_code>34345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interaction [APC]</from_name>
		<from_code>N0000193898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivator [EPC]</to_name>
		<to_code>N0000175742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholinesterase Reactivator [EPC]</to_name>
		<to_code>N0000175742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid [EPC]</from_name>
		<from_code>N0000175782</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with cannabinoid receptor agonist mechanism of action (substance)</to_name>
		<to_code>771355003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid [EPC]</from_name>
		<from_code>N0000175782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cannabinoids</to_name>
		<to_code>M0003267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid [EPC]</from_name>
		<from_code>N0000175782</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing cannabinoid receptor agonist mechanism of action (product)</to_name>
		<to_code>1290111004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid [EPC]</from_name>
		<from_code>N0000175782</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dronabinol</to_name>
		<to_code>10402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cannabinoid [EPC]</from_name>
		<from_code>N0000175782</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nabilone</to_name>
		<to_code>31447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid [EPC]</to_name>
		<to_code>N0000175782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cannabinoid [EPC]</to_name>
		<to_code>N0000175782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cannabinoids</to_name>
		<to_code>M0003267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cannabinoids</to_name>
		<to_code>M0003267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cannabinoids</to_name>
		<to_code>M0003267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175695</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atomoxetine</to_name>
		<to_code>38400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175695</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing norepinephrine reuptake inhibitor (product)</to_name>
		<to_code>407035002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175695</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viloxazine</to_name>
		<to_code>11196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175695</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with norepinephrine reuptake inhibitor mechanism of action (substance)</to_name>
		<to_code>407034003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palonosetron</to_name>
		<to_code>70561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dolasetron</to_name>
		<to_code>68091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ondansetron</to_name>
		<to_code>26225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing 5-hydroxytryptamine-3-receptor antagonist (product)</to_name>
		<to_code>108417002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with 5-hydroxytryptamine-3-receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372486003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alosetron</to_name>
		<to_code>85248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175818</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>granisetron</to_name>
		<to_code>26237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-3 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluvoxamine</to_name>
		<to_code>42355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citalopram</to_name>
		<to_code>2556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertraline</to_name>
		<to_code>36437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxetine</to_name>
		<to_code>32937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with serotonin re-uptake inhibitor mechanism of action (substance)</to_name>
		<to_code>373225007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing selective serotonin re-uptake inhibitor (product)</to_name>
		<to_code>349854005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nefazodone</to_name>
		<to_code>31565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>escitalopram</to_name>
		<to_code>321988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluoxetine</to_name>
		<to_code>4493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000175696</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trazodone</to_name>
		<to_code>10737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
		<from_code>N0000194049</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solriamfetol</to_name>
		<to_code>2121751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with norepinephrine reuptake inhibitor mechanism of action (substance)</from_name>
		<from_code>407034003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000194049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing dopamine reuptake inhibitor (product)</from_name>
		<from_code>768668007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000194049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with dopamine reuptake inhibitor mechanism of action (substance)</from_name>
		<from_code>763198001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000194049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing norepinephrine reuptake inhibitor (product)</from_name>
		<from_code>407035002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
		<to_code>N0000194049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
		<to_code>N0000185010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing serotonin receptor agonist (product)</from_name>
		<from_code>870489008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
		<to_code>N0000185010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with serotonin receptor agonist mechanism of action (substance)</from_name>
		<from_code>783923008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
		<to_code>N0000185010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depressant [EPC]</from_name>
		<from_code>N0000175758</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxybutyric acid</to_name>
		<to_code>1546380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depressant [EPC]</from_name>
		<from_code>N0000175758</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Central depressant (substance)</to_name>
		<to_code>9680003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depressant [EPC]</from_name>
		<from_code>N0000175758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depressant [EPC]</from_name>
		<from_code>N0000175758</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxybate</to_name>
		<to_code>2387302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depressant [EPC]</from_name>
		<from_code>N0000175758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
		<from_code>N0000008501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
		<from_code>N0000008501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebellum Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
		<from_code>N0000008501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Midbrain Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
		<from_code>N0000008501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
		<from_code>N0000008501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Spinal Cord Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone resin complex</from_name>
		<from_code>314667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone hydrochloride</from_name>
		<from_code>236931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital sodium</from_name>
		<from_code>91109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone bitartrate</from_name>
		<from_code>142439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Organized Electrical Activity [PE]</from_name>
		<from_code>N0000008768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin carbamate</from_name>
		<from_code>20880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybate</from_name>
		<from_code>2387302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethopropazine hydrochloride</from_name>
		<from_code>6541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine</from_name>
		<from_code>57258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>profenamine</from_name>
		<from_code>4134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine hydrochloride</from_name>
		<from_code>236460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital</from_name>
		<from_code>477631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone polistirex</from_name>
		<from_code>221107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-hydroxybutyric acid</from_name>
		<from_code>1546380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem tartrate</from_name>
		<from_code>221183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone hydrochloride</from_name>
		<from_code>203177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone tannate</from_name>
		<from_code>597355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin</from_name>
		<from_code>2399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone</from_name>
		<from_code>3423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebellum Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebellum Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Midbrain Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Midbrain Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Spinal Cord Organized Electrical Activity [PE]</to_name>
		<to_code>N0000008945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depression [PE]</from_name>
		<from_code>N0000175728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depression [PE]</from_name>
		<from_code>N0000175728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depression [PE]</from_name>
		<from_code>N0000175728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Depression [PE]</from_name>
		<from_code>N0000175728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoheptazine</from_name>
		<from_code>24484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suvorexant</from_name>
		<from_code>1547099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Activity Alteration [PE]</from_name>
		<from_code>N0000175724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zaleplon</from_name>
		<from_code>74667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-hydroxybutyric acid</from_name>
		<from_code>1546380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brivaracetam</from_name>
		<from_code>1739745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoheptazine citrate</from_name>
		<from_code>235416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baclofen</from_name>
		<from_code>1292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybate</from_name>
		<from_code>2387302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Depression [PE]</to_name>
		<to_code>N0000175728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital</from_name>
		<from_code>8004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital sodium</from_name>
		<from_code>203085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine</from_name>
		<from_code>48937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthesia [PE]</to_name>
		<to_code>N0000175975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant chloride hydrochloride</from_name>
		<from_code>2044416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone</from_name>
		<from_code>3626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine</from_name>
		<from_code>10471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymol</from_name>
		<from_code>10553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone maleate</from_name>
		<from_code>236099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiemetic [EPC]</from_name>
		<from_code>N0000178372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine maleate</from_name>
		<from_code>71529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Motility [PE]</from_name>
		<from_code>N0000008635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant</from_name>
		<from_code>2044417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Emesis Suppression [PE]</to_name>
		<to_code>N0000009034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil</from_name>
		<from_code>73032</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine hydrochloride</from_name>
		<from_code>203197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate potassium chloride</from_name>
		<from_code>1789517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine citrate</from_name>
		<from_code>221141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine</from_name>
		<from_code>8120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone resin complex</from_name>
		<from_code>314667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone hydrochloride</from_name>
		<from_code>236931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil citrate</from_name>
		<from_code>58964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine</from_name>
		<from_code>4845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone hydrochloride</from_name>
		<from_code>2122776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone hydrochloride</from_name>
		<from_code>218337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone bitartrate</from_name>
		<from_code>142439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone</from_name>
		<from_code>6813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil</from_name>
		<from_code>480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine polistirex</from_name>
		<from_code>236792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil hydrochloride</from_name>
		<from_code>203203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil hydrochloride</from_name>
		<from_code>236540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone piperazine</from_name>
		<from_code>236354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone hydrochloride</from_name>
		<from_code>203177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol hydrochloride</from_name>
		<from_code>857492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol hydrochloride</from_name>
		<from_code>82110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate</from_name>
		<from_code>4847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone tannate</from_name>
		<from_code>597355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene napsylate</from_name>
		<from_code>8786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone</from_name>
		<from_code>3423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine</from_name>
		<from_code>23744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oliceridine fumarate</from_name>
		<from_code>2392633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene hydrochloride</from_name>
		<from_code>71517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine hydrochloride</from_name>
		<from_code>91188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone sodium</from_name>
		<from_code>236529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone</from_name>
		<from_code>8160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sensory System Activity Alteration [PE]</from_name>
		<from_code>N0000175727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol</from_name>
		<from_code>10689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil</from_name>
		<from_code>56795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oliceridine</from_name>
		<from_code>2392230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine resin complex</from_name>
		<from_code>314786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene</from_name>
		<from_code>8785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone polistirex</from_name>
		<from_code>221107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine</from_name>
		<from_code>33408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine hydrochloride</from_name>
		<from_code>236608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Analgesia [PE]</to_name>
		<to_code>N0000175439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphetamine Anorectic [EPC]</from_name>
		<from_code>N0000175425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Appetite Alteration [PE]</from_name>
		<from_code>N0000175371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin</from_name>
		<from_code>1300701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retatrutide</from_name>
		<from_code>2722410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide</from_name>
		<from_code>139953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
		<from_code>N0000175423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride hemihydrate</from_name>
		<from_code>1597623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide acetate</from_name>
		<from_code>356773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride</from_name>
		<from_code>1300700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride anhydrous</from_name>
		<from_code>1808546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Suppression [PE]</to_name>
		<to_code>N0000175372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonergot Dopamine Agonist [EPC]</from_name>
		<from_code>N0000175768</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramipexole</to_name>
		<to_code>746741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonergot Dopamine Agonist [EPC]</from_name>
		<from_code>N0000175768</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropinirole</to_name>
		<to_code>72302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonergot Dopamine Agonist [EPC]</from_name>
		<from_code>N0000175768</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rotigotine</to_name>
		<to_code>616739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with dopamine receptor agonist mechanism of action (substance)</from_name>
		<from_code>418222008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonergot Dopamine Agonist [EPC]</to_name>
		<to_code>N0000175768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonergot Dopamine Agonist [EPC]</to_name>
		<to_code>N0000175768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing dopamine receptor agonist (product)</from_name>
		<from_code>384952006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonergot Dopamine Agonist [EPC]</to_name>
		<to_code>N0000175768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melatonin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175743</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tasimelteon</to_name>
		<to_code>1490468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melatonin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175743</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with melatonin agonist mechanism of action (substance)</to_name>
		<to_code>420177007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melatonin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175743</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramelteon</to_name>
		<to_code>596205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melatonin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175743</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing melatonin agonist (product)</to_name>
		<to_code>419304003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melatonin Receptor Agonist [EPC]</to_name>
		<to_code>N0000175743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Agent [APC]</from_name>
		<from_code>N0000193910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
		<to_code>N0000175423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Agent [APC]</from_name>
		<from_code>N0000193910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphetamine Anorectic [EPC]</to_name>
		<to_code>N0000175425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Agent [APC]</from_name>
		<from_code>N0000193910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine [EPC]</to_name>
		<to_code>N0000175570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Agent [APC]</from_name>
		<from_code>N0000193910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic-like Agent [EPC]</to_name>
		<to_code>N0000175769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Agent [APC]</from_name>
		<from_code>N0000193910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Receptor Agonist [EPC]</to_name>
		<to_code>N0000175883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Agent [APC]</from_name>
		<from_code>N0000193910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Releasing Agent [EPC]</to_name>
		<to_code>N0000192563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
		<from_code>N0000175423</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benzphetamine</to_name>
		<to_code>1422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
		<from_code>N0000175423</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phendimetrazine</to_name>
		<to_code>33272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
		<from_code>N0000175423</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diethylpropion</to_name>
		<to_code>3389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
		<from_code>N0000175423</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentermine</to_name>
		<to_code>8152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
		<from_code>N0000175423</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Central nervous system agent (substance)</from_name>
		<from_code>372752008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
		<to_code>N0000175423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
		<to_code>N0000175423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Sympathomimetic agent (substance)</from_name>
		<from_code>372884008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
		<to_code>N0000175423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sympathomimetic (product)</from_name>
		<from_code>86308005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
		<to_code>N0000175423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic VIP Activity [PE]</to_name>
		<to_code>N0000009688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic GABA Activity [PE]</to_name>
		<to_code>N0000009676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Gastrin Activity [PE]</to_name>
		<to_code>N0000009677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Glycine Activity [PE]</to_name>
		<to_code>N0000009679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Neurotensin Activity [PE]</to_name>
		<to_code>N0000009682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
		<to_code>N0000009681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Epinephrine Activity [PE]</to_name>
		<to_code>N0000009675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Enkephalin Activity [PE]</to_name>
		<to_code>N0000009674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Dynorphin Activity [PE]</to_name>
		<to_code>N0000009672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Endorphin Activity [PE]</to_name>
		<to_code>N0000009673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic CCK Activity [PE]</to_name>
		<to_code>N0000009669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Acetylcholine Activity [PE]</to_name>
		<to_code>N0000009666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Glutamate Activity [PE]</to_name>
		<to_code>N0000009678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Substance P Activity [PE]</to_name>
		<to_code>N0000009687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
		<to_code>N0000009668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Aspartate Activity [PE]</to_name>
		<to_code>N0000009667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Dopamine Activity [PE]</to_name>
		<to_code>N0000009671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>modafinil</from_name>
		<from_code>30125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathetic Activity Alteration [PE]</from_name>
		<from_code>N0000175647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>armodafinil</from_name>
		<from_code>641465</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline</from_name>
		<from_code>7812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic-like Agent [EPC]</from_name>
		<from_code>N0000175769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System VIP Activity [PE]</from_name>
		<from_code>N0000009112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic VIP Activity [PE]</to_name>
		<to_code>N0000009688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System GABA Activity [PE]</from_name>
		<from_code>N0000009100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic GABA Activity [PE]</to_name>
		<to_code>N0000009676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Gastrin Activity [PE]</from_name>
		<from_code>N0000009101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Gastrin Activity [PE]</to_name>
		<to_code>N0000009677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Glycine Activity [PE]</from_name>
		<from_code>N0000009103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Glycine Activity [PE]</to_name>
		<to_code>N0000009679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Neurotensin Activity [PE]</from_name>
		<from_code>N0000009106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Neurotensin Activity [PE]</to_name>
		<to_code>N0000009682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Nerve Growth Factor Activity [PE]</from_name>
		<from_code>N0000009105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
		<to_code>N0000009681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Epinephrine Activity [PE]</from_name>
		<from_code>N0000009099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Epinephrine Activity [PE]</to_name>
		<to_code>N0000009675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
		<from_code>N0000009502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Enkephalin Activity [PE]</to_name>
		<to_code>N0000009674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
		<from_code>N0000009500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Dynorphin Activity [PE]</to_name>
		<to_code>N0000009672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Endorphin Activity [PE]</from_name>
		<from_code>N0000009501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Endorphin Activity [PE]</to_name>
		<to_code>N0000009673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System CCK Activity [PE]</from_name>
		<from_code>N0000009093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic CCK Activity [PE]</to_name>
		<to_code>N0000009669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Acetylcholine Activity [PE]</from_name>
		<from_code>N0000009090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Acetylcholine Activity [PE]</to_name>
		<to_code>N0000009666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Glutamate Activity [PE]</from_name>
		<from_code>N0000009102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Glutamate Activity [PE]</to_name>
		<to_code>N0000009678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Substance P Activity [PE]</from_name>
		<from_code>N0000009111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Substance P Activity [PE]</to_name>
		<to_code>N0000009687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
		<from_code>N0000009092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
		<to_code>N0000009668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Aspartate Activity [PE]</from_name>
		<from_code>N0000009091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Aspartate Activity [PE]</to_name>
		<to_code>N0000009667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Dopamine Activity [PE]</from_name>
		<from_code>N0000009095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sympathetic Dopamine Activity [PE]</to_name>
		<to_code>N0000009671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphetamine Anorectic [EPC]</from_name>
		<from_code>N0000175425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphetamine Anorectic [EPC]</from_name>
		<from_code>N0000175425</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Amfetamine (substance)</to_name>
		<to_code>703842006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphetamine Anorectic [EPC]</from_name>
		<from_code>N0000175425</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing amfetamine (medicinal product)</to_name>
		<to_code>22672005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphetamine Anorectic [EPC]</from_name>
		<from_code>N0000175425</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methamphetamine</to_name>
		<to_code>6816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphetamine Anorectic [EPC]</to_name>
		<to_code>N0000175425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphetamines</to_name>
		<to_code>M0001015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine [EPC]</from_name>
		<from_code>N0000175570</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine</to_name>
		<to_code>3992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine [EPC]</from_name>
		<from_code>N0000175570</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>norepinephrine</to_name>
		<to_code>7512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine [EPC]</from_name>
		<from_code>N0000175570</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Catecholamine (substance)</to_name>
		<to_code>34582008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine [EPC]</from_name>
		<from_code>N0000175570</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine [EPC]</from_name>
		<from_code>N0000175570</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing catecholamine (product)</to_name>
		<to_code>766970009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine [EPC]</from_name>
		<from_code>N0000175570</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dopamine</to_name>
		<to_code>3628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine [EPC]</to_name>
		<to_code>N0000175570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine [EPC]</to_name>
		<to_code>N0000175570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droxidopa</from_name>
		<from_code>1489913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine</from_name>
		<from_code>7512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catecholamines</to_name>
		<to_code>M0003647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathomimetic-like Agent [EPC]</from_name>
		<from_code>N0000175769</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>modafinil</to_name>
		<to_code>30125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sympathomimetic (product)</from_name>
		<from_code>86308005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic-like Agent [EPC]</to_name>
		<to_code>N0000175769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Sympathomimetic agent (substance)</from_name>
		<from_code>372884008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sympathomimetic-like Agent [EPC]</to_name>
		<to_code>N0000175769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing adrenergic receptor agonist (product)</to_name>
		<to_code>764374006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-hydroxyamphetamine</to_name>
		<to_code>7839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinastine</to_name>
		<to_code>39684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000175552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta-Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000175555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenergic Receptor Agonist [EPC]</from_name>
		<from_code>N0000175883</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with adrenergic receptor agonist mechanism of action (substance)</to_name>
		<to_code>712886002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenergic Receptor Agonist [EPC]</to_name>
		<to_code>N0000175883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing alpha adrenergic receptor agonist (product)</to_name>
		<to_code>349917000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine</to_name>
		<to_code>3966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with alpha adrenergic receptor agonist mechanism of action (substance)</to_name>
		<to_code>372622007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-1 Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000186105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine</to_name>
		<to_code>3992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoephedrine</to_name>
		<to_code>8896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central alpha-2 Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000175554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brimonidine</to_name>
		<to_code>134615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midodrine</to_name>
		<to_code>6963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175552</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apraclonidine</to_name>
		<to_code>14845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-1 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000186105</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylephrine</to_name>
		<to_code>8163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing alpha adrenergic receptor agonist (product)</from_name>
		<from_code>349917000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-1 Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000186105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with alpha adrenergic receptor agonist mechanism of action (substance)</from_name>
		<from_code>372622007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-1 Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000186105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanabenz</to_name>
		<to_code>5033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)</to_name>
		<to_code>789268001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonidine</to_name>
		<to_code>2599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dexmedetomidine</to_name>
		<to_code>48937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldopa anhydrous</to_name>
		<to_code>1545996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing central alpha-2 adrenergic receptor agonist (product)</to_name>
		<to_code>789270005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tizanidine</to_name>
		<to_code>57258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175554</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanfacine</to_name>
		<to_code>40114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with beta adrenergic receptor agonist mechanism of action (substance)</to_name>
		<to_code>373227004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine</to_name>
		<to_code>3966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoproterenol</to_name>
		<to_code>6054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta3-Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000185008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine</to_name>
		<to_code>3992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta2-Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000175779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing beta adrenergic receptor agonist (product)</to_name>
		<to_code>349920008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175555</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dobutamine</to_name>
		<to_code>3616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta3-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000185008</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vibegron</to_name>
		<to_code>2472254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta3-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000185008</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirabegron</to_name>
		<to_code>1300786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta3-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000185008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with beta adrenergic receptor agonist mechanism of action (substance)</from_name>
		<from_code>373227004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta3-Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000185008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing beta adrenergic receptor agonist (product)</from_name>
		<from_code>349920008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta3-Adrenergic Agonist [EPC]</to_name>
		<to_code>N0000185008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vibegron</from_name>
		<from_code>2472254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fesoterodine</from_name>
		<from_code>797195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trospium</from_name>
		<from_code>236778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trospium chloride</from_name>
		<from_code>38891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine tartrate</from_name>
		<from_code>221174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fesoterodine fumarate</from_name>
		<from_code>797196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirabegron</from_name>
		<from_code>1300786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bladder Contractility Alteration [PE]</from_name>
		<from_code>N0000008305</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine</from_name>
		<from_code>119565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bladder Contractility [PE]</to_name>
		<to_code>N0000008420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levalbuterol</to_name>
		<to_code>237159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmeterol</to_name>
		<to_code>36117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vilanterol</to_name>
		<to_code>1424884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arformoterol</to_name>
		<to_code>304962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olodaterol</to_name>
		<to_code>1546059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)</to_name>
		<to_code>373215002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>formoterol</to_name>
		<to_code>25255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albuterol</to_name>
		<to_code>435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta2-Adrenergic Agonist [EPC]</from_name>
		<from_code>N0000175779</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing beta-2 adrenergic receptor agonist (product)</to_name>
		<to_code>320073005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Releasing Agent [EPC]</from_name>
		<from_code>N0000192563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Releasing Agent [EPC]</from_name>
		<from_code>N0000192563</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine</to_name>
		<to_code>3966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with adrenergic receptor agonist mechanism of action (substance)</from_name>
		<from_code>712886002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Releasing Agent [EPC]</to_name>
		<to_code>N0000192563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing adrenergic receptor agonist (product)</from_name>
		<from_code>764374006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Norepinephrine Releasing Agent [EPC]</to_name>
		<to_code>N0000192563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Muscular System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Norepinephrine Activity Alteration [PE]</from_name>
		<from_code>N0000009765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine hydrochloride</from_name>
		<from_code>228054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol</from_name>
		<from_code>10689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol</from_name>
		<from_code>2121751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine</from_name>
		<from_code>48937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol hydrochloride</from_name>
		<from_code>82110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solriamfetol hydrochloride</from_name>
		<from_code>2121750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Midbrain Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Spinal Cord Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebellum Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin hydrochloride</from_name>
		<from_code>142133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran hydrochloride</from_name>
		<from_code>30003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin hydrochloride</from_name>
		<from_code>236807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran</from_name>
		<from_code>588250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibenzepin</from_name>
		<from_code>3332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dothiepin</from_name>
		<from_code>3634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mazindol</from_name>
		<from_code>6664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine</from_name>
		<from_code>38400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cardiac Muscle Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Smooth Muscle Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Striated Muscle Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Enteric Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000009108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Parasympathetic Activity [PE]</from_name>
		<from_code>N0000175649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000009489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prochlorperazine</to_name>
		<to_code>8704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promethazine</to_name>
		<to_code>8745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpromazine</to_name>
		<to_code>2403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perphenazine</to_name>
		<to_code>8076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Phenothiazine and/or phenothiazine derivative (substance)</to_name>
		<to_code>767621000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioridazine</to_name>
		<to_code>10502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluoperazine</to_name>
		<to_code>10800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing phenothiazine (product)</to_name>
		<to_code>765430004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenothiazine [EPC]</from_name>
		<from_code>N0000175746</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluphenazine</to_name>
		<to_code>4496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenothiazine [EPC]</to_name>
		<to_code>N0000175746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenothiazines</to_name>
		<to_code>M0016525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175800</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>droperidol</to_name>
		<to_code>3648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175800</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoclopramide</to_name>
		<to_code>6915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175800</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with dopamine receptor D2 antagonist mechanism of action (substance)</to_name>
		<to_code>766792003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175800</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing dopamine receptor D2 antagonist (product)</to_name>
		<to_code>766793008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175800</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amisulpride</to_name>
		<to_code>46303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dopamine-2 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethosuximide</to_name>
		<to_code>4135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lamotrigine</to_name>
		<to_code>28439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>felbamate</to_name>
		<to_code>24812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valproic acid</to_name>
		<to_code>11118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenytoin</to_name>
		<to_code>8183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Anticonvulsant (substance)</to_name>
		<to_code>255632006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vigabatrin</to_name>
		<to_code>14851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiagabine</to_name>
		<to_code>31914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zonisamide</to_name>
		<to_code>39998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methsuximide</to_name>
		<to_code>47858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxcarbazepine</to_name>
		<to_code>32624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-epileptic Agent [EPC]</from_name>
		<from_code>N0000175753</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>primidone</to_name>
		<to_code>8691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
		<from_code>N0000008486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
		<from_code>N0000008486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Spinal Cord Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
		<from_code>N0000008486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebral Cortex Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
		<from_code>N0000008486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Midbrain Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
		<from_code>N0000008486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebellum Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethosuximide</from_name>
		<from_code>4135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felbamate</from_name>
		<from_code>24812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine</from_name>
		<from_code>1482502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levetiracetam</from_name>
		<from_code>114477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethadione</from_name>
		<from_code>10827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxcarbazepine</from_name>
		<from_code>32624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacosamide</from_name>
		<from_code>623400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephenytoin</from_name>
		<from_code>6757</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine acetate</from_name>
		<from_code>1482501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vigabatrin</from_name>
		<from_code>14851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Disorganized Electrical Activity [PE]</from_name>
		<from_code>N0000008578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methsuximide</from_name>
		<from_code>47858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
		<to_code>N0000008486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethosuximide</from_name>
		<from_code>4135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felbamate</from_name>
		<from_code>24812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium valproate</from_name>
		<from_code>1927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethadione</from_name>
		<from_code>10827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levetiracetam</from_name>
		<from_code>114477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxcarbazepine</from_name>
		<from_code>32624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacosamide</from_name>
		<from_code>623400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephenytoin</from_name>
		<from_code>6757</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproate</from_name>
		<from_code>40254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium valproate</from_name>
		<from_code>134422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vigabatrin</from_name>
		<from_code>14851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Agent [TC]</from_name>
		<from_code>N0000178312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methsuximide</from_name>
		<from_code>47858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenobamate</from_name>
		<from_code>2265690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-epileptic Agent [TC]</to_name>
		<to_code>N0000178313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felbamate</from_name>
		<from_code>24812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethosuximide</from_name>
		<from_code>4135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentylenetetrazole</from_name>
		<from_code>8015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metharbital</from_name>
		<from_code>6825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium valproate</from_name>
		<from_code>1927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levetiracetam</from_name>
		<from_code>114477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethadione</from_name>
		<from_code>10827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxcarbazepine</from_name>
		<from_code>32624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacosamide</from_name>
		<from_code>623400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproate</from_name>
		<from_code>40254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephenytoin</from_name>
		<from_code>6757</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vigabatrin</from_name>
		<from_code>14851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium valproate</from_name>
		<from_code>134422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methsuximide</from_name>
		<from_code>47858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epilepsy</to_name>
		<to_code>M0007564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caffeine</to_name>
		<to_code>1886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Central stimulant (substance)</to_name>
		<to_code>372620004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dexmethylphenidate</to_name>
		<to_code>352372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dextroamphetamine</to_name>
		<to_code>3288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylphenidate</to_name>
		<to_code>6901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lisdexamfetamine</to_name>
		<to_code>700810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetamine</to_name>
		<to_code>725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulant [EPC]</from_name>
		<from_code>N0000175739</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methamphetamine</to_name>
		<to_code>6816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Stimulation [PE]</from_name>
		<from_code>N0000175729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Stimulation [PE]</to_name>
		<to_code>N0000175373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnorepinephrine hydrochloride</from_name>
		<from_code>289080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>modafinil</from_name>
		<from_code>30125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine dimesylate</from_name>
		<from_code>673579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride dihydrate</from_name>
		<from_code>1010598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene hydrochloride</from_name>
		<from_code>236069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene</from_name>
		<from_code>31479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnorepinephrine</from_name>
		<from_code>156240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine citrate</from_name>
		<from_code>20033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine</from_name>
		<from_code>1886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serdexmethylphenidate</from_name>
		<from_code>2562176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone</from_name>
		<from_code>7242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risdiplam</from_name>
		<from_code>2390935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Activity Alteration [PE]</from_name>
		<from_code>N0000175724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine</from_name>
		<from_code>700810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride</from_name>
		<from_code>203192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serdexmethylphenidate chloride</from_name>
		<from_code>2562177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Central Nervous System Stimulation [PE]</to_name>
		<to_code>N0000175729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol acetate</from_name>
		<from_code>29451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Stimulation [PE]</to_name>
		<to_code>N0000175373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol</from_name>
		<from_code>6703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Stimulation [PE]</to_name>
		<to_code>N0000175373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Appetite Alteration [PE]</from_name>
		<from_code>N0000175371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Stimulation [PE]</to_name>
		<to_code>N0000175373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginseng preparation</from_name>
		<from_code>325526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Appetite Stimulation [PE]</to_name>
		<to_code>N0000175373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eletriptan</to_name>
		<to_code>231049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zolmitriptan</to_name>
		<to_code>135775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>frovatriptan</to_name>
		<to_code>228783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naratriptan</to_name>
		<to_code>141366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sumatriptan</to_name>
		<to_code>37418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rizatriptan</to_name>
		<to_code>88014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
		<from_code>N0000175765</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almotriptan</to_name>
		<to_code>279645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing serotonin 5-hydroxytryptamine-1 receptor agonist (product)</from_name>
		<from_code>363560004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
		<to_code>N0000175765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with serotonin 5-hydroxytryptamine-1 receptor agonist mechanism of action (substance)</from_name>
		<from_code>108405004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
		<to_code>N0000175765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
		<to_code>N0000175765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonist [EPC]</to_name>
		<to_code>N0000175973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Erythropoiesis-stimulating Agent [EPC]</to_name>
		<to_code>N0000175665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hemoglobin S Polymerization Inhibitor [EPC]</to_name>
		<to_code>N0000194027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-inhibitor Coagulant Complex [EPC]</to_name>
		<to_code>N0000184166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Serum Albumin [EPC]</to_name>
		<to_code>N0000184174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unfractionated Heparin [EPC]</to_name>
		<to_code>N0000175474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Direct Thrombin Inhibitor [EPC]</to_name>
		<to_code>N0000175518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-coagulant [EPC]</to_name>
		<to_code>N0000175980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Reversal Agent [EPC]</to_name>
		<to_code>N0000175983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Antagonist [EPC]</to_name>
		<to_code>N0000175476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor VIII Activator [EPC]</to_name>
		<to_code>N0000175916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombolytic Agent [EPC]</to_name>
		<to_code>N0000175526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hematopoietic Stem Cell Mobilizer [EPC]</to_name>
		<to_code>N0000178326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifibrinolytic Agent [EPC]</to_name>
		<to_code>N0000175634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Low Molecular Weight Heparin [EPC]</to_name>
		<to_code>N0000175586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Warfarin Reversal Agent [EPC]</to_name>
		<to_code>N0000175966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitor [EPC]</to_name>
		<to_code>N0000175575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</to_name>
		<to_code>N0000194160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet Aggregation Inhibitor [EPC]</to_name>
		<to_code>N0000175578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Antihemophilic Factor [EPC]</to_name>
		<to_code>N0000184167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasma Volume Expander [EPC]</to_name>
		<to_code>N0000184175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platelet-reducing Agent [EPC]</to_name>
		<to_code>N0000175638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Blood Viscosity Reducer [EPC]</to_name>
		<to_code>N0000175895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Blood Coagulation Factor [EPC]</to_name>
		<to_code>N0000184168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Erythroid Maturation Agent [EPC]</to_name>
		<to_code>N0000194025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitor [EPC]</to_name>
		<to_code>N0000175637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematology Agent [APC]</from_name>
		<from_code>N0000193901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Blood Coagulation Factor [EPC]</to_name>
		<to_code>N0000184169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with thrombopoietin receptor agonist mechanism of action (substance)</to_name>
		<to_code>438997005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing thrombopoietin receptor agonist (product)</to_name>
		<to_code>439123005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romiplostim</to_name>
		<to_code>805452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
		<from_code>N0000175973</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eltrombopag</to_name>
		<to_code>711942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thrombopoietin Receptor Agonist [EPC]</to_name>
		<to_code>N0000175973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lusutrombopag</from_name>
		<from_code>2054984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag choline</from_name>
		<from_code>2675185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Megakaryocte Cell Production [PE]</from_name>
		<from_code>N0000009395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romiplostim</from_name>
		<from_code>805452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag</from_name>
		<from_code>711942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lusutrombopag</from_name>
		<from_code>2054984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eltrombopag choline</from_name>
		<from_code>2675185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag</from_name>
		<from_code>2045726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag maleate</from_name>
		<from_code>2045727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oprelvekin</from_name>
		<from_code>139994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romiplostim</from_name>
		<from_code>805452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Hematopoiesis [PE]</from_name>
		<from_code>N0000009350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Production [PE]</to_name>
		<to_code>N0000175970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>darbepoetin alfa</to_name>
		<to_code>283838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Erythropoietin (substance)</to_name>
		<to_code>83042003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxy polyethylene glycol-epoetin beta</to_name>
		<to_code>729596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythropoietin</to_name>
		<to_code>M0007726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoetin alfa</to_name>
		<to_code>105694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
		<from_code>N0000175665</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing erythropoietin receptor agonist (product)</to_name>
		<to_code>1156736000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginesatide</from_name>
		<from_code>1248798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darbepoetin alfa</from_name>
		<from_code>283838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythroid Maturation Agent [EPC]</from_name>
		<from_code>N0000194025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin, E-coli derived</from_name>
		<from_code>259321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luspatercept-aamt</from_name>
		<from_code>2262543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa</from_name>
		<from_code>105694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luspatercept</from_name>
		<from_code>2262544</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin (recombinant DNA origin)</from_name>
		<from_code>314845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa-epbx</from_name>
		<from_code>2047589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin</from_name>
		<from_code>61148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Hematopoiesis [PE]</from_name>
		<from_code>N0000009350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrem</from_name>
		<from_code>56570</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxsil</from_name>
		<from_code>77754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy polyethylene glycol-epoetin beta</from_name>
		<from_code>729596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetholone</from_name>
		<from_code>7813</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Erythroid Cell Production [PE]</to_name>
		<to_code>N0000009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darbepoetin alfa</from_name>
		<from_code>283838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythropoietin</to_name>
		<to_code>M0007726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy polyethylene glycol-epoetin beta</from_name>
		<from_code>729596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythropoietin</to_name>
		<to_code>M0007726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginesatide</from_name>
		<from_code>1248798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythropoietin</to_name>
		<to_code>M0007726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa</from_name>
		<from_code>105694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythropoietin</to_name>
		<to_code>M0007726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
		<from_code>N0000194027</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voxelotor</to_name>
		<to_code>2265678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
		<from_code>N0000194027</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with hemoglobin S polymerization inhibitor mechanism of action (substance)</to_name>
		<to_code>833303001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
		<from_code>N0000194027</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing hemoglobin S polymerization inhibitor (product)</to_name>
		<to_code>870492007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
		<from_code>N0000184166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
		<from_code>N0000184166</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing anti-inhibitor coagulant complex (medicinal product)</to_name>
		<to_code>346427004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
		<from_code>N0000184166</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anti-inhibitor coagulant complex</to_name>
		<to_code>314504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
		<from_code>N0000184166</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Anti-inhibitor coagulant complex (substance)</to_name>
		<to_code>109003006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
		<from_code>N0000184166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Coagulation Activity Alteration [PE]</from_name>
		<from_code>N0000175977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor Xa (recombinant), inactivated-zhzo</from_name>
		<from_code>2045125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine hydrochloride</from_name>
		<from_code>236471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamines</from_name>
		<from_code>8826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>andexanet alfa</from_name>
		<from_code>2045114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Heparin Reversal Agent [EPC]</from_name>
		<from_code>N0000175983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Warfarin Reversal Agent [EPC]</from_name>
		<from_code>N0000175966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reversed Anticoagulation Activity [PE]</to_name>
		<to_code>N0000175982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing human serum albumin (medicinal product)</to_name>
		<to_code>8658008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serum Albumin</to_name>
		<to_code>M0019692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Oncotic Pressure [PE]</to_name>
		<to_code>N0000009457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Human serum albumin (substance)</to_name>
		<to_code>387497000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Serum Albumin [EPC]</from_name>
		<from_code>N0000184174</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin human, USP</to_name>
		<to_code>828529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Serum Albumin [EPC]</to_name>
		<to_code>N0000184174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Serum Albumin [EPC]</to_name>
		<to_code>N0000184174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl starch 130-0.4</from_name>
		<from_code>1363352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium citrate anhydrous</from_name>
		<from_code>1310549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate</from_name>
		<from_code>56466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasma protein fraction</from_name>
		<from_code>33835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Intravascular Volume Alteration [PE]</from_name>
		<from_code>N0000009732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Intravascular Volume [PE]</to_name>
		<to_code>N0000009361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serum Albumin</to_name>
		<to_code>M0019692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serum Albumin</to_name>
		<to_code>M0019692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serum Albumin</to_name>
		<to_code>M0019692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Oncotic Pressure [PE]</to_name>
		<to_code>N0000009457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Oncotic Pressure [PE]</to_name>
		<to_code>N0000009457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oncotic Pressure Alteration [PE]</from_name>
		<from_code>N0000009769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Oncotic Pressure [PE]</to_name>
		<to_code>N0000009457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Oncotic Pressure [PE]</to_name>
		<to_code>N0000009457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Oncotic Pressure [PE]</to_name>
		<to_code>N0000009457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Unfractionated Heparin [EPC]</from_name>
		<from_code>N0000175474</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Heparin (substance)</to_name>
		<to_code>372877000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Unfractionated Heparin [EPC]</from_name>
		<from_code>N0000175474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Unfractionated Heparin [EPC]</from_name>
		<from_code>N0000175474</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing heparin (medicinal product)</to_name>
		<to_code>84812008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Unfractionated Heparin [EPC]</from_name>
		<from_code>N0000175474</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin, porcine</to_name>
		<to_code>235473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Unfractionated Heparin [EPC]</to_name>
		<to_code>N0000175474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin</to_name>
		<to_code>M0010187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desirudin</to_name>
		<to_code>114934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argatroban</to_name>
		<to_code>15202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with direct thrombin inhibitor mechanism of action (substance)</to_name>
		<to_code>414010005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bivalirudin</to_name>
		<to_code>60819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argatroban anhydrous</to_name>
		<to_code>1546207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dabigatran</to_name>
		<to_code>1546356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Direct Thrombin Inhibitor [EPC]</from_name>
		<from_code>N0000175518</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing direct thrombin inhibitor (product)</to_name>
		<to_code>764885002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Direct Thrombin Inhibitor [EPC]</to_name>
		<to_code>N0000175518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desirudin</to_name>
		<to_code>114934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein C, human</to_name>
		<to_code>723868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argatroban</to_name>
		<to_code>15202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dalteparin</to_name>
		<to_code>67109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bivalirudin</to_name>
		<to_code>60819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argatroban anhydrous</to_name>
		<to_code>1546207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Anticoagulant (substance)</to_name>
		<to_code>372862008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetic acid</to_name>
		<to_code>3755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid, anhydrous</to_name>
		<to_code>221946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-coagulant [EPC]</from_name>
		<from_code>N0000175980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin, porcine</to_name>
		<to_code>235473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Coagulation Factor Activity [PE]</from_name>
		<from_code>N0000008556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prothrombin Activity [PE]</to_name>
		<to_code>N0000193995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III, human</from_name>
		<from_code>221062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin</from_name>
		<from_code>60819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium,porcine</from_name>
		<from_code>235995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivaroxaban</from_name>
		<from_code>1114195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lepirudin</from_name>
		<from_code>237057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protein C, human-lans</from_name>
		<from_code>2643198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban maleate</from_name>
		<from_code>1927955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa (activated), lyophilized</from_name>
		<from_code>353106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edoxaban</from_name>
		<from_code>1599538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin</from_name>
		<from_code>152610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Antithrombin [EPC]</from_name>
		<from_code>N0000184170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reviparin</from_name>
		<from_code>75960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Coagulation Factor Activity Alteration [PE]</from_name>
		<from_code>N0000008362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edoxaban tosylate</from_name>
		<from_code>1599564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin sodium</from_name>
		<from_code>152612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reviparin sodium</from_name>
		<from_code>75961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin</from_name>
		<from_code>280611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Coagulation Activity [PE]</from_name>
		<from_code>N0000175978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin sodium</from_name>
		<from_code>436195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parnaparin</from_name>
		<from_code>69528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin trifluoroacetate</from_name>
		<from_code>2380556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban</from_name>
		<from_code>1927851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa</from_name>
		<from_code>352374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desirudin</from_name>
		<from_code>114934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protein C, human</from_name>
		<from_code>723868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apixaban</from_name>
		<from_code>1364430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prothrombin Activity [PE]</to_name>
		<to_code>N0000193995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Heparin Reversal Agent [EPC]</from_name>
		<from_code>N0000175983</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protamines</to_name>
		<to_code>8826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anticoagulant antagonist (substance)</from_name>
		<from_code>419927001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Reversal Agent [EPC]</to_name>
		<to_code>N0000175983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Heparin Reversal Agent [EPC]</to_name>
		<to_code>N0000175983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K Antagonist [EPC]</from_name>
		<from_code>N0000175476</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>warfarin</to_name>
		<to_code>11289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Antagonist [EPC]</to_name>
		<to_code>N0000175476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K Antagonist [EPC]</to_name>
		<to_code>N0000175476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor VIII Activator [EPC]</from_name>
		<from_code>N0000175916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor VIII Activator [EPC]</from_name>
		<from_code>N0000175916</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desmopressin</to_name>
		<to_code>3251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor VIII Activator [EPC]</from_name>
		<from_code>N0000175916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hemostatic agent (substance)</from_name>
		<from_code>372681003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor VIII Activator [EPC]</to_name>
		<to_code>N0000175916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>damoctocog alfa pegol</from_name>
		<from_code>2055655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Factor Concentration [PE]</from_name>
		<from_code>N0000009253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec-rvox</from_name>
		<from_code>2641609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant), PEGylated-aucl</from_name>
		<from_code>2055654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec</from_name>
		<from_code>2641610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
		<to_code>N0000175915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emicizumab-kxwh</from_name>
		<from_code>1989795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant), PEGylated-aucl</from_name>
		<from_code>2055654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec</from_name>
		<from_code>2641610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec-rvox</from_name>
		<from_code>2641609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Factor Activity [PE]</from_name>
		<from_code>N0000009252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>damoctocog alfa pegol</from_name>
		<from_code>2055655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emicizumab</from_name>
		<from_code>1989794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
		<to_code>N0000175914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombolytic Agent [EPC]</from_name>
		<from_code>N0000175526</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urokinase</to_name>
		<to_code>11055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombolytic Agent [EPC]</from_name>
		<from_code>N0000175526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thrombolytic Agent [EPC]</from_name>
		<from_code>N0000175526</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Thrombolytic agent (substance)</to_name>
		<to_code>372742009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Fibrinolysis [PE]</from_name>
		<from_code>N0000175633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Thrombolysis [PE]</to_name>
		<to_code>N0000009695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematopoietic Stem Cell Mobilizer [EPC]</from_name>
		<from_code>N0000178326</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plerixafor</to_name>
		<to_code>733003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematopoietic Stem Cell Mobilizer [EPC]</from_name>
		<from_code>N0000178326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
		<to_code>N0000178324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immune enhancement agent (substance)</from_name>
		<from_code>372861001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hematopoietic Stem Cell Mobilizer [EPC]</to_name>
		<to_code>N0000178326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hematopoietic Stem Cell Mobilizer [EPC]</to_name>
		<to_code>N0000178326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>motixafortide acetate</from_name>
		<from_code>2664897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
		<to_code>N0000178324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hematopoietic Stem Cell Function Alteration [PE]</from_name>
		<from_code>N0000178323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
		<to_code>N0000178324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plerixafor</from_name>
		<from_code>733003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
		<to_code>N0000178324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>motixafortide</from_name>
		<from_code>2664896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
		<to_code>N0000178324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifibrinolytic Agent [EPC]</from_name>
		<from_code>N0000175634</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprotinin</to_name>
		<to_code>1056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifibrinolytic Agent [EPC]</from_name>
		<from_code>N0000175634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifibrinolytic Agent [EPC]</from_name>
		<from_code>N0000175634</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>6-aminocaproic acid</to_name>
		<to_code>99</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifibrinolytic Agent [EPC]</from_name>
		<from_code>N0000175634</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tranexamic acid</to_name>
		<to_code>10691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hemostatic agent (substance)</from_name>
		<from_code>372681003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifibrinolytic Agent [EPC]</to_name>
		<to_code>N0000175634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Plasmin inhibitor agent (substance)</from_name>
		<from_code>418901005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifibrinolytic Agent [EPC]</to_name>
		<to_code>N0000175634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>6-aminocaproic acid</from_name>
		<from_code>99</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fibrinolysis Alteration [PE]</from_name>
		<from_code>N0000175631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranexamic acid</from_name>
		<from_code>10691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Activity [PE]</from_name>
		<from_code>N0000175979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprotinin</from_name>
		<from_code>1056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Fibrinolysis [PE]</to_name>
		<to_code>N0000175632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Low Molecular Weight Heparin [EPC]</from_name>
		<from_code>N0000175586</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enoxaparin</to_name>
		<to_code>67108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Low Molecular Weight Heparin [EPC]</from_name>
		<from_code>N0000175586</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing low molecular weight heparin (product)</to_name>
		<to_code>87233003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Low Molecular Weight Heparin [EPC]</from_name>
		<from_code>N0000175586</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dalteparin</to_name>
		<to_code>67109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Low Molecular Weight Heparin [EPC]</from_name>
		<from_code>N0000175586</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Low molecular weight heparin (substance)</to_name>
		<to_code>373294004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Low Molecular Weight Heparin [EPC]</from_name>
		<from_code>N0000175586</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin, Low-Molecular-Weight</to_name>
		<to_code>M0010191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Low Molecular Weight Heparin [EPC]</to_name>
		<to_code>N0000175586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin, Low-Molecular-Weight</to_name>
		<to_code>M0010191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin, Low-Molecular-Weight</to_name>
		<to_code>M0010191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin, Low-Molecular-Weight</to_name>
		<to_code>M0010191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin, Low-Molecular-Weight</to_name>
		<to_code>M0010191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparin, Low-Molecular-Weight</to_name>
		<to_code>M0010191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Warfarin Reversal Agent [EPC]</from_name>
		<from_code>N0000175966</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K1</to_name>
		<to_code>8308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Warfarin Reversal Agent [EPC]</from_name>
		<from_code>N0000175966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prothrombin Activity [PE]</to_name>
		<to_code>N0000175965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prothrombin Activity [PE]</to_name>
		<to_code>N0000175965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Factor Activity [PE]</from_name>
		<from_code>N0000009252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prothrombin Activity [PE]</to_name>
		<to_code>N0000175965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Prothrombin Activity [PE]</to_name>
		<to_code>N0000175965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pozelimab</to_name>
		<to_code>2663938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zilucoplan</to_name>
		<to_code>2672489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor D Inhibitor [EPC]</to_name>
		<to_code>N0000194113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ravulizumab</to_name>
		<to_code>2107301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eculizumab</to_name>
		<to_code>591781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Classical Complement Pathway Inhibitor [EPC]</to_name>
		<to_code>N0000193991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with complement inhibitor mechanism of action (substance)</to_name>
		<to_code>8491006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avacincaptad pegol</to_name>
		<to_code>2645108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Inhibitor [EPC]</from_name>
		<from_code>N0000175575</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegcetacoplan</to_name>
		<to_code>2557372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitor [EPC]</to_name>
		<to_code>N0000175575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Inhibitor [EPC]</to_name>
		<to_code>N0000175575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Factor D Inhibitor [EPC]</from_name>
		<from_code>N0000194113</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>danicopan</to_name>
		<to_code>2678952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor D Inhibitor [EPC]</to_name>
		<to_code>N0000194113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
		<from_code>8491006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor D Inhibitor [EPC]</to_name>
		<to_code>N0000194113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000193991</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sutimlimab</to_name>
		<to_code>2591404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000193991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor B Inhibitor [EPC]</to_name>
		<to_code>N0000194111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000193991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitor [EPC]</to_name>
		<to_code>N0000194109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
		<from_code>8491006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Classical Complement Pathway Inhibitor [EPC]</to_name>
		<to_code>N0000193991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement Factor B Inhibitor [EPC]</from_name>
		<from_code>N0000194111</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iptacopan</to_name>
		<to_code>2671061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
		<from_code>8491006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement Factor B Inhibitor [EPC]</to_name>
		<to_code>N0000194111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement C5 Inhibitor [EPC]</from_name>
		<from_code>N0000194109</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crovalimab</to_name>
		<to_code>2686619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitor [EPC]</to_name>
		<to_code>N0000194109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitor [EPC]</to_name>
		<to_code>N0000194109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
		<from_code>8491006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement C5 Inhibitor [EPC]</to_name>
		<to_code>N0000194109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</from_name>
		<from_code>N0000194160</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>concizumab</to_name>
		<to_code>2708333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirofiban</to_name>
		<to_code>73137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticlopidine</to_name>
		<to_code>10594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptifibatide</to_name>
		<to_code>75635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with platelet aggregation inhibitor mechanism of action (substance)</to_name>
		<to_code>771452004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspirin</to_name>
		<to_code>1191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing platelet aggregation inhibitor (product)</to_name>
		<to_code>773388004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dipyridamole</to_name>
		<to_code>3521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
		<from_code>N0000175578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Antagonist [EPC]</to_name>
		<to_code>N0000190996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor tetrasodium</from_name>
		<from_code>1656051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel bisulfate</from_name>
		<from_code>236991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine hydrochloride</from_name>
		<from_code>97</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel</from_name>
		<from_code>613391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel hydrochloride</from_name>
		<from_code>847020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticagrelor</from_name>
		<from_code>1116632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caplacizumab-yhdp</from_name>
		<from_code>2110604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil sodium</from_name>
		<from_code>342691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac</from_name>
		<from_code>19737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Coagulation Activity [PE]</from_name>
		<from_code>N0000175978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar</from_name>
		<from_code>1537034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease-activated Receptor-1 Antagonist [EPC]</from_name>
		<from_code>N0000190996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
		<from_code>N0000182142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyridamole</from_name>
		<from_code>3521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lepirudin</from_name>
		<from_code>237057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor</from_name>
		<from_code>1656052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylamide</from_name>
		<from_code>9518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine</from_name>
		<from_code>10594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar sulfate</from_name>
		<from_code>1537050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil diolamine</from_name>
		<from_code>1927409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac sodium</from_name>
		<from_code>47364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caplacizumab</from_name>
		<from_code>2110605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate</from_name>
		<from_code>52364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Alteration [PE]</from_name>
		<from_code>N0000009807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Aggregation [PE]</to_name>
		<to_code>N0000008832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease-activated Receptor-1 Antagonist [EPC]</from_name>
		<from_code>N0000190996</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorapaxar</to_name>
		<to_code>1537034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease-activated Receptor-1 Antagonist [EPC]</to_name>
		<to_code>N0000190996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, human</to_name>
		<to_code>203083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Antihemophilic factor agent (substance)</to_name>
		<to_code>373768009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, human recombinant</to_name>
		<to_code>1300486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Antihemophilic Factor [EPC]</from_name>
		<from_code>N0000184167</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing antihemophilic factor agent (medicinal product)</to_name>
		<to_code>59057006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Activity [PE]</from_name>
		<from_code>N0000175979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Aggregation [PE]</to_name>
		<to_code>N0000009524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Activity [PE]</from_name>
		<from_code>N0000175979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Endothelial Coagulation Activity [PE]</to_name>
		<to_code>N0000009292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Activity [PE]</from_name>
		<from_code>N0000175979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX (recombinant), glycopegylated</from_name>
		<from_code>1990855</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>andexanet alfa</from_name>
		<from_code>2045114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX, human-lans</from_name>
		<from_code>2643192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor Xa (recombinant), inactivated-zhzo</from_name>
		<from_code>2045125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VII, human-lans</from_name>
		<from_code>2643196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VII</from_name>
		<from_code>4254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Coagulation Activity Alteration [PE]</from_name>
		<from_code>N0000175977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothrombin, human-lans</from_name>
		<from_code>2643202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor X</from_name>
		<from_code>4262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human</from_name>
		<from_code>2264108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albutrepenonacog alfa</from_name>
		<from_code>1743992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonacog alfa</from_name>
		<from_code>1300488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human-lans</from_name>
		<from_code>2643194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coagulation Factor IX (Human)</from_name>
		<from_code>617148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen,I-125</from_name>
		<from_code>314623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothrombin, human</from_name>
		<from_code>1441689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor, human</from_name>
		<from_code>826072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen concentrate (human)</from_name>
		<from_code>831503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor IX</from_name>
		<from_code>4249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VII, human</from_name>
		<from_code>1426164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX, human</from_name>
		<from_code>221099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Activity [PE]</to_name>
		<to_code>N0000175979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor, human</from_name>
		<from_code>826072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Aggregation [PE]</to_name>
		<to_code>N0000009524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet Aggregation Alteration [PE]</from_name>
		<from_code>N0000009807</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Aggregation [PE]</to_name>
		<to_code>N0000009524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verteporfin</from_name>
		<from_code>118886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Aggregation [PE]</to_name>
		<to_code>N0000009524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor</from_name>
		<from_code>11274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Platelet Aggregation [PE]</to_name>
		<to_code>N0000009524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verteporfin</from_name>
		<from_code>118886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Endothelial Coagulation Activity [PE]</to_name>
		<to_code>N0000009292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelial Coagulation Activity Alteration [PE]</from_name>
		<from_code>N0000009039</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Endothelial Coagulation Activity [PE]</to_name>
		<to_code>N0000009292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Factor Activity [PE]</from_name>
		<from_code>N0000009252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
		<to_code>N0000184153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Factor Activity [PE]</from_name>
		<from_code>N0000009252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Fibrin Polymerization Activity [PE]</to_name>
		<to_code>N0000184155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Coagulation Factor Activity [PE]</from_name>
		<from_code>N0000009252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor X Activity [PE]</to_name>
		<to_code>N0000184154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor</from_name>
		<from_code>11274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin alfa</from_name>
		<from_code>1367075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant FVIIa</from_name>
		<from_code>314620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin</from_name>
		<from_code>10528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen</from_name>
		<from_code>4385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K3</from_name>
		<from_code>6728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ion</from_name>
		<from_code>1316581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothrombin, human-lans</from_name>
		<from_code>2643202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human-chmt</from_name>
		<from_code>2730328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human</from_name>
		<from_code>2264108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor X</from_name>
		<from_code>4262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, human</from_name>
		<from_code>825006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human-lans</from_name>
		<from_code>2643194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonacog alfa</from_name>
		<from_code>1300488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>marstacimab</from_name>
		<from_code>2697133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>marstacimab-hncq</from_name>
		<from_code>2697132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen,I-125</from_name>
		<from_code>314623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Coagulation Factor Activity Alteration [PE]</from_name>
		<from_code>N0000008362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor Activity [PE]</to_name>
		<to_code>N0000009252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidanacogene elaparvovec</from_name>
		<from_code>2681011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
		<to_code>N0000184153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidanacogene elaparvovec-dzkt</from_name>
		<from_code>2681020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
		<to_code>N0000184153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptacog alfa activated</from_name>
		<from_code>253149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
		<to_code>N0000184153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Fibrin Polymerization Activity [PE]</to_name>
		<to_code>N0000184155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab</from_name>
		<from_code>2708333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor X Activity [PE]</to_name>
		<to_code>N0000184154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptacog alfa activated</from_name>
		<from_code>253149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor X Activity [PE]</to_name>
		<to_code>N0000184154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab-mtci</from_name>
		<from_code>2708340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Coagulation Factor X Activity [PE]</to_name>
		<to_code>N0000184154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Plasma expander (substance)</to_name>
		<to_code>372578001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dextran 70</to_name>
		<to_code>3274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl starch 130-0.4</to_name>
		<to_code>1363352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dextran 75</to_name>
		<to_code>3275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hetastarch</to_name>
		<to_code>5531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Volume Expander [EPC]</from_name>
		<from_code>N0000184175</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dextran 40</to_name>
		<to_code>3272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasma Volume Expander [EPC]</to_name>
		<to_code>N0000184175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasma Volume Expander [EPC]</to_name>
		<to_code>N0000184175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-reducing Agent [EPC]</from_name>
		<from_code>N0000175638</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with platelet aggregation inhibitor mechanism of action (substance)</to_name>
		<to_code>771452004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-reducing Agent [EPC]</from_name>
		<from_code>N0000175638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Production [PE]</to_name>
		<to_code>N0000175972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-reducing Agent [EPC]</from_name>
		<from_code>N0000175638</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing platelet aggregation inhibitor (product)</to_name>
		<to_code>773388004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-reducing Agent [EPC]</from_name>
		<from_code>N0000175638</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anagrelide</to_name>
		<to_code>596724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platelet-reducing Agent [EPC]</from_name>
		<from_code>N0000175638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen sodium</from_name>
		<from_code>2099290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Production [PE]</to_name>
		<to_code>N0000175972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen</from_name>
		<from_code>2099289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Production [PE]</to_name>
		<to_code>N0000175972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Hematopoiesis [PE]</from_name>
		<from_code>N0000008656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Production [PE]</to_name>
		<to_code>N0000175972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide hydrochloride</from_name>
		<from_code>236612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Production [PE]</to_name>
		<to_code>N0000175972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide</from_name>
		<from_code>596724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Production [PE]</to_name>
		<to_code>N0000175972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide hydrochloride</from_name>
		<from_code>236612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide</from_name>
		<from_code>596724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Megakaryocte Cell Production [PE]</from_name>
		<from_code>N0000008703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
		<to_code>N0000175971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Viscosity Reducer [EPC]</from_name>
		<from_code>N0000175895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Blood Viscosity [PE]</to_name>
		<to_code>N0000175893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Viscosity Reducer [EPC]</from_name>
		<from_code>N0000175895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentoxifylline</to_name>
		<to_code>8013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Viscosity modifier (substance)</from_name>
		<from_code>418681006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Blood Viscosity Reducer [EPC]</to_name>
		<to_code>N0000175895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxelotor</from_name>
		<from_code>2265678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Blood Viscosity [PE]</to_name>
		<to_code>N0000175893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hemorrheologic Alteration [PE]</from_name>
		<from_code>N0000175892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Blood Viscosity [PE]</to_name>
		<to_code>N0000175893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentoxifylline</from_name>
		<from_code>8013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Blood Viscosity [PE]</to_name>
		<to_code>N0000175893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Blood Viscosity [PE]</to_name>
		<to_code>N0000175893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Blood Viscosity [PE]</to_name>
		<to_code>N0000175893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antithrombin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194148</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fitusiran</to_name>
		<to_code>2709439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antithrombin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Coagulant (substance)</from_name>
		<from_code>373746004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antithrombin-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givosiran</from_name>
		<from_code>2265712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine liposome</from_name>
		<from_code>968804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen</from_name>
		<from_code>1367839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Integrity Alteration [PE]</from_name>
		<from_code>N0000009821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen sodium</from_name>
		<from_code>2099290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fitusiran</from_name>
		<from_code>2709439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen sodium</from_name>
		<from_code>1367838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran</from_name>
		<from_code>2053490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran lipid complex</from_name>
		<from_code>2284711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine anhydrous</from_name>
		<from_code>1546005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone hydrochloride</from_name>
		<from_code>203129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran sodium lipid complex</from_name>
		<from_code>2284710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givosiran sodium</from_name>
		<from_code>2265859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptozocin</from_name>
		<from_code>10114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran sodium</from_name>
		<from_code>2053491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>volanesorsen</from_name>
		<from_code>2637345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine</from_name>
		<from_code>10485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone</from_name>
		<from_code>7005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofersen</from_name>
		<from_code>2634995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplontersen</from_name>
		<from_code>2671939</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen</from_name>
		<from_code>2099289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacarbazine</from_name>
		<from_code>3098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran</from_name>
		<from_code>2604578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxuridine</from_name>
		<from_code>4488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentostatin</from_name>
		<from_code>8011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eteplirsen</from_name>
		<from_code>1810569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>volanesorsen sodium</from_name>
		<from_code>2637346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased RNA Integrity [PE]</to_name>
		<to_code>N0000008852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin alfa</to_name>
		<to_code>1367075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin</to_name>
		<to_code>10528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium ion</to_name>
		<to_code>1316581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothrombin, human</to_name>
		<to_code>1441689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Coagulation related substance (substance)</to_name>
		<to_code>443017007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing coagulation protein (product)</to_name>
		<to_code>1003715001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Erythroid Maturation Agent [EPC]</from_name>
		<from_code>N0000194025</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>luspatercept</to_name>
		<to_code>2262544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hematologic agent (substance)</from_name>
		<from_code>373708006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Erythroid Maturation Agent [EPC]</to_name>
		<to_code>N0000194025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fondaparinux</to_name>
		<to_code>321208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rivaroxaban</to_name>
		<to_code>1114195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing coagulation factor Xa inhibitor (product)</to_name>
		<to_code>385576000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apixaban</to_name>
		<to_code>1364430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with coagulation factor Xa inhibitor mechanism of action (substance)</to_name>
		<to_code>385577009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Factor Xa Inhibitor [EPC]</from_name>
		<from_code>N0000175637</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edoxaban</to_name>
		<to_code>1599538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Factor Xa Inhibitor [EPC]</to_name>
		<to_code>N0000175637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin, human</to_name>
		<to_code>825006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptacog alfa activated</to_name>
		<to_code>253149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fibrinogen, human</to_name>
		<to_code>2264108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>factor XIII, human</to_name>
		<to_code>1091605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor X, human</to_name>
		<to_code>1426166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor IX, human</to_name>
		<to_code>221099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fibrinogen concentrate (human)</to_name>
		<to_code>831503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>factor VII, human</to_name>
		<to_code>1426164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>von Willebrand factor, human</to_name>
		<to_code>826072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nonacog alfa</to_name>
		<to_code>1300488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Blood Coagulation Factor [EPC]</from_name>
		<from_code>N0000184169</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coagulation Factor IX (Human)</to_name>
		<to_code>617148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Coagulation related substance (substance)</from_name>
		<from_code>443017007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Blood Coagulation Factor [EPC]</to_name>
		<to_code>N0000184169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing coagulation protein (product)</from_name>
		<from_code>1003715001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Blood Coagulation Factor [EPC]</to_name>
		<to_code>N0000184169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen</from_name>
		<from_code>4385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin alfa</from_name>
		<from_code>1367075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptacog alfa activated</from_name>
		<from_code>253149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranexamic acid</from_name>
		<from_code>10691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin</from_name>
		<from_code>10528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant FVIIa</from_name>
		<from_code>314620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor</from_name>
		<from_code>11274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX, human</from_name>
		<from_code>221099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VII, human</from_name>
		<from_code>1426164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen concentrate (human)</from_name>
		<from_code>831503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor, human</from_name>
		<from_code>826072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothrombin, human</from_name>
		<from_code>1441689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen,I-125</from_name>
		<from_code>314623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coagulation Factor IX (Human)</from_name>
		<from_code>617148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonacog alfa</from_name>
		<from_code>1300488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, human</from_name>
		<from_code>825006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human</from_name>
		<from_code>2264108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Factors</to_name>
		<to_code>M0002684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective [APC]</from_name>
		<from_code>N0000193879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial [APC]</to_name>
		<to_code>N0000193882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective [APC]</from_name>
		<from_code>N0000193879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic [EPC]</to_name>
		<to_code>N0000175486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitor [EPC]</to_name>
		<to_code>N0000175524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide Antimicrobial [EPC]</to_name>
		<to_code>N0000175935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic [EPC]</to_name>
		<to_code>N0000175484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</to_name>
		<to_code>N0000175616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antiviral [EPC]</to_name>
		<to_code>N0000175466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonamide Antimicrobial [EPC]</to_name>
		<to_code>N0000175504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
		<to_code>N0000175572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitor [EPC]</to_name>
		<to_code>N0000175889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polyene Antimicrobial [EPC]</to_name>
		<to_code>N0000175936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
		<to_code>N0000175887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Antimicrobial [EPC]</to_name>
		<to_code>N0000175505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial [APC]</to_name>
		<to_code>N0000193880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal [APC]</to_name>
		<to_code>N0000193881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis C Virus NS5A Inhibitor [EPC]</to_name>
		<to_code>N0000191256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitroimidazole Antimicrobial [EPC]</to_name>
		<to_code>N0000175435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal [EPC]</to_name>
		<to_code>N0000175485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Quinolone Antimicrobial [EPC]</to_name>
		<to_code>N0000175937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</to_name>
		<to_code>N0000193857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimicrobial [APC]</from_name>
		<from_code>N0000193882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Influenza A M2 Protein Inhibitor [EPC]</to_name>
		<to_code>N0000175543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zanamivir</to_name>
		<to_code>69722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peramivir</to_name>
		<to_code>619693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing neuraminidase inhibitor (product)</to_name>
		<to_code>409227000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oseltamivir</to_name>
		<to_code>260101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with neuraminidase inhibitor mechanism of action (substance)</to_name>
		<to_code>409228005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuraminidase Inhibitor [EPC]</from_name>
		<from_code>N0000175524</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oseltamivir carboxylate</to_name>
		<to_code>1546279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neuraminidase Inhibitor [EPC]</to_name>
		<to_code>N0000175524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin</to_name>
		<to_code>4053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin</to_name>
		<to_code>18631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with macrolide structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>372480009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin anhydrous</to_name>
		<to_code>1299904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clarithromycin</to_name>
		<to_code>21212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antimicrobial [EPC]</from_name>
		<from_code>N0000175935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing macrolide (product)</from_name>
		<from_code>763878009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide Antimicrobial [EPC]</to_name>
		<to_code>N0000175935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide [EPC]</from_name>
		<from_code>N0000175877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide Antimicrobial [EPC]</to_name>
		<to_code>N0000175935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisabolol</from_name>
		<from_code>19461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fecal microbiota, live-jslm</from_name>
		<from_code>2626728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimicrobial [EPC]</from_name>
		<from_code>N0000175506</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole sodium</from_name>
		<from_code>236084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.alpha.-bisabolol, (-)-EPI-</from_name>
		<from_code>2118535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorite</from_name>
		<from_code>1483317</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfabenzamide</from_name>
		<from_code>37320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fecal microbiota, live</from_name>
		<from_code>2626724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</from_name>
		<from_code>N0000175954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexinidazole</from_name>
		<from_code>2564146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>besifloxacin</from_name>
		<from_code>819911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycins</from_name>
		<from_code>9385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole</from_name>
		<from_code>10193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fleroxacin</from_name>
		<from_code>42322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorous acid</from_name>
		<from_code>1483316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
		<from_code>N0000175478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laurylpyridinium</from_name>
		<from_code>2381133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-bisabolol, (+-)-</from_name>
		<from_code>1306126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelaic acid</from_name>
		<from_code>18602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laurylpyridinium chloride</from_name>
		<from_code>2381132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taurolidine</from_name>
		<from_code>2670453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycin sodium</from_name>
		<from_code>236475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oleandomycin</from_name>
		<from_code>7629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin mesylate</from_name>
		<from_code>2709213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypochlorite</from_name>
		<from_code>9881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimicrobial Agent [TC]</to_name>
		<to_code>N0000178300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000193976</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maribavir</to_name>
		<to_code>2586068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>195085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nevirapine</to_name>
		<to_code>53654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilpivirine</to_name>
		<to_code>1102270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etravirine</to_name>
		<to_code>475969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175463</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doravirine</to_name>
		<to_code>2055755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
		<from_code>108709006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
		<from_code>372531002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine</from_name>
		<from_code>1102270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine hydrochloride</from_name>
		<from_code>1102287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etravirine</from_name>
		<from_code>475969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ectoparasiticide [EPC]</to_name>
		<to_code>N0000194050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthelmintic [EPC]</to_name>
		<to_code>N0000175481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pediculicide [EPC]</to_name>
		<to_code>N0000181811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antileishmanial [EPC]</to_name>
		<to_code>N0000190851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitic Diseases</to_name>
		<to_code>M0015919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivermectin</to_name>
		<to_code>6069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiparasitic [EPC]</from_name>
		<from_code>N0000175484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitic Diseases</to_name>
		<to_code>M0015919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anti-infective agent (substance)</from_name>
		<from_code>373249005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic [EPC]</to_name>
		<to_code>N0000175484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperonyl butoxide</from_name>
		<from_code>8345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivermectin</from_name>
		<from_code>6069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine</from_name>
		<from_code>3820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrethrins</from_name>
		<from_code>8991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinosad</from_name>
		<from_code>299081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine hydrochloride</from_name>
		<from_code>82015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzyl alcohol</from_name>
		<from_code>1426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malathion</from_name>
		<from_code>6606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pediculicide [EPC]</from_name>
		<from_code>N0000181811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxidectin</from_name>
		<from_code>1047072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiparasitic Agent [TC]</to_name>
		<to_code>N0000178302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ectoparasiticide [EPC]</from_name>
		<from_code>N0000194050</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lotilaner</to_name>
		<to_code>1998841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with anthelmintic mechanism of action (substance)</to_name>
		<to_code>372802005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albendazole</to_name>
		<to_code>430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebendazole</to_name>
		<to_code>6672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiabendazole</to_name>
		<to_code>10450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>praziquantel</to_name>
		<to_code>8628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthelmintics</to_name>
		<to_code>M0001301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triclabendazole</to_name>
		<to_code>2118525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthelmintic [EPC]</from_name>
		<from_code>N0000175481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hygromycin B</from_name>
		<from_code>1426887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine citrate</from_name>
		<from_code>342992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxamniquine</from_name>
		<from_code>7778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine sulfate</from_name>
		<from_code>1549138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albendazole</from_name>
		<from_code>430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine hexahydrate</from_name>
		<from_code>271743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine adipate</from_name>
		<from_code>33746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine hydrate</from_name>
		<from_code>67518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel pamoate</from_name>
		<from_code>8985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flubendazole</from_name>
		<from_code>25096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine phosphate</from_name>
		<from_code>54749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiabendazole</from_name>
		<from_code>10450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel</from_name>
		<from_code>8984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine</from_name>
		<from_code>8340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebendazole</from_name>
		<from_code>6672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine citrate</from_name>
		<from_code>203175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine</from_name>
		<from_code>3384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praziquantel</from_name>
		<from_code>8628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel tartrate</from_name>
		<from_code>2197593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihelminthic Agent [TC]</to_name>
		<to_code>N0000178298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxamniquine</from_name>
		<from_code>7778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albendazole</from_name>
		<from_code>430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praziquantel</from_name>
		<from_code>8628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebendazole</from_name>
		<from_code>6672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiabendazole</from_name>
		<from_code>10450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albendazole</from_name>
		<from_code>430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxamniquine</from_name>
		<from_code>7778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiabendazole</from_name>
		<from_code>10450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebendazole</from_name>
		<from_code>6672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niclosamide</from_name>
		<from_code>7402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praziquantel</from_name>
		<from_code>8628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helminthiasis</to_name>
		<to_code>M0010007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthelmintics</to_name>
		<to_code>M0001301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pediculicide [EPC]</from_name>
		<from_code>N0000181811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivermectin</to_name>
		<to_code>6069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pediculicide [EPC]</from_name>
		<from_code>N0000181811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benzyl alcohol</to_name>
		<to_code>1426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pediculicide [EPC]</from_name>
		<from_code>N0000181811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pediculicide [EPC]</from_name>
		<from_code>N0000181811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spinosad</to_name>
		<to_code>299081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pediculicide [EPC]</from_name>
		<from_code>N0000181811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Insecticide (substance)</from_name>
		<from_code>33278000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pediculicide [EPC]</to_name>
		<to_code>N0000181811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzyl alcohol</from_name>
		<from_code>1426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malathion</from_name>
		<from_code>6606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivermectin</from_name>
		<from_code>6069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinosad</from_name>
		<from_code>299081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrethrins</from_name>
		<from_code>8991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivermectin</from_name>
		<from_code>6069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzyl alcohol</from_name>
		<from_code>1426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperonyl butoxide</from_name>
		<from_code>8345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinosad</from_name>
		<from_code>299081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrethrins</from_name>
		<from_code>8991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lice Infestations</to_name>
		<to_code>M0016085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antileishmanial [EPC]</from_name>
		<from_code>N0000190851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antileishmanial [EPC]</from_name>
		<from_code>N0000190851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antileishmanial [EPC]</from_name>
		<from_code>N0000190851</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miltefosine</to_name>
		<to_code>1494066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antileishmanial [EPC]</from_name>
		<from_code>N0000190851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiprotozoal mechanism of action (substance)</from_name>
		<from_code>372857007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antileishmanial [EPC]</to_name>
		<to_code>N0000190851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ornidazole</from_name>
		<from_code>7701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimorazole</from_name>
		<from_code>7427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</from_name>
		<from_code>N0000175490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diloxanide</from_name>
		<from_code>67182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diloxanide furoate</from_name>
		<from_code>23203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitazoxanide</from_name>
		<from_code>31819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine succinate</from_name>
		<from_code>2054091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine</from_name>
		<from_code>569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine hydrochloride</from_name>
		<from_code>81945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiprotozoal Agent [TC]</to_name>
		<to_code>N0000178303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis</to_name>
		<to_code>M0012333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flubendazole</from_name>
		<from_code>25096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitic Diseases</to_name>
		<to_code>M0015919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine citrate</from_name>
		<from_code>203175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitic Diseases</to_name>
		<to_code>M0015919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylcarbamazine</from_name>
		<from_code>3384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitic Diseases</to_name>
		<to_code>M0015919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flubendazole</from_name>
		<from_code>25096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitic Diseases</to_name>
		<to_code>M0015919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
		<from_code>N0000175616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
		<from_code>N0000175616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]</to_name>
		<to_code>N0000193808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
		<from_code>N0000175616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with human immunodeficiency virus fusion inhibitor mechanism of action (substance)</from_name>
		<from_code>409126003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</to_name>
		<to_code>N0000175616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing fusion inhibitor (product)</from_name>
		<from_code>397359002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</to_name>
		<to_code>N0000175616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]</from_name>
		<from_code>N0000193808</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibalizumab</to_name>
		<to_code>2043283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluridine</to_name>
		<to_code>10803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribavirin</to_name>
		<to_code>9344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idoxuridine</to_name>
		<to_code>5653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000180187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000180188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganciclovir</to_name>
		<to_code>4678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antiviral [EPC]</from_name>
		<from_code>N0000175466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Nucleoside analog (substance)</from_name>
		<from_code>714629005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antiviral [EPC]</to_name>
		<to_code>N0000175466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antiviral [EPC]</to_name>
		<to_code>N0000175466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing nucleoside analog (product)</from_name>
		<from_code>768613008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antiviral [EPC]</to_name>
		<to_code>N0000175466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idoxuridine</from_name>
		<from_code>5653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remdesivir</from_name>
		<from_code>2284718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idoxuridine</from_name>
		<from_code>5653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virus Diseases</to_name>
		<to_code>M0022758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir anhydrous</to_name>
		<to_code>1546017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lamivudine</to_name>
		<to_code>68244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entecavir anhydrous</to_name>
		<to_code>1546027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175656</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adefovir</to_name>
		<to_code>16521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
		<from_code>108709006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
		<from_code>372531002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idoxuridine</from_name>
		<from_code>5653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir anhydrous</from_name>
		<from_code>1546007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir sulfate</from_name>
		<from_code>221052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MeSH</from_namespace>
		<from_name>Nucleosides</from_name>
		<from_code>M0015066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antifungal [EPC]</from_name>
		<from_code>N0000175467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zidovudine</from_name>
		<from_code>11413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emtricitabine</from_name>
		<from_code>276237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog [EPC]</from_name>
		<from_code>N0000175465</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>didanosine</from_name>
		<from_code>3364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir</from_name>
		<from_code>83171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stavudine</from_name>
		<from_code>59763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladribine</from_name>
		<from_code>44157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir anhydrous</from_name>
		<from_code>1546027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog [EXT]</to_name>
		<to_code>N0000175459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nucleosides</to_name>
		<to_code>M0015066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emtricitabine</from_name>
		<from_code>276237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nucleosides</to_name>
		<to_code>M0015066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nucleosides</to_name>
		<to_code>M0015066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform M), recombinant</from_name>
		<from_code>2588218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus</from_name>
		<from_code>1427211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B immune globulin</from_name>
		<from_code>26744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inebilizumab</from_name>
		<from_code>2373951</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab-mwge</from_name>
		<from_code>2391551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</from_name>
		<from_code>1427171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab</from_name>
		<from_code>1876366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform S), recombinant</from_name>
		<from_code>2588219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen (isoform L), recombinant</from_name>
		<from_code>2588217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inebilizumab-cdon</from_name>
		<from_code>2373950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab</from_name>
		<from_code>2391541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab-ocsq</from_name>
		<from_code>2693449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B</to_name>
		<to_code>M0010210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>didanosine</from_name>
		<from_code>3364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brincidofovir</from_name>
		<from_code>2599518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirsevimab</from_name>
		<from_code>2642401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilgavimab</from_name>
		<from_code>2587306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfuvirtide</from_name>
		<from_code>139896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab</from_name>
		<from_code>2716802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir sodium</from_name>
		<from_code>1433867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir sulfate</from_name>
		<from_code>221052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine hydrochloride</from_name>
		<from_code>1102287</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peramivir</from_name>
		<from_code>619693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide</from_name>
		<from_code>1721603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raltegravir potassium</from_name>
		<from_code>1235585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</from_name>
		<from_code>2685002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir</from_name>
		<from_code>260101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilpivirine</from_name>
		<from_code>1102270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imdevimab</from_name>
		<from_code>2465249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen</from_name>
		<from_code>85763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticovirimat monohydrate</from_name>
		<from_code>2055103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir marboxil</from_name>
		<from_code>2099995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer sodium</from_name>
		<from_code>2710445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil</from_name>
		<from_code>300195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ledipasvir</from_name>
		<from_code>1591922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilobelimab</from_name>
		<from_code>2639620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palivizumab</from_name>
		<from_code>194279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir</from_name>
		<from_code>2625651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idoxuridine</from_name>
		<from_code>5653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emtricitabine</from_name>
		<from_code>276237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir</from_name>
		<from_code>1433868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer</from_name>
		<from_code>2710434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-lactoglobulin (bovine)</from_name>
		<from_code>2722644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanamivir</from_name>
		<from_code>69722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen sodium</from_name>
		<from_code>314633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab-uiyk</from_name>
		<from_code>2043313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peramivir anhydrous</from_name>
		<from_code>1598096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotrovimab</from_name>
		<from_code>2550731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir</from_name>
		<from_code>2197842</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stavudine</from_name>
		<from_code>59763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remdesivir</from_name>
		<from_code>2284718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molnupiravir</from_name>
		<from_code>2587901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clesrovimab-cfor</from_name>
		<from_code>2716803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemivibart</from_name>
		<from_code>2677789</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casirivimab</from_name>
		<from_code>2465242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maribavir</from_name>
		<from_code>2586068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab</from_name>
		<from_code>2472152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bictegravir sodium</from_name>
		<from_code>1999661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raltegravir</from_name>
		<from_code>719872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixagevimab</from_name>
		<from_code>2587300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bictegravir</from_name>
		<from_code>1999660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine hydrochloride</from_name>
		<from_code>82093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer free acid</from_name>
		<from_code>2710444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir anhydrous</from_name>
		<from_code>1546027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bebtelovimab</from_name>
		<from_code>2592360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirmatrelvir</from_name>
		<from_code>2587892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab-zykl</from_name>
		<from_code>2472151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirsevimab-alip</from_name>
		<from_code>2642402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine</from_name>
		<from_code>9386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil succinate</from_name>
		<from_code>1928942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenacapavir sodium</from_name>
		<from_code>2625652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat monohydrate</from_name>
		<from_code>2055677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir phosphate</from_name>
		<from_code>259275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bamlanivimab</from_name>
		<from_code>2463114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiviral Agent [TC]</to_name>
		<to_code>N0000178304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acyclovir</to_name>
		<to_code>281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valacyclovir</to_name>
		<to_code>73645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180187</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>famciclovir</to_name>
		<to_code>68099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000180187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000180187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180188</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acyclovir</to_name>
		<to_code>281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180188</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valacyclovir</to_name>
		<to_code>73645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000180188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000180188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E, recombinant</from_name>
		<from_code>1986820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum oleoresin</from_name>
		<from_code>235787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capsaicin</from_name>
		<from_code>1992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E</from_name>
		<from_code>1986821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster</to_name>
		<to_code>M0010280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stavudine</to_name>
		<to_code>59763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir anhydrous</to_name>
		<to_code>1546017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zidovudine</to_name>
		<to_code>11413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>didanosine</to_name>
		<to_code>3364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emtricitabine</to_name>
		<to_code>276237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abacavir</to_name>
		<to_code>190521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lamivudine</to_name>
		<to_code>68244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
		<from_code>N0000175462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
		<from_code>108709006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
		<from_code>372531002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
		<to_code>N0000175462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penciclovir</to_name>
		<to_code>59839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valacyclovir</to_name>
		<to_code>73645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesviridae Infections</to_name>
		<to_code>M0010285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acyclovir</to_name>
		<to_code>281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesviridae Infections</to_name>
		<to_code>M0010285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesviridae Infections</to_name>
		<to_code>M0010285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesviridae Infections</to_name>
		<to_code>M0010285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valganciclovir</to_name>
		<to_code>275891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cidofovir anhydrous</to_name>
		<to_code>1546007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganciclovir</to_name>
		<to_code>4678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamethoxazole</to_name>
		<to_code>10180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonamides</to_name>
		<to_code>M0020790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with sulfonamide structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>372788003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfisoxazole</to_name>
		<to_code>10207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antimicrobial [EPC]</from_name>
		<from_code>N0000175504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonamide Antimicrobial [EPC]</to_name>
		<to_code>N0000175504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sulfonamide (product)</from_name>
		<from_code>763875007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonamide Antimicrobial [EPC]</to_name>
		<to_code>N0000175504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfadiazine</to_name>
		<to_code>10171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonamides</to_name>
		<to_code>M0020790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with sulfonamide structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>372788003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfacetamide</to_name>
		<to_code>10169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175503</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver sulfadiazine</to_name>
		<to_code>9793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sulfonamide (product)</from_name>
		<from_code>763875007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calteridol</from_name>
		<from_code>1424676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nargenicin</from_name>
		<from_code>2668421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenethicillin</from_name>
		<from_code>33277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium chloride</from_name>
		<from_code>1379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxylenol</from_name>
		<from_code>20877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin calcium</from_name>
		<from_code>221128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>josamycin</from_name>
		<from_code>6084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefetamet</from_name>
		<from_code>20482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozenoxacin</from_name>
		<from_code>1994739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin</from_name>
		<from_code>2181306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftiofur sodium</from_name>
		<from_code>1370372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazolidinylurea</from_name>
		<from_code>1310602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium bromide</from_name>
		<from_code>1425981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam sodium</from_name>
		<from_code>221167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin sodium</from_name>
		<from_code>267417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vonoprazan</from_name>
		<from_code>2604577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide acetate</from_name>
		<from_code>6573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium latamoxef</from_name>
		<from_code>258330</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>josamycin propionate</from_name>
		<from_code>28069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline dihydrochloride</from_name>
		<from_code>2055907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin hydrochloride</from_name>
		<from_code>42553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin</from_name>
		<from_code>26797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin disodium</from_name>
		<from_code>258332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole medocaril sodium</from_name>
		<from_code>2691334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrofuran Antibacterial [EPC]</from_name>
		<from_code>N0000175494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulopenem etzadroxil</from_name>
		<from_code>2717834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin</from_name>
		<from_code>2190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftiofur hydrochloride</from_name>
		<from_code>1311520</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline hydrochloride</from_name>
		<from_code>2059038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daptomycin</from_name>
		<from_code>22299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefovecin sodium</from_name>
		<from_code>1591924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfapyridine</from_name>
		<from_code>10188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide</from_name>
		<from_code>10169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin sodium</from_name>
		<from_code>203836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxalactam</from_name>
		<from_code>7069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidaxomicin</from_name>
		<from_code>1111103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaborbactam</from_name>
		<from_code>1945213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfabenzamide</from_name>
		<from_code>37320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline tosylate</from_name>
		<from_code>2059268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temocillin</from_name>
		<from_code>37775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin sodium</from_name>
		<from_code>235750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium</from_name>
		<from_code>1378</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfanilamide</from_name>
		<from_code>10184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefatrizine</from_name>
		<from_code>2179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotiam hydrochloride</from_name>
		<from_code>236202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline</from_name>
		<from_code>21272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin</from_name>
		<from_code>626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.beta.-D-glucouronic acid</from_name>
		<from_code>2569975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antibacterial [EPC]</from_name>
		<from_code>N0000175432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicol-class Antibacterial [EPC]</from_name>
		<from_code>N0000175480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole</from_name>
		<from_code>2691333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin magnesium</from_name>
		<from_code>235825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfopristin</from_name>
		<from_code>229369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin liposomal</from_name>
		<from_code>2059180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftiofur</from_name>
		<from_code>1311521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulopenem</from_name>
		<from_code>2717833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin hydrochloride</from_name>
		<from_code>82036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide sodium</from_name>
		<from_code>82101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin</from_name>
		<from_code>8372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin</from_name>
		<from_code>42372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium chloride (in water)</from_name>
		<from_code>124073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azidocillin</from_name>
		<from_code>18609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotiam</from_name>
		<from_code>2188</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citronella oil</from_name>
		<from_code>1309376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talampicillin</from_name>
		<from_code>10322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin</from_name>
		<from_code>30005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>besifloxacin</from_name>
		<from_code>819911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpirome</from_name>
		<from_code>27130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin sodium</from_name>
		<from_code>273443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miocamycin</from_name>
		<from_code>6985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacytine</from_name>
		<from_code>78902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azidocillin sodium</from_name>
		<from_code>236787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pristinamycin</from_name>
		<from_code>66958</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbenicillin</from_name>
		<from_code>10168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpirome sulfate</from_name>
		<from_code>236104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver sulfadiazine</from_name>
		<from_code>9793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver</from_name>
		<from_code>2606543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin</from_name>
		<from_code>4448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline sodium</from_name>
		<from_code>102758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vonoprazan fumarate</from_name>
		<from_code>2604576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate</from_name>
		<from_code>2640868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefovecin</from_name>
		<from_code>1591901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antibacterial [EPC]</from_name>
		<from_code>N0000175431</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam</from_name>
		<from_code>37617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin</from_name>
		<from_code>29629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V calcium</from_name>
		<from_code>236517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefodizime</from_name>
		<from_code>20485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxacillin sodium monohydrate</from_name>
		<from_code>1309402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol sulfate tosylate</from_name>
		<from_code>2265863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V benzathine</from_name>
		<from_code>18926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin</from_name>
		<from_code>6398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finafloxacin</from_name>
		<from_code>1598641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin sodium</from_name>
		<from_code>1812261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin</from_name>
		<from_code>1311566</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroxoline</from_name>
		<from_code>31901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclosan</from_name>
		<from_code>10795</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin</from_name>
		<from_code>1266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol</from_name>
		<from_code>2265702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talampicillin napsylate</from_name>
		<from_code>235836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calteridol calcium</from_name>
		<from_code>1424675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Streptogramin Antibacterial [EPC]</from_name>
		<from_code>N0000175502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin</from_name>
		<from_code>2015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phenethicillin</from_name>
		<from_code>132907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate, liposomal</from_name>
		<from_code>2059179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin indanyl sodium</from_name>
		<from_code>56461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifaximin</from_name>
		<from_code>35619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin mesylate</from_name>
		<from_code>2709213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin diacetate</from_name>
		<from_code>236200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antibacterial Agent [TC]</to_name>
		<to_code>N0000178296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CCR5 Co-receptor Antagonist [EPC]</from_name>
		<from_code>N0000175572</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maraviroc</to_name>
		<to_code>620216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with chemokine receptor antagonist mechanism of action (substance)</from_name>
		<from_code>429602006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
		<to_code>N0000175572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chemokine receptor antagonist (product)</from_name>
		<from_code>427804001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
		<to_code>N0000175572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
		<to_code>N0000175572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175470</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>foscarnet</to_name>
		<to_code>33562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000175470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog [EXT]</to_name>
		<to_code>N0000175469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000175470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog [EXT]</to_name>
		<to_code>N0000175469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MeSH</from_namespace>
		<from_name>Diphosphates</from_name>
		<from_code>M0018275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog [EXT]</to_name>
		<to_code>N0000175469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000180291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog [EXT]</to_name>
		<to_code>N0000175469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog [EXT]</to_name>
		<to_code>N0000175469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrophosphate Analog [EXT]</to_name>
		<to_code>N0000175469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>PCSK9 Inhibitor [EPC]</to_name>
		<to_code>N0000191731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lopinavir</to_name>
		<to_code>195088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with protease inhibitor mechanism of action (substance)</to_name>
		<to_code>372528003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saquinavir</to_name>
		<to_code>83395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritonavir</to_name>
		<to_code>85762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human alpha-1 Proteinase Inhibitor [EPC]</to_name>
		<to_code>N0000184171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitor [EPC]</to_name>
		<to_code>N0000191728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin Converting Enzyme Inhibitor [EPC]</to_name>
		<to_code>N0000175562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human C1 Esterase Inhibitor [EPC]</to_name>
		<to_code>N0000184172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nelfinavir</to_name>
		<to_code>134527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Proteasome Inhibitor [EPC]</to_name>
		<to_code>N0000175604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing protease inhibitor (product)</to_name>
		<to_code>764890004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>190548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Plasma Kallikrein Inhibitor [EPC]</to_name>
		<to_code>N0000192750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indinavir anhydrous</to_name>
		<to_code>1546024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atazanavir</to_name>
		<to_code>343047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>darunavir</to_name>
		<to_code>460132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</to_name>
		<to_code>N0000175913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>228656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Protease Inhibitor [EPC]</from_name>
		<from_code>N0000175889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</to_name>
		<to_code>N0000182639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Inhibitor [EPC]</to_name>
		<to_code>N0000175889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>PCSK9 Inhibitor [EPC]</from_name>
		<from_code>N0000191731</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing proprotein convertase subtilisin/kexin type 9 inhibitor (product)</to_name>
		<to_code>770371005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>PCSK9 Inhibitor [EPC]</from_name>
		<from_code>N0000191731</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alirocumab</to_name>
		<to_code>1659152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>PCSK9 Inhibitor [EPC]</from_name>
		<from_code>N0000191731</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evolocumab</to_name>
		<to_code>1665684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>PCSK9 Inhibitor [EPC]</from_name>
		<from_code>N0000191731</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance)</to_name>
		<to_code>737573001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
		<from_code>N0000184171</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha 1-proteinase inhibitor, human</to_name>
		<to_code>991743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
		<from_code>N0000184171</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Human alpha1 proteinase inhibitor (substance)</to_name>
		<to_code>14767006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
		<from_code>N0000184171</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing human alpha1 proteinase inhibitor (medicinal product)</to_name>
		<to_code>786963003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neprilysin Inhibitor [EPC]</from_name>
		<from_code>N0000191728</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacubitrilat</to_name>
		<to_code>1860608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neprilysin Inhibitor [EPC]</from_name>
		<from_code>N0000191728</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with neprilysin inhibitor mechanism of action (substance)</to_name>
		<to_code>786886009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing protease inhibitor (product)</from_name>
		<from_code>764890004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitor [EPC]</to_name>
		<to_code>N0000191728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hypotensive agent (substance)</from_name>
		<from_code>372586001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitor [EPC]</to_name>
		<to_code>N0000191728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neprilysin Inhibitor [EPC]</to_name>
		<to_code>N0000191728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lisinopril anhydrous</to_name>
		<to_code>1546022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moexiprilat</to_name>
		<to_code>1546358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fosinopril</to_name>
		<to_code>50166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trandolapril</to_name>
		<to_code>38454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perindoprilat</to_name>
		<to_code>1546400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perindopril</to_name>
		<to_code>54552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramiprilat</to_name>
		<to_code>1546377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benazepril</to_name>
		<to_code>18867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalaprilat anhydrous</to_name>
		<to_code>1545989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benazeprilat</to_name>
		<to_code>1546196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)</to_name>
		<to_code>372733002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinapril</to_name>
		<to_code>35208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinaprilat</to_name>
		<to_code>1546359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fosinoprilat</to_name>
		<to_code>1546393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing angiotensin-converting enzyme inhibitor (product)</to_name>
		<to_code>41549009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>captopril</to_name>
		<to_code>1998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramipril</to_name>
		<to_code>35296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalapril</to_name>
		<to_code>3827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
		<from_code>N0000175562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trandolaprilat</to_name>
		<to_code>1546379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin Converting Enzyme Inhibitor [EPC]</to_name>
		<to_code>N0000175562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
		<from_code>N0000184172</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C1 esterase inhibitor (human)</to_name>
		<to_code>809864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
		<from_code>N0000184172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
		<from_code>N0000184172</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with C1 esterase inhibitor mechanism of action (substance)</to_name>
		<to_code>34737006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
		<from_code>N0000184172</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing C1 esterase inhibitor (product)</to_name>
		<to_code>441508005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Vascular Permeability [PE]</from_name>
		<from_code>N0000010252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-mrbb</from_name>
		<from_code>2706479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-ayyh</from_name>
		<from_code>2696256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Permeability Alteration [PE]</from_name>
		<from_code>N0000010250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclesonide</from_name>
		<from_code>274964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen sodium</from_name>
		<from_code>2724362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen</from_name>
		<from_code>2724361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebetralstat</from_name>
		<from_code>2717944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept</from_name>
		<from_code>1232150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide</from_name>
		<from_code>52151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziv-aflibercept</from_name>
		<from_code>1304475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide tromethamine</from_name>
		<from_code>28859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-yszy</from_name>
		<from_code>2715399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflibercept-boav</from_name>
		<from_code>2725885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Vascular Permeability [PE]</to_name>
		<to_code>N0000010252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zileuton</from_name>
		<from_code>40575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Capillary Permeability [PE]</to_name>
		<to_code>N0000010253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proteasome Inhibitor [EPC]</from_name>
		<from_code>N0000175604</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing proteasome inhibitor (product)</to_name>
		<to_code>409217006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proteasome Inhibitor [EPC]</from_name>
		<from_code>N0000175604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carfilzomib</to_name>
		<to_code>1302966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proteasome Inhibitor [EPC]</from_name>
		<from_code>N0000175604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bortezomib</to_name>
		<to_code>358258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proteasome Inhibitor [EPC]</from_name>
		<from_code>N0000175604</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with proteasome inhibitor mechanism of action (substance)</to_name>
		<to_code>409218001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Proteasome Inhibitor [EPC]</from_name>
		<from_code>N0000175604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixazomib</to_name>
		<to_code>1723735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lanadelumab</to_name>
		<to_code>2055641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>berotralstat</to_name>
		<to_code>2467540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ecallantide</to_name>
		<to_code>658708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with kallikrein inhibitor mechanism of action (substance)</to_name>
		<to_code>444676004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing kallikrein inhibitor (product)</to_name>
		<to_code>444715003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
		<from_code>N0000192750</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebetralstat</to_name>
		<to_code>2717944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alogliptin</to_name>
		<to_code>1368001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>linagliptin</to_name>
		<to_code>1100699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing dipeptidyl peptidase IV inhibitor (product)</to_name>
		<to_code>422403005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saxagliptin anhydrous</to_name>
		<to_code>1546030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sitagliptin</to_name>
		<to_code>593411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000175913</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)</to_name>
		<to_code>423837000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</to_name>
		<to_code>N0000175913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glecaprevir</to_name>
		<to_code>1940635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grazoprevir anhydrous</to_name>
		<to_code>1871173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing Hepatitis C virus NS3/4A protease inhibitor (product)</to_name>
		<to_code>714427003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)</to_name>
		<to_code>714426007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voxilaprevir</to_name>
		<to_code>1939323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
		<from_code>N0000182639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>natamycin</to_name>
		<to_code>7268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antimicrobial [EPC]</from_name>
		<from_code>N0000175936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polyene Antimicrobial [EPC]</to_name>
		<to_code>N0000175936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anti-infective agent (substance)</from_name>
		<from_code>373249005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polyene Antimicrobial [EPC]</to_name>
		<to_code>N0000175936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabotegravir</to_name>
		<to_code>2475077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elvitegravir</to_name>
		<to_code>1306286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dolutegravir</to_name>
		<to_code>1433868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raltegravir</to_name>
		<to_code>719872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
		<from_code>N0000175887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing integrase strand transfer inhibitor (product)</from_name>
		<from_code>428617003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
		<to_code>N0000175887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with integrase strand transfer inhibitor mechanism of action (substance)</from_name>
		<from_code>427965001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
		<to_code>N0000175887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
		<to_code>N0000175887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>demeclocycline</to_name>
		<to_code>3154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing tetracycline (medicinal product)</to_name>
		<to_code>66261008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracycline</to_name>
		<to_code>10395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with tetracycline structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>373206009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxytetracycline anhydrous</to_name>
		<to_code>1545999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
		<from_code>N0000175505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Antimicrobial [EPC]</to_name>
		<to_code>N0000175505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ketolide Antibacterial [EPC]</to_name>
		<to_code>N0000175492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penem Antibacterial [EPC]</to_name>
		<to_code>N0000175496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymyxin-class Antibacterial [EPC]</to_name>
		<to_code>N0000175499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monobactam Antibacterial [EPC]</to_name>
		<to_code>N0000175493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Antibacterial [EPC]</to_name>
		<to_code>N0000175938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminoglycoside Antibacterial [EPC]</to_name>
		<to_code>N0000175477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lincosamide Antibacterial [EPC]</to_name>
		<to_code>N0000175443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial [EPC]</to_name>
		<to_code>N0000175483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicol-class Antibacterial [EPC]</to_name>
		<to_code>N0000175480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pleuromutilin Antibacterial [EPC]</to_name>
		<to_code>N0000175434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fluoroquinolone Antibacterial [EPC]</to_name>
		<to_code>N0000193223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rifamycin Antibacterial [EPC]</to_name>
		<to_code>N0000175500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide Antibacterial [EPC]</to_name>
		<to_code>N0000175431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000175491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cephalosporin Antibacterial [EPC]</to_name>
		<to_code>N0000175488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penicillin-class Antibacterial [EPC]</to_name>
		<to_code>N0000175497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000175509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitrofuran Antibacterial [EPC]</to_name>
		<to_code>N0000175494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000191281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antibacterial [APC]</from_name>
		<from_code>N0000193880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxazolidinone Antibacterial [EPC]</to_name>
		<to_code>N0000175495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ketolides</to_name>
		<to_code>M0462018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Ketolide (substance)</to_name>
		<to_code>410909006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>274786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ketolide Antibacterial [EPC]</from_name>
		<from_code>N0000175492</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing ketolide (product)</to_name>
		<to_code>410910001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ketolide Antibacterial [EPC]</to_name>
		<to_code>N0000175492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ketolides</to_name>
		<to_code>M0462018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ertapenem</to_name>
		<to_code>325642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing carbapenem (product)</to_name>
		<to_code>350134005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Carbapenem (substance)</to_name>
		<to_code>396345004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipenem anhydrous</to_name>
		<to_code>1545986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meropenem anhydrous</to_name>
		<to_code>1546029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penem Antibacterial [EPC]</from_name>
		<from_code>N0000175496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penem Antibacterial [EPC]</to_name>
		<to_code>N0000175496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbapenems</to_name>
		<to_code>M0024174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Polymyxin (substance)</to_name>
		<to_code>373224006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polymyxin B</to_name>
		<to_code>8536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polymyxins</to_name>
		<to_code>M0017217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymyxin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175499</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colistimethate</to_name>
		<to_code>2708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymyxin-class Antibacterial [EPC]</to_name>
		<to_code>N0000175499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polymyxins</to_name>
		<to_code>M0017217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polymyxins</to_name>
		<to_code>M0017217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polymyxins</to_name>
		<to_code>M0017217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polymyxins</to_name>
		<to_code>M0017217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Monobactam (substance)</to_name>
		<to_code>409132008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing monobactam (product)</to_name>
		<to_code>409133003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Monobactams</to_name>
		<to_code>M0014030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monobactam Antibacterial [EPC]</from_name>
		<from_code>N0000175493</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aztreonam</to_name>
		<to_code>1272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monobactam Antibacterial [EPC]</to_name>
		<to_code>N0000175493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antibacterial mechanism of action (substance)</from_name>
		<from_code>419241000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monobactam Antibacterial [EPC]</to_name>
		<to_code>N0000175493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Monobactams</to_name>
		<to_code>M0014030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eravacycline</to_name>
		<to_code>2055906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tigecycline</to_name>
		<to_code>384455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Antibacterial [EPC]</from_name>
		<from_code>N0000175938</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>omadacycline</to_name>
		<to_code>2059269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing tetracycline (medicinal product)</from_name>
		<from_code>66261008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Antibacterial [EPC]</to_name>
		<to_code>N0000175938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Antibacterial [EPC]</to_name>
		<to_code>N0000175938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with tetracycline structure and antibacterial mechanism of action (substance)</from_name>
		<from_code>373206009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Antibacterial [EPC]</to_name>
		<to_code>N0000175938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptomycin</to_name>
		<to_code>10109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kanamycin</to_name>
		<to_code>6099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tobramycin</to_name>
		<to_code>10627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amikacin</to_name>
		<to_code>641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with aminoglycoside structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>14443002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>neomycin</to_name>
		<to_code>7299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminoglycoside Antibacterial [EPC]</from_name>
		<from_code>N0000175477</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentamicin</to_name>
		<to_code>1596450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing aminoglycoside (product)</from_name>
		<from_code>324116004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminoglycoside Antibacterial [EPC]</to_name>
		<to_code>N0000175477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminoglycoside Antibacterial [EPC]</to_name>
		<to_code>N0000175477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clindamycin</to_name>
		<to_code>2582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Lincomycin (substance)</to_name>
		<to_code>372677003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincosamides</to_name>
		<to_code>M0515779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lincosamide Antibacterial [EPC]</from_name>
		<from_code>N0000175443</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing lincomycin (medicinal product)</to_name>
		<to_code>2596005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lincosamide Antibacterial [EPC]</to_name>
		<to_code>N0000175443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethambutol</to_name>
		<to_code>4110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rifamycin Antimycobacterial [EPC]</to_name>
		<to_code>N0000175501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptomycin</to_name>
		<to_code>10109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoniazid</to_name>
		<to_code>6038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with antimycobacterial mechanism of action (substance)</to_name>
		<to_code>419278002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrazinamide</to_name>
		<to_code>8987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pretomanid</to_name>
		<to_code>2198359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimycobacterial [EPC]</from_name>
		<from_code>N0000175483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diarylquinoline Antimycobacterial [EPC]</to_name>
		<to_code>N0000186775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofazimine</from_name>
		<from_code>2592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifapentine</from_name>
		<from_code>35617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazinamide</from_name>
		<from_code>8987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifabutin</from_name>
		<from_code>55672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bedaquiline</from_name>
		<from_code>1364504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
		<from_code>N0000186775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pretomanid</from_name>
		<from_code>2198359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimycobacterial [EPC]</from_name>
		<from_code>N0000175501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimycobacterial Agent [TC]</to_name>
		<to_code>N0000178301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimycobacterial [EPC]</from_name>
		<from_code>N0000175501</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifapentine</to_name>
		<to_code>35617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimycobacterial [EPC]</from_name>
		<from_code>N0000175501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimycobacterial [EPC]</from_name>
		<from_code>N0000175501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifamycins</to_name>
		<to_code>M0019113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimycobacterial [EPC]</from_name>
		<from_code>N0000175501</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifabutin</to_name>
		<to_code>55672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antimycobacterial [EPC]</from_name>
		<from_code>N0000175501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rifamycin Antimycobacterial [EPC]</to_name>
		<to_code>N0000175501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with rifamycin structure (substance)</from_name>
		<from_code>406756000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rifamycin Antimycobacterial [EPC]</to_name>
		<to_code>N0000175501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
		<from_code>N0000186775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
		<from_code>N0000186775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
		<from_code>N0000186775</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bedaquiline</to_name>
		<to_code>1364504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
		<from_code>N0000186775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarylquinolines</to_name>
		<to_code>M0582947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diarylquinoline Antimycobacterial [EPC]</to_name>
		<to_code>N0000186775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antimycobacterial mechanism of action (substance)</from_name>
		<from_code>419278002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Diarylquinoline Antimycobacterial [EPC]</to_name>
		<to_code>N0000186775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bedaquiline</from_name>
		<from_code>1364504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarylquinolines</to_name>
		<to_code>M0582947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicol-class Antibacterial [EPC]</from_name>
		<from_code>N0000175480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicol-class Antibacterial [EPC]</from_name>
		<from_code>N0000175480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramphenicol</to_name>
		<to_code>2348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicol-class Antibacterial [EPC]</from_name>
		<from_code>N0000175480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicol-class Antibacterial [EPC]</from_name>
		<from_code>N0000175480</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Amphenicol (substance)</to_name>
		<to_code>830163009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicol-class Antibacterial [EPC]</from_name>
		<from_code>N0000175480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicols [EXT]</to_name>
		<to_code>N0000175479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicol-class Antibacterial [EPC]</to_name>
		<to_code>N0000175480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amphenicols [EXT]</from_name>
		<from_code>N0000175479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chloramphenicol</to_name>
		<to_code>M0004121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicols [EXT]</to_name>
		<to_code>N0000175479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicols [EXT]</to_name>
		<to_code>N0000175479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicols [EXT]</to_name>
		<to_code>N0000175479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicols [EXT]</to_name>
		<to_code>N0000175479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MeSH</from_namespace>
		<from_name>Benzyl Alcohols</from_name>
		<from_code>M0002386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amphenicols [EXT]</to_name>
		<to_code>N0000175479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chloramphenicol</to_name>
		<to_code>M0004121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lefamulin</to_name>
		<to_code>2198944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Pleuromutilin (substance)</to_name>
		<to_code>426045001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retapamulin</to_name>
		<to_code>642274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pleuromutilin Antibacterial [EPC]</from_name>
		<from_code>N0000175434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleuromutilin</to_name>
		<to_code>M000764986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pleuromutilin Antibacterial [EPC]</to_name>
		<to_code>N0000175434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleuromutilin</to_name>
		<to_code>M000764986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluoroquinolones</to_name>
		<to_code>M0372253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxifloxacin</to_name>
		<to_code>139462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciprofloxacin</to_name>
		<to_code>2551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>delafloxacin</to_name>
		<to_code>1927663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
		<from_code>N0000193223</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levofloxacin</to_name>
		<to_code>82122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Fluoroquinolone Antibacterial [EPC]</to_name>
		<to_code>N0000193223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluoroquinolones</to_name>
		<to_code>M0372253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluoroquinolones</to_name>
		<to_code>M0372253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluoroquinolones</to_name>
		<to_code>M0372253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluoroquinolones</to_name>
		<to_code>M0372253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175511</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mafenide</to_name>
		<to_code>6572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
		<from_code>N0000175511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamides [EXT]</to_name>
		<to_code>N0000175512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sulfonamide (product)</from_name>
		<from_code>763875007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with sulfonamide structure and antibacterial mechanism of action (substance)</from_name>
		<from_code>372788003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
		<to_code>N0000175511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylated Sulfonamides [EXT]</from_name>
		<from_code>N0000175512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mafenide</to_name>
		<to_code>M0012880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamides [EXT]</to_name>
		<to_code>N0000175512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MeSH</from_namespace>
		<from_name>Sulfonamides</from_name>
		<from_code>M0020790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamides [EXT]</to_name>
		<to_code>N0000175512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamides [EXT]</to_name>
		<to_code>N0000175512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide acetate</from_name>
		<from_code>6573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylated Sulfonamides [EXT]</to_name>
		<to_code>N0000175512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mafenide</to_name>
		<to_code>M0012880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifaximin</to_name>
		<to_code>35619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifampin</to_name>
		<to_code>9384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifamycins</to_name>
		<to_code>M0019113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rifamycin Antibacterial [EPC]</from_name>
		<from_code>N0000175500</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing rifamycin (medicinal product)</to_name>
		<to_code>783681005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rifamycin Antibacterial [EPC]</to_name>
		<to_code>N0000175500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with rifamycin structure (substance)</from_name>
		<from_code>406756000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rifamycin Antibacterial [EPC]</to_name>
		<to_code>N0000175500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antibacterial [EPC]</from_name>
		<from_code>N0000175431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antibacterial [EPC]</from_name>
		<from_code>N0000175431</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fidaxomicin</to_name>
		<to_code>1111103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antibacterial [EPC]</from_name>
		<from_code>N0000175431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antibacterial [EPC]</from_name>
		<from_code>N0000175431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide Antibacterial [EPC]</from_name>
		<from_code>N0000175431</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with macrolide structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>372480009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide [EPC]</from_name>
		<from_code>N0000175877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide Antibacterial [EPC]</to_name>
		<to_code>N0000175431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing macrolide (product)</from_name>
		<from_code>763878009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide Antibacterial [EPC]</to_name>
		<to_code>N0000175431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with glycopeptide structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>414355008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing glycopeptide (product)</to_name>
		<to_code>765125009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vancomycin</to_name>
		<to_code>11124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycopeptides</to_name>
		<to_code>M0009481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000175491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefdinir</to_name>
		<to_code>25037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefazolin</to_name>
		<to_code>2180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftaroline</to_name>
		<to_code>1040005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftizoxime</to_name>
		<to_code>2192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefpodoxime</to_name>
		<to_code>20489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefditoren</to_name>
		<to_code>83682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftolozane</to_name>
		<to_code>1597609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefprozil</to_name>
		<to_code>19552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefepime</to_name>
		<to_code>20481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalexin anhydrous</to_name>
		<to_code>1299782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftazidime anhydrous</to_name>
		<to_code>1545984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotaxime</to_name>
		<to_code>2186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefixime anhydrous</to_name>
		<to_code>1546021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefoxitin</to_name>
		<to_code>2189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefaclor anhydrous</to_name>
		<to_code>1450910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefiderocol</to_name>
		<to_code>2265702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotetan</to_name>
		<to_code>2187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftriaxone</to_name>
		<to_code>2193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftobiprole</to_name>
		<to_code>2691333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Cephalosporin (substance)</to_name>
		<to_code>764147003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftibuten</to_name>
		<to_code>20492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefuroxime</to_name>
		<to_code>2194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cephalosporin Antibacterial [EPC]</from_name>
		<from_code>N0000175488</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefadroxil anhydrous</to_name>
		<to_code>1545975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cephalosporin Antibacterial [EPC]</to_name>
		<to_code>N0000175488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol</from_name>
		<from_code>2265702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole</from_name>
		<from_code>2691333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephalosporins</to_name>
		<to_code>M0003827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175489</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoprim</to_name>
		<to_code>10829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antibacterial mechanism of action (substance)</from_name>
		<from_code>419241000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</from_name>
		<from_code>784020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antifolate (product)</from_name>
		<from_code>349846008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin G</to_name>
		<to_code>7980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with penicillin structure (substance)</to_name>
		<to_code>764146007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin V</to_name>
		<to_code>7984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing penicillin (product)</to_name>
		<to_code>890458001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxicillin anhydrous</to_name>
		<to_code>1297882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxacillin</to_name>
		<to_code>7773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperacillin anhydrous</to_name>
		<to_code>1546000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nafcillin</to_name>
		<to_code>7233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dicloxacillin</to_name>
		<to_code>3356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticarcillin</to_name>
		<to_code>10591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ampicillin</to_name>
		<to_code>733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Penicillin-class Antibacterial [EPC]</from_name>
		<from_code>N0000175497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penicillin-class Antibacterial [EPC]</to_name>
		<to_code>N0000175497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin indanyl sodium</from_name>
		<from_code>56461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin disodium</from_name>
		<from_code>258332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin</from_name>
		<from_code>2015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillins</to_name>
		<to_code>M0016152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175509</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>daptomycin</to_name>
		<to_code>22299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175509</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with cyclic lipopeptide structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>406440006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000175509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000175509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrofuran Antibacterial [EPC]</from_name>
		<from_code>N0000175494</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitrofurantoin, macrocrystals</to_name>
		<to_code>235559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrofuran Antibacterial [EPC]</from_name>
		<from_code>N0000175494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrofuran Antibacterial [EPC]</from_name>
		<from_code>N0000175494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrofuran Antibacterial [EPC]</from_name>
		<from_code>N0000175494</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitrofurantoin</to_name>
		<to_code>7454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrofuran Antibacterial [EPC]</from_name>
		<from_code>N0000175494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrofurans</to_name>
		<to_code>M0014892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antibacterial mechanism of action (substance)</from_name>
		<from_code>419241000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitrofuran Antibacterial [EPC]</to_name>
		<to_code>N0000175494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitrofuran Antibacterial [EPC]</to_name>
		<to_code>N0000175494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrofurans</to_name>
		<to_code>M0014892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrofurans</to_name>
		<to_code>M0014892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dalbavancin</to_name>
		<to_code>1539239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telavancin</to_name>
		<to_code>473837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oritavancin</to_name>
		<to_code>1547611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
		<from_code>N0000191281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with glycopeptide structure and antibacterial mechanism of action (substance)</from_name>
		<from_code>414355008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000191281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000191281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing glycopeptide (product)</from_name>
		<from_code>765125009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
		<to_code>N0000191281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MeSH</from_namespace>
		<from_name>Glycopeptides</from_name>
		<from_code>M0009481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipoglycopeptides [EXT]</to_name>
		<to_code>N0000191280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycopeptides</to_name>
		<to_code>M0009481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycopeptides</to_name>
		<to_code>M0009481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
		<from_code>N0000175515</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mupirocin</to_name>
		<to_code>42372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antibacterial mechanism of action (substance)</from_name>
		<from_code>419241000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Synthetase Inhibitor Antibacterial [EPC]</to_name>
		<to_code>N0000175515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with oxazolidinone structure and antibacterial mechanism of action (substance)</to_name>
		<to_code>372649007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tedizolid</to_name>
		<to_code>1540825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxazolidinones</to_name>
		<to_code>M0361132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>linezolid</to_name>
		<to_code>190376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxazolidinone Antibacterial [EPC]</from_name>
		<from_code>N0000175495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxazolidinone Antibacterial [EPC]</to_name>
		<to_code>N0000175495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxazolidinones</to_name>
		<to_code>M0361132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxazolidinones</to_name>
		<to_code>M0361132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxazolidinones</to_name>
		<to_code>M0361132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polyene Antifungal [EPC]</to_name>
		<to_code>N0000175498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antifungal [EPC]</to_name>
		<to_code>N0000175467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Azole Antifungal [EPC]</to_name>
		<to_code>N0000175487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipid-based Polyene Antifungal [EPC]</to_name>
		<to_code>N0000175510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Triterpenoid Antifungal [EPC]</to_name>
		<to_code>N0000193966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Echinocandin Antifungal [EPC]</to_name>
		<to_code>N0000175507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzylamine Antifungal [EPC]</to_name>
		<to_code>N0000175875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antifungal [APC]</from_name>
		<from_code>N0000193881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allylamine Antifungal [EPC]</to_name>
		<to_code>N0000175874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175498</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin B</to_name>
		<to_code>732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175498</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nystatin</to_name>
		<to_code>7597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polyene Antifungal [EPC]</to_name>
		<to_code>N0000175498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polyene Antifungal [EPC]</to_name>
		<to_code>N0000175498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc undecylenate</from_name>
		<from_code>89748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allylamine Antifungal [EPC]</from_name>
		<from_code>N0000175874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bifonazole</from_name>
		<from_code>19295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecylenic acid</from_name>
		<from_code>10989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tavaborole</from_name>
		<from_code>1543173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutrimazole</from_name>
		<from_code>61773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoconazole nitrate</from_name>
		<from_code>203157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzylamine Antifungal [EPC]</from_name>
		<from_code>N0000175875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenbendazole</from_name>
		<from_code>4325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecylenate</from_name>
		<from_code>314881</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omoconazole</from_name>
		<from_code>32411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloprogin</from_name>
		<from_code>26422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rezafungin acetate</from_name>
		<from_code>2639156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antifungal [EPC]</from_name>
		<from_code>N0000175467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine</from_name>
		<from_code>31476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoconazole</from_name>
		<from_code>27901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp citrate</from_name>
		<from_code>2560215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloticasone</from_name>
		<from_code>2719926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole nitrate</from_name>
		<from_code>56226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp</from_name>
		<from_code>2560213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omoconazole mononitrate</from_name>
		<from_code>134933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolnaftate</from_name>
		<from_code>10637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxaborole Antifungal [EPC]</from_name>
		<from_code>N0000191279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rezafungin</from_name>
		<from_code>2639155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium undecylenate</from_name>
		<from_code>89746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B lipid complex</from_name>
		<from_code>2001759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium undecylenate</from_name>
		<from_code>1744166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antifungal Agent [TC]</to_name>
		<to_code>N0000178297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antifungal [EPC]</from_name>
		<from_code>N0000175467</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flucytosine</to_name>
		<to_code>4451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antifungal [EPC]</from_name>
		<from_code>N0000175467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Analog Antifungal [EPC]</from_name>
		<from_code>N0000175467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Nucleoside analog (substance)</from_name>
		<from_code>714629005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antifungal [EPC]</to_name>
		<to_code>N0000175467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing nucleoside analog (product)</from_name>
		<from_code>768613008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antifungal [EPC]</to_name>
		<to_code>N0000175467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Analog Antifungal [EPC]</to_name>
		<to_code>N0000175467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>itraconazole</to_name>
		<to_code>28031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terconazole</to_name>
		<to_code>37806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxiconazole</to_name>
		<to_code>32638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>butoconazole</to_name>
		<to_code>19884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clotrimazole</to_name>
		<to_code>2623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tioconazole</to_name>
		<to_code>38298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isavuconazole</to_name>
		<to_code>1720882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>posaconazole</to_name>
		<to_code>282446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketoconazole</to_name>
		<to_code>6135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efinaconazole</to_name>
		<to_code>1539753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miconazole</to_name>
		<to_code>6932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>luliconazole</to_name>
		<to_code>1482680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulconazole</to_name>
		<to_code>37319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>econazole</to_name>
		<to_code>3743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing azole (product)</to_name>
		<to_code>764881006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertaconazole</to_name>
		<to_code>36435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with azole structure and antifungal mechanism of action (substance)</to_name>
		<to_code>373236000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voriconazole</to_name>
		<to_code>121243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluconazole</to_name>
		<to_code>4450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Azole Antifungal [EPC]</from_name>
		<from_code>N0000175487</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oteseconazole</to_name>
		<to_code>2602577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Azole Antifungal [EPC]</to_name>
		<to_code>N0000175487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azoles</to_name>
		<to_code>M0002083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175510</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin B</to_name>
		<to_code>732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
		<from_code>N0000175510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipid-based Polyene Antifungal [EPC]</to_name>
		<to_code>N0000175510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lipid-based Polyene Antifungal [EPC]</to_name>
		<to_code>N0000175510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyenes</to_name>
		<to_code>M0017172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Triterpenoid Antifungal [EPC]</from_name>
		<from_code>N0000193966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triterpenes</to_name>
		<to_code>M0022020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Triterpenoid Antifungal [EPC]</to_name>
		<to_code>N0000193966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rezafungin</to_name>
		<to_code>2639155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caspofungin</to_name>
		<to_code>140108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anidulafungin</to_name>
		<to_code>341018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>micafungin</to_name>
		<to_code>325887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Echinocandin (substance)</to_name>
		<to_code>373570003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Echinocandin Antifungal [EPC]</from_name>
		<from_code>N0000175507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinocandins</to_name>
		<to_code>M0507131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Echinocandin Antifungal [EPC]</to_name>
		<to_code>N0000175507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rezafungin</from_name>
		<from_code>2639155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daptomycin</from_name>
		<from_code>22299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipopeptides</to_name>
		<to_code>M0519359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinocandins</to_name>
		<to_code>M0507131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinocandins</to_name>
		<to_code>M0507131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinocandins</to_name>
		<to_code>M0507131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinocandins</to_name>
		<to_code>M0507131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinocandins</to_name>
		<to_code>M0507131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzylamine Antifungal [EPC]</from_name>
		<from_code>N0000175875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzylamine Antifungal [EPC]</from_name>
		<from_code>N0000175875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzylamine Antifungal [EPC]</from_name>
		<from_code>N0000175875</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>butenafine</to_name>
		<to_code>47461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzylamine Antifungal [EPC]</from_name>
		<from_code>N0000175875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzylamines</to_name>
		<to_code>M0002392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzylamine Antifungal [EPC]</to_name>
		<to_code>N0000175875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzylamine Antifungal [EPC]</to_name>
		<to_code>N0000175875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzylamines</to_name>
		<to_code>M0002392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzylamines</to_name>
		<to_code>M0002392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allylamine Antifungal [EPC]</from_name>
		<from_code>N0000175874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allylamine Antifungal [EPC]</from_name>
		<from_code>N0000175874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allylamine Antifungal [EPC]</from_name>
		<from_code>N0000175874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allylamine</to_name>
		<to_code>M0000751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allylamine Antifungal [EPC]</from_name>
		<from_code>N0000175874</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naftifine</to_name>
		<to_code>31476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allylamine Antifungal [EPC]</from_name>
		<from_code>N0000175874</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terbinafine</to_name>
		<to_code>37801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allylamine Antifungal [EPC]</to_name>
		<to_code>N0000175874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allylamine Antifungal [EPC]</to_name>
		<to_code>N0000175874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allylamine</to_name>
		<to_code>M0000751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allylamine</to_name>
		<to_code>M0000751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine</from_name>
		<from_code>31476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allylamine</to_name>
		<to_code>M0000751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allylamine</to_name>
		<to_code>M0000751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)</to_name>
		<to_code>712516001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pibrentasvir</to_name>
		<to_code>1940636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velpatasvir</to_name>
		<to_code>1799206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>1734628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing Hepatitis C virus protein NS5A inhibitor (product)</to_name>
		<to_code>714013001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ledipasvir</to_name>
		<to_code>1591922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
		<from_code>N0000191256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metronidazole</to_name>
		<to_code>6922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Nitroimidazole (substance)</to_name>
		<to_code>373235001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tinidazole</to_name>
		<to_code>10612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fexinidazole</to_name>
		<to_code>2564146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing nitroimidazole (product)</to_name>
		<to_code>350157004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secnidazole</to_name>
		<to_code>36314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitroimidazoles</to_name>
		<to_code>M0014907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
		<from_code>N0000175435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitroimidazole Antimicrobial [EPC]</to_name>
		<to_code>N0000175435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentamidine</to_name>
		<to_code>7994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitazoxanide</to_name>
		<to_code>31819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atovaquone</to_name>
		<to_code>60212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial [EPC]</to_name>
		<to_code>N0000175482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflornithine</to_name>
		<to_code>569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paromomycin</to_name>
		<to_code>7934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiprotozoal [EPC]</from_name>
		<from_code>N0000175485</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with antiprotozoal mechanism of action (substance)</to_name>
		<to_code>372857007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>primaquine</to_name>
		<to_code>8687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with antimalarial mechanism of action (substance)</to_name>
		<to_code>373287002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroquine</to_name>
		<to_code>2393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefloquine</to_name>
		<to_code>6694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxychloroquine</to_name>
		<to_code>5521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>artemether</to_name>
		<to_code>18343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lumefantrine</to_name>
		<to_code>847728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine</to_name>
		<to_code>9071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atovaquone</to_name>
		<to_code>60212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
		<to_code>N0000175934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimalarial [EPC]</from_name>
		<from_code>N0000175482</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proguanil</to_name>
		<to_code>2382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine</from_name>
		<from_code>9061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
		<from_code>N0000175934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine monohydrochloride</from_name>
		<from_code>82092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine succinate</from_name>
		<from_code>2054091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimalarial Agent [TC]</to_name>
		<to_code>N0000178299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
		<from_code>N0000175934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
		<from_code>N0000175934</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrimethamine</to_name>
		<to_code>9010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
		<from_code>N0000175934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</from_name>
		<from_code>784020001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
		<to_code>N0000175934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antifolate (product)</from_name>
		<from_code>349846008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
		<to_code>N0000175934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antimalarial mechanism of action (substance)</from_name>
		<from_code>373287002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
		<to_code>N0000175934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine succinate</from_name>
		<from_code>2054091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine succinate</from_name>
		<from_code>2054091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapsone</from_name>
		<from_code>3108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria</to_name>
		<to_code>M0012910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemifloxacin</to_name>
		<to_code>138099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>besifloxacin</to_name>
		<to_code>819911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ofloxacin</to_name>
		<to_code>7623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinolones</to_name>
		<to_code>M0023650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gatifloxacin anhydrous</to_name>
		<to_code>1546025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Quinolone Antimicrobial [EPC]</from_name>
		<from_code>N0000175937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing quinoline (product)</from_name>
		<from_code>713590000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Quinolone Antimicrobial [EPC]</to_name>
		<to_code>N0000175937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Quinolone Antimicrobial [EPC]</to_name>
		<to_code>N0000175937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Quinolone (substance)</from_name>
		<from_code>764148008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Quinolone Antimicrobial [EPC]</to_name>
		<to_code>N0000175937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</from_name>
		<from_code>N0000193857</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tecovirimat</to_name>
		<to_code>2055104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</to_name>
		<to_code>N0000193857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Influenza A M2 Protein Inhibitor [EPC]</from_name>
		<from_code>N0000175543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimantadine</to_name>
		<to_code>9386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Influenza A M2 Protein Inhibitor [EPC]</from_name>
		<from_code>N0000175543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amantadine</to_name>
		<to_code>620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Influenza A M2 Protein Inhibitor [EPC]</to_name>
		<to_code>N0000175543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiseptic [EPC]</from_name>
		<from_code>N0000175486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiseptic [EPC]</from_name>
		<from_code>N0000175486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiseptic [EPC]</from_name>
		<from_code>N0000175486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiseptic [EPC]</from_name>
		<from_code>N0000175486</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone-iodine</to_name>
		<to_code>8611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiseptic [EPC]</from_name>
		<from_code>N0000175486</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexachlorophene</to_name>
		<to_code>5293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiseptic [EPC]</from_name>
		<from_code>N0000175486</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Anti-infective agent (substance)</to_name>
		<to_code>373249005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>becaplermin</from_name>
		<from_code>115238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Communicable Diseases</to_name>
		<to_code>M0004868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenol</from_name>
		<from_code>33290</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-infective Agent [TC]</from_name>
		<from_code>N0000178295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liquefied phenol</from_name>
		<from_code>239351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen peroxide</from_name>
		<from_code>5499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.beta.-D-glucouronic acid</from_name>
		<from_code>2569975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiseptic Agent [TC]</to_name>
		<to_code>N0000178305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Viral Therapy [APC]</from_name>
		<from_code>N0000194073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adeno-associated Virus Vector [EPC]</to_name>
		<to_code>N0000193790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Viral Therapy [APC]</from_name>
		<from_code>N0000194073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</to_name>
		<to_code>N0000194065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Viral Therapy [APC]</from_name>
		<from_code>N0000194073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenovirus Vector-Based Gene Therapy [EPC]</to_name>
		<to_code>N0000194066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adeno-associated Virus Vector [EPC]</from_name>
		<from_code>N0000193790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adeno-Associated Virus</to_name>
		<to_code>M0478942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adeno-associated Virus Vector [EPC]</from_name>
		<from_code>N0000193790</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voretigene neparvovec</to_name>
		<to_code>1995537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adeno-associated Virus Vector [EPC]</from_name>
		<from_code>N0000193790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viruses, Genetically-modified [EXT]</to_name>
		<to_code>N0000191722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voretigene neparvovec</from_name>
		<from_code>1995537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adeno-Associated Virus</to_name>
		<to_code>M0478942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Virus Vector [EPC]</from_name>
		<from_code>N0000193797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viruses, Genetically-modified [EXT]</to_name>
		<to_code>N0000191722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Viruses, Genetically-modified [EXT]</to_name>
		<to_code>N0000191722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing genetically modified virus (product)</from_name>
		<from_code>1002248007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</to_name>
		<to_code>N0000194065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Recombinant adeno-associated virus gene (substance)</from_name>
		<from_code>788109007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</to_name>
		<to_code>N0000194065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Recombinant adeno-associated virus gene (substance)</from_name>
		<from_code>788109007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenovirus Vector-Based Gene Therapy [EPC]</to_name>
		<to_code>N0000194066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing genetically modified virus (product)</from_name>
		<from_code>1002248007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenovirus Vector-Based Gene Therapy [EPC]</to_name>
		<to_code>N0000194066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K [EPC]</to_name>
		<to_code>N0000180191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxocobalamin</to_name>
		<to_code>5514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidote for Acetaminophen Overdose [EPC]</to_name>
		<to_code>N0000175961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decorporation Agent [EPC]</to_name>
		<to_code>N0000192801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Medicinal product acting as antidote agent (product)</to_name>
		<to_code>89626004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folate Analog [EPC]</to_name>
		<to_code>N0000178369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin B6 Analog [EPC]</to_name>
		<to_code>N0000192800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fomepizole</to_name>
		<to_code>15226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin [EPC]</to_name>
		<to_code>N0000175944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine</to_name>
		<to_code>197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Antidote (substance)</to_name>
		<to_code>372892004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carnitine Analog [EPC]</to_name>
		<to_code>N0000175903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote [EPC]</from_name>
		<from_code>N0000175429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Analog [EPC]</to_name>
		<to_code>N0000175453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K [EPC]</from_name>
		<from_code>N0000180191</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vitamin K and/or vitamin K derivative (substance)</to_name>
		<to_code>65183007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K [EPC]</from_name>
		<from_code>N0000180191</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vitamin K and/or vitamin K derivative (product)</to_name>
		<to_code>74226000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K [EPC]</from_name>
		<from_code>N0000180191</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K1</to_name>
		<to_code>8308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin K [EPC]</from_name>
		<from_code>N0000180191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin K</to_name>
		<to_code>M0022806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin K [EPC]</to_name>
		<to_code>N0000180191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin K</to_name>
		<to_code>M0022806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin K</to_name>
		<to_code>M0022806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin K</to_name>
		<to_code>M0022806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine</from_name>
		<from_code>3820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succimer</from_name>
		<from_code>3446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin disodium</from_name>
		<from_code>2107308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride dihydrate</from_name>
		<from_code>1010598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine hydrochloride</from_name>
		<from_code>236471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor Xa (recombinant), inactivated-zhzo</from_name>
		<from_code>2045125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium anhydrous</from_name>
		<from_code>1371967</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetate disodium</from_name>
		<from_code>259268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin</from_name>
		<from_code>5514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium</from_name>
		<from_code>1368950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin</from_name>
		<from_code>877015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2 (equine)</from_name>
		<from_code>2101270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Centruroides (scorpion) immune F(ab')2 (equine)</from_name>
		<from_code>1119986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimercaprol</from_name>
		<from_code>3445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium monohydrate</from_name>
		<from_code>2001422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2</from_name>
		<from_code>2101271</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin acetate</from_name>
		<from_code>236302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene hydrochloride</from_name>
		<from_code>236069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene</from_name>
		<from_code>31479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prussian blue insoluble</from_name>
		<from_code>24902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetic acid</from_name>
		<from_code>3690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine hydrochloride</from_name>
		<from_code>82015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Therapeutic Categories [TC]</from_name>
		<from_code>N0000178293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate</from_name>
		<from_code>618371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamines</from_name>
		<from_code>8826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride</from_name>
		<from_code>203192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>andexanet alfa</from_name>
		<from_code>2045114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium</from_name>
		<from_code>1903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone</from_name>
		<from_code>7242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
		<to_code>N0000178294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
		<from_code>N0000175961</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine</to_name>
		<to_code>197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
		<from_code>N0000175961</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
		<from_code>N0000175961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antidote (substance)</from_name>
		<from_code>372892004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidote for Acetaminophen Overdose [EPC]</to_name>
		<to_code>N0000175961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt</from_name>
		<from_code>1310300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol, L-</from_name>
		<from_code>1742749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin</from_name>
		<from_code>5514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol</from_name>
		<from_code>9945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin acetate</from_name>
		<from_code>236302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poisoning</to_name>
		<to_code>M0017099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium</from_name>
		<from_code>9641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium chloride</from_name>
		<from_code>2200142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racemethionine</from_name>
		<from_code>9100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peptide Metabolism Alteration [PE]</from_name>
		<from_code>N0000175959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium selenate</from_name>
		<from_code>36717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenious acid</from_name>
		<from_code>36344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glutathione Concentration [PE]</to_name>
		<to_code>N0000175960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decorporation Agent [EPC]</from_name>
		<from_code>N0000192801</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prussian blue insoluble</to_name>
		<to_code>24902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decorporation Agent [EPC]</to_name>
		<to_code>N0000192801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antidote (substance)</from_name>
		<from_code>372892004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decorporation Agent [EPC]</to_name>
		<to_code>N0000192801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog [EPC]</from_name>
		<from_code>N0000178369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog [EPC]</from_name>
		<from_code>N0000178369</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>leucovorin</to_name>
		<to_code>6313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog [EPC]</from_name>
		<from_code>N0000178369</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levomefolic acid</to_name>
		<to_code>1025342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog [EPC]</from_name>
		<from_code>N0000178369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog [EPC]</from_name>
		<from_code>N0000178369</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levoleucovorin</to_name>
		<to_code>877015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog [EPC]</from_name>
		<from_code>N0000178369</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Folate and/or folate derivative (substance)</to_name>
		<to_code>792796007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing folic acid (medicinal product)</from_name>
		<from_code>6247001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folate Analog [EPC]</to_name>
		<to_code>N0000178369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B6 Analog [EPC]</from_name>
		<from_code>N0000192800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B6 Analog [EPC]</from_name>
		<from_code>N0000192800</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxine</to_name>
		<to_code>684879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B6 Analog [EPC]</from_name>
		<from_code>N0000192800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 6</to_name>
		<to_code>M0018248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vitamin B6 and/or vitamin B6 derivative (substance)</from_name>
		<from_code>787967009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin B6 Analog [EPC]</to_name>
		<to_code>N0000192800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin B6 Analog [EPC]</to_name>
		<to_code>N0000192800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing vitamin B and/or vitamin B derivative (product)</from_name>
		<from_code>768761005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin B6 Analog [EPC]</to_name>
		<to_code>N0000192800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B6</from_name>
		<from_code>42954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 6</to_name>
		<to_code>M0018248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal phosphate</from_name>
		<from_code>9004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 6</to_name>
		<to_code>M0018248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B6</from_name>
		<from_code>42954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 6</to_name>
		<to_code>M0018248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine hydrochloride</from_name>
		<from_code>203164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 6</to_name>
		<to_code>M0018248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine</from_name>
		<from_code>684879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 6</to_name>
		<to_code>M0018248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin [EPC]</from_name>
		<from_code>N0000175944</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing insulin (product)</to_name>
		<to_code>39487003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin [EPC]</from_name>
		<from_code>N0000175944</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, regular, human</to_name>
		<to_code>253182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin [EPC]</from_name>
		<from_code>N0000175944</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Insulin (substance)</to_name>
		<to_code>67866001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin [EPC]</from_name>
		<from_code>N0000175944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin [EPC]</to_name>
		<to_code>N0000175944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin [EPC]</to_name>
		<to_code>N0000175944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin [EPC]</to_name>
		<to_code>N0000175944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carnitine Analog [EPC]</from_name>
		<from_code>N0000175903</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing levocarnitine (medicinal product)</to_name>
		<to_code>329486002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carnitine Analog [EPC]</from_name>
		<from_code>N0000175903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carnitine</to_name>
		<to_code>M0003493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carnitine Analog [EPC]</from_name>
		<from_code>N0000175903</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Levocarnitine (substance)</to_name>
		<to_code>372601001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carnitine Analog [EPC]</from_name>
		<from_code>N0000175903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carnitine Analog [EPC]</from_name>
		<from_code>N0000175903</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levocarnitine</to_name>
		<to_code>42955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine</from_name>
		<from_code>2106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carnitine</to_name>
		<to_code>M0003493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine</from_name>
		<from_code>193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carnitine</to_name>
		<to_code>M0003493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine</from_name>
		<from_code>42955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carnitine</to_name>
		<to_code>M0003493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin lispro</to_name>
		<to_code>86009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin glulisine, human</to_name>
		<to_code>400008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin detemir</to_name>
		<to_code>139825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin glargine</to_name>
		<to_code>274783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin degludec</to_name>
		<to_code>1670007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin Analog [EPC]</from_name>
		<from_code>N0000175453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin aspart, human</to_name>
		<to_code>51428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Analog [EPC]</to_name>
		<to_code>N0000175453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing insulin (product)</from_name>
		<from_code>39487003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Analog [EPC]</to_name>
		<to_code>N0000175453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Analog [EPC]</to_name>
		<to_code>N0000175453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Analog [EPC]</to_name>
		<to_code>N0000175453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Insulin (substance)</from_name>
		<from_code>67866001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin Analog [EPC]</to_name>
		<to_code>N0000175453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin degludec</from_name>
		<from_code>1670007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart, human</from_name>
		<from_code>51428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, human</from_name>
		<from_code>253182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glulisine, human</from_name>
		<from_code>400008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart protamine, human</from_name>
		<from_code>352385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin detemir</from_name>
		<from_code>139825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro protamine, human</from_name>
		<from_code>314684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, human</from_name>
		<from_code>314683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, human</from_name>
		<from_code>221110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, human</from_name>
		<from_code>253181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro</from_name>
		<from_code>86009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glargine</from_name>
		<from_code>274783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin</to_name>
		<to_code>M0011417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen [EPC]</to_name>
		<to_code>N0000175824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Stimulating Hormone [EPC]</to_name>
		<to_code>N0000175949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D2 Analog [EPC]</to_name>
		<to_code>N0000175907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>C-type Natriuretic Peptide Analog [EPC]</to_name>
		<to_code>N0000193980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
		<to_code>N0000193453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D3 Analog [EPC]</to_name>
		<to_code>N0000175908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholecystokinin Analog [EPC]</to_name>
		<to_code>N0000175798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Analog [EPC]</to_name>
		<to_code>N0000175454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progesterone [EPC]</to_name>
		<to_code>N0000175601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>l-Thyroxine [EPC]</to_name>
		<to_code>N0000175945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin [EPC]</to_name>
		<to_code>N0000175942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone Analog [EPC]</to_name>
		<to_code>N0000180852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenocorticotropic Hormone [EPC]</to_name>
		<to_code>N0000175941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone [EPC]</to_name>
		<to_code>N0000180851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin [EPC]</to_name>
		<to_code>N0000175838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leptin Analog [EPC]</to_name>
		<to_code>N0000190854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D [EPC]</to_name>
		<to_code>N0000175952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-2 Analog [EPC]</to_name>
		<to_code>N0000190992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Analog [EPC]</to_name>
		<to_code>N0000177910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin-class Hormone [EPC]</to_name>
		<to_code>N0000175813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D Analog [EPC]</to_name>
		<to_code>N0000175849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen [EPC]</to_name>
		<to_code>N0000175825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxytocic [EPC]</to_name>
		<to_code>N0000175828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid [EPC]</to_name>
		<to_code>N0000175576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Analog [EPC]</to_name>
		<to_code>N0000175905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Growth Hormone [EPC]</to_name>
		<to_code>N0000175606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
		<to_code>N0000182144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Analog [EPC]</to_name>
		<to_code>N0000175785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin [EPC]</to_name>
		<to_code>N0000175602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>l-Triiodothyronine [EPC]</to_name>
		<to_code>N0000175946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hormone [APC]</from_name>
		<from_code>N0000193874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Analog [EPC]</to_name>
		<to_code>N0000175904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluoxymesterone</to_name>
		<to_code>4494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with androgen receptor agonist mechanism of action (substance)</to_name>
		<to_code>126162007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyltestosterone</to_name>
		<to_code>6904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>danazol</to_name>
		<to_code>3102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nandrolone</to_name>
		<to_code>7244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing androgen receptor agonist (product)</to_name>
		<to_code>66349002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen [EPC]</from_name>
		<from_code>N0000175824</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone</to_name>
		<to_code>10379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen [EPC]</to_name>
		<to_code>N0000175824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen [EPC]</to_name>
		<to_code>N0000175824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyltestosterone</from_name>
		<from_code>6904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Testosterone Congeners</to_name>
		<to_code>M0447347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyltestosterone</from_name>
		<from_code>6904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androstanes</to_name>
		<to_code>M0001109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Stimulating Hormone [EPC]</from_name>
		<from_code>N0000175949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyrotropin</to_name>
		<to_code>M0021496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Stimulating Hormone [EPC]</from_name>
		<from_code>N0000175949</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing thyrotrophin (medicinal product)</to_name>
		<to_code>326013007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Stimulating Hormone [EPC]</from_name>
		<from_code>N0000175949</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyrotropin alfa</to_name>
		<to_code>4952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Stimulating Hormone [EPC]</from_name>
		<from_code>N0000175949</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Thyrotrophin (substance)</to_name>
		<to_code>65428006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Stimulating Hormone [EPC]</to_name>
		<to_code>N0000175949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin</from_name>
		<from_code>10579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyrotropin</to_name>
		<to_code>M0021496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin alfa</from_name>
		<from_code>4952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyrotropin</to_name>
		<to_code>M0021496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D2 Analog [EPC]</from_name>
		<from_code>N0000175907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergocalciferols</to_name>
		<to_code>M0007651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D2 Analog [EPC]</from_name>
		<from_code>N0000175907</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paricalcitol</to_name>
		<to_code>73710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D2 Analog [EPC]</from_name>
		<from_code>N0000175907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D2 Analog [EPC]</from_name>
		<from_code>N0000175907</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxercalciferol</to_name>
		<to_code>11516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Ergocalciferol (substance)</from_name>
		<from_code>23433006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D2 Analog [EPC]</to_name>
		<to_code>N0000175907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D2 Analog [EPC]</to_name>
		<to_code>N0000175907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D2 Analog [EPC]</to_name>
		<to_code>N0000175907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing ergocalciferol (medicinal product)</from_name>
		<from_code>71516007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D2 Analog [EPC]</to_name>
		<to_code>N0000175907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C-type Natriuretic Peptide Analog [EPC]</from_name>
		<from_code>N0000193980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C-type Natriuretic Peptide Analog [EPC]</from_name>
		<from_code>N0000193980</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vosoritide</to_name>
		<to_code>2586354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C-type Natriuretic Peptide Analog [EPC]</from_name>
		<from_code>N0000193980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Natriuretic Peptide, C-Type</to_name>
		<to_code>M0029831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>C-type natriuretic peptide (substance)</from_name>
		<from_code>413731007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>C-type Natriuretic Peptide Analog [EPC]</to_name>
		<to_code>N0000193980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>C-type Natriuretic Peptide Analog [EPC]</to_name>
		<to_code>N0000193980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vosoritide</from_name>
		<from_code>2586354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Natriuretic Peptide, C-Type</to_name>
		<to_code>M0029831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone-Related Peptide Analog [EPC]</from_name>
		<from_code>N0000193453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone-Related Peptide Analog [EPC]</from_name>
		<from_code>N0000193453</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abaloparatide</to_name>
		<to_code>1921069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone-Related Peptide Analog [EPC]</from_name>
		<from_code>N0000193453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone-Related Protein</to_name>
		<to_code>M0150746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Parathormone related peptide (substance)</from_name>
		<from_code>112117005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
		<to_code>N0000193453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing parathyroid and/or parathyroid hormone derivative (product)</from_name>
		<from_code>1148676003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
		<to_code>N0000193453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
		<to_code>N0000193453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abaloparatide</from_name>
		<from_code>1921069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone-Related Protein</to_name>
		<to_code>M0150746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D3 Analog [EPC]</from_name>
		<from_code>N0000175908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecalciferol</to_name>
		<to_code>M0004229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D3 Analog [EPC]</from_name>
		<from_code>N0000175908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D3 Analog [EPC]</from_name>
		<from_code>N0000175908</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcitriol</to_name>
		<to_code>1894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D3 Analog [EPC]</from_name>
		<from_code>N0000175908</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcifediol anhydrous</to_name>
		<to_code>1855064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D3 Analog [EPC]</to_name>
		<to_code>N0000175908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Colecalciferol (substance)</from_name>
		<from_code>18414002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D3 Analog [EPC]</to_name>
		<to_code>N0000175908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing colecalciferol (medicinal product)</from_name>
		<from_code>108943009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D3 Analog [EPC]</to_name>
		<to_code>N0000175908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D3 Analog [EPC]</to_name>
		<to_code>N0000175908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol anhydrous</from_name>
		<from_code>1855064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecalciferol</to_name>
		<to_code>M0004229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecalciferol</to_name>
		<to_code>M0004229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paricalcitol</from_name>
		<from_code>73710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecalciferol</to_name>
		<to_code>M0004229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitriol</from_name>
		<from_code>1894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecalciferol</to_name>
		<to_code>M0004229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholecystokinin Analog [EPC]</from_name>
		<from_code>N0000175798</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sincalide</to_name>
		<to_code>9800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholecystokinin Analog [EPC]</from_name>
		<from_code>N0000175798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecystokinin</to_name>
		<to_code>M0004235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholecystokinin Analog [EPC]</to_name>
		<to_code>N0000175798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cholecystokinin (substance)</from_name>
		<from_code>46225008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholecystokinin Analog [EPC]</to_name>
		<to_code>N0000175798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing cholecystokinin (medicinal product)</from_name>
		<from_code>25085002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cholecystokinin Analog [EPC]</to_name>
		<to_code>N0000175798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecystokinin</from_name>
		<from_code>2420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecystokinin</to_name>
		<to_code>M0004235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholecystokinin</to_name>
		<to_code>M0004235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafluprost</to_name>
		<to_code>1244607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>latanoprost</to_name>
		<to_code>43611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bimatoprost</to_name>
		<to_code>283810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Prostaglandin analog (substance)</to_name>
		<to_code>417971006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>travoprost</to_name>
		<to_code>283809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dinoprostone</to_name>
		<to_code>3478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboprost</to_name>
		<to_code>2051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin Analog [EPC]</from_name>
		<from_code>N0000175454</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprostadil</to_name>
		<to_code>598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Analog [EPC]</to_name>
		<to_code>N0000175454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing prostaglandin (product)</from_name>
		<from_code>350067007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin Analog [EPC]</to_name>
		<to_code>N0000175454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafluprost</from_name>
		<from_code>1244607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>latanoprost</from_name>
		<from_code>43611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl unoprostone</from_name>
		<from_code>135313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinoprostone</from_name>
		<from_code>3478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>travoprost</from_name>
		<from_code>283809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>unoprostone</from_name>
		<from_code>1546408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimatoprost</from_name>
		<from_code>283810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins</to_name>
		<to_code>M0017805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone [EPC]</from_name>
		<from_code>N0000175601</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Progesterone (substance)</to_name>
		<to_code>16683002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone [EPC]</from_name>
		<from_code>N0000175601</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing progesterone (medicinal product)</to_name>
		<to_code>50318003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone [EPC]</from_name>
		<from_code>N0000175601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>progesterone</to_name>
		<to_code>8727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone [EPC]</from_name>
		<from_code>N0000175601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone</to_name>
		<to_code>M0017672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progesterone [EPC]</to_name>
		<to_code>N0000175601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone</to_name>
		<to_code>M0017672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone</to_name>
		<to_code>M0017672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Thyroxine [EPC]</from_name>
		<from_code>N0000175945</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Levothyroxine (substance)</to_name>
		<to_code>710809001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Thyroxine [EPC]</from_name>
		<from_code>N0000175945</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levothyroxine</to_name>
		<to_code>10582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Thyroxine [EPC]</from_name>
		<from_code>N0000175945</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing levothyroxine (medicinal product)</to_name>
		<to_code>768532006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Thyroxine [EPC]</from_name>
		<from_code>N0000175945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroxine</to_name>
		<to_code>M0021504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>l-Thyroxine [EPC]</to_name>
		<to_code>N0000175945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroxine</to_name>
		<to_code>M0021504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroxine</to_name>
		<to_code>M0021504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium</from_name>
		<from_code>40144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroxine</to_name>
		<to_code>M0021504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin [EPC]</from_name>
		<from_code>N0000175942</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Calcitonin (substance)</to_name>
		<to_code>63730009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin [EPC]</from_name>
		<from_code>N0000175942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcitonin</to_name>
		<to_code>M0003145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin [EPC]</from_name>
		<from_code>N0000175942</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcitonin (medicinal product)</to_name>
		<to_code>22657006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin [EPC]</from_name>
		<from_code>N0000175942</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon calcitonin</to_name>
		<to_code>36118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin [EPC]</to_name>
		<to_code>N0000175942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitonin</from_name>
		<from_code>1311287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcitonin</to_name>
		<to_code>M0003145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon calcitonin</from_name>
		<from_code>36118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcitonin</to_name>
		<to_code>M0003145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone Analog [EPC]</from_name>
		<from_code>N0000180852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone</to_name>
		<to_code>M0015931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone Analog [EPC]</from_name>
		<from_code>N0000180852</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teriparatide</to_name>
		<to_code>32915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone Analog [EPC]</from_name>
		<from_code>N0000180852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing parathyroid and/or parathyroid hormone derivative (product)</from_name>
		<from_code>1148676003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone Analog [EPC]</to_name>
		<to_code>N0000180852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Parathyroid hormone and/or parathyroid hormone derivative (substance)</from_name>
		<from_code>1148672001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone Analog [EPC]</to_name>
		<to_code>N0000180852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone Analog [EPC]</to_name>
		<to_code>N0000180852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenocorticotropic Hormone [EPC]</from_name>
		<from_code>N0000175941</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticotropin</to_name>
		<to_code>376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenocorticotropic Hormone [EPC]</from_name>
		<from_code>N0000175941</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cosyntropin</to_name>
		<to_code>2890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenocorticotropic Hormone [EPC]</from_name>
		<from_code>N0000175941</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Adrenocorticotropic hormone (substance)</to_name>
		<to_code>40789008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenocorticotropic Hormone [EPC]</from_name>
		<from_code>N0000175941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenocorticotropic Hormone</to_name>
		<to_code>M0000499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing anterior pituitary hormone (product)</from_name>
		<from_code>392573000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenocorticotropic Hormone [EPC]</to_name>
		<to_code>N0000175941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenocorticotropic Hormone [EPC]</to_name>
		<to_code>N0000175941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenocorticotropic Hormone</to_name>
		<to_code>M0000499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin</from_name>
		<from_code>2890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenocorticotropic Hormone</to_name>
		<to_code>M0000499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenocorticotropic Hormone</to_name>
		<to_code>M0000499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone [EPC]</from_name>
		<from_code>N0000180851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone</to_name>
		<to_code>M0015931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parathyroid Hormone [EPC]</from_name>
		<from_code>N0000180851</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parathyroid hormone</to_name>
		<to_code>1427222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Parathyroid hormone and/or parathyroid hormone derivative (substance)</from_name>
		<from_code>1148672001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone [EPC]</to_name>
		<to_code>N0000180851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing parathyroid and/or parathyroid hormone derivative (product)</from_name>
		<from_code>1148676003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone [EPC]</to_name>
		<to_code>N0000180851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parathyroid Hormone [EPC]</to_name>
		<to_code>N0000180851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parathyroid hormone</from_name>
		<from_code>1427222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone</to_name>
		<to_code>M0015931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriparatide</from_name>
		<from_code>32915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone</to_name>
		<to_code>M0015931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parathyroid hormone</from_name>
		<from_code>1427222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parathyroid Hormone</to_name>
		<to_code>M0015931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin [EPC]</from_name>
		<from_code>N0000175838</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>follicle stimulating hormone</to_name>
		<to_code>227518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin [EPC]</from_name>
		<from_code>N0000175838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin [EPC]</from_name>
		<from_code>N0000175838</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lutropin alfa</to_name>
		<to_code>388084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin [EPC]</from_name>
		<from_code>N0000175838</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choriogonadotropin alfa</to_name>
		<to_code>283550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin [EPC]</from_name>
		<from_code>N0000175838</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing gonad regulating hormone (product)</to_name>
		<to_code>350361002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin [EPC]</from_name>
		<from_code>N0000175838</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with gonadotropin mechanism of action (substance)</to_name>
		<to_code>31895006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin [EPC]</to_name>
		<to_code>N0000175838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choriogonadotropin alfa</from_name>
		<from_code>283550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chorionic gonadotropin</from_name>
		<from_code>4986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin alfa</from_name>
		<from_code>386938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urofollitropin</from_name>
		<from_code>134404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin beta</from_name>
		<from_code>25357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone</from_name>
		<from_code>227518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lutropin alfa</from_name>
		<from_code>388084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonadotropins</to_name>
		<to_code>M0009540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leptin Analog [EPC]</from_name>
		<from_code>N0000190854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leptin</to_name>
		<to_code>M0328567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leptin Analog [EPC]</from_name>
		<from_code>N0000190854</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metreleptin</to_name>
		<to_code>1491625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leptin Analog [EPC]</from_name>
		<from_code>N0000190854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Leptin (substance)</from_name>
		<from_code>414601001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leptin Analog [EPC]</to_name>
		<to_code>N0000190854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing peptide hormone (product)</from_name>
		<from_code>787864003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leptin Analog [EPC]</to_name>
		<to_code>N0000190854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leptin Analog [EPC]</to_name>
		<to_code>N0000190854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leptin</from_name>
		<from_code>1441651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leptin</to_name>
		<to_code>M0328567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metreleptin</from_name>
		<from_code>1491625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leptin</to_name>
		<to_code>M0328567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D [EPC]</from_name>
		<from_code>N0000175952</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vitamin D and/or vitamin D derivative (product)</to_name>
		<to_code>11563006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D [EPC]</from_name>
		<from_code>N0000175952</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholecalciferol</to_name>
		<to_code>2418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D [EPC]</from_name>
		<from_code>N0000175952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D [EPC]</from_name>
		<from_code>N0000175952</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vitamin D and/or vitamin D derivative (substance)</to_name>
		<to_code>30178006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D [EPC]</to_name>
		<to_code>N0000175952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D [EPC]</to_name>
		<to_code>N0000175952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-2 Analog [EPC]</from_name>
		<from_code>N0000190992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-2 Analog [EPC]</from_name>
		<from_code>N0000190992</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teduglutide</to_name>
		<to_code>1364468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-2 Analog [EPC]</from_name>
		<from_code>N0000190992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 2</to_name>
		<to_code>M0358087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Glucagon-like peptide 2 (substance)</from_name>
		<from_code>88602005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-2 Analog [EPC]</to_name>
		<to_code>N0000190992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-2 Analog [EPC]</to_name>
		<to_code>N0000190992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing peptide hormone (product)</from_name>
		<from_code>787864003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-2 Analog [EPC]</to_name>
		<to_code>N0000190992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-2 Analog [EPC]</to_name>
		<to_code>N0000190992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teduglutide</from_name>
		<from_code>1364468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 2</to_name>
		<to_code>M0358087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amylin Analog [EPC]</from_name>
		<from_code>N0000177910</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Amylin analog (substance)</to_name>
		<to_code>417485007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amylin Analog [EPC]</from_name>
		<from_code>N0000177910</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramlintide</to_name>
		<to_code>139953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Analog [EPC]</to_name>
		<to_code>N0000177910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing amylin (medicinal product)</from_name>
		<from_code>417446000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Analog [EPC]</to_name>
		<to_code>N0000177910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amylin Analog [EPC]</to_name>
		<to_code>N0000177910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Secretin-class Hormone [EPC]</from_name>
		<from_code>N0000175813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Secretin</to_name>
		<to_code>M0019589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Secretin-class Hormone [EPC]</from_name>
		<from_code>N0000175813</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Secretin (substance)</to_name>
		<to_code>19205004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Secretin-class Hormone [EPC]</from_name>
		<from_code>N0000175813</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secretin</to_name>
		<to_code>9627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Secretin-class Hormone [EPC]</from_name>
		<from_code>N0000175813</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing secretin (medicinal product)</to_name>
		<to_code>68622003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Secretin-class Hormone [EPC]</to_name>
		<to_code>N0000175813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secretin</from_name>
		<from_code>9627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Secretin</to_name>
		<to_code>M0019589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secretin</from_name>
		<from_code>9627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Secretin</to_name>
		<to_code>M0019589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D Analog [EPC]</from_name>
		<from_code>N0000175849</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcipotriene</to_name>
		<to_code>29365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D Analog [EPC]</from_name>
		<from_code>N0000175849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D Analog [EPC]</from_name>
		<from_code>N0000175849</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paricalcitol</to_name>
		<to_code>73710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin D Analog [EPC]</from_name>
		<from_code>N0000175849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D Analog [EPC]</to_name>
		<to_code>N0000175849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vitamin D and/or vitamin D derivative (substance)</from_name>
		<from_code>30178006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D Analog [EPC]</to_name>
		<to_code>N0000175849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing vitamin D and/or vitamin D derivative (product)</from_name>
		<from_code>11563006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D Analog [EPC]</to_name>
		<to_code>N0000175849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin D Analog [EPC]</to_name>
		<to_code>N0000175849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burosumab</from_name>
		<from_code>2043855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin D</from_name>
		<from_code>11253</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene</from_name>
		<from_code>29365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burosumab-twza</from_name>
		<from_code>2043854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin D</to_name>
		<to_code>M0022797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing estrogen receptor agonist (product)</to_name>
		<to_code>61946003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethinyl estradiol</to_name>
		<to_code>4124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol</to_name>
		<to_code>4083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estrogens, conjugated (USP)</to_name>
		<to_code>4099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estetrol</to_name>
		<to_code>2539031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen [EPC]</from_name>
		<from_code>N0000175825</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with estrogen receptor agonist mechanism of action (substance)</to_name>
		<to_code>1052201004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen [EPC]</to_name>
		<to_code>N0000175825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen [EPC]</to_name>
		<to_code>N0000175825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estranes</to_name>
		<to_code>M0007786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol</from_name>
		<from_code>2539031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene</from_name>
		<from_code>1441386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene acetate</from_name>
		<from_code>1442171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estradiol Congeners</to_name>
		<to_code>M0447348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxytocic [EPC]</from_name>
		<from_code>N0000175828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxytocin</to_name>
		<to_code>M0015703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxytocic [EPC]</from_name>
		<from_code>N0000175828</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxytocin</to_name>
		<to_code>7824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxytocic [EPC]</from_name>
		<from_code>N0000175828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxytocic [EPC]</from_name>
		<from_code>N0000175828</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Oxytocic agent (substance)</to_name>
		<to_code>410937004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxytocin</to_name>
		<to_code>M0015703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oxytocin</to_name>
		<to_code>M0015703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin acetate</from_name>
		<from_code>1733680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin acetate</from_name>
		<from_code>1733680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinoprostone</from_name>
		<from_code>3478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uterine Smooth Muscle Contraction or Tone [PE]</from_name>
		<from_code>N0000009901</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
		<to_code>N0000009705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone</to_name>
		<to_code>8638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mometasone</to_name>
		<to_code>108118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluocinolone acetonide</to_name>
		<to_code>4461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Corticosteroid and/or corticosteroid derivative (substance)</to_name>
		<to_code>304275008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>beclomethasone</to_name>
		<to_code>1347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amcinonide</to_name>
		<to_code>17652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flunisolide anhydrous</to_name>
		<to_code>1546428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing corticosteroid and/or corticosteroid derivative (product)</to_name>
		<to_code>79440004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halobetasol</to_name>
		<to_code>41208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flurandrenolide</to_name>
		<to_code>4500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halcinonide</to_name>
		<to_code>5084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vamorolone</to_name>
		<to_code>2669799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desonide</to_name>
		<to_code>3254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluticasone</to_name>
		<to_code>41126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desoximetasone</to_name>
		<to_code>3255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diflorasone</to_name>
		<to_code>91311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alclometasone</to_name>
		<to_code>108088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>betamethasone</to_name>
		<to_code>1514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>budesonide</to_name>
		<to_code>19831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluorometholone</to_name>
		<to_code>4491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medrysone</to_name>
		<to_code>29439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylprednisolone</to_name>
		<to_code>6902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>loteprednol</to_name>
		<to_code>237027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluocinonide</to_name>
		<to_code>4462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clocortolone</to_name>
		<to_code>21249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deflazacort</to_name>
		<to_code>22396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobetasol</to_name>
		<to_code>2590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone</to_name>
		<to_code>5492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone</to_name>
		<to_code>10759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dexamethasone</to_name>
		<to_code>3264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cortisone</to_name>
		<to_code>2878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisone</to_name>
		<to_code>8640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticosteroid [EPC]</from_name>
		<from_code>N0000175576</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone acetonide</to_name>
		<to_code>10761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid [EPC]</to_name>
		<to_code>N0000175576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticosteroid [EPC]</to_name>
		<to_code>N0000175576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Analog [EPC]</from_name>
		<from_code>N0000175905</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desmopressin</to_name>
		<to_code>3251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Analog [EPC]</from_name>
		<from_code>N0000175905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasopressins</to_name>
		<to_code>M0022562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Analog [EPC]</from_name>
		<from_code>N0000175905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antidiuretic hormone (medicinal product)</from_name>
		<from_code>772208008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Analog [EPC]</to_name>
		<to_code>N0000175905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Analog [EPC]</to_name>
		<to_code>N0000175905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antidiuretic hormone (substance)</from_name>
		<from_code>77671006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Analog [EPC]</to_name>
		<to_code>N0000175905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasopressins</to_name>
		<to_code>M0022562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasopressins</to_name>
		<to_code>M0022562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasopressins</to_name>
		<to_code>M0022562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasopressins</to_name>
		<to_code>M0022562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argipressin</from_name>
		<from_code>1098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasopressins</to_name>
		<to_code>M0022562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Growth Hormone [EPC]</from_name>
		<from_code>N0000175606</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatropin</to_name>
		<to_code>61148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Growth Hormone [EPC]</from_name>
		<from_code>N0000175606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Human Growth Hormone (Mammalian)</to_name>
		<to_code>M0397867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Growth Hormone [EPC]</from_name>
		<from_code>N0000175606</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lonapegsomatropin</to_name>
		<to_code>2569562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with growth hormone receptor agonist mechanism of action (substance)</from_name>
		<from_code>1234929001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Growth Hormone [EPC]</to_name>
		<to_code>N0000175606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing anterior pituitary hormone (product)</from_name>
		<from_code>392573000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Growth Hormone [EPC]</to_name>
		<to_code>N0000175606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Growth Hormone [EPC]</to_name>
		<to_code>N0000175606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin</from_name>
		<from_code>61148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Human Growth Hormone (Mammalian)</to_name>
		<to_code>M0397867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin (recombinant DNA origin)</from_name>
		<from_code>314845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Human Growth Hormone (Mammalian)</to_name>
		<to_code>M0397867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
		<from_code>N0000182144</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tesamorelin</to_name>
		<to_code>1044584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
		<from_code>N0000182144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
		<from_code>N0000182144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GHRH Activity [PE]</to_name>
		<to_code>N0000009327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
		<from_code>N0000182144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Growth Hormone-Releasing Hormone</to_name>
		<to_code>M0020158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Somatotropin releasing factor (substance)</from_name>
		<from_code>16628008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
		<to_code>N0000182144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing somatotropin releasing factor (product)</from_name>
		<from_code>20091003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
		<to_code>N0000182144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
		<to_code>N0000182144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GHRH Activity Alteration [PE]</from_name>
		<from_code>N0000009045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GHRH Activity [PE]</to_name>
		<to_code>N0000009327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin acetate</from_name>
		<from_code>1044583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GHRH Activity [PE]</to_name>
		<to_code>N0000009327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin</from_name>
		<from_code>1044584</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GHRH Activity [PE]</to_name>
		<to_code>N0000009327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin</from_name>
		<from_code>1044584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Growth Hormone-Releasing Hormone</to_name>
		<to_code>M0020158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin E1 Analog [EPC]</from_name>
		<from_code>N0000175785</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>misoprostol</to_name>
		<to_code>42331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin E1 Analog [EPC]</from_name>
		<from_code>N0000175785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins E, Synthetic</to_name>
		<to_code>M0017811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Analog [EPC]</to_name>
		<to_code>N0000175785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing E series prostaglandin (product)</from_name>
		<from_code>713623003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Analog [EPC]</to_name>
		<to_code>N0000175785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Prostaglandin group E (substance)</from_name>
		<from_code>418517007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Analog [EPC]</to_name>
		<to_code>N0000175785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>misoprostol</from_name>
		<from_code>42331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins E, Synthetic</to_name>
		<to_code>M0017811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethynodiol</to_name>
		<to_code>24591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dienogest</to_name>
		<to_code>22968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>drospirenone</to_name>
		<to_code>11636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>megestrol</to_name>
		<to_code>6703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levonorgestrel</to_name>
		<to_code>6373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>segesterone</to_name>
		<to_code>2055978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin-containing Intrauterine System [EPC]</to_name>
		<to_code>N0000175832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desogestrel</to_name>
		<to_code>22656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>norelgestromin</to_name>
		<to_code>326374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>norethindrone</to_name>
		<to_code>7514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Synthetic progestogen (substance)</to_name>
		<to_code>419430000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medroxyprogesterone</to_name>
		<to_code>6691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>17-alpha-hydroxyprogesterone</to_name>
		<to_code>5542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etonogestrel</to_name>
		<to_code>14584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin [EPC]</from_name>
		<from_code>N0000175602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>norgestimate</to_name>
		<to_code>31994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin [EPC]</to_name>
		<to_code>N0000175602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing steroid (product)</from_name>
		<from_code>768759001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin [EPC]</to_name>
		<to_code>N0000175602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin-containing Intrauterine System [EPC]</from_name>
		<from_code>N0000175832</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levonorgestrel</to_name>
		<to_code>6373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin-containing Intrauterine System [EPC]</from_name>
		<from_code>N0000175832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin-containing Intrauterine System [EPC]</from_name>
		<from_code>N0000175832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Progesterone (substance)</from_name>
		<from_code>16683002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin-containing Intrauterine System [EPC]</to_name>
		<to_code>N0000175832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Drug-device combination product (product)</from_name>
		<from_code>411115002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin-containing Intrauterine System [EPC]</to_name>
		<to_code>N0000175832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper chloride</from_name>
		<from_code>150596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper Cu-64</from_name>
		<from_code>2200143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper</from_name>
		<from_code>2837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric chloride</from_name>
		<from_code>21833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper gluconate</from_name>
		<from_code>2839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper-containing Intrauterine Device [EPC]</from_name>
		<from_code>N0000175831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ovum Fertilization Alteration [PE]</from_name>
		<from_code>N0000175829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric oxide</from_name>
		<from_code>21837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper sulfate</from_name>
		<from_code>21579</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibit Ovum Fertilization [PE]</to_name>
		<to_code>N0000175830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol</from_name>
		<from_code>24591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol acetate</from_name>
		<from_code>29451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol</from_name>
		<from_code>6703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Progesterone Congeners</to_name>
		<to_code>M0447349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Triiodothyronine [EPC]</from_name>
		<from_code>N0000175946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triiodothyronine</to_name>
		<to_code>M0021977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Triiodothyronine [EPC]</from_name>
		<from_code>N0000175946</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>liothyronine</to_name>
		<to_code>10814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Triiodothyronine [EPC]</from_name>
		<from_code>N0000175946</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing liothyronine (medicinal product)</to_name>
		<to_code>350358003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>l-Triiodothyronine [EPC]</from_name>
		<from_code>N0000175946</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Liothyronine (substance)</to_name>
		<to_code>61275002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>l-Triiodothyronine [EPC]</to_name>
		<to_code>N0000175946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine sodium</from_name>
		<from_code>142448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triiodothyronine</to_name>
		<to_code>M0021977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine</from_name>
		<from_code>10814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triiodothyronine</to_name>
		<to_code>M0021977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine</from_name>
		<from_code>10814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triiodothyronine</to_name>
		<to_code>M0021977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lanreotide</to_name>
		<to_code>68092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing somatostatin analog (product)</to_name>
		<to_code>109054006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>octreotide</to_name>
		<to_code>7617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Somatostatin analog (substance)</to_name>
		<to_code>395985006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Somatostatin</to_name>
		<to_code>M0020152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Somatostatin Analog [EPC]</from_name>
		<from_code>N0000175904</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pasireotide</to_name>
		<to_code>1364105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Somatostatin Analog [EPC]</to_name>
		<to_code>N0000175904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide</from_name>
		<from_code>7617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Somatostatin</to_name>
		<to_code>M0020152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatostatin</from_name>
		<from_code>9939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Somatostatin</to_name>
		<to_code>M0020152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanreotide</from_name>
		<from_code>68092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Somatostatin</to_name>
		<to_code>M0020152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide acetate</from_name>
		<from_code>221130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Somatostatin</to_name>
		<to_code>M0020152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide</from_name>
		<from_code>1364105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Somatostatin</to_name>
		<to_code>M0020152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergen [APC]</from_name>
		<from_code>N0000193889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allergenic Extract [APC]</to_name>
		<to_code>N0000193890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergen [APC]</from_name>
		<from_code>N0000193889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Chemical Allergen [EPC]</to_name>
		<to_code>N0000185370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergen [APC]</from_name>
		<from_code>N0000193889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Chemical Allergen [EPC]</to_name>
		<to_code>N0000185508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Pollen Allergenic Extract [EPC]</to_name>
		<to_code>N0000185006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Fungal Allergenic Extract [EPC]</to_name>
		<to_code>N0000185372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Food Allergenic Extract [EPC]</to_name>
		<to_code>N0000185371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Pollen Allergenic Extract [EPC]</to_name>
		<to_code>N0000185367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized House Dust Allergenic Extract [EPC]</to_name>
		<to_code>N0000185374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epidermal and Animal Specific Allergenic Extract [APC]</to_name>
		<to_code>N0000193899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allergenic Extract [APC]</from_name>
		<from_code>N0000193890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Bacterial Allergenic Extract [EPC]</to_name>
		<to_code>N0000185369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bermuda grass pollen extract</to_name>
		<to_code>851906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orchard grass pollen extract</to_name>
		<to_code>851878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Timothy grass pollen extract</to_name>
		<to_code>851994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet vernal grass pollen extract</to_name>
		<to_code>851898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadow fescue grass pollen extract</to_name>
		<to_code>851918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perennial rye grass pollen extract</to_name>
		<to_code>852819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>short ragweed pollen extract</to_name>
		<to_code>896135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kentucky bluegrass pollen extract</to_name>
		<to_code>852834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Pollen Allergenic Extract [EPC]</to_name>
		<to_code>N0000185006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt grass pollen extract</from_name>
		<from_code>852329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ash pollen extract</from_name>
		<from_code>1484982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allscale pollen extract</from_name>
		<from_code>897304</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra extract</from_name>
		<from_code>1370435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sardine allergenic extract</from_name>
		<from_code>974129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>northern pike allergenic extract</from_name>
		<from_code>889602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard greens allergenic extract</from_name>
		<from_code>899452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>live oak pollen extract</from_name>
		<from_code>867311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nickel</from_name>
		<from_code>1311629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whey protein hydrolysate</from_name>
		<from_code>2266754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black-eyed pea allergenic extract</from_name>
		<from_code>899490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hard maple pollen extract</from_name>
		<from_code>851874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shagbark hickory pollen extract</from_name>
		<from_code>852221</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Corylus americana nut oil</from_name>
		<from_code>1603849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern ragweed pollen extract</from_name>
		<from_code>885750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white oak pollen extract</from_name>
		<from_code>852294</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald-faced hornet venom protein</from_name>
		<from_code>1297525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cumin allergenic extract</from_name>
		<from_code>901365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit hair extract</from_name>
		<from_code>895527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Verticillium albo-atrum allergenic extract</from_name>
		<from_code>968467</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-oxydiethylene-2-benzothiazole sulfenamide</from_name>
		<from_code>1363711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Austrian pine pollen extract</from_name>
		<from_code>900750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lichtheimia corymbifera allergenic extract</from_name>
		<from_code>995727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sheep sorrel pollen extract</from_name>
		<from_code>852213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosquito allergenic extract</from_name>
		<from_code>974741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-isopropyl-N-phenyl-4-phenylenediamine</from_name>
		<from_code>1363710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt syrup</from_name>
		<from_code>1306883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Camelus bactrianus hair extract</from_name>
		<from_code>2590604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona cypress pollen extract</from_name>
		<from_code>852814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California scrub oak pollen extract</from_name>
		<from_code>852802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Italian rye grass pollen extract</from_name>
		<from_code>1014340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oyster, unspecified preparation</from_name>
		<from_code>1315121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carob allergenic extract</from_name>
		<from_code>904498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellowfin tuna allergenic extract</from_name>
		<from_code>2102488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt cedar pollen extract</from_name>
		<from_code>852806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broccoli allergenic extract</from_name>
		<from_code>899386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phanerodontia chrysosporium allergenic extract</from_name>
		<from_code>968114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western juniper pollen extract</from_name>
		<from_code>852589</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bahia grass pollen extract</from_name>
		<from_code>852673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA</from_name>
		<from_code>350060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lambs quarters pollen extract</from_name>
		<from_code>852237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut extract</from_name>
		<from_code>1372248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. circinelloides allergenic extract</from_name>
		<from_code>2101422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit extract</from_name>
		<from_code>124323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glaucum allergenic extract</from_name>
		<from_code>1986792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-cyclohexyl-2-benzothiazosulfenamide</from_name>
		<from_code>1306886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Garrys oak pollen extract</from_name>
		<from_code>900987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perennial rye grass pollen extract</from_name>
		<from_code>852819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pepper tree pollen extract</from_name>
		<from_code>852140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pollen extract</from_name>
		<from_code>897403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green olive allergenic extract</from_name>
		<from_code>971379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut pollen extract</from_name>
		<from_code>852577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pacific halibut allergenic extract</from_name>
		<from_code>882469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat hair extract</from_name>
		<from_code>895503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow hornet venom protein</from_name>
		<from_code>1297537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cochliobolus spicifer allergenic extract</from_name>
		<from_code>995699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western white pine pollen extract</from_name>
		<from_code>900743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humicola grisea allergenic extract</from_name>
		<from_code>1014391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Utah juniper pollen extract</from_name>
		<from_code>852597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broad leaved paperbark pollen extract</from_name>
		<from_code>903913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canyon ragweed pollen extract</from_name>
		<from_code>851942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenylguanidine</from_name>
		<from_code>1368170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP</from_name>
		<from_code>349980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acrothecium robustum allergenic extract</from_name>
		<from_code>905088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western larch pollen extract</from_name>
		<from_code>2166614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sour cherry allergenic extract</from_name>
		<from_code>1012134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potato allergenic extract</from_name>
		<from_code>892632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bronopol</from_name>
		<from_code>1114345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pineapple extract</from_name>
		<from_code>1492174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hackberry pollen extract</from_name>
		<from_code>852324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango extract</from_name>
		<from_code>1426332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lombardy poplar pollen extract</from_name>
		<from_code>852348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burweed marshelder pollen extract</from_name>
		<from_code>852551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dark leaved mugwort pollen extract</from_name>
		<from_code>896246</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lens scale pollen extract</from_name>
		<from_code>852096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>longleaf pine pollen extract</from_name>
		<from_code>1014360</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary grass pollen extract</from_name>
		<from_code>852697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Iris germanica var. florentina root extract</from_name>
		<from_code>1993233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra extract</from_name>
		<from_code>1370787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley extract</from_name>
		<from_code>1370766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut allergenic extract</from_name>
		<from_code>891633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylenediamine</from_name>
		<from_code>1362740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>banana allergenic extract</from_name>
		<from_code>891830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linden pollen extract</from_name>
		<from_code>852070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben calcium</from_name>
		<from_code>1867698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kidney bean allergenic extract</from_name>
		<from_code>891637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pinus cembroides pollen extract</from_name>
		<from_code>2590679</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken feather extract</from_name>
		<from_code>894934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cheat grass pollen extract</from_name>
		<from_code>852225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European beech pollen extract</from_name>
		<from_code>1484981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common carp allergenic extract</from_name>
		<from_code>901390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palo verde pollen extract</from_name>
		<from_code>852359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet vernal grass pollen extract</from_name>
		<from_code>851898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange allergenic extract</from_name>
		<from_code>892565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber extract</from_name>
		<from_code>1305719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris root allergenic extract</from_name>
		<from_code>1098353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesquite pollen extract</from_name>
		<from_code>852320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rye allergenic extract</from_name>
		<from_code>892638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon allergenic extract</from_name>
		<from_code>901382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog hair extract</from_name>
		<from_code>895542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paper birch pollen extract</from_name>
		<from_code>899576</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canada goldenrod pollen extract</from_name>
		<from_code>995743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narrowleaf marshelder pollen extract</from_name>
		<from_code>1098130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nux vomica extract</from_name>
		<from_code>314743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canadian bluegrass pollen extract</from_name>
		<from_code>1014731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Allium cepa bulb extract</from_name>
		<from_code>2695867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chinese elm pollen extract</from_name>
		<from_code>852844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantaloupe allergenic extract</from_name>
		<from_code>892517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylparaben</from_name>
		<from_code>19075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redberry juniper pollen extract</from_name>
		<from_code>900113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tall oat grass pollen extract</from_name>
		<from_code>1006506</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haddock allergenic extract</from_name>
		<from_code>899428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celery allergenic extract</from_name>
		<from_code>892372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue spruce pollen extract</from_name>
		<from_code>900704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>european olive pollen extract</from_name>
		<from_code>852653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black walnut pollen extract</from_name>
		<from_code>852561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tag alder pollen extract</from_name>
		<from_code>851902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wormwood sage pollen extract</from_name>
		<from_code>852007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white fish allergenic extract</from_name>
		<from_code>901265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apple extract</from_name>
		<from_code>1424865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladosporium sphaerospermum allergenic extract</from_name>
		<from_code>867202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>privet pollen extract</from_name>
		<from_code>852622</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum allergenic extract</from_name>
		<from_code>2101722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow foxtail pollen extract</from_name>
		<from_code>1484974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara preparation</from_name>
		<from_code>235940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton schoenleinii allergenic extract</from_name>
		<from_code>968422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gray birch pollen extract</from_name>
		<from_code>852178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocklebur pollen extract</from_name>
		<from_code>852025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chickpea allergenic extract</from_name>
		<from_code>1011049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver maple pollen extract</from_name>
		<from_code>851866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>post oak pollen extract</from_name>
		<from_code>901011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig dander</from_name>
		<from_code>2166593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redroot pigweed pollen extract</from_name>
		<from_code>851930</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry allergenic extract</from_name>
		<from_code>899734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peach allergenic extract</from_name>
		<from_code>892575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus allergenic extract</from_name>
		<from_code>999384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coffee bean allergenic extract</from_name>
		<from_code>891727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black olive allergenic extract</from_name>
		<from_code>974650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paprika allergenic extract</from_name>
		<from_code>899873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow dander extract</from_name>
		<from_code>2166591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coffea arabica seed extract</from_name>
		<from_code>2695791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white poplar pollen extract</from_name>
		<from_code>852382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern bayberry pollen extract</from_name>
		<from_code>867260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pussy willow pollen extract</from_name>
		<from_code>852174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shortleaf pine pollen extract</from_name>
		<from_code>852709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton fiber allergenic extract</from_name>
		<from_code>966925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house fly allergenic extract</from_name>
		<from_code>350173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apple allergenic extract</from_name>
		<from_code>891771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white catfish allergenic extract</from_name>
		<from_code>971166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English sole allergenic extract</from_name>
		<from_code>974140</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neurospora intermedia allergenic extract</from_name>
		<from_code>867274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water birch pollen extract</from_name>
		<from_code>852166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1311644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt allergenic extract</from_name>
		<from_code>1006510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red currant allergenic extract</from_name>
		<from_code>972480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat skin extract</from_name>
		<from_code>852252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetracoccosporium paxianum allergenic extract</from_name>
		<from_code>968502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scallop allergenic extract</from_name>
		<from_code>899916</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg (chicken) allergenic extract</from_name>
		<from_code>904507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red oak pollen extract</from_name>
		<from_code>852268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date allergenic extract</from_name>
		<from_code>899742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sandbur ragweed pollen extract</from_name>
		<from_code>851955</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat hair extract</from_name>
		<from_code>248123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clioquinol</from_name>
		<from_code>5942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quince extract</from_name>
		<from_code>1370761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog dander extract</from_name>
		<from_code>2167551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disperse blue 106</from_name>
		<from_code>1368171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed extract</from_name>
		<from_code>1309391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saltbush pollen extract</from_name>
		<from_code>897316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fivehorn smotherweed pollen extract</from_name>
		<from_code>852124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sudan grass pollen extract</from_name>
		<from_code>1098455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ditiocarb, zinc salt</from_name>
		<from_code>1427192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa bean allergenic extract</from_name>
		<from_code>891721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quackgrass pollen extract</from_name>
		<from_code>852343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European aspen pollen extract</from_name>
		<from_code>2166596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</from_name>
		<from_code>350160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dill allergenic extract</from_name>
		<from_code>975763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS</from_name>
		<from_code>350125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bulbous buttercup pollen extract</from_name>
		<from_code>1484985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western waterhemp pollen extract</from_name>
		<from_code>851934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium roquefortii allergenic extract</from_name>
		<from_code>972365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apricot allergenic extract</from_name>
		<from_code>895574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS</from_name>
		<from_code>350081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red snapper allergenic extract</from_name>
		<from_code>889646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valley oak pollen extract</from_name>
		<from_code>1111024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon preparation</from_name>
		<from_code>1421430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodgepole pine pollen extract</from_name>
		<from_code>898324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat pollen extract</from_name>
		<from_code>867361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>greasewood pollen extract</from_name>
		<from_code>852152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dogfennel pollen extract</from_name>
		<from_code>867218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syncephalastrum racemosum allergenic extract</from_name>
		<from_code>968506</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus var. oryzae protease</from_name>
		<from_code>1307040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast live oak pollen extract</from_name>
		<from_code>852302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quaternium-15</from_name>
		<from_code>283678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt</from_name>
		<from_code>1310300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thimerosal</from_name>
		<from_code>10472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg white (chicken) allergenic extract</from_name>
		<from_code>892616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary feather extract</from_name>
		<from_code>894961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avocado allergenic extract</from_name>
		<from_code>895582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanolin alcohols</from_name>
		<from_code>1426478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme allergenic extract</from_name>
		<from_code>974527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula mucilaginosa allergenic extract</from_name>
		<from_code>967529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus repens allergenic extract</from_name>
		<from_code>1006310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia graminis allergenic extract</from_name>
		<from_code>999487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton seed extract</from_name>
		<from_code>1309369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safflower seed extract</from_name>
		<from_code>1440241</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit allergenic extract</from_name>
		<from_code>899424</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-chloro-2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow hair extract</from_name>
		<from_code>895488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white willow pollen extract</from_name>
		<from_code>1484986</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pine pollen extract</from_name>
		<from_code>900754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>2102052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lime (citrus) extract</from_name>
		<from_code>1305725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>winterfat pollen extract</from_name>
		<from_code>852613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
		<from_code>N0000185374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pepper extract</from_name>
		<from_code>1313692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Carya laciniosa pollen extract</from_name>
		<from_code>1305551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hypomyces perniciosus allergenic extract</from_name>
		<from_code>1192968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian olive pollen extract</from_name>
		<from_code>852367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>largemouth bass allergenic extract</from_name>
		<from_code>1098183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kapok tree fiber allergenic extract</from_name>
		<from_code>852315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shad scale pollen extract</from_name>
		<from_code>852087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sea scallop preparation</from_name>
		<from_code>1426396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red bell pepper allergenic extract</from_name>
		<from_code>901329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose wheat smut allergenic extract</from_name>
		<from_code>968437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixocortol pivalate</from_name>
		<from_code>38336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</from_name>
		<from_code>1440973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat flea allergenic extract</from_name>
		<from_code>886638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buckwheat allergenic extract</from_name>
		<from_code>899394</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow pine pollen extract</from_name>
		<from_code>852716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian pepper tree pollen extract</from_name>
		<from_code>2632070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish allergenic extract</from_name>
		<from_code>974687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern yellow jacket venom protein</from_name>
		<from_code>1297529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium sarciniforme allergenic extract</from_name>
		<from_code>968130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Colletotrichum coccodes allergenic extract</from_name>
		<from_code>1192729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>1340182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humulus lupulus pollen extract</from_name>
		<from_code>1740937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia pollen extract</from_name>
		<from_code>851732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alnus glutinosa bark extract</from_name>
		<from_code>1441543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ustilago maydis extract</from_name>
		<from_code>1427134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Indian wormwood sage pollen extract</from_name>
		<from_code>1006495</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix repens pollen extract</from_name>
		<from_code>2533912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit skin extract</from_name>
		<from_code>895195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pisum sativum (pea) extract</from_name>
		<from_code>1426912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper allergenic extract</from_name>
		<from_code>899363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oregano allergenic extract</from_name>
		<from_code>1010965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium camemberti allergenic extract</from_name>
		<from_code>966943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl-p-hydroxybenzoate</from_name>
		<from_code>1362892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix lutea pollen extract</from_name>
		<from_code>2590686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pale dock pollen extract</from_name>
		<from_code>1232604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lime allergenic extract</from_name>
		<from_code>1011060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma exigua var. exigua allergenic extract</from_name>
		<from_code>867284</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cricket allergenic extract</from_name>
		<from_code>973447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American elm pollen extract</from_name>
		<from_code>852054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrolyzed casein (enzymatic; 1000 MW)</from_name>
		<from_code>1812932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mountain cedar pollen extract</from_name>
		<from_code>852581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Helminthosporium solani allergenic extract</from_name>
		<from_code>867232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Oregon ash pollen extract</from_name>
		<from_code>900045</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil allergenic extract</from_name>
		<from_code>899444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American house dust mite allergenic extract</from_name>
		<from_code>1116977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cauliflower allergenic extract</from_name>
		<from_code>899661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sydney golden wattle pollen extract</from_name>
		<from_code>895365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald cypress pollen extract</from_name>
		<from_code>995747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldibromo glutaronitrile</from_name>
		<from_code>1307044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>littleseed canary grass pollen extract</from_name>
		<from_code>1098232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western yellow jacket venom protein</from_name>
		<from_code>1297535</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nettle pollen extract</from_name>
		<from_code>852046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine allergenic extract</from_name>
		<from_code>1011412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green bell pepper allergenic extract</from_name>
		<from_code>862478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fig allergenic extract</from_name>
		<from_code>973880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice allergenic extract</from_name>
		<from_code>895552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia striiformis allergenic extract</from_name>
		<from_code>852311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango allergenic extract</from_name>
		<from_code>1011404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedar elm pollen extract</from_name>
		<from_code>1014191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red mulberry pollen extract</from_name>
		<from_code>852680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fremont cottonwood pollen extract</from_name>
		<from_code>852355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goat milk allergenic extract</from_name>
		<from_code>862475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed allergenic extract</from_name>
		<from_code>901203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse hair extract</from_name>
		<from_code>1993210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mulberry pollen extract</from_name>
		<from_code>899593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM</from_name>
		<from_code>317581</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Schinus terebinthifolius pollen extract</from_name>
		<from_code>2590688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>careless weed pollen extract</from_name>
		<from_code>851926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocean perch preparation</from_name>
		<from_code>2471431</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horseradish allergenic extract</from_name>
		<from_code>1011043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lawsonia inermis leaf extract</from_name>
		<from_code>1307699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower pollen extract</from_name>
		<from_code>852509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated rye grass pollen extract</from_name>
		<from_code>1014774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfalfa pollen extract</from_name>
		<from_code>852634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef allergenic extract</from_name>
		<from_code>892599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common hazel pollen extract</from_name>
		<from_code>1484979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silk allergenic extract</from_name>
		<from_code>314455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clam allergenic extract</from_name>
		<from_code>892539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raspberry extract</from_name>
		<from_code>1370769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Douglas fir pollen extract</from_name>
		<from_code>1098257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gliocladium viride extract</from_name>
		<from_code>2101008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Epicoccum nigrum allergenic extract</from_name>
		<from_code>852466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamb allergenic extract</from_name>
		<from_code>971849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitternut hickory pollen extract</from_name>
		<from_code>899645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat gluten extract</from_name>
		<from_code>1370781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver ragweed pollen extract</from_name>
		<from_code>852306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Malus domestica pollen extract</from_name>
		<from_code>2593689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben sodium</from_name>
		<from_code>1311574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basil allergenic extract</from_name>
		<from_code>899355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jack pine pollen extract</from_name>
		<from_code>1014690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grama grass pollen extract</from_name>
		<from_code>852197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grape extract</from_name>
		<from_code>253172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisal fiber allergenic extract</from_name>
		<from_code>851882</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn grain extract</from_name>
		<from_code>1423924</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean allergenic extract</from_name>
		<from_code>891668</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylparaben</from_name>
		<from_code>29903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apis mellifera preparation</from_name>
		<from_code>285219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tuna allergenic extract</from_name>
		<from_code>892503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic mackerel allergenic extract</from_name>
		<from_code>2198984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint allergenic extract</from_name>
		<from_code>901313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American cockroach allergenic extract</from_name>
		<from_code>905258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig hair extract</from_name>
		<from_code>895507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zucchini extract</from_name>
		<from_code>1649134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crested dogstail pollen extract</from_name>
		<from_code>1484980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poverty weed pollen extract</from_name>
		<from_code>852539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American basswood pollen extract</from_name>
		<from_code>995754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Passalora fulva allergenic extract</from_name>
		<from_code>883442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creeping bentgrass pollen extract</from_name>
		<from_code>1094116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canis lupus familiaris hair extract</from_name>
		<from_code>854025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rattus norvegicus hair preparation</from_name>
		<from_code>2471704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poppy seed allergenic extract</from_name>
		<from_code>1011017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Concord grape allergenic extract</from_name>
		<from_code>901191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herring allergenic extract</from_name>
		<from_code>899434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Strychnos nux-vomica seed extract</from_name>
		<from_code>1309678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg allergenic extract</from_name>
		<from_code>891652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burning bush pollen extract</from_name>
		<from_code>852593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codfish allergenic extract</from_name>
		<from_code>892543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora tarda allergenic extract</from_name>
		<from_code>852404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parthenolide</from_name>
		<from_code>32941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acremonium strictum allergenic extract</from_name>
		<from_code>905070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black oak pollen extract</from_name>
		<from_code>852260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pyrethrum cinerariifolium allergenic extract</from_name>
		<from_code>967970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsnip allergenic extract</from_name>
		<from_code>1011027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry birch pollen extract</from_name>
		<from_code>852144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European house dust mite allergenic extract</from_name>
		<from_code>1116979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epidermophyton floccosum allergenic extract</from_name>
		<from_code>995707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog flea allergenic extract</from_name>
		<from_code>886637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white (mexican) dock pollen extract</from_name>
		<from_code>1014743</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut allergenic extract</from_name>
		<from_code>891695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red alder pollen extract</from_name>
		<from_code>851914</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish extract</from_name>
		<from_code>1314656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem oak pollen extract</from_name>
		<from_code>1014766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cod, unspecified preparation</from_name>
		<from_code>1426437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arroyo willow pollen extract</from_name>
		<from_code>852170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leek allergenic extract</from_name>
		<from_code>1010932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English oak pollen extract</from_name>
		<from_code>1484984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tomato allergenic extract</from_name>
		<from_code>892499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cola acuminata seed extract</from_name>
		<from_code>1307595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lima bean allergenic extract</from_name>
		<from_code>891641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma harzianum allergenic extract</from_name>
		<from_code>968197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>swordfish allergenic extract</from_name>
		<from_code>901283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>licorice root extract</from_name>
		<from_code>235524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cucumis sativus fruit extract</from_name>
		<from_code>2700058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef liver preparation</from_name>
		<from_code>1330085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desert ragweed pollen extract</from_name>
		<from_code>851981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common wasp venom protein</from_name>
		<from_code>1297527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma destructiva allergenic extract</from_name>
		<from_code>966995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cootamundra wattle pollen extract</from_name>
		<from_code>895353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rat skin extract</from_name>
		<from_code>895279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mexican tea pollen extract</from_name>
		<from_code>897391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus globulus pollen extract</from_name>
		<from_code>852386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliocladium allergenic extract</from_name>
		<from_code>1192997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trout allergenic extract</from_name>
		<from_code>882482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton tonsurans allergenic extract</from_name>
		<from_code>1098619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant extract</from_name>
		<from_code>1315116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brazil nut allergenic extract</from_name>
		<from_code>891514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit bush pollen extract</from_name>
		<from_code>851969</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2'-dithiobisbenzothiazole</from_name>
		<from_code>1306112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bean extract</from_name>
		<from_code>1370773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck feather extract</from_name>
		<from_code>892851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine bush pollen extract</from_name>
		<from_code>851894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium expansum allergenic extract</from_name>
		<from_code>967111</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geraniol</from_name>
		<from_code>1368875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein allergenic extract</from_name>
		<from_code>862460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese black pine pollen extract</from_name>
		<from_code>900777</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass smut allergenic extract</from_name>
		<from_code>852128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
		<from_code>N0000185369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chinquapin oak pollen extract</from_name>
		<from_code>2167695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rough marshelder pollen extract</from_name>
		<from_code>852532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chocolate allergenic extract</from_name>
		<from_code>1010915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oyster allergenic extract</from_name>
		<from_code>973274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat allergenic extract</from_name>
		<from_code>971932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Australian pine pollen extract</from_name>
		<from_code>852229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microsporum audouinii allergenic extract</from_name>
		<from_code>1014395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American lobster allergenic extract</from_name>
		<from_code>1997187</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prairie sagebrush pollen extract</from_name>
		<from_code>867142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian balsam</from_name>
		<from_code>33219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse dander extract</from_name>
		<from_code>2167548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>veal allergenic extract</from_name>
		<from_code>1012026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger allergenic extract</from_name>
		<from_code>899420</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1352501</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carrot allergenic extract</from_name>
		<from_code>892368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitch pine pollen extract</from_name>
		<from_code>900758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus rubra pollen allergenic extract</from_name>
		<from_code>1426632</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster skin extract</from_name>
		<from_code>852663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidurea</from_name>
		<from_code>1368885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rocky Mountain juniper pollen extract</from_name>
		<from_code>852601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoeugenol</from_name>
		<from_code>1363706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Blatta orientalis preparation</from_name>
		<from_code>1346617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida tropicalis allergenic extract</from_name>
		<from_code>967033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey allergenic extract</from_name>
		<from_code>975119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger var. niger extract</from_name>
		<from_code>854082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor racemosus allergenic extract</from_name>
		<from_code>852687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue crab preparation</from_name>
		<from_code>1315126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-tert-butylphenol-formaldehyde resin (low molecular weight)</from_name>
		<from_code>1427189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Callistemon citrinus pollen extract</from_name>
		<from_code>2171260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Platycladus orientalis pollen extract</from_name>
		<from_code>1360623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra root powder extract</from_name>
		<from_code>2711885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf plantain pollen extract</from_name>
		<from_code>1484983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haematonectria haematococca allergenic extract</from_name>
		<from_code>852503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey feather extract</from_name>
		<from_code>1594963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2-bis(4-glycidyloxyphenyl)propane</from_name>
		<from_code>1368138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion allergenic extract</from_name>
		<from_code>899466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus lunatus allergenic extract</from_name>
		<from_code>852264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>weakleaf bur ragweed pollen extract</from_name>
		<from_code>1117083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pignut hickory pollen extract</from_name>
		<from_code>899650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint preparation</from_name>
		<from_code>33093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic aldehyde</from_name>
		<from_code>1368153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microascus brevicaulis allergenic extract</from_name>
		<from_code>1192992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slash pine pollen extract</from_name>
		<from_code>900731</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white hickory pollen extract</from_name>
		<from_code>852193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow sweet clover pollen extract</from_name>
		<from_code>1014447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>groundsel pollen extract</from_name>
		<from_code>897332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>microsporum canis allergenic extract</from_name>
		<from_code>1014399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neurospora sitophila allergenic extract</from_name>
		<from_code>1098200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya allergenic extract</from_name>
		<from_code>1011426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse hair extract</from_name>
		<from_code>895515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsam poplar pollen extract</from_name>
		<from_code>1014762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sorghum bicolor pollen extract</from_name>
		<from_code>1311406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black willow pollen extract</from_name>
		<from_code>852162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern yellow jacket venom protein</from_name>
		<from_code>1297533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tree of heaven pollen extract</from_name>
		<from_code>851890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl cinnamal</from_name>
		<from_code>1311606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut allergenic extract</from_name>
		<from_code>891611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acer pseudoplatanus pollen extract</from_name>
		<from_code>1801702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clonostachys rosea f. rosea allergenic extract</from_name>
		<from_code>1426481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German wasp venom protein</from_name>
		<from_code>1297531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mast Cell Function Alteration [PE]</from_name>
		<from_code>N0000175627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow birch pollen extract</from_name>
		<from_code>899550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES</from_name>
		<from_code>350004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog skin extract</from_name>
		<from_code>852839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California mugwort pollen extract</from_name>
		<from_code>892734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amaranthus hybridus pollen extract</from_name>
		<from_code>1363561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean allergenic extract</from_name>
		<from_code>901291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspen pollen extract</from_name>
		<from_code>852339</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus nidulans allergenic extract</from_name>
		<from_code>1368357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scrub pine pollen extract</from_name>
		<from_code>1013913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow fescue grass pollen extract</from_name>
		<from_code>851918</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef liver allergenic extract</from_name>
		<from_code>972689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black carpenter ant allergenic extract</from_name>
		<from_code>2057909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wing scale pollen extract</from_name>
		<from_code>852074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white ash pollen extract</from_name>
		<from_code>852450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet potato allergenic extract</from_name>
		<from_code>901307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pumpkin allergenic extract</from_name>
		<from_code>883459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colonial bent grass pollen extract</from_name>
		<from_code>1484937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated oat pollen extract</from_name>
		<from_code>852114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber allergenic extract</from_name>
		<from_code>899738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit allergenic extract</from_name>
		<from_code>813859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides farinae</from_name>
		<from_code>852810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern sycamore pollen extract</from_name>
		<from_code>852746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium digitatum allergenic extract</from_name>
		<from_code>1427044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic preparation</from_name>
		<from_code>265647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazolidinylurea</from_name>
		<from_code>1310602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-MERCAPTOBENZOTHIAZOLE</from_name>
		<from_code>1306880</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic allergenic extract</from_name>
		<from_code>899414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley allergenic extract</from_name>
		<from_code>899877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn extract</from_name>
		<from_code>1323308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster hair extract</from_name>
		<from_code>1594965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant allergenic extract</from_name>
		<from_code>972601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>honeydew melon allergenic extract</from_name>
		<from_code>899476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golden chain pollen extract</from_name>
		<from_code>1996102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western wheatgrass pollen extract</from_name>
		<from_code>852659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red cedar pollen extract</from_name>
		<from_code>852609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Quercus marilandica pollen extract</from_name>
		<from_code>1437222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated mushroom allergenic extract</from_name>
		<from_code>901369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated barley pollen extract</from_name>
		<from_code>1098118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus glabra pollen extract</from_name>
		<from_code>2369372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley allergenic extract</from_name>
		<from_code>862453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oneseed juniper pollen extract</from_name>
		<from_code>900108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water oak pollen extract</from_name>
		<from_code>1013944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast maple pollen extract</from_name>
		<from_code>851736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syringa vulgaris pollen extract</from_name>
		<from_code>2634236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broomweed pollen extract</from_name>
		<from_code>1094193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lobster allergenic extract</from_name>
		<from_code>892561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cow milk allergenic extract</from_name>
		<from_code>892665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gambels oak pollen extract</from_name>
		<from_code>852276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plains cottonwood pollen extract</from_name>
		<from_code>867297</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date palm pollen extract</from_name>
		<from_code>852704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed allergenic extract</from_name>
		<from_code>901199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black sea bass allergenic extract</from_name>
		<from_code>2102474</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant ragweed pollen extract</from_name>
		<from_code>851998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. lusitanicus allergenic extract</from_name>
		<from_code>2101473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint flowering top extract</from_name>
		<from_code>2168421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pin oak pollen extract</from_name>
		<from_code>900999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>para grass pollen extract</from_name>
		<from_code>894750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shrimp allergenic extract</from_name>
		<from_code>892592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brown rice preparation</from_name>
		<from_code>1311040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed extract</from_name>
		<from_code>1310046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>box elder maple pollen extract</from_name>
		<from_code>851740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redwood pollen extract</from_name>
		<from_code>1014707</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tabanus nigrovittatus extract</from_name>
		<from_code>2590185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides pteronyssinus</from_name>
		<from_code>852826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bur oak pollen extract</from_name>
		<from_code>900991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English plantain pollen extract</from_name>
		<from_code>852742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper preparation</from_name>
		<from_code>259314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>annual bluegrass pollen extract</from_name>
		<from_code>898404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German cockroach allergenic extract</from_name>
		<from_code>905276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vitis vinifera pollen extract</from_name>
		<from_code>2669695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut allergenic extract</from_name>
		<from_code>891658</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Calocedrus decurrens pollen extract</from_name>
		<from_code>2670160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alkali blite pollen extract</from_name>
		<from_code>852106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorquinaldol</from_name>
		<from_code>2407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>algal fungi allergenic extract</from_name>
		<from_code>966692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goose feather extract</from_name>
		<from_code>894783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Leucanthemum vulgare pollen</from_name>
		<from_code>2102006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cottonwood pollen extract</from_name>
		<from_code>852376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage leaf allergenic extract</from_name>
		<from_code>1011627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jute fiber allergenic extract</from_name>
		<from_code>852412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway seed allergenic extract</from_name>
		<from_code>899637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus amstelodami extract</from_name>
		<from_code>2101007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Scotch pine pollen extract</from_name>
		<from_code>900764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet gum pollen extract</from_name>
		<from_code>852627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slender ragweed pollen extract</from_name>
		<from_code>851990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strawberry allergenic extract</from_name>
		<from_code>892484</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton rubrum allergenic extract</from_name>
		<from_code>968413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS</from_name>
		<from_code>350075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine carbamate</from_name>
		<from_code>2375923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watermelon preparation</from_name>
		<from_code>260014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brussels sprout allergenic extract</from_name>
		<from_code>899390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut allergenic extract</from_name>
		<from_code>891687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobacco leaf allergenic extract</from_name>
		<from_code>852062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, CAMEL</from_name>
		<from_code>314336</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass smut allergenic extract</from_name>
		<from_code>1014385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinach allergenic extract</from_name>
		<from_code>901317</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mongolian gerbil skin allergenic extract</from_name>
		<from_code>895070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg extract</from_name>
		<from_code>1353217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-cyclohexyl-N'-phenyl-1,4-phenylenediamine</from_name>
		<from_code>1427136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf cattail pollen extract</from_name>
		<from_code>1232637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grain sorghum pollen extract</from_name>
		<from_code>1098438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pear preparation</from_name>
		<from_code>1367125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern white pine pollen extract</from_name>
		<from_code>852738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salsola tragus pollen extract</from_name>
		<from_code>1314927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western black willow pollen extract</from_name>
		<from_code>1014755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheasant feather extract</from_name>
		<from_code>1594964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiram</from_name>
		<from_code>10517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck allergenic extract</from_name>
		<from_code>972037</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crab allergenic extract</from_name>
		<from_code>892610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvetleaf huckleberry allergenic extract</from_name>
		<from_code>2102487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean extract</from_name>
		<from_code>2275721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burrobrush pollen extract</from_name>
		<from_code>852526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse skin extract</from_name>
		<from_code>852693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvet grass pollen extract</from_name>
		<from_code>852514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium cladosporioides extract</from_name>
		<from_code>867198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flounder allergenic extract</from_name>
		<from_code>899746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green ash pollen extract</from_name>
		<from_code>852491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Brazilian pepper tree pollen extract</from_name>
		<from_code>2632068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lettuce allergenic extract</from_name>
		<from_code>899448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia longifolia pollen extract</from_name>
		<from_code>853983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetramethylthiuram monosulfide</from_name>
		<from_code>1363713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamyl alcohol</from_name>
		<from_code>1362889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>northern quahog preparation</from_name>
		<from_code>1925437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian thistle pollen extract</from_name>
		<from_code>852158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red maple pollen extract</from_name>
		<from_code>851744</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk (chicken) allergenic extract</from_name>
		<from_code>892620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Koelers grass pollen extract</from_name>
		<from_code>852605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>string bean allergenic extract</from_name>
		<from_code>891676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cytisus scoparius flowering top extract</from_name>
		<from_code>2168418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-mercaptobenzothiazole</from_name>
		<from_code>1358845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard pollen extract</from_name>
		<from_code>852205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squash allergenic extract</from_name>
		<from_code>975509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosin</from_name>
		<from_code>1362931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium chrysogenum var. chrysogenum allergenic extract</from_name>
		<from_code>854130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pistachio nut allergenic extract</from_name>
		<from_code>904606</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parakeet feather allergenic extract</from_name>
		<from_code>1192987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic halibut preparation</from_name>
		<from_code>1424920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turnip allergenic extract</from_name>
		<from_code>883414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver birch pollen allergenic extract</from_name>
		<from_code>1306108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig skin extract</from_name>
		<from_code>852298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black locust pollen extract</from_name>
		<from_code>867325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed extract</from_name>
		<from_code>853406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium compactum allergenic extract</from_name>
		<from_code>999457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pork allergenic extract</from_name>
		<from_code>892628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipentamethylenethiuram disulfide</from_name>
		<from_code>1426773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butylparaben</from_name>
		<from_code>1306937</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil seed extract</from_name>
		<from_code>1426921</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>queen palm pollen extract</from_name>
		<from_code>867353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Paecilomyces variotii allergenic extract</from_name>
		<from_code>966979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white sweet clover pollen extract</from_name>
		<from_code>1014735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black oak pollen extract</from_name>
		<from_code>1014721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osage orange pollen extract</from_name>
		<from_code>1098189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast sage pollen extract</from_name>
		<from_code>852011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken allergenic extract</from_name>
		<from_code>892653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra allergenic extract</from_name>
		<from_code>1011021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium italicum allergenic extract</from_name>
		<from_code>967960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine extract</from_name>
		<from_code>1426364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Solidago virgaurea pollen extract</from_name>
		<from_code>1309242</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparagus allergenic extract</from_name>
		<from_code>891796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic salmon allergenic extract</from_name>
		<from_code>900031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loblolly pine pollen extract</from_name>
		<from_code>900770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white mulberry pollen extract</from_name>
		<from_code>852669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon allergenic extract</from_name>
		<from_code>899673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose barley smut allergenic extract</from_name>
		<from_code>968492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American chestnut allergenic extract</from_name>
		<from_code>891752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia dealbata pollen extract</from_name>
		<from_code>2202946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow dock pollen extract</from_name>
		<from_code>852209</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant wild rye pollen extract</from_name>
		<from_code>900148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raspberry allergenic extract</from_name>
		<from_code>899906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet wormwood pollen extract</from_name>
		<from_code>2167819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharomyces cerevisiae allergenic extract</from_name>
		<from_code>350141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut pollen extract</from_name>
		<from_code>852569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium solani allergenic extract</from_name>
		<from_code>867349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Geotrichum candidum allergenic extract</from_name>
		<from_code>999463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>London planetree</from_name>
		<from_code>2166616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitter dock pollen extract</from_name>
		<from_code>1014739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western sycamore pollen extract</from_name>
		<from_code>852750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>river birch pollen extract</from_name>
		<from_code>852148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabbage allergenic extract</from_name>
		<from_code>899398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black imported fire ant allergenic extract</from_name>
		<from_code>995738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N,N'-diphenyl-4-phenylenediamine</from_name>
		<from_code>1363709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California juniper pollen extract</from_name>
		<from_code>852585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stachybotrys chartarum allergenic extract</from_name>
		<from_code>968123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red imported fire ant allergenic extract</from_name>
		<from_code>867341</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mung bean allergenic extract</from_name>
		<from_code>891647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern cottonwood pollen extract</from_name>
		<from_code>852363</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape allergenic extract</from_name>
		<from_code>892317</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pekoe tea allergenic extract</from_name>
		<from_code>966696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Khuskia oryzae allergenic extract</from_name>
		<from_code>892338</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella fujikuroi extract</from_name>
		<from_code>2043450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella zeae allergenic extract</from_name>
		<from_code>1922751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cashew nut allergenic extract</from_name>
		<from_code>892526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plum allergenic extract</from_name>
		<from_code>899470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape extract</from_name>
		<from_code>1307718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white alder pollen extract</from_name>
		<from_code>851910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora betae allergenic extract</from_name>
		<from_code>852756</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watermelon allergenic extract</from_name>
		<from_code>901258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc dibutyldithiocarbamate</from_name>
		<from_code>1426942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venison allergenic extract</from_name>
		<from_code>882488</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxycitronellal</from_name>
		<from_code>1362893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watercress allergenic extract</from_name>
		<from_code>1011418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apiospora montagnei allergenic extract</from_name>
		<from_code>1006258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptomyces griseus allergenic extract</from_name>
		<from_code>1314592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Siberian elm pollen extract</from_name>
		<from_code>1299981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue beech pollen extract</from_name>
		<from_code>899611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common cocklebur pollen extract</from_name>
		<from_code>902215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut pollen extract</from_name>
		<from_code>852281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum extract</from_name>
		<from_code>852617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit peel extract</from_name>
		<from_code>1358897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Periplaneta australasiae extract</from_name>
		<from_code>2590183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic cod allergenic extract</from_name>
		<from_code>900025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orchard grass pollen extract</from_name>
		<from_code>851878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bay leaf extract</from_name>
		<from_code>1606480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dendryphiella vinosa allergenic extract</from_name>
		<from_code>995703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora herbarum allergenic extract</from_name>
		<from_code>971198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic halibut allergenic extract</from_name>
		<from_code>2261370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perch allergenic extract</from_name>
		<from_code>976711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avocado oil</from_name>
		<from_code>1311611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona ash pollen extract</from_name>
		<from_code>852496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Grindelia ciliata pollen extract</from_name>
		<from_code>2043451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bluefish allergenic extract</from_name>
		<from_code>892181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben</from_name>
		<from_code>34706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem artichoke extract</from_name>
		<from_code>1648701</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Histamine Release [PE]</to_name>
		<to_code>N0000175629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoma exigua var. exigua allergenic extract</to_name>
		<to_code>867284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Microascus brevicaulis allergenic extract</to_name>
		<to_code>1192992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleospora tarda allergenic extract</to_name>
		<to_code>852404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>algal fungi allergenic extract</to_name>
		<to_code>966692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acremonium strictum allergenic extract</to_name>
		<to_code>905070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>loose barley smut allergenic extract</to_name>
		<to_code>968492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eurotium herbariorum allergenic extract</to_name>
		<to_code>999450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat smut allergenic extract</to_name>
		<to_code>852797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus amstelodami extract</to_name>
		<to_code>2101007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helminthosporium solani allergenic extract</to_name>
		<to_code>867232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS</to_name>
		<to_code>350125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosporium herbarum allergenic extract</to_name>
		<to_code>466198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verticillium albo-atrum allergenic extract</to_name>
		<to_code>968467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microsporum canis allergenic extract</to_name>
		<to_code>1014399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium roquefortii allergenic extract</to_name>
		<to_code>972365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neurospora sitophila allergenic extract</to_name>
		<to_code>1098200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysonilia sitophila allergenic extract</to_name>
		<to_code>314411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epidermophyton floccosum allergenic extract</to_name>
		<to_code>995707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemphylium solani allergenic extract</to_name>
		<to_code>867349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geotrichum candidum allergenic extract</to_name>
		<to_code>999463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharomyces cerevisiae allergenic extract</to_name>
		<to_code>350141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Lichtheimia corymbifera allergenic extract</to_name>
		<to_code>995727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton rubrum allergenic extract</to_name>
		<to_code>968413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phanerodontia chrysosporium allergenic extract</to_name>
		<to_code>968114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Puccinia striiformis allergenic extract</to_name>
		<to_code>852311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clonostachys rosea f. rosea allergenic extract</to_name>
		<to_code>1426481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichoderma harzianum allergenic extract</to_name>
		<to_code>968197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syncephalastrum racemosum allergenic extract</to_name>
		<to_code>968506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus flavus var. oryzae protease</to_name>
		<to_code>1307040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bermuda grass smut allergenic extract</to_name>
		<to_code>1014385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida albicans allergenic extract</to_name>
		<to_code>214355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM</to_name>
		<to_code>317581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cochliobolus sativus allergenic extract</to_name>
		<to_code>852398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stachybotrys chartarum allergenic extract</to_name>
		<to_code>968123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor circinelloides f. circinelloides allergenic extract</to_name>
		<to_code>2101422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn smut allergenic extract</to_name>
		<to_code>314488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA</to_name>
		<to_code>350060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoma destructiva allergenic extract</to_name>
		<to_code>966995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cladosporium sphaerospermum allergenic extract</to_name>
		<to_code>867202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodotorula mucilaginosa allergenic extract</to_name>
		<to_code>967529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus terreus allergenic extract</to_name>
		<to_code>314324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Khuskia oryzae allergenic extract</to_name>
		<to_code>892338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus nidulans allergenic extract</to_name>
		<to_code>1368357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gibberella fujikuroi extract</to_name>
		<to_code>2043450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium glaucum allergenic extract</to_name>
		<to_code>1986792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gibberella zeae allergenic extract</to_name>
		<to_code>1922751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus repens allergenic extract</to_name>
		<to_code>1006310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Puccinia graminis allergenic extract</to_name>
		<to_code>999487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gliocladium allergenic extract</to_name>
		<to_code>1192997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Fusarium oxysporum allergenic extract</to_name>
		<to_code>2101722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharomyces cerevisiae</to_name>
		<to_code>9511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodotorula rubra allergenic extract</to_name>
		<to_code>867321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton tonsurans allergenic extract</to_name>
		<to_code>1098619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton schoenleinii allergenic extract</to_name>
		<to_code>968422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosporium cladosporioides extract</to_name>
		<to_code>867198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhizopus arrhizus allergenic extract</to_name>
		<to_code>314443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cochliobolus spicifer allergenic extract</to_name>
		<to_code>995699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Johnson grass smut allergenic extract</to_name>
		<to_code>852128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida albicans</to_name>
		<to_code>1963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Humicola grisea allergenic extract</to_name>
		<to_code>1014391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleospora betae allergenic extract</to_name>
		<to_code>852756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium expansum allergenic extract</to_name>
		<to_code>967111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gliocladium viride extract</to_name>
		<to_code>2101008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypomyces perniciosus allergenic extract</to_name>
		<to_code>1192968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aureobasidium pullulans var. pullutans allergenic extract</to_name>
		<to_code>852102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium digitatum allergenic extract</to_name>
		<to_code>1427044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epicoccum nigrum allergenic extract</to_name>
		<to_code>852466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alternaria alternata allergenic extract</to_name>
		<to_code>901845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Microsporum audouinii allergenic extract</to_name>
		<to_code>1014395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>loose wheat smut allergenic extract</to_name>
		<to_code>968437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus flavus allergenic extract</to_name>
		<to_code>999384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apiospora montagnei allergenic extract</to_name>
		<to_code>1006258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acrothecium robustum allergenic extract</to_name>
		<to_code>905088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhizopus stolonifer allergenic extract</to_name>
		<to_code>967721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium chrysogenum var. chrysogenum allergenic extract</to_name>
		<to_code>854130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Fusarium oxysporum vasinfectum allergenic extract</to_name>
		<to_code>867228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chaetomium globosum allergenic extract</to_name>
		<to_code>466197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor plumbeus allergenic extract</to_name>
		<to_code>314415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemphylium sarciniforme allergenic extract</to_name>
		<to_code>968130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton mentagrophytes allergenic extract</to_name>
		<to_code>867357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colletotrichum coccodes allergenic extract</to_name>
		<to_code>1192729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dendryphiella vinosa allergenic extract</to_name>
		<to_code>995703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curvularia inequalis allergenic extract</to_name>
		<to_code>999438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleospora herbarum allergenic extract</to_name>
		<to_code>971198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ustilago maydis extract</to_name>
		<to_code>1427134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor circinelloides f. lusitanicus allergenic extract</to_name>
		<to_code>2101473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>neurospora intermedia allergenic extract</to_name>
		<to_code>867274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oat smut allergenic extract</to_name>
		<to_code>349978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida tropicalis allergenic extract</to_name>
		<to_code>967033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cephalosporium roseum extract</to_name>
		<to_code>1925834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichoderma viride allergenic extract</to_name>
		<to_code>968401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passalora fulva allergenic extract</to_name>
		<to_code>883442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus fumigatus allergenic extract</to_name>
		<to_code>466192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor racemosus allergenic extract</to_name>
		<to_code>852687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus niger var. niger extract</to_name>
		<to_code>854082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haematonectria haematococca allergenic extract</to_name>
		<to_code>852503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichothecium roseum allergenic extract</to_name>
		<to_code>968426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Fusarium compactum allergenic extract</to_name>
		<to_code>999457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tetracoccosporium paxianum allergenic extract</to_name>
		<to_code>968502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paecilomyces variotii allergenic extract</to_name>
		<to_code>966979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium italicum allergenic extract</to_name>
		<to_code>967960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cochliobolus lunatus allergenic extract</to_name>
		<to_code>852264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Botrytis cinerea allergenic extract</to_name>
		<to_code>466195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
		<from_code>N0000185372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium camemberti allergenic extract</to_name>
		<to_code>966943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Fungal Allergenic Extract [EPC]</to_name>
		<to_code>N0000185372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS</from_name>
		<from_code>350125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS</from_name>
		<from_code>350125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acremonium strictum allergenic extract</from_name>
		<from_code>905070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose barley smut allergenic extract</from_name>
		<from_code>968492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora tarda allergenic extract</from_name>
		<from_code>852404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>algal fungi allergenic extract</from_name>
		<from_code>966692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma exigua var. exigua allergenic extract</from_name>
		<from_code>867284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microascus brevicaulis allergenic extract</from_name>
		<from_code>1192992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton rubrum allergenic extract</from_name>
		<from_code>968413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium solani allergenic extract</from_name>
		<from_code>867349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Geotrichum candidum allergenic extract</from_name>
		<from_code>999463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharomyces cerevisiae allergenic extract</from_name>
		<from_code>350141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lichtheimia corymbifera allergenic extract</from_name>
		<from_code>995727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Verticillium albo-atrum allergenic extract</from_name>
		<from_code>968467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>microsporum canis allergenic extract</from_name>
		<from_code>1014399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neurospora sitophila allergenic extract</from_name>
		<from_code>1098200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium roquefortii allergenic extract</from_name>
		<from_code>972365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epidermophyton floccosum allergenic extract</from_name>
		<from_code>995707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus amstelodami extract</from_name>
		<from_code>2101007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Helminthosporium solani allergenic extract</from_name>
		<from_code>867232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM</from_name>
		<from_code>317581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stachybotrys chartarum allergenic extract</from_name>
		<from_code>968123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syncephalastrum racemosum allergenic extract</from_name>
		<from_code>968506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma harzianum allergenic extract</from_name>
		<from_code>968197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus var. oryzae protease</from_name>
		<from_code>1307040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass smut allergenic extract</from_name>
		<from_code>1014385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phanerodontia chrysosporium allergenic extract</from_name>
		<from_code>968114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clonostachys rosea f. rosea allergenic extract</from_name>
		<from_code>1426481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia striiformis allergenic extract</from_name>
		<from_code>852311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliocladium allergenic extract</from_name>
		<from_code>1192997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum allergenic extract</from_name>
		<from_code>2101722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glaucum allergenic extract</from_name>
		<from_code>1986792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella zeae allergenic extract</from_name>
		<from_code>1922751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus repens allergenic extract</from_name>
		<from_code>1006310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia graminis allergenic extract</from_name>
		<from_code>999487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma destructiva allergenic extract</from_name>
		<from_code>966995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladosporium sphaerospermum allergenic extract</from_name>
		<from_code>867202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula mucilaginosa allergenic extract</from_name>
		<from_code>967529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Khuskia oryzae allergenic extract</from_name>
		<from_code>892338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella fujikuroi extract</from_name>
		<from_code>2043450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus nidulans allergenic extract</from_name>
		<from_code>1368357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. circinelloides allergenic extract</from_name>
		<from_code>2101422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA</from_name>
		<from_code>350060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gliocladium viride extract</from_name>
		<from_code>2101008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hypomyces perniciosus allergenic extract</from_name>
		<from_code>1192968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium digitatum allergenic extract</from_name>
		<from_code>1427044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass smut allergenic extract</from_name>
		<from_code>852128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humicola grisea allergenic extract</from_name>
		<from_code>1014391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora betae allergenic extract</from_name>
		<from_code>852756</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium expansum allergenic extract</from_name>
		<from_code>967111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium cladosporioides extract</from_name>
		<from_code>867198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cochliobolus spicifer allergenic extract</from_name>
		<from_code>995699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton tonsurans allergenic extract</from_name>
		<from_code>1098619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton schoenleinii allergenic extract</from_name>
		<from_code>968422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium chrysogenum var. chrysogenum allergenic extract</from_name>
		<from_code>854130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated mushroom allergenic extract</from_name>
		<from_code>901369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microsporum audouinii allergenic extract</from_name>
		<from_code>1014395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus allergenic extract</from_name>
		<from_code>999384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose wheat smut allergenic extract</from_name>
		<from_code>968437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apiospora montagnei allergenic extract</from_name>
		<from_code>1006258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acrothecium robustum allergenic extract</from_name>
		<from_code>905088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Epicoccum nigrum allergenic extract</from_name>
		<from_code>852466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Passalora fulva allergenic extract</from_name>
		<from_code>883442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger var. niger extract</from_name>
		<from_code>854082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor racemosus allergenic extract</from_name>
		<from_code>852687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora herbarum allergenic extract</from_name>
		<from_code>971198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. lusitanicus allergenic extract</from_name>
		<from_code>2101473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ustilago maydis extract</from_name>
		<from_code>1427134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neurospora intermedia allergenic extract</from_name>
		<from_code>867274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida tropicalis allergenic extract</from_name>
		<from_code>967033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dendryphiella vinosa allergenic extract</from_name>
		<from_code>995703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium sarciniforme allergenic extract</from_name>
		<from_code>968130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Colletotrichum coccodes allergenic extract</from_name>
		<from_code>1192729</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium camemberti allergenic extract</from_name>
		<from_code>966943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium italicum allergenic extract</from_name>
		<from_code>967960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus lunatus allergenic extract</from_name>
		<from_code>852264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Paecilomyces variotii allergenic extract</from_name>
		<from_code>966979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haematonectria haematococca allergenic extract</from_name>
		<from_code>852503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium compactum allergenic extract</from_name>
		<from_code>999457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetracoccosporium paxianum allergenic extract</from_name>
		<from_code>968502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fungal Proteins</to_name>
		<to_code>M0008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM</from_name>
		<from_code>317581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA</from_name>
		<from_code>350060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bay leaf extract</to_name>
		<to_code>1606480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zucchini extract</to_name>
		<to_code>1649134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cow milk allergenic extract</to_name>
		<to_code>892665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lobster allergenic extract</to_name>
		<to_code>892561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spearmint allergenic extract</to_name>
		<to_code>901313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English sole allergenic extract</to_name>
		<to_code>974140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white catfish allergenic extract</to_name>
		<to_code>971166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple allergenic extract</to_name>
		<to_code>891771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean allergenic extract</to_name>
		<to_code>891668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage extract</to_name>
		<to_code>1354504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic mackerel allergenic extract</to_name>
		<to_code>2198984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tuna allergenic extract</to_name>
		<to_code>892503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avocado oil</to_name>
		<to_code>1311611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red currant allergenic extract</to_name>
		<to_code>972480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perch allergenic extract</to_name>
		<to_code>976711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint flowering top extract</to_name>
		<to_code>2168421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barley malt allergenic extract</to_name>
		<to_code>1006510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lemon extract</to_name>
		<to_code>1364291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame seed allergenic extract</to_name>
		<to_code>901199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black sea bass allergenic extract</to_name>
		<to_code>2102474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic halibut allergenic extract</to_name>
		<to_code>2261370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scallop allergenic extract</to_name>
		<to_code>899916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame seed extract</to_name>
		<to_code>1310046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brown rice preparation</to_name>
		<to_code>1311040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bluefish allergenic extract</to_name>
		<to_code>892181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg (chicken) allergenic extract</to_name>
		<to_code>904507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shrimp allergenic extract</to_name>
		<to_code>892592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herring allergenic extract</to_name>
		<to_code>899434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Concord grape allergenic extract</to_name>
		<to_code>901191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quince extract</to_name>
		<to_code>1370761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jerusalem artichoke extract</to_name>
		<to_code>1648701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>date allergenic extract</to_name>
		<to_code>899742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poppy seed allergenic extract</to_name>
		<to_code>1011017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Whey Proteins</to_name>
		<to_code>1723989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit allergenic extract</to_name>
		<to_code>813859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber allergenic extract</to_name>
		<to_code>899738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clam allergenic extract</to_name>
		<to_code>892539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynara preparation</to_name>
		<to_code>235940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>beef allergenic extract</to_name>
		<to_code>892599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape extract</to_name>
		<to_code>1307718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis fruit extract</to_name>
		<to_code>1310189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tragacanth</to_name>
		<to_code>1368197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raspberry extract</to_name>
		<to_code>1370769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garlic preparation</to_name>
		<to_code>265647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chickpea allergenic extract</to_name>
		<to_code>1011049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peach allergenic extract</to_name>
		<to_code>892575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watercress allergenic extract</to_name>
		<to_code>1011418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated mushroom allergenic extract</to_name>
		<to_code>901369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green bell pepper extract</to_name>
		<to_code>1315118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venison allergenic extract</to_name>
		<to_code>882488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lamb allergenic extract</to_name>
		<to_code>971849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn extract</to_name>
		<to_code>1323308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsley allergenic extract</to_name>
		<to_code>899877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garlic allergenic extract</to_name>
		<to_code>899414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watermelon allergenic extract</to_name>
		<to_code>901258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honeydew melon allergenic extract</to_name>
		<to_code>899476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eggplant allergenic extract</to_name>
		<to_code>972601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat gluten extract</to_name>
		<to_code>1370781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry allergenic extract</to_name>
		<to_code>899734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn grain extract</to_name>
		<to_code>1423924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barley allergenic extract</to_name>
		<to_code>862453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paprika allergenic extract</to_name>
		<to_code>899873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>karaya gum extract</to_name>
		<to_code>852617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic cod allergenic extract</to_name>
		<to_code>900025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coffea arabica seed extract</to_name>
		<to_code>2695791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit peel extract</to_name>
		<to_code>1358897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coffee bean allergenic extract</to_name>
		<to_code>891727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anise seed extract</to_name>
		<to_code>1309292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>basil allergenic extract</to_name>
		<to_code>899355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grape extract</to_name>
		<to_code>253172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black olive allergenic extract</to_name>
		<to_code>974650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabbage allergenic extract</to_name>
		<to_code>899398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango allergenic extract</to_name>
		<to_code>1011404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fig allergenic extract</to_name>
		<to_code>973880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cantaloupe allergenic extract</to_name>
		<to_code>892517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green bell pepper allergenic extract</to_name>
		<to_code>862478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut allergenic extract</to_name>
		<to_code>891611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allspice allergenic extract</to_name>
		<to_code>895552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dill extract</to_name>
		<to_code>2108821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mung bean allergenic extract</to_name>
		<to_code>891647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger root</to_name>
		<to_code>125921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goat milk allergenic extract</to_name>
		<to_code>862475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celery allergenic extract</to_name>
		<to_code>892372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haddock allergenic extract</to_name>
		<to_code>899428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower seed allergenic extract</to_name>
		<to_code>901203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white fish allergenic extract</to_name>
		<to_code>901265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon allergenic extract</to_name>
		<to_code>892584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orange pekoe tea allergenic extract</to_name>
		<to_code>966696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanilla bean allergenic extract</to_name>
		<to_code>901291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple extract</to_name>
		<to_code>1424865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape allergenic extract</to_name>
		<to_code>892317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horseradish allergenic extract</to_name>
		<to_code>1011043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>beef liver allergenic extract</to_name>
		<to_code>972689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plum allergenic extract</to_name>
		<to_code>899470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pumpkin allergenic extract</to_name>
		<to_code>883459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet potato allergenic extract</to_name>
		<to_code>901307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spearmint extract</to_name>
		<to_code>1372258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cashew nut allergenic extract</to_name>
		<to_code>892526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ocean perch preparation</to_name>
		<to_code>2471431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lime allergenic extract</to_name>
		<to_code>1011060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orange allergenic extract</to_name>
		<to_code>892565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber extract</to_name>
		<to_code>1305719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint preparation</to_name>
		<to_code>33093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparagus allergenic extract</to_name>
		<to_code>891796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic salmon allergenic extract</to_name>
		<to_code>900031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common carp allergenic extract</to_name>
		<to_code>901390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon allergenic extract</to_name>
		<to_code>899673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lemon allergenic extract</to_name>
		<to_code>901382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean preparation</to_name>
		<to_code>287515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rye allergenic extract</to_name>
		<to_code>892638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya allergenic extract</to_name>
		<to_code>1011426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raspberry allergenic extract</to_name>
		<to_code>899906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsicum extract</to_name>
		<to_code>319780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cauliflower allergenic extract</to_name>
		<to_code>899661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lentil allergenic extract</to_name>
		<to_code>899444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American chestnut allergenic extract</to_name>
		<to_code>891752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium cepa bulb extract</to_name>
		<to_code>2695867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangerine allergenic extract</to_name>
		<to_code>1011412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharomyces cerevisiae allergenic extract</to_name>
		<to_code>350141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango extract</to_name>
		<to_code>1426332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turnip allergenic extract</to_name>
		<to_code>883414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic halibut preparation</to_name>
		<to_code>1424920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pineapple extract</to_name>
		<to_code>1492174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pecan pollen extract</to_name>
		<to_code>852272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>blue crab preparation</to_name>
		<to_code>1315126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turkey allergenic extract</to_name>
		<to_code>975119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>whole wheat allergenic extract</to_name>
		<to_code>901299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>banana allergenic extract</to_name>
		<to_code>891830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hazelnut allergenic extract</to_name>
		<to_code>891633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lentil seed extract</to_name>
		<to_code>1426921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra root powder extract</to_name>
		<to_code>2711885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>okra extract</to_name>
		<to_code>1370787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork allergenic extract</to_name>
		<to_code>892628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot extract</to_name>
		<to_code>1353891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barley extract</to_name>
		<to_code>1370766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyme preparation</to_name>
		<to_code>319823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kidney bean allergenic extract</to_name>
		<to_code>891637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black pepper allergenic extract</to_name>
		<to_code>899363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oregano allergenic extract</to_name>
		<to_code>1010965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pisum sativum (pea) extract</to_name>
		<to_code>1426912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>onion allergenic extract</to_name>
		<to_code>899466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangerine extract</to_name>
		<to_code>1426364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>okra allergenic extract</to_name>
		<to_code>1011021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken allergenic extract</to_name>
		<to_code>892653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colloidal oatmeal</to_name>
		<to_code>221082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flounder allergenic extract</to_name>
		<to_code>899746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bean extract</to_name>
		<to_code>1370773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brazil nut allergenic extract</to_name>
		<to_code>891514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eggplant extract</to_name>
		<to_code>1315116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>onion extract</to_name>
		<to_code>1370469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trout allergenic extract</to_name>
		<to_code>882482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry preparation</to_name>
		<to_code>125933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharomyces cerevisiae</to_name>
		<to_code>9511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flaxseed extract</to_name>
		<to_code>318224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pacific halibut allergenic extract</to_name>
		<to_code>882469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>northern quahog preparation</to_name>
		<to_code>1925437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chocolate allergenic extract</to_name>
		<to_code>1010915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lime (citrus) extract</to_name>
		<to_code>1305725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein allergenic extract</to_name>
		<to_code>862460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lettuce allergenic extract</to_name>
		<to_code>899448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red pepper extract</to_name>
		<to_code>1313692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg yolk (chicken) allergenic extract</to_name>
		<to_code>892620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oat allergenic extract</to_name>
		<to_code>971932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American lobster allergenic extract</to_name>
		<to_code>1997187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>string bean allergenic extract</to_name>
		<to_code>891676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red bell pepper allergenic extract</to_name>
		<to_code>901329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sea scallop preparation</to_name>
		<to_code>1426396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oyster allergenic extract</to_name>
		<to_code>973274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brussels sprout extract</to_name>
		<to_code>2099275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon preparation</to_name>
		<to_code>285245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>largemouth bass allergenic extract</to_name>
		<to_code>1098183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>veal allergenic extract</to_name>
		<to_code>1012026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrot allergenic extract</to_name>
		<to_code>892368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radish allergenic extract</to_name>
		<to_code>974687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger allergenic extract</to_name>
		<to_code>899420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pistachio nut allergenic extract</to_name>
		<to_code>904606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhubarb preparation</to_name>
		<to_code>91266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potato allergenic extract</to_name>
		<to_code>892632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sour cherry allergenic extract</to_name>
		<to_code>1012134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat preparation</to_name>
		<to_code>1441652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>squash allergenic extract</to_name>
		<to_code>975509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove allergenic extract</to_name>
		<to_code>899724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>buckwheat allergenic extract</to_name>
		<to_code>899394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English walnut allergenic extract</to_name>
		<to_code>891687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tomato allergenic extract</to_name>
		<to_code>892499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cod, unspecified preparation</to_name>
		<to_code>1426437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brussels sprout allergenic extract</to_name>
		<to_code>899390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red snapper allergenic extract</to_name>
		<to_code>889646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>broccoli allergenic extract</to_name>
		<to_code>899386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>leek allergenic extract</to_name>
		<to_code>1010932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon preparation</to_name>
		<to_code>1421430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carob allergenic extract</to_name>
		<to_code>904498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oyster, unspecified preparation</to_name>
		<to_code>1315121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellowfin tuna allergenic extract</to_name>
		<to_code>2102488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nutmeg extract</to_name>
		<to_code>1353217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>licorice root extract</to_name>
		<to_code>235524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spinach allergenic extract</to_name>
		<to_code>901317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis sativus fruit extract</to_name>
		<to_code>2700058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lima bean allergenic extract</to_name>
		<to_code>891641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida albicans allergenic extract</to_name>
		<to_code>214355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cola acuminata seed extract</to_name>
		<to_code>1307595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg extract</to_name>
		<to_code>1315115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>swordfish allergenic extract</to_name>
		<to_code>901283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyme allergenic extract</to_name>
		<to_code>974527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>duck allergenic extract</to_name>
		<to_code>972037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oats preparation</to_name>
		<to_code>285251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut extract</to_name>
		<to_code>1372248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avocado allergenic extract</to_name>
		<to_code>895582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>beef liver preparation</to_name>
		<to_code>1330085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pear preparation</to_name>
		<to_code>1367125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hops extract</to_name>
		<to_code>259266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard seed allergenic extract</to_name>
		<to_code>899456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg white (chicken) allergenic extract</to_name>
		<to_code>892616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almond allergenic extract</to_name>
		<to_code>892507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green olive allergenic extract</to_name>
		<to_code>971379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit allergenic extract</to_name>
		<to_code>899424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya extract</to_name>
		<to_code>1992412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower seed extract</to_name>
		<to_code>1440241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanilla bean extract</to_name>
		<to_code>2275721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium glaucum allergenic extract</to_name>
		<to_code>1986792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velvetleaf huckleberry allergenic extract</to_name>
		<to_code>2102487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit extract</to_name>
		<to_code>124323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crab allergenic extract</to_name>
		<to_code>892610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger extract</to_name>
		<to_code>285241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codfish allergenic extract</to_name>
		<to_code>892543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>1370435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>northern pike allergenic extract</to_name>
		<to_code>889602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peanut allergenic extract</to_name>
		<to_code>891658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard greens allergenic extract</to_name>
		<to_code>899452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sardine allergenic extract</to_name>
		<to_code>974129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower seed extract</to_name>
		<to_code>1309391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn allergenic extract</to_name>
		<to_code>892547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black pepper preparation</to_name>
		<to_code>259314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nutmeg allergenic extract</to_name>
		<to_code>891652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoa extract</to_name>
		<to_code>1373895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoa bean allergenic extract</to_name>
		<to_code>891721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dill allergenic extract</to_name>
		<to_code>975763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage leaf allergenic extract</to_name>
		<to_code>1011627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corylus americana nut oil</to_name>
		<to_code>1603849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black-eyed pea allergenic extract</to_name>
		<to_code>899490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugar beet allergenic extract</to_name>
		<to_code>899359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove preparation</to_name>
		<to_code>1364295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black walnut allergenic extract</to_name>
		<to_code>891695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsnip allergenic extract</to_name>
		<to_code>1011027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cumin allergenic extract</to_name>
		<to_code>901365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caraway seed allergenic extract</to_name>
		<to_code>899637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strawberry allergenic extract</to_name>
		<to_code>892484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watermelon preparation</to_name>
		<to_code>260014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radish extract</to_name>
		<to_code>1314656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barley malt syrup</to_name>
		<to_code>1306883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
		<from_code>N0000185371</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot allergenic extract</to_name>
		<to_code>895574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Food specific diagnostic allergen extract (product)</from_name>
		<from_code>411536006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Food Allergenic Extract [EPC]</to_name>
		<to_code>N0000185371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cumin allergenic extract</from_name>
		<from_code>901365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sour cherry allergenic extract</from_name>
		<from_code>1012134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basil allergenic extract</from_name>
		<from_code>899355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paprika allergenic extract</from_name>
		<from_code>899873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum extract</from_name>
		<from_code>852617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger allergenic extract</from_name>
		<from_code>899420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint preparation</from_name>
		<from_code>33093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg allergenic extract</from_name>
		<from_code>891652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whey protein hydrolysate</from_name>
		<from_code>2266754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pepper extract</from_name>
		<from_code>1313692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon allergenic extract</from_name>
		<from_code>899673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dill allergenic extract</from_name>
		<from_code>975763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean allergenic extract</from_name>
		<from_code>901291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme allergenic extract</from_name>
		<from_code>974527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean extract</from_name>
		<from_code>2275721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oregano allergenic extract</from_name>
		<from_code>1010965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit extract</from_name>
		<from_code>124323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horseradish allergenic extract</from_name>
		<from_code>1011043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice allergenic extract</from_name>
		<from_code>895552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carob allergenic extract</from_name>
		<from_code>904498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint allergenic extract</from_name>
		<from_code>901313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg extract</from_name>
		<from_code>1353217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint flowering top extract</from_name>
		<from_code>2168421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red currant allergenic extract</from_name>
		<from_code>972480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Additives</to_name>
		<to_code>M0008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mountain cedar pollen extract</to_name>
		<to_code>852581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesquite pollen extract</to_name>
		<to_code>852320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>loblolly pine pollen extract</to_name>
		<to_code>900770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white mulberry pollen extract</to_name>
		<to_code>852669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western ragweed pollen extract</to_name>
		<to_code>851985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American elm pollen extract</to_name>
		<to_code>852054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>slash pine pollen extract</to_name>
		<to_code>900731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white hickory pollen extract</to_name>
		<to_code>852193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>groundsel pollen extract</to_name>
		<to_code>897332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellow sweet clover pollen extract</to_name>
		<to_code>1014447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cheat grass pollen extract</to_name>
		<to_code>852225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European beech pollen extract</to_name>
		<to_code>1484981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix lutea pollen extract</to_name>
		<to_code>2590686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pignut hickory pollen extract</to_name>
		<to_code>899650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palo verde pollen extract</to_name>
		<to_code>852359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pale dock pollen extract</to_name>
		<to_code>1232604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>beech pollen extract</to_name>
		<to_code>852419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canadian bluegrass pollen extract</to_name>
		<to_code>1014731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>littleseed canary grass pollen extract</to_name>
		<to_code>1098232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sorghum bicolor pollen extract</to_name>
		<to_code>1311406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>London planetree</to_name>
		<to_code>2166616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redtop grass pollen extract</to_name>
		<to_code>851870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nettle pollen extract</to_name>
		<to_code>852046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black willow pollen extract</to_name>
		<to_code>852162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet wormwood pollen extract</to_name>
		<to_code>2167819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>narrowleaf marshelder pollen extract</to_name>
		<to_code>1098130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sydney golden wattle pollen extract</to_name>
		<to_code>895365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bald cypress pollen extract</to_name>
		<to_code>995747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black walnut pollen extract</to_name>
		<to_code>852569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>balsam poplar pollen extract</to_name>
		<to_code>1014762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paper birch pollen extract</to_name>
		<to_code>899576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canada goldenrod pollen extract</to_name>
		<to_code>995743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia dealbata pollen extract</to_name>
		<to_code>2202946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellow dock pollen extract</to_name>
		<to_code>852209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>giant wild rye pollen extract</to_name>
		<to_code>900148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Oregon ash pollen extract</to_name>
		<to_code>900045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California juniper pollen extract</to_name>
		<to_code>852585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>blue spruce pollen extract</to_name>
		<to_code>900704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellow birch pollen extract</to_name>
		<to_code>899550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mulberry pollen extract</to_name>
		<to_code>899593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES</to_name>
		<to_code>350004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>european olive pollen extract</to_name>
		<to_code>852653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California black walnut pollen extract</to_name>
		<to_code>852561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Fremont cottonwood pollen extract</to_name>
		<to_code>852355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tall oat grass pollen extract</to_name>
		<to_code>1006506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn pollen extract</to_name>
		<to_code>852015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>river birch pollen extract</to_name>
		<to_code>852148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer pseudoplatanus pollen extract</to_name>
		<to_code>1801702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedar elm pollen extract</to_name>
		<to_code>1014191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red mulberry pollen extract</to_name>
		<to_code>852680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tree of heaven pollen extract</to_name>
		<to_code>851890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese elm pollen extract</to_name>
		<to_code>852844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bitter dock pollen extract</to_name>
		<to_code>1014739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redberry juniper pollen extract</to_name>
		<to_code>900113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western sycamore pollen extract</to_name>
		<to_code>852750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wing scale pollen extract</to_name>
		<to_code>852074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white ash pollen extract</to_name>
		<to_code>852450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadow foxtail pollen extract</to_name>
		<to_code>1484974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>privet pollen extract</to_name>
		<to_code>852622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspen pollen extract</to_name>
		<to_code>852339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scrub pine pollen extract</to_name>
		<to_code>1013913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>careless weed pollen extract</to_name>
		<to_code>851926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California mugwort pollen extract</to_name>
		<to_code>892734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tag alder pollen extract</to_name>
		<to_code>851902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern cottonwood pollen extract</to_name>
		<to_code>852363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wormwood sage pollen extract</to_name>
		<to_code>852007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus hybridus pollen extract</to_name>
		<to_code>1363561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinus terebinthifolius pollen extract</to_name>
		<to_code>2590688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>post oak pollen extract</to_name>
		<to_code>901011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Douglas fir pollen extract</to_name>
		<to_code>1098257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white alder pollen extract</to_name>
		<to_code>851910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver maple pollen extract</to_name>
		<to_code>851866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocklebur pollen extract</to_name>
		<to_code>852025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated oat pollen extract</to_name>
		<to_code>852114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern sycamore pollen extract</to_name>
		<to_code>852746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower pollen extract</to_name>
		<to_code>852509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gray birch pollen extract</to_name>
		<to_code>852178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated rye grass pollen extract</to_name>
		<to_code>1014774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfalfa pollen extract</to_name>
		<to_code>852634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colonial bent grass pollen extract</to_name>
		<to_code>1484937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common hazel pollen extract</to_name>
		<to_code>1484979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oneseed juniper pollen extract</to_name>
		<to_code>900108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water oak pollen extract</to_name>
		<to_code>1013944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coast maple pollen extract</to_name>
		<to_code>851736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common cocklebur pollen extract</to_name>
		<to_code>902215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hazelnut pollen extract</to_name>
		<to_code>852281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jack pine pollen extract</to_name>
		<to_code>1014690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus glabra pollen extract</to_name>
		<to_code>2369372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grama grass pollen extract</to_name>
		<to_code>852197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver ragweed pollen extract</to_name>
		<to_code>852306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red cedar pollen extract</to_name>
		<to_code>852609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western wheatgrass pollen extract</to_name>
		<to_code>852659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siberian elm pollen extract</to_name>
		<to_code>1299981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus marilandica pollen extract</to_name>
		<to_code>1437222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus domestica pollen extract</to_name>
		<to_code>2593689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated barley pollen extract</to_name>
		<to_code>1098118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>blue beech pollen extract</to_name>
		<to_code>899611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redroot pigweed pollen extract</to_name>
		<to_code>851930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bitternut hickory pollen extract</to_name>
		<to_code>899645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golden chain pollen extract</to_name>
		<to_code>1996102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mugwort sage pollen extract</to_name>
		<to_code>852029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pin oak pollen extract</to_name>
		<to_code>900999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American basswood pollen extract</to_name>
		<to_code>995754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>para grass pollen extract</to_name>
		<to_code>894750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water birch pollen extract</to_name>
		<to_code>852166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>date palm pollen extract</to_name>
		<to_code>852704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>giant ragweed pollen extract</to_name>
		<to_code>851998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poverty weed pollen extract</to_name>
		<to_code>852539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>broomweed pollen extract</to_name>
		<to_code>1094193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crested dogstail pollen extract</to_name>
		<to_code>1484980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gambels oak pollen extract</to_name>
		<to_code>852276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plains cottonwood pollen extract</to_name>
		<to_code>867297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white poplar pollen extract</to_name>
		<to_code>852382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern bayberry pollen extract</to_name>
		<to_code>867260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pussy willow pollen extract</to_name>
		<to_code>852174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syringa vulgaris pollen extract</to_name>
		<to_code>2634236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shortleaf pine pollen extract</to_name>
		<to_code>852709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dandelion pollen extract</to_name>
		<to_code>852079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redwood pollen extract</to_name>
		<to_code>1014707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sandbur ragweed pollen extract</to_name>
		<to_code>851955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>smooth brome pollen extract</to_name>
		<to_code>852217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>box elder maple pollen extract</to_name>
		<to_code>851740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red oak pollen extract</to_name>
		<to_code>852268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grindelia ciliata pollen extract</to_name>
		<to_code>2043451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spiny pigweed pollen extract</to_name>
		<to_code>895919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creeping bentgrass pollen extract</to_name>
		<to_code>1094116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arizona ash pollen extract</to_name>
		<to_code>852496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hard maple pollen extract</to_name>
		<to_code>851874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shagbark hickory pollen extract</to_name>
		<to_code>852221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quackgrass pollen extract</to_name>
		<to_code>852343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Leucanthemum vulgare pollen</to_name>
		<to_code>2102006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European aspen pollen extract</to_name>
		<to_code>2166596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black oak pollen extract</to_name>
		<to_code>852260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black cottonwood pollen extract</to_name>
		<to_code>852376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>live oak pollen extract</to_name>
		<to_code>867311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sudan grass pollen extract</to_name>
		<to_code>1098455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium repens pollen extract</to_name>
		<to_code>1363563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>burning bush pollen extract</to_name>
		<to_code>852593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fivehorn smotherweed pollen extract</to_name>
		<to_code>852124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saltbush pollen extract</to_name>
		<to_code>897316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera pollen extract</to_name>
		<to_code>2669695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calocedrus decurrens pollen extract</to_name>
		<to_code>2670160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alkali blite pollen extract</to_name>
		<to_code>852106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salt grass pollen extract</to_name>
		<to_code>852329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bur oak pollen extract</to_name>
		<to_code>900991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ash pollen extract</to_name>
		<to_code>1484982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English plantain pollen extract</to_name>
		<to_code>852742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allscale pollen extract</to_name>
		<to_code>897304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>annual bluegrass pollen extract</to_name>
		<to_code>898404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arizona cypress pollen extract</to_name>
		<to_code>852814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS</to_name>
		<to_code>350081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS</to_name>
		<to_code>350075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California scrub oak pollen extract</to_name>
		<to_code>852802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Austrian pine pollen extract</to_name>
		<to_code>900750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sheep sorrel pollen extract</to_name>
		<to_code>852213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scotch pine pollen extract</to_name>
		<to_code>900764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet gum pollen extract</to_name>
		<to_code>852627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western waterhemp pollen extract</to_name>
		<to_code>851934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>slender ragweed pollen extract</to_name>
		<to_code>851990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white (mexican) dock pollen extract</to_name>
		<to_code>1014743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red alder pollen extract</to_name>
		<to_code>851914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern ragweed pollen extract</to_name>
		<to_code>885750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bulbous buttercup pollen extract</to_name>
		<to_code>1484985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white oak pollen extract</to_name>
		<to_code>852294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cherry birch pollen extract</to_name>
		<to_code>852144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coast live oak pollen extract</to_name>
		<to_code>852302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bahia grass pollen extract</to_name>
		<to_code>852673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dogfennel pollen extract</to_name>
		<to_code>867218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western juniper pollen extract</to_name>
		<to_code>852589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat pollen extract</to_name>
		<to_code>867361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English oak pollen extract</to_name>
		<to_code>1484984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>greasewood pollen extract</to_name>
		<to_code>852152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jerusalem oak pollen extract</to_name>
		<to_code>1014766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Italian rye grass pollen extract</to_name>
		<to_code>1014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arroyo willow pollen extract</to_name>
		<to_code>852170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salt cedar pollen extract</to_name>
		<to_code>852806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valley oak pollen extract</to_name>
		<to_code>1111024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lodgepole pine pollen extract</to_name>
		<to_code>898324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pepper tree pollen extract</to_name>
		<to_code>852140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus globulus pollen extract</to_name>
		<to_code>852386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>burrobrush pollen extract</to_name>
		<to_code>852526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orange pollen extract</to_name>
		<to_code>897403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugar beet pollen extract</to_name>
		<to_code>852132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mexican tea pollen extract</to_name>
		<to_code>897391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garrys oak pollen extract</to_name>
		<to_code>900987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desert ragweed pollen extract</to_name>
		<to_code>851981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern white pine pollen extract</to_name>
		<to_code>852738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salsola tragus pollen extract</to_name>
		<to_code>1314927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western black willow pollen extract</to_name>
		<to_code>1014755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cootamundra wattle pollen extract</to_name>
		<to_code>895353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>false ragweed pollen extract</to_name>
		<to_code>851938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lambs quarters pollen extract</to_name>
		<to_code>852237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grain sorghum pollen extract</to_name>
		<to_code>1098438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>broadleaf cattail pollen extract</to_name>
		<to_code>1232637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Utah juniper pollen extract</to_name>
		<to_code>852597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chinquapin oak pollen extract</to_name>
		<to_code>2167695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rough marshelder pollen extract</to_name>
		<to_code>852532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carya laciniosa pollen extract</to_name>
		<to_code>1305551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Russian thistle pollen extract</to_name>
		<to_code>852158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>broad leaved paperbark pollen extract</to_name>
		<to_code>903913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine bush pollen extract</to_name>
		<to_code>851894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>winterfat pollen extract</to_name>
		<to_code>852613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green ash pollen extract</to_name>
		<to_code>852491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Brazilian pepper tree pollen extract</to_name>
		<to_code>2632068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western white pine pollen extract</to_name>
		<to_code>900743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese black pine pollen extract</to_name>
		<to_code>900777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia longifolia pollen extract</to_name>
		<to_code>853983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit bush pollen extract</to_name>
		<to_code>851969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red pine pollen extract</to_name>
		<to_code>900754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white willow pollen extract</to_name>
		<to_code>1484986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense pollen extract</to_name>
		<to_code>2102052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English walnut pollen extract</to_name>
		<to_code>852577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velvet grass pollen extract</to_name>
		<to_code>852514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peruvian pepper tree pollen extract</to_name>
		<to_code>2632070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prairie sagebrush pollen extract</to_name>
		<to_code>867142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard pollen extract</to_name>
		<to_code>852205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellow pine pollen extract</to_name>
		<to_code>852716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Koelers grass pollen extract</to_name>
		<to_code>852605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Australian pine pollen extract</to_name>
		<to_code>852229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shad scale pollen extract</to_name>
		<to_code>852087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western larch pollen extract</to_name>
		<to_code>2166614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canyon ragweed pollen extract</to_name>
		<to_code>851942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Russian olive pollen extract</to_name>
		<to_code>852367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red maple pollen extract</to_name>
		<to_code>851744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Indian wormwood sage pollen extract</to_name>
		<to_code>1006495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dark leaved mugwort pollen extract</to_name>
		<to_code>896246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lens scale pollen extract</to_name>
		<to_code>852096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>longleaf pine pollen extract</to_name>
		<to_code>1014360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix repens pollen extract</to_name>
		<to_code>2533912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black locust pollen extract</to_name>
		<to_code>867325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common sagebrush pollen extract</to_name>
		<to_code>852020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canary grass pollen extract</to_name>
		<to_code>852697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>burweed marshelder pollen extract</to_name>
		<to_code>852551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Humulus lupulus pollen extract</to_name>
		<to_code>1740937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia pollen extract</to_name>
		<to_code>851732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense pollen extract</to_name>
		<to_code>1340182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Lombardy poplar pollen extract</to_name>
		<to_code>852348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rocky Mountain juniper pollen extract</to_name>
		<to_code>852601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver birch pollen allergenic extract</to_name>
		<to_code>1306108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Johnson grass pollen extract</to_name>
		<to_code>852136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitch pine pollen extract</to_name>
		<to_code>900758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus rubra pollen allergenic extract</to_name>
		<to_code>1426632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pecan pollen extract</to_name>
		<to_code>852272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hackberry pollen extract</to_name>
		<to_code>852324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus cembroides pollen extract</to_name>
		<to_code>2590679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago virgaurea pollen extract</to_name>
		<to_code>1309242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coast sage pollen extract</to_name>
		<to_code>852011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California black oak pollen extract</to_name>
		<to_code>1014721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>osage orange pollen extract</to_name>
		<to_code>1098189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>linden pollen extract</to_name>
		<to_code>852070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>weakleaf bur ragweed pollen extract</to_name>
		<to_code>1117083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>queen palm pollen extract</to_name>
		<to_code>867353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white sweet clover pollen extract</to_name>
		<to_code>1014735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Callistemon citrinus pollen extract</to_name>
		<to_code>2171260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycladus orientalis pollen extract</to_name>
		<to_code>1360623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
		<from_code>N0000185367</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>broadleaf plantain pollen extract</to_name>
		<to_code>1484983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Pollen Allergenic Extract [EPC]</to_name>
		<to_code>N0000185367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES</from_name>
		<from_code>350004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES</from_name>
		<from_code>350004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common cocklebur pollen extract</from_name>
		<from_code>902215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jack pine pollen extract</from_name>
		<from_code>1014690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut pollen extract</from_name>
		<from_code>852281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus glabra pollen extract</from_name>
		<from_code>2369372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grama grass pollen extract</from_name>
		<from_code>852197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oneseed juniper pollen extract</from_name>
		<from_code>900108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water oak pollen extract</from_name>
		<from_code>1013944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast maple pollen extract</from_name>
		<from_code>851736</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redroot pigweed pollen extract</from_name>
		<from_code>851930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitternut hickory pollen extract</from_name>
		<from_code>899645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golden chain pollen extract</from_name>
		<from_code>1996102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver ragweed pollen extract</from_name>
		<from_code>852306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western wheatgrass pollen extract</from_name>
		<from_code>852659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red cedar pollen extract</from_name>
		<from_code>852609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Quercus marilandica pollen extract</from_name>
		<from_code>1437222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Siberian elm pollen extract</from_name>
		<from_code>1299981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Malus domestica pollen extract</from_name>
		<from_code>2593689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated barley pollen extract</from_name>
		<from_code>1098118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue beech pollen extract</from_name>
		<from_code>899611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white alder pollen extract</from_name>
		<from_code>851910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver maple pollen extract</from_name>
		<from_code>851866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>post oak pollen extract</from_name>
		<from_code>901011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Douglas fir pollen extract</from_name>
		<from_code>1098257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower pollen extract</from_name>
		<from_code>852509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated rye grass pollen extract</from_name>
		<from_code>1014774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gray birch pollen extract</from_name>
		<from_code>852178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colonial bent grass pollen extract</from_name>
		<from_code>1484937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfalfa pollen extract</from_name>
		<from_code>852634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common hazel pollen extract</from_name>
		<from_code>1484979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocklebur pollen extract</from_name>
		<from_code>852025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated oat pollen extract</from_name>
		<from_code>852114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern sycamore pollen extract</from_name>
		<from_code>852746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redwood pollen extract</from_name>
		<from_code>1014707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sandbur ragweed pollen extract</from_name>
		<from_code>851955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creeping bentgrass pollen extract</from_name>
		<from_code>1094116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona ash pollen extract</from_name>
		<from_code>852496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>box elder maple pollen extract</from_name>
		<from_code>851740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red oak pollen extract</from_name>
		<from_code>852268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Grindelia ciliata pollen extract</from_name>
		<from_code>2043451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water birch pollen extract</from_name>
		<from_code>852166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date palm pollen extract</from_name>
		<from_code>852704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poverty weed pollen extract</from_name>
		<from_code>852539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant ragweed pollen extract</from_name>
		<from_code>851998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pin oak pollen extract</from_name>
		<from_code>900999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American basswood pollen extract</from_name>
		<from_code>995754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>para grass pollen extract</from_name>
		<from_code>894750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orchard grass pollen extract</from_name>
		<from_code>851878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white poplar pollen extract</from_name>
		<from_code>852382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern bayberry pollen extract</from_name>
		<from_code>867260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pussy willow pollen extract</from_name>
		<from_code>852174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syringa vulgaris pollen extract</from_name>
		<from_code>2634236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shortleaf pine pollen extract</from_name>
		<from_code>852709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broomweed pollen extract</from_name>
		<from_code>1094193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crested dogstail pollen extract</from_name>
		<from_code>1484980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gambels oak pollen extract</from_name>
		<from_code>852276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plains cottonwood pollen extract</from_name>
		<from_code>867297</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet wormwood pollen extract</from_name>
		<from_code>2167819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narrowleaf marshelder pollen extract</from_name>
		<from_code>1098130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sydney golden wattle pollen extract</from_name>
		<from_code>895365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald cypress pollen extract</from_name>
		<from_code>995747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut pollen extract</from_name>
		<from_code>852569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsam poplar pollen extract</from_name>
		<from_code>1014762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canadian bluegrass pollen extract</from_name>
		<from_code>1014731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>littleseed canary grass pollen extract</from_name>
		<from_code>1098232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sorghum bicolor pollen extract</from_name>
		<from_code>1311406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>London planetree</from_name>
		<from_code>2166616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nettle pollen extract</from_name>
		<from_code>852046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black willow pollen extract</from_name>
		<from_code>852162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Oregon ash pollen extract</from_name>
		<from_code>900045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paper birch pollen extract</from_name>
		<from_code>899576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canada goldenrod pollen extract</from_name>
		<from_code>995743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia dealbata pollen extract</from_name>
		<from_code>2202946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow dock pollen extract</from_name>
		<from_code>852209</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant wild rye pollen extract</from_name>
		<from_code>900148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesquite pollen extract</from_name>
		<from_code>852320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loblolly pine pollen extract</from_name>
		<from_code>900770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white mulberry pollen extract</from_name>
		<from_code>852669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American elm pollen extract</from_name>
		<from_code>852054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mountain cedar pollen extract</from_name>
		<from_code>852581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cheat grass pollen extract</from_name>
		<from_code>852225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European beech pollen extract</from_name>
		<from_code>1484981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix lutea pollen extract</from_name>
		<from_code>2590686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pignut hickory pollen extract</from_name>
		<from_code>899650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palo verde pollen extract</from_name>
		<from_code>852359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet vernal grass pollen extract</from_name>
		<from_code>851898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pale dock pollen extract</from_name>
		<from_code>1232604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slash pine pollen extract</from_name>
		<from_code>900731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white hickory pollen extract</from_name>
		<from_code>852193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow sweet clover pollen extract</from_name>
		<from_code>1014447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>groundsel pollen extract</from_name>
		<from_code>897332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow fescue grass pollen extract</from_name>
		<from_code>851918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>privet pollen extract</from_name>
		<from_code>852622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow foxtail pollen extract</from_name>
		<from_code>1484974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wing scale pollen extract</from_name>
		<from_code>852074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white ash pollen extract</from_name>
		<from_code>852450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California mugwort pollen extract</from_name>
		<from_code>892734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tag alder pollen extract</from_name>
		<from_code>851902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern cottonwood pollen extract</from_name>
		<from_code>852363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wormwood sage pollen extract</from_name>
		<from_code>852007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Schinus terebinthifolius pollen extract</from_name>
		<from_code>2590688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspen pollen extract</from_name>
		<from_code>852339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scrub pine pollen extract</from_name>
		<from_code>1013913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>careless weed pollen extract</from_name>
		<from_code>851926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fremont cottonwood pollen extract</from_name>
		<from_code>852355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tall oat grass pollen extract</from_name>
		<from_code>1006506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue spruce pollen extract</from_name>
		<from_code>900704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California juniper pollen extract</from_name>
		<from_code>852585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow birch pollen extract</from_name>
		<from_code>899550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mulberry pollen extract</from_name>
		<from_code>899593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>european olive pollen extract</from_name>
		<from_code>852653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black walnut pollen extract</from_name>
		<from_code>852561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chinese elm pollen extract</from_name>
		<from_code>852844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tree of heaven pollen extract</from_name>
		<from_code>851890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitter dock pollen extract</from_name>
		<from_code>1014739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redberry juniper pollen extract</from_name>
		<from_code>900113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western sycamore pollen extract</from_name>
		<from_code>852750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>river birch pollen extract</from_name>
		<from_code>852148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acer pseudoplatanus pollen extract</from_name>
		<from_code>1801702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedar elm pollen extract</from_name>
		<from_code>1014191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red mulberry pollen extract</from_name>
		<from_code>852680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prairie sagebrush pollen extract</from_name>
		<from_code>867142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard pollen extract</from_name>
		<from_code>852205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow pine pollen extract</from_name>
		<from_code>852716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian pepper tree pollen extract</from_name>
		<from_code>2632070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canyon ragweed pollen extract</from_name>
		<from_code>851942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian olive pollen extract</from_name>
		<from_code>852367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red maple pollen extract</from_name>
		<from_code>851744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Koelers grass pollen extract</from_name>
		<from_code>852605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Australian pine pollen extract</from_name>
		<from_code>852229</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shad scale pollen extract</from_name>
		<from_code>852087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western larch pollen extract</from_name>
		<from_code>2166614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>winterfat pollen extract</from_name>
		<from_code>852613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine bush pollen extract</from_name>
		<from_code>851894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green ash pollen extract</from_name>
		<from_code>852491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Brazilian pepper tree pollen extract</from_name>
		<from_code>2632068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western white pine pollen extract</from_name>
		<from_code>900743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese black pine pollen extract</from_name>
		<from_code>900777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia longifolia pollen extract</from_name>
		<from_code>853983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Utah juniper pollen extract</from_name>
		<from_code>852597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chinquapin oak pollen extract</from_name>
		<from_code>2167695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rough marshelder pollen extract</from_name>
		<from_code>852532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Carya laciniosa pollen extract</from_name>
		<from_code>1305551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian thistle pollen extract</from_name>
		<from_code>852158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broad leaved paperbark pollen extract</from_name>
		<from_code>903913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut pollen extract</from_name>
		<from_code>852577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvet grass pollen extract</from_name>
		<from_code>852514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit bush pollen extract</from_name>
		<from_code>851969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white willow pollen extract</from_name>
		<from_code>1484986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pine pollen extract</from_name>
		<from_code>900754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>2102052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black oak pollen extract</from_name>
		<from_code>1014721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osage orange pollen extract</from_name>
		<from_code>1098189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast sage pollen extract</from_name>
		<from_code>852011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linden pollen extract</from_name>
		<from_code>852070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>weakleaf bur ragweed pollen extract</from_name>
		<from_code>1117083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pinus cembroides pollen extract</from_name>
		<from_code>2590679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Solidago virgaurea pollen extract</from_name>
		<from_code>1309242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Callistemon citrinus pollen extract</from_name>
		<from_code>2171260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Platycladus orientalis pollen extract</from_name>
		<from_code>1360623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf plantain pollen extract</from_name>
		<from_code>1484983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>queen palm pollen extract</from_name>
		<from_code>867353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white sweet clover pollen extract</from_name>
		<from_code>1014735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burweed marshelder pollen extract</from_name>
		<from_code>852551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humulus lupulus pollen extract</from_name>
		<from_code>1740937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia pollen extract</from_name>
		<from_code>851732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Indian wormwood sage pollen extract</from_name>
		<from_code>1006495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dark leaved mugwort pollen extract</from_name>
		<from_code>896246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix repens pollen extract</from_name>
		<from_code>2533912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lens scale pollen extract</from_name>
		<from_code>852096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>longleaf pine pollen extract</from_name>
		<from_code>1014360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black locust pollen extract</from_name>
		<from_code>867325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary grass pollen extract</from_name>
		<from_code>852697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitch pine pollen extract</from_name>
		<from_code>900758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus rubra pollen allergenic extract</from_name>
		<from_code>1426632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hackberry pollen extract</from_name>
		<from_code>852324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>1340182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lombardy poplar pollen extract</from_name>
		<from_code>852348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rocky Mountain juniper pollen extract</from_name>
		<from_code>852601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver birch pollen allergenic extract</from_name>
		<from_code>1306108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Austrian pine pollen extract</from_name>
		<from_code>900750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sheep sorrel pollen extract</from_name>
		<from_code>852213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona cypress pollen extract</from_name>
		<from_code>852814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS</from_name>
		<from_code>350081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California scrub oak pollen extract</from_name>
		<from_code>852802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS</from_name>
		<from_code>350075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern ragweed pollen extract</from_name>
		<from_code>885750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bulbous buttercup pollen extract</from_name>
		<from_code>1484985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white oak pollen extract</from_name>
		<from_code>852294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry birch pollen extract</from_name>
		<from_code>852144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Scotch pine pollen extract</from_name>
		<from_code>900764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet gum pollen extract</from_name>
		<from_code>852627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western waterhemp pollen extract</from_name>
		<from_code>851934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slender ragweed pollen extract</from_name>
		<from_code>851990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white (mexican) dock pollen extract</from_name>
		<from_code>1014743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red alder pollen extract</from_name>
		<from_code>851914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>live oak pollen extract</from_name>
		<from_code>867311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sudan grass pollen extract</from_name>
		<from_code>1098455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hard maple pollen extract</from_name>
		<from_code>851874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shagbark hickory pollen extract</from_name>
		<from_code>852221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quackgrass pollen extract</from_name>
		<from_code>852343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European aspen pollen extract</from_name>
		<from_code>2166596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Leucanthemum vulgare pollen</from_name>
		<from_code>2102006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black oak pollen extract</from_name>
		<from_code>852260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cottonwood pollen extract</from_name>
		<from_code>852376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt grass pollen extract</from_name>
		<from_code>852329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bur oak pollen extract</from_name>
		<from_code>900991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ash pollen extract</from_name>
		<from_code>1484982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English plantain pollen extract</from_name>
		<from_code>852742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>annual bluegrass pollen extract</from_name>
		<from_code>898404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allscale pollen extract</from_name>
		<from_code>897304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burning bush pollen extract</from_name>
		<from_code>852593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saltbush pollen extract</from_name>
		<from_code>897316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fivehorn smotherweed pollen extract</from_name>
		<from_code>852124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vitis vinifera pollen extract</from_name>
		<from_code>2669695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Calocedrus decurrens pollen extract</from_name>
		<from_code>2670160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alkali blite pollen extract</from_name>
		<from_code>852106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mexican tea pollen extract</from_name>
		<from_code>897391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Garrys oak pollen extract</from_name>
		<from_code>900987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus globulus pollen extract</from_name>
		<from_code>852386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perennial rye grass pollen extract</from_name>
		<from_code>852819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burrobrush pollen extract</from_name>
		<from_code>852526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pepper tree pollen extract</from_name>
		<from_code>852140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pollen extract</from_name>
		<from_code>897403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lambs quarters pollen extract</from_name>
		<from_code>852237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf cattail pollen extract</from_name>
		<from_code>1232637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grain sorghum pollen extract</from_name>
		<from_code>1098438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern white pine pollen extract</from_name>
		<from_code>852738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salsola tragus pollen extract</from_name>
		<from_code>1314927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desert ragweed pollen extract</from_name>
		<from_code>851981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western black willow pollen extract</from_name>
		<from_code>1014755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cootamundra wattle pollen extract</from_name>
		<from_code>895353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dogfennel pollen extract</from_name>
		<from_code>867218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western juniper pollen extract</from_name>
		<from_code>852589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bahia grass pollen extract</from_name>
		<from_code>852673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast live oak pollen extract</from_name>
		<from_code>852302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem oak pollen extract</from_name>
		<from_code>1014766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Italian rye grass pollen extract</from_name>
		<from_code>1014340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arroyo willow pollen extract</from_name>
		<from_code>852170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valley oak pollen extract</from_name>
		<from_code>1111024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt cedar pollen extract</from_name>
		<from_code>852806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodgepole pine pollen extract</from_name>
		<from_code>898324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English oak pollen extract</from_name>
		<from_code>1484984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat pollen extract</from_name>
		<from_code>867361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>greasewood pollen extract</from_name>
		<from_code>852152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pollen</to_name>
		<to_code>M0017130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia longifolia pollen extract</from_name>
		<from_code>853983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS</from_name>
		<from_code>350081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS</from_name>
		<from_code>350075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grain sorghum pollen extract</from_name>
		<from_code>1098438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
		<from_code>N0000185374</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house dust allergenic extract</to_name>
		<to_code>852519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
		<from_code>N0000185374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>House Dust</to_name>
		<to_code>M0006896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>House dust specific diagnostic allergen extract (product)</from_name>
		<from_code>411538007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized House Dust Allergenic Extract [EPC]</to_name>
		<to_code>N0000185374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>House Dust</to_name>
		<to_code>M0006896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Animal Skin Allergenic Extract [EPC]</to_name>
		<to_code>N0000185004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</to_name>
		<to_code>N0000185364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Feather Allergenic Extract [EPC]</to_name>
		<to_code>N0000185373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Animal Hair Allergenic Extract [EPC]</to_name>
		<to_code>N0000185003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Insect Allergenic Extract [EPC]</to_name>
		<to_code>N0000185365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</to_name>
		<to_code>N0000185368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Plant Allergenic Extract [EPC]</to_name>
		<to_code>N0000185375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Insect Allergenic Extract [EPC]</to_name>
		<to_code>N0000185005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
		<from_code>N0000193899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</to_name>
		<to_code>N0000185363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185004</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat skin extract</to_name>
		<to_code>851949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Animal material diagnostic allergen extract (product)</from_name>
		<from_code>1208743009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Animal Skin Allergenic Extract [EPC]</to_name>
		<to_code>N0000185004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse dander extract</from_name>
		<from_code>2167548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig skin extract</from_name>
		<from_code>852298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rat skin extract</from_name>
		<from_code>895279</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse skin extract</from_name>
		<from_code>852693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog skin extract</from_name>
		<from_code>852839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</from_name>
		<from_code>350160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig dander</from_name>
		<from_code>2166593</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat skin extract</from_name>
		<from_code>852252</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow dander extract</from_name>
		<from_code>2166591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mongolian gerbil skin allergenic extract</from_name>
		<from_code>895070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster skin extract</from_name>
		<from_code>852663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog dander extract</from_name>
		<from_code>2167551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit skin extract</from_name>
		<from_code>895195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Epidermal [EXT]</to_name>
		<to_code>N0000185377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syrian hamster skin extract</to_name>
		<to_code>852663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>domestic cow skin extract</to_name>
		<to_code>852256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European rabbit skin extract</to_name>
		<to_code>895195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guinea pig skin extract</to_name>
		<to_code>852298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dog skin extract</to_name>
		<to_code>894987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse skin extract</to_name>
		<to_code>852479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rat skin extract</to_name>
		<to_code>895279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>domestic goat skin extract</to_name>
		<to_code>852252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house mouse skin extract</to_name>
		<to_code>852693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hog skin extract</to_name>
		<to_code>852839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
		<from_code>N0000185364</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mongolian gerbil skin allergenic extract</to_name>
		<to_code>895070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Animal material diagnostic allergen extract (product)</from_name>
		<from_code>1208743009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</to_name>
		<to_code>N0000185364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>duck feather extract</to_name>
		<to_code>892851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parakeet feather allergenic extract</to_name>
		<to_code>1192987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canary feather extract</to_name>
		<to_code>894961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken feather extract</to_name>
		<to_code>894934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goose feather extract</to_name>
		<to_code>894783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turkey feather extract</to_name>
		<to_code>1594963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
		<from_code>N0000185373</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pheasant feather extract</to_name>
		<to_code>1594964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Animal material diagnostic allergen extract (product)</from_name>
		<from_code>1208743009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Feather Allergenic Extract [EPC]</to_name>
		<to_code>N0000185373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goose feather extract</from_name>
		<from_code>894783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey feather extract</from_name>
		<from_code>1594963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken feather extract</from_name>
		<from_code>894934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheasant feather extract</from_name>
		<from_code>1594964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parakeet feather allergenic extract</from_name>
		<from_code>1192987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck feather extract</from_name>
		<from_code>892851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary feather extract</from_name>
		<from_code>894961</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feathers</to_name>
		<to_code>M0008280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185003</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat hair extract</to_name>
		<to_code>248123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Animal material diagnostic allergen extract (product)</from_name>
		<from_code>1208743009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Animal Hair Allergenic Extract [EPC]</to_name>
		<to_code>N0000185003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>German cockroach allergenic extract</to_name>
		<to_code>905276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk allergenic extract</to_name>
		<to_code>314455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dog flea allergenic extract</to_name>
		<to_code>886637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American cockroach allergenic extract</to_name>
		<to_code>905258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Blatta orientalis preparation</to_name>
		<to_code>1346617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house fly allergenic extract</to_name>
		<to_code>350173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat flea allergenic extract</to_name>
		<to_code>886638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cricket allergenic extract</to_name>
		<to_code>973447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tabanus nigrovittatus extract</to_name>
		<to_code>2590185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</to_name>
		<to_code>N0000185366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mosquito allergenic extract</to_name>
		<to_code>974741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185365</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Periplaneta australasiae extract</to_name>
		<to_code>2590183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Insect specific diagnostic allergen extract (product)</from_name>
		<from_code>411539004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Insect Allergenic Extract [EPC]</to_name>
		<to_code>N0000185365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black imported fire ant allergenic extract</to_name>
		<to_code>995738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red imported fire ant allergenic extract</to_name>
		<to_code>867341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>black carpenter ant allergenic extract</to_name>
		<to_code>2057909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthropod Venoms</to_name>
		<to_code>M0001758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Insect venom specific diagnostic allergen extract (product)</from_name>
		<from_code>411546008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</to_name>
		<to_code>N0000185366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salivary Proteins and Peptides</to_name>
		<to_code>M0515971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dog dander extract</to_name>
		<to_code>2167551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse dander extract</to_name>
		<to_code>2167548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>domestic cow dander extract</to_name>
		<to_code>2166591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guinea pig dander</to_name>
		<to_code>2166593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
		<from_code>N0000185368</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</to_name>
		<to_code>350160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Animal material diagnostic allergen extract (product)</from_name>
		<from_code>1208743009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</to_name>
		<to_code>N0000185368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat hair extract</from_name>
		<from_code>248123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salivary Proteins and Peptides</to_name>
		<to_code>M0515971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salivary Proteins and Peptides</to_name>
		<to_code>M0515971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit hair extract</from_name>
		<from_code>895527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salivary Proteins and Peptides</to_name>
		<to_code>M0515971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog dander extract</from_name>
		<from_code>2167551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse dander extract</from_name>
		<from_code>2167548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow dander extract</from_name>
		<from_code>2166591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat hair extract</from_name>
		<from_code>248123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig dander</from_name>
		<from_code>2166593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</from_name>
		<from_code>350160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dander</to_name>
		<to_code>M0576325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP</from_name>
		<from_code>350160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra root powder extract</to_name>
		<to_code>2711885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>okra extract</to_name>
		<to_code>1370787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orange pekoe tea allergenic extract</to_name>
		<to_code>966696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hops extract</to_name>
		<to_code>259266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard seed allergenic extract</to_name>
		<to_code>899456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape allergenic extract</to_name>
		<to_code>892317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lentil seed extract</to_name>
		<to_code>1426921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jerusalem artichoke extract</to_name>
		<to_code>1648701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>date allergenic extract</to_name>
		<to_code>899742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poppy seed allergenic extract</to_name>
		<to_code>1011017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velvetleaf huckleberry allergenic extract</to_name>
		<to_code>2102487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cotton seed extract</to_name>
		<to_code>1309369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>okra allergenic extract</to_name>
		<to_code>1011021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horseradish allergenic extract</to_name>
		<to_code>1011043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos nux-vomica seed extract</to_name>
		<to_code>1309678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kidney bean allergenic extract</to_name>
		<to_code>891637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Concord grape allergenic extract</to_name>
		<to_code>901191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green olive allergenic extract</to_name>
		<to_code>971379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Lawsonia inermis leaf extract</to_name>
		<to_code>1307699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower seed extract</to_name>
		<to_code>1440241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fig allergenic extract</to_name>
		<to_code>973880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brussels sprout allergenic extract</to_name>
		<to_code>899390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>leek allergenic extract</to_name>
		<to_code>1010932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allspice allergenic extract</to_name>
		<to_code>895552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage extract</to_name>
		<to_code>1354504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carob allergenic extract</to_name>
		<to_code>904498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bay leaf extract</to_name>
		<to_code>1606480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turnip allergenic extract</to_name>
		<to_code>883414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger root</to_name>
		<to_code>125921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cola acuminata seed extract</to_name>
		<to_code>1307595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tobacco leaf allergenic extract</to_name>
		<to_code>852062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus glutinosa bark extract</to_name>
		<to_code>1441543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nutmeg extract</to_name>
		<to_code>1353217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>licorice root extract</to_name>
		<to_code>235524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red currant allergenic extract</to_name>
		<to_code>972480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint flowering top extract</to_name>
		<to_code>2168421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barley malt allergenic extract</to_name>
		<to_code>1006510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</to_name>
		<to_code>N0000185376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris germanica var. florentina root extract</to_name>
		<to_code>1993233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonseed extract</to_name>
		<to_code>853406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mung bean allergenic extract</to_name>
		<to_code>891647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cumin allergenic extract</to_name>
		<to_code>901365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eggplant allergenic extract</to_name>
		<to_code>972601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lentil allergenic extract</to_name>
		<to_code>899444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caraway seed allergenic extract</to_name>
		<to_code>899637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry allergenic extract</to_name>
		<to_code>899734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American chestnut allergenic extract</to_name>
		<to_code>891752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watercress allergenic extract</to_name>
		<to_code>1011418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsicum extract</to_name>
		<to_code>319780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cauliflower allergenic extract</to_name>
		<to_code>899661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anise seed extract</to_name>
		<to_code>1309292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhubarb preparation</to_name>
		<to_code>91266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cytisus scoparius flowering top extract</to_name>
		<to_code>2168418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sour cherry allergenic extract</to_name>
		<to_code>1012134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>basil allergenic extract</to_name>
		<to_code>899355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>barley malt syrup</to_name>
		<to_code>1306883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove allergenic extract</to_name>
		<to_code>899724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn grain extract</to_name>
		<to_code>1423924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coffea arabica seed extract</to_name>
		<to_code>2695791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger allergenic extract</to_name>
		<to_code>899420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint preparation</to_name>
		<to_code>33093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eggplant extract</to_name>
		<to_code>1315116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynara preparation</to_name>
		<to_code>235940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry preparation</to_name>
		<to_code>125933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flaxseed extract</to_name>
		<to_code>318224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape extract</to_name>
		<to_code>1307718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis fruit extract</to_name>
		<to_code>1310189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nutmeg allergenic extract</to_name>
		<to_code>891652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger extract</to_name>
		<to_code>285241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonseed allergenic extract</to_name>
		<to_code>852440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>1370435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colloidal oatmeal</to_name>
		<to_code>221082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orris root allergenic extract</to_name>
		<to_code>1098353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard greens allergenic extract</to_name>
		<to_code>899452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chickpea allergenic extract</to_name>
		<to_code>1011049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugar beet allergenic extract</to_name>
		<to_code>899359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove preparation</to_name>
		<to_code>1364295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tragacanth</to_name>
		<to_code>1368197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyrethrum cinerariifolium allergenic extract</to_name>
		<to_code>967970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dill allergenic extract</to_name>
		<to_code>975763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage leaf allergenic extract</to_name>
		<to_code>1011627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
		<from_code>N0000185375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corylus americana nut oil</to_name>
		<to_code>1603849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Plant Allergenic Extract [EPC]</to_name>
		<to_code>N0000185375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jute fiber allergenic extract</to_name>
		<to_code>852412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sisal fiber allergenic extract</to_name>
		<to_code>851882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cotton fiber allergenic extract</to_name>
		<to_code>966925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
		<from_code>N0000185376</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kapok tree fiber allergenic extract</to_name>
		<to_code>852315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</to_name>
		<to_code>N0000185376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chickpea allergenic extract</from_name>
		<from_code>1011049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chocolate allergenic extract</from_name>
		<from_code>1010915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic preparation</from_name>
		<from_code>265647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant extract</from_name>
		<from_code>1315116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara preparation</from_name>
		<from_code>235940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape extract</from_name>
		<from_code>1307718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cytisus scoparius flowering top extract</from_name>
		<from_code>2168418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coffee bean allergenic extract</from_name>
		<from_code>891727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basil allergenic extract</from_name>
		<from_code>899355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sour cherry allergenic extract</from_name>
		<from_code>1012134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisal fiber allergenic extract</from_name>
		<from_code>851882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn grain extract</from_name>
		<from_code>1423924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coffea arabica seed extract</from_name>
		<from_code>2695791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger allergenic extract</from_name>
		<from_code>899420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic allergenic extract</from_name>
		<from_code>899414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant allergenic extract</from_name>
		<from_code>972601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry allergenic extract</from_name>
		<from_code>899734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watercress allergenic extract</from_name>
		<from_code>1011418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kapok tree fiber allergenic extract</from_name>
		<from_code>852315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>string bean allergenic extract</from_name>
		<from_code>891676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed allergenic extract</from_name>
		<from_code>901199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alnus glutinosa bark extract</from_name>
		<from_code>1441543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint flowering top extract</from_name>
		<from_code>2168421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red currant allergenic extract</from_name>
		<from_code>972480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt allergenic extract</from_name>
		<from_code>1006510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Iris germanica var. florentina root extract</from_name>
		<from_code>1993233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed extract</from_name>
		<from_code>853406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bay leaf extract</from_name>
		<from_code>1606480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton fiber allergenic extract</from_name>
		<from_code>966925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turnip allergenic extract</from_name>
		<from_code>883414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem artichoke extract</from_name>
		<from_code>1648701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poppy seed allergenic extract</from_name>
		<from_code>1011017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date allergenic extract</from_name>
		<from_code>899742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra allergenic extract</from_name>
		<from_code>1011021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Strychnos nux-vomica seed extract</from_name>
		<from_code>1309678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Concord grape allergenic extract</from_name>
		<from_code>901191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kidney bean allergenic extract</from_name>
		<from_code>891637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra extract</from_name>
		<from_code>1370787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra root powder extract</from_name>
		<from_code>2711885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed extract</from_name>
		<from_code>1310046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil seed extract</from_name>
		<from_code>1426921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa bean allergenic extract</from_name>
		<from_code>891721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dill allergenic extract</from_name>
		<from_code>975763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage leaf allergenic extract</from_name>
		<from_code>1011627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pyrethrum cinerariifolium allergenic extract</from_name>
		<from_code>967970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Corylus americana nut oil</from_name>
		<from_code>1603849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed extract</from_name>
		<from_code>1309391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint preparation</from_name>
		<from_code>33093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg allergenic extract</from_name>
		<from_code>891652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra extract</from_name>
		<from_code>1370435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris root allergenic extract</from_name>
		<from_code>1098353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard greens allergenic extract</from_name>
		<from_code>899452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt syrup</from_name>
		<from_code>1306883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nux vomica extract</from_name>
		<from_code>314743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway seed allergenic extract</from_name>
		<from_code>899637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil allergenic extract</from_name>
		<from_code>899444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cumin allergenic extract</from_name>
		<from_code>901365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jute fiber allergenic extract</from_name>
		<from_code>852412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American chestnut allergenic extract</from_name>
		<from_code>891752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cauliflower allergenic extract</from_name>
		<from_code>899661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lima bean allergenic extract</from_name>
		<from_code>891641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cola acuminata seed extract</from_name>
		<from_code>1307595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed allergenic extract</from_name>
		<from_code>901203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobacco leaf allergenic extract</from_name>
		<from_code>852062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>licorice root extract</from_name>
		<from_code>235524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg extract</from_name>
		<from_code>1353217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mung bean allergenic extract</from_name>
		<from_code>891647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brussels sprout allergenic extract</from_name>
		<from_code>899390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fig allergenic extract</from_name>
		<from_code>973880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice allergenic extract</from_name>
		<from_code>895552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leek allergenic extract</from_name>
		<from_code>1010932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carob allergenic extract</from_name>
		<from_code>904498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvetleaf huckleberry allergenic extract</from_name>
		<from_code>2102487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton seed extract</from_name>
		<from_code>1309369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horseradish allergenic extract</from_name>
		<from_code>1011043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green olive allergenic extract</from_name>
		<from_code>971379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safflower seed extract</from_name>
		<from_code>1440241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lawsonia inermis leaf extract</from_name>
		<from_code>1307699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pekoe tea allergenic extract</from_name>
		<from_code>966696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape allergenic extract</from_name>
		<from_code>892317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins</to_name>
		<to_code>M0016962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Dermatophagoides</to_name>
		<to_code>M0419493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house dust mite extract, Dermatophagoides farinae</to_name>
		<to_code>852810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European house dust mite allergenic extract</to_name>
		<to_code>1116979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house dust mite extract, Dermatophagoides pteronyssinus</to_name>
		<to_code>852826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American house dust mite allergenic extract</to_name>
		<to_code>1116977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Insect Venom Allergenic Extract [EPC]</to_name>
		<to_code>N0000185021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
		<from_code>N0000185005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Insect specific diagnostic allergen extract (product)</from_name>
		<from_code>411539004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Insect Allergenic Extract [EPC]</to_name>
		<to_code>N0000185005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American house dust mite allergenic extract</from_name>
		<from_code>1116977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Dermatophagoides</to_name>
		<to_code>M0419493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides farinae</from_name>
		<from_code>852810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Dermatophagoides</to_name>
		<to_code>M0419493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides pteronyssinus</from_name>
		<from_code>852826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Dermatophagoides</to_name>
		<to_code>M0419493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European house dust mite allergenic extract</from_name>
		<from_code>1116979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Dermatophagoides</to_name>
		<to_code>M0419493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides farinae</from_name>
		<from_code>852810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides farinae</from_name>
		<from_code>852810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides pteronyssinus</from_name>
		<from_code>852826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust mite extract, Dermatophagoides pteronyssinus</from_name>
		<from_code>852826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellow hornet venom protein</to_name>
		<to_code>1297537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common wasp venom protein</to_name>
		<to_code>1297527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bald-faced hornet venom protein</to_name>
		<to_code>1297525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthropod Venoms</to_name>
		<to_code>M0001758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern yellow jacket venom protein</to_name>
		<to_code>1297529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern yellow jacket venom protein</to_name>
		<to_code>1297533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apis mellifera preparation</to_name>
		<to_code>285219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western yellow jacket venom protein</to_name>
		<to_code>1297535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
		<from_code>N0000185021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>German wasp venom protein</to_name>
		<to_code>1297531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Insect venom specific diagnostic allergen extract (product)</from_name>
		<from_code>411546008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Insect Venom Allergenic Extract [EPC]</to_name>
		<to_code>N0000185021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black imported fire ant allergenic extract</from_name>
		<from_code>995738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Blatta orientalis preparation</from_name>
		<from_code>1346617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house fly allergenic extract</from_name>
		<from_code>350173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silk allergenic extract</from_name>
		<from_code>314455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American cockroach allergenic extract</from_name>
		<from_code>905258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog flea allergenic extract</from_name>
		<from_code>886637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European house dust mite allergenic extract</from_name>
		<from_code>1116979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American house dust mite allergenic extract</from_name>
		<from_code>1116977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German cockroach allergenic extract</from_name>
		<from_code>905276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black carpenter ant allergenic extract</from_name>
		<from_code>2057909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red imported fire ant allergenic extract</from_name>
		<from_code>867341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Periplaneta australasiae extract</from_name>
		<from_code>2590183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tabanus nigrovittatus extract</from_name>
		<from_code>2590185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosquito allergenic extract</from_name>
		<from_code>974741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat flea allergenic extract</from_name>
		<from_code>886638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cricket allergenic extract</from_name>
		<from_code>973447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Proteins</to_name>
		<to_code>M0028968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camelus bactrianus hair extract</to_name>
		<to_code>2590604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse hair extract</to_name>
		<to_code>895515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT, CAMEL</to_name>
		<to_code>314336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house mouse hair extract</to_name>
		<to_code>1993210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP</to_name>
		<to_code>349980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canis lupus familiaris hair extract</to_name>
		<to_code>854025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guinea pig hair extract</to_name>
		<to_code>895507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>domestic goat hair extract</to_name>
		<to_code>895503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rattus norvegicus hair preparation</to_name>
		<to_code>2471704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>domestic cow hair extract</to_name>
		<to_code>895488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syrian hamster hair extract</to_name>
		<to_code>1594965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European rabbit hair extract</to_name>
		<to_code>895527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
		<from_code>N0000185363</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hog hair extract</to_name>
		<to_code>895542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Animal material diagnostic allergen extract (product)</from_name>
		<from_code>1208743009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</to_name>
		<to_code>N0000185363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, CAMEL</from_name>
		<from_code>314336</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT, CAMEL</from_name>
		<from_code>314336</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Camelus bactrianus hair extract</from_name>
		<from_code>2590604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse hair extract</from_name>
		<from_code>895515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse hair extract</from_name>
		<from_code>1993210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP</from_name>
		<from_code>349980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canis lupus familiaris hair extract</from_name>
		<from_code>854025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig hair extract</from_name>
		<from_code>895507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat hair extract</from_name>
		<from_code>895503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rattus norvegicus hair preparation</from_name>
		<from_code>2471704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow hair extract</from_name>
		<from_code>895488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster hair extract</from_name>
		<from_code>1594965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit hair extract</from_name>
		<from_code>895527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog hair extract</from_name>
		<from_code>895542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Animal Fur</to_name>
		<to_code>M0370530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP</from_name>
		<from_code>349980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
		<from_code>N0000185369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Proteins</to_name>
		<to_code>M0002130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
		<from_code>N0000185369</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptomyces griseus allergenic extract</to_name>
		<to_code>1314592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
		<from_code>N0000185369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Bacterial Allergenic Extract [EPC]</to_name>
		<to_code>N0000185369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptomyces griseus allergenic extract</from_name>
		<from_code>1314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Proteins</to_name>
		<to_code>M0002130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185370</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerin</to_name>
		<to_code>4910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Non-Standardized Chemical Allergen [EPC]</to_name>
		<to_code>N0000185370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benzocaine</to_name>
		<to_code>1399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eugenol</to_name>
		<to_code>4186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamyl alcohol</to_name>
		<to_code>1362889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetramethylthiuram monosulfide</to_name>
		<to_code>1363713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ditiocarb, zinc salt</to_name>
		<to_code>1427192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parthenolide</to_name>
		<to_code>32941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorquinaldol</to_name>
		<to_code>2407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nickel</to_name>
		<to_code>1311629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geraniol</to_name>
		<to_code>1368875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,2'-dithiobisbenzothiazole</to_name>
		<to_code>1306112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamic aldehyde</to_name>
		<to_code>1368153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl-p-hydroxybenzoate</to_name>
		<to_code>1362892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-chloro-2-methyl-4-isothiazolin-3-one</to_name>
		<to_code>1367119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>disperse blue 106</to_name>
		<to_code>1368171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Evernia prunastri extract</to_name>
		<to_code>1352501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosin</to_name>
		<to_code>1362931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldibromo glutaronitrile</to_name>
		<to_code>1307044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peruvian balsam</to_name>
		<to_code>33219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dibucaine</to_name>
		<to_code>3339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>N-isopropyl-N-phenyl-4-phenylenediamine</to_name>
		<to_code>1363710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-mercaptobenzothiazole</to_name>
		<to_code>1358845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tixocortol pivalate</to_name>
		<to_code>38336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>N-oxydiethylene-2-benzothiazole sulfenamide</to_name>
		<to_code>1363711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zinc dibutyldithiocarbamate</to_name>
		<to_code>1426942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine</to_name>
		<to_code>4158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxycitronellal</to_name>
		<to_code>1362893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-MERCAPTOBENZOTHIAZOLE</to_name>
		<to_code>1306880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diazolidinylurea</to_name>
		<to_code>1310602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diphenylguanidine</to_name>
		<to_code>1368170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>N-cyclohexyl-N'-phenyl-1,4-phenylenediamine</to_name>
		<to_code>1427136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-tert-butylphenol-formaldehyde resin (low molecular weight)</to_name>
		<to_code>1427189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-15</to_name>
		<to_code>283678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>formaldehyde</to_name>
		<to_code>4530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt</to_name>
		<to_code>1310300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Evernia prunastri extract</to_name>
		<to_code>1311644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>N,N'-diphenyl-4-phenylenediamine</to_name>
		<to_code>1363709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold</to_name>
		<to_code>1311190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoeugenol</to_name>
		<to_code>1363706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidurea</to_name>
		<to_code>1368885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amyl cinnamal</to_name>
		<to_code>1311606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benzylparaben</to_name>
		<to_code>19075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylparaben</to_name>
		<to_code>29903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bronopol</to_name>
		<to_code>1114345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clioquinol</to_name>
		<to_code>5942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>N-cyclohexyl-2-benzothiazosulfenamide</to_name>
		<to_code>1306886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylparaben</to_name>
		<to_code>34706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiram</to_name>
		<to_code>10517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium</to_name>
		<to_code>2496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-phenylenediamine</to_name>
		<to_code>1362740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lanolin alcohols</to_name>
		<to_code>1426478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,2-bis(4-glycidyloxyphenyl)propane</to_name>
		<to_code>1368138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dipentamethylenethiuram disulfide</to_name>
		<to_code>1426773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>butylparaben</to_name>
		<to_code>1306937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Standardized Chemical Allergen [EPC]</from_name>
		<from_code>N0000185508</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thimerosal</to_name>
		<to_code>10472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic allergen extract (product)</from_name>
		<from_code>411123000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Standardized Chemical Allergen [EPC]</to_name>
		<to_code>N0000185508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango extract</from_name>
		<from_code>1426332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoeugenol</from_name>
		<from_code>1363706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Blatta orientalis preparation</from_name>
		<from_code>1346617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lombardy poplar pollen extract</from_name>
		<from_code>852348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rocky Mountain juniper pollen extract</from_name>
		<from_code>852601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitch pine pollen extract</from_name>
		<from_code>900758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus rubra pollen allergenic extract</from_name>
		<from_code>1426632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bronopol</from_name>
		<from_code>1114345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pineapple extract</from_name>
		<from_code>1492174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidurea</from_name>
		<from_code>1368885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hackberry pollen extract</from_name>
		<from_code>852324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster skin extract</from_name>
		<from_code>852663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dark leaved mugwort pollen extract</from_name>
		<from_code>896246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lens scale pollen extract</from_name>
		<from_code>852096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>longleaf pine pollen extract</from_name>
		<from_code>1014360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger var. niger extract</from_name>
		<from_code>854082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor racemosus allergenic extract</from_name>
		<from_code>852687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue crab preparation</from_name>
		<from_code>1315126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-tert-butylphenol-formaldehyde resin (low molecular weight)</from_name>
		<from_code>1427189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary grass pollen extract</from_name>
		<from_code>852697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Iris germanica var. florentina root extract</from_name>
		<from_code>1993233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida tropicalis allergenic extract</from_name>
		<from_code>967033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey allergenic extract</from_name>
		<from_code>975119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burweed marshelder pollen extract</from_name>
		<from_code>852551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylenediamine</from_name>
		<from_code>1362740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turkey feather extract</from_name>
		<from_code>1594963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>banana allergenic extract</from_name>
		<from_code>891830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2-bis(4-glycidyloxyphenyl)propane</from_name>
		<from_code>1368138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut allergenic extract</from_name>
		<from_code>891633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra extract</from_name>
		<from_code>1370787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Callistemon citrinus pollen extract</from_name>
		<from_code>2171260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Platycladus orientalis pollen extract</from_name>
		<from_code>1360623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra root powder extract</from_name>
		<from_code>2711885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haematonectria haematococca allergenic extract</from_name>
		<from_code>852503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf plantain pollen extract</from_name>
		<from_code>1484983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley extract</from_name>
		<from_code>1370766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken feather extract</from_name>
		<from_code>894934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kidney bean allergenic extract</from_name>
		<from_code>891637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pinus cembroides pollen extract</from_name>
		<from_code>2590679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus lunatus allergenic extract</from_name>
		<from_code>852264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion allergenic extract</from_name>
		<from_code>899466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linden pollen extract</from_name>
		<from_code>852070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>weakleaf bur ragweed pollen extract</from_name>
		<from_code>1117083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit bush pollen extract</from_name>
		<from_code>851969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2'-dithiobisbenzothiazole</from_name>
		<from_code>1306112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow hornet venom protein</from_name>
		<from_code>1297537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cochliobolus spicifer allergenic extract</from_name>
		<from_code>995699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bean extract</from_name>
		<from_code>1370773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat hair extract</from_name>
		<from_code>895503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant extract</from_name>
		<from_code>1315116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brazil nut allergenic extract</from_name>
		<from_code>891514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut pollen extract</from_name>
		<from_code>852577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trout allergenic extract</from_name>
		<from_code>882482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton tonsurans allergenic extract</from_name>
		<from_code>1098619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pacific halibut allergenic extract</from_name>
		<from_code>882469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chinquapin oak pollen extract</from_name>
		<from_code>2167695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rough marshelder pollen extract</from_name>
		<from_code>852532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Utah juniper pollen extract</from_name>
		<from_code>852597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broad leaved paperbark pollen extract</from_name>
		<from_code>903913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chocolate allergenic extract</from_name>
		<from_code>1010915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium expansum allergenic extract</from_name>
		<from_code>967111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geraniol</from_name>
		<from_code>1368875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck feather extract</from_name>
		<from_code>892851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine bush pollen extract</from_name>
		<from_code>851894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humicola grisea allergenic extract</from_name>
		<from_code>1014391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western white pine pollen extract</from_name>
		<from_code>900743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein allergenic extract</from_name>
		<from_code>862460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese black pine pollen extract</from_name>
		<from_code>900777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass smut allergenic extract</from_name>
		<from_code>852128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acrothecium robustum allergenic extract</from_name>
		<from_code>905088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat allergenic extract</from_name>
		<from_code>971932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Australian pine pollen extract</from_name>
		<from_code>852229</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American lobster allergenic extract</from_name>
		<from_code>1997187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microsporum audouinii allergenic extract</from_name>
		<from_code>1014395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western larch pollen extract</from_name>
		<from_code>2166614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oyster allergenic extract</from_name>
		<from_code>973274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canyon ragweed pollen extract</from_name>
		<from_code>851942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenylguanidine</from_name>
		<from_code>1368170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>veal allergenic extract</from_name>
		<from_code>1012026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1352501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carrot allergenic extract</from_name>
		<from_code>892368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger allergenic extract</from_name>
		<from_code>899420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potato allergenic extract</from_name>
		<from_code>892632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prairie sagebrush pollen extract</from_name>
		<from_code>867142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sour cherry allergenic extract</from_name>
		<from_code>1012134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse dander extract</from_name>
		<from_code>2167548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian balsam</from_name>
		<from_code>33219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English oak pollen extract</from_name>
		<from_code>1484984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tomato allergenic extract</from_name>
		<from_code>892499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phanerodontia chrysosporium allergenic extract</from_name>
		<from_code>968114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cod, unspecified preparation</from_name>
		<from_code>1426437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem oak pollen extract</from_name>
		<from_code>1014766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt cedar pollen extract</from_name>
		<from_code>852806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broccoli allergenic extract</from_name>
		<from_code>899386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leek allergenic extract</from_name>
		<from_code>1010932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Italian rye grass pollen extract</from_name>
		<from_code>1014340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arroyo willow pollen extract</from_name>
		<from_code>852170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oyster, unspecified preparation</from_name>
		<from_code>1315121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carob allergenic extract</from_name>
		<from_code>904498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellowfin tuna allergenic extract</from_name>
		<from_code>2102488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>licorice root extract</from_name>
		<from_code>235524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bahia grass pollen extract</from_name>
		<from_code>852673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cucumis sativus fruit extract</from_name>
		<from_code>2700058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lima bean allergenic extract</from_name>
		<from_code>891641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cola acuminata seed extract</from_name>
		<from_code>1307595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma harzianum allergenic extract</from_name>
		<from_code>968197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western juniper pollen extract</from_name>
		<from_code>852589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>swordfish allergenic extract</from_name>
		<from_code>901283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common wasp venom protein</from_name>
		<from_code>1297527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desert ragweed pollen extract</from_name>
		<from_code>851981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma destructiva allergenic extract</from_name>
		<from_code>966995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cootamundra wattle pollen extract</from_name>
		<from_code>895353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lambs quarters pollen extract</from_name>
		<from_code>852237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef liver preparation</from_name>
		<from_code>1330085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut extract</from_name>
		<from_code>1372248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. circinelloides allergenic extract</from_name>
		<from_code>2101422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pollen extract</from_name>
		<from_code>897403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus globulus pollen extract</from_name>
		<from_code>852386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perennial rye grass pollen extract</from_name>
		<from_code>852819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pepper tree pollen extract</from_name>
		<from_code>852140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliocladium allergenic extract</from_name>
		<from_code>1192997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green olive allergenic extract</from_name>
		<from_code>971379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-cyclohexyl-2-benzothiazosulfenamide</from_name>
		<from_code>1306886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rat skin extract</from_name>
		<from_code>895279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit extract</from_name>
		<from_code>124323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glaucum allergenic extract</from_name>
		<from_code>1986792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mexican tea pollen extract</from_name>
		<from_code>897391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Garrys oak pollen extract</from_name>
		<from_code>900987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codfish allergenic extract</from_name>
		<from_code>892543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burning bush pollen extract</from_name>
		<from_code>852593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra extract</from_name>
		<from_code>1370435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sardine allergenic extract</from_name>
		<from_code>974129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>northern pike allergenic extract</from_name>
		<from_code>889602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard greens allergenic extract</from_name>
		<from_code>899452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ash pollen extract</from_name>
		<from_code>1484982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salt grass pollen extract</from_name>
		<from_code>852329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg allergenic extract</from_name>
		<from_code>891652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allscale pollen extract</from_name>
		<from_code>897304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hard maple pollen extract</from_name>
		<from_code>851874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shagbark hickory pollen extract</from_name>
		<from_code>852221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parthenolide</from_name>
		<from_code>32941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pyrethrum cinerariifolium allergenic extract</from_name>
		<from_code>967970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acremonium strictum allergenic extract</from_name>
		<from_code>905070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Corylus americana nut oil</from_name>
		<from_code>1603849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black oak pollen extract</from_name>
		<from_code>852260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nickel</from_name>
		<from_code>1311629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black-eyed pea allergenic extract</from_name>
		<from_code>899490</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>live oak pollen extract</from_name>
		<from_code>867311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora tarda allergenic extract</from_name>
		<from_code>852404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epidermophyton floccosum allergenic extract</from_name>
		<from_code>995707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog flea allergenic extract</from_name>
		<from_code>886637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European house dust mite allergenic extract</from_name>
		<from_code>1116979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red alder pollen extract</from_name>
		<from_code>851914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-oxydiethylene-2-benzothiazole sulfenamide</from_name>
		<from_code>1363711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white (mexican) dock pollen extract</from_name>
		<from_code>1014743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Verticillium albo-atrum allergenic extract</from_name>
		<from_code>968467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut allergenic extract</from_name>
		<from_code>891695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsnip allergenic extract</from_name>
		<from_code>1011027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern ragweed pollen extract</from_name>
		<from_code>885750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cumin allergenic extract</from_name>
		<from_code>901365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit hair extract</from_name>
		<from_code>895527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white oak pollen extract</from_name>
		<from_code>852294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald-faced hornet venom protein</from_name>
		<from_code>1297525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry birch pollen extract</from_name>
		<from_code>852144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Camelus bactrianus hair extract</from_name>
		<from_code>2590604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona cypress pollen extract</from_name>
		<from_code>852814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish extract</from_name>
		<from_code>1314656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California scrub oak pollen extract</from_name>
		<from_code>852802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Austrian pine pollen extract</from_name>
		<from_code>900750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lichtheimia corymbifera allergenic extract</from_name>
		<from_code>995727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt syrup</from_name>
		<from_code>1306883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sheep sorrel pollen extract</from_name>
		<from_code>852213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosquito allergenic extract</from_name>
		<from_code>974741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-isopropyl-N-phenyl-4-phenylenediamine</from_name>
		<from_code>1363710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cow milk allergenic extract</from_name>
		<from_code>892665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton fiber allergenic extract</from_name>
		<from_code>966925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broomweed pollen extract</from_name>
		<from_code>1094193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lobster allergenic extract</from_name>
		<from_code>892561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gambels oak pollen extract</from_name>
		<from_code>852276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plains cottonwood pollen extract</from_name>
		<from_code>867297</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English sole allergenic extract</from_name>
		<from_code>974140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house fly allergenic extract</from_name>
		<from_code>350173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apple allergenic extract</from_name>
		<from_code>891771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white catfish allergenic extract</from_name>
		<from_code>971166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pussy willow pollen extract</from_name>
		<from_code>852174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syringa vulgaris pollen extract</from_name>
		<from_code>2634236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shortleaf pine pollen extract</from_name>
		<from_code>852709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white poplar pollen extract</from_name>
		<from_code>852382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern bayberry pollen extract</from_name>
		<from_code>867260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint flowering top extract</from_name>
		<from_code>2168421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red currant allergenic extract</from_name>
		<from_code>972480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pin oak pollen extract</from_name>
		<from_code>900999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley malt allergenic extract</from_name>
		<from_code>1006510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic goat skin extract</from_name>
		<from_code>852252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>para grass pollen extract</from_name>
		<from_code>894750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water birch pollen extract</from_name>
		<from_code>852166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neurospora intermedia allergenic extract</from_name>
		<from_code>867274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed allergenic extract</from_name>
		<from_code>901199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black sea bass allergenic extract</from_name>
		<from_code>2102474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant ragweed pollen extract</from_name>
		<from_code>851998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor circinelloides f. lusitanicus allergenic extract</from_name>
		<from_code>2101473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1311644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date palm pollen extract</from_name>
		<from_code>852704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed extract</from_name>
		<from_code>1310046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scallop allergenic extract</from_name>
		<from_code>899916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brown rice preparation</from_name>
		<from_code>1311040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>box elder maple pollen extract</from_name>
		<from_code>851740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red oak pollen extract</from_name>
		<from_code>852268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg (chicken) allergenic extract</from_name>
		<from_code>904507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shrimp allergenic extract</from_name>
		<from_code>892592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetracoccosporium paxianum allergenic extract</from_name>
		<from_code>968502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat hair extract</from_name>
		<from_code>248123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clioquinol</from_name>
		<from_code>5942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quince extract</from_name>
		<from_code>1370761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redwood pollen extract</from_name>
		<from_code>1014707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>date allergenic extract</from_name>
		<from_code>899742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sandbur ragweed pollen extract</from_name>
		<from_code>851955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tabanus nigrovittatus extract</from_name>
		<from_code>2590185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber allergenic extract</from_name>
		<from_code>899738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit allergenic extract</from_name>
		<from_code>813859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocklebur pollen extract</from_name>
		<from_code>852025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated oat pollen extract</from_name>
		<from_code>852114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern sycamore pollen extract</from_name>
		<from_code>852746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton schoenleinii allergenic extract</from_name>
		<from_code>968422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gray birch pollen extract</from_name>
		<from_code>852178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara preparation</from_name>
		<from_code>235940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colonial bent grass pollen extract</from_name>
		<from_code>1484937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium digitatum allergenic extract</from_name>
		<from_code>1427044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>post oak pollen extract</from_name>
		<from_code>901011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig dander</from_name>
		<from_code>2166593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic preparation</from_name>
		<from_code>265647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chickpea allergenic extract</from_name>
		<from_code>1011049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver maple pollen extract</from_name>
		<from_code>851866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red cedar pollen extract</from_name>
		<from_code>852609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peach allergenic extract</from_name>
		<from_code>892575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western wheatgrass pollen extract</from_name>
		<from_code>852659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated barley pollen extract</from_name>
		<from_code>1098118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus allergenic extract</from_name>
		<from_code>999384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Quercus marilandica pollen extract</from_name>
		<from_code>1437222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated mushroom allergenic extract</from_name>
		<from_code>901369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley allergenic extract</from_name>
		<from_code>899877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn extract</from_name>
		<from_code>1323308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syrian hamster hair extract</from_name>
		<from_code>1594965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redroot pigweed pollen extract</from_name>
		<from_code>851930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazolidinylurea</from_name>
		<from_code>1310602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-MERCAPTOBENZOTHIAZOLE</from_name>
		<from_code>1306880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic allergenic extract</from_name>
		<from_code>899414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant allergenic extract</from_name>
		<from_code>972601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>honeydew melon allergenic extract</from_name>
		<from_code>899476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golden chain pollen extract</from_name>
		<from_code>1996102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry allergenic extract</from_name>
		<from_code>899734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barley allergenic extract</from_name>
		<from_code>862453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oneseed juniper pollen extract</from_name>
		<from_code>900108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow dander extract</from_name>
		<from_code>2166591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water oak pollen extract</from_name>
		<from_code>1013944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paprika allergenic extract</from_name>
		<from_code>899873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coffea arabica seed extract</from_name>
		<from_code>2695791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast maple pollen extract</from_name>
		<from_code>851736</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coffee bean allergenic extract</from_name>
		<from_code>891727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black olive allergenic extract</from_name>
		<from_code>974650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulmus glabra pollen extract</from_name>
		<from_code>2369372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acer pseudoplatanus pollen extract</from_name>
		<from_code>1801702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clonostachys rosea f. rosea allergenic extract</from_name>
		<from_code>1426481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylparaben</from_name>
		<from_code>19075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern yellow jacket venom protein</from_name>
		<from_code>1297533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantaloupe allergenic extract</from_name>
		<from_code>892517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chinese elm pollen extract</from_name>
		<from_code>852844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tree of heaven pollen extract</from_name>
		<from_code>851890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut allergenic extract</from_name>
		<from_code>891611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl cinnamal</from_name>
		<from_code>1311606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redberry juniper pollen extract</from_name>
		<from_code>900113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue spruce pollen extract</from_name>
		<from_code>900704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow birch pollen extract</from_name>
		<from_code>899550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>european olive pollen extract</from_name>
		<from_code>852653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog skin extract</from_name>
		<from_code>852839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black walnut pollen extract</from_name>
		<from_code>852561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tall oat grass pollen extract</from_name>
		<from_code>1006506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German wasp venom protein</from_name>
		<from_code>1297531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celery allergenic extract</from_name>
		<from_code>892372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haddock allergenic extract</from_name>
		<from_code>899428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus nidulans allergenic extract</from_name>
		<from_code>1368357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspen pollen extract</from_name>
		<from_code>852339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scrub pine pollen extract</from_name>
		<from_code>1013913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladosporium sphaerospermum allergenic extract</from_name>
		<from_code>867202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wormwood sage pollen extract</from_name>
		<from_code>852007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white fish allergenic extract</from_name>
		<from_code>901265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California mugwort pollen extract</from_name>
		<from_code>892734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tag alder pollen extract</from_name>
		<from_code>851902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean allergenic extract</from_name>
		<from_code>901291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amaranthus hybridus pollen extract</from_name>
		<from_code>1363561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apple extract</from_name>
		<from_code>1424865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum allergenic extract</from_name>
		<from_code>2101722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef liver allergenic extract</from_name>
		<from_code>972689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet potato allergenic extract</from_name>
		<from_code>901307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pumpkin allergenic extract</from_name>
		<from_code>883459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black carpenter ant allergenic extract</from_name>
		<from_code>2057909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow foxtail pollen extract</from_name>
		<from_code>1484974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wing scale pollen extract</from_name>
		<from_code>852074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white ash pollen extract</from_name>
		<from_code>852450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>privet pollen extract</from_name>
		<from_code>852622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadow fescue grass pollen extract</from_name>
		<from_code>851918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slash pine pollen extract</from_name>
		<from_code>900731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange allergenic extract</from_name>
		<from_code>892565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Microascus brevicaulis allergenic extract</from_name>
		<from_code>1192992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow sweet clover pollen extract</from_name>
		<from_code>1014447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>groundsel pollen extract</from_name>
		<from_code>897332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris root allergenic extract</from_name>
		<from_code>1098353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white hickory pollen extract</from_name>
		<from_code>852193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber extract</from_name>
		<from_code>1305719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pignut hickory pollen extract</from_name>
		<from_code>899650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint preparation</from_name>
		<from_code>33093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cheat grass pollen extract</from_name>
		<from_code>852225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European beech pollen extract</from_name>
		<from_code>1484981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic aldehyde</from_name>
		<from_code>1368153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common carp allergenic extract</from_name>
		<from_code>901390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palo verde pollen extract</from_name>
		<from_code>852359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet vernal grass pollen extract</from_name>
		<from_code>851898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon allergenic extract</from_name>
		<from_code>901382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rye allergenic extract</from_name>
		<from_code>892638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesquite pollen extract</from_name>
		<from_code>852320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paper birch pollen extract</from_name>
		<from_code>899576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canada goldenrod pollen extract</from_name>
		<from_code>995743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neurospora sitophila allergenic extract</from_name>
		<from_code>1098200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya allergenic extract</from_name>
		<from_code>1011426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>microsporum canis allergenic extract</from_name>
		<from_code>1014399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hog hair extract</from_name>
		<from_code>895542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nux vomica extract</from_name>
		<from_code>314743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canadian bluegrass pollen extract</from_name>
		<from_code>1014731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sorghum bicolor pollen extract</from_name>
		<from_code>1311406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black willow pollen extract</from_name>
		<from_code>852162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Allium cepa bulb extract</from_name>
		<from_code>2695867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse hair extract</from_name>
		<from_code>895515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narrowleaf marshelder pollen extract</from_name>
		<from_code>1098130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsam poplar pollen extract</from_name>
		<from_code>1014762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turnip allergenic extract</from_name>
		<from_code>883414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>1340182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver birch pollen allergenic extract</from_name>
		<from_code>1306108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Colletotrichum coccodes allergenic extract</from_name>
		<from_code>1192729</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic halibut preparation</from_name>
		<from_code>1424920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern yellow jacket venom protein</from_name>
		<from_code>1297529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium sarciniforme allergenic extract</from_name>
		<from_code>968130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parakeet feather allergenic extract</from_name>
		<from_code>1192987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix repens pollen extract</from_name>
		<from_code>2533912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Indian wormwood sage pollen extract</from_name>
		<from_code>1006495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black locust pollen extract</from_name>
		<from_code>867325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed extract</from_name>
		<from_code>853406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Humulus lupulus pollen extract</from_name>
		<from_code>1740937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ustilago maydis extract</from_name>
		<from_code>1427134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig skin extract</from_name>
		<from_code>852298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia pollen extract</from_name>
		<from_code>851732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alnus glutinosa bark extract</from_name>
		<from_code>1441543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Paecilomyces variotii allergenic extract</from_name>
		<from_code>966979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil seed extract</from_name>
		<from_code>1426921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>queen palm pollen extract</from_name>
		<from_code>867353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white sweet clover pollen extract</from_name>
		<from_code>1014735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European rabbit skin extract</from_name>
		<from_code>895195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium compactum allergenic extract</from_name>
		<from_code>999457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pork allergenic extract</from_name>
		<from_code>892628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipentamethylenethiuram disulfide</from_name>
		<from_code>1426773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butylparaben</from_name>
		<from_code>1306937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium camemberti allergenic extract</from_name>
		<from_code>966943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Solidago virgaurea pollen extract</from_name>
		<from_code>1309242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pisum sativum (pea) extract</from_name>
		<from_code>1426912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper allergenic extract</from_name>
		<from_code>899363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oregano allergenic extract</from_name>
		<from_code>1010965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California black oak pollen extract</from_name>
		<from_code>1014721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>osage orange pollen extract</from_name>
		<from_code>1098189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast sage pollen extract</from_name>
		<from_code>852011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>okra allergenic extract</from_name>
		<from_code>1011021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium italicum allergenic extract</from_name>
		<from_code>967960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine extract</from_name>
		<from_code>1426364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chicken allergenic extract</from_name>
		<from_code>892653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white willow pollen extract</from_name>
		<from_code>1484986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pine pollen extract</from_name>
		<from_code>900754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trifolium pratense pollen extract</from_name>
		<from_code>2102052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flounder allergenic extract</from_name>
		<from_code>899746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium cladosporioides extract</from_name>
		<from_code>867198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-chloro-2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow hair extract</from_name>
		<from_code>895488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvet grass pollen extract</from_name>
		<from_code>852514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetramethylthiuram monosulfide</from_name>
		<from_code>1363713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamyl alcohol</from_name>
		<from_code>1362889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>northern quahog preparation</from_name>
		<from_code>1925437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian thistle pollen extract</from_name>
		<from_code>852158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hypomyces perniciosus allergenic extract</from_name>
		<from_code>1192968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Carya laciniosa pollen extract</from_name>
		<from_code>1305551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green ash pollen extract</from_name>
		<from_code>852491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Brazilian pepper tree pollen extract</from_name>
		<from_code>2632068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lime (citrus) extract</from_name>
		<from_code>1305725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>winterfat pollen extract</from_name>
		<from_code>852613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lettuce allergenic extract</from_name>
		<from_code>899448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pepper extract</from_name>
		<from_code>1313692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shad scale pollen extract</from_name>
		<from_code>852087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk (chicken) allergenic extract</from_name>
		<from_code>892620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Koelers grass pollen extract</from_name>
		<from_code>852605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kapok tree fiber allergenic extract</from_name>
		<from_code>852315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>string bean allergenic extract</from_name>
		<from_code>891676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose wheat smut allergenic extract</from_name>
		<from_code>968437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sea scallop preparation</from_name>
		<from_code>1426396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red bell pepper allergenic extract</from_name>
		<from_code>901329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Russian olive pollen extract</from_name>
		<from_code>852367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red maple pollen extract</from_name>
		<from_code>851744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>largemouth bass allergenic extract</from_name>
		<from_code>1098183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian pepper tree pollen extract</from_name>
		<from_code>2632070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish allergenic extract</from_name>
		<from_code>974687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosin</from_name>
		<from_code>1362931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium chrysogenum var. chrysogenum allergenic extract</from_name>
		<from_code>854130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pistachio nut allergenic extract</from_name>
		<from_code>904606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cytisus scoparius flowering top extract</from_name>
		<from_code>2168418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-mercaptobenzothiazole</from_name>
		<from_code>1358845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat flea allergenic extract</from_name>
		<from_code>886638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixocortol pivalate</from_name>
		<from_code>38336</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squash allergenic extract</from_name>
		<from_code>975509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buckwheat allergenic extract</from_name>
		<from_code>899394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard pollen extract</from_name>
		<from_code>852205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow pine pollen extract</from_name>
		<from_code>852716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>greasewood pollen extract</from_name>
		<from_code>852152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English walnut allergenic extract</from_name>
		<from_code>891687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat pollen extract</from_name>
		<from_code>867361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brussels sprout allergenic extract</from_name>
		<from_code>899390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red snapper allergenic extract</from_name>
		<from_code>889646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valley oak pollen extract</from_name>
		<from_code>1111024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon preparation</from_name>
		<from_code>1421430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodgepole pine pollen extract</from_name>
		<from_code>898324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mongolian gerbil skin allergenic extract</from_name>
		<from_code>895070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coast live oak pollen extract</from_name>
		<from_code>852302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg extract</from_name>
		<from_code>1353217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinach allergenic extract</from_name>
		<from_code>901317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N-cyclohexyl-N'-phenyl-1,4-phenylenediamine</from_name>
		<from_code>1427136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quaternium-15</from_name>
		<from_code>283678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt</from_name>
		<from_code>1310300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dogfennel pollen extract</from_name>
		<from_code>867218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass smut allergenic extract</from_name>
		<from_code>1014385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Syncephalastrum racemosum allergenic extract</from_name>
		<from_code>968506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus var. oryzae protease</from_name>
		<from_code>1307040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobacco leaf allergenic extract</from_name>
		<from_code>852062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanolin alcohols</from_name>
		<from_code>1426478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western black willow pollen extract</from_name>
		<from_code>1014755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme allergenic extract</from_name>
		<from_code>974527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern white pine pollen extract</from_name>
		<from_code>852738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salsola tragus pollen extract</from_name>
		<from_code>1314927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiram</from_name>
		<from_code>10517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula mucilaginosa allergenic extract</from_name>
		<from_code>967529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duck allergenic extract</from_name>
		<from_code>972037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheasant feather extract</from_name>
		<from_code>1594964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pear preparation</from_name>
		<from_code>1367125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avocado allergenic extract</from_name>
		<from_code>895582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thimerosal</from_name>
		<from_code>10472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broadleaf cattail pollen extract</from_name>
		<from_code>1232637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg white (chicken) allergenic extract</from_name>
		<from_code>892616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canary feather extract</from_name>
		<from_code>894961</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burrobrush pollen extract</from_name>
		<from_code>852526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safflower seed extract</from_name>
		<from_code>1440241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse skin extract</from_name>
		<from_code>852693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit allergenic extract</from_name>
		<from_code>899424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean extract</from_name>
		<from_code>2275721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus repens allergenic extract</from_name>
		<from_code>1006310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia graminis allergenic extract</from_name>
		<from_code>999487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crab allergenic extract</from_name>
		<from_code>892610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velvetleaf huckleberry allergenic extract</from_name>
		<from_code>2102487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton seed extract</from_name>
		<from_code>1309369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saltbush pollen extract</from_name>
		<from_code>897316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fivehorn smotherweed pollen extract</from_name>
		<from_code>852124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Calocedrus decurrens pollen extract</from_name>
		<from_code>2670160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alkali blite pollen extract</from_name>
		<from_code>852106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vitis vinifera pollen extract</from_name>
		<from_code>2669695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut allergenic extract</from_name>
		<from_code>891658</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed extract</from_name>
		<from_code>1309391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bur oak pollen extract</from_name>
		<from_code>900991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog dander extract</from_name>
		<from_code>2167551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disperse blue 106</from_name>
		<from_code>1368171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German cockroach allergenic extract</from_name>
		<from_code>905276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>English plantain pollen extract</from_name>
		<from_code>852742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper preparation</from_name>
		<from_code>259314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>annual bluegrass pollen extract</from_name>
		<from_code>898404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goose feather extract</from_name>
		<from_code>894783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quackgrass pollen extract</from_name>
		<from_code>852343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European aspen pollen extract</from_name>
		<from_code>2166596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Leucanthemum vulgare pollen</from_name>
		<from_code>2102006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ditiocarb, zinc salt</from_name>
		<from_code>1427192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa bean allergenic extract</from_name>
		<from_code>891721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dill allergenic extract</from_name>
		<from_code>975763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage leaf allergenic extract</from_name>
		<from_code>1011627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cottonwood pollen extract</from_name>
		<from_code>852376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse skin extract</from_name>
		<from_code>852479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorquinaldol</from_name>
		<from_code>2407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>algal fungi allergenic extract</from_name>
		<from_code>966692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sudan grass pollen extract</from_name>
		<from_code>1098455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet gum pollen extract</from_name>
		<from_code>852627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western waterhemp pollen extract</from_name>
		<from_code>851934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Scotch pine pollen extract</from_name>
		<from_code>900764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium roquefortii allergenic extract</from_name>
		<from_code>972365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>slender ragweed pollen extract</from_name>
		<from_code>851990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bulbous buttercup pollen extract</from_name>
		<from_code>1484985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway seed allergenic extract</from_name>
		<from_code>899637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus amstelodami extract</from_name>
		<from_code>2101007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jute fiber allergenic extract</from_name>
		<from_code>852412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton rubrum allergenic extract</from_name>
		<from_code>968413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strawberry allergenic extract</from_name>
		<from_code>892484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watermelon preparation</from_name>
		<from_code>260014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apricot allergenic extract</from_name>
		<from_code>895574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American cockroach allergenic extract</from_name>
		<from_code>905258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bay leaf extract</from_name>
		<from_code>1606480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guinea pig hair extract</from_name>
		<from_code>895507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zucchini extract</from_name>
		<from_code>1649134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint allergenic extract</from_name>
		<from_code>901313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crested dogstail pollen extract</from_name>
		<from_code>1484980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dendryphiella vinosa allergenic extract</from_name>
		<from_code>995703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylparaben</from_name>
		<from_code>29903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orchard grass pollen extract</from_name>
		<from_code>851878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apis mellifera preparation</from_name>
		<from_code>285219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean allergenic extract</from_name>
		<from_code>891668</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tuna allergenic extract</from_name>
		<from_code>892503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic mackerel allergenic extract</from_name>
		<from_code>2198984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perch allergenic extract</from_name>
		<from_code>976711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American basswood pollen extract</from_name>
		<from_code>995754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avocado oil</from_name>
		<from_code>1311611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Passalora fulva allergenic extract</from_name>
		<from_code>883442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poverty weed pollen extract</from_name>
		<from_code>852539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora herbarum allergenic extract</from_name>
		<from_code>971198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic halibut allergenic extract</from_name>
		<from_code>2261370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Canis lupus familiaris hair extract</from_name>
		<from_code>854025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rattus norvegicus hair preparation</from_name>
		<from_code>2471704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Grindelia ciliata pollen extract</from_name>
		<from_code>2043451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bluefish allergenic extract</from_name>
		<from_code>892181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creeping bentgrass pollen extract</from_name>
		<from_code>1094116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arizona ash pollen extract</from_name>
		<from_code>852496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Strychnos nux-vomica seed extract</from_name>
		<from_code>1309678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Concord grape allergenic extract</from_name>
		<from_code>901191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herring allergenic extract</from_name>
		<from_code>899434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem artichoke extract</from_name>
		<from_code>1648701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylparaben</from_name>
		<from_code>34706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poppy seed allergenic extract</from_name>
		<from_code>1011017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silk allergenic extract</from_name>
		<from_code>314455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clam allergenic extract</from_name>
		<from_code>892539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated rye grass pollen extract</from_name>
		<from_code>1014774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower pollen extract</from_name>
		<from_code>852509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beef allergenic extract</from_name>
		<from_code>892599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common hazel pollen extract</from_name>
		<from_code>1484979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfalfa pollen extract</from_name>
		<from_code>852634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape extract</from_name>
		<from_code>1307718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Douglas fir pollen extract</from_name>
		<from_code>1098257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gliocladium viride extract</from_name>
		<from_code>2101008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raspberry extract</from_name>
		<from_code>1370769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora betae allergenic extract</from_name>
		<from_code>852756</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white alder pollen extract</from_name>
		<from_code>851910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apiospora montagnei allergenic extract</from_name>
		<from_code>1006258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptomyces griseus allergenic extract</from_name>
		<from_code>1314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watercress allergenic extract</from_name>
		<from_code>1011418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver ragweed pollen extract</from_name>
		<from_code>852306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blue beech pollen extract</from_name>
		<from_code>899611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Siberian elm pollen extract</from_name>
		<from_code>1299981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Malus domestica pollen extract</from_name>
		<from_code>2593689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc dibutyldithiocarbamate</from_name>
		<from_code>1426942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venison allergenic extract</from_name>
		<from_code>882488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxycitronellal</from_name>
		<from_code>1362893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamb allergenic extract</from_name>
		<from_code>971849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watermelon allergenic extract</from_name>
		<from_code>901258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Epicoccum nigrum allergenic extract</from_name>
		<from_code>852466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat gluten extract</from_name>
		<from_code>1370781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitternut hickory pollen extract</from_name>
		<from_code>899645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisal fiber allergenic extract</from_name>
		<from_code>851882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn grain extract</from_name>
		<from_code>1423924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum extract</from_name>
		<from_code>852617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic cod allergenic extract</from_name>
		<from_code>900025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit peel extract</from_name>
		<from_code>1358897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Periplaneta australasiae extract</from_name>
		<from_code>2590183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jack pine pollen extract</from_name>
		<from_code>1014690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hazelnut pollen extract</from_name>
		<from_code>852281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basil allergenic extract</from_name>
		<from_code>899355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common cocklebur pollen extract</from_name>
		<from_code>902215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grama grass pollen extract</from_name>
		<from_code>852197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grape extract</from_name>
		<from_code>253172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>river birch pollen extract</from_name>
		<from_code>852148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabbage allergenic extract</from_name>
		<from_code>899398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Puccinia striiformis allergenic extract</from_name>
		<from_code>852311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red mulberry pollen extract</from_name>
		<from_code>852680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black imported fire ant allergenic extract</from_name>
		<from_code>995738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango allergenic extract</from_name>
		<from_code>1011404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedar elm pollen extract</from_name>
		<from_code>1014191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fig allergenic extract</from_name>
		<from_code>973880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green bell pepper allergenic extract</from_name>
		<from_code>862478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice allergenic extract</from_name>
		<from_code>895552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western sycamore pollen extract</from_name>
		<from_code>852750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitter dock pollen extract</from_name>
		<from_code>1014739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>California juniper pollen extract</from_name>
		<from_code>852585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stachybotrys chartarum allergenic extract</from_name>
		<from_code>968123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mulberry pollen extract</from_name>
		<from_code>899593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red imported fire ant allergenic extract</from_name>
		<from_code>867341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mung bean allergenic extract</from_name>
		<from_code>891647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goat milk allergenic extract</from_name>
		<from_code>862475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>N,N'-diphenyl-4-phenylenediamine</from_name>
		<from_code>1363709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fremont cottonwood pollen extract</from_name>
		<from_code>852355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house mouse hair extract</from_name>
		<from_code>1993210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed allergenic extract</from_name>
		<from_code>901203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Khuskia oryzae allergenic extract</from_name>
		<from_code>892338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella fujikuroi extract</from_name>
		<from_code>2043450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>careless weed pollen extract</from_name>
		<from_code>851926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern cottonwood pollen extract</from_name>
		<from_code>852363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Schinus terebinthifolius pollen extract</from_name>
		<from_code>2590688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orange pekoe tea allergenic extract</from_name>
		<from_code>966696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wine grape allergenic extract</from_name>
		<from_code>892317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horseradish allergenic extract</from_name>
		<from_code>1011043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plum allergenic extract</from_name>
		<from_code>899470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lawsonia inermis leaf extract</from_name>
		<from_code>1307699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gibberella zeae allergenic extract</from_name>
		<from_code>1922751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cashew nut allergenic extract</from_name>
		<from_code>892526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocean perch preparation</from_name>
		<from_code>2471431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lime allergenic extract</from_name>
		<from_code>1011060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phoma exigua var. exigua allergenic extract</from_name>
		<from_code>867284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl-p-hydroxybenzoate</from_name>
		<from_code>1362892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparagus allergenic extract</from_name>
		<from_code>891796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salix lutea pollen extract</from_name>
		<from_code>2590686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pale dock pollen extract</from_name>
		<from_code>1232604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Atlantic salmon allergenic extract</from_name>
		<from_code>900031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon allergenic extract</from_name>
		<from_code>899673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loose barley smut allergenic extract</from_name>
		<from_code>968492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mountain cedar pollen extract</from_name>
		<from_code>852581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>white mulberry pollen extract</from_name>
		<from_code>852669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cricket allergenic extract</from_name>
		<from_code>973447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loblolly pine pollen extract</from_name>
		<from_code>900770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American elm pollen extract</from_name>
		<from_code>852054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Acacia dealbata pollen extract</from_name>
		<from_code>2202946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raspberry allergenic extract</from_name>
		<from_code>899906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow dock pollen extract</from_name>
		<from_code>852209</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cauliflower allergenic extract</from_name>
		<from_code>899661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>giant wild rye pollen extract</from_name>
		<from_code>900148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Oregon ash pollen extract</from_name>
		<from_code>900045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Helminthosporium solani allergenic extract</from_name>
		<from_code>867232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lentil allergenic extract</from_name>
		<from_code>899444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American house dust mite allergenic extract</from_name>
		<from_code>1116977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>American chestnut allergenic extract</from_name>
		<from_code>891752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>littleseed canary grass pollen extract</from_name>
		<from_code>1098232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine allergenic extract</from_name>
		<from_code>1011412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>London planetree</from_name>
		<from_code>2166616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western yellow jacket venom protein</from_name>
		<from_code>1297535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nettle pollen extract</from_name>
		<from_code>852046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sydney golden wattle pollen extract</from_name>
		<from_code>895365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald cypress pollen extract</from_name>
		<from_code>995747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet wormwood pollen extract</from_name>
		<from_code>2167819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharomyces cerevisiae allergenic extract</from_name>
		<from_code>350141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldibromo glutaronitrile</from_name>
		<from_code>1307044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Geotrichum candidum allergenic extract</from_name>
		<from_code>999463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black walnut pollen extract</from_name>
		<from_code>852569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium solani allergenic extract</from_name>
		<from_code>867349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allergens</to_name>
		<to_code>M0000728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antisense Oligonucleotide [EPC]</to_name>
		<to_code>N0000191626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitor [EPC]</to_name>
		<to_code>N0000175588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Drug [EPC]</to_name>
		<to_code>N0000175558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrimidine Analog [EPC]</to_name>
		<to_code>N0000191809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Small Interfering RNA [EPC]</to_name>
		<to_code>N0000193848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibitor [EPC]</to_name>
		<to_code>N0000175592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitor [APC]</to_name>
		<to_code>N0000193907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Agent [APC]</to_name>
		<to_code>N0000193911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000193222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Related Agent [APC]</from_name>
		<from_code>N0000193906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-based Drug [EPC]</to_name>
		<to_code>N0000175413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nusinersen</to_name>
		<to_code>1863556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mipomersen</to_name>
		<to_code>1367839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eplontersen</to_name>
		<to_code>2671939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inotersen</to_name>
		<to_code>2099289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tofersen</to_name>
		<to_code>2634995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olezarsen</to_name>
		<to_code>2701418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eteplirsen</to_name>
		<to_code>1810569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casimersen</to_name>
		<to_code>2480096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transthyretin-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000193849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antisense Oligonucleotide [EPC]</from_name>
		<from_code>N0000191626</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golodirsen</to_name>
		<to_code>2267207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Oligonucleotide (substance)</from_name>
		<from_code>23243007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antisense Oligonucleotide [EPC]</to_name>
		<to_code>N0000191626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antisense Oligonucleotide [EPC]</to_name>
		<to_code>N0000191626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golodirsen</from_name>
		<from_code>2267207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casimersen</from_name>
		<from_code>2480096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eteplirsen</from_name>
		<from_code>1810569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olezarsen</from_name>
		<from_code>2701418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofersen</from_name>
		<from_code>2634995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen</from_name>
		<from_code>2099289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen</from_name>
		<from_code>1367839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplontersen</from_name>
		<from_code>2671939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen sodium</from_name>
		<from_code>1367838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nusinersen</from_name>
		<from_code>1863556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oligonucleotides, Antisense</to_name>
		<to_code>M0025055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>APOC-III-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased RNA Degradation [PE]</to_name>
		<to_code>N0000194154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>APOC-III-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194144</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olezarsen</to_name>
		<to_code>2701418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antisense oligonucleotide (substance)</from_name>
		<from_code>724032006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antilipemic agent (substance)</from_name>
		<from_code>373267003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antisense oligonucleotide (product)</from_name>
		<from_code>773815004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plozasiran</from_name>
		<from_code>2727175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased RNA Degradation [PE]</to_name>
		<to_code>N0000194154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plozasiran sodium</from_name>
		<from_code>2727337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased RNA Degradation [PE]</to_name>
		<to_code>N0000194154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olezarsen</from_name>
		<from_code>2701418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased RNA Degradation [PE]</to_name>
		<to_code>N0000194154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Post-transcriptional RNA Interaction [PE]</from_name>
		<from_code>N0000194155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased RNA Degradation [PE]</to_name>
		<to_code>N0000194154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fitusiran</from_name>
		<from_code>2709439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased RNA Degradation [PE]</to_name>
		<to_code>N0000194154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193849</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inotersen</to_name>
		<to_code>2099289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193849</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patisiran</to_name>
		<to_code>2053490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193849</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eplontersen</to_name>
		<to_code>2671939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193849</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vutrisiran</to_name>
		<to_code>2604578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antisense oligonucleotide (substance)</from_name>
		<from_code>724032006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transthyretin-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000193849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000194024</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>givosiran</to_name>
		<to_code>2265712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Transacylase (substance)</from_name>
		<from_code>130074009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</to_name>
		<to_code>N0000194024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>belinostat</to_name>
		<to_code>1543543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romidepsin</to_name>
		<to_code>877510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with histone deacetylase inhibitor mechanism of action (substance)</to_name>
		<to_code>423078004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>givinostat</to_name>
		<to_code>2678889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing histone deacetylase inhibitor (product)</to_name>
		<to_code>423081009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panobinostat</to_name>
		<to_code>1603350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
		<from_code>N0000175588</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorinostat</to_name>
		<to_code>194337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histone Deacetylase Inhibitor [EPC]</to_name>
		<to_code>N0000175588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorambucil</to_name>
		<to_code>2346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trabectedin</to_name>
		<to_code>1716278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lomustine</to_name>
		<to_code>6466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclophosphamide anhydrous</to_name>
		<to_code>1545988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>busulfan</to_name>
		<to_code>1828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mechlorethamine</to_name>
		<to_code>6674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ifosfamide</to_name>
		<to_code>5657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lurbinectedin</to_name>
		<to_code>2374729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procarbazine</to_name>
		<to_code>8702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melphalan</to_name>
		<to_code>6718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dacarbazine</to_name>
		<to_code>3098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carmustine</to_name>
		<to_code>2105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temozolomide</to_name>
		<to_code>37776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing alkylating agent (product)</to_name>
		<to_code>19768003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptozocin</to_name>
		<to_code>10114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiotepa</to_name>
		<to_code>10473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Alkylating agent (substance)</to_name>
		<to_code>372669002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitomycin</to_name>
		<to_code>632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkylating Drug [EPC]</from_name>
		<from_code>N0000175558</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bendamustine</to_name>
		<to_code>134547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkylating Drug [EPC]</to_name>
		<to_code>N0000175558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Analog [EPC]</from_name>
		<from_code>N0000191809</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Pyrimidine analog (substance)</to_name>
		<to_code>372544007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Analog [EPC]</from_name>
		<from_code>N0000191809</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uridine</to_name>
		<to_code>11017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Analog [EPC]</from_name>
		<from_code>N0000191809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrimidines</to_name>
		<to_code>M0018260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Analog [EPC]</from_name>
		<from_code>N0000191809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uridine triacetate</from_name>
		<from_code>1665222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrimidines</to_name>
		<to_code>M0018260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uridine</from_name>
		<from_code>11017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrimidines</to_name>
		<to_code>M0018260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Small Interfering RNA [EPC]</from_name>
		<from_code>N0000193848</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>RNA, Small Interfering</to_name>
		<to_code>M0406100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Small Interfering RNA [EPC]</from_name>
		<from_code>N0000193848</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fitusiran</to_name>
		<to_code>2709439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Small Interfering RNA [EPC]</from_name>
		<from_code>N0000193848</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patisiran</to_name>
		<to_code>2053490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Small Interfering RNA [EPC]</from_name>
		<from_code>N0000193848</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vutrisiran</to_name>
		<to_code>2604578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Small Interfering RNA [EPC]</from_name>
		<from_code>N0000193848</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>givosiran</to_name>
		<to_code>2265712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Ribonucleic acid, double stranded (substance)</from_name>
		<from_code>102761003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Small Interfering RNA [EPC]</to_name>
		<to_code>N0000193848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givosiran</from_name>
		<from_code>2265712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>RNA, Small Interfering</to_name>
		<to_code>M0406100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vutrisiran</from_name>
		<from_code>2604578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>RNA, Small Interfering</to_name>
		<to_code>M0406100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran</from_name>
		<from_code>2053490</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>RNA, Small Interfering</to_name>
		<to_code>M0406100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fitusiran</from_name>
		<from_code>2709439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>RNA, Small Interfering</to_name>
		<to_code>M0406100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with microtubule inhibitor mechanism of action (substance)</to_name>
		<to_code>429771008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>docetaxel anhydrous</to_name>
		<to_code>1299922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixabepilone</to_name>
		<to_code>337523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabazitaxel</to_name>
		<to_code>996051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirbanibulin</to_name>
		<to_code>2471078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paclitaxel</to_name>
		<to_code>56946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eribulin</to_name>
		<to_code>1045453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microtubule Inhibitor [EPC]</from_name>
		<from_code>N0000175592</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing microtubule inhibitor (product)</to_name>
		<to_code>427876003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular Structure Alteration [PE]</from_name>
		<from_code>N0000008346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin mesylate</from_name>
		<from_code>1045452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin-blmf</from_name>
		<from_code>2387833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin</from_name>
		<from_code>1045453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel</from_name>
		<from_code>56946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirvetuximab soravtansine</from_name>
		<from_code>2621548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisotumab vedotin-tftv</from_name>
		<from_code>2571093</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab</from_name>
		<from_code>2268307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tubulin Inhibiting Agent [EPC]</from_name>
		<from_code>N0000175848</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab vedotin</from_name>
		<from_code>2277607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirvetuximab soravtansine-gynx</from_name>
		<from_code>2621549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab</from_name>
		<from_code>2714237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisotumab vedotin</from_name>
		<from_code>2571094</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin</from_name>
		<from_code>2387834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab vedotin-ejfv</from_name>
		<from_code>2268306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirbanibulin</from_name>
		<from_code>2471078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisotumab</from_name>
		<from_code>2571095</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab vedotin</from_name>
		<from_code>2721996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brentuximab vedotin</from_name>
		<from_code>1147320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab</from_name>
		<from_code>2387844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab vedotin-tllv</from_name>
		<from_code>2714236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microtubule Inhibition [PE]</to_name>
		<to_code>N0000175085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Metabolic Inhibitor [EPC]</to_name>
		<to_code>N0000175595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000191493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RNA Polymerase Inhibitor [APC]</to_name>
		<to_code>N0000193946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folate Analog Metabolic Inhibitor [EPC]</to_name>
		<to_code>N0000175584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</to_name>
		<to_code>N0000193800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000185502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimetabolite [EPC]</to_name>
		<to_code>N0000180853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
		<from_code>N0000193907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000175609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleic Acid Synthesis Inhibitor [APC]</to_name>
		<to_code>N0000193907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemcitabine</to_name>
		<to_code>12574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluridine</to_name>
		<to_code>10803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azacitidine</to_name>
		<to_code>1251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capecitabine</to_name>
		<to_code>194000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nelarabine</to_name>
		<to_code>274771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fludarabine</to_name>
		<to_code>24698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>decitabine</to_name>
		<to_code>15657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytarabine</to_name>
		<to_code>3041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofarabine</to_name>
		<to_code>44151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercaptopurine anhydrous</to_name>
		<to_code>1546028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluorouracil</to_name>
		<to_code>4492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentostatin</to_name>
		<to_code>8011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antimetabolite (product)</from_name>
		<from_code>58760003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Metabolic Inhibitor [EPC]</to_name>
		<to_code>N0000175595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antimetabolite (substance)</from_name>
		<from_code>372785000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nucleoside Metabolic Inhibitor [EPC]</to_name>
		<to_code>N0000175595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sofosbuvir</to_name>
		<to_code>1484911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action (substance)</to_name>
		<to_code>736610007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191493</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing Hepatitis C virus protein NS5B inhibitor (product)</to_name>
		<to_code>768630005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RNA Polymerase Inhibitor [APC]</from_name>
		<from_code>N0000193946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000193948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000193948</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remdesivir</to_name>
		<to_code>2284718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with RNA polymerase inhibitor mechanism of action (substance)</from_name>
		<from_code>710805007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000193948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing RNA polymerase inhibitor (product)</from_name>
		<from_code>770369005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000193948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175584</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralatrexate</to_name>
		<to_code>662019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175584</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed</to_name>
		<to_code>68446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175584</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methotrexate</to_name>
		<to_code>6851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
		<from_code>N0000175584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antifolate (substance)</from_name>
		<from_code>372612001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folate Analog Metabolic Inhibitor [EPC]</to_name>
		<to_code>N0000175584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antifolate (product)</from_name>
		<from_code>349846008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Folate Analog Metabolic Inhibitor [EPC]</to_name>
		<to_code>N0000175584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin</from_name>
		<from_code>877015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralatrexate</from_name>
		<from_code>662019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid</to_name>
		<to_code>M0008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
		<from_code>N0000193800</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>letermovir</to_name>
		<to_code>1988648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
		<from_code>N0000193800</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with Cytomegalovirus terminase complex inhibitor mechanism of action (substance)</to_name>
		<to_code>768631009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
		<from_code>N0000193800</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing Cytomegalovirus terminase complex inhibitor (product)</to_name>
		<to_code>770376000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
		<from_code>N0000193800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
		<from_code>N0000193800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</to_name>
		<to_code>N0000193800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrimidine Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000185502</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teriflunomide</to_name>
		<to_code>1310520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000185502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000185502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000185502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyurea</to_name>
		<to_code>5552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing antimetabolite (product)</to_name>
		<to_code>58760003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
		<to_code>N0000175613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Purine Antimetabolite [EPC]</to_name>
		<to_code>N0000175712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioguanine anhydrous</to_name>
		<to_code>1546005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Antimetabolite (substance)</to_name>
		<to_code>372785000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite [EPC]</from_name>
		<from_code>N0000180853</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>floxuridine</to_name>
		<to_code>4488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite Immunosuppressant [EPC]</from_name>
		<from_code>N0000175613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antimetabolite Immunosuppressant [EPC]</from_name>
		<from_code>N0000175613</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycophenolic acid</to_name>
		<to_code>7145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunosuppressant (substance)</from_name>
		<from_code>372823004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
		<to_code>N0000175613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antimetabolite (substance)</from_name>
		<from_code>372785000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
		<to_code>N0000175613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antimetabolite (product)</from_name>
		<from_code>58760003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
		<to_code>N0000175613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
		<to_code>N0000175613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologic Activity [PE]</from_name>
		<from_code>N0000175550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000008665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologic Activity [PE]</from_name>
		<from_code>N0000175550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologic Activity [PE]</from_name>
		<from_code>N0000175550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000008664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>siltuximab</from_name>
		<from_code>1535218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecallantide</from_name>
		<from_code>658708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allogenic bone-marrow-derived mesenchymal stem cells</from_name>
		<from_code>2700761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Activity Alteration [PE]</from_name>
		<from_code>N0000009073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
		<from_code>N0000182637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate sodium</from_name>
		<from_code>408142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolic acid</from_name>
		<from_code>7145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-anoh</from_name>
		<from_code>2705421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belimumab</from_name>
		<from_code>1092437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus</from_name>
		<from_code>35302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-aazg</from_name>
		<from_code>2679427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib</from_name>
		<from_code>2716558</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone</from_name>
		<from_code>4458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus protein-bound</from_name>
		<from_code>2712352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remestemcel-L</from_name>
		<from_code>2700765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axatilimab</from_name>
		<from_code>2691526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritlecitinib</from_name>
		<from_code>2641595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-bavi</from_name>
		<from_code>2680283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab</from_name>
		<from_code>612865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib citrate</from_name>
		<from_code>1358492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deflazacort</from_name>
		<from_code>22396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate</from_name>
		<from_code>265323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lifitegrast</from_name>
		<from_code>1801820</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab-ocsq</from_name>
		<from_code>2693449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deuruxolitinib phosphate</from_name>
		<from_code>2716557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritlecitinib tosylate</from_name>
		<from_code>2641596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canakinumab</from_name>
		<from_code>853491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remestemcel-L-rknd</from_name>
		<from_code>2700764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dupilumab</from_name>
		<from_code>1876376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axatilimab-csfr</from_name>
		<from_code>2691528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib</from_name>
		<from_code>1357536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone pivalate</from_name>
		<from_code>25113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologic Activity [PE]</to_name>
		<to_code>N0000175550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Biogenic Amine Production [PE]</to_name>
		<to_code>N0000008662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Production [PE]</to_name>
		<to_code>N0000008677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Production [PE]</to_name>
		<to_code>N0000008386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kallidin Production [PE]</to_name>
		<to_code>N0000008674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Antibody Production [PE]</to_name>
		<to_code>N0000008392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologically Active Molecule Production Alteration [PE]</from_name>
		<from_code>N0000009076</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000008665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Production [PE]</to_name>
		<to_code>N0000008665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab</from_name>
		<from_code>2691310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penpulimab</from_name>
		<from_code>2712542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retifanlimab-dlwr</from_name>
		<from_code>2632980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remestemcel-L-rknd</from_name>
		<from_code>2700764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retifanlimab</from_name>
		<from_code>2632981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab-tpzi</from_name>
		<from_code>2669407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab-ilto</from_name>
		<from_code>2691309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pembrolizumab</from_name>
		<from_code>1547545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toripalimab</from_name>
		<from_code>2669406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab-ipdl</from_name>
		<from_code>2717512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous tacrolimus</from_name>
		<from_code>235991</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-aazg</from_name>
		<from_code>2679427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosibelimab</from_name>
		<from_code>2717511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimecrolimus</from_name>
		<from_code>321952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus monohydrate</from_name>
		<from_code>484288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-anoh</from_name>
		<from_code>2705421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pembrolizumab-pmph</from_name>
		<from_code>2723753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-bavi</from_name>
		<from_code>2680283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab</from_name>
		<from_code>612865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penpulimab-kcqx</from_name>
		<from_code>2712646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remestemcel-L</from_name>
		<from_code>2700765</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Production [PE]</to_name>
		<to_code>N0000008573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Biogenic Amine Production [PE]</from_name>
		<from_code>N0000008662</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Production [PE]</to_name>
		<to_code>N0000008659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Biogenic Amine Production [PE]</from_name>
		<from_code>N0000008662</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Production [PE]</to_name>
		<to_code>N0000008895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Production [PE]</to_name>
		<to_code>N0000008659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Production [PE]</to_name>
		<to_code>N0000008659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat ethyl</from_name>
		<from_code>1872441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Production [PE]</to_name>
		<to_code>N0000008895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat etiprate</from_name>
		<from_code>1872448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Production [PE]</to_name>
		<to_code>N0000008895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat</from_name>
		<from_code>1872382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Production [PE]</to_name>
		<to_code>N0000008895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
		<from_code>N0000008686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Eicosanoid Production [PE]</to_name>
		<to_code>N0000008592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
		<to_code>N0000008831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Production [PE]</from_name>
		<from_code>N0000008592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Production [PE]</from_name>
		<from_code>N0000008592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Production [PE]</from_name>
		<from_code>N0000008592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Production [PE]</to_name>
		<to_code>N0000008683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium</from_name>
		<from_code>1605114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate</from_name>
		<from_code>52364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclesonide</from_name>
		<from_code>274964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suprofen</from_name>
		<from_code>10255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nepafenac</from_name>
		<from_code>298665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate (shark)</from_name>
		<from_code>1789516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac sodium</from_name>
		<from_code>47364</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, porcine</from_name>
		<from_code>1306202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfates</from_name>
		<from_code>2473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylamide</from_name>
		<from_code>9518</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (porcine)</from_name>
		<from_code>1366974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carprofen</from_name>
		<from_code>20343</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, bovine</from_name>
		<from_code>1306129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trolamine salicylate</from_name>
		<from_code>38866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacetin</from_name>
		<from_code>8113</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone piperazine</from_name>
		<from_code>236354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac</from_name>
		<from_code>19737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclofenac</from_name>
		<from_code>16689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexketoprofen</from_name>
		<from_code>237162</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (bovine)</from_name>
		<from_code>1299929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate A sodium</from_name>
		<from_code>476847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (shark)</from_name>
		<from_code>1358172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valdecoxib</from_name>
		<from_code>278567</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rofecoxib</from_name>
		<from_code>232158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone sodium</from_name>
		<from_code>236529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone</from_name>
		<from_code>8160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexketoprofen trometamol</from_name>
		<from_code>233386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Production [PE]</to_name>
		<to_code>N0000008836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Production [PE]</to_name>
		<to_code>N0000009006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Production [PE]</to_name>
		<to_code>N0000008683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apremilast</from_name>
		<from_code>1492727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Production [PE]</to_name>
		<to_code>N0000008683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zileuton</from_name>
		<from_code>40575</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Production [PE]</to_name>
		<to_code>N0000008683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Kinin Production [PE]</from_name>
		<from_code>N0000008677</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Production [PE]</to_name>
		<to_code>N0000008424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garadacimab-gxii</from_name>
		<from_code>2717168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Production [PE]</to_name>
		<to_code>N0000008424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garadacimab</from_name>
		<from_code>2717169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Production [PE]</to_name>
		<to_code>N0000008424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebetralstat</from_name>
		<from_code>2717944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Production [PE]</to_name>
		<to_code>N0000008424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus protein-bound</from_name>
		<from_code>2712352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Antibody Production [PE]</to_name>
		<to_code>N0000008392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iptacopan</from_name>
		<from_code>2671061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iptacopan hydrochloride</from_name>
		<from_code>2671062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Production [PE]</to_name>
		<to_code>N0000008570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kallidin Activity [PE]</to_name>
		<to_code>N0000008672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Biogenic Amine Activity [PE]</to_name>
		<to_code>N0000008660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Antibody Activity [PE]</to_name>
		<to_code>N0000008390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anakinra</from_name>
		<from_code>72435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate</from_name>
		<from_code>265323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glatiramer acetate</from_name>
		<from_code>84375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologically Active Molecule Activity Alteration [PE]</from_name>
		<from_code>N0000009074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glatiramer</from_name>
		<from_code>214582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adapalene</from_name>
		<from_code>60223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlexanox</from_name>
		<from_code>46307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolic acid</from_name>
		<from_code>7145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate sodium</from_name>
		<from_code>408142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
		<to_code>N0000008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natalizumab-sztn</from_name>
		<from_code>2725169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vedolizumab</from_name>
		<from_code>1538097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natalizumab</from_name>
		<from_code>354770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efalizumab</from_name>
		<from_code>356988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa</from_name>
		<from_code>352374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa (activated), lyophilized</from_name>
		<from_code>353106</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Activity [PE]</to_name>
		<to_code>N0000008384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danicopan</from_name>
		<from_code>2678952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narsoplimab-wuug</from_name>
		<from_code>2732292</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crovalimab</from_name>
		<from_code>2686619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilobelimab</from_name>
		<from_code>2639620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacopan</from_name>
		<from_code>2572100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crovalimab-akkz</from_name>
		<from_code>2686620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>narsoplimab</from_name>
		<from_code>2732291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Activity [PE]</to_name>
		<to_code>N0000008568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Eicosanoid Activity [PE]</to_name>
		<to_code>N0000008590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
		<from_code>N0000008684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000008829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Activity [PE]</from_name>
		<from_code>N0000008590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Activity [PE]</from_name>
		<from_code>N0000008590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Activity [PE]</from_name>
		<from_code>N0000008590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Activity [PE]</to_name>
		<to_code>N0000009004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Activity [PE]</to_name>
		<to_code>N0000008681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Activity [PE]</to_name>
		<to_code>N0000008834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trapidil</from_name>
		<from_code>10735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000008829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000008829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifenprodil</from_name>
		<from_code>27403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000008829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifenprodil tartrate</from_name>
		<from_code>289912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
		<to_code>N0000008829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Kinin Activity [PE]</from_name>
		<from_code>N0000008675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Activity [PE]</to_name>
		<to_code>N0000008422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Activity [PE]</to_name>
		<to_code>N0000008675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen</from_name>
		<from_code>2724361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Activity [PE]</to_name>
		<to_code>N0000008422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen sodium</from_name>
		<from_code>2724362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Activity [PE]</to_name>
		<to_code>N0000008422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lebrikizumab</from_name>
		<from_code>2693758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delgocitinib</from_name>
		<from_code>2721163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab-asmn</from_name>
		<from_code>2053449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimecrolimus</from_name>
		<from_code>321952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nerandomilast</from_name>
		<from_code>2725523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab-mrkz</from_name>
		<from_code>2668385</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basiliximab</from_name>
		<from_code>196102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>momelotinib dihydrochloride monohydrate</from_name>
		<from_code>2665205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lebrikizumab-lbkz</from_name>
		<from_code>2693778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclizumab</from_name>
		<from_code>190353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab</from_name>
		<from_code>2668384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimekizumab-bkzx</from_name>
		<from_code>2668080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risankizumab-rzaa</from_name>
		<from_code>2166132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimekizumab</from_name>
		<from_code>2668041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarilumab</from_name>
		<from_code>1923319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab-ilto</from_name>
		<from_code>2691309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab</from_name>
		<from_code>2053436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nemolizumab</from_name>
		<from_code>2691310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risankizumab</from_name>
		<from_code>2166040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duvelisib</from_name>
		<from_code>2058509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>momelotinib</from_name>
		<from_code>2665204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Activity [PE]</to_name>
		<to_code>N0000008571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Biogenic Amine Activity [PE]</from_name>
		<from_code>N0000008660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Biogenic Amine Activity [PE]</from_name>
		<from_code>N0000008660</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Histamine Activity [PE]</from_name>
		<from_code>N0000008657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Histamine Activity [PE]</from_name>
		<from_code>N0000008657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Histamine Activity [PE]</from_name>
		<from_code>N0000008657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Muscular System Histamine Activity [PE]</to_name>
		<to_code>N0000008749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valbenazine tosylate</from_name>
		<from_code>1923002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine</from_name>
		<from_code>135391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline phosphate</from_name>
		<from_code>866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine tannate</from_name>
		<from_code>686390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine</from_name>
		<from_code>863035</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine</from_name>
		<from_code>10849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine hydrochloride</from_name>
		<from_code>1294532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine</from_name>
		<from_code>33408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine resin complex</from_name>
		<from_code>314786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene</from_name>
		<from_code>6822</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline hydrochloride</from_name>
		<from_code>81954</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine besilate</from_name>
		<from_code>658552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine hydrochloride</from_name>
		<from_code>236599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine hydrochloride</from_name>
		<from_code>203150</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loratadine</from_name>
		<from_code>28889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline</from_name>
		<from_code>865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine hydrochloride</from_name>
		<from_code>236961</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valbenazine</from_name>
		<from_code>1918219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine difumarate</from_name>
		<from_code>221094</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine</from_name>
		<from_code>22696</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine</from_name>
		<from_code>18603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutetrabenazine</from_name>
		<from_code>1876905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen</from_name>
		<from_code>6146</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine hydrochloride</from_name>
		<from_code>71534</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine Activity Alteration [PE]</from_name>
		<from_code>N0000009071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide</from_name>
		<from_code>52151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine polistirex</from_name>
		<from_code>236792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine hydrochloride</from_name>
		<from_code>235725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine</from_name>
		<from_code>2354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine</from_name>
		<from_code>39684</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine maleate</from_name>
		<from_code>48936</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequitazine</from_name>
		<from_code>29528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine</from_name>
		<from_code>33283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene hydrochloride</from_name>
		<from_code>235721</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrabenazine</from_name>
		<from_code>10390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine hydrochloride</from_name>
		<from_code>235824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine hydrochloride</from_name>
		<from_code>236474</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine tannate</from_name>
		<from_code>1099727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine</from_name>
		<from_code>28627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide tromethamine</from_name>
		<from_code>28859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen fumarate</from_name>
		<from_code>11404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine citrate</from_name>
		<from_code>221141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astemizole</from_name>
		<from_code>42328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desloratadine</from_name>
		<from_code>275635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine</from_name>
		<from_code>87636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate, (R)-</from_name>
		<from_code>2622915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terfenadine</from_name>
		<from_code>42330</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine tartrate</from_name>
		<from_code>221137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine</from_name>
		<from_code>28144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine</from_name>
		<from_code>20610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline sulfate</from_name>
		<from_code>2680384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Activity [PE]</to_name>
		<to_code>N0000008657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sensory-Somatic Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Enteric Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000008988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008408</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Parasympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000008793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000008988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Parasympathetic Activity [PE]</from_name>
		<from_code>N0000175648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Parasympathetic Histamine Activity [PE]</to_name>
		<to_code>N0000008793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebral Cortex Histamine Activity [PE]</to_name>
		<to_code>N0000008542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Midbrain Histamine Activity [PE]</to_name>
		<to_code>N0000008722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Histamine Activity [PE]</to_name>
		<to_code>N0000008440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebellum Histamine Activity [PE]</to_name>
		<to_code>N0000008519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
		<from_code>N0000008496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Spinal Cord Histamine Activity [PE]</to_name>
		<to_code>N0000008940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceprometazine</from_name>
		<from_code>161203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant</from_name>
		<from_code>2197878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant hydrochloride</from_name>
		<from_code>2197879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
		<to_code>N0000008496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Histamine Activity [PE]</from_name>
		<from_code>N0000008749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Smooth Muscle Histamine Activity [PE]</to_name>
		<to_code>N0000008913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Histamine Activity [PE]</from_name>
		<from_code>N0000008749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Histamine Activity [PE]</to_name>
		<to_code>N0000008964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Histamine Activity [PE]</from_name>
		<from_code>N0000008749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cardiac Muscle Histamine Activity [PE]</to_name>
		<to_code>N0000008467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Serotonin Activity [PE]</from_name>
		<from_code>N0000008893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Serotonin Activity [PE]</from_name>
		<from_code>N0000008893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Serotonin Activity [PE]</from_name>
		<from_code>N0000008893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Muscular System Serotonin Activity [PE]</to_name>
		<to_code>N0000008755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertindole</from_name>
		<from_code>41996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valbenazine tosylate</from_name>
		<from_code>1923002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin Activity Alteration [PE]</from_name>
		<from_code>N0000009844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutetrabenazine</from_name>
		<from_code>1876905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrabenazine</from_name>
		<from_code>10390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flibanserin</from_name>
		<from_code>1665509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valbenazine</from_name>
		<from_code>1918219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Activity [PE]</to_name>
		<to_code>N0000008893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008822</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sensory-Somatic Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008822</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Autonomic Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008822</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Parasympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000008799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008414</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000008994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Parasympathetic Activity [PE]</from_name>
		<from_code>N0000175648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Parasympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000008799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Serotonin Activity [PE]</to_name>
		<to_code>N0000008994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Midbrain Serotonin Activity [PE]</to_name>
		<to_code>N0000008728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Brain Stem Serotonin Activity [PE]</to_name>
		<to_code>N0000008446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebral Cortex Serotonin Activity [PE]</to_name>
		<to_code>N0000008548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cerebellum Serotonin Activity [PE]</to_name>
		<to_code>N0000008525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
		<from_code>N0000008502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Spinal Cord Serotonin Activity [PE]</to_name>
		<to_code>N0000008946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
		<to_code>N0000008502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Serotonin Activity [PE]</from_name>
		<from_code>N0000008755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cardiac Muscle Serotonin Activity [PE]</to_name>
		<to_code>N0000008473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Serotonin Activity [PE]</from_name>
		<from_code>N0000008755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Striated Muscle Serotonin Activity [PE]</to_name>
		<to_code>N0000008970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Muscular System Serotonin Activity [PE]</from_name>
		<from_code>N0000008755</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Smooth Muscle Serotonin Activity [PE]</to_name>
		<to_code>N0000008919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Antibody Degradation [PE]</to_name>
		<to_code>N0000008391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000008685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Degradation [PE]</to_name>
		<to_code>N0000008569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kinin Degradation [PE]</to_name>
		<to_code>N0000008676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cytokine Degradation [PE]</to_name>
		<to_code>N0000008572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</to_name>
		<to_code>N0000008661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Kallidin Degradation [PE]</to_name>
		<to_code>N0000008673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adhesion Factor Degradation [PE]</to_name>
		<to_code>N0000008385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologically Active Molecule Degradation Alteration [PE]</from_name>
		<from_code>N0000009075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Immunologically Active Molecule Degradation [PE]</to_name>
		<to_code>N0000008664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Platelet Activating Factor Degradation [PE]</to_name>
		<to_code>N0000008830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
		<from_code>N0000008685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Eicosanoid Degradation [PE]</to_name>
		<to_code>N0000008591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Degradation [PE]</from_name>
		<from_code>N0000008591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Leukotriene Degradation [PE]</to_name>
		<to_code>N0000008682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Degradation [PE]</from_name>
		<from_code>N0000008591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Prostaglandin Degradation [PE]</to_name>
		<to_code>N0000008835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Eicosanoid Degradation [PE]</from_name>
		<from_code>N0000008591</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Thromboxane Degradation [PE]</to_name>
		<to_code>N0000009005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zilucoplan</from_name>
		<from_code>2672489</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Degradation [PE]</to_name>
		<to_code>N0000008569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zilucoplan sodium</from_name>
		<from_code>2672492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Complement Degradation [PE]</to_name>
		<to_code>N0000008569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Kinin Degradation [PE]</from_name>
		<from_code>N0000008676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolaprilat</from_name>
		<from_code>1546379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril</from_name>
		<from_code>39990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat dihydrate</from_name>
		<from_code>2672730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril</from_name>
		<from_code>60245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril calcium</from_name>
		<from_code>259493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril hydrochloride</from_name>
		<from_code>259335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinoprilat</from_name>
		<from_code>1546393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinaprilat</from_name>
		<from_code>1546359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramiprilat</from_name>
		<from_code>1546377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Bradykinin Degradation [PE]</to_name>
		<to_code>N0000008423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
		<from_code>N0000008661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
		<from_code>N0000008661</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Degradation [PE]</to_name>
		<to_code>N0000008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Serotonin Degradation [PE]</to_name>
		<to_code>N0000008894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Histamine Degradation [PE]</to_name>
		<to_code>N0000008658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with purine antagonist mechanism of action (substance)</to_name>
		<to_code>372613006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azathioprine</to_name>
		<to_code>1256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cladribine</to_name>
		<to_code>44157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing purine antagonist (product)</to_name>
		<to_code>349847004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Purine Antimetabolite [EPC]</from_name>
		<from_code>N0000175712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Purines</to_name>
		<to_code>M0018169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Purines</to_name>
		<to_code>M0018169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladribine</from_name>
		<from_code>44157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Purines</to_name>
		<to_code>M0018169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etoposide</to_name>
		<to_code>4179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irinotecan</to_name>
		<to_code>51499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000194142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with topoisomerase inhibitor mechanism of action (substance)</to_name>
		<to_code>372537003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000175414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>topotecan</to_name>
		<to_code>57308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing topoisomerase inhibitor (product)</to_name>
		<to_code>108780008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175609</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitoxantrone</to_name>
		<to_code>7005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000194142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000194142</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepotidacin</to_name>
		<to_code>2709212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with topoisomerase inhibitor mechanism of action (substance)</from_name>
		<from_code>372537003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000194142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antibacterial mechanism of action (substance)</from_name>
		<from_code>419241000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000194142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen</from_name>
		<from_code>10324</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valrubicin</from_name>
		<from_code>31435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelarabine</from_name>
		<from_code>274771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine</from_name>
		<from_code>569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen citrate</from_name>
		<from_code>40137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene citrate</from_name>
		<from_code>49953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan</from_name>
		<from_code>6718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate</from_name>
		<from_code>42333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>besifloxacin</from_name>
		<from_code>819911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozenoxacin</from_name>
		<from_code>1994739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthralin</from_name>
		<from_code>873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaliplatin</from_name>
		<from_code>32592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>busulfan</from_name>
		<from_code>1828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine hydrochloride</from_name>
		<from_code>81945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofarabine</from_name>
		<from_code>44151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan hydrochloride</from_name>
		<from_code>235857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifosfamide</from_name>
		<from_code>5657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fleroxacin</from_name>
		<from_code>42322</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benznidazole</from_name>
		<from_code>18994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finafloxacin</from_name>
		<from_code>1598641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>DNA Replication Alteration [PE]</from_name>
		<from_code>N0000008380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide monohydrate</from_name>
		<from_code>2679071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene</from_name>
		<from_code>38409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetyldithranol</from_name>
		<from_code>38536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipobroman</from_name>
		<from_code>8347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladribine</from_name>
		<from_code>44157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate glucuronate</from_name>
		<from_code>38725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temozolomide</from_name>
		<from_code>37776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carmustine</from_name>
		<from_code>2105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomustine</from_name>
		<from_code>6466</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorambucil</from_name>
		<from_code>2346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased DNA Replication [PE]</to_name>
		<to_code>N0000008577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175414</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epirubicin</to_name>
		<to_code>3995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175414</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idarubicin</to_name>
		<to_code>5650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175414</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxorubicin</to_name>
		<to_code>3639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
		<from_code>N0000175414</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>daunorubicin</to_name>
		<to_code>3109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing topoisomerase inhibitor (product)</from_name>
		<from_code>108780008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000175414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anthracycline (substance)</from_name>
		<from_code>372540003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000175414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with topoisomerase inhibitor mechanism of action (substance)</from_name>
		<from_code>372537003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
		<to_code>N0000175414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthracyclines</to_name>
		<to_code>M0028312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tubulin Agent [APC]</from_name>
		<from_code>N0000193911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vinca Alkaloid [EPC]</to_name>
		<to_code>N0000175612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tubulin Agent [APC]</from_name>
		<from_code>N0000193911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Inhibiting Agent [EPC]</to_name>
		<to_code>N0000175848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vinca Alkaloid [EPC]</from_name>
		<from_code>N0000175612</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vinca alkaloid (substance)</to_name>
		<to_code>61864009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vinca Alkaloid [EPC]</from_name>
		<from_code>N0000175612</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vincristine</to_name>
		<to_code>11202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vinca Alkaloid [EPC]</from_name>
		<from_code>N0000175612</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinorelbine</to_name>
		<to_code>39541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vinca Alkaloid [EPC]</from_name>
		<from_code>N0000175612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vinca Alkaloid [EPC]</from_name>
		<from_code>N0000175612</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinblastine</to_name>
		<to_code>11198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing alkaloid (product)</from_name>
		<from_code>768593004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vinca Alkaloid [EPC]</to_name>
		<to_code>N0000175612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkaloid [EPC]</from_name>
		<from_code>N0000193949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vinca Alkaloid [EPC]</to_name>
		<to_code>N0000175612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine</from_name>
		<from_code>11202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine sulfate</from_name>
		<from_code>11203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinca Alkaloids</to_name>
		<to_code>M0022674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tubulin Inhibiting Agent [EPC]</from_name>
		<from_code>N0000175848</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tubulin Inhibiting Agent [EPC]</from_name>
		<from_code>N0000175848</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>griseofulvin</to_name>
		<to_code>5021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing microtubule inhibitor (product)</from_name>
		<from_code>427876003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Inhibiting Agent [EPC]</to_name>
		<to_code>N0000175848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with microtubule inhibitor mechanism of action (substance)</from_name>
		<from_code>429771008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tubulin Inhibiting Agent [EPC]</to_name>
		<to_code>N0000175848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podofilox</from_name>
		<from_code>8463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine</from_name>
		<from_code>11202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin</from_name>
		<from_code>1045453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel protein-bound</from_name>
		<from_code>486610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mitosis Alteration [PE]</from_name>
		<from_code>N0000009750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine sulfate</from_name>
		<from_code>11203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel</from_name>
		<from_code>56946</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantharidin</from_name>
		<from_code>1984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin mesylate</from_name>
		<from_code>1045452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthralin</from_name>
		<from_code>873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetyldithranol</from_name>
		<from_code>38536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Mitosis [PE]</to_name>
		<to_code>N0000008732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193222</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</to_name>
		<to_code>N0000194059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</from_name>
		<from_code>N0000193222</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nusinersen</to_name>
		<to_code>1863556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</from_name>
		<from_code>N0000194059</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risdiplam</to_name>
		<to_code>2390935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-based Drug [EPC]</from_name>
		<from_code>N0000175413</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-containing Compounds [EXT]</to_name>
		<to_code>N0000175073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-based Drug [EPC]</from_name>
		<from_code>N0000175413</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing platinum and/or platinum compound (product)</to_name>
		<to_code>768621002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-based Drug [EPC]</from_name>
		<from_code>N0000175413</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxaliplatin</to_name>
		<to_code>32592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-based Drug [EPC]</from_name>
		<from_code>N0000175413</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisplatin</to_name>
		<to_code>2555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-based Drug [EPC]</from_name>
		<from_code>N0000175413</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Platinum compound (substance)</to_name>
		<to_code>11996000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-based Drug [EPC]</from_name>
		<from_code>N0000175413</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboplatin</to_name>
		<to_code>40048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-based Drug [EPC]</to_name>
		<to_code>N0000175413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-based Drug [EPC]</to_name>
		<to_code>N0000175413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-containing Compounds [EXT]</from_name>
		<from_code>N0000175073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Organoplatinum Compounds</to_name>
		<to_code>M0015422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Platinum-containing Compounds [EXT]</from_name>
		<from_code>N0000175073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-containing Compounds [EXT]</to_name>
		<to_code>N0000175073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-containing Compounds [EXT]</to_name>
		<to_code>N0000175073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-containing Compounds [EXT]</to_name>
		<to_code>N0000175073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaliplatin</from_name>
		<from_code>32592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Platinum-containing Compounds [EXT]</to_name>
		<to_code>N0000175073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum Compounds</to_name>
		<to_code>M0026727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interaction [APC]</from_name>
		<from_code>N0000193898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Inhibitor [APC]</to_name>
		<to_code>N0000193897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interaction [APC]</from_name>
		<from_code>N0000193898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Stabilizer [EPC]</to_name>
		<to_code>N0000194077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Interaction [APC]</from_name>
		<from_code>N0000193898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Enzyme Activator [APC]</to_name>
		<to_code>N0000193896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitor [EPC]</to_name>
		<to_code>N0000182135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitor Immunosuppressant [EPC]</to_name>
		<to_code>N0000175457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 5 Inhibitor [EPC]</to_name>
		<to_code>N0000175599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitor [EPC]</to_name>
		<to_code>N0000175930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitor [EPC]</to_name>
		<to_code>N0000175611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitor [EPC]</to_name>
		<to_code>N0000175598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitor [EPC]</to_name>
		<to_code>N0000175783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymidine Phosphorylase Inhibitor [EPC]</to_name>
		<to_code>N0000191870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitor [EPC]</to_name>
		<to_code>N0000175939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Dehydropeptidase Inhibitor [EPC]</to_name>
		<to_code>N0000175514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesyltransferase Inhibitor [EPC]</to_name>
		<to_code>N0000193938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbonic Anhydrase Inhibitor [EPC]</to_name>
		<to_code>N0000175517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitor [EPC]</to_name>
		<to_code>N0000182633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</to_name>
		<to_code>N0000193615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitor [EPC]</to_name>
		<to_code>N0000191001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitor [EPC]</to_name>
		<to_code>N0000175845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methyltransferase Inhibitor [EPC]</to_name>
		<to_code>N0000193930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000191623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Xanthine Oxidase Inhibitor [EPC]</to_name>
		<to_code>N0000175698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tryptophan Hydroxylase Inhibitor [EPC]</to_name>
		<to_code>N0000193303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanin Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitor [EPC]</to_name>
		<to_code>N0000175900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxaborole Antifungal [EPC]</to_name>
		<to_code>N0000191279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-alpha Reductase Inhibitor [EPC]</to_name>
		<to_code>N0000175836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatase Inhibitor [EPC]</to_name>
		<to_code>N0000175563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>5-Lipoxygenase Inhibitor [EPC]</to_name>
		<to_code>N0000175956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cortisol Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000193935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Glucosidase Inhibitor [EPC]</to_name>
		<to_code>N0000175559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oligonucleotide Telomerase Inhibitor [EPC]</to_name>
		<to_code>N0000194125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</to_name>
		<to_code>N0000175809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catechol-O-Methyltransferase Inhibitor [EPC]</to_name>
		<to_code>N0000175757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Inhibitor [EPC]</to_name>
		<to_code>N0000193999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</to_name>
		<to_code>N0000193852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonsteroidal Anti-inflammatory Drug [EPC]</to_name>
		<to_code>N0000175722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitor [EPC]</to_name>
		<to_code>N0000182961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</to_name>
		<to_code>N0000193913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldehyde Dehydrogenase Inhibitor [EPC]</to_name>
		<to_code>N0000175679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Intestinal Lipase Inhibitor [EPC]</to_name>
		<to_code>N0000175591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</to_name>
		<to_code>N0000193987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitor [EPC]</to_name>
		<to_code>N0000194021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000175605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitor [EPC]</to_name>
		<to_code>N0000194115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</to_name>
		<to_code>N0000175754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HMG-CoA Reductase Inhibitor [EPC]</to_name>
		<to_code>N0000175589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
		<to_code>N0000194047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selectin Blocker [EPC]</to_name>
		<to_code>N0000194032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Inhibitor [APC]</from_name>
		<from_code>N0000193897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylxanthine [EPC]</to_name>
		<to_code>N0000175790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 2D6 Inhibitor [EPC]</from_name>
		<from_code>N0000182135</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine</to_name>
		<to_code>9068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitor [EPC]</to_name>
		<to_code>N0000182135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 2D6 Inhibitor [EPC]</to_name>
		<to_code>N0000182135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voclosporin</to_name>
		<to_code>2475166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with calcineurin inhibitor mechanism of action (substance)</to_name>
		<to_code>416798007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcineurin inhibitor (product)</to_name>
		<to_code>416587008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimecrolimus</to_name>
		<to_code>321952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous tacrolimus</to_name>
		<to_code>235991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175457</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclosporine</to_name>
		<to_code>3008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcineurin Inhibitor Immunosuppressant [EPC]</to_name>
		<to_code>N0000175457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avanafil</to_name>
		<to_code>1291301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sildenafil</to_name>
		<to_code>136411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tadalafil</to_name>
		<to_code>358263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with phosphodiesterase 5 inhibitor mechanism of action (substance)</to_name>
		<to_code>407313002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing phosphodiesterase 5 inhibitor (product)</to_name>
		<to_code>407316005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
		<from_code>N0000175599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vardenafil</to_name>
		<to_code>306674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vaborbactam</to_name>
		<to_code>1945213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazobactam</to_name>
		<to_code>37617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relebactam anhydrous</to_name>
		<to_code>2268500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulbactam</to_name>
		<to_code>10167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clavulanic acid</to_name>
		<to_code>21216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avibactam</to_name>
		<to_code>1603834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>beta Lactamase Inhibitor [EPC]</from_name>
		<from_code>N0000175930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>durlobactam</to_name>
		<to_code>2639089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with beta-lactam structure and antibacterial mechanism of action (substance)</from_name>
		<from_code>373297006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitor [EPC]</to_name>
		<to_code>N0000175930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>beta Lactamase Inhibitor [EPC]</to_name>
		<to_code>N0000175930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Urease Inhibitor [EPC]</from_name>
		<from_code>N0000175611</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetohydroxamic acid</to_name>
		<to_code>16728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitor [EPC]</to_name>
		<to_code>N0000175611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Anti-infective agent (substance)</from_name>
		<from_code>373249005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitor [EPC]</to_name>
		<to_code>N0000175611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Urease Inhibitor [EPC]</to_name>
		<to_code>N0000175611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
		<from_code>N0000175598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilostazol</to_name>
		<to_code>21107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
		<from_code>N0000175598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milrinone</to_name>
		<to_code>52769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
		<from_code>N0000175598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ensifentrine</to_name>
		<to_code>2687215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing phosphodiesterase inhibitor (product)</from_name>
		<from_code>346625000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitor [EPC]</to_name>
		<to_code>N0000175598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with phosphodiesterase inhibitor mechanism of action (substance)</from_name>
		<from_code>373692009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 3 Inhibitor [EPC]</to_name>
		<to_code>N0000175598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucosylceramide Synthase Inhibitor [EPC]</from_name>
		<from_code>N0000175783</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miglustat</to_name>
		<to_code>402316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucosylceramide Synthase Inhibitor [EPC]</from_name>
		<from_code>N0000175783</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eliglustat</to_name>
		<to_code>1547220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with glycosidase inhibitor mechanism of action (substance)</from_name>
		<from_code>426848000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitor [EPC]</to_name>
		<to_code>N0000175783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing glycosidase inhibitor (product)</from_name>
		<from_code>427386005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucosylceramide Synthase Inhibitor [EPC]</to_name>
		<to_code>N0000175783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
		<from_code>N0000191870</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tipiracil</to_name>
		<to_code>1670304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
		<from_code>N0000191870</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with thymidine phosphorylase inhibitor mechanism of action (substance)</to_name>
		<to_code>724028000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
		<from_code>N0000191870</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing thymidine phosphorylase inhibitor (product)</to_name>
		<to_code>770366003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175939</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product)</to_name>
		<to_code>123954005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175939</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketorolac</to_name>
		<to_code>35827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175939</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)</to_name>
		<to_code>387050005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Non-steroidal anti-inflammatory agent (substance)</from_name>
		<from_code>372665008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclooxygenase Inhibitor [EPC]</to_name>
		<to_code>N0000175939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adrenal Steroid Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175928</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metyrapone</to_name>
		<to_code>6923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
		<from_code>103022008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hormone receptor antagonist (product)</from_name>
		<from_code>327298003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adrenal Steroid Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Dehydropeptidase Inhibitor [EPC]</from_name>
		<from_code>N0000175514</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilastatin</to_name>
		<to_code>2540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing peptide hydrolase inhibitor (product)</from_name>
		<from_code>422745008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Dehydropeptidase Inhibitor [EPC]</to_name>
		<to_code>N0000175514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with peptide hydrolase inhibitor mechanism of action (substance)</from_name>
		<from_code>412127001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Dehydropeptidase Inhibitor [EPC]</to_name>
		<to_code>N0000175514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Farnesyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000193938</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lonafarnib</to_name>
		<to_code>2467553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing transferase inhibitor (product)</from_name>
		<from_code>427059003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesyltransferase Inhibitor [EPC]</to_name>
		<to_code>N0000193938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with transferase inhibitor mechanism of action (substance)</from_name>
		<from_code>415742001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesyltransferase Inhibitor [EPC]</to_name>
		<to_code>N0000193938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brinzolamide</to_name>
		<to_code>194881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with carbonic anhydrase inhibitor mechanism of action (substance)</to_name>
		<to_code>372816000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing carbonic anhydrase inhibitor (product)</to_name>
		<to_code>68402007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dorzolamide</to_name>
		<to_code>60207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dichlorphenamide</to_name>
		<to_code>3353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
		<from_code>N0000175517</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetazolamide</to_name>
		<to_code>167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
		<from_code>N0000182633</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing cytochrome P450 17A1 inhibitor (product)</to_name>
		<to_code>773477006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
		<from_code>N0000182633</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with cytochrome P450 17A1 inhibitor mechanism of action (substance)</to_name>
		<to_code>771360004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
		<from_code>N0000182633</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abiraterone</to_name>
		<to_code>1100072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitor [EPC]</to_name>
		<to_code>N0000182633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 17A1 Inhibitor [EPC]</to_name>
		<to_code>N0000182633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000193615</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action (substance)</to_name>
		<to_code>768675008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000193615</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing isocitrate dehydrogenase-2 inhibitor (product)</to_name>
		<to_code>768676009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000193615</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enasidenib</to_name>
		<to_code>1940332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000193615</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorasidenib</to_name>
		<to_code>2690647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inhibitor [EPC]</from_name>
		<from_code>N0000191001</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritonavir</to_name>
		<to_code>85762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytochrome P450 3A Inhibitor [EPC]</from_name>
		<from_code>N0000191001</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobicistat</to_name>
		<to_code>1306284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitor [EPC]</to_name>
		<to_code>N0000191001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytochrome P450 3A Inhibitor [EPC]</to_name>
		<to_code>N0000191001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175569</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metyrosine</to_name>
		<to_code>266604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hypotensive agent (substance)</from_name>
		<from_code>372586001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decarboxylase Inhibitor [EPC]</from_name>
		<from_code>N0000175845</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflornithine</to_name>
		<to_code>569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decarboxylase Inhibitor [EPC]</from_name>
		<from_code>N0000175845</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)</to_name>
		<to_code>418795002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitor [EPC]</to_name>
		<to_code>N0000175845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decarboxylase Inhibitor [EPC]</to_name>
		<to_code>N0000175845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000193930</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazemetostat</to_name>
		<to_code>2274378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000193930</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing methyltransferase inhibitor (product)</to_name>
		<to_code>429453000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000193930</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with methyltransferase inhibitor mechanism of action (substance)</to_name>
		<to_code>427911001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olaparib</to_name>
		<to_code>1597582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rucaparib</to_name>
		<to_code>1862579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>niraparib</to_name>
		<to_code>1918231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
		<from_code>N0000191623</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talazoparib</to_name>
		<to_code>2099704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</to_name>
		<to_code>N0000191623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175698</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allopurinol</to_name>
		<to_code>519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175698</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>febuxostat</to_name>
		<to_code>73689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175698</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with xanthine oxidase inhibitor mechanism of action (substance)</to_name>
		<to_code>419262004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
		<from_code>N0000175698</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing xanthine oxidase inhibitor (product)</to_name>
		<to_code>350062001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175918</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylthiouracil</to_name>
		<to_code>8794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175918</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methimazole</to_name>
		<to_code>6835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antithyroid agent (substance)</from_name>
		<from_code>418416001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000175918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000193303</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with tryptophan hydroxylase inhibitor mechanism of action (substance)</to_name>
		<to_code>733735003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000193303</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telotristat</to_name>
		<to_code>1872382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000193303</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing tryptophan hydroxylase inhibitor (product)</to_name>
		<to_code>770368002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanin Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depigmenting Activity [PE]</to_name>
		<to_code>N0000175851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanin Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000175854</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroquinone</to_name>
		<to_code>5509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Depigmenting Activity [PE]</from_name>
		<from_code>N0000175851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocyte Destruction [PE]</to_name>
		<to_code>N0000175852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobenzone</from_name>
		<from_code>17145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depigmenting Activity [PE]</to_name>
		<to_code>N0000175851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequinol</from_name>
		<from_code>15080</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depigmenting Activity [PE]</to_name>
		<to_code>N0000175851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinone</from_name>
		<from_code>5509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depigmenting Activity [PE]</to_name>
		<to_code>N0000175851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dermatologic Activity Alteration [PE]</from_name>
		<from_code>N0000009020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Depigmenting Activity [PE]</to_name>
		<to_code>N0000175851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renin Inhibitor [EPC]</from_name>
		<from_code>N0000175900</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aliskiren</to_name>
		<to_code>325646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renin Inhibitor [EPC]</from_name>
		<from_code>N0000175900</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing renin inhibitor (product)</to_name>
		<to_code>426230004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renin Inhibitor [EPC]</from_name>
		<from_code>N0000175900</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with renin inhibitor mechanism of action (substance)</to_name>
		<to_code>426228001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renin Inhibitor [EPC]</to_name>
		<to_code>N0000175900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxaborole Antifungal [EPC]</from_name>
		<from_code>N0000191279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Boron Compounds</to_name>
		<to_code>M0002832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxaborole Antifungal [EPC]</from_name>
		<from_code>N0000191279</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tavaborole</to_name>
		<to_code>1543173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxaborole Antifungal [EPC]</from_name>
		<from_code>N0000191279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxaborole Antifungal [EPC]</from_name>
		<from_code>N0000191279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxaborole Antifungal [EPC]</to_name>
		<to_code>N0000191279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antifungal mechanism of action (substance)</from_name>
		<from_code>373219008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxaborole Antifungal [EPC]</to_name>
		<to_code>N0000191279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tavaborole</from_name>
		<from_code>1543173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Boron Compounds</to_name>
		<to_code>M0002832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tavaborole</from_name>
		<from_code>1543173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoconazole</from_name>
		<from_code>27901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenbendazole</from_name>
		<from_code>4325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecylenate</from_name>
		<from_code>314881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thimerosal</from_name>
		<from_code>10472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoconazole nitrate</from_name>
		<from_code>203157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoconazole</from_name>
		<from_code>27901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tavaborole</from_name>
		<from_code>1543173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium undecylenate</from_name>
		<from_code>1744166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoconazole nitrate</from_name>
		<from_code>203157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludrocortisone</from_name>
		<from_code>4452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenbendazole</from_name>
		<from_code>4325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludrocortisone acetate</from_name>
		<from_code>165516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine</from_name>
		<from_code>31476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecylenic acid</from_name>
		<from_code>10989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc undecylenate</from_name>
		<from_code>89748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bifonazole</from_name>
		<from_code>19295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bifonazole</from_name>
		<from_code>19295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine</from_name>
		<from_code>31476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium undecylenate</from_name>
		<from_code>89746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoses</to_name>
		<to_code>M0014313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175836</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dutasteride</to_name>
		<to_code>228790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175836</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with 5-alpha reductase inhibitor mechanism of action (substance)</to_name>
		<to_code>406757009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175836</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing 5-alpha reductase inhibitor (product)</to_name>
		<to_code>770377009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175836</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>finasteride</to_name>
		<to_code>25025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatase Inhibitor [EPC]</from_name>
		<from_code>N0000175563</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing aromatase inhibitor (product)</to_name>
		<to_code>108775004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatase Inhibitor [EPC]</from_name>
		<from_code>N0000175563</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>exemestane</to_name>
		<to_code>258494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatase Inhibitor [EPC]</from_name>
		<from_code>N0000175563</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with aromatase inhibitor mechanism of action (substance)</to_name>
		<to_code>413575009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatase Inhibitor [EPC]</from_name>
		<from_code>N0000175563</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anastrozole</to_name>
		<to_code>84857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatase Inhibitor [EPC]</from_name>
		<from_code>N0000175563</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>letrozole</to_name>
		<to_code>72965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175956</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zileuton</to_name>
		<to_code>40575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175956</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with 5-lipoxygenase inhibitor mechanism of action (substance)</to_name>
		<to_code>108934000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175956</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing 5-lipoxygenase inhibitor (product)</to_name>
		<to_code>413358002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cortisol Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000193935</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>osilodrostat</to_name>
		<to_code>2286252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cortisol Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000193935</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levoketoconazole</to_name>
		<to_code>2588846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with steroid 11-beta-monooxygenase inhibitor mechanism of action (substance)</from_name>
		<from_code>863920002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cortisol Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000193935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cortisol Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000193935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
		<from_code>N0000175559</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing alpha-glucosidase inhibitor (product)</to_name>
		<to_code>109072000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
		<from_code>N0000175559</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miglitol</to_name>
		<to_code>30009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
		<from_code>N0000175559</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acarbose</to_name>
		<to_code>16681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
		<from_code>N0000175559</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with alpha-glucosidase inhibitor mechanism of action (substance)</to_name>
		<to_code>762432004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Glucosidase Inhibitor [EPC]</to_name>
		<to_code>N0000175559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oligonucleotide Telomerase Inhibitor [EPC]</from_name>
		<from_code>N0000194125</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imetelstat</to_name>
		<to_code>2685236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oligonucleotide Telomerase Inhibitor [EPC]</to_name>
		<to_code>N0000194125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oligonucleotide Telomerase Inhibitor [EPC]</to_name>
		<to_code>N0000194125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175809</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with 4-hydroxyphenylpyruvate dioxygenase inhibitor mechanism of action (substance)</to_name>
		<to_code>785815005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</from_name>
		<from_code>N0000175809</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitisinone</to_name>
		<to_code>61805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with oxidoreductase inhibitor mechanism of action (substance)</from_name>
		<from_code>784019007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</to_name>
		<to_code>N0000175809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000175757</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entacapone</to_name>
		<to_code>60307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000175757</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolcapone</to_name>
		<to_code>72937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000175757</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with catechol-O-methyltransferase inhibitor mechanism of action (substance)</to_name>
		<to_code>372646000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000175757</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing catechol-O-methyltransferase inhibitor (product)</to_name>
		<to_code>356845001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
		<from_code>N0000175757</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>opicapone</to_name>
		<to_code>2362167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</to_name>
		<to_code>N0000194080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193999</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>belzutifan</to_name>
		<to_code>2567226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000194080</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>daprodustat</to_name>
		<to_code>2628210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</from_name>
		<from_code>N0000194080</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vadadustat</to_name>
		<to_code>2679296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</to_name>
		<to_code>N0000194080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</to_name>
		<to_code>N0000194080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</from_name>
		<from_code>N0000193852</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>baloxavir</to_name>
		<to_code>2197842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</to_name>
		<to_code>N0000193852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celecoxib</to_name>
		<to_code>140587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meloxicam</to_name>
		<to_code>41493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Non-steroidal anti-inflammatory agent (substance)</to_name>
		<to_code>372665008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diflunisal</to_name>
		<to_code>3393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flurbiprofen</to_name>
		<to_code>4502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulindac</to_name>
		<to_code>10237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diclofenac</to_name>
		<to_code>3355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspirin</to_name>
		<to_code>1191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketoprofen</to_name>
		<to_code>6142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naproxen</to_name>
		<to_code>7258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indomethacin</to_name>
		<to_code>5781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piroxicam</to_name>
		<to_code>8356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nepafenac</to_name>
		<to_code>298665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fenoprofen</to_name>
		<to_code>4331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketorolac</to_name>
		<to_code>35827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibuprofen</to_name>
		<to_code>5640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenamic acid</to_name>
		<to_code>6693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nabumetone</to_name>
		<to_code>31448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bromfenac</to_name>
		<to_code>19737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxaprozin</to_name>
		<to_code>32613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etodolac</to_name>
		<to_code>24605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
		<from_code>N0000175722</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolmetin</to_name>
		<to_code>10636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonsteroidal Anti-inflammatory Drug [EPC]</to_name>
		<to_code>N0000175722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac</from_name>
		<from_code>19737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac sodium</from_name>
		<from_code>47364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nepafenac</from_name>
		<from_code>298665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Inflammatory Agents, Non-Steroidal</to_name>
		<to_code>M0001335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000182961</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apremilast</to_name>
		<to_code>1492727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000182961</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roflumilast</to_name>
		<to_code>1091836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000182961</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crisaborole</to_name>
		<to_code>1865953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
		<from_code>N0000182961</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ensifentrine</to_name>
		<to_code>2687215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing phosphodiesterase inhibitor (product)</from_name>
		<from_code>346625000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitor [EPC]</to_name>
		<to_code>N0000182961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with phosphodiesterase inhibitor mechanism of action (substance)</from_name>
		<from_code>373692009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphodiesterase 4 Inhibitor [EPC]</to_name>
		<to_code>N0000182961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</from_name>
		<from_code>N0000193913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bempedoic acid</to_name>
		<to_code>2282403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</to_name>
		<to_code>N0000193913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</to_name>
		<to_code>N0000193913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aldehyde Dehydrogenase Inhibitor [EPC]</from_name>
		<from_code>N0000175679</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>disulfiram</to_name>
		<to_code>3554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldehyde Dehydrogenase Inhibitor [EPC]</to_name>
		<to_code>N0000175679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldehyde Dehydrogenase Inhibitor [EPC]</to_name>
		<to_code>N0000175679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
		<from_code>N0000175591</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing lipase inhibitor (product)</to_name>
		<to_code>116092004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
		<from_code>N0000175591</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with lipase inhibitor mechanism of action (substance)</to_name>
		<to_code>372581006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
		<from_code>N0000175591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orlistat</to_name>
		<to_code>37925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
		<from_code>N0000193987</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing isocitrate dehydrogenase-1 inhibitor (product)</to_name>
		<to_code>773258006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
		<from_code>N0000193987</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivosidenib</to_name>
		<to_code>2049873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
		<from_code>N0000193987</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with isocitrate dehydrogenase-1 inhibitor mechanism of action (substance)</to_name>
		<to_code>773233001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
		<from_code>N0000193987</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorasidenib</to_name>
		<to_code>2690647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nuclear Export Inhibitor [EPC]</from_name>
		<from_code>N0000194021</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selinexor</to_name>
		<to_code>2178390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitor [EPC]</to_name>
		<to_code>N0000194021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitor [EPC]</to_name>
		<to_code>N0000194021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nuclear Export Inhibitor [EPC]</to_name>
		<to_code>N0000194021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tucatinib</to_name>
		<to_code>2361285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirdametinib</to_name>
		<to_code>2705551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>neratinib</to_name>
		<to_code>1940643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tivozanib</to_name>
		<to_code>2534233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorafenib</to_name>
		<to_code>495881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lenvatinib</to_name>
		<to_code>1603296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruxolitinib</to_name>
		<to_code>1193326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Janus Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000190858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing protein kinase inhibitor (product)</to_name>
		<to_code>427510007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avutometinib</to_name>
		<to_code>2714515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vandetanib</to_name>
		<to_code>1098413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with protein kinase inhibitor mechanism of action (substance)</to_name>
		<to_code>426265004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bosutinib</to_name>
		<to_code>1307619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quizartinib</to_name>
		<to_code>2643048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lazertinib</to_name>
		<to_code>2691150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avapritinib</to_name>
		<to_code>2272107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capmatinib</to_name>
		<to_code>2362165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pacritinib</to_name>
		<to_code>2595243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dabrafenib</to_name>
		<to_code>1424911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceritinib</to_name>
		<to_code>1535457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirtobrutinib</to_name>
		<to_code>2629338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dasatinib anhydrous</to_name>
		<to_code>1546019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erlotinib</to_name>
		<to_code>337525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zanubrutinib</to_name>
		<to_code>2262435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brigatinib</to_name>
		<to_code>1921217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>larotrectinib</to_name>
		<to_code>2105628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vimseltinib</to_name>
		<to_code>2705378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabozantinib</to_name>
		<to_code>1363268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idelalisib</to_name>
		<to_code>1544460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
		<to_code>N0000175625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midostaurin</to_name>
		<to_code>1919083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilzabrutinib</to_name>
		<to_code>2722398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lorlatinib</to_name>
		<to_code>2103164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunitinib</to_name>
		<to_code>357977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alectinib</to_name>
		<to_code>1727455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lapatinib</to_name>
		<to_code>480167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axitinib</to_name>
		<to_code>1242999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trametinib</to_name>
		<to_code>1425099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acalabrutinib</to_name>
		<to_code>1986808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crizotinib</to_name>
		<to_code>1148495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nintedanib</to_name>
		<to_code>1592737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>osimertinib</to_name>
		<to_code>1721560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erdafitinib</to_name>
		<to_code>2123125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selumetinib</to_name>
		<to_code>2289380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>leniolisib</to_name>
		<to_code>2633005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sirolimus</to_name>
		<to_code>35302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remibrutinib</to_name>
		<to_code>2724365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemigatinib</to_name>
		<to_code>2359268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taletrectinib</to_name>
		<to_code>2716919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zongertinib</to_name>
		<to_code>2721604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abemaciclib</to_name>
		<to_code>1946825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilaciclib</to_name>
		<to_code>2479690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palbociclib</to_name>
		<to_code>1601374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>futibatinib</to_name>
		<to_code>2628190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gefitinib</to_name>
		<to_code>328134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vemurafenib</to_name>
		<to_code>1147220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribociclib</to_name>
		<to_code>1873916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temsirolimus</to_name>
		<to_code>657797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inavolisib</to_name>
		<to_code>2695422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ripretinib</to_name>
		<to_code>2369389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tepotinib</to_name>
		<to_code>2477103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regorafenib</to_name>
		<to_code>1312397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imatinib</to_name>
		<to_code>282388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selpercatinib</to_name>
		<to_code>2370147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
		<to_code>N0000191009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/neu Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ponatinib</to_name>
		<to_code>1364347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afatinib</to_name>
		<to_code>1430438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tovorafenib</to_name>
		<to_code>2682434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nilotinib</to_name>
		<to_code>662281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralsetinib</to_name>
		<to_code>2394936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pazopanib</to_name>
		<to_code>714438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pexidartinib</to_name>
		<to_code>2183102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>repotrectinib</to_name>
		<to_code>2670644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibrutinib</to_name>
		<to_code>1442981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>everolimus</to_name>
		<to_code>141704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000175605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobimetinib</to_name>
		<to_code>1722365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>upadacitinib</to_name>
		<to_code>2196092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deuruxolitinib</to_name>
		<to_code>2716558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with Janus kinase inhibitor mechanism of action (substance)</to_name>
		<to_code>704312008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tofacitinib</to_name>
		<to_code>1357536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abrocitinib</to_name>
		<to_code>2591476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing Janus kinase inhibitor (product)</to_name>
		<to_code>704315005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruxolitinib</to_name>
		<to_code>1193326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>delgocitinib</to_name>
		<to_code>2721163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitor [EPC]</to_name>
		<to_code>N0000194043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Janus Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000190858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>baricitinib</to_name>
		<to_code>2047232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tyrosine Kinase 2 Inhibitor [EPC]</from_name>
		<from_code>N0000194043</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deucravacitinib</to_name>
		<to_code>2612087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing Janus kinase inhibitor (product)</from_name>
		<from_code>704315005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitor [EPC]</to_name>
		<to_code>N0000194043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with Janus kinase inhibitor mechanism of action (substance)</from_name>
		<from_code>704312008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tyrosine Kinase 2 Inhibitor [EPC]</to_name>
		<to_code>N0000194043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rho Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000193788</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with Rho-associated protein kinase inhibitor mechanism of action (substance)</to_name>
		<to_code>781256007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Rho Kinase Inhibitor [EPC]</from_name>
		<from_code>N0000193788</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>netarsudil</to_name>
		<to_code>1992864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing protein kinase inhibitor (product)</from_name>
		<from_code>427510007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Rho Kinase Inhibitor [EPC]</to_name>
		<to_code>N0000193788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175664</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with epidermal growth factor receptor inhibitor mechanism of action (substance)</to_name>
		<to_code>409402009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175664</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panitumumab</to_name>
		<to_code>263034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175664</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>necitumumab</to_name>
		<to_code>1723738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175664</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetuximab</to_name>
		<to_code>318341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with protein kinase inhibitor mechanism of action (substance)</from_name>
		<from_code>426265004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing protein kinase inhibitor (product)</from_name>
		<from_code>427510007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175625</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>everolimus</to_name>
		<to_code>141704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
		<from_code>N0000175625</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sirolimus</to_name>
		<to_code>35302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing protein kinase inhibitor (product)</from_name>
		<from_code>427510007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
		<to_code>N0000175625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunosuppressant (substance)</from_name>
		<from_code>372823004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
		<to_code>N0000175625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
		<to_code>N0000175625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</from_name>
		<from_code>N0000191009</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramucirumab</to_name>
		<to_code>1535922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with angiogenesis inhibitor mechanism of action (substance)</from_name>
		<from_code>409408008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
		<to_code>N0000191009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing angiogenesis inhibitor (product)</from_name>
		<from_code>409407003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
		<to_code>N0000191009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)</from_name>
		<from_code>786910006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
		<to_code>N0000191009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175661</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pertuzumab</to_name>
		<to_code>1298944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175661</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)</to_name>
		<to_code>784176007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175661</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab</to_name>
		<to_code>224905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175661</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>margetuximab</to_name>
		<to_code>2473851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HER2/neu Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gamma Secretase Inhibitor [EPC]</from_name>
		<from_code>N0000194115</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nirogacestat</to_name>
		<to_code>2670631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitor [EPC]</to_name>
		<to_code>N0000194115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitor [EPC]</to_name>
		<to_code>N0000194115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gamma Secretase Inhibitor [EPC]</to_name>
		<to_code>N0000194115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</from_name>
		<from_code>N0000175754</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)</to_name>
		<to_code>418795002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</from_name>
		<from_code>N0000175754</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbidopa</to_name>
		<to_code>2019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</to_name>
		<to_code>N0000175754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</to_name>
		<to_code>N0000175754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fluvastatin</to_name>
		<to_code>41127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosuvastatin</to_name>
		<to_code>301542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (product)</to_name>
		<to_code>96302009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pravastatin</to_name>
		<to_code>42463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simvastatin</to_name>
		<to_code>36567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor mechanism of action (substance)</to_name>
		<to_code>372912004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitavastatin</to_name>
		<to_code>861634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lovastatin</to_name>
		<to_code>6472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
		<from_code>N0000175589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atorvastatin</to_name>
		<to_code>83367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>HMG-CoA Reductase Inhibitor [EPC]</to_name>
		<to_code>N0000175589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiac Myosin Inhibitor [EPC]</from_name>
		<from_code>N0000194047</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mavacamten</to_name>
		<to_code>2600867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme inhibitor (product)</from_name>
		<from_code>407314008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
		<to_code>N0000194047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
		<to_code>N0000194047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cardiovascular agent (substance)</from_name>
		<from_code>373247007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
		<to_code>N0000194047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
		<from_code>407312007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
		<to_code>N0000194047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selectin Blocker [EPC]</from_name>
		<from_code>N0000194032</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crizanlizumab</to_name>
		<to_code>2262279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing selective adhesion molecule inhibitor (product)</from_name>
		<from_code>415513007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selectin Blocker [EPC]</to_name>
		<to_code>N0000194032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylxanthine [EPC]</from_name>
		<from_code>N0000175790</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Methylated xanthine derivative (substance)</to_name>
		<to_code>259553003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylxanthine [EPC]</from_name>
		<from_code>N0000175790</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caffeine</to_name>
		<to_code>1886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylxanthine [EPC]</from_name>
		<from_code>N0000175790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Xanthines</to_name>
		<to_code>M0023046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylxanthine [EPC]</from_name>
		<from_code>N0000175790</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theophylline anhydrous</to_name>
		<to_code>91178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylxanthine [EPC]</from_name>
		<from_code>N0000175790</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing methylated xanthine derivative (product)</to_name>
		<to_code>765419002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylxanthine [EPC]</to_name>
		<to_code>N0000175790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine</from_name>
		<from_code>1886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Xanthines</to_name>
		<to_code>M0023046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentoxifylline</from_name>
		<from_code>8013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Xanthines</to_name>
		<to_code>M0023046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine citrate</from_name>
		<from_code>20033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Xanthines</to_name>
		<to_code>M0023046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Xanthines</to_name>
		<to_code>M0023046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Stabilizer [EPC]</from_name>
		<from_code>N0000194077</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miglustat</to_name>
		<to_code>402316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activator [APC]</from_name>
		<from_code>N0000193896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activator [EPC]</to_name>
		<to_code>N0000190483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activator [APC]</from_name>
		<from_code>N0000193896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</to_name>
		<to_code>N0000184144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activator [APC]</from_name>
		<from_code>N0000193896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
		<to_code>N0000190485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activator [APC]</from_name>
		<from_code>N0000193896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Activator [EPC]</to_name>
		<to_code>N0000194170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activator [APC]</from_name>
		<from_code>N0000193896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
		<to_code>N0000185500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme Activator [APC]</from_name>
		<from_code>N0000193896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyruvate Kinase Activator [EPC]</to_name>
		<to_code>N0000194008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenylalanine Hydroxylase Activator [EPC]</from_name>
		<from_code>N0000190483</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sapropterin</to_name>
		<to_code>753340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenylalanine Hydroxylase Activator [EPC]</from_name>
		<from_code>N0000190483</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Phenylalanine 4-monooxygenase (substance)</to_name>
		<to_code>9923001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with hydrolase mechanism of action (substance)</from_name>
		<from_code>74628008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Hydroxylase Activator [EPC]</to_name>
		<to_code>N0000190483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</from_name>
		<from_code>N0000184144</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carglumic acid</to_name>
		<to_code>401713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme activator mechanism of action (substance)</from_name>
		<from_code>771366005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</to_name>
		<to_code>N0000184144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Soluble Guanylate Cyclase Stimulator [EPC]</from_name>
		<from_code>N0000190485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riociguat</to_name>
		<to_code>1439816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Soluble Guanylate Cyclase Stimulator [EPC]</from_name>
		<from_code>N0000190485</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vericiguat</to_name>
		<to_code>2475830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Medicinal product acting as vasodilator (product)</from_name>
		<from_code>58944007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
		<to_code>N0000190485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vasodilator (substance)</from_name>
		<from_code>372787008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
		<to_code>N0000190485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
		<to_code>N0000190485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme activator mechanism of action (substance)</from_name>
		<from_code>771366005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Protease Activator [EPC]</to_name>
		<to_code>N0000194170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Guanylate Cyclase-C Agonist [EPC]</from_name>
		<from_code>N0000185500</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>linaclotide</to_name>
		<to_code>1307404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Guanylate Cyclase-C Agonist [EPC]</from_name>
		<from_code>N0000185500</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plecanatide</to_name>
		<to_code>1873752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
		<to_code>N0000185500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme (product)</from_name>
		<from_code>11402001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
		<to_code>N0000185500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme activator mechanism of action (substance)</from_name>
		<from_code>771366005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
		<to_code>N0000185500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyruvate Kinase Activator [EPC]</from_name>
		<from_code>N0000194008</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Pyruvate kinase (substance)</to_name>
		<to_code>71975005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyruvate Kinase Activator [EPC]</from_name>
		<from_code>N0000194008</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitapivat</to_name>
		<to_code>2594468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunotherapy [APC]</from_name>
		<from_code>N0000194070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Processed Thymus Tissue-based Immunotherapy [EPC]</to_name>
		<to_code>N0000194076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunotherapy [APC]</from_name>
		<from_code>N0000194070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</to_name>
		<to_code>N0000183906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunotherapy [APC]</from_name>
		<from_code>N0000194070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Cellular Immunotherapy [EPC]</to_name>
		<to_code>N0000184997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Antigen of live attenuated Mycobacterium bovis (substance)</to_name>
		<to_code>718280005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>BCG Vaccine</to_name>
		<to_code>M0002239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing antigen of live attenuated Mycobacterium bovis (medicinal product)</to_name>
		<to_code>418268006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>BCG, live, Tice strain</to_name>
		<to_code>221050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
		<from_code>N0000183906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Macrophage Proliferation [PE]</to_name>
		<to_code>N0000183884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</to_name>
		<to_code>N0000183906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Monocyte Activation [PE]</from_name>
		<from_code>N0000183883</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Macrophage Proliferation [PE]</to_name>
		<to_code>N0000183884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Macrophage Proliferation [PE]</to_name>
		<to_code>N0000183884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
		<from_code>N0000184997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor-derived Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
		<from_code>N0000184997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genetically-modified Autologous T Cells [EPC]</to_name>
		<to_code>N0000193549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
		<from_code>N0000184997</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sipuleucel-T</to_name>
		<to_code>997261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
		<from_code>N0000184997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Autologous [EXT]</to_name>
		<to_code>N0000184310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immune enhancement agent (substance)</from_name>
		<from_code>372861001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Cellular Immunotherapy [EPC]</to_name>
		<to_code>N0000184997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Cellular Immunotherapy [EPC]</to_name>
		<to_code>N0000184997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axicabtagene ciloleucel</to_name>
		<to_code>1987398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisagenlecleucel</to_name>
		<to_code>1986438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing genetically modified T-cell (product)</to_name>
		<to_code>764087006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
		<from_code>N0000193549</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Genetically modified T-cell (substance)</to_name>
		<to_code>764084004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genetically-modified Autologous T Cells [EPC]</to_name>
		<to_code>N0000193549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Genetically modified T-cell (substance)</from_name>
		<from_code>764084004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing genetically modified T-cell (product)</from_name>
		<from_code>764087006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing genetically modified T-cell (product)</from_name>
		<from_code>764087006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Genetically modified T-cell (substance)</from_name>
		<from_code>764084004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cells, Cultured, Autologous, Genetically-modified [EXT]</from_name>
		<from_code>N0000193547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axicabtagene ciloleucel</from_name>
		<from_code>1987398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisagenlecleucel</from_name>
		<from_code>1986438</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Genetically modified T-cell (substance)</from_name>
		<from_code>764084004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing genetically modified T-cell (product)</from_name>
		<from_code>764087006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
		<to_code>N0000194068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cells, Cultured, Autologous [EXT]</from_name>
		<from_code>N0000184310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Cultured Cell [EPC]</from_name>
		<from_code>N0000184317</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Autologous [EXT]</to_name>
		<to_code>N0000184310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sipuleucel-T</from_name>
		<from_code>997261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Autologous [EXT]</to_name>
		<to_code>N0000184310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Autologous [EXT]</to_name>
		<to_code>N0000184310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Autologous, Genetically-modified [EXT]</to_name>
		<to_code>N0000193547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid Emulsion [EPC]</from_name>
		<from_code>N0000191261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipids</to_name>
		<to_code>M0012553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid Emulsion [EPC]</from_name>
		<from_code>N0000191261</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Fat emulsion (substance)</to_name>
		<to_code>47413004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid Emulsion [EPC]</from_name>
		<from_code>N0000191261</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Intravenous nutrition - fats (product)</to_name>
		<to_code>346535003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid Emulsion [EPC]</from_name>
		<from_code>N0000191261</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olive oil</to_name>
		<to_code>1309250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lipid Emulsion [EPC]</from_name>
		<from_code>N0000191261</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean oil</to_name>
		<to_code>9949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olive oil</from_name>
		<from_code>1309250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipids</to_name>
		<to_code>M0012553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lipids</to_name>
		<to_code>M0012553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</to_name>
		<to_code>N0000183904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Rubella Virus Vaccine [EPC]</to_name>
		<to_code>N0000183909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Rotavirus Vaccine [EPC]</to_name>
		<to_code>N0000183908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</to_name>
		<to_code>N0000183894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Poliovirus Vaccine [EPC]</to_name>
		<to_code>N0000183898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Pneumococcal Vaccine [EPC]</to_name>
		<to_code>N0000183897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</to_name>
		<to_code>N0000194157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Rabies Virus Vaccine [EPC]</to_name>
		<to_code>N0000183899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</to_name>
		<to_code>N0000183912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</to_name>
		<to_code>N0000183903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</to_name>
		<to_code>N0000183887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Influenza B Virus Vaccine [EPC]</to_name>
		<to_code>N0000183893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Human Adenovirus Type 4 Vaccine [EPC]</to_name>
		<to_code>N0000183913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tick-Borne Encephalitis Vaccine [EPC]</to_name>
		<to_code>N0000194159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Hepatitis A Virus Vaccine [EPC]</to_name>
		<to_code>N0000183889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Vaccinia Virus Vaccine [EPC]</to_name>
		<to_code>N0000183917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Rotavirus Vaccine [EPC]</to_name>
		<to_code>N0000183916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Meningococcal Vaccine [EPC]</to_name>
		<to_code>N0000183895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Salmonella Typhi Vaccine [EPC]</to_name>
		<to_code>N0000183901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>COVID-19 mRNA Vaccine [EPC]</to_name>
		<to_code>N0000194097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</to_name>
		<to_code>N0000183905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</to_name>
		<to_code>N0000194168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Bordetella Pertussis Vaccine [EPC]</to_name>
		<to_code>N0000183896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</to_name>
		<to_code>N0000183910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Hepatitis B Virus Vaccine [EPC]</to_name>
		<to_code>N0000183890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Human Papillomavirus Vaccine [EPC]</to_name>
		<to_code>N0000183891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</to_name>
		<to_code>N0000183888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Influenza A Virus Vaccine [EPC]</to_name>
		<to_code>N0000183892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Measles Virus Vaccine [EPC]</to_name>
		<to_code>N0000183907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</to_name>
		<to_code>N0000183911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Clostridium Tetani Vaccine [EPC]</to_name>
		<to_code>N0000183900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Human Adenovirus Type 7 Vaccine [EPC]</to_name>
		<to_code>N0000183914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vaccine [APC]</from_name>
		<from_code>N0000193912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Mumps Virus Vaccine [EPC]</to_name>
		<to_code>N0000183918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
		<from_code>N0000183904</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Mycobacterium bovis antigen (medicinal product)</to_name>
		<to_code>1861000221106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
		<from_code>N0000183904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>BCG Vaccine</to_name>
		<to_code>M0002239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
		<from_code>N0000183904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
		<from_code>N0000183904</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>BCG, live, Tice strain</to_name>
		<to_code>221050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>BCG Vaccine</to_name>
		<to_code>M0002239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
		<from_code>N0000183909</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubella virus vaccine live (Wistar RA 27-3 strain)</to_name>
		<to_code>762817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
		<from_code>N0000183909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
		<from_code>N0000183909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rubella Vaccine</to_name>
		<to_code>M0019294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Rubella virus antigen (medicinal product)</from_name>
		<from_code>836388000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Rubella Virus Vaccine [EPC]</to_name>
		<to_code>N0000183909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rubella Vaccine</to_name>
		<to_code>M0019294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rubella Vaccine</to_name>
		<to_code>M0019294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183908</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)</to_name>
		<to_code>1081000221109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183908</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</to_name>
		<to_code>805573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
		<from_code>N0000183894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Japanese Encephalitis Vaccines</to_name>
		<to_code>M0357284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
		<from_code>N0000183894</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</to_name>
		<to_code>1300779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
		<from_code>N0000183894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Japanese encephalitis virus antigen (medicinal product)</from_name>
		<from_code>836378001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</to_name>
		<to_code>N0000183894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</from_name>
		<from_code>1300779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Japanese Encephalitis Vaccines</to_name>
		<to_code>M0357284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
		<from_code>N0000183898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poliovirus Vaccines</to_name>
		<to_code>M0361653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
		<from_code>N0000183898</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus vaccine inactivated, type 1 (Mahoney)</to_name>
		<to_code>763096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
		<from_code>N0000183898</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus vaccine inactivated, type 2 (MEF-1)</to_name>
		<to_code>763098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
		<from_code>N0000183898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
		<from_code>N0000183898</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus vaccine inactivated, type 3 (Saukett)</to_name>
		<to_code>763100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Human poliovirus antigen (medicinal product)</from_name>
		<from_code>1031000221108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Poliovirus Vaccine [EPC]</to_name>
		<to_code>N0000183898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 3 (Saukett)</from_name>
		<from_code>763100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poliovirus Vaccines</to_name>
		<to_code>M0361653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 1 (Mahoney)</from_name>
		<from_code>763096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poliovirus Vaccines</to_name>
		<to_code>M0361653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 2 (MEF-1)</from_name>
		<from_code>763098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poliovirus Vaccines</to_name>
		<to_code>M0361653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</to_name>
		<to_code>854974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</to_name>
		<to_code>854964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</to_name>
		<to_code>854958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</to_name>
		<to_code>854956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</to_name>
		<to_code>854948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</to_name>
		<to_code>854944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</to_name>
		<to_code>854938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</to_name>
		<to_code>854940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</to_name>
		<to_code>854952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</to_name>
		<to_code>854972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</to_name>
		<to_code>854932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</to_name>
		<to_code>854966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</to_name>
		<to_code>854950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</to_name>
		<to_code>854936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</to_name>
		<to_code>854942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</to_name>
		<to_code>854970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</to_name>
		<to_code>854960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</to_name>
		<to_code>854954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</to_name>
		<to_code>854962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</to_name>
		<to_code>854930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</to_name>
		<to_code>854934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</to_name>
		<to_code>854968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
		<from_code>N0000183897</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</to_name>
		<to_code>854946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Streptococcus pneumoniae antigen (medicinal product)</from_name>
		<from_code>836398006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Pneumococcal Vaccine [EPC]</to_name>
		<to_code>N0000183897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</from_name>
		<from_code>N0000194157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus mRNA [EXT]</to_name>
		<to_code>N0000194158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing virus antigen (medicinal product)</from_name>
		<from_code>836369007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</to_name>
		<to_code>N0000194157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Syncytial Virus mRNA [EXT]</to_name>
		<to_code>N0000194158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
		<from_code>N0000183899</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</to_name>
		<to_code>830464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
		<from_code>N0000183899</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabies virus vaccine flury-lep strain</to_name>
		<to_code>830457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
		<from_code>N0000183899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies Vaccines</to_name>
		<to_code>M0018367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
		<from_code>N0000183899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Rabies lyssavirus antigen (medicinal product)</from_name>
		<from_code>836393002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Rabies Virus Vaccine [EPC]</to_name>
		<to_code>N0000183899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies Vaccines</to_name>
		<to_code>M0018367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies Vaccines</to_name>
		<to_code>M0018367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
		<from_code>N0000183912</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product)</to_name>
		<to_code>1121000221106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
		<from_code>N0000183912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Yellow Fever Vaccine</to_name>
		<to_code>M0357360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
		<from_code>N0000183912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
		<from_code>N0000183912</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>yellow fever virus strain 17D-204 live antigen</to_name>
		<to_code>804187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Yellow Fever Vaccine</to_name>
		<to_code>M0357360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Yellow Fever Vaccine</to_name>
		<to_code>M0357360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
		<from_code>N0000183903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
		<from_code>N0000183903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthrax Vaccines</to_name>
		<to_code>M0356664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
		<from_code>N0000183903</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bacillus anthracis strain V770-NP1-R antigens</to_name>
		<to_code>1368371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Bacillus anthracis antigen (medicinal product)</from_name>
		<from_code>836384003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</to_name>
		<to_code>N0000183903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bacillus anthracis strain V770-NP1-R antigens</from_name>
		<from_code>1368371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anthrax Vaccines</to_name>
		<to_code>M0356664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
		<from_code>N0000183887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria Toxoid</to_name>
		<to_code>M0006523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
		<from_code>N0000183887</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diphtheria toxoid vaccine, inactivated</to_name>
		<to_code>798304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
		<from_code>N0000183887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Corynebacterium diphtheriae antigen (medicinal product)</from_name>
		<from_code>836381006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</to_name>
		<to_code>N0000183887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria Toxoid</to_name>
		<to_code>M0006523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria Toxoid</to_name>
		<to_code>M0006523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria Toxoid</to_name>
		<to_code>M0006523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza Vaccines</to_name>
		<to_code>M0011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing influenza virus antigen (medicinal product)</from_name>
		<from_code>836377006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Influenza B Virus Vaccine [EPC]</to_name>
		<to_code>N0000183893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
		<from_code>N0000183913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
		<from_code>N0000183913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human adenovirus E serotype 4 strain CL-68578</to_name>
		<to_code>1299785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
		<from_code>N0000183913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adenovirus Vaccines</to_name>
		<to_code>M0569028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Adenovirus antigen (medicinal product)</from_name>
		<from_code>836400005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Human Adenovirus Type 4 Vaccine [EPC]</to_name>
		<to_code>N0000183913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
		<from_code>N0000194159</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
		<from_code>N0000194159</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing Tick-borne encephalitis virus antigen (medicinal product)</to_name>
		<to_code>836403007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
		<from_code>N0000194159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vaccines, Tick-Borne Encephalitis [EXT]</to_name>
		<to_code>N0000194162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vaccines, Tick-Borne Encephalitis [EXT]</to_name>
		<to_code>N0000194162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis A Vaccines</to_name>
		<to_code>M0357587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis A vaccine (inactivated) strain HM175</to_name>
		<to_code>798361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183889</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis A virus strain CR 326F antigen, inactivated</to_name>
		<to_code>2274413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Hepatitis A virus antigen (medicinal product)</from_name>
		<from_code>836375003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Hepatitis A Virus Vaccine [EPC]</to_name>
		<to_code>N0000183889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus strain CR 326F antigen, inactivated</from_name>
		<from_code>2274413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis A Vaccines</to_name>
		<to_code>M0357587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A vaccine (inactivated) strain HM175</from_name>
		<from_code>798361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis A Vaccines</to_name>
		<to_code>M0357587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hepatitis A Vaccine, Inactivated</from_name>
		<from_code>253174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis A Vaccines</to_name>
		<to_code>M0357587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
		<from_code>N0000183917</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vaccinia virus strain New York City Board of Health live antigen</to_name>
		<to_code>1492300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
		<from_code>N0000183917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox Vaccine</to_name>
		<to_code>M0019978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
		<from_code>N0000183917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Vaccinia virus antigen (medicinal product)</from_name>
		<from_code>836389008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Vaccinia Virus Vaccine [EPC]</to_name>
		<to_code>N0000183917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox Vaccine</to_name>
		<to_code>M0019978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaccinia virus strain New York City Board of Health live antigen</from_name>
		<from_code>1492300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox Vaccine</to_name>
		<to_code>M0019978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G3 vaccine</to_name>
		<to_code>798290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</to_name>
		<to_code>798294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G2 vaccine</to_name>
		<to_code>798288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G4 vaccine</to_name>
		<to_code>798292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Rotavirus Vaccine [EPC]</from_name>
		<from_code>N0000183916</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G1 vaccine</to_name>
		<to_code>798286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Rotavirus antigen (medicinal product)</from_name>
		<from_code>836387005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Rotavirus Vaccine [EPC]</to_name>
		<to_code>N0000183916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotavirus Vaccines</to_name>
		<to_code>M0357125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>29501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>M0127318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</to_name>
		<to_code>797633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</to_name>
		<to_code>797629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</to_name>
		<to_code>797631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
		<from_code>N0000183895</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</to_name>
		<to_code>797635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Neisseria meningitidis antigen (medicinal product)</from_name>
		<from_code>836401009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Meningococcal Vaccine [EPC]</to_name>
		<to_code>N0000183895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group Y</from_name>
		<from_code>314725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group W-135</from_name>
		<from_code>314724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group C polysaccharide</from_name>
		<from_code>29503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningococcal Vaccines</to_name>
		<to_code>M0357647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>M0127318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group C polysaccharide</from_name>
		<from_code>29503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>M0127318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group Y</from_name>
		<from_code>314725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>M0127318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>M0127318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group W-135</from_name>
		<from_code>314724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>M0127318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183901</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</to_name>
		<to_code>807219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vi polysaccharide vaccine, typhoid</to_name>
		<to_code>M0161214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Typhoid</to_name>
		<to_code>M0022188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)</from_name>
		<from_code>836390004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Salmonella Typhi Vaccine [EPC]</to_name>
		<to_code>N0000183901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vi polysaccharide vaccine, typhoid</to_name>
		<to_code>M0161214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vi polysaccharide vaccine, typhoid</to_name>
		<to_code>M0161214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>COVID-19 mRNA Vaccine [EPC]</from_name>
		<from_code>N0000194097</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SARS-CoV-2 mRNA [EXT]</to_name>
		<to_code>N0000194098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>COVID-19 mRNA Vaccine [EPC]</from_name>
		<from_code>N0000194097</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)</to_name>
		<to_code>1119349007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>SARS-CoV-2 mRNA [EXT]</to_name>
		<to_code>N0000194098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183905</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella-zoster virus vaccine live (Oka-Merck) strain</to_name>
		<to_code>1292422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183905</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Varicella Virus Vaccine Live (Oka-Merck) strain</to_name>
		<to_code>805486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183905</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)</to_name>
		<to_code>2221000221107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster Vaccine</to_name>
		<to_code>M0491099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster Vaccine</to_name>
		<to_code>M0491099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster Vaccine</to_name>
		<to_code>M0491099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</from_name>
		<from_code>N0000194168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Conjugate</to_name>
		<to_code>M0027265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</from_name>
		<from_code>N0000194168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antigen of Streptococcus pneumoniae capsular polysaccharide conjugated (substance)</from_name>
		<from_code>714078004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</to_name>
		<to_code>N0000194168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)</from_name>
		<from_code>981000221107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</to_name>
		<to_code>N0000194168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Conjugate</to_name>
		<to_code>M0027265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</from_name>
		<from_code>854942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</from_name>
		<from_code>854936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</from_name>
		<from_code>854970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</from_name>
		<from_code>854950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</from_name>
		<from_code>854960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</from_name>
		<from_code>854954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</from_name>
		<from_code>854962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</from_name>
		<from_code>854930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</from_name>
		<from_code>854968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</from_name>
		<from_code>854946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</from_name>
		<from_code>854934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</from_name>
		<from_code>854964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</from_name>
		<from_code>854974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</from_name>
		<from_code>854956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</from_name>
		<from_code>854948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</from_name>
		<from_code>854958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</from_name>
		<from_code>854938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</from_name>
		<from_code>854944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</from_name>
		<from_code>854940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</from_name>
		<from_code>854952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</from_name>
		<from_code>854932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</from_name>
		<from_code>854966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</from_name>
		<from_code>854972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumococcal Vaccines</to_name>
		<to_code>M0357124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertussis Vaccine</to_name>
		<to_code>M0016424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bordetella pertussis pertactin vaccine, inactivated</to_name>
		<to_code>1300184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated</to_name>
		<to_code>1300182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated</to_name>
		<to_code>1300180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
		<from_code>N0000183896</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Bordetella pertussis toxoid vaccine, inactivated</to_name>
		<to_code>1300186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Bordetella pertussis antigen (medicinal product)</from_name>
		<from_code>601000221108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Bordetella Pertussis Vaccine [EPC]</to_name>
		<to_code>N0000183896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis toxoid vaccine, inactivated</from_name>
		<from_code>1300186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertussis Vaccine</to_name>
		<to_code>M0016424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertussis Vaccine</to_name>
		<to_code>M0016424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis pertactin vaccine, inactivated</from_name>
		<from_code>1300184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertussis Vaccine</to_name>
		<to_code>M0016424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated</from_name>
		<from_code>1300180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertussis Vaccine</to_name>
		<to_code>M0016424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated</from_name>
		<from_code>1300182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertussis Vaccine</to_name>
		<to_code>M0016424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183910</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salmonella typhi Ty21a live antigen</to_name>
		<to_code>762595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Typhoid</to_name>
		<to_code>M0022188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
		<from_code>N0000183910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)</from_name>
		<from_code>836390004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</to_name>
		<to_code>N0000183910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Typhoid</to_name>
		<to_code>M0022188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Typhoid</to_name>
		<to_code>M0022188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B Vaccines</to_name>
		<to_code>M0026310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183890</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</to_name>
		<to_code>1427171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183890</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B surface antigen vaccine</to_name>
		<to_code>797752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
		<from_code>N0000183890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Hepatitis B virus antigen (medicinal product)</from_name>
		<from_code>836374004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Hepatitis B Virus Vaccine [EPC]</to_name>
		<to_code>N0000183890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B Vaccines</to_name>
		<to_code>M0026310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</from_name>
		<from_code>1427171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B Vaccines</to_name>
		<to_code>M0026310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>L1 protein, human papillomavirus type 18 vaccine</to_name>
		<to_code>798266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>L1 protein, human papillomavirus type 11 vaccine</to_name>
		<to_code>798262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>L1 protein, human papillomavirus type 6 vaccine</to_name>
		<to_code>798268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papillomavirus Vaccines</to_name>
		<to_code>M0498157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
		<from_code>N0000183891</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>L1 protein, human papillomavirus type 16 vaccine</to_name>
		<to_code>798264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing human papillomavirus antigen (medicinal product)</from_name>
		<from_code>836379009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Human Papillomavirus Vaccine [EPC]</to_name>
		<to_code>N0000183891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papillomavirus Vaccines</to_name>
		<to_code>M0498157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papillomavirus Vaccines</to_name>
		<to_code>M0498157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papillomavirus Vaccines</to_name>
		<to_code>M0498157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papillomavirus Vaccines</to_name>
		<to_code>M0498157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
		<from_code>N0000183888</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</to_name>
		<to_code>1300464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
		<from_code>N0000183888</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</to_name>
		<to_code>1300806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
		<from_code>N0000183888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
		<from_code>N0000183888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Vaccines</to_name>
		<to_code>M0027264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
		<from_code>N0000183888</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine</to_name>
		<to_code>798444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Haemophilus influenzae type b antigen (medicinal product)</from_name>
		<from_code>836380007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</to_name>
		<to_code>N0000183888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Vaccines</to_name>
		<to_code>M0027264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</from_name>
		<from_code>1300806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Vaccines</to_name>
		<to_code>M0027264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine</from_name>
		<from_code>798444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Vaccines</to_name>
		<to_code>M0027264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183892</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen</to_name>
		<to_code>1804259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza Vaccines</to_name>
		<to_code>M0011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
		<from_code>N0000183892</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza A virus vaccine, A-California-7-2009 X-181 (H1N1), Inactivated</to_name>
		<to_code>1303850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing influenza virus antigen (medicinal product)</from_name>
		<from_code>836377006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Influenza A Virus Vaccine [EPC]</to_name>
		<to_code>N0000183892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 X-181 (H1N1), Inactivated</from_name>
		<from_code>1303850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 X-181 (H1N1), Inactivated</from_name>
		<from_code>1303850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza Vaccines</to_name>
		<to_code>M0011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
		<from_code>N0000183907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
		<from_code>N0000183907</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Measles morbillivirus antigen (medicinal product)</to_name>
		<to_code>871766009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
		<from_code>N0000183907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles Vaccine</to_name>
		<to_code>M0013153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
		<from_code>N0000183907</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>measles virus vaccine live, Enders' attenuated Edmonston strain</to_name>
		<to_code>804179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles Vaccine</to_name>
		<to_code>M0013153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles Vaccine</to_name>
		<to_code>M0013153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183911</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella-zoster virus vaccine live (Oka-Merck) strain</to_name>
		<to_code>1292422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183911</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)</to_name>
		<to_code>2221000221107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183911</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Varicella Virus Vaccine Live (Oka-Merck) strain</to_name>
		<to_code>805486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
		<from_code>N0000183911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox Vaccine</to_name>
		<to_code>M0028909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox Vaccine</to_name>
		<to_code>M0028909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox Vaccine</to_name>
		<to_code>M0028909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
		<from_code>N0000183900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
		<from_code>N0000183900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetanus Toxoid</to_name>
		<to_code>M0021204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
		<from_code>N0000183900</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetanus toxoid vaccine, inactivated</to_name>
		<to_code>798306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Clostridium tetani antigen (medicinal product)</from_name>
		<from_code>863911006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inactivated Clostridium Tetani Vaccine [EPC]</to_name>
		<to_code>N0000183900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetanus Toxoid</to_name>
		<to_code>M0021204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetanus Toxoid</to_name>
		<to_code>M0021204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
		<from_code>N0000183914</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human adenovirus B serotype 7 strain 55142</to_name>
		<to_code>1802483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
		<from_code>N0000183914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
		<from_code>N0000183914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adenovirus Vaccines</to_name>
		<to_code>M0569028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vaccine product containing Adenovirus antigen (medicinal product)</from_name>
		<from_code>836400005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Live Human Adenovirus Type 7 Vaccine [EPC]</to_name>
		<to_code>N0000183914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaccinia virus strain New York City Board of Health live antigen</from_name>
		<from_code>1492300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Live, Unattenuated</to_name>
		<to_code>M0569003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adenovirus Vaccines</to_name>
		<to_code>M0569028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adenovirus Vaccines</to_name>
		<to_code>M0569028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
		<from_code>N0000183918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
		<from_code>N0000183918</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vaccine product containing only live attenuated Measles morbillivirus antigen (medicinal product)</to_name>
		<to_code>871766009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
		<from_code>N0000183918</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mumps virus vaccine live, Jeryl Lynn strain</to_name>
		<to_code>798372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
		<from_code>N0000183918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mumps Vaccine</to_name>
		<to_code>M0014203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Acellular Tissue Engineered Vessel [EPC]</from_name>
		<from_code>N0000194163</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Tissue engineered blood vessel (substance)</to_name>
		<to_code>780846007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antirheumatic Agent [EPC]</from_name>
		<from_code>N0000175713</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>leflunomide</to_name>
		<to_code>27169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antirheumatic Agent [EPC]</from_name>
		<from_code>N0000175713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antirheumatic Agent [EPC]</from_name>
		<from_code>N0000175713</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxychloroquine</to_name>
		<to_code>5521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antirheumatic Agent [EPC]</from_name>
		<from_code>N0000175713</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillamine</to_name>
		<to_code>7975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antirheumatic Agent [EPC]</from_name>
		<from_code>N0000175713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antirheumatic Agent [EPC]</from_name>
		<from_code>N0000175713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-anoh</from_name>
		<from_code>2705421</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baricitinib</from_name>
		<from_code>2047232</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-aazg</from_name>
		<from_code>2679427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>upadacitinib</from_name>
		<from_code>2196092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-bavi</from_name>
		<from_code>2680283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab</from_name>
		<from_code>612865</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib citrate</from_name>
		<from_code>1358492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Therapeutic Categories [TC]</from_name>
		<from_code>N0000178293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allopurinol</from_name>
		<from_code>519</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib</from_name>
		<from_code>1357536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allopurinol sodium</from_name>
		<from_code>80566</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antirheumatic Agent [TC]</to_name>
		<to_code>N0000178308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica sinensis preparation</from_name>
		<from_code>328141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rheumatic Diseases</to_name>
		<to_code>M0019014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Agent [APC]</from_name>
		<from_code>N0000193895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Skin Test Antigen [EPC]</to_name>
		<to_code>N0000184316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diagnostic Agent [APC]</from_name>
		<from_code>N0000193895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Helicobacter pylori Diagnostic [EPC]</to_name>
		<to_code>N0000175886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skin Test Antigen [EPC]</from_name>
		<from_code>N0000184316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skin Test Antigen [EPC]</from_name>
		<from_code>N0000184316</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coccidioides immitis spherule</to_name>
		<to_code>1549330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skin Test Antigen [EPC]</from_name>
		<from_code>N0000184316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens</to_name>
		<to_code>M0001407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skin Test Antigen [EPC]</from_name>
		<from_code>N0000184316</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>purified protein derivative of tuberculin</to_name>
		<to_code>8948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skin Test Antigen [EPC]</from_name>
		<from_code>N0000184316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tuberculosis Skin Test [EPC]</to_name>
		<to_code>N0000184315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Diagnostic substance (substance)</from_name>
		<from_code>373782009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Skin Test Antigen [EPC]</to_name>
		<to_code>N0000184316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine oleate</from_name>
		<from_code>24460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oats preparation</from_name>
		<from_code>285251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous iodide</from_name>
		<from_code>1720256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet pollen extract</from_name>
		<from_code>852132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide sodium</from_name>
		<from_code>221173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide mono</from_name>
		<from_code>1552007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>house dust allergenic extract</from_name>
		<from_code>852519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiopronin</from_name>
		<from_code>6765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alirocumab</from_name>
		<from_code>1659152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin calcium</from_name>
		<from_code>221128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus</from_name>
		<from_code>6204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alogliptin benzoate</from_name>
		<from_code>1368000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide</from_name>
		<from_code>393575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine hydrochloride</from_name>
		<from_code>2117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil</from_name>
		<from_code>6984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium</from_name>
		<from_code>21232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitroprusside</from_name>
		<from_code>9895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium</from_name>
		<from_code>1546438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone lactate</from_name>
		<from_code>155120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine hydrobromide</from_name>
		<from_code>860693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chloride</from_name>
		<from_code>46241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide, anhydrous</from_name>
		<from_code>2462023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone</from_name>
		<from_code>52769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam</from_name>
		<from_code>24853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>masoprocol</from_name>
		<from_code>227239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin disodium</from_name>
		<from_code>258332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentoxifylline</from_name>
		<from_code>8013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine</from_name>
		<from_code>5470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam mesylate</from_name>
		<from_code>203151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrine</from_name>
		<from_code>10318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil sodium</from_name>
		<from_code>342691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan</from_name>
		<from_code>75207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflutren</from_name>
		<from_code>283753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glimepiride</from_name>
		<from_code>25789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivastigmine tartrate</from_name>
		<from_code>994808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabergoline</from_name>
		<from_code>47579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fiber</from_name>
		<from_code>70727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline sulfate</from_name>
		<from_code>10369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine hydrochloride</from_name>
		<from_code>82027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chloride anhydrous</from_name>
		<from_code>1608145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podofilox</from_name>
		<from_code>8463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</from_name>
		<from_code>1440973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin phenyl sodium</from_name>
		<from_code>42580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cranberry preparation</from_name>
		<from_code>125933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate</from_name>
		<from_code>1651695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine tartrate</from_name>
		<from_code>221174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beets preparation</from_name>
		<from_code>319826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazinamide</from_name>
		<from_code>8987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil diolamine</from_name>
		<from_code>1927409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate ester</from_name>
		<from_code>1926479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine</from_name>
		<from_code>9000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aureobasidium pullulans var. pullutans allergenic extract</from_name>
		<from_code>852102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chloride hexahydrate</from_name>
		<from_code>17611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin hydrochloride</from_name>
		<from_code>82036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazamide</from_name>
		<from_code>10633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolnaftate</from_name>
		<from_code>10637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifapentine</from_name>
		<from_code>35617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol</from_name>
		<from_code>435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine</from_name>
		<from_code>592464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine mesylate</from_name>
		<from_code>227240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine hydrochloride</from_name>
		<from_code>71512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver sulfadiazine</from_name>
		<from_code>9793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat bran</from_name>
		<from_code>253190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donepezil hydrochloride</from_name>
		<from_code>236559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium</from_name>
		<from_code>69120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine</from_name>
		<from_code>3616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine</from_name>
		<from_code>5933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypochlorite</from_name>
		<from_code>9881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medium chain triglycerides</from_name>
		<from_code>1310578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrolyzed casein (enzymatic; 1000 MW)</from_name>
		<from_code>1812932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichothecium roseum allergenic extract</from_name>
		<from_code>968426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine bromide</from_name>
		<from_code>9001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barium sulfate</from_name>
		<from_code>1331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiotropium bromide monohydrate</from_name>
		<from_code>1298831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methazolamide</from_name>
		<from_code>6826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine hydrochloride</from_name>
		<from_code>203121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactobacillic acid</from_name>
		<from_code>2002583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium bromide</from_name>
		<from_code>48212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton mentagrophytes allergenic extract</from_name>
		<from_code>867357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemon extract</from_name>
		<from_code>1364291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin</from_name>
		<from_code>6398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine</from_name>
		<from_code>8149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat skin extract</from_name>
		<from_code>851949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine</from_name>
		<from_code>4637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riluzole</from_name>
		<from_code>35623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrine hydrochloride</from_name>
		<from_code>235972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol sulfate</from_name>
		<from_code>142153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin indanyl sodium</from_name>
		<from_code>56461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Juniperus communis fruit extract</from_name>
		<from_code>1310189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metrizamide</from_name>
		<from_code>6920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alogliptin</from_name>
		<from_code>1368001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus arrhizus allergenic extract</from_name>
		<from_code>314443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>modafinil</from_name>
		<from_code>30125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin</from_name>
		<from_code>2015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine</from_name>
		<from_code>119565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide</from_name>
		<from_code>10635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric subsulfate solution</from_name>
		<from_code>24912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypersensitivity</to_name>
		<to_code>M0010851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tuberculosis Skin Test [EPC]</from_name>
		<from_code>N0000184315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tuberculosis Skin Test [EPC]</from_name>
		<from_code>N0000184315</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>purified protein derivative of tuberculin</to_name>
		<to_code>8948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tuberculosis Skin Test [EPC]</from_name>
		<from_code>N0000184315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Bacterial</to_name>
		<to_code>M0001408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, RIT-4385 strain</from_name>
		<from_code>2603501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazinamide</from_name>
		<from_code>8987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, attenuated Schwarz strain</from_name>
		<from_code>2603499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazinamide</from_name>
		<from_code>8987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculosis</to_name>
		<to_code>M0022106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Bacterial</to_name>
		<to_code>M0001408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Helicobacter pylori Diagnostic [EPC]</from_name>
		<from_code>N0000175886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Helicobacter pylori Diagnostic [EPC]</from_name>
		<from_code>N0000175886</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urea c-13</to_name>
		<to_code>226724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole sodium</from_name>
		<from_code>1294569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole sodium</from_name>
		<from_code>253191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole strontium</from_name>
		<from_code>1435522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole sodium</from_name>
		<from_code>1792108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole</from_name>
		<from_code>40790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium dihydrate</from_name>
		<from_code>1601995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole</from_name>
		<from_code>114979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole magnesium</from_name>
		<from_code>236486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium</from_name>
		<from_code>283562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole</from_name>
		<from_code>283742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole sodium</from_name>
		<from_code>226868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole (as pantoprazole sodium sesquihydrate)</from_name>
		<from_code>236632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter Infections</to_name>
		<to_code>M0025165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclobenzaprine</to_name>
		<to_code>21949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorzoxazone</to_name>
		<to_code>2410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>orphenadrine</to_name>
		<to_code>7715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaxalone</to_name>
		<to_code>59078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carisoprodol</to_name>
		<to_code>2101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methocarbamol</to_name>
		<to_code>6845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175737</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Skeletal Muscle Relaxant [EPC]</to_name>
		<to_code>N0000175738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormezanone</from_name>
		<from_code>2373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neuromuscular Activity Alteration [PE]</from_name>
		<from_code>N0000175726</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
		<to_code>N0000175730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skeletal Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175738</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Skeletal muscle relaxant (substance)</to_name>
		<to_code>372666009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Skeletal Muscle Relaxant [EPC]</from_name>
		<from_code>N0000175738</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dantrolene</to_name>
		<to_code>3105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonist [EPC]</to_name>
		<to_code>N0000192797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
		<to_code>N0000191421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Agonist [APC]</to_name>
		<to_code>N0000193886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>RANK Ligand Inhibitor [EPC]</to_name>
		<to_code>N0000187055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonist [EPC]</to_name>
		<to_code>N0000193985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interaction [EPC]</to_name>
		<to_code>N0000193866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonist [EPC]</to_name>
		<to_code>N0000191872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000194166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000194063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Activin Signaling Inhibitor [EPC]</to_name>
		<to_code>N0000194100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Receptor Antagonist [APC]</to_name>
		<to_code>N0000193887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Antagonist [EPC]</to_name>
		<to_code>N0000193952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonist [EPC]</to_name>
		<to_code>N0000192799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonist [EPC]</to_name>
		<to_code>N0000191495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type I interferon Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Antagonist [EPC]</to_name>
		<to_code>N0000191006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000193989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD123 Interaction [EPC]</to_name>
		<to_code>N0000193864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Interaction [APC]</from_name>
		<from_code>N0000193888</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
		<to_code>N0000181816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-12 Antagonist [EPC]</from_name>
		<from_code>N0000192797</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab</to_name>
		<to_code>847083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-12 Antagonist [EPC]</from_name>
		<from_code>N0000192797</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-srlf</to_name>
		<to_code>2717063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-12 Antagonist [EPC]</from_name>
		<from_code>N0000192797</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-aekn</to_name>
		<to_code>2705377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonist [EPC]</to_name>
		<to_code>N0000192797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonist [EPC]</to_name>
		<to_code>N0000192797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-12 Antagonist [EPC]</to_name>
		<to_code>N0000192797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
		<from_code>N0000191421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Fusion Proteins</to_name>
		<to_code>M0018640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
		<from_code>N0000191421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoconjugates</to_name>
		<to_code>M0028142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
		<from_code>N0000191421</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>blinatumomab</to_name>
		<to_code>1597258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
		<to_code>N0000191421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
		<to_code>N0000191421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
		<to_code>N0000191421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E2 Receptor Agonist [EPC]</to_name>
		<to_code>N0000194041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</to_name>
		<to_code>N0000175655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Agonist [EPC]</to_name>
		<to_code>N0000194118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Secretagogue Receptor Agonist [EPC]</to_name>
		<to_code>N0000193785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacyclin Receptor Agonist [EPC]</to_name>
		<to_code>N0000192339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</to_name>
		<to_code>N0000194015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor beta Agonist [EPC]</to_name>
		<to_code>N0000194131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Serotonin-4 Receptor Agonist [EPC]</to_name>
		<to_code>N0000193871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000191263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aryl Hydrocarbon Receptor Agonist [EPC]</to_name>
		<to_code>N0000194018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium-sensing Receptor Agonist [EPC]</to_name>
		<to_code>N0000175902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesoid X Receptor Agonist [EPC]</to_name>
		<to_code>N0000192561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mu-Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000191867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</to_name>
		<to_code>N0000194128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonist [EPC]</to_name>
		<to_code>N0000178375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Agonist [EPC]</to_name>
		<to_code>N0000180189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Agonist [EPC]</to_name>
		<to_code>N0000194045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin Receptor Agonist [EPC]</to_name>
		<to_code>N0000194029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Agonist [APC]</from_name>
		<from_code>N0000193886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-1 Receptor Agonist [EPC]</to_name>
		<to_code>N0000178480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin E2 Receptor Agonist [EPC]</from_name>
		<from_code>N0000194041</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>omidenepag</to_name>
		<to_code>2612691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
		<from_code>771380003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E2 Receptor Agonist [EPC]</to_name>
		<to_code>N0000194041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing prostaglandin (product)</from_name>
		<from_code>350067007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E2 Receptor Agonist [EPC]</to_name>
		<to_code>N0000194041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing gonadotropin releasing factor (product)</to_name>
		<to_code>75969007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>leuprolide</to_name>
		<to_code>42375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triptorelin</to_name>
		<to_code>38782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histrelin</to_name>
		<to_code>50975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Gonadotropin releasing factor (substance)</to_name>
		<to_code>49869009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nafarelin</to_name>
		<to_code>28656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
		<from_code>N0000175655</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goserelin</to_name>
		<to_code>50610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin</from_name>
		<from_code>28656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide acetate</from_name>
		<from_code>203217</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GnRH Secretion Alteration [PE]</from_name>
		<from_code>N0000009052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin acetate</from_name>
		<from_code>203147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide mesylate</from_name>
		<from_code>2595041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene citrate</from_name>
		<from_code>142431</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin</from_name>
		<from_code>50975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin pamoate</from_name>
		<from_code>338529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene</from_name>
		<from_code>2596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide</from_name>
		<from_code>42375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin</from_name>
		<from_code>38782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased GnRH Secretion [PE]</to_name>
		<to_code>N0000009332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-15 Receptor Agonist [EPC]</from_name>
		<from_code>N0000194118</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nogapendekin alfa inbakicept-pmln</to_name>
		<to_code>2682677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Agonist [EPC]</to_name>
		<to_code>N0000194118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-15 Receptor Agonist [EPC]</to_name>
		<to_code>N0000194118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Secretagogue Receptor Agonist [EPC]</from_name>
		<from_code>N0000193785</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macimorelin</to_name>
		<to_code>1999420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacyclin Receptor Agonist [EPC]</from_name>
		<from_code>N0000192339</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selexipag</to_name>
		<to_code>1729002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacyclin Receptor Agonist [EPC]</from_name>
		<from_code>N0000192339</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with prostacyclin receptor agonist mechanism of action (substance)</to_name>
		<to_code>771378009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</from_name>
		<from_code>N0000194015</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirzepatide</to_name>
		<to_code>2601723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
		<from_code>771380003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</to_name>
		<to_code>N0000194015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thyroid Hormone Receptor beta Agonist [EPC]</from_name>
		<from_code>N0000194131</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resmetirom</to_name>
		<to_code>2677894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
		<from_code>771380003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thyroid Hormone Receptor beta Agonist [EPC]</to_name>
		<to_code>N0000194131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
		<from_code>N0000193871</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with serotonin 5-hydroxytryptamine-4 receptor agonist mechanism of action (substance)</to_name>
		<to_code>783582009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
		<from_code>N0000193871</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prucalopride</to_name>
		<to_code>2107310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
		<from_code>N0000193871</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing serotonin 5-hydroxytryptamine-4 receptor agonist (product)</to_name>
		<to_code>785336003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
		<from_code>N0000193871</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tegaserod</to_name>
		<to_code>139778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing selective estrogen receptor modulator (product)</to_name>
		<to_code>109030001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raloxifene</to_name>
		<to_code>72143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomiphene</to_name>
		<to_code>2596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toremifene</to_name>
		<to_code>38409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamoxifen</to_name>
		<to_code>10324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ospemifene</to_name>
		<to_code>1370971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Selective estrogen receptor modulator (substance)</to_name>
		<to_code>415515000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000175826</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bazedoxifene</to_name>
		<to_code>1441386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000175826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000191263</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing progesterone receptor antagonist (product)</to_name>
		<to_code>768669004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000191263</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with progesterone receptor antagonist mechanism of action (substance)</to_name>
		<to_code>767105009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000191263</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing progesterone receptor agonist (product)</to_name>
		<to_code>788316003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000191263</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ulipristal</to_name>
		<to_code>1005921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
		<from_code>N0000191263</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with progesterone receptor agonist mechanism of action (substance)</to_name>
		<to_code>773603001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hormone (product)</from_name>
		<from_code>22091006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000191263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Steroid hormone (substance)</from_name>
		<from_code>112113009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000191263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
		<to_code>N0000191263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aryl Hydrocarbon Receptor Agonist [EPC]</from_name>
		<from_code>N0000194018</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tapinarof</to_name>
		<to_code>2602286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
		<from_code>771380003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aryl Hydrocarbon Receptor Agonist [EPC]</to_name>
		<to_code>N0000194018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
		<from_code>N0000175902</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etelcalcetide</to_name>
		<to_code>1876119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
		<from_code>N0000175902</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with calcium-sensing receptor activator mechanism of action (substance)</to_name>
		<to_code>409389003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
		<from_code>N0000175902</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcium-sensing receptor activator (product)</to_name>
		<to_code>409390007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
		<from_code>N0000175902</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinacalcet</to_name>
		<to_code>407990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
		<from_code>N0000192561</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with farnesoid X receptor agonist mechanism of action (substance)</to_name>
		<to_code>765343003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
		<from_code>N0000192561</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing farnesoid X receptor agonist (product)</to_name>
		<to_code>765344009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cholelitholytic AND/OR choleretic agent (substance)</from_name>
		<from_code>105925009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesoid X Receptor Agonist [EPC]</to_name>
		<to_code>N0000192561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hormone (product)</from_name>
		<from_code>22091006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Farnesoid X Receptor Agonist [EPC]</to_name>
		<to_code>N0000192561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>mu-Opioid Receptor Agonist [EPC]</from_name>
		<from_code>N0000191867</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eluxadoline</to_name>
		<to_code>1653781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
		<from_code>404642006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mu-Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000191867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing opioid receptor agonist (product)</from_name>
		<from_code>360204007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>mu-Opioid Receptor Agonist [EPC]</to_name>
		<to_code>N0000191867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with peroxisome proliferator-activated receptor agonist mechanism of action (substance)</to_name>
		<to_code>725745008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elafibranor</to_name>
		<to_code>2684941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</to_name>
		<to_code>N0000180186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</to_name>
		<to_code>N0000175596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</to_name>
		<to_code>N0000194127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
		<from_code>N0000194128</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing peroxisome proliferator-activated receptor agonist (product)</to_name>
		<to_code>1172677005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
		<from_code>N0000180186</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with peroxisome proliferator-activated receptor agonist mechanism of action (substance)</to_name>
		<to_code>725745008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
		<from_code>N0000180186</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosiglitazone</to_name>
		<to_code>84108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
		<from_code>N0000180186</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing peroxisome proliferator-activated gamma receptor agonist (product)</to_name>
		<to_code>764135009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
		<from_code>N0000180186</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pioglitazone</to_name>
		<to_code>33738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with peroxisome proliferator-activated alpha receptor agonist mechanism of action (substance)</to_name>
		<to_code>442526006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fenofibric acid</to_name>
		<to_code>24852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fenofibrate</to_name>
		<to_code>8703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing peroxisome proliferator-activated alpha receptor agonist (product)</to_name>
		<to_code>441755002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemfibrozil</to_name>
		<to_code>4719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
		<from_code>N0000175596</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pioglitazone</to_name>
		<to_code>33738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing peroxisome proliferator-activated receptor agonist (product)</from_name>
		<from_code>1172677005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</to_name>
		<to_code>N0000194127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with peroxisome proliferator-activated receptor agonist mechanism of action (substance)</from_name>
		<from_code>725745008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</to_name>
		<to_code>N0000194127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Agonist [EPC]</from_name>
		<from_code>N0000178375</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing adenosine A2 receptor agonist (product)</to_name>
		<to_code>432062000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Agonist [EPC]</from_name>
		<from_code>N0000178375</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with adenosine A2 receptor agonist mechanism of action (substance)</to_name>
		<to_code>429578004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Agonist [EPC]</from_name>
		<from_code>N0000178375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regadenoson</to_name>
		<to_code>640062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Adenosine Receptor Agonist [EPC]</from_name>
		<from_code>N0000178375</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenosine</to_name>
		<to_code>296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cardiovascular agent (substance)</from_name>
		<from_code>373247007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonist [EPC]</to_name>
		<to_code>N0000178375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Adenosine Receptor Agonist [EPC]</to_name>
		<to_code>N0000178375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostaglandin E1 Agonist [EPC]</from_name>
		<from_code>N0000180189</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprostadil</to_name>
		<to_code>598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Prostaglandin group E (substance)</from_name>
		<from_code>418517007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Agonist [EPC]</to_name>
		<to_code>N0000180189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing E series prostaglandin (product)</from_name>
		<from_code>713623003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostaglandin E1 Agonist [EPC]</to_name>
		<to_code>N0000180189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194045</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vasopressin receptor agonist (product)</to_name>
		<to_code>788630002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194045</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terlipressin</to_name>
		<to_code>57048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194045</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with vasopressin receptor agonist mechanism of action (substance)</to_name>
		<to_code>788629007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cardiovascular agent (substance)</from_name>
		<from_code>373247007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Agonist [EPC]</to_name>
		<to_code>N0000194045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Agonist [EPC]</to_name>
		<to_code>N0000194045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194029</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing melanocortin receptor agonist (product)</to_name>
		<to_code>1137664003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194029</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bremelanotide</to_name>
		<to_code>2176312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194029</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with melanocortin receptor agonist mechanism of action (substance)</to_name>
		<to_code>1137636008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin Receptor Agonist [EPC]</from_name>
		<from_code>N0000194029</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin 4 Receptor Agonist [EPC]</to_name>
		<to_code>N0000193940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Melanocyte stimulating hormone analog (substance)</from_name>
		<from_code>425855007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin Receptor Agonist [EPC]</to_name>
		<to_code>N0000194029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Melanocortin 4 Receptor Agonist [EPC]</from_name>
		<from_code>N0000193940</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>setmelanotide</to_name>
		<to_code>2469247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Centrally acting appetite suppressant (substance)</from_name>
		<from_code>373335004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin 4 Receptor Agonist [EPC]</to_name>
		<to_code>N0000193940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing melanocortin receptor agonist (product)</from_name>
		<from_code>1137664003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Melanocortin 4 Receptor Agonist [EPC]</to_name>
		<to_code>N0000193940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)</to_name>
		<to_code>416171004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing glucagon-like peptide 1 receptor agonist (product)</to_name>
		<to_code>416636000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirzepatide</to_name>
		<to_code>2601723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>exenatide</to_name>
		<to_code>60548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lixisenatide</to_name>
		<to_code>1440051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dulaglutide</to_name>
		<to_code>1551291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>semaglutide</to_name>
		<to_code>1991302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GLP-1 Receptor Agonist [EPC]</from_name>
		<from_code>N0000178480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>liraglutide</to_name>
		<to_code>475968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>GLP-1 Receptor Agonist [EPC]</to_name>
		<to_code>N0000178480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dulaglutide</from_name>
		<from_code>1551291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albiglutide</from_name>
		<from_code>1534763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liraglutide</from_name>
		<from_code>475968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semaglutide</from_name>
		<from_code>1991302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exenatide</from_name>
		<from_code>60548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lixisenatide</from_name>
		<from_code>1440051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucagon-Like Peptide 1</to_name>
		<to_code>M0160181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RANK Ligand Inhibitor [EPC]</from_name>
		<from_code>N0000187055</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action (substance)</to_name>
		<to_code>764144005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RANK Ligand Inhibitor [EPC]</from_name>
		<from_code>N0000187055</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing receptor activator of nuclear factor kappa-B ligand inhibitor (product)</to_name>
		<to_code>764134008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>RANK Ligand Inhibitor [EPC]</from_name>
		<from_code>N0000187055</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>denosumab</to_name>
		<to_code>993449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-13 Antagonist [EPC]</from_name>
		<from_code>N0000193985</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tralokinumab</to_name>
		<to_code>2589225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-13 Antagonist [EPC]</from_name>
		<from_code>N0000193985</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lebrikizumab</to_name>
		<to_code>2693758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonist [EPC]</to_name>
		<to_code>N0000193985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonist [EPC]</to_name>
		<to_code>N0000193985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-13 Antagonist [EPC]</to_name>
		<to_code>N0000193985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemokine Receptor Type 4 Interaction [EPC]</from_name>
		<from_code>N0000193866</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mogamulizumab</to_name>
		<to_code>2054068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemokine Receptor Type 4 Interaction [EPC]</from_name>
		<from_code>N0000193866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CXC Chemokine Receptor 4 Antagonist [EPC]</to_name>
		<to_code>N0000194104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with antiviral mechanism of action (substance)</from_name>
		<from_code>372701006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Chemokine Receptor Type 4 Interaction [EPC]</to_name>
		<to_code>N0000193866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CXC Chemokine Receptor 4 Antagonist [EPC]</from_name>
		<from_code>N0000194104</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mavorixafor</to_name>
		<to_code>2684021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with chemokine receptor antagonist mechanism of action (substance)</from_name>
		<from_code>429602006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CXC Chemokine Receptor 4 Antagonist [EPC]</to_name>
		<to_code>N0000194104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chemokine receptor antagonist (product)</from_name>
		<from_code>427804001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CXC Chemokine Receptor 4 Antagonist [EPC]</to_name>
		<to_code>N0000194104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Antagonist [EPC]</from_name>
		<from_code>N0000191872</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepolizumab</to_name>
		<to_code>1720597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Antagonist [EPC]</from_name>
		<from_code>N0000191872</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interleukin 5 receptor antagonist mechanism of action (substance)</to_name>
		<to_code>716045008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Antagonist [EPC]</from_name>
		<from_code>N0000191872</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reslizumab</to_name>
		<to_code>1746889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-5 Antagonist [EPC]</from_name>
		<from_code>N0000191872</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interleukin 5 receptor antagonist (product)</to_name>
		<to_code>770621002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-5 Antagonist [EPC]</to_name>
		<to_code>N0000191872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000194166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000194063</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glofitamab</to_name>
		<to_code>2639782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000194063</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epcoritamab</to_name>
		<to_code>2637392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000194063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000194063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000194063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Activin Signaling Inhibitor [EPC]</from_name>
		<from_code>N0000194100</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotatercept</to_name>
		<to_code>2678930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000178376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Androgen Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000175560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000190480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endothelin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-2 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-4 Receptor alpha Antagonist [EPC]</to_name>
		<to_code>N0000193342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Estrogen Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bradykinin B2 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000182965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Opioid Antagonist [EPC]</to_name>
		<to_code>N0000175691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neonatal Fc Receptor Blocker [EPC]</to_name>
		<to_code>N0000194004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Platelet Inhibitor [EPC]</to_name>
		<to_code>N0000182142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hedgehog Pathway Inhibitor [EPC]</to_name>
		<to_code>N0000184149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000193926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Orexin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000191000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldosterone Antagonist [EPC]</to_name>
		<to_code>N0000175557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-1 Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000175519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</to_name>
		<to_code>N0000194053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
		<to_code>N0000194121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</to_name>
		<to_code>N0000193543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</to_name>
		<to_code>N0000194108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin Antagonist [EPC]</to_name>
		<to_code>N0000175841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
		<to_code>N0000193276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Blocker [EPC]</to_name>
		<to_code>N0000175610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Blocker [EPC]</to_name>
		<to_code>N0000175561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Receptor Antagonist [APC]</from_name>
		<from_code>N0000193887</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Growth Hormone Receptor Antagonist [EPC]</to_name>
		<to_code>N0000190119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000178376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin V2 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000178376</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vasopressin receptor antagonist (product)</to_name>
		<to_code>770374002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000178376</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with vasopressin receptor antagonist mechanism of action (substance)</to_name>
		<to_code>422027004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasopressin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000178376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasopressin V2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193181</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolvaptan</to_name>
		<to_code>358257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flutamide</to_name>
		<to_code>4508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bicalutamide</to_name>
		<to_code>83008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nilutamide</to_name>
		<to_code>31805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clascoterone</to_name>
		<to_code>2474340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enzalutamide</to_name>
		<to_code>1307298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with androgen receptor antagonist mechanism of action (substance)</to_name>
		<to_code>1196804006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Androgen Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175560</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing androgen receptor antagonist (product)</to_name>
		<to_code>346324007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190480</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interleukin receptor antagonist (product)</to_name>
		<to_code>770620001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocilizumab</to_name>
		<to_code>612865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190480</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interleukin receptor antagonist mechanism of action (substance)</to_name>
		<to_code>716044007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190480</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarilumab</to_name>
		<to_code>1923319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000190480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macitentan</to_name>
		<to_code>1442132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambrisentan</to_name>
		<to_code>358274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bosentan anhydrous</to_name>
		<to_code>1468845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprocitentan</to_name>
		<to_code>2679059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atrasentan</to_name>
		<to_code>2710449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing endothelin receptor antagonist (product)</to_name>
		<to_code>385560009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with endothelin receptor antagonist mechanism of action (substance)</to_name>
		<to_code>385561008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endothelin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175581</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sparsentan</to_name>
		<to_code>2630535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>famotidine</to_name>
		<to_code>4278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranitidine</to_name>
		<to_code>9143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nizatidine</to_name>
		<to_code>42319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing histamine H2 receptor antagonist (product)</to_name>
		<to_code>108661002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cimetidine</to_name>
		<to_code>2541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175784</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with histamine H2 receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372524001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-2 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
		<from_code>N0000193342</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dupilumab</to_name>
		<to_code>1876376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
		<from_code>N0000193342</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interleukin-4 receptor alpha antagonist mechanism of action (substance)</to_name>
		<to_code>733486009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
		<from_code>N0000193342</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interleukin-4 receptor alpha antagonist (product)</to_name>
		<to_code>764413006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-4 Receptor alpha Antagonist [EPC]</to_name>
		<to_code>N0000193342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing gonadotropin releasing hormone receptor antagonist (product)</to_name>
		<to_code>116101001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with gonadotropin releasing hormone receptor antagonist mechanism of action (substance)</to_name>
		<to_code>395962005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elagolix</to_name>
		<to_code>2049846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganirelix</to_name>
		<to_code>35825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrorelix</to_name>
		<to_code>68147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>degarelix</to_name>
		<to_code>475230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175839</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relugolix</to_name>
		<to_code>2472778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175582</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with estrogen receptor antagonist mechanism of action (substance)</to_name>
		<to_code>373336003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175582</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imlunestrant</to_name>
		<to_code>2725912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175582</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing estrogen receptor antagonist (product)</to_name>
		<to_code>349849001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175582</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fulvestrant</to_name>
		<to_code>282357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Estrogen Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175582</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elacestrant</to_name>
		<to_code>2628469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bradykinin B2 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000182965</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>icatibant</to_name>
		<to_code>1148138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alvimopan anhydrous</to_name>
		<to_code>1516803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naloxone</to_name>
		<to_code>7242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samidorphan</to_name>
		<to_code>2559612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing opioid receptor antagonist (product)</to_name>
		<to_code>14103001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naldemedine</to_name>
		<to_code>1876597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylnaltrexone</to_name>
		<to_code>29899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naloxegol</to_name>
		<to_code>1551777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with opioid receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372656001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nalmefene</to_name>
		<to_code>31479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Opioid Antagonist [EPC]</from_name>
		<from_code>N0000175691</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>naltrexone</to_name>
		<to_code>7243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
		<from_code>N0000194004</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rozanolixizumab</to_name>
		<to_code>2642274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
		<from_code>N0000194004</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efgartigimod alfa</to_name>
		<to_code>2587717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
		<from_code>N0000194004</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Immunoglobulin, Fc fragment (substance)</to_name>
		<to_code>69311000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimegepant</to_name>
		<to_code>2282307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)</to_name>
		<to_code>771595002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcitonin gene-related peptide receptor antagonist (product)</to_name>
		<to_code>771677008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atogepant</to_name>
		<to_code>2571813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ubrogepant</to_name>
		<to_code>2268216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193917</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zavegepant</to_name>
		<to_code>2637955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
		<from_code>N0000182142</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cangrelor</to_name>
		<to_code>1656052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
		<from_code>N0000182142</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticagrelor</to_name>
		<to_code>1116632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
		<from_code>N0000182142</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopidogrel</to_name>
		<to_code>32968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
		<from_code>N0000182142</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prasugrel</to_name>
		<to_code>613391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with platelet aggregation inhibitor mechanism of action (substance)</from_name>
		<from_code>771452004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Platelet Inhibitor [EPC]</to_name>
		<to_code>N0000182142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing platelet aggregation inhibitor (product)</from_name>
		<from_code>773388004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P2Y12 Platelet Inhibitor [EPC]</to_name>
		<to_code>N0000182142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000184149</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sonidegib</to_name>
		<to_code>1659191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000184149</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vismodegib</to_name>
		<to_code>1242987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
		<from_code>N0000184149</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glasdegib</to_name>
		<to_code>2105845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hedgehog Pathway Inhibitor [EPC]</to_name>
		<to_code>N0000184149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000193926</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teprotumumab</to_name>
		<to_code>2274803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing protein kinase inhibitor (product)</from_name>
		<from_code>427510007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000193926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with protein kinase inhibitor mechanism of action (substance)</from_name>
		<from_code>426265004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000193926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000191000</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>daridorexant</to_name>
		<to_code>2591497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000191000</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with orexin receptor antagonist mechanism of action (substance)</to_name>
		<to_code>838466008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000191000</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing orexin receptor antagonist (product)</to_name>
		<to_code>870488000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000191000</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suvorexant</to_name>
		<to_code>1547099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Orexin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000191000</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lemborexant</to_name>
		<to_code>2272403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aldosterone Antagonist [EPC]</from_name>
		<from_code>N0000175557</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spironolactone</to_name>
		<to_code>9997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aldosterone Antagonist [EPC]</from_name>
		<from_code>N0000175557</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with aldosterone receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372603003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aldosterone Antagonist [EPC]</from_name>
		<from_code>N0000175557</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing aldosterone receptor antagonist (product)</to_name>
		<to_code>346312000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aldosterone Antagonist [EPC]</from_name>
		<from_code>N0000175557</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eplerenone</to_name>
		<to_code>298869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aldosterone Antagonist [EPC]</to_name>
		<to_code>N0000175557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175519</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinastine</to_name>
		<to_code>39684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175519</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketotifen</to_name>
		<to_code>6146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
		<from_code>N0000175519</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olopatadine</to_name>
		<to_code>135391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with histamine H1 receptor antagonist mechanism of action (substance)</from_name>
		<from_code>373228009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-1 Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000175519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing histamine H1 receptor antagonist (product)</from_name>
		<from_code>349955005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Histamine-1 Receptor Inhibitor [EPC]</to_name>
		<to_code>N0000175519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193970</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>finerenone</to_name>
		<to_code>2562811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
		<from_code>103022008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hormone receptor antagonist (product)</from_name>
		<from_code>327298003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
		<from_code>N0000194053</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing histamine H3 receptor antagonist (product)</to_name>
		<to_code>765158000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
		<from_code>N0000194053</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitolisant</to_name>
		<to_code>2197878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
		<from_code>N0000194053</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with histamine H3 receptor antagonist mechanism of action (substance)</to_name>
		<to_code>764504006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175786</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rolapitant</to_name>
		<to_code>1665496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175786</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprepitant</to_name>
		<to_code>358255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175786</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>netupitant</to_name>
		<to_code>1552337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing neurokinin 1 receptor antagonist (product)</from_name>
		<from_code>409206005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with neurokinin 1 receptor antagonist mechanism of action (substance)</from_name>
		<from_code>409207001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-31 Receptor alpha Antagonist [EPC]</from_name>
		<from_code>N0000194121</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nemolizumab</to_name>
		<to_code>2691310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
		<to_code>N0000194121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
		<to_code>N0000194121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
		<to_code>N0000194121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levocetirizine</to_name>
		<to_code>356887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alcaftadine</to_name>
		<to_code>1000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing histamine H1 receptor antagonist (product)</to_name>
		<to_code>349955005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olopatadine</to_name>
		<to_code>135391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetirizine</to_name>
		<to_code>20610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbinoxamine</to_name>
		<to_code>20220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fexofenadine</to_name>
		<to_code>87636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azelastine</to_name>
		<to_code>18603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desloratadine</to_name>
		<to_code>275635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpheniramine</to_name>
		<to_code>2400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diphenhydramine</to_name>
		<to_code>3498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with histamine H1 receptor antagonist mechanism of action (substance)</to_name>
		<to_code>373228009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrivastine</to_name>
		<to_code>19959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bepotastine</to_name>
		<to_code>863035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175710</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interleukin 1 receptor antagonist mechanism of action (substance)</to_name>
		<to_code>430866006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175710</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interleukin 1 receptor antagonist (product)</to_name>
		<to_code>430817009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175710</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anakinra</to_name>
		<to_code>72435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-36 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194039</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spesolimab</to_name>
		<to_code>2610417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranibizumab</to_name>
		<to_code>595060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bevacizumab-tnjn</to_name>
		<to_code>2700660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept</to_name>
		<to_code>1232150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bevacizumab</to_name>
		<to_code>253337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept-mrbb</to_name>
		<to_code>2706479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
		<from_code>N0000193543</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)</to_name>
		<to_code>786910006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing angiogenesis inhibitor (product)</from_name>
		<from_code>409407003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</to_name>
		<to_code>N0000193543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175775</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vedolizumab</to_name>
		<to_code>1538097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175775</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>natalizumab</to_name>
		<to_code>354770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Integrin Receptor Antagonist [EPC]</from_name>
		<from_code>N0000175775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</to_name>
		<to_code>N0000192701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with selective adhesion molecule inhibitor mechanism of action (substance)</from_name>
		<from_code>415514001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing selective adhesion molecule inhibitor (product)</from_name>
		<from_code>415513007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Integrin Receptor Antagonist [EPC]</to_name>
		<to_code>N0000175775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</from_name>
		<from_code>N0000192701</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lifitegrast</to_name>
		<to_code>1801820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Neurokinin 3 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194090</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fezolinetant</to_name>
		<to_code>2637134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with receptor antagonist mechanism of action (substance)</from_name>
		<from_code>771382006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Neurokinin 3 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</from_name>
		<from_code>N0000194108</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axatilimab</to_name>
		<to_code>2691526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Complement 5a Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193973</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avacopan</to_name>
		<to_code>2572100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Complement 5a Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</from_name>
		<from_code>N0000194151</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crinecerfont</to_name>
		<to_code>2701386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with corticotropin releasing hormone antagonist mechanism of action (substance)</from_name>
		<from_code>418825003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hormone receptor antagonist (product)</from_name>
		<from_code>327298003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</to_name>
		<to_code>N0000194151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide diaspartate</from_name>
		<from_code>1364104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichlorphenamide</from_name>
		<from_code>3353</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crinecerfont</from_name>
		<from_code>2701386</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide</from_name>
		<from_code>1364105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pituitary Gland Activity Alteration [PE]</from_name>
		<from_code>N0000009805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pasireotide pamoate</from_name>
		<from_code>1597818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
		<to_code>N0000008382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin Antagonist [EPC]</from_name>
		<from_code>N0000175841</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing progesterone receptor antagonist (product)</to_name>
		<to_code>768669004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Progestin Antagonist [EPC]</from_name>
		<from_code>N0000175841</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mifepristone</to_name>
		<to_code>6964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
		<from_code>103022008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Progestin Antagonist [EPC]</to_name>
		<to_code>N0000175841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-17 Receptor A Antagonist [EPC]</from_name>
		<from_code>N0000193276</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brodalumab</to_name>
		<to_code>1872251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
		<to_code>N0000193276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
		<to_code>N0000193276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
		<to_code>N0000193276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etanercept</to_name>
		<to_code>214555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golimumab</to_name>
		<to_code>819300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab</to_name>
		<to_code>327361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab</to_name>
		<to_code>191831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-aaty</to_name>
		<to_code>2639649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-bwwd</to_name>
		<to_code>2612153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-ryvk</to_name>
		<to_code>2677776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab-dyyb</to_name>
		<to_code>1790539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
		<from_code>N0000175610</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>certolizumab pegol</to_name>
		<to_code>709271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Blocker [EPC]</to_name>
		<to_code>N0000175610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tumor Necrosis Factor Blocker [EPC]</to_name>
		<to_code>N0000175610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprosartan</to_name>
		<to_code>83515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olmesartan</to_name>
		<to_code>321064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sparsentan</to_name>
		<to_code>2630535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with angiotensin II receptor antagonist mechanism of action (substance)</to_name>
		<to_code>372913009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>losartan</to_name>
		<to_code>52175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing angiotensin II receptor antagonist (product)</to_name>
		<to_code>96308008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irbesartan</to_name>
		<to_code>83818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azilsartan</to_name>
		<to_code>1091643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valsartan</to_name>
		<to_code>69749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>candesartan</to_name>
		<to_code>214354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
		<from_code>N0000175561</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telmisartan</to_name>
		<to_code>73494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiotensin 2 Receptor Blocker [EPC]</to_name>
		<to_code>N0000175561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190119</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with growth hormone receptor antagonist mechanism of action (substance)</to_name>
		<to_code>788643002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190119</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing growth hormone receptor antagonist (product)</to_name>
		<to_code>870491000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
		<from_code>N0000190119</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegvisomant</to_name>
		<to_code>278739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
		<from_code>N0000193952</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptinezumab</to_name>
		<to_code>2282660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
		<from_code>N0000193952</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)</to_name>
		<to_code>771595002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
		<from_code>N0000193952</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcitonin gene-related peptide receptor antagonist (product)</to_name>
		<to_code>771677008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interleukin 23 receptor antagonist mechanism of action (substance)</to_name>
		<to_code>771592004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab</to_name>
		<to_code>847083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guselkumab</to_name>
		<to_code>1928588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-srlf</to_name>
		<to_code>2717063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-aekn</to_name>
		<to_code>2705377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interleukin 23 receptor antagonist (product)</to_name>
		<to_code>771678003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirikizumab</to_name>
		<to_code>2668384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tildrakizumab</to_name>
		<to_code>2053436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-23 Antagonist [EPC]</from_name>
		<from_code>N0000192799</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risankizumab</to_name>
		<to_code>2166040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-23 Antagonist [EPC]</to_name>
		<to_code>N0000192799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-17A Antagonist [EPC]</from_name>
		<from_code>N0000191495</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixekizumab</to_name>
		<to_code>1745099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-17A Antagonist [EPC]</from_name>
		<from_code>N0000191495</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secukinumab</to_name>
		<to_code>1599788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonist [EPC]</to_name>
		<to_code>N0000191495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
		<from_code>716044007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonist [EPC]</to_name>
		<to_code>N0000191495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing interleukin receptor antagonist (product)</from_name>
		<from_code>770620001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-17A Antagonist [EPC]</to_name>
		<to_code>N0000191495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Type I interferon Receptor Antagonist [EPC]</from_name>
		<from_code>N0000193967</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anifrolumab</to_name>
		<to_code>2565265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with receptor antagonist mechanism of action (substance)</from_name>
		<from_code>771382006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Type I interferon Receptor Antagonist [EPC]</to_name>
		<to_code>N0000193967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Antagonist [EPC]</from_name>
		<from_code>N0000191006</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interleukin receptor antagonist (product)</to_name>
		<to_code>770620001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Antagonist [EPC]</from_name>
		<from_code>N0000191006</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interleukin receptor antagonist mechanism of action (substance)</to_name>
		<to_code>716044007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin-6 Antagonist [EPC]</from_name>
		<from_code>N0000191006</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>siltuximab</to_name>
		<to_code>1535218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interleukin Agent [APC]</from_name>
		<from_code>N0000193903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin-6 Antagonist [EPC]</to_name>
		<to_code>N0000191006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
		<from_code>N0000193989</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tebentafusp</to_name>
		<to_code>2590743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000193989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000193989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
		<to_code>N0000193989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD123 Interaction [EPC]</from_name>
		<from_code>N0000193864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytotoxins</to_name>
		<to_code>M0005633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD123 Interaction [EPC]</from_name>
		<from_code>N0000193864</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tagraxofusp</to_name>
		<to_code>2109055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD123 Interaction [EPC]</to_name>
		<to_code>N0000193864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
		<from_code>N0000181816</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fingolimod</to_name>
		<to_code>1012892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
		<from_code>N0000181816</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ponesimod</to_name>
		<to_code>2532300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
		<from_code>N0000181816</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>siponimod</to_name>
		<to_code>2121085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
		<from_code>N0000181816</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ozanimod</to_name>
		<to_code>2288236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
		<to_code>N0000181816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
		<to_code>N0000181816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
		<to_code>N0000181816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Drug [EPC]</to_name>
		<to_code>N0000175882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Actinomycin [EPC]</to_name>
		<to_code>N0000180850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Barbiturate [EPC]</to_name>
		<to_code>N0000175693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aluminum Complex [EPC]</to_name>
		<to_code>N0000175801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium [EPC]</to_name>
		<to_code>N0000175901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiazolidinedione [EPC]</to_name>
		<to_code>N0000180190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nicotinic Acid [EPC]</to_name>
		<to_code>N0000175594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfone [EPC]</to_name>
		<to_code>N0000175881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bismuth [EPC]</to_name>
		<to_code>N0000180183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon beta [EPC]</to_name>
		<to_code>N0000191625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Medium-chain Triglyceride [EPC]</to_name>
		<to_code>N0000194023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacycline [EPC]</to_name>
		<to_code>N0000175603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzothiazole [EPC]</to_name>
		<to_code>N0000175740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Porphyrin Precursor [EPC]</to_name>
		<to_code>N0000175846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glycosaminoglycan [EPC]</to_name>
		<to_code>N0000175837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Glycoside [EPC]</to_name>
		<to_code>N0000175568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amino Acid [EPC]</to_name>
		<to_code>N0000175780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiazide Diuretic [EPC]</to_name>
		<to_code>N0000175419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Retinoid [EPC]</to_name>
		<to_code>N0000175607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thalidomide Analog [EPC]</to_name>
		<to_code>N0000184014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glinide [EPC]</to_name>
		<to_code>N0000175428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parenteral Iron Replacement [EPC]</to_name>
		<to_code>N0000177913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Alkaloid [EPC]</to_name>
		<to_code>N0000193949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Hydroxy Acid [EPC]</to_name>
		<to_code>N0000175842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyridone [EPC]</to_name>
		<to_code>N0000191420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyrethroid [EPC]</to_name>
		<to_code>N0000175847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminosalicylate [EPC]</to_name>
		<to_code>N0000175781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitrate Vasodilator [EPC]</to_name>
		<to_code>N0000175415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amide Local Anesthetic [EPC]</to_name>
		<to_code>N0000175682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Semifluorinated Alkane [EPC]</to_name>
		<to_code>N0000194071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bisphosphonate [EPC]</to_name>
		<to_code>N0000175579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biguanide [EPC]</to_name>
		<to_code>N0000175565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon alpha [EPC]</to_name>
		<to_code>N0000175521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ester Local Anesthetic [EPC]</to_name>
		<to_code>N0000175683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Omega-3 Fatty Acid [EPC]</to_name>
		<to_code>N0000175583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Psoralen [EPC]</to_name>
		<to_code>N0000175879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon gamma [EPC]</to_name>
		<to_code>N0000175541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reducing and Complexing Thiol [EPC]</to_name>
		<to_code>N0000175898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclic Pyranopterin Monophosphate [EPC]</to_name>
		<to_code>N0000193919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Macrolide [EPC]</to_name>
		<to_code>N0000175877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Steroid [EPC]</to_name>
		<to_code>N0000194034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Chemical Structure [APC]</from_name>
		<from_code>N0000193894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonylurea [EPC]</to_name>
		<to_code>N0000175608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarecycline</to_name>
		<to_code>2059018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxycycline anhydrous</to_name>
		<to_code>1545992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minocycline</to_name>
		<to_code>6980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tetracycline-class Drug [EPC]</from_name>
		<from_code>N0000175882</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>doxycycline</to_name>
		<to_code>3640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing tetracycline (medicinal product)</from_name>
		<from_code>66261008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Drug [EPC]</to_name>
		<to_code>N0000175882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with tetracycline structure and antibacterial mechanism of action (substance)</from_name>
		<from_code>373206009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tetracycline-class Drug [EPC]</to_name>
		<to_code>N0000175882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetracyclines</to_name>
		<to_code>M0021223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Actinomycin [EPC]</from_name>
		<from_code>N0000180850</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Dactinomycin (substance)</to_name>
		<to_code>387353003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Actinomycin [EPC]</from_name>
		<from_code>N0000180850</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dactinomycin</to_name>
		<to_code>3100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Actinomycin [EPC]</from_name>
		<from_code>N0000180850</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing dactinomycin (medicinal product)</to_name>
		<to_code>64127001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Actinomycin [EPC]</from_name>
		<from_code>N0000180850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dactinomycin</to_name>
		<to_code>M0005644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dactinomycin</to_name>
		<to_code>M0005644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dactinomycin</to_name>
		<to_code>M0005644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Barbiturate [EPC]</from_name>
		<from_code>N0000175693</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Barbiturate (substance)</to_name>
		<to_code>372798009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Barbiturate [EPC]</from_name>
		<from_code>N0000175693</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methohexital</to_name>
		<to_code>6847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Barbiturate [EPC]</from_name>
		<from_code>N0000175693</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing barbiturate (product)</to_name>
		<to_code>60978003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Barbiturate [EPC]</from_name>
		<from_code>N0000175693</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>butalbital</to_name>
		<to_code>19860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Barbiturate [EPC]</from_name>
		<from_code>N0000175693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium oxybate</from_name>
		<from_code>2387309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium oxybate</from_name>
		<from_code>9899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butalbital</from_name>
		<from_code>19860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium oxybate</from_name>
		<from_code>2387307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxybate</from_name>
		<from_code>2387308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybate</from_name>
		<from_code>2387302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Barbiturates</to_name>
		<to_code>M0002177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aluminum Complex [EPC]</from_name>
		<from_code>N0000175801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Organometallic Compounds</to_name>
		<to_code>M0015420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aluminum Complex [EPC]</from_name>
		<from_code>N0000175801</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucralfate</to_name>
		<to_code>10156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing aluminium and/or aluminium compound (product)</from_name>
		<from_code>768690007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aluminum Complex [EPC]</to_name>
		<to_code>N0000175801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Aluminium compound (substance)</from_name>
		<from_code>41433005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aluminum Complex [EPC]</to_name>
		<to_code>N0000175801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate</from_name>
		<from_code>10156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Organometallic Compounds</to_name>
		<to_code>M0015420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium [EPC]</from_name>
		<from_code>N0000175901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium [EPC]</from_name>
		<from_code>N0000175901</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium</to_name>
		<to_code>1895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium [EPC]</from_name>
		<from_code>N0000175901</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Calcium (substance)</to_name>
		<to_code>5540006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium [EPC]</from_name>
		<from_code>N0000175901</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcium (medicinal product)</to_name>
		<to_code>767113005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium [EPC]</to_name>
		<to_code>N0000175901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate</from_name>
		<from_code>1919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium levulinate</from_name>
		<from_code>47624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate</from_name>
		<from_code>1925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate</from_name>
		<from_code>47613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium acetate</from_name>
		<from_code>214342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glycerophosphate</from_name>
		<from_code>1909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride dihydrate</from_name>
		<from_code>221068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate dibasic</from_name>
		<from_code>47627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride</from_name>
		<from_code>1901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium creosotate</from_name>
		<from_code>317206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate</from_name>
		<from_code>1908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tricalcium phosphate</from_name>
		<from_code>47628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium hydroxide</from_name>
		<from_code>1910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pantothenate</from_name>
		<from_code>1918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pangamate</from_name>
		<from_code>1917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium amino acid chelate</from_name>
		<from_code>994438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium iodized</from_name>
		<from_code>317207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium lactate</from_name>
		<from_code>47622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium</from_name>
		<from_code>1895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glubionate</from_name>
		<from_code>25806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Compounds</to_name>
		<to_code>M0026683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazolidinedione [EPC]</from_name>
		<from_code>N0000180190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazolidinediones</to_name>
		<to_code>M0447306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazolidinedione [EPC]</from_name>
		<from_code>N0000180190</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing thiazolidinedione (product)</to_name>
		<to_code>109086001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazolidinedione [EPC]</from_name>
		<from_code>N0000180190</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Thiazolidinedione (substance)</to_name>
		<to_code>372568004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazolidinedione [EPC]</from_name>
		<from_code>N0000180190</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pioglitazone</to_name>
		<to_code>33738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazolidinedione [EPC]</from_name>
		<from_code>N0000180190</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosiglitazone</to_name>
		<to_code>84108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiazolidinedione [EPC]</to_name>
		<to_code>N0000180190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazolidinediones</to_name>
		<to_code>M0447306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazolidinediones</to_name>
		<to_code>M0447306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazolidinediones</to_name>
		<to_code>M0447306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazolidinediones</to_name>
		<to_code>M0447306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nicotinic Acid [EPC]</from_name>
		<from_code>N0000175594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nicotinic Acids</to_name>
		<to_code>M0014839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nicotinic Acid [EPC]</from_name>
		<from_code>N0000175594</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing nicotinic acid (medicinal product)</to_name>
		<to_code>63639004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nicotinic Acid [EPC]</from_name>
		<from_code>N0000175594</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>niacin</to_name>
		<to_code>7393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nicotinic Acid [EPC]</from_name>
		<from_code>N0000175594</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Nicotinic acid (substance)</to_name>
		<to_code>273943001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nicotinic Acid [EPC]</to_name>
		<to_code>N0000175594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nicotinic Acids</to_name>
		<to_code>M0014839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nicotinic Acids</to_name>
		<to_code>M0014839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfone [EPC]</from_name>
		<from_code>N0000175881</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dapsone</to_name>
		<to_code>3108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfone [EPC]</from_name>
		<from_code>N0000175881</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Sulfone (substance)</to_name>
		<to_code>363549008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfone [EPC]</from_name>
		<from_code>N0000175881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfones</to_name>
		<to_code>M0020791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sulfur and/or sulfur compound (product)</from_name>
		<from_code>768610006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfone [EPC]</to_name>
		<to_code>N0000175881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapsone</from_name>
		<from_code>3108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfones</to_name>
		<to_code>M0020791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bismuth [EPC]</from_name>
		<from_code>N0000180183</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bismuth subsalicylate</to_name>
		<to_code>19478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bismuth [EPC]</from_name>
		<from_code>N0000180183</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bismuth cation</to_name>
		<to_code>1546284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bismuth [EPC]</from_name>
		<from_code>N0000180183</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Bismuth (substance)</to_name>
		<to_code>23172004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bismuth [EPC]</from_name>
		<from_code>N0000180183</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing bismuth (medicinal product)</to_name>
		<to_code>82290007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bismuth [EPC]</from_name>
		<from_code>N0000180183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bismuth</to_name>
		<to_code>M0002611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bismuth</to_name>
		<to_code>M0002611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bismuth</to_name>
		<to_code>M0002611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth cation</from_name>
		<from_code>1546284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bismuth</to_name>
		<to_code>M0002611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon beta [EPC]</from_name>
		<from_code>N0000191625</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon beta-1a</to_name>
		<to_code>75917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon beta [EPC]</from_name>
		<from_code>N0000191625</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Interferon beta (substance)</to_name>
		<to_code>420710006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon beta [EPC]</from_name>
		<from_code>N0000191625</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginterferon beta-1a</to_name>
		<to_code>1546168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon beta [EPC]</from_name>
		<from_code>N0000191625</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon beta-1b</to_name>
		<to_code>72257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon beta [EPC]</from_name>
		<from_code>N0000191625</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interferon beta (product)</to_name>
		<to_code>136112008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon beta [EPC]</from_name>
		<from_code>N0000191625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon-beta</to_name>
		<to_code>M0025715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon beta [EPC]</to_name>
		<to_code>N0000191625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Medium-chain Triglyceride [EPC]</from_name>
		<from_code>N0000194023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triglycerides</to_name>
		<to_code>M0021969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Medium-chain Triglyceride [EPC]</from_name>
		<from_code>N0000194023</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triheptanoin</to_name>
		<to_code>1313234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Triacylglycerol (substance)</from_name>
		<from_code>85600001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Medium-chain Triglyceride [EPC]</to_name>
		<to_code>N0000194023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Medium-chain Triglyceride [EPC]</to_name>
		<to_code>N0000194023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triheptanoin</from_name>
		<from_code>1313234</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triglycerides</to_name>
		<to_code>M0021969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline [EPC]</from_name>
		<from_code>N0000175603</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing prostacyclin PGI2 (product)</to_name>
		<to_code>65484006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline [EPC]</from_name>
		<from_code>N0000175603</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Prostacyclin (substance)</to_name>
		<to_code>373305006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline [EPC]</from_name>
		<from_code>N0000175603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline [EPC]</from_name>
		<from_code>N0000175603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iloprost</to_name>
		<to_code>40138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline [EPC]</from_name>
		<from_code>N0000175603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacycline Vasodilator [EPC]</to_name>
		<to_code>N0000175416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacycline [EPC]</to_name>
		<to_code>N0000175603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline Vasodilator [EPC]</from_name>
		<from_code>N0000175416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline Vasodilator [EPC]</from_name>
		<from_code>N0000175416</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treprostinil</to_name>
		<to_code>343048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline Vasodilator [EPC]</from_name>
		<from_code>N0000175416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Prostacycline Vasodilator [EPC]</from_name>
		<from_code>N0000175416</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoprostenol</to_name>
		<to_code>8814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing prostacyclin PGI2 (product)</from_name>
		<from_code>65484006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacycline Vasodilator [EPC]</to_name>
		<to_code>N0000175416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Prostacyclin (substance)</from_name>
		<from_code>373305006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Prostacycline Vasodilator [EPC]</to_name>
		<to_code>N0000175416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloprost</from_name>
		<from_code>40138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinoprostone</from_name>
		<from_code>3478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prostaglandins I</to_name>
		<to_code>M0017817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilation [PE]</from_name>
		<from_code>N0000009909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilation [PE]</from_name>
		<from_code>N0000009909</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclandelate</from_name>
		<from_code>2970</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital</from_name>
		<from_code>38077</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib disodium</from_name>
		<from_code>2055929</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buflomedil hydrochloride</from_name>
		<from_code>235934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroprusside</from_name>
		<from_code>7476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital sodium</from_name>
		<from_code>314874</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riociguat</from_name>
		<from_code>1439816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Tone Alteration [PE]</from_name>
		<from_code>N0000009906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythritol</from_name>
		<from_code>1369563</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibopamine hydrochloride</from_name>
		<from_code>284157</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Astragalus preparation</from_name>
		<from_code>319818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine hydrochloride</from_name>
		<from_code>203132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide choline</from_name>
		<from_code>2711542</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetiedil citrate</from_name>
		<from_code>236204</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide</from_name>
		<from_code>3327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine</from_name>
		<from_code>6756</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resveratrol</from_name>
		<from_code>1000492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urapidil</from_name>
		<from_code>39230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethaphan camsylate</from_name>
		<from_code>38680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine codecarboxylate</from_name>
		<from_code>158387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone lactate</from_name>
		<from_code>155120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trapidil</from_name>
		<from_code>10735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine hydrochloride</from_name>
		<from_code>236481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifenprodil</from_name>
		<from_code>27403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetiedil</from_name>
		<from_code>20609</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrate Vasodilator [EPC]</from_name>
		<from_code>N0000175415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibopamine</from_name>
		<from_code>51253</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone</from_name>
		<from_code>52769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flosequinan</from_name>
		<from_code>25089</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifenprodil tartrate</from_name>
		<from_code>289912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buflomedil</from_name>
		<from_code>19836</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyphylline</from_name>
		<from_code>3714</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine</from_name>
		<from_code>7895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephentermine sulfate</from_name>
		<from_code>82042</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib</from_name>
		<from_code>2044896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilation [PE]</to_name>
		<to_code>N0000009909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Venous Vasodilation [PE]</from_name>
		<from_code>N0000009911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Venous Vasodilation [PE]</from_name>
		<from_code>N0000009911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasodilation [PE]</to_name>
		<to_code>N0000009818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Venous Vasodilation [PE]</from_name>
		<from_code>N0000009911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicorandil</from_name>
		<from_code>31748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin mesylate</from_name>
		<from_code>39173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride</from_name>
		<from_code>235224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin</from_name>
		<from_code>8629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin</from_name>
		<from_code>37798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin hydrochloride</from_name>
		<from_code>203210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin</from_name>
		<from_code>49276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl nitrite</from_name>
		<from_code>742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetranitrate</from_name>
		<from_code>7992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride anhydrous</from_name>
		<from_code>1299927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasodilation [PE]</to_name>
		<to_code>N0000009911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avanafil</from_name>
		<from_code>1291301</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil</from_name>
		<from_code>136411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tadalafil</from_name>
		<from_code>358263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride trihydrate</from_name>
		<from_code>1309396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil citrate</from_name>
		<from_code>221161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride</from_name>
		<from_code>307306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil</from_name>
		<from_code>306674</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Penile Venous Vasodilation [PE]</to_name>
		<to_code>N0000009798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasodilation [PE]</to_name>
		<to_code>N0000009818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil</from_name>
		<from_code>136411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasodilation [PE]</to_name>
		<to_code>N0000009818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tadalafil</from_name>
		<from_code>358263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasodilation [PE]</to_name>
		<to_code>N0000009818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasodilation [PE]</to_name>
		<to_code>N0000009818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil citrate</from_name>
		<from_code>221161</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasodilation [PE]</to_name>
		<to_code>N0000009818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guafacine hydrochloride</from_name>
		<from_code>862004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine</from_name>
		<from_code>40114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitroprusside</from_name>
		<from_code>9895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz acetate</from_name>
		<from_code>227225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz</from_name>
		<from_code>5033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasodilation [PE]</to_name>
		<to_code>N0000009883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucosal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Splanchnic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine</from_name>
		<from_code>2376944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine maleate</from_name>
		<from_code>2377031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan medoxomil</from_name>
		<from_code>1091642</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine mesylate</from_name>
		<from_code>227240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl nitrite</from_name>
		<from_code>742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicorandil</from_name>
		<from_code>31748</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine</from_name>
		<from_code>5470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sulfate</from_name>
		<from_code>235959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine</from_name>
		<from_code>3409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride anhydrous</from_name>
		<from_code>1299927</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetranitrate</from_name>
		<from_code>7992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan</from_name>
		<from_code>1091643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin mesylate</from_name>
		<from_code>39173</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin</from_name>
		<from_code>8629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine</from_name>
		<from_code>233603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplerenone</from_name>
		<from_code>298869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine hydrochloride</from_name>
		<from_code>82027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine</from_name>
		<from_code>8153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin</from_name>
		<from_code>49276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin hydrochloride</from_name>
		<from_code>203210</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan kamedoxomil</from_name>
		<from_code>1294597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sul hemipenthy</from_name>
		<from_code>259379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride</from_name>
		<from_code>235224</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin</from_name>
		<from_code>37798</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine butyrate</from_name>
		<from_code>977863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Coronary Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008375</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilvadipine</from_name>
		<from_code>53692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine benzoate</from_name>
		<from_code>2184116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine hydrochloride</from_name>
		<from_code>82019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacidipine</from_name>
		<from_code>28382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine hydrochloride</from_name>
		<from_code>153679</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrendipine</from_name>
		<from_code>7441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barnidipine hydrochloride</from_name>
		<from_code>283819</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil</from_name>
		<from_code>83213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regadenoson</from_name>
		<from_code>640062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyridamole</from_name>
		<from_code>3521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline hydrochloride</from_name>
		<from_code>236767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepirodipine</from_name>
		<from_code>39879</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil dihydrochloride</from_name>
		<from_code>83214</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline</from_name>
		<from_code>4327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regadenoson anhydrous</from_name>
		<from_code>1546015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine</from_name>
		<from_code>4459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine</from_name>
		<from_code>135056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Systemic Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloprost</from_name>
		<from_code>40138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nesiritide</from_name>
		<from_code>19666</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guafacine hydrochloride</from_name>
		<from_code>862004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine hydrochloride</from_name>
		<from_code>82019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil diolamine</from_name>
		<from_code>1927409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz</from_name>
		<from_code>5033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz acetate</from_name>
		<from_code>227225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine</from_name>
		<from_code>6066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine</from_name>
		<from_code>40114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine hydrochloride</from_name>
		<from_code>82033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil sodium</from_name>
		<from_code>342691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitroprusside</from_name>
		<from_code>9895</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine</from_name>
		<from_code>4459</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cerebral Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008352</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucosal Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Splanchnic Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilator [EPC]</from_name>
		<from_code>N0000175564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine hydrochloride</from_name>
		<from_code>82027</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil</from_name>
		<from_code>6984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pinacidil</from_name>
		<from_code>33717</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sul hemipenthy</from_name>
		<from_code>259379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sulfate</from_name>
		<from_code>235959</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine</from_name>
		<from_code>3409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine</from_name>
		<from_code>5470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175383</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oropharyngeal Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175383</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175383</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175383</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucosal Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oropharyngeal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oropharyngeal Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genitourinary Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009059</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Conjunctival Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscular Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cutaneous Arterial Vasodilation [PE]</from_name>
		<from_code>N0000008377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pulmonary Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009816</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Efferent Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arteriolar Vasodilation [PE]</from_name>
		<from_code>N0000175390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Afferent Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Efferent Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009828</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Efferent Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Afferent Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Afferent Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Splanchnic Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009856</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Splanchnic Arteriolar Vasodilation [PE]</to_name>
		<to_code>N0000175393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate ester</from_name>
		<from_code>1926479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil</from_name>
		<from_code>6984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate</from_name>
		<from_code>1651695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasodilation [PE]</to_name>
		<to_code>N0000008372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oropharyngeal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Afferent Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arterial Vasodilation [PE]</from_name>
		<from_code>N0000009826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Efferent Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinaprilat</from_name>
		<from_code>1546359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam</from_name>
		<from_code>24853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam mesylate</from_name>
		<from_code>203151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolaprilat</from_name>
		<from_code>1546379</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril hydrochloride</from_name>
		<from_code>259335</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinoprilat</from_name>
		<from_code>1546393</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramiprilat</from_name>
		<from_code>1546377</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril</from_name>
		<from_code>60245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat dihydrate</from_name>
		<from_code>2672730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril</from_name>
		<from_code>39990</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril calcium</from_name>
		<from_code>259493</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selexipag</from_name>
		<from_code>1729002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil diolamine</from_name>
		<from_code>1927409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan</from_name>
		<from_code>75207</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloprost</from_name>
		<from_code>40138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nesiritide</from_name>
		<from_code>19666</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macitentan</from_name>
		<from_code>1442132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambrisentan</from_name>
		<from_code>358274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil sodium</from_name>
		<from_code>342691</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasodilation [PE]</to_name>
		<to_code>N0000009754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzothiazole [EPC]</from_name>
		<from_code>N0000175740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzothiazoles</to_name>
		<to_code>M0483511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzothiazole [EPC]</from_name>
		<from_code>N0000175740</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Benzothiazole (substance)</to_name>
		<to_code>422377009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Benzothiazole [EPC]</from_name>
		<from_code>N0000175740</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riluzole</to_name>
		<to_code>35623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing thiazole (product)</from_name>
		<from_code>768624005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Benzothiazole [EPC]</to_name>
		<to_code>N0000175740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riluzole</from_name>
		<from_code>35623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzothiazoles</to_name>
		<to_code>M0483511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Porphyrin Precursor [EPC]</from_name>
		<from_code>N0000175846</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing 5-aminolevulinic acid (medicinal product)</to_name>
		<to_code>409398000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Porphyrin Precursor [EPC]</from_name>
		<from_code>N0000175846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminolevulinic Acid</to_name>
		<to_code>M0000951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Porphyrin Precursor [EPC]</from_name>
		<from_code>N0000175846</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 5-aminolevulinate</to_name>
		<to_code>337068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Porphyrin Precursor [EPC]</from_name>
		<from_code>N0000175846</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminolevulinic acid</to_name>
		<to_code>683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Porphyrin Precursor [EPC]</from_name>
		<from_code>N0000175846</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>5-aminolevulinic acid (substance)</to_name>
		<to_code>259496005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminolevulinic Acid</to_name>
		<to_code>M0000951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 5-aminolevulinate</from_name>
		<from_code>337068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminolevulinic Acid</to_name>
		<to_code>M0000951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminolevulinic Acid</to_name>
		<to_code>M0000951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycosaminoglycan [EPC]</from_name>
		<from_code>N0000175837</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Mucopolysaccharide (substance)</to_name>
		<to_code>82565009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycosaminoglycan [EPC]</from_name>
		<from_code>N0000175837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycosaminoglycans</to_name>
		<to_code>M0009496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycosaminoglycan [EPC]</from_name>
		<from_code>N0000175837</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentosan polysulfate</to_name>
		<to_code>155046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentosan polysulfate</from_name>
		<from_code>155046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycosaminoglycans</to_name>
		<to_code>M0009496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiac Glycoside [EPC]</from_name>
		<from_code>N0000175568</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing glycoside (product)</to_name>
		<to_code>33589008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiac Glycoside [EPC]</from_name>
		<from_code>N0000175568</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Digitalis glycoside (substance)</to_name>
		<to_code>406759007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiac Glycoside [EPC]</from_name>
		<from_code>N0000175568</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>digoxin</to_name>
		<to_code>3407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiac Glycoside [EPC]</from_name>
		<from_code>N0000175568</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Glycosides</to_name>
		<to_code>M0003451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cardiac Glycoside [EPC]</to_name>
		<to_code>N0000175568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Glycosides</to_name>
		<to_code>M0003451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aromatic Amino Acid [EPC]</to_name>
		<to_code>N0000193220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alanine</to_name>
		<to_code>426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutamine</to_name>
		<to_code>4885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing amino acid (product)</to_name>
		<to_code>764883009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
		<to_code>N0000175797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid [EPC]</from_name>
		<from_code>N0000175780</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Amino acid (substance)</to_name>
		<to_code>52518006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatic Amino Acid [EPC]</from_name>
		<from_code>N0000193220</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>levodopa</to_name>
		<to_code>6375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aromatic Amino Acid [EPC]</from_name>
		<from_code>N0000193220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids, Aromatic</to_name>
		<to_code>M0370111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levodopa</from_name>
		<from_code>6375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids, Aromatic</to_name>
		<to_code>M0370111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid Hypertonic Solution [EPC]</from_name>
		<from_code>N0000175797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amino Acid Hypertonic Solution [EPC]</from_name>
		<from_code>N0000175797</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing amino acid (product)</from_name>
		<from_code>764883009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
		<to_code>N0000175797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Total parenteral nutrition agent (substance)</from_name>
		<from_code>789708003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
		<to_code>N0000175797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Amino acid (substance)</from_name>
		<from_code>52518006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
		<to_code>N0000175797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutamine</from_name>
		<from_code>4885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alanine</from_name>
		<from_code>426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-alanine</from_name>
		<from_code>61</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutamic acid</from_name>
		<from_code>25916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amino Acids</from_name>
		<from_code>658</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amino Acids</to_name>
		<to_code>M0000922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bendroflumethiazide</to_name>
		<to_code>1369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrochlorothiazide</to_name>
		<to_code>5487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroflumethiazide</to_name>
		<to_code>5495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorothiazide</to_name>
		<to_code>2396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Thiazide diuretic (substance)</to_name>
		<to_code>372747003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide Diuretic [EPC]</from_name>
		<from_code>N0000175419</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polythiazide</to_name>
		<to_code>8565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diuretic [APC]</from_name>
		<from_code>N0000193873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiazide Diuretic [EPC]</to_name>
		<to_code>N0000175419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide</from_name>
		<from_code>3327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazoxide choline</from_name>
		<from_code>2711542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiazides</to_name>
		<to_code>M0471776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bexarotene</to_name>
		<to_code>233272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazarotene</to_name>
		<to_code>83947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tretinoin</to_name>
		<to_code>10753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acitretin</to_name>
		<to_code>16818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adapalene</to_name>
		<to_code>60223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing retinoid (product)</to_name>
		<to_code>116085009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alitretinoin</to_name>
		<to_code>81864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isotretinoin</to_name>
		<to_code>6064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifarotene</to_name>
		<to_code>2205637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palovarotene</to_name>
		<to_code>2663954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Retinoid [EPC]</from_name>
		<from_code>N0000175607</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Retinoid (substance)</to_name>
		<to_code>372579009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palovarotene</from_name>
		<from_code>2663954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isotretinoin</from_name>
		<from_code>6064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifarotene</from_name>
		<from_code>2205637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alitretinoin</from_name>
		<from_code>81864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alitretinoin</from_name>
		<from_code>81864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin</from_name>
		<from_code>10753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adapalene</from_name>
		<from_code>60223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bexarotene</from_name>
		<from_code>233272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinoids</to_name>
		<to_code>M0018962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thalidomide Analog [EPC]</from_name>
		<from_code>N0000184014</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomalidomide</to_name>
		<to_code>1369713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thalidomide Analog [EPC]</from_name>
		<from_code>N0000184014</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lenalidomide</to_name>
		<to_code>342369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thalidomide Analog [EPC]</from_name>
		<from_code>N0000184014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thalidomide</to_name>
		<to_code>M0021267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thalidomide Analog [EPC]</from_name>
		<from_code>N0000184014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Thalidomide (substance)</from_name>
		<from_code>78702007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thalidomide Analog [EPC]</to_name>
		<to_code>N0000184014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thalidomide</to_name>
		<to_code>M0021267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenalidomide</from_name>
		<from_code>342369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thalidomide</to_name>
		<to_code>M0021267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomalidomide</from_name>
		<from_code>1369713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thalidomide</to_name>
		<to_code>M0021267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinide [EPC]</from_name>
		<from_code>N0000175428</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>repaglinide</to_name>
		<to_code>73044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinide [EPC]</from_name>
		<from_code>N0000175428</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing meglitinide (medicinal product)</to_name>
		<to_code>109075003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinide [EPC]</from_name>
		<from_code>N0000175428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glinides [EXT]</to_name>
		<to_code>N0000177907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinide [EPC]</from_name>
		<from_code>N0000175428</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Meglitinide (substance)</to_name>
		<to_code>372566000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinide [EPC]</from_name>
		<from_code>N0000175428</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nateglinide</to_name>
		<to_code>274332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinides [EXT]</from_name>
		<from_code>N0000177907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>repaglinide</to_name>
		<to_code>M0196126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinides [EXT]</from_name>
		<from_code>N0000177907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meglitinide</to_name>
		<to_code>M0096461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glinides [EXT]</from_name>
		<from_code>N0000177907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nateglinide</to_name>
		<to_code>M0353981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glinides [EXT]</to_name>
		<to_code>N0000177907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repaglinide</from_name>
		<from_code>73044</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glinides [EXT]</to_name>
		<to_code>N0000177907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nateglinide</from_name>
		<from_code>274332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Glinides [EXT]</to_name>
		<to_code>N0000177907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repaglinide</from_name>
		<from_code>73044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>repaglinide</to_name>
		<to_code>M0196126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nateglinide</from_name>
		<from_code>274332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nateglinide</to_name>
		<to_code>M0353981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ferric cation</to_name>
		<to_code>1546357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ferumoxytol</to_name>
		<to_code>473387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron Compounds</to_name>
		<to_code>M0540735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing iron in parenteral dose form (medicinal product form)</to_name>
		<to_code>255668001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron</to_name>
		<to_code>M0011718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron sucrose</to_name>
		<to_code>24909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Parenteral Iron Replacement [EPC]</from_name>
		<from_code>N0000177913</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ferric gluconate complex</to_name>
		<to_code>261435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parenteral Iron Replacement [EPC]</to_name>
		<to_code>N0000177913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Iron supplement (substance)</from_name>
		<from_code>438641000124100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Parenteral Iron Replacement [EPC]</to_name>
		<to_code>N0000177913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron</to_name>
		<to_code>M0011718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxytol</from_name>
		<from_code>473387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron</to_name>
		<to_code>M0011718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric cation</from_name>
		<from_code>1546357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron</to_name>
		<to_code>M0011718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron</to_name>
		<to_code>M0011718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iron</to_name>
		<to_code>M0011718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkaloid [EPC]</from_name>
		<from_code>N0000193949</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Alkaloid (substance)</to_name>
		<to_code>419001004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkaloid [EPC]</from_name>
		<from_code>N0000193949</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing alkaloid (product)</to_name>
		<to_code>768593004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkaloid [EPC]</from_name>
		<from_code>N0000193949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alkaloids</to_name>
		<to_code>M0000713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Alkaloid [EPC]</from_name>
		<from_code>N0000193949</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colchicine</to_name>
		<to_code>2683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alkaloids</to_name>
		<to_code>M0000713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Hydroxy Acid [EPC]</from_name>
		<from_code>N0000175842</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium lactate</to_name>
		<to_code>215247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>alpha-Hydroxy Acid [EPC]</from_name>
		<from_code>N0000175842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydroxy Acids</to_name>
		<to_code>M0010745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Acid (substance)</from_name>
		<from_code>34957004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>alpha-Hydroxy Acid [EPC]</to_name>
		<to_code>N0000175842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium lactate</from_name>
		<from_code>215247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydroxy Acids</to_name>
		<to_code>M0010745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyridone [EPC]</from_name>
		<from_code>N0000191420</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirfenidone</to_name>
		<to_code>1592254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyridone [EPC]</from_name>
		<from_code>N0000191420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyridones</to_name>
		<to_code>M0018236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Pyridine and/or pyridine derivative (substance)</from_name>
		<from_code>300067003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pyridone [EPC]</to_name>
		<to_code>N0000191420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirfenidone</from_name>
		<from_code>1592254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyridones</to_name>
		<to_code>M0018236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrethroid [EPC]</from_name>
		<from_code>N0000175847</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing pyrethroid (product)</to_name>
		<to_code>768767009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrethroid [EPC]</from_name>
		<from_code>N0000175847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrethrins</to_name>
		<to_code>M0018228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrethroid [EPC]</from_name>
		<from_code>N0000175847</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>permethrin</to_name>
		<to_code>33199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pyrethroid [EPC]</from_name>
		<from_code>N0000175847</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Pyrethroid (substance)</to_name>
		<to_code>768075009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrethrins</from_name>
		<from_code>8991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrethrins</to_name>
		<to_code>M0018228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrethrins</to_name>
		<to_code>M0018228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminosalicylate [EPC]</from_name>
		<from_code>N0000175781</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>olsalazine</to_name>
		<to_code>32385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminosalicylate [EPC]</from_name>
		<from_code>N0000175781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminosalicylic Acids</to_name>
		<to_code>M0000971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminosalicylate [EPC]</from_name>
		<from_code>N0000175781</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfasalazine</to_name>
		<to_code>9524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminosalicylate [EPC]</from_name>
		<from_code>N0000175781</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesalamine</to_name>
		<to_code>52582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Aminosalicylate [EPC]</from_name>
		<from_code>N0000175781</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>balsalazide</to_name>
		<to_code>18747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Salicylate (substance)</from_name>
		<from_code>255637000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminosalicylate [EPC]</to_name>
		<to_code>N0000175781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing salicylate (product)</from_name>
		<from_code>350312004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminosalicylate [EPC]</to_name>
		<to_code>N0000175781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Aminosalicylate [EPC]</to_name>
		<to_code>N0000175781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrate Vasodilator [EPC]</from_name>
		<from_code>N0000175415</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosorbide dinitrate</to_name>
		<to_code>6058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrate Vasodilator [EPC]</from_name>
		<from_code>N0000175415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrate Vasodilator [EPC]</from_name>
		<from_code>N0000175415</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosorbide mononitrate</to_name>
		<to_code>28004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrate Vasodilator [EPC]</from_name>
		<from_code>N0000175415</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitroglycerin</to_name>
		<to_code>4917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrate Vasodilator [EPC]</from_name>
		<from_code>N0000175415</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Nitrate-based vasodilating agent (substance)</to_name>
		<to_code>372700007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitrate Vasodilator [EPC]</to_name>
		<to_code>N0000175415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil citrate</from_name>
		<from_code>221161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil</from_name>
		<from_code>306674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride</from_name>
		<from_code>307306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avanafil</from_name>
		<from_code>1291301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil</from_name>
		<from_code>136411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tadalafil</from_name>
		<from_code>358263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vardenafil hydrochloride trihydrate</from_name>
		<from_code>1309396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitrates</to_name>
		<to_code>M0014874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bupivacaine</to_name>
		<to_code>1815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropivacaine</to_name>
		<to_code>35780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lidocaine</to_name>
		<to_code>6387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Amide and/or amide derivative (substance)</to_name>
		<to_code>299987008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepivacaine</to_name>
		<to_code>6759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prilocaine</to_name>
		<to_code>8686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Amide Local Anesthetic [EPC]</from_name>
		<from_code>N0000175682</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>articaine</to_name>
		<to_code>592464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Local Anesthetic [EPC]</from_name>
		<from_code>N0000175539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Amide Local Anesthetic [EPC]</to_name>
		<to_code>N0000175682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine</from_name>
		<from_code>259453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride anhydrous</from_name>
		<from_code>1375412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proparacaine hydrochloride</from_name>
		<from_code>227778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine</from_name>
		<from_code>592464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine</from_name>
		<from_code>1815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride</from_name>
		<from_code>236539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine</from_name>
		<from_code>35780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride anhydrous</from_name>
		<from_code>2198974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine hydrochloride</from_name>
		<from_code>259454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride</from_name>
		<from_code>267396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ester Local Anesthetic [EPC]</from_name>
		<from_code>N0000175683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine hydrochloride</from_name>
		<from_code>91189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine</from_name>
		<from_code>10391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine hydrochloride</from_name>
		<from_code>203185</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proparacaine</from_name>
		<from_code>34905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sensory System Activity Alteration [PE]</from_name>
		<from_code>N0000175727</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Local Anesthetic [EPC]</from_name>
		<from_code>N0000175539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine</from_name>
		<from_code>6759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthesia [PE]</to_name>
		<to_code>N0000175976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine</from_name>
		<from_code>35780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride</from_name>
		<from_code>236539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine</from_name>
		<from_code>1815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine</from_name>
		<from_code>592464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine hydrochloride</from_name>
		<from_code>203185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine</from_name>
		<from_code>6759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride</from_name>
		<from_code>267396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amides</to_name>
		<to_code>M0000897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Semifluorinated Alkane [EPC]</from_name>
		<from_code>N0000194071</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluorohexyloctane</to_name>
		<to_code>2637547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Semifluorinated Alkane [EPC]</from_name>
		<from_code>N0000194071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Semifluorinated Alkane [EXT]</to_name>
		<to_code>N0000194072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Fluorinated hydrocarbon (substance)</from_name>
		<from_code>42850000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Semifluorinated Alkane [EPC]</to_name>
		<to_code>N0000194071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Semifluorinated Alkane [EXT]</to_name>
		<to_code>N0000194072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MeSH</from_namespace>
		<from_name>Hydrocarbons, Fluorinated</from_name>
		<from_code>M0010695</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Semifluorinated Alkane [EXT]</to_name>
		<to_code>N0000194072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perfluorohexyloctane</from_name>
		<from_code>2637547</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Semifluorinated Alkane [EXT]</to_name>
		<to_code>N0000194072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronic acid</to_name>
		<to_code>55685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pamidronic acid</to_name>
		<to_code>1546406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alendronic acid</to_name>
		<to_code>236083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Bisphosphonate (substance)</to_name>
		<to_code>372907000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidronic acid</to_name>
		<to_code>1356715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing bisphosphonate (product)</to_name>
		<to_code>96281001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibandronic acid</to_name>
		<to_code>115265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bisphosphonate [EPC]</from_name>
		<from_code>N0000175579</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zoledronic acid anhydrous</to_name>
		<to_code>1546014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid</from_name>
		<from_code>77655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronic acid</from_name>
		<from_code>236083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronate</from_name>
		<from_code>115264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronic acid</from_name>
		<from_code>55685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronic acid</from_name>
		<from_code>1546406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid anhydrous</from_name>
		<from_code>1546014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate</from_name>
		<from_code>73056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronate</from_name>
		<from_code>46041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronic acid</from_name>
		<from_code>1356715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronate</from_name>
		<from_code>11473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate disodium</from_name>
		<from_code>9872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate</from_name>
		<from_code>42682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronic acid</from_name>
		<from_code>115265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium</from_name>
		<from_code>60334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronate</from_name>
		<from_code>57230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronate disodium</from_name>
		<from_code>105443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronate disodium</from_name>
		<from_code>83153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphosphonates</to_name>
		<to_code>M0006519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biguanide [EPC]</from_name>
		<from_code>N0000175565</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Biguanide (substance)</to_name>
		<to_code>373306007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biguanide [EPC]</from_name>
		<from_code>N0000175565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biguanides</to_name>
		<to_code>M0002471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biguanide [EPC]</from_name>
		<from_code>N0000175565</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing biguanide (product)</to_name>
		<to_code>109082004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Biguanide [EPC]</from_name>
		<from_code>N0000175565</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metformin</to_name>
		<to_code>6809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Biguanide [EPC]</to_name>
		<to_code>N0000175565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biguanide</from_name>
		<from_code>1918319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biguanides</to_name>
		<to_code>M0002471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin hydrochloride</from_name>
		<from_code>235743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biguanides</to_name>
		<to_code>M0002471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin</from_name>
		<from_code>6809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biguanides</to_name>
		<to_code>M0002471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Interferon alfa (substance)</to_name>
		<to_code>45754009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon alfa-2b [EPC]</to_name>
		<to_code>N0000193982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>120608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interferon alfa (product)</to_name>
		<to_code>136111001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alpha [EPC]</from_name>
		<from_code>N0000175521</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-n3</to_name>
		<to_code>612937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon alpha [EPC]</to_name>
		<to_code>N0000175521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>M0374956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alfa-2b [EPC]</from_name>
		<from_code>N0000193982</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropeginterferon alfa-2b</to_name>
		<to_code>2587059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alfa-2b [EPC]</from_name>
		<from_code>N0000193982</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Interferon alfa-2b (substance)</to_name>
		<to_code>386915008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alfa-2b [EPC]</from_name>
		<from_code>N0000193982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon alfa-2b</to_name>
		<to_code>M0023695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon alfa-2b [EPC]</from_name>
		<from_code>N0000193982</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interferon alfa-2b (medicinal product)</to_name>
		<to_code>108797002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropeginterferon alfa-2b</from_name>
		<from_code>2587059</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon alfa-2b</to_name>
		<to_code>M0023695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon alfa-2b</to_name>
		<to_code>M0023695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>M0263641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ester Local Anesthetic [EPC]</from_name>
		<from_code>N0000175683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esters</to_name>
		<to_code>M0007766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ester Local Anesthetic [EPC]</from_name>
		<from_code>N0000175683</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroprocaine</to_name>
		<to_code>20859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ester Local Anesthetic [EPC]</from_name>
		<from_code>N0000175683</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracaine</to_name>
		<to_code>10391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Local anesthetic (substance)</from_name>
		<from_code>373477003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ester Local Anesthetic [EPC]</to_name>
		<to_code>N0000175683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Local Anesthetic [EPC]</from_name>
		<from_code>N0000175539</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ester Local Anesthetic [EPC]</to_name>
		<to_code>N0000175683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine hydrochloride</from_name>
		<from_code>91189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esters</to_name>
		<to_code>M0007766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esters</to_name>
		<to_code>M0007766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine</from_name>
		<from_code>10391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esters</to_name>
		<to_code>M0007766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esters</to_name>
		<to_code>M0007766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Omega-3 Fatty Acid [EPC]</from_name>
		<from_code>N0000175583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatty Acids, Omega-3</to_name>
		<to_code>M0023885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Omega-3 Fatty Acid [EPC]</from_name>
		<from_code>N0000175583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>omega-3 fatty acids</to_name>
		<to_code>4301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Omega-3 Fatty Acid [EPC]</from_name>
		<from_code>N0000175583</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>N-3 fatty acid (substance)</to_name>
		<to_code>226365003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatty Acids, Omega-3</to_name>
		<to_code>M0023885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omega-3 fatty acids</from_name>
		<from_code>4301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatty Acids, Omega-3</to_name>
		<to_code>M0023885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omega-3 fatty acids</from_name>
		<from_code>4301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatty Acids, Omega-3</to_name>
		<to_code>M0023885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Psoralen [EPC]</from_name>
		<from_code>N0000175879</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Psoralen (substance)</to_name>
		<to_code>419047007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Psoralen [EPC]</from_name>
		<from_code>N0000175879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoralens</to_name>
		<to_code>M0017973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Psoralen [EPC]</from_name>
		<from_code>N0000175879</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxsalen</to_name>
		<to_code>6854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Psoralen [EPC]</from_name>
		<from_code>N0000175879</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing psoralen (product)</to_name>
		<to_code>255694005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoralens</to_name>
		<to_code>M0017973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoralens</to_name>
		<to_code>M0017973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoralens</to_name>
		<to_code>M0017973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma [EPC]</from_name>
		<from_code>N0000175541</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon gamma-1b</to_name>
		<to_code>5882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma [EPC]</from_name>
		<from_code>N0000175541</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Interferon gamma (substance)</to_name>
		<to_code>420303002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma [EPC]</from_name>
		<from_code>N0000175541</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interferon gamma (medicinal product)</to_name>
		<to_code>136113003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma [EPC]</from_name>
		<from_code>N0000175541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon-gamma</to_name>
		<to_code>M0011490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon gamma [EPC]</to_name>
		<to_code>N0000175541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-interferon</from_name>
		<from_code>1421648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon-gamma</to_name>
		<to_code>M0011490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon-gamma</to_name>
		<to_code>M0011490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reducing and Complexing Thiol [EPC]</from_name>
		<from_code>N0000175898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-substituted Glycines</to_name>
		<to_code>M0289359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Reducing and Complexing Thiol [EPC]</from_name>
		<from_code>N0000175898</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiopronin</to_name>
		<to_code>6765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reducing and Complexing Thiol [EPC]</to_name>
		<to_code>N0000175898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Organic sulfur compound (substance)</from_name>
		<from_code>89309003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reducing and Complexing Thiol [EPC]</to_name>
		<to_code>N0000175898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing sulfur and/or sulfur compound (product)</from_name>
		<from_code>768610006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Reducing and Complexing Thiol [EPC]</to_name>
		<to_code>N0000175898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiopronin</from_name>
		<from_code>6765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-substituted Glycines</to_name>
		<to_code>M0289359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclic Pyranopterin Monophosphate [EPC]</from_name>
		<from_code>N0000193919</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>fosdenopterin</to_name>
		<to_code>2531288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclic Pyranopterin Monophosphate [EPC]</from_name>
		<from_code>N0000193919</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclic Pyranopterin Monophosphate [EXT]</to_name>
		<to_code>N0000193920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cyclic Pyranopterin Monophosphate [EPC]</from_name>
		<from_code>N0000193919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pterins</to_name>
		<to_code>M0018073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing pteridine (product)</from_name>
		<from_code>768768004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclic Pyranopterin Monophosphate [EPC]</to_name>
		<to_code>N0000193919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Pterins (substance)</from_name>
		<from_code>22078005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclic Pyranopterin Monophosphate [EPC]</to_name>
		<to_code>N0000193919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclic Pyranopterin Monophosphate [EXT]</to_name>
		<to_code>N0000193920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosdenopterin</from_name>
		<from_code>2531288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cyclic Pyranopterin Monophosphate [EXT]</to_name>
		<to_code>N0000193920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide [EPC]</from_name>
		<from_code>N0000175877</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin</to_name>
		<to_code>4053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide [EPC]</from_name>
		<from_code>N0000175877</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing macrolide (product)</to_name>
		<to_code>763878009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide [EPC]</from_name>
		<from_code>N0000175877</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Macrolide (substance)</to_name>
		<to_code>428787002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Macrolide [EPC]</from_name>
		<from_code>N0000175877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidaxomicin</from_name>
		<from_code>1111103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Macrolides</to_name>
		<to_code>M0028311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Acid [EPC]</to_name>
		<to_code>N0000175802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Steroids</to_name>
		<to_code>M0020527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Steroid (substance)</to_name>
		<to_code>116566001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Steroid [EPC]</from_name>
		<from_code>N0000194034</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing steroid (product)</to_name>
		<to_code>768759001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid [EPC]</from_name>
		<from_code>N0000175802</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ursodiol</to_name>
		<to_code>11065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid [EPC]</from_name>
		<from_code>N0000175802</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholic acid</to_name>
		<to_code>1440856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid [EPC]</from_name>
		<from_code>N0000175802</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chenodeoxycholic acid</to_name>
		<to_code>2323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid [EPC]</from_name>
		<from_code>N0000175802</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Bile acid (substance)</to_name>
		<to_code>431067008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid [EPC]</from_name>
		<from_code>N0000175802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bile Acids and Salts</to_name>
		<to_code>M0002475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid [EPC]</from_name>
		<from_code>N0000175802</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing bile acid (product)</to_name>
		<to_code>765126005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chenodeoxycholic acid</from_name>
		<from_code>2323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bile Acids and Salts</to_name>
		<to_code>M0002475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursodiol</from_name>
		<from_code>11065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bile Acids and Salts</to_name>
		<to_code>M0002475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholic acid</from_name>
		<from_code>1440856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bile Acids and Salts</to_name>
		<to_code>M0002475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing sulfonylurea (product)</to_name>
		<to_code>34012005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glimepiride</to_name>
		<to_code>25789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glipizide</to_name>
		<to_code>4821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolazamide</to_name>
		<to_code>10633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Sulfonylurea (substance)</to_name>
		<to_code>372711004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyburide</to_name>
		<to_code>4815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sulfonylurea [EPC]</from_name>
		<from_code>N0000175608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sulfonylurea [EPC]</to_name>
		<to_code>N0000175608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide</from_name>
		<from_code>10635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazamide</from_name>
		<from_code>10633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glimepiride</from_name>
		<from_code>25789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glipizide</from_name>
		<from_code>4821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide sodium</from_name>
		<from_code>221173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide</from_name>
		<from_code>4815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpropamide</from_name>
		<from_code>2404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfonylurea Compounds</to_name>
		<to_code>M0020795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin B Complex Member [EPC]</to_name>
		<to_code>N0000175714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin B12 [EPC]</to_name>
		<to_code>N0000175951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Provitamin D2 Compound [EPC]</to_name>
		<to_code>N0000175909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Salt [EPC]</to_name>
		<to_code>N0000175600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin C [EPC]</to_name>
		<to_code>N0000193618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin or Mineral [APC]</from_name>
		<from_code>N0000193877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vitamin A [EPC]</to_name>
		<to_code>N0000175950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B Complex Member [EPC]</from_name>
		<from_code>N0000175714</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-aminobenzoic acid</to_name>
		<to_code>74</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B Complex Member [EPC]</from_name>
		<from_code>N0000175714</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vitamin B and/or vitamin B derivative (substance)</to_name>
		<to_code>103069003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B Complex Member [EPC]</from_name>
		<from_code>N0000175714</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B Complex</to_name>
		<to_code>M0022792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B Complex Member [EPC]</from_name>
		<from_code>N0000175714</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vitamin B and/or vitamin B derivative (product)</to_name>
		<to_code>768761005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminobenzoic acid</from_name>
		<from_code>74</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B Complex</to_name>
		<to_code>M0022792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B complex</from_name>
		<from_code>11251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B Complex</to_name>
		<to_code>M0022792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B12 [EPC]</from_name>
		<from_code>N0000175951</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vitamin B12 and/or vitamin B12 derivative (substance)</to_name>
		<to_code>781584003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B12 [EPC]</from_name>
		<from_code>N0000175951</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin B12</to_name>
		<to_code>11248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B12 [EPC]</from_name>
		<from_code>N0000175951</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin B 12</to_name>
		<to_code>M0022794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin B12 [EPC]</from_name>
		<from_code>N0000175951</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing vitamin B12 and/or vitamin B12 derivative (product)</to_name>
		<to_code>781629003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Provitamin D2 Compound [EPC]</from_name>
		<from_code>N0000175909</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergocalciferol</to_name>
		<to_code>4018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Provitamin D2 Compound [EPC]</from_name>
		<from_code>N0000175909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergocalciferols</to_name>
		<to_code>M0007651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing ergocalciferol (medicinal product)</from_name>
		<from_code>71516007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Provitamin D2 Compound [EPC]</to_name>
		<to_code>N0000175909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Ergocalciferol (substance)</from_name>
		<from_code>23433006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Provitamin D2 Compound [EPC]</to_name>
		<to_code>N0000175909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxercalciferol</from_name>
		<from_code>11516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergocalciferols</to_name>
		<to_code>M0007651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergocalciferol</from_name>
		<from_code>4018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergocalciferols</to_name>
		<to_code>M0007651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paricalcitol</from_name>
		<from_code>73710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergocalciferols</to_name>
		<to_code>M0007651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Salt [EPC]</from_name>
		<from_code>N0000175600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium ion</to_name>
		<to_code>1318915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Salt [EPC]</from_name>
		<from_code>N0000175600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cation</to_name>
		<to_code>1311382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Salt [EPC]</from_name>
		<from_code>N0000175600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Compounds</to_name>
		<to_code>M0026737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing potassium (medicinal product)</from_name>
		<from_code>767119009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Salt [EPC]</to_name>
		<to_code>N0000175600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Potassium (substance)</from_name>
		<from_code>88480006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Salt [EPC]</to_name>
		<to_code>N0000175600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ion</from_name>
		<from_code>1318915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Compounds</to_name>
		<to_code>M0026737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium cation</from_name>
		<from_code>1311382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Compounds</to_name>
		<to_code>M0026737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin C [EPC]</from_name>
		<from_code>N0000193618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascorbic Acid</to_name>
		<to_code>M0001797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin C [EPC]</from_name>
		<from_code>N0000193618</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbic acid</to_name>
		<to_code>1151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbic acid</from_name>
		<from_code>1151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascorbic Acid</to_name>
		<to_code>M0001797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbic acid</from_name>
		<from_code>1151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascorbic Acid</to_name>
		<to_code>M0001797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin A [EPC]</from_name>
		<from_code>N0000175950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin A</to_name>
		<to_code>M0022788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin A [EPC]</from_name>
		<from_code>N0000175950</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin A</to_name>
		<to_code>11246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin A [EPC]</from_name>
		<from_code>N0000175950</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Retinol (substance)</to_name>
		<to_code>82622003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vitamin A [EPC]</from_name>
		<from_code>N0000175950</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing retinol (medicinal product)</to_name>
		<to_code>82156005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A</from_name>
		<from_code>11246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin A</to_name>
		<to_code>M0022788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinol acetate</from_name>
		<from_code>35400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin A</to_name>
		<to_code>M0022788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A</from_name>
		<from_code>11246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin A</to_name>
		<to_code>M0022788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A palmitate</from_name>
		<from_code>35406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin A</to_name>
		<to_code>M0022788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD4-directed Blocking Antibody [EPC]</to_name>
		<to_code>N0000193806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BCL-2 Inhibitor [EPC]</to_name>
		<to_code>N0000192515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</to_name>
		<to_code>N0000182637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interferon gamma Blocker [EPC]</to_name>
		<to_code>N0000193856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Chimeric Antigen Receptor [EPC]</to_name>
		<to_code>N0000193546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective T Cell Costimulation Blocker [EPC]</to_name>
		<to_code>N0000182830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Programmed Death Ligand-1 Blocker [EPC]</to_name>
		<to_code>N0000193338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Activation Gene-3 Blocker [EPC]</to_name>
		<to_code>N0000194003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody [EPC]</to_name>
		<to_code>N0000194084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Monoclonal Antibody [EPC]</to_name>
		<to_code>N0000193863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Menin Inhibitor [EPC]</to_name>
		<to_code>N0000194139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Interleukin Agent [APC]</to_name>
		<to_code>N0000193903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Immunologic Agent [APC]</from_name>
		<from_code>N0000193902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective T Cell Costimulation Modulator [EPC]</to_name>
		<to_code>N0000182159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000193806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD4-directed Blocking Antibody [EPC]</from_name>
		<from_code>N0000193806</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibalizumab</to_name>
		<to_code>2043283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD4-directed Blocking Antibody [EPC]</to_name>
		<to_code>N0000193806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD4-directed Blocking Antibody [EPC]</to_name>
		<to_code>N0000193806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>BCL-2 Inhibitor [EPC]</from_name>
		<from_code>N0000192515</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>BCL-2 Inhibitor [EPC]</from_name>
		<from_code>N0000192515</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venetoclax</to_name>
		<to_code>1747556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>BCL-2 Inhibitor [EPC]</to_name>
		<to_code>N0000192515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine</from_name>
		<from_code>11202</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp</from_name>
		<from_code>2109055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-abbs</from_name>
		<from_code>2105824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cellular Death Alteration [PE]</from_name>
		<from_code>N0000008340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talimogene laherparepvec</from_name>
		<from_code>1721264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niraparib tosylate monohydrate</from_name>
		<from_code>2640208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorinostat</from_name>
		<from_code>194337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertuzumab-zzxf</from_name>
		<from_code>2382597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin</from_name>
		<from_code>1045453</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dordaviprone</from_name>
		<from_code>2721194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotuzumab ozogamicin</from_name>
		<from_code>1942950</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab</from_name>
		<from_code>2268307</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxetumomab pasudotox-tdfk</from_name>
		<from_code>2099305</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomalidomide</from_name>
		<from_code>1369713</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanidatamab-hrii</from_name>
		<from_code>2698200</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fam-trastuzumab deruxtecan-nxki</from_name>
		<from_code>2267574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ingenol mebutate</from_name>
		<from_code>1242806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelarabine</from_name>
		<from_code>274771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carfilzomib</from_name>
		<from_code>1302966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab-gcpt</from_name>
		<from_code>2719477</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talazoparib tosylate</from_name>
		<from_code>2099703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenalidomide</from_name>
		<from_code>342369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanidatamab</from_name>
		<from_code>2698198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erlotinib hydrochloride</from_name>
		<from_code>477320</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-arrx</from_name>
		<from_code>2472325</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bortezomib</from_name>
		<from_code>358258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab vedotin-ejfv</from_name>
		<from_code>2268306</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>durvalumab</from_name>
		<from_code>1919503</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolbetuximab</from_name>
		<from_code>2695869</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfortumab vedotin</from_name>
		<from_code>2277607</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isatuximab</from_name>
		<from_code>2282018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venetoclax</from_name>
		<from_code>1747556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol</from_name>
		<from_code>2121416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gilteritinib fumarate</from_name>
		<from_code>2105823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niraparib</from_name>
		<from_code>1918231</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin-blmf</from_name>
		<from_code>2387833</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacomitinib anhydrous</from_name>
		<from_code>2058848</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polatuzumab vedotin-piiq</from_name>
		<from_code>2174091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertuzumab</from_name>
		<from_code>1298944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofarabine</from_name>
		<from_code>44151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacomitinib</from_name>
		<from_code>2058849</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-dkst</from_name>
		<from_code>2103478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab</from_name>
		<from_code>2387844</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxetumomab pasudotox</from_name>
		<from_code>2099295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cemiplimab-rwlc</from_name>
		<from_code>2058825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Death Inducer [EPC]</from_name>
		<from_code>N0000184015</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine</from_name>
		<from_code>12574</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide</from_name>
		<from_code>4179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine liposome</from_name>
		<from_code>968804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mogamulizumab</from_name>
		<from_code>2054068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polatuzumab vedotin</from_name>
		<from_code>2174090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midostaurin</from_name>
		<from_code>1919083</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide phosphate</from_name>
		<from_code>24614</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab</from_name>
		<from_code>2626349</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idelalisib</from_name>
		<from_code>1544460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab</from_name>
		<from_code>224905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denileukin diftitox-cxdl</from_name>
		<from_code>2700746</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-dttb</from_name>
		<from_code>2289225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolbetuximab-clzb</from_name>
		<from_code>2695870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niraparib tosylate</from_name>
		<from_code>2637447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab</from_name>
		<from_code>2714237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurbinectedin</from_name>
		<from_code>2374729</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romidepsin</from_name>
		<from_code>877510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belinostat</from_name>
		<from_code>1543543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-pkrb</from_name>
		<from_code>2107051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentostatin</from_name>
		<from_code>8011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol-mknl</from_name>
		<from_code>2121417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gefitinib</from_name>
		<from_code>328134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gilteritinib</from_name>
		<from_code>2105806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linvoseltamab</from_name>
		<from_code>2719416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinutuximab</from_name>
		<from_code>1606274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 1, human</from_name>
		<from_code>1316105</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fedratinib hydrochloride</from_name>
		<from_code>2197594</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inavolisib</from_name>
		<from_code>2695422</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan</from_name>
		<from_code>51499</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-anns</from_name>
		<from_code>2174802</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belantamab mafodotin</from_name>
		<from_code>2387834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp-erzs</from_name>
		<from_code>2109054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan hydrochloride</from_name>
		<from_code>153329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixazomib</from_name>
		<from_code>1723735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemtuzumab ozogamicin</from_name>
		<from_code>1294580</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talazoparib</from_name>
		<from_code>2099704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ado-trastuzumab emtansine</from_name>
		<from_code>1371041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine sulfate</from_name>
		<from_code>11203</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dordaviprone hydrochloride</from_name>
		<from_code>2721193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-131</from_name>
		<from_code>1546415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>datopotamab deruxtecan</from_name>
		<from_code>2703033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fedratinib</from_name>
		<from_code>2197490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selinexor</from_name>
		<from_code>2178390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eribulin mesylate</from_name>
		<from_code>1045452</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ublituximab-xiiy</from_name>
		<from_code>2626348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-qyyp</from_name>
		<from_code>2280730</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>datopotamab deruxtecan-dlnk</from_name>
		<from_code>2703034</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>decitabine</from_name>
		<from_code>15657</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-oysk</from_name>
		<from_code>2375543</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cemiplimab</from_name>
		<from_code>2058826</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab deruxtecan</from_name>
		<from_code>2267582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>larotrectinib</from_name>
		<from_code>2105628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab vedotin</from_name>
		<from_code>2721996</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erlotinib</from_name>
		<from_code>337525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixazomib citrate</from_name>
		<from_code>1723734</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine hydrochloride</from_name>
		<from_code>236234</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telisotuzumab vedotin-tllv</from_name>
		<from_code>2714236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>larotrectinib sulfate</from_name>
		<from_code>2104548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziftomenib</from_name>
		<from_code>2725985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab</from_name>
		<from_code>121191</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobenguane I-131</from_name>
		<from_code>2053281</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-pvvr</from_name>
		<from_code>2273510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-zzxf</from_name>
		<from_code>2382599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B lipid complex</from_name>
		<from_code>2001759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cellular Death [PE]</to_name>
		<to_code>N0000009176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
		<from_code>N0000182637</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased B Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
		<from_code>N0000182637</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>belimumab</to_name>
		<to_code>1092437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</to_name>
		<to_code>N0000182637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</to_name>
		<to_code>N0000182637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belimumab</from_name>
		<from_code>1092437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased B Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Lymphocyte Activation [PE]</from_name>
		<from_code>N0000178329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased B Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib</from_name>
		<from_code>2633005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased B Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leniolisib phosphate</from_name>
		<from_code>2633006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased B Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma Blocker [EPC]</from_name>
		<from_code>N0000193856</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing interferon gamma inhibitor (product)</to_name>
		<to_code>785335004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma Blocker [EPC]</from_name>
		<from_code>N0000193856</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with interferon gamma inhibitor mechanism of action (substance)</to_name>
		<to_code>782982005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Interferon gamma Blocker [EPC]</from_name>
		<from_code>N0000193856</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emapalumab</to_name>
		<to_code>2104604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Chimeric Antigen Receptor [EPC]</from_name>
		<from_code>N0000193546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>CD19-specific chimeric antigen receptor</to_name>
		<to_code>M000615883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Chimeric Antigen Receptor [EPC]</from_name>
		<from_code>N0000193546</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisagenlecleucel</to_name>
		<to_code>1986438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Chimeric Antigen Receptor [EPC]</from_name>
		<from_code>N0000193546</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axicabtagene ciloleucel</to_name>
		<to_code>1987398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Chimeric antigen receptor (substance)</from_name>
		<from_code>709140006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Chimeric Antigen Receptor [EPC]</to_name>
		<to_code>N0000193546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisagenlecleucel</from_name>
		<from_code>1986438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>CD19-specific chimeric antigen receptor</to_name>
		<to_code>M000615883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axicabtagene ciloleucel</from_name>
		<from_code>1987398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>CD19-specific chimeric antigen receptor</to_name>
		<to_code>M000615883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
		<from_code>N0000182830</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
		<to_code>N0000182829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
		<from_code>N0000182830</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>belatacept</to_name>
		<to_code>1112973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunosuppressant (substance)</from_name>
		<from_code>372823004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective T Cell Costimulation Blocker [EPC]</to_name>
		<to_code>N0000182830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
		<to_code>N0000182829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belatacept</from_name>
		<from_code>1112973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
		<to_code>N0000182829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T Lymphocyte Costimulation Activity Modulation [PE]</from_name>
		<from_code>N0000182154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
		<to_code>N0000182829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased T Lymphocyte Activation [PE]</from_name>
		<from_code>N0000182155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
		<to_code>N0000182829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
		<from_code>N0000193338</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing programmed cell death protein 1 inhibitor (product)</to_name>
		<to_code>782819009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
		<from_code>N0000193338</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cosibelimab</to_name>
		<to_code>2717511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
		<from_code>N0000193338</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avelumab</to_name>
		<to_code>1875534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
		<from_code>N0000193338</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)</to_name>
		<to_code>781566000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
		<from_code>N0000193338</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>durvalumab</to_name>
		<to_code>1919503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Activation Gene-3 Blocker [EPC]</from_name>
		<from_code>N0000194003</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relatlimab</to_name>
		<to_code>2596773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Activation Gene-3 Blocker [EPC]</to_name>
		<to_code>N0000194003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Activation Gene-3 Blocker [EPC]</to_name>
		<to_code>N0000194003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD3-directed Antibody [EPC]</from_name>
		<from_code>N0000194084</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teplizumab</to_name>
		<to_code>2621880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing antibody (product)</from_name>
		<from_code>768606008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody [EPC]</to_name>
		<to_code>N0000194084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunologic agent (substance)</from_name>
		<from_code>373244000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD3-directed Antibody [EPC]</to_name>
		<to_code>N0000194084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000193863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
		<to_code>N0000194010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000193863</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing monoclonal antibody (product)</to_name>
		<to_code>108807002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000193863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antibodies, Monoclonal</to_name>
		<to_code>M0001357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000193863</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Monoclonal antibody (substance)</to_name>
		<to_code>49616005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000193863</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mogamulizumab</to_name>
		<to_code>2054068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Monoclonal Antibody [EPC]</from_name>
		<from_code>N0000193863</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thymic Stromal Lymphopoietin Blocker [EPC]</from_name>
		<from_code>N0000194010</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tezepelumab</to_name>
		<to_code>2587789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
		<to_code>N0000194010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immunoglobulin IgG2 (substance)</from_name>
		<from_code>63306009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
		<to_code>N0000194010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
		<to_code>N0000194010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000194013</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Inebilizumab (substance)</to_name>
		<to_code>879883007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000194013</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing inebilizumab (medicinal product)</to_name>
		<to_code>879892005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
		<from_code>N0000194013</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inebilizumab</to_name>
		<to_code>2373951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Monoclonal antibody (substance)</from_name>
		<from_code>49616005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing monoclonal antibody (product)</from_name>
		<from_code>108807002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD19-directed Cytolytic Antibody [EPC]</to_name>
		<to_code>N0000194013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175667</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aldesleukin</to_name>
		<to_code>70223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-2</to_name>
		<to_code>M0011506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175667</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Factor [APC]</from_name>
		<from_code>N0000193885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing cytokine (product)</from_name>
		<from_code>108803003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Immune enhancement agent (substance)</from_name>
		<from_code>372861001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytokine agent (substance)</from_name>
		<from_code>373686003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lymphocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lymphocyte Cell Production [PE]</from_name>
		<from_code>N0000009391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Production [PE]</to_name>
		<to_code>N0000009690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lymphocyte Cell Production [PE]</from_name>
		<from_code>N0000009391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased B Lymphocyte Production [PE]</to_name>
		<to_code>N0000009114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nivolumab-nvhy</from_name>
		<from_code>2700791</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nivolumab-rmbw</from_name>
		<from_code>2596770</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elapegademase-lvlr</from_name>
		<from_code>2059218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Hematopoiesis [PE]</from_name>
		<from_code>N0000009350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nivolumab</from_name>
		<from_code>1597876</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elapegademase</from_name>
		<from_code>2059219</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Cell Production [PE]</to_name>
		<to_code>N0000009391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab-gxbm</from_name>
		<from_code>2639781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Production [PE]</to_name>
		<to_code>N0000009690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glofitamab</from_name>
		<from_code>2639782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased T Lymphocyte Production [PE]</to_name>
		<to_code>N0000009690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denileukin diftitox</from_name>
		<from_code>214470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-2</to_name>
		<to_code>M0011506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-2</to_name>
		<to_code>M0011506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Lymphocyte Activation [PE]</from_name>
		<from_code>N0000178328</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased B Lymphocyte Activation [PE]</to_name>
		<to_code>N0000182158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elotuzumab</from_name>
		<from_code>1726104</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1a</from_name>
		<from_code>75917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1b</from_name>
		<from_code>72257</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lymphocyte Function Alteration [PE]</from_name>
		<from_code>N0000178327</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Lymphocyte Activation [PE]</to_name>
		<to_code>N0000178328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Menin Inhibitor [EPC]</from_name>
		<from_code>N0000194139</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revumenib</to_name>
		<to_code>2698325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antineoplastic agent (substance)</from_name>
		<from_code>372688009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Menin Inhibitor [EPC]</to_name>
		<to_code>N0000194139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
		<from_code>N0000182159</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abatacept</to_name>
		<to_code>614391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
		<from_code>N0000182159</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Modulation [PE]</to_name>
		<to_code>N0000182154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
		<from_code>372558009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective T Cell Costimulation Modulator [EPC]</to_name>
		<to_code>N0000182159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing immunomodulator (product)</from_name>
		<from_code>108940007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Selective T Cell Costimulation Modulator [EPC]</to_name>
		<to_code>N0000182159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T Lymphocyte Activity Modulation [PE]</from_name>
		<from_code>N0000182153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Modulation [PE]</to_name>
		<to_code>N0000182154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T Lymphocyte Costimulation Activity Modulation [PE]</to_name>
		<to_code>N0000182154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytolytic Agent [EPC]</from_name>
		<from_code>N0000191548</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deoxycholic acid</to_name>
		<to_code>3194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytolytic Agent [EPC]</from_name>
		<from_code>N0000191548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxin (substance)</from_name>
		<from_code>255825000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytolytic Agent [EPC]</to_name>
		<to_code>N0000191548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine</from_name>
		<from_code>9061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofarabine</from_name>
		<from_code>44151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daptomycin</from_name>
		<from_code>22299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole nitrate</from_name>
		<from_code>236601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine monohydrochloride</from_name>
		<from_code>82092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Membrane Alteration [PE]</from_name>
		<from_code>N0000008334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luliconazole</from_name>
		<from_code>1482680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxidectin</from_name>
		<from_code>1047072</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deoxycholic acid</from_name>
		<from_code>3194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cell Membrane Integrity [PE]</to_name>
		<to_code>N0000008476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antihypoglycemic Agent [EPC]</to_name>
		<to_code>N0000190852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Blood Glucose Regulator [APC]</from_name>
		<from_code>N0000193891</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</to_name>
		<to_code>N0000187059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihypoglycemic Agent [EPC]</from_name>
		<from_code>N0000190852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihypoglycemic Agent [EPC]</from_name>
		<from_code>N0000190852</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucagon</to_name>
		<to_code>4832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihypoglycemic Agent [EPC]</from_name>
		<from_code>N0000190852</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dasiglucagon</to_name>
		<to_code>2535233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antihypoglycemic Agent [EPC]</from_name>
		<from_code>N0000190852</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glucose Metabolism Alteration [PE]</from_name>
		<from_code>N0000009061</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese monoxide</from_name>
		<from_code>1728312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium</from_name>
		<from_code>40144</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroglobulin</from_name>
		<from_code>10565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese gluconate</from_name>
		<from_code>52403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese</from_name>
		<from_code>6623</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (beef)</from_name>
		<from_code>325521</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine sodium</from_name>
		<from_code>142448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese sulfate</from_name>
		<from_code>29268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium anhydrous</from_name>
		<from_code>1372638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (USP)</from_name>
		<from_code>10572</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese dioxide</from_name>
		<from_code>29263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine</from_name>
		<from_code>10814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Gluconeogenesis [PE]</to_name>
		<to_code>N0000009340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucosidase alfa</from_name>
		<from_code>629565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Glycogen Metabolism Alteration [PE]</from_name>
		<from_code>N0000009064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasiglucagon</from_name>
		<from_code>2535233</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Glycogenolysis [PE]</to_name>
		<to_code>N0000009345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotagliflozin</to_name>
		<to_code>2638675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing sodium glucose cotransporter subtype 2 inhibitor (product)</to_name>
		<to_code>703677008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>empagliflozin</to_name>
		<to_code>1545653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bexagliflozin</to_name>
		<to_code>2627044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dapagliflozin</to_name>
		<to_code>1488564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canagliflozin anhydrous</to_name>
		<to_code>1546031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
		<from_code>N0000187059</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance)</to_name>
		<to_code>703673007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Tubular Transport Inhibitor [EPC]</from_name>
		<from_code>N0000194156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Organic Ion Transport Alteration [PE]</to_name>
		<to_code>N0000009831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Organic Ion Transport Alteration [PE]</from_name>
		<from_code>N0000009831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Organic Ion Transport Alteration [PE]</from_name>
		<from_code>N0000009831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000008864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal/Urological Activity Alteration [PE]</from_name>
		<from_code>N0000009832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Organic Ion Transport Alteration [PE]</to_name>
		<to_code>N0000009831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Organic Ion Excretion [PE]</from_name>
		<from_code>N0000009556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Anion Excretion [PE]</to_name>
		<to_code>N0000009554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Organic Ion Excretion [PE]</from_name>
		<from_code>N0000009556</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Cation Excretion [PE]</to_name>
		<to_code>N0000009555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>empagliflozin</from_name>
		<from_code>1545653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapagliflozin propanediol</from_name>
		<from_code>1486966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesna</from_name>
		<from_code>44</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin</from_name>
		<from_code>1373458</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin anhydrous</from_name>
		<from_code>1546031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapagliflozin</from_name>
		<from_code>1488564</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000009556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Renal Organic Anion Excretion [PE]</from_name>
		<from_code>N0000009554</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uricosuric Activity [PE]</to_name>
		<to_code>N0000009896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uricosuric Activity [PE]</to_name>
		<to_code>N0000009896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probenecid</from_name>
		<from_code>8698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uricosuric Activity [PE]</to_name>
		<to_code>N0000009896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lesinurad</from_name>
		<from_code>1731031</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uricosuric Activity [PE]</to_name>
		<to_code>N0000009896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal Organic Ion Excretion [PE]</from_name>
		<from_code>N0000008864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal Organic Anion Excretion [PE]</to_name>
		<to_code>N0000008862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Renal Organic Ion Excretion [PE]</from_name>
		<from_code>N0000008864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal Organic Cation Excretion [PE]</to_name>
		<to_code>N0000008863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probenecid</from_name>
		<from_code>8698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000008864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Renal Organic Ion Excretion [PE]</to_name>
		<to_code>N0000008864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Factor [APC]</from_name>
		<from_code>N0000193885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</to_name>
		<to_code>N0000175671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Factor [APC]</from_name>
		<from_code>N0000193885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Human Platelet-derived Growth Factor [EPC]</to_name>
		<to_code>N0000175885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Factor [APC]</from_name>
		<from_code>N0000193885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Nerve Growth Factor [EPC]</to_name>
		<to_code>N0000193854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Growth Factor [APC]</from_name>
		<from_code>N0000193885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</from_name>
		<from_code>N0000175671</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palifermin</to_name>
		<to_code>196319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</from_name>
		<from_code>N0000175671</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fibroblast Growth Factor 7</to_name>
		<to_code>M0168688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</from_name>
		<from_code>N0000175671</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Epithelial Proliferation [PE]</to_name>
		<to_code>N0000175675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Keratinocyte growth factor (substance)</from_name>
		<from_code>417539006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</to_name>
		<to_code>N0000175671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing recombinant human keratinocyte growth factor (medicinal product)</from_name>
		<from_code>416470008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</to_name>
		<to_code>N0000175671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palifermin</from_name>
		<from_code>196319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fibroblast Growth Factor 7</to_name>
		<to_code>M0168688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibroblast growth factor 7</from_name>
		<from_code>1789471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fibroblast Growth Factor 7</to_name>
		<to_code>M0168688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Epithelial Proliferation Alteration [PE]</from_name>
		<from_code>N0000175673</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Epithelial Proliferation [PE]</to_name>
		<to_code>N0000175675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palifermin</from_name>
		<from_code>196319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Epithelial Proliferation [PE]</to_name>
		<to_code>N0000175675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>becaplermin</from_name>
		<from_code>115238</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Epithelial Proliferation [PE]</to_name>
		<to_code>N0000175675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
		<from_code>N0000175885</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>becaplermin</to_name>
		<to_code>115238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
		<from_code>N0000175885</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Human platelet-derived growth factor (substance)</to_name>
		<to_code>372557004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
		<from_code>N0000175885</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing human platelet-derived growth factor (product)</to_name>
		<to_code>108937007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
		<from_code>N0000175885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platelet-Derived Growth Factor</to_name>
		<to_code>M0017024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>becaplermin</from_name>
		<from_code>115238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platelet-Derived Growth Factor</to_name>
		<to_code>M0017024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Nerve Growth Factor [EPC]</from_name>
		<from_code>N0000193854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Proteins</to_name>
		<to_code>M0018641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Nerve Growth Factor [EPC]</from_name>
		<from_code>N0000193854</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cenegermin</to_name>
		<to_code>2104332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Nerve Growth Factor [EPC]</from_name>
		<from_code>N0000193854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nerve Growth Factor</to_name>
		<to_code>M0328210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Nerve growth factor (substance)</from_name>
		<from_code>12915002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Nerve Growth Factor [EPC]</to_name>
		<to_code>N0000193854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cenegermin</from_name>
		<from_code>2104332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nerve Growth Factor</to_name>
		<to_code>M0328210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nerve growth factor</from_name>
		<from_code>7327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nerve Growth Factor</to_name>
		<to_code>M0328210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sargramostim</to_name>
		<to_code>69634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>filgrastim</to_name>
		<to_code>68442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim</to_name>
		<to_code>338036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflapegrastim</to_name>
		<to_code>2612526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efbemalenograstim alfa</to_name>
		<to_code>2670630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Leukocyte Growth Factor [EPC]</from_name>
		<from_code>N0000175666</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte-Macrophage Colony-Stimulating Factor</to_name>
		<to_code>M0024695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Colony stimulating factor (substance)</from_name>
		<from_code>372559001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing colony stimulating factor (product)</from_name>
		<from_code>108966005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Leukocyte Growth Factor [EPC]</to_name>
		<to_code>N0000175666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim</from_name>
		<from_code>2612526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte Colony-Stimulating Factor</to_name>
		<to_code>M0024696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Myeloid Cell Production [PE]</from_name>
		<from_code>N0000009451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Myeloid Cell Production [PE]</from_name>
		<from_code>N0000009451</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Monocytic Cell Production [PE]</to_name>
		<to_code>N0000009426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-ayow</from_name>
		<from_code>2595942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim</from_name>
		<from_code>2612526</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-pbbk</from_name>
		<from_code>2602779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enasidenib</from_name>
		<from_code>1940332</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivosidenib</from_name>
		<from_code>2049873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-aafi</from_name>
		<from_code>2057198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-fpgk</from_name>
		<from_code>2613761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enasidenib mesylate</from_name>
		<from_code>1940331</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-apgf</from_name>
		<from_code>2469333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim-xnst</from_name>
		<from_code>2612537</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Hematopoiesis [PE]</from_name>
		<from_code>N0000009350</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Myeloid Cell Production [PE]</to_name>
		<to_code>N0000009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-txid</from_name>
		<from_code>2700365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-apgf</from_name>
		<from_code>2469333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-aafi</from_name>
		<from_code>2057198</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-fpgk</from_name>
		<from_code>2613761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-pbbk</from_name>
		<from_code>2602779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-jmdb</from_name>
		<from_code>2048018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-ayow</from_name>
		<from_code>2595942</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Granulocytic Cell Production [PE]</to_name>
		<to_code>N0000009348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte-Macrophage Colony-Stimulating Factor</to_name>
		<to_code>M0024695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte-Macrophage Colony-Stimulating Factor</to_name>
		<to_code>M0024695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte-Macrophage Colony-Stimulating Factor</to_name>
		<to_code>M0024695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte-Macrophage Colony-Stimulating Factor</to_name>
		<to_code>M0024695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granulocyte-Macrophage Colony-Stimulating Factor</to_name>
		<to_code>M0024695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anesthetic [APC]</from_name>
		<from_code>N0000193878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Local Anesthetic [EPC]</to_name>
		<to_code>N0000175539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anesthetic [APC]</from_name>
		<from_code>N0000193878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>General Anesthetic [EPC]</to_name>
		<to_code>N0000175681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Local Anesthetic [EPC]</from_name>
		<from_code>N0000175539</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proparacaine</to_name>
		<to_code>34905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Local Anesthetic [EPC]</from_name>
		<from_code>N0000175539</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Local anesthetic (substance)</to_name>
		<to_code>373477003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevoflurane</to_name>
		<to_code>36453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoflurane</to_name>
		<to_code>6026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>desflurane</to_name>
		<to_code>27340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>General anesthetic (substance)</to_name>
		<to_code>373288007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propofol</to_name>
		<to_code>8782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketamine</to_name>
		<to_code>6130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>General Anesthetic [EPC]</from_name>
		<from_code>N0000175681</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etomidate</to_name>
		<to_code>4177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </to_name>
		<to_code>N0000194082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endoglycosidase [EPC]</to_name>
		<to_code>N0000175531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</to_name>
		<to_code>N0000175822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carboxypeptidase [EPC]</to_name>
		<to_code>N0000184013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uric Acid-specific Enzyme [EPC]</to_name>
		<to_code>N0000175670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</to_name>
		<to_code>N0000192342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lysosomal beta Glucuronidase [EPC]</to_name>
		<to_code>N0000193804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</to_name>
		<to_code>N0000192343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sucrose-specific Enzyme [EPC]</to_name>
		<to_code>N0000175819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</to_name>
		<to_code>N0000175821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</to_name>
		<to_code>N0000175823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</to_name>
		<to_code>N0000191865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</to_name>
		<to_code>N0000193414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</to_name>
		<to_code>N0000175820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Deoxyribonuclease 1 [EPC]</to_name>
		<to_code>N0000175958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Asparagine-specific Enzyme [EPC]</to_name>
		<to_code>N0000175669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Metabolizing Enzyme [EPC]</to_name>
		<to_code>N0000193858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Enzyme [APC]</from_name>
		<from_code>N0000193884</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Collagen-specific Enzyme [EPC]</to_name>
		<to_code>N0000175843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </from_name>
		<from_code>N0000194082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lysosomal alpha-Mannosidase</to_name>
		<to_code>M0446508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Alpha-mannosidase (substance)</from_name>
		<from_code>10949002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </to_name>
		<to_code>N0000194082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endoglycosidase [EPC]</from_name>
		<from_code>N0000175531</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase, human recombinant</to_name>
		<to_code>1300478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endoglycosidase [EPC]</from_name>
		<from_code>N0000175531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoside Hydrolases</to_name>
		<to_code>M0009499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endoglycosidase [EPC]</from_name>
		<from_code>N0000175531</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase, bovine</to_name>
		<to_code>578350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endoglycosidase [EPC]</from_name>
		<from_code>N0000175531</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase, ovine</to_name>
		<to_code>486164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Endoglycosidase [EPC]</from_name>
		<from_code>N0000175531</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>berahyaluronidase alfa</to_name>
		<to_code>2723752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme mechanism of action (substance)</from_name>
		<from_code>90668006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endoglycosidase [EPC]</to_name>
		<to_code>N0000175531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme (product)</from_name>
		<from_code>11402001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Endoglycosidase [EPC]</to_name>
		<to_code>N0000175531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, bovine</from_name>
		<from_code>578350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoside Hydrolases</to_name>
		<to_code>M0009499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, ovine</from_name>
		<from_code>486164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoside Hydrolases</to_name>
		<to_code>M0009499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berahyaluronidase alfa</from_name>
		<from_code>2723752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoside Hydrolases</to_name>
		<to_code>M0009499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, human recombinant</from_name>
		<from_code>1300478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoside Hydrolases</to_name>
		<to_code>M0009499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase</from_name>
		<from_code>5464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoside Hydrolases</to_name>
		<to_code>M0009499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Galactosidase</to_name>
		<to_code>M0000793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175822</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegunigalsidase alfa</to_name>
		<to_code>2637446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175822</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agalsidase beta</to_name>
		<to_code>338817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</to_name>
		<to_code>N0000175822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Lysosomal enzyme (substance)</from_name>
		<from_code>102765007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</to_name>
		<to_code>N0000175822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agalsidase beta</from_name>
		<from_code>338817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Galactosidase</to_name>
		<to_code>M0000793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-D-galactosidase enzyme</from_name>
		<from_code>259351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Galactosidase</to_name>
		<to_code>M0000793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carboxypeptidase [EPC]</from_name>
		<from_code>N0000184013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carboxypeptidases</to_name>
		<to_code>M0003411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carboxypeptidase [EPC]</from_name>
		<from_code>N0000184013</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucarpidase</to_name>
		<to_code>1242127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Carboxypeptidase [EPC]</from_name>
		<from_code>N0000184013</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Carboxypeptidase (substance)</to_name>
		<to_code>304265005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing protease (product)</from_name>
		<from_code>116536008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Carboxypeptidase [EPC]</to_name>
		<to_code>N0000184013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucarpidase</from_name>
		<from_code>1242127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carboxypeptidases</to_name>
		<to_code>M0003411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uric Acid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175670</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegloticase</to_name>
		<to_code>1011650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uric Acid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urate Oxidase</to_name>
		<to_code>M0022307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uric Acid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175670</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Urate oxidase (substance)</to_name>
		<to_code>84131000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Uric Acid-specific Enzyme [EPC]</from_name>
		<from_code>N0000175670</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rasburicase</to_name>
		<to_code>283821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with hydrolase mechanism of action (substance)</from_name>
		<from_code>74628008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Uric Acid-specific Enzyme [EPC]</to_name>
		<to_code>N0000175670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasburicase</from_name>
		<from_code>283821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urate Oxidase</to_name>
		<to_code>M0022307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegloticase</from_name>
		<from_code>1011650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urate Oxidase</to_name>
		<to_code>M0022307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</from_name>
		<from_code>N0000192342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lysosomal Acid Cholesterol Esterase</to_name>
		<to_code>M0507876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</from_name>
		<from_code>N0000192342</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebelipase alfa</to_name>
		<to_code>1726975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</from_name>
		<from_code>N0000192342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</to_name>
		<to_code>N0000192342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Lysosomal enzyme (substance)</from_name>
		<from_code>102765007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</to_name>
		<to_code>N0000192342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebelipase alfa</from_name>
		<from_code>1726975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lysosomal Acid Cholesterol Esterase</to_name>
		<to_code>M0507876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
		<from_code>N0000193804</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vestronidase alfa</to_name>
		<to_code>1989819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
		<from_code>N0000193804</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Beta-glucuronidase (substance)</to_name>
		<to_code>75097003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
		<from_code>N0000193804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucuronidase</to_name>
		<to_code>M0009366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
		<from_code>N0000193804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Proteins</to_name>
		<to_code>M0018641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lysosomal beta Glucuronidase [EPC]</to_name>
		<to_code>N0000193804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</from_name>
		<from_code>N0000192343</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebelipase alfa</to_name>
		<to_code>1726975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Lysosomal enzyme (substance)</from_name>
		<from_code>102765007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</to_name>
		<to_code>N0000192343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</to_name>
		<to_code>N0000192343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sucrose-specific Enzyme [EPC]</from_name>
		<from_code>N0000175819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sucrose-specific Enzyme [EPC]</from_name>
		<from_code>N0000175819</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacrosidase</to_name>
		<to_code>214817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sucrose-specific Enzyme [EPC]</from_name>
		<from_code>N0000175819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Fructofuranosidase</to_name>
		<to_code>M0071827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme (product)</from_name>
		<from_code>11402001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sucrose-specific Enzyme [EPC]</to_name>
		<to_code>N0000175819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme mechanism of action (substance)</from_name>
		<from_code>90668006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sucrose-specific Enzyme [EPC]</to_name>
		<to_code>N0000175819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacrosidase</from_name>
		<from_code>214817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Fructofuranosidase</to_name>
		<to_code>M0071827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175821</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Alpha-glucosidase (substance)</to_name>
		<to_code>16783009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175821</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing alpha-glucosidase (medicinal product)</to_name>
		<to_code>398923002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175821</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avalglucosidase alfa</to_name>
		<to_code>2565814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175821</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alglucosidase alfa</to_name>
		<to_code>629565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elosulfase alfa</from_name>
		<from_code>1489914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha glucosidase</from_name>
		<from_code>2475361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galsulfase</from_name>
		<from_code>578033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucosidase alfa</from_name>
		<from_code>629565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laronidase</from_name>
		<from_code>392509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agalsidase beta</from_name>
		<from_code>338817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idursulfase</from_name>
		<from_code>644101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegunigalsidase alfa</from_name>
		<from_code>2637446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avalglucosidase alfa</from_name>
		<from_code>2565814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Glucosidases</to_name>
		<to_code>M0000794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
		<from_code>N0000175823</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idursulfase</to_name>
		<to_code>644101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
		<from_code>N0000175823</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elosulfase alfa</to_name>
		<to_code>1489914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
		<from_code>N0000175823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfatases</to_name>
		<to_code>M0020759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
		<from_code>N0000175823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
		<from_code>N0000175823</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galsulfase</to_name>
		<to_code>578033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
		<from_code>N0000175823</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>laronidase</to_name>
		<to_code>392509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Lysosomal enzyme (substance)</from_name>
		<from_code>102765007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</to_name>
		<to_code>N0000175823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</to_name>
		<to_code>N0000175823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idursulfase</from_name>
		<from_code>644101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfatases</to_name>
		<to_code>M0020759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elosulfase alfa</from_name>
		<from_code>1489914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfatases</to_name>
		<to_code>M0020759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galsulfase</from_name>
		<from_code>578033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfatases</to_name>
		<to_code>M0020759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laronidase</from_name>
		<from_code>392509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfatases</to_name>
		<to_code>M0020759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</from_name>
		<from_code>N0000191865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alkaline Phosphatase</to_name>
		<to_code>M0000712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</from_name>
		<from_code>N0000191865</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asfotase alfa</to_name>
		<to_code>1720259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</to_name>
		<to_code>N0000191865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Alkaline phosphatase (substance)</from_name>
		<from_code>57056007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</to_name>
		<to_code>N0000191865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asfotase alfa</from_name>
		<from_code>1720259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alkaline Phosphatase</to_name>
		<to_code>M0000712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</from_name>
		<from_code>N0000193414</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerliponase alfa</to_name>
		<to_code>1922436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</from_name>
		<from_code>N0000193414</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Tripeptidyl-peptidase I (substance)</to_name>
		<to_code>130587008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</from_name>
		<from_code>N0000193414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tripeptidyl-Peptidase 1</to_name>
		<to_code>M000748625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing hydrolase (product)</from_name>
		<from_code>772034009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</to_name>
		<to_code>N0000193414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerliponase alfa</from_name>
		<from_code>1922436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tripeptidyl-Peptidase 1</to_name>
		<to_code>M000748625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
		<from_code>N0000175820</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imiglucerase</to_name>
		<to_code>84959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
		<from_code>N0000175820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucosylceramidase</to_name>
		<to_code>M0009360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
		<from_code>N0000175820</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velaglucerase alfa</to_name>
		<to_code>901805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
		<from_code>N0000175820</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taliglucerase alfa</to_name>
		<to_code>1291609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
		<from_code>N0000175820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
		<from_code>N0000175820</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Glucosylceramidase (substance)</to_name>
		<to_code>259429006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme (product)</from_name>
		<from_code>11402001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</to_name>
		<to_code>N0000175820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucerase</from_name>
		<from_code>46049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucosylceramidase</to_name>
		<to_code>M0009360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taliglucerase alfa</from_name>
		<from_code>1291609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucosylceramidase</to_name>
		<to_code>M0009360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velaglucerase alfa</from_name>
		<from_code>901805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucosylceramidase</to_name>
		<to_code>M0009360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiglucerase</from_name>
		<from_code>84959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucosylceramidase</to_name>
		<to_code>M0009360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
		<from_code>N0000175958</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dornase alfa</to_name>
		<to_code>337623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
		<from_code>N0000175958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Deoxyribonuclease I</to_name>
		<to_code>M0006007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
		<from_code>N0000175958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Proteins</to_name>
		<to_code>M0018641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing deoxyribonuclease (medicinal product)</from_name>
		<from_code>330151006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Deoxyribonuclease 1 [EPC]</to_name>
		<to_code>N0000175958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Deoxyribonuclease I (substance)</from_name>
		<from_code>32707001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Recombinant Human Deoxyribonuclease 1 [EPC]</to_name>
		<to_code>N0000175958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dornase alfa</from_name>
		<from_code>337623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Deoxyribonuclease I</to_name>
		<to_code>M0006007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Asparagine-specific Enzyme [EPC]</from_name>
		<from_code>N0000175669</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegaspargase</to_name>
		<to_code>34132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Asparagine-specific Enzyme [EPC]</from_name>
		<from_code>N0000175669</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Asparaginase (substance)</to_name>
		<to_code>371014004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Asparagine-specific Enzyme [EPC]</from_name>
		<from_code>N0000175669</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing asparaginase (medicinal product)</to_name>
		<to_code>18811003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Asparagine-specific Enzyme [EPC]</from_name>
		<from_code>N0000175669</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calaspargase pegol</to_name>
		<to_code>2121416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Asparagine-specific Enzyme [EPC]</from_name>
		<from_code>N0000175669</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparaginase</to_name>
		<to_code>1156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Asparagine-specific Enzyme [EPC]</from_name>
		<from_code>N0000175669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asparaginase</to_name>
		<to_code>M0001815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaspargase</from_name>
		<from_code>34132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asparaginase</to_name>
		<to_code>M0001815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asparaginase</to_name>
		<to_code>M0001815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol</from_name>
		<from_code>2121416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asparaginase</to_name>
		<to_code>M0001815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asparaginase</to_name>
		<to_code>M0001815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phenylalanine Metabolizing Enzyme [EPC]</from_name>
		<from_code>N0000193858</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegvaliase</to_name>
		<to_code>2046360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing enzyme (product)</from_name>
		<from_code>11402001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Metabolizing Enzyme [EPC]</to_name>
		<to_code>N0000193858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with enzyme mechanism of action (substance)</from_name>
		<from_code>90668006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phenylalanine Metabolizing Enzyme [EPC]</to_name>
		<to_code>N0000193858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Collagen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175843</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagenase</to_name>
		<to_code>58939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Collagen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175843</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing collagenase (medicinal product)</to_name>
		<to_code>417416003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Collagen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175843</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagenase Clostridium histolyticum</to_name>
		<to_code>898492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Collagen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175843</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Collagenase (substance)</to_name>
		<to_code>772213007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Collagen-specific Enzyme [EPC]</from_name>
		<from_code>N0000175843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagenases</to_name>
		<to_code>M0026363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase</from_name>
		<from_code>58939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagenases</to_name>
		<to_code>M0026363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase</from_name>
		<from_code>58939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagenases</to_name>
		<to_code>M0026363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase Clostridium histolyticum</from_name>
		<from_code>898492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagenases</to_name>
		<to_code>M0026363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pharmacologic Cardiac Stress Test Agent [EPC]</to_name>
		<to_code>N0000193963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dietary Cholesterol Absorption Inhibitor [EPC]</to_name>
		<to_code>N0000175911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiarrhythmic [EPC]</to_name>
		<to_code>N0000175426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasodilator [EPC]</to_name>
		<to_code>N0000175940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Acid Sequestrant [EPC]</to_name>
		<to_code>N0000180292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine-depleting Sympatholytic [EPC]</to_name>
		<to_code>N0000175640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000191627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstrictor [EPC]</to_name>
		<to_code>N0000192562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</to_name>
		<to_code>N0000186779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Agent [EPC]</to_name>
		<to_code>N0000175814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal [EPC]</to_name>
		<to_code>N0000175427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [APC]</from_name>
		<from_code>N0000193893</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiopoietin-like 3 Inhibitor [EPC]</to_name>
		<to_code>N0000193915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pharmacologic Cardiac Stress Test Agent [EPC]</from_name>
		<from_code>N0000193963</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regadenoson anhydrous</to_name>
		<to_code>1546015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cardiovascular agent (substance)</from_name>
		<from_code>373247007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pharmacologic Cardiac Stress Test Agent [EPC]</to_name>
		<to_code>N0000193963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dietary Cholesterol Absorption Inhibitor [EPC]</from_name>
		<from_code>N0000175911</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ezetimibe</to_name>
		<to_code>341248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dietary Cholesterol Absorption Inhibitor [EPC]</from_name>
		<from_code>N0000175911</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antilipemic agent (substance)</from_name>
		<from_code>373267003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Dietary Cholesterol Absorption Inhibitor [EPC]</to_name>
		<to_code>N0000175911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursodiol</from_name>
		<from_code>11065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ezetimibe</from_name>
		<from_code>341248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursadiol</from_name>
		<from_code>2045735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cholesterol Absorption Alteration [PE]</from_name>
		<from_code>N0000008358</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Cholesterol Absorption [PE]</to_name>
		<to_code>N0000008553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Antiarrhythmic agent (substance)</to_name>
		<to_code>372813008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lidocaine</to_name>
		<to_code>6387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibutilide</to_name>
		<to_code>41289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mexiletine</to_name>
		<to_code>6926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procainamide</to_name>
		<to_code>8700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiodarone</to_name>
		<to_code>703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>disopyramide</to_name>
		<to_code>3541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>flecainide</to_name>
		<to_code>4441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotalol</to_name>
		<to_code>9947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propafenone</to_name>
		<to_code>8754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dofetilide</to_name>
		<to_code>49247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine</to_name>
		<to_code>9068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiarrhythmic [EPC]</from_name>
		<from_code>N0000175426</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dronedarone</to_name>
		<to_code>233698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide</from_name>
		<from_code>3541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide fumarate</from_name>
		<from_code>51256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encainide hydrochloride</from_name>
		<from_code>281189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallopamil hydrochloride</from_name>
		<from_code>439837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encainide</from_name>
		<from_code>42368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide monohydrochloride</from_name>
		<from_code>142145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide</from_name>
		<from_code>42359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol</from_name>
		<from_code>7801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine codecarboxylate</from_name>
		<from_code>158387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide fumarate</from_name>
		<from_code>51256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide</from_name>
		<from_code>3541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide monohydrochloride</from_name>
		<from_code>142145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitalin</from_name>
		<from_code>1923401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide</from_name>
		<from_code>42359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carazolol</from_name>
		<from_code>20192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine</from_name>
		<from_code>9392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine</from_name>
		<from_code>40169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline hydrochloride</from_name>
		<from_code>236767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine hydrochloride</from_name>
		<from_code>221126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine hydrochloride</from_name>
		<from_code>203132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide</from_name>
		<from_code>41289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine hydrochloride</from_name>
		<from_code>105470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol hydrochloride</from_name>
		<from_code>81947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide phosphate</from_name>
		<from_code>203178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine hydrochloride</from_name>
		<from_code>221126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol</from_name>
		<from_code>597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallopamil</from_name>
		<from_code>4648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrate</from_name>
		<from_code>283561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine</from_name>
		<from_code>40169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline</from_name>
		<from_code>4327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol hydrochloride</from_name>
		<from_code>203131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine</from_name>
		<from_code>7895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omega-3 fatty acids</from_name>
		<from_code>4301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide phosphate</from_name>
		<from_code>203178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>practolol</from_name>
		<from_code>8620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide</from_name>
		<from_code>41289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arrhythmias, Cardiac</to_name>
		<to_code>M0001715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide fumarate</from_name>
		<from_code>51256</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallopamil</from_name>
		<from_code>4648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide</from_name>
		<from_code>3541</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine</from_name>
		<from_code>40169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine hydrochloride</from_name>
		<from_code>221126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [TC]</from_name>
		<from_code>N0000178309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallopamil hydrochloride</from_name>
		<from_code>439837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine monophosphate</from_name>
		<from_code>309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>practolol</from_name>
		<from_code>8620</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide phosphate</from_name>
		<from_code>203178</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitalin</from_name>
		<from_code>1923401</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine phosphate disodium</from_name>
		<from_code>1306123</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide</from_name>
		<from_code>41289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide</from_name>
		<from_code>42359</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide monohydrochloride</from_name>
		<from_code>142145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine</from_name>
		<from_code>296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-arrhythmic Agent [TC]</to_name>
		<to_code>N0000178311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitric oxide</to_name>
		<to_code>7442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>nitroprusside</to_name>
		<to_code>7476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vasodilator (substance)</to_name>
		<to_code>372787008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasodilator [EPC]</from_name>
		<from_code>N0000175940</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilator [EPC]</to_name>
		<to_code>N0000175564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilator [EPC]</from_name>
		<from_code>N0000175564</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydralazine</to_name>
		<to_code>5470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasodilator [EPC]</from_name>
		<from_code>N0000175564</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minoxidil</to_name>
		<to_code>6984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Vasodilator (substance)</from_name>
		<from_code>372787008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasodilator [EPC]</to_name>
		<to_code>N0000175564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid Sequestrant [EPC]</from_name>
		<from_code>N0000180292</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colesevelam</to_name>
		<to_code>141626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid Sequestrant [EPC]</from_name>
		<from_code>N0000180292</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholestyramine resin</to_name>
		<to_code>2447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid Sequestrant [EPC]</from_name>
		<from_code>N0000180292</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Bile acid sequestrant antilipemic agent (substance)</to_name>
		<to_code>372872006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Bile Acid Sequestrant [EPC]</from_name>
		<from_code>N0000180292</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colestipol</to_name>
		<to_code>2685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Bile Acid Sequestrant [EPC]</to_name>
		<to_code>N0000180292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine-depleting Sympatholytic [EPC]</from_name>
		<from_code>N0000175640</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reserpine</to_name>
		<to_code>9260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Catecholamine-depleting Sympatholytic [EPC]</from_name>
		<from_code>N0000175640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Centrally acting hypotensive agent (substance)</from_name>
		<from_code>372740001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Catecholamine-depleting Sympatholytic [EPC]</to_name>
		<to_code>N0000175640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Aspartate Activity [PE]</to_name>
		<to_code>N0000008975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Glycine Activity [PE]</to_name>
		<to_code>N0000008987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
		<to_code>N0000008976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
		<to_code>N0000008989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Dynorphin Activity [PE]</to_name>
		<to_code>N0000008980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Neurotensin Activity [PE]</to_name>
		<to_code>N0000008990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000008991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic CCK Activity [PE]</to_name>
		<to_code>N0000008977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Gastrin Activity [PE]</to_name>
		<to_code>N0000008985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Glutamate Activity [PE]</to_name>
		<to_code>N0000008986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Substance P Activity [PE]</to_name>
		<to_code>N0000008995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Endorphin Activity [PE]</to_name>
		<to_code>N0000008981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Epinephrine Activity [PE]</to_name>
		<to_code>N0000008983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Enkephalin Activity [PE]</to_name>
		<to_code>N0000008982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic VIP Activity [PE]</to_name>
		<to_code>N0000008996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic GABA Activity [PE]</to_name>
		<to_code>N0000008984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Dopamine Activity [PE]</to_name>
		<to_code>N0000008979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Sympathetic Activity [PE]</from_name>
		<from_code>N0000175650</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethaphan camsylate</from_name>
		<from_code>38680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sympathetic Activity Alteration [PE]</from_name>
		<from_code>N0000175647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Activity [PE]</to_name>
		<to_code>N0000175650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Aspartate Activity [PE]</from_name>
		<from_code>N0000008395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Aspartate Activity [PE]</to_name>
		<to_code>N0000008975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Glycine Activity [PE]</from_name>
		<from_code>N0000008407</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Glycine Activity [PE]</to_name>
		<to_code>N0000008987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
		<from_code>N0000008396</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
		<to_code>N0000008976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Nerve Growth Factor Activity [PE]</from_name>
		<from_code>N0000008409</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
		<to_code>N0000008989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
		<from_code>N0000008808</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Dynorphin Activity [PE]</to_name>
		<to_code>N0000008980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Neurotensin Activity [PE]</from_name>
		<from_code>N0000008410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Neurotensin Activity [PE]</to_name>
		<to_code>N0000008990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000008411</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000008991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</from_name>
		<from_code>N0000008394</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Acetylcholine Activity [PE]</to_name>
		<to_code>N0000008974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System CCK Activity [PE]</from_name>
		<from_code>N0000008397</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic CCK Activity [PE]</to_name>
		<to_code>N0000008977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Gastrin Activity [PE]</from_name>
		<from_code>N0000008405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Gastrin Activity [PE]</to_name>
		<to_code>N0000008985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Glutamate Activity [PE]</from_name>
		<from_code>N0000008406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Glutamate Activity [PE]</to_name>
		<to_code>N0000008986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Substance P Activity [PE]</from_name>
		<from_code>N0000008415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Substance P Activity [PE]</to_name>
		<to_code>N0000008995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</from_name>
		<from_code>N0000008809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Endorphin Activity [PE]</to_name>
		<to_code>N0000008981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Epinephrine Activity [PE]</from_name>
		<from_code>N0000008403</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Epinephrine Activity [PE]</to_name>
		<to_code>N0000008983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
		<from_code>N0000008810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Enkephalin Activity [PE]</to_name>
		<to_code>N0000008982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System VIP Activity [PE]</from_name>
		<from_code>N0000008416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic VIP Activity [PE]</to_name>
		<to_code>N0000008996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System GABA Activity [PE]</from_name>
		<from_code>N0000008404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic GABA Activity [PE]</to_name>
		<to_code>N0000008984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Dopamine Activity [PE]</from_name>
		<from_code>N0000008399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Dopamine Activity [PE]</to_name>
		<to_code>N0000008979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine</from_name>
		<from_code>220982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine hydrochloride</from_name>
		<from_code>133041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
		<from_code>N0000008412</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
		<to_code>N0000008992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000191627</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mipomersen</to_name>
		<to_code>1367839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</from_name>
		<from_code>N0000191627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Antilipemic agent (substance)</from_name>
		<from_code>373267003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</to_name>
		<to_code>N0000191627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifabutin</from_name>
		<from_code>55672</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate glucuronate</from_name>
		<from_code>38725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>volanesorsen</from_name>
		<from_code>2637345</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Translation Alteration [PE]</from_name>
		<from_code>N0000009894</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn</from_name>
		<from_code>2561249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen sodium</from_name>
		<from_code>314633</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium hemipentahydrate</from_name>
		<from_code>2056898</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline tosylate</from_name>
		<from_code>2059268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaspargase</from_name>
		<from_code>34132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetyldithranol</from_name>
		<from_code>38536</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran lipid complex</from_name>
		<from_code>2284711</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fitusiran</from_name>
		<from_code>2709439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium heptahydrate</from_name>
		<from_code>1666923</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plozasiran</from_name>
		<from_code>2727175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oleandomycin</from_name>
		<from_code>7629</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacarbazine</from_name>
		<from_code>3098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp-erzs</from_name>
		<from_code>2109054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran sodium lipid complex</from_name>
		<from_code>2284710</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran sodium</from_name>
		<from_code>2053491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibeprenlimab-szsi</from_name>
		<from_code>2728394</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate</from_name>
		<from_code>42333</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium</from_name>
		<from_code>282443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen</from_name>
		<from_code>1367839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxetumomab pasudotox</from_name>
		<from_code>2099295</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline dihydrochloride</from_name>
		<from_code>2055907</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide (11.beta.,16.alpha.(S))</from_name>
		<from_code>1367172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelaic acid</from_name>
		<from_code>18602</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegvisomant</from_name>
		<from_code>278739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofersen</from_name>
		<from_code>2634995</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline hydrochloride</from_name>
		<from_code>2059038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen</from_name>
		<from_code>85763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralatrexate</from_name>
		<from_code>662019</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen</from_name>
		<from_code>2724361</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed monohydrate</from_name>
		<from_code>2590669</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benznidazole</from_name>
		<from_code>18994</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omacetaxine</from_name>
		<from_code>1546446</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patisiran</from_name>
		<from_code>2053490</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol-mknl</from_name>
		<from_code>2121417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plozasiran sodium</from_name>
		<from_code>2727337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>volanesorsen sodium</from_name>
		<from_code>2637346</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen sodium</from_name>
		<from_code>2724362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed dipotassium</from_name>
		<from_code>2699334</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifaximin</from_name>
		<from_code>35619</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate, liposomal</from_name>
		<from_code>2059179</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfopristin</from_name>
		<from_code>229369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin liposomal</from_name>
		<from_code>2059180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol</from_name>
		<from_code>2121416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibeprenlimab</from_name>
		<from_code>2728380</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifapentine</from_name>
		<from_code>35617</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthralin</from_name>
		<from_code>873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine hydrochloride</from_name>
		<from_code>81945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen sodium</from_name>
		<from_code>1367838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxetumomab pasudotox-tdfk</from_name>
		<from_code>2099305</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed tromethamine anhydrous</from_name>
		<from_code>2604776</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp</from_name>
		<from_code>2109055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate</from_name>
		<from_code>2640868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Striated Muscle Anabolism Alteration [PE]</from_name>
		<from_code>N0000009877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine</from_name>
		<from_code>569</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Protein Synthesis [PE]</to_name>
		<to_code>N0000008841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasoconstrictor [EPC]</from_name>
		<from_code>N0000192562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>oxymetazoline</to_name>
		<to_code>7812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasoconstrictor [EPC]</from_name>
		<from_code>N0000192562</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Vasopressor (substance)</to_name>
		<to_code>870406003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasoconstrictor [EPC]</from_name>
		<from_code>N0000192562</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>angiotensin II</to_name>
		<to_code>1999003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasoconstrictor [EPC]</from_name>
		<from_code>N0000192562</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasoconstriction [PE]</from_name>
		<from_code>N0000009908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Venous Vasoconstriction [PE]</to_name>
		<to_code>N0000009910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vasoconstriction [PE]</from_name>
		<from_code>N0000009908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Tone Alteration [PE]</from_name>
		<from_code>N0000009906</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobetaxolol hydrochloride</from_name>
		<from_code>261718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline</from_name>
		<from_code>39841</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xylometazoline hydrochloride</from_name>
		<from_code>54220</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanadelumab</from_name>
		<from_code>2055641</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecallantide</from_name>
		<from_code>658708</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octopamine hydrochloride</from_name>
		<from_code>1744461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argipressin</from_name>
		<from_code>1098</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galcanezumab-gnlm</from_name>
		<from_code>2058868</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobetaxolol</from_name>
		<from_code>353497</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanadelumab-flyo</from_name>
		<from_code>2055640</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline hydrochloride</from_name>
		<from_code>106101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine hydrochloride</from_name>
		<from_code>3266</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonordefrin</from_name>
		<from_code>132889</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droxidopa</from_name>
		<from_code>1489913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galcanezumab</from_name>
		<from_code>2058846</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octopamine</from_name>
		<from_code>1311141</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>angiotensin II</from_name>
		<from_code>1999003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline</from_name>
		<from_code>7812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>angiotensin II acetate, human</from_name>
		<from_code>2204740</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vasoconstriction [PE]</to_name>
		<to_code>N0000009908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Venous Vasoconstriction [PE]</from_name>
		<from_code>N0000009910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Venous Vasoconstriction [PE]</to_name>
		<to_code>N0000009817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Venous Vasoconstriction [PE]</from_name>
		<from_code>N0000009910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasoconstriction [PE]</to_name>
		<to_code>N0000009882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasoconstriction [PE]</to_name>
		<to_code>N0000009882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Venous Vasoconstriction [PE]</to_name>
		<to_code>N0000009882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Splanchnic Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008298</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucosal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrate</from_name>
		<from_code>283561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine, DL-</from_name>
		<from_code>1657875</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noradrenaline hydrochloride</from_name>
		<from_code>2256931</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine</from_name>
		<from_code>7512</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Pulmonary Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009815</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Pulmonary Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucosal Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Splanchnic Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Muscular Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oropharyngeal Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175399</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Mucosal Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Conjunctival Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008371</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oropharyngeal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oropharyngeal Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Respiratory Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009834</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Genitourinary Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cutaneous Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008376</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cerebral Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008351</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Efferent Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arteriolar Vasoconstriction [PE]</from_name>
		<from_code>N0000175406</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Afferent Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Efferent Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009827</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Efferent Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Afferent Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009823</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Afferent Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Splanchnic Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009855</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Splanchnic Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Systemic Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009941</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Coronary Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000008374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Coronary Arteriolar Vasoconstriction [PE]</to_name>
		<to_code>N0000175397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Afferent Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Renal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009825</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Efferent Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Renal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine hydrochloride</from_name>
		<from_code>105470</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine</from_name>
		<from_code>9392</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Muscular Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Systemic Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Respiratory Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oropharyngeal Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
		<from_code>N0000009751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline</from_name>
		<from_code>7812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine hydrochloride</from_name>
		<from_code>8164</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine tannate</from_name>
		<from_code>221139</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrozoline hydrochloride</from_name>
		<from_code>57983</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline hydrochloride</from_name>
		<from_code>82054</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline hydrochloride</from_name>
		<from_code>106101</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline</from_name>
		<from_code>7247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine bitartrate</from_name>
		<from_code>91167</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine</from_name>
		<from_code>8163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline nitrate</from_name>
		<from_code>235810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrozoline</from_name>
		<from_code>37935</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000008371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine</from_name>
		<from_code>9000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine bromide</from_name>
		<from_code>9001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
		<to_code>N0000009058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
		<from_code>N0000186779</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing microsomal triglyceride transfer protein inhibitor (product)</to_name>
		<to_code>774308007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
		<from_code>N0000186779</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lomitapide</to_name>
		<to_code>1364479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
		<from_code>N0000186779</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with microsomal triglyceride transfer protein inhibitor mechanism of action (substance)</to_name>
		<to_code>774302008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sclerosing Agent [EPC]</from_name>
		<from_code>N0000175814</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sclerosing Agent [EPC]</from_name>
		<from_code>N0000175814</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Sclerosing agent (substance)</to_name>
		<to_code>372654003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sclerosing Agent [EPC]</from_name>
		<from_code>N0000175814</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>laureth-9</to_name>
		<to_code>236545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sclerosing Agent [EPC]</from_name>
		<from_code>N0000175814</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polidocanol</to_name>
		<to_code>968170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sclerosing Agent [EPC]</from_name>
		<from_code>N0000175814</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanolamine</to_name>
		<to_code>24457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sclerosing Agent [EPC]</to_name>
		<to_code>N0000175814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laureth-9 phosphate</from_name>
		<from_code>2373964</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laureth-9</from_name>
		<from_code>236545</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine</from_name>
		<from_code>24457</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talc</from_name>
		<from_code>10323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Vascular Alterations [PE]</from_name>
		<from_code>N0000020002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polidocanol</from_name>
		<from_code>968170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine hydrochloride</from_name>
		<from_code>1311530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine oleate</from_name>
		<from_code>24460</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine thenoate</from_name>
		<from_code>236213</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Vascular Sclerosing Activity [PE]</to_name>
		<to_code>N0000009905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-anginal [EPC]</from_name>
		<from_code>N0000175427</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranolazine</to_name>
		<to_code>35829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-anginal [EPC]</from_name>
		<from_code>N0000175427</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-anginal [EPC]</from_name>
		<from_code>N0000175427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Anti-anginal [EPC]</from_name>
		<from_code>N0000175427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cardiovascular agent (substance)</from_name>
		<from_code>373247007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal [EPC]</to_name>
		<to_code>N0000175427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine benzoate</from_name>
		<from_code>2184116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cardiovascular Agent [TC]</from_name>
		<from_code>N0000178309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-anginal Agent [TC]</to_name>
		<to_code>N0000178310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl nitrite</from_name>
		<from_code>742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilvadipine</from_name>
		<from_code>53692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine</from_name>
		<from_code>7895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine codecarboxylate</from_name>
		<from_code>158387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline</from_name>
		<from_code>4327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil</from_name>
		<from_code>83213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine hydrochloride</from_name>
		<from_code>203132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil dihydrochloride</from_name>
		<from_code>83214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetranitrate</from_name>
		<from_code>7992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Astragalus preparation</from_name>
		<from_code>319818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fendiline hydrochloride</from_name>
		<from_code>236767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris</to_name>
		<to_code>M0001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Angiopoietin-like 3 Inhibitor [EPC]</from_name>
		<from_code>N0000193915</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evinacumab</to_name>
		<to_code>2478335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with lipase inhibitor mechanism of action (substance)</from_name>
		<from_code>372581006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiopoietin-like 3 Inhibitor [EPC]</to_name>
		<to_code>N0000193915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing lipase inhibitor (product)</from_name>
		<from_code>116092004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Angiopoietin-like 3 Inhibitor [EPC]</to_name>
		<to_code>N0000193915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Dermal Fibroblast Cell Therapy [EPC]</to_name>
		<to_code>N0000194145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy [EPC]</to_name>
		<to_code>N0000194164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</to_name>
		<to_code>N0000184318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Pancreatic Islet Cellular Therapy [EPC]</to_name>
		<to_code>N0000194075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cellularized Scaffold Cell Therapy [EPC]</to_name>
		<to_code>N0000194074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Chondrocyte Cell Therapy [EPC]</to_name>
		<to_code>N0000194149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Autologous Fibroblast Cell Therapy [EPC]</to_name>
		<to_code>N0000194150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cell Therapy [APC]</from_name>
		<from_code>N0000194069</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Epidermal Keratinocyte Cell Therapy [EPC]</to_name>
		<to_code>N0000194146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
		<from_code>N0000184318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy [EPC]</to_name>
		<to_code>N0000194081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
		<from_code>N0000184318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hematopoietic Stem Cells</to_name>
		<to_code>M0010055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
		<from_code>N0000184318</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Allogeneic [EXT]</to_name>
		<to_code>N0000185022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
		<from_code>N0000184318</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human cord blood hematopoietic progenitor cell</to_name>
		<to_code>1307732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Hematopoietic factor (substance)</from_name>
		<from_code>17948008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</to_name>
		<to_code>N0000184318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human cord blood hematopoietic progenitor cell</from_name>
		<from_code>1307732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hematopoietic Stem Cells</to_name>
		<to_code>M0010055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Allogeneic [EXT]</to_name>
		<to_code>N0000185022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human cord blood hematopoietic progenitor cell</from_name>
		<from_code>1307732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Allogeneic [EXT]</to_name>
		<to_code>N0000185022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Autologous Chondrocyte Cell Therapy [EPC]</from_name>
		<from_code>N0000194149</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Autologous cultured chondrocyte (substance)</to_name>
		<to_code>840610002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diuretic [APC]</from_name>
		<from_code>N0000193873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiazide-like Diuretic [EPC]</to_name>
		<to_code>N0000175420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diuretic [APC]</from_name>
		<from_code>N0000193873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Diuretic [EPC]</to_name>
		<to_code>N0000175810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Diuretic [APC]</from_name>
		<from_code>N0000193873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Loop Diuretic [EPC]</to_name>
		<to_code>N0000175590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide-like Diuretic [EPC]</from_name>
		<from_code>N0000175420</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indapamide</to_name>
		<to_code>5764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide-like Diuretic [EPC]</from_name>
		<from_code>N0000175420</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metolazone</to_name>
		<to_code>6916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Thiazide-like Diuretic [EPC]</from_name>
		<from_code>N0000175420</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorthalidone</to_name>
		<to_code>2409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Thiazide diuretic (substance)</from_name>
		<from_code>372747003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Thiazide-like Diuretic [EPC]</to_name>
		<to_code>N0000175420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Diuretic [EPC]</from_name>
		<from_code>N0000175810</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Osmotic diuretic (substance)</to_name>
		<to_code>372792005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Diuretic [EPC]</from_name>
		<from_code>N0000175810</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mannitol</to_name>
		<to_code>6628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Diuretic [EPC]</to_name>
		<to_code>N0000175810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Loop diuretic (substance)</to_name>
		<to_code>372691009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>torsemide</to_name>
		<to_code>38413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethacrynic acid</to_name>
		<to_code>4109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>furosemide</to_name>
		<to_code>4603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Loop Diuretic [EPC]</from_name>
		<from_code>N0000175590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bumetanide</to_name>
		<to_code>1808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelator [EPC]</to_name>
		<to_code>N0000175473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Demulcent [EPC]</to_name>
		<to_code>N0000175535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive Therapeutic Agent [EPC]</to_name>
		<to_code>N0000175872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cystine Depleting Agent [EPC]</to_name>
		<to_code>N0000187051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper-containing Intrauterine Device [EPC]</to_name>
		<to_code>N0000175831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoactivated Radical Generator [EPC]</to_name>
		<to_code>N0000175984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Binder [EPC]</to_name>
		<to_code>N0000175597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitrogen Binding Agent [EPC]</to_name>
		<to_code>N0000175807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Potassium Binder [EPC]</to_name>
		<to_code>N0000178378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Absorption Inhibitor [EPC]</to_name>
		<to_code>N0000175530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoenhancer [EPC]</to_name>
		<to_code>N0000175540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Methylating Agent [EPC]</to_name>
		<to_code>N0000175805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Disclosing Agent [EPC]</to_name>
		<to_code>N0000194020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Oxidation-Reduction Agent [EPC]</to_name>
		<to_code>N0000192516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metabolic Alkalinizer [EPC]</to_name>
		<to_code>N0000175896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Nitric Oxide Releasing Agent [EPC]</to_name>
		<to_code>N0000194124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Transthyretin Stabilizer [EPC]</to_name>
		<to_code>N0000194134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Laxative [EPC]</to_name>
		<to_code>N0000175811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Physical or Chemical Agent [APC]</from_name>
		<from_code>N0000193908</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calculi Dissolution Agent [EPC]</to_name>
		<to_code>N0000175835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelator [EPC]</from_name>
		<from_code>N0000175473</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dimercaprol</to_name>
		<to_code>3445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelator [EPC]</from_name>
		<from_code>N0000175473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelator [EPC]</to_name>
		<to_code>N0000175522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelator [EPC]</from_name>
		<from_code>N0000175473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Chelator [EPC]</to_name>
		<to_code>N0000194014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelator [EPC]</from_name>
		<from_code>N0000175473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Calcium Binder [EPC]</to_name>
		<to_code>N0000175567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metal Chelator [EPC]</from_name>
		<from_code>N0000175473</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelator [EPC]</to_name>
		<to_code>N0000175963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chelating agent (product)</from_name>
		<from_code>350075001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelator [EPC]</to_name>
		<to_code>N0000175473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with chelating agent mechanism of action (substance)</from_name>
		<from_code>372627001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Metal Chelator [EPC]</to_name>
		<to_code>N0000175473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Iron Chelator [EPC]</from_name>
		<from_code>N0000175522</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deferoxamine</to_name>
		<to_code>3131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Iron Chelator [EPC]</from_name>
		<from_code>N0000175522</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deferiprone</to_name>
		<to_code>11645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Iron Chelator [EPC]</from_name>
		<from_code>N0000175522</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deferasirox</to_name>
		<to_code>614373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chelating agent (product)</from_name>
		<from_code>350075001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelator [EPC]</to_name>
		<to_code>N0000175522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with chelating agent mechanism of action (substance)</from_name>
		<from_code>372627001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Iron Chelator [EPC]</to_name>
		<to_code>N0000175522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper Chelator [EPC]</from_name>
		<from_code>N0000194014</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trientine</to_name>
		<to_code>10798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chelating agent (product)</from_name>
		<from_code>350075001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Chelator [EPC]</to_name>
		<to_code>N0000194014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with chelating agent mechanism of action (substance)</from_name>
		<from_code>372627001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper Chelator [EPC]</to_name>
		<to_code>N0000194014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Binder [EPC]</from_name>
		<from_code>N0000175567</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulose sodium phosphate</to_name>
		<to_code>342965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Binder [EPC]</from_name>
		<from_code>N0000175567</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing calcium exchange resin (product)</to_name>
		<to_code>35392005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calcium Binder [EPC]</from_name>
		<from_code>N0000175567</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Calcium exchange resin (substance)</to_name>
		<to_code>372716009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lead Chelator [EPC]</from_name>
		<from_code>N0000175963</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetic acid</to_name>
		<to_code>3690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lead Chelator [EPC]</from_name>
		<from_code>N0000175963</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succimer</to_name>
		<to_code>3446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Lead Chelator [EPC]</from_name>
		<from_code>N0000175963</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetic acid</to_name>
		<to_code>3755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chelating agent (product)</from_name>
		<from_code>350075001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelator [EPC]</to_name>
		<to_code>N0000175963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with chelating agent mechanism of action (substance)</from_name>
		<from_code>372627001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Lead Chelator [EPC]</to_name>
		<to_code>N0000175963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Demulcent [EPC]</from_name>
		<from_code>N0000175535</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type H)</to_name>
		<to_code>1811461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Demulcent [EPC]</from_name>
		<from_code>N0000175535</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (1600000 WAMW)</to_name>
		<to_code>2048727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Demulcent [EPC]</from_name>
		<from_code>N0000175535</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropylcellulose</to_name>
		<to_code>27291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Therapeutic Agent [EPC]</from_name>
		<from_code>N0000175872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioligand Therapeutic Agent [EPC]</to_name>
		<to_code>N0000194017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Therapeutic Agent [EPC]</from_name>
		<from_code>N0000175872</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium cation Sr-89</to_name>
		<to_code>2280602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Therapeutic Agent [EPC]</from_name>
		<from_code>N0000175872</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</to_name>
		<to_code>N0000187053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive Therapeutic Agent [EPC]</from_name>
		<from_code>N0000175872</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodide ion I-131</to_name>
		<to_code>1546415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Radioactive isotope (substance)</from_name>
		<from_code>89457008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive Therapeutic Agent [EPC]</to_name>
		<to_code>N0000175872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing radioactive isotope (product)</from_name>
		<from_code>785317008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive Therapeutic Agent [EPC]</to_name>
		<to_code>N0000175872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioligand Therapeutic Agent [EPC]</from_name>
		<from_code>N0000194017</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lutetium Lu 177 vipivotide tetraxetan</to_name>
		<to_code>2597053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Lutetium-177 (substance)</from_name>
		<from_code>447553000</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioligand Therapeutic Agent [EPC]</to_name>
		<to_code>N0000194017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</from_name>
		<from_code>N0000187053</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radium Ra-223 cation</to_name>
		<to_code>1745075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Radioactive isotope (substance)</from_name>
		<from_code>89457008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</to_name>
		<to_code>N0000187053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing radioactive isotope (product)</from_name>
		<from_code>785317008</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</to_name>
		<to_code>N0000187053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cystine Depleting Agent [EPC]</from_name>
		<from_code>N0000187051</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteamine</to_name>
		<to_code>3022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper-containing Intrauterine Device [EPC]</from_name>
		<from_code>N0000175831</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper</to_name>
		<to_code>2837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper-containing Intrauterine Device [EPC]</from_name>
		<from_code>N0000175831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper-containing Intrauterine Device [EPC]</from_name>
		<from_code>N0000175831</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Copper-containing intrauterine device (product)</to_name>
		<to_code>714594000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Copper (substance)</from_name>
		<from_code>66925006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Copper-containing Intrauterine Device [EPC]</to_name>
		<to_code>N0000175831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper sulfate</from_name>
		<from_code>21579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric oxide</from_name>
		<from_code>21837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper gluconate</from_name>
		<from_code>2839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric chloride</from_name>
		<from_code>21833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper</from_name>
		<from_code>2837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper</from_name>
		<from_code>2837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper chloride</from_name>
		<from_code>150596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper</to_name>
		<to_code>M0005152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoactivated Radical Generator [EPC]</from_name>
		<from_code>N0000175984</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dihematoporphyrin ether</to_name>
		<to_code>23066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoactivated Radical Generator [EPC]</from_name>
		<from_code>N0000175984</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoactivated Radical Generator [EPC]</from_name>
		<from_code>N0000175984</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxsalen</to_name>
		<to_code>6854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Photosensitizing agent (product)</from_name>
		<from_code>108817007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photoactivated Radical Generator [EPC]</to_name>
		<to_code>N0000175984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verteporfin</from_name>
		<from_code>118886</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoctrizole</from_name>
		<from_code>1310510</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoenhancer [EPC]</from_name>
		<from_code>N0000175540</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drometrizole</from_name>
		<from_code>1426903</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihematoporphyrin ether</from_name>
		<from_code>23066</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar</from_name>
		<from_code>2635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 5-aminolevulinate</from_name>
		<from_code>337068</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar pitch volatiles</from_name>
		<from_code>90732</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar extract</from_name>
		<from_code>90735</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Flavin Mononucleotide</from_name>
		<from_code>4509</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate</from_name>
		<from_code>1925821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl aminolevulinate hydrochloride</from_name>
		<from_code>1300479</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Dermatologic Activity Alteration [PE]</from_name>
		<from_code>N0000009020</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Photosensitizing Activity [PE]</to_name>
		<to_code>N0000009801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphate Binder [EPC]</from_name>
		<from_code>N0000175597</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium ion</to_name>
		<to_code>1316581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphate Binder [EPC]</from_name>
		<from_code>N0000175597</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lanthanum cation (3+)</to_name>
		<to_code>1546443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphate Binder [EPC]</from_name>
		<from_code>N0000175597</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ferric cation</to_name>
		<to_code>1546357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Phosphate Binder [EPC]</from_name>
		<from_code>N0000175597</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevelamer</to_name>
		<to_code>214824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Product containing chelating agent (product)</from_name>
		<from_code>350075001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Binder [EPC]</to_name>
		<to_code>N0000175597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with anion exchange resin mechanism of action (substance)</from_name>
		<from_code>372604009</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Phosphate Binder [EPC]</to_name>
		<to_code>N0000175597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrogen Binding Agent [EPC]</from_name>
		<from_code>N0000175807</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>benzoic acid</to_name>
		<to_code>18989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrogen Binding Agent [EPC]</from_name>
		<from_code>N0000175807</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylacetic acid</to_name>
		<to_code>33332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitrogen Binding Agent [EPC]</from_name>
		<from_code>N0000175807</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-phenylbutyric acid</to_name>
		<to_code>1546447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Binder [EPC]</from_name>
		<from_code>N0000178378</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium polystyrene sulfonate</to_name>
		<to_code>56512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Binder [EPC]</from_name>
		<from_code>N0000178378</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Product containing potassium exchange resin (product)</to_name>
		<to_code>18679008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Binder [EPC]</from_name>
		<from_code>N0000178378</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patiromer</to_name>
		<to_code>1716203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Potassium Binder [EPC]</from_name>
		<from_code>N0000178378</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Potassium exchange resin (substance)</to_name>
		<to_code>372667000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper Absorption Inhibitor [EPC]</from_name>
		<from_code>N0000175530</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>zinc cation</to_name>
		<to_code>1546264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Copper Absorption Inhibitor [EPC]</from_name>
		<from_code>N0000175530</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Copper Ion Absorption [PE]</to_name>
		<to_code>N0000175529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc cation</from_name>
		<from_code>1546264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Copper Ion Absorption [PE]</to_name>
		<to_code>N0000175529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased Inorganic Ion Absorption [PE]</from_name>
		<from_code>N0000175528</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Copper Ion Absorption [PE]</to_name>
		<to_code>N0000175529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoenhancer [EPC]</from_name>
		<from_code>N0000175540</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin 5'-phosphate</to_name>
		<to_code>1925821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoenhancer [EPC]</from_name>
		<from_code>N0000175540</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>verteporfin</to_name>
		<to_code>118886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Photoenhancer [EPC]</from_name>
		<from_code>N0000175540</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Flavin Mononucleotide</to_name>
		<to_code>4509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylating Agent [EPC]</from_name>
		<from_code>N0000175805</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>betaine, anhydrous</to_name>
		<to_code>350374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylating Agent [EPC]</from_name>
		<from_code>N0000175805</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with methyltransferase mechanism of action (substance)</to_name>
		<to_code>130055001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Methylating Agent [EPC]</from_name>
		<from_code>N0000175805</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>betaine</to_name>
		<to_code>1512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Disclosing Agent [EPC]</from_name>
		<from_code>N0000194020</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>brilliant blue G</to_name>
		<to_code>1998867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Dye (substance)</from_name>
		<from_code>61789006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Disclosing Agent [EPC]</to_name>
		<to_code>N0000194020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Oxidation-Reduction Agent [EPC]</from_name>
		<from_code>N0000192516</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene blue cation</to_name>
		<to_code>1546414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Metabolic Alkalinizer [EPC]</from_name>
		<from_code>N0000175896</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium citrate anhydrous</to_name>
		<to_code>1374802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitric Oxide Releasing Agent [EPC]</from_name>
		<from_code>N0000194124</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitric Oxide Releasing Agent [EPC]</from_name>
		<from_code>N0000194124</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>berdazimer free acid</to_name>
		<to_code>2710444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Muscular System Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Central Nervous System Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009455</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl nitrite</from_name>
		<from_code>742</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetranitrate</from_name>
		<from_code>7992</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer free acid</from_name>
		<from_code>2710444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer</from_name>
		<from_code>2710434</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Nitric Oxide Activity Alteration [PE]</from_name>
		<from_code>N0000009762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>berdazimer sodium</from_name>
		<from_code>2710445</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Striated Muscle Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cardiac Muscle Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Muscular System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Smooth Muscle Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebellum Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Brain Stem Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Midbrain Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Cerebral Cortex Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009195</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Spinal Cord Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Enteric Nervous System Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009511</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
		<from_code>N0000009107</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased Parasympathetic Activity [PE]</from_name>
		<from_code>N0000175649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Parasympathetic Nitric Oxide Activity [PE]</to_name>
		<to_code>N0000009488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Transthyretin Stabilizer [EPC]</from_name>
		<from_code>N0000194134</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acoramidis</to_name>
		<to_code>2698312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfate ion</to_name>
		<to_code>1426598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 3350</to_name>
		<to_code>221147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium ion</to_name>
		<to_code>1318915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cation</to_name>
		<to_code>1364429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lactitol</to_name>
		<to_code>28395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cation</to_name>
		<to_code>1311382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium cation</to_name>
		<to_code>1426853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</to_name>
		<to_code>N0000194056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Osmotic Laxative [EPC]</from_name>
		<from_code>N0000175811</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>lactulose</to_name>
		<to_code>6218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Laxative [EPC]</to_name>
		<to_code>N0000175811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Laxative (substance)</from_name>
		<from_code>372800002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Osmotic Laxative [EPC]</to_name>
		<to_code>N0000175811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium cation</from_name>
		<from_code>1426853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine</from_name>
		<from_code>1876597</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfate ion</from_name>
		<from_code>1426598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine tosylate</from_name>
		<from_code>1876598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium cation</from_name>
		<from_code>1364429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dihydrogen phosphate dihydrate</from_name>
		<from_code>1311311</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium cation</from_name>
		<from_code>1311382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sennosides, USP</from_name>
		<from_code>36387</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Increased GI Motility [PE]</from_name>
		<from_code>N0000009329</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picosulfate sodium</from_name>
		<from_code>33688</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium hydrogen phosphate dehydrate</from_name>
		<from_code>1311230</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dried sodium phosphate</from_name>
		<from_code>1366977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, monohydrate</from_name>
		<from_code>1311342</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (4000 CPS)</from_name>
		<from_code>1297402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic, anhydrous</from_name>
		<from_code>349753</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic</from_name>
		<from_code>236719</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate</from_name>
		<from_code>36709</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil</from_name>
		<from_code>6972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Stimulant Laxative [EPC]</from_name>
		<from_code>N0000175812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>senna concentrate</from_name>
		<from_code>219860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deacetylbisacodyl</from_name>
		<from_code>1872905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dodecahydrate</from_name>
		<from_code>1311326</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil, light</from_name>
		<from_code>577312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sodium phosphate</from_name>
		<from_code>2288215</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sennoside A&amp;B, calcium salt</from_name>
		<from_code>267741</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dihydrate</from_name>
		<from_code>1311323</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, anhydrous</from_name>
		<from_code>314838</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate,monobasic,monohydrate</from_name>
		<from_code>221125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic</from_name>
		<from_code>235496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (100 CPS)</from_name>
		<from_code>1310583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose</from_name>
		<from_code>6873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate dihydrate</from_name>
		<from_code>314837</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heavy mineral oil</from_name>
		<from_code>258439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ion</from_name>
		<from_code>1318915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic sodium phosphate, dihydrate</from_name>
		<from_code>1311286</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malt soup extract</from_name>
		<from_code>91264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Increased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000009371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer</from_name>
		<from_code>214824</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malt soup extract</from_name>
		<from_code>91264</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil</from_name>
		<from_code>6972</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (100 CPS)</from_name>
		<from_code>1310583</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose</from_name>
		<from_code>6873</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (4000 CPS)</from_name>
		<from_code>1297402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer carbonate</from_name>
		<from_code>660890</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heavy mineral oil</from_name>
		<from_code>258439</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ion</from_name>
		<from_code>1318915</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</from_name>
		<from_code>N0000009736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium cation</from_name>
		<from_code>1311382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer hydrochloride</from_name>
		<from_code>237125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucroferric oxyhydroxide</from_name>
		<from_code>1484283</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium cation</from_name>
		<from_code>1426853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium cation</from_name>
		<from_code>1364429</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfate ion</from_name>
		<from_code>1426598</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil, light</from_name>
		<from_code>577312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</from_name>
		<from_code>N0000194056</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Substance with sodium-hydrogen exchanger isoform 3 transporter inhibitor mechanism of action (substance)</to_name>
		<to_code>789707008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</from_name>
		<from_code>N0000194056</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenapanor</to_name>
		<to_code>2199674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Substance with cellular transport inhibitor mechanism of action (substance)</from_name>
		<from_code>771357006</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</to_name>
		<to_code>N0000194056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calculi Dissolution Agent [EPC]</from_name>
		<from_code>N0000175835</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gluconolactone</to_name>
		<to_code>25842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calculi Dissolution Agent [EPC]</from_name>
		<from_code>N0000175835</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid, anhydrous</to_name>
		<to_code>221946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Calculi Dissolution Agent [EPC]</from_name>
		<from_code>N0000175835</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium cation</to_name>
		<to_code>1426853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
		<from_code>N0000184319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Scaffolds</to_name>
		<to_code>M0505082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
		<from_code>N0000184319</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
		<to_code>N0000184309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
		<from_code>N0000184319</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen type I, bovine</to_name>
		<to_code>1426855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
		<from_code>N0000184319</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>foreskin fibroblast, neonatal</to_name>
		<to_code>1427137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
		<from_code>N0000184319</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>foreskin keratinocyte, neonatal</to_name>
		<to_code>1427138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Replacement agent (substance)</from_name>
		<from_code>373545003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
		<to_code>N0000184319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Graft (substance)</from_name>
		<from_code>260667007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
		<to_code>N0000184319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Biological surgical material (substance)</from_name>
		<from_code>260992007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
		<to_code>N0000184319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foreskin fibroblast, neonatal</from_name>
		<from_code>1427137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Scaffolds</to_name>
		<to_code>M0505082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foreskin keratinocyte, neonatal</from_name>
		<from_code>1427138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Scaffolds</to_name>
		<to_code>M0505082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foreskin keratinocyte, neonatal</from_name>
		<from_code>1427138</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
		<to_code>N0000184309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foreskin fibroblast, neonatal</from_name>
		<from_code>1427137</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
		<to_code>N0000184309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Terminology Extensions for Classification [EXT]</from_name>
		<from_code>N0000193784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
		<to_code>N0000184309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytotoxin [EPC]</from_name>
		<from_code>N0000193862</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD25-directed Cytotoxin [EPC]</to_name>
		<to_code>N0000177912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytotoxin [EPC]</from_name>
		<from_code>N0000193862</from_code>
		<to_namespace>SNOMED CT</to_namespace>
		<to_name>Cytotoxic (substance)</to_name>
		<to_code>373526007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytotoxin [EPC]</from_name>
		<from_code>N0000193862</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytotoxins</to_name>
		<to_code>M0005633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytotoxin [EPC]</from_name>
		<from_code>N0000193862</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tagraxofusp</to_name>
		<to_code>2109055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>CD25-directed Cytotoxin [EPC]</from_name>
		<from_code>N0000177912</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>denileukin diftitox</to_name>
		<to_code>214470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Cytotoxic (substance)</from_name>
		<from_code>373526007</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>CD25-directed Cytotoxin [EPC]</to_name>
		<to_code>N0000177912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tagraxofusp</from_name>
		<from_code>2109055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytotoxins</to_name>
		<to_code>M0005633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Ileal Bile Acid Transporter Inhibitor [EPC]</to_name>
		<to_code>N0000193957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiemetic [EPC]</to_name>
		<to_code>N0000178372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal [EPC]</to_name>
		<to_code>N0000178374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gastrointestinal Motility Inhibitor [EPC]</to_name>
		<to_code>N0000190853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulant Laxative [EPC]</to_name>
		<to_code>N0000175812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [APC]</from_name>
		<from_code>N0000193900</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytoprotective Agent [EPC]</to_name>
		<to_code>N0000180854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ileal Bile Acid Transporter Inhibitor [EPC]</from_name>
		<from_code>N0000193957</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maralixibat</to_name>
		<to_code>2571074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Ileal Bile Acid Transporter Inhibitor [EPC]</from_name>
		<from_code>N0000193957</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>odevixibat</to_name>
		<to_code>2563966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiemetic [EPC]</from_name>
		<from_code>N0000178372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclizine</to_name>
		<to_code>6676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiemetic [EPC]</from_name>
		<from_code>N0000178372</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiemetic [EPC]</from_name>
		<from_code>N0000178372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiemetic [EPC]</from_name>
		<from_code>N0000178372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antiemetic [EPC]</from_name>
		<from_code>N0000178372</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethobenzamide</to_name>
		<to_code>38685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Gastrointestinal agent (substance)</from_name>
		<from_code>373258003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antiemetic [EPC]</to_name>
		<to_code>N0000178372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Central Nervous System Agent [TC]</from_name>
		<from_code>N0000178312</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine maleate</from_name>
		<from_code>71529</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [TC]</from_name>
		<from_code>N0000178370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant</from_name>
		<from_code>2044417</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone</from_name>
		<from_code>3626</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine</from_name>
		<from_code>10471</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant chloride hydrochloride</from_name>
		<from_code>2044416</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone maleate</from_name>
		<from_code>236099</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Anti-emetic Agent [TC]</to_name>
		<to_code>N0000178371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine maleate</from_name>
		<from_code>71529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant</from_name>
		<from_code>2044417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine</from_name>
		<from_code>8352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine</from_name>
		<from_code>10471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant chloride hydrochloride</from_name>
		<from_code>2044416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine hydrochloride</from_name>
		<from_code>235775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymol</from_name>
		<from_code>10553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine hydrochloride</from_name>
		<from_code>235725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine</from_name>
		<from_code>2354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vomiting</to_name>
		<to_code>M0022844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>diphenoxylate</to_name>
		<to_code>3500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crofelemer</to_name>
		<to_code>1364449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>difenoxin</to_name>
		<to_code>23024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Antidiarrheal [EPC]</from_name>
		<from_code>N0000178374</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Gastrointestinal agent (substance)</from_name>
		<from_code>373258003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal [EPC]</to_name>
		<to_code>N0000178374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kaolin light</from_name>
		<from_code>104100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>attapulgite</from_name>
		<from_code>18516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat ethyl</from_name>
		<from_code>1872441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat</from_name>
		<from_code>1872382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (4000 CPS)</from_name>
		<from_code>1297402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifaximin</from_name>
		<from_code>35619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat etiprate</from_name>
		<from_code>1872448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide</from_name>
		<from_code>7617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide</from_name>
		<from_code>89784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kaolin</from_name>
		<from_code>6102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide acetate</from_name>
		<from_code>221130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitazoxanide</from_name>
		<from_code>31819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated attapulgite</from_name>
		<from_code>133050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quercetin</from_name>
		<from_code>9060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (100 CPS)</from_name>
		<from_code>1310583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose</from_name>
		<from_code>6873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malt soup extract</from_name>
		<from_code>91264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide iodide</from_name>
		<from_code>6051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diarrhea</to_name>
		<to_code>M0006212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>senna concentrate</from_name>
		<from_code>219860</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</from_name>
		<from_code>N0000009738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Motility [PE]</from_name>
		<from_code>N0000008635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Motility [PE]</to_name>
		<to_code>N0000008679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat</from_name>
		<from_code>1872382</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kaolin light</from_name>
		<from_code>104100</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kaolin</from_name>
		<from_code>6102</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat etiprate</from_name>
		<from_code>1872448</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_TC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat ethyl</from_name>
		<from_code>1872441</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Agent [TC]</from_name>
		<from_code>N0000178370</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Antidiarrheal Agent [TC]</to_name>
		<to_code>N0000178373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated attapulgite</from_name>
		<from_code>133050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>attapulgite</from_name>
		<from_code>18516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</from_name>
		<from_code>N0000009736</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
		<to_code>N0000009870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Motility Inhibitor [EPC]</from_name>
		<from_code>N0000190853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Motility Inhibitor [EPC]</from_name>
		<from_code>N0000190853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Gastrointestinal Motility Inhibitor [EPC]</from_name>
		<from_code>N0000190853</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucagon</to_name>
		<to_code>4832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Gastrointestinal agent (substance)</from_name>
		<from_code>373258003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Gastrointestinal Motility Inhibitor [EPC]</to_name>
		<to_code>N0000190853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Esophageal Muscle Tone [PE]</to_name>
		<to_code>N0000008628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased LES Tone [PE]</to_name>
		<to_code>N0000008678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Small Intestinal Muscle Tone [PE]</to_name>
		<to_code>N0000008898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Pyloric Sphincter Tone [PE]</to_name>
		<to_code>N0000008851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sphincter of Odi Tone [PE]</to_name>
		<to_code>N0000008925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased UES Tone [PE]</to_name>
		<to_code>N0000009012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Muscle Tone [PE]</to_name>
		<to_code>N0000008641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Anal Sphincter Tone [PE]</to_name>
		<to_code>N0000008389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Muscle Tone [PE]</to_name>
		<to_code>N0000008680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
		<from_code>N0000008636</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gallbladder Tone [PE]</to_name>
		<to_code>N0000008639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethaverine</from_name>
		<from_code>24464</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethaverine hydrochloride</from_name>
		<from_code>235229</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperidolate hydrochloride</from_name>
		<from_code>102170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperidolate</from_name>
		<from_code>59064</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GI Smooth Muscle Tone Alteration [PE]</from_name>
		<from_code>N0000009049</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine hydrochloride</from_name>
		<from_code>142443</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine</from_name>
		<from_code>8718</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
		<to_code>N0000008636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Esophageal Muscle Tone [PE]</to_name>
		<to_code>N0000008628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Small Intestinal Muscle Tone [PE]</to_name>
		<to_code>N0000008898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Small Intestinal Muscle Tone [PE]</to_name>
		<to_code>N0000008898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sphincter of Odi Tone [PE]</to_name>
		<to_code>N0000008925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Sphincter of Odi Tone [PE]</to_name>
		<to_code>N0000008925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Muscle Tone [PE]</to_name>
		<to_code>N0000008680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Large Intestinal Muscle Tone [PE]</to_name>
		<to_code>N0000008680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Motility [PE]</from_name>
		<from_code>N0000008635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Biliary Motility [PE]</to_name>
		<to_code>N0000008419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Motility [PE]</from_name>
		<from_code>N0000008635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Motility [PE]</from_name>
		<from_code>N0000008635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Esophageal Motility [PE]</to_name>
		<to_code>N0000008627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Decreased GI Motility [PE]</from_name>
		<from_code>N0000008635</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Small Intestinal Motility [PE]</to_name>
		<to_code>N0000008897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>attapulgite</from_name>
		<from_code>18516</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>GI Motility Alteration [PE]</from_name>
		<from_code>N0000009048</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide</from_name>
		<from_code>89784</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide iodide</from_name>
		<from_code>6051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisotropine</from_name>
		<from_code>89780</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol hydrochloride</from_name>
		<from_code>857492</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octotropine methylbromide</from_name>
		<from_code>17945</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated attapulgite</from_name>
		<from_code>133050</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased GI Motility [PE]</to_name>
		<to_code>N0000008635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lixisenatide</from_name>
		<from_code>1440051</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exenatide</from_name>
		<from_code>60548</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline</from_name>
		<from_code>6821</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline bromide</from_name>
		<from_code>91163</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dulaglutide</from_name>
		<from_code>1551291</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albiglutide</from_name>
		<from_code>1534763</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide</from_name>
		<from_code>139953</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retatrutide</from_name>
		<from_code>2722410</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide acetate</from_name>
		<from_code>356773</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liraglutide</from_name>
		<from_code>475968</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semaglutide</from_name>
		<from_code>1991302</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Decreased Gastric Motility [PE]</to_name>
		<to_code>N0000008640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Stimulant Laxative [EPC]</from_name>
		<from_code>N0000175812</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>deacetylbisacodyl</to_name>
		<to_code>1872905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Stimulant Laxative [EPC]</from_name>
		<from_code>N0000175812</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Stimulant Laxative [EPC]</from_name>
		<from_code>N0000175812</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bisacodyl</to_name>
		<to_code>1596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Laxative (substance)</from_name>
		<from_code>372800002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulant Laxative [EPC]</to_name>
		<to_code>N0000175812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linaclotide</from_name>
		<from_code>1307404</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</from_name>
		<from_code>N0000009738</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lubiprostone</from_name>
		<from_code>623033</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium cation</from_name>
		<from_code>1426853</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deacetylbisacodyl</from_name>
		<from_code>1872905</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_PE</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
		<to_code>N0000009871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytoprotective Agent [EPC]</from_name>
		<from_code>N0000180854</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>bleomycin</to_name>
		<to_code>1622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytoprotective Agent [EPC]</from_name>
		<from_code>N0000180854</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-mercaptoethanesulfonic acid</to_name>
		<to_code>1546354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Cytoprotective Agent [EPC]</from_name>
		<from_code>N0000180854</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>dexrazoxane</to_name>
		<to_code>42736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>SNOMED CT</from_namespace>
		<from_name>Gastrointestinal agent (substance)</from_name>
		<from_code>373258003</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Cytoprotective Agent [EPC]</to_name>
		<to_code>N0000180854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>G [Preparations]</to_name>
		<to_code>N0000010589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>W [Preparations]</to_name>
		<to_code>N0000010605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>A [Preparations]</to_name>
		<to_code>N0000010583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>P [Preparations]</to_name>
		<to_code>N0000010598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>I [Preparations]</to_name>
		<to_code>N0000010591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>H [Preparations]</to_name>
		<to_code>N0000010590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>U [Preparations]</to_name>
		<to_code>N0000010603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>M [Preparations]</to_name>
		<to_code>N0000010595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>J [Preparations]</to_name>
		<to_code>N0000010592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>S [Preparations]</to_name>
		<to_code>N0000010601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>T [Preparations]</to_name>
		<to_code>N0000010602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>V [Preparations]</to_name>
		<to_code>N0000010604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>E [Preparations]</to_name>
		<to_code>N0000010587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>C [Preparations]</to_name>
		<to_code>N0000010585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Q [Preparations]</to_name>
		<to_code>N0000010599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>R [Preparations]</to_name>
		<to_code>N0000010600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>K [Preparations]</to_name>
		<to_code>N0000010593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Y [Preparations]</to_name>
		<to_code>N0000010607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>O [Preparations]</to_name>
		<to_code>N0000010597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>Z [Preparations]</to_name>
		<to_code>N0000010608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>X [Preparations]</to_name>
		<to_code>N0000010606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>D [Preparations]</to_name>
		<to_code>N0000010586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>L [Preparations]</to_name>
		<to_code>N0000010594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>F [Preparations]</to_name>
		<to_code>N0000010588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>N [Preparations]</to_name>
		<to_code>N0000010596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Preparations by Generic Ingredient</from_name>
		<from_code>N0000010582</from_code>
		<to_namespace>MED-RT</to_namespace>
		<to_name>B [Preparations]</to_name>
		<to_code>N0000010584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gugulu extract</to_name>
		<to_code>26346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium barbadense leaf extract</to_name>
		<to_code>2200139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gluceptate sodium</to_name>
		<to_code>317595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galium boreale leaf extract</to_name>
		<to_code>1488226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-aminobutyrate</to_name>
		<to_code>618771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galcanezumab-gnlm</to_name>
		<to_code>2058868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganirelix acetate</to_name>
		<to_code>259264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl tribehenate- isostearate- eicosandioate</to_name>
		<to_code>1376099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadodiamide</to_name>
		<to_code>41144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadofosveset trisodium</to_name>
		<to_code>1364289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerin</to_name>
		<to_code>4910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goserelin acetate</to_name>
		<to_code>203146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guaiacum officinale wood oil</to_name>
		<to_code>2637099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gatifloxacin</to_name>
		<to_code>228476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyrrhizin, ammoniated pentahydrate</to_name>
		<to_code>1371367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grindelia squarrosa flowering top extract</to_name>
		<to_code>1426158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ginkgo biloba leaf extract</to_name>
		<to_code>259265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiacol</to_name>
		<to_code>5031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-17 stearate</to_name>
		<to_code>1314241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana lutea root extract</to_name>
		<to_code>1307945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-cyclodextrin</to_name>
		<to_code>1366989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>1370435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutaric acid</to_name>
		<to_code>1943799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycine zinc chelate</to_name>
		<to_code>806626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza uralensis whole extract</to_name>
		<to_code>1535491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-linolenic acid</to_name>
		<to_code>25605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl triacetyl 12-hydroxystearate</to_name>
		<to_code>2696552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerophosphoinositol lysine</to_name>
		<to_code>2461971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glofitamab-gxbm</to_name>
		<to_code>2639781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepotidacin mesylate</to_name>
		<to_code>2709213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Giardia lamblia</to_name>
		<to_code>1439028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit oil</to_name>
		<to_code>1309212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green olive allergenic extract</to_name>
		<to_code>971379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gliocladium allergenic extract</to_name>
		<to_code>1192997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentian violet cation</to_name>
		<to_code>1546369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonadotropin releasing hormone, D-Arg(6) ethyl amide acetate</to_name>
		<to_code>1306117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit extract</to_name>
		<to_code>124323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceran polyricinoleic acid ester</to_name>
		<to_code>1541750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garrys oak pollen extract</to_name>
		<to_code>900987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl rosinate</to_name>
		<to_code>1928891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ganoderma lucidum whole extract</to_name>
		<to_code>2287734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl stearate - PEG-100 stearate</to_name>
		<to_code>2167167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galangal oil</to_name>
		<to_code>1307682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green english pea allergenic extract</to_name>
		<to_code>2102798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ginko biloba leaf oil</to_name>
		<to_code>1356135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycogen</to_name>
		<to_code>1426910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallic acid</to_name>
		<to_code>1311389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>germanium citrate lactate</to_name>
		<to_code>1427153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galactose</to_name>
		<to_code>4626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gefitinib</to_name>
		<to_code>328134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galium aparine extract</to_name>
		<to_code>1345678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepefrine tartrate</to_name>
		<to_code>236858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana urnula flower extract</to_name>
		<to_code>1358176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanfacine</to_name>
		<to_code>40114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glebionis coronaria whole extract</to_name>
		<to_code>1800486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepirone</to_name>
		<to_code>2672253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galantamine</to_name>
		<to_code>4637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl behenate-eicosadioate</to_name>
		<to_code>1371968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentian preparation</to_name>
		<to_code>319824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-methacryloxypropyltrimethoxysilane</to_name>
		<to_code>2386843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold monosulfide</to_name>
		<to_code>1546210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiacolsulfonic acid</to_name>
		<to_code>26288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golden seal extract</to_name>
		<to_code>408114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium thunbergii flowering top extract</to_name>
		<to_code>2119796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-glyceryl monooleate</to_name>
		<to_code>1426374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium maculatum whole extract</to_name>
		<to_code>1487830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia indica fruit extract</to_name>
		<to_code>1376212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger allergenic extract</to_name>
		<to_code>899420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gliclazide</to_name>
		<to_code>4816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl distearate</to_name>
		<to_code>1311690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranylgeranylacetone</to_name>
		<to_code>1362746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gelsemium sempervirens whole extract</to_name>
		<to_code>1493692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium maculatum root extract</to_name>
		<to_code>1346619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl stearate citrate</to_name>
		<to_code>1426411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-adipate</to_name>
		<to_code>1426925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia mangostana fruit extract</to_name>
		<to_code>1654961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gaultheria procumbens top extract</to_name>
		<to_code>1310285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium herbaceum flower extract</to_name>
		<to_code>2593942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucagon (rDNA)</to_name>
		<to_code>261716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol palmitate</to_name>
		<to_code>1307155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garadacimab-gxii</to_name>
		<to_code>2717168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia cambogia preparation</to_name>
		<to_code>253168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 2-caprylate</to_name>
		<to_code>2680301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginsenoside</to_name>
		<to_code>349656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ganoderma lucidum stem extract</to_name>
		<to_code>1309999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ginkgo biloba extract</to_name>
		<to_code>236809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geraniol</to_name>
		<to_code>1368875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-8</to_name>
		<to_code>2396433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl phosphate</to_name>
		<to_code>1423803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutarate</to_name>
		<to_code>1943800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza echinata root extract</to_name>
		<to_code>1652101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galega officinalis extract</to_name>
		<to_code>1862095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol ester of hydrogenated rosin</to_name>
		<to_code>1999410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>givinostat</to_name>
		<to_code>2678889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gilteritinib fumarate</to_name>
		<to_code>2105823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gelidiella acerosa extract</to_name>
		<to_code>1372013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>genistein</to_name>
		<to_code>25696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiac</to_name>
		<to_code>1373150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gynostemma pentaphyllum leaf extract</to_name>
		<to_code>1855195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-linolenate</to_name>
		<to_code>618453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza inflata root extract</to_name>
		<to_code>1307598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gratiola officinalis extract</to_name>
		<to_code>1336269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>giant scallop preparation</to_name>
		<to_code>1869802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl</to_name>
		<to_code>2531034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geum urbanum root extract</to_name>
		<to_code>1541240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gladiolus communis whole extract</to_name>
		<to_code>2590646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucose oxidase</to_name>
		<to_code>1427073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl monobehenate</to_name>
		<to_code>1655567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gluconate</to_name>
		<to_code>70599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-26 caprylate</to_name>
		<to_code>2058982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerophosphoinositol choline</to_name>
		<to_code>2123309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl palmitostearate</to_name>
		<to_code>1423683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gaultheria procumbens whole extract</to_name>
		<to_code>2601099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanethidine sulfate</to_name>
		<to_code>203181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucan endo-1,3-.alpha.-glucosidase AGN1</to_name>
		<to_code>2118531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycosine</to_name>
		<to_code>2359267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutethimide</to_name>
		<to_code>4903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1,3-dioleate</to_name>
		<to_code>1424662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra root powder extract</to_name>
		<to_code>2711885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guar hydroxypropyltrimonium (1.7 substituents per saccharide)</to_name>
		<to_code>1368618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glasdegib maleate</to_name>
		<to_code>2105844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganirelix</to_name>
		<to_code>35825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyoxal trimer, dihydrate</to_name>
		<to_code>1426857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guar gum</to_name>
		<to_code>26344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guselkumab</to_name>
		<to_code>1928588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guava extract</to_name>
		<to_code>1426645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-17 cocoate</to_name>
		<to_code>1312391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin type B bovine (160 bloom)</to_name>
		<to_code>1800668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grepafloxacin</to_name>
		<to_code>83719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gardenia jasminoides whole extract</to_name>
		<to_code>1541884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-laurate</to_name>
		<to_code>1990422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golodirsen</to_name>
		<to_code>2267207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grindelia hirsutula flowering top extract</to_name>
		<to_code>1309683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranium wilfordii whole extract</to_name>
		<to_code>1733805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guarana preparation</to_name>
		<to_code>236953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gellan gum (low acyl)</to_name>
		<to_code>1420964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold keratinate</to_name>
		<to_code>50598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>givosiran</to_name>
		<to_code>2265712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemfibrozil</to_name>
		<to_code>4719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gekko gecko preparation</to_name>
		<to_code>2627246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucamine</to_name>
		<to_code>1313187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gabapentin</to_name>
		<to_code>25480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium herbaceum seed resin</to_name>
		<to_code>1601996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gleptoferron</to_name>
		<to_code>1855078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutamine</to_name>
		<to_code>4885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium herbaceum root bark extract</to_name>
		<to_code>1309785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia cambogia fruit extract</to_name>
		<to_code>1311595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiol</to_name>
		<to_code>2542348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemcitabine hydrochloride</to_name>
		<to_code>236234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grape seed extract</to_name>
		<to_code>237116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galactose monohydrate</to_name>
		<to_code>1492336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gaultheria procumbens leaf extract</to_name>
		<to_code>1358001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana crassicaulis whole extract</to_name>
		<to_code>2106825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guar hydroxypropyltrimonium chloride (1.7 substituents per saccharide)</to_name>
		<to_code>1368617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium thunbergii whole extract</to_name>
		<to_code>2583870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gynostemma pentaphyllum top extract</to_name>
		<to_code>1372927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemtuzumab ozogamicin</to_name>
		<to_code>1294580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol phenylbutyrate</to_name>
		<to_code>1368451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-glyceryl capryl ether</to_name>
		<to_code>2665085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentian, stemless, whole extract</to_name>
		<to_code>1657728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-2</to_name>
		<to_code>2537434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl monolaurate</to_name>
		<to_code>314647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>groundsel pollen extract</to_name>
		<to_code>897332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerin 1,3-dimethyl ether</to_name>
		<to_code>2471705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerin 2-methyl ether</to_name>
		<to_code>2604173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganciclovir</to_name>
		<to_code>4678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gracilaria gracilis whole extract</to_name>
		<to_code>2463738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ginkgo biloba seed extract</to_name>
		<to_code>1673560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonorrheal urethral secretion human</to_name>
		<to_code>1311177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grape seed oil</to_name>
		<to_code>1309208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glechoma longituba whole extract</to_name>
		<to_code>1537757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-stearate</to_name>
		<to_code>1427173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginseng root</to_name>
		<to_code>259385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green tea leaf extract</to_name>
		<to_code>283567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gila monster venom</to_name>
		<to_code>1595880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garadacimab</to_name>
		<to_code>2717169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyrrhizinate</to_name>
		<to_code>1359426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanabenz</to_name>
		<to_code>5033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galanthus nivalis seed extract</to_name>
		<to_code>1358173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl dipalmitate</to_name>
		<to_code>2383341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucose-6-phosphate</to_name>
		<to_code>1541246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gardenia jasminoides flower extract</to_name>
		<to_code>1800485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra leaf extract</to_name>
		<to_code>1313045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallamine</to_name>
		<to_code>4638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glipizide</to_name>
		<to_code>4821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galcanezumab</to_name>
		<to_code>2058846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin</to_name>
		<to_code>4716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallic acid monohydrate</to_name>
		<to_code>1426746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycine propionyl-L-carnitine</to_name>
		<to_code>2669317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium wilfordii top extract</to_name>
		<to_code>1489547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl diisostearate</to_name>
		<to_code>1735038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gleditsia sinensis seed extract</to_name>
		<to_code>2686032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallamine triethiodide</to_name>
		<to_code>4639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycopyrrolate</to_name>
		<to_code>4955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger root</to_name>
		<to_code>125921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>German wasp venom protein</to_name>
		<to_code>1297531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutamic acid hydrochloride</to_name>
		<to_code>91269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gleditsia sinensis fruit extract</to_name>
		<to_code>1311596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycidyl methacrylate</to_name>
		<to_code>1869700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaietolin</to_name>
		<to_code>236315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-7 trimethyl ether</to_name>
		<to_code>1371446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glecaprevir</to_name>
		<to_code>1940635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>GLY-GLN-PRO-ARG-OH</to_name>
		<to_code>2613778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-26</to_name>
		<to_code>1426630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl acrylate - acrylic acid copolymer (300000 CP AT 2%)</to_name>
		<to_code>2612496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyphosate</to_name>
		<to_code>1800093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl cocoate</to_name>
		<to_code>1311694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-undecylenate</to_name>
		<to_code>1607316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyburide, micronized</to_name>
		<to_code>217364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucametacin</to_name>
		<to_code>25834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucosamine hydrochloride</to_name>
		<to_code>236608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycocholic acid</to_name>
		<to_code>1426482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gypsophila paniculata root extract</to_name>
		<to_code>1655986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganaxolone</to_name>
		<to_code>2604689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanabenz acetate</to_name>
		<to_code>227225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>germanium sesquioxide</to_name>
		<to_code>1314410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentianella amarella whole extract</to_name>
		<to_code>1800661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Graptophyllum pictum whole extract</to_name>
		<to_code>2048125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green bell pepper extract</to_name>
		<to_code>1315118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garlic allergenic extract</to_name>
		<to_code>899414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gymnema sylvestre preparation</to_name>
		<to_code>283569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutaral</to_name>
		<to_code>4888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadoterate meglumine</to_name>
		<to_code>1421151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golden chain pollen extract</to_name>
		<to_code>1996102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiazulene</to_name>
		<to_code>26290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl ricinoleate</to_name>
		<to_code>1427077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-5 lactate</to_name>
		<to_code>1483736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garlic preparation</to_name>
		<to_code>265647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guinea pig dander</to_name>
		<to_code>2166593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galium odoratum extract</to_name>
		<to_code>1351003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol cetearate</to_name>
		<to_code>1428870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerin 1-methyl ether</to_name>
		<to_code>2604172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutamic acid</to_name>
		<to_code>25916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garden cress sprout extract</to_name>
		<to_code>1312593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaifenesin.beta.-isomer</to_name>
		<to_code>2569484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentisate</to_name>
		<to_code>1368642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1,2-dioleate, (S)-</to_name>
		<to_code>2673193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>germanium cation (4+)</to_name>
		<to_code>1546439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gynostemma pentaphyllum whole extract</to_name>
		<to_code>2705690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glatiramer acetate</to_name>
		<to_code>84375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallopamil hydrochloride</to_name>
		<to_code>439837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grevillea buxifolia flower extract</to_name>
		<to_code>1807126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galsulfase</to_name>
		<to_code>578033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glatiramer</to_name>
		<to_code>214582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadobenate</to_name>
		<to_code>692620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl citrate</to_name>
		<to_code>1432297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucuronolactone</to_name>
		<to_code>1535222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-20 cocoate</to_name>
		<to_code>2285323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycosmis citrifolia whole extract</to_name>
		<to_code>2535258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanfacine hydrochloride</to_name>
		<to_code>203142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanethidine monosulfate</to_name>
		<to_code>82023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gray birch pollen extract</to_name>
		<to_code>852178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonadorelin hydrochloride</to_name>
		<to_code>204194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-25 PCA isostearate</to_name>
		<to_code>2383340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonadorelin</to_name>
		<to_code>6384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranium extract</to_name>
		<to_code>1372247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl lactopalmitate/stearate</to_name>
		<to_code>2002787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glehnia littoralis root extract</to_name>
		<to_code>1309431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grifola frondosa whole extract</to_name>
		<to_code>1371312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golden seal root extract</to_name>
		<to_code>283680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>1734630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Globularia cordifolia whole extract</to_name>
		<to_code>1994299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gliquidone</to_name>
		<to_code>25793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gliocladium viride allergenic extract</to_name>
		<to_code>2101353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucose glutamate</to_name>
		<to_code>2468430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol formal, .alpha.,.alpha'</to_name>
		<to_code>2679989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucosamine</to_name>
		<to_code>4845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyrrhizic acid</to_name>
		<to_code>26143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galanthus nivalis extract</to_name>
		<to_code>1719258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-18</to_name>
		<to_code>1311613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garden lady's mantle extract</to_name>
		<to_code>1314299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium-67</to_name>
		<to_code>1546372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyoxal trimer</to_name>
		<to_code>1426858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycine</to_name>
		<to_code>4919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-7 triacetate</to_name>
		<to_code>1535631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycylhydroxyprolylproline</to_name>
		<to_code>1860610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl behenate</to_name>
		<to_code>1305749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galantamine hydrobromide</to_name>
		<to_code>860693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl monoundecylenate</to_name>
		<to_code>1658440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold</to_name>
		<to_code>1311190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gestrinone</to_name>
		<to_code>4792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginseng preparation</to_name>
		<to_code>325526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>giant ragweed pollen extract</to_name>
		<to_code>851998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Genista tinctoria extract</to_name>
		<to_code>1650835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-20</to_name>
		<to_code>1608320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucagon hydrochloride</to_name>
		<to_code>253170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gleditsia sinensis thorn extract</to_name>
		<to_code>2375525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gambels oak pollen extract</to_name>
		<to_code>852276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium chloride,Ga-67</to_name>
		<to_code>314639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-interferon</to_name>
		<to_code>1421648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gallus gallus gizzard lining preparation</to_name>
		<to_code>2106428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanadrel</to_name>
		<to_code>26296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>griseofulvin microsize</to_name>
		<to_code>91077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galactoarabinan</to_name>
		<to_code>1425353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl monooleate citrate</to_name>
		<to_code>1991257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadofosveset</to_name>
		<to_code>1364290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl dioleate</to_name>
		<to_code>2387831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guaiacum officinale wood extract</to_name>
		<to_code>2637098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gramicidin</to_name>
		<to_code>5011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol formal</to_name>
		<to_code>1311689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl caprate</to_name>
		<to_code>1366664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycolide</to_name>
		<to_code>1540882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranial</to_name>
		<to_code>2119367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-terpinene</to_name>
		<to_code>2393523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycidyl acrylate</to_name>
		<to_code>1735329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galbanum oil</to_name>
		<to_code>1307685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold tribromide</to_name>
		<to_code>1433888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol distearate</to_name>
		<to_code>1367188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza glabra whole extract</to_name>
		<to_code>1535490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goose feather extract</to_name>
		<to_code>894783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>givosiran sodium</to_name>
		<to_code>2265859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1,3-dibehenate</to_name>
		<to_code>2535257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guizotia abyssinica seed oil</to_name>
		<to_code>1552172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>germanium dioxide</to_name>
		<to_code>1309238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gelsemium sempervirens preparation</to_name>
		<to_code>285153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ginger extract</to_name>
		<to_code>285241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grevillea speciosa flower extract</to_name>
		<to_code>1648700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl abietate</to_name>
		<to_code>1426927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold trichloride</to_name>
		<to_code>1311297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glaucine</to_name>
		<to_code>1368876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold cation (3+)</to_name>
		<to_code>1546374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium 67 citrate</to_name>
		<to_code>272758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl isostearate</to_name>
		<to_code>1311695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>German cockroach allergenic extract</to_name>
		<to_code>905276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gestonorone caproate</to_name>
		<to_code>4791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl laurate</to_name>
		<to_code>1311693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glechoma hederacea extract</to_name>
		<to_code>1310140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaietolin, (S)-</to_name>
		<to_code>2643153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl triacetyl ricinoleate</to_name>
		<to_code>2635083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit allergenic extract</to_name>
		<to_code>899424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit juice</to_name>
		<to_code>1431224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranium oil, Algerian type</to_name>
		<to_code>1309347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycoprotein hormones, alpha subunit</to_name>
		<to_code>1427201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold cation (1+)</to_name>
		<to_code>2045117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golden seal root</to_name>
		<to_code>253171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucose pentaacetate</to_name>
		<to_code>1792129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glasdegib</to_name>
		<to_code>2105845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grindelia squarrosa whole extract</to_name>
		<to_code>1606334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycopyrronium tosylate</to_name>
		<to_code>2052857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4'-galactosyllactose</to_name>
		<to_code>2607019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guaiacum sanctum resin</to_name>
		<to_code>1311271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycine hydrochloride</to_name>
		<to_code>1311532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green peppercorn extract</to_name>
		<to_code>1372272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold monoiodide</to_name>
		<to_code>1486799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gryllus bimaculatus extract</to_name>
		<to_code>2611453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucosamine sulfate potassium chloride</to_name>
		<to_code>1789517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gatifloxacin hemihydrate</to_name>
		<to_code>1999763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ginkgo biloba root extract</to_name>
		<to_code>1918243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-nonalactone</to_name>
		<to_code>1659905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium maculatum root oil</to_name>
		<to_code>1487505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.gamma.-tocopherol</to_name>
		<to_code>2368126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemeprost</to_name>
		<to_code>12449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gastric mucins</to_name>
		<to_code>4698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadolinium oxide</to_name>
		<to_code>1311118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gilteritinib</to_name>
		<to_code>2105806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>greasewood pollen extract</to_name>
		<to_code>852152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golimumab</to_name>
		<to_code>819300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glofitamab</to_name>
		<to_code>2639782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galphimia glauca whole extract</to_name>
		<to_code>1368327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma linoleic acid</to_name>
		<to_code>283563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl stearate SE</to_name>
		<to_code>1364379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl linoleate</to_name>
		<to_code>1368193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucarpidase</to_name>
		<to_code>1242127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gotu kola extract</to_name>
		<to_code>319837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium</to_name>
		<to_code>1310124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-31</to_name>
		<to_code>2634161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grindelia hirsutula whole extract</to_name>
		<to_code>1492939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ginkgo biloba whole extract</to_name>
		<to_code>2475187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanidine</to_name>
		<to_code>50675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepotidacin</to_name>
		<to_code>2709212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucuronate</to_name>
		<to_code>1426907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gestodene</to_name>
		<to_code>25734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerin methyl ether</to_name>
		<to_code>2099713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol dilaurate</to_name>
		<to_code>2204571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glechoma hederacea flowering top extract</to_name>
		<to_code>1431284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma linolenic oil</to_name>
		<to_code>283564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gardenia taitensis flower extract</to_name>
		<to_code>1309426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana manshurica root extract</to_name>
		<to_code>2680317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grepafloxacin hydrochloride</to_name>
		<to_code>236862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit seed extract</to_name>
		<to_code>259449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycine max whole extract</to_name>
		<to_code>1366326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyrrhizate</to_name>
		<to_code>1370586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gastrodia elata tuber extract</to_name>
		<to_code>2462454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl palmitate</to_name>
		<to_code>1426928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanine</to_name>
		<to_code>1372539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadolinium cation (3+)</to_name>
		<to_code>1546429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium nitrate</to_name>
		<to_code>25544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl caprylate</to_name>
		<to_code>1307152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garden snail mucin preparation</to_name>
		<to_code>1428846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-aminobutyric acid</to_name>
		<to_code>4617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana cruciata root extract</to_name>
		<to_code>1862096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>griseofulvin</to_name>
		<to_code>5021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gastric mucin,pork</to_name>
		<to_code>237040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green ash pollen extract</to_name>
		<to_code>852491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium hirsutum whole extract</to_name>
		<to_code>2283031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyoxyloyl carbocysteine</to_name>
		<to_code>2668156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadopiclenol</to_name>
		<to_code>2618720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamithromycin</to_name>
		<to_code>1113697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-6</to_name>
		<to_code>1492338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1,2-dioleate</to_name>
		<to_code>1426915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gitalin</to_name>
		<to_code>89791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl linolenate</to_name>
		<to_code>1307262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-18 ethylhexanoate</to_name>
		<to_code>1426944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>griseofulvin, ultramicrocrystalline</to_name>
		<to_code>217398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium herbaceum whole extract</to_name>
		<to_code>1373723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glabridin</to_name>
		<to_code>1603522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gardenia cornuta whole extract</to_name>
		<to_code>2001130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-7</to_name>
		<to_code>1371311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold sodium thiomalate</to_name>
		<to_code>4981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gelidium sesquipedale extract</to_name>
		<to_code>1735037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl myristate</to_name>
		<to_code>1311692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin type a porcine (160 bloom)</to_name>
		<to_code>2380371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranial propylene glycol acetal</to_name>
		<to_code>2373649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grape seed proanthocyanidins</to_name>
		<to_code>283566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guarea guidonia bark extract</to_name>
		<to_code>1862097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanethidine</to_name>
		<to_code>5036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyoxal</to_name>
		<to_code>4967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>golotimod</to_name>
		<to_code>2367440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyrrhizin, ammoniated</to_name>
		<to_code>1311505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-diacetyltartarate 2,3-stearate</to_name>
		<to_code>1372310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guinea pig skin extract</to_name>
		<to_code>852298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium GA-68 gozetotide</to_name>
		<to_code>2586016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-undecalactone</to_name>
		<to_code>1376148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentamicin sulfate</to_name>
		<to_code>1870193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadobutrol</to_name>
		<to_code>84990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia mangostana bark extract</to_name>
		<to_code>1874548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentianella quinquefolia extract</to_name>
		<to_code>1719251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl stearate</to_name>
		<to_code>1311155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentian violet</to_name>
		<to_code>4778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol (1-(12-hydroxystearate))</to_name>
		<to_code>1944766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol salicylate</to_name>
		<to_code>26051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goserelin</to_name>
		<to_code>50610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glechoma longituba top extract</to_name>
		<to_code>1429391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium robertianum leaf extract</to_name>
		<to_code>2670081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>geranyl acetate</to_name>
		<to_code>1807120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonadotropin releasing factor analog-diphtheria toxoid conjugate</to_name>
		<to_code>1191668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl caprylate-caprate</to_name>
		<to_code>1312392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin hydrolysate (porcine skin, MW 3000)</to_name>
		<to_code>1366990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucose 1,6-bisphosphate</to_name>
		<to_code>2565267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucomannan</to_name>
		<to_code>11454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>garlic powder</to_name>
		<to_code>325524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geotrichum candidum allergenic extract</to_name>
		<to_code>999463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gardenia yellow extract</to_name>
		<to_code>2632124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gum talha extract</to_name>
		<to_code>1370785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyl-isolysine</to_name>
		<to_code>1813047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>giant wild rye pollen extract</to_name>
		<to_code>900148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiacolsulfonate</to_name>
		<to_code>636827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol oleate</to_name>
		<to_code>1314312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium cation Ga-67</to_name>
		<to_code>1546371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glimepiride</to_name>
		<to_code>25789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl hydroxystearate</to_name>
		<to_code>2531033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucosyl steviol</to_name>
		<to_code>1307153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl arachidonate</to_name>
		<to_code>1427076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia mangostana fruit rind extract</to_name>
		<to_code>1356679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Garcinia indica seed butter extract</to_name>
		<to_code>1309811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guazuma ulmifolia leaf extract</to_name>
		<to_code>1307837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutamate</to_name>
		<to_code>70602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Griffonia simplicifolia seed extract</to_name>
		<to_code>2274242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gymnadenia conopsea whole extract</to_name>
		<to_code>2386029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin type B bovine (230 bloom)</to_name>
		<to_code>1998844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-oryzanol</to_name>
		<to_code>25608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glicofosfopeptical</to_name>
		<to_code>236463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ganciclovir sodium</to_name>
		<to_code>82131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galbanum</to_name>
		<to_code>1796918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gastrodia elata whole extract</to_name>
		<to_code>2359266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadoversetamide</to_name>
		<to_code>228833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gluconolactone</to_name>
		<to_code>25842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanidine hydrochloride</to_name>
		<to_code>50676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grape seed</to_name>
		<to_code>237115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycolic acid</to_name>
		<to_code>587318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grain mill dust allergenic extract</to_name>
		<to_code>894795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana manshurica whole extract</to_name>
		<to_code>1547559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycorine</to_name>
		<to_code>2360433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gibberella zeae allergenic extract</to_name>
		<to_code>1922751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadolinium</to_name>
		<to_code>1310171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>greater celandine</to_name>
		<to_code>236982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanylcystamine</to_name>
		<to_code>1658444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanosine</to_name>
		<to_code>1591890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadopentetate dimeglumine</to_name>
		<to_code>25486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gibberella fujikuroi extract</to_name>
		<to_code>2043450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentianella amarella flower extract</to_name>
		<to_code>1309428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gestronol</to_name>
		<to_code>4793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol 1,2-didocosanoate</to_name>
		<to_code>1427150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerylphosphorylcholine</to_name>
		<to_code>4918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin type B bovine (200 bloom)</to_name>
		<to_code>1866344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galium boreale whole extract</to_name>
		<to_code>2375720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1,3-distearate</to_name>
		<to_code>2048118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycolate</to_name>
		<to_code>70603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucosyl hesperidin</to_name>
		<to_code>1433192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallopamil</to_name>
		<to_code>4648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glibornuride</to_name>
		<to_code>102846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gabapentin enacarbil</to_name>
		<to_code>1101333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol dimethacrylate</to_name>
		<to_code>1427079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>greater galangal extract</to_name>
		<to_code>1372251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goat milk allergenic extract</to_name>
		<to_code>862475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Griffonia preparation</to_name>
		<to_code>259412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Guaiacum officinale resin</to_name>
		<to_code>1352520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green bell pepper allergenic extract</to_name>
		<to_code>862478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol monolactate</to_name>
		<to_code>2101719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gluconic acid</to_name>
		<to_code>2475956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycofurol</to_name>
		<to_code>1427078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gliotoxin</to_name>
		<to_code>1661743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepefrine</to_name>
		<to_code>41157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapiprant</to_name>
		<to_code>1862951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaraprolose (1300 MPA.S at 1%)</to_name>
		<to_code>1940005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit peel extract</to_name>
		<to_code>1358897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin type A porcine (195 bloom)</to_name>
		<to_code>2679778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanadrel sulfate</to_name>
		<to_code>91239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutathione disulfide</to_name>
		<to_code>25953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaiacol ethylglycolate</to_name>
		<to_code>236314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gardenian blue</to_name>
		<to_code>1659909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonadorelin diacetate tetrahydrate</to_name>
		<to_code>1298838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grape extract</to_name>
		<to_code>253172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grama grass pollen extract</to_name>
		<to_code>852197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>galectin-3</to_name>
		<to_code>2688018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gellan gum (high acyl)</to_name>
		<to_code>2001326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gleditsia sinensis whole extract</to_name>
		<to_code>1442703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gardenia resinifera resin</to_name>
		<to_code>1541725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guaifenesin</to_name>
		<to_code>5032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gelsemium sempervirens root extract</to_name>
		<to_code>1309695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemcitabine</to_name>
		<to_code>12574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycereth-2 cocoate</to_name>
		<to_code>1305748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goose allergenic extract</to_name>
		<to_code>882485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucosamine sulfate</to_name>
		<to_code>4847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Galphimia glauca flowering top extract</to_name>
		<to_code>1346618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gonadorelin acetate</to_name>
		<to_code>204193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadoxetate</to_name>
		<to_code>802624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gliocladium viride extract</to_name>
		<to_code>2101008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Geranium robertianum extract</to_name>
		<to_code>1313750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grazoprevir anhydrous</to_name>
		<to_code>1871173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gallium cation</to_name>
		<to_code>1546282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-arachidonate</to_name>
		<to_code>1987475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>granisetron hydrochloride</to_name>
		<to_code>142149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadobenate dimeglumine</to_name>
		<to_code>68173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadopentetate</to_name>
		<to_code>1546432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamma-octalactone</to_name>
		<to_code>2043769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gelatin type B bovine (150 bloom)</to_name>
		<to_code>2463112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gozetotide</to_name>
		<to_code>2588949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyburide</to_name>
		<to_code>4815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucose</to_name>
		<to_code>4850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentisic acid ethanolamide</to_name>
		<to_code>1427180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>grapefruit seed oil</to_name>
		<to_code>1306130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gardenia jasminoides fruit extract</to_name>
		<to_code>1311374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gepirone hydrochloride</to_name>
		<to_code>2672254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentisic acid</to_name>
		<to_code>1368641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza uralensis extract</to_name>
		<to_code>1342493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemifloxacin mesylate</to_name>
		<to_code>402429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>goldenseal extract</to_name>
		<to_code>1372255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycerol 1,3-dimethacrylate</to_name>
		<to_code>1860613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gold sodium thiosulfate</to_name>
		<to_code>9876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guggul lipids</to_name>
		<to_code>283568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycylglycine</to_name>
		<to_code>1362904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guafacine hydrochloride</to_name>
		<to_code>862004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucagon</to_name>
		<to_code>4832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadoteridol</to_name>
		<to_code>25483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gamboge</to_name>
		<to_code>89698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>granisetron</to_name>
		<to_code>26237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gadoxetate disodium</to_name>
		<to_code>637320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Grindelia ciliata pollen extract</to_name>
		<to_code>2043451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gardenoside</to_name>
		<to_code>2585534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl 1-linolenate</to_name>
		<to_code>1987476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gelidium cartilagineum extract</to_name>
		<to_code>1435391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glutathione</to_name>
		<to_code>4890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gigartina skottsbergii</to_name>
		<to_code>2628326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Glycyrrhiza uralensis root extract</to_name>
		<to_code>2266490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guanylcystamine hydrobromide</to_name>
		<to_code>1658443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gluceptate</to_name>
		<to_code>50470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycyrrhetinic acid</to_name>
		<to_code>1311506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>giant puffball extract</to_name>
		<to_code>1311063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glucuronic acid</to_name>
		<to_code>1426906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol stearate SE</to_name>
		<to_code>1735330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycol stearate</to_name>
		<to_code>1426255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gymnema sylvestre leaf extract</to_name>
		<to_code>1493693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gemifloxacin</to_name>
		<to_code>138099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guinea pig hair extract</to_name>
		<to_code>895507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glycopyrronium</to_name>
		<to_code>1546438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glymidine</to_name>
		<to_code>102848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gatifloxacin anhydrous</to_name>
		<to_code>1546025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>germanium</to_name>
		<to_code>4784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gossypium hirsutum leaf extract</to_name>
		<to_code>2669812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Gentiana macrophylla root extract</to_name>
		<to_code>1309427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl monostearate</to_name>
		<to_code>1311165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>glyceryl dilaurate</to_name>
		<to_code>1311691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>guava juice</to_name>
		<to_code>1731014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>green tea extract</to_name>
		<to_code>659476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Genipa americana fruit extract</to_name>
		<to_code>1492037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gentamicin</to_name>
		<to_code>1596450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>G [Preparations]</from_name>
		<from_code>N0000010589</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>gambir leaf extract</to_name>
		<to_code>1609190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gugulu extract</from_name>
		<from_code>26346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guggulu extract</to_name>
		<to_code>M0070234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadodiamide</from_name>
		<from_code>41144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acute Kidney Injury</to_name>
		<to_code>M0541307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadodiamide</from_name>
		<from_code>41144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadodiamide</to_name>
		<to_code>M0178725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadodiamide</from_name>
		<from_code>41144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadodiamide</from_name>
		<from_code>41144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chronic Kidney Diseases</to_name>
		<to_code>M0560882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopentetate dimeglumine</from_name>
		<from_code>25486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acute Kidney Injury</to_name>
		<to_code>M0541307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoversetamide</from_name>
		<from_code>228833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acute Kidney Injury</to_name>
		<to_code>M0541307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopentetate dimeglumine</from_name>
		<from_code>25486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopentetate dimeglumine</from_name>
		<from_code>25486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chronic Kidney Diseases</to_name>
		<to_code>M0560882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopentetate dimeglumine</from_name>
		<from_code>25486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gadopentetate Dimeglumine</to_name>
		<to_code>M0329085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaproterenol</from_name>
		<from_code>7688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tromethamine hydrochloride</from_name>
		<from_code>1311534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziv-aflibercept</from_name>
		<from_code>1304475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide</from_name>
		<from_code>7617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodinated glycerol</from_name>
		<from_code>27723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus crispatus</from_name>
		<from_code>2054188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gefitinib</from_name>
		<from_code>328134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zidovudine</from_name>
		<from_code>11413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine hemihydrate</from_name>
		<from_code>1992054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium permanganate</from_name>
		<from_code>8604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine</from_name>
		<from_code>2376944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene</from_name>
		<from_code>8785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine hydrochloride</from_name>
		<from_code>236474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</from_name>
		<from_code>1663632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl unoprostone</from_name>
		<from_code>135313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>borage oil</from_name>
		<from_code>68905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 45 vaccine</from_name>
		<from_code>1596932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Maryland/15/2016 antigen</from_name>
		<from_code>2048563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole</from_name>
		<from_code>36435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladribine</from_name>
		<from_code>44157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>memantine</from_name>
		<from_code>6719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadofosveset trisodium</from_name>
		<from_code>1364289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene hydrochloride</from_name>
		<from_code>71517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</from_name>
		<from_code>854974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha,alpha-dibromo-d-camphor</from_name>
		<from_code>1858362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonoctocog alfa</from_name>
		<from_code>1796377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril calcium</from_name>
		<from_code>259493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriparatide acetate</from_name>
		<from_code>114260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban</from_name>
		<from_code>1927851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide</from_name>
		<from_code>52151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital sodium</from_name>
		<from_code>82077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azacitidine</from_name>
		<from_code>1251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose hydrous</from_name>
		<from_code>1297771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin acetate</from_name>
		<from_code>1294622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic, dodecahydrate</from_name>
		<from_code>1311345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen</from_name>
		<from_code>1601233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline</from_name>
		<from_code>7247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulism immune globulin IV human</from_name>
		<from_code>544488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivastigmine</from_name>
		<from_code>183379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine dimesylate</from_name>
		<from_code>673579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxytol</from_name>
		<from_code>473387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium</from_name>
		<from_code>19685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin</from_name>
		<from_code>38782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranexamic acid</from_name>
		<from_code>10691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminobenzoic acid</from_name>
		<from_code>74</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine sulfate</from_name>
		<from_code>1549138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dutasteride</from_name>
		<from_code>228790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate micronized</from_name>
		<from_code>221100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorine</from_name>
		<from_code>1310123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paraldehyde</from_name>
		<from_code>7909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium anhydrous</from_name>
		<from_code>1372638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam</from_name>
		<from_code>4501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium chloride (in water)</from_name>
		<from_code>124073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropylcellulose</from_name>
		<from_code>27291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lyme Disease Vaccine</from_name>
		<from_code>214177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese dioxide</from_name>
		<from_code>29263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase</from_name>
		<from_code>58939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylamide</from_name>
		<from_code>9518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, pork</from_name>
		<from_code>235279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal sodium</from_name>
		<from_code>1362690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha 1-proteinase inhibitor, human</from_name>
		<from_code>991743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine</from_name>
		<from_code>6066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxandrolone</from_name>
		<from_code>7779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa</from_name>
		<from_code>105694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demecarium</from_name>
		<from_code>107771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimegepant</from_name>
		<from_code>2282307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin</from_name>
		<from_code>6809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium besylate</from_name>
		<from_code>1219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus bifidus</from_name>
		<from_code>236855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, human</from_name>
		<from_code>253181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-oysk</from_name>
		<from_code>2375543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin trifluoroacetate</from_name>
		<from_code>2380556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine</from_name>
		<from_code>10485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 6 vaccine</from_name>
		<from_code>798268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan monohydrate</from_name>
		<from_code>498193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</from_name>
		<from_code>2380837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89 chloride</from_name>
		<from_code>281890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine hydrochloride</from_name>
		<from_code>71534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ingenol mebutate</from_name>
		<from_code>1242806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinaprilat</from_name>
		<from_code>1546359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine aspartate</from_name>
		<from_code>18254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin alfa</from_name>
		<from_code>386938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-alanine</from_name>
		<from_code>61</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>misoprostol</from_name>
		<from_code>42331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green</from_name>
		<from_code>5775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline dihydrochloride</from_name>
		<from_code>2055907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, prompt zinc, beef</from_name>
		<from_code>235284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl acetate hydrochloride</from_name>
		<from_code>82043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</from_name>
		<from_code>2048564</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine resin complex</from_name>
		<from_code>314786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium</from_name>
		<from_code>282443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate</from_name>
		<from_code>56443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</from_name>
		<from_code>2180337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutaral</from_name>
		<from_code>4888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole</from_name>
		<from_code>746741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide fumarate</from_name>
		<from_code>51256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darbepoetin alfa</from_name>
		<from_code>283838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapagliflozin propanediol</from_name>
		<from_code>1486966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofazimine</from_name>
		<from_code>2592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin acetate</from_name>
		<from_code>1044583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone tosylate</from_name>
		<from_code>2275731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutamic acid</from_name>
		<from_code>25916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, bovine</from_name>
		<from_code>1306129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glatiramer</from_name>
		<from_code>214582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol trifenatate</from_name>
		<from_code>1424883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romosozumab-aqqg</from_name>
		<from_code>2123180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin</from_name>
		<from_code>5514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human) - hipp</from_name>
		<from_code>2167145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine sodium</from_name>
		<from_code>142448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin alfa</from_name>
		<from_code>4952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cefa</from_name>
		<from_code>801150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium,chelated</from_name>
		<from_code>259277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine, inactivated</from_name>
		<from_code>845525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin pamoate</from_name>
		<from_code>338529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil</from_name>
		<from_code>136411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate potassium chloride</from_name>
		<from_code>1789517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine hydrochloride</from_name>
		<from_code>1426681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole sodium</from_name>
		<from_code>1294569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group B vaccine</from_name>
		<from_code>1593128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fremanezumab</from_name>
		<from_code>2056691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine</from_name>
		<from_code>8163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</from_name>
		<from_code>854954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tribasic sodium phosphate</from_name>
		<from_code>36710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronic acid</from_name>
		<from_code>1356715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varenicline tartrate</from_name>
		<from_code>636674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel bisulfate</from_name>
		<from_code>236991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin calcium</from_name>
		<from_code>323828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate</from_name>
		<from_code>56466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>empagliflozin</from_name>
		<from_code>1545653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitisinone</from_name>
		<from_code>61805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givosiran sodium</from_name>
		<from_code>2265859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dried sodium phosphate</from_name>
		<from_code>1366977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant antihemophilic factor VIII</from_name>
		<from_code>253151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium</from_name>
		<from_code>9641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir marboxil</from_name>
		<from_code>2099995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine anhydrous</from_name>
		<from_code>1545987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basiliximab</from_name>
		<from_code>196102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxides</from_name>
		<from_code>72901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solifenacin</from_name>
		<from_code>322167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus</from_name>
		<from_code>1491862</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaine hydrochloride</from_name>
		<from_code>81965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea</from_name>
		<from_code>11002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Phuket/3073/2013 antigen</from_name>
		<from_code>1657228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine pyrophosphate</from_name>
		<from_code>10459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>didanosine</from_name>
		<from_code>3364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanidine</from_name>
		<from_code>50675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate</from_name>
		<from_code>2353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride dihydrate</from_name>
		<from_code>1010598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinoprostone</from_name>
		<from_code>3478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous dextrose</from_name>
		<from_code>349730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiabendazole</from_name>
		<from_code>10450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiglucerase</from_name>
		<from_code>84959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine hydrochloride</from_name>
		<from_code>1311530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine</from_name>
		<from_code>863035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin hydrochloride</from_name>
		<from_code>82036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon calcitonin</from_name>
		<from_code>36118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estazolam</from_name>
		<from_code>4077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umeclidinium bromide</from_name>
		<from_code>1487512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitazoxanide</from_name>
		<from_code>31819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel</from_name>
		<from_code>8984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone hydrochloride</from_name>
		<from_code>218337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic anhydrous</from_name>
		<from_code>1307158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lacticaseibacillus rhamnosus GG</from_name>
		<from_code>602811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium acetate</from_name>
		<from_code>214342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride dihydrate</from_name>
		<from_code>2397714</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine hydrochloride</from_name>
		<from_code>203164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malathion</from_name>
		<from_code>6606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenine</from_name>
		<from_code>290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol</from_name>
		<from_code>10689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline tosylate</from_name>
		<from_code>2059268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticagrelor</from_name>
		<from_code>1116632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium</from_name>
		<from_code>1378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetyldithranol</from_name>
		<from_code>38536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin</from_name>
		<from_code>1044584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea preparation</from_name>
		<from_code>228041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxsil</from_name>
		<from_code>77754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E, recombinant</from_name>
		<from_code>1986820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine hydrochloride</from_name>
		<from_code>155142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine fumarate</from_name>
		<from_code>360300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alitretinoin</from_name>
		<from_code>81864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raloxifene hydrochloride</from_name>
		<from_code>166551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 400</from_name>
		<from_code>8514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer carbonate</from_name>
		<from_code>660890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonacog alfa</from_name>
		<from_code>1300488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine</from_name>
		<from_code>10154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene</from_name>
		<from_code>1441386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor (natural)</from_name>
		<from_code>1298738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclidinium</from_name>
		<from_code>1303098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene citrate</from_name>
		<from_code>49953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone</from_name>
		<from_code>52769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium acetate tetrahydrate</from_name>
		<from_code>317246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palivizumab</from_name>
		<from_code>194279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 3 (Saukett)</from_name>
		<from_code>763100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin beta</from_name>
		<from_code>25357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide anhydrous</from_name>
		<from_code>1445143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium</from_name>
		<from_code>6574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E</from_name>
		<from_code>11256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide</from_name>
		<from_code>4179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine bitartrate</from_name>
		<from_code>221140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloral hydrate</from_name>
		<from_code>2344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium cation</from_name>
		<from_code>1546399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin acetate</from_name>
		<from_code>204193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, beef-pork</from_name>
		<from_code>235275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</from_name>
		<from_code>854972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan hydrochloride</from_name>
		<from_code>235857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dornase alfa</from_name>
		<from_code>337623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil citrate</from_name>
		<from_code>58964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dulaglutide</from_name>
		<from_code>1551291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine chloride</from_name>
		<from_code>1311519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine</from_name>
		<from_code>296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</from_name>
		<from_code>854946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine tosylate</from_name>
		<from_code>1876598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suprofen</from_name>
		<from_code>10255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium chloride</from_name>
		<from_code>712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutamide</from_name>
		<from_code>4508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine</from_name>
		<from_code>40114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dorzolamide</from_name>
		<from_code>60207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine tannate</from_name>
		<from_code>1099727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proparacaine</from_name>
		<from_code>34905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iso-sulfan blue</from_name>
		<from_code>27863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octoxynol-9</from_name>
		<from_code>54034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus delbrueckii subsp. bulgaricus</from_name>
		<from_code>100272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Colorado/06/2017 antigen</from_name>
		<from_code>2054177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride</from_name>
		<from_code>236539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumazenil</from_name>
		<from_code>4457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylstilbestrol</from_name>
		<from_code>3390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tromethamine</from_name>
		<from_code>10865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib mesylate</from_name>
		<from_code>284924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vedolizumab</from_name>
		<from_code>1538097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Utah/9/2014 antigen</from_name>
		<from_code>1657133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride anhydrous</from_name>
		<from_code>1808546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein sodium</from_name>
		<from_code>57789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese</from_name>
		<from_code>6623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praziquantel</from_name>
		<from_code>8628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine hydrochloride</from_name>
		<from_code>133041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-8 dioleate</from_name>
		<from_code>1363621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zalcitabine</from_name>
		<from_code>3363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutethimide</from_name>
		<from_code>4903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idoxuridine</from_name>
		<from_code>5653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine hydrochloride</from_name>
		<from_code>235426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursodiol</from_name>
		<from_code>11065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</from_name>
		<from_code>1664171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (shark)</from_name>
		<from_code>1358172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choriogonadotropin alfa</from_name>
		<from_code>283550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dupilumab</from_name>
		<from_code>1876376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium acetate</from_name>
		<from_code>54987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronic acid</from_name>
		<from_code>115265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin</from_name>
		<from_code>8372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum chlorohydrate</from_name>
		<from_code>17610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A</from_name>
		<from_code>11246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium levulinate</from_name>
		<from_code>47624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crotamiton</from_name>
		<from_code>21766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyridamole</from_name>
		<from_code>3521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium lactate</from_name>
		<from_code>47622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine bitartrate</from_name>
		<from_code>91167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentostatin</from_name>
		<from_code>8011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline</from_name>
		<from_code>44281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium hemipentahydrate</from_name>
		<from_code>2056898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>equine diphtheria antitoxin</from_name>
		<from_code>91602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate</from_name>
		<from_code>18889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium</from_name>
		<from_code>283562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vibrio cholerae CVD 103-HGR strain live antigen</from_name>
		<from_code>1812935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin</from_name>
		<from_code>301542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VII</from_name>
		<from_code>4254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</from_name>
		<from_code>1657222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daptomycin</from_name>
		<from_code>22299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</from_name>
		<from_code>1928289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea hydrochloride</from_name>
		<from_code>1862866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine</from_name>
		<from_code>7512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate</from_name>
		<from_code>39954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant residues 743-1636 deleted</from_name>
		<from_code>1300485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clioquinol</from_name>
		<from_code>5942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa-epbx</from_name>
		<from_code>2047589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane</from_name>
		<from_code>42736</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin carbamate</from_name>
		<from_code>20880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin</from_name>
		<from_code>10753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raloxifene</from_name>
		<from_code>72143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 2 (MEF-1)</from_name>
		<from_code>763098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alemtuzumab</from_name>
		<from_code>117055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate trihydrate</from_name>
		<from_code>1440975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium</from_name>
		<from_code>7883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate, monobasic, anhydrous</from_name>
		<from_code>1426444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichlorphenamide</from_name>
		<from_code>3353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine</from_name>
		<from_code>259453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole dihydrochloride</from_name>
		<from_code>236747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbachol</from_name>
		<from_code>1999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide, micronized</from_name>
		<from_code>217364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepic acid</from_name>
		<from_code>235408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital</from_name>
		<from_code>8134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human chorionic gonadotropin</from_name>
		<from_code>340705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylpenicilloyl polylysine</from_name>
		<from_code>19079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir sulfate</from_name>
		<from_code>221052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caramiphen edisylate</from_name>
		<from_code>133053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate sodium anhydrous</from_name>
		<from_code>2279515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>latanoprost</from_name>
		<from_code>43611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etelcalcetide hydrochloride</from_name>
		<from_code>1876122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol tetrasodium</from_name>
		<from_code>281876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</from_name>
		<from_code>1300779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilutamide</from_name>
		<from_code>31805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium hydrogen phosphate dehydrate</from_name>
		<from_code>1311230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butacaine</from_name>
		<from_code>1829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium tosylate</from_name>
		<from_code>1737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine hydrochloride</from_name>
		<from_code>1311532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine phosphate</from_name>
		<from_code>105556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desloratadine</from_name>
		<from_code>275635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant), PEGylated-aucl</from_name>
		<from_code>2055654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lodoxamide tromethamine</from_name>
		<from_code>28859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine triphosphate</from_name>
		<from_code>318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glargine</from_name>
		<from_code>274783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine citrate</from_name>
		<from_code>20033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium chloride</from_name>
		<from_code>52796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V calcium</from_name>
		<from_code>236517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine hydrochloride</from_name>
		<from_code>6538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine</from_name>
		<from_code>8153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium benzoate</from_name>
		<from_code>56455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor tetrasodium</from_name>
		<from_code>1656051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyestradiol phosphate</from_name>
		<from_code>34120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate dibasic trihydrate</from_name>
		<from_code>2475957</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group W-135</from_name>
		<from_code>314724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride anhydrous</from_name>
		<from_code>1667640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide, bovine lung</from_name>
		<from_code>1788946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paricalcitol</from_name>
		<from_code>73710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol hydrochloride</from_name>
		<from_code>142144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen</from_name>
		<from_code>1593130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium</from_name>
		<from_code>33742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronate disodium</from_name>
		<from_code>105443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, bovine</from_name>
		<from_code>2264114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetylated hyaluronate</from_name>
		<from_code>2198976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anakinra</from_name>
		<from_code>72435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carprofen</from_name>
		<from_code>20343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen citrate</from_name>
		<from_code>40137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel protein-bound</from_name>
		<from_code>486610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol acetate</from_name>
		<from_code>1046243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine besilate</from_name>
		<from_code>658552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>blinatumomab</from_name>
		<from_code>1597258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus</from_name>
		<from_code>1426911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin sodium</from_name>
		<from_code>273443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-ocsq</from_name>
		<from_code>2693451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin calcium pentahydrate</from_name>
		<from_code>1648126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar</from_name>
		<from_code>2635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</from_name>
		<from_code>1666425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin mesylate</from_name>
		<from_code>39173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Astragalus preparation</from_name>
		<from_code>319818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voclosporin</from_name>
		<from_code>2475166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-chloro-2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine acetate</from_name>
		<from_code>1482501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin acetate</from_name>
		<from_code>1733680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium polystyrene sulfonate</from_name>
		<from_code>56512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor, human</from_name>
		<from_code>826072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lactobacillus helveticus</from_name>
		<from_code>1310845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oprelvekin</from_name>
		<from_code>139994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir phosphate</from_name>
		<from_code>259275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine</from_name>
		<from_code>28627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin</from_name>
		<from_code>37798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinamate</from_name>
		<from_code>24474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine</from_name>
		<from_code>4126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine</from_name>
		<from_code>1815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbetapentane</from_name>
		<from_code>20217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixekizumab</from_name>
		<from_code>1745099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teniposide</from_name>
		<from_code>10362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate disodium</from_name>
		<from_code>9872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoteridol</from_name>
		<from_code>25483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol</from_name>
		<from_code>1520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Iowa/06/2017 antigen</from_name>
		<from_code>2056523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brolucizumab</from_name>
		<from_code>2204915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxuridine</from_name>
		<from_code>4488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasma protein fraction</from_name>
		<from_code>33835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline</from_name>
		<from_code>865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium gluconate</from_name>
		<from_code>52358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patiromer sorbitex calcium</from_name>
		<from_code>2204723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelaic acid</from_name>
		<from_code>18602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bexarotene</from_name>
		<from_code>233272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium lactate</from_name>
		<from_code>215247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate hydrochloride</from_name>
		<from_code>235398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbetapentane tannate</from_name>
		<from_code>221070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, tribasic, pentahydrate</from_name>
		<from_code>1313280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertaconazole nitrate</from_name>
		<from_code>236601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin</from_name>
		<from_code>1300701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium citrate sesquihydrate</from_name>
		<from_code>2049608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 18 vaccine</from_name>
		<from_code>798266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate</from_name>
		<from_code>4847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivermectin</from_name>
		<from_code>6069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine tannate</from_name>
		<from_code>686390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/46/2015 antigen</from_name>
		<from_code>1942125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noradrenaline hydrochloride</from_name>
		<from_code>2256931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptinezumab</from_name>
		<from_code>2282660</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine</from_name>
		<from_code>57258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</from_name>
		<from_code>854960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Limosilactobacillus reuteri</from_name>
		<from_code>285156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine</from_name>
		<from_code>14845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzonatate</from_name>
		<from_code>18993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine hydrochloride</from_name>
		<from_code>3266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finasteride</from_name>
		<from_code>25025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride anhydrous</from_name>
		<from_code>1375412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic</from_name>
		<from_code>1111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorotrianisene</from_name>
		<from_code>2397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin</from_name>
		<from_code>28656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tyrosine</from_name>
		<from_code>10962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oliceridine</from_name>
		<from_code>2392230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenious acid</from_name>
		<from_code>36344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronate disodium</from_name>
		<from_code>83153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</from_name>
		<from_code>1946964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B immune globulin</from_name>
		<from_code>26744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-hydroxyamphetamine</from_name>
		<from_code>7839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibasic sodium phosphate heptahydrate</from_name>
		<from_code>221090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis pertactin vaccine, inactivated</from_name>
		<from_code>1300184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydroiodide</from_name>
		<from_code>539765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate</from_name>
		<from_code>1925821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cod liver oil</from_name>
		<from_code>2669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone hydrochloride</from_name>
		<from_code>203177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam</from_name>
		<from_code>37617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entacapone</from_name>
		<from_code>60307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin</from_name>
		<from_code>41127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol</from_name>
		<from_code>33767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine hydrochloride</from_name>
		<from_code>82033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril</from_name>
		<from_code>39990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine</from_name>
		<from_code>38400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium valproate</from_name>
		<from_code>134422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII</from_name>
		<from_code>4271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</from_name>
		<from_code>2177290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast</from_name>
		<from_code>88249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icodextrin</from_name>
		<from_code>140480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mumps Vaccine</from_name>
		<from_code>763656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate</from_name>
		<from_code>104994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine</from_name>
		<from_code>8175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate</from_name>
		<from_code>142131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonordefrin</from_name>
		<from_code>132889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, dibasic</from_name>
		<from_code>1482795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin calcium</from_name>
		<from_code>979509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brolucizumab-dbll</from_name>
		<from_code>2204916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyprylon</from_name>
		<from_code>6910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole sodium</from_name>
		<from_code>226868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel</from_name>
		<from_code>613391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine liposome</from_name>
		<from_code>968804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin</from_name>
		<from_code>857974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide</from_name>
		<from_code>42375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate dihydrate</from_name>
		<from_code>314837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anastrozole</from_name>
		<from_code>84857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</from_name>
		<from_code>854970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimegepant sulfate</from_name>
		<from_code>2282322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran etexilate</from_name>
		<from_code>1037042</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapiprazole hydrochloride</from_name>
		<from_code>235757</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rofecoxib</from_name>
		<from_code>232158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan tannate</from_name>
		<from_code>259262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitotane</from_name>
		<from_code>7004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene citrate</from_name>
		<from_code>142431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam maleate</from_name>
		<from_code>142441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline</from_name>
		<from_code>2449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-aafi</from_name>
		<from_code>2057198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine</from_name>
		<from_code>20610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine phosphate</from_name>
		<from_code>54749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin acetate</from_name>
		<from_code>236538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate</from_name>
		<from_code>36709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remimazolam</from_name>
		<from_code>2383941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyacetone</from_name>
		<from_code>3430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlexanox</from_name>
		<from_code>46307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate</from_name>
		<from_code>42682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactic acid</from_name>
		<from_code>28393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine hydrochloride</from_name>
		<from_code>91293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine, DL-</from_name>
		<from_code>1729154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil</from_name>
		<from_code>56795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lifitegrast</from_name>
		<from_code>1801820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria antitoxin</from_name>
		<from_code>3510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergocalciferol</from_name>
		<from_code>4018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegloticase</from_name>
		<from_code>1011650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (4000 CPS at 1%)</from_name>
		<from_code>1307036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium carbonate</from_name>
		<from_code>29155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group A polysaccharide</from_name>
		<from_code>29501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate</from_name>
		<from_code>29164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous tacrolimus</from_name>
		<from_code>235991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziconotide acetate</from_name>
		<from_code>486126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-qyyp</from_name>
		<from_code>2280730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine sulfate</from_name>
		<from_code>91166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclizumab</from_name>
		<from_code>190353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine</from_name>
		<from_code>40169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl cellulose (type H)</from_name>
		<from_code>1811461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bortezomib</from_name>
		<from_code>358258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine</from_name>
		<from_code>34347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine</from_name>
		<from_code>4919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide (11.beta.,16.alpha.(S))</from_name>
		<from_code>1367172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric derisomaltose</from_name>
		<from_code>2274394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin</from_name>
		<from_code>9346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibasic potassium phosphate</from_name>
		<from_code>55018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-abbs</from_name>
		<from_code>2105824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed</from_name>
		<from_code>68446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylbenzethonium chloride</from_name>
		<from_code>1796444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methsuximide</from_name>
		<from_code>47858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl chloride</from_name>
		<from_code>4141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lacticaseibacillus rhamnosus</from_name>
		<from_code>100278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hyaluronate</from_name>
		<from_code>42892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate</from_name>
		<from_code>58300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia spirit, aromatic</from_name>
		<from_code>317201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine</from_name>
		<from_code>1091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenethicillin</from_name>
		<from_code>33277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citrate</from_name>
		<from_code>114200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol</from_name>
		<from_code>36117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole strontium</from_name>
		<from_code>1435522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor</from_name>
		<from_code>11274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>D-biotin</from_name>
		<from_code>314583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine disulfide</from_name>
		<from_code>38041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyestradiol</from_name>
		<from_code>34119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chloride</from_name>
		<from_code>8591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probenecid</from_name>
		<from_code>8698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone hydrochloride</from_name>
		<from_code>2122776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal phosphate</from_name>
		<from_code>9004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene</from_name>
		<from_code>31479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol acetate</from_name>
		<from_code>29451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine hydrochloride</from_name>
		<from_code>221126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium valproate</from_name>
		<from_code>1927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine</from_name>
		<from_code>193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin</from_name>
		<from_code>6398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benznidazole</from_name>
		<from_code>18994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B lipid complex</from_name>
		<from_code>2001759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solifenacin succinate</from_name>
		<from_code>476588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin degludec</from_name>
		<from_code>1670007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</from_name>
		<from_code>854938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone tannate</from_name>
		<from_code>597355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acidulated phosphate fluoride</from_name>
		<from_code>236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin anhydrous</from_name>
		<from_code>1546030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 31 vaccine</from_name>
		<from_code>1596930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate monohydrate</from_name>
		<from_code>1309410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romosozumab</from_name>
		<from_code>2123126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 52 vaccine</from_name>
		<from_code>1596933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cat's claw preparation</from_name>
		<from_code>285223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ledipasvir</from_name>
		<from_code>1591922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-oysk</from_name>
		<from_code>2119708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab-mwge</from_name>
		<from_code>2391551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resorcinol</from_name>
		<from_code>35382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet</from_name>
		<from_code>4778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix acetate</from_name>
		<from_code>259338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride</from_name>
		<from_code>1901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin sulfate</from_name>
		<from_code>1621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>unoprostone</from_name>
		<from_code>1546408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canakinumab</from_name>
		<from_code>853491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nateglinide</from_name>
		<from_code>274332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen sodium</from_name>
		<from_code>1367838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine</from_name>
		<from_code>10849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green acid form</from_name>
		<from_code>2199577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arformoterol tartrate</from_name>
		<from_code>668284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil citrate</from_name>
		<from_code>221161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol</from_name>
		<from_code>6628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol</from_name>
		<from_code>2121416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil hydrochloride</from_name>
		<from_code>203203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brinzolamide</from_name>
		<from_code>194881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienestrol</from_name>
		<from_code>3368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>memantine hydrochloride</from_name>
		<from_code>236685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dacarbazine</from_name>
		<from_code>3098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine hydrochloride</from_name>
		<from_code>82093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cholera Vaccine</from_name>
		<from_code>2427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine</from_name>
		<from_code>6759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin</from_name>
		<from_code>23410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride hemihydrate</from_name>
		<from_code>1597623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium</from_name>
		<from_code>30077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethadione</from_name>
		<from_code>10827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine, D-</from_name>
		<from_code>1742746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone</from_name>
		<from_code>227518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hong Kong/259/2010 antigen</from_name>
		<from_code>1801603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 5-aminolevulinate</from_name>
		<from_code>337068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc oxide</from_name>
		<from_code>11423</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenolsulfonphthalein</from_name>
		<from_code>8141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine phosphate</from_name>
		<from_code>25102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrochloride</from_name>
		<from_code>267251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutilide</from_name>
		<from_code>41289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, beef</from_name>
		<from_code>235282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine, DL-</from_name>
		<from_code>1310540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine hydrochloride</from_name>
		<from_code>91188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifabutin</from_name>
		<from_code>55672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tadalafil</from_name>
		<from_code>358263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX (recombinant), glycopegylated</from_name>
		<from_code>1990855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecothiopate</from_name>
		<from_code>89778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone maleate</from_name>
		<from_code>236099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfapyridine</from_name>
		<from_code>10188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate sodium</from_name>
		<from_code>9887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethopropazine hydrochloride</from_name>
		<from_code>6541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zaleplon</from_name>
		<from_code>74667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminohippurate sodium</from_name>
		<from_code>203194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</from_name>
		<from_code>1928290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, beef-pork</from_name>
		<from_code>314685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, human</from_name>
		<from_code>825006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium lactate</from_name>
		<from_code>56489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-zzxf</from_name>
		<from_code>2382595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate</from_name>
		<from_code>236216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone lactate</from_name>
		<from_code>155120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capsaicin</from_name>
		<from_code>1992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa (activated), lyophilized</from_name>
		<from_code>353106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethosuximide</from_name>
		<from_code>4135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil sodium</from_name>
		<from_code>266663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine hydrochloride</from_name>
		<from_code>97</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encainide</from_name>
		<from_code>42368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine phosphate disodium</from_name>
		<from_code>1306123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levalbuterol tartrate</from_name>
		<from_code>487066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline</from_name>
		<from_code>10368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine iodide</from_name>
		<from_code>262295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium</from_name>
		<from_code>23651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</from_name>
		<from_code>854964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate</from_name>
		<from_code>8703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecallantide</from_name>
		<from_code>658708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine hydrochloride</from_name>
		<from_code>203841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolic acid</from_name>
		<from_code>7145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloride ion</from_name>
		<from_code>153974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine nitrate</from_name>
		<from_code>103244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glycerophosphate</from_name>
		<from_code>1909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine</from_name>
		<from_code>10391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 16 vaccine</from_name>
		<from_code>798264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol xinafoate</from_name>
		<from_code>72616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide sodium</from_name>
		<from_code>1746523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone, porcine</from_name>
		<from_code>1594665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol-mknl</from_name>
		<from_code>2121417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine B-domain truncated recombinant</from_name>
		<from_code>1592899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitolterol</from_name>
		<from_code>19499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium perborate</from_name>
		<from_code>36702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosutinib monohydrate</from_name>
		<from_code>1314319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allopurinol</from_name>
		<from_code>519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinol acetate</from_name>
		<from_code>35400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen sodium</from_name>
		<from_code>2099290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A virus strain CR 326F antigen, inactivated</from_name>
		<from_code>2274413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine maleate</from_name>
		<from_code>48936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol, L-</from_name>
		<from_code>1742749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</from_name>
		<from_code>1657130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zileuton</from_name>
		<from_code>40575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (2000 CPS at 1%)</from_name>
		<from_code>1299925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropinirole hydrochloride</from_name>
		<from_code>236553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dodecahydrate</from_name>
		<from_code>1311326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast sodium</from_name>
		<from_code>115713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin</from_name>
		<from_code>596723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human)</from_name>
		<from_code>617615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin meglumine</from_name>
		<from_code>1927662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calamine</from_name>
		<from_code>106212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen</from_name>
		<from_code>10324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol linoleate, D-</from_name>
		<from_code>1427235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inotersen</from_name>
		<from_code>2099289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Darwin/7/2019 antigen</from_name>
		<from_code>2380838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</from_name>
		<from_code>854950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene hydrochloride</from_name>
		<from_code>236069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticorelin ovine</from_name>
		<from_code>74671</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine mesylate</from_name>
		<from_code>227240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium bromide</from_name>
		<from_code>7884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felbamate</from_name>
		<from_code>24812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine aminobenzoate</from_name>
		<from_code>1010241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dehydrated alcohol</from_name>
		<from_code>1310469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster virus glycoprotein E</from_name>
		<from_code>1986821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nesiritide</from_name>
		<from_code>19666</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrate</from_name>
		<from_code>283561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid</from_name>
		<from_code>21183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bicarbonate</from_name>
		<from_code>34296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine hydrochloride</from_name>
		<from_code>91240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talampicillin</from_name>
		<from_code>10322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinacalcet hydrochloride</from_name>
		<from_code>384379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (USP)</from_name>
		<from_code>10572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin</from_name>
		<from_code>42372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benralizumab</from_name>
		<from_code>1989100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine anhydrous</from_name>
		<from_code>1546005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa butter</from_name>
		<from_code>21389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avanafil</from_name>
		<from_code>1291301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>periciazine</from_name>
		<from_code>8766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor oil</from_name>
		<from_code>1297880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine hydrochloride</from_name>
		<from_code>91189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trabectedin</from_name>
		<from_code>1716278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapiprazole</from_name>
		<from_code>22298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide phosphate</from_name>
		<from_code>203178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab</from_name>
		<from_code>2053436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazepam</from_name>
		<from_code>8627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-anns</from_name>
		<from_code>2174802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium</from_name>
		<from_code>3752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, pork</from_name>
		<from_code>93108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, ovine</from_name>
		<from_code>486164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasburicase</from_name>
		<from_code>283821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium gluconate</from_name>
		<from_code>89903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium</from_name>
		<from_code>1605114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenugreek seed meal</from_name>
		<from_code>282436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitonin</from_name>
		<from_code>1311287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alanine, DL-</from_name>
		<from_code>1546161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin</from_name>
		<from_code>1727875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene hydrochloride</from_name>
		<from_code>235721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro protamine, human</from_name>
		<from_code>314684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprotinin</from_name>
		<from_code>1056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine</from_name>
		<from_code>10454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic sodium phosphate, dihydrate</from_name>
		<from_code>1311286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vibegron</from_name>
		<from_code>2472254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride</from_name>
		<from_code>1300700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab</from_name>
		<from_code>2478335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molybdenum</from_name>
		<from_code>7024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidaxomicin</from_name>
		<from_code>1111103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ado-trastuzumab emtansine</from_name>
		<from_code>1371041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine</from_name>
		<from_code>700810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride anhydrous</from_name>
		<from_code>1299927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer hydrochloride</from_name>
		<from_code>237125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin hydrochloride</from_name>
		<from_code>1541465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropinirole</from_name>
		<from_code>72302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miglitol</from_name>
		<from_code>30009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panthenol</from_name>
		<from_code>1044977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valrubicin</from_name>
		<from_code>31435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride anhydrous</from_name>
		<from_code>2198974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendamustine</from_name>
		<from_code>134547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</from_name>
		<from_code>2380835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, esterified (USP)</from_name>
		<from_code>214549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidronate tetrasodium</from_name>
		<from_code>1364894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine</from_name>
		<from_code>134615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>repaglinide</from_name>
		<from_code>73044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin hydrochloride</from_name>
		<from_code>42553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethchlorvynol</from_name>
		<from_code>4118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ospemifene</from_name>
		<from_code>1370971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idelalisib</from_name>
		<from_code>1544460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine</from_name>
		<from_code>10814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir sodium</from_name>
		<from_code>1433867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloperidone</from_name>
		<from_code>73178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alternaria alternata allergenic extract</from_name>
		<from_code>901845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liquefied phenol</from_name>
		<from_code>239351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated</from_name>
		<from_code>1300180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-D-glucopyranose</from_name>
		<from_code>1442190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ipodate</from_name>
		<from_code>1911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital</from_name>
		<from_code>477631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m disofenin</from_name>
		<from_code>37665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, monohydrate</from_name>
		<from_code>1311342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucerase</from_name>
		<from_code>46049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m sestamibi</from_name>
		<from_code>1482913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanolin alcohols</from_name>
		<from_code>1426478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate, dihydrate</from_name>
		<from_code>1310463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybenzone</from_name>
		<from_code>32673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine hydrochloride, (+)-</from_name>
		<from_code>1539210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine citrate</from_name>
		<from_code>221141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaproterenol sulfate</from_name>
		<from_code>6804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronate</from_name>
		<from_code>62372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine</from_name>
		<from_code>6023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine citrate</from_name>
		<from_code>342992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reslizumab</from_name>
		<from_code>1746889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaine citrate</from_name>
		<from_code>160460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab</from_name>
		<from_code>121191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene acetate</from_name>
		<from_code>1442171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride anhydrous</from_name>
		<from_code>1311539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umeclidinium</from_name>
		<from_code>1487514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide monohydrate</from_name>
		<from_code>1309404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evolocumab</from_name>
		<from_code>1665684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine benzoate</from_name>
		<from_code>2184116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iocetamic acid</from_name>
		<from_code>183830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine hydrochloride</from_name>
		<from_code>228054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine monohydrate</from_name>
		<from_code>1314248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbetapentane citrate</from_name>
		<from_code>283547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone resin complex</from_name>
		<from_code>314667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate dibasic trihydrate</from_name>
		<from_code>237119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daratumumab</from_name>
		<from_code>1721947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human</from_name>
		<from_code>2264108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidocaine hydrochloride</from_name>
		<from_code>227221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dihydrogen phosphate dihydrate</from_name>
		<from_code>1311311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donepezil hydrochloride</from_name>
		<from_code>236559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone</from_name>
		<from_code>3143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</from_name>
		<from_code>1664339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boric acid</from_name>
		<from_code>1700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronic acid</from_name>
		<from_code>236083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,iodinated I-131 serum</from_name>
		<from_code>314301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine</from_name>
		<from_code>33408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate calcium</from_name>
		<from_code>152761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor IX</from_name>
		<from_code>4249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</from_name>
		<from_code>854936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin pidolate</from_name>
		<from_code>1992674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol</from_name>
		<from_code>1424884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus immune globulin, human</from_name>
		<from_code>91603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolvaptan</from_name>
		<from_code>358257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarilumab</from_name>
		<from_code>1923319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</from_name>
		<from_code>1801767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium</from_name>
		<from_code>60334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexfenfluramine</from_name>
		<from_code>3268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptozocin</from_name>
		<from_code>10114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin-releasing hormone</from_name>
		<from_code>10580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifampridine phosphate</from_name>
		<from_code>2106337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline phosphate</from_name>
		<from_code>866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>encainide hydrochloride</from_name>
		<from_code>281189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apixaban</from_name>
		<from_code>1364430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormezanone</from_name>
		<from_code>2373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histoplasmin</from_name>
		<from_code>5363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</from_name>
		<from_code>854952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirabegron</from_name>
		<from_code>1300786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</from_name>
		<from_code>2056521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine</from_name>
		<from_code>87636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turoctocog alfa</from_name>
		<from_code>1737557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban maleate</from_name>
		<from_code>1927955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biotin</from_name>
		<from_code>1588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black cohosh extract</from_name>
		<from_code>236665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine</from_name>
		<from_code>6536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>attapulgite</from_name>
		<from_code>18516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenol</from_name>
		<from_code>33290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrem</from_name>
		<from_code>56570</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 7 vaccine live</from_name>
		<from_code>1099937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipivefrin hydrochloride</from_name>
		<from_code>203156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate glucuronate</from_name>
		<from_code>38725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1b</from_name>
		<from_code>72257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</from_name>
		<from_code>854940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>androstenedione</from_name>
		<from_code>784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine sulfate</from_name>
		<from_code>11203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapagliflozin</from_name>
		<from_code>1488564</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium molybdate</from_name>
		<from_code>17789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium anhydrous</from_name>
		<from_code>1926958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin</from_name>
		<from_code>61148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate</from_name>
		<from_code>265323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-arrx</from_name>
		<from_code>2472325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avobenzone</from_name>
		<from_code>45045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyamphetamine hydrobromide</from_name>
		<from_code>82066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium chloride</from_name>
		<from_code>2200142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline hydrochloride</from_name>
		<from_code>2059038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurophate</from_name>
		<from_code>6027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, bovine</from_name>
		<from_code>578350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine tartrate</from_name>
		<from_code>39171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpropamide</from_name>
		<from_code>2404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemannan</from_name>
		<from_code>1426875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine hydrate</from_name>
		<from_code>67518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifampridine</from_name>
		<from_code>2106338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine</from_name>
		<from_code>24457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate anhydrous</from_name>
		<from_code>1792467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam hydrochloride</from_name>
		<from_code>71484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese sulfate</from_name>
		<from_code>29268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>armodafinil</from_name>
		<from_code>641465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle</from_name>
		<from_code>1601236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen</from_name>
		<from_code>1367839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium</from_name>
		<from_code>7213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alphaprodine</from_name>
		<from_code>594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin diacetate tetrahydrate</from_name>
		<from_code>1298838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine</from_name>
		<from_code>8701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide monohydrochloride</from_name>
		<from_code>142145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulin G, human</from_name>
		<from_code>1426680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</from_name>
		<from_code>1794331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint oil</from_name>
		<from_code>33094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur hexafluoride</from_name>
		<from_code>1599276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fanolesomab</from_name>
		<from_code>1314371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium chloride</from_name>
		<from_code>1379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine chloride</from_name>
		<from_code>20814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine thenoate</from_name>
		<from_code>236213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 3</from_name>
		<from_code>2197292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanol</from_name>
		<from_code>448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin hydrochloride</from_name>
		<from_code>46043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine mononitrate</from_name>
		<from_code>10456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyltestosterone</from_name>
		<from_code>6904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium bromide</from_name>
		<from_code>32521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 11 vaccine</from_name>
		<from_code>798262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifosfamide</from_name>
		<from_code>5657</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belimumab</from_name>
		<from_code>1092437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar extract</from_name>
		<from_code>90735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beractant</from_name>
		<from_code>46967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon beta-1a</from_name>
		<from_code>75917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol oxalate</from_name>
		<from_code>1593586</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronate</from_name>
		<from_code>11473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galcanezumab-gnlm</from_name>
		<from_code>2058868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaine</from_name>
		<from_code>1512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine</from_name>
		<from_code>797635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan polistirex</from_name>
		<from_code>236146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus monohydrate</from_name>
		<from_code>484288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E d-alpha</from_name>
		<from_code>220892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus vaccine inactivated, type 1 (Mahoney)</from_name>
		<from_code>763096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sodium phosphate</from_name>
		<from_code>2288215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oseltamivir</from_name>
		<from_code>260101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium bromide</from_name>
		<from_code>11153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenalidomide</from_name>
		<from_code>342369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linagliptin</from_name>
		<from_code>1100699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate</from_name>
		<from_code>34322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laureth-9 phosphate</from_name>
		<from_code>2373964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etretinate</from_name>
		<from_code>4182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole</from_name>
		<from_code>40790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem tartrate</from_name>
		<from_code>221183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine</from_name>
		<from_code>8340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sermorelin acetate</from_name>
		<from_code>58932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxcarbazepine</from_name>
		<from_code>32624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide sodium</from_name>
		<from_code>82101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peramivir</from_name>
		<from_code>619693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl aminolevulinate hydrochloride</from_name>
		<from_code>1300479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendamustine hydrochloride</from_name>
		<from_code>1114693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride tetrahydrate</from_name>
		<from_code>2003593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole</from_name>
		<from_code>6371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glipizide</from_name>
		<from_code>4821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcohol, x-ray exposed (1000 rad)</from_name>
		<from_code>1368126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethiodized oil</from_name>
		<from_code>4125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric sulfate</from_name>
		<from_code>24913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate anhydrous</from_name>
		<from_code>1299928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levetiracetam</from_name>
		<from_code>114477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine</from_name>
		<from_code>1876597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, beef</from_name>
		<from_code>314686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimantadine</from_name>
		<from_code>9386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfanilamide</from_name>
		<from_code>10184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-n3</from_name>
		<from_code>612937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pantothenate</from_name>
		<from_code>1918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>purified protein derivative of tuberculin</from_name>
		<from_code>8948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zanamivir</from_name>
		<from_code>69722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valdecoxib</from_name>
		<from_code>278567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lixisenatide</from_name>
		<from_code>1440051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene</from_name>
		<from_code>38409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine</from_name>
		<from_code>6676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</from_name>
		<from_code>1663630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</from_name>
		<from_code>1301887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octreotide acetate</from_name>
		<from_code>221130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol</from_name>
		<from_code>25284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa</from_name>
		<from_code>352374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropicamide</from_name>
		<from_code>10869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib</from_name>
		<from_code>495881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin</from_name>
		<from_code>60819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol HCl</from_name>
		<from_code>235447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus</from_name>
		<from_code>1427211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin</from_name>
		<from_code>26797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone decanoate</from_name>
		<from_code>37858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol</from_name>
		<from_code>6750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine</from_name>
		<from_code>35780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginseng preparation</from_name>
		<from_code>325526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine</from_name>
		<from_code>11202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen peroxide</from_name>
		<from_code>5499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoterol hydrobromide</from_name>
		<from_code>203124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone sodium sulfate</from_name>
		<from_code>1366962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum oleoresin</from_name>
		<from_code>235787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide acetate</from_name>
		<from_code>203217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ascorbate</from_name>
		<from_code>267366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine hydrochloride</from_name>
		<from_code>236608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaliplatin</from_name>
		<from_code>32592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone hydrochloride</from_name>
		<from_code>203129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin sodium</from_name>
		<from_code>72875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halazepam</from_name>
		<from_code>26412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sermorelin</from_name>
		<from_code>56188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium</from_name>
		<from_code>40144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid anhydrous</from_name>
		<from_code>1546014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepolizumab</from_name>
		<from_code>1720597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone</from_name>
		<from_code>1827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acellular pertussis vaccine, inactivated</from_name>
		<from_code>798302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin</from_name>
		<from_code>6384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone</from_name>
		<from_code>2275602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, beef-pork</from_name>
		<from_code>317598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum magnesium silicate</from_name>
		<from_code>17614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edaravone</from_name>
		<from_code>1921877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panthenol triacetate, (+)-</from_name>
		<from_code>1426597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate</from_name>
		<from_code>52364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gilteritinib</from_name>
		<from_code>2105806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbic acid</from_name>
		<from_code>1151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naxitamab</from_name>
		<from_code>2474039</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichloralphenazone</from_name>
		<from_code>22892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crisaborole</from_name>
		<from_code>1865953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantothenic acid</from_name>
		<from_code>7891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperonyl butoxide</from_name>
		<from_code>8345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine</from_name>
		<from_code>33283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</from_name>
		<from_code>1928528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daratumumab-fihj</from_name>
		<from_code>2375130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy polyethylene glycol-epoetin beta</from_name>
		<from_code>729596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentosan polysulphate sodium</from_name>
		<from_code>134413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine hydrochloride</from_name>
		<from_code>476316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letrozole</from_name>
		<from_code>72965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phensuximide</from_name>
		<from_code>33309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium cation</from_name>
		<from_code>1546421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium fluoride f-18</from_name>
		<from_code>1311495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol,DL-alpha</from_name>
		<from_code>402899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloid sulfur</from_name>
		<from_code>89767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin</from_name>
		<from_code>8629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic potassium phosphate</from_name>
		<from_code>55019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomustine</from_name>
		<from_code>6466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate (1:1)</from_name>
		<from_code>317238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal polysaccharide vaccine group Y</from_name>
		<from_code>314725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine bitartrate</from_name>
		<from_code>81990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine</from_name>
		<from_code>22696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide</from_name>
		<from_code>139953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronate</from_name>
		<from_code>46041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate calcium trisodium</from_name>
		<from_code>132879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephenytoin</from_name>
		<from_code>6757</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pertechnetate Tc 99m</from_name>
		<from_code>10349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine</from_name>
		<from_code>27084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebendazole</from_name>
		<from_code>6672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alefacept</from_name>
		<from_code>299635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chorionic gonadotropin</from_name>
		<from_code>4986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baclofen</from_name>
		<from_code>1292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>becaplermin</from_name>
		<from_code>115238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobutrol</from_name>
		<from_code>84990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin</from_name>
		<from_code>50610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide hydrochloride</from_name>
		<from_code>236612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caplacizumab-yhdp</from_name>
		<from_code>2110604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacemide</from_name>
		<from_code>33253</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butalbital</from_name>
		<from_code>19860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinestradol</from_name>
		<from_code>35215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriflunomide</from_name>
		<from_code>1310520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod</from_name>
		<from_code>1012892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclidinium bromide</from_name>
		<from_code>1303097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate</from_name>
		<from_code>82819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polidocanol</from_name>
		<from_code>968170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel tartrate</from_name>
		<from_code>2197593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextranomer</from_name>
		<from_code>22708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, human</from_name>
		<from_code>314683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levalbuterol hydrochloride</from_name>
		<from_code>237160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin subcutaneous (human) - klhw</from_name>
		<from_code>2196290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lepirudin</from_name>
		<from_code>237057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-pkrb</from_name>
		<from_code>2107051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A palmitate</from_name>
		<from_code>35406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII, human</from_name>
		<from_code>826070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brivaracetam</from_name>
		<from_code>1739745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verteporfin</from_name>
		<from_code>118886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iophendylate</from_name>
		<from_code>5968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>padimate-O</from_name>
		<from_code>32786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludrocortisone acetate</from_name>
		<from_code>165516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol acetate</from_name>
		<from_code>39625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil</from_name>
		<from_code>31563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro</from_name>
		<from_code>86009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orlistat</from_name>
		<from_code>37925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/60/2008 antigen</from_name>
		<from_code>1657226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivastigmine tartrate</from_name>
		<from_code>994808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>d-alpha-tocopheryl acetate</from_name>
		<from_code>1441649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate anhydrous</from_name>
		<from_code>1657484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proparacaine hydrochloride</from_name>
		<from_code>227778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carmustine</from_name>
		<from_code>2105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpelisib</from_name>
		<from_code>2169285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel</from_name>
		<from_code>56946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hylan G-F 20</from_name>
		<from_code>284637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</from_name>
		<from_code>2380834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine</from_name>
		<from_code>1886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>witch hazel</from_name>
		<from_code>89821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine maleate</from_name>
		<from_code>71529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demecarium bromide</from_name>
		<from_code>22482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate disodium</from_name>
		<from_code>637320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>feverfew extract</from_name>
		<from_code>114203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate anhydrous</from_name>
		<from_code>2106283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domperidone</from_name>
		<from_code>3626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin A myristate</from_name>
		<from_code>1813433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur, colloidal</from_name>
		<from_code>221083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegvisomant</from_name>
		<from_code>278739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide acetate</from_name>
		<from_code>6573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/7/2009 (H1N1) antigen</from_name>
		<from_code>1657331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate</from_name>
		<from_code>42333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alanine</from_name>
		<from_code>426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic</from_name>
		<from_code>235496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-133</from_name>
		<from_code>259282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate, heptahydrate</from_name>
		<from_code>1311282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcarnitine hydrochloride, DL-</from_name>
		<from_code>1593400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin hydrochloride</from_name>
		<from_code>203210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium bromide</from_name>
		<from_code>66983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</from_name>
		<from_code>854934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexpanthenol</from_name>
		<from_code>22701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium</from_name>
		<from_code>1218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etidocaine</from_name>
		<from_code>4171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir anhydrous</from_name>
		<from_code>1546007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran etexilate mesylate</from_name>
		<from_code>1037041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desirudin</from_name>
		<from_code>114934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 4 vaccine live</from_name>
		<from_code>1099933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride dihydrate</from_name>
		<from_code>221068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antipyrine</from_name>
		<from_code>1001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethynodrel</from_name>
		<from_code>7515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 58 vaccine</from_name>
		<from_code>1596934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam monohydrate</from_name>
		<from_code>2184136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type B</from_name>
		<from_code>2167673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclesonide</from_name>
		<from_code>274964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>degarelix acetate</from_name>
		<from_code>835863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicalutamide</from_name>
		<from_code>83008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone isocaproate</from_name>
		<from_code>75806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trospium</from_name>
		<from_code>236778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin sodium</from_name>
		<from_code>221072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix acetate</from_name>
		<from_code>259264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dezocine</from_name>
		<from_code>22713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium amino acid chelate</from_name>
		<from_code>486895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, DL-</from_name>
		<from_code>2370134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate, anhydrous</from_name>
		<from_code>267453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin</from_name>
		<from_code>29629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab deruxtecan</from_name>
		<from_code>2267582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol, (+)-</from_name>
		<from_code>1648123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole sodium</from_name>
		<from_code>1792108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine hydrochloride</from_name>
		<from_code>57555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopentolate</from_name>
		<from_code>3001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoterol</from_name>
		<from_code>4333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine difumarate</from_name>
		<from_code>221094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium,porcine</from_name>
		<from_code>235995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic</from_name>
		<from_code>236719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine</from_name>
		<from_code>221060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrantel pamoate</from_name>
		<from_code>8985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loratadine</from_name>
		<from_code>28889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline hydrochloride</from_name>
		<from_code>82054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferiprone</from_name>
		<from_code>11645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose</from_name>
		<from_code>27244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hepatitis A Vaccine, Inactivated</from_name>
		<from_code>253174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zafirlukast</from_name>
		<from_code>114970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin aspart protamine, human</from_name>
		<from_code>352385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate</from_name>
		<from_code>47613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inulin</from_name>
		<from_code>5924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamsulosin hydrochloride</from_name>
		<from_code>236495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eslicarbazepine</from_name>
		<from_code>1482502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</from_name>
		<from_code>2379531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated attapulgite</from_name>
		<from_code>133050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glubionate</from_name>
		<from_code>25806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate lysine</from_name>
		<from_code>236477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin liposomal</from_name>
		<from_code>2059180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>damoctocog alfa pegol</from_name>
		<from_code>2055655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</from_name>
		<from_code>854944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene napsylate</from_name>
		<from_code>8786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, human</from_name>
		<from_code>221110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alendronate sodium</from_name>
		<from_code>203152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium cation</from_name>
		<from_code>1546373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole hydrochloride</from_name>
		<from_code>227227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kava preparation</from_name>
		<from_code>285228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyanocobalamin Co57</from_name>
		<from_code>91516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinestrol</from_name>
		<from_code>9066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptinezumab-jjmr</from_name>
		<from_code>2283045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin</from_name>
		<from_code>2890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor XIII a-subunit (recombinant)</from_name>
		<from_code>1488293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine monophosphate</from_name>
		<from_code>309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givosiran</from_name>
		<from_code>2265712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen sodium</from_name>
		<from_code>314633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acarbose</from_name>
		<from_code>16681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride</from_name>
		<from_code>235224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - slra</from_name>
		<from_code>2123035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolcapone</from_name>
		<from_code>72937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronate</from_name>
		<from_code>115264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium selenate</from_name>
		<from_code>36717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone acetate</from_name>
		<from_code>2055977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrapone</from_name>
		<from_code>6923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinone</from_name>
		<from_code>5509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorambucil</from_name>
		<from_code>2346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine phosphoserinate</from_name>
		<from_code>236803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine hydrochloride</from_name>
		<from_code>8164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine hydrochloride</from_name>
		<from_code>236599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine</from_name>
		<from_code>4089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene</from_name>
		<from_code>2596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</from_name>
		<from_code>854932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthrax immune globulin, human</from_name>
		<from_code>1722335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibandronate sodium</from_name>
		<from_code>236916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PERTUSSIS VACCINE,ADSORBED</from_name>
		<from_code>402543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midostaurin</from_name>
		<from_code>1919083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytomegalovirus immune globulin, human</from_name>
		<from_code>1997443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin tetrabutyrate</from_name>
		<from_code>2106328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine hydrochloride</from_name>
		<from_code>1294532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoterate meglumine</from_name>
		<from_code>1421151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis toxoid vaccine, inactivated</from_name>
		<from_code>1300186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium dihydrogen phosphate</from_name>
		<from_code>236560</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated</from_name>
		<from_code>1741397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosutinib</from_name>
		<from_code>1307619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium hemi-pentahydrate</from_name>
		<from_code>1356127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab-asmn</from_name>
		<from_code>2053449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol acetate</from_name>
		<from_code>221142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dihydrate</from_name>
		<from_code>1311323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</from_name>
		<from_code>1664172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hemin</from_name>
		<from_code>5175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium citrate anhydrous</from_name>
		<from_code>1310549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol</from_name>
		<from_code>6703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa anhydrous</from_name>
		<from_code>1545982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium tosylate</from_name>
		<from_code>2052857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cosyntropin hexahydrate</from_name>
		<from_code>1653802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phenethicillin</from_name>
		<from_code>132907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine</from_name>
		<from_code>28144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifaximin</from_name>
		<from_code>35619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine</from_name>
		<from_code>3022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bentoquatam</from_name>
		<from_code>134568</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib tosylate</from_name>
		<from_code>597744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>echothiophate iodide</from_name>
		<from_code>3740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simoctocog alfa</from_name>
		<from_code>1729084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gotu kola extract</from_name>
		<from_code>319837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramiprilat</from_name>
		<from_code>1546377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine</from_name>
		<from_code>24698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trelstar pamoate</from_name>
		<from_code>905060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glulisine, human</from_name>
		<from_code>400008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfampridine</from_name>
		<from_code>897018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, beef</from_name>
		<from_code>235280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ocrelizumab</from_name>
		<from_code>1876366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metipranolol</from_name>
		<from_code>10824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin anhydrous</from_name>
		<from_code>1546031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl acid succinate,D-alpha</from_name>
		<from_code>314875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine hydrochloride</from_name>
		<from_code>235725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium chloride</from_name>
		<from_code>3754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin hydrochloride</from_name>
		<from_code>235743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium perborate tetrahydrate</from_name>
		<from_code>2104324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine hydrochloride</from_name>
		<from_code>236460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase Clostridium histolyticum</from_name>
		<from_code>898492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin sodium</from_name>
		<from_code>487070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine</from_name>
		<from_code>18603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfates</from_name>
		<from_code>2473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine chloride</from_name>
		<from_code>40165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin</from_name>
		<from_code>50975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin acetate</from_name>
		<from_code>236302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine</from_name>
		<from_code>1819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K3</from_name>
		<from_code>6728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon beta-1a</from_name>
		<from_code>1546168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludrocortisone</from_name>
		<from_code>4452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin 5'-phosphate sodium</from_name>
		<from_code>1925820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacytine</from_name>
		<from_code>78902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, pork</from_name>
		<from_code>221108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocainide</from_name>
		<from_code>42359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxate</from_name>
		<from_code>288262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate</from_name>
		<from_code>10156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol hydrochloride</from_name>
		<from_code>82110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium nitrate</from_name>
		<from_code>25544</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine, DL-</from_name>
		<from_code>1657875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agalsidase beta</from_name>
		<from_code>338817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantharidin</from_name>
		<from_code>1984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanidine hydrochloride</from_name>
		<from_code>50676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziconotide</from_name>
		<from_code>68503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium phosphate</from_name>
		<from_code>1919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>L1 protein, human papillomavirus type 33 vaccine</from_name>
		<from_code>1596931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole magnesium</from_name>
		<from_code>236486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 300</from_name>
		<from_code>8513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone hydrochloride</from_name>
		<from_code>203192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemetrexed disodium heptahydrate</from_name>
		<from_code>1666923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII</from_name>
		<from_code>4257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinutuximab</from_name>
		<from_code>1606274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lente insulin, beef-pork</from_name>
		<from_code>314682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil</from_name>
		<from_code>73032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine hydrochloride</from_name>
		<from_code>203197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</from_name>
		<from_code>2180338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, 1-stearyl ester</from_name>
		<from_code>1435636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indacaterol maleate</from_name>
		<from_code>1114325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline sulfate</from_name>
		<from_code>10369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diroximel fumarate</from_name>
		<from_code>2261783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin</from_name>
		<from_code>49276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trospium chloride</from_name>
		<from_code>38891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol</from_name>
		<from_code>9945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360571</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oil (containing omega-3 acids)</from_name>
		<from_code>2053495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone</from_name>
		<from_code>6813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiquimod</from_name>
		<from_code>59943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kelp preparation</from_name>
		<from_code>285155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene</from_name>
		<from_code>29365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine hydrobromide</from_name>
		<from_code>235428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fam-trastuzumab deruxtecan-nxki</from_name>
		<from_code>2267574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anagrelide</from_name>
		<from_code>596724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adapalene</from_name>
		<from_code>60223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droxidopa</from_name>
		<from_code>1489913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium glycinate</from_name>
		<from_code>476818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin</from_name>
		<from_code>1992672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide phosphate</from_name>
		<from_code>24614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel hydrochloride</from_name>
		<from_code>847020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate A sodium</from_name>
		<from_code>476847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine hydrochloride</from_name>
		<from_code>1426886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxylenol</from_name>
		<from_code>20877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-dkst</from_name>
		<from_code>2103478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor X</from_name>
		<from_code>4262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine</from_name>
		<from_code>12574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital sodium</from_name>
		<from_code>203085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urofollitropin</from_name>
		<from_code>134404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hemophilus B polysaccharide</from_name>
		<from_code>314656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate dimeglumine</from_name>
		<from_code>68173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, D-</from_name>
		<from_code>1426447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride</from_name>
		<from_code>267396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultralente insulin, beef-pork</from_name>
		<from_code>235281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose</from_name>
		<from_code>4850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone</from_name>
		<from_code>7005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ezetimibe</from_name>
		<from_code>341248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan</from_name>
		<from_code>51499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (beef)</from_name>
		<from_code>325521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium 99m</from_name>
		<from_code>90650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone bitartrate</from_name>
		<from_code>142439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (porcine)</from_name>
		<from_code>1366974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin lispro-aabc</from_name>
		<from_code>2376838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamsulosin</from_name>
		<from_code>77492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alphaprodine hydrochloride</from_name>
		<from_code>7433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, B</from_name>
		<from_code>618365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor</from_name>
		<from_code>1656052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caplacizumab</from_name>
		<from_code>2110605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</from_name>
		<from_code>854948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthrax immune globulin</from_name>
		<from_code>1722336</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytomegalovirus immune globulin</from_name>
		<from_code>22178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzoyl peroxide</from_name>
		<from_code>1418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fulvestrant</from_name>
		<from_code>282357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine tartrate</from_name>
		<from_code>1364375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium guaiacolsulfonate</from_name>
		<from_code>91275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate dihydrate</from_name>
		<from_code>998038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegademase bovine</from_name>
		<from_code>59768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin hydrochloride</from_name>
		<from_code>1947247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesna</from_name>
		<from_code>44</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 4</from_name>
		<from_code>2197293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-zzxf</from_name>
		<from_code>2382599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium-111</from_name>
		<from_code>90540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Victoria/705/2018 antigen</from_name>
		<from_code>2380575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>siltuximab</from_name>
		<from_code>1535218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temozolomide</from_name>
		<from_code>37776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine monohydrate</from_name>
		<from_code>236112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib ditosylate</from_name>
		<from_code>481474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albendazole</from_name>
		<from_code>430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, beef</from_name>
		<from_code>235278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</from_name>
		<from_code>854966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</from_name>
		<from_code>2056525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donepezil</from_name>
		<from_code>135447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arformoterol</from_name>
		<from_code>304962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic trioxide</from_name>
		<from_code>18330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</from_name>
		<from_code>854942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exemestane</from_name>
		<from_code>258494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine</from_name>
		<from_code>10594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine</from_name>
		<from_code>220982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine adipate</from_name>
		<from_code>33746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbenicillin</from_name>
		<from_code>10168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine maleate</from_name>
		<from_code>2377031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>helium</from_name>
		<from_code>5140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidurea</from_name>
		<from_code>1368885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib</from_name>
		<from_code>480167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole (as pantoprazole sodium sesquihydrate)</from_name>
		<from_code>236632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab</from_name>
		<from_code>224905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antirabies serum,equine</from_name>
		<from_code>485234</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinoprilat</from_name>
		<from_code>1546393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</from_name>
		<from_code>2380836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfuvirtide</from_name>
		<from_code>139896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naftifine</from_name>
		<from_code>31476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen</from_name>
		<from_code>1593127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, prompt zinc, pork</from_name>
		<from_code>235286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine</from_name>
		<from_code>135391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacituzumab govitecan</from_name>
		<from_code>2360232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meningococcal group C polysaccharide</from_name>
		<from_code>29503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic, anhydrous</from_name>
		<from_code>349753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, human</from_name>
		<from_code>253182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir</from_name>
		<from_code>83171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satralizumab</from_name>
		<from_code>2391541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide mesylate</from_name>
		<from_code>8048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorescein</from_name>
		<from_code>25138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecobalamin</from_name>
		<from_code>29421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galcanezumab</from_name>
		<from_code>2058846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine acetate</from_name>
		<from_code>6537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol hydrochloride</from_name>
		<from_code>236883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc chloride</from_name>
		<from_code>39937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saxagliptin hydrochloride</from_name>
		<from_code>1043560</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</from_name>
		<from_code>1301885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodohippurate I131 sodium</from_name>
		<from_code>91540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, porcine</from_name>
		<from_code>1306202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</from_name>
		<from_code>1657127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranibizumab</from_name>
		<from_code>595060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metipranolol hydrochloride</from_name>
		<from_code>314731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate</from_name>
		<from_code>1908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine hydrochloride</from_name>
		<from_code>235824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine</from_name>
		<from_code>620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine hydrochloride</from_name>
		<from_code>282415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obinutuzumab</from_name>
		<from_code>974779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer</from_name>
		<from_code>214824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niclosamide</from_name>
		<from_code>7402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated-exei</from_name>
		<from_code>2275722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linolenic acid</from_name>
		<from_code>52071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin microsphere</from_name>
		<from_code>221175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemtuzumab ozogamicin</from_name>
		<from_code>1294580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin (recombinant DNA origin)</from_name>
		<from_code>314845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>devil's claw preparation</from_name>
		<from_code>236279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil hydrochloride</from_name>
		<from_code>236540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital</from_name>
		<from_code>38077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immune globulin intravenous (human) - ifas</from_name>
		<from_code>2102433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine</from_name>
		<from_code>4845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen</from_name>
		<from_code>85763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclacillin</from_name>
		<from_code>2968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B6</from_name>
		<from_code>42954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etelcalcetide</from_name>
		<from_code>1876119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine</from_name>
		<from_code>2360574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabotegravir</from_name>
		<from_code>2475077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam sodium</from_name>
		<from_code>221167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane, beef</from_name>
		<from_code>317235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol</from_name>
		<from_code>1551777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testolactone</from_name>
		<from_code>10378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium fluoride</from_name>
		<from_code>9873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane I-123</from_name>
		<from_code>1426874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine</from_name>
		<from_code>155080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin</from_name>
		<from_code>1373458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrosine</from_name>
		<from_code>266604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine sulfate</from_name>
		<from_code>621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glatiramer acetate</from_name>
		<from_code>84375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, anhydrous</from_name>
		<from_code>314838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate,monobasic,monohydrate</from_name>
		<from_code>221125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxamniquine</from_name>
		<from_code>7778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate</from_name>
		<from_code>692620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gonadorelin hydrochloride</from_name>
		<from_code>204194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine hydrochloride</from_name>
		<from_code>259454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantothenic acid, (+-)-</from_name>
		<from_code>2394646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anthrax Vaccine Adsorbed</from_name>
		<from_code>404774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Washington/02/2019 antigen</from_name>
		<from_code>2280293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamisole phosphate</from_name>
		<from_code>1535214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen fumarate</from_name>
		<from_code>11404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxone</from_name>
		<from_code>7242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apraclonidine hydrochloride</from_name>
		<from_code>91350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pamidronic acid</from_name>
		<from_code>1546406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol</from_name>
		<from_code>31555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peramivir anhydrous</from_name>
		<from_code>1598096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen</from_name>
		<from_code>1601232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-40 sorbitan diisostearate</from_name>
		<from_code>1363615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine</from_name>
		<from_code>48937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprobarbital</from_name>
		<from_code>17381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone</from_name>
		<from_code>3423</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil</from_name>
		<from_code>480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclandelate</from_name>
		<from_code>2970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocarnitine</from_name>
		<from_code>42955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apremilast</from_name>
		<from_code>1492727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod hydrochloride</from_name>
		<from_code>1012891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnitine</from_name>
		<from_code>2106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam</from_name>
		<from_code>2184137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital sodium</from_name>
		<from_code>91109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apomorphine hydrochloride</from_name>
		<from_code>71225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin alfa</from_name>
		<from_code>1367075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oliceridine fumarate</from_name>
		<from_code>2392633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetholone</from_name>
		<from_code>7813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthralin</from_name>
		<from_code>873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troglitazone</from_name>
		<from_code>72610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>busulfan</from_name>
		<from_code>1828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eugenol</from_name>
		<from_code>4186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix</from_name>
		<from_code>68147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronate</from_name>
		<from_code>57230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine phosphate sodium</from_name>
		<from_code>4090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate sodium</from_name>
		<from_code>408142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroglobulin</from_name>
		<from_code>10565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plerixafor</from_name>
		<from_code>733003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole sodium</from_name>
		<from_code>253191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen</from_name>
		<from_code>1601231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimecrolimus</from_name>
		<from_code>321952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate malate</from_name>
		<from_code>1487143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoversetamide</from_name>
		<from_code>228833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacituzumab</from_name>
		<from_code>2360231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan hydrochloride</from_name>
		<from_code>153329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-tqjs</from_name>
		<from_code>2693885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metreleptin</from_name>
		<from_code>1491625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine hydrochloride</from_name>
		<from_code>106558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrethrins</from_name>
		<from_code>8991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodoquinol</from_name>
		<from_code>3435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium</from_name>
		<from_code>71535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, A</from_name>
		<from_code>253166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine</from_name>
		<from_code>684879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride hexahydrate</from_name>
		<from_code>221118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Latrodectus mactans antivenin</from_name>
		<from_code>89887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</from_name>
		<from_code>2380574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir</from_name>
		<from_code>2197842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic, monohydrate</from_name>
		<from_code>1311357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dorzolamide hydrochloride</from_name>
		<from_code>236065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine</from_name>
		<from_code>2354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar pitch volatiles</from_name>
		<from_code>90732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (bovine)</from_name>
		<from_code>1299929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenugreek seed preparation</from_name>
		<from_code>360375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide</from_name>
		<from_code>10169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deflazacort</from_name>
		<from_code>22396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine</from_name>
		<from_code>3966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide</from_name>
		<from_code>1311089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III, human</from_name>
		<from_code>221062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>degarelix</from_name>
		<from_code>475230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guafacine hydrochloride</from_name>
		<from_code>862004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</from_name>
		<from_code>854968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotigotine</from_name>
		<from_code>616739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levodopa</from_name>
		<from_code>6375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis A vaccine (inactivated) strain HM175</from_name>
		<from_code>798361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine hydrochloride</from_name>
		<from_code>203150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine</from_name>
		<from_code>8120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitolterol mesylate</from_name>
		<from_code>47187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartic acid</from_name>
		<from_code>1169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine</from_name>
		<from_code>8328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allopurinol sodium</from_name>
		<from_code>80566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride monohydrate</from_name>
		<from_code>1298851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur</from_name>
		<from_code>10223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin</from_name>
		<from_code>877015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stanozolol</from_name>
		<from_code>10032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet cation</from_name>
		<from_code>1546369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone (micronized)</from_name>
		<from_code>221168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium</from_name>
		<from_code>2496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabotegravir sodium</from_name>
		<from_code>2475076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine hydrochloride</from_name>
		<from_code>102397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine methylbromide</from_name>
		<from_code>27085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone polistirex</from_name>
		<from_code>221107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V benzathine</from_name>
		<from_code>18926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (1500 MPA.S at 1%)</from_name>
		<from_code>1312606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronic acid</from_name>
		<from_code>5463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin acetate</from_name>
		<from_code>203146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol anhydrous</from_name>
		<from_code>1855064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipobroman</from_name>
		<from_code>8347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole nitrate</from_name>
		<from_code>56226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin tartrate</from_name>
		<from_code>1791686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital sodium</from_name>
		<from_code>314874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid</from_name>
		<from_code>77655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanreotide acetate</from_name>
		<from_code>236167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride</from_name>
		<from_code>6579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproate</from_name>
		<from_code>40254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine</from_name>
		<from_code>569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexlansoprazole</from_name>
		<from_code>816346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b</from_name>
		<from_code>50937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix</from_name>
		<from_code>35825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remimazolam besylate</from_name>
		<from_code>2383942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa</from_name>
		<from_code>2019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</from_name>
		<from_code>1657224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>travoprost</from_name>
		<from_code>283809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene</from_name>
		<from_code>6822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emtricitabine</from_name>
		<from_code>276237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin acetate</from_name>
		<from_code>203147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exenatide</from_name>
		<from_code>60548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate dipotassium</from_name>
		<from_code>2607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl cellulose (5000 CPS at 1%)</from_name>
		<from_code>1307084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflornithine hydrochloride</from_name>
		<from_code>81945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfopristin</from_name>
		<from_code>229369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride</from_name>
		<from_code>3565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suxamethonium bromide</from_name>
		<from_code>121039</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eszopiclone</from_name>
		<from_code>461016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sitagliptin phosphate</from_name>
		<from_code>621590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine</from_name>
		<from_code>6673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quazepam</from_name>
		<from_code>35185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gilteritinib fumarate</from_name>
		<from_code>2105823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine</from_name>
		<from_code>10798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine hexahydrate</from_name>
		<from_code>271743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigo carmine</from_name>
		<from_code>227312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole</from_name>
		<from_code>283742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cevimeline hydrochloride</from_name>
		<from_code>260036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium dihydrate</from_name>
		<from_code>1601995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, prompt zinc, beef-pork</from_name>
		<from_code>235283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varenicline</from_name>
		<from_code>591622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</from_name>
		<from_code>1427020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin</from_name>
		<from_code>1622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinacalcet</from_name>
		<from_code>407990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate (shark)</from_name>
		<from_code>1789516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolaprilat</from_name>
		<from_code>1546379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</from_name>
		<from_code>2379530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</from_name>
		<from_code>2177291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica sinensis preparation</from_name>
		<from_code>328141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</from_name>
		<from_code>1666421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indacaterol</from_name>
		<from_code>1114326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX, human</from_name>
		<from_code>221099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopanoic acid</from_name>
		<from_code>5967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racemethionine</from_name>
		<from_code>9100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine hydrochloride</from_name>
		<from_code>236234</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stavudine</from_name>
		<from_code>59763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous zinc acetate</from_name>
		<from_code>1299637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanreotide</from_name>
		<from_code>68092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine</from_name>
		<from_code>194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patiromer</from_name>
		<from_code>1716203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticorelin ovine triflutate</from_name>
		<from_code>74670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate monohydrate</from_name>
		<from_code>1298846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dl-alpha tocopheryl acetate</from_name>
		<from_code>317841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide</from_name>
		<from_code>8047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal</from_name>
		<from_code>9471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin antibodies Fab fragments</from_name>
		<from_code>203223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen</from_name>
		<from_code>6146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine hydrochloride</from_name>
		<from_code>89918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone hydrochloride</from_name>
		<from_code>236931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nepafenac</from_name>
		<from_code>298665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane hydrochloride</from_name>
		<from_code>1294534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ROTAVIRUS VACCINE, LIVE</from_name>
		<from_code>253199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rho(D) immune globulin, human</from_name>
		<from_code>1789837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene hydrate</from_name>
		<from_code>1299898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline hydrochloride</from_name>
		<from_code>81954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolutegravir</from_name>
		<from_code>1433868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secukinumab</from_name>
		<from_code>1599788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor</from_name>
		<from_code>1952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succimer</from_name>
		<from_code>3446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VII, human</from_name>
		<from_code>1426164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin calcium</from_name>
		<from_code>221128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</from_name>
		<from_code>854930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine hydrochloride</from_name>
		<from_code>235370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine mesylate</from_name>
		<from_code>6024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E DL-alpha</from_name>
		<from_code>220893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase-fihj</from_name>
		<from_code>2375132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, regular, pork</from_name>
		<from_code>221109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</from_name>
		<from_code>1427171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B12</from_name>
		<from_code>11248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapsone</from_name>
		<from_code>3108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/9/2014 antigen</from_name>
		<from_code>1723997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albutrepenonacog alfa</from_name>
		<from_code>1743992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 2</from_name>
		<from_code>2197291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levalbuterol</from_name>
		<from_code>237159</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese monoxide</from_name>
		<from_code>1728312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid monohydrate</from_name>
		<from_code>221079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isotretinoin</from_name>
		<from_code>6064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronidase, human recombinant</from_name>
		<from_code>1300478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</from_name>
		<from_code>2280296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talampicillin napsylate</from_name>
		<from_code>235836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pregabalin</from_name>
		<from_code>187832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese gluconate</from_name>
		<from_code>52403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trastuzumab-dttb</from_name>
		<from_code>2289225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chenodeoxycholic acid</from_name>
		<from_code>2323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopentolate hydrochloride</from_name>
		<from_code>106029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</from_name>
		<from_code>854962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacubitril</from_name>
		<from_code>1656328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muromonab-CD3</from_name>
		<from_code>42405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated</from_name>
		<from_code>1300182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dengue virus live antigen, CYD serotype 1</from_name>
		<from_code>2197290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine hydrochloride</from_name>
		<from_code>236471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micafungin</from_name>
		<from_code>325887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvalent Crotalidae antivenin</from_name>
		<from_code>91596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine polistirex</from_name>
		<from_code>236792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apomorphine</from_name>
		<from_code>1043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bacillus anthracis strain V770-NP1-R antigens</from_name>
		<from_code>1368371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzylpenicilloyl polylysine</from_name>
		<from_code>19079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxelotor</from_name>
		<from_code>2265678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>profenamine</from_name>
		<from_code>4134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab-dgnb</from_name>
		<from_code>2478646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline nitrate</from_name>
		<from_code>235810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isatuximab-irfc</from_name>
		<from_code>2282019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin, E-coli derived</from_name>
		<from_code>259321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol</from_name>
		<from_code>25255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liraglutide</from_name>
		<from_code>475968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl</from_name>
		<from_code>237005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mazindol</from_name>
		<from_code>6664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacrosidase</from_name>
		<from_code>214817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacituzumab govitecan-hziy</from_name>
		<from_code>2360530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine</from_name>
		<from_code>10471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertuzumab</from_name>
		<from_code>1298944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</from_name>
		<from_code>854956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isatuximab</from_name>
		<from_code>2282018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine maleate</from_name>
		<from_code>860647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium stearate</from_name>
		<from_code>1310567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamine hydrochloride</from_name>
		<from_code>235355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semaglutide</from_name>
		<from_code>1991302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riboflavin sodium</from_name>
		<from_code>2109051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine tartrate</from_name>
		<from_code>221137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamines</from_name>
		<from_code>8826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine</from_name>
		<from_code>6704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</from_name>
		<from_code>854958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine tannate</from_name>
		<from_code>221139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate</from_name>
		<from_code>5976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin</from_name>
		<from_code>2399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temocillin</from_name>
		<from_code>37775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaspargase</from_name>
		<from_code>34132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate</from_name>
		<from_code>73056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine</from_name>
		<from_code>23744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfabenzamide</from_name>
		<from_code>37320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan hydrobromide</from_name>
		<from_code>102490</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil hydrochloride</from_name>
		<from_code>142428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homosalate</from_name>
		<from_code>91326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fremanezumab-vfrm</from_name>
		<from_code>2056690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronate sodium monohydrate</from_name>
		<from_code>1356128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyllin copper complex</from_name>
		<from_code>82242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloprogin</from_name>
		<from_code>26422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium chloride</from_name>
		<from_code>49275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine hydrochloride</from_name>
		<from_code>203185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole</from_name>
		<from_code>114979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclizine hydrochloride</from_name>
		<from_code>82041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan</from_name>
		<from_code>6718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caramiphen</from_name>
		<from_code>20191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoxycorticosterone pivalate</from_name>
		<from_code>22537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bicarbonate</from_name>
		<from_code>36676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Panama/45/90 antigen</from_name>
		<from_code>2262062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertuzumab-zzxf</from_name>
		<from_code>2382597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose monohydrate</from_name>
		<from_code>1299920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam anhydrous</from_name>
		<from_code>2268500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octinoxate</from_name>
		<from_code>13369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital</from_name>
		<from_code>8004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ligilactobacillus salivarius</from_name>
		<from_code>2110033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>revefenacin</from_name>
		<from_code>2102775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminoglutethimide</from_name>
		<from_code>677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin disodium</from_name>
		<from_code>2107308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimatoprost</from_name>
		<from_code>283810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octisalate</from_name>
		<from_code>91327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-jmdb</from_name>
		<from_code>2048018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzalkonium bromide</from_name>
		<from_code>1425981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disopyramide</from_name>
		<from_code>3541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramlintide acetate</from_name>
		<from_code>356773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric chloride</from_name>
		<from_code>21833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate</from_name>
		<from_code>802624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate</from_name>
		<from_code>39626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lacticaseibacillus casei</from_name>
		<from_code>1592255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartate magnesium hydrochloride</from_name>
		<from_code>1167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis B surface antigen vaccine</from_name>
		<from_code>797752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin</from_name>
		<from_code>10528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyburide</from_name>
		<from_code>4815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Hypersensitivity</to_name>
		<to_code>M0006829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadofosveset trisodium</from_name>
		<from_code>1364289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadofosveset trisodium</to_name>
		<to_code>M0458591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutaral</from_name>
		<from_code>4888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutaral</from_name>
		<from_code>4888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glutaral</to_name>
		<to_code>M0009386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous iodide</from_name>
		<from_code>1720256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine</from_name>
		<from_code>5933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous iodide</from_name>
		<from_code>1720256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen peroxide</from_name>
		<from_code>5499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine</from_name>
		<from_code>5933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Surgical Wound Infection</to_name>
		<to_code>M0020904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granisetron Hydrochloride</to_name>
		<to_code>M0329234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron hydrochloride</from_name>
		<from_code>142149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron mesylate</from_name>
		<from_code>29398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dolasetron</from_name>
		<from_code>68091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Nausea and Vomiting</to_name>
		<to_code>M0029915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>granisetron</from_name>
		<from_code>26237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granisetron</to_name>
		<to_code>M0026935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoteridol</from_name>
		<from_code>25483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadoteridol</to_name>
		<to_code>M0172747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Exfoliative</to_name>
		<to_code>M0006047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gold</to_name>
		<to_code>M0009521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold</from_name>
		<from_code>1311190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis</to_name>
		<to_code>M0004770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Exfoliative</to_name>
		<to_code>M0006047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Exfoliative</to_name>
		<to_code>M0006047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Exfoliative</to_name>
		<to_code>M0006047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Exfoliative</to_name>
		<to_code>M0006047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Exfoliative</to_name>
		<to_code>M0006047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis</to_name>
		<to_code>M0004770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gold Sodium Thiomalate</to_name>
		<to_code>M0009527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiomalate</from_name>
		<from_code>4981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis</to_name>
		<to_code>M0004770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis</to_name>
		<to_code>M0004770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belimumab</from_name>
		<from_code>1092437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lupus Erythematosus, Systemic</to_name>
		<to_code>M0012757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab</from_name>
		<from_code>612865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib citrate</from_name>
		<from_code>1358492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine sulfate</from_name>
		<from_code>153972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baricitinib</from_name>
		<from_code>2047232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-aazg</from_name>
		<from_code>2679427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-abbs</from_name>
		<from_code>2105824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-anoh</from_name>
		<from_code>2705421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anakinra</from_name>
		<from_code>72435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-arrx</from_name>
		<from_code>2472325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-bavi</from_name>
		<from_code>2680283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine</from_name>
		<from_code>10798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarilumab</from_name>
		<from_code>1923319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxychloroquine</from_name>
		<from_code>5521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golimumab</from_name>
		<from_code>819300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine hydrochloride</from_name>
		<from_code>235370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat dihydrate</from_name>
		<from_code>2672730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclofenac</from_name>
		<from_code>16689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>upadacitinib</from_name>
		<from_code>2196092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine tetrahydrochloride</from_name>
		<from_code>2611541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab</from_name>
		<from_code>121191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofacitinib</from_name>
		<from_code>1357536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rituximab-pvvr</from_name>
		<from_code>2273510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valdecoxib</from_name>
		<from_code>278567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Rheumatoid</to_name>
		<to_code>M0001750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate glucuronate</from_name>
		<from_code>38725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate</from_name>
		<from_code>42333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Marrow Diseases</to_name>
		<to_code>M0002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine hydrochloride</from_name>
		<from_code>1649479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol hydrochloride</from_name>
		<from_code>236883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin, E-coli derived</from_name>
		<from_code>259321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metipranolol hydrochloride</from_name>
		<from_code>314731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod hydrochloride</from_name>
		<from_code>2288235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat</from_name>
		<from_code>3829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine</from_name>
		<from_code>1649480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone decanoate</from_name>
		<from_code>37858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol</from_name>
		<from_code>1520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod</from_name>
		<from_code>2288236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat dihydrate</from_name>
		<from_code>2672730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotagliflozin</from_name>
		<from_code>2638675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasma protein fraction</from_name>
		<from_code>33835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone hydrochloride</from_name>
		<from_code>203129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone</from_name>
		<from_code>7005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>landiolol</from_name>
		<from_code>2712070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone (micronized)</from_name>
		<from_code>221168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etripamil</from_name>
		<from_code>2730302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vericiguat</from_name>
		<from_code>2475830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod lauryl sulfate</from_name>
		<from_code>2610292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone lactate</from_name>
		<from_code>155120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone isocaproate</from_name>
		<from_code>75806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol</from_name>
		<from_code>31555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metipranolol</from_name>
		<from_code>10824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitroprusside</from_name>
		<from_code>9895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine</from_name>
		<from_code>5470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin</from_name>
		<from_code>61148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam mesylate</from_name>
		<from_code>203151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone</from_name>
		<from_code>52769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoldopam</from_name>
		<from_code>24853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol hydrochloride</from_name>
		<from_code>142144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine</from_name>
		<from_code>1649480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>landiolol hydrochloride</from_name>
		<from_code>2712069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatropin (recombinant DNA origin)</from_name>
		<from_code>314845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod hydrochloride</from_name>
		<from_code>1012891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,iodinated I-131 serum</from_name>
		<from_code>314301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>somatrem</from_name>
		<from_code>56570</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydralazine hydrochloride</from_name>
		<from_code>82027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sacubitril</from_name>
		<from_code>1656328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>siponimod</from_name>
		<from_code>2121085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine hydrochloride</from_name>
		<from_code>1649479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod</from_name>
		<from_code>1012892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flosequinan</from_name>
		<from_code>25089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Failure</to_name>
		<to_code>M0009953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gold</to_name>
		<to_code>M0009521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arsenic Poisoning</to_name>
		<to_code>M0328100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gold Sodium Thiosulfate</to_name>
		<to_code>M0020105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold sodium thiosulfate</from_name>
		<from_code>9876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimercaprol</from_name>
		<from_code>3445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arsenic Poisoning</to_name>
		<to_code>M0328100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arsenic Poisoning</to_name>
		<to_code>M0328100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arsenic Poisoning</to_name>
		<to_code>M0328100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric sulfate</from_name>
		<from_code>24913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arsenic Poisoning</to_name>
		<to_code>M0328100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal phosphate</from_name>
		<from_code>9004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine</from_name>
		<from_code>684879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesna</from_name>
		<from_code>44</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium</from_name>
		<from_code>3752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine</from_name>
		<from_code>4126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tetanus Antitoxin</from_name>
		<from_code>10385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>24-homo-1,25-dihydroxyvitamin D3</from_name>
		<from_code>1423458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline</from_name>
		<from_code>10368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumazenil</from_name>
		<from_code>4457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine hydrochloride</from_name>
		<from_code>203164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucarpidase</from_name>
		<from_code>1242127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride</from_name>
		<from_code>1901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium cation</from_name>
		<from_code>1546421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine</from_name>
		<from_code>684879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal phosphate</from_name>
		<from_code>9004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racemethionine</from_name>
		<from_code>9100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine hydrochloride</from_name>
		<from_code>203164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumazenil</from_name>
		<from_code>4457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium chloride</from_name>
		<from_code>3754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxercalciferol</from_name>
		<from_code>11516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paricalcitol</from_name>
		<from_code>73710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate monohydrate</from_name>
		<from_code>1298846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone</from_name>
		<from_code>52769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrine</from_name>
		<from_code>10318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride anhydrous</from_name>
		<from_code>1667640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin antibodies Fab fragments</from_name>
		<from_code>203223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxoid vaccine, inactivated</from_name>
		<from_code>798306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarucizumab</from_name>
		<from_code>1716191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbutaline sulfate</from_name>
		<from_code>10369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate</from_name>
		<from_code>1908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milrinone lactate</from_name>
		<from_code>155120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin calcium</from_name>
		<from_code>979509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin disodium</from_name>
		<from_code>2107308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitriol</from_name>
		<from_code>1894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin antibodies Fab fragments</from_name>
		<from_code>203223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane</from_name>
		<from_code>42736</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrine hydrochloride</from_name>
		<from_code>235972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine anhydrous</from_name>
		<from_code>1545987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin</from_name>
		<from_code>877015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexrazoxane hydrochloride</from_name>
		<from_code>1294534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bicarbonate</from_name>
		<from_code>36676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoleucovorin calcium pentahydrate</from_name>
		<from_code>1648126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride dihydrate</from_name>
		<from_code>221068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Toxicity</to_name>
		<to_code>M0006855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole</from_name>
		<from_code>3743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolnaftate</from_name>
		<from_code>10637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole</from_name>
		<from_code>37319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine hydrochloride</from_name>
		<from_code>236558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omoconazole mononitrate</from_name>
		<from_code>134933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulconazole nitrate</from_name>
		<from_code>56798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butenafine</from_name>
		<from_code>47461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole nitrate</from_name>
		<from_code>56226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omoconazole</from_name>
		<from_code>32411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxiconazole</from_name>
		<from_code>32638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>econazole nitrate</from_name>
		<from_code>142434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tinea Versicolor</to_name>
		<to_code>M0021568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoxetate disodium</from_name>
		<from_code>637320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadoxetic acid disodium</to_name>
		<to_code>M0198898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoterate meglumine</from_name>
		<from_code>1421151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadoterate meglumine</to_name>
		<to_code>M0196199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gramicidin</to_name>
		<to_code>M0009601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gramicidin</from_name>
		<from_code>5011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propamidine</from_name>
		<from_code>34633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V benzathine</from_name>
		<from_code>18926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin</from_name>
		<from_code>2181306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propamidine isethionate</from_name>
		<from_code>34634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V calcium</from_name>
		<from_code>236517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole sodium</from_name>
		<from_code>236084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacytine</from_name>
		<from_code>78902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fleroxacin</from_name>
		<from_code>42322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole</from_name>
		<from_code>10193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Positive Bacterial Infections</to_name>
		<to_code>M0025728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eye Infections, Bacterial</to_name>
		<to_code>M0024228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Central Nervous System Infections</to_name>
		<to_code>M0003806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gentamicin Sulfate</to_name>
		<to_code>M0009170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis, Tuberculous</to_name>
		<to_code>M0022129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin sulfate</from_name>
		<from_code>1870193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide sodium</from_name>
		<from_code>82101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parachlorophenol</from_name>
		<from_code>14982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver acetate</from_name>
		<from_code>137939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylbenzethonium chloride</from_name>
		<from_code>1796444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylbenzethonium chloride</from_name>
		<from_code>1796444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daptomycin</from_name>
		<from_code>22299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin meglumine</from_name>
		<from_code>1927662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide</from_name>
		<from_code>10169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium perborate</from_name>
		<from_code>36702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium permanganate</from_name>
		<from_code>8604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline tosylate</from_name>
		<from_code>2059268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium perborate tetrahydrate</from_name>
		<from_code>2104324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Bacterial</to_name>
		<to_code>M0026097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gentamicin</to_name>
		<to_code>M0580977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Central Nervous System Infections</to_name>
		<to_code>M0003806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis, Tuberculous</to_name>
		<to_code>M0022129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentamicin</from_name>
		<from_code>1596450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia Infections</to_name>
		<to_code>M0025671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis</to_name>
		<to_code>M0007392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omidubicel-onlv</from_name>
		<from_code>2637354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gentamicin</to_name>
		<to_code>M0580977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omidubicel</from_name>
		<from_code>2637355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gentamicin</to_name>
		<to_code>M0580977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endocarditis, Bacterial</to_name>
		<to_code>M0007393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Central Nervous System Infections</to_name>
		<to_code>M0003806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Central Nervous System Infections</to_name>
		<to_code>M0003806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Central Nervous System Infections</to_name>
		<to_code>M0003806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Central Nervous System Infections</to_name>
		<to_code>M0003806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus Infections</to_name>
		<to_code>M0017900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin sodium</from_name>
		<from_code>267417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin</from_name>
		<from_code>2190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas Infections</to_name>
		<to_code>M0017955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin</from_name>
		<from_code>8372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Astragalus preparation</from_name>
		<from_code>319818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin</from_name>
		<from_code>30005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclacillin</from_name>
		<from_code>2968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin hydrochloride</from_name>
		<from_code>42553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miocamycin</from_name>
		<from_code>6985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin diacetate</from_name>
		<from_code>236200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Tract Infections</to_name>
		<to_code>M0018919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin meglumine</from_name>
		<from_code>1927662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin sodium</from_name>
		<from_code>203836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin</from_name>
		<from_code>626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin</from_name>
		<from_code>1266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate</from_name>
		<from_code>2640868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli Infections</to_name>
		<to_code>M0007733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases, Infectious</to_name>
		<to_code>M0002779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole</from_name>
		<from_code>2182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin</from_name>
		<from_code>626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefmetazole sodium</from_name>
		<from_code>203140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin meglumine</from_name>
		<from_code>1927662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Klebsiella Infections</to_name>
		<to_code>M0012059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin sodium</from_name>
		<from_code>267417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin hydrochloride</from_name>
		<from_code>82036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous iodide</from_name>
		<from_code>1720256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin</from_name>
		<from_code>2190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine</from_name>
		<from_code>5933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclacillin</from_name>
		<from_code>2968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin</from_name>
		<from_code>6398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finafloxacin</from_name>
		<from_code>1598641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin meglumine</from_name>
		<from_code>1927662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin hydrochloride</from_name>
		<from_code>1541465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Infections</to_name>
		<to_code>M0020423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohydroxamic acid</from_name>
		<from_code>16728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol sulfate tosylate</from_name>
		<from_code>2265863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valrubicin</from_name>
		<from_code>31435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate sodium</from_name>
		<from_code>48305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin mesylate</from_name>
		<from_code>2709213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam monohydrate</from_name>
		<from_code>2184136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin</from_name>
		<from_code>2015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin indanyl sodium</from_name>
		<from_code>56461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefiderocol</from_name>
		<from_code>2265702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroxoline</from_name>
		<from_code>31901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulopenem</from_name>
		<from_code>2717833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin</from_name>
		<from_code>37771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin</from_name>
		<from_code>8372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin</from_name>
		<from_code>4550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam</from_name>
		<from_code>2184137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacytine</from_name>
		<from_code>78902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroxoline</from_name>
		<from_code>31901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin tromethamine</from_name>
		<from_code>142135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin</from_name>
		<from_code>2049549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin</from_name>
		<from_code>626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin phenyl sodium</from_name>
		<from_code>42580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam anhydrous</from_name>
		<from_code>2268500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistimethate</from_name>
		<from_code>2708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin disodium</from_name>
		<from_code>258332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plazomicin sulfate</from_name>
		<from_code>2052872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulopenem etzadroxil</from_name>
		<from_code>2717834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfomycin sodium</from_name>
		<from_code>2727193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclacillin</from_name>
		<from_code>2968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivampicillin hydrochloride</from_name>
		<from_code>42553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temafloxacin hydrochloride</from_name>
		<from_code>295217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohydroxamic acid</from_name>
		<from_code>16728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Tract Infections</to_name>
		<to_code>M0022373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin mesylate</from_name>
		<from_code>2709213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Resistance, Bacterial</to_name>
		<to_code>M0368434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Resistance, Bacterial</to_name>
		<to_code>M0368434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepotidacin</from_name>
		<from_code>2709212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gepotidacin</to_name>
		<to_code>M000624677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride</from_name>
		<from_code>236539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride monohydrate</from_name>
		<from_code>1298851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine</from_name>
		<from_code>35780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride anhydrous</from_name>
		<from_code>2198974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide</from_name>
		<from_code>6572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mafenide acetate</from_name>
		<from_code>6573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Septicemia</to_name>
		<to_code>M0019666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin</from_name>
		<from_code>30005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin diacetate</from_name>
		<from_code>236200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Soft Tissue Infections</to_name>
		<to_code>M0027697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate dimeglumine</from_name>
		<from_code>68173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadobenic acid, dimeglumine salt</to_name>
		<to_code>M0324761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadobenate dimeglumine</from_name>
		<from_code>68173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadobenic acid</to_name>
		<to_code>M0177858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoversetamide</from_name>
		<from_code>228833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chronic Kidney Diseases</to_name>
		<to_code>M0560882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadoversetamide</from_name>
		<from_code>228833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadoversetamide</to_name>
		<to_code>M0291274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acyclovir</to_name>
		<to_code>M0000326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ganciclovir Sodium</to_name>
		<to_code>M0024169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir sodium</from_name>
		<from_code>82131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapsone</from_name>
		<from_code>3108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine</from_name>
		<from_code>6704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir anhydrous</from_name>
		<from_code>1546007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir</from_name>
		<from_code>83171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>AIDS-Related Opportunistic Infections</to_name>
		<to_code>M0025965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ganciclovir</to_name>
		<to_code>M0024168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acyclovir</to_name>
		<to_code>M0000326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganciclovir</from_name>
		<from_code>4678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efbemalenograstim alfa</from_name>
		<from_code>2670630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan</from_name>
		<from_code>6718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-apgf</from_name>
		<from_code>2469333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uracil mustard</from_name>
		<from_code>10996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifosfamide</from_name>
		<from_code>5657</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim-xnst</from_name>
		<from_code>2612537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-jmdb</from_name>
		<from_code>2048018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim</from_name>
		<from_code>2612526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-fpgk</from_name>
		<from_code>2613761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efbemalenograstim alfa-vuxw</from_name>
		<from_code>2670656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-apgf</from_name>
		<from_code>2469333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carmustine</from_name>
		<from_code>2105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-jmdb</from_name>
		<from_code>2048018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-aafi</from_name>
		<from_code>2057198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan hydrochloride</from_name>
		<from_code>235857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-fpgk</from_name>
		<from_code>2613761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-pbbk</from_name>
		<from_code>2602779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipobroman</from_name>
		<from_code>8347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-ayow</from_name>
		<from_code>2595942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neutropenia</to_name>
		<to_code>M0014782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen sodium</from_name>
		<from_code>314633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir</from_name>
		<from_code>83171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomivirsen</from_name>
		<from_code>85763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cidofovir anhydrous</from_name>
		<from_code>1546007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Retinitis</to_name>
		<to_code>M0026791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acyclovir</to_name>
		<to_code>M0000326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegademase bovine</from_name>
		<from_code>59768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifosfamide</from_name>
		<from_code>5657</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fulvestrant</from_name>
		<from_code>282357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uracil mustard</from_name>
		<from_code>10996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag</from_name>
		<from_code>2045726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipobroman</from_name>
		<from_code>8347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avatrombopag maleate</from_name>
		<from_code>2045727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lusutrombopag</from_name>
		<from_code>2054984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carmustine</from_name>
		<from_code>2105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifabutin</from_name>
		<from_code>55672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib disodium</from_name>
		<from_code>2055929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oprelvekin</from_name>
		<from_code>139994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium,porcine</from_name>
		<from_code>235995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan</from_name>
		<from_code>6718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiopronin</from_name>
		<from_code>6765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lepirudin</from_name>
		<from_code>237057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan hydrochloride</from_name>
		<from_code>235857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostamatinib</from_name>
		<from_code>2044896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixabepilone</from_name>
		<from_code>337523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombocytopenia</to_name>
		<to_code>M0021428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaiacol</from_name>
		<from_code>5031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Guaiacol</to_name>
		<to_code>M0009668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gentiana lutea root extract</from_name>
		<from_code>1307945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gentian root extract</to_name>
		<to_code>M000743912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-cyclodextrin</from_name>
		<from_code>1366989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-cyclodextrin</to_name>
		<to_code>M0081435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra extract</from_name>
		<from_code>1370435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>M000756821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra extract</from_name>
		<from_code>1370435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza inflata root extract</from_name>
		<from_code>1307598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>M000756821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza uralensis root extract</from_name>
		<from_code>2266490</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>M000756821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>licorice</from_name>
		<from_code>42769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycyrrhiza glabra extract</to_name>
		<to_code>M000756821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutaric acid</from_name>
		<from_code>1943799</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glutaric acid</to_name>
		<to_code>M0109300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-linolenic acid</from_name>
		<from_code>25605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-Linolenic Acid</to_name>
		<to_code>M0027133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Giardia lamblia</from_name>
		<from_code>1439028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Giardia lamblia</to_name>
		<to_code>M0025623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceran polyricinoleic acid ester</from_name>
		<from_code>1541750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glyceran polyricinoleic acid ester</to_name>
		<to_code>M0093384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycogen</from_name>
		<from_code>1426910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycogen</to_name>
		<to_code>M0009459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallic acid</from_name>
		<from_code>1311389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallic Acid</to_name>
		<to_code>M0008960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galactose</from_name>
		<from_code>4626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Galactose</to_name>
		<to_code>M0008938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone</from_name>
		<from_code>2672253</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone</from_name>
		<from_code>2672253</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gepirone</to_name>
		<to_code>M0119304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran</from_name>
		<from_code>588250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran</from_name>
		<from_code>1433212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone hydrochloride</from_name>
		<from_code>1086768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomilnacipran hydrochloride</from_name>
		<from_code>1433211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepirone hydrochloride</from_name>
		<from_code>2672254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milnacipran hydrochloride</from_name>
		<from_code>30003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone</from_name>
		<from_code>1086769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Major Depressive Disorder</to_name>
		<to_code>M0006031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-methacryloxypropyltrimethoxysilane</from_name>
		<from_code>2386843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methacryloxypropyltrimethoxysilane</to_name>
		<to_code>M0068281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaiacolsulfonic acid</from_name>
		<from_code>26288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guaiacolsulfonic acid</to_name>
		<to_code>M0061685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger allergenic extract</from_name>
		<from_code>899420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliclazide</from_name>
		<from_code>4816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gliclazide</to_name>
		<to_code>M0009266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geranylgeranylacetone</from_name>
		<from_code>1362746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tetraprenylacetone</to_name>
		<to_code>M000633537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geranylgeranylacetone</from_name>
		<from_code>1362746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>geranylgeranylacetone</to_name>
		<to_code>M0097855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginsenoside</from_name>
		<from_code>349656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ginsenosides</to_name>
		<to_code>M0062224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ginkgo biloba extract</from_name>
		<from_code>236809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Memory Disorders</to_name>
		<to_code>M0013349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ginkgo biloba extract</from_name>
		<from_code>236809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ginkgo biloba extract</to_name>
		<to_code>M0174492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geraniol</from_name>
		<from_code>1368875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>geraniol</to_name>
		<to_code>M0051261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutarate</from_name>
		<from_code>1943800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glutarates</to_name>
		<to_code>M0009387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>genistein</from_name>
		<from_code>25696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genistein</to_name>
		<to_code>M0029441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaiac</from_name>
		<from_code>1373150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Guaiac</to_name>
		<to_code>M0009667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose oxidase</from_name>
		<from_code>1427073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucose Oxidase</to_name>
		<to_code>M0009344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluconate</from_name>
		<from_code>70599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>D-gluconate</to_name>
		<to_code>M000623299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl palmitostearate</from_name>
		<from_code>1423683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>precirol</to_name>
		<to_code>M0053400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycosine</from_name>
		<from_code>2359267</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycosine</to_name>
		<to_code>M0062230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Glycyrrhiza glabra root powder extract</from_name>
		<from_code>2711885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guar gum</from_name>
		<from_code>26344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guar gum</to_name>
		<to_code>M0051358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grepafloxacin</from_name>
		<from_code>83719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grepafloxacin</to_name>
		<to_code>M0203132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl 1-laurate</from_name>
		<from_code>1990422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monoglycerol laurate</to_name>
		<to_code>M0074879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl 1-laurate</from_name>
		<from_code>1990422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monolaurin</to_name>
		<to_code>M0074881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gellan gum (low acyl)</from_name>
		<from_code>1420964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gellan gum</to_name>
		<to_code>M0139025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gold keratinate</from_name>
		<from_code>50598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gold keratinate</to_name>
		<to_code>M0041814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gleptoferron</from_name>
		<from_code>1855078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gleptoferron</to_name>
		<to_code>M0114398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaiol</from_name>
		<from_code>2542348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guaiol</to_name>
		<to_code>M0443331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grape seed extract</from_name>
		<from_code>237116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Grape Seed Extract</to_name>
		<to_code>M0528092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerol phenylbutyrate</from_name>
		<from_code>1368451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycerol phenylbutyrate</to_name>
		<to_code>M0571227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl monolaurate</from_name>
		<from_code>314647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycerol monolaurate</to_name>
		<to_code>M0074876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose-6-phosphate</from_name>
		<from_code>1541246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucose-6-Phosphate</to_name>
		<to_code>M0028730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallamine</from_name>
		<from_code>4638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallamine</to_name>
		<to_code>M0008953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gelatin</from_name>
		<from_code>4716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gelatin</to_name>
		<to_code>M0009052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine propionyl-L-carnitine</from_name>
		<from_code>2669317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycine propionyl l-carnitine</to_name>
		<to_code>M000594420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger root</from_name>
		<from_code>125921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rhizoma zingiberis</to_name>
		<to_code>M000744386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>German wasp venom protein</from_name>
		<from_code>1297531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bald-faced hornet venom protein</from_name>
		<from_code>1297525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eastern yellow jacket venom protein</from_name>
		<from_code>1297529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>southern yellow jacket venom protein</from_name>
		<from_code>1297533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow hornet venom protein</from_name>
		<from_code>1297537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western yellow jacket venom protein</from_name>
		<from_code>1297535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common wasp venom protein</from_name>
		<from_code>1297527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wasp venoms</from_name>
		<from_code>11291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Wasp Venoms</to_name>
		<to_code>M0022877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycidyl methacrylate</from_name>
		<from_code>1869700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycidyl methacrylate</to_name>
		<to_code>M0051321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir</to_name>
		<to_code>M000616894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glecaprevir</to_name>
		<to_code>M000636259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glecaprevir</from_name>
		<from_code>1940635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir</to_name>
		<to_code>M000616894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir</to_name>
		<to_code>M000616894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir</to_name>
		<to_code>M000616894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir</to_name>
		<to_code>M000616894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir</to_name>
		<to_code>M000616894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir</to_name>
		<to_code>M0028681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lopinavir</to_name>
		<to_code>M0558541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Darunavir</to_name>
		<to_code>M0461844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir anhydrous</to_name>
		<to_code>M000634943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>M0278998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir anhydrous</from_name>
		<from_code>1871173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir</to_name>
		<to_code>M0028681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir</to_name>
		<to_code>M0028681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir</to_name>
		<to_code>M0028681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir</to_name>
		<to_code>M0028681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir</to_name>
		<to_code>M0028681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Darunavir</to_name>
		<to_code>M0461844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lopinavir</to_name>
		<to_code>M0558541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>M0581079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>M0278998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grazoprevir</from_name>
		<from_code>1734630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamazepine</to_name>
		<to_code>M0003328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aficamten</from_name>
		<from_code>2731469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bictegravir sodium</from_name>
		<from_code>1999661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bictegravir</from_name>
		<from_code>1999660</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxilaprevir</from_name>
		<from_code>1939323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifampin</to_name>
		<to_code>M0019110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ledipasvir</from_name>
		<from_code>1591922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velpatasvir</from_name>
		<from_code>1799206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir</from_name>
		<from_code>1606218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclatasvir dihydrochloride</from_name>
		<from_code>1606217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir sodium</from_name>
		<from_code>1484518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C, Chronic</to_name>
		<to_code>M0029252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Darunavir</to_name>
		<to_code>M0461844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Darunavir</to_name>
		<to_code>M0461844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Darunavir</to_name>
		<to_code>M0461844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lopinavir</to_name>
		<to_code>M0558541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lopinavir</to_name>
		<to_code>M0558541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenytoin</to_name>
		<to_code>M0016580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>M0581079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>M0581079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>M0581079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>M0581079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grazoprevir</to_name>
		<to_code>M0581079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methazolamide</from_name>
		<from_code>6826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin</from_name>
		<from_code>596723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital sodium</from_name>
		<from_code>82077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant</from_name>
		<from_code>2197878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital sodium</from_name>
		<from_code>203085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate</from_name>
		<from_code>8703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital</from_name>
		<from_code>8004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetholone</from_name>
		<from_code>7813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paraldehyde</from_name>
		<from_code>7909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital</from_name>
		<from_code>8134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin sodium</from_name>
		<from_code>72875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloral hydrate</from_name>
		<from_code>2344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin sodium</from_name>
		<from_code>221072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate micronized</from_name>
		<from_code>221100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine</from_name>
		<from_code>4637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix sodium</from_name>
		<from_code>2049847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium chloride</from_name>
		<from_code>712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine hydrobromide</from_name>
		<from_code>860693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitolisant hydrochloride</from_name>
		<from_code>2197879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazinamide</from_name>
		<from_code>8987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Failure</to_name>
		<to_code>M0025970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir tromethamine</from_name>
		<from_code>2380374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fostemsavir</from_name>
		<from_code>2380373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum perforatum</to_name>
		<to_code>M0030110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>M0258297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>M0278998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>M0278998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>M0278998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus monohydrate</from_name>
		<from_code>484288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan</from_name>
		<from_code>75207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan monohydrate</from_name>
		<from_code>498193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous tacrolimus</from_name>
		<from_code>235991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclosporine</to_name>
		<to_code>M0025279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glecaprevir</to_name>
		<to_code>M000636259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glecaprevir</to_name>
		<to_code>M000636259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyphosate</from_name>
		<from_code>1800093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glyphosate</to_name>
		<to_code>M0056912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucametacin</from_name>
		<from_code>25834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glucametacin</to_name>
		<to_code>M0056167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycocholic acid</from_name>
		<from_code>1426482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycocholic Acid</to_name>
		<to_code>M0009454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic allergenic extract</from_name>
		<from_code>899414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaiazulene</from_name>
		<from_code>26290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guaiazulene</to_name>
		<to_code>M0045508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garlic preparation</from_name>
		<from_code>265647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucuronolactone</from_name>
		<from_code>1535222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glucuronolactone</to_name>
		<to_code>M0046169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliquidone</from_name>
		<from_code>25793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gliquidone</to_name>
		<to_code>M0056903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycyrrhizic acid</from_name>
		<from_code>26143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycyrrhizic Acid</to_name>
		<to_code>M0029245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium-67</from_name>
		<from_code>1546372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallium-67</to_name>
		<to_code>M000627955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl behenate</from_name>
		<from_code>1305749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glyceryl behenate</to_name>
		<to_code>M0229060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gestrinone</from_name>
		<from_code>4792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gestrinone</to_name>
		<to_code>M0009218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galactoarabinan</from_name>
		<from_code>1425353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arabinogalactan</to_name>
		<to_code>M0047317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadofosveset</from_name>
		<from_code>1364290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadofosveset</to_name>
		<to_code>M000639045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerol formal</from_name>
		<from_code>1311689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycerol formal</to_name>
		<to_code>M0084377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geranial</from_name>
		<from_code>2119367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>geranial</to_name>
		<to_code>M0309828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-terpinene</from_name>
		<from_code>2393523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-terpinene</to_name>
		<to_code>M0070425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycidyl acrylate</from_name>
		<from_code>1735329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,3-epoxypropyl acrylate</to_name>
		<to_code>M0172793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>germanium dioxide</from_name>
		<from_code>1309238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>germanium oxide</to_name>
		<to_code>M0120621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glaucine</from_name>
		<from_code>1368876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glaucine</to_name>
		<to_code>M0046271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium 67 citrate</from_name>
		<from_code>272758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gallium citrate (1:1); 67Ga-labeled</to_name>
		<to_code>M0327733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gestonorone caproate</from_name>
		<from_code>4791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gestonorone Caproate</to_name>
		<to_code>M0009215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycoprotein hormones, alpha subunit</from_name>
		<from_code>1427201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycoprotein Hormones, alpha Subunit</to_name>
		<to_code>M0023540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose pentaacetate</from_name>
		<from_code>1792129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glucose pentaacetate</to_name>
		<to_code>M0274371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.gamma.-tocopherol</from_name>
		<from_code>2368126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-Tocopherol</to_name>
		<to_code>M0022801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemeprost</from_name>
		<from_code>12449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gemeprost</to_name>
		<to_code>M0075715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gastric mucins</from_name>
		<from_code>4698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastric Mucins</to_name>
		<to_code>M0009008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadolinium oxide</from_name>
		<from_code>1311118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadolinium oxide</to_name>
		<to_code>M0096617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium</from_name>
		<from_code>1310124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Positron-Emission Tomography</to_name>
		<to_code>M0021646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium</from_name>
		<from_code>1310124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallium</to_name>
		<to_code>M0008961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium GA-68 gozetotide</from_name>
		<from_code>2586016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Positron-Emission Tomography</to_name>
		<to_code>M0021646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gozetotide</from_name>
		<from_code>2588949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Positron-Emission Tomography</to_name>
		<to_code>M0021646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium GA-68 gozetotide</from_name>
		<from_code>2586016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))</to_name>
		<to_code>M0587030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium GA-68 gozetotide</from_name>
		<from_code>2586016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>68Ga-PSMA</to_name>
		<to_code>M000650846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium GA-68 gozetotide</from_name>
		<from_code>2586016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gallium 68 PSMA-11</to_name>
		<to_code>M000750569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gozetotide</from_name>
		<from_code>2588949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Radioactive Tracers</to_name>
		<to_code>M0018403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gozetotide</from_name>
		<from_code>2588949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>PSMA-11</to_name>
		<to_code>M000762343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea c-13</from_name>
		<from_code>226724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Radioactive Tracers</to_name>
		<to_code>M0018403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucuronate</from_name>
		<from_code>1426907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucuronate</to_name>
		<to_code>M0095418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gestodene</from_name>
		<from_code>25734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gestodene</to_name>
		<to_code>M0103314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grepafloxacin hydrochloride</from_name>
		<from_code>236862</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grepafloxacin hydrochloride</to_name>
		<to_code>M0401903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapefruit seed extract</from_name>
		<from_code>259449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grapefruit seed extract</to_name>
		<to_code>M000747484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gastrodia elata tuber extract</from_name>
		<from_code>2462454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrodia elata tuber</to_name>
		<to_code>M000745639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanine</from_name>
		<from_code>1372539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Guanine</to_name>
		<to_code>M0009679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl caprylate</from_name>
		<from_code>1307152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glyceryl monocaprylate</to_name>
		<to_code>M000623322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-aminobutyric acid</from_name>
		<from_code>4617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-Aminobutyric Acid</to_name>
		<to_code>M0008927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopiclenol</from_name>
		<from_code>2618720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gadopiclenol</to_name>
		<to_code>M000679592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadopiclenol</from_name>
		<from_code>2618720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gadolinium 2,2',2''-(3,6,9,15-tetraazabicyclo(9.3.1)pentadeca-1(15),11,13-triene-3,6,9-triyl)tris(5-((2,3-dihydroxypropyl)amino)-5-oxopentanoate)</to_name>
		<to_code>M000679593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamithromycin</from_name>
		<from_code>1113697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamithromycin</to_name>
		<to_code>M0550265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl 1,2-dioleate</from_name>
		<from_code>1426915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,2-dioleoylglycerol</to_name>
		<to_code>M000622965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glabridin</from_name>
		<from_code>1603522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glabridin</to_name>
		<to_code>M0279872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grape seed proanthocyanidins</from_name>
		<from_code>283566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Grape Seed Proanthocyanidins</to_name>
		<to_code>M0528926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyoxal</from_name>
		<from_code>4967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glyoxal</to_name>
		<to_code>M0009511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golotimod</from_name>
		<from_code>2367440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>golotimod</to_name>
		<to_code>M0444429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycol salicylate</from_name>
		<from_code>26051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycol salicylate</to_name>
		<to_code>M0075189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>geranyl acetate</from_name>
		<from_code>1807120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>geranyl acetate</to_name>
		<to_code>M0395796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose 1,6-bisphosphate</from_name>
		<from_code>2565267</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glucose-1,6-bisphosphate</to_name>
		<to_code>M0066481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gardenia yellow extract</from_name>
		<from_code>2632124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gardenia yellow</to_name>
		<to_code>M0161192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl arachidonate</from_name>
		<from_code>1427076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-arachidonyl monoglyceride</to_name>
		<to_code>M0086812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutamate</from_name>
		<from_code>70602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glutamate</to_name>
		<to_code>M0028012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamma-oryzanol</from_name>
		<from_code>25608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-oryzanol</to_name>
		<to_code>M0060738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Gastrodia elata whole extract</from_name>
		<from_code>2359266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrodia elata whole</to_name>
		<to_code>M000745638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluconolactone</from_name>
		<from_code>25842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-glucono-1,5-lactone</to_name>
		<to_code>M0056469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gadolinium</from_name>
		<from_code>1310171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gadolinium</to_name>
		<to_code>M0008930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanosine</from_name>
		<from_code>1591890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Guanosine</to_name>
		<to_code>M0009684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gestronol</from_name>
		<from_code>4793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gestronol</to_name>
		<to_code>M0009216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerylphosphorylcholine</from_name>
		<from_code>4918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycerylphosphorylcholine</to_name>
		<to_code>M0009450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycolate</from_name>
		<from_code>70603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycolate</to_name>
		<to_code>M0484987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosyl hesperidin</from_name>
		<from_code>1433192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glucosyl hesperidin</to_name>
		<to_code>M0468233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glibornuride</from_name>
		<from_code>102846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glibornuride</to_name>
		<to_code>M0198293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goat milk allergenic extract</from_name>
		<from_code>862475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goat milk allergenic extract</from_name>
		<from_code>862475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Milk Proteins</to_name>
		<to_code>M0013890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Milk Proteins</to_name>
		<to_code>M0013890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cow milk allergenic extract</from_name>
		<from_code>892665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Milk Proteins</to_name>
		<to_code>M0013890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green bell pepper allergenic extract</from_name>
		<from_code>862478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>green bell pepper allergenic extract</from_name>
		<from_code>862478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish extract</from_name>
		<from_code>1314656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet potato allergenic extract</from_name>
		<from_code>901307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Allium cepa bulb extract</from_name>
		<from_code>2695867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pumpkin allergenic extract</from_name>
		<from_code>883459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish allergenic extract</from_name>
		<from_code>974687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carrot allergenic extract</from_name>
		<from_code>892368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kidney bean allergenic extract</from_name>
		<from_code>891637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squash allergenic extract</from_name>
		<from_code>975509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pisum sativum (pea) extract</from_name>
		<from_code>1426912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potato allergenic extract</from_name>
		<from_code>892632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper allergenic extract</from_name>
		<from_code>899363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion allergenic extract</from_name>
		<from_code>899466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cauliflower allergenic extract</from_name>
		<from_code>899661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red bell pepper allergenic extract</from_name>
		<from_code>901329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant allergenic extract</from_name>
		<from_code>972601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley allergenic extract</from_name>
		<from_code>899877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsnip allergenic extract</from_name>
		<from_code>1011027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cucumis sativus fruit extract</from_name>
		<from_code>2700058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinach allergenic extract</from_name>
		<from_code>901317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celery allergenic extract</from_name>
		<from_code>892372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lettuce allergenic extract</from_name>
		<from_code>899448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chickpea allergenic extract</from_name>
		<from_code>1011049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tomato allergenic extract</from_name>
		<from_code>892499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bean extract</from_name>
		<from_code>1370773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber extract</from_name>
		<from_code>1305719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard greens allergenic extract</from_name>
		<from_code>899452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber allergenic extract</from_name>
		<from_code>899738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabbage allergenic extract</from_name>
		<from_code>899398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bay leaf extract</from_name>
		<from_code>1606480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zucchini extract</from_name>
		<from_code>1649134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>broccoli allergenic extract</from_name>
		<from_code>899386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leek allergenic extract</from_name>
		<from_code>1010932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black pepper preparation</from_name>
		<from_code>259314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brussels sprout allergenic extract</from_name>
		<from_code>899390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant extract</from_name>
		<from_code>1315116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean allergenic extract</from_name>
		<from_code>891668</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparagus allergenic extract</from_name>
		<from_code>891796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onion extract</from_name>
		<from_code>1370469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara preparation</from_name>
		<from_code>235940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plant Proteins, Dietary</to_name>
		<to_code>M0022575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluconic acid</from_name>
		<from_code>2475956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gluconic acid</to_name>
		<to_code>M0096893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycofurol</from_name>
		<from_code>1427078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycofurol</to_name>
		<to_code>M0070225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gliotoxin</from_name>
		<from_code>1661743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gliotoxin</to_name>
		<to_code>M0009277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gepefrine</from_name>
		<from_code>41157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gepefrine</to_name>
		<to_code>M0131929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>grapiprant</from_name>
		<from_code>1862951</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>grapiprant</to_name>
		<to_code>M0513563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutathione disulfide</from_name>
		<from_code>25953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glutathione Disulfide</to_name>
		<to_code>M0029384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Galphimia glauca flowering top extract</from_name>
		<from_code>1346618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Galphimia glauca flowering top</to_name>
		<to_code>M000745636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentisic acid</from_name>
		<from_code>1368641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,5-dihydroxybenzoic acid</to_name>
		<to_code>M0056827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guggul lipids</from_name>
		<from_code>283568</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gugulipid</to_name>
		<to_code>M0070231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycylglycine</from_name>
		<from_code>1362904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycylglycine</to_name>
		<to_code>M0009507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gamboge</from_name>
		<from_code>89698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gamboge</to_name>
		<to_code>M0499454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gardenoside</from_name>
		<from_code>2585534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gardenoside</to_name>
		<to_code>M0158681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutathione</from_name>
		<from_code>4890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glutathione</to_name>
		<to_code>M0009388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gluceptate</from_name>
		<from_code>50470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glucoheptonate</to_name>
		<to_code>M0051278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycyrrhetinic acid</from_name>
		<from_code>1311506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycyrrhetinic Acid</to_name>
		<to_code>M0009508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucuronic acid</from_name>
		<from_code>1426906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glucuronic Acid</to_name>
		<to_code>M0095420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glymidine</from_name>
		<from_code>102848</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glymidine</to_name>
		<to_code>M0198145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>germanium</from_name>
		<from_code>4784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Germanium</to_name>
		<to_code>M0009205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glyceryl monostearate</from_name>
		<from_code>1311165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glyceryl monostearate</to_name>
		<to_code>M0138717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wing scale pollen extract</to_name>
		<to_code>852074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white ash pollen extract</to_name>
		<to_code>852450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water</to_name>
		<to_code>11295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white kidney bean allergenic extract</to_name>
		<to_code>1012179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>whole eriodictyon californicum extract</to_name>
		<to_code>1432475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western black willow pollen extract</to_name>
		<to_code>1014755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wasp venoms</to_name>
		<to_code>11291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wasabi root extract</to_name>
		<to_code>1309429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wormwood sage pollen extract</to_name>
		<to_code>852007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white fish allergenic extract</to_name>
		<to_code>901265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>walnut allergenic extract</to_name>
		<to_code>314470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape allergenic extract</to_name>
		<to_code>892317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat middlings extract</to_name>
		<to_code>1427080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wood tar hydrocarbon distillate</to_name>
		<to_code>1537751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white mustard seed allergenic extract</to_name>
		<to_code>2102844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white bryony extract</to_name>
		<to_code>236988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white wax</to_name>
		<to_code>11327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white sweetclover top extract</to_name>
		<to_code>1996983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape juice</to_name>
		<to_code>1429968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watermelon seed oil</to_name>
		<to_code>1747703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>winged elm whole extract</to_name>
		<to_code>1657759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western juniper pollen extract</to_name>
		<to_code>852589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat pollen extract</to_name>
		<to_code>867361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wild oat whole extract</to_name>
		<to_code>1657725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>whortleberry substance</to_name>
		<to_code>581386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat bran allergenic extract</to_name>
		<to_code>1012140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wasabi preparation</to_name>
		<to_code>1009447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Waltheria indica leaf extract</to_name>
		<to_code>1370105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western sycamore pollen extract</to_name>
		<to_code>852750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat germ oil unsaponifiables</to_name>
		<to_code>2594592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white spirit type 1</to_name>
		<to_code>1301854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western yellow jacket venom protein</to_name>
		<to_code>1297535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watermelon preparation</to_name>
		<to_code>260014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat sprout extract</to_name>
		<to_code>1482550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>warfarin sodium</to_name>
		<to_code>114194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white pepper allergenic extract</to_name>
		<to_code>1011633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>West Indian lemongrass oil</to_name>
		<to_code>1305654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>West Nile virus</to_name>
		<to_code>1316080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western waterhemp pollen extract</to_name>
		<to_code>851934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white (mexican) dock pollen extract</to_name>
		<to_code>1014743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Withania somnifera root extract</to_name>
		<to_code>1309279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>winter savory oil</to_name>
		<to_code>2105837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wasp venom protein</to_name>
		<to_code>260051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat smut allergenic extract</to_name>
		<to_code>852797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white oak pollen extract</to_name>
		<to_code>852294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Withania somnifera flower extract</to_name>
		<to_code>1307643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wood ant preparation</to_name>
		<to_code>1311080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>whey protein hydrolysate</to_name>
		<to_code>2266754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white mulberry pollen extract</to_name>
		<to_code>852669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white seedless grape allergenic extract</to_name>
		<to_code>904815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western ragweed pollen extract</to_name>
		<to_code>851985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white hickory pollen extract</to_name>
		<to_code>852193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white oak bark extract</to_name>
		<to_code>1319902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white mulberry extract</to_name>
		<to_code>1307721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wild thyme extract</to_name>
		<to_code>2286806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watercress preparation</to_name>
		<to_code>287516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>witch hazel</to_name>
		<to_code>89821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>weakleaf bur ragweed pollen extract</to_name>
		<to_code>1117083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Whey Proteins</to_name>
		<to_code>1723989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water, O-18</to_name>
		<to_code>1551628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white sweet clover pollen extract</to_name>
		<to_code>1014735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white kidney bean extract</to_name>
		<to_code>616546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>warfarin</to_name>
		<to_code>11289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Withania somnifera leaf extract</to_name>
		<to_code>1307587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wormwood extract</to_name>
		<to_code>1309324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white pine oil</to_name>
		<to_code>1306057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>whole Melia azederach extract</to_name>
		<to_code>1432474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat dextrin</to_name>
		<to_code>637366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat bran extract</to_name>
		<to_code>1427046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water birch pollen extract</to_name>
		<to_code>852166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>whole wheat allergenic extract</to_name>
		<to_code>901299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>withanolide D</to_name>
		<to_code>2604033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Wolfiporia cocos sclerotium extract</to_name>
		<to_code>2697972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white rice extract</to_name>
		<to_code>1315124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white poplar whole extract</to_name>
		<to_code>1657755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white catfish allergenic extract</to_name>
		<to_code>971166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Withania somnifera whole extract</to_name>
		<to_code>1876359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Wyethia helenioides root extract</to_name>
		<to_code>1310148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Wolfiporia extensa whole extract</to_name>
		<to_code>1803878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white poplar pollen extract</to_name>
		<to_code>852382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water oak pollen extract</to_name>
		<to_code>1013944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat preparation</to_name>
		<to_code>1441652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white-tailed deer hair extract</to_name>
		<to_code>895538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watermelon seed extract</to_name>
		<to_code>1716106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wogonin</to_name>
		<to_code>2001619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watercress allergenic extract</to_name>
		<to_code>1011418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western wheatgrass pollen extract</to_name>
		<to_code>852659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wormwood oil</to_name>
		<to_code>1305653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>water, O-15</to_name>
		<to_code>1427071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western larch pollen extract</to_name>
		<to_code>2166614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white mustard seed extract</to_name>
		<to_code>1486503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>watermelon allergenic extract</to_name>
		<to_code>901258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>walnut oil</to_name>
		<to_code>1337618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white tea extract</to_name>
		<to_code>1651698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat gluten extract</to_name>
		<to_code>1370781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat germ preparation</to_name>
		<to_code>314896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white currant fruit extract</to_name>
		<to_code>2045113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white alder pollen extract</to_name>
		<to_code>851910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>winterfat pollen extract</to_name>
		<to_code>852613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>western white pine pollen extract</to_name>
		<to_code>900743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white willow pollen extract</to_name>
		<to_code>1484986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>white pepper oil</to_name>
		<to_code>1442510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wheat germ oil</to_name>
		<to_code>72385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>warfarin potassium</to_name>
		<to_code>82118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wine grape extract</to_name>
		<to_code>1307718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>W [Preparations]</from_name>
		<from_code>N0000010605</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>wild yam extract</to_name>
		<to_code>237020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>water</from_name>
		<from_code>11295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Water</to_name>
		<to_code>M0022883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>West Indian lemongrass oil</from_name>
		<from_code>1305654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lemongrass oil</to_name>
		<to_code>M0150017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>West Nile virus</from_name>
		<from_code>1316080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>West Nile virus</to_name>
		<to_code>M0022929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whey protein hydrolysate</from_name>
		<from_code>2266754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Whey Proteins</from_name>
		<from_code>1723989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat dextrin</from_name>
		<from_code>637366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat bran extract</from_name>
		<from_code>1427046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>withanolide D</from_name>
		<from_code>2604033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>withanolide D</to_name>
		<to_code>M0055813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wogonin</from_name>
		<from_code>2001619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>wogonin</to_name>
		<to_code>M0226921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>watercress allergenic extract</from_name>
		<from_code>1011418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>wheat germ oil</to_name>
		<to_code>M0143154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat germ oil</from_name>
		<from_code>72385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amino methacrylate copolymer</to_name>
		<to_code>1311153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actinidia polygama fruit extract</to_name>
		<to_code>1307674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia decurrens flower wax</to_name>
		<to_code>1607326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus allochrous whole extract</to_name>
		<to_code>2375707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum silicate</to_name>
		<to_code>1362917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apraclonidine</to_name>
		<to_code>14845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alisma plantago-aquatica subsp. orientale whole extract</to_name>
		<to_code>2263060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisindione</to_name>
		<to_code>17941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alphaprodine hydrochloride</to_name>
		<to_code>7433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alisma plantago-aquatica root</to_name>
		<to_code>2118534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylamide</to_name>
		<to_code>1368125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asperagenin</to_name>
		<to_code>1866040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic</to_name>
		<to_code>1111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albuterol sulfate</to_name>
		<to_code>142153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anthrax immune globulin</to_name>
		<to_code>1722336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anacardium occidentale whole extract</to_name>
		<to_code>2180254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acyclovir</to_name>
		<to_code>281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ajmaline</to_name>
		<to_code>423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arroyo willow pollen extract</to_name>
		<to_code>852170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azelate</to_name>
		<to_code>618278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argania spinosa leaf extract</to_name>
		<to_code>1593611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoproxan</to_name>
		<to_code>1440271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium thioglycolate</to_name>
		<to_code>1482632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aristotelia chilensis fruit extract</to_name>
		<to_code>1655978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia nigra root extract</to_name>
		<to_code>2560105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-dihydroartemisinin</to_name>
		<to_code>2584841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica dahurica var. formosana whole extract</to_name>
		<to_code>1539965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alcuronium chloride</to_name>
		<to_code>66852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argentine canola pollen extract</to_name>
		<to_code>1484975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfatradiol</to_name>
		<to_code>1926478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus esculentus whole extract</to_name>
		<to_code>2119173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl octapeptide-3</to_name>
		<to_code>1313046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aphanizomenon flos-aquae</to_name>
		<to_code>1310848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxicillin</to_name>
		<to_code>723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyltryptophanate</to_name>
		<to_code>1366817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiloride</to_name>
		<to_code>644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acemetacin</to_name>
		<to_code>16695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arabica coffee bean allergenic extract</to_name>
		<to_code>891502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acremonium strictum allergenic extract</to_name>
		<to_code>905070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave polianthes flower wax</to_name>
		<to_code>2180547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminomethylpropanol (perfluoro-C6-C12 ethyl)phosphate</to_name>
		<to_code>1491008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopropyl dimethicone (1000 MPA.S)</to_name>
		<to_code>2463336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atomoxetine</to_name>
		<to_code>38400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acellular tissue engineered vessel-tyod</to_name>
		<to_code>2700340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl sulfide</to_name>
		<to_code>17376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albendazole</to_name>
		<to_code>430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium laureth-5 sulfate</to_name>
		<to_code>1306944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agathosma betulina leaf extract</to_name>
		<to_code>1309499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arbekacin</to_name>
		<to_code>26397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus propinquus root extract</to_name>
		<to_code>1309814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic trioxide</to_name>
		<to_code>18330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Azadirachta indica bark extract</to_name>
		<to_code>1307661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus glutinosa leaf extract</to_name>
		<to_code>1992670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, human</to_name>
		<to_code>203083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ardeparin sodium</to_name>
		<to_code>87865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum magnesium hydroxide carbonate</to_name>
		<to_code>2468436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylose, tapioca</to_name>
		<to_code>2171590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydroxide, dried (USP)</to_name>
		<to_code>81948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arformoterol</to_name>
		<to_code>304962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alizapride</to_name>
		<to_code>17311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>advantame</to_name>
		<to_code>1591894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-amino-5,6-dichloroquinazolin-3(4h )-yl)acetic acid</to_name>
		<to_code>2634407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium phosphate, dibasic</to_name>
		<to_code>1427061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer negundo root bark extract</to_name>
		<to_code>1925204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl tetrapeptide-15</to_name>
		<to_code>1733675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amitriptyline</to_name>
		<to_code>704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspartame</to_name>
		<to_code>1311524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus hypochondriacus seed extract</to_name>
		<to_code>2541498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus viridis subsp. crispa leaf extract</to_name>
		<to_code>2054070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia nilotica bark extract</to_name>
		<to_code>1987639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adenophora stricta root extract</to_name>
		<to_code>1305553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.,.beta.'-diglycerin</to_name>
		<to_code>1648687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anastrozole</to_name>
		<to_code>84857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Andrographis paniculata top extract</to_name>
		<to_code>1998719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-isopropyl-phenethyl alcohol</to_name>
		<to_code>2458326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allergenic extract, pigweed, spiny, pollen</to_name>
		<to_code>314428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ardisia crenata root extract</to_name>
		<to_code>2610397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen</to_name>
		<to_code>2626471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Absidia capillata allergenic extract</to_name>
		<to_code>1306881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antirabies serum,equine</to_name>
		<to_code>485234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Australian pine pollen extract</to_name>
		<to_code>852229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atipamezole</to_name>
		<to_code>18475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atipamezole hydrochloride</to_name>
		<to_code>390043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American lobster allergenic extract</to_name>
		<to_code>1997187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica archangelica leaf extract</to_name>
		<to_code>1309286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>African Pygeum extract</to_name>
		<to_code>580117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony trisulfide</to_name>
		<to_code>1316091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avilamycin</to_name>
		<to_code>1661561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allantoin, (+)-</to_name>
		<to_code>1739978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha glucosidase</to_name>
		<to_code>2475361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aconitic acid, (Z)-</to_name>
		<to_code>1313275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amprolium</to_name>
		<to_code>1006654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous lactose</to_name>
		<to_code>1307662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum napellus root extract</to_name>
		<to_code>1330284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum chloride hexahydrate</to_name>
		<to_code>17611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica biserrata whole extract</to_name>
		<to_code>2360136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anifrolumab</to_name>
		<to_code>2565265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atorvastatin calcium</to_name>
		<to_code>83366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctostaphylos tomentosa whole extract</to_name>
		<to_code>2591795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>angiotensin II</to_name>
		<to_code>1999003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia zerumbet leaf extract</to_name>
		<to_code>1309392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus hippocastanum bark extract</to_name>
		<to_code>1309398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acai berry extract</to_name>
		<to_code>848929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus hybridus pollen extract</to_name>
		<to_code>1363561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus nidulans allergenic extract</to_name>
		<to_code>1368357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin human-kjda</to_name>
		<to_code>2054166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus americanus whole extract</to_name>
		<to_code>2592616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-atto</to_name>
		<to_code>2103479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amyloglucosidase (Aspergillus niger)</to_name>
		<to_code>2593716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amlexanox</to_name>
		<to_code>46307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ambrosia artemisiifolia extract</to_name>
		<to_code>1347557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Althaea officinalis flower extract</to_name>
		<to_code>1435101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydroxide gel</to_name>
		<to_code>613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adansonia digitata seed oil</to_name>
		<to_code>1421429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acriflavine hydrochloride</to_name>
		<to_code>1664337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-isomethionyl acetate, (2R)-(+)</to_name>
		<to_code>1664336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine, DL-</to_name>
		<to_code>1729154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amyl acetate</to_name>
		<to_code>1370452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot kernel oil</to_name>
		<to_code>1318515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer pseudoplatanus pollen extract</to_name>
		<to_code>1801702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American eel preparation</to_name>
		<to_code>2375518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aldioxa</to_name>
		<to_code>23161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer campestre leaf bud extract</to_name>
		<to_code>2054071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apis cerana worker secretion preparation</to_name>
		<to_code>1373205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azelastine hydrochloride</to_name>
		<to_code>235824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloysia citrodora leaf oil</to_name>
		<to_code>2531386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum virginicum whole extract</to_name>
		<to_code>2667258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acesulfame</to_name>
		<to_code>1310546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambenonium chloride</to_name>
		<to_code>624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminacrine hydrochloride</to_name>
		<to_code>81949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amantadine hydrochloride</to_name>
		<to_code>282415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atovaquone</to_name>
		<to_code>60212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein</to_name>
		<to_code>2631084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ampicillin trihydrate</to_name>
		<to_code>203115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amantadine</to_name>
		<to_code>620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl acrylate</to_name>
		<to_code>1788869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica anomala root extract</to_name>
		<to_code>2590914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha 1-antitrypsin</to_name>
		<to_code>535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous tacrolimus</to_name>
		<to_code>235991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus ruber</to_name>
		<to_code>1324086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor (recombinant) pegylated-exei</to_name>
		<to_code>2275722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple wood extract</to_name>
		<to_code>2479556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aethusa cynapium extract</to_name>
		<to_code>1351000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl cyclohexaneacetate</to_name>
		<to_code>2557380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetamidopropyl trimonium chloride</to_name>
		<to_code>1483777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Althaea officinalis root extract</to_name>
		<to_code>1306165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-amino-2-ethyl-1,3-propanediol</to_name>
		<to_code>1539638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia annua leaf extract</to_name>
		<to_code>1656306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atomoxetine hydrochloride</to_name>
		<to_code>353103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus manihot whole extract</to_name>
		<to_code>2637343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>artemisia pallens whole extract</to_name>
		<to_code>1603472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopropanediol</to_name>
		<to_code>2050415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-(((2-(2-amino-3-hydroxy-2-(hydroxymethyl)propoxy)-1-hydroxypropyl)hydroxyphosphoryl)oxy)-1-hydroxypropyl)phosphonate</to_name>
		<to_code>2380376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aralia cordata root extract</to_name>
		<to_code>1420958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almasilate anhydrous</to_name>
		<to_code>1944248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asiatic acid</to_name>
		<to_code>1551574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia maritima flower extract</to_name>
		<to_code>1309672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atractylodes macrocephala root extract</to_name>
		<to_code>1372633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Azadirachta indica whole extract</to_name>
		<to_code>1722379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-aminophenol</to_name>
		<to_code>1435279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium methacrylate</to_name>
		<to_code>1988680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetophenazine</to_name>
		<to_code>16735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anthoxanthum odoratum extract</to_name>
		<to_code>1319268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arbutamine</to_name>
		<to_code>61609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anaplasma phagocytophilum</to_name>
		<to_code>2168766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-amino-2-hydroxytoluene</to_name>
		<to_code>1740236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amorphophallus konjac root extract</to_name>
		<to_code>1537210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica dahurica whole extract</to_name>
		<to_code>1490679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alectinib</to_name>
		<to_code>1727455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia cina flower extract</to_name>
		<to_code>1309510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aristolochia clematitis whole extract</to_name>
		<to_code>1552036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alstonia constricta bark extract</to_name>
		<to_code>1441544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus chinensis seed extract</to_name>
		<to_code>1868198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidyl alcohol</to_name>
		<to_code>1368131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine</to_name>
		<to_code>1091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ascophyllum nodosum extract</to_name>
		<to_code>1311127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica gigas root extract</to_name>
		<to_code>1307664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-amylcinnamaldehyde, (E)-</to_name>
		<to_code>2265846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloysia citrodora flower oil</to_name>
		<to_code>2391535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almagate</to_name>
		<to_code>2475181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum napellus extract</to_name>
		<to_code>1310220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonia spirit, aromatic</to_name>
		<to_code>317201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies balsamea leaf oil</to_name>
		<to_code>1356479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum heterotropoides var. mandshuricum root extract</to_name>
		<to_code>1365709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetamine sulfate</to_name>
		<to_code>81952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anemone pratensis flowering top extract</to_name>
		<to_code>1811457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adipate ion</to_name>
		<to_code>2109241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amantadine sulfate</to_name>
		<to_code>621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-amino-1,3-propanediol</to_name>
		<to_code>2467839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetamine aspartate monohydrate</to_name>
		<to_code>405812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allethrin</to_name>
		<to_code>513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aloe vera leaf extract</to_name>
		<to_code>1306128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anthrax Vaccine Adsorbed</to_name>
		<to_code>404774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>artemether</to_name>
		<to_code>18343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot fruit oil</to_name>
		<to_code>1428854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl triethylhexyl citrate</to_name>
		<to_code>1313223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Antiaris toxicara resin</to_name>
		<to_code>1370298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl arginine</to_name>
		<to_code>2469242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>altrenogest</to_name>
		<to_code>1314612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ansuvimab</to_name>
		<to_code>2472152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprolium</to_name>
		<to_code>1546166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amikacin sulfate, liposomal</to_name>
		<to_code>2059179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adefovir dipivoxil</to_name>
		<to_code>141400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alogliptin</to_name>
		<to_code>1368001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonia N-13</to_name>
		<to_code>1305558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anamu preparation</to_name>
		<to_code>283537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ardisia japonica stem extract</to_name>
		<to_code>1309405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alcea rosea flower extract</to_name>
		<to_code>1307576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium stearate</to_name>
		<to_code>1312975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apraclonidine hydrochloride</to_name>
		<to_code>91350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonia</to_name>
		<to_code>1299884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actinidia chinensis whole extract</to_name>
		<to_code>1356482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin,aggregated</to_name>
		<to_code>317176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anti-interleukin-1.alpha. immunoglobulin G rabbit</to_name>
		<to_code>1426469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopterin sodium</to_name>
		<to_code>1440263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anamirta cocculus fruit extract</to_name>
		<to_code>2591794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin B lipid complex</to_name>
		<to_code>2001759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amodimethicone (240 CST)</to_name>
		<to_code>2471080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almotriptan malate</to_name>
		<to_code>283792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia vulgaris top oil</to_name>
		<to_code>1360630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcarnitine</to_name>
		<to_code>193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avacincaptad pegol sodium</to_name>
		<to_code>2645107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-aminophenol</to_name>
		<to_code>1740241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-aminobutyric acid, L-</to_name>
		<to_code>2464936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica chamissonis flower extract</to_name>
		<to_code>1309288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl glucoside</to_name>
		<to_code>1306933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus nuttallii leaf extract</to_name>
		<to_code>1309768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abetimus sodium</to_name>
		<to_code>1311599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aloglutamol</to_name>
		<to_code>17392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actaea racemosa whole extract</to_name>
		<to_code>1651691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>algal fungi allergenic extract</to_name>
		<to_code>966692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atropa belladonna root extract</to_name>
		<to_code>1353220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab</to_name>
		<to_code>327361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia concinna fruit extract</to_name>
		<to_code>1928182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer saccharum leaf extract</to_name>
		<to_code>2471077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprobarbital</to_name>
		<to_code>17381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aronia arbutifolia whole extract</to_name>
		<to_code>2001614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acidulated phosphate fluoride</to_name>
		<to_code>236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Avena sativa leaf extract</to_name>
		<to_code>1307606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adansonia digitata fruit pulp extract</to_name>
		<to_code>2391137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica archangelica root extract</to_name>
		<to_code>1309828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrimonia eupatoria leaf extract</to_name>
		<to_code>1994294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>annual bluegrass pollen extract</to_name>
		<to_code>898404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amodimethicone (3500 CST)</to_name>
		<to_code>1483728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asplenium scolopendrium whole extract</to_name>
		<to_code>1543293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Armoracia rusticana whole extract</to_name>
		<to_code>1946395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfentanil</to_name>
		<to_code>480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alkali blite pollen extract</to_name>
		<to_code>852106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amorolfine hydrochloride</to_name>
		<to_code>293865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Araneus diadematus preparation</to_name>
		<to_code>1353218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminophylline</to_name>
		<to_code>689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apremilast</to_name>
		<to_code>1492727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium hookeri whole extract</to_name>
		<to_code>2630720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aquaporin-4</to_name>
		<to_code>2370867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylic acid/ethylene copolymer (600 mPa.s)</to_name>
		<to_code>1792115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia officinarum whole extract</to_name>
		<to_code>2055272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopentamide, sulfate</to_name>
		<to_code>1006396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies sibirica leaf oil</to_name>
		<to_code>1306158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aquilegia canadensis whole extract</to_name>
		<to_code>2103291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agatolimod sodium</to_name>
		<to_code>2665621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arisaema triphyllum root extract</to_name>
		<to_code>1309954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astacus astacus extract</to_name>
		<to_code>1370790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Areca catechu fruit rind extract</to_name>
		<to_code>2477851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium hydroxide</to_name>
		<to_code>1362884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetamidoethoxyethanol</to_name>
		<to_code>2370868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apomorphine hydrochloride</to_name>
		<to_code>71225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amodimethicone (1300 CST)</to_name>
		<to_code>1535932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asplenium scolopendrium top extract</to_name>
		<to_code>1482547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apaflurane</to_name>
		<to_code>1368129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum sieboldii root extract</to_name>
		<to_code>1307817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arimoclomol</to_name>
		<to_code>2694283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albuterol</to_name>
		<to_code>435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>6-aminocaproic acid</to_name>
		<to_code>99</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum kusnezoffii whole extract</to_name>
		<to_code>2375524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arabica coffee oil</to_name>
		<to_code>1362134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>228656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adrenal cortex extract</to_name>
		<to_code>91413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amodiaquine hydrochloride</to_name>
		<to_code>314495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidyl glucoside</to_name>
		<to_code>1368132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic trichloride</to_name>
		<to_code>2533832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid red 35</to_name>
		<to_code>2274098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anthralin</to_name>
		<to_code>873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alectinib hydrochloride</to_name>
		<to_code>1727454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alchemilla vulgaris flowering top extract</to_name>
		<to_code>2711887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anacardium occidentale fruit extract</to_name>
		<to_code>1358956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies koreana leaf extract</to_name>
		<to_code>2178060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl hexapeptide-49</to_name>
		<to_code>1798383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-aminohippuric acid</to_name>
		<to_code>7832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum zirconium pentachlorohydrex gly</to_name>
		<to_code>1305899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer nigrum whole extract</to_name>
		<to_code>2539930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anacardium occidentale bark extract</to_name>
		<to_code>2591602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arformoterol tartrate</to_name>
		<to_code>668284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium glycyrrhizinate trihydrate</to_name>
		<to_code>2640215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axicabtagene ciloleucel</to_name>
		<to_code>1987398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia dealbata flower wax</to_name>
		<to_code>2180546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium fistulosum bulb extract</to_name>
		<to_code>1599142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alyssoides utriculata extract</to_name>
		<to_code>1925581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia catechu whole extract</to_name>
		<to_code>1650239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfentanil hydrochloride</to_name>
		<to_code>203203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin monohydrate</to_name>
		<to_code>1298839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arisaema erubescens whole extract</to_name>
		<to_code>2199293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony tartrate ion</to_name>
		<to_code>2384445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amber</to_name>
		<to_code>1311393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylsalicylsalicylic acid</to_name>
		<to_code>1858285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adipic acid</to_name>
		<to_code>17050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alverine</to_name>
		<to_code>17627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actaea dahurica whole extract</to_name>
		<to_code>2678311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum</to_name>
		<to_code>1311504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abetimus</to_name>
		<to_code>1311600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin sodium dihydrogen phosphate</to_name>
		<to_code>2679612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agkistrodon contortrix venom</to_name>
		<to_code>1310455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha bisabolene</to_name>
		<to_code>2675320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia oxyphylla fruit extract</to_name>
		<to_code>2592957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alarelin acetate</to_name>
		<to_code>2641624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl farnesylcysteine</to_name>
		<to_code>1868830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-terpineol, (+)-</to_name>
		<to_code>2398338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium phosphate,monobasic</to_name>
		<to_code>314493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus hippocastanum seed oil</to_name>
		<to_code>1535452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arisaema consanguineum root extract</to_name>
		<to_code>1724419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adansonia digiata whole extract</to_name>
		<to_code>1539421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arabidopsis thaliana extract</to_name>
		<to_code>1314265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-amylase</to_name>
		<to_code>560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine, D-</to_name>
		<to_code>1742746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambergris</to_name>
		<to_code>1311494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies sachalinensis var. sachalinensis oil</to_name>
		<to_code>1309280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminosalicylate</to_name>
		<to_code>113374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia princeps leaf oil</to_name>
		<to_code>1547467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avacincaptad pegol</to_name>
		<to_code>2645108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adonis vernalis flowering top extract</to_name>
		<to_code>1546862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflatoxin B1</to_name>
		<to_code>2282017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aquaporin-1</to_name>
		<to_code>2463337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anguilla rostrata blood serum</to_name>
		<to_code>1313312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anileridine</to_name>
		<to_code>17933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-acetonaphthone</to_name>
		<to_code>2378835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus canadensis root extract</to_name>
		<to_code>2532930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atazanavir</to_name>
		<to_code>343047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopheryloxyacetate</to_name>
		<to_code>1995482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus moschatus seed extract</to_name>
		<to_code>1352512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium acryloyldimethyltaurate - beheneth-25 methacrylate crosspolymer (52000 MPA.S)</to_name>
		<to_code>1541234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrivastine</to_name>
		<to_code>19959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot kernal oil PEG-6 esters</to_name>
		<to_code>1305536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>7-aminodesacetoxycephalosporanic acid</to_name>
		<to_code>1990418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acenocoumarol</to_name>
		<to_code>154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azintamide</to_name>
		<to_code>402580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American chestnut allergenic extract</to_name>
		<to_code>891752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcarnitine, DL-</to_name>
		<to_code>1310540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminobenzoate</to_name>
		<to_code>143980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia dealbata pollen extract</to_name>
		<to_code>2202946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony sulfate</to_name>
		<to_code>2564026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atropa belladona whole extract</to_name>
		<to_code>1361461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia decurrens extract</to_name>
		<to_code>1362813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfaxalone</to_name>
		<to_code>1544577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aviscumine</to_name>
		<to_code>2591797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonio methacrylate copolymer type A</to_name>
		<to_code>1424665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica angustifolia flower extract</to_name>
		<to_code>1309943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica dahurica var. formosana root extract</to_name>
		<to_code>1923500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic salmon allergenic extract</to_name>
		<to_code>900031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminium triglycinate</to_name>
		<to_code>1659193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn</to_name>
		<to_code>2561249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adenium obesum whole extract</to_name>
		<to_code>2599920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atorvastatin</to_name>
		<to_code>83367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid violet 43</to_name>
		<to_code>1426422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aquilaria malaccensis stem extract</to_name>
		<to_code>1307715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aromadendrin</to_name>
		<to_code>1601985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum starch octenylsuccinate</to_name>
		<to_code>1426415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium iodide</to_name>
		<to_code>1720161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antithrombin III, human</to_name>
		<to_code>221062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-aminobenzoate</to_name>
		<to_code>618974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apium graveolens whole extract</to_name>
		<to_code>2102723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies alba leafy twig extract</to_name>
		<to_code>1545037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alaria esculenta extract</to_name>
		<to_code>1358846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aqua regia</to_name>
		<to_code>1537801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave atrovirens top extract</to_name>
		<to_code>2591600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arizona ash pollen extract</to_name>
		<to_code>852496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparaginase Erwinia chrysanthemi</to_name>
		<to_code>1431738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminohippurate sodium</to_name>
		<to_code>203194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atezolizumab-tqjs</to_name>
		<to_code>2693883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia catechu wood extract</to_name>
		<to_code>1811251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-pinene</to_name>
		<to_code>2362183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avocado oil</to_name>
		<to_code>1311611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abrocitinib</to_name>
		<to_code>2591476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl tetrapeptide-2</to_name>
		<to_code>2476004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminolevulinate</to_name>
		<to_code>155002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acepromazine maleate</to_name>
		<to_code>1114057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum zirconium pentachlorohydrate</to_name>
		<to_code>1306097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus flavus var. oryzae</to_name>
		<to_code>1329940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspartic acid</to_name>
		<to_code>1169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfacalcidol</to_name>
		<to_code>12062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abutilon theophrasti seed extract</to_name>
		<to_code>2592956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agastache foeniculum whole extract</to_name>
		<to_code>2470030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer saccharinum whole extract</to_name>
		<to_code>1597887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl tetraisopalmitate</to_name>
		<to_code>1356761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allopurinol sodium</to_name>
		<to_code>80566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amisulpride</to_name>
		<to_code>46303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-amino-5-nitrothiazole</to_name>
		<to_code>1665683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprazolam</to_name>
		<to_code>596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenosine phosphate disodium</to_name>
		<to_code>1306123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl dipeptide-1 cetyl ester</to_name>
		<to_code>1374852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amprolium ion</to_name>
		<to_code>1546165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnebia euchroma root extract</to_name>
		<to_code>2047171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-amylcinnamyl acetate</to_name>
		<to_code>2395800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony triiodide</to_name>
		<to_code>1423913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus rhombifolia bark extract</to_name>
		<to_code>2590595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus glabra nut extract</to_name>
		<to_code>1357998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argon</to_name>
		<to_code>1368133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer saccharum whole extract</to_name>
		<to_code>1597886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha, alpha-dimethylbenzyl alcohol</to_name>
		<to_code>1306124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl glutamic acid</to_name>
		<to_code>2001205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aztreonam</to_name>
		<to_code>1272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Avena sativa flowering top extract</to_name>
		<to_code>1309702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium polyacryloyldimethyl taurate (55000 MPA.S)</to_name>
		<to_code>2105930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum carmichaelii root extract</to_name>
		<to_code>1310071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anise oil</to_name>
		<to_code>90926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acorus calamus var. angustatus whole extract</to_name>
		<to_code>2539292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acryloyldimethyltaurate</to_name>
		<to_code>1370664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrovitamin A</to_name>
		<to_code>2669473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer pensylvanicum whole extract</to_name>
		<to_code>2590593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylated lanolin alcohols</to_name>
		<to_code>1364294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer negundo inner bark extract</to_name>
		<to_code>1727167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium valerate</to_name>
		<to_code>1441545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achillea millefolium root oil</to_name>
		<to_code>2467730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amentoflavone</to_name>
		<to_code>2643210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia afra leaf extract</to_name>
		<to_code>2732339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>artesunate</to_name>
		<to_code>18346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyldigoxins</to_name>
		<to_code>199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aframomum angustifolium seed extract</to_name>
		<to_code>1309401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia abrotanum whole extract</to_name>
		<to_code>1313225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alosetron</to_name>
		<to_code>85248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asterias rubens preparation</to_name>
		<to_code>1192621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum ferox root extract</to_name>
		<to_code>1348454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylocaine</to_name>
		<to_code>40660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum dimyristate</to_name>
		<to_code>1305555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica sinensis root oil</to_name>
		<to_code>1990417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atractylodes japonica root oil</to_name>
		<to_code>1305643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arimoclomol citrate</to_name>
		<to_code>2694282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidyl behenate</to_name>
		<to_code>1314266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopropazine fumarate</to_name>
		<to_code>1440268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abarelix</to_name>
		<to_code>301739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azficel-T</to_name>
		<to_code>1114112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple cider vinegar</to_name>
		<to_code>360262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anethum graveolens whole extract</to_name>
		<to_code>1600751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alchemilla xanthochlora flowering top extract</to_name>
		<to_code>1309722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetaminophen</to_name>
		<to_code>161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Antirrhinum majus leaf extract</to_name>
		<to_code>2590598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium xylenesulfonate</to_name>
		<to_code>1423272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abobotulinumtoxinA</to_name>
		<to_code>860168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, porcine B-domain truncated recombinant</to_name>
		<to_code>1592899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Austrian pine pollen extract</to_name>
		<to_code>900750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arizona cypress pollen extract</to_name>
		<to_code>852814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Althaea officinalis leaf extract</to_name>
		<to_code>1307864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-bisabolol, (+)-</to_name>
		<to_code>1487162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid green 50</to_name>
		<to_code>2532534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argan oil</to_name>
		<to_code>1305642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe vera leaf polysaccharides</to_name>
		<to_code>1739980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argipressin</to_name>
		<to_code>1098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica montana flower water</to_name>
		<to_code>1486086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allopurinol</to_name>
		<to_code>519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argentina anserina flowering top extract</to_name>
		<to_code>1309729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin B</to_name>
		<to_code>732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>archangelenone</to_name>
		<to_code>2667257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ammopiptanthus mongolicus stem extract</to_name>
		<to_code>2668551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia seyal whole extract</to_name>
		<to_code>2398145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ash pollen extract</to_name>
		<to_code>1484982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetoxolone</to_name>
		<to_code>16784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atenolol</to_name>
		<to_code>1202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica dahurica root extract</to_name>
		<to_code>1306167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alanylglutamine</to_name>
		<to_code>1359422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Androctonus australis venom</to_name>
		<to_code>1486798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anamirta cocculus seed extract</to_name>
		<to_code>1310018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol linoleate, D-</to_name>
		<to_code>1427235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-aaty</to_name>
		<to_code>2639649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple juice</to_name>
		<to_code>1358965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctostaphylos uva-ursi whole extract</to_name>
		<to_code>1658432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum heterotropoides extract</to_name>
		<to_code>1372478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydromethylenecitric acid</to_name>
		<to_code>2286804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaryllis belladonna whole extract</to_name>
		<to_code>2591601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ardeparin</to_name>
		<to_code>87866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus mongholicus whole extract</to_name>
		<to_code>2360134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Averrhoa carambola leaf extract</to_name>
		<to_code>1307642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept-ayyh</to_name>
		<to_code>2696256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydroxyphosphate</to_name>
		<to_code>1423457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetaldehyde</to_name>
		<to_code>1311137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyldigitoxin</to_name>
		<to_code>132871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-chlorohydrin, (+/-)-</to_name>
		<to_code>2396781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anti-inhibitor coagulant complex</to_name>
		<to_code>314504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum oxide</to_name>
		<to_code>615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asunaprevir</to_name>
		<to_code>1652103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine aminobenzoate</to_name>
		<to_code>1010241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acai fruit pulp</to_name>
		<to_code>1482538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agathosma crenulata whole extract</to_name>
		<to_code>2001811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ampelopsis japonica root extract</to_name>
		<to_code>1309394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anifrolumab-fnia</to_name>
		<to_code>2565276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ancrod</to_name>
		<to_code>772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl .alpha.-ionone</to_name>
		<to_code>2396431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acoramidis hydrochloride</to_name>
		<to_code>2698313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia umbelliformis whole extract</to_name>
		<to_code>1539423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ailanthus altissima bark extract</to_name>
		<to_code>2200073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctium lappa root oil</to_name>
		<to_code>1866039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adrafinil</to_name>
		<to_code>45938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony arsenate</to_name>
		<to_code>1313314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acmella oleracea flowering top extract</to_name>
		<to_code>1547712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic rock crab preparation</to_name>
		<to_code>1599642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anacystis nidulans</to_name>
		<to_code>2200639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-citronellal</to_name>
		<to_code>2472775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aripiprazole lauroxil</to_name>
		<to_code>1673265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetone</to_name>
		<to_code>178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avanafil</to_name>
		<to_code>1291301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum sulfate tetradecahydrate</to_name>
		<to_code>1306098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Akkermansia muciniphila</to_name>
		<to_code>2729260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum sulfate anhydrous</to_name>
		<to_code>1593147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl tocopheryl phosphate</to_name>
		<to_code>1427200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambroxol acefyllinate</to_name>
		<to_code>236595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetiamine hydrochloride</to_name>
		<to_code>236301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amyris balsamifera oil</to_name>
		<to_code>1305639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alarelin</to_name>
		<to_code>2641623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin,iodinated I-125 serum</to_name>
		<to_code>317177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium lauroyl sarcosinate</to_name>
		<to_code>1489759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha ionone</to_name>
		<to_code>1859172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin anhydrous</to_name>
		<to_code>1299904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antilymphocyte immunoglobulin</to_name>
		<to_code>973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia galanga whole extract</to_name>
		<to_code>1733796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aloe extract</to_name>
		<to_code>91263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple extract</to_name>
		<to_code>1424865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum dicetyl phosphate</to_name>
		<to_code>2045337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminocaproate</to_name>
		<to_code>113373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrisorcin</to_name>
		<to_code>89729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-bisabolol, (+-)-</to_name>
		<to_code>1306126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidic acid</to_name>
		<to_code>1716331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylmandelic acid, (+)-</to_name>
		<to_code>1430397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia catechu bark extract</to_name>
		<to_code>1547465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amoeba proteus</to_name>
		<to_code>1313311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amorolfine</to_name>
		<to_code>17804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azilsartan medoxomil</to_name>
		<to_code>1091642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alisma plantago-aquatica subsp. orientale root extract</to_name>
		<to_code>1372632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylocaine hydrochloride</to_name>
		<to_code>235793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica acutiloba root extract</to_name>
		<to_code>1309200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amitriptyline oxide</to_name>
		<to_code>236734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anigozanthos flavidus flowering top extract</to_name>
		<to_code>2621642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum stearate</to_name>
		<to_code>46243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid red 337</to_name>
		<to_code>2621122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alanine, DL-</to_name>
		<to_code>1546161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetoin</to_name>
		<to_code>2683094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus hybridus leaf extract</to_name>
		<to_code>2590597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspartate</to_name>
		<to_code>42543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aconitine</to_name>
		<to_code>1441664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica flowers extract</to_name>
		<to_code>283674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acorus calamus extract</to_name>
		<to_code>1310280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammoniac</to_name>
		<to_code>1314236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arum maculatum root extract</to_name>
		<to_code>1309789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anthemis arvensis flowering top extract</to_name>
		<to_code>1995251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl hexanoate</to_name>
		<to_code>1807113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>17300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin</to_name>
		<to_code>18631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alloin</to_name>
		<to_code>17354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe vera preparation</to_name>
		<to_code>318340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica sinensis preparation</to_name>
		<to_code>328141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl carboxymethyl cocoyl glycine</to_name>
		<to_code>1313222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-asarone</to_name>
		<to_code>2375532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiloride hydrochloride, anhydrous</to_name>
		<to_code>1298837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous zinc acetate</to_name>
		<to_code>1299637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alatrofloxacin mesylate</to_name>
		<to_code>221054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alginic acid</to_name>
		<to_code>17305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambroxol hydrochloride</to_name>
		<to_code>438399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asparagus adscendens root extract</to_name>
		<to_code>1483729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprotinin</to_name>
		<to_code>1056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albiglutide</to_name>
		<to_code>1534763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisyl acetate</to_name>
		<to_code>2605801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amsacrine</to_name>
		<to_code>739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afatinib dimaleate</to_name>
		<to_code>1430441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple pectin</to_name>
		<to_code>283540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-allyl-2,6-dimethoxyphenol</to_name>
		<to_code>1423781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpine strawberry extract</to_name>
		<to_code>1328308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allogenic bone-marrow-derived mesenchymal stem cells</to_name>
		<to_code>2700761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcholine</to_name>
		<to_code>194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azlocillin sodium</to_name>
		<to_code>203836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aliskiren</to_name>
		<to_code>325646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminolevulinic acid hydrochloride</to_name>
		<to_code>261715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia tridentata top oil</to_name>
		<to_code>1546863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arundinaria gigantea whole extract</to_name>
		<to_code>2632731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ado-trastuzumab emtansine</to_name>
		<to_code>1371041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia capillaris whole extract</to_name>
		<to_code>2570731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine hydrochloride</to_name>
		<to_code>89918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asclepias incarnata root extract</to_name>
		<to_code>2102724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>air</to_name>
		<to_code>411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ADAMTS13, recombinant</to_name>
		<to_code>2670285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argania spinosa seed extract</to_name>
		<to_code>1435100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acefylline methylsilanol mannuronate</to_name>
		<to_code>2560400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-damascone</to_name>
		<to_code>2398332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctostaphylos uva-ursi leaf extract</to_name>
		<to_code>1306212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amodiaquine</to_name>
		<to_code>720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anastatica hierochuntica whole extract</to_name>
		<to_code>2583869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine amide</to_name>
		<to_code>1591923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aconitate</to_name>
		<to_code>1721299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amivantamab-vmjw</to_name>
		<to_code>2549198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alstonia scholaris bark extract</to_name>
		<to_code>1673122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asimina triloba whole extract</to_name>
		<to_code>2534453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceglutamide aluminum</to_name>
		<to_code>1426378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amlodipine besylate</to_name>
		<to_code>104416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetazolamide</to_name>
		<to_code>167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arnatto leaf extract</to_name>
		<to_code>1659194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica montana extract</to_name>
		<to_code>285208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ageratina herbacea whole extract</to_name>
		<to_code>2630719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>andexanet alfa</to_name>
		<to_code>2045114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine ferulate</to_name>
		<to_code>2107305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>activated charcoal</to_name>
		<to_code>272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atractylodes macrocephala whole extract</to_name>
		<to_code>2263062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antazoline hydrochloride</to_name>
		<to_code>81954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alogliptin benzoate</to_name>
		<to_code>1368000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amaranth dye</to_name>
		<to_code>1433189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-adaz</to_name>
		<to_code>2641642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argeratina aromatica root extract</to_name>
		<to_code>1315107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aronia melanocarpa fruit extract</to_name>
		<to_code>1311541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony potassium tartrate</to_name>
		<to_code>981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alternaria alternata allergenic extract</to_name>
		<to_code>901845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer negundo wood extract</to_name>
		<to_code>2121052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl hexapeptide-8</to_name>
		<to_code>1314329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrostemma githago seed extract</to_name>
		<to_code>1428414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atoltivimab-ebgn</to_name>
		<to_code>2461430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus flavus allergenic extract</to_name>
		<to_code>999384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum sodium silicate</to_name>
		<to_code>1427203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adrenalone</to_name>
		<to_code>17073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium laureth-7 sulfate</to_name>
		<to_code>2059294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia senegal whole extract</to_name>
		<to_code>1989248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus manihot flower extract</to_name>
		<to_code>1739231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(3-aminopropyl)diethanolamine</to_name>
		<to_code>2371035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allergenic extract, false ragweed pollen</to_name>
		<to_code>314365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>altretamine</to_name>
		<to_code>5296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angostura bark extract</to_name>
		<to_code>1322552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetic acid C-11</to_name>
		<to_code>2550706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acorus gramineus root extract</to_name>
		<to_code>1306197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus repens allergenic extract</to_name>
		<to_code>1006310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-acetoxy-3-pentyltetrahydropyran</to_name>
		<to_code>2589802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctium lappa whole extract</to_name>
		<to_code>1312542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albutrepenonacog alfa</to_name>
		<to_code>1743992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetone sodium bisulfite</to_name>
		<to_code>1364858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alglucerase</to_name>
		<to_code>46049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylopectin</to_name>
		<to_code>1368128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetic monoethanolamide</to_name>
		<to_code>1311639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-aminomethylbenzoic acid</to_name>
		<to_code>14852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acebutolol</to_name>
		<to_code>149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alcuronium</to_name>
		<to_code>460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acesulfame potassium</to_name>
		<to_code>1310545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aralia chinensis whole extract</to_name>
		<to_code>1746485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alseroxylon</to_name>
		<to_code>599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axatilimab-csfr</to_name>
		<to_code>2691528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acmella oleracea whole extract</to_name>
		<to_code>1546861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aducanumab</to_name>
		<to_code>2557217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Androctonus australis whole extract</to_name>
		<to_code>2002063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anazolene acid</to_name>
		<to_code>1440972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ansuvimab-zykl</to_name>
		<to_code>2472151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus hippocastanum flower extract</to_name>
		<to_code>1309497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acalypha indica extract</to_name>
		<to_code>1441294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminosalicylic acid</to_name>
		<to_code>7833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agaric acid</to_name>
		<to_code>1441428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azlocillin</to_name>
		<to_code>1266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axitinib</to_name>
		<to_code>1242999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-aacf</to_name>
		<to_code>2640849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium picrate</to_name>
		<to_code>1859364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia vulgaris root extract</to_name>
		<to_code>1341384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprenolol hydrochloride</to_name>
		<to_code>81947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ardisia gigantifolia root extract</to_name>
		<to_code>2634530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetohydroxamic acid</to_name>
		<to_code>16728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-lactose</to_name>
		<to_code>2359362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparagus cochinchinesis tuber extract</to_name>
		<to_code>1307675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amitriptyline pamoate</to_name>
		<to_code>235737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American aloe stem extract</to_name>
		<to_code>1601988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylamidopropyltrimonium chloride/acrylamide copolymer (400 MPA.S)</to_name>
		<to_code>1735030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-D-galactosidase enzyme</to_name>
		<to_code>259351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avutometinib</to_name>
		<to_code>2714515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apomorphine</to_name>
		<to_code>1043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopromazine</to_name>
		<to_code>2462496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allo-2-hydroxycitric acid</to_name>
		<to_code>2369353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony</to_name>
		<to_code>1311407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amlodipine benzoate</to_name>
		<to_code>2184116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abametapir</to_name>
		<to_code>2475532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium thiocyanate</to_name>
		<to_code>2109607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-acetylanisole</to_name>
		<to_code>2612428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atractylodes lancea root extract</to_name>
		<to_code>1307719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-ethyl-3,4-methylenedioxybenzylamine</to_name>
		<to_code>2698077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-anisic acid</to_name>
		<to_code>1426595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allylthiourea</to_name>
		<to_code>1318494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidonate</to_name>
		<to_code>1368625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia pollen extract</to_name>
		<to_code>851732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus glutinosa bark extract</to_name>
		<to_code>1441543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asiaticoside</to_name>
		<to_code>18405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acyclovir sodium</to_name>
		<to_code>81944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer saccharum bark-sap extract</to_name>
		<to_code>1309406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe emodin</to_name>
		<to_code>2561527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl pentaerythritol</to_name>
		<to_code>2003177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alendronic acid</to_name>
		<to_code>236083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin,iodinated I-131 serum</to_name>
		<to_code>314301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica biserrata root extract</to_name>
		<to_code>1366320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-terpinyl acetate, (-)-</to_name>
		<to_code>2398336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agathosma crenulata leaf extract</to_name>
		<to_code>2048881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus niger allergenic extract</to_name>
		<to_code>1742530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adefovir</to_name>
		<to_code>16521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acamprosate calcium</to_name>
		<to_code>152761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adiantum capillus-veneris leaf extract</to_name>
		<to_code>1649017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrimonia eupatoria flowering top extract</to_name>
		<to_code>1309504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia baileyana pollen extract</to_name>
		<to_code>895223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies alba leaf oil</to_name>
		<to_code>1549633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopentamide</to_name>
		<to_code>1006397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl lactoside</to_name>
		<to_code>2268052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple cider</to_name>
		<to_code>2593711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>all-trans-retinol</to_name>
		<to_code>1367187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aronia melanocarpa fruit juice</to_name>
		<to_code>1311549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adansonia digitata fruit extract</to_name>
		<to_code>1424863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetamine saccharate</to_name>
		<to_code>540810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid red 1</to_name>
		<to_code>1863219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antazoline phosphate</to_name>
		<to_code>866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atrasentan hydrochloride</to_name>
		<to_code>2710448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acepromazine</to_name>
		<to_code>155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisacril</to_name>
		<to_code>1311637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia absinthium whole extract</to_name>
		<to_code>2166649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic cation</to_name>
		<to_code>1485046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amilomer</to_name>
		<to_code>259399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amifampridine phosphate</to_name>
		<to_code>2106337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydrate</to_name>
		<to_code>1305556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-acetoxy-1, 8-cineole, (+)-endo-</to_name>
		<to_code>2386028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspergillopepsin I (Aspergillus phoenicis)</to_name>
		<to_code>2593717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aconite</to_name>
		<to_code>242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asenapine maleate</to_name>
		<to_code>860647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apixaban</to_name>
		<to_code>1364430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica archangelica whole extract</to_name>
		<to_code>2533831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ambrosia psilostachya top extract</to_name>
		<to_code>1368328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(2-aminoethoxy)ethanol</to_name>
		<to_code>1737111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abatacept</to_name>
		<to_code>614391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic triiodide</to_name>
		<to_code>1309691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aldesleukin</to_name>
		<to_code>70223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actinidia chinensis seed extract</to_name>
		<to_code>1307842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aji pepper extract</to_name>
		<to_code>1311143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alglucosidase alfa</to_name>
		<to_code>629565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceglutamide</to_name>
		<to_code>1426379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave americana whole extract</to_name>
		<to_code>1996979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica cordifolia flower extract</to_name>
		<to_code>1307964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctium minus root extract</to_name>
		<to_code>1996103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alclometasone</to_name>
		<to_code>108088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica montana root extract</to_name>
		<to_code>1309947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>attapulgite</to_name>
		<to_code>18516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amyl salicylate</to_name>
		<to_code>236149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adrenalone hydrochloride</to_name>
		<to_code>236364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium ferrous sulfate</to_name>
		<to_code>17784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aducanumab-avwa</to_name>
		<to_code>2557218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ahnfeltiopsis concinna extract</to_name>
		<to_code>1328285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3A,4,5,6,7,7A-hexahydro-1H-4,7-methanoinden-6-yl acetate</to_name>
		<to_code>2467276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambroxol</to_name>
		<to_code>625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid black 52</to_name>
		<to_code>1435106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia tridentata whole extract</to_name>
		<to_code>2533833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopheryloxyacetic acid</to_name>
		<to_code>1995481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctium lappa fruit oil</to_name>
		<to_code>1541708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achyranthes japonica whole extract</to_name>
		<to_code>1314262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acmella oleracea flower extract</to_name>
		<to_code>1307610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopyrine</to_name>
		<to_code>695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminolevulinic acid</to_name>
		<to_code>683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica anomala whole extract</to_name>
		<to_code>1991256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American elm pollen extract</to_name>
		<to_code>852054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atriplex polycarpa whole extract</to_name>
		<to_code>2590599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenovirus type 7 vaccine live</to_name>
		<to_code>1099937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allantoin glycyrrhetinic acid</to_name>
		<to_code>1862870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achillea ptarmica whole extract</to_name>
		<to_code>2375523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium molybdate</to_name>
		<to_code>17789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azathioprine</to_name>
		<to_code>1256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azilsartan</to_name>
		<to_code>1091643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>androstenedione</to_name>
		<to_code>784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atazanavir sulfate</to_name>
		<to_code>358299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abciximab</to_name>
		<to_code>83929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrimonia pilosa whole extract</to_name>
		<to_code>1547466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus exscapus whole flowering-fruiting extract</to_name>
		<to_code>1605083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atipamezole hydrochloridde</to_name>
		<to_code>2123357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avobenzone</to_name>
		<to_code>45045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus caudatus seed extract</to_name>
		<to_code>1307690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum zirconium octachlorohydrex gly</to_name>
		<to_code>1306096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acemannan</to_name>
		<to_code>1426875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amifampridine</to_name>
		<to_code>2106338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alibendol</to_name>
		<to_code>236219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspidosperma quebracho-blanco root extract</to_name>
		<to_code>2591796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminophylline dihydrate</to_name>
		<to_code>1298965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argemone mexicana extract</to_name>
		<to_code>1537756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amomum villosum var. xanthioides whole extract</to_name>
		<to_code>1535473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Azadirachta indica seed oil</to_name>
		<to_code>1305648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous liquid lanolin</to_name>
		<to_code>1305544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afoxolaner</to_name>
		<to_code>1442093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amomum subulatum fruit extract</to_name>
		<to_code>2687236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-isomethylionyl acetate, (2S)-(+)-</to_name>
		<to_code>2727158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica sinensis whole extract</to_name>
		<to_code>1370729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amikacin</to_name>
		<to_code>641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apalutamide</to_name>
		<to_code>1999574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ambrosia peruviana leaf extract</to_name>
		<to_code>1307757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylic acid-sodium acrylate copolymer (1:1; 600 MPA.S at 0.2%)</to_name>
		<to_code>1429914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic mackerel allergenic extract</to_name>
		<to_code>2198984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, human recombinant</to_name>
		<to_code>1300486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alphaprodine</to_name>
		<to_code>594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia angustissima bark extract</to_name>
		<to_code>1370191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium benzoate</to_name>
		<to_code>1312540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acorus calamus root extract</to_name>
		<to_code>1309395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum chlorohydrate anhydrous</to_name>
		<to_code>2102410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>armodafinil</to_name>
		<to_code>641465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopropyl ascorbyl phosphate</to_name>
		<to_code>1307558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia galanga leaf extract</to_name>
		<to_code>1309959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agaricus subrufescens extract</to_name>
		<to_code>1655977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alcaftadine</to_name>
		<to_code>1000082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allogeneic processed thymus tissue</to_name>
		<to_code>2626460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminoglutethimide</to_name>
		<to_code>677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amitriptyline hydrochloride</to_name>
		<to_code>203168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-eleostearic acid</to_name>
		<to_code>2630219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetamidopropyl trimonium</to_name>
		<to_code>1483778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum cation</to_name>
		<to_code>1546162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcholine chloride</to_name>
		<to_code>20814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adansonia digitata leaf extract</to_name>
		<to_code>1428848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol succinate</to_name>
		<to_code>39626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspartame acesulfame</to_name>
		<to_code>1371304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abaloparatide</to_name>
		<to_code>1921069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5.alpha.-hydroxy laxogenin</to_name>
		<to_code>1801703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium laureth-2 sulfate</to_name>
		<to_code>1307565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(all-Z)-4,7,10,13,16-docosapentaenoic acid</to_name>
		<to_code>1360626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfalfa pollen extract</to_name>
		<to_code>852634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspartate magnesium hydrochloride</to_name>
		<to_code>1167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-azetidinecarboxylic acid, (+)-</to_name>
		<to_code>2397715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aliskiren hemifumarate</to_name>
		<to_code>732498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-(.alpha.-aminopropyl)benzyl alcohol</to_name>
		<to_code>1654972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almond allergenic extract</to_name>
		<to_code>892507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ajuga turkestanica top extract</to_name>
		<to_code>1307592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-fkjp</to_name>
		<to_code>2640402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenite ion</to_name>
		<to_code>1546382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine zinc</to_name>
		<to_code>1490795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfuzosin hydrochloride</to_name>
		<to_code>46043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopropyl dihydrogen phosphate</to_name>
		<to_code>1367492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arisaema dracontium root extract</to_name>
		<to_code>1313734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ABT-925</to_name>
		<to_code>1661017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia capillaris leaf extract</to_name>
		<to_code>2390758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amidoline</to_name>
		<to_code>17684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aleurites moluccanus whole extract</to_name>
		<to_code>2287547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adrenocorticotropin (ACTH 1-18),I-125 (TYR)</to_name>
		<to_code>314298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica gigas root oil</to_name>
		<to_code>1541881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avibactam</to_name>
		<to_code>1603834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminopterin</to_name>
		<to_code>1440264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>auranofin</to_name>
		<to_code>1227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium ion</to_name>
		<to_code>1313310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid yellow 1</to_name>
		<to_code>2465831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Armadillidium vulgare whole extract</to_name>
		<to_code>2531930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept-boav</to_name>
		<to_code>2725885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alteplase</to_name>
		<to_code>8410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylate/butylaminoethyl methacrylate/methyl acrylate/methyl methacrylate/octylacrylamide copolymer (40000 WAMW)</to_name>
		<to_code>2695992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alchemilla xanthochlora whole extract</to_name>
		<to_code>2107417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alternanthera sessilis extract</to_name>
		<to_code>1788870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-(.alpha.-aminopropyl)benzyl alcohol hydrochloride, erythro-(+/-)-</to_name>
		<to_code>1812466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminobutyric acid</to_name>
		<to_code>70582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-aqvh</to_name>
		<to_code>2640387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum sesquichlorohydrate</to_name>
		<to_code>543375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aquilegia vulgaris extract</to_name>
		<to_code>1320411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe andongensis leaf extract</to_name>
		<to_code>1420957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allobarbital</to_name>
		<to_code>516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atropine sulfate</to_name>
		<to_code>153971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprostadil isopropyl ester</to_name>
		<to_code>1813427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparaginase</to_name>
		<to_code>1156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisate</to_name>
		<to_code>1370666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acoltremon</to_name>
		<to_code>2716801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-(((2-(2-amino-3-hydroxy-2-(hydroxymethyl)propoxy)-1-hydroxypropyl)hydroxyphosphoryl)oxy)-1-hydroxypropyl)phosphonic acid</to_name>
		<to_code>2380375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium acryloyldimethyltaurate</to_name>
		<to_code>1305559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1.alpha.,24S-dihydroxyvitamin D2</to_name>
		<to_code>1536458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha,alpha-dibromo-d-camphor</to_name>
		<to_code>1858362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ainsliaea fragrans top extract</to_name>
		<to_code>1552574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atrasentan</to_name>
		<to_code>2710449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ancestim</to_name>
		<to_code>140502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Azadirachta indica seed extract</to_name>
		<to_code>1442504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl cyclohexanebutyrate</to_name>
		<to_code>2584843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amanita muscaria extract</to_name>
		<to_code>1311039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.N-(methoxycarbonyl)-L-arginine</to_name>
		<to_code>2272971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl methacrylate-glycol dimethacrylate crosspolymer</to_name>
		<to_code>1747570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azacitidine</to_name>
		<to_code>1251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbate manganese</to_name>
		<to_code>1144960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anthraquinone glycoside</to_name>
		<to_code>283538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atractylodes lancea whole extract</to_name>
		<to_code>2263061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcholinesterase</to_name>
		<to_code>195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arbekacin sulfate</to_name>
		<to_code>237044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum pendulum root extract</to_name>
		<to_code>2683196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abrus precatorius whole extract</to_name>
		<to_code>2180253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aniba rosaeodora whole extract</to_name>
		<to_code>2539792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl hexamethyl tetralin</to_name>
		<to_code>2289007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antioxidant 119</to_name>
		<to_code>1489543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aquilaria sinensis wood extract</to_name>
		<to_code>2106559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum potassium sulfate</to_name>
		<to_code>54989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ALV-001</to_name>
		<to_code>2540430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atropa belladonna flowering top extract</to_name>
		<to_code>1811764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-aminobenzoic acid</to_name>
		<to_code>74</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylopectin (4,5-dihydroxy-1,3-dimethylimdazolidin-2-one cross linked)</to_name>
		<to_code>2634494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus niger var. niger extract</to_name>
		<to_code>854082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-lactalbumin (bovine)</to_name>
		<to_code>2621574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyltributyl citrate</to_name>
		<to_code>1362881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl isostearate</to_name>
		<to_code>2106325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avatrombopag</to_name>
		<to_code>2045726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum carmichaeli whole extract</to_name>
		<to_code>2695417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetamide</to_name>
		<to_code>2475952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiloride hydrochloride</to_name>
		<to_code>142424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astacus crayfish whole extract</to_name>
		<to_code>2180412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-amylase A type 1-2</to_name>
		<to_code>1306125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anacaulase</to_name>
		<to_code>2626723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin B colloidal dispersion</to_name>
		<to_code>101299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidonic acid</to_name>
		<to_code>1368624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl hexapeptide-1</to_name>
		<to_code>2588845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agropyron fragile whole extract</to_name>
		<to_code>1492182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple peel extract</to_name>
		<to_code>2625124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydroxide</to_name>
		<to_code>612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat</to_name>
		<to_code>2626470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azidocillin</to_name>
		<to_code>18609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anacyclus pyrethrum root extract</to_name>
		<to_code>1309397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha tocopherol</to_name>
		<to_code>237099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ailanthus altissima whole extract</to_name>
		<to_code>1809829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avapritinib</to_name>
		<to_code>2272107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylene</to_name>
		<to_code>200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alteromonas macleodii</to_name>
		<to_code>1551569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfalfa seed extract</to_name>
		<to_code>1306199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum acetotartrate</to_name>
		<to_code>46239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous calcium iodide</to_name>
		<to_code>214236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avacopan</to_name>
		<to_code>2572100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum tristearate</to_name>
		<to_code>1363698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl methacrylate-glycol dimethacrylate crosspolymer (low allyl methacrylate)</to_name>
		<to_code>1790180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afatinib</to_name>
		<to_code>1430438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica root oil</to_name>
		<to_code>1305640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha hydroxy acids</to_name>
		<to_code>236797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Annickia chlorantha bark extract</to_name>
		<to_code>1307648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ampicillin (anhydrous)</to_name>
		<to_code>221058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>angiotensin II acetate, human</to_name>
		<to_code>2204740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(-)-ambroxide</to_name>
		<to_code>2557381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apigenin</to_name>
		<to_code>1368130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-methylbenzyl acetate</to_name>
		<to_code>2374917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aficamten</to_name>
		<to_code>2731469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alverine citrate</to_name>
		<to_code>71767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminosalicylic sodium</to_name>
		<to_code>89753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylglucosamine</to_name>
		<to_code>1362871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alcohol, x-ray exposed (1000 rad)</to_name>
		<to_code>1368126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>angelicin</to_name>
		<to_code>2690789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argatroban</to_name>
		<to_code>15202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminoethylphosphinic acid</to_name>
		<to_code>1540525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspen pollen extract</to_name>
		<to_code>852339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arbutin</to_name>
		<to_code>1367175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antazoline sulfate</to_name>
		<to_code>2680384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>astemizole</to_name>
		<to_code>42328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asclepias quadrifolia whole extract</to_name>
		<to_code>1314267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aletris farinosa root extract</to_name>
		<to_code>1309950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha 1-proteinase inhibitor, human</to_name>
		<to_code>991743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium hypophosphite</to_name>
		<to_code>2360135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avibactam sodium</to_name>
		<to_code>1603833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acexamic acid</to_name>
		<to_code>15978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia capillaris flower extract</to_name>
		<to_code>1307554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amyl cinnamal</to_name>
		<to_code>1311606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argemone mexicana whole extract</to_name>
		<to_code>1442191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetate</to_name>
		<to_code>164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ananas comosus whole extract</to_name>
		<to_code>2284291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe arborescens leaf extract</to_name>
		<to_code>1422928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetophenone</to_name>
		<to_code>2467143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica pubescens root extract</to_name>
		<to_code>1307573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anaerococcus tetradius</to_name>
		<to_code>1592903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actaea dahurica root extract</to_name>
		<to_code>1657850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica gigas whole extract</to_name>
		<to_code>2287730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atracurium besylate</to_name>
		<to_code>1219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asclepias tuberosa flowering top extract</to_name>
		<to_code>1309805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus hypochondriacus whole extract</to_name>
		<to_code>1539422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>astaxanthin</to_name>
		<to_code>18451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminaphthone</to_name>
		<to_code>46276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aloe vera flower extract</to_name>
		<to_code>1309199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony cation (3+)</to_name>
		<to_code>1546167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ABCB4 protein, human</to_name>
		<to_code>2117853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apis cerana whole preparation</to_name>
		<to_code>1545170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ampelopsis delavayana root extract</to_name>
		<to_code>2665623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-amino-2-methyl-1-propanol</to_name>
		<to_code>1310544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Albizia julibrissin bark extract</to_name>
		<to_code>1307572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amivantamab-lpuj</to_name>
		<to_code>2729288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anemone americana extract</to_name>
		<to_code>1311411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylated sucrose distearate</to_name>
		<to_code>1427064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylic acid/2-ethylhexyl acrylate/styrene copolymer (500000 MW)</to_name>
		<to_code>2361309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceclofenac</to_name>
		<to_code>16689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abacavir</to_name>
		<to_code>190521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica polymorpha root extract</to_name>
		<to_code>1648927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium lauryl sulfate</to_name>
		<to_code>1424667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparagine monohydrate</to_name>
		<to_code>1666924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic halibut preparation</to_name>
		<to_code>2174524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl sulfisoxazole</to_name>
		<to_code>40595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia abrotanum flowering top extract</to_name>
		<to_code>1336267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine pyroglutamate</to_name>
		<to_code>1482633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achillea millefolium seed extract</to_name>
		<to_code>2592615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus moschatus flower extract</to_name>
		<to_code>2263153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisotropine</to_name>
		<to_code>89780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-isomethylionone</to_name>
		<to_code>1368186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amanita phalloides whole extract</to_name>
		<to_code>1441299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine aspartate</to_name>
		<to_code>18254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alcloxa</to_name>
		<to_code>1305554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acebutolol hydrochloride</to_name>
		<to_code>142130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus viridis leaf extract</to_name>
		<to_code>1357999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avalglucosidase alfa</to_name>
		<to_code>2565814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ardisia gigantifolia whole extract</to_name>
		<to_code>2610398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achyrocline satureioides extract</to_name>
		<to_code>1318236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ancylostoma caninum</to_name>
		<to_code>2469251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atropa belladonna whole extract</to_name>
		<to_code>1363430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alum, potassium anhydrous</to_name>
		<to_code>1363564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Azadirachta indica flower extract</to_name>
		<to_code>1307952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisum extract</to_name>
		<to_code>1320407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl heptanoate</to_name>
		<to_code>2383533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acacia decurrens flower extract</to_name>
		<to_code>1791834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyltriethyl citrate</to_name>
		<to_code>1311603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe africana leaf extract</to_name>
		<to_code>2675984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anise seed extract</to_name>
		<to_code>1309292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydroxyide-glycine (2:1)</to_name>
		<to_code>1371308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atorvastatin calcium propylene glycol solvate</to_name>
		<to_code>1483793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alum, potassium</to_name>
		<to_code>221456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetophenazine maleate</to_name>
		<to_code>91127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adipic acid-diglycol crosspolymer (20000 MPA.S)</to_name>
		<to_code>1605702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alclometasone dipropionate</to_name>
		<to_code>17268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum sulfate</to_name>
		<to_code>17621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminacrine</to_name>
		<to_code>645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus mongholicus root extract</to_name>
		<to_code>2001494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amcinonide</to_name>
		<to_code>17652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrimonia eupatoria flower extract</to_name>
		<to_code>1309501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium cocoyl isethionate</to_name>
		<to_code>1426647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apis mellifera ven protein</to_name>
		<to_code>259525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium sulfate</to_name>
		<to_code>1362695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Albuca bracteata whole extract</to_name>
		<to_code>2002576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum sulfate octadecahydrate</to_name>
		<to_code>2178309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonio methacrylate copolymer type B</to_name>
		<to_code>1306198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alexitol</to_name>
		<to_code>644634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus niger preparation</to_name>
		<to_code>350312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydroxide sulfate (Al(OH)(SO4))</to_name>
		<to_code>1806902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acellular pertussis vaccine, inactivated</to_name>
		<to_code>798302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica acutiloba root oil</to_name>
		<to_code>1371908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylase</to_name>
		<to_code>743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American plum fruit extract</to_name>
		<to_code>1737115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alvimopan</to_name>
		<to_code>480639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus serrulata pollen extract</to_name>
		<to_code>2043275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-glucan oligosaccharide</to_name>
		<to_code>1424647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcellulose</to_name>
		<to_code>1425216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atoltivimab</to_name>
		<to_code>2461338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave tequilana juice</to_name>
		<to_code>2122086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisyl alcohol</to_name>
		<to_code>1424668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>17-alpha-hydroxyprogesterone</to_name>
		<to_code>5542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum chlorohydrex propylene glycol</to_name>
		<to_code>1313224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alcea rosea root extract</to_name>
		<to_code>1799146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-terpinyl acetate, (+/-)-</to_name>
		<to_code>2261734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave tequilana top extract</to_name>
		<to_code>1441296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allspice oil</to_name>
		<to_code>2373647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azaperone</to_name>
		<to_code>2601502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum magnesium silicate</to_name>
		<to_code>17614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia princeps leaf extract</to_name>
		<to_code>1309411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbic acid</to_name>
		<to_code>1151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aloxiprin</to_name>
		<to_code>17393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic salmon oil</to_name>
		<to_code>2644110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherylquinone</to_name>
		<to_code>1376149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-phellandrene</to_name>
		<to_code>2530131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arbutus andrachne leafy shoot extract</to_name>
		<to_code>1859365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenosine triphosphate disodium</to_name>
		<to_code>1306127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept-mrbb</to_name>
		<to_code>2706479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allantoin calcium pantothenate</to_name>
		<to_code>2045944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidate</to_name>
		<to_code>1716332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afamitresgene autoleucel</to_name>
		<to_code>2690256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adiastatic barley malt extract</to_name>
		<to_code>221053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcarnitine hydrochloride</to_name>
		<to_code>476316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl cyclohexanepropionate</to_name>
		<to_code>2383931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-amylcinnamaldehyde dimethyl acetal</to_name>
		<to_code>2384440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus amstelodami extract</to_name>
		<to_code>2101007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus carnea whole extract</to_name>
		<to_code>1801064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>12-(9-anthroyloxy)stearic acid</to_name>
		<to_code>1922739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica sinensis root extract</to_name>
		<to_code>1307866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-bisabolol, (-)-EPI-</to_name>
		<to_code>2118535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atidarsagene autotemcel</to_name>
		<to_code>2677916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amniotic fluid (bovine)</to_name>
		<to_code>1368127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony pentasulfide</to_name>
		<to_code>1337969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetanilide</to_name>
		<to_code>162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atorvastatin calcium trihydrate</to_name>
		<to_code>1297766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiloxate</to_name>
		<to_code>1426854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alcaligenes faecalis</to_name>
		<to_code>1316425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin,microsphere human serum</to_name>
		<to_code>314302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxapine</to_name>
		<to_code>722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adzuki bean extract</to_name>
		<to_code>1735031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agastache rugosa whole extract</to_name>
		<to_code>2539293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprindine hydrochloride</to_name>
		<to_code>236158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achyranthes bidentata whole extract</to_name>
		<to_code>2569976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.,.beta.-methylene adenosine 5'-diphosphate</to_name>
		<to_code>2552302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almitrine</to_name>
		<to_code>528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afamelanotide acetate</to_name>
		<to_code>2278002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic tribromide</to_name>
		<to_code>1313315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid blue 80</to_name>
		<to_code>2563676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine glutamate</to_name>
		<to_code>114464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ampicillin</to_name>
		<to_code>733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amifostine anhydrous</to_name>
		<to_code>1545987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amikacin sulfate</to_name>
		<to_code>643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ampicillin sodium</to_name>
		<to_code>81953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alendronate</to_name>
		<to_code>46041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>articaine</to_name>
		<to_code>592464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl decapeptide-3</to_name>
		<to_code>1992055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylic acid/isophorone diisocyanate/PEG-27 copolymer</to_name>
		<to_code>1649132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Azadirachta indica leaf extract</to_name>
		<to_code>1307640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl amyl glycolate</to_name>
		<to_code>2566287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-aminophenol</to_name>
		<to_code>1435285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspidosperma quebracho-blanco bark extract</to_name>
		<to_code>1309812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium fistulosum whoe extract</to_name>
		<to_code>1812762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-ryvk</to_name>
		<to_code>2677776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic halibut preparation</to_name>
		<to_code>1424920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alefacept</to_name>
		<to_code>299635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agastache urticifolia whole extract</to_name>
		<to_code>2533830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anthoxanthum odoratum antigen</to_name>
		<to_code>465168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>althiazide</to_name>
		<to_code>17599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acipimox</to_name>
		<to_code>16817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atezolizumab</to_name>
		<to_code>1792776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alum, ammonium anhydrous</to_name>
		<to_code>2101716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparagine</to_name>
		<to_code>1157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anagrelide hydrochloride</to_name>
		<to_code>236612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium salicylate</to_name>
		<to_code>236220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous dextrose</to_name>
		<to_code>349730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin B liposomal</to_name>
		<to_code>236594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azilsartan kamedoxomil</to_name>
		<to_code>1294597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asparagus cochinchinensis whole extract</to_name>
		<to_code>2001179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia senegal flower extract</to_name>
		<to_code>1484143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Areca catechu seed extract</to_name>
		<to_code>2591405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl trifluoromethylphenyl valylglycine, DL-</to_name>
		<to_code>1922906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aclidinium bromide</to_name>
		<to_code>1303097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus gummifer root extract</to_name>
		<to_code>2256948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acamprosate</to_name>
		<to_code>82819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-bwwd</to_name>
		<to_code>2612153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Albatrellus confluens fruiting body extract</to_name>
		<to_code>2603280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aniline</to_name>
		<to_code>1441546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Avena sativa whole extract</to_name>
		<to_code>1314244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alginate</to_name>
		<to_code>1370451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atropine</to_name>
		<to_code>1223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-ionene</to_name>
		<to_code>2572112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambroxol-theophylline-7-acetate</to_name>
		<to_code>186010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asclepias tuberosa root extract</to_name>
		<to_code>1309413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Althaea officinalis whole extract</to_name>
		<to_code>1428412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminometradine</to_name>
		<to_code>1440266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allura red AC dye</to_name>
		<to_code>1310600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept</to_name>
		<to_code>1232150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus terreus allergenic extract</to_name>
		<to_code>314324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus propinquus root polysaccharides</to_name>
		<to_code>2532931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave tequilana inulin</to_name>
		<to_code>2714500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe ferox leaf preparation</to_name>
		<to_code>1309503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid orange 20</to_name>
		<to_code>2375722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actinidia chinensis root extract</to_name>
		<to_code>1363985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azathioprine sodium</to_name>
		<to_code>267476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphotericin</to_name>
		<to_code>42527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agathosma betulina leaf oil</to_name>
		<to_code>2108820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aphloia theiformis leaf extract</to_name>
		<to_code>1425901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid blue 25</to_name>
		<to_code>2178278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acecarbromal</to_name>
		<to_code>16688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum zirconium trichlorohydrex gly</to_name>
		<to_code>1370425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenine</to_name>
		<to_code>290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abiraterone acetate</to_name>
		<to_code>1100071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus terreus extract</to_name>
		<to_code>999408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amanita phalloides</to_name>
		<to_code>1858554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agar</to_name>
		<to_code>397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum lycoctonum extract</to_name>
		<to_code>1441295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>9,10-anthraquinone</to_name>
		<to_code>1482551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anileridine hydrochloride</to_name>
		<to_code>235413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminobutyrate</to_name>
		<to_code>618257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amezinium</to_name>
		<to_code>17665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl coenzyme A</to_name>
		<to_code>1490796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acer saccharum sap extract</to_name>
		<to_code>1372011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Argania spinosa whole extract</to_name>
		<to_code>1482541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum fluoride</to_name>
		<to_code>2273602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ailanthus altissima flowering twig extract</to_name>
		<to_code>1348450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atosiban acetate</to_name>
		<to_code>2680385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alitretinoin</to_name>
		<to_code>81864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum dilinoleate</to_name>
		<to_code>2121673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adina rubella root extract</to_name>
		<to_code>1746483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylated lanolin</to_name>
		<to_code>1789515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azosemide</to_name>
		<to_code>18651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asparagus allergenic extract</to_name>
		<to_code>891796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple seed extract</to_name>
		<to_code>1369395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ampelopsis glandulosa var. brevipedunculata fruit extract</to_name>
		<to_code>1746484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpelisib</to_name>
		<to_code>2169285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylate</to_name>
		<to_code>1364500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrostis gigantea top extract</to_name>
		<to_code>1310102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-amylcinnamyl alcohol</to_name>
		<to_code>1312537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alloxan</to_name>
		<to_code>2466730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfalfa top extract</to_name>
		<to_code>1668214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anagallis arvensis extract</to_name>
		<to_code>1336266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aclidinium</to_name>
		<to_code>1303098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atropa belladonna fruiting top extract</to_name>
		<to_code>1312380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple fruit oil</to_name>
		<to_code>1485785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astrocaryum vulgare kernel oil</to_name>
		<to_code>2465235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angophora costata whole extract</to_name>
		<to_code>2121070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic halibut allergenic extract</to_name>
		<to_code>2261370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amitraz</to_name>
		<to_code>17763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>artichoke allergenic extract</to_name>
		<to_code>891776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica pubescens whole extract</to_name>
		<to_code>1490681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum chloride</to_name>
		<to_code>46241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azeloyl diglycinate</to_name>
		<to_code>1370630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-cyclodextrin</to_name>
		<to_code>1362882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acitretin</to_name>
		<to_code>16818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus chinensis whole extract</to_name>
		<to_code>2621641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Atlantic cod allergenic extract</to_name>
		<to_code>900025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alanine</to_name>
		<to_code>426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agarum clathratum extract</to_name>
		<to_code>1331688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apiospora montagnei allergenic extract</to_name>
		<to_code>1006258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aclarubicin</to_name>
		<to_code>239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus hippocastanum leaf extract</to_name>
		<to_code>1309498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcarnitine hydrochloride, DL-</to_name>
		<to_code>1593400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anethole trithione</to_name>
		<to_code>820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid red 337 free acid</to_name>
		<to_code>2619779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylsalicylate sodium</to_name>
		<to_code>314293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artocarpus styracifolius root extract</to_name>
		<to_code>2610399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agaricus blazei whole extract</to_name>
		<to_code>2360132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avelumab</to_name>
		<to_code>1875534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia annua whole extract</to_name>
		<to_code>2001172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atracurium</to_name>
		<to_code>1218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azatadine</to_name>
		<to_code>18600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anidulafungin</to_name>
		<to_code>341018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia montana leaf extract</to_name>
		<to_code>1942696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agalsidase alfa</to_name>
		<to_code>2691830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antithrombin alfa</to_name>
		<to_code>1427179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arginine cocoate</to_name>
		<to_code>2386216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allantoin ascorbate</to_name>
		<to_code>2559842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-hexylcinnamaldehyde, (2E)-</to_name>
		<to_code>1747473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-aminobutan-2-ol</to_name>
		<to_code>2375706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antipyrine</to_name>
		<to_code>1001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium cepa whole extract</to_name>
		<to_code>1313308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acai extract</to_name>
		<to_code>824547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenovirus type 4 vaccine live</to_name>
		<to_code>1099933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achyranthes japonica root extract</to_name>
		<to_code>2585447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aphanamixis polystachya whole extract</to_name>
		<to_code>2711882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenosine</to_name>
		<to_code>296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave americana leaf extract</to_name>
		<to_code>1307838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-arbutin</to_name>
		<to_code>1363429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apiole</to_name>
		<to_code>314506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anistreplase</to_name>
		<to_code>40028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asenapine</to_name>
		<to_code>784649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arched swimming crab, cooked preparation</to_name>
		<to_code>1315108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia dracunculus whole extract</to_name>
		<to_code>1797516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adina rubella whole extract</to_name>
		<to_code>1747176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum europaeum extract</to_name>
		<to_code>1012890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylate/isobutyl methacrylate/N-tert-octylacrylamide copolymer (40000 MW)</to_name>
		<to_code>2642867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica seed extract</to_name>
		<to_code>1606330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anacaulase-bcdb</to_name>
		<to_code>2626722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avens extract</to_name>
		<to_code>1313319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium chloride</to_name>
		<to_code>712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amanita muscaria var. muscaria fruiting body extract</to_name>
		<to_code>1310111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprindine</to_name>
		<to_code>1054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenate</to_name>
		<to_code>1375924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abronia frangrans flower extract</to_name>
		<to_code>2000574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminomethyl propanediol</to_name>
		<to_code>1307680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum iodide</to_name>
		<to_code>2280603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydroxylitol</to_name>
		<to_code>1307762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceclidine hydrochloride</to_name>
		<to_code>2721767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum aspirin</to_name>
		<to_code>611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-terpineol</to_name>
		<to_code>1371307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfalfa preparation</to_name>
		<to_code>285243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceneuramate</to_name>
		<to_code>2613559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl salicylate</to_name>
		<to_code>91101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aristolochia cymbifera flower extract</to_name>
		<to_code>1858973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amonafide</to_name>
		<to_code>1440270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine</to_name>
		<to_code>197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminohydroxybutyric acid</to_name>
		<to_code>236512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arachidyl propionate</to_name>
		<to_code>1306211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Avicularia avicularia preparation</to_name>
		<to_code>1426667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amaranth acid</to_name>
		<to_code>1546381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol succinate, DL-</to_name>
		<to_code>2370134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus serrulata bark extract</to_name>
		<to_code>1428415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia absinthium extract</to_name>
		<to_code>1428850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atorvastatin calcium anhydrous</to_name>
		<to_code>2569977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>axatilimab</to_name>
		<to_code>2691526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allscale pollen extract</to_name>
		<to_code>897304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium phosphate</to_name>
		<to_code>17792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambrein</to_name>
		<to_code>2584842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anamirta cocculus whole extract</to_name>
		<to_code>1545038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica keiskei top extract</to_name>
		<to_code>1311538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl phosphate</to_name>
		<to_code>1370605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alatrofloxacin</to_name>
		<to_code>141440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium sativum whole extract</to_name>
		<to_code>1441536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amosulalol hydrochloride</to_name>
		<to_code>2667255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aniracetam</to_name>
		<to_code>17939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, porcine</to_name>
		<to_code>221060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica cordifolia whole extract</to_name>
		<to_code>2047350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amobarbital</to_name>
		<to_code>719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alnus glutinosa whole extract</to_name>
		<to_code>1999662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ascaris lumbricoides preparation</to_name>
		<to_code>1351898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceneuramic acid</to_name>
		<to_code>2613558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylopectin, corn</to_name>
		<to_code>2590757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium laurate</to_name>
		<to_code>1442516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetamine aspartate</to_name>
		<to_code>221057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aesculus carnea flower extract</to_name>
		<to_code>1309770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adagrasib</to_name>
		<to_code>2625882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azidocillin sodium</to_name>
		<to_code>236787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adiphenine</to_name>
		<to_code>333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-aminobutyrate</to_name>
		<to_code>2464937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia argyi whole extract</to_name>
		<to_code>2385106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achillea millefolium oil</to_name>
		<to_code>1740240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum bromide</to_name>
		<to_code>2272620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-glucoheptonic acid, magnesium salt (2:1)</to_name>
		<to_code>289497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>activated attapulgite</to_name>
		<to_code>133050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arbutamine hydrochloride</to_name>
		<to_code>236829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alexitol sodium</to_name>
		<to_code>236340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acai oil</to_name>
		<to_code>1309282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anchovy preparation</to_name>
		<to_code>1310517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hexafluorosilicate nonahydrate</to_name>
		<to_code>2592958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminophylline hydrate</to_name>
		<to_code>388049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astrocaryum aculeatum seed oil</to_name>
		<to_code>1655568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia annua flowering top extract</to_name>
		<to_code>2103290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>artemisinin</to_name>
		<to_code>2367409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol, L-</to_name>
		<to_code>2378842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acrothecium robustum allergenic extract</to_name>
		<to_code>905088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin microspheres, human</to_name>
		<to_code>1370439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica dahurica leaf extract</to_name>
		<to_code>1606210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allantoin</to_name>
		<to_code>508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aureobasidium pullulans var. pullutans allergenic extract</to_name>
		<to_code>852102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amikacin liposomal</to_name>
		<to_code>2059180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azatadine maleate</to_name>
		<to_code>58275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argan shell extract</to_name>
		<to_code>2634309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arum palaestinum whole extract</to_name>
		<to_code>2122983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum nitrate</to_name>
		<to_code>2360133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azurite</to_name>
		<to_code>2539938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acoramidis</to_name>
		<to_code>2698312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-isobutylphenethyl alcohol</to_name>
		<to_code>1720936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asfotase alfa</to_name>
		<to_code>1720259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alosetron hydrochloride</to_name>
		<to_code>85247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylate/isobutyl methacrylate/N-tert-octylacrylamide copolymer (75000 MW)</to_name>
		<to_code>1918245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid violet 9</to_name>
		<to_code>2367763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alendronate sodium</to_name>
		<to_code>203152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acriflavine</to_name>
		<to_code>249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum chasmanthum whole extract</to_name>
		<to_code>2667737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum chlorohydrate</to_name>
		<to_code>17610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum subacetate</to_name>
		<to_code>235461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amanita pantherina whole extract</to_name>
		<to_code>1441298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceprometazine</to_name>
		<to_code>161203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amdinocillin</to_name>
		<to_code>626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apocarotenal</to_name>
		<to_code>1376342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anethum graveolens leaf extract</to_name>
		<to_code>2390284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amyl nitrite</to_name>
		<to_code>742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylarginyltryptophyl diphenylglycine</to_name>
		<to_code>2586022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alkanna tinctoria root extract</to_name>
		<to_code>1799373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agkistrodon piscivorus antivenin</to_name>
		<to_code>885183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl tocopheryl maleate</to_name>
		<to_code>1362140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum chloride anhydrous</to_name>
		<to_code>1608145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenosine monophosphate</to_name>
		<to_code>309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amineptin</to_name>
		<to_code>17698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avotermin</to_name>
		<to_code>1427086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiodarone hydrochloride</to_name>
		<to_code>203114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aculyn excel (polymer dispersion)</to_name>
		<to_code>2390961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actaea cimicifuga root extract</to_name>
		<to_code>1309284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ATLANTIC SALMON TRANSGENIC WHOLE (OPAFP-GHC2 RDNA CONSTRUCT INSERTED INTO .ALPHA.-LOCUS IN THE EO-1.ALPHA. LINEAGE)</to_name>
		<to_code>1728305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ADAMTS13, recombinant-krhn</to_name>
		<to_code>2670286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acarbose</to_name>
		<to_code>16681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ajmalicine</to_name>
		<to_code>17205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-ketoglutaric acid</to_name>
		<to_code>17511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antithrombin III</to_name>
		<to_code>1009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-glycerophosphorylethanolamine, (R)-</to_name>
		<to_code>1876508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic trisulfide</to_name>
		<to_code>1667210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acacia decurrens whole extract</to_name>
		<to_code>1723136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apocynum cannabinum root extract</to_name>
		<to_code>1309506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>argatroban anhydrous</to_name>
		<to_code>1546207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Allium cepa bulb extract</to_name>
		<to_code>2695867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspalathus linearis whole extract</to_name>
		<to_code>1653340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin,chromated Cr-51 serum</to_name>
		<to_code>314299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acorus gramineus whole extract</to_name>
		<to_code>2693986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave tequilana leaf extract</to_name>
		<to_code>1307543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asian ginseng extract</to_name>
		<to_code>1370774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus fumigatus</to_name>
		<to_code>1182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Andrographis paniculata whole extract</to_name>
		<to_code>1534766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alisma plantago-aquatica whole extract</to_name>
		<to_code>1549554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum carbonate</to_name>
		<to_code>89858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ajuga reptans whole extract</to_name>
		<to_code>1649347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia absinthium flowering top extract</to_name>
		<to_code>2168436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aurothiomalate</to_name>
		<to_code>42547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbic acid 2-sulfate</to_name>
		<to_code>1370459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American ginseng root</to_name>
		<to_code>259473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amnonium acryloyldimethyltaurate - vp copolymer</to_name>
		<to_code>1307094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asciminib</to_name>
		<to_code>2584304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor, human recombinant residues 743-1636 deleted</to_name>
		<to_code>1300485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Actaea spicata root extract</to_name>
		<to_code>1309496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anacamptis morio flower extract</to_name>
		<to_code>2101419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alemtuzumab</to_name>
		<to_code>117055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetohexamide</to_name>
		<to_code>173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alfalfa oil</to_name>
		<to_code>323994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-pinene, (+)-</to_name>
		<to_code>2371700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avatrombopag maleate</to_name>
		<to_code>2045727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avutometinib potassium</to_name>
		<to_code>2714514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe andongensis whole extract</to_name>
		<to_code>2359255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>angoumois grain moth allergenic extract</to_name>
		<to_code>892360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetamine</to_name>
		<to_code>725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alpinia officinarum leaf extract</to_name>
		<to_code>1307832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azithromycin dihydrate</to_name>
		<to_code>253155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aldosterone</to_name>
		<to_code>1312358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American elderberry extract</to_name>
		<to_code>1310213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxicillin sodium</to_name>
		<to_code>267360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anthrax immune globulin, human</to_name>
		<to_code>1722335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amlodipine</to_name>
		<to_code>17767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>albumin human, USP</to_name>
		<to_code>828529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum heterotropoides root extract</to_name>
		<to_code>1922732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple allergenic extract</to_name>
		<to_code>891771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia vulgaris whole extract</to_name>
		<to_code>1541882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus niger var. niger allergenic extract</to_name>
		<to_code>1006297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Alisma plantago-aquatica top extract</to_name>
		<to_code>1428214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe succotrina whole extract</to_name>
		<to_code>2374552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acellular tissue engineered vessel</to_name>
		<to_code>2700338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anisole</to_name>
		<to_code>2594597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adansonia digitata seed extract</to_name>
		<to_code>1428849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aminoquinuride</to_name>
		<to_code>17747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agaricus campestris var. campestris whole extract</to_name>
		<to_code>1441297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum flufenamate</to_name>
		<to_code>17612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alirocumab</to_name>
		<to_code>1659152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alum, ammonium</to_name>
		<to_code>2101717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alkyl (C12-15) benzoate</to_name>
		<to_code>1310548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium carbonate</to_name>
		<to_code>1310190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Adonis vernalis extract</to_name>
		<to_code>1342649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aceclidine</to_name>
		<to_code>2721766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agaricus bisporus whole extract</to_name>
		<to_code>2180257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony cation (5+)</to_name>
		<to_code>1546283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atogepant</to_name>
		<to_code>2571813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allicin</to_name>
		<to_code>2729790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor (recombinant) pegylated</to_name>
		<to_code>1741397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abacavir sulfate</to_name>
		<to_code>221052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>annatto extract</to_name>
		<to_code>1313764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol calcium succinate, DL-</to_name>
		<to_code>2598017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl methylsilanol pectinate</to_name>
		<to_code>1314268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amygdalin</to_name>
		<to_code>1371051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ajowan oil</to_name>
		<to_code>1855063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aurothioglucose</to_name>
		<to_code>4980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnebia guttata root extract</to_name>
		<to_code>2586023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>afamelanotide</to_name>
		<to_code>2262250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl tetrapeptide-11</to_name>
		<to_code>2371701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avocado allergenic extract</to_name>
		<to_code>895582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-aminocyclopropanol</to_name>
		<to_code>2645303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprocitentan</to_name>
		<to_code>2679059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almitrine dimesylate</to_name>
		<to_code>529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot juice</to_name>
		<to_code>1307043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-succinimidyloxy carbonyl-omega-methoxy, polyoxyethylene MW 5000</to_name>
		<to_code>2399028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aflibercept-yszy</to_name>
		<to_code>2715399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl sucrose</to_name>
		<to_code>1307102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus flavus var. oryzae protease</to_name>
		<to_code>1307040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abemaciclib</to_name>
		<to_code>1946825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azulene</to_name>
		<to_code>2675343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprenolol</to_name>
		<to_code>597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl tetrapeptide-3</to_name>
		<to_code>2000919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl alcohol</to_name>
		<to_code>2385331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anogeissus leiocarpus bark extract</to_name>
		<to_code>1309403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abrus precatorius seed extract</to_name>
		<to_code>1309951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adenosine triphosphate</to_name>
		<to_code>318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azelamide monoethanolamine</to_name>
		<to_code>1428860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia umbelliformis flower extract</to_name>
		<to_code>1307806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor (recombinant), PEGylated-aucl</to_name>
		<to_code>2055654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amaranthus caudatus whole extract</to_name>
		<to_code>1655564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot allergenic extract</to_name>
		<to_code>895574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arundo pliniana root extract</to_name>
		<to_code>1309800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achlys triphylla whole extract</to_name>
		<to_code>2367761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acalabrutinib</to_name>
		<to_code>1986808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium nonoxynol-9 sulfate</to_name>
		<to_code>2584966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-d-glucopyranose</to_name>
		<to_code>1800492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agave tequilana stem extract</to_name>
		<to_code>2644446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alminoprofen</to_name>
		<to_code>17387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asparagopsis armata extract</to_name>
		<to_code>1363627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anethole</to_name>
		<to_code>17881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arachis hypogaea whole extract</to_name>
		<to_code>1792311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus root extract</to_name>
		<to_code>479542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-cubebene, (-)-</to_name>
		<to_code>2530130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ACV tripeptide</to_name>
		<to_code>1551571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acryloyldimethyltaurate-acrylamide copolymer</to_name>
		<to_code>1370665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl</to_name>
		<to_code>2631083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrimonia pilosa leaf extract</to_name>
		<to_code>2697821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprepitant</to_name>
		<to_code>358255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anemone nemorosa extract</to_name>
		<to_code>1310266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acrylic acid</to_name>
		<to_code>1368626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica seed oil</to_name>
		<to_code>1305641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ammi visnaga fruit extract</to_name>
		<to_code>1353222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus niger immunoserum rabbit</to_name>
		<to_code>1313283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apis cerana whole extract</to_name>
		<to_code>2590180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspalathus linearis leaf extract</to_name>
		<to_code>1307645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcholinesterase human</to_name>
		<to_code>1372465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almond oil</to_name>
		<to_code>1305638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl tetrapeptide-9</to_name>
		<to_code>1307099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azelastine</to_name>
		<to_code>18603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum phosphate</to_name>
		<to_code>17618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Acacia dealbata flower extract</to_name>
		<to_code>1488998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allyl methacrylate</to_name>
		<to_code>2203551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum acetate</to_name>
		<to_code>17609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetic anhydride</to_name>
		<to_code>1370450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol acetate</to_name>
		<to_code>1046243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arisaema erubescens root extract</to_name>
		<to_code>1307669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apricot extract</to_name>
		<to_code>1353891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anakinra</to_name>
		<to_code>72435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum zirconium tetrachlorohydrex gly</to_name>
		<to_code>1305896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aralia hispida root extract</to_name>
		<to_code>1310007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ambrosia confertiflora whole extract</to_name>
		<to_code>2121053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus esculentus seed extract</to_name>
		<to_code>1437307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>abiraterone</to_name>
		<to_code>1100072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asciminib hydrochloride</to_name>
		<to_code>2584303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aratinga erythrogenys feather extract</to_name>
		<to_code>2481134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbate</to_name>
		<to_code>1370460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aripiprazole</to_name>
		<to_code>89013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium bromide</to_name>
		<to_code>1313309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-adbm</to_name>
		<to_code>2103477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arabic gum allergenic extract</to_name>
		<to_code>905301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aprinocarsen</to_name>
		<to_code>2634355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ABT-925 anhydrous free base</to_name>
		<to_code>1661016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl aspartic acid</to_name>
		<to_code>1872378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe spicata whole extract</to_name>
		<to_code>2590596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>asafetida extract</to_name>
		<to_code>319779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium laureth-12 sulfate</to_name>
		<to_code>1744402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium alginate</to_name>
		<to_code>1926208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arthrospira platensis</to_name>
		<to_code>1321355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aristolochia clematitis root extract</to_name>
		<to_code>1309735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum hydride</to_name>
		<to_code>1540524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus chinensis whole extract</to_name>
		<to_code>2106824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambenonium</to_name>
		<to_code>623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adalimumab-afzb</to_name>
		<to_code>2619155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allylestrenol</to_name>
		<to_code>525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetic acid</to_name>
		<to_code>168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia argyi leaf extract</to_name>
		<to_code>1307649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apple seed oil</to_name>
		<to_code>1799009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agalsidase beta</to_name>
		<to_code>338817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arctium lappa fruit extract</to_name>
		<to_code>1307677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astragalus preparation</to_name>
		<to_code>319818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetiamine</to_name>
		<to_code>236300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxicillin anhydrous</to_name>
		<to_code>1297882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achyranthes bidentata root extract</to_name>
		<to_code>1307854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe arborescens flower extract</to_name>
		<to_code>2288156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetoxolone aluminum</to_name>
		<to_code>268907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aloe polysaccharide</to_name>
		<to_code>476786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe arborescens whole extract</to_name>
		<to_code>2055101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anredera cordifolia leaf extract</to_name>
		<to_code>2669315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia mongolica leaf extract</to_name>
		<to_code>2043274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-glycerophosphorylethanolamine monohydrate, (R)-</to_name>
		<to_code>1876507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anemarrhena asphodeloides whole extract</to_name>
		<to_code>1544272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>atosiban</to_name>
		<to_code>59639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ambrisentan</to_name>
		<to_code>358274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Akebia stem extract</to_name>
		<to_code>2166038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Agrimonia eupatoria extract</to_name>
		<to_code>1314595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>algestone</to_name>
		<to_code>595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amiodarone</to_name>
		<to_code>703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Astrocaryum murumuru seed butter extract</to_name>
		<to_code>1307542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achillea millefolium extract</to_name>
		<to_code>1372250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amivantamab</to_name>
		<to_code>2549199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>apazone</to_name>
		<to_code>1029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allspice allergenic extract</to_name>
		<to_code>895552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ascorbyl dipalmitate</to_name>
		<to_code>1608545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Achillea millefolium flowering top extract</to_name>
		<to_code>1747299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-acrylamido-2-methyl-1-propanesulfonic acid</to_name>
		<to_code>2109231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abies sibirica whole extract</to_name>
		<to_code>1856267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium laureth-3 sulfate</to_name>
		<to_code>1307773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetazolamide sodium</to_name>
		<to_code>91406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anhydrous lanolin</to_name>
		<to_code>1363703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium silicofluoride</to_name>
		<to_code>314494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amanita pantherina fruiting body extract</to_name>
		<to_code>2360891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American house dust mite allergenic extract</to_name>
		<to_code>1116977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amomum testaceum seed extract</to_name>
		<to_code>2058909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amphetaminil</to_name>
		<to_code>17813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alprostadil</to_name>
		<to_code>598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amifostine</to_name>
		<to_code>4126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Angelica atropurpurea root extract</to_name>
		<to_code>1435861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-alpha-vitamin D</to_name>
		<to_code>350465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aniba rosaeodora wood extract</to_name>
		<to_code>1312541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium</to_name>
		<to_code>709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylated glycol stearate</to_name>
		<to_code>1859171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Amomum villosum seed extract</to_name>
		<to_code>1872379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aconitic acid</to_name>
		<to_code>1721298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apocynum androsaemifolium root extract</to_name>
		<to_code>1309830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>agatolimod</to_name>
		<to_code>2665622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asclepias curassavica extract</to_name>
		<to_code>1348451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>arsenic acid</to_name>
		<to_code>1375923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alvimopan anhydrous</to_name>
		<to_code>1516803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Artemisia princeps whole extract</to_name>
		<to_code>1600435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum sieboldii extract</to_name>
		<to_code>1793894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Abelmoschus moschatus whole extract</to_name>
		<to_code>2048130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amdinocillin pivoxil</to_name>
		<to_code>627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl tetrapeptide-5</to_name>
		<to_code>2052918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>allogeneic processed thymus tissue-agdc</to_name>
		<to_code>2626459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica extract</to_name>
		<to_code>144377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>avalglucosidase alfa-ngpt</to_name>
		<to_code>2565813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amobarbital sodium</to_name>
		<to_code>1314242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Arnica montana flower extract</to_name>
		<to_code>1306166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum kusnezoffi root extract</to_name>
		<to_code>1364986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>androsterone</to_name>
		<to_code>1312359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>azelaic acid</to_name>
		<to_code>18602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adapalene</to_name>
		<to_code>60223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium lactate</to_name>
		<to_code>215247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine sodium</to_name>
		<to_code>237163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amoxicillin trihydrate</to_name>
		<to_code>133008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aluminum distearate</to_name>
		<to_code>1307778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amosulalol</to_name>
		<to_code>2667256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>anagrelide</to_name>
		<to_code>596724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American basswood pollen extract</to_name>
		<to_code>995754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antimony trioxide</to_name>
		<to_code>2477431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>antazoline</to_name>
		<to_code>865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aspergillus fumigatus allergenic extract</to_name>
		<to_code>466192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ammonium acetate</to_name>
		<to_code>1362883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aralia racemosa root extract</to_name>
		<to_code>1309833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Apis mellifera preparation</to_name>
		<to_code>285219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>American cockroach allergenic extract</to_name>
		<to_code>905258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(3-amino-4-hydroxyphenyl)-2-((2-(4-methoxyphenyl)-1-methylethyl)amino)ethanol</to_name>
		<to_code>2283758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-amino-1-butanol</to_name>
		<to_code>2588247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amylmetacresol</to_name>
		<to_code>236248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acid blue 9 ammonium</to_name>
		<to_code>2101006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>.alpha.-terpinene</to_name>
		<to_code>2542349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>articaine hydrochloride</to_name>
		<to_code>2117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aloe vera whole extract</to_name>
		<to_code>1312539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>amodimethicone (800 CST)</to_name>
		<to_code>1427215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetyl cedrene</to_name>
		<to_code>2289006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-chlorohydrin</to_name>
		<to_code>2699583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha, alpha'-diglycerol</to_name>
		<to_code>2473375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>aspirin</to_name>
		<to_code>1191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Anemarrhena asphodeloides root extract</to_name>
		<to_code>1735152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aristolochia serpentaria root extract</to_name>
		<to_code>1442192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>acetylcysteine magnesium</to_name>
		<to_code>1809634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Aconitum carmichaelii lateral root extract</to_name>
		<to_code>1875523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ailanthus altissima fruit extract</to_name>
		<to_code>2590594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-hexylcinnamaldehyde</to_name>
		<to_code>1311811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>almotriptan</to_name>
		<to_code>279645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Asarum canadense root extract</to_name>
		<to_code>1428416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>adiphenine hydrochloride</to_name>
		<to_code>235433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>A [Preparations]</from_name>
		<from_code>N0000010583</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>alpha-tocopherol succinate, D-</to_name>
		<to_code>1426447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum silicate</from_name>
		<from_code>1362917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aluminum Silicates</to_name>
		<to_code>M0000833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrylamide</from_name>
		<from_code>1368125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acrylamide</to_name>
		<to_code>M0029842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster Ophthalmicus</to_name>
		<to_code>M0010281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epstein-Barr Virus Infections</to_name>
		<to_code>M0029738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Encephalitis, Herpes Simplex</to_name>
		<to_code>M0328381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir</from_name>
		<from_code>281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Zoster Ophthalmicus</to_name>
		<to_code>M0010281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epstein-Barr Virus Infections</to_name>
		<to_code>M0029738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acyclovir Sodium</to_name>
		<to_code>M0000327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Encephalitis, Herpes Simplex</to_name>
		<to_code>M0328381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytomegalovirus Infections</to_name>
		<to_code>M0005604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acyclovir sodium</from_name>
		<from_code>81944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epstein-Barr Virus Infections</to_name>
		<to_code>M0029738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chickenpox</to_name>
		<to_code>M0004041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzyl alcohol</from_name>
		<from_code>1426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resveratrol</from_name>
		<from_code>1000492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Labialis</to_name>
		<to_code>M0010278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Genitalis</to_name>
		<to_code>M0010276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ajmaline</from_name>
		<from_code>423</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ajmaline</to_name>
		<to_code>M0000613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium thioglycolate</from_name>
		<from_code>1482632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-mercaptoacetate, monoammonium salt</to_name>
		<to_code>M0313431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcuronium chloride</from_name>
		<from_code>66852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcuronium Chloride</to_name>
		<to_code>M0330741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfatradiol</from_name>
		<from_code>1926478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfatradiol</to_name>
		<to_code>M0509901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aphanizomenon flos-aquae</from_name>
		<from_code>1310848</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aphanizomenon flos-aquae</to_name>
		<to_code>M000674040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemetacin</from_name>
		<from_code>16695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acemetacin</to_name>
		<to_code>M0087620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allyl sulfide</from_name>
		<from_code>17376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allyl sulfide</to_name>
		<to_code>M0115824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arbekacin</from_name>
		<from_code>26397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arbekacin</to_name>
		<to_code>M0100125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Astragalus propinquus root extract</from_name>
		<from_code>1309814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Huang Qi</to_name>
		<to_code>M0089313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alizapride</from_name>
		<from_code>17311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alizapride</to_name>
		<to_code>M0105043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>advantame</from_name>
		<from_code>1591894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-(N-(3-(3-hydroxy-4-methoxyphenyl) propyl)-alpha-aspartyl)-L-phenylalanine 1-methyl ester</to_name>
		<to_code>M0571172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium phosphate, dibasic</from_name>
		<from_code>1427061</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>diammonium phosphate</to_name>
		<to_code>M0315932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amitriptyline</to_name>
		<to_code>M0000975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_active_metabolites</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline</from_name>
		<from_code>704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nortriptyline</to_name>
		<to_code>M0015002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide hydrochloride</from_name>
		<from_code>155056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procainamide</from_name>
		<from_code>8700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cisapride</to_name>
		<to_code>M0029858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>M000595362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir Sulfate</to_name>
		<to_code>M0445555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nevirapine</to_name>
		<to_code>M0029429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pibrentasvir</to_name>
		<to_code>M000636260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir sulfate</from_name>
		<from_code>358299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergotamine</to_name>
		<to_code>M0007662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Metronidazole</to_name>
		<to_code>M0013695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypnotics and Sedatives</to_name>
		<to_code>M0010885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antipsychotic Agents</to_name>
		<to_code>M0021770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disulfiram</to_name>
		<to_code>M0006600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprenavir</from_name>
		<from_code>228656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lovastatin</to_name>
		<to_code>M0012707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>M000595362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nevirapine</to_name>
		<to_code>M0029429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pibrentasvir</to_name>
		<to_code>M000636260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atazanavir</from_name>
		<from_code>343047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>M000595362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>M000595362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>M000595362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>M000595362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir</to_name>
		<to_code>M0028961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triazolam</to_name>
		<to_code>M0021910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfuzosin</to_name>
		<to_code>M0137486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lurasidone</to_name>
		<to_code>M0517365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nevirapine</to_name>
		<to_code>M0029429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nevirapine</to_name>
		<to_code>M0029429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simvastatin</to_name>
		<to_code>M0029425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Midazolam</to_name>
		<to_code>M0013843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pibrentasvir</from_name>
		<from_code>1940636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pibrentasvir</to_name>
		<to_code>M000636260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylergonovine</to_name>
		<to_code>M0013636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan</from_name>
		<from_code>51499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irinotecan</to_name>
		<to_code>M0147530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroergotamine</to_name>
		<to_code>M0006401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sildenafil</from_name>
		<from_code>136411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sildenafil</to_name>
		<to_code>M0265894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zidovudine</from_name>
		<from_code>11413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efavirenz</from_name>
		<from_code>195085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir sulfate</from_name>
		<from_code>221052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamivudine</from_name>
		<from_code>68244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enfuvirtide</from_name>
		<from_code>139896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stavudine</from_name>
		<from_code>59763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zalcitabine</from_name>
		<from_code>3363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>didanosine</from_name>
		<from_code>3364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acquired Immunodeficiency Syndrome</to_name>
		<to_code>M0000245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergonovine</to_name>
		<to_code>M0007653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letermovir</from_name>
		<from_code>1988648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pimozide</to_name>
		<to_code>M0016871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azithromycin Dihydrate</to_name>
		<to_code>M0329138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neisseriaceae Infections</to_name>
		<to_code>M0025673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin dihydrate</from_name>
		<from_code>253155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethritis</to_name>
		<to_code>M0022336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neisseriaceae Infections</to_name>
		<to_code>M0025673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin sodium dihydrogen phosphate</from_name>
		<from_code>2679612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxylenol</from_name>
		<from_code>20877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin diacetate</from_name>
		<from_code>236200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypochlorite</from_name>
		<from_code>9881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen peroxide</from_name>
		<from_code>5499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxyquinoline</from_name>
		<from_code>110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin disodium</from_name>
		<from_code>142447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorous acid</from_name>
		<from_code>1483316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorite</from_name>
		<from_code>1483317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midecamycin</from_name>
		<from_code>30005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypochlorite</from_name>
		<from_code>9881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorite</from_name>
		<from_code>1483317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorous acid</from_name>
		<from_code>1483316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxyquinoline sulfate</from_name>
		<from_code>42836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin hydrochloride</from_name>
		<from_code>1541465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticarcillin</from_name>
		<from_code>10591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Infectious</to_name>
		<to_code>M0019935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neisseriaceae Infections</to_name>
		<to_code>M0025673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin anhydrous</from_name>
		<from_code>1299904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green</from_name>
		<from_code>5775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriflunomide</from_name>
		<from_code>1310520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolvaptan</from_name>
		<from_code>358257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen sodium</from_name>
		<from_code>1367838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene citrate</from_name>
		<from_code>142431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rose bengal sodium I 131</from_name>
		<from_code>82097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil</from_name>
		<from_code>343048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine hydrochloride</from_name>
		<from_code>1649479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimercaprol</from_name>
		<from_code>3445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine</from_name>
		<from_code>10594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine monohydrate</from_name>
		<from_code>1314248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivabradine</from_name>
		<from_code>1649480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium valproate</from_name>
		<from_code>134422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate (1:1)</from_name>
		<from_code>317238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproate</from_name>
		<from_code>40254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone hydrochloride</from_name>
		<from_code>259319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zafirlukast</from_name>
		<from_code>114970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate</from_name>
		<from_code>104994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrabenazine</from_name>
		<from_code>10390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol</from_name>
		<from_code>31555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine hydrochloride</from_name>
		<from_code>6538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pioglitazone</from_name>
		<from_code>33738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin hydrochloride</from_name>
		<from_code>235743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin</from_name>
		<from_code>41127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zileuton</from_name>
		<from_code>40575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene acetate</from_name>
		<from_code>1442171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin calcium</from_name>
		<from_code>323828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethynodrel</from_name>
		<from_code>7515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilutamide</from_name>
		<from_code>31805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, B</from_name>
		<from_code>618365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin hydrochloride</from_name>
		<from_code>46043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine hemihydrate</from_name>
		<from_code>2462459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium valproate</from_name>
		<from_code>1927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene sodium</from_name>
		<from_code>3106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichloralphenazone</from_name>
		<from_code>22892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chenodeoxycholic acid</from_name>
		<from_code>2323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mipomersen</from_name>
		<from_code>1367839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine hydrochloride</from_name>
		<from_code>97</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin sodium</from_name>
		<from_code>72875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nevirapine</from_name>
		<from_code>53654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucerase</from_name>
		<from_code>46049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutetrabenazine</from_name>
		<from_code>1876905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene</from_name>
		<from_code>1441386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flibanserin</from_name>
		<from_code>1665509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dantrolene</from_name>
		<from_code>3105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine</from_name>
		<from_code>8120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichlorphenamide</from_name>
		<from_code>3353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secretin</from_name>
		<from_code>9627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene</from_name>
		<from_code>2596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin</from_name>
		<from_code>6809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone</from_name>
		<from_code>84108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolcapone</from_name>
		<from_code>72937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daclizumab</from_name>
		<from_code>190353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medium chain triglycerides</from_name>
		<from_code>1310578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin</from_name>
		<from_code>301542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil sodium</from_name>
		<from_code>342691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treprostinil diolamine</from_name>
		<from_code>1927409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine acetate</from_name>
		<from_code>6537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kava preparation</from_name>
		<from_code>285228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nebivolol hydrochloride</from_name>
		<from_code>236883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosiglitazone maleate</from_name>
		<from_code>253198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, A</from_name>
		<from_code>253166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine hydrochloride</from_name>
		<from_code>203197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiglucerase</from_name>
		<from_code>84959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodoquinol</from_name>
		<from_code>3435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine</from_name>
		<from_code>6536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Diseases</to_name>
		<to_code>M0012644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neisseriaceae Infections</to_name>
		<to_code>M0025673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azithromycin Monohydrate</to_name>
		<to_code>M0329139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin monohydrate</from_name>
		<from_code>1298839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin</from_name>
		<from_code>1266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Hemophilus B polysaccharide</from_name>
		<from_code>314656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclacillin</from_name>
		<from_code>2968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae type b</from_name>
		<from_code>50937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin sodium</from_name>
		<from_code>203836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus Infections</to_name>
		<to_code>M0009740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzimidazoles</to_name>
		<to_code>M0002348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alatrofloxacin</to_name>
		<to_code>M0278267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin</from_name>
		<from_code>141440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norfloxacin</from_name>
		<from_code>7517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probenecid</from_name>
		<from_code>8698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin mesylate</from_name>
		<from_code>262299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate</from_name>
		<from_code>2640868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pefloxacin</from_name>
		<from_code>7960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gonorrhea</to_name>
		<to_code>M0009553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alatrofloxacin mesylate</to_name>
		<to_code>M0423832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Benzimidazoles</to_name>
		<to_code>M0002348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alatrofloxacin mesylate</from_name>
		<from_code>221054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline</from_name>
		<from_code>2059269</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omadacycline tosylate</from_name>
		<from_code>2059268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Bacterial</to_name>
		<to_code>M0027639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline</from_name>
		<from_code>21272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline sodium</from_name>
		<from_code>102758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia Infections</to_name>
		<to_code>M0004107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neisseriaceae Infections</to_name>
		<to_code>M0025673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azithromycin</from_name>
		<from_code>18631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azithromycin</to_name>
		<to_code>M0027129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections, Nontuberculous</to_name>
		<to_code>M0014288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tonsillitis</to_name>
		<to_code>M0021666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephradine</from_name>
		<from_code>2239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid phosphate</from_name>
		<from_code>1540824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin</from_name>
		<from_code>1927663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin</from_name>
		<from_code>2238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tedizolid</from_name>
		<from_code>1540825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline</from_name>
		<from_code>1040005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin sodium</from_name>
		<from_code>82048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin sodium</from_name>
		<from_code>203171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin</from_name>
		<from_code>1547611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin sodium</from_name>
		<from_code>9860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin</from_name>
		<from_code>1539239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfopristin</from_name>
		<from_code>229369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin sodium</from_name>
		<from_code>42562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil acetate</from_name>
		<from_code>1743286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefazolin</from_name>
		<from_code>2180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole</from_name>
		<from_code>2178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftaroline fosamil</from_name>
		<from_code>1040004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalothin</from_name>
		<from_code>2236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephapirin benzathine</from_name>
		<from_code>1294563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin hydrochloride</from_name>
		<from_code>864624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delafloxacin meglumine</from_name>
		<from_code>1927662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oritavancin diphosphate</from_name>
		<from_code>1549827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalbavancin hydrochloride</from_name>
		<from_code>1541465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mezlocillin</from_name>
		<from_code>6927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefamandole nafate</from_name>
		<from_code>20473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telavancin</from_name>
		<from_code>473837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcal Infections</to_name>
		<to_code>M0020568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin hydrochloride</from_name>
		<from_code>281942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin anhydrous</from_name>
		<from_code>1299782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antipyrine</from_name>
		<from_code>1001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin monohydrate</from_name>
		<from_code>215948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephalexin</from_name>
		<from_code>2231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Media</to_name>
		<to_code>M0015563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Mycoplasma</to_name>
		<to_code>M0017072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azithromycin</to_name>
		<to_code>M0027129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteroides Infections</to_name>
		<to_code>M0002147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor anhydrous</from_name>
		<from_code>1450910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide anhydrous</from_name>
		<from_code>1445143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin hydrochloride</from_name>
		<from_code>235762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenugreek seed meal</from_name>
		<from_code>282436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomefloxacin</from_name>
		<from_code>28872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten dihydrate</from_name>
		<from_code>1297879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bambuterol hydrochloride</from_name>
		<from_code>235862</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodinated glycerol</from_name>
		<from_code>27723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dirithromycin</from_name>
		<from_code>23437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyphylline</from_name>
		<from_code>3714</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium cation</from_name>
		<from_code>1546373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide monohydrate</from_name>
		<from_code>1309404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime anhydrous</from_name>
		<from_code>1546021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bambuterol</from_name>
		<from_code>18751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftibuten</from_name>
		<from_code>20492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefaclor</from_name>
		<from_code>2176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dornase alfa</from_name>
		<from_code>337623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenugreek seed preparation</from_name>
		<from_code>360375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium</from_name>
		<from_code>7213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefixime</from_name>
		<from_code>25033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchitis</to_name>
		<to_code>M0002972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrozoline</from_name>
		<from_code>37935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil anhydrous</from_name>
		<from_code>1546020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline hydrochloride</from_name>
		<from_code>106101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine tannate</from_name>
		<from_code>686390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrozoline hydrochloride</from_name>
		<from_code>57983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline hydrochloride</from_name>
		<from_code>82054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin mesylate</from_name>
		<from_code>221177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir</from_name>
		<from_code>25037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline</from_name>
		<from_code>7247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetazoline</from_name>
		<from_code>7812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefdinir monohydrate</from_name>
		<from_code>1306064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naphazoline nitrate</from_name>
		<from_code>235810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine maleate</from_name>
		<from_code>48936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefprozil</from_name>
		<from_code>19552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine</from_name>
		<from_code>22696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinusitis</to_name>
		<to_code>M0019901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin</from_name>
		<from_code>1266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin</from_name>
		<from_code>1266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azlocillin</to_name>
		<to_code>M0002078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin</from_name>
		<from_code>1266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin sodium</from_name>
		<from_code>203836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin sodium</from_name>
		<from_code>203836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azlocillin sodium</from_name>
		<from_code>203836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azlocillin Sodium</to_name>
		<to_code>M0580899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constriction, Pathologic</to_name>
		<to_code>M0005049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alosetron</to_name>
		<to_code>M0240025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ischemic</to_name>
		<to_code>M0025968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluvoxamine</to_name>
		<to_code>M0025397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Adhesions</to_name>
		<to_code>M0000418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron</from_name>
		<from_code>85248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix sodium</from_name>
		<from_code>2049847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdominal Pain</to_name>
		<to_code>M0024135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constriction, Pathologic</to_name>
		<to_code>M0005049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Adhesions</to_name>
		<to_code>M0000418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluvoxamine</to_name>
		<to_code>M0025397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ischemic</to_name>
		<to_code>M0025968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alosetron hydrochloride</from_name>
		<from_code>85247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alosetron hydrochloride</to_name>
		<to_code>M0326799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene acetate</from_name>
		<from_code>1442171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene</from_name>
		<from_code>1441386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophilia</to_name>
		<to_code>M0029461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 400</from_name>
		<from_code>8514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barium sulfate</from_name>
		<from_code>1331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 300</from_name>
		<from_code>8513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Perforation</to_name>
		<to_code>M0011577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide</from_name>
		<from_code>89784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lubiprostone</from_name>
		<from_code>623033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline bromide</from_name>
		<from_code>91163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor</from_name>
		<from_code>2199674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor hydrochloride</from_name>
		<from_code>2199673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline</from_name>
		<from_code>6821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linaclotide</from_name>
		<from_code>1307404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide iodide</from_name>
		<from_code>6051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifaximin</from_name>
		<from_code>35619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Irritable Bowel Syndrome</to_name>
		<to_code>M0004816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine phosphate</from_name>
		<from_code>105556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol</from_name>
		<from_code>24591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinestrol</from_name>
		<from_code>9066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine</from_name>
		<from_code>4089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, esterified (USP)</from_name>
		<from_code>214549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorotrianisene</from_name>
		<from_code>2397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, A</from_name>
		<from_code>253166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol tetrasodium</from_name>
		<from_code>281876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethynodrel</from_name>
		<from_code>7515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienestrol</from_name>
		<from_code>3368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, B</from_name>
		<from_code>618365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol</from_name>
		<from_code>25284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylstilbestrol</from_name>
		<from_code>3390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estramustine phosphate sodium</from_name>
		<from_code>4090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thrombophlebitis</to_name>
		<to_code>M0021432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine sodium</from_name>
		<from_code>104123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miglitol</from_name>
		<from_code>30009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vedolizumab</from_name>
		<from_code>1538097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium</from_name>
		<from_code>2689322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium</from_name>
		<from_code>1546438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide</from_name>
		<from_code>18747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olsalazine</from_name>
		<from_code>32385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etrasimod arginine</from_name>
		<from_code>2668046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>balsalazide disodium</from_name>
		<from_code>153718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium tosylate</from_name>
		<from_code>2052857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etrasimod</from_name>
		<from_code>2668045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab</from_name>
		<from_code>2668384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acarbose</from_name>
		<from_code>16681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirikizumab-mrkz</from_name>
		<from_code>2668385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium bromide</from_name>
		<from_code>2689321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ulcerative</to_name>
		<to_code>M0004771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol</from_name>
		<from_code>1551777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium acetate</from_name>
		<from_code>54987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate</from_name>
		<from_code>4440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bicarbonate</from_name>
		<from_code>34296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnaltrexone</from_name>
		<from_code>29899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil</from_name>
		<from_code>6972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnaltrexone bromide</from_name>
		<from_code>979111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate hydrochloride</from_name>
		<from_code>142437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone hydrochloride</from_name>
		<from_code>236931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linaclotide</from_name>
		<from_code>1307404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone resin complex</from_name>
		<from_code>314667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor hydrochloride</from_name>
		<from_code>2199673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil, light</from_name>
		<from_code>577312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer carbonate</from_name>
		<from_code>660890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenapanor</from_name>
		<from_code>2199674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin</from_name>
		<from_code>7299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer</from_name>
		<from_code>214824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium cation</from_name>
		<from_code>1546421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acarbose</from_name>
		<from_code>16681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol oxalate</from_name>
		<from_code>1593586</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neomycin sulfate</from_name>
		<from_code>7300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone polistirex</from_name>
		<from_code>221107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barium sulfate</from_name>
		<from_code>1331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine bromide</from_name>
		<from_code>9001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevelamer hydrochloride</from_name>
		<from_code>237125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 400</from_name>
		<from_code>8514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone tannate</from_name>
		<from_code>597355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium chloride</from_name>
		<from_code>3754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine tartrate</from_name>
		<from_code>235774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 300</from_name>
		<from_code>8513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium</from_name>
		<from_code>3752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine tartrate</from_name>
		<from_code>221174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine</from_name>
		<from_code>119565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone hydrochloride</from_name>
		<from_code>2122776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone bitartrate</from_name>
		<from_code>142439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine sulfate</from_name>
		<from_code>30236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine</from_name>
		<from_code>7052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium polystyrene sulfonate</from_name>
		<from_code>56512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chloride</from_name>
		<from_code>8591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine</from_name>
		<from_code>9000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morphine hydrochloride</from_name>
		<from_code>235751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plecanatide</from_name>
		<from_code>1873752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lubiprostone</from_name>
		<from_code>623033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium gluconate</from_name>
		<from_code>89903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heavy mineral oil</from_name>
		<from_code>258439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine</from_name>
		<from_code>1876597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine tosylate</from_name>
		<from_code>1876598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intestinal Obstruction</to_name>
		<to_code>M0011575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Frostbite</to_name>
		<to_code>M0008850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe vera preparation</from_name>
		<from_code>318340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdomen, Acute</to_name>
		<to_code>M0000006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric subsulfate solution</from_name>
		<from_code>24912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine-125</from_name>
		<from_code>253341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alginic acid</from_name>
		<from_code>17305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen</from_name>
		<from_code>2626471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine</from_name>
		<from_code>5933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat</from_name>
		<from_code>2626470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium alginate</from_name>
		<from_code>56446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alginate</from_name>
		<from_code>1370451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase</from_name>
		<from_code>58939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone-iodine</from_name>
		<from_code>8611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous iodide</from_name>
		<from_code>1720256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase Clostridium histolyticum</from_name>
		<from_code>898492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Burns</to_name>
		<to_code>M0003064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alginic acid</from_name>
		<from_code>17305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alginic Acid</to_name>
		<to_code>M0053297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alginic acid</from_name>
		<from_code>17305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium trihydrate</from_name>
		<from_code>2688630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole sodium</from_name>
		<from_code>1792108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium alginate</from_name>
		<from_code>56446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole strontium</from_name>
		<from_code>1435522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole sodium</from_name>
		<from_code>253191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole (as pantoprazole sodium sesquihydrate)</from_name>
		<from_code>236632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole sodium</from_name>
		<from_code>226868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium</from_name>
		<from_code>283562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium carbonate</from_name>
		<from_code>29155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexlansoprazole sesquihydrate</from_name>
		<from_code>2673463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole</from_name>
		<from_code>114979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alginate</from_name>
		<from_code>1370451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium dihydrate</from_name>
		<from_code>1601995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantoprazole</from_name>
		<from_code>40790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole sodium</from_name>
		<from_code>1294569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bicarbonate</from_name>
		<from_code>36676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole</from_name>
		<from_code>283742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexlansoprazole</from_name>
		<from_code>816346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole magnesium</from_name>
		<from_code>236486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroesophageal Reflux</to_name>
		<to_code>M0009024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alginate</from_name>
		<from_code>1370451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alginates</to_name>
		<to_code>M0000707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amikacin Sulfate</to_name>
		<to_code>M0000904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin sulfate</from_name>
		<from_code>643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin anhydrous</from_name>
		<from_code>1546000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane sulfate</from_name>
		<from_code>1597608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam</from_name>
		<from_code>2184137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam sodium</from_name>
		<from_code>1603833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline dihydrochloride</from_name>
		<from_code>2055907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin sulfate</from_name>
		<from_code>7276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftolozane</from_name>
		<from_code>1597609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin</from_name>
		<from_code>8339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem</from_name>
		<from_code>5690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin</from_name>
		<from_code>2540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aztreonam</from_name>
		<from_code>1272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem anhydrous</from_name>
		<from_code>1545986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam monohydrate</from_name>
		<from_code>2184136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tobramycin</from_name>
		<from_code>10627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacillin sodium</from_name>
		<from_code>203134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>relebactam anhydrous</from_name>
		<from_code>2268500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilastatin sodium</from_name>
		<from_code>82128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipenem monohydrate</from_name>
		<from_code>2184135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intraabdominal Infections</to_name>
		<to_code>M0549889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avibactam</from_name>
		<from_code>1603834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>avibactam</to_name>
		<to_code>M0576517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amikacin</to_name>
		<to_code>M0000903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amikacin</from_name>
		<from_code>641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam sodium</from_name>
		<from_code>82100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam</from_name>
		<from_code>10167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime</from_name>
		<from_code>2192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin</from_name>
		<from_code>6099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A sulfate</from_name>
		<from_code>1300476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbactam pivoxyl</from_name>
		<from_code>166010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin sulfate</from_name>
		<from_code>203183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftizoxime sodium</from_name>
		<from_code>82126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kanamycin A</from_name>
		<from_code>1727573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acinetobacter Infections</to_name>
		<to_code>M0000230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoalbuminemia</to_name>
		<to_code>M0404823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human-kjda</from_name>
		<from_code>2054166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icodextrin</from_name>
		<from_code>140480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medium chain triglycerides</from_name>
		<from_code>1310578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ascites</to_name>
		<to_code>M0001791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serum Albumin, Human</to_name>
		<to_code>M000630561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoalbuminemia</to_name>
		<to_code>M0404823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin human, USP</from_name>
		<from_code>828529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beractant</from_name>
		<from_code>46967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam maleate</from_name>
		<from_code>142441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Premature</to_name>
		<to_code>M0011288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoalbuminemia</to_name>
		<to_code>M0404823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,aggregated</from_name>
		<from_code>317176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beractant</from_name>
		<from_code>46967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calfactant</from_name>
		<from_code>232539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beractant</from_name>
		<from_code>46967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poractant alfa</from_name>
		<from_code>236381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calfactant</from_name>
		<from_code>232539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome, Newborn</to_name>
		<to_code>M0018890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoalbuminemia</to_name>
		<to_code>M0404823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,microsphere human serum</from_name>
		<from_code>314302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luspatercept-aamt</from_name>
		<from_code>2262543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa</from_name>
		<from_code>105694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>luspatercept</from_name>
		<from_code>2262544</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daprodustat</from_name>
		<from_code>2628210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vadadustat</from_name>
		<from_code>2679296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darbepoetin alfa</from_name>
		<from_code>283838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxsil</from_name>
		<from_code>77754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albumin,iodinated I-131 serum</from_name>
		<from_code>314301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylestrenol</from_name>
		<from_code>4162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetholone</from_name>
		<from_code>7813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy polyethylene glycol-epoetin beta</from_name>
		<from_code>729596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ascorbate</from_name>
		<from_code>267366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa-epbx</from_name>
		<from_code>2047589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasma protein fraction</from_name>
		<from_code>33835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia</to_name>
		<to_code>M0001119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine hydrochloride</from_name>
		<from_code>203121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dobutamine</from_name>
		<from_code>3616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone</from_name>
		<from_code>738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inamrinone lactate</from_name>
		<from_code>91236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiac Output, Low</to_name>
		<to_code>M0003453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolvaptan</from_name>
		<from_code>358257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypovolemia</to_name>
		<to_code>M0328462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anidulafungin</from_name>
		<from_code>341018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peritonitis</to_name>
		<to_code>M0016367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasma protein fraction</from_name>
		<from_code>33835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl starch 130-0.4</from_name>
		<from_code>1363352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine, DL-</from_name>
		<from_code>1657875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol bitartrate</from_name>
		<from_code>6806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>noradrenaline hydrochloride</from_name>
		<from_code>2256931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine bitartrate</from_name>
		<from_code>7508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norepinephrine</from_name>
		<from_code>7512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium lactate</from_name>
		<from_code>56489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaraminol</from_name>
		<from_code>6805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine hydrochloride</from_name>
		<from_code>71512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine</from_name>
		<from_code>8149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shock</to_name>
		<to_code>M0019782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin sulfate</from_name>
		<from_code>1621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine phosphate disodium</from_name>
		<from_code>1306123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin</from_name>
		<from_code>1622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon-133</from_name>
		<from_code>259282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine monophosphate</from_name>
		<from_code>309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine</from_name>
		<from_code>296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenosine triphosphate</from_name>
		<from_code>318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lung Diseases</to_name>
		<to_code>M0012744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate calcium</from_name>
		<from_code>152761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inulin</from_name>
		<from_code>5924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin</from_name>
		<from_code>1373458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallium nitrate</from_name>
		<from_code>25544</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium citrate anhydrous</from_name>
		<from_code>1310549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lesinurad</from_name>
		<from_code>1731031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium</from_name>
		<from_code>1368950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate</from_name>
		<from_code>82819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminohippurate sodium</from_name>
		<from_code>203194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxilan</from_name>
		<from_code>27793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine monohydrate</from_name>
		<from_code>1314248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate (1:1)</from_name>
		<from_code>317238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burosumab-twza</from_name>
		<from_code>2043854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine hydrochloride</from_name>
		<from_code>133041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yohimbine</from_name>
		<from_code>220982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichlorphenamide</from_name>
		<from_code>3353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine</from_name>
		<from_code>8120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine mesylate</from_name>
		<from_code>227240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate</from_name>
		<from_code>104994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burosumab</from_name>
		<from_code>2043855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium</from_name>
		<from_code>1903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine hydrochloride</from_name>
		<from_code>6538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine</from_name>
		<from_code>8153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin anhydrous</from_name>
		<from_code>1546031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate</from_name>
		<from_code>56466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>empagliflozin</from_name>
		<from_code>1545653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium anhydrous</from_name>
		<from_code>1371967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigo carmine</from_name>
		<from_code>227312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate calcium disodium monohydrate</from_name>
		<from_code>2001422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine acetate</from_name>
		<from_code>6537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenolsulfonphthalein</from_name>
		<from_code>8141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichloralphenazone</from_name>
		<from_code>22892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine hydrochloride</from_name>
		<from_code>203197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lysine</from_name>
		<from_code>6536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Diseases</to_name>
		<to_code>M0012014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Respiratory Distress Syndrome</to_name>
		<to_code>M0018891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrogen</from_name>
		<from_code>7456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Frostbite</to_name>
		<to_code>M0008850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Frostbite</to_name>
		<to_code>M0008850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine</from_name>
		<from_code>34347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crotamiton</from_name>
		<from_code>21766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline</from_name>
		<from_code>865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maralixibat chloride</from_name>
		<from_code>2571073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline hydrochloride</from_name>
		<from_code>81954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil sodium</from_name>
		<from_code>266663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difelikefalin</from_name>
		<from_code>2569089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil</from_name>
		<from_code>31563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint oil</from_name>
		<from_code>33094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine</from_name>
		<from_code>2354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>odevixibat sesquihydrate</from_name>
		<from_code>2563978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difelikefalin acetate</from_name>
		<from_code>2569090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline phosphate</from_name>
		<from_code>866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine hydrochloride</from_name>
		<from_code>235725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloticasone</from_name>
		<from_code>2719926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>odevixibat</from_name>
		<from_code>2563966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maralixibat</from_name>
		<from_code>2571074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloidal oatmeal</from_name>
		<from_code>221082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine hydrochloride</from_name>
		<from_code>57555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pruritus</to_name>
		<to_code>M0017935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Appendicitis</to_name>
		<to_code>M0001610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar</from_name>
		<from_code>2635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloid sulfur</from_name>
		<from_code>89767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar pitch volatiles</from_name>
		<from_code>90732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolic acid</from_name>
		<from_code>7145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine</from_name>
		<from_code>10485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ixekizumab</from_name>
		<from_code>1745099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur</from_name>
		<from_code>10223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brodalumab</from_name>
		<from_code>1872251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spesolimab</from_name>
		<from_code>2610417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab-asmn</from_name>
		<from_code>2053449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risankizumab</from_name>
		<from_code>2166040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine anhydrous</from_name>
		<from_code>1546005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone pivalate</from_name>
		<from_code>25113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efalizumab</from_name>
		<from_code>356988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetyldithranol</from_name>
		<from_code>38536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risankizumab-rzaa</from_name>
		<from_code>2166132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>24-homo-1,25-dihydroxyvitamin D3</from_name>
		<from_code>1423458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anthralin</from_name>
		<from_code>873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cod liver oil</from_name>
		<from_code>2669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimekizumab</from_name>
		<from_code>2668041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guselkumab</from_name>
		<from_code>1928588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone</from_name>
		<from_code>4458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etretinate</from_name>
		<from_code>4182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alefacept</from_name>
		<from_code>299635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur, colloidal</from_name>
		<from_code>221083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitriol</from_name>
		<from_code>1894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar extract</from_name>
		<from_code>90735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene hydrate</from_name>
		<from_code>1299898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcipotriene</from_name>
		<from_code>29365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildrakizumab</from_name>
		<from_code>2053436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spesolimab-sbzo</from_name>
		<from_code>2610418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bimekizumab-bkzx</from_name>
		<from_code>2668080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapinarof</from_name>
		<from_code>2602286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psoriasis</to_name>
		<to_code>M0017975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, anhydrous</from_name>
		<from_code>314838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate,monobasic,monohydrate</from_name>
		<from_code>221125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 400</from_name>
		<from_code>8514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sodium phosphate</from_name>
		<from_code>2288215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sennoside A&amp;B, calcium salt</from_name>
		<from_code>267741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnaltrexone</from_name>
		<from_code>29899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dihydrate</from_name>
		<from_code>1311323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil, light</from_name>
		<from_code>577312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol, L-</from_name>
		<from_code>1742749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnaltrexone bromide</from_name>
		<from_code>979111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dodecahydrate</from_name>
		<from_code>1311326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (4000 CPS)</from_name>
		<from_code>1297402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic sodium phosphate, dihydrate</from_name>
		<from_code>1311286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malt soup extract</from_name>
		<from_code>91264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol</from_name>
		<from_code>9945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycerin</from_name>
		<from_code>4910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol</from_name>
		<from_code>1551777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica sinensis preparation</from_name>
		<from_code>328141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naloxegol oxalate</from_name>
		<from_code>1593586</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heavy mineral oil</from_name>
		<from_code>258439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic</from_name>
		<from_code>235496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose</from_name>
		<from_code>6873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (100 CPS)</from_name>
		<from_code>1310583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate dihydrate</from_name>
		<from_code>314837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sennosides, USP</from_name>
		<from_code>36387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picosulfate sodium</from_name>
		<from_code>33688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfate ion</from_name>
		<from_code>1426598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine</from_name>
		<from_code>1876597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naldemedine tosylate</from_name>
		<from_code>1876598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dihydrogen phosphate dihydrate</from_name>
		<from_code>1311311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lubiprostone</from_name>
		<from_code>623033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium cation</from_name>
		<from_code>1426853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plecanatide</from_name>
		<from_code>1873752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil</from_name>
		<from_code>6972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linaclotide</from_name>
		<from_code>1307404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>senna concentrate</from_name>
		<from_code>219860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (100 CPS)</from_name>
		<from_code>1310583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic</from_name>
		<from_code>236719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose</from_name>
		<from_code>6873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 300</from_name>
		<from_code>8513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate</from_name>
		<from_code>36709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lactulose</from_name>
		<from_code>6218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, monohydrate</from_name>
		<from_code>1311342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic, anhydrous</from_name>
		<from_code>349753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylcellulose (4000 CPS)</from_name>
		<from_code>1297402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium hydrogen phosphate dehydrate</from_name>
		<from_code>1311230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dried sodium phosphate</from_name>
		<from_code>1366977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fiber</from_name>
		<from_code>70727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malt soup extract</from_name>
		<from_code>91264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Constipation</to_name>
		<to_code>M0005043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine stearate</from_name>
		<from_code>38625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine dioleate</from_name>
		<from_code>1813434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine isostearate</from_name>
		<from_code>1789185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine oleate</from_name>
		<from_code>1788982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine hydrochloride</from_name>
		<from_code>1368178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine laurylaminopropionate</from_name>
		<from_code>1996998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine</from_name>
		<from_code>38623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine polypeptide oleate condensate</from_name>
		<from_code>38624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine phosphate</from_name>
		<from_code>2287550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate</from_name>
		<from_code>4847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine hydriodide</from_name>
		<from_code>1942478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate potassium chloride</from_name>
		<from_code>1789517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt</from_name>
		<from_code>1310300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine sulfate</from_name>
		<from_code>1655913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine</from_name>
		<from_code>4845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine hydrochloride</from_name>
		<from_code>236608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine acetate</from_name>
		<from_code>2360432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Back Pain</to_name>
		<to_code>M0002115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloe extract</from_name>
		<from_code>91263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdomen, Acute</to_name>
		<to_code>M0000006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisacodyl</from_name>
		<from_code>1596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdomen, Acute</to_name>
		<to_code>M0000006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casanthranol</from_name>
		<from_code>66870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abdomen, Acute</to_name>
		<to_code>M0000006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Adhesions</to_name>
		<to_code>M0000418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Adhesions</to_name>
		<to_code>M0000418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Adhesions</to_name>
		<to_code>M0000418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tissue Adhesions</to_name>
		<to_code>M0000418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vedolizumab</from_name>
		<from_code>1538097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminosalicylic acid</from_name>
		<from_code>7833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natalizumab</from_name>
		<from_code>354770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obiltoxaximab</from_name>
		<from_code>1746906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brodalumab</from_name>
		<from_code>1872251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natalizumab-sztn</from_name>
		<from_code>2725169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crohn Disease</to_name>
		<to_code>M0005335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis</to_name>
		<to_code>M0006630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium</from_name>
		<from_code>1546438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 400</from_name>
		<from_code>8514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride</from_name>
		<from_code>2107310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium bromide</from_name>
		<from_code>2689321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 3350</from_name>
		<from_code>221147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium</from_name>
		<from_code>2689322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium tosylate</from_name>
		<from_code>2052857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 300</from_name>
		<from_code>8513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prucalopride succinate</from_name>
		<from_code>2107309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycols</from_name>
		<from_code>8516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Megacolon, Toxic</to_name>
		<to_code>M0013293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramelteon</from_name>
		<from_code>596205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluvoxamine</to_name>
		<to_code>M0025397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluvoxamine</to_name>
		<to_code>M0025397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fluvoxamine</to_name>
		<to_code>M0025397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ischemic</to_name>
		<to_code>M0025968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colitis, Ischemic</to_name>
		<to_code>M0025968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alosetron</to_name>
		<to_code>M0240025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alosetron</to_name>
		<to_code>M0240025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astemizole</from_name>
		<from_code>42328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Astemizole</to_name>
		<to_code>M0025303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astemizole</from_name>
		<from_code>42328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astemizole</from_name>
		<from_code>42328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astemizole</from_name>
		<from_code>42328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine hydrochloride</from_name>
		<from_code>235824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene hydrochloride</from_name>
		<from_code>235721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine hydrochloride</from_name>
		<from_code>236474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine maleate</from_name>
		<from_code>48936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine</from_name>
		<from_code>33283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine hydrochloride</from_name>
		<from_code>235725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide monohydrate</from_name>
		<from_code>1309404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast sodium</from_name>
		<from_code>115713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorcyclizine</from_name>
		<from_code>2354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen fumarate</from_name>
		<from_code>11404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine polistirex</from_name>
		<from_code>236792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine polistirex</from_name>
		<from_code>407885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine</from_name>
		<from_code>20610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium cation</from_name>
		<from_code>1546373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine</from_name>
		<from_code>87636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate, (R)-</from_name>
		<from_code>2622915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desloratadine</from_name>
		<from_code>275635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine citrate</from_name>
		<from_code>221141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine tartrate</from_name>
		<from_code>221137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine hydrochloride</from_name>
		<from_code>3266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclesonide</from_name>
		<from_code>274964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide</from_name>
		<from_code>203212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine</from_name>
		<from_code>8896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium</from_name>
		<from_code>7213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine resin complex</from_name>
		<from_code>314786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine</from_name>
		<from_code>33408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen</from_name>
		<from_code>6146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine tannate</from_name>
		<from_code>686390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine</from_name>
		<from_code>18603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast</from_name>
		<from_code>88249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine</from_name>
		<from_code>22696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine hydrochloride</from_name>
		<from_code>91168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loratadine</from_name>
		<from_code>28889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide (11.beta.,16.alpha.(S))</from_name>
		<from_code>1367172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine hydrochloride</from_name>
		<from_code>203150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipratropium bromide anhydrous</from_name>
		<from_code>1445143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine sulfate</from_name>
		<from_code>91169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methapyrilene</from_name>
		<from_code>6822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Perennial</to_name>
		<to_code>M0019020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine hydrochloride</from_name>
		<from_code>71534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine tannate</from_name>
		<from_code>1099727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine hydrochloride</from_name>
		<from_code>235824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen</from_name>
		<from_code>6146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelastine</from_name>
		<from_code>18603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline sulfate</from_name>
		<from_code>2680384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine hydrochloride</from_name>
		<from_code>1294532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine difumarate</from_name>
		<from_code>221094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil</from_name>
		<from_code>31563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcaftadine</from_name>
		<from_code>1000082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine</from_name>
		<from_code>39684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triprolidine</from_name>
		<from_code>10849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinastine hydrochloride</from_name>
		<from_code>236961</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emedastine</from_name>
		<from_code>28144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine hydrochloride</from_name>
		<from_code>236599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrysone</from_name>
		<from_code>29439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline</from_name>
		<from_code>865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine</from_name>
		<from_code>863035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketotifen fumarate</from_name>
		<from_code>11404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepotastine besilate</from_name>
		<from_code>658552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline phosphate</from_name>
		<from_code>866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine</from_name>
		<from_code>28627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antazoline hydrochloride</from_name>
		<from_code>81954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olopatadine</from_name>
		<from_code>135391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil sodium</from_name>
		<from_code>266663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast</from_name>
		<from_code>19551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemirolast potassium</from_name>
		<from_code>259318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Conjunctivitis, Allergic</to_name>
		<to_code>M0005017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine</from_name>
		<from_code>33283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine dihydrochloride</from_name>
		<from_code>142136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine maleate</from_name>
		<from_code>48936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequitazine</from_name>
		<from_code>29528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine hydrochloride</from_name>
		<from_code>236474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine</from_name>
		<from_code>33408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine resin complex</from_name>
		<from_code>314786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine polistirex</from_name>
		<from_code>236792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine hydrochloride</from_name>
		<from_code>350466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine</from_name>
		<from_code>5333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine tannate</from_name>
		<from_code>686390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine</from_name>
		<from_code>20610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine phosphate</from_name>
		<from_code>26925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexbrompheniramine</from_name>
		<from_code>22696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine aminosalicylate</from_name>
		<from_code>159340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine</from_name>
		<from_code>8132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindamine tartrate</from_name>
		<from_code>221137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetirizine hydrochloride</from_name>
		<from_code>203150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loratadine</from_name>
		<from_code>28889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyltoloxamine citrate</from_name>
		<from_code>221141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pheniramine maleate</from_name>
		<from_code>266959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desloratadine</from_name>
		<from_code>275635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fexofenadine</from_name>
		<from_code>87636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urticaria</to_name>
		<to_code>M0022414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Delavirdine</to_name>
		<to_code>M0029713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Metronidazole</to_name>
		<to_code>M0013695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Metronidazole</to_name>
		<to_code>M0013695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride tetrahydrate</from_name>
		<from_code>2003593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic anhydrous</from_name>
		<from_code>1307158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium hydrogen phosphate dehydrate</from_name>
		<from_code>1311230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone (micronized)</from_name>
		<from_code>221168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, monohydrate</from_name>
		<from_code>1311342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probenecid</from_name>
		<from_code>8698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic, anhydrous</from_name>
		<from_code>349753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brinzolamide</from_name>
		<from_code>194881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chloride</from_name>
		<from_code>8591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate</from_name>
		<from_code>36709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium,chelated</from_name>
		<from_code>259277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid monohydrate</from_name>
		<from_code>221079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum magnesium silicate</from_name>
		<from_code>17614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet sodium</from_name>
		<from_code>57529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium gluconate</from_name>
		<from_code>89903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium chloride</from_name>
		<from_code>712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dorzolamide</from_name>
		<from_code>60207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine</from_name>
		<from_code>4637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, 1-stearyl ester</from_name>
		<from_code>1435636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergocalciferol</from_name>
		<from_code>4018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarnet</from_name>
		<from_code>33562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone isocaproate</from_name>
		<from_code>75806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin</from_name>
		<from_code>6809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride hexahydrate</from_name>
		<from_code>221118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenolsulfonphthalein</from_name>
		<from_code>8141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic, monohydrate</from_name>
		<from_code>1311357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic sodium phosphate, dihydrate</from_name>
		<from_code>1311286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dorzolamide hydrochloride</from_name>
		<from_code>236065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium amino acid chelate</from_name>
		<from_code>486895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol anhydrous</from_name>
		<from_code>1855064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibasic sodium phosphate heptahydrate</from_name>
		<from_code>221090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium carbonate</from_name>
		<from_code>29155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfabenzamide</from_name>
		<from_code>37320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tribasic sodium phosphate</from_name>
		<from_code>36710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metformin hydrochloride</from_name>
		<from_code>235743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate anhydrous</from_name>
		<from_code>1657484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dodecahydrate</from_name>
		<from_code>1311326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate dibasic trihydrate</from_name>
		<from_code>2475957</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride anhydrous</from_name>
		<from_code>1311539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate</from_name>
		<from_code>29164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium oxide</from_name>
		<from_code>6582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sodium phosphate</from_name>
		<from_code>2288215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icodextrin</from_name>
		<from_code>140480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methazolamide</from_name>
		<from_code>6826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, tribasic, dodecahydrate</from_name>
		<from_code>1311345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobasic potassium phosphate</from_name>
		<from_code>55019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chloride</from_name>
		<from_code>6579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dried sodium phosphate</from_name>
		<from_code>1366977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic</from_name>
		<from_code>236719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fomepizole</from_name>
		<from_code>15226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium acetate tetrahydrate</from_name>
		<from_code>317246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone decanoate</from_name>
		<from_code>37858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate dibasic trihydrate</from_name>
		<from_code>237119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium phosphate</from_name>
		<from_code>34322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate anhydrous</from_name>
		<from_code>1792467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium gluconate</from_name>
		<from_code>52358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium aspartate</from_name>
		<from_code>142131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>galantamine hydrobromide</from_name>
		<from_code>860693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dihydrogen phosphate dihydrate</from_name>
		<from_code>1311311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, dibasic</from_name>
		<from_code>1482795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin</from_name>
		<from_code>1992672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, tribasic, pentahydrate</from_name>
		<from_code>1313280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finerenone</from_name>
		<from_code>2562811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium</from_name>
		<from_code>6574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium glycinate</from_name>
		<from_code>476818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibasic potassium phosphate</from_name>
		<from_code>55018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin pidolate</from_name>
		<from_code>1992674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate micronized</from_name>
		<from_code>221100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium citrate sesquihydrate</from_name>
		<from_code>2049608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, monobasic</from_name>
		<from_code>235496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate dihydrate</from_name>
		<from_code>314837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acitretin</from_name>
		<from_code>16818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bicarbonate</from_name>
		<from_code>34296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid</from_name>
		<from_code>21183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloral hydrate</from_name>
		<from_code>2344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium acetate</from_name>
		<from_code>54987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferasirox</from_name>
		<from_code>614373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate</from_name>
		<from_code>8703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate lysine</from_name>
		<from_code>236477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium stearate</from_name>
		<from_code>1310567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lesinurad</from_name>
		<from_code>1731031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, dihydrate</from_name>
		<from_code>1311323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate, dibasic, anhydrous</from_name>
		<from_code>314838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phosphate,monobasic,monohydrate</from_name>
		<from_code>221125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartate magnesium hydrochloride</from_name>
		<from_code>1167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure</to_name>
		<to_code>M0025974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bepridil</to_name>
		<to_code>M0024153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amprenavir</to_name>
		<to_code>M0250495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 7 vaccine live</from_name>
		<from_code>1099937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carmustine</from_name>
		<from_code>2105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alitretinoin</from_name>
		<from_code>81864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raloxifene hydrochloride</from_name>
		<from_code>166551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue cation</from_name>
		<from_code>1546414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan</from_name>
		<from_code>75207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone</from_name>
		<from_code>6813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine sulfate</from_name>
		<from_code>11203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine</from_name>
		<from_code>9392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel</from_name>
		<from_code>56946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin sodium</from_name>
		<from_code>71227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine phosphate</from_name>
		<from_code>25102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfabenzamide</from_name>
		<from_code>37320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin</from_name>
		<from_code>1044584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric chloride</from_name>
		<from_code>21833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp</from_name>
		<from_code>2560213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine hydrochloride</from_name>
		<from_code>66925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enzalutamide</from_name>
		<from_code>1307298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orlistat</from_name>
		<from_code>37925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ulipristal</from_name>
		<from_code>1005921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone</from_name>
		<from_code>227518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine</from_name>
		<from_code>28627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone hydrochloride</from_name>
		<from_code>82063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcitriol</from_name>
		<from_code>1894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abiraterone acetate</from_name>
		<from_code>1100071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, A</from_name>
		<from_code>253166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotepa</from_name>
		<from_code>10473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan hydrochloride</from_name>
		<from_code>153329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienestrol</from_name>
		<from_code>3368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadone hydrochloride</from_name>
		<from_code>218337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambrisentan</from_name>
		<from_code>358274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retatrutide</from_name>
		<from_code>2722410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride hemihydrate</from_name>
		<from_code>1597623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donislecel</from_name>
		<from_code>2642217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urofollitropin</from_name>
		<from_code>134404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital sodium</from_name>
		<from_code>203085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol monohydrate</from_name>
		<from_code>2539035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan hydrochloride</from_name>
		<from_code>235857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone</from_name>
		<from_code>7005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril maleate</from_name>
		<from_code>203123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin</from_name>
		<from_code>1300701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide</from_name>
		<from_code>4179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine hydrochloride</from_name>
		<from_code>1426886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix</from_name>
		<from_code>2049846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoposide phosphate</from_name>
		<from_code>24614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital</from_name>
		<from_code>8004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine</from_name>
		<from_code>12574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiopronin</from_name>
		<from_code>6765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin hydrochloride</from_name>
		<from_code>81992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bexarotene</from_name>
		<from_code>233272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin beta</from_name>
		<from_code>25357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melphalan</from_name>
		<from_code>6718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, attenuated Schwarz strain</from_name>
		<from_code>2603499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper</from_name>
		<from_code>2837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam hydrochloride</from_name>
		<from_code>71484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teniposide</from_name>
		<from_code>10362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>degarelix</from_name>
		<from_code>475230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene</from_name>
		<from_code>1441386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurophate</from_name>
		<from_code>6027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine anhydrous</from_name>
		<from_code>1546028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylestrenol</from_name>
		<from_code>4162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ulipristal</from_name>
		<from_code>1005921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxuridine</from_name>
		<from_code>4488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene citrate</from_name>
		<from_code>49953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper chloride</from_name>
		<from_code>150596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper Cu-64</from_name>
		<from_code>2200143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpropamide</from_name>
		<from_code>2404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bazedoxifene acetate</from_name>
		<from_code>1442171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin calcium</from_name>
		<from_code>323828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine hydrochloride</from_name>
		<from_code>154985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone</from_name>
		<from_code>3423</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate liposome</from_name>
		<from_code>221087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalapril</from_name>
		<from_code>3827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-bnht</from_name>
		<from_code>2717527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillamine</from_name>
		<from_code>7975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomustine</from_name>
		<from_code>6466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin liposomal</from_name>
		<from_code>214468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fludarabine</from_name>
		<from_code>24698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trelstar pamoate</from_name>
		<from_code>905060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohydroxamic acid</from_name>
		<from_code>16728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyestradiol phosphate</from_name>
		<from_code>34120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letrozole</from_name>
		<from_code>72965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol acetate</from_name>
		<from_code>29451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin pamoate</from_name>
		<from_code>338529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-kyqq</from_name>
		<from_code>2725924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine</from_name>
		<from_code>3022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gotu kola extract</from_name>
		<from_code>319837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elinzanetant</from_name>
		<from_code>2725511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ulipristal acetate</from_name>
		<from_code>1005920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>megestrol</from_name>
		<from_code>6703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol tetrasodium</from_name>
		<from_code>281876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-dssb</from_name>
		<from_code>2725498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isotretinoin</from_name>
		<from_code>6064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide</from_name>
		<from_code>10635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus B serotype 7 strain 55142</from_name>
		<from_code>1802483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-qbde</from_name>
		<from_code>2725562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir hydrochloride</from_name>
		<from_code>283815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sonidegib</from_name>
		<from_code>1659191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix</from_name>
		<from_code>68147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estazolam</from_name>
		<from_code>4077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab</from_name>
		<from_code>993449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin citrate</from_name>
		<from_code>1364321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin sulfate</from_name>
		<from_code>1621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valganciclovir</from_name>
		<from_code>275891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dinoprostone</from_name>
		<from_code>3478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisplatin</from_name>
		<from_code>2555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butalbital</from_name>
		<from_code>19860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymetholone</from_name>
		<from_code>7813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>24-homo-1,25-dihydroxyvitamin D3</from_name>
		<from_code>1423458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>busulfan</from_name>
		<from_code>1828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teriflunomide</from_name>
		<from_code>1310520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ledipasvir</from_name>
		<from_code>1591922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper sulfate</from_name>
		<from_code>21579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone</from_name>
		<from_code>3143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital sodium</from_name>
		<from_code>91109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomalidomide</from_name>
		<from_code>1369713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercaptopurine</from_name>
		<from_code>103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liraglutide</from_name>
		<from_code>475968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin</from_name>
		<from_code>5650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrorelix acetate</from_name>
		<from_code>259338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abiraterone</from_name>
		<from_code>1100072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin</from_name>
		<from_code>50610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine bitartrate</from_name>
		<from_code>81990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ulipristal acetate</from_name>
		<from_code>1005920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin</from_name>
		<from_code>50975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel protein-bound</from_name>
		<from_code>486610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen citrate</from_name>
		<from_code>40137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol</from_name>
		<from_code>25284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride</from_name>
		<from_code>1300700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin</from_name>
		<from_code>301542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin microsphere</from_name>
		<from_code>221175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemtuzumab ozogamicin</from_name>
		<from_code>1294580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine</from_name>
		<from_code>10485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorambucil</from_name>
		<from_code>2346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol</from_name>
		<from_code>2539031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-mobz</from_name>
		<from_code>2729308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergocalciferol</from_name>
		<from_code>4018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valdecoxib</from_name>
		<from_code>278567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone terephthalate</from_name>
		<from_code>159821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemcitabine hydrochloride</from_name>
		<from_code>236234</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toremifene</from_name>
		<from_code>38409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sonidegib phosphate</from_name>
		<from_code>1659192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donislecel-jujn</from_name>
		<from_code>2642260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentostatin</from_name>
		<from_code>8011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenytoin</from_name>
		<from_code>8183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macitentan</from_name>
		<from_code>1442132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol</from_name>
		<from_code>24591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrotachysterol</from_name>
		<from_code>3429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bleomycin</from_name>
		<from_code>1622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxandrolone</from_name>
		<from_code>7779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfanilamide</from_name>
		<from_code>10184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lutropin alfa</from_name>
		<from_code>388084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazepam</from_name>
		<from_code>8627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-nxxp</from_name>
		<from_code>2723334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl nitrite</from_name>
		<from_code>742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capecitabine</from_name>
		<from_code>194000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin acetate</from_name>
		<from_code>236538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin acetate</from_name>
		<from_code>1044583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolbutamide sodium</from_name>
		<from_code>221173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrienone</from_name>
		<from_code>7519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procarbazine</from_name>
		<from_code>8702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, RIT-4385 strain</from_name>
		<from_code>2603501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid anhydrous</from_name>
		<from_code>1546014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyestradiol</from_name>
		<from_code>34119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital</from_name>
		<from_code>477631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ospemifene</from_name>
		<from_code>1370971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone sodium sulfate</from_name>
		<from_code>1366962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide acetate</from_name>
		<from_code>203217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone acetate</from_name>
		<from_code>2055977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human adenovirus E serotype 4 strain CL-68578</from_name>
		<from_code>1299785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocabastine hydrochloride</from_name>
		<from_code>1294532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaliplatin</from_name>
		<from_code>32592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital</from_name>
		<from_code>8134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin sodium</from_name>
		<from_code>72875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone hydrochloride</from_name>
		<from_code>203129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-bmwo</from_name>
		<from_code>2717851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follitropin alfa</from_name>
		<from_code>386938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zonisamide</from_name>
		<from_code>39998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>misoprostol</from_name>
		<from_code>42331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, esterified (USP)</from_name>
		<from_code>214549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene</from_name>
		<from_code>2596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincristine</from_name>
		<from_code>11202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elagolix sodium</from_name>
		<from_code>2049847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bortezomib</from_name>
		<from_code>358258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89 chloride</from_name>
		<from_code>281890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper gluconate</from_name>
		<from_code>2839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetohexamide</from_name>
		<from_code>173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol</from_name>
		<from_code>24591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone decanoate</from_name>
		<from_code>37858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin</from_name>
		<from_code>10753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raloxifene</from_name>
		<from_code>72143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydromorphone hydrochloride</from_name>
		<from_code>203177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temozolomide</from_name>
		<from_code>37776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylstilbestrol</from_name>
		<from_code>3390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib ditosylate</from_name>
		<from_code>481474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin</from_name>
		<from_code>41127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>riociguat</from_name>
		<from_code>1439816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histrelin acetate</from_name>
		<from_code>1294622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonoxynol-9</from_name>
		<from_code>53750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin</from_name>
		<from_code>596723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital sodium</from_name>
		<from_code>82077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daunorubicin</from_name>
		<from_code>3109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imatinib mesylate</from_name>
		<from_code>284924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zoledronic acid</from_name>
		<from_code>77655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorcaserin hydrochloride anhydrous</from_name>
		<from_code>1808546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atrasentan</from_name>
		<from_code>2710449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bosentan anhydrous</from_name>
		<from_code>1468845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene</from_name>
		<from_code>8785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin sodium</from_name>
		<from_code>221072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thalidomide</from_name>
		<from_code>10432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix acetate</from_name>
		<from_code>259264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone isocaproate</from_name>
		<from_code>75806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol anhydrous</from_name>
		<from_code>1855064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene hydrochloride</from_name>
		<from_code>71517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin acetate</from_name>
		<from_code>203146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cladribine</from_name>
		<from_code>44157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylthiouracil</from_name>
		<from_code>8794</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finasteride</from_name>
		<from_code>25025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic</from_name>
		<from_code>1111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutamide</from_name>
		<from_code>4508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>degarelix acetate</from_name>
		<from_code>835863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine</from_name>
		<from_code>3041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ifosfamide</from_name>
		<from_code>5657</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fulvestrant</from_name>
		<from_code>282357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorotrianisene</from_name>
		<from_code>2397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bicalutamide</from_name>
		<from_code>83008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choriogonadotropin alfa</from_name>
		<from_code>283550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin</from_name>
		<from_code>28656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stanozolol</from_name>
		<from_code>10032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ezetimibe</from_name>
		<from_code>341248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine tartrate</from_name>
		<from_code>114527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irinotecan</from_name>
		<from_code>51499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adenovirus type 4 vaccine live</from_name>
		<from_code>1099933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethynodrel</from_name>
		<from_code>7515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone (micronized)</from_name>
		<from_code>221168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palovarotene</from_name>
		<from_code>2663954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic conjugated estrogens, B</from_name>
		<from_code>618365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>follicle stimulating hormone, porcine</from_name>
		<from_code>1594665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leflunomide</from_name>
		<from_code>27169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyltestosterone</from_name>
		<from_code>6904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric oxide</from_name>
		<from_code>21837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomiphene citrate</from_name>
		<from_code>142431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boceprevir</from_name>
		<from_code>1102129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene napsylate</from_name>
		<from_code>8786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp citrate</from_name>
		<from_code>2560215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octoxynol-9</from_name>
		<from_code>54034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam maleate</from_name>
		<from_code>142441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quazepam</from_name>
		<from_code>35185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idarubicin hydrochloride</from_name>
		<from_code>82124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide</from_name>
		<from_code>42375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytarabine liposome</from_name>
		<from_code>968804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinorelbine</from_name>
		<from_code>39541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lapatinib</from_name>
		<from_code>480167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dutasteride</from_name>
		<from_code>228790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anastrozole</from_name>
		<from_code>84857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam</from_name>
		<from_code>4501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choriogonadotropin alfa</from_name>
		<from_code>283550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalbuphine</from_name>
		<from_code>7238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rofecoxib</from_name>
		<from_code>232158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazamide</from_name>
		<from_code>10633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioguanine anhydrous</from_name>
		<from_code>1546005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triptorelin</from_name>
		<from_code>38782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganirelix</from_name>
		<from_code>35825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver sulfadiazine</from_name>
		<from_code>9793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide mesylate</from_name>
		<from_code>2595041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine hydrochloride</from_name>
		<from_code>105470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue anhydrous</from_name>
		<from_code>2198975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>travoprost</from_name>
		<from_code>283809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequinol</from_name>
		<from_code>15080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethynodrel</from_name>
		<from_code>7515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin acetate</from_name>
		<from_code>203147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tamoxifen</from_name>
		<from_code>10324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enalaprilat anhydrous</from_name>
		<from_code>1545989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exemestane</from_name>
		<from_code>258494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic trioxide</from_name>
		<from_code>18330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mumps Vaccine</from_name>
		<from_code>763656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>denosumab-bbdz</from_name>
		<from_code>2715382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenalidomide</from_name>
		<from_code>342369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy</to_name>
		<to_code>M0017471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atrasentan</from_name>
		<from_code>2710449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atrasentan</to_name>
		<to_code>M0393223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atrasentan</from_name>
		<from_code>2710449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid</to_name>
		<to_code>M000642028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atrasentan</from_name>
		<from_code>2710449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteinuria</to_name>
		<to_code>M0017891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibeprenlimab-szsi</from_name>
		<from_code>2728394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteinuria</to_name>
		<to_code>M0017891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparsentan</from_name>
		<from_code>2630535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteinuria</to_name>
		<to_code>M0017891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibeprenlimab</from_name>
		<from_code>2728380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteinuria</to_name>
		<to_code>M0017891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone phenpropionate</from_name>
		<from_code>31495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</from_name>
		<from_code>805573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulism immune globulin IV human</from_name>
		<from_code>544488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</from_name>
		<from_code>798294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sargramostim</from_name>
		<from_code>69634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G1 vaccine</from_name>
		<from_code>798286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G3 vaccine</from_name>
		<from_code>798290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G4 vaccine</from_name>
		<from_code>798292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ROTAVIRUS VACCINE, LIVE</from_name>
		<from_code>253199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine</from_name>
		<from_code>134615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone decanoate</from_name>
		<from_code>31494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human-bovine reassortant rotavirus strain G2 vaccine</from_name>
		<from_code>798288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver sulfadiazine</from_name>
		<from_code>9793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dactinomycin</from_name>
		<from_code>3100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nandrolone</from_name>
		<from_code>7244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine tartrate</from_name>
		<from_code>39171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant</to_name>
		<to_code>M0011265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlexanox</from_name>
		<from_code>46307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine hydrochloride</from_name>
		<from_code>142443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finasteride</from_name>
		<from_code>25025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benznidazole</from_name>
		<from_code>18994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxsalen</from_name>
		<from_code>6854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lyme Disease Vaccine</from_name>
		<from_code>214177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyclidine</from_name>
		<from_code>8718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dutasteride</from_name>
		<from_code>228790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bezlotoxumab</from_name>
		<from_code>1855048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Child</to_name>
		<to_code>M0004045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propafenone</to_name>
		<to_code>M0017736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antipsychotic Agents</to_name>
		<to_code>M0021770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antipsychotic Agents</to_name>
		<to_code>M0021770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol monohydrate</from_name>
		<from_code>2539035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin</from_name>
		<from_code>17300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol</from_name>
		<from_code>2539031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfuzosin hydrochloride</from_name>
		<from_code>46043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide acetate</from_name>
		<from_code>42686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ritonavir</to_name>
		<to_code>M0028918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disulfiram</to_name>
		<to_code>M0006600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disulfiram</to_name>
		<to_code>M0006600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disulfiram</to_name>
		<to_code>M0006600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disulfiram</to_name>
		<to_code>M0006600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benznidazole</from_name>
		<from_code>18994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disulfiram</to_name>
		<to_code>M0006600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flecainide</from_name>
		<from_code>4441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Flecainide</to_name>
		<to_code>M0008556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atazanavir Sulfate</to_name>
		<to_code>M0445555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline oxide</from_name>
		<from_code>236734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod</from_name>
		<from_code>2288236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar</from_name>
		<from_code>1537034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ponesimod</from_name>
		<from_code>2532300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finerenone</from_name>
		<from_code>2562811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor</from_name>
		<from_code>1656052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium anhydrous</from_name>
		<from_code>1372638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (USP)</from_name>
		<from_code>10572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine hydrochloride</from_name>
		<from_code>91240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil</from_name>
		<from_code>6984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ospemifene</from_name>
		<from_code>1370971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evolocumab</from_name>
		<from_code>1665684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine</from_name>
		<from_code>6673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticagrelor</from_name>
		<from_code>1116632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>siponimod</from_name>
		<from_code>2121085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor tetrasodium</from_name>
		<from_code>1656051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel bisulfate</from_name>
		<from_code>236991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium</from_name>
		<from_code>40144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate</from_name>
		<from_code>1651695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin</from_name>
		<from_code>3995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (beef)</from_name>
		<from_code>325521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate ester</from_name>
		<from_code>1926479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parnaparin</from_name>
		<from_code>69528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epirubicin hydrochloride</from_name>
		<from_code>203213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol</from_name>
		<from_code>24591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozanimod hydrochloride</from_name>
		<from_code>2288235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel</from_name>
		<from_code>613391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel hydrochloride</from_name>
		<from_code>847020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alirocumab</from_name>
		<from_code>1659152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar sulfate</from_name>
		<from_code>1537050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Infarction</to_name>
		<to_code>M0014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amitriptyline Hydrochloride</to_name>
		<to_code>M0330766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_active_metabolites</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline hydrochloride</from_name>
		<from_code>203168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nortriptyline</to_name>
		<to_code>M0015002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amitriptyline Hydrochloride</to_name>
		<to_code>M0330766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amitriptyline Hydrochloride</to_name>
		<to_code>M0330766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine hydrochloride</from_name>
		<from_code>203185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor (natural)</from_name>
		<from_code>1298738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine</from_name>
		<from_code>259453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate hydrochloride</from_name>
		<from_code>235398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine hydrochloride</from_name>
		<from_code>91189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine</from_name>
		<from_code>35780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride anhydrous</from_name>
		<from_code>2198974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor oil</from_name>
		<from_code>1297880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene napsylate</from_name>
		<from_code>8786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl acetate hydrochloride</from_name>
		<from_code>82043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol hydrochloride</from_name>
		<from_code>82110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capsaicin</from_name>
		<from_code>1992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine hydrochloride</from_name>
		<from_code>2117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alphaprodine</from_name>
		<from_code>594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate A sodium</from_name>
		<from_code>476847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum oleoresin</from_name>
		<from_code>235787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine</from_name>
		<from_code>1819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhydrous</from_name>
		<from_code>1545976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor</from_name>
		<from_code>1952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine</from_name>
		<from_code>2653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine hydrochloride</from_name>
		<from_code>228054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride monohydrate</from_name>
		<from_code>1298851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine anhyd</from_name>
		<from_code>236131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine</from_name>
		<from_code>8701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trolamine salicylate</from_name>
		<from_code>38866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, bovine</from_name>
		<from_code>1306129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine hydrochloride</from_name>
		<from_code>259454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine</from_name>
		<from_code>592464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride</from_name>
		<from_code>267396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine</from_name>
		<from_code>23088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol</from_name>
		<from_code>1841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene hydrochloride</from_name>
		<from_code>71517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dezocine</from_name>
		<from_code>22713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine</from_name>
		<from_code>6759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol glucuronide</from_name>
		<from_code>2704947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronic acid</from_name>
		<from_code>5463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propoxyphene</from_name>
		<from_code>8785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine hydrochloride</from_name>
		<from_code>106558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine hydrochloride</from_name>
		<from_code>57555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium</from_name>
		<from_code>1605114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlorofluoromethane</from_name>
		<from_code>38578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol, (+)-</from_name>
		<from_code>1648123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitriptyline pamoate</from_name>
		<from_code>235737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate (shark)</from_name>
		<from_code>1789516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol hydrochloride</from_name>
		<from_code>857492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, porcine</from_name>
		<from_code>1306202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tryptophan</from_name>
		<from_code>10898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmedetomidine</from_name>
		<from_code>48937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha,alpha-dibromo-d-camphor</from_name>
		<from_code>1858362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butacaine</from_name>
		<from_code>1829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antipyrine</from_name>
		<from_code>1001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine hydrochloride</from_name>
		<from_code>91188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine</from_name>
		<from_code>10391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone hydrochloride</from_name>
		<from_code>2122776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dyclonine</from_name>
		<from_code>23744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoheptazine citrate</from_name>
		<from_code>235416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine camsyl</from_name>
		<from_code>236236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil citrate</from_name>
		<from_code>58964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benoxinate</from_name>
		<from_code>18889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine</from_name>
		<from_code>8686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine hydrochloride</from_name>
		<from_code>81985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoheptazine</from_name>
		<from_code>24484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine</from_name>
		<from_code>1815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate</from_name>
		<from_code>52364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (bovine)</from_name>
		<from_code>1299929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone hydrochloride</from_name>
		<from_code>203129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfates</from_name>
		<from_code>2473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine</from_name>
		<from_code>8701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl citrate</from_name>
		<from_code>142436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine hydrochloride</from_name>
		<from_code>2117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor</from_name>
		<from_code>1952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>articaine</from_name>
		<from_code>592464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitoxantrone</from_name>
		<from_code>7005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine hydrochloride</from_name>
		<from_code>259454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prilocaine hydrochloride</from_name>
		<from_code>2557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trolamine salicylate</from_name>
		<from_code>38866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buprenorphine hydrochloride</from_name>
		<from_code>203841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hyaluronate</from_name>
		<from_code>42892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl chloride</from_name>
		<from_code>4141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liquefied phenol</from_name>
		<from_code>239351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl</from_name>
		<from_code>237005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine</from_name>
		<from_code>3339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin carbamate</from_name>
		<from_code>20880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthol</from_name>
		<from_code>6750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (shark)</from_name>
		<from_code>1358172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor (natural)</from_name>
		<from_code>1298738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine hydrochloride</from_name>
		<from_code>203185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dibucaine hydrochloride</from_name>
		<from_code>235402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89 chloride</from_name>
		<from_code>281890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramoxine</from_name>
		<from_code>34347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphor oil</from_name>
		<from_code>1297880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine</from_name>
		<from_code>8120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil hydrochloride</from_name>
		<from_code>203203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine</from_name>
		<from_code>259453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine hydrochloride</from_name>
		<from_code>91189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl</from_name>
		<from_code>4337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracaine</from_name>
		<from_code>10391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (porcine)</from_name>
		<from_code>1366974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenol</from_name>
		<from_code>33290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoheptazine citrate</from_name>
		<from_code>235416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin</from_name>
		<from_code>2399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sufentanil</from_name>
		<from_code>56795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butacaine</from_name>
		<from_code>1829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alphaprodine hydrochloride</from_name>
		<from_code>7433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramadol</from_name>
		<from_code>10689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil hydrochloride</from_name>
		<from_code>236540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyllin copper complex</from_name>
		<from_code>82242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupivacaine hydrochloride anhydrous</from_name>
		<from_code>1375412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate anhydrous</from_name>
		<from_code>1652891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fentanyl hydrochloride</from_name>
		<from_code>1652097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacetin</from_name>
		<from_code>8113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine hydrochloride</from_name>
		<from_code>1115966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoheptazine</from_name>
		<from_code>24484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepivacaine</from_name>
		<from_code>6759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrocodeine bitartrate</from_name>
		<from_code>104966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylamide</from_name>
		<from_code>9518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine</from_name>
		<from_code>2670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazopyridine hydrochloride</from_name>
		<from_code>203197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha,alpha-dibromo-d-camphor</from_name>
		<from_code>1858362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropivacaine hydrochloride</from_name>
		<from_code>236539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remifentanil</from_name>
		<from_code>73032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaine hydrochloride</from_name>
		<from_code>106558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfentanil</from_name>
		<from_code>480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabidiol</from_name>
		<from_code>2045371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pain</to_name>
		<to_code>M0015742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nortriptyline</to_name>
		<to_code>M0015002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dibenzoxazepines</to_name>
		<to_code>M0006253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amoxapine</to_name>
		<to_code>M0001008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxapine</from_name>
		<from_code>722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychophysiologic Disorders</to_name>
		<to_code>M0018036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amoxapine</to_name>
		<to_code>M0001008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amoxapine</to_name>
		<to_code>M0001008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartame</from_name>
		<from_code>1311524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspartame</to_name>
		<to_code>M0001821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Andrographis paniculata top extract</from_name>
		<from_code>1998719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Andrographis paniculata top extract</to_name>
		<to_code>M000757327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antirabies serum,equine</from_name>
		<from_code>485234</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies</to_name>
		<to_code>M0018366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine flury-lep strain</from_name>
		<from_code>830457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies</to_name>
		<to_code>M0018366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies immune globulin, human</from_name>
		<from_code>89886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies</to_name>
		<to_code>M0018366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</from_name>
		<from_code>830464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies</to_name>
		<to_code>M0018366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atipamezole</from_name>
		<from_code>18475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>atipamezole</to_name>
		<to_code>M0144628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>African Pygeum extract</from_name>
		<from_code>580117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pygeum extract</to_name>
		<to_code>M000744240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antimony trisulfide</from_name>
		<from_code>1316091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>antimony trisulfide</to_name>
		<to_code>M0177013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avilamycin</from_name>
		<from_code>1661561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>avilamycin</to_name>
		<to_code>M0049299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amprolium</from_name>
		<from_code>1006654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amprolium</to_name>
		<to_code>M0001031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous lactose</from_name>
		<from_code>1307662</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anhydrous Lactose</to_name>
		<to_code>M0582744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acriflavine hydrochloride</from_name>
		<from_code>1664337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3,6-diamino-10-methylacridinium chloride hydrochloride</to_name>
		<to_code>M0316859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acriflavine hydrochloride</from_name>
		<from_code>1664337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acriflavine chloride</to_name>
		<to_code>M0316863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amyl acetate</from_name>
		<from_code>1370452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amyl acetate</to_name>
		<to_code>M0047453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldioxa</from_name>
		<from_code>23161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aldioxa</to_name>
		<to_code>M0067845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acesulfame</from_name>
		<from_code>1310546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetosulfame</to_name>
		<to_code>M0048866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminacrine hydrochloride</from_name>
		<from_code>81949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminacrine Hydrochloride</to_name>
		<to_code>M0000910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha 1-antitrypsin</from_name>
		<from_code>535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha 1-Antitrypsin</to_name>
		<to_code>M0000780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus ruber</from_name>
		<from_code>1324086</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillus ruber</to_name>
		<to_code>M000688678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asiatic acid</from_name>
		<from_code>1551574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>asiatic acid</to_name>
		<to_code>M0067469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminophenol</from_name>
		<from_code>1435279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-aminophenol</to_name>
		<to_code>M0087507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arbutamine</from_name>
		<from_code>61609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arbutamine</to_name>
		<to_code>M0205855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anaplasma phagocytophilum</from_name>
		<from_code>2168766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anaplasma phagocytophilum</to_name>
		<to_code>M0425509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-amino-2-hydroxytoluene</from_name>
		<from_code>1740236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-amino-2-hydroxytoluene</to_name>
		<to_code>M0533417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amorphophallus konjac root extract</from_name>
		<from_code>1537210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amorphophallus konjac root extract</to_name>
		<to_code>M000745031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia spirit, aromatic</from_name>
		<from_code>317201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia spirit, aromatic</from_name>
		<from_code>317201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Bites and Stings</to_name>
		<to_code>M0011381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xenon</from_name>
		<from_code>11363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium chloride</from_name>
		<from_code>52796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metocurine iodide</from_name>
		<from_code>203206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital sodium</from_name>
		<from_code>314874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium chloride</from_name>
		<from_code>49275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital</from_name>
		<from_code>38077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine hydrochloride</from_name>
		<from_code>259454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desflurane</from_name>
		<from_code>27340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levobupivacaine</from_name>
		<from_code>259453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium</from_name>
		<from_code>23651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium</from_name>
		<from_code>30077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unconsciousness</to_name>
		<to_code>M0022251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ichthammol</from_name>
		<from_code>5645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Bites and Stings</to_name>
		<to_code>M0011381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boric acid</from_name>
		<from_code>1700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insect Bites and Stings</to_name>
		<to_code>M0011381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-amino-1,3-propanediol</from_name>
		<from_code>2467839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>serinol</to_name>
		<to_code>M0196208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allethrin</from_name>
		<from_code>513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allethrin</to_name>
		<to_code>M000652137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allethrin</from_name>
		<from_code>513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allethrins</to_name>
		<to_code>M0000732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Artemether</to_name>
		<to_code>M0102449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemether</from_name>
		<from_code>18343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine</from_name>
		<from_code>9061</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil hydrochloride</from_name>
		<from_code>142428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil hydrochloride</from_name>
		<from_code>142428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine monohydrochloride</from_name>
		<from_code>82092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Falciparum</to_name>
		<to_code>M0025570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl arginine</from_name>
		<from_code>2469242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-acetyl-L-arginine</to_name>
		<to_code>M0040025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altrenogest</from_name>
		<from_code>1314612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>altrenogest</to_name>
		<to_code>M0080712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab</from_name>
		<from_code>2472152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebola Virus, Zaire</to_name>
		<to_code>M0383755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab</from_name>
		<from_code>2472152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebola Virus, Zaire</to_name>
		<to_code>M0383755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab</from_name>
		<from_code>2472152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ansuvimab</to_name>
		<to_code>M000742065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab-zykl</from_name>
		<from_code>2472151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebola Virus, Zaire</to_name>
		<to_code>M0383755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus envelope glycoprotein</from_name>
		<from_code>2624742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebola Virus, Zaire</to_name>
		<to_code>M0383755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein</from_name>
		<from_code>2624741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebola Virus, Zaire</to_name>
		<to_code>M0383755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab-zykl</from_name>
		<from_code>2472151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebola Virus, Zaire</to_name>
		<to_code>M0383755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ansuvimab-zykl</from_name>
		<from_code>2472151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ebanga</to_name>
		<to_code>M000742066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium stearate</from_name>
		<from_code>1312975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium stearate</to_name>
		<to_code>M0582741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonia</from_name>
		<from_code>1299884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ammonia</to_name>
		<to_code>M0000981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminopterin sodium</from_name>
		<from_code>1440263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminopterin Sodium</to_name>
		<to_code>M0331223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-aminophenol</from_name>
		<from_code>1740241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-aminophenol</to_name>
		<to_code>M0089741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbyl glucoside</from_name>
		<from_code>1306933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ascorbic acid 2-O-glucoside</to_name>
		<to_code>M0179812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abetimus sodium</from_name>
		<from_code>1311599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>abetimus sodium</to_name>
		<to_code>M0582737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloglutamol</from_name>
		<from_code>17392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aloglutamol</to_name>
		<to_code>M0059955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amorolfine hydrochloride</from_name>
		<from_code>293865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amorolfin hydrochloride</to_name>
		<to_code>M0321110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aquaporin-4</from_name>
		<from_code>2370867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aquaporin 4</to_name>
		<to_code>M0241190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminopentamide, sulfate</from_name>
		<from_code>1006396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aminopentamide, sulfate</to_name>
		<to_code>M0311958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium hydroxide</from_name>
		<from_code>1362884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ammonium Hydroxide</to_name>
		<to_code>M0062804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apaflurane</from_name>
		<from_code>1368129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>heptafluoropropane</to_name>
		<to_code>M000755025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apaflurane</from_name>
		<from_code>1368129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>apaflurane</to_name>
		<to_code>M0247820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amodiaquine hydrochloride</from_name>
		<from_code>314495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amodiaquine Hydrochloride</to_name>
		<to_code>M0496322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic trichloride</from_name>
		<from_code>2533832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arsenic trichloride</to_name>
		<to_code>M0144186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminohippuric acid</from_name>
		<from_code>7832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>p-Aminohippuric Acid</to_name>
		<to_code>M0015718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>axicabtagene ciloleucel</from_name>
		<from_code>1987398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>axicabtagene ciloleucel</to_name>
		<to_code>M000645968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amber</from_name>
		<from_code>1311393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amber</to_name>
		<to_code>M0027940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylsalicylic acid</from_name>
		<from_code>1858285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetylsalicylsalicylic acid</to_name>
		<to_code>M0048913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adipic acid</from_name>
		<from_code>17050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>adipic acid</to_name>
		<to_code>M0095028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alverine</from_name>
		<from_code>17627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alverine</to_name>
		<to_code>M0056687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum</from_name>
		<from_code>1311504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aluminum</to_name>
		<to_code>M0000824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abetimus</from_name>
		<from_code>1311600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>abetimus</to_name>
		<to_code>M0443426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alpinia oxyphylla fruit extract</from_name>
		<from_code>2592957</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alpinia oxyphylla fruit extract</to_name>
		<to_code>M0409349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alpinia oxyphylla fruit extract</from_name>
		<from_code>2592957</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>yi-zhi</to_name>
		<to_code>M0505862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium phosphate,monobasic</from_name>
		<from_code>314493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monoammonium phosphate</to_name>
		<to_code>M0315931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambergris</from_name>
		<from_code>1311494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ambergris</to_name>
		<to_code>M0027941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aflatoxin B1</from_name>
		<from_code>2282017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aflatoxin B1</to_name>
		<to_code>M0025321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aquaporin-1</from_name>
		<from_code>2463337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aquaporin 1</to_name>
		<to_code>M0195494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anileridine</from_name>
		<from_code>17933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anileridine</to_name>
		<to_code>M0263104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>7-aminodesacetoxycephalosporanic acid</from_name>
		<from_code>1990418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>7-aminodesacetoxycephalosporanic acid</to_name>
		<to_code>M0062780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acenocoumarol</from_name>
		<from_code>154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acenocoumarol</to_name>
		<to_code>M0000105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azintamide</from_name>
		<from_code>402580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>azintamid</to_name>
		<to_code>M0058166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfaxalone</from_name>
		<from_code>1544577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alphaxalone</to_name>
		<to_code>M0049068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aviscumine</from_name>
		<from_code>2591797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aviscumine</to_name>
		<to_code>M0464895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acid violet 43</from_name>
		<from_code>1426422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acid Violet 43</to_name>
		<to_code>M0427561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aromadendrin</from_name>
		<from_code>1601985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aromadedrin</to_name>
		<to_code>M0214420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum starch octenylsuccinate</from_name>
		<from_code>1426415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum starch octenylsuccinate</to_name>
		<to_code>M0443410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium iodide</from_name>
		<from_code>1720161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium iodide</to_name>
		<to_code>M0587077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III, human</from_name>
		<from_code>221062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III Deficiency</to_name>
		<to_code>M0029883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III, human</from_name>
		<from_code>221062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Veno-Occlusive Disease</to_name>
		<to_code>M0010204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III, human</from_name>
		<from_code>221062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III Deficiency</to_name>
		<to_code>M0029883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III Deficiency</to_name>
		<to_code>M0029883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III Deficiency</to_name>
		<to_code>M0029883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III Deficiency</to_name>
		<to_code>M0029883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III Deficiency</to_name>
		<to_code>M0029883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide</from_name>
		<from_code>1311089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Veno-Occlusive Disease</to_name>
		<to_code>M0010204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide, bovine lung</from_name>
		<from_code>1788946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Veno-Occlusive Disease</to_name>
		<to_code>M0010204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>defibrotide sodium</from_name>
		<from_code>1746523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Veno-Occlusive Disease</to_name>
		<to_code>M0010204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>6-aminocaproic acid</from_name>
		<from_code>99</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Disseminated Intravascular Coagulation</to_name>
		<to_code>M0006587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminobenzoate</from_name>
		<from_code>618974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>para-Aminobenzoates</to_name>
		<to_code>M0568273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aqua regia</from_name>
		<from_code>1537801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aqua regia</to_name>
		<to_code>M0077745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase Erwinia chrysanthemi</from_name>
		<from_code>1431738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>asparaginase erwinia chrysanthemi recombinant</to_name>
		<to_code>M000750563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-pinene</from_name>
		<from_code>2362183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-pinene</to_name>
		<to_code>M0047005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinate</from_name>
		<from_code>155002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-Aminolaevulinate</to_name>
		<to_code>M0000952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acepromazine maleate</from_name>
		<from_code>1114057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acepromazine Maleate</to_name>
		<to_code>M0330684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus flavus var. oryzae</from_name>
		<from_code>1329940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillus oryzae</to_name>
		<to_code>M0001858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alfacalcidol</from_name>
		<from_code>12062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alfacalcidol</to_name>
		<to_code>M0051654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amisulpride</from_name>
		<from_code>46303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amisulpride</to_name>
		<to_code>M0058773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-amino-5-nitrothiazole</from_name>
		<from_code>1665683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-amino-5-nitrothiazole</to_name>
		<to_code>M0107208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl dipeptide-1 cetyl ester</from_name>
		<from_code>1374852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetyltyrosyl-arginine cetyl ester</to_name>
		<to_code>M000622999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argon</from_name>
		<from_code>1368133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Argon</to_name>
		<to_code>M0001693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise oil</from_name>
		<from_code>90926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anise oil</to_name>
		<to_code>M000743808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrovitamin A</from_name>
		<from_code>2669473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anhydrovitamin A</to_name>
		<to_code>M0098856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amentoflavone</from_name>
		<from_code>2643210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amentoflavone</to_name>
		<to_code>M0057258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artesunate</from_name>
		<from_code>18346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dihydroartemisinine-12-alpha-succinate</to_name>
		<to_code>M000640560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artesunate</from_name>
		<from_code>18346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Artesunate</to_name>
		<to_code>M0118766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artesunate</from_name>
		<from_code>18346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Succinyl Dihydroartemisinin</to_name>
		<to_code>M000640561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyldigoxins</from_name>
		<from_code>199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetyldigoxins</to_name>
		<to_code>M0000182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylocaine</from_name>
		<from_code>40660</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amylocaine</to_name>
		<to_code>M0065148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acid green 50</from_name>
		<from_code>2532534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acid green 50</to_name>
		<to_code>M0585829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acid green 50</from_name>
		<from_code>2532534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>green 5</to_name>
		<to_code>M0082870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argan oil</from_name>
		<from_code>1305642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>argan oil</to_name>
		<to_code>M0554329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetoxolone</from_name>
		<from_code>16784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetylglycyrrhetinic acid</to_name>
		<to_code>M0061122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alanylglutamine</from_name>
		<from_code>1359422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alanylglutamine</to_name>
		<to_code>M0153017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxyphosphate</from_name>
		<from_code>1423457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum hydroxyphosphate</to_name>
		<to_code>M0188691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaldehyde</from_name>
		<from_code>1311137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetaldehyde</to_name>
		<to_code>M0000111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyldigitoxin</from_name>
		<from_code>132871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetyldigitoxin</to_name>
		<to_code>M0000181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.alpha.-chlorohydrin, (+/-)-</from_name>
		<from_code>2396781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Chlorohydrin</to_name>
		<to_code>M0000786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum oxide</from_name>
		<from_code>615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aluminum Oxide</to_name>
		<to_code>M0000828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>asunaprevir</to_name>
		<to_code>M0573379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asunaprevir</from_name>
		<from_code>1652103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milk thistle extract</from_name>
		<from_code>283579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium</from_name>
		<from_code>7676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opium tincture</from_name>
		<from_code>221134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>OPIUM, POWDERED</from_name>
		<from_code>221135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acarbose</from_name>
		<from_code>16681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec</from_name>
		<from_code>2641610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec-rvox</from_name>
		<from_code>2641609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone acetate</from_name>
		<from_code>2055977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zafirlukast</from_name>
		<from_code>114970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Liver Cirrhosis</to_name>
		<to_code>M0012636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ancrod</from_name>
		<from_code>772</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ancrod</to_name>
		<to_code>M0001092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allyl .alpha.-ionone</from_name>
		<from_code>2396431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allyl alpha-ionone</to_name>
		<to_code>M0518180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adrafinil</from_name>
		<from_code>45938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>adrafinil</to_name>
		<to_code>M0077767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetone</from_name>
		<from_code>178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetone</to_name>
		<to_code>M0000142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambroxol acefyllinate</from_name>
		<from_code>236595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ambroxol-theophylline-7-acetate</to_name>
		<to_code>M0207191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambroxol-theophylline-7-acetate</from_name>
		<from_code>186010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ambroxol-theophylline-7-acetate</to_name>
		<to_code>M0207191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alarelin</from_name>
		<from_code>2641623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alarelin</to_name>
		<to_code>M000732187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha ionone</from_name>
		<from_code>1859172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-ionone</to_name>
		<to_code>M0058513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antilymphocyte immunoglobulin</from_name>
		<from_code>973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antilymphocyte Immunoglobulin</to_name>
		<to_code>M0001463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arachidic acid</from_name>
		<from_code>1716331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arachidic acid</to_name>
		<to_code>M0248917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amorolfine</from_name>
		<from_code>17804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amorolfine</to_name>
		<to_code>M0116983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylocaine hydrochloride</from_name>
		<from_code>235793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amylocaine hydrochloride</to_name>
		<to_code>M0312917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum stearate</from_name>
		<from_code>46243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum monostearate</to_name>
		<to_code>M0098165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acid red 337</from_name>
		<from_code>2621122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acid red 337</to_name>
		<to_code>M0569099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetoin</from_name>
		<from_code>2683094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetoin</to_name>
		<to_code>M0000137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspartate</from_name>
		<from_code>42543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspartate</to_name>
		<to_code>M0001841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitine</from_name>
		<from_code>1441664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aconitine</to_name>
		<to_code>M0000236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arnica flowers extract</from_name>
		<from_code>283674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arnicae flos extract</to_name>
		<to_code>M000742825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arnica montana flower extract</from_name>
		<from_code>1306166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arnicae flos extract</to_name>
		<to_code>M000742825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arnica montana flower extract</from_name>
		<from_code>1306166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arnica montana flower</to_name>
		<to_code>M000742887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alloin</from_name>
		<from_code>17354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alloin</to_name>
		<to_code>M0049044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-asarone</from_name>
		<from_code>2375532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-asarone</to_name>
		<to_code>M000623342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisyl acetate</from_name>
		<from_code>2605801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anisyl acetate</to_name>
		<to_code>M0580700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amsacrine</from_name>
		<from_code>739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amsacrine</to_name>
		<to_code>M0001039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-allyl-2,6-dimethoxyphenol</from_name>
		<from_code>1423781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-allyl-2,6-dimethoxyphenol</to_name>
		<to_code>M0290837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminolevulinic Acid Hydrochloride</to_name>
		<to_code>M0477089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratosis, Actinic</to_name>
		<to_code>M0518969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid hydrochloride</from_name>
		<from_code>261715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrins</to_name>
		<to_code>M0017336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin</from_name>
		<from_code>5021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primidone</from_name>
		<from_code>8691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital sodium</from_name>
		<from_code>203085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyflurane</from_name>
		<from_code>6857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprobarbital</from_name>
		<from_code>17381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trioxsalen</from_name>
		<from_code>10844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital</from_name>
		<from_code>477631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital</from_name>
		<from_code>6847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methohexital sodium</from_name>
		<from_code>91185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital sodium</from_name>
		<from_code>82077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinamate</from_name>
		<from_code>24474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin microsize</from_name>
		<from_code>91077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verteporfin</from_name>
		<from_code>118886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital</from_name>
		<from_code>8134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephobarbital</from_name>
		<from_code>6758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentobarbital</from_name>
		<from_code>8004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butalbital</from_name>
		<from_code>19860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital sodium</from_name>
		<from_code>91109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethchlorvynol</from_name>
		<from_code>4118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet</from_name>
		<from_code>4778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet cation</from_name>
		<from_code>1546369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>griseofulvin, ultramicrocrystalline</from_name>
		<from_code>217398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrias</to_name>
		<to_code>M0017334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrinogens</to_name>
		<to_code>M0017335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratosis, Actinic</to_name>
		<to_code>M0518969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminolevulinic acid</from_name>
		<from_code>683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrins</to_name>
		<to_code>M0017336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 5-aminolevulinate</from_name>
		<from_code>337068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyrinogens</to_name>
		<to_code>M0017335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiquimod</from_name>
		<from_code>59943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratosis, Actinic</to_name>
		<to_code>M0518969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ingenol mebutate</from_name>
		<from_code>1242806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratosis, Actinic</to_name>
		<to_code>M0518969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl aminolevulinate hydrochloride</from_name>
		<from_code>1300479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratosis, Actinic</to_name>
		<to_code>M0518969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 5-aminolevulinate</from_name>
		<from_code>337068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratosis, Actinic</to_name>
		<to_code>M0518969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-damascone</from_name>
		<from_code>2398332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-damascone</to_name>
		<to_code>M0480475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arctostaphylos uva-ursi leaf extract</from_name>
		<from_code>1306212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arctostaphylos uva-ursi leaf</to_name>
		<to_code>M000744341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amodiaquine</from_name>
		<from_code>720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amodiaquine</to_name>
		<to_code>M0001005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitate</from_name>
		<from_code>1721299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aconitate</to_name>
		<to_code>M000636804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceglutamide aluminum</from_name>
		<from_code>1426378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aceglutamide aluminum</to_name>
		<to_code>M0042963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>andexanet alfa</from_name>
		<from_code>2045114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>andexanet alfa</to_name>
		<to_code>M000613281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>andexanet alfa</from_name>
		<from_code>2045114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desirudin</from_name>
		<from_code>114934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesna</from_name>
		<from_code>44</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apixaban</from_name>
		<from_code>1364430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human-lans</from_name>
		<from_code>2643194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fitusiran</from_name>
		<from_code>2709439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor, human</from_name>
		<from_code>826072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran etexilate mesylate</from_name>
		<from_code>1037041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIIa</from_name>
		<from_code>4256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated-exei</from_name>
		<from_code>2275722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine B-domain truncated recombinant</from_name>
		<from_code>1592899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dabigatran etexilate</from_name>
		<from_code>1037042</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonoctocog alfa</from_name>
		<from_code>1796377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol valerate</from_name>
		<from_code>24395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor VIIa (recombinant)-jncw</from_name>
		<from_code>2386863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simoctocog alfa</from_name>
		<from_code>1729084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII, human</from_name>
		<from_code>826070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine hydrochloride</from_name>
		<from_code>97</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turoctocog alfa</from_name>
		<from_code>1737557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens, conjugated (USP)</from_name>
		<from_code>4099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptacog alfa activated</from_name>
		<from_code>253149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII</from_name>
		<from_code>4257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor XIII a-subunit (recombinant)</from_name>
		<from_code>1488293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboplatin</from_name>
		<from_code>40048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa (activated), lyophilized</from_name>
		<from_code>353106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human-lans</from_name>
		<from_code>2643194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprotinin</from_name>
		<from_code>1056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin acetate</from_name>
		<from_code>203147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrogens</from_name>
		<from_code>4100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen,I-125</from_name>
		<from_code>314623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor X, human</from_name>
		<from_code>1426166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesna</from_name>
		<from_code>44</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine</from_name>
		<from_code>27084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium</from_name>
		<from_code>2689322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone</from_name>
		<from_code>10379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII, human</from_name>
		<from_code>826070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simoctocog alfa</from_name>
		<from_code>1729084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab</from_name>
		<from_code>2708333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIII</from_name>
		<from_code>4257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor XIII a-subunit (recombinant)</from_name>
		<from_code>1488293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone decanoate</from_name>
		<from_code>37858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rivaroxaban</from_name>
		<from_code>1114195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptacog alfa activated</from_name>
		<from_code>253149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turoctocog alfa</from_name>
		<from_code>1737557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lonoctocog alfa</from_name>
		<from_code>1796377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor Xa (recombinant), inactivated-zhzo</from_name>
		<from_code>2045125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor VIIa</from_name>
		<from_code>4256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated-exei</from_name>
		<from_code>2275722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine B-domain truncated recombinant</from_name>
		<from_code>1592899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol</from_name>
		<from_code>4083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>concizumab-mtci</from_name>
		<from_code>2708340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar sulfate</from_name>
		<from_code>1537050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine</from_name>
		<from_code>10594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine hydrobromide</from_name>
		<from_code>235428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor VIIa (recombinant)-jncw</from_name>
		<from_code>2386863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn</from_name>
		<from_code>2561249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drotrecogin alfa</from_name>
		<from_code>352374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, human</from_name>
		<from_code>825006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine</from_name>
		<from_code>221060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor IX complex</from_name>
		<from_code>1670383</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fibrinogen, human</from_name>
		<from_code>2264108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vorapaxar</from_name>
		<from_code>1537034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant residues 743-1636 deleted</from_name>
		<from_code>1300485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium bromide</from_name>
		<from_code>2689321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor X</from_name>
		<from_code>4262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin, bovine</from_name>
		<from_code>2264114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant antihemophilic factor VIII</from_name>
		<from_code>253151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban</from_name>
		<from_code>1927851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol hemihydrate</from_name>
		<from_code>236859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII</from_name>
		<from_code>4271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaspargase</from_name>
		<from_code>34132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated</from_name>
		<from_code>1741397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel bisulfate</from_name>
		<from_code>236991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor tetrasodium</from_name>
		<from_code>1656051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estropipate</from_name>
		<from_code>33747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium estrone sulfate</from_name>
		<from_code>91428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol cypionate</from_name>
		<from_code>1000146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin alfa</from_name>
		<from_code>1367075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anti-inhibitor coagulant complex</from_name>
		<from_code>314504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone isocaproate</from_name>
		<from_code>75806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estrone</from_name>
		<from_code>4103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betrixaban maleate</from_name>
		<from_code>1927955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol acetate</from_name>
		<from_code>405416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant residues 743-1636 deleted</from_name>
		<from_code>1300485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafarelin</from_name>
		<from_code>28656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant antihemophilic factor VIII</from_name>
		<from_code>253151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII</from_name>
		<from_code>4271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human</from_name>
		<from_code>203083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor X</from_name>
		<from_code>4262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine methylbromide</from_name>
		<from_code>27085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>6-aminocaproic acid</from_name>
		<from_code>99</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, human recombinant</from_name>
		<from_code>1300486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor IX complex</from_name>
		<from_code>1670383</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor, porcine</from_name>
		<from_code>221060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>von Willebrand factor</from_name>
		<from_code>11274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>factor XIII, human</from_name>
		<from_code>1091605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cangrelor</from_name>
		<from_code>1656052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thrombin</from_name>
		<from_code>10528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antihemophilic factor (recombinant) pegylated</from_name>
		<from_code>1741397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estradiol 3-benzoate</from_name>
		<from_code>60661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone (micronized)</from_name>
		<from_code>221168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhage</to_name>
		<to_code>M0010152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amaranth dye</from_name>
		<from_code>1433189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amaranth Dye</to_name>
		<to_code>M0000852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antimony potassium tartrate</from_name>
		<from_code>981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antimony Potassium Tartrate</to_name>
		<to_code>M0001473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl hexapeptide-8</from_name>
		<from_code>1314329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide</to_name>
		<to_code>M0586966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atoltivimab-ebgn</from_name>
		<from_code>2461430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>atoltivimab-ebgn</to_name>
		<to_code>M000767503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adrenalone</from_name>
		<from_code>17073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>adrenalone</to_name>
		<to_code>M0119882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylopectin</from_name>
		<from_code>1368128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amylopectin</to_name>
		<to_code>M0001054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-aminomethylbenzoic acid</from_name>
		<from_code>14852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-aminomethylbenzoic acid</to_name>
		<to_code>M0065124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alcuronium</from_name>
		<from_code>460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcuronium</to_name>
		<to_code>M0000669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acesulfame potassium</from_name>
		<from_code>1310545</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acesulfame potassium</to_name>
		<to_code>M0309536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alseroxylon</from_name>
		<from_code>599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alseroxylon</to_name>
		<to_code>M0018532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agaric acid</from_name>
		<from_code>1441428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>agaric acid</to_name>
		<to_code>M0057678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allo-2-hydroxycitric acid</from_name>
		<from_code>2369353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allo-2-hydroxycitric acid</to_name>
		<to_code>M0310126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antimony</from_name>
		<from_code>1311407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antimony</to_name>
		<to_code>M0001472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium thiocyanate</from_name>
		<from_code>2109607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium thiocyanate</to_name>
		<to_code>M0088065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-acetylanisole</from_name>
		<from_code>2612428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-acetylanisole</to_name>
		<to_code>M0133543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-anisic acid</from_name>
		<from_code>1426595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-anisic acid</to_name>
		<to_code>M0045608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allylthiourea</from_name>
		<from_code>1318494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allylthiourea</to_name>
		<to_code>M0054903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asiaticoside</from_name>
		<from_code>18405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>asiaticoside</to_name>
		<to_code>M0045500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aloe emodin</from_name>
		<from_code>2561527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aloe emodin</to_name>
		<to_code>M0007303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminopentamide</from_name>
		<from_code>1006397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aminopentamide</to_name>
		<to_code>M0059974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>all-trans-retinol</from_name>
		<from_code>1367187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinol</to_name>
		<to_code>M0370269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atrasentan hydrochloride</from_name>
		<from_code>2710448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atrasentan Hydrochloride</to_name>
		<to_code>M000642029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acepromazine</from_name>
		<from_code>155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acepromazine</to_name>
		<to_code>M0000107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconite</from_name>
		<from_code>242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aconite</to_name>
		<to_code>M0000234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine maleate</from_name>
		<from_code>860647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine maleate</from_name>
		<from_code>860647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine maleate</from_name>
		<from_code>860647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>asenapine maleate</to_name>
		<to_code>M0176757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine maleate</from_name>
		<from_code>860647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine</from_name>
		<from_code>31914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium valproate</from_name>
		<from_code>9919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan L-malate</from_name>
		<from_code>2570387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiagabine hydrochloride</from_name>
		<from_code>236875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>divalproex sodium</from_name>
		<from_code>266856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan</from_name>
		<from_code>2559612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valproic acid</from_name>
		<from_code>11118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topiramate</from_name>
		<from_code>38404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bipolar Disorder</to_name>
		<to_code>M0002571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>asenapine</to_name>
		<to_code>M0513342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asenapine</from_name>
		<from_code>784649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flutamide</from_name>
		<from_code>4508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir sulfate</from_name>
		<from_code>221052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabazitaxel</from_name>
		<from_code>996051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol-mknl</from_name>
		<from_code>2121417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calaspargase pegol</from_name>
		<from_code>2121416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abacavir</from_name>
		<from_code>190521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatic Insufficiency</to_name>
		<to_code>M0461663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan L-malate</from_name>
		<from_code>2570387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine dimalonate</from_name>
		<from_code>236771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole</from_name>
		<from_code>89013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone</from_name>
		<from_code>115698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride anhydrous</from_name>
		<from_code>1362139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone mesylate</from_name>
		<from_code>353116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine</from_name>
		<from_code>8042</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samidorphan</from_name>
		<from_code>2559612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride</from_name>
		<from_code>1294533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brexpiprazole</from_name>
		<from_code>1658314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziprasidone hydrochloride, monohydrate</from_name>
		<from_code>284925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipotiazine palmitate</from_name>
		<from_code>235745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone</from_name>
		<from_code>2275602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline tartrate</from_name>
		<from_code>2694829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluspirilene</from_name>
		<from_code>4507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aripiprazole lauroxil</from_name>
		<from_code>1673265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumateperone tosylate</from_name>
		<from_code>2275731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertindole</from_name>
		<from_code>41996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperacetazine</from_name>
		<from_code>8338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloperidone</from_name>
		<from_code>73178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xanomeline</from_name>
		<from_code>2694828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginseng preparation</from_name>
		<from_code>325526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipothiazine</from_name>
		<from_code>8348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Schizophrenia</to_name>
		<to_code>M0019489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-(2-aminoethoxy)ethanol</from_name>
		<from_code>1737111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(2-aminoethoxy)ethanol</to_name>
		<to_code>M0286895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abatacept</to_name>
		<to_code>M0442852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Recombinant Fusion Proteins</to_name>
		<to_code>M0018640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abatacept</from_name>
		<from_code>614391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canakinumab</from_name>
		<from_code>853491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-aazg</from_name>
		<from_code>2679427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-anoh</from_name>
		<from_code>2705421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfasalazine</from_name>
		<from_code>9524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab</from_name>
		<from_code>612865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocilizumab-bavi</from_name>
		<from_code>2680283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Juvenile</to_name>
		<to_code>M0001748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-kfce</from_name>
		<from_code>2705577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-auub</from_name>
		<from_code>2700665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab</from_name>
		<from_code>847083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aauz</from_name>
		<from_code>2702602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-aekn</from_name>
		<from_code>2705377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-stba</from_name>
		<from_code>2700389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-srlf</from_name>
		<from_code>2717063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-hmny</from_name>
		<from_code>2725083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ustekinumab-ttwe</from_name>
		<from_code>2705553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothioglucose</from_name>
		<from_code>4980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secukinumab</from_name>
		<from_code>1599788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apremilast</from_name>
		<from_code>1492727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Psoriatic</to_name>
		<to_code>M0023901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic triiodide</from_name>
		<from_code>1309691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arsenic triiodide</to_name>
		<to_code>M0523715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucosidase alfa</from_name>
		<from_code>629565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycogen Storage Disease Type II</to_name>
		<to_code>M0009470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucosidase alfa</from_name>
		<from_code>629565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alglucosidase alfa</to_name>
		<to_code>M0497623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alglucosidase alfa</from_name>
		<from_code>629565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>analogs &amp; derivatives</to_name>
		<to_code>M0030233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cipaglucosidase alfa</from_name>
		<from_code>2667433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycogen Storage Disease Type II</to_name>
		<to_code>M0009470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avalglucosidase alfa-ngpt</from_name>
		<from_code>2565813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycogen Storage Disease Type II</to_name>
		<to_code>M0009470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avalglucosidase alfa</from_name>
		<from_code>2565814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycogen Storage Disease Type II</to_name>
		<to_code>M0009470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cipaglucosidase alfa-atga</from_name>
		<from_code>2667434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glycogen Storage Disease Type II</to_name>
		<to_code>M0009470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceglutamide</from_name>
		<from_code>1426379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aceglutamide</to_name>
		<to_code>M0100174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adrenalone hydrochloride</from_name>
		<from_code>236364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>adrenalone hydrochloride</to_name>
		<to_code>M0321354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium ferrous sulfate</from_name>
		<from_code>17784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium ferrous sulfate</to_name>
		<to_code>M0115039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambroxol</from_name>
		<from_code>625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ambroxol</to_name>
		<to_code>M0000855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopheryloxyacetic acid</from_name>
		<from_code>1995481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid</to_name>
		<to_code>M0470340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminopyrine</from_name>
		<from_code>695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminopyrine</to_name>
		<to_code>M0000965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemannan</from_name>
		<from_code>1426875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acemannan</to_name>
		<to_code>M0162908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acemannan</from_name>
		<from_code>1426875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leukemia, Feline</to_name>
		<to_code>M0025292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Azadirachta indica seed oil</from_name>
		<from_code>1305648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>neem oil</to_name>
		<to_code>M0043031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>afoxolaner</from_name>
		<from_code>1442093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>afoxolaner</to_name>
		<to_code>M000595012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>(all-Z)-4,7,10,13,16-docosapentaenoic acid</from_name>
		<from_code>1360626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cis-7,10,13,16,19-docosapentaenoic acid</to_name>
		<to_code>M000636321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenite ion</from_name>
		<from_code>1546382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arsenite</to_name>
		<to_code>M0063967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ABT-925</from_name>
		<from_code>1661017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ABT-925</to_name>
		<to_code>M0589804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amidoline</from_name>
		<from_code>17684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amidoline</to_name>
		<to_code>M0043196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminopterin</from_name>
		<from_code>1440264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminopterin</to_name>
		<to_code>M0000962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminobutyric acid</from_name>
		<from_code>70582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminobutyric Acid</to_name>
		<to_code>M0000941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum sesquichlorohydrate</from_name>
		<from_code>543375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum sesquichlorohydrate</to_name>
		<to_code>M0528650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allobarbital</from_name>
		<from_code>516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allobarbital</to_name>
		<to_code>M0225316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ancestim</from_name>
		<from_code>140502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ancestim</to_name>
		<to_code>M0276004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholinesterase</from_name>
		<from_code>195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetylcholinesterase</to_name>
		<to_code>M0000169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arbekacin sulfate</from_name>
		<from_code>237044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arbekacin sulfate</to_name>
		<to_code>M0423889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum potassium sulfate</from_name>
		<from_code>54989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium aluminum sulfate</to_name>
		<to_code>M0206881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyltributyl citrate</from_name>
		<from_code>1362881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetyltributylcitrate</to_name>
		<to_code>M0494749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyltributyl citrate</from_name>
		<from_code>1362881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-acetyltributylcitrate</to_name>
		<to_code>M0063878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetamide</from_name>
		<from_code>2475952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetamide</to_name>
		<to_code>M0096876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arachidonic acid</from_name>
		<from_code>1368624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arachidonic Acid</to_name>
		<to_code>M0025459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylene</from_name>
		<from_code>200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetylene</to_name>
		<to_code>M0000186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alteromonas macleodii</from_name>
		<from_code>1551569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alteromonas macleodii</to_name>
		<to_code>M000669606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum acetotartrate</from_name>
		<from_code>46239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum acetotartrate</to_name>
		<to_code>M0122330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacopan</from_name>
		<from_code>2572100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>avacopan</to_name>
		<to_code>M000633038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avacopan</from_name>
		<from_code>2572100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</to_name>
		<to_code>M0528192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum tristearate</from_name>
		<from_code>1363698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum tristearate</to_name>
		<to_code>M0098166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apigenin</from_name>
		<from_code>1368130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Apigenin</to_name>
		<to_code>M0357150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-methylbenzyl acetate</from_name>
		<from_code>2374917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-methylbenzyl acetate</to_name>
		<to_code>M0580679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alverine citrate</from_name>
		<from_code>71767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alverine citrate</to_name>
		<to_code>M0311275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylglucosamine</from_name>
		<from_code>1362871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-Acetylglucosamine</to_name>
		<to_code>M000764947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylglucosamine</from_name>
		<from_code>1362871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-Acetyl-D-Glucosamine</to_name>
		<to_code>M000764948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylglucosamine</from_name>
		<from_code>1362871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetylglucosamine</to_name>
		<to_code>M0000189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>angelicin</from_name>
		<from_code>2690789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>angelicin</to_name>
		<to_code>M0058141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arbutin</from_name>
		<from_code>1367175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arbutin</to_name>
		<to_code>M0001660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acexamic acid</from_name>
		<from_code>15978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>6-acetylaminocaproic acid</to_name>
		<to_code>M0070739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetate</from_name>
		<from_code>164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetates</to_name>
		<to_code>M0000125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenone</from_name>
		<from_code>2467143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetophenone</to_name>
		<to_code>M0116334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica pubescens root extract</from_name>
		<from_code>1307573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>duhuo</to_name>
		<to_code>M000602382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Anaerococcus tetradius</from_name>
		<from_code>1592903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anaerococcus tetradius</to_name>
		<to_code>M0016246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>astaxanthin</from_name>
		<from_code>18451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>astaxanthine</to_name>
		<to_code>M0047832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminaphthone</from_name>
		<from_code>46276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aminaftone</to_name>
		<to_code>M0066071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ABCB4 protein, human</from_name>
		<from_code>2117853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ABCB4 protein, human</to_name>
		<to_code>M0452338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-amino-2-methyl-1-propanol</from_name>
		<from_code>1310544</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-amino-2-methyl-1-propanol</to_name>
		<to_code>M0049164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium lauryl sulfate</from_name>
		<from_code>1424667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dodecyl sulfate, ammonium salt</to_name>
		<to_code>M0317994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-isomethylionone</from_name>
		<from_code>1368186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-isomethylionone</to_name>
		<to_code>M0479055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ancylostoma caninum</from_name>
		<from_code>2469251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ancylostoma caninum</to_name>
		<to_code>M0001096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anise</to_name>
		<to_code>M0399424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anise seed extract</from_name>
		<from_code>1309292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anisi fructus</to_name>
		<to_code>M000743809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alum, potassium</from_name>
		<from_code>221456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alum</to_name>
		<to_code>M000644324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminacrine</from_name>
		<from_code>645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminacrine</to_name>
		<to_code>M0000909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium sulfate</from_name>
		<from_code>1362695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ammonium Sulfate</to_name>
		<to_code>M0000986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylase</from_name>
		<from_code>743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amylases</to_name>
		<to_code>M0001046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcellulose</from_name>
		<from_code>1425216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetylcellulose</to_name>
		<to_code>M0046362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atoltivimab</from_name>
		<from_code>2461338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>atoltivimab</to_name>
		<to_code>M000742068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisyl alcohol</from_name>
		<from_code>1424668</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anisyl alcohol</to_name>
		<to_code>M0183628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice oil</from_name>
		<from_code>2373647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimenta oil</to_name>
		<to_code>M0129054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azaperone</from_name>
		<from_code>2601502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Azaperone</to_name>
		<to_code>M0002062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aloxiprin</from_name>
		<from_code>17393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aloxiprin</to_name>
		<to_code>M0056680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherylquinone</from_name>
		<from_code>1376149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tocopherylquinone</to_name>
		<to_code>M0043000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.alpha.-phellandrene</from_name>
		<from_code>2530131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha phellandrene</to_name>
		<to_code>M0046925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>12-(9-anthroyloxy)stearic acid</from_name>
		<from_code>1922739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>12-(9-anthroyloxy)stearic acid</to_name>
		<to_code>M0087321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica sinensis root extract</from_name>
		<from_code>1307866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>angelicae sinensis extract</to_name>
		<to_code>M0130196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antimony pentasulfide</from_name>
		<from_code>1337969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>antimony pentasulfide</to_name>
		<to_code>M0167832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetanilide</from_name>
		<from_code>162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetanilide</from_name>
		<from_code>162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syncope</to_name>
		<to_code>M0020955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetanilide</from_name>
		<from_code>162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetanilide</to_name>
		<to_code>M0000122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine</from_name>
		<from_code>194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcholine chloride</from_name>
		<from_code>20814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octopamine hydrochloride</from_name>
		<from_code>1744461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quercetin</from_name>
		<from_code>9060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon dioxide</from_name>
		<from_code>2034</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine,DL-</from_name>
		<from_code>236948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate, (R)-</from_name>
		<from_code>2622915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butalbital</from_name>
		<from_code>19860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium benzoate</from_name>
		<from_code>56455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine</from_name>
		<from_code>8156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octopamine</from_name>
		<from_code>1311141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Headache</to_name>
		<to_code>M0009824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syncope</to_name>
		<to_code>M0020955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syncope</to_name>
		<to_code>M0020955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syncope</to_name>
		<to_code>M0020955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syncope</to_name>
		<to_code>M0020955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloxate</from_name>
		<from_code>1426854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-(4-methoxyphenyl)-2-propenoic acid 3-methylbutyl ester</to_name>
		<to_code>M0208414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Alcaligenes faecalis</from_name>
		<from_code>1316425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcaligenes faecalis</to_name>
		<to_code>M0441454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.alpha.,.beta.-methylene adenosine 5'-diphosphate</from_name>
		<from_code>2552302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha,beta-methyleneadenosine 5'-diphosphate</to_name>
		<to_code>M0515143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almitrine</from_name>
		<from_code>528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Almitrine</to_name>
		<to_code>M0024158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acid blue 80</from_name>
		<from_code>2563676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acid blue 80</to_name>
		<to_code>M0397140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arginine glutamate</from_name>
		<from_code>114464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arginine glutamate</to_name>
		<to_code>M0082577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-aminophenol</from_name>
		<from_code>1435285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-aminophenol</to_name>
		<to_code>M0156323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>althiazide</from_name>
		<from_code>17599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>althiazide</to_name>
		<to_code>M0049073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acipimox</from_name>
		<from_code>16817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acipimox</to_name>
		<to_code>M0089804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparagine</from_name>
		<from_code>1157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asparagine</to_name>
		<to_code>M0001818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aniline</from_name>
		<from_code>1441546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aniline</to_name>
		<to_code>M0081119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Allura red AC dye</from_name>
		<from_code>1310600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allura Red AC Dye</to_name>
		<to_code>M0047789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin</from_name>
		<from_code>42527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amphotericin</to_name>
		<to_code>M000636813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acid blue 25</from_name>
		<from_code>2178278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acid Blue 25</to_name>
		<to_code>M0537736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acecarbromal</from_name>
		<from_code>16688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acecarbromal</to_name>
		<to_code>M0081274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Amanita phalloides</from_name>
		<from_code>1858554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amanita phalloides</to_name>
		<to_code>M000686954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>agar</from_name>
		<from_code>397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Agar</to_name>
		<to_code>M0000553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>9,10-anthraquinone</from_name>
		<from_code>1482551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>9,10-anthraquinone</to_name>
		<to_code>M0126292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anileridine hydrochloride</from_name>
		<from_code>235413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anileridine hydrochloride</to_name>
		<to_code>M0327430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amezinium</from_name>
		<from_code>17665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amezinium</to_name>
		<to_code>M0090031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl coenzyme A</from_name>
		<from_code>1490796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetyl Coenzyme A</to_name>
		<to_code>M0000158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum fluoride</from_name>
		<from_code>2273602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum fluoride</to_name>
		<to_code>M0100930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azosemide</from_name>
		<from_code>18651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>azosemide</to_name>
		<to_code>M0069534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparagus allergenic extract</from_name>
		<from_code>891796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrylate</from_name>
		<from_code>1364500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acrylate</to_name>
		<to_code>M0462159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alloxan</from_name>
		<from_code>2466730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alloxan</to_name>
		<to_code>M0000748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amitraz</from_name>
		<from_code>17763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amitraz</to_name>
		<to_code>M0063921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-cyclodextrin</from_name>
		<from_code>1362882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-cyclodextrin</to_name>
		<to_code>M0101690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclarubicin</from_name>
		<from_code>239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aclacinomycin</to_name>
		<to_code>M0057251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aclarubicin</from_name>
		<from_code>239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aclarubicin</to_name>
		<to_code>M0023487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anethole trithione</from_name>
		<from_code>820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anethole Trithione</to_name>
		<to_code>M0001171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apiole</from_name>
		<from_code>314506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>apiole</to_name>
		<to_code>M0414249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprindine</from_name>
		<from_code>1054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aprindine</to_name>
		<to_code>M0001626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenate</from_name>
		<from_code>1375924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arsenate</to_name>
		<to_code>M0365391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum aspirin</from_name>
		<from_code>611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum acetylsalicylate</to_name>
		<to_code>M000608349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-terpineol</from_name>
		<from_code>1371307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-terpineol</to_name>
		<to_code>M0066974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amonafide</from_name>
		<from_code>1440270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amonafide</to_name>
		<to_code>M0112303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium phosphate</from_name>
		<from_code>17792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium phosphate</to_name>
		<to_code>M0083381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambrein</from_name>
		<from_code>2584842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ambrein</to_name>
		<to_code>M0200332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aniracetam</from_name>
		<from_code>17939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aniracetam</to_name>
		<to_code>M0111076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adiphenine</from_name>
		<from_code>333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>adiphenine</to_name>
		<to_code>M0225321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arbutamine hydrochloride</from_name>
		<from_code>236829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arbutamine hydrochloride</to_name>
		<to_code>M0423890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>artemisinin</from_name>
		<from_code>2367409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>artemisinin</to_name>
		<to_code>M0098515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum nitrate</from_name>
		<from_code>2360133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum nitrate</to_name>
		<to_code>M0144419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-isobutylphenethyl alcohol</from_name>
		<from_code>1720936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-methyl-1-phenylpentan-2-ol</to_name>
		<to_code>M0118005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acriflavine</from_name>
		<from_code>249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acriflavine</to_name>
		<to_code>M0000250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acriflavine</from_name>
		<from_code>249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3,6-diamino-10-methylacridinium chloride</to_name>
		<to_code>M000750903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apocarotenal</from_name>
		<from_code>1376342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>apocarotenal</to_name>
		<to_code>M0046234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agkistrodon piscivorus antivenin</from_name>
		<from_code>885183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium chloride</from_name>
		<from_code>49275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium chloride</from_name>
		<from_code>52796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium besylate</from_name>
		<from_code>1219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxacurium</from_name>
		<from_code>23651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atracurium</from_name>
		<from_code>1218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mivacurium</from_name>
		<from_code>30077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paralysis</to_name>
		<to_code>M0015877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvalent Crotalidae antivenin</from_name>
		<from_code>91596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2</from_name>
		<from_code>2101271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalidae immune F(ab')2 (equine)</from_name>
		<from_code>2101270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Snake Bites</to_name>
		<to_code>M0019987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raxibacumab</from_name>
		<from_code>1366567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus adamanteus antivenin</from_name>
		<from_code>885185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>North American coral snake antivenin</from_name>
		<from_code>979384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus scutulatus antivenin</from_name>
		<from_code>885189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Crotalus atrox antivenin</from_name>
		<from_code>885187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obiltoxaximab</from_name>
		<from_code>1746906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Death</to_name>
		<to_code>M0005701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amineptin</from_name>
		<from_code>17698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amineptin</to_name>
		<to_code>M0058027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>avotermin</from_name>
		<from_code>1427086</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>avotermin</to_name>
		<to_code>M0558305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ajmalicine</from_name>
		<from_code>17205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>raubasine</to_name>
		<to_code>M0047444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-ketoglutaric acid</from_name>
		<from_code>17511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-Ketoglutaric Acid</to_name>
		<to_code>M0094667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antithrombin III</from_name>
		<from_code>1009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antithrombin III</to_name>
		<to_code>M0001509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic trisulfide</from_name>
		<from_code>1667210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arsenic trisulfide</to_name>
		<to_code>M0133048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Allium cepa bulb extract</from_name>
		<from_code>2695867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Asian ginseng extract</from_name>
		<from_code>1370774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asian ginseng</to_name>
		<to_code>M000744128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Korean ginseng root extract</from_name>
		<from_code>259471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asian ginseng</to_name>
		<to_code>M000744128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Andrographis paniculata whole extract</from_name>
		<from_code>1534766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Andrographis paniculata extract</to_name>
		<to_code>M000753653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aurothiomalate</from_name>
		<from_code>42547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aurothiomalate</to_name>
		<to_code>M0009528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ascorbic acid 2-sulfate</from_name>
		<from_code>1370459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ascorbic acid 2-sulfate</to_name>
		<to_code>M0042371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldosterone</from_name>
		<from_code>1312358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aldosterone</to_name>
		<to_code>M0000686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisole</from_name>
		<from_code>2594597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anisole</to_name>
		<to_code>M0169221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminoquinuride</from_name>
		<from_code>17747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aminoquinuride</to_name>
		<to_code>M0056695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum flufenamate</from_name>
		<from_code>17612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum flufenamate</to_name>
		<to_code>M0090244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alum, ammonium</from_name>
		<from_code>2101717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum ammonium sulfate</to_name>
		<to_code>M0166065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium carbonate</from_name>
		<from_code>1310190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium carbonate</to_name>
		<to_code>M0120586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium carbonate</from_name>
		<from_code>1310190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>diammonium carbonate</to_name>
		<to_code>M0582730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>annatto extract</from_name>
		<from_code>1313764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>annatto</to_name>
		<to_code>M0152834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amygdalin</from_name>
		<from_code>1371051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amygdalin</to_name>
		<to_code>M0001043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-aminocyclopropanol</from_name>
		<from_code>2645303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-aminocyclopropanol</to_name>
		<to_code>M0062774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almitrine dimesylate</from_name>
		<from_code>529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Almitrine Dimesylate</to_name>
		<to_code>M0329453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azulene</from_name>
		<from_code>2675343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>azulene</to_name>
		<to_code>M0047123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allyl alcohol</from_name>
		<from_code>2385331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allyl alcohol</to_name>
		<to_code>M0049050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alminoprofen</from_name>
		<from_code>17387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alminoprofen</to_name>
		<to_code>M0090409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anethole</from_name>
		<from_code>17881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anethole</to_name>
		<to_code>M0049202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Agrimonia pilosa leaf extract</from_name>
		<from_code>2697821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Agrimonia pilosa leaf</to_name>
		<to_code>M000744830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrylic acid</from_name>
		<from_code>1368626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acrylic acid</to_name>
		<to_code>M0111473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond oil</from_name>
		<from_code>1305638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>almond oil</to_name>
		<to_code>M0187501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum phosphate</from_name>
		<from_code>17618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminum phosphate</to_name>
		<to_code>M0059957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allyl methacrylate</from_name>
		<from_code>2203551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>allyl methacrylate</to_name>
		<to_code>M0108492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic anhydride</from_name>
		<from_code>1370450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetic anhydride</to_name>
		<to_code>M0099680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apricot extract</from_name>
		<from_code>1353891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prunus armeniaca fruit</to_name>
		<to_code>M000744763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium bromide</from_name>
		<from_code>1313309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium bromide</to_name>
		<to_code>M0146471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprinocarsen</from_name>
		<from_code>2634355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aprinocarsen</to_name>
		<to_code>M0469884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl aspartic acid</from_name>
		<from_code>1872378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-acetylaspartic acid</to_name>
		<to_code>M0040206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Arthrospira platensis</from_name>
		<from_code>1321355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthrospira platensis</to_name>
		<to_code>M000672958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allylestrenol</from_name>
		<from_code>525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Allylestrenol</to_name>
		<to_code>M0000752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tympanic Membrane Perforation</to_name>
		<to_code>M0027248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acetic Acid</to_name>
		<to_code>M0028791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetic acid</from_name>
		<from_code>168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine tartrate</from_name>
		<from_code>221174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolterodine</from_name>
		<from_code>119565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valrubicin</from_name>
		<from_code>31435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urinary Bladder Diseases</to_name>
		<to_code>M0002630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine hydrochloride</from_name>
		<from_code>1049105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>boric acid</from_name>
		<from_code>1700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzocaine</from_name>
		<from_code>1399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>finafloxacin</from_name>
		<from_code>1598641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone</from_name>
		<from_code>4458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethasone pivalate</from_name>
		<from_code>25113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum acetate</from_name>
		<from_code>17609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Otitis Externa</to_name>
		<to_code>M0015562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaginosis, Bacterial</to_name>
		<to_code>M0025299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetoxolone aluminum</from_name>
		<from_code>268907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetylglycyrrhetinic acid, aluminum salt</to_name>
		<to_code>M0312186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>algestone</from_name>
		<from_code>595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Algestone</to_name>
		<to_code>M0000801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apazone</from_name>
		<from_code>1029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Apazone</to_name>
		<to_code>M0001566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allspice allergenic extract</from_name>
		<from_code>895552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-acrylamido-2-methyl-1-propanesulfonic acid</from_name>
		<from_code>2109231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-acrylamido-2-methylpropanesulfonate</to_name>
		<to_code>M0157933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetaminil</from_name>
		<from_code>17813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amphetaminil</to_name>
		<to_code>M0263091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium</from_name>
		<from_code>709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ammonium</to_name>
		<to_code>M0000984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrocitric Acid</to_name>
		<to_code>M000642249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Achilleic Acid</to_name>
		<to_code>M000642244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carboxyglutaconic Acid</to_name>
		<to_code>M000642245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Equisetic Acid</to_name>
		<to_code>M000642248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Citridinic Acid</to_name>
		<to_code>M000642247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aconitic Acid</to_name>
		<to_code>M0000235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aconitic acid</from_name>
		<from_code>1721298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Citridic Acid</to_name>
		<to_code>M000642246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>arsenic acid</from_name>
		<from_code>1375923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>arsenic acid</to_name>
		<to_code>M0085283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin pivoxil</from_name>
		<from_code>627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amdinocillin Pivoxil</to_name>
		<to_code>M0000877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>androsterone</from_name>
		<from_code>1312359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Androsterone</to_name>
		<to_code>M0001116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>antimony trioxide</from_name>
		<from_code>2477431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>antimony trioxide</to_name>
		<to_code>M0113565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ammonium acetate</from_name>
		<from_code>1362883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ammonium acetate</to_name>
		<to_code>M0070783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Apis mellifera preparation</from_name>
		<from_code>285219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bee Venoms</to_name>
		<to_code>M0002274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-amino-1-butanol</from_name>
		<from_code>2588247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-amino-1-butanol</to_name>
		<to_code>M0049110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylmetacresol</from_name>
		<from_code>236248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amylmetacresol</to_name>
		<to_code>M0538347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>.alpha.-terpinene</from_name>
		<from_code>2542349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-terpinene</to_name>
		<to_code>M0313696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl cedrene</from_name>
		<from_code>2289006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>acetyl cedrene</to_name>
		<to_code>M0243501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-hexylcinnamaldehyde</from_name>
		<from_code>1311811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexyl cinnamic aldehyde</to_name>
		<to_code>M0214024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-hexylcinnamaldehyde</from_name>
		<from_code>1311811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-hexylcinnamaldehyde</to_name>
		<to_code>M0549015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitate</to_name>
		<to_code>1370621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene</to_name>
		<to_code>1314239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora edulis seed oil</to_name>
		<to_code>1363440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylenimine hydrochloride (20000 MW)</to_name>
		<to_code>2469930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment yellow 3</to_name>
		<to_code>1491868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 stearate</to_name>
		<to_code>1314849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phragmites australis whole extract</to_name>
		<to_code>1368339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pizotyline</to_name>
		<to_code>8373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-14 palmeth-60 hexyl dicarbamate</to_name>
		<to_code>1314317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proflavine</to_name>
		<to_code>8723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phryma leptostachya root extact</to_name>
		<to_code>2001496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphatidylcholine, soybean</to_name>
		<to_code>2109751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium roseum oil</to_name>
		<to_code>1813398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl tetraoleate</to_name>
		<to_code>1314196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluoropolymethylisopropyl ether</to_name>
		<to_code>1430131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone</to_name>
		<to_code>8610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium acetate</to_name>
		<to_code>54987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pratia purpurascens exctract</to_name>
		<to_code>2378838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propoxyphene napsylate</to_name>
		<to_code>8786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pivampicillin</to_name>
		<to_code>8372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothrombin</to_name>
		<to_code>1441688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin V</to_name>
		<to_code>7984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol ethyl ether</to_name>
		<to_code>2385887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica seed extract</to_name>
		<to_code>1310004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-20 methyl glucose ether distearate</to_name>
		<to_code>1373204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-10 (1000 MPA.S at 2%)</to_name>
		<to_code>1486717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoisocytidine</to_name>
		<to_code>34930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosteryl/isostearyl/cetyl/stearyl/behenyl dimer dilinoleate</to_name>
		<to_code>2048257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoleate</to_name>
		<to_code>2475954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyruvic acid</to_name>
		<to_code>35161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluorohexyloctane</to_name>
		<to_code>2637547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythritol tetranitrate</to_name>
		<to_code>7992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid), (85:15; 23000 MW)</to_name>
		<to_code>2631025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4-oleate</to_name>
		<to_code>1540876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parecoxib</to_name>
		<to_code>279950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid) (50:50; 46000 MW)</to_name>
		<to_code>1999996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethyloxazoline (500000 MW)</to_name>
		<to_code>2182794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirfenidone</to_name>
		<to_code>1592254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>praziquantel</to_name>
		<to_code>8628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>padimate A</to_name>
		<to_code>1363712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylhydrazine</to_name>
		<to_code>8167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylparaben calcium</to_name>
		<to_code>1867698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus cembroides pollen extract</to_name>
		<to_code>2590679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-17</to_name>
		<to_code>1313179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrantel pamoate</to_name>
		<to_code>8985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ptelea trifoliata bark extract</to_name>
		<to_code>1309713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pilocarpus jaborandii whole extract</to_name>
		<to_code>2045372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphate ion</to_name>
		<to_code>486961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 dimethicone</to_name>
		<to_code>1314194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phellodendron amurense whole extract</to_name>
		<to_code>1594581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pinaverium bromide</to_name>
		<to_code>54743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 dioleate</to_name>
		<to_code>1363621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-phenylenediamine</to_name>
		<to_code>1362740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 60</to_name>
		<to_code>1368867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 glyceryl laurate</to_name>
		<to_code>2002789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pilocarpine hydrochloride</to_name>
		<to_code>235426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-propoxy-2-propanol</to_name>
		<to_code>1358844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax notoginseng root extract</to_name>
		<to_code>1365707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramiverine</to_name>
		<to_code>190433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-7 (70/30 acrylamide/dadmac; 2600000 MW)</to_name>
		<to_code>1738847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polymyxin B sulfate</to_name>
		<to_code>388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 beeswax</to_name>
		<to_code>2399032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 methylglucose distearate</to_name>
		<to_code>2476007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paltusotine hydrochloride</to_name>
		<to_code>2724364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl pentapeptide-4</to_name>
		<to_code>1426596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus dulcis flower extract</to_name>
		<to_code>2053442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 21</to_name>
		<to_code>1992411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycodon grandiflorum leaf extract</to_name>
		<to_code>1309786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pelargonate</to_name>
		<to_code>2054105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propiomazine hydrochloride</to_name>
		<to_code>6232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium graveolens flower oil</to_name>
		<to_code>1307705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>placebo</to_name>
		<to_code>8375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proparacaine</to_name>
		<to_code>34905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (1100000 MW)</to_name>
		<to_code>1426412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 4500</to_name>
		<to_code>1358490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimavanserin</to_name>
		<to_code>1791685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Poa pratensis allergenic extract</to_name>
		<to_code>1922745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentazocine hydrochloride</to_name>
		<to_code>104973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol monolaurate</to_name>
		<to_code>1356149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 caprate</to_name>
		<to_code>2569078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl tetracaprylate-tetracaprate</to_name>
		<to_code>1313199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30 stearate</to_name>
		<to_code>1368155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium orotate</to_name>
		<to_code>8602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picric acid</to_name>
		<to_code>1320642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus sylvestris cone extract</to_name>
		<to_code>1372561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus nigra leaf bud extract</to_name>
		<to_code>2055003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>primidone</to_name>
		<to_code>8691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonum aviculare whole extract</to_name>
		<to_code>1992543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrazon</to_name>
		<to_code>1874547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paliperidone palmitate</to_name>
		<to_code>858045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxyisopropanol</to_name>
		<to_code>1313723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomegranate extract</to_name>
		<to_code>725206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prolactin</to_name>
		<to_code>1426890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propiverine</to_name>
		<to_code>55175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramoxine hydrochloride</to_name>
		<to_code>57555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium perchlorate</to_name>
		<to_code>34318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl proline</to_name>
		<to_code>1370622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pfaffia paniculata root extract</to_name>
		<to_code>1311512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica var. nucipersica whole extract</to_name>
		<to_code>2533910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Porphyra umbilicalis extract</to_name>
		<to_code>1368343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prifinium</to_name>
		<to_code>236174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-palmitate</to_name>
		<to_code>1726445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 stearate</to_name>
		<to_code>1313257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperonal</to_name>
		<to_code>33753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pepper tree pollen extract</to_name>
		<to_code>852140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perennial rye grass pollen extract</to_name>
		<to_code>852819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirlimycin</to_name>
		<to_code>1367292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliglusam hydrochloride</to_name>
		<to_code>2368131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago lanceolata whole extract</to_name>
		<to_code>2587643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus armeniaca whole extract</to_name>
		<to_code>1373159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phragmites australis stem extract</to_name>
		<to_code>1922526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cocoyl glycinate</to_name>
		<to_code>1655990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palovarotene</to_name>
		<to_code>2663954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitavastatin calcium</to_name>
		<to_code>861640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylamide (10000 MW)</to_name>
		<to_code>1313719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peptostreptococcus anaerobius</to_name>
		<to_code>1311307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Proteus rettgeri</to_name>
		<to_code>2002418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perlite</to_name>
		<to_code>1858075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paramethasone acetate</to_name>
		<to_code>32895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl oligopeptide</to_name>
		<to_code>1314373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus alba bark extract</to_name>
		<to_code>1876511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 335</to_name>
		<to_code>1313711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-15 glyceryl stearate</to_name>
		<to_code>1363611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol (108000 MW)</to_name>
		<to_code>2668414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitavastatin magnesium</to_name>
		<to_code>2001252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphoric acid</to_name>
		<to_code>8259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paritaprevir dihydrate</to_name>
		<to_code>1600436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenazocine</to_name>
		<to_code>8119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (65000 MW)</to_name>
		<to_code>2644879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-phenyl propionic acid</to_name>
		<to_code>2627300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoephedrine tannate</to_name>
		<to_code>221151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paulownia tomentosa leaf extract</to_name>
		<to_code>1310113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinellia ternata root extract</to_name>
		<to_code>1307663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium palmitate</to_name>
		<to_code>1674188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-70 lanolin</to_name>
		<to_code>2374550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine dihydrochloride</to_name>
		<to_code>2562175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K90</to_name>
		<to_code>1310497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-28 (1100000 MW)</to_name>
		<to_code>1426914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomegranate seed oil</to_name>
		<to_code>1306095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PERTUSSIS VACCINE,ADSORBED</to_name>
		<to_code>402543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Potentilla erecta root extract</to_name>
		<to_code>1307737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polybutene (1400 MW)</to_name>
		<to_code>1313725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petasites hybridus leaf extract</to_name>
		<to_code>1369687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylate-13</to_name>
		<to_code>2637016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenobarbital</to_name>
		<to_code>8134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyester-10</to_name>
		<to_code>1314200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piribedil mesylate</to_name>
		<to_code>236380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylacetic acid</to_name>
		<to_code>33332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peach allergenic extract</to_name>
		<to_code>892575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium hydroxide</to_name>
		<to_code>34311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-150 dilaurate</to_name>
		<to_code>1857718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prezatide copper</to_name>
		<to_code>1314233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(4-vinylpyridine-N-oxide)</to_name>
		<to_code>2634299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parnaparin</to_name>
		<to_code>69528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polymethylsilsesquioxane (4.5 microns)</to_name>
		<to_code>1426430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipoxolan</to_name>
		<to_code>33758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamine 1304</to_name>
		<to_code>2374352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudomonas aeruginosa</to_name>
		<to_code>1310913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prabotulinumtoxinA-xvfs</to_name>
		<to_code>2117869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirbuterol acetate</to_name>
		<to_code>221142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphite</to_name>
		<to_code>1793924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propicillin</to_name>
		<to_code>34649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol-hydroxyethylcellulose stearyldimonium chloride</to_name>
		<to_code>1723159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persea americana seed butter extract</to_name>
		<to_code>1309494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pea allergenic extract</to_name>
		<to_code>892569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphatidylserine</to_name>
		<to_code>89959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pasireotide diaspartate</to_name>
		<to_code>1364104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenobarbital quinidine</to_name>
		<to_code>54620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora edulis fruit extract</to_name>
		<to_code>1655989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sodium saccharate</to_name>
		<to_code>1788996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-9 oleate</to_name>
		<to_code>2534443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Psidium guajava leaf extract</to_name>
		<to_code>1799150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim-apgf</to_name>
		<to_code>2469333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus tremuloides bark extract</to_name>
		<to_code>1310106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus sylvestris flowering top extract</to_name>
		<to_code>1310084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrethrum extract</to_name>
		<to_code>1232405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrrole</to_name>
		<to_code>1338938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxine phosphoserinate</to_name>
		<to_code>236803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phaeodactylum tricornutum extract</to_name>
		<to_code>1592735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoleic acid</to_name>
		<to_code>2475955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phellodendrine</to_name>
		<to_code>2622304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus vaccine inactivated, type 2 (MEF-1)</to_name>
		<to_code>763098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum multiflorum root extract</to_name>
		<to_code>1307696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physalis virginiana whole extract</to_name>
		<to_code>2590678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 methyl ether</to_name>
		<to_code>1314193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propicillin potassium</to_name>
		<to_code>236615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-120 glyceryl stearate</to_name>
		<to_code>1739983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancuronium</to_name>
		<to_code>7883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,3-pentanedione</to_name>
		<to_code>2693283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palladium</to_name>
		<to_code>1311279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-3 benzyl ether ethylhexanoate</to_name>
		<to_code>1436961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylephrine hydrochloride</to_name>
		<to_code>8164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-9 stearate</to_name>
		<to_code>1307086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pussy willow pollen extract</to_name>
		<to_code>852174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plasminogen</to_name>
		<to_code>2557200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parecoxib sodium</to_name>
		<to_code>279951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus x yedoensis leaf extract</to_name>
		<to_code>1539419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propantheline bromide</to_name>
		<to_code>8762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piscidia piscipula whole extract</to_name>
		<to_code>1991790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-12-PEG-50 lanolin</to_name>
		<to_code>1495078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramipexole dihydrochloride</to_name>
		<to_code>236747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phylloquinone omega-hydroxylase CYP4F11</to_name>
		<to_code>2727173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone k25-28</to_name>
		<to_code>1313718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed disodium hemipentahydrate</to_name>
		<to_code>2056898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycodon grandiflorus whole extract</to_name>
		<to_code>2634295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(methyl methacrylate; 450000 MW)</to_name>
		<to_code>1433496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl acetaldehyde dimethyl acetal</to_name>
		<to_code>2467130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoperidine hydrochloride</to_name>
		<to_code>106508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Perilla frutescens leaf oil</to_name>
		<to_code>1307672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyester-5 (tg-38)</to_name>
		<to_code>1865719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 triisostearate</to_name>
		<to_code>1649137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago major leaf extract</to_name>
		<to_code>1310005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosterols</to_name>
		<to_code>8310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patisiran lipid complex</to_name>
		<to_code>2284711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosphingosine hydrochloride</to_name>
		<to_code>1534773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus lannesiana flower extract</to_name>
		<to_code>2710465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propyperone</to_name>
		<to_code>1999765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantolactone, (R)-</to_name>
		<to_code>1427236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium silicate</to_name>
		<to_code>1311377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitamidopropyltrimonium chloride</to_name>
		<to_code>1489928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-14 1-((methylphenyl)ethyl)phenyl ether</to_name>
		<to_code>2169287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 cocamine</to_name>
		<to_code>2395446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proscillaridin</to_name>
		<to_code>8795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 stearate</to_name>
		<to_code>1312712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4 laurate</to_name>
		<to_code>2640867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperocaine</to_name>
		<to_code>33752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 40 castor oil</to_name>
		<to_code>1309216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol diacetate</to_name>
		<to_code>1427008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phaseolus lunatus whole extract</to_name>
		<to_code>2708829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipamperone dihydrochloride</to_name>
		<to_code>289159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus densiflora leaf extract</to_name>
		<to_code>1541723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pamabrom</to_name>
		<to_code>54365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-24-glycereth-24</to_name>
		<to_code>1653592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG:PPG-4-12:dimethicone</to_name>
		<to_code>1366993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procyclidine</to_name>
		<to_code>8718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-47 (methacrylamidopropyltrimethylammonium chloride-co-methyl acrylate-co-acrylic acid 45:10:45; 1200000 MW)</to_name>
		<to_code>1601597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>practolol</to_name>
		<to_code>8620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylamide (crosslinked; 0.01-0.2 mole percent bisacrylamide)</to_name>
		<to_code>1313270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-25-25 dimethicone</to_name>
		<to_code>1541248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plazomicin</to_name>
		<to_code>2049549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitavastatin sodium</to_name>
		<to_code>1944734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylephrine bitartrate</to_name>
		<to_code>91167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycerin-6</to_name>
		<to_code>1313721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment blue 1</to_name>
		<to_code>1793744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol (100000 MW)</to_name>
		<to_code>1796719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralmorelin dihydrochloride</to_name>
		<to_code>1492038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 80</to_name>
		<to_code>8560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium aspartate</to_name>
		<to_code>8589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dicaprylate-dicaprate</to_name>
		<to_code>1426622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-1 trideceth-6</to_name>
		<to_code>1427227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pholcodine</to_name>
		<to_code>33431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus speciosa leaf extract</to_name>
		<to_code>1309953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 2000</to_name>
		<to_code>1364383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylmercuric nitrate</to_name>
		<to_code>89722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleione yunnanensis whole extract</to_name>
		<to_code>2711362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid 7:3:1; 280000 MW)</to_name>
		<to_code>1427228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentostatin</to_name>
		<to_code>8011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-4 (1600 MPA.S at 2%)</to_name>
		<to_code>2550710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propyl acetate</to_name>
		<to_code>1649519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluoroperhydrophenanthrene</to_name>
		<to_code>1540875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prochlorperazine</to_name>
		<to_code>8704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol myristyl ether acetate</to_name>
		<to_code>1356703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyracantha fortuneana fruit extract</to_name>
		<to_code>1311666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine bark extract</to_name>
		<to_code>259276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrithioxin</to_name>
		<to_code>9020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsley seed oil</to_name>
		<to_code>1309236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoephedrine</to_name>
		<to_code>8896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-15-15 dimethicone</to_name>
		<to_code>1494197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein C</to_name>
		<to_code>8834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus mume fruit oil</to_name>
		<to_code>1735540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudolarix amabilis bark extract</to_name>
		<to_code>1547621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>profluralin</to_name>
		<to_code>2665290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Papaya preparation</to_name>
		<to_code>324030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 lauramide</to_name>
		<to_code>1363617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(perfluorohexyl)ethanol</to_name>
		<to_code>1986349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platostoma chinensis whole extract</to_name>
		<to_code>1358479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylmercuric acetate</to_name>
		<to_code>1426778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phytolacca americana whole extract</to_name>
		<to_code>1661745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 oleate</to_name>
		<to_code>2285326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 14000</to_name>
		<to_code>1368893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrrolidonecarboxylic acid</to_name>
		<to_code>9036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium bromide</to_name>
		<to_code>34299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propionic acid</to_name>
		<to_code>34658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perindopril erbumine</to_name>
		<to_code>72260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pawpaw extract</to_name>
		<to_code>1650241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pareptide</to_name>
		<to_code>2619909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propionate</to_name>
		<to_code>121047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Portulaca pilosa whole extract</to_name>
		<to_code>2178065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyethylene-24-cholesteryl ether</to_name>
		<to_code>1362898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium arsenite</to_name>
		<to_code>1426894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pholedrine</to_name>
		<to_code>33432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 distearate</to_name>
		<to_code>2467842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paromomycin sulfate</to_name>
		<to_code>66912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plumeria rubra flower extract</to_name>
		<to_code>1307812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pamidronate disodium</to_name>
		<to_code>105443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium camemberti allergenic extract</to_name>
		<to_code>966943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polacrillin</to_name>
		<to_code>1370589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica leaf extract</to_name>
		<to_code>1310019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium carbonate 1 1/2 hydrate</to_name>
		<to_code>1311294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-30-160 copolymer</to_name>
		<to_code>1426947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment yellow 1</to_name>
		<to_code>1872250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proquazone</to_name>
		<to_code>2669456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paclitaxel protein-bound</to_name>
		<to_code>486610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 distearate</to_name>
		<to_code>2199654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pulegone</to_name>
		<to_code>2393774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-aminohippurate</to_name>
		<to_code>42837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla montana whole extract</to_name>
		<to_code>2591603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pancratium maritimum whole extract</to_name>
		<to_code>1992541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylethyl alcohol</to_name>
		<to_code>8126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium graveolens flowering top extract</to_name>
		<to_code>1307599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxybenzamine hydrochloride</to_name>
		<to_code>71512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus</to_name>
		<to_code>1427212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PROPINOX HCL</to_name>
		<to_code>236776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paris polyphylla root extract</to_name>
		<to_code>1307586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment red 48</to_name>
		<to_code>1426161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30 glyceryl linoleate</to_name>
		<to_code>1862480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prochlorperazine mesylate</to_name>
		<to_code>235739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-12/SMDI copolymer</to_name>
		<to_code>1440239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K60</to_name>
		<to_code>2359275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginterferon beta-1a</to_name>
		<to_code>1546168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panaxynol</to_name>
		<to_code>2676953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propafenone hydrochloride</to_name>
		<to_code>203135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl hydroxypropyltrimonium amylopectin/glycerin crosspolymer</to_name>
		<to_code>2637852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pacific salmon allergenic extract</to_name>
		<to_code>1098247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polypropylene (30000 MW)</to_name>
		<to_code>2118848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paprika oil</to_name>
		<to_code>1307689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-10 glyceryl stearate</to_name>
		<to_code>1426935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protriptyline</to_name>
		<to_code>8886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(N-acetyl, N-arginyl)glucosamine (50000-80000 MW)</to_name>
		<to_code>1372682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pear allergenic extract</to_name>
		<to_code>899883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentapeptide-18</to_name>
		<to_code>2684981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-propoxy-1-propanol</to_name>
		<to_code>1356481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piellia ternata whole extract</to_name>
		<to_code>1547571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potato starch</to_name>
		<to_code>1427056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimobendan</to_name>
		<to_code>1110783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol (40000 MW)</to_name>
		<to_code>1855459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phleum pratense top extract</to_name>
		<to_code>1350211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyestradiol phosphate</to_name>
		<to_code>34120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperacetazine</to_name>
		<to_code>8338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>praseodymium</to_name>
		<to_code>1311481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 6000</to_name>
		<to_code>1314384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 dilaurate</to_name>
		<to_code>2265844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium roquefortii allergenic extract</to_name>
		<to_code>972365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentolamine</to_name>
		<to_code>8153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin V calcium</to_name>
		<to_code>236517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine</to_name>
		<to_code>2593177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-60 glyceryl stearate</to_name>
		<to_code>1652252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polacrillin potassium</to_name>
		<to_code>1314377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitostearate</to_name>
		<to_code>1743154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 7000000</to_name>
		<to_code>1312731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylisohexanol</to_name>
		<to_code>1376152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pteridium aquilinum root extract</to_name>
		<to_code>1309767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plumeria rubra whole extract</to_name>
		<to_code>1921563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycodon grandiflorum root extract</to_name>
		<to_code>1307614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium phosphate dibasic trihydrate</to_name>
		<to_code>2475957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poldine methylsulfate</to_name>
		<to_code>33927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parethoxycaine HCl</to_name>
		<to_code>236250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pibrentasvir</to_name>
		<to_code>1940636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipecuronium</to_name>
		<to_code>33742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 propylheptyl ether</to_name>
		<to_code>2584305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paricalcitol</to_name>
		<to_code>73710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sodium saccharate dihydrate</to_name>
		<to_code>1801709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinctada margaritifera shell extract</to_name>
		<to_code>1874550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus tabuliformis pollen extract</to_name>
		<to_code>1801708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus thunbergii leaf extract</to_name>
		<to_code>2665416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralidoxime cation</to_name>
		<to_code>1546365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Puccinia graminis allergenic extract</to_name>
		<to_code>999487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus serotina bark extract</to_name>
		<to_code>1307851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirenoxine</to_name>
		<to_code>228080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phymatolithon calcareum preparation</to_name>
		<to_code>1731724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl stearate</to_name>
		<to_code>2664062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (75000 MW)</to_name>
		<to_code>1312723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-15 cocamine</to_name>
		<to_code>1366668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pefloxacin mesylate</to_name>
		<to_code>262299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxyacetate</to_name>
		<to_code>1426336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paeonia lactiflora root oil</to_name>
		<to_code>2106562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium phenethicillin</to_name>
		<to_code>132907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pertussis vaccine</to_name>
		<to_code>8080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxal</to_name>
		<to_code>9002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimethixene</to_name>
		<to_code>33712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phloroglucinol</to_name>
		<to_code>8196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proxyphylline</to_name>
		<to_code>34906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid), (50:50; 12000 MW)</to_name>
		<to_code>1536460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parthenium hysterophorus extract</to_name>
		<to_code>1432796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyrithione Disulfide</to_name>
		<to_code>236295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 450</to_name>
		<to_code>1363441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>punica granatum whole extract</to_name>
		<to_code>1432478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata root extract</to_name>
		<to_code>1745930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus salicina fruit extract</to_name>
		<to_code>2630164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perflexane</to_name>
		<to_code>1540828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polawax polysorbate</to_name>
		<to_code>1425089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirisudanol maleate</to_name>
		<to_code>236172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polymetaphosphate</to_name>
		<to_code>1364922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pau d'arco preparation</to_name>
		<to_code>342940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-11 (1000000 MW)</to_name>
		<to_code>1426654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemigatinib</to_name>
		<to_code>2359268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus strobus cone extract</to_name>
		<to_code>2590680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prasugrel hydrochloride</to_name>
		<to_code>847020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sorbate</to_name>
		<to_code>8606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-80 glyceryl cocoate</to_name>
		<to_code>1492189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peptones</to_name>
		<to_code>8040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-(p-hydroxyphenyl)-2-butanone</to_name>
		<to_code>1860422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pea fiber extract</to_name>
		<to_code>2630721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednicarbate</to_name>
		<to_code>34369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>primaquine</to_name>
		<to_code>8687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycolate</to_name>
		<to_code>2466982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipemidic acid</to_name>
		<to_code>8337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palopegteriparatide</to_name>
		<to_code>2693635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prolintane hydrochloride</to_name>
		<to_code>235831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothrombin, human-lans</to_name>
		<to_code>2643202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemirolast</to_name>
		<to_code>19551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium hydroxycitrate</to_name>
		<to_code>2671200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentobarbital sodium</to_name>
		<to_code>203085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork kidney preparation</to_name>
		<to_code>1311167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetate pentasodium</to_name>
		<to_code>314774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-nitrobiphenyl</to_name>
		<to_code>2571811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylic acid (8000 MW)</to_name>
		<to_code>1484857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(phosphonooxy)- 2-propenoic acid</to_name>
		<to_code>2385888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palm oil</to_name>
		<to_code>32809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl trimethicone</to_name>
		<to_code>1310585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-4-30 copolymer</to_name>
		<to_code>2694076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prosolv SMCC 50</to_name>
		<to_code>1426703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllostachys reticulata resin</to_name>
		<to_code>1312720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>passion flower extract</to_name>
		<to_code>285159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polystyrene sulfonate</to_name>
		<to_code>1546437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicilloyl polylysine</to_name>
		<to_code>2667743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phragmites australis root extract</to_name>
		<to_code>1307738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pichia jadinii extract</to_name>
		<to_code>1427220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimagedine</to_name>
		<to_code>1311670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dilaurate</to_name>
		<to_code>1986789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 rapeseed sterol</to_name>
		<to_code>1307700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parachlorophenol</to_name>
		<to_code>14982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poppy seed allergenic extract</to_name>
		<to_code>1011017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palm kernel glycerides</to_name>
		<to_code>1592262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prenylamine lactate</to_name>
		<to_code>34407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol behenate</to_name>
		<to_code>1859169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picrasma quassioides wood extract</to_name>
		<to_code>1361660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium thiocyanate</to_name>
		<to_code>1427066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene terephthalate (intrinsic viscosity 1.00-2.00)</to_name>
		<to_code>2000034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 234</to_name>
		<to_code>1651699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 stearate</to_name>
		<to_code>1648781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paliperidone</to_name>
		<to_code>679314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pafolacianine sodium</to_name>
		<to_code>2586858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl sarcosinate</to_name>
		<to_code>1726121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenethyl octanoate</to_name>
		<to_code>2632413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poverty weed pollen extract</to_name>
		<to_code>852539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyamide-8 (4500 MW)</to_name>
		<to_code>1802853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl dipeptide-7</to_name>
		<to_code>1368160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 900000</to_name>
		<to_code>1441534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patiromer sorbitex calcium</to_name>
		<to_code>2204723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perampanel</to_name>
		<to_code>1356552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palbociclib</to_name>
		<to_code>1601374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (45000 MW)</to_name>
		<to_code>2266494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passalora fulva allergenic extract</to_name>
		<to_code>883442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulex irritans preparation</to_name>
		<to_code>1311151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polarcrillin</to_name>
		<to_code>1370669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 glyceryl stearate</to_name>
		<to_code>1313177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plasma protein fraction</to_name>
		<to_code>33835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Propionibacterium acnes</to_name>
		<to_code>1310910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polygeline</to_name>
		<to_code>8521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-(2-methylbutyrate)</to_name>
		<to_code>1542901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium stearate</to_name>
		<to_code>1368705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pozelimab</to_name>
		<to_code>2663938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim-pbbk</to_name>
		<to_code>2602779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palonosetron hydrochloride</to_name>
		<to_code>397405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata fruit extract</to_name>
		<to_code>1311651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30 glyceryl laurate</to_name>
		<to_code>2002790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein S, human-lans</to_name>
		<to_code>2643200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pacific ocean perch allergenic extract</to_name>
		<to_code>2102486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl glycine</to_name>
		<to_code>1359086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaverine codecarboxylate</to_name>
		<to_code>158387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllostachys nigra leaf extract</to_name>
		<to_code>2601715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-14 dimethicone</to_name>
		<to_code>1535606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piketoprofen</to_name>
		<to_code>82910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 2-stearate</to_name>
		<to_code>2173390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>policresulen</to_name>
		<to_code>54908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantolactone, (+-)-</to_name>
		<to_code>1426783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluoromethyldecalin</to_name>
		<to_code>1986868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>progabide</to_name>
		<to_code>34568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper cubeba fruit extract</to_name>
		<to_code>1310227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-26</to_name>
		<to_code>1541885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pasireotide</to_name>
		<to_code>1364105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paromomycin</to_name>
		<to_code>7934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentifylline</to_name>
		<to_code>33086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-150 stearate</to_name>
		<to_code>1368156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenazocine hydrobromide</to_name>
		<to_code>104979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipazethate</to_name>
		<to_code>33740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pivmecillinam hydrochloride</to_name>
		<to_code>102745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perindoprilat</to_name>
		<to_code>1546400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pale dock pollen extract</to_name>
		<to_code>1232604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-15</to_name>
		<to_code>2637755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 sorbitan stearate</to_name>
		<to_code>1489549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoma exigua var. exigua allergenic extract</to_name>
		<to_code>867284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penstemon davidsonii whole extract</to_name>
		<to_code>2533902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphorylcholine</to_name>
		<to_code>2585444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium bitartrate</to_name>
		<to_code>223779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoephedrine polistirex</to_name>
		<to_code>407885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polydatin</to_name>
		<to_code>1364277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus sylvestris bark extract</to_name>
		<to_code>1491859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pembrolizumab-pmph</to_name>
		<to_code>2723753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisone</to_name>
		<to_code>8640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Periploca sepium root bark extract</to_name>
		<to_code>1485537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petroselinum crispum extract</to_name>
		<to_code>1353886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polylactic acid-polyglycolic acid copolymer</to_name>
		<to_code>1309726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmatine</to_name>
		<to_code>1314367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus dulcis whole extract</to_name>
		<to_code>1999192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 300</to_name>
		<to_code>8513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax ginseng root water extract</to_name>
		<to_code>1309490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipoxolan hydrochloride</to_name>
		<to_code>235861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-20-15 dimethicone</to_name>
		<to_code>1426939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenicarbazide</to_name>
		<to_code>235808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perazine</to_name>
		<to_code>8042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propofol</to_name>
		<to_code>8782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>petroleum alkylate</to_name>
		<to_code>1652847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygala senega whole extract</to_name>
		<to_code>1649447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed disodium heptahydrate</to_name>
		<to_code>1666923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-10 caprylyl ether</to_name>
		<to_code>2621119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea abies wood extract</to_name>
		<to_code>1372259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sulfooleate</to_name>
		<to_code>1426700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 sorbitan stearate</to_name>
		<to_code>1918052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenazopyridine hydrochloride</to_name>
		<to_code>203197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl tetraisostearate</to_name>
		<to_code>1358489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panobinostat lactate</to_name>
		<to_code>1603349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Puccinia striiformis allergenic extract</to_name>
		<to_code>852311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytonadiol tetrasodium diphosphate</to_name>
		<to_code>1926458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosteryl macadamiate</to_name>
		<to_code>1866045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peruvian balsam</to_name>
		<to_code>33219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine</to_name>
		<to_code>8340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-3 benzyl ether myristate</to_name>
		<to_code>1314314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prairie sagebrush pollen extract</to_name>
		<to_code>867142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 methyl ether</to_name>
		<to_code>1367495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 pentaricinoleate</to_name>
		<to_code>2376936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol t-butyl ether</to_name>
		<to_code>2471085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phlebodium aureum root extract</to_name>
		<to_code>1790089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxyacetic acid</to_name>
		<to_code>1426335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plazomicin sulfate</to_name>
		<to_code>2052872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper methysticum whole extract</to_name>
		<to_code>1314199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllanthus niruri whole extract</to_name>
		<to_code>1374404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Portulaca grandiflora whole extract</to_name>
		<to_code>1594930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenethylamine hydrochloride</to_name>
		<to_code>1364287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>physostigmine</to_name>
		<to_code>8299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 laurate</to_name>
		<to_code>1363623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment red 7</to_name>
		<to_code>1872249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-8 distearate</to_name>
		<to_code>1363622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrimethamine</to_name>
		<to_code>9010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paraldehyde</to_name>
		<to_code>7909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol (18000 MW)</to_name>
		<to_code>1809900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poractant alfa</to_name>
		<to_code>236381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyrola asarifolia whole extract</to_name>
		<to_code>2467132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium expansum allergenic extract</to_name>
		<to_code>967111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,5-pentanediol</to_name>
		<to_code>1362880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylic acid (300000 MW)</to_name>
		<to_code>1719257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint oil terpeneless</to_name>
		<to_code>2467554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-16 (N-vinylpyrrolidinone:3-methyl-1-vinylimidazolium chloride (5:5))</to_name>
		<to_code>1371321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyruvaldehyde</to_name>
		<to_code>1373350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prademagene zamikeracel</to_name>
		<to_code>2713314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Primula veris extract</to_name>
		<to_code>1311310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ptychopetalum olacoides root extract</to_name>
		<to_code>1432990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 propylheptyl ether</to_name>
		<to_code>1541886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pivalic acid</to_name>
		<to_code>1426868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plectranthus barbatus whole extract</to_name>
		<to_code>1544131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peramivir</to_name>
		<to_code>619693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-125-30 copolymer</to_name>
		<to_code>2386336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancrelipase protease</to_name>
		<to_code>1427034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein S</to_name>
		<to_code>34822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus dulcis bark extract</to_name>
		<to_code>1307665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralmorelin</to_name>
		<to_code>1492039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Papaver rhoeas flower extract</to_name>
		<to_code>1310150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 distearate</to_name>
		<to_code>1421890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylalanine,DL-</to_name>
		<to_code>236948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea abies whole extract</to_name>
		<to_code>2587642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propionamide</to_name>
		<to_code>1366667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petasites amplus whole extract</to_name>
		<to_code>2564006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procyanidin A2</to_name>
		<to_code>2631026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patent blue violet</to_name>
		<to_code>32950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium chlorate</to_name>
		<to_code>59203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycladus orientalis pollen extract</to_name>
		<to_code>1360623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone tebutate</to_name>
		<to_code>34376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosterol esters</to_name>
		<to_code>637205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parathyroid hormone</to_name>
		<to_code>1427222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium nitrite</to_name>
		<to_code>1365705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago asiatica extract</to_name>
		<to_code>1367497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoephedrine hydrochloride</to_name>
		<to_code>91168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylethyl resorcinol</to_name>
		<to_code>1313724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polixetonium chloride</to_name>
		<to_code>1736633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phytolacca octandra leaf extract</to_name>
		<to_code>2053440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>primycin</to_name>
		<to_code>2479689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium phosphate</to_name>
		<to_code>34322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago seed</to_name>
		<to_code>82088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pacific oyster preparation</to_name>
		<to_code>2199491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 3350</to_name>
		<to_code>221147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrrolidone carboxylic acid ethyl cocoyl arginate</to_name>
		<to_code>1741922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleurotus eryngii whole extract</to_name>
		<to_code>2360030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perhexiline</to_name>
		<to_code>8050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propafenone</to_name>
		<to_code>8754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-150 pentaerythrityl tetrastearate</to_name>
		<to_code>1312646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygala senega root extract</to_name>
		<to_code>1310087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polygalacturonic acid</to_name>
		<to_code>1918053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-60 almond glycerides</to_name>
		<to_code>1363618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus laurocerasus leaf extract</to_name>
		<to_code>1310017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picosulfurate</to_name>
		<to_code>1546458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantoprazole</to_name>
		<to_code>40790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine sulfate</to_name>
		<to_code>1549138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 cocamine</to_name>
		<to_code>2169288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pimpinella anisum extract</to_name>
		<to_code>1426421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol di(2-methylbutyrate)</to_name>
		<to_code>1739982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum odoratum whole extract</to_name>
		<to_code>1373158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol monopalmitostearate</to_name>
		<to_code>1427010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pamidronate</to_name>
		<to_code>11473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum biflorum root etxract</to_name>
		<to_code>1373157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphocellulose</to_name>
		<to_code>33504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 2-(2-methylbutyrate)</to_name>
		<to_code>1947503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propoxyphene</to_name>
		<to_code>8785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyurethane-39</to_name>
		<to_code>2690255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peanut oil, hydrogenated</to_name>
		<to_code>1540357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Proteus mirabilis</to_name>
		<to_code>1310903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyrus communis flower extract</to_name>
		<to_code>2122083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propoxyphene hydrochloride</to_name>
		<to_code>71517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patisiran</to_name>
		<to_code>2053490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-(p-methoxyphenyl)propylene-1,2-oxide</to_name>
		<to_code>2370138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirtobrutinib</to_name>
		<to_code>2629338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 124</to_name>
		<to_code>1314379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol (MW 94000)</to_name>
		<to_code>1790286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>platelet glycoprotein VI</to_name>
		<to_code>2637677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Punica granatum leaf extract</to_name>
		<to_code>1794166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pokeweed preparation</to_name>
		<to_code>285160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleospora tarda allergenic extract</to_name>
		<to_code>852404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pimpinella saxifraga whole extract</to_name>
		<to_code>2592626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus mugo subsp. mugo leafy twig extract</to_name>
		<to_code>1796979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polacrilin</to_name>
		<to_code>1314376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyrethrum cinerariifolium allergenic extract</to_name>
		<to_code>967970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium brevicompactum</to_name>
		<to_code>1426666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parthenolide</to_name>
		<to_code>32941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus pinaster whole extract</to_name>
		<to_code>1855094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginterferon alfa-2b</to_name>
		<to_code>253453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protease</to_name>
		<to_code>8031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus vaccine inactivated, type 1 (Mahoney)</to_name>
		<to_code>763096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 8 stearate</to_name>
		<to_code>1367133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paramethasone</to_name>
		<to_code>7910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pteris ensiformis whole extract</to_name>
		<to_code>2592977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenobarbital sodium</to_name>
		<to_code>82077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-68</to_name>
		<to_code>1740239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-250 distearate</to_name>
		<to_code>2376934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K25</to_name>
		<to_code>1367141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pueraria montana var. chinensis root extract</to_name>
		<to_code>1307687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllanthus niruri top extract</to_name>
		<to_code>1311656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-9 polydimethylsiloxyethyl dimethicone</to_name>
		<to_code>1371303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polydextrose</to_name>
		<to_code>1363053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 oleate</to_name>
		<to_code>1798371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-caprylate</to_name>
		<to_code>2668060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dibenzoate</to_name>
		<to_code>1314212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene oxide 200000</to_name>
		<to_code>1809901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoma destructiva allergenic extract</to_name>
		<to_code>966995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PLUMERIA EXTRACT</to_name>
		<to_code>1313235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl acetate</to_name>
		<to_code>1541597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 rapeseedamide</to_name>
		<to_code>1307829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plozasiran sodium</to_name>
		<to_code>2727337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyepsilon-lysine (4000 MW)</to_name>
		<to_code>1996987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium permanganate</to_name>
		<to_code>8604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-60 sorbitan stearate</to_name>
		<to_code>1487142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tripeptide-8</to_name>
		<to_code>2583628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyurethane-34 (40 MPA)</to_name>
		<to_code>1673802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 40 hydrogenated castor oil</to_name>
		<to_code>1305669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed disodium</to_name>
		<to_code>282443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prasterone sodium sulfate</to_name>
		<to_code>1366962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-80 sorbitan laurate</to_name>
		<to_code>1440237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea abies flower bud extract</to_name>
		<to_code>1310000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyester-8 (1400 MW, cyanodiphenylpropenoyl capped)</to_name>
		<to_code>1314201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyltoloxamine resin complex</to_name>
		<to_code>314786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipothiazine</to_name>
		<to_code>8348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2-propanedithiol</to_name>
		<to_code>2281674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsley allergenic extract</to_name>
		<to_code>899877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl tetraethylhexanoate</to_name>
		<to_code>1426406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium pyrophosphate</to_name>
		<to_code>1426658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 stearate</to_name>
		<to_code>1309367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia lactiflora whole extract</to_name>
		<to_code>1490687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxal 5-phosphate glutamate</to_name>
		<to_code>2374916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 40 stearate</to_name>
		<to_code>1426432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physostigma venenosum whole extract</to_name>
		<to_code>2001678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-oleate</to_name>
		<to_code>2468052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-15 hydroxystearate</to_name>
		<to_code>1807443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonum arenastrum whole extract</to_name>
		<to_code>1535496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tripeptide-53 amide</to_name>
		<to_code>1868209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pacritinib</to_name>
		<to_code>2595243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramipexole</to_name>
		<to_code>746741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 65</to_name>
		<to_code>1426405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phryma leptostachya whole extract</to_name>
		<to_code>1945226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-90 diisostearate</to_name>
		<to_code>1648139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plasmin</to_name>
		<to_code>4388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pravastatin sodium</to_name>
		<to_code>203144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 400000</to_name>
		<to_code>1312738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycerin-10</to_name>
		<to_code>1314205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Proteus vulgaris</to_name>
		<to_code>1316073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pentadiplandra brazzeana root extract</to_name>
		<to_code>2667744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium olivate</to_name>
		<to_code>2286254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenethylamine</to_name>
		<to_code>1309741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone</to_name>
		<to_code>8638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 hexaoleate</to_name>
		<to_code>1541747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pepsin A</to_name>
		<to_code>8016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pediculus humanus var. capitis</to_name>
		<to_code>1600442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirbuterol HCl</to_name>
		<to_code>235447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-20-6 dimethicone</to_name>
		<to_code>1426780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium oxybate</to_name>
		<to_code>2387309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perillaldehyde</to_name>
		<to_code>1426913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperacillin sodium</to_name>
		<to_code>203134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxalene</to_name>
		<to_code>1314414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment yellow 138</to_name>
		<to_code>1438510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propentofylline</to_name>
		<to_code>34644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl salicylate</to_name>
		<to_code>36122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peanut oil</to_name>
		<to_code>18235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-3</to_name>
		<to_code>1796120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pradofloxacin</to_name>
		<to_code>1367269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyamide-5</to_name>
		<to_code>2620843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentane</to_name>
		<to_code>1311563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomiferin</to_name>
		<to_code>2593691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 MPA.S)</to_name>
		<to_code>1607777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium graveolens whole extract</to_name>
		<to_code>1442512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago lanceolata leaf extract</to_name>
		<to_code>1309370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>para grass pollen extract</to_name>
		<to_code>894750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sulfate</to_name>
		<to_code>34323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2,3-propanetriol, 2-(4-aminobenzoate)</to_name>
		<to_code>2362184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(lactic-co-glycolic acid) (50/50, 0.45-0.6 dL/g inherent viscosity)</to_name>
		<to_code>1309725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint flowering top extract</to_name>
		<to_code>2168421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla patens extract</to_name>
		<to_code>1311154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenmetrazine</to_name>
		<to_code>8133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procainamide hydrochloride</to_name>
		<to_code>155056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polifeprosan 20</to_name>
		<to_code>1426339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 hydrogenated lanolin</to_name>
		<to_code>2047758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl fragment</to_name>
		<to_code>1742481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothionamide</to_name>
		<to_code>8871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Parietaria officinalis leaf extract</to_name>
		<to_code>1650423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phormidium persicinum</to_name>
		<to_code>1425936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium lauroyl glutamate</to_name>
		<to_code>1789747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polistes fuscatus whole extract</to_name>
		<to_code>2590184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picosulfate sodium</to_name>
		<to_code>33688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 338</to_name>
		<to_code>1364384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pumice</to_name>
		<to_code>1989334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-150 lanolin</to_name>
		<to_code>2590668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirenzepine hydrochloride</to_name>
		<to_code>235775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pridinol monomesylate</to_name>
		<to_code>55092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 3500</to_name>
		<to_code>1312707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper hancei top extract</to_name>
		<to_code>2553103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>purified protein derivative of tuberculin</to_name>
		<to_code>8948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancrelipase amylase</to_name>
		<to_code>1427033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylic acid (450000 MW)</to_name>
		<to_code>1314282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promethazine dioxide</to_name>
		<to_code>236815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytic acid</to_name>
		<to_code>8302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pazopanib hydrochloride</to_name>
		<to_code>732187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ponatinib hydrochloride</to_name>
		<to_code>1364953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl-n-tert-butylnitrone</to_name>
		<to_code>2694077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (400000 MW)</to_name>
		<to_code>1664621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya allergenic extract</to_name>
		<to_code>1011426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peptide-T</to_name>
		<to_code>2644766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea mariana whole extract</to_name>
		<to_code>2048035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 35 castor oil</to_name>
		<to_code>1309246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 sorbitan isostearate</to_name>
		<to_code>1372933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-4 myristyl ether</to_name>
		<to_code>2387832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium tartrate</to_name>
		<to_code>55024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxyethyl caprylate</to_name>
		<to_code>1361658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procyanidolic oligomer</to_name>
		<to_code>236649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picaridin</to_name>
		<to_code>1737729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia californica whole extract</to_name>
		<to_code>2539935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4 isostearate</to_name>
		<to_code>1367130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia veitchii root extract</to_name>
		<to_code>1420976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia anomala root extract</to_name>
		<to_code>1923501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pueraria candollei var. mirifica root extract</to_name>
		<to_code>1876118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>progesterone</to_name>
		<to_code>8727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-7 (76-24 acrylamide-dadmac; 120 kD)</to_name>
		<to_code>1314324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus dulcis pollen extract</to_name>
		<to_code>2631943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus mume fruit extract</to_name>
		<to_code>1311663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pignut hickory pollen extract</to_name>
		<to_code>899650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panitumumab</to_name>
		<to_code>263034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cyanide</to_name>
		<to_code>1923819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia x suffruticosa seed extract</to_name>
		<to_code>2590667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>providone-Iodine</to_name>
		<to_code>544983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment violet 23</to_name>
		<to_code>2397126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>platinic chloride</to_name>
		<to_code>1549109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piroctone olamine</to_name>
		<to_code>33783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-15 stearyl ether benzoate</to_name>
		<to_code>1426945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pheniramine</to_name>
		<to_code>8132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomegranate juice</to_name>
		<to_code>1358975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-10 (30000 MPA.S at 2%)</to_name>
		<to_code>1428215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium methoxysalicylate</to_name>
		<to_code>1551457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenformin hydrochloride</to_name>
		<to_code>235288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-69 (350000 MW)</to_name>
		<to_code>2268049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-47 (methacrylamidopropyltrimethylammonium chloride-co-methyl acrylate-co-acrylic acid 46:8:46; 1300000 MW)</to_name>
		<to_code>2641594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2-propanediamine</to_name>
		<to_code>1999575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podophyllum hexandrum root extract</to_name>
		<to_code>2630722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pumpkin allergenic extract</to_name>
		<to_code>883459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-80 stearate</to_name>
		<to_code>1484396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>8-p-menthene-1,2-diol, (+)-</to_name>
		<to_code>2050063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>petrolatum</to_name>
		<to_code>8091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penoxsulam</to_name>
		<to_code>1482792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phlomoides rotata whole extract</to_name>
		<to_code>1725036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 dioleate</to_name>
		<to_code>2588485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pacific cod preparation</to_name>
		<to_code>1421438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procaterol</to_name>
		<to_code>34530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipamperone</to_name>
		<to_code>33739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penbutolol sulfate</to_name>
		<to_code>82070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperine</to_name>
		<to_code>1311146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetate</to_name>
		<to_code>618371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1,2-distearate</to_name>
		<to_code>1370193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 9000</to_name>
		<to_code>1606853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pangamic acid</to_name>
		<to_code>7886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-105-5 copolymer</to_name>
		<to_code>1426949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenytoin</to_name>
		<to_code>8183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-phenyldodecane-p-sulfonate</to_name>
		<to_code>2571860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 81</to_name>
		<to_code>1996988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>precyclemone B</to_name>
		<to_code>2397689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancreas extract</to_name>
		<to_code>236439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylenes</to_name>
		<to_code>8519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenacemide</to_name>
		<to_code>33253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-22 (4500 MPA.S)</to_name>
		<to_code>1442517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 monoisostearate</to_name>
		<to_code>1435110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>policosanol</to_name>
		<to_code>69440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-55 hydrogenated castor oil</to_name>
		<to_code>1359087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pistachio nut allergenic extract</to_name>
		<to_code>904606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 hydrogenated lanolin</to_name>
		<to_code>1601993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pilocarpus jaborandi leaf extract</to_name>
		<to_code>1310081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya seed oil</to_name>
		<to_code>2637855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitic acid</to_name>
		<to_code>1426390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 hydroxyethyl cocamide/isostearamide</to_name>
		<to_code>1594765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus speciosa flower extract</to_name>
		<to_code>2359274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl sh-tripeptide-4 amide</to_name>
		<to_code>1868208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegvaliase-pqpz</to_name>
		<to_code>2046361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 laurate</to_name>
		<to_code>1363614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 sorbitan peroleate</to_name>
		<to_code>2570564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 diheptanoate</to_name>
		<to_code>1314230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium magnesium aspartate</to_name>
		<to_code>1793925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipenzolate bromide</to_name>
		<to_code>202840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perphenazine enanthate</to_name>
		<to_code>33212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polatuzumab vedotin-piiq</to_name>
		<to_code>2174091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment blue 16</to_name>
		<to_code>1999764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4 caprate</to_name>
		<to_code>1792715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polidocanol</to_name>
		<to_code>968170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piroctone</to_name>
		<to_code>2058907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pheniramine maleate</to_name>
		<to_code>266959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-phytase B (Aspergillus niger)</to_name>
		<to_code>1313304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Parthenocissus quinquefolia leaf extract</to_name>
		<to_code>1859367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonum cuspidatum root extract</to_name>
		<to_code>1309457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium ascorbate</to_name>
		<to_code>1592259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 behenate</to_name>
		<to_code>1998842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus densiflora whole extract</to_name>
		<to_code>2288428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-5 propylheptyl ether</to_name>
		<to_code>2173920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phellodendron chinensis bark extract</to_name>
		<to_code>1307612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-32 laurate</to_name>
		<to_code>2588246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>probucol</to_name>
		<to_code>8699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-25 propylene glycol stearate</to_name>
		<to_code>1314192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudostellaria heterophylla whole extract</to_name>
		<to_code>1600746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polypodium lepidopteris root extract</to_name>
		<to_code>2275614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pasteurella multocida</to_name>
		<to_code>1437221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus lambertiana resin</to_name>
		<to_code>1359088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-methylaminophenol sulfate</to_name>
		<to_code>2625121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetate calcium trisodium</to_name>
		<to_code>132879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Perilla frutescens fruit extract</to_name>
		<to_code>1311653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 sorbitan stearate</to_name>
		<to_code>2101529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piprozoline</to_name>
		<to_code>33761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramlintide</to_name>
		<to_code>139953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudopterogorgia elisabethae extract</to_name>
		<to_code>1314386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-200 glyceryl stearate</to_name>
		<to_code>2396889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persea americana whole extract</to_name>
		<to_code>2533908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmidrol</to_name>
		<to_code>2001986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmarosa oil</to_name>
		<to_code>1309374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-9</to_name>
		<to_code>1314210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pheretima aspergillum extract</to_name>
		<to_code>1746488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-120 stearate</to_name>
		<to_code>1362145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peanut (Arachis hypogaea) allergen-dnfp</to_name>
		<to_code>2279402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prucalopride</to_name>
		<to_code>2107310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium sidoides whole extract</to_name>
		<to_code>2712656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parakeet feather allergenic extract</to_name>
		<to_code>1192987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (2300 MW)</to_name>
		<to_code>1312736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phormium tenax seed oil</to_name>
		<to_code>2001129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylic acid (800000 MW)</to_name>
		<to_code>1309736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol/polyvinyl acetate copolymer (8:1; 50000MW)</to_name>
		<to_code>1996999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 10000</to_name>
		<to_code>2200636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>purslane extract</to_name>
		<to_code>1424645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus laurocerasus whole extract</to_name>
		<to_code>1998616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentadecanoic acid</to_name>
		<to_code>1987138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylephrine</to_name>
		<to_code>8163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polystyrene sulfonic acid</to_name>
		<to_code>1546436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>primaquine phosphate</to_name>
		<to_code>8689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-11 stearyl ether</to_name>
		<to_code>1426946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperonyl butoxide</to_name>
		<to_code>8345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG/PPG-10/2 dimethicone</to_name>
		<to_code>1726094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax ginseng fruit extract</to_name>
		<to_code>1311648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phensuximide</to_name>
		<to_code>33309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persicaria tinctoria leaf extract</to_name>
		<to_code>1307670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegoterate</to_name>
		<to_code>1607779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosphingosine</to_name>
		<to_code>1363444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pikea robusta extract</to_name>
		<to_code>1421146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-3 cocamine</to_name>
		<to_code>1804257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentosan polysulphate sodium</to_name>
		<to_code>134413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium salicylate</to_name>
		<to_code>235418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancreatic lipase</to_name>
		<to_code>1427018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenindamine</to_name>
		<to_code>33283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus tremuloides whole extract</to_name>
		<to_code>1990853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4 palmitate</to_name>
		<to_code>2699678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propolis</to_name>
		<to_code>8783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prazosin</to_name>
		<to_code>8629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxyethanol</to_name>
		<to_code>89552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 cocamide</to_name>
		<to_code>1307041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polistirex</to_name>
		<to_code>1312709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetate zinc trisodium</to_name>
		<to_code>408077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30 glyceryl cocoate</to_name>
		<to_code>2386217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palifermin</to_name>
		<to_code>196319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pangamate</to_name>
		<to_code>646818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>platinum</to_name>
		<to_code>1311280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglucose sorbitol carboxymethyl ether</to_name>
		<to_code>1537909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ppg-26 oleate</to_name>
		<to_code>2046780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridostigmine bromide</to_name>
		<to_code>9001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peach kernel oil glycereth-8 esters</to_name>
		<to_code>1547570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paullinia cupana seed extract</to_name>
		<to_code>1311509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginesatide acetate</to_name>
		<to_code>1248797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein C, human</to_name>
		<to_code>723868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Primula veris flower extract</to_name>
		<to_code>1487833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycladus orientalis seed extract</to_name>
		<to_code>1306120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyritinol hydrochloride</to_name>
		<to_code>236508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potato peel extract</to_name>
		<to_code>2465570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegaptanib</to_name>
		<to_code>498509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyurethane-34 (55 MPA)</to_name>
		<to_code>2589707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 hydroxyethyl stearamide</to_name>
		<to_code>1482786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pear preparation</to_name>
		<to_code>1367125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peucedanum praeruptorum root extract</to_name>
		<to_code>1535495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium,chelated</to_name>
		<to_code>259277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork intestine preparation</to_name>
		<to_code>1311392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pittosporum pentandrum whole extract</to_name>
		<to_code>2045733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phospholipids</to_name>
		<to_code>8246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluorooctyl triethoxysilane</to_name>
		<to_code>1312743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus armeniaca leaf extract</to_name>
		<to_code>1487507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 1450</to_name>
		<to_code>1367110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysaccharide iron complex</to_name>
		<to_code>105669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 11000</to_name>
		<to_code>1314585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dicaprylate</to_name>
		<to_code>1426619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physalis alkekengi calyx extract</to_name>
		<to_code>1369564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium dichromate</to_name>
		<to_code>8595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 85</to_name>
		<to_code>1368887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyamide-3 (12000 MW)</to_name>
		<to_code>1788948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>permethrin</to_name>
		<to_code>33199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panthenol triacetate, (+)-</to_name>
		<to_code>1426597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantothenic acid</to_name>
		<to_code>7891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Perilla frutescens seed oil</to_name>
		<to_code>1307703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penpulimab-kcqx</to_name>
		<to_code>2712646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pafuramidine</to_name>
		<to_code>718967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phellinus linteus mycelium extract</to_name>
		<to_code>1312717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (35000 MW)</to_name>
		<to_code>1314206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-100 stearate</to_name>
		<to_code>1367120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein S, human</to_name>
		<to_code>1426165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus sylvestris whole extract</to_name>
		<to_code>1800666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plumeria alba flower oil</to_name>
		<to_code>2589085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pogostemon cablin top extract</to_name>
		<to_code>1307646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-60 glyceryl isostearate</to_name>
		<to_code>1356490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyllysylvalyldiaminobutyric acid</to_name>
		<to_code>1538143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-55 propylene glycol oleate</to_name>
		<to_code>2623642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentapeptide-59</to_name>
		<to_code>2698197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax quinquefolius whole extract</to_name>
		<to_code>1428042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunella vulgaris leaf extract</to_name>
		<to_code>1800821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peoniflorin</to_name>
		<to_code>2288155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxal phosphate anhydrous</to_name>
		<to_code>1599827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Periplaneta australasiae extract</to_name>
		<to_code>2590183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>policapram</to_name>
		<to_code>2668059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudognaphalium luteoalbum whole extract</to_name>
		<to_code>1812325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine needle oil (pinus mugo)</to_name>
		<to_code>1360627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 182</to_name>
		<to_code>1314380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylhexedrine hydrochloride</to_name>
		<to_code>236461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipecuronium bromide</to_name>
		<to_code>66983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica fruiting top extract</to_name>
		<to_code>2387539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 350</to_name>
		<to_code>1368165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Portulaca grandiflora seed extract</to_name>
		<to_code>1594931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax ginseng leaf extract</to_name>
		<to_code>1918244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllostachys edulis stem extract</to_name>
		<to_code>2413034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prazosin hydrochloride</to_name>
		<to_code>203210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylpropanolamine bitartrate</to_name>
		<to_code>221140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-14 1-((methylphenyl)ethyl)phenyl ether ammonium sulfate</to_name>
		<to_code>2169286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piroxicam</to_name>
		<to_code>8356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleospora betae allergenic extract</to_name>
		<to_code>852756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygala tenuifolia root extract</to_name>
		<to_code>1429948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-30</to_name>
		<to_code>1482540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 50 hydrogenated castor oil</to_name>
		<to_code>1426435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol, (R)-</to_name>
		<to_code>1314303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora caerulea fruit extract</to_name>
		<to_code>2667742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 40</to_name>
		<to_code>1367265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium aluminate</to_name>
		<to_code>1922748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polynoxylin</to_name>
		<to_code>34188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 sorbitan laurate</to_name>
		<to_code>1859168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Perilla frutescens leaf extract</to_name>
		<to_code>1309493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pozelimab-bbfg</to_name>
		<to_code>2663939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Perilla frutescens seed extract</to_name>
		<to_code>1307814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenmetrazine hydrochloride</to_name>
		<to_code>203198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phyllostachys nigra sap extract</to_name>
		<to_code>1430251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-p-menthene-8-thiol</to_name>
		<to_code>1940004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piroxicam-beta-cyclodextrin</to_name>
		<to_code>68115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K12</to_name>
		<to_code>1305759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyester-7</to_name>
		<to_code>1368161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-phytase A (Aspergillus niger)</to_name>
		<to_code>2700156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylparaben</to_name>
		<to_code>34706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platanus x acerifolia whole extract</to_name>
		<to_code>1428421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peptone,dried</to_name>
		<to_code>314776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 dioleate</to_name>
		<to_code>1552357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Potentilla discolor whole extract</to_name>
		<to_code>2120566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pholedrine sulfate</to_name>
		<to_code>236644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomegranate fruit rind extract</to_name>
		<to_code>1311658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proteoglycan 4</to_name>
		<to_code>2619327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethyelene glycol 7000</to_name>
		<to_code>1309368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago major extract</to_name>
		<to_code>1311368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polidronium chloride</to_name>
		<to_code>1426891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralatrexate</to_name>
		<to_code>662019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentafluoropropane</to_name>
		<to_code>1591891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium capitatum leaf extract</to_name>
		<to_code>2634294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednimustine</to_name>
		<to_code>8637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pargeverine hydrochloride</to_name>
		<to_code>236455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethyloxazoline (200000 MW)</to_name>
		<to_code>2118533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylamide (1300000 MW)</to_name>
		<to_code>1356764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-butyrate</to_name>
		<to_code>2263157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium behenoyl hydroxyproline</to_name>
		<to_code>1596135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea abies leaf extract</to_name>
		<to_code>1549108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tripeptide-1</to_name>
		<to_code>1722914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax pseudoginseng root extract</to_name>
		<to_code>1376500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(lactic-co-glycolic acid) (75/25, 0.23-0.26 dL/g inherent viscosity)</to_name>
		<to_code>1309730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poppy seed oil</to_name>
		<to_code>1432299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palivizumab</to_name>
		<to_code>194279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylate-1 crosspolymer</to_name>
		<to_code>2622907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poliovirus vaccine inactivated, type 3 (Saukett)</to_name>
		<to_code>763100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid), (75:25; 20000 MW)</to_name>
		<to_code>2664061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-200 dilaurate</to_name>
		<to_code>1314191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-32 dioleate</to_name>
		<to_code>1747346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polypodium virginianum root extract</to_name>
		<to_code>2636531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum odoratum root extract</to_name>
		<to_code>1307550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-44</to_name>
		<to_code>1744029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla koreana root extract</to_name>
		<to_code>1307667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-120 methyl glucose dioleate</to_name>
		<to_code>1309363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-propanol, 1,1'-oxybis(3-(1-naphthalenyloxy))-</to_name>
		<to_code>2637686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propanediol caprylate</to_name>
		<to_code>2621210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegvisomant</to_name>
		<to_code>278739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-propanol</to_name>
		<to_code>1362872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 glyceryl triisostearate</to_name>
		<to_code>1540273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penbutolol</to_name>
		<to_code>7973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus mugo subsp. mugo bark extract</to_name>
		<to_code>1488821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxetine hydrochloride, hemihydrate</to_name>
		<to_code>1298842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyroligneous acid</to_name>
		<to_code>1535931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>padimate-O</to_name>
		<to_code>32786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Padang cassia oil</to_name>
		<to_code>1489763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-36-41 dimethyl ether</to_name>
		<to_code>1427043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim</to_name>
		<to_code>338036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-10 methyl glucose ether</to_name>
		<to_code>1428877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petiveria alliacea preparation</to_name>
		<to_code>705701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(dl-lactic-co-glycolic acid), (50:50; 63000 mw)</to_name>
		<to_code>1309728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol, (S)-</to_name>
		<to_code>1663407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2-propanediol, 1-benzoate</to_name>
		<to_code>1797116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax ginseng flower extract</to_name>
		<to_code>1307726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polythiazide</to_name>
		<to_code>8565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proparacaine hydrochloride</to_name>
		<to_code>227778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine needle oil (pinus sylvestris)</to_name>
		<to_code>1305670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytol</to_name>
		<to_code>2046119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pinene</to_name>
		<to_code>2385340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, inner salt, (2S)-</to_name>
		<to_code>1433756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium metaphosphate</to_name>
		<to_code>1426446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paclitaxel</to_name>
		<to_code>56946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 dimethicone (300 CST)</to_name>
		<to_code>1367152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 400</to_name>
		<to_code>8514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 laurate</to_name>
		<to_code>1490690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K29-32</to_name>
		<to_code>1305758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pterocarpus marsupium whole extract</to_name>
		<to_code>2469236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus mume flower oil</to_name>
		<to_code>2571812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaverine hydrochloride</to_name>
		<to_code>203132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentylamine</to_name>
		<to_code>1367190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea mariana leaf oil</to_name>
		<to_code>1362141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pratia purpurascens extract</to_name>
		<to_code>2380572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment red 1</to_name>
		<to_code>1872248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(phthalocyaninato(2-)) copper</to_name>
		<to_code>1424646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG/PPG-30/10 dimethicone</to_name>
		<to_code>1734019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment yellow 109</to_name>
		<to_code>1999676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrantel tartrate</to_name>
		<to_code>2197593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrantel</to_name>
		<to_code>8984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl salicyate</to_name>
		<to_code>895808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrophyllite</to_name>
		<to_code>2636602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrrolidinyl diaminopyrimidine oxide</to_name>
		<to_code>1741137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine-N-butyl methacrylate; 4:1)</to_name>
		<to_code>1313968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pilocarpus microphyllus leaf extract</to_name>
		<to_code>1667354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrilamine</to_name>
		<to_code>9009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegaptanib sodium</to_name>
		<to_code>594119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus pinaster wood extract</to_name>
		<to_code>2001194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pridinol</to_name>
		<to_code>34479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-200 hydrogenated glyceryl palmate</to_name>
		<to_code>1552360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 caprate</to_name>
		<to_code>2169283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-15 stearyl ether</to_name>
		<to_code>1313178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 hydrogenated castor oil</to_name>
		<to_code>1356707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 20 cetostearyl ether</to_name>
		<to_code>1307046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propanediol dicaprylate</to_name>
		<to_code>1436167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus cerasifera whole extract</to_name>
		<to_code>1800076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium aminobenzoate</to_name>
		<to_code>142141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentermine hydrochloride</to_name>
		<to_code>82078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 soy sterol</to_name>
		<to_code>1314190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Punica granatum flower extract</to_name>
		<to_code>1307706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propyl gallate</to_name>
		<to_code>1311134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phellodendron amurense bark extract</to_name>
		<to_code>1307947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus radiata bark extract</to_name>
		<to_code>2621118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxine hydrochloride</to_name>
		<to_code>203164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phendimetrazine</to_name>
		<to_code>33272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenindione</to_name>
		<to_code>8130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potato allergenic extract</to_name>
		<to_code>892632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancreatic triacylglycerol lipase</to_name>
		<to_code>2475193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phytolacca americana root extract</to_name>
		<to_code>1309711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenolate sodium</to_name>
		<to_code>1495317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pterocarpus soyauxii wood extract</to_name>
		<to_code>2003231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus domestica subsp. insititia seed oil</to_name>
		<to_code>1422929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium bicarbonate</to_name>
		<to_code>34296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-55</to_name>
		<to_code>2691821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium ion</to_name>
		<to_code>1318915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K17</to_name>
		<to_code>1313249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-20-20 dimethicone</to_name>
		<to_code>1426672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dipropionate</to_name>
		<to_code>1806903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothipendyl</to_name>
		<to_code>55244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl isoleucine</to_name>
		<to_code>1733679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylbutazone</to_name>
		<to_code>8160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-32 distearate</to_name>
		<to_code>2463530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piretanide</to_name>
		<to_code>33770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 rapeseed sterol</to_name>
		<to_code>1862481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 glyceryl dimyristate</to_name>
		<to_code>1307096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proglumide</to_name>
		<to_code>8730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (85000 MW)</to_name>
		<to_code>1812933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pogostemon cablin whole extract</to_name>
		<to_code>1487834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 60 hydrogenated castor oil</to_name>
		<to_code>1307688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>periciazine</to_name>
		<to_code>8766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 331</to_name>
		<to_code>1486516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)</to_name>
		<to_code>1369405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitolisant</to_name>
		<to_code>2197878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 188</to_name>
		<to_code>155152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium asparaginate</to_name>
		<to_code>1313174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-23 glyceryl distearate</to_name>
		<to_code>1721435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pacific halibut allergenic extract</to_name>
		<to_code>882469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 oleate</to_name>
		<to_code>2383936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllanthus emblica fruit juice</to_name>
		<to_code>1356140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potash</to_name>
		<to_code>1370422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-25-laureth-25</to_name>
		<to_code>1371318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-propenoic acid, 2-cyano-3,3-diphenyl-2,2-bis(((2-cyano-1-oxo-3,3-diphenyl-2-propenyl)oxy)methyl)-1,3-propanediyl ester</to_name>
		<to_code>2372916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl glutamate</to_name>
		<to_code>1370585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphonic acid</to_name>
		<to_code>1427087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium</to_name>
		<to_code>8588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prochlorperazine maleate</to_name>
		<to_code>8706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirenzepine</to_name>
		<to_code>8352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 sorbitan stearate</to_name>
		<to_code>2601100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol salicylate</to_name>
		<to_code>236449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piroxicam cinnamate</to_name>
		<to_code>33787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythritol</to_name>
		<to_code>33055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene oxide 5000000</to_name>
		<to_code>1944252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piflufolastat</to_name>
		<to_code>2556617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 8000000</to_name>
		<to_code>1370827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Primula hendersonii whole extract</to_name>
		<to_code>2533896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium citrate anhydrous</to_name>
		<to_code>1374802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus x yedoensis flower extract</to_name>
		<to_code>2388333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-45 palm kernel glycerides</to_name>
		<to_code>1489761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(lactic-co-glycolic acid) (85/15, 0.25-0.27 dL/g inherent viscosity)</to_name>
		<to_code>1309732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-10 cetyl ether</to_name>
		<to_code>1356702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Padina pavonica extract</to_name>
		<to_code>1424357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancuronium bromide</to_name>
		<to_code>7884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-6 (15000 MW)</to_name>
		<to_code>1373446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentolamine mesylate</to_name>
		<to_code>227240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-75 dilaurate</to_name>
		<to_code>2562173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3,4,9,10-perylenetetracarboxylic diimide</to_name>
		<to_code>1491869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl myristyl serinate</to_name>
		<to_code>2667641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,5-piperazinedione</to_name>
		<to_code>1313303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polarcrillin sodium</to_name>
		<to_code>1366978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 ricinoleate</to_name>
		<to_code>1373726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>petroleum distillate</to_name>
		<to_code>90737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Proteins</to_name>
		<to_code>8859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pineapple extract</to_name>
		<to_code>1492174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 hydrogenated castor oil</to_name>
		<to_code>1926952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycerin-20</to_name>
		<to_code>2396435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantanus orientalis whole extract</to_name>
		<to_code>2055002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 isoceteth-20 acetate</to_name>
		<to_code>1314209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid), (75:25; 9500 MW)</to_name>
		<to_code>2671242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-3 distearate</to_name>
		<to_code>1489764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-14-4 dimethicone</to_name>
		<to_code>1426673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment orange 34</to_name>
		<to_code>2000532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin V benzathine</to_name>
		<to_code>18926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine tar</to_name>
		<to_code>8333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus resinosa whole extract</to_name>
		<to_code>2283757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipobroman</to_name>
		<to_code>8347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridinolcarbamate</to_name>
		<to_code>8997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenethyl benzoate</to_name>
		<to_code>1426333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dioleate</to_name>
		<to_code>1369688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 2-oleate</to_name>
		<to_code>1788995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylthiouracil</to_name>
		<to_code>8794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus massoniana resin</to_name>
		<to_code>1311586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 500</to_name>
		<to_code>1313266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 stearate</to_name>
		<to_code>1363612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pioglitazone</to_name>
		<to_code>33738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 soy sterol</to_name>
		<to_code>1863569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 acrylate</to_name>
		<to_code>1940009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus spinosa whole extract</to_name>
		<to_code>1442995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirinitramide</to_name>
		<to_code>8354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG/PPG-18/12 dimethicone</to_name>
		<to_code>2387543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper capense whole extract</to_name>
		<to_code>2667251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper wallichii leafy twig extract</to_name>
		<to_code>2610404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentermine resin</to_name>
		<to_code>221138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perindopril</to_name>
		<to_code>54552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pineapple allergenic extract</to_name>
		<to_code>899895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Papaver orientale seed oil</to_name>
		<to_code>2413033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 caprate</to_name>
		<to_code>2467277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus mume whole extract</to_name>
		<to_code>1600745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol alginate</to_name>
		<to_code>1361656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantethine</to_name>
		<to_code>32863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-20 glyceryl stearate</to_name>
		<to_code>1309365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palm acid</to_name>
		<to_code>1426624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proline, DL-</to_name>
		<to_code>1426951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimavanserin tartrate</to_name>
		<to_code>1791686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promestriene</to_name>
		<to_code>34625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2-stearate</to_name>
		<to_code>1922746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelargonium sidoides root extract</to_name>
		<to_code>1310166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus spinosa fruit extract</to_name>
		<to_code>1482548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pexidartinib</to_name>
		<to_code>2183102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl lysyldioxymethionyllysine</to_name>
		<to_code>1424459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 soy sterol</to_name>
		<to_code>1433643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium glaucum allergenic extract</to_name>
		<to_code>1986792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralsetinib</to_name>
		<to_code>2394936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 polyricinoleate</to_name>
		<to_code>2643065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper sarmentosum whole extract</to_name>
		<to_code>2711692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 glyceryl isostearate</to_name>
		<to_code>1435865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platanus occidentalis whole extract</to_name>
		<to_code>1440278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peptostreptococcus anaerobius DNA</to_name>
		<to_code>2536938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pelvetia canaliculata extract</to_name>
		<to_code>1426416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya extract</to_name>
		<to_code>1992412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 laurate</to_name>
		<to_code>1313256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-90 stearate</to_name>
		<to_code>1543741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 ethylhexanoate</to_name>
		<to_code>1726669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pefloxacin</to_name>
		<to_code>7960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl distearate</to_name>
		<to_code>1312716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyhydroxystearic acid (2300 MW)</to_name>
		<to_code>1307042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parethoxycaine</to_name>
		<to_code>236249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentazocine</to_name>
		<to_code>8001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitamidopropyltrimonium</to_name>
		<to_code>1489929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol hydroxystearate</to_name>
		<to_code>2003790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-10 (400 CPS at 2%)</to_name>
		<to_code>1367143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya juice</to_name>
		<to_code>1312645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Potentilla anserina whole extract</to_name>
		<to_code>1442994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plasmodium malariae</to_name>
		<to_code>1432989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 2500</to_name>
		<to_code>2119177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork collagen preparation</to_name>
		<to_code>1311319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physalis pubescens fruit juice</to_name>
		<to_code>2603287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemoline</to_name>
		<to_code>7966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cocoate</to_name>
		<to_code>1426445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 dilaurate</to_name>
		<to_code>1312710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoenix dactylifera seed extract</to_name>
		<to_code>1368338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 decaoleate</to_name>
		<to_code>1421889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 2-behenate</to_name>
		<to_code>2383937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago asiatica seed extract</to_name>
		<to_code>2118532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 105</to_name>
		<to_code>2465732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 184</to_name>
		<to_code>1368182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phanerodontia chrysosporium allergenic extract</to_name>
		<to_code>968114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-3 oleate</to_name>
		<to_code>1648138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 sesquiisostearate</to_name>
		<to_code>1742941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoenix dactylifera whole extract</to_name>
		<to_code>1992542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Perilla frutescens whole extract</to_name>
		<to_code>2590049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polytetrafluoroethylene</to_name>
		<to_code>1358182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>purslane oil</to_name>
		<to_code>1367164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-6 (150000 MW)</to_name>
		<to_code>1999412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prolinal</to_name>
		<to_code>2569079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenolsulfonate</to_name>
		<to_code>1651702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus tremula flowering top extract</to_name>
		<to_code>1310100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 diisostearate</to_name>
		<to_code>1431226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium citrate</to_name>
		<to_code>54993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tetrapeptide-95</to_name>
		<to_code>2668591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paprika allergenic extract</to_name>
		<to_code>899873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protriptyline hydrochloride</to_name>
		<to_code>203199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid) (75:25; 140000 MW)</to_name>
		<to_code>1947144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-5 trioleate</to_name>
		<to_code>2399029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitavastatin</to_name>
		<to_code>861634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Porphyra tenera extract</to_name>
		<to_code>1808534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone sodium succinate</to_name>
		<to_code>55063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pistacia lentiscus resin</to_name>
		<to_code>1313236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene oxide</to_name>
		<to_code>1368175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patisiran sodium lipid complex</to_name>
		<to_code>2284710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylpropanol</to_name>
		<to_code>2475178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pafolacianine</to_name>
		<to_code>2586857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Punica granatum seed extract</to_name>
		<to_code>1310067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>post oak pollen extract</to_name>
		<to_code>901011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl acetate phthalate</to_name>
		<to_code>1367129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol monocaprate</to_name>
		<to_code>2099293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prajmalium bitartrate</to_name>
		<to_code>236896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrilamine tannate</to_name>
		<to_code>221152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycerol polyricinoleic acid</to_name>
		<to_code>1541749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 700</to_name>
		<to_code>1312721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paris quadrifolia extract</to_name>
		<to_code>1492935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phendimetrazine tartrate</to_name>
		<to_code>58157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentylenetetrazole</to_name>
		<to_code>8015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procarbazine</to_name>
		<to_code>8702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylhexedrine</to_name>
		<to_code>8792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus armeniaca seed extract</to_name>
		<to_code>1309458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus cerasifera flower extract</to_name>
		<to_code>1353883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panthenol</to_name>
		<to_code>1044977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ponatinib</to_name>
		<to_code>1364347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 60 castor oil</to_name>
		<to_code>1309972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>physostigmine salicylate</to_name>
		<to_code>33656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol</to_name>
		<to_code>34693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proxigermanium</to_name>
		<to_code>158660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyl 15 hydroxystearate</to_name>
		<to_code>2472795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phellinus linteus whole extract</to_name>
		<to_code>1314197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl methicone (500 CST)</to_name>
		<to_code>1654388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-menthane-3,8-diol</to_name>
		<to_code>2385886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pargyline</to_name>
		<to_code>7930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-allyl ether</to_name>
		<to_code>1544276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palonosetron</to_name>
		<to_code>70561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrodifenium bromide</to_name>
		<to_code>9021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 MW)</to_name>
		<to_code>1798376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pivampicillin hydrochloride</to_name>
		<to_code>42553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium metabisulfite</to_name>
		<to_code>1362899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 200</to_name>
		<to_code>1368864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium tellurite</to_name>
		<to_code>1921888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata extract</to_name>
		<to_code>253193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panobinostat</to_name>
		<to_code>1603350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 hydrogenated castor oil</to_name>
		<to_code>1651596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 oleate</to_name>
		<to_code>1356767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythritol 3,5-di-tert-butyl-4-hydroxyhydrocinnamate</to_name>
		<to_code>1926329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrilamine maleate</to_name>
		<to_code>82091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemirolast potassium</to_name>
		<to_code>259318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllanthus emblica fruit extract</to_name>
		<to_code>1311654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudotsuga menziesii resin</to_name>
		<to_code>2463335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-39 (35-35-30 acrylic acid-acrylamide-dadmac; 1500000 MW)</to_name>
		<to_code>1426649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piridocaine hydrochloride</to_name>
		<to_code>1947298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysilicone-15</to_name>
		<to_code>1367142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia lactiflora flower extract</to_name>
		<to_code>1594764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propiomazine</to_name>
		<to_code>8770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prucalopride succinate</to_name>
		<to_code>2107309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine nut oil</to_name>
		<to_code>2102725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>POLYQUATERNIUM-80</to_name>
		<to_code>2604571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid) (50:50; 15000 MW)</to_name>
		<to_code>2257287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-myristate</to_name>
		<to_code>2282661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenformin</to_name>
		<to_code>8129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paper birch pollen extract</to_name>
		<to_code>899576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus palustris leaf extract</to_name>
		<to_code>1366330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patiromer</to_name>
		<to_code>1716203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perflutren</to_name>
		<to_code>283753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dicaprate</to_name>
		<to_code>1427009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pergolide</to_name>
		<to_code>8047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palo verde pollen extract</to_name>
		<to_code>852359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 900</to_name>
		<to_code>1314204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl tetrastearate</to_name>
		<to_code>1307090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralidoxime iodide</to_name>
		<to_code>55052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>permanganate</to_name>
		<to_code>1923815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium triiodide</to_name>
		<to_code>1376155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 glyceryl stearate</to_name>
		<to_code>2699125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>privet pollen extract</to_name>
		<to_code>852622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parasorbate</to_name>
		<to_code>1998744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pazopanib</to_name>
		<to_code>714438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrazinamide</to_name>
		<to_code>8987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-51/SMDI copolymer</to_name>
		<to_code>1721621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>psyllium seed coatings,blond</to_name>
		<to_code>314812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penfluridol</to_name>
		<to_code>7974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prazepam</to_name>
		<to_code>8627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetate calcium</to_name>
		<to_code>1369590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridostigmine</to_name>
		<to_code>9000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium 37 (200 MPA.S)</to_name>
		<to_code>1314234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycladus orientalis whole extract</to_name>
		<to_code>1923816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirlimycin hydrochloride</to_name>
		<to_code>1367291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polacrilin potassium</to_name>
		<to_code>1367128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrophosphoric acid</to_name>
		<to_code>1546425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 glyceryl cocoate</to_name>
		<to_code>1307098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine hexahydrate</to_name>
		<to_code>271743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-pyrrolidone</to_name>
		<to_code>1358473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(p-hydroxyphenyl)dimethylsulfonium chloride</to_name>
		<to_code>1921086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium gluconate</to_name>
		<to_code>89903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginesatide</to_name>
		<to_code>1248798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phlebodium aureum leaf extract</to_name>
		<to_code>2539431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promazine hydrochloride</to_name>
		<to_code>142444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentamidine</to_name>
		<to_code>7994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-8-ceteth-20</to_name>
		<to_code>2534445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pummelo extract</to_name>
		<to_code>1363624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluorodimethylcyclohexane</to_name>
		<to_code>1876640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylamide (crosslinked; 2 mole percent bisacrylamide)</to_name>
		<to_code>1993232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>posterior pituitary hormones</to_name>
		<to_code>8366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphate ion(2-)</to_name>
		<to_code>2699657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persicaria punctata extract</to_name>
		<to_code>1482544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentapeptide-34 trifluoroacetate</to_name>
		<to_code>2610316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plasminogen, human-tvmh</to_name>
		<to_code>2557201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentagastrin</to_name>
		<to_code>7993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancrelipase</to_name>
		<to_code>235379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podocarpus elatus whole extract</to_name>
		<to_code>1803720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promethazine</to_name>
		<to_code>8745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peruvian pepper tree pollen extract</to_name>
		<to_code>2632070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyltoloxamine</to_name>
		<to_code>33408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 ricinoleate</to_name>
		<to_code>1313258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethyloxazoline (5000 MW)</to_name>
		<to_code>2468051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudevernia furfuracea extract</to_name>
		<to_code>1426918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procaterol hydrochloride</to_name>
		<to_code>58918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propiolactone</to_name>
		<to_code>1311565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podocarpus elatus fruit extract</to_name>
		<to_code>2122672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-9 dimethicone</to_name>
		<to_code>1312396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperidinepropionic acid</to_name>
		<to_code>1356491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphatidylcholine:ceramide cholinephosphotransferase 1</to_name>
		<to_code>2606778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus cerasus flower extract</to_name>
		<to_code>2643154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Proteus inconstans</to_name>
		<to_code>1310846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-phenylethanol</to_name>
		<to_code>2001176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphocysteamine</to_name>
		<to_code>8226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pertuzumab</to_name>
		<to_code>1298944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cetyl phosphate</to_name>
		<to_code>1367140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-37 (10000 MPA.S)</to_name>
		<to_code>1370678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-175 distearate</to_name>
		<to_code>2534442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piflufolastat F-18</to_name>
		<to_code>2556616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomegranate fruit extract</to_name>
		<to_code>1246101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plukenetia volubilis seed oil</to_name>
		<to_code>1307822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petasites fragrans extract</to_name>
		<to_code>1428876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyhydroxystearic acid</to_name>
		<to_code>1872909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper excelsum leaf extract</to_name>
		<to_code>2690737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus cerasus flower bud extract</to_name>
		<to_code>1860609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-25 stearate</to_name>
		<to_code>2108126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pullulan</to_name>
		<to_code>1425878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palm kernelate</to_name>
		<to_code>1370620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tripeptide-5</to_name>
		<to_code>1314284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol monostearate</to_name>
		<to_code>1314411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>profenamine</to_name>
		<to_code>4134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phytolacca americana fruit extract</to_name>
		<to_code>1314247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 237</to_name>
		<to_code>1492190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tetrapeptide-94</to_name>
		<to_code>2668590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pelargonic acid</to_name>
		<to_code>2054104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pisum sativum (pea) extract</to_name>
		<to_code>1426912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ponazuril</to_name>
		<to_code>298983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium oleate</to_name>
		<to_code>1426936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata whole extract</to_name>
		<to_code>1732648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-12</to_name>
		<to_code>1793745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phaseolus vulgaris whole extract</to_name>
		<to_code>1876358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physalis angulata extract</to_name>
		<to_code>1338937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polypodium leucotomos</to_name>
		<to_code>578377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenprocoumon</to_name>
		<to_code>8150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium iodide</to_name>
		<to_code>8597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pepper extract</to_name>
		<to_code>1427085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pumpkin whole allergenic extract</to_name>
		<to_code>2102476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polignate sodium</to_name>
		<to_code>1541249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrithione sodium</to_name>
		<to_code>2464540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment orange 2</to_name>
		<to_code>1491867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physalia physalis preparation</to_name>
		<to_code>1354527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prasterone</to_name>
		<to_code>3143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycolic acid</to_name>
		<to_code>2466981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peach juice</to_name>
		<to_code>1651320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 tetraisostearate</to_name>
		<to_code>2665127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol ricinoleate</to_name>
		<to_code>1944253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pecan pollen extract</to_name>
		<to_code>852272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyaminopropyl biguanide hydrochloride</to_name>
		<to_code>2370881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pristinamycin</to_name>
		<to_code>66958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K15</to_name>
		<to_code>1314251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proguanil</to_name>
		<to_code>2382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plicamycin</to_name>
		<to_code>6995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed tromethamine anhydrous</to_name>
		<to_code>2604776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pongamia pinnata fruit extract</to_name>
		<to_code>2672261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothrombin, human</to_name>
		<to_code>1441689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol (130000 MW)</to_name>
		<to_code>2273236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyurethane-62</to_name>
		<to_code>2565487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin G benzathine</to_name>
		<to_code>7982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polihexanide hydrochloride</to_name>
		<to_code>1790898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pasireotide pamoate</to_name>
		<to_code>1597818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyoxyethylene ether</to_name>
		<to_code>235534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pembrolizumab</to_name>
		<to_code>1547545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (2600000 MW)</to_name>
		<to_code>2003713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyhydroxystearic acid stearate</to_name>
		<to_code>1872908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine citrate</to_name>
		<to_code>342992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus sylvestris sprout extract</to_name>
		<to_code>1809827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine nut extract</to_name>
		<to_code>1872038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(sodium vinyl sulfonate)</to_name>
		<to_code>52259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propamidine isethionate</to_name>
		<to_code>34634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paritaprevir</to_name>
		<to_code>1597373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol heptanoate</to_name>
		<to_code>1427060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 lanolin</to_name>
		<to_code>2288210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylacetate</to_name>
		<to_code>70619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(vinylpyrrolidone-co-vinyl-acetate)</to_name>
		<to_code>1311488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenelzine sulfate</to_name>
		<to_code>8124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxetine</to_name>
		<to_code>32937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago major seed extract</to_name>
		<to_code>1310080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Parietaria officinalis extract</to_name>
		<to_code>1351897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonum bistorta root extract</to_name>
		<to_code>1309456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protamine hydrochloride</to_name>
		<to_code>236471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus serrulata flower extract</to_name>
		<to_code>1310037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-39 (31-40-29 acrylic acid-acrylamide-dadmac; 1500000 MW)</to_name>
		<to_code>1421900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemivibart</to_name>
		<to_code>2677789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus balsamifera leaf bud extract</to_name>
		<to_code>1428422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia suffruticosa root extract</to_name>
		<to_code>1307975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantolactone</to_name>
		<to_code>1427237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvalent Crotalidae antivenin</to_name>
		<to_code>91596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piscidia piscipula root bark extract</to_name>
		<to_code>1309296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyltoloxamine polistirex</to_name>
		<to_code>236792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone-iodine</to_name>
		<to_code>8611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-3 alpha-linolenamide</to_name>
		<to_code>1312711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-5</to_name>
		<to_code>1862971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium laurate</to_name>
		<to_code>1808535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 dilaurate</to_name>
		<to_code>1363613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plantain preparation</to_name>
		<to_code>285246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetic acid</to_name>
		<to_code>3690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pregabalin</to_name>
		<to_code>187832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipazetate hydrochloride</to_name>
		<to_code>236487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polygalacturonate</to_name>
		<to_code>1918054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyltoloxamine citrate</to_name>
		<to_code>221141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenelzine</to_name>
		<to_code>8123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleiogynium timoriense fruit extract</to_name>
		<to_code>2376935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago ovata seed extract</to_name>
		<to_code>1309942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-18-18-dimethicone</to_name>
		<to_code>1426610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-50 stearate</to_name>
		<to_code>2118846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pueraria montana var. lobata root extract</to_name>
		<to_code>1309751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-5-ceteth-20</to_name>
		<to_code>1424874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prajmaline</to_name>
		<to_code>8622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-53</to_name>
		<to_code>1601984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petasites hybridus root extract</to_name>
		<to_code>1541241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG 12 buteth 16</to_name>
		<to_code>1314243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picrotoxin</to_name>
		<to_code>2539172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegbovigrastim</to_name>
		<to_code>1746487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus sylvestris leafy twig</to_name>
		<to_code>1310095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment green 7</to_name>
		<to_code>1918055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 100000</to_name>
		<to_code>1735332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus pinaster seed oil</to_name>
		<to_code>1864321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prilocaine</to_name>
		<to_code>8686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-3 distearoylamidoethylmonium methosulfate</to_name>
		<to_code>1427016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pectin</to_name>
		<to_code>32987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 2000000</to_name>
		<to_code>1438115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>posaconazole</to_name>
		<to_code>282446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 acrylate-perfluorohexylethyl acrylate copolymer</to_name>
		<to_code>1986367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-9 propylheptyl ether</to_name>
		<to_code>2669404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus spinosa flower bud extract</to_name>
		<to_code>1309816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 soy sterol</to_name>
		<to_code>1314288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim-jmdb</to_name>
		<to_code>2048018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 isostearate</to_name>
		<to_code>2118918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persea americana leaf extract</to_name>
		<to_code>1307844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperacillin</to_name>
		<to_code>8339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylparaben sodium</to_name>
		<to_code>1311574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylacetaldehyde</to_name>
		<to_code>1367159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procaine</to_name>
		<to_code>8701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentobarbital</to_name>
		<to_code>8004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propyliodone</to_name>
		<to_code>8793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-10 (10000 MPA.S at 2%)</to_name>
		<to_code>2049895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phendimetrazine hydrochloride</to_name>
		<to_code>297716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphatidylinositols</to_name>
		<to_code>8217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2-ceteth-9</to_name>
		<to_code>2369367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxine dipalmitate</to_name>
		<to_code>1314231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramlintide acetate</to_name>
		<to_code>356773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla vulgaris extract</to_name>
		<to_code>1311188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG &amp; PPG-17-6 copolymer</to_name>
		<to_code>1359423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(2-(2-(2-phenoxyethoxy)ethoxy)ethoxy)ethanol</to_name>
		<to_code>1655970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint oil</to_name>
		<to_code>33094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Portulaca oleracea whole extract</to_name>
		<to_code>1358898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prosopis cineraria wood extract</to_name>
		<to_code>2590684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>podophyllin</to_name>
		<to_code>8462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata flower extract</to_name>
		<to_code>1355833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegcetacoplan</to_name>
		<to_code>2557372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 diisostearate</to_name>
		<to_code>1738092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 hydroxyethyl cocamide</to_name>
		<to_code>1421437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plum preparation</to_name>
		<to_code>307387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyurethane-35 (not more than MPA.S at 40 %)</to_name>
		<to_code>2557220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-150 disetearate</to_name>
		<to_code>1305728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 stearate</to_name>
		<to_code>2286803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>psyllium hydrocolloid</to_name>
		<to_code>314809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prenylamine</to_name>
		<to_code>8674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proglumetacin</to_name>
		<to_code>34769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine hydrate</to_name>
		<to_code>67518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 250</to_name>
		<to_code>1872039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium arsenite anhydrous</to_name>
		<to_code>1426895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>persimmon extract</to_name>
		<to_code>1322526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 2-myristate</to_name>
		<to_code>2285327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procyclidine hydrochloride</to_name>
		<to_code>142443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyvinyl alcohol</to_name>
		<to_code>8570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 35000</to_name>
		<to_code>1368894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyruvate</to_name>
		<to_code>72031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitolisant hydrochloride</to_name>
		<to_code>2197879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>8-pentadecanone</to_name>
		<to_code>2691820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium oxide</to_name>
		<to_code>1599267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsley extract</to_name>
		<to_code>317857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pidotimod</to_name>
		<to_code>40450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentamidine isethionate</to_name>
		<to_code>7995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pertuzumab-zzxf</to_name>
		<to_code>2382597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrophosphate</to_name>
		<to_code>1364533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmate</to_name>
		<to_code>1356711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone phosphate</to_name>
		<to_code>34374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimagedine hydrochloride</to_name>
		<to_code>1311669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-3 myristyl ether</to_name>
		<to_code>1427148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycols</to_name>
		<to_code>8516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>petroleum preparation</to_name>
		<to_code>324028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylbutyrate</to_name>
		<to_code>81647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proguanil hydrochloride</to_name>
		<to_code>142428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium oxyquinolone</to_name>
		<to_code>325520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phospholipid,beef</to_name>
		<to_code>236757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium estrone</to_name>
		<to_code>325519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium tetrachloroaurate dihydrate</to_name>
		<to_code>2120298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paltusotine</to_name>
		<to_code>2724363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pistacia lentiscus seed oil</to_name>
		<to_code>1363831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenol</to_name>
		<to_code>33290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegaspargase</to_name>
		<to_code>34132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxetine mesylate</to_name>
		<to_code>436212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata seed extract</to_name>
		<to_code>1371911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenacetin</to_name>
		<to_code>8113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peracetic acid</to_name>
		<to_code>2045732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pinaverium</to_name>
		<to_code>33724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyester (adipic acid, 1,6-hexanediol, neopentyl glycol)</to_name>
		<to_code>2289218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>progesterone, micronized</to_name>
		<to_code>259409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium lauryl sulfate</to_name>
		<to_code>1427140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-behenate</to_name>
		<to_code>2101072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 dipalmitate</to_name>
		<to_code>2480113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platycladus orientalis leaf extract</to_name>
		<to_code>1309453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin G</to_name>
		<to_code>7980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>platinic chloride hexahydrate</to_name>
		<to_code>1720938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancreatic alpha-amylase</to_name>
		<to_code>2475192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin G potassium</to_name>
		<to_code>203133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pearl (Hyriopsis cumingii) extract</to_name>
		<to_code>1438509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pentaclethra macroloba seed oil</to_name>
		<to_code>1997156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panicum miliaceum whole extract</to_name>
		<to_code>2592976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylehrine</to_name>
		<to_code>325517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petasites japonicus root extract</to_name>
		<to_code>1368337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 300000</to_name>
		<to_code>1426702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peumus boldus leaf extract</to_name>
		<to_code>1310049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-14 PPG-7 ethylhexyl ether</to_name>
		<to_code>2266812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus apetala whole extract</to_name>
		<to_code>1607315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus trichocarpa whole extract</to_name>
		<to_code>2590683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-dodecylbenzenesulfonic acid</to_name>
		<to_code>1495319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>porfimer sodium</to_name>
		<to_code>333848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propantheline</to_name>
		<to_code>8761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentosan polysulfate</to_name>
		<to_code>155046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene terephthalate (intrinsic viscosity 0.40-0.70)</to_name>
		<to_code>2047189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoma glomerata allergenic extract</to_name>
		<to_code>975996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 12000</to_name>
		<to_code>1989912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(DL-lactic-co-glycolic acid), (75:25; 140000 MW)</to_name>
		<to_code>2639716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paramethadione</to_name>
		<to_code>32894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-phenylpropanal propylene glycol acetal</to_name>
		<to_code>1947505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tetrapeptide-7</to_name>
		<to_code>1314277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protamines</to_name>
		<to_code>8826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proximadiol</to_name>
		<to_code>2562551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenindamine tartrate</to_name>
		<to_code>221137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(laurylglucoside)-7</to_name>
		<to_code>1927429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (800000 MW)</to_name>
		<to_code>1374805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polymyxin B</to_name>
		<to_code>8536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrithione</to_name>
		<to_code>35100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbates</to_name>
		<to_code>8561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 61</to_name>
		<to_code>1923243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium citrate monohydrate</to_name>
		<to_code>221149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium nitrate</to_name>
		<to_code>34316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone sodium phosphate</to_name>
		<to_code>55062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>podofilox</to_name>
		<to_code>8463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perflunafene</to_name>
		<to_code>2462501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Portulaca oleracea leaf extract</to_name>
		<to_code>1429042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylephrine tannate</to_name>
		<to_code>221139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 myristate</to_name>
		<to_code>2603288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantoprazole (as pantoprazole sodium sesquihydrate)</to_name>
		<to_code>236632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4 stearate</to_name>
		<to_code>1873581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propamidine</to_name>
		<to_code>34633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 stearate</to_name>
		<to_code>2539173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protamine sulfate (USP)</to_name>
		<to_code>8825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prasugrel</to_name>
		<to_code>613391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim-bmez</to_name>
		<to_code>2260702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrisuccideanol</to_name>
		<to_code>35097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 diisostearate</to_name>
		<to_code>1364380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 dimethicone/PPG-20 crosspolymer</to_name>
		<to_code>1600596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 isostearate</to_name>
		<to_code>1366669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-45/dodecyl glycol copolymer</to_name>
		<to_code>1940010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium iodate</to_name>
		<to_code>34312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenolsulfonic acid</to_name>
		<to_code>1651701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Propionibacterium avidum</to_name>
		<to_code>1310909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphorus 32</to_name>
		<to_code>258478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,3-propanediol</to_name>
		<to_code>1363030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plectranthus barbatus root extract</to_name>
		<to_code>1309454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-9 diglycidyl ether and sodium hyaluronate cross polymer</to_name>
		<to_code>1421547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-30 cetyl ether</to_name>
		<to_code>2002065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillin</to_name>
		<to_code>70618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promethazine hydrochloride</to_name>
		<to_code>142445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosteryl isostearyl dimer dilinoleate</to_name>
		<to_code>1735045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol caprylate</to_name>
		<to_code>1661194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralidoxime</to_name>
		<to_code>34345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 isostearate</to_name>
		<to_code>2199864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perhexiline maleate</to_name>
		<to_code>33169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-75 stearate</to_name>
		<to_code>1363620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promethazine hydrobromide</to_name>
		<to_code>485608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednazoline</to_name>
		<to_code>168651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peucedanum ostruthium leaf extract</to_name>
		<to_code>1311511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG PPG116-66 copolymer</to_name>
		<to_code>1366231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrrolidone carboxylate</to_name>
		<to_code>1370623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Poncirus trifoliata fruit extract</to_name>
		<to_code>1358900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 polyricinoleate</to_name>
		<to_code>2465731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-14-7 dimethyl ether</to_name>
		<to_code>1356766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin G procaine</to_name>
		<to_code>7983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paraffin</to_name>
		<to_code>7906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petiveria alliacea whole extract</to_name>
		<to_code>1373036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine adipate</to_name>
		<to_code>33746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paris polyphylla whole extract</to_name>
		<to_code>1793743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyritidium</to_name>
		<to_code>1420978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polygonum cuspidatum leaf extract</to_name>
		<to_code>1492339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-PPG-17-18 dimethicone</to_name>
		<to_code>1373725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum cyrtonema root extract</to_name>
		<to_code>1592900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum sibiricum root extract</to_name>
		<to_code>1372637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxetine hydrochloride anhydrous</to_name>
		<to_code>1311626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-tert-butylphenol-formaldehyde resin (low molecular weight)</to_name>
		<to_code>1427189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podophyllum hexandrum whole extract</to_name>
		<to_code>2636601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protein C, human-lans</to_name>
		<to_code>2643198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint allergenic extract</to_name>
		<to_code>1010971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pothos repens root extract</to_name>
		<to_code>2634552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pizotyline malate</to_name>
		<to_code>235747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus tremula whole extract</to_name>
		<to_code>1545791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylpropanolamine</to_name>
		<to_code>8175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonatum multiflorum whole extract</to_name>
		<to_code>1435866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin G sodium</to_name>
		<to_code>9900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentigide</to_name>
		<to_code>1362920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-phenylphenol</to_name>
		<to_code>236677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine:N-butyl methacrylate; 3:7)</to_name>
		<to_code>1359090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-chloro-m-cresol</to_name>
		<to_code>1370582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pitch pine pollen extract</to_name>
		<to_code>900758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 407</to_name>
		<to_code>155155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene carbonate</to_name>
		<to_code>1363696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pine whole extract</to_name>
		<to_code>2121056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pseudoephedrine sulfate</to_name>
		<to_code>91169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 dimethicone (220 CST)</to_name>
		<to_code>2621708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propiverine hydrochloride</to_name>
		<to_code>55176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyamide-3 (30000 MW)</to_name>
		<to_code>1926330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylate crosspolymer-6</to_name>
		<to_code>2698020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Packera aurea extract</to_name>
		<to_code>1330093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 oleate</to_name>
		<to_code>1370731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Porphyra yezoensis extract</to_name>
		<to_code>1426917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-50 shea butter</to_name>
		<to_code>2462445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium undecylenate</to_name>
		<to_code>1744166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 palmitate</to_name>
		<to_code>2384782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Punica granatum root bark extract</to_name>
		<to_code>1354526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pSCN5A-Neo</to_name>
		<to_code>2204567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-5 polyricinoleate</to_name>
		<to_code>2612152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsnip allergenic extract</to_name>
		<to_code>1011027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednylidene</to_name>
		<to_code>12473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-16 soy sterol</to_name>
		<to_code>1855888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylsilanetriol</to_name>
		<to_code>2637676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-hydroxyamphetamine</to_name>
		<to_code>7839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tripeptide-54 amide</to_name>
		<to_code>1868210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pindolol</to_name>
		<to_code>8332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polidronium</to_name>
		<to_code>1426892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago australis whole extract</to_name>
		<to_code>2590681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus densiflora bark extract</to_name>
		<to_code>1310107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pumpkin seed extract</to_name>
		<to_code>126291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pteridium aquilinum whole extract</to_name>
		<to_code>1482545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phoenix reclinata fruit extract</to_name>
		<to_code>1801066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propyphenazone</to_name>
		<to_code>34710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrvinium pamoate</to_name>
		<to_code>55347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 pentastearate</to_name>
		<to_code>1876663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pLDLR-Neo</to_name>
		<to_code>2204566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peroxidase</to_name>
		<to_code>1600930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-32 (30000 MPA.S at 2%)</to_name>
		<to_code>1655569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla vulgaris top extract</to_name>
		<to_code>2621829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Poa pratensis top extract</to_name>
		<to_code>1326503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parasorbic acid</to_name>
		<to_code>1998743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-26-buteth-26</to_name>
		<to_code>1423273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phleum pratense allergenic extract</to_name>
		<to_code>1922743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirbuterol</to_name>
		<to_code>33767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-10 (125 MPA.S at 2%)</to_name>
		<to_code>1429395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentetreotide</to_name>
		<to_code>69893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 beta-sitosterol</to_name>
		<to_code>1808613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-10 (20000 MPA.S at 2%)</to_name>
		<to_code>2467131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunella vulgaris extract</to_name>
		<to_code>2001198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica whole extract</to_name>
		<to_code>2585445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone K30</to_name>
		<to_code>1297406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine, 1-(4'-methoxy(1,1'-biphenyl)-2-yl)-</to_name>
		<to_code>1594338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone acetate</to_name>
		<to_code>34372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polixetonium</to_name>
		<to_code>1549143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>platinic iodide</to_name>
		<to_code>1720940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus mume flower extract</to_name>
		<to_code>1307653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenolphthalein</to_name>
		<to_code>155122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-11 avocado glycerides</to_name>
		<to_code>1543415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propranolol glycol</to_name>
		<to_code>2105554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed dipotassium</to_name>
		<to_code>2699334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus halepensis resin</to_name>
		<to_code>2629718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-37 (3000 MPA.S)</to_name>
		<to_code>1372481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persicaria tinctoria top extract</to_name>
		<to_code>1424359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylpropanolamine hydrochloride</to_name>
		<to_code>3266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 600000</to_name>
		<to_code>1314203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palm kernel acid</to_name>
		<to_code>1426626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium citrate trihydrate</to_name>
		<to_code>2634820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegademase bovine</to_name>
		<to_code>59768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tetrapeptide-10</to_name>
		<to_code>2387076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycerin-3</to_name>
		<to_code>1426428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perphenazine</to_name>
		<to_code>8076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium guaiacolsulfonate</to_name>
		<to_code>91275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pyrus communis flower whole extract</to_name>
		<to_code>2565688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poison ivy extract</to_name>
		<to_code>236106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus serotina fruit extract</to_name>
		<to_code>1311664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperacillin anhydrous</to_name>
		<to_code>1546000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 methyl glucose sesquistearate</to_name>
		<to_code>1430130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-4 polyricinoleate</to_name>
		<to_code>2677422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylisothiocyanate</to_name>
		<to_code>1368174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphorus</to_name>
		<to_code>8263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prune preparation</to_name>
		<to_code>340262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polihexanide</to_name>
		<to_code>1373041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prevotella intermedia</to_name>
		<to_code>2591816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dinitrate</to_name>
		<to_code>2370146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylephrine hydrochloride, DL-</to_name>
		<to_code>2670532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyroglutamate</to_name>
		<to_code>155060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pridinol hydrochloride</to_name>
		<to_code>236869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora edulis fruit juice</to_name>
		<to_code>1539635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polaprezinc</to_name>
		<to_code>2179843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenethicillin</to_name>
		<to_code>33277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxypropione</to_name>
		<to_code>133070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plectranthus amboinicus whole extract</to_name>
		<to_code>2360893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-7 trimethylolpropane coconut ether</to_name>
		<to_code>2597522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium digitatum allergenic extract</to_name>
		<to_code>1427044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyestradiol</to_name>
		<to_code>34119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysaccharide-K</to_name>
		<to_code>1804843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantothenic acid, (+-)-</to_name>
		<to_code>2394646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenmetrazine theoclate</to_name>
		<to_code>236652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>p-anisaldehyde</to_name>
		<to_code>1940008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pregnenolone</to_name>
		<to_code>114052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly(lactide)</to_name>
		<to_code>1424562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prochlorperazine edisylate</to_name>
		<to_code>8705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium cocoyl glutamate</to_name>
		<to_code>1425355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia obovata root extract</to_name>
		<to_code>1865702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentoxifylline</to_name>
		<to_code>8013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pramoxine</to_name>
		<to_code>34347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylmercury</to_name>
		<to_code>1426779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phlorhizin</to_name>
		<to_code>1362735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus koraiensis seed oil</to_name>
		<to_code>1488820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglycerin-4</to_name>
		<to_code>1486795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-150-decyl alcohol-SMDI copolymer (1350 MPA.S at 3%)</to_name>
		<to_code>1435521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillin V potassium</to_name>
		<to_code>203195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prolintane</to_name>
		<to_code>34604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plantago indica seed coat extract</to_name>
		<to_code>2120183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-39 (22.5-51-26.5 acrylic acid-acrylamide-DADMAC; 1600000 MW)</to_name>
		<to_code>1428041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proxibarbal</to_name>
		<to_code>83885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrogallol</to_name>
		<to_code>9022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>porcine heart preparation</to_name>
		<to_code>1311301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picea mariana resin</to_name>
		<to_code>1311051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proflavine hemisulfate</to_name>
		<to_code>8724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 4000</to_name>
		<to_code>1310594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phellodendron chinense whole extract</to_name>
		<to_code>1945225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prolinamidoethyl imidazole</to_name>
		<to_code>1362142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pin oak pollen extract</to_name>
		<to_code>900999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prothipendyl hydrochloride</to_name>
		<to_code>236710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-90 glyceryl isostearate</to_name>
		<to_code>2387540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pistachio oil</to_name>
		<to_code>1307870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene oxide 2000000</to_name>
		<to_code>2044901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-80 sorbitan palmitate</to_name>
		<to_code>1430440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed</to_name>
		<to_code>68446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork liver preparation</to_name>
		<to_code>1311071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytosteryl/octyldodecyl lauroyl glutamate</to_name>
		<to_code>1796718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plains cottonwood pollen extract</to_name>
		<to_code>867297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ponesimod</to_name>
		<to_code>2532300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper kadsura stem extract</to_name>
		<to_code>1307855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>passiflora incarnata flowering top extract</to_name>
		<to_code>1309979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica flower bud extract</to_name>
		<to_code>1945838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegloticase</to_name>
		<to_code>1011650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pecan allergenic extract</to_name>
		<to_code>892332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pimpinella saxifraga root extract</to_name>
		<to_code>1310033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 8000</to_name>
		<to_code>1307312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 1-stearate</to_name>
		<to_code>2169962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla koreana whole extract</to_name>
		<to_code>1429953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pisum sativum whole allergenic extract</to_name>
		<to_code>2261371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Porphyridium purpureum extract</to_name>
		<to_code>1328315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physalis alkekengi fruit extract</to_name>
		<to_code>1435097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegvaliase</to_name>
		<to_code>2046360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podophyllum peltatum preparation</to_name>
		<to_code>324036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plum seed oil</to_name>
		<to_code>1309455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia officinalis root extract</to_name>
		<to_code>1310101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 laurate</to_name>
		<to_code>1426747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pinacidil</to_name>
		<to_code>33717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentazocine lactate</to_name>
		<to_code>203196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phragmites karka whole extract</to_name>
		<to_code>2261383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegunigalsidase alfa</to_name>
		<to_code>2637446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peppermint preparation</to_name>
		<to_code>33093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-4 caprylic-capric glycerides</to_name>
		<to_code>2474631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 1500</to_name>
		<to_code>1314382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment brown 1</to_name>
		<to_code>2000531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phthalimidoperoxycaproic acid</to_name>
		<to_code>2665626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim-fpgk</to_name>
		<to_code>2613761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plant stanol ester</to_name>
		<to_code>259320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pergolide mesylate</to_name>
		<to_code>8048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ptychopetalum olacoides wood extract</to_name>
		<to_code>1371302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 methyl ether</to_name>
		<to_code>1312727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrroloquinolinedione tricarboxylic acid</to_name>
		<to_code>2471086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-1-PEG-9 lauryl glycol ether</to_name>
		<to_code>1489919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimeclone</to_name>
		<to_code>2673756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentadecalactone</to_name>
		<to_code>1312715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt</to_name>
		<to_code>1440970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 distearate</to_name>
		<to_code>2621544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla pratensis extract</to_name>
		<to_code>283682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pargyline hydrochloride</to_name>
		<to_code>82069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium mercuric iodide</to_name>
		<to_code>1426940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax notoginseng whole extract</to_name>
		<to_code>1606213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plum juice</to_name>
		<to_code>2604570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plasacryl T20</to_name>
		<to_code>2668190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperazine phosphate</to_name>
		<to_code>54749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 cocamide</to_name>
		<to_code>2630879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus massoniana leaf extract</to_name>
		<to_code>1746489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Physostigma venenosum seed extract</to_name>
		<to_code>1310076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picosulfuric acid</to_name>
		<to_code>1546457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phloretin</to_name>
		<to_code>1368167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Psidium guajava extract</to_name>
		<to_code>1428840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus taeda bark extract</to_name>
		<to_code>1593612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimeclone hydrochloride</to_name>
		<to_code>2673755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper methysticum root extract</to_name>
		<to_code>1309452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium azeloyl diglycinate</to_name>
		<to_code>1366229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polybutester</to_name>
		<to_code>2049679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia officinalis whole extract</to_name>
		<to_code>1489760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyaminopropyl biguanide</to_name>
		<to_code>1314381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-75 lanolin</to_name>
		<to_code>1363619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaveretum hydrochloride</to_name>
		<to_code>253192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium lactate</to_name>
		<to_code>314797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudognaphalium obtusifolium extract</to_name>
		<to_code>1311121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phentermine</to_name>
		<to_code>8152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium chromate(VI)</to_name>
		<to_code>34303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork brain preparation</to_name>
		<to_code>1311069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-32 hydrogenated palm glycerides</to_name>
		<to_code>1547622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenyl butyrate</to_name>
		<to_code>1545685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl tripeptide-1 acetate</to_name>
		<to_code>2109750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pancreatin</to_name>
		<to_code>7880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penciclovir</to_name>
		<to_code>59839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllanthus emblica whole extract</to_name>
		<to_code>2178752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 glyceryl oleate</to_name>
		<to_code>1726095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium chrysogenum var. chrysogenum allergenic extract</to_name>
		<to_code>854130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Planatus occidentalis bark extract</to_name>
		<to_code>1370990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panthenyl ethyl ether</to_name>
		<to_code>1356484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podophyllum peltatum root extract</to_name>
		<to_code>1310099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium lauryl phosphate</to_name>
		<to_code>1593446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol methyl ether</to_name>
		<to_code>1367160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 dimethicone (600 CST)</to_name>
		<to_code>1368157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol butyl ether</to_name>
		<to_code>1799007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-10 beta-sitosteryl ether</to_name>
		<to_code>2604569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegfilgrastim-cbqv</to_name>
		<to_code>2102692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plerixafor</to_name>
		<to_code>733003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Peptide Hydrolases</to_name>
		<to_code>8028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylheptyl caprylate</to_name>
		<to_code>1427011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (200000 MW)</to_name>
		<to_code>1366994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-20 glyceryl triisostearate</to_name>
		<to_code>1545358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylbutazone piperazine</to_name>
		<to_code>236354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax japonicus root extract</to_name>
		<to_code>1307794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phthalylsulfathiazole</to_name>
		<to_code>33632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propanidid</to_name>
		<to_code>8758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Plumeria alba flower extract</to_name>
		<to_code>1999323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl hexapeptide-12</to_name>
		<to_code>1732116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 1000</to_name>
		<to_code>1368863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perindopril arginine</to_name>
		<to_code>1600711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paclitaxel poliglumex</to_name>
		<to_code>2473230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus virginiana bark extract</to_name>
		<to_code>1442700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimecrolimus</to_name>
		<to_code>321952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Picrorhiza kurroa whole extract</to_name>
		<to_code>2557800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantoprazole sodium</to_name>
		<to_code>253191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium italicum allergenic extract</to_name>
		<to_code>967960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prezatide copper acetate</to_name>
		<to_code>1314596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-propenoic acid, 3-hydroxypropyl ester</to_name>
		<to_code>2689781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6-dioleate</to_name>
		<to_code>1431309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phospholipase D1</to_name>
		<to_code>2608530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>parsley oil</to_name>
		<to_code>1482539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica twig extract</to_name>
		<to_code>2570281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-37 (25000 MPA.S)</to_name>
		<to_code>1372567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pork allergenic extract</to_name>
		<to_code>892628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pioglitazone hydrochloride</to_name>
		<to_code>259319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrethrum allergenic extract</to_name>
		<to_code>2102029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prussian blue insoluble</to_name>
		<to_code>24902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium glucoheptonate</to_name>
		<to_code>236259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paecilomyces variotii allergenic extract</to_name>
		<to_code>966979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 ricinoleate</to_name>
		<to_code>2534444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propionaldehyde</to_name>
		<to_code>2359273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>panthenyl ethyl ether acetate</to_name>
		<to_code>1657859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus strobus bark extract</to_name>
		<to_code>1309309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pomalidomide</to_name>
		<to_code>1369713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-phenyl-1-propanol</to_name>
		<to_code>2479688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-16 macademia glycerides</to_name>
		<to_code>2360894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegunigalsidase alfa-iwxj</to_name>
		<to_code>2637445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pigment red 5</to_name>
		<to_code>1372631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyllysylvalyldiaminobutyroylthreonine</to_name>
		<to_code>1486022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perazine dimalonate</to_name>
		<to_code>236771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium aluminum disilicate</to_name>
		<to_code>2267407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>povidone (K-30) simethicone emulsion</to_name>
		<to_code>1305760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus tabuliformis bark extract</to_name>
		<to_code>1307671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-3 distearate</to_name>
		<to_code>1367498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-25 hydrogenated castor oil</to_name>
		<to_code>1356139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pygeum africanum preparation</to_name>
		<to_code>236466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylic acid (250000 MW)</to_name>
		<to_code>1309733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 distearate</to_name>
		<to_code>2619244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picolinic acid</to_name>
		<to_code>33684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>proline</to_name>
		<to_code>8737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol 2-methylbutyrate</to_name>
		<to_code>2059293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralidoxime mesylate</to_name>
		<to_code>55053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30 castor oil</to_name>
		<to_code>1485183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus americana whole extract</to_name>
		<to_code>1811765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Portulaca oreracea seed extract</to_name>
		<to_code>1608546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyester-5 (TG-48)</to_name>
		<to_code>2289012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procainamide</to_name>
		<to_code>8700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peramivir anhydrous</to_name>
		<to_code>1598096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30-dipolyhydroxystearate</to_name>
		<to_code>1363570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol diethylhexanoate</to_name>
		<to_code>1426620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium bisulfite</to_name>
		<to_code>1426433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,10,15,19,23-pentahydrosqualene</to_name>
		<to_code>1862733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-60 lanolin</to_name>
		<to_code>1603523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 glyceryl isostearate</to_name>
		<to_code>1440235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentaerythrityl tetrabehenate</to_name>
		<to_code>1542375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium hydroxyquinoline sulfate</to_name>
		<to_code>235776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phanera variegata whole extract</to_name>
		<to_code>2381134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protocatechualdehyde</to_name>
		<to_code>1362689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-40 sorbitan diisostearate</to_name>
		<to_code>1363615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium carbonate</to_name>
		<to_code>34300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pravastatin</to_name>
		<to_code>42463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pemetrexed monohydrate</to_name>
		<to_code>2590669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-5 oleate</to_name>
		<to_code>1363616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pineapple juice</to_name>
		<to_code>1799149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pralidoxime chloride</to_name>
		<to_code>55322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palm kernel oil</to_name>
		<to_code>1309252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphoramidic acid</to_name>
		<to_code>1312381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propane</to_name>
		<to_code>1362877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penicillamine</to_name>
		<to_code>7975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 dipolyhydroxystearate</to_name>
		<to_code>1363445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 hydroxyethyl isostearamide</to_name>
		<to_code>1940148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 caprylate</to_name>
		<to_code>2533031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peanut allergenic extract</to_name>
		<to_code>891658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plutonium</to_name>
		<to_code>1600135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prednisolone sodium metasulphobenzoate</to_name>
		<to_code>268872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-7 (70-30 acrylamide-DADMAC; 900 kD)</to_name>
		<to_code>1314297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipemidate</to_name>
		<to_code>113831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-20 methyl glucose ether</to_name>
		<to_code>1368183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pongamol</to_name>
		<to_code>1426400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrvinium</to_name>
		<to_code>35163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>probenecid</to_name>
		<to_code>8698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petroselinum crispum root extract</to_name>
		<to_code>1311510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propranolol hydrochloride</to_name>
		<to_code>82084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulmonaria officinalis whole extract</to_name>
		<to_code>1809896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penpulimab</to_name>
		<to_code>2712542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pulsatilla alpina whole extract</to_name>
		<to_code>2583871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium chloride</to_name>
		<to_code>8591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyquaternium-7 (70-30 acrylamide-DADMAC; 1600 kD)</to_name>
		<to_code>1426394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pegoxol 7 stearate</to_name>
		<to_code>1367127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propinox</to_name>
		<to_code>76273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pretomanid</to_name>
		<to_code>2198359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-phenylazo-2-naphthylamine</to_name>
		<to_code>1430252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pueraria montana var. lobata whole extract</to_name>
		<to_code>1435397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxal phosphate</to_name>
		<to_code>9004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pheasant feather extract</to_name>
		<to_code>1594964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium tartrate hemihydrate</to_name>
		<to_code>2054999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>penconazole</to_name>
		<to_code>2593184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper aduncum leaf extract</to_name>
		<to_code>1374405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-175 diisostearate</to_name>
		<to_code>1426160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))</to_name>
		<to_code>1440971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pisum sativum whole extract</to_name>
		<to_code>1866393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propanediol 1-phosphate</to_name>
		<to_code>2603037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-6 stearate</to_name>
		<to_code>1998843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propofol lipid emulsion</to_name>
		<to_code>2559907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrrolidine</to_name>
		<to_code>2585446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipenzolate</to_name>
		<to_code>33743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>psyllium</to_name>
		<to_code>8928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phospholipid phosphatase 1</to_name>
		<to_code>2562174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 600</to_name>
		<to_code>1310598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pamidronic acid</to_name>
		<to_code>1546406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polygalic acid</to_name>
		<to_code>1735162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperidolate</to_name>
		<to_code>59064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoxybenzamine</to_name>
		<to_code>8149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 sesquioleate</to_name>
		<to_code>2261377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-6 sorbitan oleate</to_name>
		<to_code>1485119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyamide-3 (20000 MW)</to_name>
		<to_code>2643443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunella vulgaris flower extract</to_name>
		<to_code>2533909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 &amp; SMDI copolymer</to_name>
		<to_code>1366992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phytase</to_name>
		<to_code>1043631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisoprene (34000 MW)</to_name>
		<to_code>2118834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Panax ginseng whole extract</to_name>
		<to_code>1368530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-8 caprylic-capric glycerides</to_name>
		<to_code>1543773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sodium tartrate</to_name>
		<to_code>1311363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pumpkin seed oil</to_name>
		<to_code>466570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 pentaoleate</to_name>
		<to_code>2384444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol dibutyrate</to_name>
		<to_code>2370144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pilocarpine</to_name>
		<to_code>8328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polatuzumab vedotin</to_name>
		<to_code>2174090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenolate</to_name>
		<to_code>1495318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysulfated glycosaminoglycan</to_name>
		<to_code>1085955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentastarch</to_name>
		<to_code>816249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>picrate</to_name>
		<to_code>1443000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaya seed extract</to_name>
		<to_code>1537752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pandanus tectorius root extract</to_name>
		<to_code>1546706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylbutazone sodium</to_name>
		<to_code>236529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propylene glycol propyl ether</to_name>
		<to_code>1947500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Padang cassia bark extract</to_name>
		<to_code>2665289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paroxetine hydrochloride</to_name>
		<to_code>235830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium sulfide</to_name>
		<to_code>236907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 stearate</to_name>
		<to_code>1312395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>patisiran sodium</to_name>
		<to_code>2053491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunus persica flower extract</to_name>
		<to_code>1310009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perflenapent</to_name>
		<to_code>2474632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phosphatidylethanolamines</to_name>
		<to_code>8215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pradofloxacin trihydrate</to_name>
		<to_code>2680581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pipotiazine palmitate</to_name>
		<to_code>235745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propranolol</to_name>
		<to_code>8787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 20000</to_name>
		<to_code>1747569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenothrin</to_name>
		<to_code>33303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pimozide</to_name>
		<to_code>8331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pilocarpine nitrate</to_name>
		<to_code>103244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (55000 MW)</to_name>
		<to_code>1925580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prilocaine hydrochloride</to_name>
		<to_code>2557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polysorbate 20</to_name>
		<to_code>8559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polymethylsilsesquioxane (11 microns)</to_name>
		<to_code>1426429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 181</to_name>
		<to_code>1371947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudolarix amabilis whole extract</to_name>
		<to_code>1999322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pheniramine aminosalicylate</to_name>
		<to_code>159340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus densiflora root extract</to_name>
		<to_code>1367496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-10 caprylate</to_name>
		<to_code>2559843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poldine</to_name>
		<to_code>33926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylate</to_name>
		<to_code>1370575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium benzoate</to_name>
		<to_code>54991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium ascorbyl tocopheryl phosphate</to_name>
		<to_code>1427199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus massoniana pollen extract</to_name>
		<to_code>1801707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piribedil</to_name>
		<to_code>8353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenoperidine</to_name>
		<to_code>8143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylhydrazine hydrochloride</to_name>
		<to_code>292726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Persicaria filiformis flowering top extract</to_name>
		<to_code>1990420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora incarnata seed oil</to_name>
		<to_code>1309491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pinus thunbergii whole extract</to_name>
		<to_code>1600141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenylalanine</to_name>
		<to_code>8156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-50 lanolin</to_name>
		<to_code>2686033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-14 butyl ether</to_name>
		<to_code>1368192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peg-32 stearate</to_name>
		<to_code>1309366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-12 glyceryl laurate</to_name>
		<to_code>2540678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>protamone</to_name>
		<to_code>453012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus tremuloides leaf extract</to_name>
		<to_code>1310108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piridocaine</to_name>
		<to_code>1947299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poly-L-lysine (30000-70000 MW)</to_name>
		<to_code>2380370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pleospora herbarum allergenic extract</to_name>
		<to_code>971198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pentapeptide-31</to_name>
		<to_code>1875949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenazopyridine</to_name>
		<to_code>8120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paulownia tomentosa whole extract</to_name>
		<to_code>2479550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyacrylamide (1500 MW)</to_name>
		<to_code>1312742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Protortonia cacti preparation</to_name>
		<to_code>1355830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (1000 MW)</to_name>
		<to_code>1368895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perch allergenic extract</to_name>
		<to_code>976711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Passiflora edulis whole extract</to_name>
		<to_code>2049986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer</to_name>
		<to_code>155156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia suffruticosa flower oil</to_name>
		<to_code>1739225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pirarubicin</to_name>
		<to_code>33764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaveretum</to_name>
		<to_code>7894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>perfluoromethylcyclopentane</to_name>
		<to_code>2048724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>paregoric</to_name>
		<to_code>32926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pennyroyal oil</to_name>
		<to_code>1309213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonum cuspidatum whole extract</to_name>
		<to_code>1420977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-(p-hydroxyphenyl)-2-butanone acetate</to_name>
		<to_code>1307548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyglyceryl-2 myristate</to_name>
		<to_code>2188090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenytoin sodium</to_name>
		<to_code>71227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyisobutylene (1300 MW)</to_name>
		<to_code>1426426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pacritinib citrate</to_name>
		<to_code>2595242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pantothenate</to_name>
		<to_code>62400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyridoxine</to_name>
		<to_code>684879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phenolsulfonphthalein</to_name>
		<to_code>8141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>phthalylsulfacetamide</to_name>
		<to_code>89736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Penicillium glabrum</to_name>
		<to_code>1328760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PPG-2 myristyl ether propionate</to_name>
		<to_code>1426407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procarbazine hydrochloride</to_name>
		<to_code>66925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Petiveria alliacea root extract</to_name>
		<to_code>1309495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pseudognaphalium luteoalbum leaf extract</to_name>
		<to_code>1353219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene terephthalate (intrinsic visconsity 0.70-1.00)</to_name>
		<to_code>1737846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Phyllolobium chinense seed extract</to_name>
		<to_code>2665341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Piper betle leaf extract</to_name>
		<to_code>1421446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-30 glyceryl stearate</to_name>
		<to_code>1747476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Populus alba leaf extract</to_name>
		<to_code>2053441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pear juice</to_name>
		<to_code>1313233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Polygonum aviculare top extract</to_name>
		<to_code>1310279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium methylparaben</to_name>
		<to_code>1535699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>physostigmine sulfate</to_name>
		<to_code>106047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piracetam</to_name>
		<to_code>8351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pexidartinib hydrochloride</to_name>
		<to_code>2183103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia lactiflora root extract</to_name>
		<to_code>1307731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium lactate, DL-</to_name>
		<to_code>2571989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Paeonia suffruticosa root bark extract</to_name>
		<to_code>1307729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papaverine</to_name>
		<to_code>7895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promazine</to_name>
		<to_code>8742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Podophyllum preparation</to_name>
		<to_code>324040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>promegestone</to_name>
		<to_code>8744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plum allergenic extract</to_name>
		<to_code>899470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>piperidolate hydrochloride</to_name>
		<to_code>102170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 800</to_name>
		<to_code>1307313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(perfluorohexyl)ethanethiol</to_name>
		<to_code>2672488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Platanus occidentalis bark extract</to_name>
		<to_code>2590682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prezatide</to_name>
		<to_code>1368533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(phosphonooxy)- 2-propenoate</to_name>
		<to_code>2385889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>prickly pear fruit extract</to_name>
		<to_code>1368342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pterocarpus marsupium bark extract</to_name>
		<to_code>2465836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>poloxamer 403</to_name>
		<to_code>1422193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-phenylbutyric acid</to_name>
		<to_code>1546447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>peginterferon alfa-2a</to_name>
		<to_code>120608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>PEG-32 oleate</to_name>
		<to_code>1428875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>procaine hydrochloride</to_name>
		<to_code>106558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pyrethrins</to_name>
		<to_code>8991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,3-propanediol bis(4-aminobenzoate)</to_name>
		<to_code>1923479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plecanatide</to_name>
		<to_code>1873752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>para-cresol</to_name>
		<to_code>2467144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>palmitoyl collagen acid</to_name>
		<to_code>236410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>papain</to_name>
		<to_code>7892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 4000000</to_name>
		<to_code>1370192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Prunella vulgaris flowering top extract</to_name>
		<to_code>1309294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Pueraria montana var. lobata flowering top extract</to_name>
		<to_code>1733670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>pregna-4,17-diene-3,16-dione</to_name>
		<to_code>1088591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 1000000</to_name>
		<to_code>1314202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>potassium bromate</to_name>
		<to_code>34298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>polyethylene glycol 3000</to_name>
		<to_code>1368866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>plozasiran</to_name>
		<to_code>2727175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>P [Preparations]</from_name>
		<from_code>N0000010598</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>propolis wax</to_name>
		<to_code>1311659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palmitate</from_name>
		<from_code>1370621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Palmitates</to_name>
		<to_code>M0015777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene</from_name>
		<from_code>1314239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propylene</to_name>
		<to_code>M0061602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pizotyline</from_name>
		<from_code>8373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pizotyline</to_name>
		<to_code>M0016929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proflavine</from_name>
		<from_code>8723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proflavine</to_name>
		<to_code>M0017666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothrombin</from_name>
		<from_code>1441688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prothrombin</to_name>
		<to_code>M0017904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoisocytidine</from_name>
		<from_code>34930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pseudoisocytidine</to_name>
		<to_code>M0059590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palmitoleate</from_name>
		<from_code>2475954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palmitoleate</to_name>
		<to_code>M0052885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyruvic acid</from_name>
		<from_code>35161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyruvic Acid</to_name>
		<to_code>M0028719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetranitrate</from_name>
		<from_code>7992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pentaerythritol Tetranitrate</to_name>
		<to_code>M0016166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parecoxib</from_name>
		<from_code>279950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>parecoxib</to_name>
		<to_code>M0364955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>padimate A</from_name>
		<from_code>1363712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>padimate A</to_name>
		<to_code>M0062806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylhydrazine</from_name>
		<from_code>8167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylhydrazine</to_name>
		<to_code>M0095935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pinaverium bromide</from_name>
		<from_code>54743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pinaverium bromide</to_name>
		<to_code>M0060790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylenediamine</from_name>
		<from_code>1362740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-phenylenediamine</to_name>
		<to_code>M0094616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylenediamine</from_name>
		<from_code>1362740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-aminoaniline</to_name>
		<to_code>M000765690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-propoxy-2-propanol</from_name>
		<from_code>1358844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-propoxy-2-propanol</to_name>
		<to_code>M0157700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Panax notoginseng root extract</from_name>
		<from_code>1365707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>San-Chi</to_name>
		<to_code>M0090096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramiverine</from_name>
		<from_code>190433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pramiverine</to_name>
		<to_code>M0262765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyglyceryl-3 methylglucose distearate</from_name>
		<from_code>2476007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyglyceryl-3-methylglucose-distearate</to_name>
		<to_code>M0443333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimavanserin</to_name>
		<to_code>M0498685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin</from_name>
		<from_code>1791685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hallucinations</to_name>
		<to_code>M0009762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropinirole</from_name>
		<from_code>72302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethopropazine hydrochloride</from_name>
		<from_code>6541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa anhydrous</from_name>
		<from_code>1545982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide mesylate</from_name>
		<from_code>8048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>profenamine</from_name>
		<from_code>4134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden</from_name>
		<from_code>1589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotigotine</from_name>
		<from_code>616739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piribedil</from_name>
		<from_code>8353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foslevodopa</from_name>
		<from_code>2695775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levodopa</from_name>
		<from_code>6375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbidopa</from_name>
		<from_code>2019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opicapone</from_name>
		<from_code>2362167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole dihydrochloride</from_name>
		<from_code>236747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomethiazole edisylate</from_name>
		<from_code>20802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apomorphine hydrochloride</from_name>
		<from_code>71225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budipine</from_name>
		<from_code>19832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropatepine</from_name>
		<from_code>38876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropatepine hydrochloride</from_name>
		<from_code>236190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden lactate</from_name>
		<from_code>19377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine</from_name>
		<from_code>620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolcapone</from_name>
		<from_code>72937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine hydrochloride</from_name>
		<from_code>282415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piribedil mesylate</from_name>
		<from_code>236380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabergoline</from_name>
		<from_code>47579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnolol</from_name>
		<from_code>2562549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pramipexole</from_name>
		<from_code>746741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>foscarbidopa</from_name>
		<from_code>2695774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormethiazole</from_name>
		<from_code>2372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budipine hydrochloride</from_name>
		<from_code>236892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>istradefylline</from_name>
		<from_code>2199015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>biperiden hydrochloride</from_name>
		<from_code>91154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ropinirole hydrochloride</from_name>
		<from_code>236553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entacapone</from_name>
		<from_code>60307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amantadine sulfate</from_name>
		<from_code>621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin tartrate</from_name>
		<from_code>1791686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>apomorphine</from_name>
		<from_code>1043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pergolide</from_name>
		<from_code>8047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parkinson Disease</to_name>
		<to_code>M0015963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin tartrate</from_name>
		<from_code>1791686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimavanserin tartrate</to_name>
		<to_code>M0529250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimavanserin tartrate</from_name>
		<from_code>1791686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hallucinations</to_name>
		<to_code>M0009762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium orotate</from_name>
		<from_code>8602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Orotate</to_name>
		<to_code>M0015447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picric acid</from_name>
		<from_code>1320642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>picric acid</to_name>
		<to_code>M0047676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrazon</from_name>
		<from_code>1874547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrazon</to_name>
		<to_code>M0047240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone palmitate</from_name>
		<from_code>858045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paliperidone Palmitate</to_name>
		<to_code>M0546009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prolactin</from_name>
		<from_code>1426890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prolactin</to_name>
		<to_code>M0017689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiverine</from_name>
		<from_code>55175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propiverine</to_name>
		<to_code>M0064951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium perchlorate</from_name>
		<from_code>34318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium perchlorate</to_name>
		<to_code>M0053367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prifinium</from_name>
		<from_code>236174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prifinium</to_name>
		<to_code>M0443665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperonal</from_name>
		<from_code>33753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piperonal</to_name>
		<to_code>M0047010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirlimycin</from_name>
		<from_code>1367292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pirlimycin</to_name>
		<to_code>M0105291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peptostreptococcus anaerobius</from_name>
		<from_code>1311307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptostreptococcus anaerobius</to_name>
		<to_code>M000666804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Proteus rettgeri</from_name>
		<from_code>2002418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Providencia rettgeri</to_name>
		<to_code>M000663850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perlite</from_name>
		<from_code>1858075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Perlite</to_name>
		<to_code>M0044017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paramethasone acetate</from_name>
		<from_code>32895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paramethasone acetate</to_name>
		<to_code>M0100441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphoric acid</from_name>
		<from_code>8259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phosphoric acid</to_name>
		<to_code>M0095805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paritaprevir dihydrate</to_name>
		<to_code>M000758137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir dihydrate</from_name>
		<from_code>1600436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacrolimus</to_name>
		<to_code>M0025261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paritaprevir</from_name>
		<from_code>1597373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paritaprevir</to_name>
		<to_code>M000604260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethinyl Estradiol</to_name>
		<to_code>M0007862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colchicine</from_name>
		<from_code>2683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colchicine</to_name>
		<to_code>M0004732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sirolimus</from_name>
		<from_code>35302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sirolimus</to_name>
		<to_code>M0029863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>posaconazole</to_name>
		<to_code>M0265888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posaconazole</from_name>
		<from_code>282446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinidine</to_name>
		<to_code>M0018341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>posaconazole</to_name>
		<to_code>M0265888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>posaconazole</to_name>
		<to_code>M0265888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin</from_name>
		<from_code>140108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazole</from_name>
		<from_code>1720882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B lipid complex</from_name>
		<from_code>2001759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caspofungin acetate</from_name>
		<from_code>282363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aspergillosis</to_name>
		<to_code>M0001850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atorvastatin</to_name>
		<to_code>M0179294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Oral</to_name>
		<to_code>M0003261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flucytosine</from_name>
		<from_code>4451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B lipid complex</from_name>
		<from_code>2001759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omoconazole mononitrate</from_name>
		<from_code>134933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omoconazole</from_name>
		<from_code>32411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>natamycin</from_name>
		<from_code>7268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis</to_name>
		<to_code>M0003258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranolazine</from_name>
		<from_code>35829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ranolazine</to_name>
		<to_code>M0156295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital</from_name>
		<from_code>8134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doravirine</from_name>
		<from_code>2055755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenobarbital</to_name>
		<to_code>M0016514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>everolimus</from_name>
		<from_code>141704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Everolimus</to_name>
		<to_code>M000602394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir</from_name>
		<from_code>1597381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir</from_name>
		<from_code>460132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir hydrate</from_name>
		<from_code>2637854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir</from_name>
		<from_code>1597371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lopinavir</from_name>
		<from_code>195088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ombitasvir heminonahydrate</from_name>
		<from_code>1600437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir propylene glycolate</from_name>
		<from_code>2670599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darunavir ethanolate</from_name>
		<from_code>644682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasabuvir sodium monohydrate</from_name>
		<from_code>1600438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dronedarone</to_name>
		<to_code>M0304036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol monohydrate</from_name>
		<from_code>2539035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paritaprevir</to_name>
		<to_code>M000604260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paritaprevir</to_name>
		<to_code>M000604260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol</from_name>
		<from_code>2539031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paritaprevir</to_name>
		<to_code>M000604260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazocine</from_name>
		<from_code>8119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenazocine</to_name>
		<to_code>M0016492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-phenyl propionic acid</from_name>
		<from_code>2627300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-phenylpropionic acid</to_name>
		<to_code>M0108150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperazine dihydrochloride</from_name>
		<from_code>2562175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Piperazine Dihydrochloride</to_name>
		<to_code>M000637134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylacetic acid</from_name>
		<from_code>33332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylacetic acid</to_name>
		<to_code>M0084151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium hydroxide</from_name>
		<from_code>34311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium hydroxide</to_name>
		<to_code>M0095120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipoxolan</from_name>
		<from_code>33758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipoxolan</to_name>
		<to_code>M0040125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pseudomonas aeruginosa</from_name>
		<from_code>1310913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas aeruginosa</to_name>
		<to_code>M0017953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudomonas aeruginosa</to_name>
		<to_code>M0017953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphite</from_name>
		<from_code>1793924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phosphites</to_name>
		<to_code>M0027051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propicillin</from_name>
		<from_code>34649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propicillin</to_name>
		<to_code>M0262768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenobarbital quinidine</from_name>
		<from_code>54620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenobarbital quinidine</to_name>
		<to_code>M0103773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrrole</from_name>
		<from_code>1338938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrroles</to_name>
		<to_code>M0018276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palmitoleic acid</from_name>
		<from_code>2475955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palmitoleic acid</to_name>
		<to_code>M0052886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phellodendrine</from_name>
		<from_code>2622304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phellodendrine</to_name>
		<to_code>M0212593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propicillin potassium</from_name>
		<from_code>236615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propicillin potassium</to_name>
		<to_code>M0476020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,3-pentanedione</from_name>
		<from_code>2693283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,3-pentanedione</to_name>
		<to_code>M0060758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palladium</from_name>
		<from_code>1311279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Palladium</to_name>
		<to_code>M0015772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parecoxib sodium</from_name>
		<from_code>279951</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>parecoxib sodium</to_name>
		<to_code>M0364956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoperidine hydrochloride</from_name>
		<from_code>106508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenoperidine Hydrochloride</to_name>
		<to_code>M0329833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phytosterols</from_name>
		<from_code>8310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phytosterols</to_name>
		<to_code>M0016830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proscillaridin</from_name>
		<from_code>8795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proscillaridin</to_name>
		<to_code>M0017785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperocaine</from_name>
		<from_code>33752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piperocaine</to_name>
		<to_code>M0079803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone dihydrochloride</from_name>
		<from_code>289159</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipamperone dihydrochloride</to_name>
		<to_code>M0309166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysorbate 80</from_name>
		<from_code>8560</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polysorbate 80</to_name>
		<to_code>M0017252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel anhydrous</from_name>
		<from_code>1299922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polysorbate 80</to_name>
		<to_code>M0017252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docetaxel</from_name>
		<from_code>72962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polysorbate 80</to_name>
		<to_code>M0017252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium aspartate</from_name>
		<from_code>8589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Aspartate</to_name>
		<to_code>M0330800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pholcodine</from_name>
		<from_code>33431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pholcodine</to_name>
		<to_code>M0053095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 2000</from_name>
		<from_code>1364383</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyethylene glycol 2000</to_name>
		<to_code>M0017178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 2000</from_name>
		<from_code>1364383</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>PEG 2000</to_name>
		<to_code>M000759092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propyl acetate</from_name>
		<from_code>1649519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propyl acetate</to_name>
		<to_code>M0086973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perfluoroperhydrophenanthrene</from_name>
		<from_code>1540875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perfluoroperhydrophenanthrene</to_name>
		<to_code>M000637141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrithioxin</from_name>
		<from_code>9020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrithioxin</to_name>
		<to_code>M0018266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley seed oil</from_name>
		<from_code>1309236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protein C</from_name>
		<from_code>8834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protein C</to_name>
		<to_code>M0017852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>profluralin</from_name>
		<from_code>2665290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>profluralin</to_name>
		<to_code>M0089669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-(perfluorohexyl)ethanol</from_name>
		<from_code>1986349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>6-2 fluorotelomer alcohol</to_name>
		<to_code>M000753346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylmercuric acetate</from_name>
		<from_code>1426778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenylmercuric Acetate</to_name>
		<to_code>M0016568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrrolidonecarboxylic acid</from_name>
		<from_code>9036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrrolidonecarboxylic Acid</to_name>
		<to_code>M0018279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bromide</from_name>
		<from_code>34299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium bromide</to_name>
		<to_code>M0117052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propionic acid</from_name>
		<from_code>34658</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propionic acid</to_name>
		<to_code>M0094462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pareptide</from_name>
		<from_code>2619909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pareptide</to_name>
		<to_code>M0082948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propionate</from_name>
		<from_code>121047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propionates</to_name>
		<to_code>M0017759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyoxyethylene-24-cholesteryl ether</from_name>
		<from_code>1362898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxyethylene-24-cholesteryl ether</to_name>
		<to_code>M0102340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pholedrine</from_name>
		<from_code>33432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pholedrine</to_name>
		<to_code>M0047723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cryptosporidiosis</to_name>
		<to_code>M0005385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin sulfate</from_name>
		<from_code>66912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paromomycin Sulfate</to_name>
		<to_code>M0015971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitazoxanide</from_name>
		<from_code>31819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cryptosporidiosis</to_name>
		<to_code>M0005385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cryptosporidiosis</to_name>
		<to_code>M0005385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paromomycin</to_name>
		<to_code>M0015969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paromomycin</from_name>
		<from_code>7934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ornidazole</from_name>
		<from_code>7701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine</from_name>
		<from_code>3820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine hydrochloride</from_name>
		<from_code>82015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinidazole</from_name>
		<from_code>10612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amebiasis</to_name>
		<to_code>M0000878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proquazone</from_name>
		<from_code>2669456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>proquazone</to_name>
		<to_code>M0057649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pulegone</from_name>
		<from_code>2393774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pulegone</to_name>
		<to_code>M0118596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-aminohippurate</from_name>
		<from_code>42837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>p-Aminohippurate</to_name>
		<to_code>M0015719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylethyl alcohol</from_name>
		<from_code>8126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenylethyl Alcohol</to_name>
		<to_code>M0016505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poliovirus</from_name>
		<from_code>1427212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poliovirus</to_name>
		<to_code>M0027120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panaxynol</from_name>
		<from_code>2676953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>panaxynol</to_name>
		<to_code>M0070178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline</from_name>
		<from_code>8886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protriptyline</to_name>
		<to_code>M0017928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimobendan</from_name>
		<from_code>1110783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimobendan</to_name>
		<to_code>M0123429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praseodymium</from_name>
		<from_code>1311481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Praseodymium</to_name>
		<to_code>M0017436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 6000</from_name>
		<from_code>1314384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyethylene Glycol 6000</to_name>
		<to_code>M0017176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine</from_name>
		<from_code>2593177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-palmitoyl-2-linoleoylphosphatidylcholine</to_name>
		<to_code>M0155985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poldine methylsulfate</from_name>
		<from_code>33927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poldine methylsulfate</to_name>
		<to_code>M0096976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Prunus serotina bark extract</from_name>
		<from_code>1307851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>wild cherry bark extract</to_name>
		<to_code>M0495556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenoxine</from_name>
		<from_code>228080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pirenoxine</to_name>
		<to_code>M0045705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal</from_name>
		<from_code>9002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyridoxal</to_name>
		<to_code>M0018240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimethixene</from_name>
		<from_code>33712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimethixene</to_name>
		<to_code>M0045352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phloroglucinol</from_name>
		<from_code>8196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phloroglucinol</to_name>
		<to_code>M0016616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proxyphylline</from_name>
		<from_code>34906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>proxyphylline</to_name>
		<to_code>M0044223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parthenium hysterophorus extract</from_name>
		<from_code>1432796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parthenium hysterophorus extract</to_name>
		<to_code>M0509385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymetaphosphate</from_name>
		<from_code>1364922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polymetaphosphate</to_name>
		<to_code>M0053860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium sorbate</from_name>
		<from_code>8606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Sorbate</to_name>
		<to_code>M0020166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peptones</from_name>
		<from_code>8040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptones</to_name>
		<to_code>M0016245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-(p-hydroxyphenyl)-2-butanone</from_name>
		<from_code>1860422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>raspberry ketone</to_name>
		<to_code>M0108790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipemidic acid</from_name>
		<from_code>8337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pipemidic Acid</to_name>
		<to_code>M0016881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prolintane hydrochloride</from_name>
		<from_code>235831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prolintane hydrochloride</to_name>
		<to_code>M0309178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palm oil</from_name>
		<from_code>32809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Palm Oil</to_name>
		<to_code>M0123738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polystyrene sulfonate</from_name>
		<from_code>1546437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polystyrene sulfonate</to_name>
		<to_code>M0044353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicilloyl polylysine</from_name>
		<from_code>2667743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>penicilloyl polylysine</to_name>
		<to_code>M0043992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimagedine</from_name>
		<from_code>1311670</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimagedine</to_name>
		<to_code>M0045554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poppy seed allergenic extract</from_name>
		<from_code>1011017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poppy seed allergenic extract</from_name>
		<from_code>1011017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed extract</from_name>
		<from_code>1309391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway seed allergenic extract</from_name>
		<from_code>899637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg allergenic extract</from_name>
		<from_code>891652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed extract</from_name>
		<from_code>1310046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cola acuminata seed extract</from_name>
		<from_code>1307595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed allergenic extract</from_name>
		<from_code>901199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cotton seed extract</from_name>
		<from_code>1309369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed allergenic extract</from_name>
		<from_code>901203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Strychnos nux-vomica seed extract</from_name>
		<from_code>1309678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nutmeg extract</from_name>
		<from_code>1353217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coffea arabica seed extract</from_name>
		<from_code>2695791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed extract</from_name>
		<from_code>853406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mung bean allergenic extract</from_name>
		<from_code>891647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seed Storage Proteins</to_name>
		<to_code>M0516536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prenylamine lactate</from_name>
		<from_code>34407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prenylamine lactate</to_name>
		<to_code>M0151091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium thiocyanate</from_name>
		<from_code>1427066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium thiocyanate</to_name>
		<to_code>M0055060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paliperidone</from_name>
		<from_code>679314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paliperidone</to_name>
		<to_code>M0211957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Propionibacterium acnes</from_name>
		<from_code>1310910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propionibacterium acnes</to_name>
		<to_code>M0017762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polygeline</from_name>
		<from_code>8521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polygeline</to_name>
		<to_code>M0017190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron hydrochloride</from_name>
		<from_code>397405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Palonosetron Hydrochloride</to_name>
		<to_code>M0452615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piketoprofen</from_name>
		<from_code>82910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piketoprofen</to_name>
		<to_code>M0140278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>policresulen</from_name>
		<from_code>54908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>policresulen</to_name>
		<to_code>M000613285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perfluoromethyldecalin</from_name>
		<from_code>1986868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perfluoromethyldecalin</to_name>
		<to_code>M0113371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progabide</from_name>
		<from_code>34568</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>progabide</to_name>
		<to_code>M0069177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentifylline</from_name>
		<from_code>33086</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentifylline</to_name>
		<to_code>M0051419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenazocine hydrobromide</from_name>
		<from_code>104979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenazocine Hydrobromide</to_name>
		<to_code>M0329828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipazethate</from_name>
		<from_code>33740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipazethate</to_name>
		<to_code>M0065813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivmecillinam hydrochloride</from_name>
		<from_code>102745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pivmecillinam Hydrochloride</to_name>
		<to_code>M0475062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PPG-15</from_name>
		<from_code>2637755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxypropylene 15 stearyl ether</to_name>
		<to_code>M0420443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PPG-15 stearyl ether</from_name>
		<from_code>1313178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxypropylene 15 stearyl ether</to_name>
		<to_code>M0420443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphorylcholine</from_name>
		<from_code>2585444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phosphorylcholine</to_name>
		<to_code>M0016734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polydatin</from_name>
		<from_code>1364277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polydatin</to_name>
		<to_code>M0162499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polylactic acid-polyglycolic acid copolymer</from_name>
		<from_code>1309726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polylactic Acid-Polyglycolic Acid Copolymer</to_name>
		<to_code>M0127831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polylactic acid-polyglycolic acid copolymer</from_name>
		<from_code>1309726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poly-L-lactic-polyglycolic Acid</to_name>
		<to_code>M0578483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palmatine</from_name>
		<from_code>1314367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palmatine</to_name>
		<to_code>M0046941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Peruvian balsam</from_name>
		<from_code>33219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peruvian balsam</to_name>
		<to_code>M0084028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxyacetic acid</from_name>
		<from_code>1426335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenoxyacetic acid</to_name>
		<to_code>M0372200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenethylamine hydrochloride</from_name>
		<from_code>1364287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenethylamine hydrochloride</to_name>
		<to_code>M0318218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peg-8 distearate</from_name>
		<from_code>1363622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peg-8 distearate</to_name>
		<to_code>M0515885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrimethamine</to_name>
		<to_code>M0018253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrimethamine</from_name>
		<from_code>9010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proguanil</to_name>
		<to_code>M0004166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dapsone</from_name>
		<from_code>3108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasmosis</to_name>
		<to_code>M0021732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecobalamin</from_name>
		<from_code>29421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B12</from_name>
		<from_code>11248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin hydrochloride</from_name>
		<from_code>1947247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin acetate</from_name>
		<from_code>236302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin</from_name>
		<from_code>5514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Pernicious</to_name>
		<to_code>M0001137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proguanil</from_name>
		<from_code>2382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proguanil</to_name>
		<to_code>M0004166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,5-pentanediol</from_name>
		<from_code>1362880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,5-pentanediol</to_name>
		<to_code>M0090711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyruvaldehyde</from_name>
		<from_code>1373350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyruvaldehyde</to_name>
		<to_code>M0018286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pivalic acid</from_name>
		<from_code>1426868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pivalic acid</to_name>
		<to_code>M0047205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protein S</from_name>
		<from_code>34822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protein S</to_name>
		<to_code>M0026253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralmorelin</from_name>
		<from_code>1492039</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>growth hormone-releasing peptide-2</to_name>
		<to_code>M0242639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propionamide</from_name>
		<from_code>1366667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propionamide</to_name>
		<to_code>M0106698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procyanidin A2</from_name>
		<from_code>2631026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>procyanidin A2</to_name>
		<to_code>M0538182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patent blue violet</from_name>
		<from_code>32950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfan blue</to_name>
		<to_code>M0052916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>patent blue violet</from_name>
		<from_code>32950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>patent blue V</to_name>
		<to_code>M000633413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chlorate</from_name>
		<from_code>59203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium chlorate</to_name>
		<to_code>M0079463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium nitrite</from_name>
		<from_code>1365705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium nitrite</to_name>
		<to_code>M0122652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylethyl resorcinol</from_name>
		<from_code>1313724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-(1-phenylethyl)-1,3-benzenediol</to_name>
		<to_code>M0500701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primycin</from_name>
		<from_code>2479689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>primycin</to_name>
		<to_code>M0053415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Plantago seed</from_name>
		<from_code>82088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ispaghula seed</to_name>
		<to_code>M000744201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Plantago seed</from_name>
		<from_code>82088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plantago Seed</to_name>
		<to_code>M0018070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Plantago ovata seed extract</from_name>
		<from_code>1309942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ispaghula seed</to_name>
		<to_code>M000744201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perhexiline</from_name>
		<from_code>8050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Perhexiline</to_name>
		<to_code>M0016281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Polygala senega root extract</from_name>
		<from_code>1310087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>senegae radix</to_name>
		<to_code>M000744283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polygalacturonic acid</from_name>
		<from_code>1918053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polygalacturonic acid</to_name>
		<to_code>M0044159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphocellulose</from_name>
		<from_code>33504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phosphocellulose</to_name>
		<to_code>M0053118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Proteus mirabilis</from_name>
		<from_code>1310903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus mirabilis</to_name>
		<to_code>M0017901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus mirabilis</to_name>
		<to_code>M0017901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>platelet glycoprotein VI</from_name>
		<from_code>2637677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>platelet membrane glycoprotein VI</to_name>
		<to_code>M0258349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium brevicompactum</from_name>
		<from_code>1426666</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillium brevicompactum</to_name>
		<to_code>M000703203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parthenolide</from_name>
		<from_code>32941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>parthenolide</to_name>
		<to_code>M0043371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protease</from_name>
		<from_code>8031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptide Hydrolases</to_name>
		<to_code>M0016225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paramethasone</from_name>
		<from_code>7910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paramethasone</to_name>
		<to_code>M0015883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polydextrose</from_name>
		<from_code>1363053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polydextrose</to_name>
		<to_code>M0103576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvinyl acetate</from_name>
		<from_code>1541597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyvinyl acetate</to_name>
		<to_code>M0060809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,2-propanedithiol</from_name>
		<from_code>2281674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,2-dimercaptopropane</to_name>
		<to_code>M0193386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley allergenic extract</from_name>
		<from_code>899877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyoxyl 40 stearate</from_name>
		<from_code>1426432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxyethylene 40 stearate</to_name>
		<to_code>M0518122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plasmin</from_name>
		<from_code>4388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fibrinolysin</to_name>
		<to_code>M0008432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Proteus vulgaris</from_name>
		<from_code>1316073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus vulgaris</to_name>
		<to_code>M0017902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenethylamine</from_name>
		<from_code>1309741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenethylamine</to_name>
		<to_code>M0093420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pepsin A</from_name>
		<from_code>8016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pepsin A</to_name>
		<to_code>M0016204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perillaldehyde</from_name>
		<from_code>1426913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perillaldehyde</to_name>
		<to_code>M0103490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poloxalene</from_name>
		<from_code>1314414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poloxalene</to_name>
		<to_code>M0017132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propentofylline</from_name>
		<from_code>34644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propentofylline</to_name>
		<to_code>M0100402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PPG-3</from_name>
		<from_code>1796120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tripropylene glycol</to_name>
		<to_code>M0582183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pradofloxacin</from_name>
		<from_code>1367269</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pradofloxacin</to_name>
		<to_code>M0494206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentane</from_name>
		<from_code>1311563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentane</to_name>
		<to_code>M0103514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomiferin</from_name>
		<from_code>2593691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pomiferin</to_name>
		<to_code>M0450688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium sulfate</from_name>
		<from_code>34323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium sulfate</to_name>
		<to_code>M0098949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint flowering top extract</from_name>
		<from_code>2168421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothionamide</from_name>
		<from_code>8871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prothionamide</to_name>
		<to_code>M0017903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phormidium persicinum</from_name>
		<from_code>1425936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pseudanabaena persicina</to_name>
		<to_code>M000663818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picosulfate sodium</from_name>
		<from_code>33688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>picosulfate sodium</to_name>
		<to_code>M0047418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poloxamer 338</from_name>
		<from_code>1364384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poloxamer 338</to_name>
		<to_code>M0030093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pumice</from_name>
		<from_code>1989334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pumice</to_name>
		<to_code>M0046470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pridinol monomesylate</from_name>
		<from_code>55092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pridinol mesylate</to_name>
		<to_code>M0310624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phytic acid</from_name>
		<from_code>8302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phytic Acid</to_name>
		<to_code>M0016819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl-n-tert-butylnitrone</from_name>
		<from_code>2694077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenyl-N-tert-butylnitrone</to_name>
		<to_code>M0093330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peptide-T</from_name>
		<from_code>2644766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptide T</to_name>
		<to_code>M0024099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyoxyl 35 castor oil</from_name>
		<from_code>1309246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxyl 35 castor oil</to_name>
		<to_code>M000613560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium tartrate</from_name>
		<from_code>55024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium tartrate</to_name>
		<to_code>M0094757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picaridin</from_name>
		<from_code>1737729</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>picaridin</to_name>
		<to_code>M0464174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium cyanide</from_name>
		<from_code>1923819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Cyanide</to_name>
		<to_code>M0017377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>platinic chloride</from_name>
		<from_code>1549109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>platinic chloride</to_name>
		<to_code>M0452057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroctone olamine</from_name>
		<from_code>33783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piroctone olamine</to_name>
		<to_code>M0149235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Podophyllum hexandrum root extract</from_name>
		<from_code>2630722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Podophyllum hexandrum root</to_name>
		<to_code>M000745790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pumpkin allergenic extract</from_name>
		<from_code>883459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>petrolatum</from_name>
		<from_code>8091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Petrolatum</to_name>
		<to_code>M0016435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penoxsulam</from_name>
		<from_code>1482792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>penoxsulam</to_name>
		<to_code>M0490289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaterol</from_name>
		<from_code>34530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Procaterol</to_name>
		<to_code>M0026203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipamperone</from_name>
		<from_code>33739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipamperone</to_name>
		<to_code>M0047214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piperine</from_name>
		<from_code>1311146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piperine</to_name>
		<to_code>M0053196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pangamic acid</from_name>
		<from_code>7886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pangamic acid</to_name>
		<to_code>M0275348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylenes</from_name>
		<from_code>8519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyethylenes</to_name>
		<to_code>M0017186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>policosanol</from_name>
		<from_code>69440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>policosanol</to_name>
		<to_code>M0215534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palmitic acid</from_name>
		<from_code>1426390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Palmitic Acid</to_name>
		<to_code>M0028750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium magnesium aspartate</from_name>
		<from_code>1793925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Magnesium Aspartate</to_name>
		<to_code>M0017384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipenzolate bromide</from_name>
		<from_code>202840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipenzolate bromide</to_name>
		<to_code>M0308563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pigment blue 16</from_name>
		<from_code>1999764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phthalocyanine</to_name>
		<to_code>M0061585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pasteurella multocida</from_name>
		<from_code>1437221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pasteurella multocida</to_name>
		<to_code>M0025810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-methylaminophenol sulfate</from_name>
		<from_code>2625121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>p-Methylaminophenol sulfate</to_name>
		<to_code>M0312397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piprozoline</from_name>
		<from_code>33761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piprozoline</to_name>
		<to_code>M0044132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palmidrol</from_name>
		<from_code>2001986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palmidrol</to_name>
		<to_code>M0047861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentadecanoic acid</from_name>
		<from_code>1987138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentadecanoic acid</to_name>
		<to_code>M0300580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polystyrene sulfonic acid</from_name>
		<from_code>1546436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polystyrene sulfonic acid</to_name>
		<to_code>M0044355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PPG-11 stearyl ether</from_name>
		<from_code>1426946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxypropylene 11 stearyl ether</to_name>
		<to_code>M0420442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phytosphingosine</from_name>
		<from_code>1363444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>D-ribo-phytosphingosine</to_name>
		<to_code>M0512232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phytosphingosine</from_name>
		<from_code>1363444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phytosphingosine</to_name>
		<to_code>M0059553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxyethanol</from_name>
		<from_code>89552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenoxyethanol</to_name>
		<to_code>M0046914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetate zinc trisodium</from_name>
		<from_code>408077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pentetate Zinc Trisodium</to_name>
		<to_code>M0006871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>platinum</from_name>
		<from_code>1311280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Platinum</to_name>
		<to_code>M0017026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protein C, human</from_name>
		<from_code>723868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enzyme Precursors</to_name>
		<to_code>M0007521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protein C, human</from_name>
		<from_code>723868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protein C</to_name>
		<to_code>M0017852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyritinol hydrochloride</from_name>
		<from_code>236508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyritinol Hydrochloride</to_name>
		<to_code>M0539884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaptanib</from_name>
		<from_code>498509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pegaptanib</to_name>
		<to_code>M0479289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perfluorooctyl triethoxysilane</from_name>
		<from_code>1312743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyltriethoxysilan</to_name>
		<to_code>M0505918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Prunus armeniaca leaf extract</from_name>
		<from_code>1487507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prunus armeniaca leaf</to_name>
		<to_code>M000744762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide iron complex</from_name>
		<from_code>105669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemosiderosis</to_name>
		<to_code>M0010179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Megaloblastic</to_name>
		<to_code>M0001134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy Complications, Hematologic</to_name>
		<to_code>M0017476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric derisomaltose</from_name>
		<from_code>2274394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine</from_name>
		<from_code>10798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferumoxytol</from_name>
		<from_code>473387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trientine hydrochloride</from_name>
		<from_code>235370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Iron-Deficiency</to_name>
		<to_code>M0028144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric maltol</from_name>
		<from_code>2539932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemochromatosis</to_name>
		<to_code>M0010098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol linoleate, D-</from_name>
		<from_code>1427235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous fumarate</from_name>
		<from_code>24941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide yellow</from_name>
		<from_code>1305582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol acetate</from_name>
		<from_code>1046243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate</from_name>
		<from_code>24947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol acetate</from_name>
		<from_code>39625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat sulfate</from_name>
		<from_code>2595574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E acetate</from_name>
		<from_code>2531274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sucrose</from_name>
		<from_code>24909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric citrate</from_name>
		<from_code>1594675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dl-alpha tocopheryl acetate</from_name>
		<from_code>317841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol calcium succinate, DL-</from_name>
		<from_code>2598017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E d-alpha</from_name>
		<from_code>220892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, D-</from_name>
		<from_code>1426447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E</from_name>
		<from_code>11256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl acid succinate,D-alpha</from_name>
		<from_code>314875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E DL-alpha</from_name>
		<from_code>220893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha tocopherol</from_name>
		<from_code>237099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>d-alpha-tocopheryl acetate</from_name>
		<from_code>1441649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate</from_name>
		<from_code>39626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol,DL-alpha</from_name>
		<from_code>402899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, DL-</from_name>
		<from_code>2370134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol acetate</from_name>
		<from_code>39625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol acetate</from_name>
		<from_code>1046243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron-dextran complex</from_name>
		<from_code>5992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric ammonium citrate</from_name>
		<from_code>24897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ferric gluconate complex</from_name>
		<from_code>261435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous gluconate</from_name>
		<from_code>24942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E acetate</from_name>
		<from_code>2531274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferrous sulfate,dried</from_name>
		<from_code>259346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol linoleate, D-</from_name>
		<from_code>1427235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitapivat</from_name>
		<from_code>2594468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron,peptonized</from_name>
		<from_code>235272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ferric oxide</from_name>
		<from_code>1310572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl acid succinate,D-alpha</from_name>
		<from_code>314875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron</from_name>
		<from_code>90176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E</from_name>
		<from_code>11256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E DL-alpha</from_name>
		<from_code>220893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate</from_name>
		<from_code>39626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol,DL-alpha</from_name>
		<from_code>402899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, DL-</from_name>
		<from_code>2370134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>d-alpha-tocopheryl acetate</from_name>
		<from_code>1441649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dl-alpha tocopheryl acetate</from_name>
		<from_code>317841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin E d-alpha</from_name>
		<from_code>220892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron carbonyl</from_name>
		<from_code>262150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alpha-tocopherol succinate, D-</from_name>
		<from_code>1426447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Hemolytic</to_name>
		<to_code>M0001123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium dichromate</from_name>
		<from_code>8595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Dichromate</to_name>
		<to_code>M0017379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafuramidine</from_name>
		<from_code>718967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pafuramidine</to_name>
		<to_code>M0504256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Phellinus linteus mycelium extract</from_name>
		<from_code>1312717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phellinus linteus mycelium</to_name>
		<to_code>M000745671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peoniflorin</from_name>
		<from_code>2288155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peoniflorin</to_name>
		<to_code>M0064660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pleospora betae allergenic extract</from_name>
		<from_code>852756</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phoma betae</to_name>
		<to_code>M000703024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysorbate 40</from_name>
		<from_code>1367265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polysorbate 40</to_name>
		<to_code>M0187166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polynoxylin</from_name>
		<from_code>34188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polynoxylin</to_name>
		<to_code>M0044167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomegranate fruit rind extract</from_name>
		<from_code>1311658</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pomegranate fruit rind</to_name>
		<to_code>M000742808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polidronium chloride</from_name>
		<from_code>1426891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyquaternium 1</to_name>
		<to_code>M0163489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednimustine</from_name>
		<from_code>8637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prednimustine</to_name>
		<to_code>M0017459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-propanol</from_name>
		<from_code>1362872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-Propanol</to_name>
		<to_code>M0000657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paroxetine Hydrochloride Hemihydrate</to_name>
		<to_code>M000638648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride, hemihydrate</from_name>
		<from_code>1298842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioridazine</to_name>
		<to_code>M0021377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paroxetine Hydrochloride</to_name>
		<to_code>M0329211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride</from_name>
		<from_code>235830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Obsessive-Compulsive Disorder</to_name>
		<to_code>M0015170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine</from_name>
		<from_code>32937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paroxetine</to_name>
		<to_code>M0026386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Feeding and Eating Disorders</to_name>
		<to_code>M000601696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paroxetine Hydrochloride Anhydrous</to_name>
		<to_code>M0582617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine hydrochloride anhydrous</from_name>
		<from_code>1311626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin</from_name>
		<from_code>25480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gabapentin enacarbil</from_name>
		<from_code>1101333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phobic Disorders</to_name>
		<to_code>M0016622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paroxetine mesylate</from_name>
		<from_code>436212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine maleate</from_name>
		<from_code>203143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvoxamine</from_name>
		<from_code>42355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diazepam</from_name>
		<from_code>3322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine mesylate</from_name>
		<from_code>60841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine</from_name>
		<from_code>60842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Panic Disorder</to_name>
		<to_code>M0025297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stress Disorders, Post-Traumatic</to_name>
		<to_code>M0020602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paroxetine</to_name>
		<to_code>M0026386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyroligneous acid</from_name>
		<from_code>1535931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyroligneous acid</to_name>
		<to_code>M000609128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phytol</from_name>
		<from_code>2046119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phytol</to_name>
		<to_code>M0016825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>(phthalocyaninato(2-)) copper</from_name>
		<from_code>1424646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phthalocyanine blue</to_name>
		<to_code>M0064693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrophyllite</from_name>
		<from_code>2636602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>aluminosilicate</to_name>
		<to_code>M0140739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaptanib sodium</from_name>
		<from_code>594119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pegaptanib sodium</to_name>
		<to_code>M000597563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pridinol</from_name>
		<from_code>34479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pridinol</to_name>
		<to_code>M0053665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propyl gallate</from_name>
		<from_code>1311134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propyl Gallate</to_name>
		<to_code>M0017779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenindione</from_name>
		<from_code>8130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenindione</to_name>
		<to_code>M0016509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potato allergenic extract</from_name>
		<from_code>892632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenolate sodium</from_name>
		<from_code>1495317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenolate Sodium</to_name>
		<to_code>M0331242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothipendyl</from_name>
		<from_code>55244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prothipendyl</to_name>
		<to_code>M0189053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piretanide</from_name>
		<from_code>33770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>piretanide</to_name>
		<to_code>M0064705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proglumide</from_name>
		<from_code>8730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proglumide</to_name>
		<to_code>M0017675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)</from_name>
		<from_code>1369405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)</to_name>
		<to_code>M000635711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poloxamer 188</from_name>
		<from_code>155152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poloxamer 188</to_name>
		<to_code>M0030096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potash</from_name>
		<from_code>1370422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potash</to_name>
		<to_code>M0508255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphonic acid</from_name>
		<from_code>1427087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phosphonic acid</to_name>
		<to_code>M0571030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium</from_name>
		<from_code>8588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium</to_name>
		<to_code>M0017374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium</to_name>
		<to_code>M0017374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium</to_name>
		<to_code>M0017374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium</to_name>
		<to_code>M0017374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentaerythritol</from_name>
		<from_code>33055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentaerythritol</to_name>
		<to_code>M0052946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate anhydrous</from_name>
		<from_code>1374802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Citrate Anhydrous</to_name>
		<to_code>M0329194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridinolcarbamate</from_name>
		<from_code>8997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyridinolcarbamate</to_name>
		<to_code>M0018235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirinitramide</from_name>
		<from_code>8354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pirinitramide</to_name>
		<to_code>M0016897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol alginate</from_name>
		<from_code>1361656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propylene glycol alginate ester</to_name>
		<to_code>M0115966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantethine</from_name>
		<from_code>32863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pantethine</to_name>
		<to_code>M0046963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promestriene</from_name>
		<from_code>34625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>promestriene</to_name>
		<to_code>M0061599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glaucum allergenic extract</from_name>
		<from_code>1986792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Plasmodium malariae</from_name>
		<from_code>1432989</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plasmodium malariae</to_name>
		<to_code>M0017000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polytetrafluoroethylene</from_name>
		<from_code>1358182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polytetrafluoroethylene</to_name>
		<to_code>M0017264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prolinal</from_name>
		<from_code>2569079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prolinal</to_name>
		<to_code>M0133536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paprika allergenic extract</from_name>
		<from_code>899873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protriptyline hydrochloride</from_name>
		<from_code>203199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protriptyline Hydrochloride</to_name>
		<to_code>M0329791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protriptyline Hydrochloride</to_name>
		<to_code>M0329791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protriptyline Hydrochloride</to_name>
		<to_code>M0329791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene oxide</from_name>
		<from_code>1368175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propylene oxide</to_name>
		<to_code>M0053451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanol</from_name>
		<from_code>2475178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-phenylpropanol</to_name>
		<to_code>M0405079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pafolacianine</from_name>
		<from_code>2586857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pafolacianine</to_name>
		<to_code>M000753612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prajmalium bitartrate</from_name>
		<from_code>236896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prajmalium Bitartrate</to_name>
		<to_code>M0017434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Prunus armeniaca seed extract</from_name>
		<from_code>1309458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prunus armeniaca seed</to_name>
		<to_code>M000743799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proxigermanium</from_name>
		<from_code>158660</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propagermanium</to_name>
		<to_code>M0183145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-menthane-3,8-diol</from_name>
		<from_code>2385886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>p-menthane-3,8-diol</to_name>
		<to_code>M0047569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pargyline</from_name>
		<from_code>7930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pargyline</to_name>
		<to_code>M0015951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pargyline</to_name>
		<to_code>M0015951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pargyline</to_name>
		<to_code>M0015951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Palonosetron</to_name>
		<to_code>M0221985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palonosetron</from_name>
		<from_code>70561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one</to_name>
		<to_code>M000642093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrodifenium bromide</from_name>
		<from_code>9021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrodifenium bromide</to_name>
		<to_code>M0224839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium metabisulfite</from_name>
		<from_code>1362899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium metabisulfite</to_name>
		<to_code>M0046572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium tellurite</from_name>
		<from_code>1921888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium tellurate(IV)</to_name>
		<to_code>M0087907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenformin</from_name>
		<from_code>8129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenformin</to_name>
		<to_code>M0016508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permanganate</from_name>
		<from_code>1923815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>permanganate</to_name>
		<to_code>M0140338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium triiodide</from_name>
		<from_code>1376155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lugol's solution</to_name>
		<to_code>M0055829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrophosphoric acid</from_name>
		<from_code>1546425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>diphosphoric acid</to_name>
		<to_code>M0279078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-pyrrolidone</from_name>
		<from_code>1358473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrrolidinones</to_name>
		<to_code>M0018278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-pyrrolidone</from_name>
		<from_code>1358473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-pyrrolidone</to_name>
		<to_code>M0091749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginesatide</from_name>
		<from_code>1248798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peginesatide</to_name>
		<to_code>M0555240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pummelo extract</from_name>
		<from_code>1363624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pummelo extract</to_name>
		<to_code>M000766820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>posterior pituitary hormones</from_name>
		<from_code>8366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pituitary Hormones, Posterior</to_name>
		<to_code>M0016919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>procaterol hydrochloride</from_name>
		<from_code>58918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Procaterol Hydrochloride</to_name>
		<to_code>M0026207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiolactone</from_name>
		<from_code>1311565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propiolactone</to_name>
		<to_code>M0017758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Proteus inconstans</from_name>
		<from_code>1310846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proteus inconstans</to_name>
		<to_code>M000663856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-phenylethanol</from_name>
		<from_code>2001176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylphenyl carbinol</to_name>
		<to_code>M0042474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphocysteamine</from_name>
		<from_code>8226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phosphocysteamine</to_name>
		<to_code>M0005531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium cetyl phosphate</from_name>
		<from_code>1367140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium cetyl phosphate</to_name>
		<to_code>M0525809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat F-18</from_name>
		<from_code>2556616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>(18F)DCFPyL</to_name>
		<to_code>M0574278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat F-18</from_name>
		<from_code>2556616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid</to_name>
		<to_code>M0574277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piflufolastat F-18</from_name>
		<from_code>2556616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>18F-JK-PSMA-7</to_name>
		<to_code>M000732947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pomegranate fruit extract</from_name>
		<from_code>1246101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pomegranate</to_name>
		<to_code>M0400768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pullulan</from_name>
		<from_code>1425878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pullulan</to_name>
		<to_code>M0053517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pelargonic acid</from_name>
		<from_code>2054104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pelargonic acid</to_name>
		<to_code>M0052930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pisum sativum (pea) extract</from_name>
		<from_code>1426912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ponazuril</from_name>
		<from_code>298983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ponazuril</to_name>
		<to_code>M0371914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyglycolic acid</from_name>
		<from_code>2466981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyglycolic Acid</to_name>
		<to_code>M0017195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pristinamycin</from_name>
		<from_code>66958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pristinamycin</to_name>
		<to_code>M0375364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pristinamycin</from_name>
		<from_code>66958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pristinamycin</from_name>
		<from_code>66958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polihexanide hydrochloride</from_name>
		<from_code>1790898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polihexanide hydrochloride</to_name>
		<to_code>M0098302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poly(sodium vinyl sulfonate)</from_name>
		<from_code>52259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lyapolate sodium</to_name>
		<to_code>M0053254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poly(sodium vinyl sulfonate)</from_name>
		<from_code>52259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poly(sodium vinyl sulfonate)</to_name>
		<to_code>M0588895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylacetate</from_name>
		<from_code>70619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylacetate</to_name>
		<to_code>M0084149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poly(vinylpyrrolidone-co-vinyl-acetate)</from_name>
		<from_code>1311488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poly(vinylpyrrolidone-co-vinyl-acetate)</to_name>
		<to_code>M0354712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine hydrochloride</from_name>
		<from_code>236471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>activated charcoal</from_name>
		<from_code>272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime iodide</from_name>
		<from_code>55052</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bicarbonate</from_name>
		<from_code>36676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime mesylate</from_name>
		<from_code>55053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamines</from_name>
		<from_code>8826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime chloride</from_name>
		<from_code>55322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ovine digoxin immune fab</from_name>
		<from_code>1745257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumazenil</from_name>
		<from_code>4457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime</from_name>
		<from_code>34345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>charcoal</from_name>
		<from_code>2296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin antibodies Fab fragments</from_name>
		<from_code>203223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene hydrochloride</from_name>
		<from_code>236069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uridine</from_name>
		<from_code>11017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalmefene</from_name>
		<from_code>31479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racemethionine</from_name>
		<from_code>9100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin antibodies Fab fragments</from_name>
		<from_code>203223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pralidoxime cation</from_name>
		<from_code>1546365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uridine 5-mo-phos disod</from_name>
		<from_code>236785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uridine triacetate</from_name>
		<from_code>1665222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uridine triphosphate sodium</from_name>
		<from_code>236509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug Overdose</to_name>
		<to_code>M0568790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamines</from_name>
		<from_code>8826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protamines</to_name>
		<to_code>M0017844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protamine Sulfate</to_name>
		<to_code>M0017843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamine sulfate (USP)</from_name>
		<from_code>8825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous dextrose</from_name>
		<from_code>349730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alvimopan anhydrous</from_name>
		<from_code>1516803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose monohydrate</from_name>
		<from_code>1299920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose</from_name>
		<from_code>4850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose hydrous</from_name>
		<from_code>1297771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-D-glucopyranose</from_name>
		<from_code>1442190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxymethylcellulose calcium</from_name>
		<from_code>1307734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin</from_name>
		<from_code>280611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin sodium</from_name>
		<from_code>436195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin</from_name>
		<from_code>5224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid</from_name>
		<from_code>78484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin</from_name>
		<from_code>7773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium</from_name>
		<from_code>9893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin calcium</from_name>
		<from_code>20044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danaparoid sodium</from_name>
		<from_code>103843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium</from_name>
		<from_code>9877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, bovine</from_name>
		<from_code>236025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, porcine</from_name>
		<from_code>235473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin sodium</from_name>
		<from_code>436195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin, bovine</from_name>
		<from_code>1856273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bemiparin</from_name>
		<from_code>280611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxacillin sodium</from_name>
		<from_code>9898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alvimopan</from_name>
		<from_code>480639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin sodium monohydrate</from_name>
		<from_code>485026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desirudin</from_name>
		<from_code>114934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nafcillin</from_name>
		<from_code>7233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparin sodium, porcine</from_name>
		<from_code>314659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postoperative Complications</to_name>
		<to_code>M0017367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pantolactone</from_name>
		<from_code>1427237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pantolactone</to_name>
		<to_code>M0046939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvalent Crotalidae antivenin</from_name>
		<from_code>91596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amylase / lipase / protease</from_name>
		<from_code>392491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose hydrous</from_name>
		<from_code>1297771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesterol</from_name>
		<from_code>2438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine</from_name>
		<from_code>8156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose</from_name>
		<from_code>4850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous dextrose</from_name>
		<from_code>349730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose monohydrate</from_name>
		<from_code>1299920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Yellow Fever Vaccine</from_name>
		<from_code>89890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine,DL-</from_name>
		<from_code>236948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oil (containing omega-3 acids)</from_name>
		<from_code>2053495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-D-glucopyranose</from_name>
		<from_code>1442190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quercetin</from_name>
		<from_code>9060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Food Hypersensitivity</to_name>
		<to_code>M0008686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium laurate</from_name>
		<from_code>1808535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lauric acid, potassium salt</to_name>
		<to_code>M0318825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetic acid</from_name>
		<from_code>3690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetic acid</from_name>
		<from_code>3690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pentetic Acid</to_name>
		<to_code>M0006866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linolenic acid</from_name>
		<from_code>52071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin</from_name>
		<from_code>1044584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tesamorelin acetate</from_name>
		<from_code>1044583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromic phosphate P32</from_name>
		<from_code>121070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Neoplasms</to_name>
		<to_code>M0014585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipazetate hydrochloride</from_name>
		<from_code>236487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipazethate monohydrochloride</to_name>
		<to_code>M0313053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Pueraria montana var. lobata root extract</from_name>
		<from_code>1309751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Puerariae radix</to_name>
		<to_code>M000745675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prajmaline</from_name>
		<from_code>8622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prajmaline</to_name>
		<to_code>M0017433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picrotoxin</from_name>
		<from_code>2539172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Picrotoxin</to_name>
		<to_code>M0016843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegbovigrastim</from_name>
		<from_code>1746487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pegbovigrastim</to_name>
		<to_code>M000655006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pectin</from_name>
		<from_code>32987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methoxypectin</to_name>
		<to_code>M000640253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyglyceryl-6 isostearate</from_name>
		<from_code>2118918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyglyceryl-6 isostearate</to_name>
		<to_code>M0525805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylacetaldehyde</from_name>
		<from_code>1367159</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylacetaldehyde</to_name>
		<to_code>M0060768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propyliodone</from_name>
		<from_code>8793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propyliodone</to_name>
		<to_code>M0017783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphatidylinositols</from_name>
		<from_code>8217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phosphatidylinositols</to_name>
		<to_code>M0016648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Podophyllin</to_name>
		<to_code>M0017086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nevus</to_name>
		<to_code>M0014786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papilloma</to_name>
		<to_code>M0015836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Oral Manifestations</to_name>
		<to_code>M0015371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Condylomata Acuminata</to_name>
		<to_code>M0004994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podophyllin</from_name>
		<from_code>8462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethral Diseases</to_name>
		<to_code>M0022332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cantharidin</from_name>
		<from_code>1984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>podofilox</from_name>
		<from_code>8463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formalin</from_name>
		<from_code>314636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrogen</from_name>
		<from_code>7456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formaldehyde</from_name>
		<from_code>4530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Warts</to_name>
		<to_code>M0022875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imiquimod</from_name>
		<from_code>59943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Condylomata Acuminata</to_name>
		<to_code>M0004994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Condylomata Acuminata</to_name>
		<to_code>M0004994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Condylomata Acuminata</to_name>
		<to_code>M0004994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-n3</from_name>
		<from_code>612937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Condylomata Acuminata</to_name>
		<to_code>M0004994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Condylomata Acuminata</to_name>
		<to_code>M0004994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone acetate</from_name>
		<from_code>2055977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium picolinate</from_name>
		<from_code>59308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium citrate</from_name>
		<from_code>52356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetes Mellitus</to_name>
		<to_code>M0006148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethral Diseases</to_name>
		<to_code>M0022332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethral Diseases</to_name>
		<to_code>M0022332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethral Diseases</to_name>
		<to_code>M0022332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethral Diseases</to_name>
		<to_code>M0022332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethral Diseases</to_name>
		<to_code>M0022332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prenylamine</from_name>
		<from_code>8674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prenylamine</to_name>
		<to_code>M0017547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proglumetacin</from_name>
		<from_code>34769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>proglumetacin</to_name>
		<to_code>M0072058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyvinyl alcohol</from_name>
		<from_code>8570</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polyvinyl Alcohol</to_name>
		<to_code>M0017272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyruvate</from_name>
		<from_code>72031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyruvate</to_name>
		<to_code>M0028720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium oxide</from_name>
		<from_code>1599267</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium oxide</to_name>
		<to_code>M0187193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pidotimod</from_name>
		<from_code>40450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pidotimod</to_name>
		<to_code>M0178639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrophosphate</from_name>
		<from_code>1364533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrophosphate</to_name>
		<to_code>M0569649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimagedine hydrochloride</from_name>
		<from_code>1311669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pimagedine hydrochloride</to_name>
		<to_code>M0308589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutyrate</from_name>
		<from_code>81647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-phenylbutyrate</to_name>
		<to_code>M0204039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacetin</from_name>
		<from_code>8113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenacetin</to_name>
		<to_code>M0016487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacetin</from_name>
		<from_code>8113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenacetin</from_name>
		<from_code>8113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sevoflurane</from_name>
		<from_code>36453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine</from_name>
		<from_code>4126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine anhydrous</from_name>
		<from_code>1545987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Acute</to_name>
		<to_code>M0012015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate</from_name>
		<from_code>52364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime pentahydrate</from_name>
		<from_code>235552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>feverfew extract</from_name>
		<from_code>114203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetaminophen</from_name>
		<from_code>161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime hydrochloride</from_name>
		<from_code>236058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mumps Vaccine</from_name>
		<from_code>763656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylamide</from_name>
		<from_code>9518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime sodium</from_name>
		<from_code>221071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenyl salicylate</from_name>
		<from_code>36122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime</from_name>
		<from_code>2191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftazidime anhydrous</from_name>
		<from_code>1545984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefepime</from_name>
		<from_code>20481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fever</to_name>
		<to_code>M0008421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peracetic acid</from_name>
		<from_code>2045732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peracetic Acid</to_name>
		<to_code>M0016248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pinaverium</from_name>
		<from_code>33724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pinaverium</to_name>
		<to_code>M0060791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>porfimer sodium</from_name>
		<from_code>333848</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porfimer Sodium</to_name>
		<to_code>M0372990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentosan polysulfate</from_name>
		<from_code>155046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pentosan Polysulfate</to_name>
		<to_code>M0016193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paramethadione</from_name>
		<from_code>32894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paramethadione</to_name>
		<to_code>M0047469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proximadiol</from_name>
		<from_code>2562551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>proximadiol</to_name>
		<to_code>M0057129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrithione</from_name>
		<from_code>35100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrithione</to_name>
		<to_code>M0052791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysorbates</from_name>
		<from_code>8561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polysorbates</to_name>
		<to_code>M0017253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium nitrate</from_name>
		<from_code>34316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium nitrate</to_name>
		<to_code>M0081527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflunafene</from_name>
		<from_code>2462501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perfluorodecalin</to_name>
		<to_code>M0052977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrisuccideanol</from_name>
		<from_code>35097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrisuccideanol</to_name>
		<to_code>M0054534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodate</from_name>
		<from_code>34312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium iodate</to_name>
		<to_code>M0118670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Propionibacterium avidum</from_name>
		<from_code>1310909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cutibacterium avidum</to_name>
		<to_code>M000674983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphorus 32</from_name>
		<from_code>258478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phosphorus-32</to_name>
		<to_code>M000627837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,3-propanediol</from_name>
		<from_code>1363030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,3-propanediol</to_name>
		<to_code>M0123739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perhexiline maleate</from_name>
		<from_code>33169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perhexiline maleate</to_name>
		<to_code>M0080750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednazoline</from_name>
		<from_code>168651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prednazoline</to_name>
		<to_code>M0124680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paraffin</from_name>
		<from_code>7906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Paraffin</to_name>
		<to_code>M0015864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Podophyllum hexandrum whole extract</from_name>
		<from_code>2636601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sinopodophyllum hexandrum whole</to_name>
		<to_code>M000745788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentigide</from_name>
		<from_code>1362920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentigide</to_name>
		<to_code>M0120080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-phenylphenol</from_name>
		<from_code>236677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-phenylphenol</to_name>
		<to_code>M0045414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poloxamer 407</from_name>
		<from_code>155155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poloxamer 407</to_name>
		<to_code>M0030099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene carbonate</from_name>
		<from_code>1363696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propylene carbonate</to_name>
		<to_code>M0133458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiverine hydrochloride</from_name>
		<from_code>55176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propiverine hydrochloride</to_name>
		<to_code>M0312891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsnip allergenic extract</from_name>
		<from_code>1011027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednylidene</from_name>
		<from_code>12473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prednylidene</to_name>
		<to_code>M0110615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propyphenazone</from_name>
		<from_code>34710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propyphenazone</to_name>
		<to_code>M0053469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrvinium pamoate</from_name>
		<from_code>55347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrvinium pamoate</to_name>
		<to_code>M0083055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peroxidase</from_name>
		<from_code>1600930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peroxidase</to_name>
		<to_code>M0014331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parasorbic acid</from_name>
		<from_code>1998743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>parasorbic acid</to_name>
		<to_code>M0046930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentetreotide</from_name>
		<from_code>69893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pentetreotide</to_name>
		<to_code>M0218093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenolphthalein</from_name>
		<from_code>155122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenolphthalein</to_name>
		<to_code>M0029852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol glycol</from_name>
		<from_code>2105554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propranolol glycol</to_name>
		<to_code>M0060827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium guaiacolsulfonate</from_name>
		<from_code>91275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cough</to_name>
		<to_code>M0005255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium guaiacolsulfonate</from_name>
		<from_code>91275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guaiacolsulfonate potassium</to_name>
		<to_code>M0061683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylisothiocyanate</from_name>
		<from_code>1368174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylisothiocyanate</to_name>
		<to_code>M0046991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphorus</from_name>
		<from_code>8263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phosphorus</to_name>
		<to_code>M0016721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polihexanide</from_name>
		<from_code>1373041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polihexanide</to_name>
		<to_code>M0098301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Prevotella intermedia</from_name>
		<from_code>2591816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Prevotella intermedia</to_name>
		<to_code>M0028039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol dinitrate</from_name>
		<from_code>2370146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propylene glycol dinitrate</to_name>
		<to_code>M0097795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyroglutamate</from_name>
		<from_code>155060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyroglutamate</to_name>
		<to_code>M0018281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysaccharide-K</from_name>
		<from_code>1804843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polysaccharide-K</to_name>
		<to_code>M0056531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>p-anisaldehyde</from_name>
		<from_code>1940008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-anisaldehyde</to_name>
		<to_code>M0083631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poly(lactide)</from_name>
		<from_code>1424562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poly(lactide)</to_name>
		<to_code>M0104212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phlorhizin</from_name>
		<from_code>1362735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phlorhizin</to_name>
		<to_code>M0016615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prolintane</from_name>
		<from_code>34604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prolintane</to_name>
		<to_code>M0047249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proxibarbal</from_name>
		<from_code>83885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>proxibarbal</to_name>
		<to_code>M0224594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrogallol</from_name>
		<from_code>9022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pyrogallol</to_name>
		<to_code>M0018267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proflavine hemisulfate</from_name>
		<from_code>8724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proflavine Hemisulfate</to_name>
		<to_code>M0017667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 4000</from_name>
		<from_code>1310594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyethylene glycol 4000</to_name>
		<to_code>M0017181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prothipendyl hydrochloride</from_name>
		<from_code>236710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>prothipendyl hydrochloride</to_name>
		<to_code>M0325280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>passiflora incarnata flowering top extract</from_name>
		<from_code>1309979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Passiflora incarnata</to_name>
		<to_code>M000609497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 8000</from_name>
		<from_code>1307312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyethylene glycol 8000</to_name>
		<to_code>M0017177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peppermint preparation</from_name>
		<from_code>33093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plant stanol ester</from_name>
		<from_code>259320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>plant stanol ester</to_name>
		<to_code>M0361357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pargyline hydrochloride</from_name>
		<from_code>82069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pargyline Hydrochloride</to_name>
		<to_code>M0015952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phloretin</from_name>
		<from_code>1368167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phloretin</to_name>
		<to_code>M0016612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium azeloyl diglycinate</from_name>
		<from_code>1366229</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium azeloyl diglycinate</to_name>
		<to_code>M000630748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polybutester</from_name>
		<from_code>2049679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polybutester</to_name>
		<to_code>M0140324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyaminopropyl biguanide</from_name>
		<from_code>1314381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyaminopropylbiguanide</to_name>
		<to_code>M0177450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chromate(VI)</from_name>
		<from_code>34303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium chromate(VI)</to_name>
		<to_code>M0089032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Famciclovir</to_name>
		<to_code>M0168276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penciclovir</from_name>
		<from_code>59839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>penciclovir</to_name>
		<to_code>M0151646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famciclovir</from_name>
		<from_code>68099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Famciclovir</to_name>
		<to_code>M0168276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>panthenyl ethyl ether</from_name>
		<from_code>1356484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>panthenyl ethyl ether</to_name>
		<to_code>M0121642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propylene glycol methyl ether</from_name>
		<from_code>1367160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propylene glycol methyl ether</to_name>
		<to_code>M0046597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phthalylsulfathiazole</from_name>
		<from_code>33632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phthalylsulfathiazole</to_name>
		<to_code>M0263391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propanidid</from_name>
		<from_code>8758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propanidid</to_name>
		<to_code>M0017743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyethylene glycol 1000</from_name>
		<from_code>1368863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyethylene glycol 1000</to_name>
		<to_code>M0017175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paclitaxel poliglumex</from_name>
		<from_code>2473230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>paclitaxel poliglumex</to_name>
		<to_code>M0496577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyglyceryl-6-dioleate</from_name>
		<from_code>1431309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyglyceryl-6-dioleate</to_name>
		<to_code>M0458992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phospholipase D1</from_name>
		<from_code>2608530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phospholipase D1</to_name>
		<to_code>M0278152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prussian blue insoluble</from_name>
		<from_code>24902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ferric ferrocyanide</to_name>
		<to_code>M0040190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propionaldehyde</from_name>
		<from_code>2359273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propionaldehyde</to_name>
		<to_code>M0047182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-phenyl-1-propanol</from_name>
		<from_code>2479688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-phenyl-1-propanol</to_name>
		<to_code>M0544318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picolinic acid</from_name>
		<from_code>33684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>picolinic acid</to_name>
		<to_code>M0096711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>proline</from_name>
		<from_code>8737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proline</to_name>
		<to_code>M0017693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PEG-30-dipolyhydroxystearate</from_name>
		<from_code>1363570</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>PEG-30-dipolyhydroxystearate</to_name>
		<to_code>M000608961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protocatechualdehyde</from_name>
		<from_code>1362689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>protocatechualdehyde</to_name>
		<to_code>M0047224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium carbonate</from_name>
		<from_code>34300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium carbonate</to_name>
		<to_code>M0113634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>palm kernel oil</from_name>
		<from_code>1309252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palm kernel oil</to_name>
		<to_code>M000624739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phosphoramidic acid</from_name>
		<from_code>1312381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phosphoramidic acid</to_name>
		<to_code>M0057093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propane</from_name>
		<from_code>1362877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Propane</to_name>
		<to_code>M0017740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plutonium</from_name>
		<from_code>1600135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plutonium</to_name>
		<to_code>M0017052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pongamol</from_name>
		<from_code>1426400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pongamol</to_name>
		<to_code>M0527361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrvinium</from_name>
		<from_code>35163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrvinium</to_name>
		<to_code>M0083058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polyquaternium-7 (70-30 acrylamide-DADMAC; 1600 kD)</from_name>
		<from_code>1426394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyquaternium-7</to_name>
		<to_code>M0417750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propinox</from_name>
		<from_code>76273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>propinox</to_name>
		<to_code>M0231218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-phenylazo-2-naphthylamine</from_name>
		<from_code>1430252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-phenylazo-2-naphthylamine</to_name>
		<to_code>M0128134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penconazole</from_name>
		<from_code>2593184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>penconazole</to_name>
		<to_code>M0230655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))</from_name>
		<from_code>1440971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-palmitoyl-2-oleoyl--sn-glycero-3-(phospho-rac-(1-glycerol))</to_name>
		<to_code>M0393687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrrolidine</from_name>
		<from_code>2585446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pyrrolidine</to_name>
		<to_code>M0101472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipenzolate</from_name>
		<from_code>33743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pipenzolate</to_name>
		<to_code>M0045434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phytase</from_name>
		<from_code>1043631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>6-Phytase</to_name>
		<to_code>M0016817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium sodium tartrate</from_name>
		<from_code>1311363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium potassium tartrate</to_name>
		<to_code>M0524134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysulfated glycosaminoglycan</from_name>
		<from_code>1085955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycosaminoglycan polysulfate</to_name>
		<to_code>M0061843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentastarch</from_name>
		<from_code>816249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pentastarch</to_name>
		<to_code>M0514687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>picrate</from_name>
		<from_code>1443000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>picrate</to_name>
		<to_code>M0047674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perflenapent</from_name>
		<from_code>2474632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perfluoropentane</to_name>
		<to_code>M0052979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenothrin</from_name>
		<from_code>33303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenothrin</to_name>
		<to_code>M0048373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polysorbate 20</from_name>
		<from_code>8559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Polysorbate 20</to_name>
		<to_code>M0017251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poldine</from_name>
		<from_code>33926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poldine</to_name>
		<to_code>M0263377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium benzoate</from_name>
		<from_code>54991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Potassium Benzoate</to_name>
		<to_code>M0002351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium ascorbyl tocopheryl phosphate</from_name>
		<from_code>1427199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium ascorbyl tocopheryl phosphate</to_name>
		<to_code>M0182814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoperidine</from_name>
		<from_code>8143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenoperidine</to_name>
		<to_code>M0016522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylhydrazine hydrochloride</from_name>
		<from_code>292726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylhydrazine hydrochloride</to_name>
		<to_code>M0318821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>protamone</from_name>
		<from_code>453012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protamone</to_name>
		<to_code>M0461937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>poloxamer</from_name>
		<from_code>155156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Poloxamer</to_name>
		<to_code>M0030100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirarubicin</from_name>
		<from_code>33764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pirarubicin</to_name>
		<to_code>M0088759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaveretum</from_name>
		<from_code>7894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papaveretum</to_name>
		<to_code>M0015346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perfluoromethylcyclopentane</from_name>
		<from_code>2048724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>perfluoromethylcyclopentane</to_name>
		<to_code>M0297611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pennyroyal oil</from_name>
		<from_code>1309213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pennyroyal oil</to_name>
		<to_code>M0077863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenolsulfonphthalein</from_name>
		<from_code>8141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phenolsulfonphthalein</to_name>
		<to_code>M0016521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillium glabrum</from_name>
		<from_code>1328760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Penicillium glabrum</to_name>
		<to_code>M000708314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piracetam</from_name>
		<from_code>8351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Piracetam</to_name>
		<to_code>M0016891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promegestone</from_name>
		<from_code>8744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Promegestone</to_name>
		<to_code>M0017703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prezatide</from_name>
		<from_code>1368533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycyl-histidyl-lysine</to_name>
		<to_code>M0075195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-phenylbutyric acid</from_name>
		<from_code>1546447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-phenylbutyric acid</to_name>
		<to_code>M0204041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>para-cresol</from_name>
		<from_code>2467144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-cresol</to_name>
		<to_code>M0101528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papain</from_name>
		<from_code>7892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Papain</to_name>
		<to_code>M0015826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pregna-4,17-diene-3,16-dione</from_name>
		<from_code>1088591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pregna-4,17-diene-3,16-dione</to_name>
		<to_code>M0081057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bromate</from_name>
		<from_code>34298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>potassium bromate</to_name>
		<to_code>M0072049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl palmitate</to_name>
		<to_code>1939383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen</to_name>
		<to_code>2605723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoflurophate</to_name>
		<to_code>6027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indeloxazine hydrochloride</to_name>
		<to_code>1311672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen</to_name>
		<to_code>2561244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indanazoline hydrochloride</to_name>
		<to_code>292036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearamidopropyl morpholine lactate</to_name>
		<to_code>1426452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</to_name>
		<to_code>2380834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine-125</to_name>
		<to_code>253341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iobitridol</to_name>
		<to_code>87639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Imperata cylindrica root extract</to_name>
		<to_code>1309433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>invert sugar</to_name>
		<to_code>27712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, protamine zinc, beef-pork</to_name>
		<to_code>314685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A-California-7-2009-(H1N1)v-like virus vaccine</to_name>
		<to_code>864701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Iowa/06/2017 antigen</to_name>
		<to_code>2056523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</to_name>
		<to_code>1928290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indomethacin</to_name>
		<to_code>5781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoaminile</to_name>
		<to_code>27866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron fumarate</to_name>
		<to_code>486120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>icatibant</to_name>
		<to_code>1148138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isotridecyl alcohol</to_name>
		<to_code>2587641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated B-Florida-4-2006 strain</to_name>
		<to_code>805553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inert ingredients</to_name>
		<to_code>748794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isodecyl salicylate</to_name>
		<to_code>1872041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iohexol</to_name>
		<to_code>5956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopromide</to_name>
		<to_code>27781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea mauritiana tuber extract</to_name>
		<to_code>1312614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus</to_name>
		<to_code>1312375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, prompt zinc, human</to_name>
		<to_code>235285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosorbide dicaprylate</to_name>
		<to_code>2002720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens balsamina flowering top extract</to_name>
		<to_code>2594595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl ethylhexanoate</to_name>
		<to_code>1368159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoxaflutole</to_name>
		<to_code>1371313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/California/7/2009 (H1N1) antigen</to_name>
		<to_code>1657331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isometheptene</to_name>
		<to_code>27946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus, B Panama-45-90 hemmagglutinin antigen, inactivated</to_name>
		<to_code>1313274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium bromide anhydrous</to_name>
		<to_code>1445143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indole</to_name>
		<to_code>1311224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoniacinamide</to_name>
		<to_code>1312616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Panama/45/90 antigen</to_name>
		<to_code>2262062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isotridecyl isononanoate</to_name>
		<to_code>1307088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain</to_name>
		<to_code>1005909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irinotecan liposomal</to_name>
		<to_code>1719768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium</to_name>
		<to_code>7213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, pork</to_name>
		<to_code>1309342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris versicolor whole extract</to_name>
		<to_code>1875234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium</to_name>
		<to_code>1362699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Singapore/WUH4618/2021 antigen</to_name>
		<to_code>2605725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea batatas whole extract</to_name>
		<to_code>2472777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl isostearate</to_name>
		<to_code>1363996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosorbide</to_name>
		<to_code>6057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea purpurea top extract</to_name>
		<to_code>1311612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulin G, human</to_name>
		<to_code>1426680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoamyl cinnamate</to_name>
		<to_code>2046779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris versicolor root extract</to_name>
		<to_code>1333213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indigo</to_name>
		<to_code>1426889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex aquifolium whole extract</to_name>
		<to_code>2003324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007, NYMC X-175C (H3N2) strain</to_name>
		<to_code>857919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iomeprol</to_name>
		<to_code>2606484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007 (H1N1) strain</to_name>
		<to_code>805549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl isobutyrate</to_name>
		<to_code>1664340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab-qbtx</to_name>
		<to_code>2103476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Isatis tinctoria whole extract</to_name>
		<to_code>2282323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivermectin</to_name>
		<to_code>6069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inosine</to_name>
		<to_code>1483575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, regular, beef-pork</to_name>
		<to_code>235275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inga alba bark extract</to_name>
		<to_code>2480117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</to_name>
		<to_code>1794331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>icatibant acetate</to_name>
		<to_code>1294605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Illicium anisatum whole extract</to_name>
		<to_code>1918046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine I-131</to_name>
		<to_code>1546394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Issatchenkia orientalis whole extract</to_name>
		<to_code>1804171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Brisbane/46/2015 antigen</to_name>
		<to_code>1942125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irinotecan hydrochloride</to_name>
		<to_code>153329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isododecane</to_name>
		<to_code>1362913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inebilizumab-cdon</to_name>
		<to_code>2373950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immature Citrus aurantium fruit extract</to_name>
		<to_code>1372635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</to_name>
		<to_code>2056521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 oxyquinoline</to_name>
		<to_code>1314372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoceteth-25</to_name>
		<to_code>1735325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen</to_name>
		<to_code>2630221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomyrtol</to_name>
		<to_code>236265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl stearate</to_name>
		<to_code>2118123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin subcutaneous (human) - klhw</to_name>
		<to_code>2196290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iobenguane I-123</to_name>
		<to_code>1426748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isolan</to_name>
		<to_code>1807442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea nil seed extract</to_name>
		<to_code>1307600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron carbonyl</to_name>
		<to_code>262150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indigotindisulfonate</to_name>
		<to_code>325514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Hong Kong/259/2010 antigen</to_name>
		<to_code>1801603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>incobotulinumtoxinA</to_name>
		<to_code>1000104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Indigofera tinctoria leaf extract</to_name>
		<to_code>1607314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ifenprodil</to_name>
		<to_code>27403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iotrolan</to_name>
		<to_code>51474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inclisiran</to_name>
		<to_code>2588243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamic acid I-125</to_name>
		<to_code>1546452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen</to_name>
		<to_code>2605724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutane</to_name>
		<to_code>1363040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomalt</to_name>
		<to_code>1363717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron,peptonized</to_name>
		<to_code>235272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodoquinol</to_name>
		<to_code>3435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin human, rDNA origin</to_name>
		<to_code>631657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-8</to_name>
		<to_code>1426866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inositol niacinate</to_name>
		<to_code>27604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen</to_name>
		<to_code>2607735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-2a</to_name>
		<to_code>5879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Isodon rubescens whole extract</to_name>
		<to_code>1600738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-1, beta</to_name>
		<to_code>2176735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iophendylate</to_name>
		<to_code>5968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibutilide</to_name>
		<to_code>41289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inositol</to_name>
		<to_code>5833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex aquifolium fruiting top extract</to_name>
		<to_code>1486502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopulegol</to_name>
		<to_code>1314235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl myristate</to_name>
		<to_code>1809635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</to_name>
		<to_code>2180338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab-axxq</to_name>
		<to_code>2266523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</to_name>
		<to_code>2380574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipodate</to_name>
		<to_code>5976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inula helenium root extract</to_name>
		<to_code>1309723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibrexafungerp</to_name>
		<to_code>2560213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immature Juglans regia fruit rind extract</to_name>
		<to_code>1311047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomerized safflower acid</to_name>
		<to_code>1596768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Imperatoria ostruthia root extract</to_name>
		<to_code>1544247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Brisbane/60/2008 antigen</to_name>
		<to_code>1657226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin lispro</to_name>
		<to_code>86009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen</to_name>
		<to_code>2564395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inclisiran sodium</to_name>
		<to_code>2588259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ictasol</to_name>
		<to_code>236850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indacaterol maleate</to_name>
		<to_code>1114325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus antigen, Panama 2007-99 (H3N2)</to_name>
		<to_code>1366997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixazomib citrate</to_name>
		<to_code>1723734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamate</to_name>
		<to_code>5970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin-like growth factor 2, human</to_name>
		<to_code>1728769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated, A-H3N2 (A-Uruguay-716-2007) strain</to_name>
		<to_code>805469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron succinyl milk protein complex</to_name>
		<to_code>27825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-2b</to_name>
		<to_code>5880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idrocilamide</to_name>
		<to_code>19729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon beta-1b</to_name>
		<to_code>72257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-6, human</to_name>
		<to_code>1427163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipecac</to_name>
		<to_code>5975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipodate sodium</to_name>
		<to_code>9887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixekizumab</to_name>
		<to_code>1745099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearate</to_name>
		<to_code>1424880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isothiazolinone</to_name>
		<to_code>1811252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iproniazid</to_name>
		<to_code>5981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-Brisbane-10-2007 (H3N2)-like virus (A-Uruguay-716-2007 NYMC X-175C) strain</to_name>
		<to_code>805520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imiquimod</to_name>
		<to_code>59943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosorbide mononitrate</to_name>
		<to_code>28004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>intramuscular immunoglobulin</to_name>
		<to_code>108067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-12, human</to_name>
		<to_code>1318050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Indonesia/05/2005 (H5N1) antigen</to_name>
		<to_code>1869634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iocetamic acid</to_name>
		<to_code>183830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ilomastat</to_name>
		<to_code>1368877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-iodo-2-propynol</to_name>
		<to_code>2465830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl laurate</to_name>
		<to_code>1363434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin aspart-szjj</to_name>
		<to_code>2705729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isometheptene mucate (1:1)</to_name>
		<to_code>317238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isodecyl alcohol</to_name>
		<to_code>2361827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/California/122/2022 (H3N2) antigen</to_name>
		<to_code>2675569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium</to_name>
		<to_code>1549118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ichthammol</to_name>
		<to_code>5645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioxaglate</to_name>
		<to_code>5973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulin G</to_name>
		<to_code>5666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutyramide</to_name>
		<to_code>1653517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Live Attenuated, A-Uruguay -716-2007 (H3N2) (A-Brisbane-10-2007-like) strain</to_name>
		<to_code>805539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens capensis leaf extract</to_name>
		<to_code>2678350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Indian wormwood sage pollen extract</to_name>
		<to_code>1006495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isatuximab-irfc</to_name>
		<to_code>2282019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isethionic acid</to_name>
		<to_code>1364896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-1 alpha</to_name>
		<to_code>2176733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Michigan/01/2021 antigen</to_name>
		<to_code>2593400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idarubicin</to_name>
		<to_code>5650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indobufen</to_name>
		<to_code>27518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inula helenium whole extract</to_name>
		<to_code>2727317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 chloride</to_name>
		<to_code>42987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioxaglic acid</to_name>
		<to_code>1426458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indeloxazine</to_name>
		<to_code>1311673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</to_name>
		<to_code>1664339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated</to_name>
		<to_code>1427019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idarucizumab</to_name>
		<to_code>1716191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isodecyl isononanoate</to_name>
		<to_code>1495073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Phuket/3073/2013 antigen</to_name>
		<to_code>1657228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idecabtagene vicleucel</to_name>
		<to_code>2536430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iloprost</to_name>
		<to_code>40138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isotachysterol 3</to_name>
		<to_code>2673866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indomethacin sodium trihydrate</to_name>
		<to_code>258329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Austria/1359417/2021 antigen</to_name>
		<to_code>2605039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoascorbic acid</to_name>
		<to_code>1356145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen</to_name>
		<to_code>2687714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen</to_name>
		<to_code>2719300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</to_name>
		<to_code>1801767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imiglucerase</to_name>
		<to_code>84959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin argine</to_name>
		<to_code>1740938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imlunestrant tosylate</to_name>
		<to_code>2725911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivosidenib</to_name>
		<to_code>2049873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl alcohol</to_name>
		<to_code>797541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearoyl lactylate</to_name>
		<to_code>1370616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin isophane, pork</to_name>
		<to_code>221108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea pes-caprae flowering top extract</to_name>
		<to_code>1421627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imetelstat</to_name>
		<to_code>2685236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodohippurate I123 sodium</to_name>
		<to_code>91551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris missouriensis whole extract</to_name>
		<to_code>2539934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl isobutyrate</to_name>
		<to_code>1429933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioxilan</to_name>
		<to_code>27793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</to_name>
		<to_code>1666425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl myristate</to_name>
		<to_code>27985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipilimumab</to_name>
		<to_code>1094833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoceteth 20</to_name>
		<to_code>1368878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixabepilone</to_name>
		<to_code>337523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indocyanine green acid form</to_name>
		<to_code>2199577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearamidopropyl ethyldimonium ethosulfate</to_name>
		<to_code>1803005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain</to_name>
		<to_code>1005929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearamidopropyl dimethylamine</to_name>
		<to_code>2697439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl alcohol</to_name>
		<to_code>1368191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Irvingia gabonensis seed butter extract</to_name>
		<to_code>1364403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isatuximab</to_name>
		<to_code>2282018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen</to_name>
		<to_code>2688113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isorhynchophylline</to_name>
		<to_code>2562548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron</to_name>
		<to_code>90176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropylbenzyl salicylate</to_name>
		<to_code>1366670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulin M, human</to_name>
		<to_code>1314195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon gamma-1a</to_name>
		<to_code>1314240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamic acid</to_name>
		<to_code>1546451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin subcutaneous (human) - hipp</to_name>
		<to_code>2167145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen</to_name>
		<to_code>2717943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoeugenyl benzyl ether, (Z)-</to_name>
		<to_code>2467141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopanoate sodium</to_name>
		<to_code>340398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isotretinoin</to_name>
		<to_code>6064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosulfan blue inner salt</to_name>
		<to_code>1546453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl acetate</to_name>
		<to_code>1599636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Washington/02/2019 antigen</to_name>
		<to_code>2280293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulin A, human</to_name>
		<to_code>1426842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ifenprodil tartrate</to_name>
		<to_code>289912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Switzerland/3330/2017 (H1N1) antigen</to_name>
		<to_code>2198896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoflurane</to_name>
		<to_code>6026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoamyl laurate</to_name>
		<to_code>1313238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen</to_name>
		<to_code>2645084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</to_name>
		<to_code>2280296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inosinic acid</to_name>
		<to_code>5832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex paraguariensis leaf extract</to_name>
		<to_code>1305743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen</to_name>
		<to_code>2605083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Perth/722/2024 (H3N2) antigen</to_name>
		<to_code>2720359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>impacarzine</to_name>
		<to_code>2367441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isodeceth-6</to_name>
		<to_code>1312615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iobenguane sulfate I-123</to_name>
		<to_code>1427223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin glargine</to_name>
		<to_code>274783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodoxamid</to_name>
		<to_code>51471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin intravenous (human) - stwk</to_name>
		<to_code>2672094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-12</to_name>
		<to_code>1309680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imdazole</to_name>
		<to_code>2465734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imlunestrant</to_name>
		<to_code>2725912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidazole-2-hydroxybenzoate</to_name>
		<to_code>27438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipramine pamoate</to_name>
		<to_code>91118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen</to_name>
		<to_code>2641877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex pedunculosa whole extract</to_name>
		<to_code>1372636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobornyl methacrylate</to_name>
		<to_code>1491001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Washington/19/2020 (H1N1) antigen</to_name>
		<to_code>2562554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irinotecan hydrochloride liposome</to_name>
		<to_code>1719767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin intravenous (human) - kthm</to_name>
		<to_code>2726012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropylphthalimide</to_name>
		<to_code>1484281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioxapine</to_name>
		<to_code>1364410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen</to_name>
		<to_code>2593854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin glulisine, human</to_name>
		<to_code>400008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibalizumab</to_name>
		<to_code>2043283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoambrettolide</to_name>
		<to_code>2589803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, protamine zinc, human</to_name>
		<to_code>236646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated, B-Florida-4-2006-like virus (B-Florida-4-2006) strain</to_name>
		<to_code>805524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inamrinone</to_name>
		<to_code>738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoetharine</to_name>
		<to_code>6023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoflupredone acetate</to_name>
		<to_code>1364586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropylphenylbutanal</to_name>
		<to_code>2383935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</to_name>
		<to_code>1928528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen</to_name>
		<to_code>2686166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex aquifolium leaf extract</to_name>
		<to_code>1307755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium bromide monohydrate</to_name>
		<to_code>1309404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoamyl cocoate</to_name>
		<to_code>1607311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iprindole</to_name>
		<to_code>5979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropamide</to_name>
		<to_code>89784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isavuconazonium</to_name>
		<to_code>1608322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isothiazole</to_name>
		<to_code>1495075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin degludec</to_name>
		<to_code>1670007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>istradefylline</to_name>
		<to_code>2199015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl behenate</to_name>
		<to_code>1862103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodide ion I-131</to_name>
		<to_code>1546415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoproterenol sulfate</to_name>
		<to_code>82031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodohippurate</to_name>
		<to_code>314691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens glandulifera flower extract</to_name>
		<to_code>1348452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodophors</to_name>
		<to_code>596712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopanoate</to_name>
		<to_code>637485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indoramin</to_name>
		<to_code>5784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated, Influenza B (B-Florida-4-2006) strain</to_name>
		<to_code>805471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocorynoxeine</to_name>
		<to_code>2562547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-iodo-2-propynylbutylcarbamate</to_name>
		<to_code>1426467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isavuconazole</to_name>
		<to_code>1720882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</to_name>
		<to_code>2380837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipramine hydrochloride</to_name>
		<to_code>150816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopamidol</to_name>
		<to_code>5966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin intravenous (human) - ifas</to_name>
		<to_code>2102433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-n1</to_name>
		<to_code>202912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoprene</to_name>
		<to_code>1364275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indigotindisulfonic acid</to_name>
		<to_code>1546441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen</to_name>
		<to_code>2642276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus vaccine, B-Texas-6-2011, inactivated</to_name>
		<to_code>1304278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imetelstat sodium</to_name>
		<to_code>2685237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl alcohol</to_name>
		<to_code>1362928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibopamine</to_name>
		<to_code>51253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon type II</to_name>
		<to_code>5885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomethyleugenol</to_name>
		<to_code>1423782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobornyl acetate</to_name>
		<to_code>2398330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imatinib</to_name>
		<to_code>282388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ingenol mebutate</to_name>
		<to_code>1242806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inonotus obliquus fruiting body extract</to_name>
		<to_code>1311610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoceteth-10</to_name>
		<to_code>1369683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imdevimab</to_name>
		<to_code>2465249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipramine</to_name>
		<to_code>5691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibuprofen, sodium salt</to_name>
		<to_code>1429044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-1, beta, human</to_name>
		<to_code>2176734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, prompt zinc, beef</to_name>
		<to_code>235284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl ethylimidazolinium ethosulfate</to_name>
		<to_code>2056455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocyclocitral</to_name>
		<to_code>2467134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomaltulose anhydrous</to_name>
		<to_code>2607147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidocarb</to_name>
		<to_code>1740237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl palmitate</to_name>
		<to_code>1311179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium cation In-111</to_name>
		<to_code>1546281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearic diethanolamide</to_name>
		<to_code>1436959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</to_name>
		<to_code>2380835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-10</to_name>
		<to_code>1311299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens balsamina whole extract</to_name>
		<to_code>1875610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indocyanine green</to_name>
		<to_code>5775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoamyl butyrate</to_name>
		<to_code>1314272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irbesartan</to_name>
		<to_code>83818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</to_name>
		<to_code>2048564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inotuzumab ozogamicin</to_name>
		<to_code>1942950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated, A-H1N1 (A-Brisbane-59-2007) strain</to_name>
		<to_code>805467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Live Attenuated, B-Brisbane-60-2008 strain</to_name>
		<to_code>857953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen</to_name>
		<to_code>2562555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin-like growth factor 2</to_name>
		<to_code>1728770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamate sodium I125</to_name>
		<to_code>91537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl hydroxystearate</to_name>
		<to_code>1373445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibuprofen lysine</to_name>
		<to_code>36761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin isophane, beef</to_name>
		<to_code>317235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indinavir anhydrous</to_name>
		<to_code>1546024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idelalisib</to_name>
		<to_code>1544460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopentyldiol</to_name>
		<to_code>1314276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus vaccine, B-Massachusetts-2-2012-like virus</to_name>
		<to_code>1427022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-isobutyl-4-methyltetrahydropyran-4-ol</to_name>
		<to_code>1725033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibandronate sodium</to_name>
		<to_code>236916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inga edulis seed extract</to_name>
		<to_code>1420970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine-131-tositumomab</to_name>
		<to_code>234449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearamidopropyl epoxypropyl dimonium chloride</to_name>
		<to_code>2380831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioxaglate meglumine</to_name>
		<to_code>66895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoproterenol hydrochloride</to_name>
		<to_code>82030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron sorbitex</to_name>
		<to_code>27824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iloperidone</to_name>
		<to_code>73178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</to_name>
		<to_code>2180337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isodecyl neopentanoate</to_name>
		<to_code>1307092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropanolamine</to_name>
		<to_code>1736006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, regular, pork</to_name>
		<to_code>221109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron protein succinylate</to_name>
		<to_code>27823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus (H3N2) antigen</to_name>
		<to_code>1657131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl myristate</to_name>
		<to_code>1313239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007, IVR-148 (H1N1) strain</to_name>
		<to_code>857917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain</to_name>
		<to_code>1005931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibutilide fumarate</to_name>
		<to_code>51256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoetharine mesylate</to_name>
		<to_code>6024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioflupane I-123</to_name>
		<to_code>1426874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoamyl acetate</to_name>
		<to_code>1368172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin aspart-xjhz</to_name>
		<to_code>2720519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 pentetate disodium</to_name>
		<to_code>259268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Brisbane/9/2014 antigen</to_name>
		<to_code>1723997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin isophane, beef-pork</to_name>
		<to_code>317598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens balsamina flower extract</to_name>
		<to_code>1549225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl stearoyl stearate</to_name>
		<to_code>1366671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus antigen, Hong Kong 330-2001</to_name>
		<to_code>1366998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</to_name>
		<to_code>1664172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulin A</to_name>
		<to_code>1426454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain</to_name>
		<to_code>1116738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutyl stearate</to_name>
		<to_code>1489927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inamrinone lactate</to_name>
		<to_code>91236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens glandulifera whole extract</to_name>
		<to_code>1801505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidapril</to_name>
		<to_code>60245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron polysaccharide</to_name>
		<to_code>219315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidazolidinone</to_name>
		<to_code>2565925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon gamma, porcine recombinant</to_name>
		<to_code>1421647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipriflavone</to_name>
		<to_code>51487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl linoleate</to_name>
		<to_code>1605701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidocarb dipropionate</to_name>
		<to_code>1740238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidacloprid</to_name>
		<to_code>1251576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodide I-125</to_name>
		<to_code>1546266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, regular, human</to_name>
		<to_code>253182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropanolamine lauryl sulfate</to_name>
		<to_code>1731735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutylparaben</to_name>
		<to_code>1364296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl lauroyl sarcosinate</to_name>
		<to_code>1427226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfacon-1</to_name>
		<to_code>59744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inavolisib</to_name>
		<to_code>2695422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopentane</to_name>
		<to_code>1368703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indigo carmine</to_name>
		<to_code>227312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin glargine-aglr</to_name>
		<to_code>2589006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium cation</to_name>
		<to_code>1546373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoconazole nitrate</to_name>
		<to_code>203157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, protamine zinc, pork</to_name>
		<to_code>235279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium In-111 pentetreotide</to_name>
		<to_code>1724429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodohippurate I131 sodium</to_name>
		<to_code>91540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Live Attenuated, A-South Dakota-6-2007 (H1N1) (A-Brisbane-59-2007-like) strain</to_name>
		<to_code>805537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen</to_name>
		<to_code>2562553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>itraconazole</to_name>
		<to_code>28031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, regular, beef</to_name>
		<to_code>314686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab-dyyb</to_name>
		<to_code>1790539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isodecyl laurate</to_name>
		<to_code>1441186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inula helnium whole extract</to_name>
		<to_code>2471870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</to_name>
		<to_code>1303851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens balsamina leaf extract</to_name>
		<to_code>1358478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inebilizumab</to_name>
		<to_code>2373951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ilunocitinib</to_name>
		<to_code>2693414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoproterenol</to_name>
		<to_code>6054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</to_name>
		<to_code>1427020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, prompt zinc, beef-pork</to_name>
		<to_code>235283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007 (H3N2) (A-Brisbane-10-2007-like) strain</to_name>
		<to_code>805551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioversol</to_name>
		<to_code>27792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoxsuprine</to_name>
		<to_code>6066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen</to_name>
		<to_code>2388136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indol-3-yl sodium phosphate</to_name>
		<to_code>2469249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocarboxazid</to_name>
		<to_code>6011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</to_name>
		<to_code>2379530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodide ion I-123</to_name>
		<to_code>1361657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-3n,human leukocyte derived</to_name>
		<to_code>314687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-n3</to_name>
		<to_code>612937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</to_name>
		<to_code>1657127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indican</to_name>
		<to_code>2463933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodate ion</to_name>
		<to_code>1546442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris germanica root extract</to_name>
		<to_code>1309752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosteareth-5</to_name>
		<to_code>2048888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopanoic acid</to_name>
		<to_code>5967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indacaterol</to_name>
		<to_code>1114326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</to_name>
		<to_code>1666421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodixanol</to_name>
		<to_code>27729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iberis amara seed extract</to_name>
		<to_code>1309960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens walleriana whole extract</to_name>
		<to_code>2684980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoniazid</to_name>
		<to_code>6038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibalizumab-uiyk</to_name>
		<to_code>2043313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iobenguane I-131</to_name>
		<to_code>2053281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</to_name>
		<to_code>2177291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indinavir sulfate</to_name>
		<to_code>203153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus antigen</to_name>
		<to_code>1657134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibandronate</to_name>
		<to_code>115264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin isophane, human</to_name>
		<to_code>253181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-3</to_name>
		<to_code>1311225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-11</to_name>
		<to_code>1311380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropamide iodide</to_name>
		<to_code>6051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isradipine</to_name>
		<to_code>33910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>icariin</to_name>
		<to_code>1788871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin lispro protamine, human</to_name>
		<to_code>314684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidapril hydrochloride</to_name>
		<to_code>259335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin intravenous (human) - slra</to_name>
		<to_code>2123035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibutamoren</to_name>
		<to_code>1805438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inonotus obliquus whole extract</to_name>
		<to_code>2001814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</to_name>
		<to_code>1657222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus vaccine, B-Massachusetts-2-2012-like virus, recombinant</to_name>
		<to_code>1442194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indomethacin sodium</to_name>
		<to_code>1294612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea digitata root extract</to_name>
		<to_code>2590649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon gamma-1b</to_name>
		<to_code>5882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoeicosane</to_name>
		<to_code>1313241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ispaghula extract</to_name>
		<to_code>82089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2-icosapentoyl-sn-glycero-3-phosphoserine</to_name>
		<to_code>1549117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin intravenous (human) - dira</to_name>
		<to_code>2706382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus (H5N1) antigen</to_name>
		<to_code>1804260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Irvingia gabonensis seed extract</to_name>
		<to_code>1307570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</to_name>
		<to_code>1663630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iminodisuccinate</to_name>
		<to_code>1366938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodide ion</to_name>
		<to_code>1546275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indapamide</to_name>
		<to_code>5764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indanazoline</to_name>
		<to_code>27492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibuprofen</to_name>
		<to_code>5640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</to_name>
		<to_code>1928289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea purpurea seed extract</to_name>
		<to_code>1371910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iprazochrome</to_name>
		<to_code>51486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoflupredone</to_name>
		<to_code>1546449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron sucrose</to_name>
		<to_code>24909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Isodon rubescens top extract</to_name>
		<to_code>1488815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-7</to_name>
		<to_code>1367202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imperialine</to_name>
		<to_code>1860087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin detemir</to_name>
		<to_code>139825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inotersen</to_name>
		<to_code>2099289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Darwin/7/2019 antigen</to_name>
		<to_code>2380838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A-B virus immunoserum rabbit</to_name>
		<to_code>1344642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutyl alcohol</to_name>
		<to_code>1363048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Impatiens irvingii whole extract</to_name>
		<to_code>2675297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idursulfase</to_name>
		<to_code>644101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivabradine</to_name>
		<to_code>1649480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</to_name>
		<to_code>2177290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropylparaben</to_name>
		<to_code>1368879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iptacopan hydrochloride</to_name>
		<to_code>2671062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipenem</to_name>
		<to_code>5690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine</to_name>
		<to_code>5933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus vaccine, B-Wisconsin-1-2010-like virus</to_name>
		<to_code>1303855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inula helenium extract</to_name>
		<to_code>2174793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immunoglobulins, intravenous</to_name>
		<to_code>42386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infigratinib</to_name>
		<to_code>2550729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>icodextrin</to_name>
		<to_code>140480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron-dextran complex</to_name>
		<to_code>5992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imepitoin</to_name>
		<to_code>2600779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen</to_name>
		<to_code>2694005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearic acid</to_name>
		<to_code>1424879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin aspart protamine, human</to_name>
		<to_code>352385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Illicium difengpi bark extract</to_name>
		<to_code>2370870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idoxuridine</to_name>
		<to_code>5653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</to_name>
		<to_code>1657224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen</to_name>
		<to_code>1804259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indinavir</to_name>
		<to_code>114289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivacaftor</to_name>
		<to_code>1243041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris germanica var. florentina root extract</to_name>
		<to_code>1993233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>IR-3535</to_name>
		<to_code>1737733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isometheptene mucate</to_name>
		<to_code>104994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris domestica whole extract</to_name>
		<to_code>1492938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidurea</to_name>
		<to_code>1368885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ilodecakin</to_name>
		<to_code>2604685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon alfa-n1 lymphoblastoid</to_name>
		<to_code>261717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoleucine</to_name>
		<to_code>6033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isononyl isononanoate</to_name>
		<to_code>1367167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iridium</to_name>
		<to_code>1311131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoeugenol</to_name>
		<to_code>1363706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inulin</to_name>
		<to_code>5924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iron bile salts</to_name>
		<to_code>235376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl lactate</to_name>
		<to_code>1657014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ipomoea purga root extract</to_name>
		<to_code>1309706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab-abda</to_name>
		<to_code>1927283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idarubicin hydrochloride</to_name>
		<to_code>82124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-iodo-1-propanol</to_name>
		<to_code>1435281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoeugenyl acetate</to_name>
		<to_code>2393779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>infliximab</to_name>
		<to_code>191831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</to_name>
		<to_code>1664171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ispaghula husk</to_name>
		<to_code>104129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl titanium triisostearate</to_name>
		<to_code>1356144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosteareth-20</to_name>
		<to_code>1652251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris tenax extract</to_name>
		<to_code>1666105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</to_name>
		<to_code>2379531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inulin lauryl carbamate</to_name>
		<to_code>2611696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris germanica extract</to_name>
		<to_code>1428843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipenem anhydrous</to_name>
		<to_code>1545986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomaltulose</to_name>
		<to_code>2607148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iresine calea extract</to_name>
		<to_code>1441322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</to_name>
		<to_code>2380836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-6</to_name>
		<to_code>1367185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl palmitate</to_name>
		<to_code>1368901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iota-carrageenan</to_name>
		<to_code>2565488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isophorone diisocyanate</to_name>
		<to_code>2626882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iopentol</to_name>
		<to_code>27779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodipamide</to_name>
		<to_code>5936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indoramin hydrochloride</to_name>
		<to_code>235773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex aquifolium flowering top extract</to_name>
		<to_code>1309961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine bush pollen extract</to_name>
		<to_code>851894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl isostearate</to_name>
		<to_code>2623403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isothipendyl hydrochloride</to_name>
		<to_code>235726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibrexafungerp citrate</to_name>
		<to_code>2560215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetyl stearate</to_name>
		<to_code>1313240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iva angustifolia whole extract</to_name>
		<to_code>2590650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibandronic acid</to_name>
		<to_code>115265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl stearate</to_name>
		<to_code>1312620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl neopentanoate</to_name>
		<to_code>1314848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoamyl salicylate</to_name>
		<to_code>1940006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ivabradine hydrochloride</to_name>
		<to_code>1649479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>icosapent ethyl</to_name>
		<to_code>1304974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus</to_name>
		<to_code>1304122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iptacopan</to_name>
		<to_code>2671061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine povacrylex</to_name>
		<to_code>692863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, prompt zinc, pork</to_name>
		<to_code>235286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus vaccine B/Brisbane/60/2008 antigen</to_name>
		<to_code>857921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutyl acetate</to_name>
		<to_code>1603476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioflupane</to_name>
		<to_code>2571854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>idebenone</to_name>
		<to_code>51296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibutamoren mesylate</to_name>
		<to_code>1805437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin lispro-aabc</to_name>
		<to_code>2376838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imidazole</to_name>
		<to_code>2472898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isosorbide dinitrate</to_name>
		<to_code>6058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin aspart, human</to_name>
		<to_code>51428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ioxaglate sodium</to_name>
		<to_code>66896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imipenem monohydrate</to_name>
		<to_code>2184135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>irinotecan</to_name>
		<to_code>51499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibrutinib</to_name>
		<to_code>1442981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodinated glycerol</to_name>
		<to_code>27723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>intrinsic factor</to_name>
		<to_code>5920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin isophane</to_name>
		<to_code>1605101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl behenate</to_name>
		<to_code>1356483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-4</to_name>
		<to_code>5891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indole-3-carbinol</to_name>
		<to_code>2598119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus</to_name>
		<to_code>1312376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl isostearate</to_name>
		<to_code>1314415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-iodobenzylguanidine</to_name>
		<to_code>14448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobornyl acrylate</to_name>
		<to_code>1603858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen</to_name>
		<to_code>2641622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus vaccine, B-Massachusetts-2-2012 BX-51B, inactivated</to_name>
		<to_code>1428984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex cornuta whole extract</to_name>
		<to_code>2684979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isobutylene</to_name>
		<to_code>2099712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-9</to_name>
		<to_code>1309465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus (H1N1) antigen</to_name>
		<to_code>1657128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inosine pranobex</to_name>
		<to_code>6048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Live Attenuated, B-Florida-4-2006 strain</to_name>
		<to_code>805541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodamide</to_name>
		<to_code>5928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-5</to_name>
		<to_code>1367184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoetharine hydrochloride</to_name>
		<to_code>102397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Italian rye grass pollen extract</to_name>
		<to_code>1014340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isolaureth-10</to_name>
		<to_code>1869585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain</to_name>
		<to_code>1006250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iothalamate meglumine</to_name>
		<to_code>5971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ipratropium bromide</to_name>
		<to_code>203212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ifosfamide</to_name>
		<to_code>5657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,3'-iminodi-benzoic acid</to_name>
		<to_code>2588486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iso-sulfan blue</to_name>
		<to_code>27863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>indium-111</to_name>
		<to_code>90540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus</to_name>
		<to_code>1541617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl unoprostone</to_name>
		<to_code>135313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibritumomab tiuxetan</to_name>
		<to_code>262323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Isatis tinctoria root extract</to_name>
		<to_code>1307808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</to_name>
		<to_code>1946964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</to_name>
		<to_code>1663632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon beta-1a</to_name>
		<to_code>75917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interleukin-12, human recombinant</to_name>
		<to_code>1328172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Inula racemosa root extract</to_name>
		<to_code>2688454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Colorado/06/2017 antigen</to_name>
		<to_code>2054177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl linoleate</to_name>
		<to_code>1484858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isomaltitol</to_name>
		<to_code>2600777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isocetane</to_name>
		<to_code>1987477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>inotersen sodium</to_name>
		<to_code>2099290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Maryland/15/2016 antigen</to_name>
		<to_code>2048563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Victoria/705/2018 antigen</to_name>
		<to_code>2380575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen</to_name>
		<to_code>2479040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iscotrizinol</to_name>
		<to_code>2602134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isospaglumic acid</to_name>
		<to_code>236303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodine I-120</to_name>
		<to_code>1492441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isavuconazonium sulfate</to_name>
		<to_code>1608321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris domestica root extract</to_name>
		<to_code>1722034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen</to_name>
		<to_code>2708995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</to_name>
		<to_code>1657130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex pubescens root extract</to_name>
		<to_code>1309432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immature Citrus sinensis fruit extract</to_name>
		<to_code>1539815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin glargine-yfgn</to_name>
		<to_code>2563969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain</to_name>
		<to_code>1005911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Iris pallida root extract</to_name>
		<to_code>1309832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>interferon-beta</to_name>
		<to_code>4381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Utah/9/2014 antigen</to_name>
		<to_code>1657133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>immune globulin subcutaneous (human)</to_name>
		<to_code>617615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Indigofera tinctoria whole extract</to_name>
		<to_code>1735324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>insulin, protamine zinc, beef</to_name>
		<to_code>235278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isothipendyl</to_name>
		<to_code>28012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>imatinib mesylate</to_name>
		<to_code>284924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</to_name>
		<to_code>2056525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl ferulate</to_name>
		<to_code>2105548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoconazole</to_name>
		<to_code>27901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ibopamine hydrochloride</to_name>
		<to_code>284157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>intrinsic factor concentrate</to_name>
		<to_code>91500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isostearyl sebacate</to_name>
		<to_code>2606777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>iodoform</to_name>
		<to_code>27748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isoxsuprine hydrochloride</to_name>
		<to_code>82033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ilex paraguariensis whole extract</to_name>
		<to_code>1368377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>isopropyl maleate</to_name>
		<to_code>1426623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>I [Preparations]</from_name>
		<from_code>N0000010591</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ixazomib</to_name>
		<to_code>1723735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indeloxazine hydrochloride</from_name>
		<from_code>1311672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indeloxazine hydrochloride</to_name>
		<to_code>M0314344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indanazoline hydrochloride</from_name>
		<from_code>292036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indanazoline hydrochloride</to_name>
		<to_code>M0317381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobitridol</from_name>
		<from_code>87639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iobitridol</to_name>
		<to_code>M0245926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>invert sugar</from_name>
		<from_code>27712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>invert sugar</to_name>
		<to_code>M0051714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Necrotizing</to_name>
		<to_code>M0029980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ductus Arteriosus, Patent</to_name>
		<to_code>M0006877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proctitis</to_name>
		<to_code>M0017632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indomethacin</to_name>
		<to_code>M0011240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tendinopathy</to_name>
		<to_code>M0483885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin</from_name>
		<from_code>5781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine</from_name>
		<from_code>27084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone acetate</from_name>
		<from_code>221101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine hydrobromide</from_name>
		<from_code>235428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac</from_name>
		<from_code>19737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone</from_name>
		<from_code>25126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromfenac sodium</from_name>
		<from_code>47364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homatropine methylbromide</from_name>
		<from_code>27085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deflazacort</from_name>
		<from_code>22396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyllin copper complex</from_name>
		<from_code>82242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorometholone</from_name>
		<from_code>4491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps skin test antigen</from_name>
		<from_code>89854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilonacept</from_name>
		<from_code>763450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inflammation</to_name>
		<to_code>M0011307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proctitis</to_name>
		<to_code>M0017632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tendinopathy</to_name>
		<to_code>M0483885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Necrotizing</to_name>
		<to_code>M0029980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ductus Arteriosus, Patent</to_name>
		<to_code>M0006877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium trihydrate</from_name>
		<from_code>258329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate A sodium</from_name>
		<from_code>476847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine hydrochloride</from_name>
		<from_code>236608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valdecoxib</from_name>
		<from_code>278567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (shark)</from_name>
		<from_code>1358172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rofecoxib</from_name>
		<from_code>232158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate</from_name>
		<from_code>4847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, bovine</from_name>
		<from_code>1306129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline salicylate</from_name>
		<from_code>20974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin</from_name>
		<from_code>10636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (bovine)</from_name>
		<from_code>1299929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclofenac</from_name>
		<from_code>16689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfates</from_name>
		<from_code>2473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine</from_name>
		<from_code>4845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium (porcine)</from_name>
		<from_code>1366974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carprofen</from_name>
		<from_code>20343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucosamine sulfate potassium chloride</from_name>
		<from_code>1789517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate sodium</from_name>
		<from_code>1605114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolmetin sodium</from_name>
		<from_code>42935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate (shark)</from_name>
		<from_code>1789516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin sulfate, porcine</from_name>
		<from_code>1306202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis</to_name>
		<to_code>M0015509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tendinopathy</to_name>
		<to_code>M0483885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proctitis</to_name>
		<to_code>M0017632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ductus Arteriosus, Patent</to_name>
		<to_code>M0006877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indomethacin sodium</from_name>
		<from_code>1294612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Necrotizing</to_name>
		<to_code>M0029980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bursitis</to_name>
		<to_code>M0003070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate</from_name>
		<from_code>4440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flavoxate hydrochloride</from_name>
		<from_code>142437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastrointestinal Hemorrhage</to_name>
		<to_code>M0010153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tendinopathy</to_name>
		<to_code>M0483885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-fkjp</from_name>
		<from_code>2640402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aaty</from_name>
		<from_code>2639649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certolizumab pegol</from_name>
		<from_code>709271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen sodium</from_name>
		<from_code>142442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept</from_name>
		<from_code>214555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-dyyb</from_name>
		<from_code>1790539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-atto</from_name>
		<from_code>2103479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adbm</from_name>
		<from_code>2103477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-ryvk</from_name>
		<from_code>2677776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-axxq</from_name>
		<from_code>2266523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab</from_name>
		<from_code>191831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secukinumab</from_name>
		<from_code>1599788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-adaz</from_name>
		<from_code>2641642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celecoxib</from_name>
		<from_code>140587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-abda</from_name>
		<from_code>1927283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naproxen</from_name>
		<from_code>7258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aqvh</from_name>
		<from_code>2640387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-aacf</from_name>
		<from_code>2640849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab</from_name>
		<from_code>327361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-afzb</from_name>
		<from_code>2619155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>infliximab-qbtx</from_name>
		<from_code>2103476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adalimumab-bwwd</from_name>
		<from_code>2612153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aceclofenac</from_name>
		<from_code>16689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etanercept-szzs</from_name>
		<from_code>2103480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spondylitis, Ankylosing</to_name>
		<to_code>M0020377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesalamine</from_name>
		<from_code>52582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Proctitis</to_name>
		<to_code>M0017632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ductus Arteriosus, Patent</to_name>
		<to_code>M0006877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ductus Arteriosus, Patent</to_name>
		<to_code>M0006877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen</from_name>
		<from_code>4502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen lysine</from_name>
		<from_code>28199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurbiprofen sodium</from_name>
		<from_code>91351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoprofen</from_name>
		<from_code>6142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam-beta-cyclodextrin</from_name>
		<from_code>68115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam</from_name>
		<from_code>8356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meloxicam</from_name>
		<from_code>41493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflunisal</from_name>
		<from_code>3393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen calcium</from_name>
		<from_code>267171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenoprofen</from_name>
		<from_code>4331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>piroxicam cinnamate</from_name>
		<from_code>33787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronary Artery Bypass</to_name>
		<to_code>M0001560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone acetate</from_name>
		<from_code>155323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone</from_name>
		<from_code>6902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone aceponate</from_name>
		<from_code>62136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone piperazine</from_name>
		<from_code>236354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium succinate</from_name>
		<from_code>203189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulindac</from_name>
		<from_code>10237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone</from_name>
		<from_code>8160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylbutazone sodium</from_name>
		<from_code>236529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis, Gouty</to_name>
		<to_code>M0023372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabumetone</from_name>
		<from_code>31448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine hydrochloride</from_name>
		<from_code>1311532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisotropine</from_name>
		<from_code>89780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycine</from_name>
		<from_code>4919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine</from_name>
		<from_code>8352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium</from_name>
		<from_code>21232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polaprezinc</from_name>
		<from_code>2179843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel</from_name>
		<from_code>613391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasugrel hydrochloride</from_name>
		<from_code>847020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etodolac</from_name>
		<from_code>24605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium bromide</from_name>
		<from_code>48212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide iodide</from_name>
		<from_code>6051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate sodium</from_name>
		<from_code>6677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepenzolate</from_name>
		<from_code>107770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octotropine methylbromide</from_name>
		<from_code>17945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine hydrochloride</from_name>
		<from_code>235775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepenzolate bromide</from_name>
		<from_code>52560</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamate</from_name>
		<from_code>588003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfinpyrazone</from_name>
		<from_code>10205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide</from_name>
		<from_code>89784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polaprezinc</from_name>
		<from_code>2179843</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peptic Ulcer</to_name>
		<to_code>M0016211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>auranofin</from_name>
		<from_code>1227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Necrotizing</to_name>
		<to_code>M0029980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indomethacin</to_name>
		<to_code>M0011240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoaminile</from_name>
		<from_code>27866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoaminile</to_name>
		<to_code>M0056968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iohexol</to_name>
		<to_code>M0011673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iohexol</from_name>
		<from_code>5956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Adrenal Cortex Hormones</to_name>
		<to_code>M0000480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopamidol</from_name>
		<from_code>5966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iopamidol</to_name>
		<to_code>M0011680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B sulfate</from_name>
		<from_code>388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daptomycin</from_name>
		<from_code>22299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polymyxin B</from_name>
		<from_code>8536</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole</from_name>
		<from_code>2691333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftobiprole medocaril sodium</from_name>
		<from_code>2691334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacteremia</to_name>
		<to_code>M0025156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopromide</from_name>
		<from_code>27781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Injections, Intrathecal</to_name>
		<to_code>M0011358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopromide</from_name>
		<from_code>27781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopromide</from_name>
		<from_code>27781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iopromide</to_name>
		<to_code>M0115091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Injections, Intrathecal</to_name>
		<to_code>M0011358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bortezomib</from_name>
		<from_code>358258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Injections, Intrathecal</to_name>
		<to_code>M0011358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodixanol</from_name>
		<from_code>27729</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Injections, Intrathecal</to_name>
		<to_code>M0011358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ioversol</to_name>
		<to_code>M0154765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioversol</from_name>
		<from_code>27792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide</from_name>
		<from_code>9884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodide I123</from_name>
		<from_code>91531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopanoic acid</from_name>
		<from_code>5967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol chloride</from_name>
		<from_code>47088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium iodide</from_name>
		<from_code>8597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-131</from_name>
		<from_code>1546415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bethanechol</from_name>
		<from_code>19257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperthyroidism</to_name>
		<to_code>M0010871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopanoic acid</from_name>
		<from_code>5967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopanoic acid</from_name>
		<from_code>5967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iopanoic Acid</to_name>
		<to_code>M0011683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate sodium</from_name>
		<from_code>9887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ipodate</from_name>
		<from_code>1911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod</from_name>
		<from_code>139778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sincalide</from_name>
		<from_code>9800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate micronized</from_name>
		<from_code>221100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegaserod maleate</from_name>
		<from_code>339270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate</from_name>
		<from_code>8703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate</from_name>
		<from_code>5976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gallbladder Diseases</to_name>
		<to_code>M0008958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate sodium</from_name>
		<from_code>9887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ipodate Sodium</to_name>
		<to_code>M0011701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate</from_name>
		<from_code>5976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ipodate</to_name>
		<to_code>M0011700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipodate</from_name>
		<from_code>5976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iopodate</to_name>
		<to_code>M000638473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-131</from_name>
		<from_code>1546415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin alfa</from_name>
		<from_code>4952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenvatinib</from_name>
		<from_code>1603296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine</from_name>
		<from_code>10814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selpercatinib</from_name>
		<from_code>2370147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium anhydrous</from_name>
		<from_code>1372638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyrotropin alfa</from_name>
		<from_code>4952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (USP)</from_name>
		<from_code>10572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lenvatinib mesylate</from_name>
		<from_code>1604346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine</from_name>
		<from_code>10582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib</from_name>
		<from_code>495881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroid (beef)</from_name>
		<from_code>325521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorafenib tosylate</from_name>
		<from_code>597744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>liothyronine sodium</from_name>
		<from_code>142448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride</from_name>
		<from_code>142433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyroglobulin</from_name>
		<from_code>10565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vandetanib</from_name>
		<from_code>1098413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin</from_name>
		<from_code>3639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxorubicin hydrochloride liposome</from_name>
		<from_code>466523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levothyroxine sodium</from_name>
		<from_code>40144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thyroid Neoplasms</to_name>
		<to_code>M0021485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodixanol</from_name>
		<from_code>27729</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iodixanol</to_name>
		<to_code>M0130699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol</from_name>
		<from_code>9945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium,chelated</from_name>
		<from_code>259277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous dextrose</from_name>
		<from_code>349730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium</from_name>
		<from_code>6448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine sulfosalicylate</from_name>
		<from_code>235562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid monohydrate</from_name>
		<from_code>221079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium acetate</from_name>
		<from_code>54987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium citrate dihydrate</from_name>
		<from_code>221163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, 1-stearyl ester</from_name>
		<from_code>1435636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride</from_name>
		<from_code>9863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium silicate</from_name>
		<from_code>2691100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disodium citrate sesquihydrate</from_name>
		<from_code>2049608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium orotate</from_name>
		<from_code>28815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium hydroxide monohydrate</from_name>
		<from_code>1298832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol hexanitrate</from_name>
		<from_code>89792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose monohydrate</from_name>
		<from_code>1299920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid</from_name>
		<from_code>21183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate</from_name>
		<from_code>54993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine hippurate</from_name>
		<from_code>29652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bicarbonate</from_name>
		<from_code>34296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium chloride</from_name>
		<from_code>8591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citric acid, anhydrous</from_name>
		<from_code>221946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine mandelate</from_name>
		<from_code>161623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium citrate monohydrate</from_name>
		<from_code>221149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucose</from_name>
		<from_code>4850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrose hydrous</from_name>
		<from_code>1297771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium bitartrate</from_name>
		<from_code>223779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannitol</from_name>
		<from_code>6628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium aspartate</from_name>
		<from_code>746070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium citrate</from_name>
		<from_code>52105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium gluconate</from_name>
		<from_code>89903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beta-D-glucopyranose</from_name>
		<from_code>1442190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitol, L-</from_name>
		<from_code>1742749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenamine</from_name>
		<from_code>6832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lithium carbonate</from_name>
		<from_code>42351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dehydration</to_name>
		<to_code>M0005757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus</from_name>
		<from_code>1312375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain</from_name>
		<from_code>1005929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen</from_name>
		<from_code>1928289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-Brisbane-10-2007 (H3N2)-like virus (A-Uruguay-716-2007 NYMC X-175C) strain</from_name>
		<from_code>805520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain</from_name>
		<from_code>1116738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen</from_name>
		<from_code>2688113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated, A-H3N2 (A-Uruguay-716-2007) strain</from_name>
		<from_code>805469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H3N2) antigen</from_name>
		<from_code>1657131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007 (H1N1) strain</from_name>
		<from_code>805549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen</from_name>
		<from_code>1657222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen</from_name>
		<from_code>2686166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007, IVR-148 (H1N1) strain</from_name>
		<from_code>857917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen</from_name>
		<from_code>1666425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen</from_name>
		<from_code>2708995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen</from_name>
		<from_code>1663630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen</from_name>
		<from_code>1794331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen</from_name>
		<from_code>1657130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen</from_name>
		<from_code>1801767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen</from_name>
		<from_code>2180337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen</from_name>
		<from_code>2564395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007, NYMC X-175C (H3N2) strain</from_name>
		<from_code>857919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen</from_name>
		<from_code>2479040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen</from_name>
		<from_code>1928528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen</from_name>
		<from_code>2380836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir marboxil</from_name>
		<from_code>2099995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen</from_name>
		<from_code>2593854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen</from_name>
		<from_code>1666421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen</from_name>
		<from_code>1946964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen</from_name>
		<from_code>2180338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen</from_name>
		<from_code>2380574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen</from_name>
		<from_code>1663632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen</from_name>
		<from_code>2177291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen</from_name>
		<from_code>2379531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen</from_name>
		<from_code>1664171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen</from_name>
		<from_code>2719300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen</from_name>
		<from_code>2379530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/7/2009 (H1N1) antigen</from_name>
		<from_code>1657331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen</from_name>
		<from_code>2048564</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain</from_name>
		<from_code>1006250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated, A-H1N1 (A-Brisbane-59-2007) strain</from_name>
		<from_code>805467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen</from_name>
		<from_code>2562555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen</from_name>
		<from_code>2605724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen</from_name>
		<from_code>1664339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen</from_name>
		<from_code>2607735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen</from_name>
		<from_code>2562554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen</from_name>
		<from_code>2641877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen</from_name>
		<from_code>1657127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain</from_name>
		<from_code>1005909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Live Attenuated, A-South Dakota-6-2007 (H1N1) (A-Brisbane-59-2007-like) strain</from_name>
		<from_code>805537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus (H1N1) antigen</from_name>
		<from_code>1657128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen</from_name>
		<from_code>2562553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Live Attenuated, A-Uruguay -716-2007 (H3N2) (A-Brisbane-10-2007-like) strain</from_name>
		<from_code>805539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen</from_name>
		<from_code>2694005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen</from_name>
		<from_code>2645084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen</from_name>
		<from_code>1657224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen</from_name>
		<from_code>2605083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus</from_name>
		<from_code>1303851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen</from_name>
		<from_code>2280296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen</from_name>
		<from_code>2380835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen</from_name>
		<from_code>2388136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007 (H3N2) (A-Brisbane-10-2007-like) strain</from_name>
		<from_code>805551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen</from_name>
		<from_code>2720359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/California/122/2022 (H3N2) antigen</from_name>
		<from_code>2675569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen</from_name>
		<from_code>2630221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen</from_name>
		<from_code>2642276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen</from_name>
		<from_code>1928290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen</from_name>
		<from_code>2641622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen</from_name>
		<from_code>2605723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen</from_name>
		<from_code>2561244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen</from_name>
		<from_code>2056521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen</from_name>
		<from_code>2177290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen</from_name>
		<from_code>2380837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen</from_name>
		<from_code>2380834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen</from_name>
		<from_code>2717943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza A virus</to_name>
		<to_code>M0015475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxaflutole</from_name>
		<from_code>1371313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoxaflutole</to_name>
		<to_code>M0372201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene</from_name>
		<from_code>27946</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isometheptene</to_name>
		<to_code>M0051833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indole</from_name>
		<from_code>1311224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indole</to_name>
		<to_code>M0096122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium</from_name>
		<from_code>1362699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indium</to_name>
		<to_code>M0011230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoamyl cinnamate</from_name>
		<from_code>2046779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoamyl cinnamate</to_name>
		<to_code>M0518174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigo</from_name>
		<from_code>1426889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indigo</to_name>
		<to_code>M0011228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iomeprol</from_name>
		<from_code>2606484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iomeprol</to_name>
		<to_code>M0161850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inosine</from_name>
		<from_code>1483575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inosine</to_name>
		<to_code>M0011366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodine I-131</from_name>
		<from_code>1546394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iodine-131</to_name>
		<to_code>M000627491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobenguane I-123</from_name>
		<from_code>1426748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-Iodobenzylguanidine, 123I Labeled</to_name>
		<to_code>M0331309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isolan</from_name>
		<from_code>1807442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isolan</to_name>
		<to_code>M0051822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigotindisulfonate</from_name>
		<from_code>325514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indigotindisulfonate</to_name>
		<to_code>M0515721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iotrolan</from_name>
		<from_code>51474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iotrolan</to_name>
		<to_code>M0103391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran</from_name>
		<from_code>2588243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran</from_name>
		<from_code>2588243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholesterol, LDL</to_name>
		<to_code>M0012591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran</from_name>
		<from_code>2588243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran</from_name>
		<from_code>2588243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ALN-PCSsc</to_name>
		<to_code>M000626058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bempedoic acid</from_name>
		<from_code>2282403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evolocumab</from_name>
		<from_code>1665684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran sodium</from_name>
		<from_code>2588259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alirocumab</from_name>
		<from_code>1659152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evolocumab</from_name>
		<from_code>1665684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alirocumab</from_name>
		<from_code>1659152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Atherosclerosis</to_name>
		<to_code>M0001903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran sodium</from_name>
		<from_code>2588259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inclisiran sodium</from_name>
		<from_code>2588259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholesterol, LDL</to_name>
		<to_code>M0012591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab-dgnb</from_name>
		<from_code>2478646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemfibrozil</from_name>
		<from_code>4719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate micronized</from_name>
		<from_code>221100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin sodium</from_name>
		<from_code>221072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alirocumab</from_name>
		<from_code>1659152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin sodium</from_name>
		<from_code>72875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin calcium</from_name>
		<from_code>323828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibrate</from_name>
		<from_code>8703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin</from_name>
		<from_code>301542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluvastatin</from_name>
		<from_code>41127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesterol</from_name>
		<from_code>2438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evolocumab</from_name>
		<from_code>1665684</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerivastatin</from_name>
		<from_code>596723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lerodalcibep-liga</from_name>
		<from_code>2729461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium seed coatings,blond</from_name>
		<from_code>314812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ezetimibe</from_name>
		<from_code>341248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium hydrocolloid</from_name>
		<from_code>314809</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide mesylate</from_name>
		<from_code>1364478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lerodalcibep</from_name>
		<from_code>2729426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenofibric acid</from_name>
		<from_code>24852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>psyllium</from_name>
		<from_code>8928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lomitapide</from_name>
		<from_code>1364479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofibrate</from_name>
		<from_code>2594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab</from_name>
		<from_code>2478335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypercholesterolemia</to_name>
		<to_code>M0010818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobutane</from_name>
		<from_code>1363040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isobutanes</to_name>
		<to_code>M0003088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isomalt</from_name>
		<from_code>1363717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>D-Glucitol, 6-O-alpha-D-glucopyranosyl-, mixture with 1-O-alpha-D-glucopyranosyl-D-mannitol</to_name>
		<to_code>M0066784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inositol niacinate</from_name>
		<from_code>27604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inositol Niacinate</to_name>
		<to_code>M0046559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-1, beta</from_name>
		<from_code>2176735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-1beta</to_name>
		<to_code>M0011502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iophendylate</from_name>
		<from_code>5968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nervous System Diseases</to_name>
		<to_code>M0014667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iophendylate</from_name>
		<from_code>5968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iophendylate</to_name>
		<to_code>M0011684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nervous System Diseases</to_name>
		<to_code>M0014667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>altretamine</from_name>
		<from_code>5296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nervous System Diseases</to_name>
		<to_code>M0014667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PERTUSSIS VACCINE,ADSORBED</from_name>
		<from_code>402543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nervous System Diseases</to_name>
		<to_code>M0014667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inositol</from_name>
		<from_code>5833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inositol</to_name>
		<to_code>M0011374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopulegol</from_name>
		<from_code>1314235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isopulegol</to_name>
		<to_code>M0364827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp</from_name>
		<from_code>2560213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ibrexafungerp</to_name>
		<to_code>M000737384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp</from_name>
		<from_code>2560213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet cation</from_name>
		<from_code>1546369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotrimazole</from_name>
		<from_code>2623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole</from_name>
		<from_code>19884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butoconazole nitrate</from_name>
		<from_code>47464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenbendazole</from_name>
		<from_code>4325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibrexafungerp citrate</from_name>
		<from_code>2560215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nystatin</from_name>
		<from_code>7597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole nitrate</from_name>
		<from_code>42790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfanilamide</from_name>
		<from_code>10184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miconazole</from_name>
		<from_code>6932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet</from_name>
		<from_code>4778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candidiasis, Vulvovaginal</to_name>
		<to_code>M0003262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catheterization, Central Venous</to_name>
		<to_code>M0003666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iothalamate</to_name>
		<to_code>M0011687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Male Urogenital Diseases</to_name>
		<to_code>M0489510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate</from_name>
		<from_code>5970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endoscopy</to_name>
		<to_code>M0007425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-apgf</from_name>
		<from_code>2469333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abobotulinumtoxinA</from_name>
		<from_code>860168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim-xnst</from_name>
		<from_code>2612537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec</from_name>
		<from_code>2641610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>incobotulinumtoxinA</from_name>
		<from_code>1000104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimabotulinumtoxinB</from_name>
		<from_code>860178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-aafi</from_name>
		<from_code>2057198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim</from_name>
		<from_code>68442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine</from_name>
		<from_code>11198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>botulinum toxin type A</from_name>
		<from_code>1712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anakinra</from_name>
		<from_code>72435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alemtuzumab</from_name>
		<from_code>117055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>floxuridine</from_name>
		<from_code>4488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mavorixafor</from_name>
		<from_code>2684021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hylan G-F 20</from_name>
		<from_code>284637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-ayow</from_name>
		<from_code>2595942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eflapegrastim</from_name>
		<from_code>2612526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-pbbk</from_name>
		<from_code>2602779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinblastine sulfate</from_name>
		<from_code>11199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-bmez</from_name>
		<from_code>2260702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA</from_name>
		<from_code>2689280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Lyme Disease Vaccine</from_name>
		<from_code>214177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prabotulinumtoxinA-xvfs</from_name>
		<from_code>2117869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valoctocogene roxaparvovec-rvox</from_name>
		<from_code>2641609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine hydrochloride</from_name>
		<from_code>155036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 3, human</from_name>
		<from_code>11131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>daxibotulinumtoxinA-lanm</from_name>
		<from_code>2612452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sabinene</from_name>
		<from_code>2557219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-jmdb</from_name>
		<from_code>2048018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim</from_name>
		<from_code>338036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tbo-filgrastim</from_name>
		<from_code>1433764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>letibotulinumtoxinA-wlbg</from_name>
		<from_code>2689282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mechlorethamine</from_name>
		<from_code>6674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-cbqv</from_name>
		<from_code>2102692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>filgrastim-sndz</from_name>
		<from_code>1605064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluorouracil</from_name>
		<from_code>4492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegfilgrastim-fpgk</from_name>
		<from_code>2613761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>onabotulinumtoxinA</from_name>
		<from_code>860189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infections</to_name>
		<to_code>M0011294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endoscopy</to_name>
		<to_code>M0007425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate sodium I125</from_name>
		<from_code>91537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catheterization, Central Venous</to_name>
		<to_code>M0003666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline</from_name>
		<from_code>6821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase</from_name>
		<from_code>1156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean oil</from_name>
		<from_code>9949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pegaspargase</from_name>
		<from_code>34132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn</from_name>
		<from_code>2561249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methantheline bromide</from_name>
		<from_code>91163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursodiol</from_name>
		<from_code>11065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chenodeoxycholic acid</from_name>
		<from_code>2323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pancreatitis</to_name>
		<to_code>M0015809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catheterization, Central Venous</to_name>
		<to_code>M0003666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iothalamate Meglumine</to_name>
		<to_code>M0011685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Male Urogenital Diseases</to_name>
		<to_code>M0489510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endoscopy</to_name>
		<to_code>M0007425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamate meglumine</from_name>
		<from_code>5971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catheterization, Central Venous</to_name>
		<to_code>M0003666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursodiol</from_name>
		<from_code>11065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>obeticholic acid</from_name>
		<from_code>1798288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursadiol</from_name>
		<from_code>2045735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholangitis</to_name>
		<to_code>M0004228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine</from_name>
		<from_code>8149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate</from_name>
		<from_code>1651695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine</from_name>
		<from_code>8149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metyrosine</from_name>
		<from_code>266604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dasiglucagon</from_name>
		<from_code>2535233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine hydrochloride</from_name>
		<from_code>71512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon</from_name>
		<from_code>4832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenoxybenzamine hydrochloride</from_name>
		<from_code>71512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine mesylate</from_name>
		<from_code>227240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil</from_name>
		<from_code>6984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minoxidil sulfate ester</from_name>
		<from_code>1926479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine</from_name>
		<from_code>38400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine</from_name>
		<from_code>9392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentolamine</from_name>
		<from_code>8153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon hydrochloride</from_name>
		<from_code>253170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide dihydrochloride</from_name>
		<from_code>267035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritodrine hydrochloride</from_name>
		<from_code>105470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iobenguane I-131</from_name>
		<from_code>2053281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>opicapone</from_name>
		<from_code>2362167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide hydrochloride</from_name>
		<from_code>267036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucagon (rDNA)</from_name>
		<from_code>261716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoclopramide</from_name>
		<from_code>6915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pheochromocytoma</to_name>
		<to_code>M0016586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tyramine</to_name>
		<to_code>M0022194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antihypertensive Agents</to_name>
		<to_code>M0001456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Narcotics</to_name>
		<to_code>M0014481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dibenzazepine</to_name>
		<to_code>M0520052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcohols</to_name>
		<to_code>M0000663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cheese</to_name>
		<to_code>M0003999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Buspirone Hydrochloride</to_name>
		<to_code>M0350950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isocarboxazid</to_name>
		<to_code>M0011750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Caffeine</to_name>
		<to_code>M0003138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anesthetics</to_name>
		<to_code>M0001167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diuretics, Thiazide</to_name>
		<to_code>M0006628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bupropion Hydrochloride</to_name>
		<to_code>M0025362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasoconstrictor Agents</to_name>
		<to_code>M0022551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocarboxazid</from_name>
		<from_code>6011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide mesylate</from_name>
		<from_code>1922449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextromethorphan</from_name>
		<from_code>3289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safinamide</from_name>
		<from_code>1922448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dextromethorphan</to_name>
		<to_code>M0006138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sympathomimetics</to_name>
		<to_code>M0020947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tyramine</to_name>
		<to_code>M0022194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tyramine</to_name>
		<to_code>M0022194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tyramine</from_name>
		<from_code>10958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tyramine</to_name>
		<to_code>M0022194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antihypertensive Agents</to_name>
		<to_code>M0001456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antihypertensive Agents</to_name>
		<to_code>M0001456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Narcotics</to_name>
		<to_code>M0014481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Narcotics</to_name>
		<to_code>M0014481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Narcotics</to_name>
		<to_code>M0014481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Narcotics</to_name>
		<to_code>M0014481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dibenzazepine</to_name>
		<to_code>M0520052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dibenzazepine</to_name>
		<to_code>M0520052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dibenzazepine</to_name>
		<to_code>M0520052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine hydrochloride</from_name>
		<from_code>150816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Imipramine Hydrochloride</to_name>
		<to_code>M0330160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine</from_name>
		<from_code>3247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine hydrochloride</from_name>
		<from_code>203174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine</from_name>
		<from_code>700810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serdexmethylphenidate</from_name>
		<from_code>2562176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine</from_name>
		<from_code>38400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desipramine dibudinate</from_name>
		<from_code>1099738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guafacine hydrochloride</from_name>
		<from_code>862004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atomoxetine hydrochloride</from_name>
		<from_code>353103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine dimesylate</from_name>
		<from_code>673579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>modafinil</from_name>
		<from_code>30125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine</from_name>
		<from_code>60842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine</from_name>
		<from_code>40114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serdexmethylphenidate chloride</from_name>
		<from_code>2562177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine mesylate</from_name>
		<from_code>60841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Attention Deficit Disorder with Hyperactivity</to_name>
		<to_code>M0001943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine</from_name>
		<from_code>5691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Imipramine</to_name>
		<to_code>M0011056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin</from_name>
		<from_code>3251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desmopressin acetate</from_name>
		<from_code>42634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enuresis</to_name>
		<to_code>M0007497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imipramine pamoate</from_name>
		<from_code>91118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Imipramine Pamoate</to_name>
		<to_code>M000643221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Imipramine Hydrochloride</to_name>
		<to_code>M0330160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Imipramine Hydrochloride</to_name>
		<to_code>M0330160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furazolidone</from_name>
		<from_code>4601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcohols</to_name>
		<to_code>M0000663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline mesylate</from_name>
		<from_code>577300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline hydrochloride</from_name>
		<from_code>203137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rasagiline</from_name>
		<from_code>134748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selegiline</from_name>
		<from_code>9639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meperidine</to_name>
		<to_code>M0013427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cheese</to_name>
		<to_code>M0003999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cheese</to_name>
		<to_code>M0003999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Buspirone Hydrochloride</to_name>
		<to_code>M0350950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril hydrochloride</from_name>
		<from_code>235758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazepril</from_name>
		<from_code>18867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lacidipine</from_name>
		<from_code>28382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz</from_name>
		<from_code>5033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril</from_name>
		<from_code>30131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valsartan</from_name>
		<from_code>69749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan</from_name>
		<from_code>214354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan medoxomil</from_name>
		<from_code>1091642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>candesartan cilexetil</from_name>
		<from_code>135481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepirodipine</from_name>
		<from_code>39879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolaprilat</from_name>
		<from_code>1546379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Angelica sinensis preparation</from_name>
		<from_code>328141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa anhydrous</from_name>
		<from_code>1545996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan medoxomil</from_name>
		<from_code>118463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochlorothiazide</from_name>
		<from_code>5487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride</from_name>
		<from_code>235224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan</from_name>
		<from_code>83515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine butyrate</from_name>
		<from_code>977863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin</from_name>
		<from_code>37798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin</from_name>
		<from_code>49276</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eplerenone</from_name>
		<from_code>298869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pinacidil</from_name>
		<from_code>33717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril hydrochloride</from_name>
		<from_code>259335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide acetate</from_name>
		<from_code>2176311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinyl estradiol</from_name>
		<from_code>4124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reserpine</from_name>
		<from_code>9260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benazeprilat</from_name>
		<from_code>1546196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindoprilat</from_name>
		<from_code>1546400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyclothiazide</from_name>
		<from_code>6860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexiprilat</from_name>
		<from_code>1546358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polythiazide</from_name>
		<from_code>8565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terazosin hydrochloride anhydrous</from_name>
		<from_code>1299927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan</from_name>
		<from_code>1091643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indapamide</from_name>
		<from_code>5764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren</from_name>
		<from_code>325646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine</from_name>
		<from_code>36514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril</from_name>
		<from_code>35208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nilvadipine</from_name>
		<from_code>53692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bopindolol</from_name>
		<from_code>19605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sulfate</from_name>
		<from_code>235959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine hydrochloride</from_name>
		<from_code>153679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guafacine hydrochloride</from_name>
		<from_code>862004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrendipine</from_name>
		<from_code>7441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinapril hydrochloride</from_name>
		<from_code>235759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol</from_name>
		<from_code>1520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepindolol</from_name>
		<from_code>29518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine</from_name>
		<from_code>8156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinaprilat</from_name>
		<from_code>1546359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmisartan</from_name>
		<from_code>73494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>xipamide</from_name>
		<from_code>11371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclothiazide</from_name>
		<from_code>22033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>irbesartan</from_name>
		<from_code>83818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine</from_name>
		<from_code>8163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amosulalol</from_name>
		<from_code>2667256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepindolol sulfate</from_name>
		<from_code>236904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy polyethylene glycol-epoetin beta</from_name>
		<from_code>729596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramipril</from_name>
		<from_code>35296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olmesartan</from_name>
		<from_code>321064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel sulfate</from_name>
		<from_code>91239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylpropanolamine hydrochloride</from_name>
		<from_code>3266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil hydrochloride</from_name>
		<from_code>235752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine</from_name>
		<from_code>3292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin hydrochloride</from_name>
		<from_code>203210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil</from_name>
		<from_code>83213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril</from_name>
		<from_code>29046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanabenz acetate</from_name>
		<from_code>227225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deserpidine</from_name>
		<from_code>62174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol hydrochloride</from_name>
		<from_code>203145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine hydrochloride</from_name>
		<from_code>259487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rescinnamine</from_name>
		<from_code>9259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroflumethiazide</from_name>
		<from_code>5495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mibefradil dihydrochloride</from_name>
		<from_code>83214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidapril</from_name>
		<from_code>60245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine monosulfate</from_name>
		<from_code>82023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine hydrochloride</from_name>
		<from_code>203142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine</from_name>
		<from_code>135056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>darbepoetin alfa</from_name>
		<from_code>283838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril sodium</from_name>
		<from_code>227278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide</from_name>
		<from_code>2396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aliskiren hemifumarate</from_name>
		<from_code>732498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothiazide sodium</from_name>
		<from_code>91217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol hydrochloride</from_name>
		<from_code>203131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barnidipine hydrochloride</from_name>
		<from_code>283819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol</from_name>
		<from_code>19484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprocitentan</from_name>
		<from_code>2679059</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tertatolol hydrochloride</from_name>
		<from_code>236374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinethazone</from_name>
		<from_code>59743</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol</from_name>
		<from_code>597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamterene</from_name>
		<from_code>10763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bendroflumethiazide</from_name>
		<from_code>1369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlormethiazide</from_name>
		<from_code>10772</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanfacine</from_name>
		<from_code>40114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadoxolol hydrochloride</from_name>
		<from_code>236178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride</from_name>
		<from_code>1294535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moexipril hydrochloride</from_name>
		<from_code>236066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine</from_name>
		<from_code>2376944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan potassium</from_name>
		<from_code>203160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol</from_name>
		<from_code>1817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bopindolol hydrogen malonate</from_name>
		<from_code>236903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine hydrochloride</from_name>
		<from_code>8164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trandolapril</from_name>
		<from_code>38454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanadrel</from_name>
		<from_code>26296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramiprilat</from_name>
		<from_code>1546377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tertatolol</from_name>
		<from_code>37840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadoxolol</from_name>
		<from_code>31462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>losartan</from_name>
		<from_code>52175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprenolol hydrochloride</from_name>
		<from_code>81947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinopril</from_name>
		<from_code>50166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril</from_name>
		<from_code>54552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa-epbx</from_name>
		<from_code>2047589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin</from_name>
		<from_code>8629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril calcium</from_name>
		<from_code>259493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zofenopril</from_name>
		<from_code>39990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide</from_name>
		<from_code>6911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methysergide maleate</from_name>
		<from_code>203190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide</from_name>
		<from_code>2176312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betaxolol hydrochloride</from_name>
		<from_code>142144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amosulalol hydrochloride</from_name>
		<from_code>2667255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine benzoate</from_name>
		<from_code>2184116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone acetate</from_name>
		<from_code>2055977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisinopril anhydrous</from_name>
		<from_code>1546022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metolazone</from_name>
		<from_code>6916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylalanine,DL-</from_name>
		<from_code>236948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spironolactone</from_name>
		<from_code>9997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine sulfate</from_name>
		<from_code>203181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthalidone</from_name>
		<from_code>2409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carazolol</from_name>
		<from_code>20192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acrivastine</from_name>
		<from_code>19959</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spirapril</from_name>
		<from_code>36908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guanethidine</from_name>
		<from_code>5036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate hydrochloride</from_name>
		<from_code>91241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxprenolol</from_name>
		<from_code>7801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manidipine</from_name>
		<from_code>29275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprosartan mesylate</from_name>
		<from_code>236878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celiprolol</from_name>
		<from_code>20498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol hydrochloride</from_name>
		<from_code>236806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levamlodipine maleate</from_name>
		<from_code>2377031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabergoline</from_name>
		<from_code>47579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flumethiazide</from_name>
		<from_code>89911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilazapril</from_name>
		<from_code>21102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopa</from_name>
		<from_code>6876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine tannate</from_name>
		<from_code>221139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosinoprilat</from_name>
		<from_code>1546393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine sul hemipenthy</from_name>
		<from_code>259379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azilsartan kamedoxomil</from_name>
		<from_code>1294597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin alfa</from_name>
		<from_code>105694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzthiazide</from_name>
		<from_code>19008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clevidipine</from_name>
		<from_code>233603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril erbumine</from_name>
		<from_code>72260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextrothyroxine sodium</from_name>
		<from_code>40070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bisoprolol fumarate</from_name>
		<from_code>142146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxazosin mesylate</from_name>
		<from_code>39173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sibutramine hydrochloride monohydrate</from_name>
		<from_code>221160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bepridil</from_name>
		<from_code>1436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenylephrine bitartrate</from_name>
		<from_code>91167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perindopril arginine</from_name>
		<from_code>1600711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydralazine</from_name>
		<from_code>3409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypertension</to_name>
		<to_code>M0010859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isocarboxazid</to_name>
		<to_code>M0011750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isocarboxazid</to_name>
		<to_code>M0011750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeine</from_name>
		<from_code>1886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Caffeine</to_name>
		<to_code>M0003138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Caffeine</to_name>
		<to_code>M0003138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Caffeine</to_name>
		<to_code>M0003138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bupropion Hydrochloride</to_name>
		<to_code>M0025362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasoconstrictor Agents</to_name>
		<to_code>M0022551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasoconstrictor Agents</to_name>
		<to_code>M0022551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasoconstrictor Agents</to_name>
		<to_code>M0022551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol</from_name>
		<from_code>24591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestrel</from_name>
		<from_code>7518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dienogest</from_name>
		<from_code>22968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol monohydrate</from_name>
		<from_code>2539035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone acetate</from_name>
		<from_code>2055977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>segesterone</from_name>
		<from_code>2055978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estetrol</from_name>
		<from_code>2539031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine sulfate</from_name>
		<from_code>8124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenelzine</from_name>
		<from_code>8123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxilan</from_name>
		<from_code>27793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethynodiol diacetate</from_name>
		<from_code>4170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebrovascular Disorders</to_name>
		<to_code>M0003914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxilan</from_name>
		<from_code>27793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ioxilan</to_name>
		<to_code>M0155895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Male Urogenital Diseases</to_name>
		<to_code>M0489510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Male Urogenital Diseases</to_name>
		<to_code>M0489510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Male Urogenital Diseases</to_name>
		<to_code>M0489510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Male Urogenital Diseases</to_name>
		<to_code>M0489510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Endoscopy</to_name>
		<to_code>M0007425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 1</from_name>
		<from_code>214485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin potassium</from_name>
		<from_code>660767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 75</from_name>
		<from_code>3275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate sodium</from_name>
		<from_code>287734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginseng preparation</from_name>
		<from_code>325526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran</from_name>
		<from_code>42635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine</from_name>
		<from_code>10594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrexate</from_name>
		<from_code>6851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desirudin</from_name>
		<from_code>114934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxaprozin</from_name>
		<from_code>32613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 40</from_name>
		<from_code>3272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextran 70</from_name>
		<from_code>3274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticlopidine hydrochloride</from_name>
		<from_code>97</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel</from_name>
		<from_code>32968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidogrel bisulfate</from_name>
		<from_code>236991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Blood Coagulation Disorders</to_name>
		<to_code>M0002683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron succinyl milk protein complex</from_name>
		<from_code>27825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iron succinyl protein complex</to_name>
		<to_code>M000642789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron succinyl milk protein complex</from_name>
		<from_code>27825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iron succinyl milk protein complex</to_name>
		<to_code>M000642788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idrocilamide</from_name>
		<from_code>19729</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>idrocilamide</to_name>
		<to_code>M0045673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cough</to_name>
		<to_code>M0005255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipecac</from_name>
		<from_code>5975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ipecac</to_name>
		<to_code>M0011696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medazepam</from_name>
		<from_code>6680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifampridine</from_name>
		<from_code>2106338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline sodium glycinate</from_name>
		<from_code>155075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline dihydrate</from_name>
		<from_code>1298965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ganaxolone</from_name>
		<from_code>2604689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine</from_name>
		<from_code>684879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paraldehyde</from_name>
		<from_code>7909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perampanel</from_name>
		<from_code>1356552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pregabalin</from_name>
		<from_code>187832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline anhydrous</from_name>
		<from_code>91178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etomidate</from_name>
		<from_code>4177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline hydrate</from_name>
		<from_code>388049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barbital sodium</from_name>
		<from_code>235404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brivaracetam</from_name>
		<from_code>1739745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rufinamide</from_name>
		<from_code>69036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felbamate</from_name>
		<from_code>24812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxine hydrochloride</from_name>
		<from_code>203164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lamotrigine</from_name>
		<from_code>28439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfampridine</from_name>
		<from_code>897018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medium chain triglycerides</from_name>
		<from_code>1310578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifampridine phosphate</from_name>
		<from_code>2106337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>barbital</from_name>
		<from_code>1325</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stiripentol</from_name>
		<from_code>2054968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonazepam</from_name>
		<from_code>2598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridoxal phosphate</from_name>
		<from_code>9004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobazam</from_name>
		<from_code>21241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Seizures</to_name>
		<to_code>M0019597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine dioxide</from_name>
		<from_code>236815</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth-formic-iodide</from_name>
		<from_code>237148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcitrate</from_name>
		<from_code>47181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate sodium</from_name>
		<from_code>71722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant dimeglumine</from_name>
		<from_code>754763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide</from_name>
		<from_code>19041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide</from_name>
		<from_code>38685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth hydroxide</from_name>
		<from_code>235954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate</from_name>
		<from_code>82003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine lactate</from_name>
		<from_code>91071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nabilone</from_name>
		<from_code>31447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate potassium</from_name>
		<from_code>82002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzquinamide hydrochloride</from_name>
		<from_code>91272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine hydrochloride</from_name>
		<from_code>235775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronabinol</from_name>
		<from_code>10402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subcarbonate</from_name>
		<from_code>19475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosaprepitant</from_name>
		<from_code>1731071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprepitant</from_name>
		<from_code>358255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netupitant</from_name>
		<from_code>1552337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant hydrochloride</from_name>
		<from_code>1673367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine</from_name>
		<from_code>59636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethobenzamide hydrochloride</from_name>
		<from_code>57227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrous oxide</from_name>
		<from_code>7486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subnitrate</from_name>
		<from_code>19477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine</from_name>
		<from_code>8745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>docusate calcium</from_name>
		<from_code>82001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant</from_name>
		<from_code>2044417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine</from_name>
		<from_code>8352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subgallate</from_name>
		<from_code>19476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine</from_name>
		<from_code>10471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrochloride</from_name>
		<from_code>142445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosnetupitant chloride hydrochloride</from_name>
		<from_code>2044416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promethazine hydrobromide</from_name>
		<from_code>485608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimenhydrinate</from_name>
		<from_code>3444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol</from_name>
		<from_code>23370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiethylperazine maleate</from_name>
		<from_code>71529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone phosphate</from_name>
		<from_code>235486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenidol hydrochloride</from_name>
		<from_code>47877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine</from_name>
		<from_code>2977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate anhydrous</from_name>
		<from_code>2378841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine hydrochloride</from_name>
		<from_code>155017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth subsalicylate</from_name>
		<from_code>19478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bismuth</from_name>
		<from_code>1599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclizine tartrate</from_name>
		<from_code>235771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buclizine hydrochloride</from_name>
		<from_code>91070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone trimethyl acetate</from_name>
		<from_code>22694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolapitant</from_name>
		<from_code>1665496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone</from_name>
		<from_code>3264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>di-n-octyl sodium sulfosuccinate</from_name>
		<from_code>1534779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nausea</to_name>
		<to_code>M0014528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isostearate</from_name>
		<from_code>1424880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isostearate</to_name>
		<to_code>M0121756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iproniazid</from_name>
		<from_code>5981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iproniazid</to_name>
		<to_code>M0011704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iocetamic acid</from_name>
		<from_code>183830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iocetamic acid</to_name>
		<to_code>M0198136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iocetamic acid</from_name>
		<from_code>183830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biliary Tract Diseases</to_name>
		<to_code>M0002491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biliary Tract Diseases</to_name>
		<to_code>M0002491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biliary Tract Diseases</to_name>
		<to_code>M0002491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Biliary Tract Diseases</to_name>
		<to_code>M0002491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ilomastat</from_name>
		<from_code>1368877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ilomastat</to_name>
		<to_code>M0305265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate (1:1)</from_name>
		<from_code>317238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate (1:1)</from_name>
		<from_code>317238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate</from_name>
		<from_code>104994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peanut oil</from_name>
		<from_code>18235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>probucol</from_name>
		<from_code>8699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine hydrochloride</from_name>
		<from_code>993491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribavirin</from_name>
		<from_code>9344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese chloride</from_name>
		<from_code>29261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichloralphenazone</from_name>
		<from_code>22892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midodrine</from_name>
		<from_code>6963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxymesterone</from_name>
		<from_code>4494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heart Diseases</to_name>
		<to_code>M0009951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isometheptene mucate</from_name>
		<from_code>104994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium bromide</from_name>
		<from_code>48212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbachol</from_name>
		<from_code>1999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol</from_name>
		<from_code>1817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupranolol hydrochloride</from_name>
		<from_code>236806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide</from_name>
		<from_code>167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichlorphenamide</from_name>
		<from_code>3353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepindolol sulfate</from_name>
		<from_code>236904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>echothiophate iodide</from_name>
		<from_code>3740</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine hydrochloride</from_name>
		<from_code>91240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine hydrochloride</from_name>
		<from_code>203198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion hydrochloride</from_name>
		<from_code>81998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mepindolol</from_name>
		<from_code>29518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine sulfate</from_name>
		<from_code>81952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine</from_name>
		<from_code>1422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecamylamine</from_name>
		<from_code>6673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine</from_name>
		<from_code>700810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate monohydrate</from_name>
		<from_code>405812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine saccharate</from_name>
		<from_code>540810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurophate</from_name>
		<from_code>6027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecothiopate</from_name>
		<from_code>89778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine dimesylate</from_name>
		<from_code>673579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dichloralphenazone</from_name>
		<from_code>22892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clidinium</from_name>
		<from_code>21232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylpropion</from_name>
		<from_code>3389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzphetamine hydrochloride</from_name>
		<from_code>142425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenmetrazine</from_name>
		<from_code>8133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetazolamide sodium</from_name>
		<from_code>91406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine</from_name>
		<from_code>725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphetamine aspartate</from_name>
		<from_code>221057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glaucoma</to_name>
		<to_code>M0009260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isodecyl alcohol</from_name>
		<from_code>2361827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isodecyl alcohol</to_name>
		<to_code>M0552369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate</from_name>
		<from_code>5973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ioxaglate</to_name>
		<to_code>M0011691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobutyramide</from_name>
		<from_code>1653517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isobutyramide</to_name>
		<to_code>M0095740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isethionic acid</from_name>
		<from_code>1364896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isethionic Acid</to_name>
		<to_code>M0011736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indobufen</from_name>
		<from_code>27518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indobufen</to_name>
		<to_code>M0074020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 chloride</from_name>
		<from_code>42987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indium trichloride, 111In-labeled</to_name>
		<to_code>M0314297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglic acid</from_name>
		<from_code>1426458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ioxaglic Acid</to_name>
		<to_code>M0011693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indeloxazine</from_name>
		<from_code>1311673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indeloxazine</to_name>
		<to_code>M0075088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoascorbic acid</from_name>
		<from_code>1356145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoascorbic acid</to_name>
		<to_code>M0046353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl alcohol</from_name>
		<from_code>797541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-Propanol</to_name>
		<to_code>M0029450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl myristate</from_name>
		<from_code>27985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isopropyl myristate</to_name>
		<to_code>M0051850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoceteth 20</from_name>
		<from_code>1368878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoceteth 20</to_name>
		<to_code>M0560715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isorhynchophylline</from_name>
		<from_code>2562548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isorhyncophylline</to_name>
		<to_code>M0149537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iothalamic acid</from_name>
		<from_code>1546451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iothalamic Acid</to_name>
		<to_code>M0011688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl acetate</from_name>
		<from_code>1599636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isopropyl acetate</to_name>
		<to_code>M0189370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inosinic acid</from_name>
		<from_code>5832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inosinic Acid</to_name>
		<to_code>M0011370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inosinic acid</from_name>
		<from_code>5832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inosine Monophosphate</to_name>
		<to_code>M0011369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodoxamid</from_name>
		<from_code>51471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iodoxamate</to_name>
		<to_code>M0263291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-12</from_name>
		<from_code>1309680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-12</to_name>
		<to_code>M0027969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidazole-2-hydroxybenzoate</from_name>
		<from_code>27438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>imidazole-2-hydroxybenzoate</to_name>
		<to_code>M0127471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ibalizumab</to_name>
		<to_code>M0460791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab</from_name>
		<from_code>2043283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin, protamine zinc, human</from_name>
		<from_code>236646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>insulin, protamine zinc, human</to_name>
		<to_code>M0465329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflupredone acetate</from_name>
		<from_code>1364586</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoflupredone acetate</to_name>
		<to_code>M0180323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropylphenylbutanal</from_name>
		<from_code>2383935</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isopropylphenylbutanal</to_name>
		<to_code>M000627247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iprindole</from_name>
		<from_code>5979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iprindole</to_name>
		<to_code>M0011703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodophors</from_name>
		<from_code>596712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iodophors</to_name>
		<to_code>M0011665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indoramin</from_name>
		<from_code>5784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indoramin</to_name>
		<to_code>M0011253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocorynoxeine</from_name>
		<from_code>2562547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>corynoxeine, (16E,20alpha)-isomer</to_name>
		<to_code>M0323527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-iodo-2-propynylbutylcarbamate</from_name>
		<from_code>1426467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-iodo-2-propynylbutylcarbamate</to_name>
		<to_code>M0277631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-n1</from_name>
		<from_code>202912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>interferon alfa-n1</to_name>
		<to_code>M0025713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoprene</from_name>
		<from_code>1364275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoprene</to_name>
		<to_code>M0046356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigotindisulfonic acid</from_name>
		<from_code>1546441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(1,3-Dihydro-3-oxo-5-sulpho-2H-indol-2-ylidene)-3- oxoindoline-5-sulphonic acid</to_name>
		<to_code>M000638472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isostearyl alcohol</from_name>
		<from_code>1362928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isostearyl alcohol</to_name>
		<to_code>M0086306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isomethyleugenol</from_name>
		<from_code>1423782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isomethyleugenol</to_name>
		<to_code>M0097858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobornyl acetate</from_name>
		<from_code>2398330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pichtosin</to_name>
		<to_code>M0057553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isomaltulose anhydrous</from_name>
		<from_code>2607147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isomaltulose</to_name>
		<to_code>M0051828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isomaltulose</from_name>
		<from_code>2607148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isomaltulose</to_name>
		<to_code>M0051828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidocarb</from_name>
		<from_code>1740237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Imidocarb</to_name>
		<to_code>M0011050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropyl palmitate</from_name>
		<from_code>1311179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isopropyl palmitate</to_name>
		<to_code>M0046357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-10</from_name>
		<from_code>1311299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-10</to_name>
		<to_code>M0025510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green</from_name>
		<from_code>5775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indocyanine green</from_name>
		<from_code>5775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indocyanine Green</to_name>
		<to_code>M0011235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium cation</from_name>
		<from_code>1546421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium</from_name>
		<from_code>3752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine bromide</from_name>
		<from_code>9001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine</from_name>
		<from_code>9000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodohippurate I131 sodium</from_name>
		<from_code>91540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium chloride</from_name>
		<from_code>3754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urologic Diseases</to_name>
		<to_code>M0022400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin-like growth factor 2</from_name>
		<from_code>1728770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin-Like Growth Factor II</to_name>
		<to_code>M0011435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir anhydrous</from_name>
		<from_code>1546024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone hydrochloride</from_name>
		<from_code>236082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terfenadine</from_name>
		<from_code>42330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluconazole</from_name>
		<from_code>4450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetyl sulfisoxazole</from_name>
		<from_code>40595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole</from_name>
		<from_code>10207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nefazodone</from_name>
		<from_code>31565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terfenadine</to_name>
		<to_code>M0025307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir</from_name>
		<from_code>114289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir mesylate</from_name>
		<from_code>266565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ritonavir</from_name>
		<from_code>85762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir</from_name>
		<from_code>83395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tipranavir</from_name>
		<from_code>190548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Amiodarone</to_name>
		<to_code>M0000973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indinavir Sulfate</to_name>
		<to_code>M0329078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indinavir sulfate</from_name>
		<from_code>203153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprazolam</from_name>
		<from_code>596</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine mesylate</from_name>
		<from_code>142152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delavirdine</from_name>
		<from_code>83816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alprazolam</to_name>
		<to_code>M0000806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate meglumine</from_name>
		<from_code>66895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ioxaglate Meglumine</to_name>
		<to_code>M0011694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron sorbitex</from_name>
		<from_code>27824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citric acid, iron, sorbitol drug combination</to_name>
		<to_code>M0051790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iloperidone</from_name>
		<from_code>73178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iloperidone</to_name>
		<to_code>M0217926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropanolamine</from_name>
		<from_code>1736006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monoisopropanolamine</to_name>
		<to_code>M0052486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iron protein succinylate</from_name>
		<from_code>27823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iron protein succinylate</to_name>
		<to_code>M0155218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane I-123</from_name>
		<from_code>1426874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>123I-ioflupane</to_name>
		<to_code>M0509567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoamyl acetate</from_name>
		<from_code>1368172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoamyl acetate</to_name>
		<to_code>M0074029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetate disodium</from_name>
		<from_code>259268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indium-DTPA</to_name>
		<to_code>M0006867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulin A</from_name>
		<from_code>1426454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunoglobulin A</to_name>
		<to_code>M0011000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidazolidinone</from_name>
		<from_code>2565925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylene urea</to_name>
		<to_code>M0046117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ipriflavone</from_name>
		<from_code>51487</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ipriflavone</to_name>
		<to_code>M0071058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidocarb dipropionate</from_name>
		<from_code>1740238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>imidocarb dipropionate</to_name>
		<to_code>M0099455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidacloprid</from_name>
		<from_code>1251576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>imidacloprid</to_name>
		<to_code>M0219479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobutylparaben</from_name>
		<from_code>1364296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isobutylparaben</to_name>
		<to_code>M0445670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopentane</from_name>
		<from_code>1368703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isopentane</to_name>
		<to_code>M0183855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigo carmine</from_name>
		<from_code>227312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>FD&amp;C Blue No. 2</to_name>
		<to_code>M0585830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indigo carmine</from_name>
		<from_code>227312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indigo Carmine</to_name>
		<to_code>M0011229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium In-111 pentetreotide</from_name>
		<from_code>1724429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indium In 111 pentetreotide</to_name>
		<to_code>M0326202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodide ion I-123</from_name>
		<from_code>1361657</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iodine-123</to_name>
		<to_code>M000627484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indican</from_name>
		<from_code>2463933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indican</to_name>
		<to_code>M0011222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chemical and Drug Induced Liver Injury</to_name>
		<to_code>M0527454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isoniazid</to_name>
		<to_code>M0011772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoniazid</from_name>
		<from_code>6038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab-uiyk</from_name>
		<from_code>2043313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ibalizumab-uiyk</to_name>
		<to_code>M000675446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab-uiyk</from_name>
		<from_code>2043313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibalizumab-uiyk</from_name>
		<from_code>2043313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-3</from_name>
		<from_code>1311225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-3</to_name>
		<to_code>M0011508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-11</from_name>
		<from_code>1311380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-11</to_name>
		<to_code>M0026381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icariin</from_name>
		<from_code>1788871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>icariin</to_name>
		<to_code>M0158708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ispaghula extract</from_name>
		<from_code>82089</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ispaghula</to_name>
		<to_code>M0018071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iminodisuccinate</from_name>
		<from_code>1366938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iminodisuccinate</to_name>
		<to_code>M0369055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indanazoline</from_name>
		<from_code>27492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indanazoline</to_name>
		<to_code>M0089655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iprazochrome</from_name>
		<from_code>51486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iprazochrome</to_name>
		<to_code>M0054699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflupredone</from_name>
		<from_code>1546449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>9-fluoroprednisolone</to_name>
		<to_code>M0056879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-7</from_name>
		<from_code>1367202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-7</to_name>
		<to_code>M0024273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imperialine</from_name>
		<from_code>1860087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>peiminine</to_name>
		<to_code>M0136763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin detemir</from_name>
		<from_code>139825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin Detemir</to_name>
		<to_code>M0274330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobutyl alcohol</from_name>
		<from_code>1363048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isobutyl alcohol</to_name>
		<to_code>M0120594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imepitoin</from_name>
		<from_code>2600779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>imepitoin</to_name>
		<to_code>M000598231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isostearic acid</from_name>
		<from_code>1424879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isostearic acid</to_name>
		<to_code>M0121757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen</from_name>
		<from_code>1804259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza Vaccines</to_name>
		<to_code>M0011310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen</from_name>
		<from_code>1804259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>IR-3535</from_name>
		<from_code>1737733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>IR 3535</to_name>
		<to_code>M0540393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoleucine</from_name>
		<from_code>6033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Isoleucine</to_name>
		<to_code>M0011766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iridium</from_name>
		<from_code>1311131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iridium</to_name>
		<to_code>M0011709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoeugenol</from_name>
		<from_code>1363706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoeugenol</to_name>
		<to_code>M0111440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inulin</from_name>
		<from_code>5924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inulin</to_name>
		<to_code>M0011618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoeugenyl acetate</from_name>
		<from_code>2393779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methoxy-4-prop-1-enylphenyl acetate</to_name>
		<to_code>M0352281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ispaghula husk</from_name>
		<from_code>104129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ispaghula husk</to_name>
		<to_code>M000744203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-6</from_name>
		<from_code>1367185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-6</to_name>
		<to_code>M0024272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iota-carrageenan</from_name>
		<from_code>2565488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iota-Carrageenan</to_name>
		<to_code>M0003556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isophorone diisocyanate</from_name>
		<from_code>2626882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isophorone diisocyanate</to_name>
		<to_code>M0064461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iopentol</from_name>
		<from_code>27779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iopentol</to_name>
		<to_code>M0151714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodipamide</from_name>
		<from_code>5936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iodipamide</to_name>
		<to_code>M0011648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isothipendyl hydrochloride</from_name>
		<from_code>235726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isothipendyl hydrochloride</to_name>
		<to_code>M0540408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoamyl salicylate</from_name>
		<from_code>1940006</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isoamyl salicylate</to_name>
		<to_code>M0055534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icosapent ethyl</from_name>
		<from_code>1304974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eicosapentaenoic acid ethyl ester</to_name>
		<to_code>M0108217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobutyl acetate</from_name>
		<from_code>1603476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isobutyl acetate</to_name>
		<to_code>M0117027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioflupane</from_name>
		<from_code>2571854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ioflupane</to_name>
		<to_code>M0509566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>idebenone</from_name>
		<from_code>51296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>idebenone</to_name>
		<to_code>M0111395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibutamoren mesylate</from_name>
		<from_code>1805437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ibutamoren mesylate</to_name>
		<to_code>M0578056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>imidazole</from_name>
		<from_code>2472898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>imidazole</to_name>
		<to_code>M0095023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ioxaglate sodium</from_name>
		<from_code>66896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ioxaglate Sodium</to_name>
		<to_code>M0011695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intrinsic factor</from_name>
		<from_code>5920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Intrinsic Factor</to_name>
		<to_code>M0011611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin isophane</from_name>
		<from_code>1605101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Insulin, Isophane</to_name>
		<to_code>M0011436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-4</from_name>
		<from_code>5891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-4</to_name>
		<to_code>M0024266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>binetrakin</from_name>
		<from_code>1426682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-4</to_name>
		<to_code>M0024266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indole-3-carbinol</from_name>
		<from_code>2598119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>indole-3-carbinol</to_name>
		<to_code>M0066561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus</from_name>
		<from_code>1312376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus antigen</from_name>
		<from_code>1657134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated, B-Florida-4-2006-like virus (B-Florida-4-2006) strain</from_name>
		<from_code>805524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/60/2008 antigen</from_name>
		<from_code>1657226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Iowa/06/2017 antigen</from_name>
		<from_code>2056523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Maryland/15/2016 antigen</from_name>
		<from_code>2048563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Victoria/705/2018 antigen</from_name>
		<from_code>2380575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Washington/02/2019 antigen</from_name>
		<from_code>2280293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Darwin/7/2019 antigen</from_name>
		<from_code>2380838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baloxavir marboxil</from_name>
		<from_code>2099995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/WUH4618/2021 antigen</from_name>
		<from_code>2605725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Austria/1359417/2021 antigen</from_name>
		<from_code>2605039</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Michigan/01/2021 antigen</from_name>
		<from_code>2593400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/9/2014 antigen</from_name>
		<from_code>1723997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen</from_name>
		<from_code>2056525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen</from_name>
		<from_code>1664172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Live Attenuated, B-Brisbane-60-2008 strain</from_name>
		<from_code>857953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Utah/9/2014 antigen</from_name>
		<from_code>1657133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Panama/45/90 antigen</from_name>
		<from_code>2262062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated, Influenza B (B-Florida-4-2006) strain</from_name>
		<from_code>805471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Phuket/3073/2013 antigen</from_name>
		<from_code>1657228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Brisbane/46/2015 antigen</from_name>
		<from_code>1942125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Inactivated B-Florida-4-2006 strain</from_name>
		<from_code>805553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>influenza B virus B/Hong Kong/259/2010 antigen</from_name>
		<from_code>1801603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza Virus Vaccine, Live Attenuated, B-Florida-4-2006 strain</from_name>
		<from_code>805541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus</from_name>
		<from_code>1427020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Influenza B virus</to_name>
		<to_code>M0015476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-iodobenzylguanidine</from_name>
		<from_code>14448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-Iodobenzylguanidine</to_name>
		<to_code>M0029373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobornyl acrylate</from_name>
		<from_code>1603858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isobornyl acrylate</to_name>
		<to_code>M0592490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isobutylene</from_name>
		<from_code>2099712</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isobutylene</to_name>
		<to_code>M0051801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-9</from_name>
		<from_code>1309465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-9</to_name>
		<to_code>M0025726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>inosine pranobex</from_name>
		<from_code>6048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Inosine Pranobex</to_name>
		<to_code>M0011778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodamide</from_name>
		<from_code>5928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Iodamide</to_name>
		<to_code>M0011626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interleukin-5</from_name>
		<from_code>1367184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interleukin-5</to_name>
		<to_code>M0024267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iso-sulfan blue</from_name>
		<from_code>27863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iso-sulfan blue</to_name>
		<to_code>M0084883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iso-sulfan blue</from_name>
		<from_code>27863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lymphatic Abnormalities</to_name>
		<to_code>M0444479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>indium-111</from_name>
		<from_code>90540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indium-111</to_name>
		<to_code>M000628077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isomaltitol</from_name>
		<from_code>2600777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isomaltitol</to_name>
		<to_code>M0051824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isocetane</from_name>
		<from_code>1987477</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isocetane</to_name>
		<to_code>M000642790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isospaglumic acid</from_name>
		<from_code>236303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isospaglumic acid</to_name>
		<to_code>M0088582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isavuconazonium sulfate</from_name>
		<from_code>1608321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isavuconazonium sulfate</to_name>
		<to_code>M000605299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>insulin glargine-yfgn</from_name>
		<from_code>2563969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Semglee</to_name>
		<to_code>M000751185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon-beta</from_name>
		<from_code>4381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Interferon-beta</to_name>
		<to_code>M0025715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isothipendyl</from_name>
		<from_code>28012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isothipendyl</to_name>
		<to_code>M0051873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodoform</from_name>
		<from_code>27748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iodoform</to_name>
		<to_code>M0055992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypericum perforatum leaf extract</to_name>
		<to_code>1307704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana root bark-stem bark extract</to_name>
		<to_code>1309697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptylundecyl hydroxystearate</to_name>
		<to_code>1364948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (20000 WAMW)</to_name>
		<to_code>2535502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamethylindanopyran</to_name>
		<to_code>1314281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyldecyl isostearate</to_name>
		<to_code>1812580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helminthosporium solani allergenic extract</to_name>
		<to_code>867232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (750 MPA.S)</to_name>
		<to_code>2361308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Gelidium sesquipedale polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type L)</to_name>
		<to_code>1356137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxytyrosol</to_name>
		<to_code>1314227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrochloric acid</to_name>
		<to_code>5486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-lpuj</to_name>
		<to_code>2729290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Humulus lupulus whole extract</to_name>
		<to_code>1535492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated poly(C6-14 olefin; 4 CST)</to_name>
		<to_code>2639343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexane</to_name>
		<to_code>1999411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2906 (50 MPA.S)</to_name>
		<to_code>1297881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypericum perforatum flower extract</to_name>
		<to_code>1309362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2'-hydroxyacetophenone</to_name>
		<to_code>1664428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human adrenal gland preparation</to_name>
		<to_code>2277352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hard fat</to_name>
		<to_code>1368196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexylcaine hydrochloride</to_name>
		<to_code>1546032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparinoids</to_name>
		<to_code>5228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyprogesterone caproate (USP)</to_name>
		<to_code>12488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hesperidin</to_name>
		<to_code>5281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose, unspecified</to_name>
		<to_code>2204929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honey preparation</to_name>
		<to_code>285279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>humulene</to_name>
		<to_code>2266811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haloprogin</to_name>
		<to_code>26422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honey mushroom extract</to_name>
		<to_code>2592969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated didecene</to_name>
		<to_code>1440250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hordeum vulgare whole extract</to_name>
		<to_code>1858363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 0.45% stearoxy ether</to_name>
		<to_code>2601503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus syriacus bark extract</to_name>
		<to_code>1608319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroquinidine</to_name>
		<to_code>27220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homosalate</to_name>
		<to_code>91326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed casein (enzymatic; 1000 MW)</to_name>
		<to_code>1812932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxybenzoic acid</to_name>
		<to_code>1649527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxystearate</to_name>
		<to_code>1370462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heather pollen extract</to_name>
		<to_code>1484977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heroin</to_name>
		<to_code>3304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halobetasol propionate</to_name>
		<to_code>45318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed sheep wool keratin (2000 MW)</to_name>
		<to_code>2056288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyzine pamoate</to_name>
		<to_code>203182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hydroxy-4-methoxybenzenesulfonic acid</to_name>
		<to_code>1307551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse chestnut seed</to_name>
		<to_code>260020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexachlorophene</to_name>
		<to_code>5293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxydecyl ubiquinoyl dipalmitoyl glycerate</to_name>
		<to_code>1943485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homarine</to_name>
		<to_code>1426930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halobetasol</to_name>
		<to_code>41208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>high-density polyethylene</to_name>
		<to_code>1424910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horseradish allergenic extract</to_name>
		<to_code>1011043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (140 CPSat 5%)</to_name>
		<to_code>1305727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyoscyamus niger leaf extract</to_name>
		<to_code>1487831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hoodia gordonii sap extract</to_name>
		<to_code>2669318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Heloderma horridum venom</to_name>
		<to_code>1310457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (15000 MPA.S)</to_name>
		<to_code>1300445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexanoyl dipeptide-3 norleucine acetate</to_name>
		<to_code>1426471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hexenyl acetate, (3Z)-</to_name>
		<to_code>1426376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (10000 MPA.S)</to_name>
		<to_code>1437983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>helicin</to_name>
		<to_code>236999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen</to_name>
		<to_code>5497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl urea</to_name>
		<to_code>1363605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hovenia dulcis whole extract</to_name>
		<to_code>2204928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed placental protein (bovine)</to_name>
		<to_code>1311655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hygromycin B</to_name>
		<to_code>1426887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hydroxyacetophenone</to_name>
		<to_code>1919492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippophae rhamnoides whole extract</to_name>
		<to_code>1356686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</to_name>
		<to_code>1300806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type G)</to_name>
		<to_code>1596141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana leaf water extract</to_name>
		<to_code>1307819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexapeptide-10</to_name>
		<to_code>1739993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated tallow acid</to_name>
		<to_code>1425354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptaminol acefyllinate</to_name>
		<to_code>236292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bisstearyldimonium</to_name>
		<to_code>1368487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Harrisia pomanensis stem extract</to_name>
		<to_code>1431718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-tqjs</to_name>
		<to_code>2693885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose phthalate (24% phthalate, 55 CST)</to_name>
		<to_code>1368890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated soybean lecithin</to_name>
		<to_code>1426418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hieracium pilosella whole extract</to_name>
		<to_code>1649349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hericium erinaceus fruiting body extract</to_name>
		<to_code>2631132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone aceponate</to_name>
		<to_code>41277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G2 vaccine</to_name>
		<to_code>798288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hippurate</to_name>
		<to_code>1923620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house mouse hair extract</to_name>
		<to_code>1993210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hexaplex trunculus hypobranchial gland juice</to_name>
		<to_code>1312379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedera helix top extract</to_name>
		<to_code>1311601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(4-hydroxy-3-methoxyphenyl)-decan-3-one</to_name>
		<to_code>1928181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bis-hydroxyethyldimonium chloride</to_name>
		<to_code>1492301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus sabdariffa flower extract</to_name>
		<to_code>1309215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl corn starch (5% substitution by weight)</to_name>
		<to_code>1363607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxymethoxyphenyl propylmethylmethoxybenzofuran</to_name>
		<to_code>2043287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G1 vaccine</to_name>
		<to_code>798286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>habanero extract</to_name>
		<to_code>1337637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxycitronellal</to_name>
		<to_code>1362893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honey locust whole extract</to_name>
		<to_code>2263066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippophae rhamnoides fruit extract</to_name>
		<to_code>1311546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2-hexanediol</to_name>
		<to_code>1362584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human colostrum</to_name>
		<to_code>1605775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexocyclium methylsulfate</to_name>
		<to_code>235430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hemidesmus indicus root extract</to_name>
		<to_code>1309969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heavy mineral oil</to_name>
		<to_code>258439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippomane mancinella fruiting leafy twig extract</to_name>
		<to_code>1310002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptaminol</to_name>
		<to_code>5254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-nvhy</to_name>
		<to_code>2700789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hazelnut pollen extract</to_name>
		<to_code>852281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hippuric acid</to_name>
		<to_code>1923619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human parathyroid preparation</to_name>
		<to_code>1597627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydrangea arborescens root extract</to_name>
		<to_code>1309475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>10-hydroxycapric acid</to_name>
		<to_code>1368622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Gelidium rex polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated palm kernel oil</to_name>
		<to_code>1309360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-hydroxytryptophan, DL-</to_name>
		<to_code>1313305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B surface antigen vaccine</to_name>
		<to_code>797752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose, low substituted</to_name>
		<to_code>1363584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated olive oil cetyl esters</to_name>
		<to_code>1855890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl acetate</to_name>
		<to_code>1807127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haloperidol decanoate</to_name>
		<to_code>26420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyoctacosanyl hydroxystearate</to_name>
		<to_code>1367169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hymenoptera allergenic extract</to_name>
		<to_code>235614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen cyanide</to_name>
		<to_code>1367183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halofantrine hydrochloride</to_name>
		<to_code>58130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HYDROLYZED JOJOBA ESTERS (ACID FORM)</to_name>
		<to_code>1307311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Human skin proteins, partially hydrolyzed</to_name>
		<to_code>1657854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hemophilus B polysaccharide</to_name>
		<to_code>314656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase, bovine</to_name>
		<to_code>578350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (6 cps)</to_name>
		<to_code>1300454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolysed Lepidium meyenii root extract (enzymatic)</to_name>
		<to_code>1742993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helleborus extract</to_name>
		<to_code>2047647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hymetellose (4150 MPA.S)</to_name>
		<to_code>2118527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus lunariifolius whole extract</to_name>
		<to_code>2480116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus sabdariffa whole extract</to_name>
		<to_code>2568104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human cord blood hematopoietic progenitor cell</to_name>
		<to_code>1307732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexasodium hexametaphosphate</to_name>
		<to_code>1487530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexametaphosphate</to_name>
		<to_code>1487531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated rapeseed oil</to_name>
		<to_code>1440247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haberlea rhodopensis leaf extract</to_name>
		<to_code>1310093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypnea musciformis extract</to_name>
		<to_code>1363609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed oryzanol</to_name>
		<to_code>2585254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hylan G-F 20</to_name>
		<to_code>284637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herring allergenic extract</to_name>
		<to_code>899434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated palm kernel glycerides</to_name>
		<to_code>1313709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heliotropine butane-2,3-diol acetal</to_name>
		<to_code>2467279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bisstearamide monoethanolamide</to_name>
		<to_code>1541741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana whole extract</to_name>
		<to_code>1314854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyamphetamine hydrobromide</to_name>
		<to_code>82066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated methyl abietate</to_name>
		<to_code>1440228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homatropine hydrobromide</to_name>
		<to_code>235428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl methylcellulose phthalate</to_name>
		<to_code>1363587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human coxsackievirus B1</to_name>
		<to_code>1427209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus laevis flower extract</to_name>
		<to_code>2123308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (15000 MPA.S)</to_name>
		<to_code>1300451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (70000 WAMW)</to_name>
		<to_code>2099291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated avocado oil</to_name>
		<to_code>1440252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone</to_name>
		<to_code>5492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>helicidine</to_name>
		<to_code>233562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>10-hydroxydecanoate</to_name>
		<to_code>1368623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedeoma pulegioides extract</to_name>
		<to_code>1353881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropylcocoate PEG-8 dimethicone</to_name>
		<to_code>1482914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl gamma-cyclodextrin</to_name>
		<to_code>1601114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hydroxyethyl acrylate</to_name>
		<to_code>1314328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-zzxf</to_name>
		<to_code>2382595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen dimethicone (13 CST)</to_name>
		<to_code>1793893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis A vaccine (inactivated) strain HM175</to_name>
		<to_code>798361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated castor oil</to_name>
		<to_code>1309218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hydroxypropyl methacrylate</to_name>
		<to_code>2204914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Houttuynia cordata top extract</to_name>
		<to_code>2001175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus sabdariffa calyx extract</to_name>
		<to_code>1311543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Holothuria sea cucumber preparation</to_name>
		<to_code>2166042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronate</to_name>
		<to_code>62372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptyl undecylenate</to_name>
		<to_code>1307091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human papillomavirus</to_name>
		<to_code>1311095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helleborus niger root extract</to_name>
		<to_code>1309990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hydroxy-4-methoxybenzenesulfonate</to_name>
		<to_code>1370572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxybutyric acid</to_name>
		<to_code>1546380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herring sperm DNA</to_name>
		<to_code>1314256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose, unspecified</to_name>
		<to_code>1804020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose acetate succinate 16070722 (3 Mm2-S)</to_name>
		<to_code>1313185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexacosanoic acid</to_name>
		<to_code>1997245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl guar hydroxypropyltrimonium chloride</to_name>
		<to_code>2683200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyprogesterone acetate</to_name>
		<to_code>1101886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hog epithelia extract</to_name>
		<to_code>852091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bis-hydroxyethyldimonium</to_name>
		<to_code>1492302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated jojoba oil, randomized</to_name>
		<to_code>1540881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated olive oil unsaponifiables</to_name>
		<to_code>1799145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herpesvirus 6, human</to_name>
		<to_code>2167553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cetyldimonium phosphate</to_name>
		<to_code>1549632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hawthorn leaf with flower extract</to_name>
		<to_code>1309793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human ligament preparation</to_name>
		<to_code>1657853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>huperzine A</to_name>
		<to_code>2267703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Gracilaria vermiculophylla polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyssopus officinalis extract</to_name>
		<to_code>1309237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose acetate succinate 12070923 (3 MM2-S)</to_name>
		<to_code>1426290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hymecromone</to_name>
		<to_code>5556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl-alpha-cyclodextrin</to_name>
		<to_code>1442707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexylcaine</to_name>
		<to_code>26879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HC yellow no. 5</to_name>
		<to_code>1428873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypericin</to_name>
		<to_code>1546455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydnocarpus castaneus whole extract</to_name>
		<to_code>2709113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxy acetophenone</to_name>
		<to_code>1541733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxymethyl cellulose</to_name>
		<to_code>1363606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-hydroxytryptophan, D-</to_name>
		<to_code>2462458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse skin extract</to_name>
		<to_code>852479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydromorphone</to_name>
		<to_code>3423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone tannate</to_name>
		<to_code>597355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexobendine</to_name>
		<to_code>5303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethylpiperazine ethane sulfonic acid</to_name>
		<to_code>1312611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halcinonide</to_name>
		<to_code>5084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase, human recombinant</to_name>
		<to_code>1300478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hamster skin extract</to_name>
		<to_code>895062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human adenovirus B serotype 7 strain 55142</to_name>
		<to_code>1802483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyoscyamine sulfate</to_name>
		<to_code>1225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hops extract</to_name>
		<to_code>259266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halazone</to_name>
		<to_code>59838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexafluorosilicate</to_name>
		<to_code>1862869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haslea ostrearia whole extract</to_name>
		<to_code>2179290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated vegetable oil</to_name>
		<to_code>1309225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamethylcyclotrisiloxane</to_name>
		<to_code>1994321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamethylene diisocyanate-trimethylol hexyllactone crosspolymer</to_name>
		<to_code>1608039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house dust allergenic extract</to_name>
		<to_code>852519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HC yellow no. 2</to_name>
		<to_code>2386335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house mouse skin extract</to_name>
		<to_code>852693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated palm glycerides</to_name>
		<to_code>1310582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxycitric acid</to_name>
		<to_code>1312602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase</to_name>
		<to_code>5464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptane</to_name>
		<to_code>2472186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthemum nummularium whole extract</to_name>
		<to_code>1801065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hops allergenic extract</to_name>
		<to_code>899480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hesperadin</to_name>
		<to_code>1552358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated poly(C6-14 olefin; 2 CST)</to_name>
		<to_code>1722671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hexenyl butyrate, (3Z)-</to_name>
		<to_code>2000996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum arenarium whole extract</to_name>
		<to_code>1809898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hesperidin methylchalcone</to_name>
		<to_code>72086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-hydroxyethyl)(hydroxymethyl)amine</to_name>
		<to_code>2375705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated poly(C6-14 olefin; 6 CST)</to_name>
		<to_code>1812572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human sputum, Bordetella pertussis infected</to_name>
		<to_code>1312370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 50cP</to_name>
		<to_code>1363590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis C virus</to_name>
		<to_code>1491863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexanediol</to_name>
		<to_code>1307037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparan sulfate</to_name>
		<to_code>2603494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-hydroxytryptophan</to_name>
		<to_code>94</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyssopus officinalis whole extract</to_name>
		<to_code>1482787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed oryzanol oleates</to_name>
		<to_code>2044916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed soy protein (enzymatic; 2000 MW)</to_name>
		<to_code>1721695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hordeum vulgare root extract</to_name>
		<to_code>1306189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedychium spicatum root extract</to_name>
		<to_code>1928184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexadecanamide</to_name>
		<to_code>159085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bispalmitamide</to_name>
		<to_code>1942709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl cinnamate</to_name>
		<to_code>2604566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haematococcus pluvialis extract</to_name>
		<to_code>1426382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>24-homo-1,25-dihydroxyvitamin D3</to_name>
		<to_code>1423458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Harpagophytum procumbens whole extract</to_name>
		<to_code>2043285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hawthorn berry extract</to_name>
		<to_code>283571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (5500 MPA.S at 2%)</to_name>
		<to_code>1430439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Gelidium elegans polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>holmium</to_name>
		<to_code>1311388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxycaprylate</to_name>
		<to_code>1486024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-ocsq</to_name>
		<to_code>2693451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated jojoba oil/jojoba oil, randomized (iodine value 64-70)</to_name>
		<to_code>1940147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl tetrahydropyrantriol</to_name>
		<to_code>1747475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human embryo tissue preparation</to_name>
		<to_code>2539170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana top water extract</to_name>
		<to_code>1311598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human calcitonin</to_name>
		<to_code>235481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl behenamidopropyl dimonium chloride</to_name>
		<to_code>1373153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxychloroquine</to_name>
		<to_code>5521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin</to_name>
		<to_code>5224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2H-tricosafluoro-5,8,11,14-tetrakis(trifluoromethyl)-3,6,9,12,15-pentaoxaoctadecane</to_name>
		<to_code>1872907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HC blue no. 2</to_name>
		<to_code>2386334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910</to_name>
		<to_code>1363567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin sodium, porcine</to_name>
		<to_code>314659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halibut liver oil</to_name>
		<to_code>91473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose phthalate (31% phthalate, 170 CST)</to_name>
		<to_code>1368891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus bifurcatus whole extract</to_name>
		<to_code>2463334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexocyclium</to_name>
		<to_code>26867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (3 MPA.S)</to_name>
		<to_code>1300449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histoplasmin</to_name>
		<to_code>5363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated coco-glycerides</to_name>
		<to_code>1364377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated jojoba oil/jojoba oil, randomized (iodine value 40-44)</to_name>
		<to_code>1722036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-hydroxylysine</to_name>
		<to_code>1368166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypochlorite ion</to_name>
		<to_code>1800664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamethyldisilazane</to_name>
		<to_code>1986434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypomyces perniciosus allergenic extract</to_name>
		<to_code>1192968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus syriacus seed extract</to_name>
		<to_code>1372466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haberlea rhodopensis whole extract</to_name>
		<to_code>2723017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hericium americanum whole extract</to_name>
		<to_code>2359933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herpesvirus 2, human</to_name>
		<to_code>1318479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hetacillin potassium</to_name>
		<to_code>1299048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl betadex (0.6 hydroxypropyl residues per glucose)</to_name>
		<to_code>2105627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horseradish tree whole extract</to_name>
		<to_code>1661015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histamine phosphate</to_name>
		<to_code>26925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone resin complex</to_name>
		<to_code>314667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histrelin</to_name>
		<to_code>50975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hordenine sulfate</to_name>
		<to_code>236237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexetidine</to_name>
		<to_code>5301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyoscyamine</to_name>
		<to_code>153970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hematoporphyrin</to_name>
		<to_code>5164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl corn amylopectin, phosphate crosslinked (4000 MPA.S at 5%)</to_name>
		<to_code>1596138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxocobalamin acetate</to_name>
		<to_code>236302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haloperidol</to_name>
		<to_code>5093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haloperidol lactate</to_name>
		<to_code>217483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated cottonseed oil</to_name>
		<to_code>1309478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hesperetin laurate</to_name>
		<to_code>1366665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl ethylcellulose</to_name>
		<to_code>1722035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honey bee venom</to_name>
		<to_code>124427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexylene glycol</to_name>
		<to_code>1305548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208</to_name>
		<to_code>1363588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human placenta hydrolysate</to_name>
		<to_code>1329960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexoprenaline sulfate</to_name>
		<to_code>258331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedychium flavescens whole extract</to_name>
		<to_code>2590647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippophae rhamnoides fruit oil</to_name>
		<to_code>1310092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hectorite</to_name>
		<to_code>1367162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B surface antigen (isoform S), recombinant</to_name>
		<to_code>2588219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl acrylate</to_name>
		<to_code>2619243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum arenarium flower extract</to_name>
		<to_code>1656322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin sodium, bovine</to_name>
		<to_code>236025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated polyisobutene 8</to_name>
		<to_code>2642872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hetastarch</to_name>
		<to_code>5531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypochlorous acid</to_name>
		<to_code>1483316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HC yellow no. 4</to_name>
		<to_code>2179013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human breast tumor cell</to_name>
		<to_code>1345682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halometasone monohydrate</to_name>
		<to_code>237025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl distarch phosphate, high amylose corn</to_name>
		<to_code>1312394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated olive oil</to_name>
		<to_code>1658762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (1800 MPA.S at 2%)</to_name>
		<to_code>1376452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hexen-1-ol, (3Z)-</to_name>
		<to_code>1807112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-oysk</to_name>
		<to_code>2119708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxycaprylic acid</to_name>
		<to_code>1486023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Humulus lupulus pollen extract</to_name>
		<to_code>1740937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homatropine</to_name>
		<to_code>27084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis A virus</to_name>
		<to_code>1491862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone sodium phosphate</to_name>
		<to_code>235482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyestrones</to_name>
		<to_code>5530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (4000 CPS at 1%)</to_name>
		<to_code>1307036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyacinth bean extract</to_name>
		<to_code>2637948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydralazine hydrochloride</to_name>
		<to_code>82027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hexyloxypropylene glycol</to_name>
		<to_code>2059295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hog hair extract</to_name>
		<to_code>895542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed wheat protein (enzymatic, 3000 MW)</to_name>
		<to_code>1426424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxymethylglycinate</to_name>
		<to_code>1370672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptanoic acid</to_name>
		<to_code>991260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated menhaden oil</to_name>
		<to_code>1309481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse chestnut whole extract</to_name>
		<to_code>1661336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helicobacter pylori</to_name>
		<to_code>1318501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl chitosan</to_name>
		<to_code>866459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse hair extract</to_name>
		<to_code>895515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated macadamia seed oil</to_name>
		<to_code>1868613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrochlorothiazide</to_name>
		<to_code>5487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated polybutene (370 MW)</to_name>
		<to_code>1306210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone probutate</to_name>
		<to_code>27196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hemp</to_name>
		<to_code>1788846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Horse antihuman thymocyte gamma globulin</to_name>
		<to_code>107051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyoscyamine sulfate anhydrous</to_name>
		<to_code>1742407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (90000 WAMW)</to_name>
		<to_code>2055269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,6-hexamethylene diisocyanate</to_name>
		<to_code>1428547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type H)</to_name>
		<to_code>1811461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human enterovirus A</to_name>
		<to_code>1668271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B surface antigen (isoform L), recombinant</to_name>
		<to_code>2588217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedera helix flowering twig extract</to_name>
		<to_code>1330087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hura crepitans sap extract</to_name>
		<to_code>1366113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose acetate succinate 06081224 (3 MM2-S)</to_name>
		<to_code>1376345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human coxsackievirus B4</to_name>
		<to_code>1427210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen cation</to_name>
		<to_code>2557600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house fly extract</to_name>
		<to_code>967921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type EL)</to_name>
		<to_code>1653098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Houttuynia cordata whole extract</to_name>
		<to_code>1358899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine</to_name>
		<to_code>1301887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl laurdimonium chloride</to_name>
		<to_code>1648218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthemum nummularium flower extract</to_name>
		<to_code>1352521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydrangea arborescens whole extract</to_name>
		<to_code>1658431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hexenyl salicylate, cis-</to_name>
		<to_code>2359262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroquinone</to_name>
		<to_code>5509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin, porcine</to_name>
		<to_code>235473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (15 MPA.S)</to_name>
		<to_code>1300450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxylated lanolin</to_name>
		<to_code>1356701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexacosanoate</to_name>
		<to_code>1997246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexobendine hydrochloride</to_name>
		<to_code>439431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human coxsackievirus A7</to_name>
		<to_code>1435395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (40 MPA.S at 2%)</to_name>
		<to_code>1376150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydantoin</to_name>
		<to_code>1721294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexahydro-4,7-methanoinden-6-yl propionate</to_name>
		<to_code>2395762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyoscyamine hydrobromide</to_name>
		<to_code>1047802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human milk preparation</to_name>
		<to_code>1661547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexapeptide-49</to_name>
		<to_code>2584309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyectoin</to_name>
		<to_code>2119368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human epidermal growth factor</to_name>
		<to_code>1427157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthus annuus sprout extract</to_name>
		<to_code>1368332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hederagenin</to_name>
		<to_code>2045115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hovenia dulcis fruit extract</to_name>
		<to_code>1311608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2,6-hexanetriol</to_name>
		<to_code>1362577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B surface antigen (isoform M), recombinant</to_name>
		<to_code>2588218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hexenal, (2e)-</to_name>
		<to_code>2281309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyzine</to_name>
		<to_code>5553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxide ion</to_name>
		<to_code>1314279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyphenyl propamidobenzoic acid</to_name>
		<to_code>1427188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (4000 CPS)</to_name>
		<to_code>1300447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hesperetin</to_name>
		<to_code>1314255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated polybutene (1300 MW)</to_name>
		<to_code>1314287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexapeptide-9</to_name>
		<to_code>2399027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyzine hydrochloride</to_name>
		<to_code>154987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed glycosaminoglycans (bovine; 50000 MW)</to_name>
		<to_code>1313712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hafnium</to_name>
		<to_code>1534767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-qvfc</to_name>
		<to_code>2639946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyproline</to_name>
		<to_code>1311548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hottonia palustris flower extract</to_name>
		<to_code>1309467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthemum canadense extract</to_name>
		<to_code>1320405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (1600000 WAMW)</to_name>
		<to_code>2048727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase, ovine</to_name>
		<to_code>486164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (100000 MPA.S)</to_name>
		<to_code>1300448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hog skin extract</to_name>
		<to_code>852839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Houttuynia cordata flowering top extract</to_name>
		<to_code>1309469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (4000 MPA.S)</to_name>
		<to_code>1300455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</to_name>
		<to_code>1300464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine</to_name>
		<to_code>1301885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hymetellose (50 MPA.S)</to_name>
		<to_code>1939372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydrastis preparation</to_name>
		<to_code>314666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haddock allergenic extract</to_name>
		<to_code>899428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>17-hydroxystearic acid</to_name>
		<to_code>2185790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexafluorenium</to_name>
		<to_code>26826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer</to_name>
		<to_code>1729151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bisstearyldimonium chloride</to_name>
		<to_code>1368486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human adenovirus E serotype 4 strain CL-68578</to_name>
		<to_code>1299785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexapeptide-11</to_name>
		<to_code>1996982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honeydew melon allergenic extract</to_name>
		<to_code>899476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamidine</to_name>
		<to_code>26849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human chorionic gonadotropin</to_name>
		<to_code>340705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hexenal propylene glycol acetal, (1E)-</to_name>
		<to_code>1673572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated polydecene (3100 CST)</to_name>
		<to_code>2606776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen peroxide</to_name>
		<to_code>5499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Homalomena occulta root extract</to_name>
		<to_code>2610748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippeastrum puniceum whole extract</to_name>
		<to_code>1942330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydracrylic acid</to_name>
		<to_code>2673464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hordeum vulgare top extract</to_name>
		<to_code>1311547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl methylcellulose 2910</to_name>
		<to_code>1363586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-hydroxymethyl(methyleneoxy)-1-aza-3,7-dioxabicyclo(3,3,0)octane</to_name>
		<to_code>1732117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heroin hydrochloride</to_name>
		<to_code>81994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus mutabilis flower extract</to_name>
		<to_code>1724426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed elastin, bovine, alkaline (1000 MW)</to_name>
		<to_code>1312601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypophosphorous acid</to_name>
		<to_code>1423684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated poly(C6-20 olefin; 100 CST)</to_name>
		<to_code>2383934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxybenzyl alcohol</to_name>
		<to_code>2045942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone</to_name>
		<to_code>5489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroquinine</to_name>
		<to_code>2468435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana leaf extract</to_name>
		<to_code>1307887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human parvovirus B19 virus</to_name>
		<to_code>1368364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxocobalamin</to_name>
		<to_code>5514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus rosa-sinensis leaf extract</to_name>
		<to_code>1307747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hemin</to_name>
		<to_code>5175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexafluorenium bromide</to_name>
		<to_code>53017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HC red no. 3</to_name>
		<to_code>2469246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histidinal, L-</to_name>
		<to_code>2621896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen sulfite</to_name>
		<to_code>1366859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halazepam</to_name>
		<to_code>26412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hawthorn flowering top extract</to_name>
		<to_code>1653024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hawthorn preparation</to_name>
		<to_code>155097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human vaccinia immune globulin</to_name>
		<to_code>597392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxycyclophosphamide</to_name>
		<to_code>2675983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronidase-fihj</to_name>
		<to_code>2375132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroflumethiazide</to_name>
		<to_code>5495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hawthorn flower extract</to_name>
		<to_code>969139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypericum oil</to_name>
		<to_code>1352522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Pterocladiella tenuis polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin sodium</to_name>
		<to_code>9877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Huperzia serrata extract</to_name>
		<to_code>1376501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen</to_name>
		<to_code>1427171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypochlorite</to_name>
		<to_code>1483317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone valerate</to_name>
		<to_code>27199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histidine</to_name>
		<to_code>5340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptyl glucoside</to_name>
		<to_code>2462498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>holy basil leaf extract</to_name>
		<to_code>1860076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hetacillin</to_name>
		<to_code>26797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (100 MPA.S)</to_name>
		<to_code>1300444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedychium coronarium root extract</to_name>
		<to_code>1307804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1H,5H-cyclopenta(3,4)(1)benzopyrano(6,7,8-IJ)quinolizin-12(9H)-one, 2,3,6,7,10,11-hexahydro-</to_name>
		<to_code>2378833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyacinthus orientalis flower extract</to_name>
		<to_code>1796919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone hydrochloride</to_name>
		<to_code>236931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedera helix leaf extract</to_name>
		<to_code>1309795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxy-1-(5-isocamphyl)cyclohexane</to_name>
		<to_code>2557378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthus annuus whole extract</to_name>
		<to_code>1425412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexacosyl glycol</to_name>
		<to_code>2367762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Heterotheca inuloides flower extract</to_name>
		<to_code>1372928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolysed bovine collagen (enzymatic; 2000-5000 MW)</to_name>
		<to_code>1312600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human coxsackievirus B</to_name>
		<to_code>1668273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HEPATITIS A IMMUNE GLOBULIN,HU</to_name>
		<to_code>237062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl hexanoate</to_name>
		<to_code>2000994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyriopsis cumingii whole extract</to_name>
		<to_code>1495456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Holodiscus discolor whole extract</to_name>
		<to_code>2387538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,2',2'',2'''-((4-((2-hydroxyethyl)amino)-8-(piperidin-1-yl)pyrimido(5,4-D)pyrimidine-2,6-diyl)dinitrilo)tetraethanol</to_name>
		<to_code>2548676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptanes</to_name>
		<to_code>1367182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexenyl acetate, (2Z)-</to_name>
		<to_code>2274706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed sheep wool keratin (200 MW)</to_name>
		<to_code>2539169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose acetate succinate</to_name>
		<to_code>2645263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydralazine</to_name>
		<to_code>5470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hagenia abyssinica flower extract</to_name>
		<to_code>1862479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse chestnut preparation</to_name>
		<to_code>317825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B virus</to_name>
		<to_code>1427211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>highbush blueberry extract</to_name>
		<to_code>1945027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hirudin</to_name>
		<to_code>1546205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed jojoba esters (potassium salts)</to_name>
		<to_code>1789206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypalmitoyl sphinganine</to_name>
		<to_code>1747474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl methacrylate</to_name>
		<to_code>2468433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (200000 MPA.S)</to_name>
		<to_code>2631986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus rosa-sinensis flowering top extract</to_name>
		<to_code>1310008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (160000 WAMW)</to_name>
		<to_code>2166043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (280 MPA.S at 2%)</to_name>
		<to_code>1492183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>house fly allergenic extract</to_name>
		<to_code>350173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxychloroquine sulfate</to_name>
		<to_code>153972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type J)</to_name>
		<to_code>1485045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hylocereus undatus fruit extract</to_name>
		<to_code>2181533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human hair preparation</to_name>
		<to_code>1442514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl salicylate</to_name>
		<to_code>1421892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexobarbital</to_name>
		<to_code>5302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HETERZYGOUS YUCATAN MINIATURE PIG SCN5A MUTATED GENE DISRUPTED BY A SCN5A-NEO RDNA CONSTRUCT IN EXON 11</to_name>
		<to_code>2204572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen dimethicone (30 CST)</to_name>
		<to_code>2613886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (5 MPA.S)</to_name>
		<to_code>1300452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyldecyl laurate</to_name>
		<to_code>1312598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparan sulfate (porcine 5500 MW)</to_name>
		<to_code>2603493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum italicum flower extract</to_name>
		<to_code>1310048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroiodic acid</to_name>
		<to_code>27208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type e)</to_name>
		<to_code>1356136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypophosphite ion</to_name>
		<to_code>1546440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hemicellulase</to_name>
		<to_code>26514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrobromic acid</to_name>
		<to_code>1426869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>HLAL RDNA construct in SBC LAL-C chicken</to_name>
		<to_code>1796975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine</to_name>
		<to_code>798444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroquinine sulfate</to_name>
		<to_code>2468434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptanal</to_name>
		<to_code>2360434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed sericin (enzymatic; 2500 MW)</to_name>
		<to_code>1544274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis A virus strain CR 326F antigen, inactivated</to_name>
		<to_code>2274413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (3000 CPS at 1%)</to_name>
		<to_code>1363604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyisohexyl 3-cyclohexene carboxaldehyde</to_name>
		<to_code>1426621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl guar (2500-4500 MPA.S at 1%)</to_name>
		<to_code>1361655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Gelidium lingulatum polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone polistirex</to_name>
		<to_code>221107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl 5-aminolevulinate</to_name>
		<to_code>1426872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl laurdimonium</to_name>
		<to_code>1648219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halothane</to_name>
		<to_code>5095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heme arginate</to_name>
		<to_code>26506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (1500 MPA.S at 1%)</to_name>
		<to_code>1312606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,2,4,4,6,8,8-heptamethylnonane</to_name>
		<to_code>1362933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis B immune globulin</to_name>
		<to_code>26744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyaluronic acid</to_name>
		<to_code>5463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrofluoric acid</to_name>
		<to_code>5496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus B Conjugate Vaccine</to_name>
		<to_code>214606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3'-hydroxyacetophenone</to_name>
		<to_code>2560214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hordenine</to_name>
		<to_code>27120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hyssop oil</to_name>
		<to_code>1362137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamethyldisiloxane</to_name>
		<to_code>1311540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypinacolone retinoate</to_name>
		<to_code>1795946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histrelin acetate</to_name>
		<to_code>1294622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyacinthus orientalis whole extract</to_name>
		<to_code>1549103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrotalcite</to_name>
		<to_code>27221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human placental tissue preparation</to_name>
		<to_code>2176248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain P1A[8] vaccine</to_name>
		<to_code>798294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halofantrine</to_name>
		<to_code>50749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2906 (4000 mpa.s)</to_name>
		<to_code>1299222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human mammary gland preparation</to_name>
		<to_code>1372308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated polydecene (550 MW)</to_name>
		<to_code>1314588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hard maple pollen extract</to_name>
		<to_code>851874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human skin preparation</to_name>
		<to_code>1593853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyoscyamus extract</to_name>
		<to_code>314674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin, bovine</to_name>
		<to_code>1856273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>12-hydroxyeicosapentaenoic acid, (12R)-</to_name>
		<to_code>2261372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herpesvirus 3, human</to_name>
		<to_code>11131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydromorphone hydrochloride</to_name>
		<to_code>203177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histamine hydrochloride</to_name>
		<to_code>350466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (2000 CPS at 1%)</to_name>
		<to_code>1299925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>10-hydroxystearic acid</to_name>
		<to_code>2476630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hericium americanum fruiting body extract</to_name>
		<to_code>2631131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone butyrate</to_name>
		<to_code>103468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Humulus lupulus stem extract</to_name>
		<to_code>1309472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helleborus niger whole extract</to_name>
		<to_code>1999674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histidine monohydrochloride</to_name>
		<to_code>1309689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>honokiol</to_name>
		<to_code>2562546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae</to_name>
		<to_code>1364467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated jojoba oil</to_name>
		<to_code>1745008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose phthalate (31% phthalate, 40 CST)</to_name>
		<to_code>1368892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herpesvirus 1, human</to_name>
		<to_code>1316105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated palm oil</to_name>
		<to_code>1307676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hoodia gordonii extract</to_name>
		<to_code>578315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-hexadecyl-5-ethyl-2-methylpyridinium bromide</to_name>
		<to_code>2394501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)</to_name>
		<to_code>2599921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyldecanol</to_name>
		<to_code>1363575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(2-(2-hydroxypropoxy)propoxy)-1-propanol</to_name>
		<to_code>2359259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heme iron polypeptide</to_name>
		<to_code>978673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>12-hydroxystearate</to_name>
		<to_code>1368629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl laurate</to_name>
		<to_code>1367126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyoscyamus niger extract</to_name>
		<to_code>1311152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone cypionate</to_name>
		<to_code>163524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hylotelephium telephium whole extract</to_name>
		<to_code>2539933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydrastis canadensis whole preparation</to_name>
		<to_code>1314583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horehound extract</to_name>
		<to_code>1426436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>haemophilus influenzae immunoserum rabbit</to_name>
		<to_code>1367192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydnocarpus kurzii seed oil</to_name>
		<to_code>1420965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hylan</to_name>
		<to_code>27306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose</to_name>
		<to_code>27334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedeoma pulegioides leaf oil</to_name>
		<to_code>2639088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocodone bitartrate</to_name>
		<to_code>142439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptaminol adenosine phosphate</to_name>
		<to_code>236293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypoxis hemerocallidea root extract</to_name>
		<to_code>1310069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexaminolevulinate hydrochloride</to_name>
		<to_code>1426871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>halometasone</to_name>
		<to_code>26416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hottonia palustris whole extract</to_name>
		<to_code>2003474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl palmityl oxyhydroxypropyl palmitamide</to_name>
		<to_code>2471867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum italicum flower oil</to_name>
		<to_code>1309354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexadecene (mixed isomers)</to_name>
		<to_code>2173916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heptaminol hydrochloride</to_name>
		<to_code>236294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>harpagoside</to_name>
		<to_code>2048124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Heracleum hemsleyanum whole extract</to_name>
		<to_code>2610747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana top extract</to_name>
		<to_code>1307756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (4 MPA.S)</to_name>
		<to_code>2675619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human adipose preparation</to_name>
		<to_code>1368621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-hexenyl hexanoate, (3Z)-</to_name>
		<to_code>2000995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated coconut oil</to_name>
		<to_code>1307683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl starch 130-0.4</to_name>
		<to_code>1363352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl methylcellulose 2208</to_name>
		<to_code>1363585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxocobalamin hydrochloride</to_name>
		<to_code>1947247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homatropine methylbromide</to_name>
		<to_code>27085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus rosa-sinensis flower extract</to_name>
		<to_code>1923771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyacinthoides non-scripta extract</to_name>
		<to_code>1428043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hepatitis nosodes</to_name>
		<to_code>350255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexadecane</to_name>
		<to_code>2167851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human plasma preparation</to_name>
		<to_code>2539171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hesperidin complex</to_name>
		<to_code>314661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexylnicotinate</to_name>
		<to_code>235812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>heparin calcium</to_name>
		<to_code>20044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human dander preparation</to_name>
		<to_code>1484853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated jojoba oil-jojoba oil, randomized (iodine value 57-61)</to_name>
		<to_code>1483230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (3 MPA.S)</to_name>
		<to_code>1300446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexoprenaline</to_name>
		<to_code>5307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G3 vaccine</to_name>
		<to_code>798290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hydroxydecanoate</to_name>
		<to_code>1486028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (5000 CPS at 1%)</to_name>
		<to_code>1307084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyldecyl myristoyl methylaminopropionate</to_name>
		<to_code>1427017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated soybean oil</to_name>
		<to_code>1309222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum italicum flowering top extract</to_name>
		<to_code>1309358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>homarine hydrochloride</to_name>
		<to_code>1426929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histamine dihydrochloride</to_name>
		<to_code>142136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippophae rhamnoides seed oil</to_name>
		<to_code>1309359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyl decanoate</to_name>
		<to_code>1313706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum litoreum whole extract</to_name>
		<to_code>2180548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-hydroxy-2,5-dimethylfuran-2(3H)-one</to_name>
		<to_code>1313733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hydroxydecanoic acid</to_name>
		<to_code>1486027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated polydecene (1500 CST)</to_name>
		<to_code>2389632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated soybean phosphatidylcholine</to_name>
		<to_code>2392131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl bispalmitamide monoethanolamide</to_name>
		<to_code>1942708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>horse dander extract</to_name>
		<to_code>2167548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (100 MPA.S at 2%)</to_name>
		<to_code>1362147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2906 (4 mpa.s)</to_name>
		<to_code>1426846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl trimonium chloride</to_name>
		<to_code>2104987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Gracilaria chilensis polysaccharides (enzymatic; 750 MW)</to_name>
		<to_code>2044913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hekla lava</to_name>
		<to_code>1426873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>herpesvirus 5, human</to_name>
		<to_code>1316104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hieracium pilosella flowering top</to_name>
		<to_code>1310001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>high fructose corn syrup</to_name>
		<to_code>1310511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hawthorn berry</to_name>
		<to_code>283570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(1,2,6,7-3H)-testosterone</to_name>
		<to_code>1989005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine</to_name>
		<to_code>798279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Himatanthus lancifolius bark extract</to_name>
		<to_code>1374400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypotaurine</to_name>
		<to_code>2597523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroquinidine hydrochloride</to_name>
		<to_code>236160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Himanthalia elongata extract</to_name>
		<to_code>1426383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hops oil</to_name>
		<to_code>1735039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histamine</to_name>
		<to_code>5333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>12-hydroxystearic acid</to_name>
		<to_code>1368628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Halimeda opuntia extract</to_name>
		<to_code>1314311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropylcellulose</to_name>
		<to_code>27291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hedychium spicatum whole extract</to_name>
		<to_code>2629781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910-5cP</to_name>
		<to_code>1363583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Humicola grisea allergenic extract</to_name>
		<to_code>1014391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Holarrhena pubescens bark extract</to_name>
		<to_code>1307856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helleborus extract</to_name>
		<to_code>1351001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hydrangea extract</to_name>
		<to_code>1372001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hazelnut allergenic extract</to_name>
		<to_code>891633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (6500 MPA.S at 2%)</to_name>
		<to_code>1376344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolysed marine collagen (enzymatic; 2000 MW)</to_name>
		<to_code>1427229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropyl cellulose (type M)</to_name>
		<to_code>1433886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone acetate</to_name>
		<to_code>27197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexamidine diisethionate</to_name>
		<to_code>1939371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-hexadecene</to_name>
		<to_code>1313219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxypropylbetadex (0.58-0.68 MS)</to_name>
		<to_code>1363608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrolyzed Lupinus albus seed protein (enzymatic; 3500 mw)</to_name>
		<to_code>2371705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus influenzae type b</to_name>
		<to_code>50937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haematonectria haematococca allergenic extract</to_name>
		<to_code>852503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated starch hydrolysate</to_name>
		<to_code>1651693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyaluronan</to_name>
		<to_code>258347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose (280 MPA.S at 5%)</to_name>
		<to_code>1487367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippophae rhamnoides fruit juice</to_name>
		<to_code>1311604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexylresorcinol</to_name>
		<to_code>5321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthus annuus seedcake extract</to_name>
		<to_code>1307763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-hydroxyethyl methacrylate</to_name>
		<to_code>1362692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthus annuus flowering top extract</to_name>
		<to_code>1309686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogenated palm/palm kernel oil peg-6 esters</to_name>
		<to_code>2002788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hyoscyamus niger whole extract</to_name>
		<to_code>1442993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus sabdariffa seed oil</to_name>
		<to_code>2118526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 3cP</to_name>
		<to_code>1363589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2910 (50 MPA.S)</to_name>
		<to_code>1300453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyurea</to_name>
		<to_code>5552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>helium</to_name>
		<to_code>5140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (60000 MPA.S)</to_name>
		<to_code>1986432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana bark extract</to_name>
		<to_code>1307752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexyldecyl stearate</to_name>
		<to_code>1312599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexadecanolactone</to_name>
		<to_code>1438492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyestrone diacetate</to_name>
		<to_code>236161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hackberry pollen extract</to_name>
		<to_code>852324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexasodium phytate</to_name>
		<to_code>1730445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Haemophilus capsular oligosaccharide</to_name>
		<to_code>221105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helianthus annuus seed wax extract</to_name>
		<to_code>1307740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human-bovine reassortant rotavirus strain G4 vaccine</to_name>
		<to_code>798292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrogen dimethicone (20 CST)</to_name>
		<to_code>1866044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human coxsackievirus A2</to_name>
		<to_code>1435394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>human coxsackievirus B3</to_name>
		<to_code>1435396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Helichrysum gymnocephalum whole extract</to_name>
		<to_code>2099292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hepatitis A Vaccine, Inactivated</to_name>
		<to_code>253174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>histidine monohydrochloride monohydrate</to_name>
		<to_code>1305609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hibiscus rosa-sinensis whole extract</to_name>
		<to_code>2048123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydroxyethyl cellulose</to_name>
		<to_code>27244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hypericum extract</to_name>
		<to_code>1309228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexadecanal</to_name>
		<to_code>2049630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hypromellose 2208 (1500 MPA.S)</to_name>
		<to_code>2395758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hydrocortisone sodium succinate</to_name>
		<to_code>235483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hamamelis virginiana flower water extract</to_name>
		<to_code>1307636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>hexadecyl povidone (4 hexadecyl branches-repeat)</to_name>
		<to_code>1366991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>H [Preparations]</from_name>
		<from_code>N0000010590</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Hippophae rhamnoides seed extract</to_name>
		<to_code>2104183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxytyrosol</from_name>
		<from_code>1314227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(3,4-dihydroxyphenyl)ethanol</to_name>
		<to_code>M0047896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxytyrosol</from_name>
		<from_code>1314227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxytyrosol</to_name>
		<to_code>M0047899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrochloric acid</from_name>
		<from_code>5486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydrochloric Acid</to_name>
		<to_code>M0010701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexane</from_name>
		<from_code>1999411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>n-hexane</to_name>
		<to_code>M0086689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2'-hydroxyacetophenone</from_name>
		<from_code>1664428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2'-hydroxyacetophenone</to_name>
		<to_code>M0232734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexylcaine hydrochloride</from_name>
		<from_code>1546032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexylcaine hydrochloride</to_name>
		<to_code>M0308817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparinoids</from_name>
		<from_code>5228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparinoids</to_name>
		<to_code>M0010193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hesperidin</from_name>
		<from_code>5281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hesperidin</to_name>
		<to_code>M0010288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>humulene</from_name>
		<from_code>2266811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>humulene</to_name>
		<to_code>M0125911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinidine</from_name>
		<from_code>27220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroquinidine</to_name>
		<to_code>M0063018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-hydroxybenzoic acid</from_name>
		<from_code>1649527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-hydroxybenzoic acid</to_name>
		<to_code>M0115095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heroin</from_name>
		<from_code>3304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heroin</to_name>
		<to_code>M0006166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horse chestnut seed</from_name>
		<from_code>260020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>horse chestnut seed</to_name>
		<to_code>M000743971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hexachlorophene</to_name>
		<to_code>M0010306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexachlorophene</from_name>
		<from_code>5293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin sodium</from_name>
		<from_code>267257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime proxetil</from_name>
		<from_code>47835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet</from_name>
		<from_code>4778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem</from_name>
		<from_code>325642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertapenem sodium</from_name>
		<from_code>353107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefpodoxime</from_name>
		<from_code>20489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin</from_name>
		<from_code>2625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin benzathine</from_name>
		<from_code>1043213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicloxacillin</from_name>
		<from_code>3356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxacillin sodium</from_name>
		<from_code>9864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methicillin sodium</from_name>
		<from_code>267073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalfopristin</from_name>
		<from_code>229369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet cation</from_name>
		<from_code>1546369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcal Skin Infections</to_name>
		<to_code>M0020427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloid sulfur</from_name>
		<from_code>89767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin microsphere</from_name>
		<from_code>221175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur</from_name>
		<from_code>10223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioxolone</from_name>
		<from_code>2059173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone acetate</from_name>
		<from_code>31983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adapalene</from_name>
		<from_code>60223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelaic acid</from_name>
		<from_code>18602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazarotene</from_name>
		<from_code>83947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline</from_name>
		<from_code>2059018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzoyl peroxide</from_name>
		<from_code>1418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur, colloidal</from_name>
		<from_code>221083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone</from_name>
		<from_code>7514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resorcinol</from_name>
		<from_code>35382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarecycline hydrochloride</from_name>
		<from_code>2059038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifarotene</from_name>
		<from_code>2205637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline</from_name>
		<from_code>21272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tretinoin</from_name>
		<from_code>10753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norethindrone enanthate</from_name>
		<from_code>31984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline sodium</from_name>
		<from_code>102758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isotretinoin</from_name>
		<from_code>6064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Acne Vulgaris</to_name>
		<to_code>M0000231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>homarine</from_name>
		<from_code>1426930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>homarine</to_name>
		<to_code>M0056931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>high-density polyethylene</from_name>
		<from_code>1424910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>High-Density Polyethylene</to_name>
		<to_code>M0333841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horseradish allergenic extract</from_name>
		<from_code>1011043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-hexenyl acetate, (3Z)-</from_name>
		<from_code>1426376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cis-3-hexenyl acetate</to_name>
		<to_code>M0591557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen</from_name>
		<from_code>5497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydrogen</to_name>
		<to_code>M0010716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hygromycin B</from_name>
		<from_code>1426887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hygromycin B</to_name>
		<to_code>M0010798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hygromycin B</from_name>
		<from_code>1426887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parasitemia</to_name>
		<to_code>M0027759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hippurate</from_name>
		<from_code>1923620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hippurate</to_name>
		<to_code>M0096456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxycitronellal</from_name>
		<from_code>1362893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxycitronellal</to_name>
		<to_code>M0074831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,2-hexanediol</from_name>
		<from_code>1362584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,2-hexanediol</to_name>
		<to_code>M0305031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexocyclium methylsulfate</from_name>
		<from_code>235430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexocyclium methylsulfate</to_name>
		<to_code>M0313010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heptaminol</from_name>
		<from_code>5254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heptaminol</to_name>
		<to_code>M0010242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hippuric acid</from_name>
		<from_code>1923619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hippuric acid</to_name>
		<to_code>M0096457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>10-hydroxycapric acid</from_name>
		<from_code>1368622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>10-hydroxydecanoic acid</to_name>
		<to_code>M000634970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen cyanide</from_name>
		<from_code>1367183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydrogen Cyanide</to_name>
		<to_code>M0010712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mefloquine</to_name>
		<to_code>M0024162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>halofantrine hydrochloride</to_name>
		<to_code>M0450251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine hydrochloride</from_name>
		<from_code>58130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mefloquine</to_name>
		<to_code>M0024162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mefloquine</to_name>
		<to_code>M0024162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halofantrine</from_name>
		<from_code>50749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>halofantrine</to_name>
		<to_code>M0081385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine phosphate</from_name>
		<from_code>8689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>primaquine</from_name>
		<from_code>8687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malaria, Vivax</to_name>
		<to_code>M0025572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate monohydrate</from_name>
		<from_code>1298846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol</from_name>
		<from_code>149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine sulfate</from_name>
		<from_code>1249590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium tosylate</from_name>
		<from_code>1737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate anhydrous</from_name>
		<from_code>1311625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol fumarate</from_name>
		<from_code>102313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride anhydrous</from_name>
		<from_code>1667640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol succinate</from_name>
		<from_code>221124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine hydrochloride</from_name>
		<from_code>82010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephryl borate</from_name>
		<from_code>24255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glubionate</from_name>
		<from_code>25806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine hydrochloride</from_name>
		<from_code>221126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acebutolol hydrochloride</from_name>
		<from_code>142130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol</from_name>
		<from_code>6054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate</from_name>
		<from_code>6585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium</from_name>
		<from_code>19685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride</from_name>
		<from_code>1901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dopamine</from_name>
		<from_code>3628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol</from_name>
		<from_code>6918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine hydrochloride</from_name>
		<from_code>314610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluconate</from_name>
		<from_code>1908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride anhydrous</from_name>
		<from_code>1299236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol</from_name>
		<from_code>49737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine</from_name>
		<from_code>3992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate dihydrate</from_name>
		<from_code>2107060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol hydrochloride</from_name>
		<from_code>82030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine</from_name>
		<from_code>6387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metoprolol tartrate</from_name>
		<from_code>203191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate monohydrate</from_name>
		<from_code>1311259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium tosylate</from_name>
		<from_code>1737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride monohydrate</from_name>
		<from_code>2678349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoproterenol sulfate</from_name>
		<from_code>82031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deslanoside</from_name>
		<from_code>3248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esmolol hydrochloride</from_name>
		<from_code>203222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atenolol</from_name>
		<from_code>1202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bretylium</from_name>
		<from_code>19685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine bitartrate</from_name>
		<from_code>203180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moricizine</from_name>
		<from_code>40169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epinephrine hydrochloride</from_name>
		<from_code>362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chloride dihydrate</from_name>
		<from_code>221068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Fibrillation</to_name>
		<to_code>M0022595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone hydrochloride</from_name>
		<from_code>203135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lidocaine hydrochloride</from_name>
		<from_code>142440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propafenone</from_name>
		<from_code>8754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ventricular Dysfunction</to_name>
		<to_code>M0028090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>halofantrine</to_name>
		<to_code>M0081385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexametaphosphate</from_name>
		<from_code>1487531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexametaphosphate</to_name>
		<to_code>M0046316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hylan G-F 20</from_name>
		<from_code>284637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Osteoarthritis, Knee</to_name>
		<to_code>M0030009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hylan G-F 20</from_name>
		<from_code>284637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hylan G-F 20</to_name>
		<to_code>M0441627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl methylcellulose phthalate</from_name>
		<from_code>1363587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropyl methylcellulose phthalate</to_name>
		<to_code>M0151006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>helicidine</from_name>
		<from_code>233562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>helicidine</to_name>
		<to_code>M0303729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl gamma-cyclodextrin</from_name>
		<from_code>1601114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropyl-gamma-cyclodextrin</to_name>
		<to_code>M0152340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl gamma-cyclodextrin</from_name>
		<from_code>1601114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>(2-hydroxypropyl)-gamma-cyclodextrin</to_name>
		<to_code>M0508893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-hydroxyethyl acrylate</from_name>
		<from_code>1314328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-hydroxyethyl acrylate</to_name>
		<to_code>M0109831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-hydroxypropyl methacrylate</from_name>
		<from_code>2204914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-hydroxypropyl methacrylate</to_name>
		<to_code>M0094420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Houttuynia cordata top extract</from_name>
		<from_code>2001175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Houttuynia cordata top</to_name>
		<to_code>M000745673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human papillomavirus</from_name>
		<from_code>1311095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Human Papillomavirus Viruses</to_name>
		<to_code>M000598251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-hydroxybutyric acid</from_name>
		<from_code>1546380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-hydroxybutyric acid</to_name>
		<to_code>M0288532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl cellulose, unspecified</from_name>
		<from_code>1804020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropylcellulose</to_name>
		<to_code>M0051638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropylcellulose</from_name>
		<from_code>27291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropylcellulose</to_name>
		<to_code>M0051638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexacosanoic acid</from_name>
		<from_code>1997245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexacosanoic acid</to_name>
		<to_code>M0068090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 6, human</from_name>
		<from_code>2167553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesvirus 6, Human</to_name>
		<to_code>M0023992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hawthorn leaf with flower extract</from_name>
		<from_code>1309793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>crataegus extract</to_name>
		<to_code>M0050155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hymecromone</from_name>
		<from_code>5556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hymecromone</to_name>
		<to_code>M0010801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl-alpha-cyclodextrin</from_name>
		<from_code>1442707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropyl-alpha-cyclodextrin</to_name>
		<to_code>M0152338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexylcaine</from_name>
		<from_code>26879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexylcaine</to_name>
		<to_code>M0046190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>HC yellow no. 5</from_name>
		<from_code>1428873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HC yellow No. 5</to_name>
		<to_code>M0524325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypericin</from_name>
		<from_code>1546455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hypericin</to_name>
		<to_code>M0046211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexobendine</from_name>
		<from_code>5303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hexobendine</to_name>
		<to_code>M0010324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethylpiperazine ethane sulfonic acid</from_name>
		<from_code>1312611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HEPES</to_name>
		<to_code>M0010239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halazone</from_name>
		<from_code>59838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>halazone</to_name>
		<to_code>M0151607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexafluorosilicate</from_name>
		<from_code>1862869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexafluorosilicate</to_name>
		<to_code>M0046040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexamethylcyclotrisiloxane</from_name>
		<from_code>1994321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexamethylcyclotrisiloxane</to_name>
		<to_code>M0081928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxycitric acid</from_name>
		<from_code>1312602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxycitric acid</to_name>
		<to_code>M0051512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heptane</from_name>
		<from_code>2472186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heptanes</to_name>
		<to_code>M0010243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hesperadin</from_name>
		<from_code>1552358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hesperadin</to_name>
		<to_code>M0450517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hesperidin methylchalcone</from_name>
		<from_code>72086</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hesperidin methylchalcone</to_name>
		<to_code>M0102639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hepatitis C virus</from_name>
		<from_code>1491863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C virus</to_name>
		<to_code>M0024691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heparan sulfate</from_name>
		<from_code>2603494</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heparan Sulfate</to_name>
		<to_code>M0010194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-hydroxytryptophan</from_name>
		<from_code>94</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-Hydroxytryptophan</to_name>
		<to_code>M0010787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexadecanamide</from_name>
		<from_code>159085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexadecanamide</to_name>
		<to_code>M0062252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>holmium</from_name>
		<from_code>1311388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Holmium</to_name>
		<to_code>M0010492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>HC blue no. 2</from_name>
		<from_code>2386334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HC Blue No. 2</to_name>
		<to_code>M0152410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexocyclium</from_name>
		<from_code>26867</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexocyclium</to_name>
		<to_code>M0065562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-hydroxylysine</from_name>
		<from_code>1368166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydroxylysine</to_name>
		<to_code>M0010770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-hydroxylysine</from_name>
		<from_code>1368166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-Hydroxylysine</to_name>
		<to_code>M000638470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexamethyldisilazane</from_name>
		<from_code>1986434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexamethylsilazane</to_name>
		<to_code>M0082902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 2, human</from_name>
		<from_code>1318479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesvirus 2, Human</to_name>
		<to_code>M0027487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine phosphate</from_name>
		<from_code>26925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>histamine phosphate</to_name>
		<to_code>M0089478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine phosphate</from_name>
		<from_code>26925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine</from_name>
		<from_code>356887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine maleate</from_name>
		<from_code>82091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine dihydrochloride</from_name>
		<from_code>142136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mequitazine</from_name>
		<from_code>29528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine tannate</from_name>
		<from_code>221152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levocetirizine dihydrochloride</from_name>
		<from_code>402349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyrilamine</from_name>
		<from_code>9009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desloratadine</from_name>
		<from_code>275635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine</from_name>
		<from_code>5333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terfenadine</from_name>
		<from_code>42330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclesonide</from_name>
		<from_code>274964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine hydrochloride</from_name>
		<from_code>350466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine</from_name>
		<from_code>18600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azatadine maleate</from_name>
		<from_code>58275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhinitis, Allergic, Seasonal</to_name>
		<to_code>M0009814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine dihydrochloride</from_name>
		<from_code>142136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Histamine Dihydrochloride</to_name>
		<to_code>M0010392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine</from_name>
		<from_code>5333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Histamine</to_name>
		<to_code>M0010390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histamine hydrochloride</from_name>
		<from_code>350466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Histamine Hydrochloride</to_name>
		<to_code>M000638464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexetidine</from_name>
		<from_code>5301</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hexetidine</to_name>
		<to_code>M0010320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hematoporphyrin</from_name>
		<from_code>5164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hematoporphyrin</to_name>
		<to_code>M0010060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl ethylcellulose</from_name>
		<from_code>1722035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl-2-hydroxyethylcellulose</to_name>
		<to_code>M0186949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl ethylcellulose</from_name>
		<from_code>1722035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl(hydroxyethyl)cellulose</to_name>
		<to_code>M0435029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexylene glycol</from_name>
		<from_code>1305548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexylene glycol</to_name>
		<to_code>M0057801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexoprenaline sulfate</from_name>
		<from_code>258331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hexoprenaline Sulfate</to_name>
		<to_code>M0351214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hectorite</from_name>
		<from_code>1367162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hectorite</to_name>
		<to_code>M0061374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorous acid</from_name>
		<from_code>1483316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypochlorous Acid</to_name>
		<to_code>M0010892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>HC yellow no. 4</from_name>
		<from_code>2179013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-((2-(2-hydroxyethoxy)-4-nitrophenyl)amino)ethanol</to_name>
		<to_code>M0231944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halometasone monohydrate</from_name>
		<from_code>237025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>halometasone monohydrate</to_name>
		<to_code>M0450253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyestrones</from_name>
		<from_code>5530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydroxyestrones</to_name>
		<to_code>M0010760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Helicobacter pylori</from_name>
		<from_code>1318501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter pylori</to_name>
		<to_code>M0025164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vonoprazan</from_name>
		<from_code>2604577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter pylori</to_name>
		<to_code>M0025164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vonoprazan fumarate</from_name>
		<from_code>2604576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Helicobacter pylori</to_name>
		<to_code>M0025164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hemp</from_name>
		<from_code>1788846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemp</to_name>
		<to_code>M0003274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,6-hexamethylene diisocyanate</from_name>
		<from_code>1428547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,6-hexamethylene diisocyanate</to_name>
		<to_code>M0064409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human enterovirus A</from_name>
		<from_code>1668271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterovirus A, Human</to_name>
		<to_code>M0385393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Houttuynia cordata whole extract</from_name>
		<from_code>1358899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Houttuynia cordata extract</to_name>
		<to_code>M0409351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Houttuynia cordata whole extract</from_name>
		<from_code>1358899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Houttuynia cordata whole</to_name>
		<to_code>M000745672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-hexenyl salicylate, cis-</from_name>
		<from_code>2359262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cis-3-hexenyl salicylate</to_name>
		<to_code>M0079744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydantoin</from_name>
		<from_code>1721294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydantoins</to_name>
		<to_code>M0010672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hederagenin</from_name>
		<from_code>2045115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hederagenin</to_name>
		<to_code>M0085532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,2,6-hexanetriol</from_name>
		<from_code>1362577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,2,6-hexanetriol</to_name>
		<to_code>M0350374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxide ion</from_name>
		<from_code>1314279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxide ion</to_name>
		<to_code>M0098577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hesperetin</from_name>
		<from_code>1314255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hesperetin</to_name>
		<to_code>M0060438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hafnium</from_name>
		<from_code>1534767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hafnium</to_name>
		<to_code>M0009743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl cellulose (1600000 WAMW)</from_name>
		<from_code>2048727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropyl cellulose (type H)</to_name>
		<to_code>M000644828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl cellulose (type H)</from_name>
		<from_code>1811461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropyl cellulose (type H)</to_name>
		<to_code>M000644828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Houttuynia cordata flowering top extract</from_name>
		<from_code>1309469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Houttuynia cordata flowering top</to_name>
		<to_code>M000745674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexafluorenium</from_name>
		<from_code>26826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexafluorenium</to_name>
		<to_code>M0046315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexapeptide-11</from_name>
		<from_code>1996982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Phe-Val-Ala-Pro-Phe-Pro</to_name>
		<to_code>M0585622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexamidine</from_name>
		<from_code>26849</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexamidine</to_name>
		<to_code>M0071011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydracrylic acid</from_name>
		<from_code>2673464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydracrylic acid</to_name>
		<to_code>M0099152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heroin hydrochloride</from_name>
		<from_code>81994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heroin Hydrochloride</to_name>
		<to_code>M0330523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-hydroxybenzyl alcohol</from_name>
		<from_code>2045942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-hydroxybenzyl alcohol</to_name>
		<to_code>M0071029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinine</from_name>
		<from_code>2468435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroquinine</to_name>
		<to_code>M000633818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>human parvovirus B19 virus</from_name>
		<from_code>1368364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Parvovirus B19, Human</to_name>
		<to_code>M0025480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexafluorenium bromide</from_name>
		<from_code>53017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexafluorenium bromide</to_name>
		<to_code>M0046311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>HC red no. 3</from_name>
		<from_code>2469246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HC Red No. 3</to_name>
		<to_code>M0152408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histidinal, L-</from_name>
		<from_code>2621896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>histidinal</to_name>
		<to_code>M0133993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrogen sulfite</from_name>
		<from_code>1366859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydrogen sulfite</to_name>
		<to_code>M0125104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hawthorn preparation</from_name>
		<from_code>155097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hawthorn extract</to_name>
		<to_code>M000744670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-hydroxycyclophosphamide</from_name>
		<from_code>2675983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-hydroxycyclophosphamide</to_name>
		<to_code>M0059325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypochlorite</from_name>
		<from_code>1483317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypochlorite</to_name>
		<to_code>M0010893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>histidine</from_name>
		<from_code>5340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Histidine</to_name>
		<to_code>M0010400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>holy basil leaf extract</from_name>
		<from_code>1860076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>holy basil leaf extract</to_name>
		<to_code>M000744082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypromellose acetate succinate</from_name>
		<from_code>2645263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropylmethylcellulose acetate succinate</to_name>
		<to_code>M0139120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hirudin</from_name>
		<from_code>1546205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hirudin</to_name>
		<to_code>M0010382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropyl methacrylate</from_name>
		<from_code>2468433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxypropyl methacrylate</to_name>
		<to_code>M0102062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexyl salicylate</from_name>
		<from_code>1421892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexyl salicylate</to_name>
		<to_code>M0518360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroiodic acid</from_name>
		<from_code>27208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroiodic acid</to_name>
		<to_code>M0055977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hemicellulase</from_name>
		<from_code>26514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hemicellulase</to_name>
		<to_code>M0080451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrobromic acid</from_name>
		<from_code>1426869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydrobromic Acid</to_name>
		<to_code>M0027243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine</from_name>
		<from_code>798444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Inactivated</to_name>
		<to_code>M0023305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heptanal</from_name>
		<from_code>2360434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>heptanal</to_name>
		<to_code>M0133976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyisohexyl 3-cyclohexene carboxaldehyde</from_name>
		<from_code>1426621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxyisohexyl 3-cyclohexene carboxaldehyde</to_name>
		<to_code>M0243505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexyl 5-aminolevulinate</from_name>
		<from_code>1426872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-aminolevulinic acid hexyl ester</to_name>
		<to_code>M0378672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heme arginate</from_name>
		<from_code>26506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>heme arginate</to_name>
		<to_code>M0140322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2,4,4,6,8,8-heptamethylnonane</from_name>
		<from_code>1362933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,2,4,4,6,8,8-heptamethylnonane</to_name>
		<to_code>M0164659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,2,4,4,6,8,8-heptamethylnonane</from_name>
		<from_code>1362933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>isohexadecane</to_name>
		<to_code>M000642791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrofluoric acid</from_name>
		<from_code>5496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydrofluoric Acid</to_name>
		<to_code>M0010714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3'-hydroxyacetophenone</from_name>
		<from_code>2560214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3'-hydroxyacetophenone</to_name>
		<to_code>M0548672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hordenine</from_name>
		<from_code>27120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hordenine</to_name>
		<to_code>M0051458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexamethyldisiloxane</from_name>
		<from_code>1311540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>disiloxane</to_name>
		<to_code>M0165422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexamethyldisiloxane</from_name>
		<from_code>1311540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexamethyldisiloxane</to_name>
		<to_code>M0065557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrotalcite</from_name>
		<from_code>27221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydrotalcite</to_name>
		<to_code>M0055979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>10-hydroxystearic acid</from_name>
		<from_code>2476630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>10-hydroxystearic acid</to_name>
		<to_code>M0191683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>honokiol</from_name>
		<from_code>2562546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>honokiol</to_name>
		<to_code>M0047074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Haemophilus influenzae</from_name>
		<from_code>1364467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Haemophilus influenzae</to_name>
		<to_code>M0009741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)</from_name>
		<from_code>2599921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>(4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)</to_name>
		<to_code>M000743425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexyldecanol</from_name>
		<from_code>1363575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexyldecanol</to_name>
		<to_code>M0528104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexyl laurate</from_name>
		<from_code>1367126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexyl laurate</to_name>
		<to_code>M0503540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>horehound extract</from_name>
		<from_code>1426436</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Marrubium vulgare extract</to_name>
		<to_code>M000745640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Marrubium vulgare extract</from_name>
		<from_code>1424909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Marrubium vulgare extract</to_name>
		<to_code>M000745640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hylan</from_name>
		<from_code>27306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hylan</to_name>
		<to_code>M0142537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexaminolevulinate hydrochloride</from_name>
		<from_code>1426871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexaminolevulinate hydrochloride</to_name>
		<to_code>M0579461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halometasone</from_name>
		<from_code>26416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>halometasone</to_name>
		<to_code>M0111181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>heptaminol hydrochloride</from_name>
		<from_code>236294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Heptaminol Hydrochloride</to_name>
		<to_code>M0330241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>harpagoside</from_name>
		<from_code>2048124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>harpagoside</to_name>
		<to_code>M0103253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexadecane</from_name>
		<from_code>2167851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>n-hexadecane</to_name>
		<to_code>M0051408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexoprenaline</from_name>
		<from_code>5307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hexoprenaline</to_name>
		<to_code>M0010329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-hydroxydecanoate</from_name>
		<from_code>1486028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-hydroxydecanoate</to_name>
		<to_code>M0083211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexyl decanoate</from_name>
		<from_code>1313706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexyl decanoate</to_name>
		<to_code>M0504650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-hydroxydecanoic acid</from_name>
		<from_code>1486027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-hydroxydecanoic acid</to_name>
		<to_code>M0083212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 5, human</from_name>
		<from_code>1316104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesvirus 5, Human</to_name>
		<to_code>M0005606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>high fructose corn syrup</from_name>
		<from_code>1310511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>High Fructose Corn Syrup</to_name>
		<to_code>M0593348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hypotaurine</from_name>
		<from_code>2597523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hypotaurine</to_name>
		<to_code>M0045090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroquinidine hydrochloride</from_name>
		<from_code>236160</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroquinidine hydrochloride</to_name>
		<to_code>M0488225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexamidine diisethionate</from_name>
		<from_code>1939371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexamidine diisethionate</to_name>
		<to_code>M0519741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-hexadecene</from_name>
		<from_code>1313219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetene</to_name>
		<to_code>M0056478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxypropylbetadex (0.58-0.68 MS)</from_name>
		<from_code>1363608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-Hydroxypropyl-beta-cyclodextrin</to_name>
		<to_code>M0152341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexylresorcinol</from_name>
		<from_code>5321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hexylresorcinol</to_name>
		<to_code>M0010341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-hydroxyethyl methacrylate</from_name>
		<from_code>1362692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxyethyl methacrylate</to_name>
		<to_code>M0046330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hexadecanal</from_name>
		<from_code>2049630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexadecanal</to_name>
		<to_code>M0041912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ultralente insulin, beef</to_name>
		<to_code>235282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urethane</to_name>
		<to_code>1420982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ustilago maydis antigen</to_name>
		<to_code>467329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uridine triacetate</to_name>
		<to_code>1665222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Umbilicus rupestris extract</to_name>
		<to_code>2049224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urapidil</to_name>
		<to_code>39230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulex europaeus flower extract</to_name>
		<to_code>1324594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica urens extract</to_name>
		<to_code>1370792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulva lactuca extract</to_name>
		<to_code>1338620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uranium cation (6+)</to_name>
		<to_code>1546269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica dioica preparation</to_name>
		<to_code>350490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>upadacitinib</to_name>
		<to_code>2196092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-kfce</to_name>
		<to_code>2705577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>usnic acid</to_name>
		<to_code>1546707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urea hydrochloride</to_name>
		<to_code>1862866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulva compressa protein (acid hydrolyzed, 300-5000 MW)</to_name>
		<to_code>1314301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ursodeoxycholate</to_name>
		<to_code>62427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ublituximab-xiiy</to_name>
		<to_code>2626348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ubidecarenone</to_name>
		<to_code>21406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulva compressa extract</to_name>
		<to_code>1426782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>umeclidinium</to_name>
		<to_code>1487514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecylenoyl phenylalanine</to_name>
		<to_code>1716524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Undaria pinnatifida extract</to_name>
		<to_code>1355807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uranyl nitrate hexahydrate</to_name>
		<to_code>1313279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>umbralisib</to_name>
		<to_code>2478439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-ttwe</to_name>
		<to_code>2705553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undeceth-7</to_name>
		<to_code>1356141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uric acid</to_name>
		<to_code>1427088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus procera whole extract</to_name>
		<to_code>1800490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uridine triphosphate sodium</to_name>
		<to_code>236509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecylenate</to_name>
		<to_code>314881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uranium</to_name>
		<to_code>10999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Usnea barbata extract</to_name>
		<to_code>1426661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uracil mustard</to_name>
		<to_code>10996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecyl ethyleneglycol monoether</to_name>
		<to_code>1540879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecyl alcohol</to_name>
		<to_code>1310537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-auub</to_name>
		<to_code>2700665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ultramarine blue</to_name>
		<to_code>1311650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ulipristal</to_name>
		<to_code>1005921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecane</to_name>
		<to_code>1811767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Uncaria rhynchophylla stem</to_name>
		<to_code>1309283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab</to_name>
		<to_code>847083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus glabra whole extract</to_name>
		<to_code>2055748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus rubra bark extract</to_name>
		<to_code>1309484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica urens leaf extract</to_name>
		<to_code>1307566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica preparation</to_name>
		<to_code>319816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica urens homeopathic preparation</to_name>
		<to_code>285167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulkenia DHA oil</to_name>
		<to_code>1430391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ubiquinone Q2</to_name>
		<to_code>1423925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-hmny</to_name>
		<to_code>2725083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>10-undecenal</to_name>
		<to_code>2378832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>unoprostone</to_name>
		<to_code>1546408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uridine 5-mo-phos disod</to_name>
		<to_code>236785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ublituximab</to_name>
		<to_code>2626349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ursolic acid</to_name>
		<to_code>1426931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus glabra pollen extract</to_name>
		<to_code>2369372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecylenic acid monoethanolamide</to_name>
		<to_code>1314232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Uncaria sinensis whole preparation</to_name>
		<to_code>1314584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>umeclidinium bromide</to_name>
		<to_code>1487512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ultralente insulin, human</to_name>
		<to_code>221110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ultralente insulin, beef-pork</to_name>
		<to_code>235281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica dioica root extract</to_name>
		<to_code>1307579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecanedioic acid</to_name>
		<to_code>2044371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>umirolimus</to_name>
		<to_code>1942479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-stba</to_name>
		<to_code>2700389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus procera flowering twig extract</to_name>
		<to_code>1309483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Utah juniper pollen extract</to_name>
		<to_code>852597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Umbellularia californica leaf extract</to_name>
		<to_code>1864070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ursadiol</to_name>
		<to_code>2045735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulex europaeus whole extract</to_name>
		<to_code>2002714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urofollitropin</to_name>
		<to_code>134404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ubiquinone</to_name>
		<to_code>10975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undeceth-5</to_name>
		<to_code>1733673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica dioica subsp. dioica leaf extract</to_name>
		<to_code>2267408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-aauz</to_name>
		<to_code>2702602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Uncaria gambir whole extract</to_name>
		<to_code>1539191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-aekn</to_name>
		<to_code>2705377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ultramarine violet</to_name>
		<to_code>1858076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ustekinumab-srlf</to_name>
		<to_code>2717063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uridine</to_name>
		<to_code>11017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uranyl nitrate</to_name>
		<to_code>1858851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ubiquinol</to_name>
		<to_code>39085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Uncaria tomentosa leaf extract</to_name>
		<to_code>1358480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>uracil</to_name>
		<to_code>10995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ubrogepant</to_name>
		<to_code>2268216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Uncaria tomentosa root extract</to_name>
		<to_code>1435280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ulipristal acetate</to_name>
		<to_code>1005920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urea sulfate</to_name>
		<to_code>1539374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urokinase</to_name>
		<to_code>11055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Uncaria tomentosa whole extract</to_name>
		<to_code>1874893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Umbellularia californica whole extract</to_name>
		<to_code>2539937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus rubra pollen allergenic extract</to_name>
		<to_code>1426632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ursodiol</to_name>
		<to_code>11065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>umbralisib tosylate</to_name>
		<to_code>2478438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>unithiol</to_name>
		<to_code>10991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecylenic acid</to_name>
		<to_code>10989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecylcrylene dimethicone (10000 MW)</to_name>
		<to_code>1739228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Urtica dioica leaf extract</to_name>
		<to_code>1309281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ursolate</to_name>
		<to_code>1370661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urea c-13</to_name>
		<to_code>226724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>undecylenoyl glycine</to_name>
		<to_code>1426671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ustilago maydis extract</to_name>
		<to_code>1427134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ulmus davidiana root extract</to_name>
		<to_code>1309993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urea</to_name>
		<to_code>11002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>U [Preparations]</from_name>
		<from_code>N0000010603</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>urea [14C]</to_name>
		<to_code>253158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urethane</from_name>
		<from_code>1420982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urethane</to_name>
		<to_code>M0022330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ulva lactuca extract</from_name>
		<from_code>1338620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ulva lactuca</to_name>
		<to_code>M000765201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>usnic acid</from_name>
		<from_code>1546707</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>usnic acid</to_name>
		<to_code>M0198345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uric acid</from_name>
		<from_code>1427088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Uric Acid</to_name>
		<to_code>M0022340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uranium</from_name>
		<from_code>10999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Uranium</to_name>
		<to_code>M0022305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ultramarine blue</from_name>
		<from_code>1311650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ultramarine (pigment)</to_name>
		<to_code>M0054474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>undecane</from_name>
		<from_code>1811767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>undecane</to_name>
		<to_code>M0079515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Uncaria rhynchophylla stem</from_name>
		<from_code>1309283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gou-teng</to_name>
		<to_code>M0232048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubiquinone Q2</from_name>
		<from_code>1423925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ubiquinone Q2</to_name>
		<to_code>M0084299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ursolic acid</from_name>
		<from_code>1426931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ursolic Acid</to_name>
		<to_code>M0047035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>umirolimus</from_name>
		<from_code>1942479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>umirolimus</to_name>
		<to_code>M0507755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uranyl nitrate</from_name>
		<from_code>1858851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Uranyl Nitrate</to_name>
		<to_code>M0022306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubiquinol</from_name>
		<from_code>39085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ubiquinol</to_name>
		<to_code>M0044835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>uracil</from_name>
		<from_code>10995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Uracil</to_name>
		<to_code>M0022302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>unithiol</from_name>
		<from_code>10991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unithiol</to_name>
		<to_code>M0022297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,3-dimercapto-1-propanesulfonic acid</from_name>
		<from_code>1546352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Unithiol</to_name>
		<to_code>M0022297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea c-13</from_name>
		<from_code>226724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbon Radioisotopes</to_name>
		<to_code>M0003375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea c-13</from_name>
		<from_code>226724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urea</to_name>
		<to_code>M0022315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urea</from_name>
		<from_code>11002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urea</to_name>
		<to_code>M0022315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyurea</from_name>
		<from_code>5552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Urea</to_name>
		<to_code>M0022315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mercurialis annua flowering top extract</to_name>
		<to_code>1652098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha suaveolens whole extract</to_name>
		<to_code>1800487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methylaminorex, cis-(+/-)-</to_name>
		<to_code>2665286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus alba bark extract</to_name>
		<to_code>1309444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitapivat</to_name>
		<to_code>2594468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mild silver protein</to_name>
		<to_code>30021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minaprine</to_name>
		<to_code>30031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine sulfate liposomal</to_name>
		<to_code>477397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monofluorophosphate ion</to_name>
		<to_code>1546445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methocarbamol</to_name>
		<to_code>6845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mosapride</to_name>
		<to_code>135091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methaqualone</to_name>
		<to_code>6823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mogamulizumab</to_name>
		<to_code>2054068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl isobutyrate</to_name>
		<to_code>2460732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methionine</to_name>
		<to_code>6837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meptazinol hydrochloride</to_name>
		<to_code>11347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melanin synthetic (tyrosine, peroxide)</to_name>
		<to_code>1312388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mumps virus</to_name>
		<to_code>1426911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose (100 CPS)</to_name>
		<to_code>1310583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Menyanthes trifoliata extract</to_name>
		<to_code>1652100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl phenylacetate</to_name>
		<to_code>2699422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melarsomine dihydrochloride</to_name>
		<to_code>1012533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methampicillin sodium</to_name>
		<to_code>273443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mimulus guttatus flowering top extract</to_name>
		<to_code>1309946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Monarda didyma leaf extract</to_name>
		<to_code>1428851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maralixibat</to_name>
		<to_code>2571074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metronidazole benzoate</to_name>
		<to_code>103866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Marrubium vulgare extract</to_name>
		<to_code>1424909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadow brome pollen extract</to_name>
		<to_code>1484976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium stearate</to_name>
		<to_code>1310567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucuna birdwoodiana stem extract</to_name>
		<to_code>2594596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macadamia oil</to_name>
		<to_code>1307956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mirabilis jalapa seed extract</to_name>
		<to_code>1808533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 101</to_name>
		<to_code>2058847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine iotroxinate</to_name>
		<to_code>52527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malva sylvestris leaf extract</to_name>
		<to_code>1307582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric chloride</to_name>
		<to_code>1311634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methicillin sodium</to_name>
		<to_code>267073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium nitrate</to_name>
		<to_code>1362814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacholine chloride</to_name>
		<to_code>40165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclofenamate</to_name>
		<to_code>588003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium sulfate anhydrous</to_name>
		<to_code>1311625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 102</to_name>
		<to_code>2056923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate dibasic trihydrate</to_name>
		<to_code>237119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Michelia alba whole extract</to_name>
		<to_code>2635084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myricaria paniculata stem extract</to_name>
		<to_code>1725034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus nigra leaf extract</to_name>
		<to_code>2468431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medetomidine</to_name>
		<to_code>52016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefruside</to_name>
		<to_code>6696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl glutamate</to_name>
		<to_code>1370584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxy PEG-40</to_name>
		<to_code>1747568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylhomatropine</to_name>
		<to_code>1546413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>micafungin sodium</to_name>
		<to_code>487070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesterolone</to_name>
		<to_code>6781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myo-inositol trispyrophosphate</to_name>
		<to_code>1791813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium gluconogluceptate</to_name>
		<to_code>236564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methscopolamine nitrate</to_name>
		<to_code>857649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylephedrine hydrochloride</to_name>
		<to_code>1739003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methamphetamine</to_name>
		<to_code>6816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl palmitate</to_name>
		<to_code>1486520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>margetuximab</to_name>
		<to_code>2473851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-(3,4-methylenedioxyphenyl)-2-methylpropanal</to_name>
		<to_code>1376341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl dehydroabietate</to_name>
		<to_code>2637951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malmea depressa bark extract</to_name>
		<to_code>1923615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesalamine</to_name>
		<to_code>52582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitobronitol</to_name>
		<to_code>6996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl L-arginine</to_name>
		<to_code>1992539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl gluceth-20</to_name>
		<to_code>1363572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium palmitate</to_name>
		<to_code>1424873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-methyl-5-heptanone oxime</to_name>
		<to_code>2679168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>marbofloxacin</to_name>
		<to_code>69256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose (400 cps)</to_name>
		<to_code>1313702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose (25 CPS)</to_name>
		<to_code>1313701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese acetate</to_name>
		<to_code>1370629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mazindol</to_name>
		<to_code>6664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium lactate</to_name>
		<to_code>214688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medrogestone</to_name>
		<to_code>6690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maralixibat chloride</to_name>
		<to_code>2571073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl alcohol</to_name>
		<to_code>1362897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltodextrin</to_name>
		<to_code>1363050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl acetate, (+/-)-</to_name>
		<to_code>2282306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylnicotinate</to_name>
		<to_code>29900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose</to_name>
		<to_code>1000577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl ethylamido oxalate</to_name>
		<to_code>2571661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meptazinol</to_name>
		<to_code>6761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mitracarpus hirtus whole extract</to_name>
		<to_code>2467137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylheptyl isostearate</to_name>
		<to_code>2548675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacycline</to_name>
		<to_code>6812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methylphenethyl alcohol</to_name>
		<to_code>2167998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylate</to_name>
		<to_code>1424906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manidipine</to_name>
		<to_code>29275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia x alba flower oil</to_name>
		<to_code>1539426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-methyl-2-pyrrolidinone</to_name>
		<to_code>1305552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monofluorophosphate</to_name>
		<to_code>52885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>muromonab-CD3</to_name>
		<to_code>42405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mequitazine</to_name>
		<to_code>29528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium carbonate hydroxide</to_name>
		<to_code>1363704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moclobemide</to_name>
		<to_code>30121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monophenylheptamethylcyclotetrasiloxane</to_name>
		<to_code>2166046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metipranolol</to_name>
		<to_code>10824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl dihydrojasmonate, (-)-trans-</to_name>
		<to_code>2458323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaproterenol sulfate</to_name>
		<to_code>6804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric iodide</to_name>
		<to_code>1426941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mimulus guttatus whole extract</to_name>
		<to_code>1799147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Matricaria chamomilla whole extract</to_name>
		<to_code>1307559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 2-sulfolaurate</to_name>
		<to_code>1370609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moringa oleifera seed oil</to_name>
		<to_code>1309443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl salicylate</to_name>
		<to_code>29787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mivacurium chloride</to_name>
		<to_code>52796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magaldrate</to_name>
		<to_code>29151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrciaria dubia seed extract</to_name>
		<to_code>1307724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monooctanoin</to_name>
		<to_code>30198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Musa x paradisiaca flower extract</to_name>
		<to_code>1649015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mandragora officinarum preparation</to_name>
		<to_code>350386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylenedioxycinnamic acid</to_name>
		<to_code>324051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium chloride anhydrous</to_name>
		<to_code>1311539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mineral oil, light</to_name>
		<to_code>577312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mianserin</to_name>
		<to_code>6929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meningococcal polysaccharide vaccine group W-135</to_name>
		<to_code>314724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>micafungin</to_name>
		<to_code>325887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myrcene</to_name>
		<to_code>2166047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metformin hydrochloride</to_name>
		<to_code>235743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyllactic acid</to_name>
		<to_code>2685742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malt extract</to_name>
		<to_code>235375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moschus moschiferus musk sac resin</to_name>
		<to_code>1426870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoprolol fumarate</to_name>
		<to_code>102313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia officinalis bark extract</to_name>
		<to_code>1307853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenamine sulfosalicylate</to_name>
		<to_code>235562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>motixafortide</to_name>
		<to_code>2664896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 105</to_name>
		<to_code>2274239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manitol</to_name>
		<to_code>2475831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methylundecanal</to_name>
		<to_code>2378836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maranta arundiacea whole extract</to_name>
		<to_code>2102921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha pulegium whole extract</to_name>
		<to_code>2542745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>megestrol</to_name>
		<to_code>6703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese monoxide</to_name>
		<to_code>1728312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoprolol succinate</to_name>
		<to_code>221124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minocycline</to_name>
		<to_code>6980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Minquartia guianensis bark extract</to_name>
		<to_code>1374403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melamine</to_name>
		<to_code>1603851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrtus communis leaf extract</to_name>
		<to_code>1309445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl hydrogenated rosinate</to_name>
		<to_code>1490691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aluminum silicate type IC</to_name>
		<to_code>1730436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malabar plum juice</to_name>
		<to_code>2170606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl acetate</to_name>
		<to_code>2372219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk thistle seed</to_name>
		<to_code>283580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Millettia pulchra whole extract</to_name>
		<to_code>2610403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Manihot esculenta root extract</to_name>
		<to_code>1309336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium myristate</to_name>
		<to_code>1313980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-mercaptoethanesulfonic acid</to_name>
		<to_code>1546354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese gluconate</to_name>
		<to_code>52403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monoethyl fumarate</to_name>
		<to_code>52882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Momordica charantia stem extract</to_name>
		<to_code>2696971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyleugenol</to_name>
		<to_code>1368373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menadiol phosphate</to_name>
		<to_code>360777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Madhuca longifolia var. latifolia seed butter extract</to_name>
		<to_code>1808532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mockernut extract</to_name>
		<to_code>1872037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus domestica pollen extract</to_name>
		<to_code>2593689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mibefradil</to_name>
		<to_code>83213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxetumomab pasudotox</to_name>
		<to_code>2099295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mianserin hydrochloride</to_name>
		<to_code>203127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mycobacterium phlei</to_name>
		<to_code>1310907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese sulfate</to_name>
		<to_code>29268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mipomersen</to_name>
		<to_code>1367839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mannose</to_name>
		<to_code>6633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus domestica whole extract</to_name>
		<to_code>1482537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mofebutazone</to_name>
		<to_code>30202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxifloxacin hydrochloride monohydrate</to_name>
		<to_code>1926505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myrrh extract</to_name>
		<to_code>67257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk thistle fruit</to_name>
		<to_code>259389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl dihydroabietate</to_name>
		<to_code>1600931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha arvensis whole extract</to_name>
		<to_code>1490685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mycobacterium bovis</to_name>
		<to_code>1320629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha arvensis leaf oil</to_name>
		<to_code>1307691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>montmorrillonite</to_name>
		<to_code>1425919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline wax</to_name>
		<to_code>1368704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mannose, L-</to_name>
		<to_code>2123307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mifepristone</to_name>
		<to_code>6964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitoxantrone</to_name>
		<to_code>7005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese bromide</to_name>
		<to_code>2627378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxy PEG PPG-7-3 aminopropyl dimethicone</to_name>
		<to_code>1543455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mexiletine</to_name>
		<to_code>6926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus sylvestris flower extract</to_name>
		<to_code>1309743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meprednisone disodium phosphate</to_name>
		<to_code>1742508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minocycline hydrochloride</to_name>
		<to_code>6979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese pyrophosphate</to_name>
		<to_code>1721296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha aquatica var. citrata leaf extract</to_name>
		<to_code>1723158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk thistle seed extract</to_name>
		<to_code>259274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycophenolate</to_name>
		<to_code>265323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mersalyl</to_name>
		<to_code>6774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metanil yellow</to_name>
		<to_code>1305576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monostearyl citrate</to_name>
		<to_code>1368188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebeverine</to_name>
		<to_code>29410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango blossom pollen extract</to_name>
		<to_code>1006371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mintlactone</to_name>
		<to_code>1724822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepivacaine hydrochloride</to_name>
		<to_code>203185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methantheline</to_name>
		<to_code>6821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylserine</to_name>
		<to_code>1313244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mobocertinib succinate</to_name>
		<to_code>2570737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medazepam</to_name>
		<to_code>6680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miconazole nitrate</to_name>
		<to_code>42790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium palmitostearate</to_name>
		<to_code>1743153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese citrate</to_name>
		<to_code>283767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metylperon</to_name>
		<to_code>29961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Momordica balsamina immature fruit extract</to_name>
		<to_code>1311092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium glycinate</to_name>
		<to_code>476818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metronidazole hydrochloride</to_name>
		<to_code>82047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylparaben</to_name>
		<to_code>29903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medifoxamine fumarate</to_name>
		<to_code>236781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate, tribasic, pentahydrate</to_name>
		<to_code>1313280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxyphenamine hydrochloride</to_name>
		<to_code>451944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>momelotinib dihydrochloride monohydrate</to_name>
		<to_code>2665205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mugwort sage pollen extract</to_name>
		<to_code>852029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metenkefalin</to_name>
		<to_code>1349278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metamizole sodium</to_name>
		<to_code>1537943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclizine hydrochloride</to_name>
		<to_code>82041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium gluconate</to_name>
		<to_code>52358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>measles virus vaccine live, attenuated Schwarz strain</to_name>
		<to_code>2603499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melphalan</to_name>
		<to_code>6718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aspartate anhydrous</to_name>
		<to_code>1792467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manuka oil</to_name>
		<to_code>1355829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylergonovine maleate</to_name>
		<to_code>84158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mometasone furoate monohydrate</to_name>
		<to_code>153374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methadyl acetate</to_name>
		<to_code>6814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaraminol bitartrate</to_name>
		<to_code>6806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl propionate</to_name>
		<to_code>1435520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macadamia seed oil glycereth-8 esters</to_name>
		<to_code>1429937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mycobacterium tuberculosis</to_name>
		<to_code>1492936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mumps skin test antigen</to_name>
		<to_code>89854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mahonia aquifolium root bark extract</to_name>
		<to_code>1347560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus australis wood extract</to_name>
		<to_code>1428841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl salicylate</to_name>
		<to_code>1368207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrothamnus flabellifolia whole extract</to_name>
		<to_code>1872380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenorex</to_name>
		<to_code>29444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>micronomicin</to_name>
		<to_code>29996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl glucose sesquistearate</to_name>
		<to_code>1592258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monoethanolamine lauryl sulfate</to_name>
		<to_code>1370789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medronate disodium</to_name>
		<to_code>317599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malva neglecta whole extract</to_name>
		<to_code>1998848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldibromo glutaronitrile</to_name>
		<to_code>1307044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl oleoyl taurate</to_name>
		<to_code>1789473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medronate</to_name>
		<to_code>1358207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus domestica leaf extract</to_name>
		<to_code>2390285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Monardella odoratissima whole extract</to_name>
		<to_code>2533901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Murraya paniculata whole extract</to_name>
		<to_code>2045729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecasermin rinfabate</to_name>
		<to_code>616877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meropenem anhydrous</to_name>
		<to_code>1546029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methadone</to_name>
		<to_code>6813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxisylyte</to_name>
		<to_code>10561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha pulegium extract</to_name>
		<to_code>1426923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl lactate, L-</to_name>
		<to_code>1431993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Matricaria chamomilla flowering top oil</to_name>
		<to_code>1309332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Marsdenia condurango bark extract</to_name>
		<to_code>1310015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>marine non-gelling gelatin</to_name>
		<to_code>1998464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltooligosyl glucoside</to_name>
		<to_code>2469245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mountain cedar pollen extract</to_name>
		<to_code>852581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miristalkonium chloride</to_name>
		<to_code>236394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mometasone furoate</to_name>
		<to_code>30145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>99 molybdenum</to_name>
		<to_code>90574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene blue cation</to_name>
		<to_code>1546414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moexiprilat</to_name>
		<to_code>1546358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maclura cochinchinensis root extract</to_name>
		<to_code>1746486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylic acid</to_name>
		<to_code>1424905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metabisulfite ion</to_name>
		<to_code>2697173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 2-octenoate, (E)-</to_name>
		<to_code>2585678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-methylhydantoin</to_name>
		<to_code>1729875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycobacterium microti immunoserum rabbit</to_name>
		<to_code>1367196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mineral oil</to_name>
		<to_code>6972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Measles Vaccine</to_name>
		<to_code>6669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk protein concentrate</to_name>
		<to_code>2595236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia sprengeri flower bud extract</to_name>
		<to_code>2390757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate, monobasic, dihydrate</to_name>
		<to_code>1487155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirabegron</to_name>
		<to_code>1300786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-methylpentadecane</to_name>
		<to_code>2413031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meprednisone</to_name>
		<to_code>29523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Musa x paradisiaca whole extract</to_name>
		<to_code>1606331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methyl-3-decen-5-ol</to_name>
		<to_code>2557379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium L-threonate</to_name>
		<to_code>1549113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melanotransferrin</to_name>
		<to_code>2665288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango allergenic extract</to_name>
		<to_code>1011404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia kobus bark extract</to_name>
		<to_code>1312377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metocurine iodide</to_name>
		<to_code>203206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia liliiflora flower bud extract</to_name>
		<to_code>2122671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>6-methyl citronellol</to_name>
		<to_code>2046781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylprednisolone acetate</to_name>
		<to_code>155323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mulberry pollen extract</to_name>
		<to_code>899593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca ericifolia leaf oil</to_name>
		<to_code>1422485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mephentermine hydrochloride</to_name>
		<to_code>236481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha canadensis whole extract</to_name>
		<to_code>2619675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesulfen</to_name>
		<to_code>29584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mallotus japonicus flower oil</to_name>
		<to_code>1541709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine</to_name>
		<to_code>6704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxy PEG-22/dodecyl glycol polymer</to_name>
		<to_code>1940007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxyisopropanol</to_name>
		<to_code>2462502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl hexapeptide-12, (VAL-GLY-VAL-ALA-PRO-GLY)-</to_name>
		<to_code>2667329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango juice</to_name>
		<to_code>1358964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl ricinoleate</to_name>
		<to_code>1541746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morpholine</to_name>
		<to_code>1368870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mofezolac</to_name>
		<to_code>11469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mupirocin</to_name>
		<to_code>42372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus pumila whole extract</to_name>
		<to_code>2002715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metavanadate</to_name>
		<to_code>596548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mcpa triisopropanolamine</to_name>
		<to_code>2379731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Monarda didyma leaf oil</to_name>
		<to_code>2563622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melicope pteleifolia leaf extract</to_name>
		<to_code>1437851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium iodide</to_name>
		<to_code>1992669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecamylamine hydrochloride</to_name>
		<to_code>91240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monosodium ethylenediaminetetraacetate</to_name>
		<to_code>1363994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mannitol hexanitrate</to_name>
		<to_code>89792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose</to_name>
		<to_code>6873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl malate phosphonic acid</to_name>
		<to_code>1926939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mucins</to_name>
		<to_code>7076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Matricaria recutita flowering top extract</to_name>
		<to_code>1307730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>measles virus vaccine live, Enders' attenuated Edmonston strain</to_name>
		<to_code>804179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl gluceth-10</to_name>
		<to_code>1367118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenamate</to_name>
		<to_code>257844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melilotus indicus whole extract</to_name>
		<to_code>1442699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese citrate decahydrate</to_name>
		<to_code>1791698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecamylamine</to_name>
		<to_code>6673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Murraya koenigii whole extract</to_name>
		<to_code>2048122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methylbutyric acid</to_name>
		<to_code>2281310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylic acid - methyl methacrylate copolymer (1:1)</to_name>
		<to_code>1309720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxsalen</to_name>
		<to_code>6854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Millettia pinnata whole extract</to_name>
		<to_code>2590663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthol 1-propylene glycol carbonate, (-)-</to_name>
		<to_code>1371320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadowfoam seed oil fatty acids</to_name>
		<to_code>1540873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mavacamten</to_name>
		<to_code>2600867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium potassium aluminosilicate fluoride</to_name>
		<to_code>2464931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myricetin</to_name>
		<to_code>1368374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylnaltrexone bromide</to_name>
		<to_code>979111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthone 1,2-glycerol ketal, (-)-</to_name>
		<to_code>1426479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mexiletine hydrochloride</to_name>
		<to_code>142138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango seed oil</to_name>
		<to_code>1307681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metyrapone tartrate</to_name>
		<to_code>1313245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha piperita leaf extract</to_name>
		<to_code>1309326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium oxybate</to_name>
		<to_code>2387308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molybdenum trichloride</to_name>
		<to_code>2664834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese</to_name>
		<to_code>6623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl pentapeptide-4</to_name>
		<to_code>1313054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylesculetin acetate</to_name>
		<to_code>1426628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl-alpha-ionone</to_name>
		<to_code>1999321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrtus communis top extract</to_name>
		<to_code>1311125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia biondii flower extract</to_name>
		<to_code>1651700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylmethacrylate</to_name>
		<to_code>29897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monensin</to_name>
		<to_code>1368208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaclazepam</to_name>
		<to_code>614654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl myristate</to_name>
		<to_code>1425924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mephentermine sulfate</to_name>
		<to_code>82042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medium chain triglycerides</to_name>
		<to_code>1310578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus nigra fruit extract</to_name>
		<to_code>1311643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium chloride</to_name>
		<to_code>6579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methotrimeprazine</to_name>
		<to_code>6852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miocamycin</to_name>
		<to_code>6985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca alternifolia flowering top extract</to_name>
		<to_code>1435096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango extract</to_name>
		<to_code>1426332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methapyrilene</to_name>
		<to_code>6822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadowfoam estolide</to_name>
		<to_code>2640866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melia azedarach fruit extract</to_name>
		<to_code>1428838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltol</to_name>
		<to_code>1362894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metylperon hydrochloride</to_name>
		<to_code>289623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor plumbeus allergenic extract</to_name>
		<to_code>314415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldopate hydrochloride</to_name>
		<to_code>91241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moringa oleifera leaf oil</to_name>
		<to_code>1865401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristate</to_name>
		<to_code>1313976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium bromate</to_name>
		<to_code>2629642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 3-hydroxyhexanoate</to_name>
		<to_code>2605086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medigoxin</to_name>
		<to_code>6686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meperidine</to_name>
		<to_code>6754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium oleth sulfate</to_name>
		<to_code>2621831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Matricaria recutita root extract</to_name>
		<to_code>1722232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirikizumab</to_name>
		<to_code>2668384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 302</to_name>
		<to_code>2637132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene chloride</to_name>
		<to_code>1311537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl paraoxon</to_name>
		<to_code>1793922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia denudata flower bud extract</to_name>
		<to_code>2592974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxaverine</to_name>
		<to_code>52918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl-2-methylamino-1-propanol</to_name>
		<to_code>2396758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia fruit juice</to_name>
		<to_code>1311642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Momordica charantia fruit extract</to_name>
		<to_code>1306885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacycline hydrochloride</to_name>
		<to_code>235554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebhydroline</to_name>
		<to_code>29411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium amino acid chelate</to_name>
		<to_code>486895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mastocarpus stellatus extract</to_name>
		<to_code>1424904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-methyl-8-hydroxyquinoline</to_name>
		<to_code>15850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>marstacimab</to_name>
		<to_code>2697133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mosunetuzumab</to_name>
		<to_code>2625122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus domestica flower extract</to_name>
		<to_code>1309809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mosquito allergenic extract</to_name>
		<to_code>974741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mallotus japonicus bark extract</to_name>
		<to_code>2570160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malpighia glabra fruit extract</to_name>
		<to_code>1364406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molnupiravir</to_name>
		<to_code>2587901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard greens allergenic extract</to_name>
		<to_code>899452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese phosphate</to_name>
		<to_code>1313302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha arvensis leaf extract</to_name>
		<to_code>1314855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthol, (+)-</to_name>
		<to_code>1648123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylbenzyl methylbenzimidazole piperidinylmethanone</to_name>
		<to_code>1307039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca cajuputi whole extract</to_name>
		<to_code>2535503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aluminum silicate type IIA</to_name>
		<to_code>2106996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 103</to_name>
		<to_code>2413032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate, monobasic</to_name>
		<to_code>1731599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mirabilis jalapa whole extract</to_name>
		<to_code>2667640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molgramostim</to_name>
		<to_code>70161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maraviroc</to_name>
		<to_code>620216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium Mg-28</to_name>
		<to_code>2275622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 3-methylorsellinate</to_name>
		<to_code>2396434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>montelukast sodium</to_name>
		<to_code>115713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methampicillin</to_name>
		<to_code>29629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mahonia aquifolium root extract</to_name>
		<to_code>1309441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mountain pepper whole extract</to_name>
		<to_code>2048036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine benzoate</to_name>
		<to_code>236401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metrizamide</to_name>
		<to_code>6920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor circinelloides f. circinelloides allergenic extract</to_name>
		<to_code>2101422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl lactate, (+)-</to_name>
		<to_code>1551572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mountain pepper fruit extract</to_name>
		<to_code>1661437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose (4000 CPS)</to_name>
		<to_code>1297402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca quinquenervia leaf oil</to_name>
		<to_code>1307888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morrhuate</to_name>
		<to_code>1547610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercurius solubilis preparation</to_name>
		<to_code>1310193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minaxolone</to_name>
		<to_code>1495077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>MENINGOCOCCAL VACCINE B</to_name>
		<to_code>324050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia extract</to_name>
		<to_code>403712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midecamycin diacetate</to_name>
		<to_code>236200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</to_name>
		<to_code>235574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine liposomal</to_name>
		<to_code>477468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk fat, cow</to_name>
		<to_code>1305763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose (1500 CPS)</to_name>
		<to_code>1313700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium orotate dihydrate</to_name>
		<to_code>1926471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia sieboldii root extract</to_name>
		<to_code>2621832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango bark extract</to_name>
		<to_code>1925438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Momordica balsamina whole extract</to_name>
		<to_code>1740940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macadamia acid</to_name>
		<to_code>1991869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl soyate</to_name>
		<to_code>1802481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthone, (+)-</to_name>
		<to_code>2282305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maftivimab</to_name>
		<to_code>2461339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moschus moschiferus whole extract</to_name>
		<to_code>1313688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltobionate</to_name>
		<to_code>2605591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylsilanol ascorbate</to_name>
		<to_code>1314308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monosodium methylarsonate</to_name>
		<to_code>1596139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mestranol</to_name>
		<to_code>6782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methamphetamine hydrochloride</to_name>
		<to_code>82044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melia azedarach leaf extract</to_name>
		<to_code>2286575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda officinalis whole extract</to_name>
		<to_code>1486392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecasermin</to_name>
		<to_code>274403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methicone (20 CST)</to_name>
		<to_code>1313720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium, chelated</to_name>
		<to_code>215976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylparaben sodium</to_name>
		<to_code>1310557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mumps virus vaccine live, Jeryl Lynn strain</to_name>
		<to_code>798372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mupirocin calcium</to_name>
		<to_code>221128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium asparaginate</to_name>
		<to_code>1313172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca viridiflora whole extract</to_name>
		<to_code>2590662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia acuminata flower extract</to_name>
		<to_code>1307816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manidipine hydrochloride</to_name>
		<to_code>259487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol</to_name>
		<to_code>1314261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl perfluorobutyl ether</to_name>
		<to_code>1431148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenolone enanthate</to_name>
		<to_code>29654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl cocoate</to_name>
		<to_code>1871426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mezlocillin sodium</to_name>
		<to_code>82048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia sprengeri whole extract</to_name>
		<to_code>2375528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methscopolamine</to_name>
		<to_code>89785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus alba extract</to_name>
		<to_code>1370989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxypropylgluconamide</to_name>
		<to_code>1862683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midostaurin</to_name>
		<to_code>1919083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus alba root extract</to_name>
		<to_code>1307712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepenzolate bromide</to_name>
		<to_code>52560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mobocertinib</to_name>
		<to_code>2570736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myrtecaine</to_name>
		<to_code>59082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl heptine carbonate</to_name>
		<to_code>1313237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylic acid - ethyl acrylate copolymer (4500 MPA.S)</to_name>
		<to_code>1494845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mumps virus vaccine live, RIT-4385 strain</to_name>
		<to_code>2603501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myrtol</to_name>
		<to_code>174965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxamine hydrochloride</to_name>
		<to_code>203187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia officinalis flower extract</to_name>
		<to_code>1309351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus nigra root extract</to_name>
		<to_code>1307539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>modified corn starch (3-E-docecenyl succinic anhydride)</to_name>
		<to_code>1426611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium thiosulfate</to_name>
		<to_code>236420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese carbonate</to_name>
		<to_code>1314366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mandragora officinarum root extract</to_name>
		<to_code>1310014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristamidopropyl PG-dimonium chloride phosphate</to_name>
		<to_code>1440231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Medicago sativa leaf extract</to_name>
		<to_code>1309826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>m-aminobenzyl alcohol</to_name>
		<to_code>2359264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrothamnus flabellifolia leaf extract</to_name>
		<to_code>1373354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaflumizone</to_name>
		<to_code>1489918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesyloxybenzyl methoxyethyl chlorobenzamide</to_name>
		<to_code>2046118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha suaveolens leaf extract</to_name>
		<to_code>2474038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepindolol</to_name>
		<to_code>29518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl aminomethylcyclohexane carboxamide</to_name>
		<to_code>1370591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melatonin</to_name>
		<to_code>6711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mite extract</to_name>
		<to_code>236583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monobutyl maleate</to_name>
		<to_code>2001495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrtus communis whole extract</to_name>
		<to_code>1597291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl ethylene glycol carbonate, (-)-</to_name>
		<to_code>2046117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miglitol</to_name>
		<to_code>30009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl diacetylcysteinate</to_name>
		<to_code>236395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Momordica cochinchinensis seed extract</to_name>
		<to_code>1420973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltose syrup</to_name>
		<to_code>1310512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mometasone</to_name>
		<to_code>108118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium disodium EDTA</to_name>
		<to_code>1422486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl benzodioxepinone</to_name>
		<to_code>2047870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium laureth</to_name>
		<to_code>2175692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malate</to_name>
		<to_code>70612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 2-nonynoate</to_name>
		<to_code>2384443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methoxybenzoyloxyacetic acid</to_name>
		<to_code>2275628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium ascorbyl phosphate</to_name>
		<to_code>1425918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylate-methoxy PEG-10 maleate-styrene copolymer</to_name>
		<to_code>1429943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medrysone</to_name>
		<to_code>29439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenolone</to_name>
		<to_code>6833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha arvensis flower oil</to_name>
		<to_code>1305636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maclura tricuspidata whole extract</to_name>
		<to_code>1358962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk thistle extract</to_name>
		<to_code>283579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxamine</to_name>
		<to_code>6853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium hydroxide</to_name>
		<to_code>6581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melissa officinalis flowering top extract</to_name>
		<to_code>1648697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcellulose (15 CPS)</to_name>
		<to_code>1313699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrica esculenta fruit extract</to_name>
		<to_code>2671785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methotrexate sodium</to_name>
		<to_code>287734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphide</to_name>
		<to_code>1942477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl isobutyl ketone</to_name>
		<to_code>1362929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha canadensis top extract</to_name>
		<to_code>2585747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morella cerifera root bark extract</to_name>
		<to_code>1309827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylic acid - ethyl acrylate copolymer (1:1) type A</to_name>
		<to_code>1309718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-(3-methyl-2-thienyl)acrylic acid</to_name>
		<to_code>2475074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mangifera indica seed butter extract</to_name>
		<to_code>1307828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mycogone nigra allergenic extract</to_name>
		<to_code>1306122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monobasic sodium phosphate, dihydrate</to_name>
		<to_code>1311286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-myristylpicolinium</to_name>
		<to_code>1425941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha spicata extract</to_name>
		<to_code>1594933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moschus berezovskii musk sac resin</to_name>
		<to_code>1494846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3,4-methylenedioxybenzoyl methylsulfone</to_name>
		<to_code>1995882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl glucoside</to_name>
		<to_code>1313246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoprolol tartrate</to_name>
		<to_code>203191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mackerel allergenic extract</to_name>
		<to_code>889591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Macrocystis pyrifera extract</to_name>
		<to_code>1426431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>MPEG 6000 acetyl lysine</to_name>
		<to_code>2620178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moringa oleifera bark extract</to_name>
		<to_code>1307603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methapyrilene hydrochloride</to_name>
		<to_code>235721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese difluoride</to_name>
		<to_code>1921126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebhydrolin napadisylate</to_name>
		<to_code>22822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecysteine</to_name>
		<to_code>29426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl glucose dioleate</to_name>
		<to_code>1421621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aluminometasilicate type i-b</to_name>
		<to_code>1314291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melia azedarach bark extract</to_name>
		<to_code>1428837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methandrostenolone</to_name>
		<to_code>6818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaxalone</to_name>
		<to_code>59078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monoethanolamine thioglycolate</to_name>
		<to_code>2475186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myosotis arvensis extract</to_name>
		<to_code>1348449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia kobus flowering top extract</to_name>
		<to_code>1801506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyclothiazide</to_name>
		<to_code>6860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melia azedarach whole extract</to_name>
		<to_code>1429939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebeverine hydrochloride</to_name>
		<to_code>235827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metyrapone</to_name>
		<to_code>6923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meradimate</to_name>
		<to_code>91324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molybdenum</to_name>
		<to_code>7024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesquite pollen extract</to_name>
		<to_code>852320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium sulfite</to_name>
		<to_code>1990883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldopate</to_name>
		<to_code>6877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Manihot esculenta whole extract</to_name>
		<to_code>1946553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melengestrol</to_name>
		<to_code>1537799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia liliiflora whole extract</to_name>
		<to_code>1991258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercurous iodide preparation</to_name>
		<to_code>1311283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylbenzethonium</to_name>
		<to_code>29829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morrhuic acid</to_name>
		<to_code>1547609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine</to_name>
		<to_code>7052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese PCA</to_name>
		<to_code>1608391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menadiol sodium phosphate</to_name>
		<to_code>52549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadow foxtail pollen extract</to_name>
		<to_code>1484974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mesembryanthemum tortuosum whole extract</to_name>
		<to_code>2001195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl lactate</to_name>
		<to_code>1310580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine sulfate</to_name>
		<to_code>30236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor racemosus immunoserum rabbit</to_name>
		<to_code>1313972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylpropanediol</to_name>
		<to_code>1367168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrica cerifera fruit extract</to_name>
		<to_code>2623397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mogamulizumab-kpkc</to_name>
		<to_code>2054077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthone 1,2-glycerol ketal, (+/-)-</to_name>
		<to_code>2462151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl laurate</to_name>
		<to_code>1425923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirvetuximab soravtansine-gynx</to_name>
		<to_code>2621549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mucor circinelloides f. lusitanicus preparation</to_name>
		<to_code>1426705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium salicylate tetrahydrate</to_name>
		<to_code>253186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepirodipine</to_name>
		<to_code>39879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylic acid copolymer</to_name>
		<to_code>1309721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malachite green</to_name>
		<to_code>896038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia x alba whole extract</to_name>
		<to_code>2590660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric cyanide</to_name>
		<to_code>1311110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macitentan</to_name>
		<to_code>1442132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenidramium methylsulfate</to_name>
		<to_code>236422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>margaric acid</to_name>
		<to_code>1987137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>marine non-gelling gelatin, high MW</to_name>
		<to_code>1998465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenolone acetate</to_name>
		<to_code>29653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mechlorethamine</to_name>
		<to_code>6674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha piperita extract</to_name>
		<to_code>1334930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maranta arundinacea root extract</to_name>
		<to_code>1600743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myristica fragrans fruit extract</to_name>
		<to_code>1995252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maftivimab-ebgn</to_name>
		<to_code>2461432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mipomersen sodium</to_name>
		<to_code>1367838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methotrimeprazine hydrochloride</to_name>
		<to_code>91124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morazone hydrochloride</to_name>
		<to_code>236679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aluminum silicate type Ia</to_name>
		<to_code>1722910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melitracen</to_name>
		<to_code>446248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Momordica charantia whole extract</to_name>
		<to_code>1594580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mephentermine</to_name>
		<to_code>6756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methdilazine hydrochloride</to_name>
		<to_code>91121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mimosa pudica leaf extract</to_name>
		<to_code>1435523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Murraya paniculata leafy twig extract</to_name>
		<to_code>2641892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midecamycin</to_name>
		<to_code>30005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-mercaptobenzothiazole</to_name>
		<to_code>1358845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mangostin</to_name>
		<to_code>2619910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard pollen extract</to_name>
		<to_code>852205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadowfoamamidopropyl betaine</to_name>
		<to_code>1364950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl vinyl ether</to_name>
		<to_code>1729163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltose anhydrous</to_name>
		<to_code>2590661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mannitol</to_name>
		<to_code>6628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl chloride</to_name>
		<to_code>1305751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium lactate dihydrate, L-</to_name>
		<to_code>2003550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methohexital</to_name>
		<to_code>6847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltotetraose</to_name>
		<to_code>2641823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylnaltrexone</to_name>
		<to_code>29899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene glycol</to_name>
		<to_code>1797646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maple leaf sycamore pollen extract</to_name>
		<to_code>900788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methixene</to_name>
		<to_code>29682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melon extract</to_name>
		<to_code>1363610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric oxide</to_name>
		<to_code>29545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl undecylenate</to_name>
		<to_code>1543078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>motixafortide acetate</to_name>
		<to_code>2664897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthone, (+/-)-</to_name>
		<to_code>2048709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycophenolate sodium</to_name>
		<to_code>408142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myreth-3 myristate</to_name>
		<to_code>2122754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midodrine hydrochloride</to_name>
		<to_code>993491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mosla cavaleriei whole extract</to_name>
		<to_code>2641891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia seed oil</to_name>
		<to_code>1307843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia fruit extract</to_name>
		<to_code>1311641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mafenide</to_name>
		<to_code>6572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medroxyprogesterone acetate</to_name>
		<to_code>1000112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium fluoride</to_name>
		<to_code>1435860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morantel tartrate</to_name>
		<to_code>1368899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene diphosphonate</to_name>
		<to_code>29844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mephenytoin</to_name>
		<to_code>6757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Marsdenia cundurango whole extract</to_name>
		<to_code>1740939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mahonia aquifolium fruiting top extract</to_name>
		<to_code>1311636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mammal liver preparation</to_name>
		<to_code>1311117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meropenem</to_name>
		<to_code>29561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl tetrapeptide-4</to_name>
		<to_code>1312389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylsulfonylmethane</to_name>
		<to_code>23247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meningococcal polysaccharide vaccine group Y</to_name>
		<to_code>314725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>migalastat hydrochloride</to_name>
		<to_code>2054264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methyl-5-thiazoleethanol</to_name>
		<to_code>2692023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mordant yellow 10</to_name>
		<to_code>2567331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesoridazine besylate</to_name>
		<to_code>203186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercaptopurine</to_name>
		<to_code>103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus alba stem extract</to_name>
		<to_code>1307545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristamine oxide</to_name>
		<to_code>1431153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylphenidate</to_name>
		<to_code>6901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirvetuximab soravtansine</to_name>
		<to_code>2621548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylphenidate hydrochloride</to_name>
		<to_code>203188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium trisilicate</to_name>
		<to_code>29170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucuna pruriens fruit trichome extract</to_name>
		<to_code>1311060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxetumomab pasudotox-tdfk</to_name>
		<to_code>2099305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyltriethanolammonium methosulfate</to_name>
		<to_code>2288209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylprednisolone aceponate</to_name>
		<to_code>62136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molindone hydrochloride</to_name>
		<to_code>82051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebendazole</to_name>
		<to_code>6672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercury</to_name>
		<to_code>6769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maprotiline</to_name>
		<to_code>6646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxy polyethylene glycol-epoetin beta</to_name>
		<to_code>729596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>modified Vaccinia Ankara-Bavarian Nordic</to_name>
		<to_code>2464823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milbemycin oxime</to_name>
		<to_code>68730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesite</to_name>
		<to_code>2475179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melilotus officinalis top extract</to_name>
		<to_code>1347563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine iodamide</to_name>
		<to_code>29455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>micronomicin sulfate</to_name>
		<to_code>236199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monophosphoryl lipid A</to_name>
		<to_code>1363051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>16-methylheptadecanoic acid</to_name>
		<to_code>1799140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycophenolate mofetil</to_name>
		<to_code>68149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium pidolate</to_name>
		<to_code>116240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mauritia flexuosa fruit oil</to_name>
		<to_code>1307775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium malate</to_name>
		<to_code>283578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Michelia champaca flower extract</to_name>
		<to_code>1992075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium sulfate monohydrate</to_name>
		<to_code>1311259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca cajuputi leaf oil</to_name>
		<to_code>1805768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric oxide (purified)</to_name>
		<to_code>221122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meloxicam</to_name>
		<to_code>41493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mucopolysaccharide polysulfate</to_name>
		<to_code>30320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl methacrylate-glycol dimethacrylate crosspolymer</to_name>
		<to_code>1312390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Matricaria recutita extract</to_name>
		<to_code>285157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycophenolate mofetil hydrochloride</to_name>
		<to_code>237112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylcyclopentenolone</to_name>
		<to_code>2699424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monobasic potassium phosphate</to_name>
		<to_code>55019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mezlocillin</to_name>
		<to_code>6927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methazolamide</to_name>
		<to_code>6826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclocycline sulfosalicylate</to_name>
		<to_code>203162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medorrhinum</to_name>
		<to_code>350533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mica</to_name>
		<to_code>1362896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaraminol</to_name>
		<to_code>6805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenamine</to_name>
		<to_code>6832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maritime pine extract</to_name>
		<to_code>1368708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>muscone</to_name>
		<to_code>1606471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mango leaf extract</to_name>
		<to_code>1737114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methixene hydrochloride</to_name>
		<to_code>258230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoclopramide hydrochloride</to_name>
		<to_code>267036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl cinnamate</to_name>
		<to_code>1367156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(methylamino)ethanol</to_name>
		<to_code>2359260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 102 SCG</to_name>
		<to_code>2678212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mandarin oil</to_name>
		<to_code>1305716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylal</to_name>
		<to_code>2385338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mansoa alliacea bark extract</to_name>
		<to_code>1374401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylsilanol acetylmethionate</to_name>
		<to_code>1427218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium peroxide</to_name>
		<to_code>1666106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric cation</to_name>
		<to_code>1368903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>modafinil</to_name>
		<to_code>30125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium citrate</to_name>
		<to_code>52356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>MIXED VESPID VENOM PROTEIN</to_name>
		<to_code>324054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medroxyprogesterone</to_name>
		<to_code>6691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morantel</to_name>
		<to_code>1368900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene blue</to_name>
		<to_code>6878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>modified fluid gelatins</to_name>
		<to_code>52853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maca preparation</to_name>
		<to_code>319839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl sarcosinate</to_name>
		<to_code>1370597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylfolic acid</to_name>
		<to_code>486456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl benzoin</to_name>
		<to_code>1307079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mimosa tenuiflora leaf extract</to_name>
		<to_code>1862478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mutanase Schizosaccharomyces pombe</to_name>
		<to_code>1314198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metocurine</to_name>
		<to_code>29950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Machilus thunbergii bark extract</to_name>
		<to_code>1309487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midamaline</to_name>
		<to_code>2369640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meningococcal group B vaccine</to_name>
		<to_code>1593128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moexipril hydrochloride</to_name>
		<to_code>236066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magadi soda</to_name>
		<to_code>1367411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mongolian gerbil skin allergenic extract</to_name>
		<to_code>895070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>megestrol acetate</to_name>
		<to_code>29451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia leaf extract</to_name>
		<to_code>1307858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenidramium</to_name>
		<to_code>236421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Matricaria recutita leaf extract</to_name>
		<to_code>1310066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclofenamate sodium</to_name>
		<to_code>6677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium salicylate</to_name>
		<to_code>52364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mammal bone, fossilized</to_name>
		<to_code>1541729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melphalan flufenamide hydrochloride</to_name>
		<to_code>2531370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moricizine hydrochloride</to_name>
		<to_code>221126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Musa x paradisiaca leaf extract</to_name>
		<to_code>1307702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myristica fragrans whole extract</to_name>
		<to_code>1544248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristalkonium</to_name>
		<to_code>1370587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methicillin</to_name>
		<to_code>2181306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl sorbate</to_name>
		<to_code>1314223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Millettia pinnata seed extract</to_name>
		<to_code>1729164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>madecassoside</to_name>
		<to_code>87855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mandelic acid</to_name>
		<to_code>29256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medetomidine hydrochloride</to_name>
		<to_code>29428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malva sylvestris flower extract</to_name>
		<to_code>1309350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mahonia aquifolium whole extract</to_name>
		<to_code>1423797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha canadensis flowering top extract</to_name>
		<to_code>2679054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl lactate, DL-</to_name>
		<to_code>2045725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucuna pruriens whole extract</to_name>
		<to_code>2119175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylethyl ketone</to_name>
		<to_code>1363708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mangafodipir trisodium, anhydrous</to_name>
		<to_code>221119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maropitant</to_name>
		<to_code>715869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malva sylvestris whole extract</to_name>
		<to_code>1799008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxonidine</to_name>
		<to_code>30257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirdametinib</to_name>
		<to_code>2705551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melphalan hydrochloride</to_name>
		<to_code>235857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylergonovine</to_name>
		<to_code>6883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metacresol</to_name>
		<to_code>1367170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxifloxacin hydrochloride</to_name>
		<to_code>228750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methacryloyloxyethyl phosphorylcholine</to_name>
		<to_code>2584546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard oil</to_name>
		<to_code>1360631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medifoxamine</to_name>
		<to_code>29434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-methylcyclohexa-1,3-diene</to_name>
		<to_code>2174382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macelignan</to_name>
		<to_code>1872381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycophenolic acid</to_name>
		<to_code>7145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoclopramide dihydrochloride</to_name>
		<to_code>267035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mansoa alliacea leaf extract</to_name>
		<to_code>1374402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>margetuximab-cmkb</to_name>
		<to_code>2473850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methysergide</to_name>
		<to_code>6911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl aminomethylcyclohexane carboxamide hydrochloride</to_name>
		<to_code>1314856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methyl-1,4-pentanediyl dimethacrylate</to_name>
		<to_code>2106324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia obovata bark extract</to_name>
		<to_code>1309440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia biondii flower bud extract</to_name>
		<to_code>2531310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milrinone</to_name>
		<to_code>52769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium acetate tetrahydrate</to_name>
		<to_code>317246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malic acid</to_name>
		<to_code>29209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(1-methylbutyl)phenol</to_name>
		<to_code>2691520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium acetate</to_name>
		<to_code>314718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercaptopurine anhydrous</to_name>
		<to_code>1546028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxychlor</to_name>
		<to_code>2598123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl propionate</to_name>
		<to_code>1313247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malachite green oxalate</to_name>
		<to_code>1664341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mafenide acetate</to_name>
		<to_code>6573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium</to_name>
		<to_code>6574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molidustat</to_name>
		<to_code>2637535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moringa oleifera seed extract</to_name>
		<to_code>1309442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maackia floribunda stem extract</to_name>
		<to_code>1307841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melissa officinalis extract</to_name>
		<to_code>1311497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl isethionate</to_name>
		<to_code>1370619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl bromide</to_name>
		<to_code>29746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese cation (2+)</to_name>
		<to_code>1546272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methane</to_name>
		<to_code>2598120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methoxy-1-propanol</to_name>
		<to_code>2380833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepindolol sulfate</to_name>
		<to_code>236904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>merbromin</to_name>
		<to_code>6762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milrinone lactate</to_name>
		<to_code>155120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl cocoyl taurate</to_name>
		<to_code>1370610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium cation</to_name>
		<to_code>1426853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristic acid</to_name>
		<to_code>1356758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrciaria edulis fruit juice</to_name>
		<to_code>1747724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Micrococcus luteus preparation</to_name>
		<to_code>1426449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moringa oleifera fruit extract</to_name>
		<to_code>2257293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mephobarbital</to_name>
		<to_code>6758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moroxydine</to_name>
		<to_code>30227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metricus paper wasp venom protein</to_name>
		<to_code>1294630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl vinyl ether and maleic anhydride copolymer (1100000 WAMW)</to_name>
		<to_code>2669013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus australis root extract</to_name>
		<to_code>1307602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melia azederach leaf extract</to_name>
		<to_code>1428839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk thistle fruit extract</to_name>
		<to_code>284153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxidectin</to_name>
		<to_code>1047072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltitol</to_name>
		<to_code>1363049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menadiol</to_name>
		<to_code>29491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malva sylvestris seed extract</to_name>
		<to_code>1655988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aluminometasilicate type I-A</to_name>
		<to_code>1426329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium chloride hexahydrate</to_name>
		<to_code>221118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldopa anhydrous</to_name>
		<to_code>1545996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl blue</to_name>
		<to_code>2176448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mebrofenin</to_name>
		<to_code>1311500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium ascorbate</to_name>
		<to_code>1311396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miranol 2MHT modified</to_name>
		<to_code>259350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha arvensis flowering top extract</to_name>
		<to_code>1309327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monomethyl adipate</to_name>
		<to_code>2287551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl lactate</to_name>
		<to_code>1310581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moroxydine hydrochloride</to_name>
		<to_code>1291996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metahomomenthol, (+/-)-</to_name>
		<to_code>2673512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mangafodipir</to_name>
		<to_code>236987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltose monohydrate</to_name>
		<to_code>1311260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melilotus extract</to_name>
		<to_code>1372253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mauritia flexuosa whole extract</to_name>
		<to_code>1431705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldiethanolamine</to_name>
		<to_code>1371054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 3-hydroxybenzoate</to_name>
		<to_code>1373724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium lauryl sulfate</to_name>
		<to_code>1489922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristic diisopropanolamide</to_name>
		<to_code>1549874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylchloroisothiazolinone/methylisothiazolinone mixture</to_name>
		<to_code>1862287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate anhydrous</to_name>
		<to_code>1657484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxalactam</to_name>
		<to_code>7069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monomenthyl glutarate</to_name>
		<to_code>1489548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>muscadine grape extract</to_name>
		<to_code>1992540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha arvensis top extract</to_name>
		<to_code>1599157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methdilazine</to_name>
		<to_code>29648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methyl-1-pentanol</to_name>
		<to_code>2465230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepivacaine</to_name>
		<to_code>6759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myosotis sylvatica flowering top extract</to_name>
		<to_code>1310119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minoxidil sulfate</to_name>
		<to_code>1651695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclofenoxate hydrochloride</to_name>
		<to_code>236572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midazolam</to_name>
		<to_code>6960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl stearic acid</to_name>
		<to_code>1363442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mercurialis perennis extract</to_name>
		<to_code>1322554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moexipril</to_name>
		<to_code>30131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macimorelin</to_name>
		<to_code>1999420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maitake extract</to_name>
		<to_code>1311410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenamine hippurate</to_name>
		<to_code>29652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melarsomine</to_name>
		<to_code>1012534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molasses</to_name>
		<to_code>1307820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mannuronate methylsilanol</to_name>
		<to_code>1860184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia champaca flower oil</to_name>
		<to_code>2670038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methadone hydrochloride</to_name>
		<to_code>218337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medioresinol dimethyl ether</to_name>
		<to_code>2643211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl benzoate</to_name>
		<to_code>1314316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia grandiflora bark extract</to_name>
		<to_code>1307581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>momelotinib</to_name>
		<to_code>2665204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxyflurane</to_name>
		<to_code>6857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>memantine hydrochloride</to_name>
		<to_code>236685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-methoxytryptamine</to_name>
		<to_code>1426888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Myrciaria dubia fruit extract</to_name>
		<to_code>1311645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mycoplasma pneumoniae</to_name>
		<to_code>1360621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meprobamate</to_name>
		<to_code>6760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Monascus purpureus</to_name>
		<to_code>1442200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malpighia emarginata seed extract</to_name>
		<to_code>1307604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malathion</to_name>
		<to_code>6606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monosodium dl-glutamate</to_name>
		<to_code>2049260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molidustat sodium</to_name>
		<to_code>2637534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus alba leaf extract</to_name>
		<to_code>1309988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesoridazine</to_name>
		<to_code>6779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl diisopropyl propionamide</to_name>
		<to_code>1312714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myreth-4</to_name>
		<to_code>1544486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mephitis mephitis anal gland fluid preparation</to_name>
		<to_code>1311288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morella cerifera fruit wax</to_name>
		<to_code>1994303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menatetrenone</to_name>
		<to_code>29495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoprolol</to_name>
		<to_code>6918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metergoline</to_name>
		<to_code>6834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mung bean allergenic extract</to_name>
		<to_code>891647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mevalonolactone, (+/-)-</to_name>
		<to_code>1442201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mivacurium</to_name>
		<to_code>30077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-methyldeoxycytidine</to_name>
		<to_code>2642190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molybdate ion</to_name>
		<to_code>1546395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minaprine hydrochloride</to_name>
		<to_code>236400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 5-aminolevulinate</to_name>
		<to_code>337068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mycobacterium bovis immunoserum rabbit</to_name>
		<to_code>1367195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metreleptin</to_name>
		<to_code>1491625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>musk xylene</to_name>
		<to_code>1921875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morpholine salicylate</to_name>
		<to_code>236348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Menyanthes trifoliata leaf extract</to_name>
		<to_code>1667212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Microsporum audouinii allergenic extract</to_name>
		<to_code>1014395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morella pubescens fruit wax</to_name>
		<to_code>2102920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine antimoniate</to_name>
		<to_code>319866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylinositol</to_name>
		<to_code>1435864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malt soup extract</to_name>
		<to_code>91264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefloquine hydrochloride</to_name>
		<to_code>82130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnolol</to_name>
		<to_code>2562549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl anthranilate</to_name>
		<to_code>29742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyprylon</to_name>
		<to_code>6910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moringa oleifera leaf extract</to_name>
		<to_code>1307834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitomycin</to_name>
		<to_code>632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl dihydrojasmonate</to_name>
		<to_code>1307050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magaldrate anhydrous</to_name>
		<to_code>1872036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepenzolate</to_name>
		<to_code>107770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha x rotundifolia leaf extract</to_name>
		<to_code>1307557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl hydroxyurea</to_name>
		<to_code>1665338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>muramidase hydrochloride</to_name>
		<to_code>236329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyldopa</to_name>
		<to_code>6876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclocycline</to_name>
		<to_code>29418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium orotate</to_name>
		<to_code>139233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midazolam maleate</to_name>
		<to_code>142441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese dioxide</to_name>
		<to_code>29263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl-4-phenyl-2-butanol</to_name>
		<to_code>2289004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium glutamate</to_name>
		<to_code>236324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-methyltetrahydrofolic acid</to_name>
		<to_code>1313966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecysteine hydrochloride</to_name>
		<to_code>235828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl aminolevulinate hydrochloride</to_name>
		<to_code>1300479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl d-lactate, (-)-</to_name>
		<to_code>1866625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methantheline bromide</to_name>
		<to_code>91163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia officinalis whole extract</to_name>
		<to_code>2053489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meningococcal group C polysaccharide</to_name>
		<to_code>29503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Musa basjoo whole extract</to_name>
		<to_code>1314228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnesium salt</to_name>
		<to_code>90120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Machilus thunbergii branch extract</to_name>
		<to_code>2637532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mosunetuzumab-axgb</to_name>
		<to_code>2625125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metoclopramide</to_name>
		<to_code>6915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia grandiflora leaf extract</to_name>
		<to_code>1539418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mavorixafor</to_name>
		<to_code>2684021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltose</to_name>
		<to_code>1311261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitotane</to_name>
		<to_code>7004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese acetate tetrahydrate</to_name>
		<to_code>1366224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malva sylvestris flowering top extract</to_name>
		<to_code>1309488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>muramidase</to_name>
		<to_code>7094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitapivat sulfate</to_name>
		<to_code>2595574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mumps Vaccine</to_name>
		<to_code>763656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midodrine</to_name>
		<to_code>6963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miconazole</to_name>
		<to_code>6932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium chlorate</to_name>
		<to_code>1605084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadowfoam oil</to_name>
		<to_code>1309256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia seed extract</to_name>
		<to_code>1992036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine iodipamide</to_name>
		<to_code>29456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium valproate</to_name>
		<to_code>134422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Malus sylvestris whole extract</to_name>
		<to_code>1798357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentan-1-one</to_name>
		<to_code>2395764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>montelukast</to_name>
		<to_code>88249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metolazone</to_name>
		<to_code>6916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malic acid, L-</to_name>
		<to_code>1427053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylephedrine, DL-</to_name>
		<to_code>1546444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl stearate</to_name>
		<to_code>1363574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melphalan flufenamide</to_name>
		<to_code>2531369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mangiferin</to_name>
		<to_code>1362895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxifloxacin</to_name>
		<to_code>139462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(((1-methyl-2-(5-methyl-3-oxazolidinyl)ethoxy)methoxy)methoxy)methanol</to_name>
		<to_code>1801150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mimulus ringens whole extract</to_name>
		<to_code>2533899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoserpidine</to_name>
		<to_code>235829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mequinol</to_name>
		<to_code>15080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monosulfiram</to_name>
		<to_code>30206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor racemosus allergenic extract</to_name>
		<to_code>852687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl abietate</to_name>
		<to_code>2465733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium aspartate</to_name>
		<to_code>142131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate, dibasic</to_name>
		<to_code>1482795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric sulfate</to_name>
		<to_code>1311475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moxaverine hydrochloride</to_name>
		<to_code>236673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium laureth-8 sulfate</to_name>
		<to_code>2198971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midamaline hydrochloride</to_name>
		<to_code>2369639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macimorelin acetate</to_name>
		<to_code>1999419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylene blue anhydrous</to_name>
		<to_code>2198975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melothria heterophylla root extract</to_name>
		<to_code>2118847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia grandiflora flower extract</to_name>
		<to_code>1309352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-methyl anisole</to_name>
		<to_code>1313261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl 5-cyclohexylpentanol</to_name>
		<to_code>2266744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mimosa tenuiflora bark extract</to_name>
		<to_code>1307957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Manilkara obovata leaf extract</to_name>
		<to_code>1987640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 112</to_name>
		<to_code>2107304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl lactate</to_name>
		<to_code>1363720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methanesulfonic acid</to_name>
		<to_code>1426387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monomethyl fumarate</to_name>
		<to_code>1546433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese chloride</to_name>
		<to_code>29261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meglumine ioxithalamate</to_name>
		<to_code>29459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maclura tricuspidata bark extract</to_name>
		<to_code>2000993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>memantine</to_name>
		<to_code>6719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mold extract</to_name>
		<to_code>235618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium sulfate dihydrate</to_name>
		<to_code>2107060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-methoxypsoralen</to_name>
		<to_code>15842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese aspartate</to_name>
		<to_code>253187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus australis leaf extract</to_name>
		<to_code>1420974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maltobionic acid</to_name>
		<to_code>2605590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl dihydrojasmonate (synthetic)</to_name>
		<to_code>1427217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>musk ketone</to_name>
		<to_code>1438530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesna</to_name>
		<to_code>44</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moth bean extract</to_name>
		<to_code>1313183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>modified corn starch (1-octenyl succinic anhydride)</to_name>
		<to_code>1425926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melissa officinalis leaf oil</to_name>
		<to_code>1309328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(MPEG 2000)-N,N-ditetradecylacetamide</to_name>
		<to_code>2599922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthol glucuronide</to_name>
		<to_code>2704947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menadione sodium bisulfite</to_name>
		<to_code>52551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malondialdehyde</to_name>
		<to_code>1657018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metopimazine</to_name>
		<to_code>29954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>muskmelon extract</to_name>
		<to_code>1363443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>medronic acid</to_name>
		<to_code>1314368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meperidine hydrochloride</to_name>
		<to_code>103755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylephedrine</to_name>
		<to_code>1739004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenamic acid</to_name>
		<to_code>6693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menhaden oil</to_name>
		<to_code>2467841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia virginiana flower extract</to_name>
		<to_code>1307541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl trimethicone</to_name>
		<to_code>1311614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monoolein</to_name>
		<to_code>1311678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclofenoxate</to_name>
		<to_code>2228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylprednisolone sodium phosphate</to_name>
		<to_code>29917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>migalastat</to_name>
		<to_code>2054252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mizolastine</to_name>
		<to_code>61455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyltestosterone</to_name>
		<to_code>6904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclofenamic acid</to_name>
		<to_code>6678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mustard seed allergenic extract</to_name>
		<to_code>899456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristamidopropylamine oxide</to_name>
		<to_code>1485540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Madia elegans whole extract</to_name>
		<to_code>2533898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maropitant citrate</to_name>
		<to_code>818233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefenorex hydrochloride</to_name>
		<to_code>236179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maribavir</to_name>
		<to_code>2586068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mint extract</to_name>
		<to_code>1372004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia biondii bark extract</to_name>
		<to_code>1307607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maprotiline mesylate</to_name>
		<to_code>236328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaproterenol</to_name>
		<to_code>7688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mitchella repens extract</to_name>
		<to_code>2532533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese iodide</to_name>
		<to_code>2627379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melilotus officinalis whole extract</to_name>
		<to_code>2176245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Moraxella catarrhalis subsp. catarrhalis</to_name>
		<to_code>1592901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>macadamia nut allergenic extract</to_name>
		<to_code>1011066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl pyrrolidone carboxylate, (-),DL-</to_name>
		<to_code>1356713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mexican tea pollen extract</to_name>
		<to_code>897391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>m-phenylenediamine</to_name>
		<to_code>1435286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mephenesin</to_name>
		<to_code>6755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirtazapine hemihydrate</to_name>
		<to_code>1992054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mevalonolactone</to_name>
		<to_code>1442202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metharbital</to_name>
		<to_code>6825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylbenzyl acetate</to_name>
		<to_code>1427219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 301</to_name>
		<to_code>2632412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia liliiflora flower extract</to_name>
		<to_code>1310034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl-2-propylpropane-1,3-diol</to_name>
		<to_code>1648135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirtazapine</to_name>
		<to_code>15996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mesylate</to_name>
		<to_code>1426388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium nitrite</to_name>
		<to_code>2637344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl-1,2-benzoisothiazolin-3-one</to_name>
		<to_code>2362185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molsidomine</to_name>
		<to_code>7023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Macadamia ternifolia whole extract</to_name>
		<to_code>2287549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microcrystalline cellulose 200</to_name>
		<to_code>2277806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maprotiline hydrochloride</to_name>
		<to_code>203126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>measles virus preparation</to_name>
		<to_code>1312384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mitoxantrone hydrochloride</to_name>
		<to_code>203129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercury, ammoniated</to_name>
		<to_code>29542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl butetisalicylate</to_name>
		<to_code>236908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Monascus purpureus West</to_name>
		<to_code>261713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Millettia pulchra root extract</to_name>
		<to_code>2634551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl orange</to_name>
		<to_code>1551460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>momordicae</to_name>
		<to_code>853112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methandriol</to_name>
		<to_code>6817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minoxidil</to_name>
		<to_code>6984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>marstacimab-hncq</to_name>
		<to_code>2697132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malachite green cation</to_name>
		<to_code>1547770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maleic anhydride</to_name>
		<to_code>1362876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mangifera indica whole extract</to_name>
		<to_code>1731021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metomidate</to_name>
		<to_code>1311585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylbenzethonium chloride</to_name>
		<to_code>1796444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methsuximide</to_name>
		<to_code>47858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium silicate</to_name>
		<to_code>1310566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mibefradil dihydrochloride</to_name>
		<to_code>83214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metyrosine</to_name>
		<to_code>266604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melissa officinalis leaf extract</to_name>
		<to_code>1307836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mepolizumab</to_name>
		<to_code>1720597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor racemosus preparation</to_name>
		<to_code>350310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meyer lemon extract</to_name>
		<to_code>2270943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malvin</to_name>
		<to_code>1309703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mikania parviflora leaf extract</to_name>
		<to_code>1719250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl oleate</to_name>
		<to_code>1734017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morniflumate</to_name>
		<to_code>30225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacholine</to_name>
		<to_code>155080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl-4-isothiazolin-3-one</to_name>
		<to_code>1367166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,1'-((1-methyl-1,2-ethanediyl)2-propenoic acid, bis(oxy(1-methyl-2,1-ethanediyl))) ester</to_name>
		<to_code>1807444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methysergide maleate</to_name>
		<to_code>203190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metaclazepam hydrochloride</to_name>
		<to_code>29590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>millet extract</to_name>
		<to_code>1310040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myrrh oil</to_name>
		<to_code>1309206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda officianalis root extract</to_name>
		<to_code>1546412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthol</to_name>
		<to_code>6750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>masoprocol</to_name>
		<to_code>227239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mesophyllum lichenoides extract</to_name>
		<to_code>1426450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mu-conotoxin G IIIC</to_name>
		<to_code>2399555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mirabilis jalapa flowering top extract</to_name>
		<to_code>1373032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxyphenamine</to_name>
		<to_code>29704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Micrurus corallinus venom</to_name>
		<to_code>1310460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miltefosine</to_name>
		<to_code>1494066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methotrexate</to_name>
		<to_code>6851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>matrine</to_name>
		<to_code>2049547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-methyl-1,3,5-triphenyl-2-pyrazoline</to_name>
		<to_code>2593853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mirabilis jalapa top extract</to_name>
		<to_code>1441657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mirikizumab-mrkz</to_name>
		<to_code>2668385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monosodium glutamate anhydrous</to_name>
		<to_code>1313974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>molindone</to_name>
		<to_code>7019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>misoprostol</to_name>
		<to_code>42331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylprednisolone</to_name>
		<to_code>6902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morganella morganii</to_name>
		<to_code>1311228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristyl nicotinate</to_name>
		<to_code>1425406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methimazole</to_name>
		<to_code>6835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mercuric sulfide</to_name>
		<to_code>1311278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristoyl-palmitoyl oxostearamide-arachamide mea</to_name>
		<to_code>1313186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca viridiflora flowering top extract</to_name>
		<to_code>2673194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milnacipran</to_name>
		<to_code>588250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miristalkonium</to_name>
		<to_code>236393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methanolamine</to_name>
		<to_code>1430389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>madecassic acid</to_name>
		<to_code>1551573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucor circinelloides f. lusitanicus allergenic extract</to_name>
		<to_code>2101473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methscopolamine bromide</to_name>
		<to_code>56092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca alternifolia whole extract</to_name>
		<to_code>1487832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methacrylic acid - methyl methacrylate copolymer (1:2)</to_name>
		<to_code>1309724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium sulfate heptahydrate</to_name>
		<to_code>236741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>microsporum canis allergenic extract</to_name>
		<to_code>1014399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium carbonate</to_name>
		<to_code>29155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Murraya paniculata fruit extract</to_name>
		<to_code>2632263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meningococcal group A polysaccharide</to_name>
		<to_code>29501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menthyl acetate, (-)-</to_name>
		<to_code>2048710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl 2-furoate</to_name>
		<to_code>2384442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methandriol dipropionate</to_name>
		<to_code>235381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meclizine</to_name>
		<to_code>6676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metronidazole</to_name>
		<to_code>6922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maclura cochinchinensis whole extract</to_name>
		<to_code>2281308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>millet seed allergenic extract</to_name>
		<to_code>899770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metipranolol hydrochloride</to_name>
		<to_code>314731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morinda citrifolia whole extract</to_name>
		<to_code>1795583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milk thistle leaf extract</to_name>
		<to_code>1661435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium tartrate</to_name>
		<to_code>1314220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>miglustat</to_name>
		<to_code>402316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mefloquine</to_name>
		<to_code>6694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>metformin</to_name>
		<to_code>6809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mesembryanthemum crystallinum whole extract</to_name>
		<to_code>1860419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mucuna pruriens seed extract</to_name>
		<to_code>1485786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Microascus brevicaulis allergenic extract</to_name>
		<to_code>1192992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium palmitoyl glutamate</to_name>
		<to_code>1735044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-methyl-4-isothiazolin-3-one hydrochloride</to_name>
		<to_code>1804258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese sulfate anhydrous</to_name>
		<to_code>1746493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methohexital sodium</to_name>
		<to_code>91185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mechlorethamine hydrochloride</to_name>
		<to_code>155036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>menfegol</to_name>
		<to_code>31575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium oxide</to_name>
		<to_code>6582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium phosphate</to_name>
		<to_code>29164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Microcitrus australis fruit extract</to_name>
		<to_code>1370987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine tartrate</to_name>
		<to_code>235774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monensin sodium</to_name>
		<to_code>2719468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mentha aquatica leaf extract</to_name>
		<to_code>1307852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maleic acid</to_name>
		<to_code>1426330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>moricizine</to_name>
		<to_code>40169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Morus alba root bark extract</to_name>
		<to_code>1310055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl acrylate</to_name>
		<to_code>1367155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Maytenus krukovii bark extract</to_name>
		<to_code>2123365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morazone</to_name>
		<to_code>30218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylsilanol PCA</to_name>
		<to_code>2264358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Michelia alba leaf oil</to_name>
		<to_code>2043326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>mecobalamin</to_name>
		<to_code>29421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl undecenoyl leucinate</to_name>
		<to_code>1427065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monopotassium phosphite</to_name>
		<to_code>1793923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>malarial plasmodium group immunoserum rabbit</to_name>
		<to_code>1367199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>maleate</to_name>
		<to_code>1426331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>melengestrol acetate</to_name>
		<to_code>1537798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>minoxidil sulfate ester</to_name>
		<to_code>1926479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl perfluoroisobutyl ether</to_name>
		<to_code>1431149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Meningitis vaccine</to_name>
		<to_code>108542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melaleuca alternifolia leaf extract</to_name>
		<to_code>1309330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myrtle leaf oil</to_name>
		<to_code>1307835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>myristalkonium chloride</to_name>
		<to_code>1314217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mangifera indica seed extract</to_name>
		<to_code>1486517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl salicylate 2-ethylbutyrate</to_name>
		<to_code>1921110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>meadow fescue grass pollen extract</to_name>
		<to_code>851918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium chloride tetrahydrate</to_name>
		<to_code>2003593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Mercurialis perennis whole extract</to_name>
		<to_code>2591815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methyl glucose</to_name>
		<to_code>2174505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylephedrine hydrochloride, DL-</to_name>
		<to_code>1311544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Magnolia acuminata bark extract</to_name>
		<to_code>2173990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methylprednisolone sodium succinate</to_name>
		<to_code>203189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>manganese violet</to_name>
		<to_code>1313243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>milnacipran hydrochloride</to_name>
		<to_code>30003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methoxy PEG-10</to_name>
		<to_code>1805769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>midazolam hydrochloride</to_name>
		<to_code>203128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methanol</to_name>
		<to_code>1310568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>methenamine mandelate</to_name>
		<to_code>161623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>monobenzone</to_name>
		<to_code>17145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Melissa officinalis flower extract</to_name>
		<to_code>2637737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium sulfate</to_name>
		<to_code>6585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>magnesium laureth sulfate</to_name>
		<to_code>2175691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>M [Preparations]</from_name>
		<from_code>N0000010595</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>morphine hydrochloride</to_name>
		<to_code>235751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-methylaminorex, cis-(+/-)-</from_name>
		<from_code>2665286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-methylaminorex, cis-(+-)-isomer</to_name>
		<to_code>M0307355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mild silver protein</from_name>
		<from_code>30021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mild silver protein</to_name>
		<to_code>M0040287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minaprine</from_name>
		<from_code>30031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>minaprine</to_name>
		<to_code>M0048328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mosapride</from_name>
		<from_code>135091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mosapride</to_name>
		<to_code>M0173454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methionine</from_name>
		<from_code>6837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methionine</to_name>
		<to_code>M0013575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meptazinol hydrochloride</from_name>
		<from_code>11347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meptazinol Hydrochloride</to_name>
		<to_code>M0330124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl phenylacetate</from_name>
		<from_code>2699422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl phenylacetate</to_name>
		<to_code>M0083659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melarsomine dihydrochloride</from_name>
		<from_code>1012533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>melarsomine dihydrochloride</to_name>
		<to_code>M0473938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin sodium</from_name>
		<from_code>273443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin sodium</from_name>
		<from_code>273443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methampicillin, sodium salt</to_name>
		<to_code>M0474168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin sodium</from_name>
		<from_code>273443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iotroxinate</from_name>
		<from_code>52527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meglumine iotroxinate</to_name>
		<to_code>M0059368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercuric chloride</from_name>
		<from_code>1311634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mercuric Chloride</to_name>
		<to_code>M0013447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium nitrate</from_name>
		<from_code>1362814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium nitrate</to_name>
		<to_code>M0069716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine chloride</from_name>
		<from_code>40165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methacholine Chloride</to_name>
		<to_code>M0024753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine chloride</from_name>
		<from_code>40165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol hydrochloride</from_name>
		<from_code>7008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine</from_name>
		<from_code>155080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadolol</from_name>
		<from_code>7226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol hydrochloride</from_name>
		<from_code>202693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol</from_name>
		<from_code>7973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac sodium</from_name>
		<from_code>203214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol phosphate</from_name>
		<from_code>668310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac potassium</from_name>
		<from_code>81997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvedilol</from_name>
		<from_code>20352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol</from_name>
		<from_code>10600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>labetalol</from_name>
		<from_code>6185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol anhydrous</from_name>
		<from_code>1546004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penbutolol sulfate</from_name>
		<from_code>82070</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotalol</from_name>
		<from_code>9947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol hemihydrate</from_name>
		<from_code>221172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol hydrochloride</from_name>
		<from_code>142132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carteolol</from_name>
		<from_code>2116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>timolol maleate</from_name>
		<from_code>42933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bronchial Hyperreactivity</to_name>
		<to_code>M0025237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacholine</from_name>
		<from_code>155080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methacholine</to_name>
		<to_code>M0024755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medetomidine</from_name>
		<from_code>52016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Medetomidine</to_name>
		<to_code>M0140434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefruside</from_name>
		<from_code>6696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mefruside</to_name>
		<to_code>M0013288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesterolone</from_name>
		<from_code>6781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mesterolone</to_name>
		<to_code>M0013486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myo-inositol trispyrophosphate</from_name>
		<from_code>1791813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myo-inositol trispyrophosphate</to_name>
		<to_code>M0505851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl palmitate</from_name>
		<from_code>1486520</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl palmitate</to_name>
		<to_code>M0071102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitobronitol</from_name>
		<from_code>6996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mitobronitol</to_name>
		<to_code>M0013936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>marbofloxacin</from_name>
		<from_code>69256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>marbofloxacin</to_name>
		<to_code>M0214511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medrogestone</from_name>
		<from_code>6690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Medrogestone</to_name>
		<to_code>M0013278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myristyl alcohol</from_name>
		<from_code>1362897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myristyl alcohol</to_name>
		<to_code>M0075264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltodextrin</from_name>
		<from_code>1363050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maltodextrin</to_name>
		<to_code>M0052045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylnicotinate</from_name>
		<from_code>29900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl nicotinate</to_name>
		<to_code>M0052354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>microcrystalline cellulose</from_name>
		<from_code>1000577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>microcrystalline cellulose</to_name>
		<to_code>M0284606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meptazinol</from_name>
		<from_code>6761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meptazinol</to_name>
		<to_code>M0013440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacycline</from_name>
		<from_code>6812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methacycline</to_name>
		<to_code>M0013539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacrylate</from_name>
		<from_code>1424906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methacrylates</to_name>
		<to_code>M0013538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-methyl-2-pyrrolidinone</from_name>
		<from_code>1305552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-methylpyrrolidone</to_name>
		<to_code>M0116284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monofluorophosphate</from_name>
		<from_code>52885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monofluorophosphate</to_name>
		<to_code>M0060390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moclobemide</from_name>
		<from_code>30121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Moclobemide</to_name>
		<to_code>M0106138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercuric iodide</from_name>
		<from_code>1426941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mercuric iodide, red</to_name>
		<to_code>M0085433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monooctanoin</from_name>
		<from_code>30198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monooctanoin</to_name>
		<to_code>M0084569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin</from_name>
		<from_code>6929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mianserin</to_name>
		<to_code>M0013724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine</from_name>
		<from_code>11196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupentixol hydrochloride</from_name>
		<from_code>235742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine mesylate</from_name>
		<from_code>60841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol</from_name>
		<from_code>4495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tryptophan</from_name>
		<from_code>10898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flupenthixol decanoate</from_name>
		<from_code>25188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viloxazine hydrochloride</from_name>
		<from_code>142143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reboxetine</from_name>
		<from_code>60842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deutetrabenazine</from_name>
		<from_code>1876905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone hydrochloride</from_name>
		<from_code>2122776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depression</to_name>
		<to_code>M0006028</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mefloquine Hydrochloride</to_name>
		<to_code>M0024163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine hydrochloride</from_name>
		<from_code>82130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>kava preparation</from_name>
		<from_code>285228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam</from_name>
		<from_code>6960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrazepam</from_name>
		<from_code>37985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline</from_name>
		<from_code>7531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clotiazepam</from_name>
		<from_code>2622</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine</from_name>
		<from_code>5553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nortriptyline hydrochloride</from_name>
		<from_code>203130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazepam</from_name>
		<from_code>8627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nordazepam</from_name>
		<from_code>3155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Digitalis preparation</from_name>
		<from_code>91235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam hydrochloride</from_name>
		<from_code>203128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide hydrochloride</from_name>
		<from_code>203173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine hydrochloride</from_name>
		<from_code>154987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medazepam</from_name>
		<from_code>6680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal</from_name>
		<from_code>10464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlordiazepoxide</from_name>
		<from_code>2356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin hydrochloride</from_name>
		<from_code>203179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromazepam</from_name>
		<from_code>1749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>DIGITALIS,POWDERED</from_name>
		<from_code>484908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate hydrochloride</from_name>
		<from_code>203188</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone hydrochloride</from_name>
		<from_code>203116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylphenidate</from_name>
		<from_code>6901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate</from_name>
		<from_code>2353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepic acid</from_name>
		<from_code>235408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digitoxin</from_name>
		<from_code>3403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate hydrochloride</from_name>
		<from_code>353105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorazepate dipotassium</from_name>
		<from_code>2607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theobromine sod salicylate</from_name>
		<from_code>236926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamylal sodium</from_name>
		<from_code>203201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>digoxin</from_name>
		<from_code>3407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxepin</from_name>
		<from_code>3638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormezanone</from_name>
		<from_code>2373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>midazolam maleate</from_name>
		<from_code>142441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>buspirone</from_name>
		<from_code>1827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexmethylphenidate</from_name>
		<from_code>352372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyzine pamoate</from_name>
		<from_code>203182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theobromine</from_name>
		<from_code>10437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopamide</from_name>
		<from_code>2603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tofisopam</from_name>
		<from_code>38365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halazepam</from_name>
		<from_code>26412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anxiety Disorders</to_name>
		<to_code>M0001533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefloquine</from_name>
		<from_code>6694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol</from_name>
		<from_code>10804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxazepam</from_name>
		<from_code>7781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine maleate</from_name>
		<from_code>91127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pemoline</from_name>
		<from_code>7966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromperidol</from_name>
		<from_code>19777</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine hydrochloride</from_name>
		<from_code>91124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine</from_name>
		<from_code>10502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine succinate</from_name>
		<from_code>6476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziconotide</from_name>
		<from_code>68503</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamazepine</from_name>
		<from_code>2002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine enanthate</from_name>
		<from_code>33212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene</from_name>
		<from_code>10510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine hydrochloride</from_name>
		<from_code>91138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>periciazine</from_name>
		<from_code>8766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate monohydrate</from_name>
		<from_code>885604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine hydrochloride</from_name>
		<from_code>91130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol decanoate</from_name>
		<from_code>26420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluoperazine</from_name>
		<from_code>10800</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol lactate</from_name>
		<from_code>217483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine</from_name>
		<from_code>8742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ziconotide acetate</from_name>
		<from_code>486126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine</from_name>
		<from_code>61381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penfluridol</from_name>
		<from_code>7974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluperidol hydrochloride</from_name>
		<from_code>236140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>droperidol</from_name>
		<from_code>3648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine</from_name>
		<from_code>8042</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>haloperidol</from_name>
		<from_code>5093</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioridazine hydrochloride</from_name>
		<from_code>203165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone hydrochloride</from_name>
		<from_code>82051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene hydrochloride</from_name>
		<from_code>91133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methotrimeprazine</from_name>
		<from_code>6852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromperidol decanoate</from_name>
		<from_code>186024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorprothixene</from_name>
		<from_code>2406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loxapine</from_name>
		<from_code>6475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perphenazine</from_name>
		<from_code>8076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiothixene hydrochloride</from_name>
		<from_code>91135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomepromazine maleate</from_name>
		<from_code>160372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>olanzapine pamoate</from_name>
		<from_code>1294588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetophenazine</from_name>
		<from_code>16735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molindone</from_name>
		<from_code>7019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>promazine hydrochloride</from_name>
		<from_code>142444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>perazine dimalonate</from_name>
		<from_code>236771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Psychotic Disorders</to_name>
		<to_code>M0018060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mianserin hydrochloride</from_name>
		<from_code>203127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mianserin Hydrochloride</to_name>
		<to_code>M0330033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myrcene</from_name>
		<from_code>2166047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myrcene</to_name>
		<to_code>M0497184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melamine</from_name>
		<from_code>1603851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>melamine</to_name>
		<to_code>M0058547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-mercaptoethanesulfonic acid</from_name>
		<from_code>1546354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coenzyme M</to_name>
		<to_code>M0023195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monoethyl fumarate</from_name>
		<from_code>52882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl fumarate</to_name>
		<to_code>M0169698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyleugenol</from_name>
		<from_code>1368373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyleugenol</to_name>
		<to_code>M0046616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mycobacterium phlei</from_name>
		<from_code>1310907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium phlei</to_name>
		<to_code>M0014291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mannose</from_name>
		<from_code>6633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mannose</to_name>
		<to_code>M0013001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mofebutazone</from_name>
		<from_code>30202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mofebutazone</to_name>
		<to_code>M0042918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myrrh extract</from_name>
		<from_code>67257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myrrh resin</to_name>
		<to_code>M0593165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mycobacterium bovis</from_name>
		<from_code>1320629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium bovis</to_name>
		<to_code>M0014285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montmorrillonite</from_name>
		<from_code>1425919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Montmorrillonite</to_name>
		<to_code>M0002318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milk thistle seed extract</from_name>
		<from_code>259274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>milkthistle fruit</to_name>
		<to_code>M000744298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milk thistle fruit extract</from_name>
		<from_code>284153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>milkthistle fruit</to_name>
		<to_code>M000744298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mersalyl</from_name>
		<from_code>6774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mersalyl</to_name>
		<to_code>M0013455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metanil yellow</from_name>
		<from_code>1305576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metanil yellow</to_name>
		<to_code>M0046446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebeverine</from_name>
		<from_code>29410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mebeverine</to_name>
		<to_code>M0046424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mintlactone</from_name>
		<from_code>1724822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mintlactone</to_name>
		<to_code>M0364825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metylperon</from_name>
		<from_code>29961</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metylperon</to_name>
		<to_code>M0052452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylparaben</from_name>
		<from_code>29903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylparaben</to_name>
		<to_code>M0064549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medifoxamine fumarate</from_name>
		<from_code>236781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>medifoxamine fumarate</to_name>
		<to_code>M0319991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyphenamine hydrochloride</from_name>
		<from_code>451944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methoxyphenamine hydrochloride</to_name>
		<to_code>M0308936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metamizole sodium</from_name>
		<from_code>1537943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Noramidopyrine Methanesulfonate Sodium</to_name>
		<to_code>M000638436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dipyrone</from_name>
		<from_code>3523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Noramidopyrine Methanesulfonate Sodium</to_name>
		<to_code>M000638436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methadyl acetate</from_name>
		<from_code>6814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methadyl Acetate</to_name>
		<to_code>M0013546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mycobacterium tuberculosis</from_name>
		<from_code>1492936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium tuberculosis</to_name>
		<to_code>M0014292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps skin test antigen</from_name>
		<from_code>89854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Tice strain</from_name>
		<from_code>221050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella typhi Ty21a live antigen</from_name>
		<from_code>762595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rubella virus vaccine</from_name>
		<from_code>9486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live, New York City Board of Health vaccinia strain</from_name>
		<from_code>798467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster virus vaccine live (Oka-Merck) strain</from_name>
		<from_code>1292422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live vaccinia virus</from_name>
		<from_code>833079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</from_name>
		<from_code>807219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG, live, Montreal strain</from_name>
		<from_code>314513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alemtuzumab</from_name>
		<from_code>117055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus</from_name>
		<from_code>1365969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>BCG Vaccine</from_name>
		<from_code>1344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talimogene laherparepvec</from_name>
		<from_code>1721264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubella virus vaccine live (Wistar RA 27-3 strain)</from_name>
		<from_code>762817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>herpesvirus 1, human</from_name>
		<from_code>1316105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mumps virus vaccine live, Jeryl Lynn strain</from_name>
		<from_code>798372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Immunologic Deficiency Syndromes</to_name>
		<to_code>M0011155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenorex</from_name>
		<from_code>29444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mefenorex</to_name>
		<to_code>M0040574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>micronomicin</from_name>
		<from_code>29996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>micronomicin</to_name>
		<to_code>M0113544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldibromo glutaronitrile</from_name>
		<from_code>1307044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,2-dibromo-2,4-dicyanobutane</to_name>
		<to_code>M0118009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxisylyte</from_name>
		<from_code>10561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Moxisylyte</to_name>
		<to_code>M0021466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miristalkonium chloride</from_name>
		<from_code>236394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>zephiramine</to_name>
		<to_code>M0047734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>99 molybdenum</from_name>
		<from_code>90574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Molybdenum-99</to_name>
		<to_code>M000628041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methacrylic acid</from_name>
		<from_code>1424905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methacrylic acid</to_name>
		<to_code>M0052190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-methylhydantoin</from_name>
		<from_code>1729875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-methylhydantoin</to_name>
		<to_code>M0100303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mineral oil</from_name>
		<from_code>6972</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mineral Oil</to_name>
		<to_code>M0013895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprednisone</from_name>
		<from_code>29523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meprednisone</to_name>
		<to_code>M0052100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-methyl-3-decen-5-ol</from_name>
		<from_code>2557379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-methyl-3-decen-5-ol</to_name>
		<to_code>M0547074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesulfen</from_name>
		<from_code>29584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mesulfen</to_name>
		<to_code>M0058555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxy PEG-22/dodecyl glycol polymer</from_name>
		<from_code>1940007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methoxy PEG 22 dodecyl glycol copolymer</to_name>
		<to_code>M0593980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyisopropanol</from_name>
		<from_code>2462502</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-methoxy-2-propanol</to_name>
		<to_code>M0308955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl ricinoleate</from_name>
		<from_code>1541746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl ricinoleate</to_name>
		<to_code>M0046637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morpholine</from_name>
		<from_code>1368870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>morpholine</to_name>
		<to_code>M0113608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mofezolac</from_name>
		<from_code>11469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mofezolac</to_name>
		<to_code>M0155057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metavanadate</from_name>
		<from_code>596548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Metavanadate</to_name>
		<to_code>M0022509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium iodide</from_name>
		<from_code>1992669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium iodide</to_name>
		<to_code>M0497948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mucins</from_name>
		<from_code>7076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mucins</to_name>
		<to_code>M0014159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-methylbutyric acid</from_name>
		<from_code>2281310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methylbutanoic acid</to_name>
		<to_code>M0071945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myricetin</from_name>
		<from_code>1368374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myricetin</to_name>
		<to_code>M0119385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molybdenum trichloride</from_name>
		<from_code>2664834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>molybdenum trichloride</to_name>
		<to_code>M000636864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylmethacrylate</from_name>
		<from_code>29897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylmethacrylate</to_name>
		<to_code>M0029998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monensin</from_name>
		<from_code>1368208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Monensin</to_name>
		<to_code>M0014007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaclazepam</from_name>
		<from_code>614654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metaclazepam</to_name>
		<to_code>M0110854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miocamycin</from_name>
		<from_code>6985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miocamycin</from_name>
		<from_code>6985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Miocamycin</to_name>
		<to_code>M0023981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltol</from_name>
		<from_code>1362894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maltol</to_name>
		<to_code>M0052047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metylperon hydrochloride</from_name>
		<from_code>289623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metylperon hydrochloride</to_name>
		<to_code>M0310342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myristate</from_name>
		<from_code>1313976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myristate</to_name>
		<to_code>M0029412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medigoxin</from_name>
		<from_code>6686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Medigoxin</to_name>
		<to_code>M0013272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene chloride</from_name>
		<from_code>1311537</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Chloride</to_name>
		<to_code>M0013630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl paraoxon</from_name>
		<from_code>1793922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylparaoxon</to_name>
		<to_code>M0052363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxaverine</from_name>
		<from_code>52918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>moxaverine</to_name>
		<to_code>M0045568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Momordica charantia fruit extract</from_name>
		<from_code>1306885</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>bitter melon fruit</to_name>
		<to_code>M000744072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebhydroline</from_name>
		<from_code>29411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mebhydroline</to_name>
		<to_code>M0046467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-methyl-8-hydroxyquinoline</from_name>
		<from_code>15850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-methyl-8-hydroxyquinoline</to_name>
		<to_code>M0100232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard greens allergenic extract</from_name>
		<from_code>899452</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese phosphate</from_name>
		<from_code>1313302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>manganese phosphate</to_name>
		<to_code>M0360171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium phosphate, monobasic</from_name>
		<from_code>1731599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium phosphate (2:1)</to_name>
		<to_code>M0319019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molgramostim</from_name>
		<from_code>70161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>molgramostim</to_name>
		<to_code>M0219646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maraviroc</from_name>
		<from_code>620216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maraviroc</to_name>
		<to_code>M0493371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin</from_name>
		<from_code>1992672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burosumab</from_name>
		<from_code>2043855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynate sodium</from_name>
		<from_code>4108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bumetanide</from_name>
		<from_code>1808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin</from_name>
		<from_code>1373458</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine anhydrous</from_name>
		<from_code>1545987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canagliflozin anhydrous</from_name>
		<from_code>1546031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amifostine</from_name>
		<from_code>4126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>furosemide</from_name>
		<from_code>4603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacrynic acid</from_name>
		<from_code>4109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium trisilicate</from_name>
		<from_code>29170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aldesleukin</from_name>
		<from_code>70223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ertugliflozin pidolate</from_name>
		<from_code>1992674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydrotachysterol</from_name>
		<from_code>3429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium acetate</from_name>
		<from_code>214342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>torsemide</from_name>
		<from_code>38413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>burosumab-twza</from_name>
		<from_code>2043854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Kidney Failure, Chronic</to_name>
		<to_code>M0012016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin</from_name>
		<from_code>29629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methampicillin</to_name>
		<to_code>M0046566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin</from_name>
		<from_code>29629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methampicillin</from_name>
		<from_code>29629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metrizamide</from_name>
		<from_code>6920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Metrizamide</to_name>
		<to_code>M0013690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercurius solubilis preparation</from_name>
		<from_code>1310193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mercurius solubilis</to_name>
		<to_code>M000740086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minaxolone</from_name>
		<from_code>1495077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>minaxolone</to_name>
		<to_code>M0074100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango bark extract</from_name>
		<from_code>1925438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mangifera indica bark</to_name>
		<to_code>M000745669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mango bark extract</from_name>
		<from_code>1925438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mangifera indica extract</to_name>
		<to_code>M0486009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maftivimab</from_name>
		<from_code>2461339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maftivimab</to_name>
		<to_code>M000742071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltobionate</from_name>
		<from_code>2605591</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maltobionate</to_name>
		<to_code>M0049792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecasermin</from_name>
		<from_code>274403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mecasermin</to_name>
		<to_code>M0337463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylparaben sodium</from_name>
		<from_code>1310557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylparaben, sodium salt</to_name>
		<to_code>M0312799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol</from_name>
		<from_code>1314261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol</to_name>
		<to_code>M0528469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenolone enanthate</from_name>
		<from_code>29654</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methenolone enanthate</to_name>
		<to_code>M0092246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myrtecaine</from_name>
		<from_code>59082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myrtecaine</to_name>
		<to_code>M0058593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl heptine carbonate</from_name>
		<from_code>1313237</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl heptine carbonate</to_name>
		<to_code>M0079779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myrtol</from_name>
		<from_code>174965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myrtol</to_name>
		<to_code>M0156528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxamine hydrochloride</from_name>
		<from_code>203187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methoxamine Hydrochloride</to_name>
		<to_code>M0350565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>manganese carbonate</from_name>
		<from_code>1314366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>manganese carbonate</to_name>
		<to_code>M0131869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaflumizone</from_name>
		<from_code>1489918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metaflumizone</to_name>
		<to_code>M0521041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monobutyl maleate</from_name>
		<from_code>2001495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monobutyl maleate</to_name>
		<to_code>M0509684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 2-nonynoate</from_name>
		<from_code>2384443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-nonynoic acid methyl ester</to_name>
		<to_code>M0156883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium ascorbyl phosphate</from_name>
		<from_code>1425918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium ascorbate-2-phosphate</to_name>
		<to_code>M0311542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenolone</from_name>
		<from_code>6833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methenolone</to_name>
		<to_code>M0013568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxamine</from_name>
		<from_code>6853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methoxamine</to_name>
		<to_code>M0013598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl isobutyl ketone</from_name>
		<from_code>1362929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl isobutyl ketone</to_name>
		<to_code>M0047019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-(3-methyl-2-thienyl)acrylic acid</from_name>
		<from_code>2475074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-(3-methyl-2-thienyl)acrylic acid</to_name>
		<to_code>M0144102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-myristylpicolinium</from_name>
		<from_code>1425941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-myristylpicolinium</to_name>
		<to_code>M0154491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebhydrolin napadisylate</from_name>
		<from_code>22822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>diazoline</to_name>
		<to_code>M0084026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecysteine</from_name>
		<from_code>29426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mecysteine</to_name>
		<to_code>M0068308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl glucose dioleate</from_name>
		<from_code>1421621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl glucose dioleate</to_name>
		<to_code>M0589126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebeverine hydrochloride</from_name>
		<from_code>235827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mebeverine hydrochloride</to_name>
		<to_code>M0308913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meradimate</from_name>
		<from_code>91324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menthyl anthranilate</to_name>
		<to_code>M0370142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldopate</from_name>
		<from_code>6877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methyldopate</to_name>
		<to_code>M0013627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melengestrol</from_name>
		<from_code>1537799</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Melengestrol</to_name>
		<to_code>M0013322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylbenzethonium</from_name>
		<from_code>29829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylbenzethonium</to_name>
		<to_code>M0046444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol sodium phosphate</from_name>
		<from_code>52549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban anhydrous</from_name>
		<from_code>1546207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alteplase</from_name>
		<from_code>8410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chrysonilia sitophila allergenic extract</from_name>
		<from_code>314411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cladosporium herbarum allergenic extract</from_name>
		<from_code>466198</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium</from_name>
		<from_code>104466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat smut allergenic extract</from_name>
		<from_code>852797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove preparation</from_name>
		<from_code>1364295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oil (containing omega-3 acids)</from_name>
		<from_code>2053495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin trifluoroacetate</from_name>
		<from_code>2380556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine hydrochloride</from_name>
		<from_code>142432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginger extract</from_name>
		<from_code>285241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin</from_name>
		<from_code>67108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almond allergenic extract</from_name>
		<from_code>892507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nadroparin</from_name>
		<from_code>67031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>argatroban</from_name>
		<from_code>15202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux</from_name>
		<from_code>321208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hops extract</from_name>
		<from_code>259266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>walnut allergenic extract</from_name>
		<from_code>314470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bermuda grass pollen extract</from_name>
		<from_code>851906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edoxaban</from_name>
		<from_code>1599538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fulvestrant</from_name>
		<from_code>282357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fondaparinux sodium</from_name>
		<from_code>322154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxaparin sodium</from_name>
		<from_code>221095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin</from_name>
		<from_code>152610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mitomycin</from_name>
		<from_code>632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reviparin</from_name>
		<from_code>75960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>wheat preparation</from_name>
		<from_code>1441652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edoxaban tosylate</from_name>
		<from_code>1599564</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>certoparin sodium</from_name>
		<from_code>152612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aspirin</from_name>
		<from_code>1191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reviparin sodium</from_name>
		<from_code>75961</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oil of garlic</from_name>
		<from_code>1309210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon preparation</from_name>
		<from_code>285245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parnaparin</from_name>
		<from_code>69528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhodotorula rubra allergenic extract</from_name>
		<from_code>867321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mifepristone</from_name>
		<from_code>6964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin</from_name>
		<from_code>60819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin sodium</from_name>
		<from_code>87865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin sodium,porcine</from_name>
		<from_code>235995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ardeparin</from_name>
		<from_code>87866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac</from_name>
		<from_code>35827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oat smut allergenic extract</from_name>
		<from_code>349978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ginseng preparation</from_name>
		<from_code>325526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tinzaparin</from_name>
		<from_code>69646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>plicamycin</from_name>
		<from_code>6995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonidine</from_name>
		<from_code>2599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hemorrhagic Disorders</to_name>
		<to_code>M0010157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menadiol</to_name>
		<to_code>M0081632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadiol</from_name>
		<from_code>29491</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K1</from_name>
		<from_code>8308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K</from_name>
		<from_code>11258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K3</from_name>
		<from_code>6728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nonacog alfa</from_name>
		<from_code>1300488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K3</from_name>
		<from_code>6728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypoprothrombinemias</to_name>
		<to_code>M0010925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl lactate</from_name>
		<from_code>1310580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl lactate</to_name>
		<to_code>M0091552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mogamulizumab-kpkc</from_name>
		<from_code>2054077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mogamulizumab-kpkc</to_name>
		<to_code>M000677560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malachite green</from_name>
		<from_code>896038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>malachite green</to_name>
		<to_code>M0046422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercuric cyanide</from_name>
		<from_code>1311110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mercuric cyanide</to_name>
		<to_code>M0119794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>margaric acid</from_name>
		<from_code>1987137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>margaric acid</to_name>
		<to_code>M0060611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methenolone acetate</from_name>
		<from_code>29653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methenolone acetate</to_name>
		<to_code>M0103240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maftivimab-ebgn</from_name>
		<from_code>2461432</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maftivimab-ebgn</to_name>
		<to_code>M000767496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melitracen</from_name>
		<from_code>446248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>melitracene</to_name>
		<to_code>M0046428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-mercaptobenzothiazole</from_name>
		<from_code>1358845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>captax</to_name>
		<to_code>M0047196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangostin</from_name>
		<from_code>2619910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mangostin</to_name>
		<to_code>M0075503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl chloride</from_name>
		<from_code>1305751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methyl Chloride</to_name>
		<to_code>M0013610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltotetraose</from_name>
		<from_code>2641823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maltotetraose</to_name>
		<to_code>M0054853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene glycol</from_name>
		<from_code>1797646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylene glycol</to_name>
		<to_code>M000596338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methixene</from_name>
		<from_code>29682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methixene</to_name>
		<to_code>M0046452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercuric oxide</from_name>
		<from_code>29545</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mercuric oxide</to_name>
		<to_code>M0071938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium fluoride</from_name>
		<from_code>1435860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium fluoride</to_name>
		<to_code>M0098413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morantel tartrate</from_name>
		<from_code>1368899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Morantel Tartrate</to_name>
		<to_code>M0014058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene diphosphonate</from_name>
		<from_code>29844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases</to_name>
		<to_code>M0002776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene diphosphonate</from_name>
		<from_code>29844</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylene diphosphonate</to_name>
		<to_code>M0089278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine mesylate</from_name>
		<from_code>3132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases</to_name>
		<to_code>M0002776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medronate disodium</from_name>
		<from_code>317599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases</to_name>
		<to_code>M0002776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deferoxamine</from_name>
		<from_code>3131</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bone Diseases</to_name>
		<to_code>M0002776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylsulfonylmethane</from_name>
		<from_code>23247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dimethyl sulfone</to_name>
		<to_code>M0085668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-methyl-5-thiazoleethanol</from_name>
		<from_code>2692023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-(4-methyl-1,3-thiazol-5-yl)ethanol</to_name>
		<to_code>M0059687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mordant yellow 10</from_name>
		<from_code>2567331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mordant Yellow 10</to_name>
		<to_code>M0464224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercury</from_name>
		<from_code>6769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mercury</to_name>
		<to_code>M0013448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dysthymic Disorder</to_name>
		<to_code>M0028689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cocaine-Related Disorders</to_name>
		<to_code>M0029669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maprotiline</to_name>
		<to_code>M0013021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline</from_name>
		<from_code>6646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dysthymic Disorder</to_name>
		<to_code>M0028689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dysthymic Disorder</to_name>
		<to_code>M0028689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cocaine-Related Disorders</to_name>
		<to_code>M0029669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline hydrochloride</from_name>
		<from_code>203126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maprotiline Hydrochloride</to_name>
		<to_code>M0330109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine</from_name>
		<from_code>4493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluoxetine hydrochloride</from_name>
		<from_code>227224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bulimia</to_name>
		<to_code>M0003021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cocaine-Related Disorders</to_name>
		<to_code>M0029669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maprotiline Mesylate</to_name>
		<to_code>M0330110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maprotiline mesylate</from_name>
		<from_code>236328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate malate</from_name>
		<from_code>1487143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum carbonate</from_name>
		<from_code>89858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide sulfate (Al(OH)(SO4))</from_name>
		<from_code>1806902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole strontium</from_name>
		<from_code>1435522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole sodium</from_name>
		<from_code>1792108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbonate</from_name>
		<from_code>1897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magaldrate</from_name>
		<from_code>29151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>basic aluminum carbonate gel</from_name>
		<from_code>18789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin</from_name>
		<from_code>723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate</from_name>
		<from_code>10156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium trihydrate</from_name>
		<from_code>2688630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide</from_name>
		<from_code>612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium</from_name>
		<from_code>283562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine</from_name>
		<from_code>8352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine hydrochloride</from_name>
		<from_code>235775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium gluceptate</from_name>
		<from_code>47618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole</from_name>
		<from_code>7646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroxyaluminum sodium carbonate</from_name>
		<from_code>23163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole sodium</from_name>
		<from_code>226868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin sodium</from_name>
		<from_code>267360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine hydrochloride</from_name>
		<from_code>91251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cimetidine</from_name>
		<from_code>2541</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>famotidine</from_name>
		<from_code>4278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate</from_name>
		<from_code>10156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole sodium</from_name>
		<from_code>1294569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide gel</from_name>
		<from_code>613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin trihydrate</from_name>
		<from_code>133008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralfate malate</from_name>
		<from_code>1487143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium hydroxide</from_name>
		<from_code>6581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabeprazole</from_name>
		<from_code>114979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole magnesium dihydrate</from_name>
		<from_code>1601995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esomeprazole</from_name>
		<from_code>283742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nizatidine</from_name>
		<from_code>42319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine hydrochloride</from_name>
		<from_code>235775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>omeprazole magnesium</from_name>
		<from_code>236486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine hydrochloride</from_name>
		<from_code>203136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine</from_name>
		<from_code>9143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amoxicillin anhydrous</from_name>
		<from_code>1297882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazepam</from_name>
		<from_code>8627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirenzepine</from_name>
		<from_code>8352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aluminum hydroxide, dried (USP)</from_name>
		<from_code>81948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lansoprazole</from_name>
		<from_code>17128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Duodenal Ulcer</to_name>
		<to_code>M0006885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maprotiline Hydrochloride</to_name>
		<to_code>M0330109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maprotiline Hydrochloride</to_name>
		<to_code>M0330109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>milbemycin oxime</from_name>
		<from_code>68730</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>milbemycin oxime</to_name>
		<to_code>M0211535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesite</from_name>
		<from_code>2475179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesite</to_name>
		<to_code>M000633640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodamide</from_name>
		<from_code>29455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>iodamide meglumine</to_name>
		<to_code>M000636961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monophosphoryl lipid A</from_name>
		<from_code>1363051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monophosphoryl lipid A</to_name>
		<to_code>M0139357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium pidolate</from_name>
		<from_code>116240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Magnesium Pidolate</to_name>
		<to_code>M0018280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mucopolysaccharide polysulfate</from_name>
		<from_code>30320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mucopolysaccharide polysulfate</to_name>
		<to_code>M0149548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl methacrylate-glycol dimethacrylate crosspolymer</from_name>
		<from_code>1312390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl methacrylate-glycol dimethacrylate crosspolymer</to_name>
		<to_code>M0568494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclocycline sulfosalicylate</from_name>
		<from_code>203162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meclocycline sulfosalicylate</to_name>
		<to_code>M0430314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mica</from_name>
		<from_code>1362896</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mica</to_name>
		<to_code>M0058580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maritime pine extract</from_name>
		<from_code>1368708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pycnogenols</to_name>
		<to_code>M0081987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muscone</from_name>
		<from_code>1606471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>muscone</to_name>
		<to_code>M0097774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methixene hydrochloride</from_name>
		<from_code>258230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methixene hydrochloride</to_name>
		<to_code>M0308923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl cinnamate</from_name>
		<from_code>1367156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl cinnamate</to_name>
		<to_code>M0084649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mandarin oil</from_name>
		<from_code>1305716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mandarin oil</to_name>
		<to_code>M000768543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylal</from_name>
		<from_code>2385338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dimethoxymethane</to_name>
		<to_code>M0125672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium peroxide</from_name>
		<from_code>1666106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium peroxide</to_name>
		<to_code>M0506992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morantel</from_name>
		<from_code>1368900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Morantel</to_name>
		<to_code>M0014057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>modified fluid gelatins</from_name>
		<from_code>52853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>modified fluid gelatins</to_name>
		<to_code>M0085678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metocurine</from_name>
		<from_code>29950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metocurine</to_name>
		<to_code>M0102459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Magadi soda</from_name>
		<from_code>1367411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Magadi soda</to_name>
		<to_code>M0092978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>madecassoside</from_name>
		<from_code>87855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>madecassoside</to_name>
		<to_code>M0246430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mandelic acid</from_name>
		<from_code>29256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mandelic acid</to_name>
		<to_code>M0114477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medetomidine hydrochloride</from_name>
		<from_code>29428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Medetomidine Hydrochloride</to_name>
		<to_code>M0333581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylethyl ketone</from_name>
		<from_code>1363708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylethyl ketone</to_name>
		<to_code>M0046613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangafodipir trisodium, anhydrous</from_name>
		<from_code>221119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mangafodipir trisodium, anhydrous</to_name>
		<to_code>M0443226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maropitant</from_name>
		<from_code>715869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maropitant</to_name>
		<to_code>M0507934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxonidine</from_name>
		<from_code>30257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>moxonidine</to_name>
		<to_code>M0127943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metacresol</from_name>
		<from_code>1367170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-cresol</to_name>
		<to_code>M0124405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-methacryloyloxyethyl phosphorylcholine</from_name>
		<from_code>2584546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methacryloyloxyethyl phosphorylcholine</to_name>
		<to_code>M0192238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard oil</from_name>
		<from_code>1360631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mustard oil</to_name>
		<to_code>M0090057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medifoxamine</from_name>
		<from_code>29434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>medifoxamine</to_name>
		<to_code>M0105224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>macelignan</from_name>
		<from_code>1872381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>macelignan</to_name>
		<to_code>M0486938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malic acid</from_name>
		<from_code>29209</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>malic acid</to_name>
		<to_code>M0095933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium acetate</from_name>
		<from_code>314718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium acetate</to_name>
		<to_code>M000679485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxychlor</from_name>
		<from_code>2598123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methoxychlor</to_name>
		<to_code>M0013601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molidustat</from_name>
		<from_code>2637535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>molidustat</to_name>
		<to_code>M000613288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl bromide</from_name>
		<from_code>29746</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl bromide</to_name>
		<to_code>M0046604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methane</from_name>
		<from_code>2598120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methane</to_name>
		<to_code>M0013556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-methoxy-1-propanol</from_name>
		<from_code>2380833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methoxypropanol</to_name>
		<to_code>M0243326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>merbromin</from_name>
		<from_code>6762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Merbromin</to_name>
		<to_code>M0013442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myristic acid</from_name>
		<from_code>1356758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myristic Acid</to_name>
		<to_code>M0029411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moroxydine</from_name>
		<from_code>30227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>moroxydine</to_name>
		<to_code>M0046694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxidectin</from_name>
		<from_code>1047072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onchocerciasis, Ocular</to_name>
		<to_code>M0024245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxidectin</from_name>
		<from_code>1047072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>moxidectin</to_name>
		<to_code>M0317480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>praziquantel</from_name>
		<from_code>8628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onchocerciasis, Ocular</to_name>
		<to_code>M0024245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltitol</from_name>
		<from_code>1363049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maltitol</to_name>
		<to_code>M0056494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl blue</from_name>
		<from_code>2176448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methyl Blue</to_name>
		<to_code>M0371167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mebrofenin</from_name>
		<from_code>1311500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mebrofenin</to_name>
		<to_code>M000744450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium ascorbate</from_name>
		<from_code>1311396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Magnesium Ascorbate</to_name>
		<to_code>M0001799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moroxydine hydrochloride</from_name>
		<from_code>1291996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>moroxydine monohydrochloride</to_name>
		<to_code>M0308974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangafodipir</from_name>
		<from_code>236987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mangafodipir</to_name>
		<to_code>M0473859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyldiethanolamine</from_name>
		<from_code>1371054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-methyldiethanolamine</to_name>
		<to_code>M0052273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium lauryl sulfate</from_name>
		<from_code>1489922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dodecyl sulfate, magnesium salt</to_name>
		<to_code>M0317998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monomenthyl glutarate</from_name>
		<from_code>1489548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monomenthyl glutarate</to_name>
		<to_code>M0468707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenoxate hydrochloride</from_name>
		<from_code>236572</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meclofenoxate Hydrochloride</to_name>
		<to_code>M0424109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melarsomine</from_name>
		<from_code>1012534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>melarsomine</to_name>
		<to_code>M0205183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molasses</from_name>
		<from_code>1307820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Molasses</to_name>
		<to_code>M0013982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl benzoate</from_name>
		<from_code>1314316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl benzoate</to_name>
		<to_code>M0130179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-methoxytryptamine</from_name>
		<from_code>1426888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-Methoxytryptamine</to_name>
		<to_code>M0013607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mycoplasma pneumoniae</from_name>
		<from_code>1360621</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma pneumoniae</to_name>
		<to_code>M0014309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Monascus purpureus</from_name>
		<from_code>1442200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Monascus purpureus</to_name>
		<to_code>M0401384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Morus alba leaf extract</from_name>
		<from_code>1309988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Morus alba leaf</to_name>
		<to_code>M000758325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menatetrenone</from_name>
		<from_code>29495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menatetrenone</to_name>
		<to_code>M0097218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metergoline</from_name>
		<from_code>6834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Metergoline</to_name>
		<to_code>M0013569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mung bean allergenic extract</from_name>
		<from_code>891647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-methyldeoxycytidine</from_name>
		<from_code>2642190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-methyldeoxycytidine</to_name>
		<to_code>M0066662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molybdate ion</from_name>
		<from_code>1546395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>molybdate ion</to_name>
		<to_code>M0322080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minaprine hydrochloride</from_name>
		<from_code>236400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>minaprine dihydrochloride</to_name>
		<to_code>M0309456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>musk xylene</from_name>
		<from_code>1921875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>musk xylene</to_name>
		<to_code>M0098786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine antimoniate</from_name>
		<from_code>319866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meglumine Antimoniate</to_name>
		<to_code>M0428130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine antimoniate</from_name>
		<from_code>319866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-Methylglucamine Antimonate</to_name>
		<to_code>M000640802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylinositol</from_name>
		<from_code>1435864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylinositol</to_name>
		<to_code>M0505073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylinositol</from_name>
		<from_code>1435864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pinitol</to_name>
		<to_code>M0076997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl anthranilate</from_name>
		<from_code>29742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl anthranilate</to_name>
		<to_code>M0116815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl dihydrojasmonate</from_name>
		<from_code>1307050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyldihydrojasmonate</to_name>
		<to_code>M0486840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl hydroxyurea</from_name>
		<from_code>1665338</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl hydroxyurea</to_name>
		<to_code>M0068793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclocycline</from_name>
		<from_code>29418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meclocycline</to_name>
		<to_code>M0262717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium orotate</from_name>
		<from_code>139233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium orotate</to_name>
		<to_code>M0272863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-methyl-4-phenyl-2-butanol</from_name>
		<from_code>2289004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methyl-4-phenyl-2-butanol</to_name>
		<to_code>M0580614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-methyltetrahydrofolic acid</from_name>
		<from_code>1313966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N(5)-methyltetrahydrofolic acid</to_name>
		<to_code>M0047913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecysteine hydrochloride</from_name>
		<from_code>235828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mecysteine hydrochloride</to_name>
		<to_code>M0313443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltose</from_name>
		<from_code>1311261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maltose</to_name>
		<to_code>M0012956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>muramidase</from_name>
		<from_code>7094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muramidase</to_name>
		<to_code>M0014214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium chlorate</from_name>
		<from_code>1605084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium chlorate</to_name>
		<to_code>M0104574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meadowfoam oil</from_name>
		<from_code>1309256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meadowfoam oil</to_name>
		<to_code>M0503971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meglumine iodipamide</to_name>
		<to_code>M0049480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine iodipamide</from_name>
		<from_code>29456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diethylstilbestrol</from_name>
		<from_code>3390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone enanthate</from_name>
		<from_code>37859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ospemifene</from_name>
		<from_code>1370971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol</from_name>
		<from_code>25284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosfestrol tetrasodium</from_name>
		<from_code>281876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone cypionate</from_name>
		<from_code>835827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinestrol</from_name>
		<from_code>9066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone undecanoate</from_name>
		<from_code>37864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone propionate</from_name>
		<from_code>10382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorotrianisene</from_name>
		<from_code>2397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loracarbef</from_name>
		<from_code>28981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Genital Diseases, Female</to_name>
		<to_code>M0009154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mangiferin</from_name>
		<from_code>1362895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mangiferin</to_name>
		<to_code>M0061463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monosulfiram</from_name>
		<from_code>30206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monosulfiram</to_name>
		<to_code>M0054875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl abietate</from_name>
		<from_code>2465733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl abietate</to_name>
		<to_code>M0086961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercuric sulfate</from_name>
		<from_code>1311475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mercuric sulfate</to_name>
		<to_code>M0091523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxaverine hydrochloride</from_name>
		<from_code>236673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>moxaverine hydrochloride</to_name>
		<to_code>M0308604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-methyl anisole</from_name>
		<from_code>1313261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-methyl anisole</to_name>
		<to_code>M0052248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myristyl lactate</from_name>
		<from_code>1363720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myristyl lactate</to_name>
		<to_code>M0185360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methanesulfonic acid</from_name>
		<from_code>1426387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methanesulfonic acid</to_name>
		<to_code>M0133193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monomethyl fumarate</from_name>
		<from_code>1546433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monomethyl fumarate</to_name>
		<to_code>M0496490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine ioxithalamate</from_name>
		<from_code>29459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>meglumine ioxithalamate</to_name>
		<to_code>M0041964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>5-methoxypsoralen</from_name>
		<from_code>15842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-Methoxypsoralen</to_name>
		<to_code>M0079571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maltobionic acid</from_name>
		<from_code>2605590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maltobionic acid</to_name>
		<to_code>M000638735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>musk ketone</from_name>
		<from_code>1438530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>musk ketone</to_name>
		<to_code>M0098790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menadione sodium bisulfite</from_name>
		<from_code>52551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Menadione Sodium Bisulfite</to_name>
		<to_code>M0047743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malondialdehyde</from_name>
		<from_code>1657018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malondialdehyde</to_name>
		<to_code>M0012949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metopimazine</from_name>
		<from_code>29954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metopimazine</to_name>
		<to_code>M0046673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menhaden oil</from_name>
		<from_code>2467841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Menhaden oil</to_name>
		<to_code>M0103297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monoolein</from_name>
		<from_code>1311678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monoolein</to_name>
		<to_code>M0047848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenoxate</from_name>
		<from_code>2228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meclofenoxate</to_name>
		<to_code>M0003816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mizolastine</from_name>
		<from_code>61455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mizolastine</to_name>
		<to_code>M0204949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meclofenamic acid</from_name>
		<from_code>6678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meclofenamic Acid</to_name>
		<to_code>M0013184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meclofenamic Acid</to_name>
		<to_code>M0013184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mustard seed allergenic extract</from_name>
		<from_code>899456</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maropitant citrate</from_name>
		<from_code>818233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maropitant citrate</to_name>
		<to_code>M0507935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenorex hydrochloride</from_name>
		<from_code>236179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mefenorex hydrochloride</to_name>
		<to_code>M0307435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maribavir</from_name>
		<from_code>2586068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maribavir</to_name>
		<to_code>M0350667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>m-phenylenediamine</from_name>
		<from_code>1435286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-phenylenediamine</to_name>
		<to_code>M0052185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mephenesin</from_name>
		<from_code>6755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mephenesin</to_name>
		<to_code>M0013429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mevalonolactone</from_name>
		<from_code>1442202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mevalonolactone</to_name>
		<to_code>M0064561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mirtazapine</from_name>
		<from_code>15996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mirtazapine</to_name>
		<to_code>M0107850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molsidomine</from_name>
		<from_code>7023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Molsidomine</to_name>
		<to_code>M0014003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus preparation</from_name>
		<from_code>1312384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles</to_name>
		<to_code>M0013152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED</from_name>
		<from_code>235574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles</to_name>
		<to_code>M0013152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Measles Vaccine</from_name>
		<from_code>6669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles</to_name>
		<to_code>M0013152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>intramuscular immunoglobulin</from_name>
		<from_code>108067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles</to_name>
		<to_code>M0013152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>measles virus vaccine live, Enders' attenuated Edmonston strain</from_name>
		<from_code>804179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Measles</to_name>
		<to_code>M0013152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercury, ammoniated</from_name>
		<from_code>29542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>mercuric chloride, ammoniated</to_name>
		<to_code>M0091529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl orange</from_name>
		<from_code>1551460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl orange</to_name>
		<to_code>M0263223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maleic anhydride</from_name>
		<from_code>1362876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Maleic Anhydride</to_name>
		<to_code>M0012925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metomidate</from_name>
		<from_code>1311585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metomidate</to_name>
		<to_code>M0224678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium silicate</from_name>
		<from_code>1310566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>magnesium silicate</to_name>
		<to_code>M0046286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Melissa officinalis leaf extract</from_name>
		<from_code>1307836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lemon balm leaf extract</to_name>
		<to_code>M000744066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Melissa officinalis leaf extract</from_name>
		<from_code>1307836</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>melissae folium</to_name>
		<to_code>M000744065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malvin</from_name>
		<from_code>1309703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>malvin</to_name>
		<to_code>M0487711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl oleate</from_name>
		<from_code>1734017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl oleate</to_name>
		<to_code>M0047218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morniflumate</from_name>
		<from_code>30225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>morniflumate</to_name>
		<to_code>M0090196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-methyl-4-isothiazolin-3-one</from_name>
		<from_code>1367166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methyl-4-isothiazolin-3-one</to_name>
		<to_code>M0057852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaclazepam hydrochloride</from_name>
		<from_code>29590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>metaclazepam hydrochloride</to_name>
		<to_code>M0481962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myrrh oil</from_name>
		<from_code>1309206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myrrh oil</to_name>
		<to_code>M0062396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methoxyphenamine</from_name>
		<from_code>29704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methoxyphenamine</to_name>
		<to_code>M0046501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>miltefosine</to_name>
		<to_code>M0117341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sjogren-Larsson Syndrome</to_name>
		<to_code>M0024610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>miltefosine</from_name>
		<from_code>1494066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Cutaneous</to_name>
		<to_code>M0025563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B colloidal dispersion</from_name>
		<from_code>101299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine</from_name>
		<from_code>6704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B</from_name>
		<from_code>732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amphotericin B liposomal</from_name>
		<from_code>236594</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Visceral</to_name>
		<to_code>M0012335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meglumine</from_name>
		<from_code>6704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Leishmaniasis, Cutaneous</to_name>
		<to_code>M0025563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>matrine</from_name>
		<from_code>2049547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Matrine</to_name>
		<to_code>M0105670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Morganella morganii</from_name>
		<from_code>1311228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Morganella morganii</to_name>
		<to_code>M0328484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>myristyl nicotinate</from_name>
		<from_code>1425406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>myristyl nicotinate</to_name>
		<to_code>M0497260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mercuric sulfide</from_name>
		<from_code>1311278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnabar</to_name>
		<to_code>M0105596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>madecassic acid</from_name>
		<from_code>1551573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>madecassic acid</to_name>
		<to_code>M0041940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium sulfate heptahydrate</from_name>
		<from_code>236741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Magnesium Sulfate, Heptahydrate</to_name>
		<to_code>M0330102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menthyl acetate, (-)-</from_name>
		<from_code>2048710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menthyl acetate</to_name>
		<to_code>M000768544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl 2-furoate</from_name>
		<from_code>2384442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl 2-furoate</to_name>
		<to_code>M000762081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-methyl-4-isothiazolin-3-one hydrochloride</from_name>
		<from_code>1804258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methyl-4-isothiazolin-3-one hydrochloride</to_name>
		<to_code>M0311478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>menfegol</from_name>
		<from_code>31575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menfegol</to_name>
		<to_code>M0093443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>monensin sodium</from_name>
		<from_code>2719468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Monensin Sodium</to_name>
		<to_code>M0330043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maleic acid</from_name>
		<from_code>1426330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maleic acid</to_name>
		<to_code>M0095873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl acrylate</from_name>
		<from_code>1367155</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methyl acrylate</to_name>
		<to_code>M0109830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>morazone</from_name>
		<from_code>30218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>morazone</to_name>
		<to_code>M0054031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>maleate</from_name>
		<from_code>1426331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>maleate</to_name>
		<to_code>M0095871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>melengestrol acetate</from_name>
		<from_code>1537798</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Melengestrol Acetate</to_name>
		<to_code>M0013321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl glucose</from_name>
		<from_code>2174505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>methylglucoside, (alpha-D)-isomer</to_name>
		<to_code>M0317107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methanol</from_name>
		<from_code>1310568</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methanol</to_name>
		<to_code>M0000655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis stem extract</to_name>
		<to_code>2054265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus deppeana wood oil</to_name>
		<to_code>1307759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>juniper berry oil</to_name>
		<to_code>1309245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese pagoda tree flower bud extract</to_name>
		<to_code>1660771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juglans nigra bark extract</to_name>
		<to_code>1307711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese encephalitis virus vaccine, inactivated</to_name>
		<to_code>845525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jacaranda caroba flower extract</to_name>
		<to_code>1310056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jojoba oil, randomized</to_name>
		<to_code>1491858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jasminum sambac flower extract</to_name>
		<to_code>1540869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jasminum officinale leaf extract</to_name>
		<to_code>1651595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>June grass pollen extract</to_name>
		<to_code>851965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Joshua tree root extract</to_name>
		<to_code>1601986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jasmone</to_name>
		<to_code>2557370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jacobaea vulgaris extract</to_name>
		<to_code>1428420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jasminum officinale flower extract</to_name>
		<to_code>1307879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>javanicin</to_name>
		<to_code>2693988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated</to_name>
		<to_code>1300779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jerusalem artichoke extract</to_name>
		<to_code>1648701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juglans regia leaf extract</to_name>
		<to_code>1324597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus virginiana allergenic extract</to_name>
		<to_code>1314591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Justicia spicigera leaf extract</to_name>
		<to_code>2593848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juglans cinerea branch bark-root bark extract</to_name>
		<to_code>1309750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juglans regia flowering top extract</to_name>
		<to_code>1310159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis var. saxatilis fruit extract</to_name>
		<to_code>1992861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jateorhiza calumba root extract</to_name>
		<to_code>1310157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese encephalitis virus</to_name>
		<to_code>1439114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Johnson grass pollen extract</to_name>
		<to_code>852136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jerusalem oak pollen extract</to_name>
		<to_code>1014766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jammu lemongrass oil</to_name>
		<to_code>2374551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis var. saxatilis whole extract</to_name>
		<to_code>2591814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>josamycin propionate</to_name>
		<to_code>28069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jojoba butter</to_name>
		<to_code>1362138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>juniper tar</to_name>
		<to_code>6086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jatropha curcas whole extract</to_name>
		<to_code>1663394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jujube fruit extract</to_name>
		<to_code>1424897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus virginiana twig extract</to_name>
		<to_code>1314257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jasminum sambac whole extract</to_name>
		<to_code>1603478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus phoenicea resin</to_name>
		<to_code>1811260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>josamycin</to_name>
		<to_code>6084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Justicia gendarussa leaf extract</to_name>
		<to_code>1310078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus sabina leafy twig extract</to_name>
		<to_code>1309719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juglans regia whole extract</to_name>
		<to_code>1435862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jacobaea maritima leaf extract</to_name>
		<to_code>2592623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jasmine lactone</to_name>
		<to_code>1426261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jute fiber allergenic extract</to_name>
		<to_code>852412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Java citronella oil</to_name>
		<to_code>1747704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus virginiana oil</to_name>
		<to_code>1307948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jatropha curcas seed extract</to_name>
		<to_code>1309701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jarcaranda caroba leaf extract</to_name>
		<to_code>1651694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Justicia adhatoda flower extract</to_name>
		<to_code>1860077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jack pine pollen extract</to_name>
		<to_code>1014690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jasminum officinale whole extract</to_name>
		<to_code>1541719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jacobaea maritima extract</to_name>
		<to_code>1345681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jojoba wax</to_name>
		<to_code>1309258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Johnson grass smut pollen extract</to_name>
		<to_code>852118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis fruit extract</to_name>
		<to_code>1310189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus communis whole extract</to_name>
		<to_code>6085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jasmine oil</to_name>
		<to_code>1309240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jasminum grandiflorum flower extract</to_name>
		<to_code>1654012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jewel weed whole extract</to_name>
		<to_code>1657791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus sabina leaf</to_name>
		<to_code>1310161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jujube seed extract</to_name>
		<to_code>2106744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juglans nigra whole extract</to_name>
		<to_code>1370466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>jojoba acid</to_name>
		<to_code>1742509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Johnson grass smut allergenic extract</to_name>
		<to_code>852128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Japanese black pine pollen extract</to_name>
		<to_code>900777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Justicia adhatoda leaf extract</to_name>
		<to_code>1309704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>juglans regia shell extract</to_name>
		<to_code>1424881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Jasminum officinale fruit extract</to_name>
		<to_code>2564382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>J [Preparations]</from_name>
		<from_code>N0000010592</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Juniperus oxycedrus leaf oil</to_name>
		<to_code>1600140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>juniper berry oil</from_name>
		<from_code>1309245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>juniper berry oil</to_name>
		<to_code>M0296339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jasmone</from_name>
		<from_code>2557370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>jasmone</to_name>
		<to_code>M0228787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Jerusalem artichoke extract</from_name>
		<from_code>1648701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Japanese encephalitis virus</from_name>
		<from_code>1439114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Encephalitis Virus, Japanese</to_name>
		<to_code>M0007343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>juniper tar</from_name>
		<from_code>6086</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>juniper tar</to_name>
		<to_code>M0173197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jujube fruit extract</from_name>
		<from_code>1424897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>jujube fruit</to_name>
		<to_code>M000744364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jojoba wax</from_name>
		<from_code>1309258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>jojoba wax</to_name>
		<to_code>M0106871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jasmine oil</from_name>
		<from_code>1309240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>jasmine oil</to_name>
		<to_code>M0154736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>jujube seed extract</from_name>
		<from_code>2106744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>jujube seed</to_name>
		<to_code>M000744367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saw palmetto extract</to_name>
		<to_code>236344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1)</to_name>
		<to_code>2722617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sphagnum squarrosum extract</to_name>
		<to_code>1541244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevelamer</to_name>
		<to_code>214824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sonidegib phosphate</to_name>
		<to_code>1659192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>setmelanotide acetate</to_name>
		<to_code>2469248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Selenicereus grandiflorus whole extract</to_name>
		<to_code>1673559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sitagliptin</to_name>
		<to_code>593411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sorghum bicolor pollen extract</to_name>
		<to_code>1311406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sufentanil</to_name>
		<to_code>56795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sennoside B</to_name>
		<to_code>56161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatropin (recombinant DNA origin)</to_name>
		<to_code>314845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean oil</to_name>
		<to_code>9949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scleranthus annuus flowering top extract</to_name>
		<to_code>1310110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>slash pine pollen extract</to_name>
		<to_code>900731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium polyacrylate (8000 MW)</to_name>
		<to_code>1366975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sphaeranthus indicus flowering top extract</to_name>
		<to_code>1547556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose monostearate</to_name>
		<to_code>1363060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sitagliptin hydrochloride</to_name>
		<to_code>2716481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa rectum preparation</to_name>
		<to_code>1311343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguisorba minor root extract</to_name>
		<to_code>1307575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selinexor</to_name>
		<to_code>2178390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5)</to_name>
		<to_code>2610243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk, acid hydrolyzed (1000 MW)</to_name>
		<to_code>1356763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>semax</to_name>
		<to_code>2049929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Styphnolobium japonicum root extract</to_name>
		<to_code>1310022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>setmelanotide</to_name>
		<to_code>2469247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotagliflozin</to_name>
		<to_code>2638675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saururus chinensis flower extract</to_name>
		<to_code>1307789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sinapis arvensis whole extract</to_name>
		<to_code>1800491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate</to_name>
		<to_code>36709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium silicate</to_name>
		<to_code>1363697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa hypothalamus preparation</to_name>
		<to_code>1311240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, monobasic, anhydrous</to_name>
		<to_code>349753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver nitrate</to_name>
		<to_code>9789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium aromaticum seed extract</to_name>
		<to_code>2391536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>satralizumab</to_name>
		<to_code>2391541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicon tetrachloride</to_name>
		<to_code>1863221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suramin</to_name>
		<to_code>10256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium formaldehyde sulfoxylate</to_name>
		<to_code>289996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfachlorpyridazine</to_name>
		<to_code>2476008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium arsenate, dibasic, heptahydrate</to_name>
		<to_code>1364796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver mono(2-aminoethyl)phosphate</to_name>
		<to_code>162901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C14-16 olefin sulfonate</to_name>
		<to_code>1363581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoyl glutamate</to_name>
		<to_code>1370625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silodrate</to_name>
		<to_code>1373351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saxifraga granulata flowering top extract</to_name>
		<to_code>1862216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose stearate-palmitate ester (75% mono ester)</to_name>
		<to_code>1427042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saxagliptin hydrochloride</to_name>
		<to_code>1043560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tyropanoate</to_name>
		<to_code>282508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sibutramine hydrochloride</to_name>
		<to_code>1294535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinus molle bark extract</to_name>
		<to_code>1309468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage oil</to_name>
		<to_code>1305661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium fluoride</to_name>
		<to_code>9873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saposhnikovia divaricata root extract</to_name>
		<to_code>1305761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syrian hamster hair extract</to_name>
		<to_code>1594965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salcaprozate sodium</to_name>
		<to_code>2200637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium oxide</to_name>
		<to_code>1366982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sedum acre extract</to_name>
		<to_code>1330091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemona japonica root extract</to_name>
		<to_code>2632730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna occidentalis extract</to_name>
		<to_code>1441658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate,monobasic,monohydrate</to_name>
		<to_code>221125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, dibasic, anhydrous</to_name>
		<to_code>314838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Silene laciniata whole extract</to_name>
		<to_code>2533913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmeterol</to_name>
		<to_code>36117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous iodide</to_name>
		<to_code>1720256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cyclamate</to_name>
		<to_code>56467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan distearate</to_name>
		<to_code>2637172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hyaluronate</to_name>
		<to_code>42892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium caprylate</to_name>
		<to_code>1311123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucroferric oxyhydroxide</to_name>
		<to_code>1484283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safinamide mesylate</to_name>
		<to_code>1922449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-10</to_name>
		<to_code>1367147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sec-laureth-9</to_name>
		<to_code>2268074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa conjunctiva preparation</to_name>
		<to_code>1311320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamethazine sodium</to_name>
		<to_code>1364374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stevioside</to_name>
		<to_code>37106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pyrrolidone carboxylate</to_name>
		<to_code>1364924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium myristoyl isethionate</to_name>
		<to_code>1364904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium 2,5-dimethylbenzene-1-sulfonate</to_name>
		<to_code>1366944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sparganium stoloniferum root extract</to_name>
		<to_code>1546865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa pancreas preparation</to_name>
		<to_code>1311337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa rectal mucosa preparation</to_name>
		<to_code>1804846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salmonella typhi Ty21a live antigen</to_name>
		<to_code>762595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scomberomorus cavalla extract</to_name>
		<to_code>1310281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Santalum album seed extract</to_name>
		<to_code>1314224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cocoate</to_name>
		<to_code>1366928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silica dimethyl silylate</to_name>
		<to_code>1426646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium iodate</to_name>
		<to_code>1422194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium iodide I131</to_name>
		<to_code>91535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salicornia depressa whole extract</to_name>
		<to_code>2001177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium borate</to_name>
		<to_code>36680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syringa vulgaris pollen extract</to_name>
		<to_code>2634236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium nitroprusside</to_name>
		<to_code>9895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulconazole nitrate</to_name>
		<to_code>56798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sempervivum tectorum leaf extract</to_name>
		<to_code>1310112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hypophosphite</to_name>
		<to_code>1311313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic wax (1200 MW)</to_name>
		<to_code>1426425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame seed allergenic extract</to_name>
		<to_code>901199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5)</to_name>
		<to_code>2664725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spectinomycin sulfate tetrahydrate</to_name>
		<to_code>1306069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl trisiloxane</to_name>
		<to_code>2268036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serine, D-</to_name>
		<to_code>1742747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium jambos fruit rind extract</to_name>
		<to_code>2463730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix alba bark extract</to_name>
		<to_code>1307749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium estrone sulfate</to_name>
		<to_code>91428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spongilla lacustris extract</to_name>
		<to_code>1330088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenite</to_name>
		<to_code>9640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium gluconate</to_name>
		<to_code>56476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenious acid</to_name>
		<to_code>36344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hydroxide</to_name>
		<to_code>9880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siraitia grosvenorii whole extract</to_name>
		<to_code>2593688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Simmondsia chinensis seed wax extract</to_name>
		<to_code>1307760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-sulfolaurate</to_name>
		<to_code>1370581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl sulfoacetate</to_name>
		<to_code>314832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous 2-ethylhexanoate</to_name>
		<to_code>1314274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spelt seed extract</to_name>
		<to_code>1656419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen</to_name>
		<to_code>854966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver nitrite</to_name>
		<to_code>2267702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum lycopersicum extract</to_name>
		<to_code>1368361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>siltuximab</to_name>
		<to_code>1535218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous chloride dihydrate</to_name>
		<to_code>2462150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium glycerophosphate anhydrous</to_name>
		<to_code>1423802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sciadopitys verticillata root extract</to_name>
		<to_code>1592261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic conjugated estrogens, B</to_name>
		<to_code>618365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syringa vulgaris whole extract</to_name>
		<to_code>1314226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sour cherry seed oil</to_name>
		<to_code>1992671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium carbonate</to_name>
		<to_code>36685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum dulcamara whole extract</to_name>
		<to_code>1995250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl methyl taurate</to_name>
		<to_code>2479046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dodecyl sulfate</to_name>
		<to_code>9871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevoflurane</to_name>
		<to_code>36453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spanish chestnut extract</to_name>
		<to_code>1372260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotalol hydrochloride</to_name>
		<to_code>7008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen</to_name>
		<to_code>854960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin sodium</to_name>
		<to_code>281678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stearyl fumarate</to_name>
		<to_code>1364936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemona tuberosa root extract</to_name>
		<to_code>1606212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweetleaf preparation</to_name>
		<to_code>283740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin calcium</to_name>
		<to_code>1362912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa hip joint preparation</to_name>
		<to_code>1311250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium alginate</to_name>
		<to_code>56446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin sodium dihydrate</to_name>
		<to_code>1305723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium taurate</to_name>
		<to_code>1431305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serum albumin, bovine</to_name>
		<to_code>1426381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen</to_name>
		<to_code>854948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silodosin</to_name>
		<to_code>720825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarecycline</to_name>
		<to_code>2059018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>swordfish allergenic extract</to_name>
		<to_code>901283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum virginianum whole extract</to_name>
		<to_code>2592979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfachrysoidine sodium</to_name>
		<to_code>236833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sabinene</to_name>
		<to_code>2557219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium P-chloro-m-cresol</to_name>
		<to_code>1313197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver phosphate</to_name>
		<to_code>1665220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spongia tosta</to_name>
		<to_code>236133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silanamine</to_name>
		<to_code>1872906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secretin</to_name>
		<to_code>9627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saxagliptin</to_name>
		<to_code>857974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen</to_name>
		<to_code>854970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smallanthus sonchifolius whole extract</to_name>
		<to_code>2387077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silane</to_name>
		<to_code>2668415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate dihydrate</to_name>
		<to_code>314837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samarium oxide</to_name>
		<to_code>1311105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium palmitoyl sarcosinate</to_name>
		<to_code>1726120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbeth-12</to_name>
		<to_code>2534447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dodecylbenzenesulfonate</to_name>
		<to_code>1366931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Selenicereus grandiflorus stem extract</to_name>
		<to_code>1309694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacituzumab govitecan</to_name>
		<to_code>2360232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl glutamate</to_name>
		<to_code>1364850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>subtilisin</to_name>
		<to_code>1997449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stachys officinalis flower top extract</to_name>
		<to_code>1856257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705</to_name>
		<to_code>2688626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfide nonahydrate</to_name>
		<to_code>1364569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saponaria officinalis whole extract</to_name>
		<to_code>1313686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate type B corn</to_name>
		<to_code>2604035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salsolinol hydrochloride, (+/-)-</to_name>
		<to_code>2198978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax glabra whole extract</to_name>
		<to_code>2626495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame extract</to_name>
		<to_code>1358860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus dysgalactiae</to_name>
		<to_code>1491866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salsolinol hydrochloride</to_name>
		<to_code>1312374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotatercept-csrk</to_name>
		<to_code>2678931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen</to_name>
		<to_code>854942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C14-18 olefin sulfonate</to_name>
		<to_code>2123366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfite</to_name>
		<to_code>36723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pyogenes</to_name>
		<to_code>1311281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sturgeon, unspecified preparation</to_name>
		<to_code>2645123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanicula europaea extract</to_name>
		<to_code>1311101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dithionite</to_name>
		<to_code>2056673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syrian hamster skin extract</to_name>
		<to_code>852663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phenolsulfonate</to_name>
		<to_code>237124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lactate, L-</to_name>
		<to_code>2631575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulbenicillin</to_name>
		<to_code>10168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium iothalamate</to_name>
		<to_code>9886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Staphylococcus epidermidis</to_name>
		<to_code>1489915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch</to_name>
		<to_code>1366973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sisymbrium officianale whole extract</to_name>
		<to_code>1314313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium succinate hexahydrate</to_name>
		<to_code>1311369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acexamate</to_name>
		<to_code>236526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfate anhydrous</to_name>
		<to_code>1299926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stinging nettle extract</to_name>
		<to_code>580119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa lymph preparation</to_name>
		<to_code>1311253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium mannuronate methylsilanol</to_name>
		<to_code>1860183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, tribasic, monohydrate</to_name>
		<to_code>1311357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia officinalis leaf extract</to_name>
		<to_code>2697461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatorelin</to_name>
		<to_code>236901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemphylium solani allergenic extract</to_name>
		<to_code>867349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharomyces cerevisiae allergenic extract</to_name>
		<to_code>350141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicin</to_name>
		<to_code>36100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bisulfate</to_name>
		<to_code>1367207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannic oxide</to_name>
		<to_code>1363059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium cumini seed extract</to_name>
		<to_code>1310091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver cyanide</to_name>
		<to_code>1656776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfapyridine</to_name>
		<to_code>10188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfacetamide</to_name>
		<to_code>10169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium behenate</to_name>
		<to_code>2000918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertindole</to_name>
		<to_code>41996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa bone preparation</to_name>
		<to_code>1311274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siberian ginseng root extract</to_name>
		<to_code>259472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bisulfate monohydrate</to_name>
		<to_code>2463932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sargassum fulvellum extract</to_name>
		<to_code>1735047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium nitrite</to_name>
		<to_code>9894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum tuberosum extract</to_name>
		<to_code>1594966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum dulcamara stem extract</to_name>
		<to_code>1310035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl sulfonate</to_name>
		<to_code>2001128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebacate</to_name>
		<to_code>1427069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium jambos seed extract</to_name>
		<to_code>1310154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan dioleate</to_name>
		<to_code>1374406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hydride</to_name>
		<to_code>1483618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stephania tetrandra root extract</to_name>
		<to_code>1547755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somapacitan-beco</to_name>
		<to_code>2557394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin</to_name>
		<to_code>9509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>schorl tourmaline</to_name>
		<to_code>1420979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acryloyldimethyltaurate-acrylamide copolymer (1:1; 90000-150000 MPA.S)</to_name>
		<to_code>1366966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacituzumab</to_name>
		<to_code>2360231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sheanut oil</to_name>
		<to_code>1305658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium Na-22</to_name>
		<to_code>1483727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna leaf extract</to_name>
		<to_code>485853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinic acid</to_name>
		<to_code>37255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cumenesulfonate</to_name>
		<to_code>1366842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate type B</to_name>
		<to_code>2475332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic conjugated estrogens, A</to_name>
		<to_code>253166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa thalamus lateral geniculate nucleus preparation</to_name>
		<to_code>1311223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum nigrum whole extract</to_name>
		<to_code>1358893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemona sessilifolia root extract</to_name>
		<to_code>1535497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Shigella dysenteriae</to_name>
		<to_code>1316076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Serenoa preparation</to_name>
		<to_code>350488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylcholine iodide</to_name>
		<to_code>262295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saw palmetto fruit extract</to_name>
		<to_code>477189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium oxybate</to_name>
		<to_code>9899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk, base hydrolyzed (1000 MW)</to_name>
		<to_code>1426900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sinapis alba whole extract</to_name>
		<to_code>2180256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>superoxide dismutase (Mn) Saccharomyces cerevisiae</to_name>
		<to_code>2268034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum nigrum top extract</to_name>
		<to_code>1310217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos wallichiana bark extract</to_name>
		<to_code>1309949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium isostearoyl lactylate</to_name>
		<to_code>1364897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfur</to_name>
		<to_code>10223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sibeprenlimab-szsi</to_name>
		<to_code>2728394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>satraplatin</to_name>
		<to_code>1733681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pyruvate</to_name>
		<to_code>1358847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearic acid</to_name>
		<to_code>1310551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen</to_name>
		<to_code>854964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stibogluconate</to_name>
		<to_code>8010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sumatriptan succinate</to_name>
		<to_code>67158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sapindus saponaria fruit extract</to_name>
		<to_code>2588213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearalkonium</to_name>
		<to_code>1370578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium formaldehyde sulfoxylate dihydrate</to_name>
		<to_code>1592294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoxytrimethylsilane</to_name>
		<to_code>1367149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>slippery elm bark</to_name>
		<to_code>259434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicon</to_name>
		<to_code>9774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium benzenesulfonate</to_name>
		<to_code>1313277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shellac</to_name>
		<to_code>1368898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfobetaine</to_name>
		<to_code>1539813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lactate</to_name>
		<to_code>56489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen</to_name>
		<to_code>854968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spiny pigweed pollen extract</to_name>
		<to_code>895919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tallowate, beef</to_name>
		<to_code>1364938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>seractide</to_name>
		<to_code>1999800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>smooth brome pollen extract</to_name>
		<to_code>852217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra whole extract</to_name>
		<to_code>1363730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sincalide</to_name>
		<to_code>9800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>seractide acetate</to_name>
		<to_code>1999801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saralasin acetate</to_name>
		<to_code>7830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate</to_name>
		<to_code>1366851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesamin</to_name>
		<to_code>2593413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scrophularia nodosa root extract</to_name>
		<to_code>1373161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax officinalis whole extract</to_name>
		<to_code>2593902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower oil unsaponifiables</to_name>
		<to_code>2637413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearate</to_name>
		<to_code>1368706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sinecatechins</to_name>
		<to_code>753346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scopolia carniolica whole extract</to_name>
		<to_code>1594582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium propoxyhydroxypropyl thiosulfate silica</to_name>
		<to_code>1595884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebelipase alfa</to_name>
		<to_code>1726975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa joint capsule preparation</to_name>
		<to_code>1311252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phenyllactate</to_name>
		<to_code>2479569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylated gelatin</to_name>
		<to_code>56790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solifenacin succinate</to_name>
		<to_code>476588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet gum pollen extract</to_name>
		<to_code>852627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silymarin</to_name>
		<to_code>9794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scotch pine pollen extract</to_name>
		<to_code>900764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>82 strontium</to_name>
		<to_code>90611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salinomycin sodium</to_name>
		<to_code>1812261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Santalum spicatum oil</to_name>
		<to_code>1305660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium isostearate</to_name>
		<to_code>2592629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna alata whole extract</to_name>
		<to_code>1420981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan monocaprylate</to_name>
		<to_code>2050751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicon dioxide, colloidal</to_name>
		<to_code>314826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dilauramidoglutamide lysine</to_name>
		<to_code>2559703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strychnine sulfate</to_name>
		<to_code>236074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-COV-2 (COVID-19) vaccine, vector non-replicating</to_name>
		<to_code>2479831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spermine</to_name>
		<to_code>1483263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salinomycin</to_name>
		<to_code>1311566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl 1-methyl isethionate</to_name>
		<to_code>1370732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotrovimab</to_name>
		<to_code>2550731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia lavandulifolia leaf oil</to_name>
		<to_code>2469238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Serratia marcescens</to_name>
		<to_code>1426634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia sclarea seed oil</to_name>
		<to_code>1425356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scopolamine</to_name>
		<to_code>9601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower oil</to_name>
		<to_code>9515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chondroitin sulfate (porcine; 5500 MW)</to_name>
		<to_code>1314213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>surinamine</to_name>
		<to_code>2606067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dibunate</to_name>
		<to_code>235860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium thiosalicylate</to_name>
		<to_code>91100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saxagliptin anhydrous</to_name>
		<to_code>1546030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage leaf allergenic extract</to_name>
		<to_code>1011627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shea butter</to_name>
		<to_code>1310571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Shorea robusta resin</to_name>
		<to_code>2613760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ileum preparation</to_name>
		<to_code>1311229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamerazine</to_name>
		<to_code>10176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen</to_name>
		<to_code>854938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sequoiadendron giganteum whole extract</to_name>
		<to_code>2055746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>styrene</to_name>
		<to_code>1362878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa pineal gland preparation</to_name>
		<to_code>1311078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic wax (2900 MW)</to_name>
		<to_code>1872045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium percarbonate</to_name>
		<to_code>1364915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>styrene/ammonium acrylate copolymer (300000 MW)</to_name>
		<to_code>2586353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saquinavir</to_name>
		<to_code>83395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa renal pelvis preparation</to_name>
		<to_code>1311269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tallowate</to_name>
		<to_code>1364939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix alba flower extract</to_name>
		<to_code>1492934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugar beet pollen extract</to_name>
		<to_code>852132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia sclarea whole extract</to_name>
		<to_code>1797518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium c12-14 pareth-3 sulfate</to_name>
		<to_code>2277807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sapanisertib</to_name>
		<to_code>2395271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soursop extract</to_name>
		<to_code>1435098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix alba leaf extract</to_name>
		<to_code>1309459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfametrole</to_name>
		<to_code>37328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa testicle preparation</to_name>
		<to_code>1311349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>squalane</to_name>
		<to_code>1363644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Soy Proteins</to_name>
		<to_code>36853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serdexmethylphenidate chloride</to_name>
		<to_code>2562177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>string bean allergenic extract</to_name>
		<to_code>891676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scrophularia ningpoensis whole extract</to_name>
		<to_code>1490689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorghum extract</to_name>
		<to_code>1338933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus thermophilus</to_name>
		<to_code>2593692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siraitia grosvenorii fruit extract</to_name>
		<to_code>1436960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch</to_name>
		<to_code>10046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stenotaphrum secundatum whole extract</to_name>
		<to_code>2590691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa urinary bladder preparation</to_name>
		<to_code>1311359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>squash allergenic extract</to_name>
		<to_code>975509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean germ extract</to_name>
		<to_code>1370779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa gallbladder preparation</to_name>
		<to_code>1311234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-4 phosphate</to_name>
		<to_code>1592264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sennoside A&amp;B, calcium salt</to_name>
		<to_code>267741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucralfate malate</to_name>
		<to_code>1487143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saussurea involucrata flowering top extract</to_name>
		<to_code>2001182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium gentisate</to_name>
		<to_code>2053265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selank</to_name>
		<to_code>2049928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate type B potato</to_name>
		<to_code>1364926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicin extract</to_name>
		<to_code>260012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sildenafil citrate</to_name>
		<to_code>221161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus viridans group immunoserum rabbit</to_name>
		<to_code>1367198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>staphylococcus aureus immunoserum</to_name>
		<to_code>1427063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfisomidine</to_name>
		<to_code>10206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samidorphan</to_name>
		<to_code>2559612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sasa kurilensis whole extract</to_name>
		<to_code>2537437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfanilylurea</to_name>
		<to_code>37333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago virgaurea pollen extract</to_name>
		<to_code>1309242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium cumini fruit extract</to_name>
		<to_code>1811016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix alba flowering top extract</to_name>
		<to_code>1310073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chromate Cr51</to_name>
		<to_code>91510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium selenite</to_name>
		<to_code>56519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium behenoyl lactylate</to_name>
		<to_code>2548235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium 2-naphthalenesulfonate</to_name>
		<to_code>1366946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower seed oil glycereth-8 esters</to_name>
		<to_code>1431715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamerazine sodium</to_name>
		<to_code>1306109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa pituitary gland preparation</to_name>
		<to_code>1311241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver birch pollen allergenic extract</to_name>
		<to_code>1306108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix nigra bark extract</to_name>
		<to_code>1232311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicic acid</to_name>
		<to_code>1311243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearalkonium hectorite</to_name>
		<to_code>1372931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sisomicin</to_name>
		<to_code>9806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucralose</to_name>
		<to_code>1439115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix alba bark volatile oil</to_name>
		<to_code>1305659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chloride dihyrdate</to_name>
		<to_code>2471089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spermidine</to_name>
		<to_code>1483262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>satralizumab-mwge</to_name>
		<to_code>2391551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pantothenate</to_name>
		<to_code>236917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stavudine</to_name>
		<to_code>59763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium jambos leaf extract</to_name>
		<to_code>1307743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sterile water</to_name>
		<to_code>107129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sargentodoxa cuneata whole extract</to_name>
		<to_code>2665343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl stearate</to_name>
		<to_code>1426360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sophora flavescens root extract</to_name>
		<to_code>1307593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium carbonate decahydrate</to_name>
		<to_code>1362143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>S-adenosylmethionine synthase isoform type-2</to_name>
		<to_code>2262277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium perborate monohydrate</to_name>
		<to_code>1991500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevelamer hydrochloride</to_name>
		<to_code>237125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium decylglucoside hydroxypropylsulfonate</to_name>
		<to_code>1539812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfasalazine</to_name>
		<to_code>9524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serdexmethylphenidate</to_name>
		<to_code>2562176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scurrula parasitica top extract</to_name>
		<to_code>2106426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373</to_name>
		<to_code>2606073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean lecithin</to_name>
		<to_code>579598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secnidazole</to_name>
		<to_code>36314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cholate</to_name>
		<to_code>2286239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean preparation</to_name>
		<to_code>287515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenate ion</to_name>
		<to_code>1546366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium borate anhydrous</to_name>
		<to_code>1805706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium</to_name>
		<to_code>9853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium magnesium fluorosilicate</to_name>
		<to_code>1431151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Santalum album seed oil</to_name>
		<to_code>1541711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selpercatinib</to_name>
		<to_code>2370147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium gualenate</to_name>
		<to_code>2667891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simaba cedron seed extract</to_name>
		<to_code>1356130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium aminobenzoate</to_name>
		<to_code>235493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver citrate</to_name>
		<to_code>1306066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sargassum fusiforme extract</to_name>
		<to_code>1435392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose octastearate</to_name>
		<to_code>1543185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium thioglycolate</to_name>
		<to_code>1364940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spearmint extract</to_name>
		<to_code>1372258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose octaacetate</to_name>
		<to_code>37296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearic monoethanolamide</to_name>
		<to_code>1426353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannate</to_name>
		<to_code>1370640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium diacetate</to_name>
		<to_code>1547632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sequoia sempervirens bark extract</to_name>
		<to_code>2534462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sarcomphalus joazeiro bark extract</to_name>
		<to_code>2636109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa umbilical cord preparation</to_name>
		<to_code>1311355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauraminopropionate</to_name>
		<to_code>1603856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium benzotriazolyl butylphenol sulfonate</to_name>
		<to_code>1358699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Simmondsia chinensis whole extract</to_name>
		<to_code>1369689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spinacia oleracea root extract</to_name>
		<to_code>1593610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver cation</to_name>
		<to_code>1358876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium cation</to_name>
		<to_code>1546278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous cation</to_name>
		<to_code>1314283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl acrylate polymer (110000 MW)</to_name>
		<to_code>2472776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solvent brown 1</to_name>
		<to_code>2003383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium thiosulfate anhydrous</to_name>
		<to_code>1807514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen</to_name>
		<to_code>854930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium xylenesulfonate</to_name>
		<to_code>1364398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia miltiorrhiza root extract</to_name>
		<to_code>1307580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sorbus domestica whole extract</to_name>
		<to_code>2055743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfurous acid</to_name>
		<to_code>2266498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan tristearate</to_name>
		<to_code>1426397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solvent red 4</to_name>
		<to_code>1597292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secukinumab</to_name>
		<to_code>1599788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scandium chloride</to_name>
		<to_code>1921562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch, tapioca</to_name>
		<to_code>2619252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secretin acetate</to_name>
		<to_code>408108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfachlorpyridazine sodium</to_name>
		<to_code>2476009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scutellaria baicalensis whole extract</to_name>
		<to_code>1658441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenium sulfide</to_name>
		<to_code>36345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succimer</to_name>
		<to_code>3446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scabies lesion lysate (human)</to_name>
		<to_code>1427216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silica, trimethylsilyl capped</to_name>
		<to_code>1790287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Semecarpus anacardium fruit extract</to_name>
		<to_code>1424267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273</to_name>
		<to_code>2470232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia microphylla whole extract</to_name>
		<to_code>2593414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sudan red</to_name>
		<to_code>1648696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl sarcosinate</to_name>
		<to_code>1364901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan monostearate</to_name>
		<to_code>1363057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sea snail preparation</to_name>
		<to_code>1546397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Staphylococcus simulans</to_name>
		<to_code>1489917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>snow crab allergenic extract</to_name>
		<to_code>2167805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago canadensis whole extract</to_name>
		<to_code>1313689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium metasilicate</to_name>
		<to_code>1733690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfuryl fluoride</to_name>
		<to_code>2289224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguisorba officinalis top extract</to_name>
		<to_code>1368868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein</to_name>
		<to_code>2468231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax ornata root extract</to_name>
		<to_code>1924218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scallop allergenic extract</to_name>
		<to_code>899916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sedum acre whole extract</to_name>
		<to_code>2591817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna pod</to_name>
		<to_code>2166041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium taurine laurate</to_name>
		<to_code>2399553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sandbur ragweed pollen extract</to_name>
		<to_code>851955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spectinomycin</to_name>
		<to_code>270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan olivate</to_name>
		<to_code>1309248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-10 phosphate</to_name>
		<to_code>1927958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sericin 1</to_name>
		<to_code>1607312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamine</to_name>
		<to_code>1313977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sage extract</to_name>
		<to_code>1354504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spongia officinalis skeleton extract</to_name>
		<to_code>1311066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern bayberry pollen extract</to_name>
		<to_code>867260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium zirconium cyclosilicate</to_name>
		<to_code>2047628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sandalore</to_name>
		<to_code>2373965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-15</to_name>
		<to_code>1367148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptodornase</to_name>
		<to_code>10104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cetostearyl sulfate</to_name>
		<to_code>1364945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium salicylate</to_name>
		<to_code>2045402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sultopride</to_name>
		<to_code>37416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>snowball sand verbena whole extract</to_name>
		<to_code>1737112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sobrerol</to_name>
		<to_code>36669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strychnine</to_name>
		<to_code>66422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern ragweed pollen extract</to_name>
		<to_code>885750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saiga tatarica horn extract</to_name>
		<to_code>2589610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium morrhuate</to_name>
		<to_code>9892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa uterus preparation</to_name>
		<to_code>1311360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scopine</to_name>
		<to_code>2691113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamethoxazole</to_name>
		<to_code>10180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sardine allergenic extract</to_name>
		<to_code>974129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose monolaurate</to_name>
		<to_code>1363647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa capillary tissue preparation</to_name>
		<to_code>1311315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Suaeda maritima flowering top extract</to_name>
		<to_code>2590692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium</to_name>
		<to_code>10122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitol, L-</to_name>
		<to_code>1742749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotalol</to_name>
		<to_code>9947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium luehmannii fruit extract</to_name>
		<to_code>2621385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sisomicin sulfate</to_name>
		<to_code>9807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, dibasic, dodecahydrate</to_name>
		<to_code>1311326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower oil</to_name>
		<to_code>37422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soyethyl morpholinium ethosulfate</to_name>
		<to_code>1433497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Simmondsia chinesis seed extract</to_name>
		<to_code>1309470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium taurodeoxycholate</to_name>
		<to_code>1364852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmeterol xinafoate</to_name>
		<to_code>72616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stanozolol</to_name>
		<to_code>10032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hexafluorosilicate</to_name>
		<to_code>1862868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus canadensis flower extract</to_name>
		<to_code>1376215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selumetinib sulfate</to_name>
		<to_code>2361596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cocoamphoacetate</to_name>
		<to_code>1426829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601</to_name>
		<to_code>2666309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sapropterin dihydrochloride</to_name>
		<to_code>753341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl myristate</to_name>
		<to_code>1314286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samarium</to_name>
		<to_code>9549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C8-10 alkyl sulfate</to_name>
		<to_code>1997000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum lycocarpum fruit extract</to_name>
		<to_code>2619424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spinach extract</to_name>
		<to_code>2099276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfooleate</to_name>
		<to_code>1426701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salt cedar pollen extract</to_name>
		<to_code>852806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C12-15 pareth-3 sulfate</to_name>
		<to_code>1364516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>S-adenosylmethionine</to_name>
		<to_code>9504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicon disulfide</to_name>
		<to_code>1805283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shikimic acid</to_name>
		<to_code>2059172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium perborate</to_name>
		<to_code>36702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stephania tetrandra whole extract</to_name>
		<to_code>2359270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sparfloxacin</to_name>
		<to_code>18469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Staphylococcus aureus</to_name>
		<to_code>1311275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bentonite</to_name>
		<to_code>1366970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfadimethoxine sodium</to_name>
		<to_code>1306121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cation</to_name>
		<to_code>1364429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sarracenia purpurea preparation</to_name>
		<to_code>349948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinus molle fruit oil</to_name>
		<to_code>1600748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa red blood cell preparation</to_name>
		<to_code>1311255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saposhinikovia divaricata whole extract</to_name>
		<to_code>1998444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>standardized senna concentrate</to_name>
		<to_code>221166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Speranskia tuberculata whole extract</to_name>
		<to_code>2375030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ureter preparation</to_name>
		<to_code>1311356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin sodium monohydrate</to_name>
		<to_code>1670026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hydrolyzed potato starch dodecenylsuccinate</to_name>
		<to_code>2688020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shiitake mushroom preparation</to_name>
		<to_code>1362688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scrophularia ningpoensis root extract</to_name>
		<to_code>1420980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pidolate</to_name>
		<to_code>1364917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium glycinate</to_name>
		<to_code>541439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sour cherry allergenic extract</to_name>
		<to_code>1012134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ethasulfate</to_name>
		<to_code>2287560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon oil</to_name>
		<to_code>41967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2)</to_name>
		<to_code>2691168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sitagliptin phosphate</to_name>
		<to_code>621590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium palmitate</to_name>
		<to_code>1364910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schizochytrium DHA oil</to_name>
		<to_code>1538275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scolopendra subspinipes preparation</to_name>
		<to_code>1869800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stem bromelain</to_name>
		<to_code>2373652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C18 olefin sulfonate</to_name>
		<to_code>1370195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>seladelpar lysine</to_name>
		<to_code>2690868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium myreth sulfate</to_name>
		<to_code>2374347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,4-sorbitan</to_name>
		<to_code>1307571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous oxide</to_name>
		<to_code>1367135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suxamethonium bromide</to_name>
		<to_code>121039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylcholine chloride</to_name>
		<to_code>3565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>styrene/isoprene/styrene block copolymer (styrene/isoprene 15/85)</to_name>
		<to_code>2383939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfaethidole</to_name>
		<to_code>37324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago canadensis flowering top extract</to_name>
		<to_code>1309928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sapindus mukorossi fruit rind extract</to_name>
		<to_code>1356492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-12</to_name>
		<to_code>1551627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfadiazine</to_name>
		<to_code>10171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicyloyl phytosphingosine</to_name>
		<to_code>1484765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa esophagus preparation</to_name>
		<to_code>1311328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cocoyl isethionate</to_name>
		<to_code>1366839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hydrogen sulfite</to_name>
		<to_code>1366858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium myristate</to_name>
		<to_code>1744165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-21</to_name>
		<to_code>1367122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen</to_name>
		<to_code>854950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarsaparilla preparation</to_name>
		<to_code>236368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smallanthus sonchifolius root juice</to_name>
		<to_code>2623643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scleranthus annuus whole extract</to_name>
		<to_code>1799141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous chloride,anhydrous</to_name>
		<to_code>314853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarcosine</to_name>
		<to_code>1362906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sanguinarine nitrate</to_name>
		<to_code>1537754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sandalwood oil</to_name>
		<to_code>1309224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sinomenium acutum stem extract</to_name>
		<to_code>2055268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solriamfetol</to_name>
		<to_code>2121751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch glycolate</to_name>
		<to_code>1370637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sumatriptan</to_name>
		<to_code>37418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scutellaria baicalensis root extract</to_name>
		<to_code>1307750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugarcane extract</to_name>
		<to_code>1358491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharomyces lysate extract</to_name>
		<to_code>1426343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver sulfadiazine</to_name>
		<to_code>9793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sofpironium</to_name>
		<to_code>2689322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simeprevir sodium</to_name>
		<to_code>1484518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfabenzamide</to_name>
		<to_code>37320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa stomach preparation</to_name>
		<to_code>1311242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulbactam pivoxyl</to_name>
		<to_code>166010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium oleyl sulfate</to_name>
		<to_code>2621830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatrem</to_name>
		<to_code>56570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium molybdate dihydrate</to_name>
		<to_code>1423799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium 1-naphthalenesulfonate</to_name>
		<to_code>1442717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan monolaurate</to_name>
		<to_code>1363055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose</to_name>
		<to_code>10159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna alexandrina seed extract</to_name>
		<to_code>1310029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sydney golden wattle pollen extract</to_name>
		<to_code>895365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenocysteine</to_name>
		<to_code>1549332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower lecithin</to_name>
		<to_code>1487532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>styrene/isoprene/styrene block copolymer</to_name>
		<to_code>2385109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen</to_name>
		<to_code>854940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simetone</to_name>
		<to_code>1658655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearalkonium chloride</to_name>
		<to_code>1310555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solriamfetol hydrochloride</to_name>
		<to_code>2121750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa intestinal mucosa preparation</to_name>
		<to_code>2285325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samarium Sm153</to_name>
		<to_code>196342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>squill extract</to_name>
		<to_code>91613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver chloride</to_name>
		<to_code>1314846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sesamum indicum whole extract</to_name>
		<to_code>1541721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methylesculetin acetate</to_name>
		<to_code>1426627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serotonin</to_name>
		<to_code>1311214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulbactam sodium</to_name>
		<to_code>82100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silanediol salicylate</to_name>
		<to_code>1356706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scutellaria galericulata leaf extract</to_name>
		<to_code>1651696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugammadex</to_name>
		<to_code>1726988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saponaria officinalis leaf extract</to_name>
		<to_code>1488816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>semaglutide</to_name>
		<to_code>1991302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serine</to_name>
		<to_code>9671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium iodide</to_name>
		<to_code>9884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver sulfide</to_name>
		<to_code>1549110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sparassis crispa whole extract</to_name>
		<to_code>2001618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hydroxymethylglycinate</to_name>
		<to_code>1367223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium nitrate 15N</to_name>
		<to_code>2393524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon allergenic extract</to_name>
		<to_code>892584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schizonepeta tenuifolia whole extract</to_name>
		<to_code>1489550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sibutramine hydrochloride monohydrate</to_name>
		<to_code>221160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium copper chlorophyllin</to_name>
		<to_code>1366841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spike lavender oil</to_name>
		<to_code>237023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertraline</to_name>
		<to_code>36437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl acetate</to_name>
		<to_code>2200070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scrophularia nodosa leaf and stem extract</to_name>
		<to_code>1796924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sparsentan</to_name>
		<to_code>2630535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium molybdate(VI)</to_name>
		<to_code>36699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>snail preparation</to_name>
		<to_code>1368534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stypocaulon scoparium preparation</to_name>
		<to_code>1426635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salsalate</to_name>
		<to_code>36108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ferric gluconate complex</to_name>
		<to_code>261435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium nitrate</to_name>
		<to_code>1356142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower seed allergenic extract</to_name>
		<to_code>901203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic beeswax</to_name>
		<to_code>2462009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen</to_name>
		<to_code>854958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solanine</to_name>
		<to_code>1745416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfadoxine</to_name>
		<to_code>10173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acetate trihydrate</to_name>
		<to_code>237108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulpiride</to_name>
		<to_code>10239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selegiline</to_name>
		<to_code>9639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stearoamphoacetate</to_name>
		<to_code>1424268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa bronchus preparation</to_name>
		<to_code>1311322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunitinib</to_name>
		<to_code>357977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sisal fiber allergenic extract</to_name>
		<to_code>851882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfadiazine sodium</to_name>
		<to_code>220087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous tartrate</to_name>
		<to_code>56701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Selenicereus grandiflorus flower extract</to_name>
		<to_code>1307597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sorghum bicolor stem juice</to_name>
		<to_code>1309939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samarium Sm 153 lexidronam</to_name>
		<to_code>177906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk allergenic extract</to_name>
		<to_code>314455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>snow pea extract</to_name>
		<to_code>1372262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulbutiamine</to_name>
		<to_code>37317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scutellaria lateriflora top extract</to_name>
		<to_code>1311681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>S-adenosyl-L-methionine disulfate tosylate</to_name>
		<to_code>2552301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cetyl sulfate</to_name>
		<to_code>1366919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa blood preparation</to_name>
		<to_code>1311272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfur hexafluoride</to_name>
		<to_code>1599276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>styrene-acrylamide copolymer (MW 500000)</to_name>
		<to_code>1598330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinate</to_name>
		<to_code>1307106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-8 sulfate</to_name>
		<to_code>2175990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ursolate</to_name>
		<to_code>1366935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sapindus mukorossi whole extract</to_name>
		<to_code>2048121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samidorphan malate</to_name>
		<to_code>2559613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium palm kernelate</to_name>
		<to_code>1364906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulopenem etzadroxil</to_name>
		<to_code>2717834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguinaria canadensis extract</to_name>
		<to_code>1311079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium-89</to_name>
		<to_code>81638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sphinganine</to_name>
		<to_code>1947371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos nux-vomica seed extract</to_name>
		<to_code>1309678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senecio scandens flowering top extract</to_name>
		<to_code>2360032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatropin</to_name>
		<to_code>61148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stephania sinica whole extract</to_name>
		<to_code>2541939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SD alcohol 40 (20% w/w)</to_name>
		<to_code>1305764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium propionate anhydrous</to_name>
		<to_code>1432980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenium chloride</to_name>
		<to_code>2200142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>standardized enzyme lactase</to_name>
		<to_code>221165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarecycline hydrochloride</to_name>
		<to_code>2059038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sauromatum giganteum root extract</to_name>
		<to_code>2697971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methyl stearoyl taurate</to_name>
		<to_code>1356768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bicarbonate</to_name>
		<to_code>36676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ankle joint preparation</to_name>
		<to_code>1311247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic camphor</to_name>
		<to_code>1371994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>smallpox vaccine live vaccinia virus</to_name>
		<to_code>833079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>star anise oil</to_name>
		<to_code>1305656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean allergenic extract</to_name>
		<to_code>891668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl glycol carboxylate</to_name>
		<to_code>1423793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia officinalis root extract</to_name>
		<to_code>1487140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saraca indica bark extract</to_name>
		<to_code>1862313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dihydroxycetyl phosphate</to_name>
		<to_code>1366980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertraline hydrochloride</to_name>
		<to_code>155137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spongia officinalis preparation</to_name>
		<to_code>1311109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stevia rebaudiana whole extract</to_name>
		<to_code>1313685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoyl lactylate</to_name>
		<to_code>1370671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methyl cocoyl taurate</to_name>
		<to_code>1364524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sutimlimab</to_name>
		<to_code>2591404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl sulfosuccinate</to_name>
		<to_code>2634298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen</to_name>
		<to_code>854962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spiranthes spiralis root extract</to_name>
		<to_code>1997455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacubitril</to_name>
		<to_code>1656328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Styrax tonkinensis resin</to_name>
		<to_code>1990419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soybean seed oil</to_name>
		<to_code>1309980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate type A</to_name>
		<to_code>2360540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfurated lime</to_name>
		<to_code>235569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus salivarius</to_name>
		<to_code>2393605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa thymus preparation</to_name>
		<to_code>1311263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solfenacin</to_name>
		<to_code>477364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saltbush pollen extract</to_name>
		<to_code>897316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame oil</to_name>
		<to_code>1309247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylsulfathiazole</to_name>
		<to_code>37289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sargramostim</to_name>
		<to_code>69634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower seed extract</to_name>
		<to_code>1309391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa fallopian tube preparation</to_name>
		<to_code>1488225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium folate</to_name>
		<to_code>1300473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>superoxide dismutase (Cu-Zn) Saccharomyces cerevisiae</to_name>
		<to_code>1597890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symplocarpus foetidus root extract</to_name>
		<to_code>1309983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pyrophosphate</to_name>
		<to_code>1364532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamide amp</to_name>
		<to_code>1368215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern flounder allergenic extract</to_name>
		<to_code>2103223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sudan grass pollen extract</to_name>
		<to_code>1098455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa artery preparation</to_name>
		<to_code>1311207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Selaginella tamariscina extract</to_name>
		<to_code>1314318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ventricle preparation</to_name>
		<to_code>1488823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguisorba officinalis whole extract</to_name>
		<to_code>1442705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, dibasic, monohydrate</to_name>
		<to_code>1311342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus agalactiae</to_name>
		<to_code>1363918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sapindus mukorossi fruit extract</to_name>
		<to_code>1311674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower seed extract</to_name>
		<to_code>1440241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfur iodide</to_name>
		<to_code>1311379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium succinate anhydrous</to_name>
		<to_code>1307107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>surfactant protein-D homotrimer, recombinant fragment human</to_name>
		<to_code>2471087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Simaba cedron whole extract</to_name>
		<to_code>2591818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scoparia dulcis leaf extract</to_name>
		<to_code>2632265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scopolamine hydrobromide</to_name>
		<to_code>9603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saussurea involucrata whole extract</to_name>
		<to_code>1875366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebacic acid</to_name>
		<to_code>1427068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-sulfopalmitate</to_name>
		<to_code>1486522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa large intestine preparation</to_name>
		<to_code>1361462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium carbonate preparation</to_name>
		<to_code>1311308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-25</to_name>
		<to_code>2369829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenomethionine Se 75</to_name>
		<to_code>9133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatostatin acetate</to_name>
		<to_code>236092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa mesenchyme preparation</to_name>
		<to_code>1311254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacubitrilat</to_name>
		<to_code>1860608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shark preparation</to_name>
		<to_code>1309513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa bile duct preparation</to_name>
		<to_code>1311226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syncephalastrum racemosum allergenic extract</to_name>
		<to_code>968506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearic diethanolamide</to_name>
		<to_code>1314285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium propionate</to_name>
		<to_code>56513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senecio vulgaris extract</to_name>
		<to_code>1485120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago californica whole extract</to_name>
		<to_code>2177096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shad scale pollen extract</to_name>
		<to_code>852087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose cocoate</to_name>
		<to_code>1370728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium arsenate</to_name>
		<to_code>1364794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos nux-vomica whole extract</to_name>
		<to_code>1599640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sarcandra glabra whole extract</to_name>
		<to_code>2610405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarilumab</to_name>
		<to_code>1923319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacituzumab govitecan-hziy</to_name>
		<to_code>2360530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sassafra albidum root bark extract</to_name>
		<to_code>1428423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sacrosidase</to_name>
		<to_code>214817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen</to_name>
		<to_code>854936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch glycolate type a corn</to_name>
		<to_code>1370595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>snow crab, unspecified preparation</to_name>
		<to_code>1315123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfated castor oil</to_name>
		<to_code>2205488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl/octyldodecyl citrate crosspolymer</to_name>
		<to_code>2257292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sakuranin</to_name>
		<to_code>2383938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saponaria officinalis root extract</to_name>
		<to_code>1309462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saussurea costus root extract</to_name>
		<to_code>1309463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous fluoride</to_name>
		<to_code>10030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharomyces boulardii</to_name>
		<to_code>236782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenomethionine</to_name>
		<to_code>9644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos ignatii seed extract</to_name>
		<to_code>1309692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen</to_name>
		<to_code>854952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strophanthus gratus seed extract</to_name>
		<to_code>1435638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>star anise whole extract</to_name>
		<to_code>1660128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptozocin</to_name>
		<to_code>10114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen</to_name>
		<to_code>854956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-13 carboxylate</to_name>
		<to_code>1372934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium iodide I123</to_name>
		<to_code>91531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose distearate</to_name>
		<to_code>1370303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl lactylate</to_name>
		<to_code>1363427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sigesbeckia orientalis whole extract</to_name>
		<to_code>2461970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sardine, unspecified preparation</to_name>
		<to_code>1427221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa cerebral cortex preparation</to_name>
		<to_code>1311317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stevia eupatoria whole extract</to_name>
		<to_code>2560110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>styramate</to_name>
		<to_code>89818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium castorate</to_name>
		<to_code>2619157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate type a corn</to_name>
		<to_code>1363438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevabertinib</to_name>
		<to_code>2728187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scutellaria alpina flowering top extract</to_name>
		<to_code>1539427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>squalene oil</to_name>
		<to_code>253201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin N-(2-acetic acid ethyl ester)</to_name>
		<to_code>1595299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-2 phosphate</to_name>
		<to_code>2549197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sirolimus</to_name>
		<to_code>35302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symphytum officinale whole extract</to_name>
		<to_code>1492439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptococcus pneumoniae immunoserum rabbit</to_name>
		<to_code>1367194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>star anise fruit extract</to_name>
		<to_code>1311682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum dulcamara top extract</to_name>
		<to_code>1331702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium safflowerate</to_name>
		<to_code>2619158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemphylium sarciniforme allergenic extract</to_name>
		<to_code>968130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet violet leaf oil</to_name>
		<to_code>2371688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sorbus aucuparia fruit extract</to_name>
		<to_code>1367305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatropin, E-coli derived</to_name>
		<to_code>259321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dihydrogen phosphate dihydrate</to_name>
		<to_code>1311311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver</to_name>
		<to_code>2606543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>segesterone</to_name>
		<to_code>2055978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-COV-2 (COVID-19) vaccine, vector - Ad26</to_name>
		<to_code>2479830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sparassis crispa fruiting body extract</to_name>
		<to_code>2621209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptomycin</to_name>
		<to_code>10109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stachys officinalis extract</to_name>
		<to_code>1442792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sanguinarine</to_name>
		<to_code>1537755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk, enzyme hydrolyzed (1000 MW)</to_name>
		<to_code>1366710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spesolimab</to_name>
		<to_code>2610417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa prostate preparation</to_name>
		<to_code>1311340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium carbonate monohydrate</to_name>
		<to_code>1311298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dehydroacetate</to_name>
		<to_code>1366847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago velutina whole extract</to_name>
		<to_code>2473231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Shigella sonnei</to_name>
		<to_code>1491872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbeth-12 hexaoleate</to_name>
		<to_code>2185791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorafenib</to_name>
		<to_code>495881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa frontal lobe preparation</to_name>
		<to_code>1311249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sedum roseum root extract</to_name>
		<to_code>1307944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium nonoxynol-4 sulfate</to_name>
		<to_code>1869625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sepia officinalis juice</to_name>
		<to_code>1311144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sinapultide</to_name>
		<to_code>1440288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scrub pine pollen extract</to_name>
		<to_code>1013913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Semecarpus anacardium juice</to_name>
		<to_code>1350214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago virgaurea flowering top extract</to_name>
		<to_code>1309763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunvozertinib</to_name>
		<to_code>2719226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet potato allergenic extract</to_name>
		<to_code>901307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate P32</to_name>
		<to_code>91559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna leaves</to_name>
		<to_code>237929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicylamide</to_name>
		<to_code>9518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax aristolochiaefolia root extract</to_name>
		<to_code>1309473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saffron stain</to_name>
		<to_code>1363716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfanilamide</to_name>
		<to_code>10184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl glycyrrhetinate</to_name>
		<to_code>1356147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose dilaurate</to_name>
		<to_code>1745411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatrogon</to_name>
		<to_code>2644503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>southern yellow jacket venom protein</to_name>
		<to_code>1297533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose tetrastearate triacetate</to_name>
		<to_code>1423791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan sesquiisostearate</to_name>
		<to_code>1998445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium chloride</to_name>
		<to_code>37175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfisoxazole</to_name>
		<to_code>10207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methylcamphorate</to_name>
		<to_code>236440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salcaprozate</to_name>
		<to_code>2200638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serrated swimming crab, cooked preparation</to_name>
		<to_code>1315122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acetate</to_name>
		<to_code>56443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotatercept</to_name>
		<to_code>2678930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ear preparation</to_name>
		<to_code>1492941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver acetate</to_name>
		<to_code>137939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ascorbate</to_name>
		<to_code>267366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulthiame</to_name>
		<to_code>10240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Secale cereale whole extract</to_name>
		<to_code>1663403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serotonin hydrochloride</to_name>
		<to_code>1356129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sawtooth oak whole extract</to_name>
		<to_code>1995249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous fluoride dihydrate</to_name>
		<to_code>1311371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stevia rebaudiuna leaf extract</to_name>
		<to_code>1307971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinzophyton rautanenii seed oil</to_name>
		<to_code>1735510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>seaweed extract</to_name>
		<to_code>1370783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa bone marrow preparation</to_name>
		<to_code>1311276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sermorelin</to_name>
		<to_code>56188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simvastatin</to_name>
		<to_code>36567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa meniscus preparation</to_name>
		<to_code>1544128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium levulinate</to_name>
		<to_code>1358174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium o-phenylphenate</to_name>
		<to_code>1926056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame seed extract</to_name>
		<to_code>1310046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salsolinol</to_name>
		<to_code>1311309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfated mucopolysaccharides</to_name>
		<to_code>236768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shrimp allergenic extract</to_name>
		<to_code>892592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan isostearate</to_name>
		<to_code>1310513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solvent yellow 29</to_name>
		<to_code>2604572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfisoxazole diolamine</to_name>
		<to_code>10208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa hippocampus preparation</to_name>
		<to_code>1311251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium-89 chloride</to_name>
		<to_code>281890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acrylate/sodium acryloyldimethyltaurate copolymer (4000000 MW)</to_name>
		<to_code>1855662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>((2s,3s,5s)-2-(2-(2,6-dimethylphenoxy)acetamido)-5-((s)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2h)-yl)butanamido)-1,6-diphenylhexan-3-yl) 3-methyl-2-(2-oxotetrahydropyrimidin-1(2h)-yl)butanoate, (s)-</to_name>
		<to_code>1599828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa oral mucosa preparation</to_name>
		<to_code>1311232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium carboxymethyl beta-glucan (DS 0.65-0.85)</to_name>
		<to_code>1600779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phenylacetate</to_name>
		<to_code>56510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saussurea gossipiphora extract</to_name>
		<to_code>1356704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saffron extract</to_name>
		<to_code>1484904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saquinavir mesylate</to_name>
		<to_code>859857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfide</to_name>
		<to_code>1293719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl aspartate</to_name>
		<to_code>1313181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa tendon preparation</to_name>
		<to_code>1311262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia officinalis flowering top extract</to_name>
		<to_code>1370194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa placenta preparation</to_name>
		<to_code>1311338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertaconazole</to_name>
		<to_code>36435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spanish sardine preparation</to_name>
		<to_code>1591914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salicornia europaea extract</to_name>
		<to_code>1372263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spanish thyme oil</to_name>
		<to_code>1310030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soy germ</to_name>
		<to_code>259430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamidopropyl PG-dimonium chloride phosphate</to_name>
		<to_code>1307093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scotch broom pollen extract</to_name>
		<to_code>897499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearalkonium ion</to_name>
		<to_code>2641608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acetyltryptophanate</to_name>
		<to_code>1366816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfite, anhydrous</to_name>
		<to_code>1367221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanicula europaea leaf extract</to_name>
		<to_code>1309781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symphoricarpos albus whole extract</to_name>
		<to_code>2590694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, tribasic, dodecahydrate</to_name>
		<to_code>1311345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>S-methyl methanethiosulfonate</to_name>
		<to_code>2371233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium salicylate</to_name>
		<to_code>9907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shrimp shell chitin</to_name>
		<to_code>1788955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium S-(2-hydroxy-3-(3-(trihydroxysilyl)propoxy)propyl) sulfurothioate</to_name>
		<to_code>2389635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Styphnolobium japonicum flower extract</to_name>
		<to_code>1539193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugar maple pollen extract</to_name>
		<to_code>895385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Santalum paniculatum wood oil</to_name>
		<to_code>2481133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>smallpox vaccine live, New York City Board of Health vaccinia strain</to_name>
		<to_code>798467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sofpironium bromide</to_name>
		<to_code>2689321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen</to_name>
		<to_code>854974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Silybum marianum whole extract</to_name>
		<to_code>2671201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symphytum uplandicum leaf extract</to_name>
		<to_code>1367399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synephrine tartrate</to_name>
		<to_code>236359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sepiapterin</to_name>
		<to_code>2723056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-2 sulfate</to_name>
		<to_code>1364899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum dulcamara flower extract</to_name>
		<to_code>1310051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scotch spearmint oil</to_name>
		<to_code>1603524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa nerve preparation</to_name>
		<to_code>1311245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium nitrate</to_name>
		<to_code>36700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-30</to_name>
		<to_code>1366627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguinaria canadensis root extract</to_name>
		<to_code>670544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus oralis</to_name>
		<to_code>2711539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sedum roseum whole extract</to_name>
		<to_code>1545912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa jejunum preparation</to_name>
		<to_code>1311329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos ignatii preparation</to_name>
		<to_code>285165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sepia extract</to_name>
		<to_code>350376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sermorelin acetate</to_name>
		<to_code>58932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa cerebellum preparation</to_name>
		<to_code>1311316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower extract</to_name>
		<to_code>1309390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schisandra chinensis seed extract</to_name>
		<to_code>2109052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa mammary gland preparation</to_name>
		<to_code>1311332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium beta-sitosteryl sulfate</to_name>
		<to_code>1487926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium oleth sulfate</to_name>
		<to_code>2700068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>semuloparin</to_name>
		<to_code>2368733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa adrenal gland preparation</to_name>
		<to_code>1311235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bromide</to_name>
		<to_code>1311138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sea cucumber extract</to_name>
		<to_code>1735048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl sarcosinate</to_name>
		<to_code>1366863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium oleanolate</to_name>
		<to_code>1366853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sclareolide</to_name>
		<to_code>1426934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium isethionate</to_name>
		<to_code>1364895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl methylaminopropionate</to_name>
		<to_code>2182890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfacetamide sodium</to_name>
		<to_code>82101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium caseinate</to_name>
		<to_code>1366917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl methyl isethionate</to_name>
		<to_code>1487156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium potassium tartrate tetrahydrate</to_name>
		<to_code>1311362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>s typhi (ty-2 strain)</to_name>
		<to_code>221158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa corpus luteum preparation</to_name>
		<to_code>1311321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium 2-acrylamido-2-methyl-1-propane sulfonate/sodium acrylate/n-isopropylacrylamide/trimethyl(3-methacrylamidopropyl)ammonium chloride copolymer</to_name>
		<to_code>2392632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl glucoside</to_name>
		<to_code>1313979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cocoyl glycinate</to_name>
		<to_code>1424460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spectinomycin sulfate</to_name>
		<to_code>2640868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarsaparilla root extract</to_name>
		<to_code>1309670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ferrocyanide decahydrate</to_name>
		<to_code>2570734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ascorbyl phosphate</to_name>
		<to_code>1364501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sea salt</to_name>
		<to_code>1311499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secobarbital</to_name>
		<to_code>9624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ligament preparation</to_name>
		<to_code>1546869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein</to_name>
		<to_code>2606074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfaguanidine</to_name>
		<to_code>10174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra flower oil</to_name>
		<to_code>2053443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower acid</to_name>
		<to_code>2056061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methylenebisnaphthalenesulfonate</to_name>
		<to_code>2634162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharum officinarum whole extract</to_name>
		<to_code>1435103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spirulina</to_name>
		<to_code>487252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa spinal cord preparation</to_name>
		<to_code>1311257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa colon preparation</to_name>
		<to_code>1311268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan monopalmitate</to_name>
		<to_code>1363701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sultilains</to_name>
		<to_code>227410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Styphnolobium japonicum leaf extract</to_name>
		<to_code>1437505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa tooth preparation</to_name>
		<to_code>1311354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa parathyroid gland preparation</to_name>
		<to_code>1311348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet wormwood pollen extract</to_name>
		<to_code>2167819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet marjoram extract</to_name>
		<to_code>1544271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium octyl sulfate</to_name>
		<to_code>1438636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phytate</to_name>
		<to_code>9903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-20</to_name>
		<to_code>1367121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl ethylhexanoate</to_name>
		<to_code>1307083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium metabisulfite</to_name>
		<to_code>36696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acryloyldimethyltaurate</to_name>
		<to_code>1366964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfachrysoidine</to_name>
		<to_code>236832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-12 sulfate</to_name>
		<to_code>1651597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2)</to_name>
		<to_code>2691192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scandium</to_name>
		<to_code>1311273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbic acid</to_name>
		<to_code>1311139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ricinoleate</to_name>
		<to_code>2569468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silandrone</to_name>
		<to_code>2611455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>skim milk</to_name>
		<to_code>1310587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sotorasib</to_name>
		<to_code>2550714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C12-14 olefin sulfonate</to_name>
		<to_code>1366909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smallpox Vaccine</to_name>
		<to_code>9835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sangre de grado</to_name>
		<to_code>260039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix babylonica whole extract</to_name>
		<to_code>1599131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strelitzia nicolai whole extract</to_name>
		<to_code>2603830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sitocalciferol</to_name>
		<to_code>2676752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium polymetaphosphate</to_name>
		<to_code>1364921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strophanthus hispidus whole extract</to_name>
		<to_code>1998615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, tribasic anhydrous</to_name>
		<to_code>1307158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solfenacin succinate</to_name>
		<to_code>477365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>symclosene</to_name>
		<to_code>2375531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium polyacryloyldimethyl taurate</to_name>
		<to_code>2634308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samarium Sm-153 lexidronam pentasodium</to_name>
		<to_code>317675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sapropterin</to_name>
		<to_code>753340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax regelii root extract</to_name>
		<to_code>1340181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium palmitoyl proline</to_name>
		<to_code>1364912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch, rice</to_name>
		<to_code>1367117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strawberry seed oil</to_name>
		<to_code>2359272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfalene</to_name>
		<to_code>10175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stachybotrys chartarum allergenic extract</to_name>
		<to_code>968123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylcholine chloride dihydrate</to_name>
		<to_code>2397714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Santalum spicatum whole extract</to_name>
		<to_code>2059171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-23</to_name>
		<to_code>2046120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siberian elm pollen extract</to_name>
		<to_code>1299981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptomyces griseus allergenic extract</to_name>
		<to_code>1314592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarcosinate</to_name>
		<to_code>1370611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sargassum filipendula extract</to_name>
		<to_code>1426920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schisandra chinensis whole extract</to_name>
		<to_code>2375529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Staphylococcus haemolyticus</to_name>
		<to_code>1489916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stearoyl glutamate</to_name>
		<to_code>1364932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver preparation</to_name>
		<to_code>9785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen</to_name>
		<to_code>854934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon gonadotropin releasing hormone D-Arg6 analog ethyl amide</to_name>
		<to_code>1546435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>S-adenosylmethionine sulfate tosylate</to_name>
		<to_code>9506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, monobasic</to_name>
		<to_code>235496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium cation Sr-89</to_name>
		<to_code>2280602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfadimethoxine</to_name>
		<to_code>10172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spiramycin</to_name>
		<to_code>9991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfobromophthalein</to_name>
		<to_code>10212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strychnine nitrate</to_name>
		<to_code>1310185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago decurrens whole extract</to_name>
		<to_code>2631989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium valproate</to_name>
		<to_code>9919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syringa oblata whole extract</to_name>
		<to_code>2686034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoxypropyltrimonium chloride</to_name>
		<to_code>2630165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen</to_name>
		<to_code>854972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium oxalate</to_name>
		<to_code>1441659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamoxole</to_name>
		<to_code>10183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth sulfate</to_name>
		<to_code>1310569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos ignatii whole extract</to_name>
		<to_code>1663404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra subsp. cerulea fruit extract</to_name>
		<to_code>1744169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet cherry allergenic extract</to_name>
		<to_code>901303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk amino acids</to_name>
		<to_code>1307143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfur dioxide</to_name>
		<to_code>1362879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl dimethicone (400 mpa.s at 50c)</to_name>
		<to_code>2268863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose syrup</to_name>
		<to_code>1305546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Styphnolobium japonicum fruit extract</to_name>
		<to_code>2462661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfonated phenol</to_name>
		<to_code>236718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saralasin</to_name>
		<to_code>9556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan</to_name>
		<to_code>1367146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sevelamer carbonate</to_name>
		<to_code>660890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinylcholine</to_name>
		<to_code>10154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfide ion</to_name>
		<to_code>1368379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>skullcap preparation</to_name>
		<to_code>262263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silybum marianum seed oil</to_name>
		<to_code>1358002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl heptanoate</to_name>
		<to_code>1426355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfur, colloidal</to_name>
		<to_code>221083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bitartrate</to_name>
		<to_code>89900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Securidaca inappendiculata root extract</to_name>
		<to_code>2634554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>smelt allergenic extract</to_name>
		<to_code>889669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharomyces cerevisiae RNA</to_name>
		<to_code>1336135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguisorba officinalis root extract</to_name>
		<to_code>1307954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicyl alcohol</to_name>
		<to_code>1363054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spectinomycin hydrochloride</to_name>
		<to_code>267342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sigesbeckia orientalis flowering top extract</to_name>
		<to_code>2370875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sarracenia purpurea extract</to_name>
		<to_code>1605249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl fumarate</to_name>
		<to_code>2700066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoyl inulin</to_name>
		<to_code>2670452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>slender ragweed pollen extract</to_name>
		<to_code>851990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa diencephalon preparation</to_name>
		<to_code>1311324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium peroxide</to_name>
		<to_code>1366983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium citrate dihydrate</to_name>
		<to_code>221163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa duodenum preparation</to_name>
		<to_code>1311325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>85 strontium</to_name>
		<to_code>90613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium fluoride f-18</to_name>
		<to_code>1311495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia hispanica seed extract</to_name>
		<to_code>1309460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium polyacrylate (2500000 MW)</to_name>
		<to_code>1310536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strawberry allergenic extract</to_name>
		<to_code>892484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa spleen preparation</to_name>
		<to_code>1311344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chlorate</to_name>
		<to_code>1366921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen</to_name>
		<to_code>854954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharina latissima extract</to_name>
		<to_code>1356143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Shorea stepnoptera seed butter extract</to_name>
		<to_code>1664624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulconazole</to_name>
		<to_code>37319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl behenate</to_name>
		<to_code>1313978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic wax (1900 MW)</to_name>
		<to_code>1427207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium citrate</to_name>
		<to_code>56466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Serenoa repens whole extract</to_name>
		<to_code>1799374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra flowering top</to_name>
		<to_code>1307698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa cartilage preparation</to_name>
		<to_code>1311248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium bromate</to_name>
		<to_code>2534448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salsola tragus pollen extract</to_name>
		<to_code>1314927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet cherry seed oil</to_name>
		<to_code>1866226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>semduramicin</to_name>
		<to_code>1314385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl alcohol</to_name>
		<to_code>37071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secobarbital sodium</to_name>
		<to_code>91110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schizonepeta tenuifolia flowering top extract</to_name>
		<to_code>1307639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan monooleate</to_name>
		<to_code>1363056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sildenafil</to_name>
		<to_code>136411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spinach allergenic extract</to_name>
		<to_code>901317</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methyl oleoyl taurate</to_name>
		<to_code>1789472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>surfactant protein-D homotrimer</to_name>
		<to_code>2471088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steviol</to_name>
		<to_code>1363645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose tetraisostearate</to_name>
		<to_code>1356760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl hydroxypropyl sulfonate</to_name>
		<to_code>1663748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium aromaticum fruit extract</to_name>
		<to_code>1544270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa nasal mucosa preparation</to_name>
		<to_code>1311334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strophanthus hispidus seed extract</to_name>
		<to_code>1309684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatrogon-ghla</to_name>
		<to_code>2644513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfosalicylate</to_name>
		<to_code>1370604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus uberis</to_name>
		<to_code>1491864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siberian ginseng root</to_name>
		<to_code>259393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soy protein-iron complex</to_name>
		<to_code>91495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spirulina maxima preparation</to_name>
		<to_code>1427123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selexipag</to_name>
		<to_code>1729002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>superoxide dismutase (Saccharomyces cerevisiae)</to_name>
		<to_code>1804845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax lanceifolia whole extract</to_name>
		<to_code>2631988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-20 methacrylate</to_name>
		<to_code>1541738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus equinus</to_name>
		<to_code>1491865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sirolimus protein-bound</to_name>
		<to_code>2712352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hypophosphite monohydrate</to_name>
		<to_code>1311312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sutimlimab-jome</to_name>
		<to_code>2591415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spearmint oil</to_name>
		<to_code>1305657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acrylate</to_name>
		<to_code>1364499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium linoleate</to_name>
		<to_code>2471869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulopenem</to_name>
		<to_code>2717833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salmonella enterica subsp. enterica serovar typhi</to_name>
		<to_code>1716523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon calcitonin</to_name>
		<to_code>36118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugarcane allergenic extract</to_name>
		<to_code>1014711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spigelia marilandica root extract</to_name>
		<to_code>1320409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver stearate</to_name>
		<to_code>2621547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pyrophosphate decahydrate</to_name>
		<to_code>1944687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamidopropyl propylene glycol-dimonium chloride</to_name>
		<to_code>1808537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sibutramine</to_name>
		<to_code>36514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-3</to_name>
		<to_code>1790091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenium</to_name>
		<to_code>9641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfinpyrazone</to_name>
		<to_code>10205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strychnine phosphate dihydrate</to_name>
		<to_code>1483264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesquicarbonate</to_name>
		<to_code>1370673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syringa vulgaris flower extract</to_name>
		<to_code>1307782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose tristearate</to_name>
		<to_code>1923244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium trideceth sulfate</to_name>
		<to_code>1372935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>smooth sumac pollen extract</to_name>
		<to_code>1098274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa temporal lobe preparation</to_name>
		<to_code>1311347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna alata leaf extract</to_name>
		<to_code>1307824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl isethionate</to_name>
		<to_code>1364520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>star fruit extract</to_name>
		<to_code>1655993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet cherry juice</to_name>
		<to_code>2587644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>symclosene sodium</to_name>
		<to_code>2375530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pertechnetate Tc 99m</to_name>
		<to_code>10349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa Peyer's patch preparation</to_name>
		<to_code>1311199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scrophularia nodosa extract</to_name>
		<to_code>1330090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic yellow iron oxide</to_name>
		<to_code>1305585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spigelia marilandica preparation</to_name>
		<to_code>285164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C12-15 pareth-15 sulfonate</to_name>
		<to_code>1366911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>skatole</to_name>
		<to_code>1311386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SIMETHICONE-CELLULOSE</to_name>
		<to_code>283585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solifenacin</to_name>
		<to_code>322167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shark cartilage extract</to_name>
		<to_code>81782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scoparium</to_name>
		<to_code>237007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somapacitan</to_name>
		<to_code>2557373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicylic acid</to_name>
		<to_code>9525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-7</to_name>
		<to_code>1541739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safinamide</to_name>
		<to_code>1922448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium allylsulfonate</to_name>
		<to_code>2286255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sepia esculenta bone preparation</to_name>
		<to_code>1798446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stellaria media extract</to_name>
		<to_code>1371997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet vernal grass pollen extract</to_name>
		<to_code>851898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium diethyl oxalacetate</to_name>
		<to_code>1364518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simaldrate</to_name>
		<to_code>236730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cocoyl glutamate</to_name>
		<to_code>1366834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>segesterone acetate</to_name>
		<to_code>2055977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saxifraga stolonifera whole extract</to_name>
		<to_code>2709110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium selenate</to_name>
		<to_code>36717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selegiline hydrochloride</to_name>
		<to_code>203137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spinosad</to_name>
		<to_code>299081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl sulfonic acid</to_name>
		<to_code>2001127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl fumarate</to_name>
		<to_code>1370626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stannate</to_name>
		<to_code>1366867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strophanthus kombe whole extract</to_name>
		<to_code>1492171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfathiazole sodium</to_name>
		<to_code>236084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoyl glutamic acid</to_name>
		<to_code>1648782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl phosphate</to_name>
		<to_code>2003334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>summer flounder allergenic extract</to_name>
		<to_code>2588813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver carbonate</to_name>
		<to_code>2462152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium myristoyl sarcosinate</to_name>
		<to_code>1363987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solidago virgaurea whole extract</to_name>
		<to_code>1658430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stigmasterol</to_name>
		<to_code>10079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sipuleucel-T</to_name>
		<to_code>997261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch, wheat</to_name>
		<to_code>1367109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shea butter glycereth-8 esters</to_name>
		<to_code>1992673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1)</to_name>
		<to_code>2722424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silybin</to_name>
		<to_code>155067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salt cedar pollen</to_name>
		<to_code>852083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silanetriol</to_name>
		<to_code>1312740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>santonin</to_name>
		<to_code>1311390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum glaucophyllum whole extract</to_name>
		<to_code>2717827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin sodium anhydrous</to_name>
		<to_code>1362914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium glutamate</to_name>
		<to_code>1311588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbate</to_name>
		<to_code>1311140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan trioleate</to_name>
		<to_code>1363643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sometribove</to_name>
		<to_code>1427014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa limbic system preparation</to_name>
		<to_code>1311244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sparganium stoloniferium whole extract</to_name>
		<to_code>1547469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sepia esculenta whole extract</to_name>
		<to_code>1729512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>staphylococcus aureus immunoserum, rabbit</to_name>
		<to_code>1427062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salsola kali whole extract</to_name>
		<to_code>2590687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium bromide</to_name>
		<to_code>1311631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra seed oil</to_name>
		<to_code>2397121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sofosbuvir</to_name>
		<to_code>1484911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium monofluorophosphate</to_name>
		<to_code>56501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitan sesquioleate</to_name>
		<to_code>1363058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl ethoxysulfate</to_name>
		<to_code>2643470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfaquinoxaline sodium</to_name>
		<to_code>1306110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>serratiopeptidase</to_name>
		<to_code>36434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharate</to_name>
		<to_code>1788997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, dibasic, dihydrate</to_name>
		<to_code>1311323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium octoxynol-2 ethane sulfonate</to_name>
		<to_code>1366971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamethazine</to_name>
		<to_code>10178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium caprylyl sulfonate</to_name>
		<to_code>2565926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium palmitoyl glutamate</to_name>
		<to_code>1313695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safrole</to_name>
		<to_code>2383532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver maple pollen extract</to_name>
		<to_code>851866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soy sterol</to_name>
		<to_code>1363446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium pyroglutamate</to_name>
		<to_code>235455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suberic acid</to_name>
		<to_code>2044370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spesolimab-sbzo</to_name>
		<to_code>2610418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sebetralstat</to_name>
		<to_code>2717944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laurylglucosides hydroxypropylsulfonate</to_name>
		<to_code>2590742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa embryo preparation</to_name>
		<to_code>1311327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroyl glycinate</to_name>
		<to_code>2475180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia officinalis whole extract</to_name>
		<to_code>1442511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa cerebrum preparation</to_name>
		<to_code>1311215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus viridans group</to_name>
		<to_code>1363919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa pylorus preparation</to_name>
		<to_code>1311341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa intervertebral disc preparation</to_name>
		<to_code>1311365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanicula europaea top extract</to_name>
		<to_code>1810566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shortleaf pine pollen extract</to_name>
		<to_code>852709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cocoyl sarcosinate</to_name>
		<to_code>1363989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sitosterols</to_name>
		<to_code>9808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen</to_name>
		<to_code>854932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra subsp. canadensis flowering top extract</to_name>
		<to_code>1309461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa ovary preparation</to_name>
		<to_code>1311336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strychnine phosphate</to_name>
		<to_code>1733682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sepia officinalis whole extract</to_name>
		<to_code>1868205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium cholesteryl sulfate</to_name>
		<to_code>1366923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silodrate, anhydrous</to_name>
		<to_code>2398333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>1363917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>somatostatin</to_name>
		<to_code>9939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stearate</to_name>
		<to_code>1366984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saxifraga granulata whole extract</to_name>
		<to_code>1649351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symphyotrichum oblongifolium whole extract</to_name>
		<to_code>2571072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa vein preparation</to_name>
		<to_code>1311210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schisandra chinensis fruit extract</to_name>
		<to_code>1311675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sophora tetraptera flower extract</to_name>
		<to_code>1435104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ferrocyanide</to_name>
		<to_code>2383541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfide anhydrous</to_name>
		<to_code>2692871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sheep sorrel pollen extract</to_name>
		<to_code>852213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sansevieria trifasciata leaf extract</to_name>
		<to_code>1735046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharin calcium anhydrous</to_name>
		<to_code>1602283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax glabra tuber extract</to_name>
		<to_code>2118528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soy protein isolate</to_name>
		<to_code>196238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salt grass pollen extract</to_name>
		<to_code>852329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium aromaticum whole extract</to_name>
		<to_code>1358892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shagbark hickory pollen extract</to_name>
		<to_code>852221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamidopropyl dimethylamine lactate</to_name>
		<to_code>1739891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acetate, anhydrous</to_name>
		<to_code>267453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamide</to_name>
		<to_code>1607778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chloride</to_name>
		<to_code>9863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugar beet allergenic extract</to_name>
		<to_code>899359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>S-benzoylmercaptoacetyltriglycine</to_name>
		<to_code>194098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bisulfite</to_name>
		<to_code>36679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen</to_name>
		<to_code>854946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sufentanil citrate</to_name>
		<to_code>58964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>shark liver oil</to_name>
		<to_code>91472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suzetrigine</to_name>
		<to_code>2704819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simethicone</to_name>
		<to_code>9796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selamectin</to_name>
		<to_code>1044269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solvent red 27</to_name>
		<to_code>1495079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium starch glycolate Type A potato</to_name>
		<to_code>1366849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-2</to_name>
		<to_code>1426352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saccharide isomerate</to_name>
		<to_code>1314278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suprofen</to_name>
		<to_code>10255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicon dioxide</to_name>
		<to_code>9771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sambucus nigra flower extract</to_name>
		<to_code>1344643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tetradecyl sulfate</to_name>
		<to_code>9913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silk sericin</to_name>
		<to_code>1652102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamethizole</to_name>
		<to_code>10179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sultopride hydrochloride</to_name>
		<to_code>236185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Swertia chirayita whole extract</to_name>
		<to_code>2180545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-100</to_name>
		<to_code>1367131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sheep wool preparation</to_name>
		<to_code>1593854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharomyces cerevisiae</to_name>
		<to_code>9511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium capryloamphopropionate</to_name>
		<to_code>1368619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sorghum bicolor whole extract</to_name>
		<to_code>1370197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>siponimod</to_name>
		<to_code>2121085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salmonella enterica subsp. enterica serovar enteritidis</to_name>
		<to_code>1329877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa adrenal cortex preparation</to_name>
		<to_code>1807130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symphytum tuberosum root extract</to_name>
		<to_code>1310151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5)</to_name>
		<to_code>2664825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium anisate</to_name>
		<to_code>1366968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen</to_name>
		<to_code>854944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sophora flavescens whole extract</to_name>
		<to_code>1442706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strawberry juice</to_name>
		<to_code>1486794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptomycin sulfate</to_name>
		<to_code>10110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phosphate, dibasic</to_name>
		<to_code>236719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinus molle fruiting top extract</to_name>
		<to_code>2266751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium bis(1,3-dimethylbutyl) sulfosuccinate</to_name>
		<to_code>2465233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sophora tonkinensis whole extract</to_name>
		<to_code>1492933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soy sphingolipids</to_name>
		<to_code>1649138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spironolactone</to_name>
		<to_code>9997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5)</to_name>
		<to_code>2610326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium metavanadate tetrahydrate</to_name>
		<to_code>1661093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa sympathetic nerve preparation</to_name>
		<to_code>1311258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa knee joint preparation</to_name>
		<to_code>1311367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum lycopersicum fruiting top extract</to_name>
		<to_code>1653342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl triethoxysilane</to_name>
		<to_code>1367499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schoenocaulon officinale seed extract</to_name>
		<to_code>1351787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1)</to_name>
		<to_code>2722594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>staphylococcus epidermidis immunoserum rabbit</to_name>
		<to_code>1367201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sugammadex sodium</to_name>
		<to_code>1726987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia pratenis leaf extract</to_name>
		<to_code>1650833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tetrachloroaurate</to_name>
		<to_code>1366933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenite ion</to_name>
		<to_code>1546398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa thalamus preparation</to_name>
		<to_code>1311350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitol</to_name>
		<to_code>9945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>strontium chloride hexahydrate</to_name>
		<to_code>1594632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solasulfone</to_name>
		<to_code>1551455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvia apiana leaf extract</to_name>
		<to_code>2106427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sarcandra glabra top extract</to_name>
		<to_code>2634553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sargassum pallidum extract</to_name>
		<to_code>2592978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strophanthus kombe seed extract</to_name>
		<to_code>2106738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauryl phosphate</to_name>
		<to_code>2167142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2686927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Senna obtusifolia seed extract</to_name>
		<to_code>1600749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium phenylbutyrate</to_name>
		<to_code>214837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix lutea pollen extract</to_name>
		<to_code>2590686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stillingia sylvatica root extract</to_name>
		<to_code>1310050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syagrus romanzoffiana whole extract</to_name>
		<to_code>2590693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium caproyl lactylate</to_name>
		<to_code>1491979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium glycerophosphate</to_name>
		<to_code>1595589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sweet marjoram oil</to_name>
		<to_code>1305655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stellera chamaejasme whole extract</to_name>
		<to_code>2585255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stachyurus chinensis whole extract</to_name>
		<to_code>2592980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinus terebinthifolius pollen extract</to_name>
		<to_code>2590688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solvent yellow 18</to_name>
		<to_code>2566620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schinus terebinthifolius whole extract</to_name>
		<to_code>1312728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium polystyrene sulfonate</to_name>
		<to_code>56512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silanol</to_name>
		<to_code>1601667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfonmethane</to_name>
		<to_code>2534463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sapindus trifoliatus fruit extract</to_name>
		<to_code>1655992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-6 carboxylate</to_name>
		<to_code>2471090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selenium dioxide</to_name>
		<to_code>1309231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steardimonium hydroxypropyl peg-7 dimethicone phosphate chloride</to_name>
		<to_code>2564413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver sulfate</to_name>
		<to_code>2462500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfathiazole</to_name>
		<to_code>10193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch glycolate type a potato</to_name>
		<to_code>1370636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tartrate dihydrate</to_name>
		<to_code>1721438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbityl laurate</to_name>
		<to_code>1483080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hinokitiol</to_name>
		<to_code>1541742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-5 sulfate</to_name>
		<to_code>1996994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spermaceti</to_name>
		<to_code>9968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simeprevir</to_name>
		<to_code>1482790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium thiosulfate</to_name>
		<to_code>36726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium coco-sulfate</to_name>
		<to_code>1366926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose, 6-stearate</to_name>
		<to_code>1942263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver ragweed pollen extract</to_name>
		<to_code>852306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>901620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicones</to_name>
		<to_code>9778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose palmitate</to_name>
		<to_code>1367150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solketal</to_name>
		<to_code>2180790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schizandra preparation</to_name>
		<to_code>56084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium adipate</to_name>
		<to_code>2627782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sertaconazole nitrate</to_name>
		<to_code>236601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>starch glycolate type b potato</to_name>
		<to_code>1370624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix purpurea bark extract</to_name>
		<to_code>1492383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scutellaria barbata whole extract</to_name>
		<to_code>1811253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium arsenate, dibasic</to_name>
		<to_code>1364793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C14 olefin sulfonate</to_name>
		<to_code>1366913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sumbul</to_name>
		<to_code>350528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Symphoricarpos albus fruit extract</to_name>
		<to_code>1311100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sanguisorba officinalis leaf extract</to_name>
		<to_code>1360624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laureth-2 phosphate</to_name>
		<to_code>1441535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa lung preparation</to_name>
		<to_code>1311330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulisobenzone</to_name>
		<to_code>1311567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium laurate</to_name>
		<to_code>1425357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-22</to_name>
		<to_code>1790090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunflower pollen extract</to_name>
		<to_code>852509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smilax ornata whole extract</to_name>
		<to_code>1999193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus mutans</to_name>
		<to_code>1363920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sunitinib malate</to_name>
		<to_code>616275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium palmate</to_name>
		<to_code>1356710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>safflower seed allergenic extract</to_name>
		<to_code>901195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sophora pachycarpa whole extract</to_name>
		<to_code>2630723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Selaginella lepidophylla whole extract</to_name>
		<to_code>2560702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>superoxide dismutase</to_name>
		<to_code>10245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tartrate</to_name>
		<to_code>56524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stiripentol</to_name>
		<to_code>2054968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scarlet red</to_name>
		<to_code>36224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silicon nitride</to_name>
		<to_code>1989508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver iodide</to_name>
		<to_code>1423914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synthetic wax (1800 MW)</to_name>
		<to_code>1426675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spatholobus suberectus stem extract</to_name>
		<to_code>1661793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>St. John's wort extract</to_name>
		<to_code>258326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>suvorexant</to_name>
		<to_code>1547099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium fumarate</to_name>
		<to_code>56475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sialyl Lewis A</to_name>
		<to_code>2619423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium triethanolamine tris(dihydrogen phosphate)</to_name>
		<to_code>2534446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Shorea robusta seed butter extract</to_name>
		<to_code>1808536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Siberian ginseng preparation</to_name>
		<to_code>319812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>soy acid</to_name>
		<to_code>1484859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spearmint allergenic extract</to_name>
		<to_code>901313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Swertia japonica extract</to_name>
		<to_code>1370776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Strychnos mitis whole extract</to_name>
		<to_code>2627242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Smallanthus sonchifolius leaf extract</to_name>
		<to_code>2552300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hydroxypropylsulfonate laurylglucoside-7 crosspolymer</to_name>
		<to_code>2120184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chlorite</to_name>
		<to_code>992920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium ironedetate</to_name>
		<to_code>105673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2S)-3-phenylpropane-1,2-diol</to_name>
		<to_code>2557900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-stearoyl-sn-glycero-3-phosphocholine</to_name>
		<to_code>2707701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum nigrum fruit extract</to_name>
		<to_code>2470130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>scandium iodide</to_name>
		<to_code>1989390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Schisandra chinensis fruit oil</to_name>
		<to_code>2540130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium copper chlorophyllin A</to_name>
		<to_code>2583872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauroamphoacetate</to_name>
		<to_code>1307260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>seladelpar</to_name>
		<to_code>2690869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulindac</to_name>
		<to_code>10237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium benzoate</to_name>
		<to_code>56455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stemona tuberosa whole extract</to_name>
		<to_code>2631990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sakuranetin</to_name>
		<to_code>2263158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>succinic anhydride</to_name>
		<to_code>1374803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-sec-butyl cyclohexanone</to_name>
		<to_code>2383930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulbactam</to_name>
		<to_code>10167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sea scallop allergenic extract</to_name>
		<to_code>2103230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>silver fluoride</to_name>
		<to_code>1544125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sarcosinate</to_name>
		<to_code>1364526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>steareth-4</to_name>
		<to_code>1605200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium succinate</to_name>
		<to_code>1311370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium perborate tetrahydrate</to_name>
		<to_code>2104324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sclerocarya birrea seed oil</to_name>
		<to_code>1596688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sinusitisinum</to_name>
		<to_code>1311385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>senna concentrate</to_name>
		<to_code>219860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>798232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>solanum anomalum whole extract</to_name>
		<to_code>2602285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium potassium aluminum silicate</to_name>
		<to_code>2634307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium lauriminodipropionate</to_name>
		<to_code>1942335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Simmondsia chinensis leaf extract</to_name>
		<to_code>1534775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium methyl 2-sulfolaurate</to_name>
		<to_code>1364522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Syzygium nervosum flower bud extract</to_name>
		<to_code>1733672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>squalene</to_name>
		<to_code>10014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dithionate</to_name>
		<to_code>1443001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saccharomyces cerevisiae var. boulardii CNCM I-1079</to_name>
		<to_code>2704557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sassafras oil</to_name>
		<to_code>1309664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salmon preparation</to_name>
		<to_code>1421430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium sulfate</to_name>
		<to_code>36721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>selumetinib</to_name>
		<to_code>2289380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix alba whole extract</to_name>
		<to_code>1801067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorafenib tosylate</to_name>
		<to_code>597744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfate ion</to_name>
		<to_code>1426598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine</to_name>
		<to_code>2566292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>simoctocog alfa</to_name>
		<to_code>1729084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sarolaner</to_name>
		<to_code>1740360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saxagliptin hydrochloride dihydrate</to_name>
		<to_code>2643444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium C12 olefin sulfonate</to_name>
		<to_code>1366906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>secretin human, synthetic</to_name>
		<to_code>606396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saururus chinensis whole extract</to_name>
		<to_code>1435868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptococcus pyogenes immunoserum rabbit</to_name>
		<to_code>1367197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>short ragweed pollen extract</to_name>
		<to_code>896135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa achilles tendon preparation</to_name>
		<to_code>1311366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sea scallop preparation</to_name>
		<to_code>1426396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sorbitol monooleate</to_name>
		<to_code>1812934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Solanum melongena whole extract</to_name>
		<to_code>1722378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamidoethyl diethylamine</to_name>
		<to_code>1363699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearoamphoacetate</to_name>
		<to_code>1424269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearyl caprylate</to_name>
		<to_code>1806912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salvadora persica root extract</to_name>
		<to_code>2462495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium chloride, (22)Na</to_name>
		<to_code>1370679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stannous chloride</to_name>
		<to_code>37032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium glycolate</to_name>
		<to_code>1356762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium stearoyl lactylate</to_name>
		<to_code>1366986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa urethra preparation</to_name>
		<to_code>1311358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa superior gastric plexus preparation</to_name>
		<to_code>1311346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium tripolyphosphate anhydrous</to_name>
		<to_code>1487533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sudan III</to_name>
		<to_code>1426472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Selaginella lepidophylla extract</to_name>
		<to_code>1793746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Saxifraga stolonifera leaf extract</to_name>
		<to_code>1307949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>star anise extract</to_name>
		<to_code>1350212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sesame oil unsaponifiables</to_name>
		<to_code>2568106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sibeprenlimab</to_name>
		<to_code>2728380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa dander preparation</to_name>
		<to_code>1356131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sonidegib</to_name>
		<to_code>1659191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucralfate</to_name>
		<to_code>10156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfobutylether-beta-cyclodextrin</to_name>
		<to_code>1426608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa eye preparation</to_name>
		<to_code>1311361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sucrose acetate isobutyrate</to_name>
		<to_code>1363646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2</to_name>
		<to_code>2468230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa tonsil preparation</to_name>
		<to_code>1311264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa lymph vessel preparation</to_name>
		<to_code>2176310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium acetylated hyaluronate</to_name>
		<to_code>2198976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfamethoxypyridazine</to_name>
		<to_code>10181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Stevia serrata flower oil</to_name>
		<to_code>2479555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa solar plexus preparation</to_name>
		<to_code>1311256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfonated oleic acid</to_name>
		<to_code>1546402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sinapsis arvensis flowering-fruiting top extract</to_name>
		<to_code>1309471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfobromophthalein sodium</to_name>
		<to_code>203200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium myristoyl glutamate</to_name>
		<to_code>1313693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stepronin</to_name>
		<to_code>2375829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfuric acid</to_name>
		<to_code>10231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium dichloroacetate</to_name>
		<to_code>1366930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>salicylate</to_name>
		<to_code>9522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa vagus nerve preparation</to_name>
		<to_code>1311266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>synephrine</to_name>
		<to_code>10288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sodium hypochlorite</to_name>
		<to_code>9881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sandalwood extract</to_name>
		<to_code>1425087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sus scrofa brainstem preparation</to_name>
		<to_code>1311212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Scrophularia buegeriana root extract</to_name>
		<to_code>1539194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfacytine</to_name>
		<to_code>78902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearic acid D7</to_name>
		<to_code>1804568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sennosides, USP</to_name>
		<to_code>36387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Spigelia anthelmia preparation</to_name>
		<to_code>1310235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stichopus sea cucumber</to_name>
		<to_code>1665462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>samidorphan L-malate</to_name>
		<to_code>2570387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>saffron oil</to_name>
		<to_code>2624695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>streptokinase</to_name>
		<to_code>10106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Salix repens pollen extract</to_name>
		<to_code>2533912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>spirapril</to_name>
		<to_code>36908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>sulfaquinoxaline</to_name>
		<to_code>1306111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Sargassum muticum extract</to_name>
		<to_code>1663473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>S [Preparations]</from_name>
		<from_code>N0000010601</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>stearamidopropyl betaine</to_name>
		<to_code>2257291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose monostearate</from_name>
		<from_code>1363060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose monostearate</to_name>
		<to_code>M0069428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semax</from_name>
		<from_code>2049929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Semax</to_name>
		<to_code>M0139469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>setmelanotide</from_name>
		<from_code>2469247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>setmelanotide</to_name>
		<to_code>M000620282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium silicate</from_name>
		<from_code>1363697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium silicate</to_name>
		<to_code>M0047391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silicon tetrachloride</from_name>
		<from_code>1863221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silicon tetrachloride</to_name>
		<to_code>M0118636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suramin</from_name>
		<from_code>10256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Suramin</to_name>
		<to_code>M0020853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium formaldehyde sulfoxylate</from_name>
		<from_code>289996</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>formaldehydesulfoxylate, monosodium salt</to_name>
		<to_code>M0311371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfachlorpyridazine</from_name>
		<from_code>2476008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfachlorpyridazine</to_name>
		<to_code>M0020739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver mono(2-aminoethyl)phosphate</from_name>
		<from_code>162901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver mono(2-aminoethyl)phosphate</to_name>
		<to_code>M0088448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tyropanoate</from_name>
		<from_code>282508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Tyropanoate</to_name>
		<to_code>M0353576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salcaprozate sodium</from_name>
		<from_code>2200637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salcaprozate sodium</to_name>
		<to_code>M0542222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium oxide</from_name>
		<from_code>1366982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium oxide</to_name>
		<to_code>M0254336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium cyclamate</from_name>
		<from_code>56467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Cyclamate</to_name>
		<to_code>M0005448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium caprylate</from_name>
		<from_code>1311123</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium caprylate</to_name>
		<to_code>M0098906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>steareth-10</from_name>
		<from_code>1367147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poly(oxyethylene) (10) stearyl ether</to_name>
		<to_code>M000637137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stevioside</from_name>
		<from_code>37106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stevioside</to_name>
		<to_code>M0058754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iodate</from_name>
		<from_code>1422194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium iodate</to_name>
		<to_code>M0100877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium borate</from_name>
		<from_code>36680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium borate</to_name>
		<to_code>M0056248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypophosphite</from_name>
		<from_code>1311313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium hypophosphite</to_name>
		<to_code>M0053864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed allergenic extract</from_name>
		<from_code>901199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate tetrahydrate</from_name>
		<from_code>1306069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline</from_name>
		<from_code>21272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline sodium</from_name>
		<from_code>102758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin sulfate</from_name>
		<from_code>2640868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycoplasma Infections</to_name>
		<to_code>M0014307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin hydrochloride</from_name>
		<from_code>267342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spectinomycin Hydrochloride</to_name>
		<to_code>M000613692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spectinomycin</from_name>
		<from_code>270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spectinomycin</to_name>
		<to_code>M0000292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenite</from_name>
		<from_code>9640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Selenite</to_name>
		<to_code>M0027223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium gluconate</from_name>
		<from_code>56476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium gluconate</to_name>
		<to_code>M0096891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hydroxide</from_name>
		<from_code>9880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Hydroxide</to_name>
		<to_code>M0020107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous chloride dihydrate</from_name>
		<from_code>2462150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stannous chloride dihydrate</to_name>
		<to_code>M000613556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium carbonate</from_name>
		<from_code>36685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium carbonate</to_name>
		<to_code>M0047386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharin sodium</from_name>
		<from_code>281678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saccharin Sodium</to_name>
		<to_code>M0361498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium stearyl fumarate</from_name>
		<from_code>1364936</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium stearyl fumarate</to_name>
		<to_code>M0509632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharin calcium</from_name>
		<from_code>1362912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saccharin Calcium</to_name>
		<to_code>M0019328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium alginate</from_name>
		<from_code>56446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Alginate</to_name>
		<to_code>M0310540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serum albumin, bovine</from_name>
		<from_code>1426381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serum Albumin, Bovine</to_name>
		<to_code>M0019693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sabinene</from_name>
		<from_code>2557219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mites</to_name>
		<to_code>M0013934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sabinene</from_name>
		<from_code>2557219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sabinene</to_name>
		<to_code>M0107834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sabinene</from_name>
		<from_code>2557219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Deodorants</to_name>
		<to_code>M0005987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver phosphate</from_name>
		<from_code>1665220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver phosphate</to_name>
		<to_code>M0117203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samarium oxide</from_name>
		<from_code>1311105</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>samarium oxide</to_name>
		<to_code>M0332093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium palmitoyl sarcosinate</from_name>
		<from_code>1726120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palmitoyl sarcosine, sodium salt</to_name>
		<to_code>M0312645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dodecylbenzenesulfonate</from_name>
		<from_code>1366931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dodecylbenzenesulfonic acid, sodium salt</to_name>
		<to_code>M0307560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>subtilisin</from_name>
		<from_code>1997449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Subtilisin</to_name>
		<to_code>M0328357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium sulfide nonahydrate</from_name>
		<from_code>1364569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium sulfide nonahydrate</to_name>
		<to_code>M000633558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus dysgalactiae</from_name>
		<from_code>1491866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus dysgalactiae</to_name>
		<to_code>M000659211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium sulfite</from_name>
		<from_code>36723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium sulfite</to_name>
		<to_code>M0083911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pyogenes</from_name>
		<from_code>1311281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pyogenes</to_name>
		<to_code>M0020575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dithionite</from_name>
		<from_code>2056673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Dithionite</to_name>
		<to_code>M0006617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium iothalamate</from_name>
		<from_code>9886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Iothalamate</to_name>
		<to_code>M0330182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Staphylococcus epidermidis</from_name>
		<from_code>1489915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcus epidermidis</to_name>
		<to_code>M0020432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acexamate</from_name>
		<from_code>236526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium acexamate</to_name>
		<to_code>M0070737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Stemphylium solani allergenic extract</from_name>
		<from_code>867349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stemphylium solani</to_name>
		<to_code>M000705290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharomyces cerevisiae allergenic extract</from_name>
		<from_code>350141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicin</from_name>
		<from_code>36100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salicin</to_name>
		<to_code>M0047403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bisulfate</from_name>
		<from_code>1367207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium bisulfate</to_name>
		<to_code>M0311701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannic oxide</from_name>
		<from_code>1363059</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stannic oxide</to_name>
		<to_code>M0131933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Siberian ginseng root extract</from_name>
		<from_code>259472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eleutherococci extract</to_name>
		<to_code>M000743830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eleuthero preparation</from_name>
		<from_code>1368902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eleutherococci extract</to_name>
		<to_code>M000743830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bisulfate monohydrate</from_name>
		<from_code>2463932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium bisulfate, monohydrate</to_name>
		<to_code>M0311697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitrite</from_name>
		<from_code>9894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Nitrite</to_name>
		<to_code>M0020113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hydride</from_name>
		<from_code>1483618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium hydride</to_name>
		<to_code>M0516491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharin</from_name>
		<from_code>9509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saccharin</to_name>
		<to_code>M0019327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium Na-22</from_name>
		<from_code>1483727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium-22</to_name>
		<to_code>M000627814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Senna leaf extract</from_name>
		<from_code>485853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Senna Leaf</to_name>
		<to_code>M000744288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinic acid</from_name>
		<from_code>37255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Succinic Acid</to_name>
		<to_code>M0029380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Shigella dysenteriae</from_name>
		<from_code>1316076</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shigella dysenteriae</to_name>
		<to_code>M0019772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saw palmetto fruit extract</from_name>
		<from_code>477189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>saw palmetto extract</to_name>
		<to_code>M0121688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saw palmetto extract</from_name>
		<from_code>236344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>saw palmetto extract</to_name>
		<to_code>M0121688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur</from_name>
		<from_code>10223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfur</to_name>
		<to_code>M0020797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur</from_name>
		<from_code>10223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur</from_name>
		<from_code>10223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resorcinol</from_name>
		<from_code>35382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol etabonate</from_name>
		<from_code>52177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzoyl peroxide</from_name>
		<from_code>1418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur, colloidal</from_name>
		<from_code>221083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loteprednol</from_name>
		<from_code>237027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloid sulfur</from_name>
		<from_code>89767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azelaic acid</from_name>
		<from_code>18602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosacea</to_name>
		<to_code>M0019267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur, colloidal</from_name>
		<from_code>221083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc pyrithione</from_name>
		<from_code>39952</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketoconazole</from_name>
		<from_code>6135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide sodium</from_name>
		<from_code>82101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar</from_name>
		<from_code>2635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colloid sulfur</from_name>
		<from_code>89767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar pitch volatiles</from_name>
		<from_code>90732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levoketoconazole</from_name>
		<from_code>2588846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide</from_name>
		<from_code>10169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coal tar extract</from_name>
		<from_code>90735</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone</from_name>
		<from_code>2878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisone</from_name>
		<from_code>8640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dermatitis, Seborrheic</to_name>
		<to_code>M0019584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>satraplatin</from_name>
		<from_code>1733681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>satraplatin</to_name>
		<to_code>M0437778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearic acid</from_name>
		<from_code>1310551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearic acid</to_name>
		<to_code>M0098170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium stibogluconate</from_name>
		<from_code>8010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antimony Sodium Gluconate</to_name>
		<to_code>M0001475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silicon</from_name>
		<from_code>9774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silicon</to_name>
		<to_code>M0019854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium benzenesulfonate</from_name>
		<from_code>1313277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium benzenesulfonate</to_name>
		<to_code>M0101056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shellac</from_name>
		<from_code>1368898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>shellac</to_name>
		<to_code>M0045063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfobetaine</from_name>
		<from_code>1539813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfobetaine</to_name>
		<to_code>M0464615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saralasin acetate</from_name>
		<from_code>7830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saralasin Acetate</to_name>
		<to_code>M0019422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium starch glycolate</from_name>
		<from_code>1366851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium starch glycolate</to_name>
		<to_code>M0139236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesamin</from_name>
		<from_code>2593413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sesamin</to_name>
		<to_code>M0153023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearate</from_name>
		<from_code>1368706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stearates</to_name>
		<to_code>M0020466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylated gelatin</from_name>
		<from_code>56790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>succinylated gelatin</to_name>
		<to_code>M0167019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silymarin</from_name>
		<from_code>9794</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silymarin</to_name>
		<to_code>M0019873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>82 strontium</from_name>
		<from_code>90611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Strontium-82</to_name>
		<to_code>M000628013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin sodium</from_name>
		<from_code>1812261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coccidiosis</to_name>
		<to_code>M0004678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin sodium</from_name>
		<from_code>1812261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin sodium</from_name>
		<from_code>1812261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin sodium</from_name>
		<from_code>1812261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coccidiosis</to_name>
		<to_code>M0004678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin</from_name>
		<from_code>1311566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coccidiosis</to_name>
		<to_code>M0004678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin</from_name>
		<from_code>1311566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coccidiosis</to_name>
		<to_code>M0004678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin</from_name>
		<from_code>1311566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salinomycin</to_name>
		<to_code>M0055726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin</from_name>
		<from_code>1311566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salinomycin</from_name>
		<from_code>1311566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spermine</from_name>
		<from_code>1483263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spermine</to_name>
		<to_code>M0020288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotrovimab</from_name>
		<from_code>2550731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sotrovimab</to_name>
		<to_code>M000742086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sotrovimab</from_name>
		<from_code>2550731</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronavirus Infections</to_name>
		<to_code>M0027585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nirmatrelvir</from_name>
		<from_code>2587892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronavirus Infections</to_name>
		<to_code>M0027585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etesevimab</from_name>
		<from_code>2477854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronavirus Infections</to_name>
		<to_code>M0027585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>molnupiravir</from_name>
		<from_code>2587901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronavirus Infections</to_name>
		<to_code>M0027585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remdesivir</from_name>
		<from_code>2284718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coronavirus Infections</to_name>
		<to_code>M0027585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Serratia marcescens</from_name>
		<from_code>1426634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serratia marcescens</to_name>
		<to_code>M0019689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safflower oil</from_name>
		<from_code>9515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Safflower Oil</to_name>
		<to_code>M0019344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage leaf allergenic extract</from_name>
		<from_code>1011627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamerazine</from_name>
		<from_code>10176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfamerazine</to_name>
		<to_code>M0020746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>styrene</from_name>
		<from_code>1362878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Styrene</to_name>
		<to_code>M0029766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium percarbonate</from_name>
		<from_code>1364915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium percarbonate</to_name>
		<to_code>M0106855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sapanisertib</from_name>
		<from_code>2395271</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sapanisertib</to_name>
		<to_code>M000655303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfametrole</from_name>
		<from_code>37328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfametrole</to_name>
		<to_code>M0058763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squalane</from_name>
		<from_code>1363644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>squalane</to_name>
		<to_code>M0072078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Soy Proteins</from_name>
		<from_code>36853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>string bean allergenic extract</from_name>
		<from_code>891676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus thermophilus</from_name>
		<from_code>2593692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus thermophilus</to_name>
		<to_code>M0460997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>starch</from_name>
		<from_code>10046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Starch</to_name>
		<to_code>M0020435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetastarch</from_name>
		<from_code>5531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Starch</to_name>
		<to_code>M0020435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyethyl starch 130-0.4</from_name>
		<from_code>1363352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Starch</to_name>
		<to_code>M0020435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squash allergenic extract</from_name>
		<from_code>975509</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selank</from_name>
		<from_code>2049928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Selank</to_name>
		<to_code>M0408941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicin extract</from_name>
		<from_code>260012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>willow bark</to_name>
		<to_code>M0399913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicin extract</from_name>
		<from_code>260012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>willow bark extract</to_name>
		<to_code>M000744271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisomidine</from_name>
		<from_code>10206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfisomidine</to_name>
		<to_code>M0020778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfanilylurea</from_name>
		<from_code>37333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfanilylurea</to_name>
		<to_code>M0053960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chromate Cr51</from_name>
		<from_code>91510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium chromate(VI), 51Cr-labeled cpd</to_name>
		<to_code>M0318041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium selenite</from_name>
		<from_code>56519</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Selenite</to_name>
		<to_code>M0027224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silicic acid</from_name>
		<from_code>1311243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silicic Acid</to_name>
		<to_code>M0019853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisomicin</from_name>
		<from_code>9806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sisomicin</to_name>
		<to_code>M0019903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucralose</from_name>
		<from_code>1439115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trichlorosucrose</to_name>
		<to_code>M0086527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spermidine</from_name>
		<from_code>1483262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spermidine</to_name>
		<to_code>M0020287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearyl stearate</from_name>
		<from_code>1426360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearyl stearate</to_name>
		<to_code>M0523920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium carbonate decahydrate</from_name>
		<from_code>1362143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium carbonate decahydrate</to_name>
		<to_code>M0047387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean lecithin</from_name>
		<from_code>579598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>secnidazole</to_name>
		<to_code>M0066920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secnidazole</from_name>
		<from_code>36314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nitroimidazoles</to_name>
		<to_code>M0014907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium cholate</from_name>
		<from_code>2286239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Cholate</to_name>
		<to_code>M0029995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium</from_name>
		<from_code>9853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium</to_name>
		<to_code>M0020091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium gualenate</from_name>
		<from_code>2667891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Na salt of azulene SN</to_name>
		<to_code>M0320265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thioglycolate</from_name>
		<from_code>1364940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-mercaptoacetate, monosodium salt</to_name>
		<to_code>M0313430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose octaacetate</from_name>
		<from_code>37296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose octaacetate</to_name>
		<to_code>M0087855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium diacetate</from_name>
		<from_code>1547632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium diacetate</to_name>
		<to_code>M0545846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate anhydrous</from_name>
		<from_code>1807514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium thiosulfate anhydrous</to_name>
		<to_code>M000623643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salvia miltiorrhiza root extract</from_name>
		<from_code>1307580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>dan-shen root extract</to_name>
		<to_code>M0092772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan tristearate</from_name>
		<from_code>1426397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan tristearate</to_name>
		<to_code>M0509245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scandium chloride</from_name>
		<from_code>1921562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>scandium chloride</to_name>
		<to_code>M0539580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273</from_name>
		<from_code>2470232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Elasomeran</to_name>
		<to_code>M000757965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sudan red</from_name>
		<from_code>1648696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sudan red</to_name>
		<to_code>M0102594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium lauroyl sarcosinate</from_name>
		<from_code>1364901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sarkosyl</to_name>
		<to_code>M0084357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan monostearate</from_name>
		<from_code>1363057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan monostearate</to_name>
		<to_code>M0053882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Staphylococcus simulans</from_name>
		<from_code>1489917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcus simulans</to_name>
		<to_code>M000659914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium metasilicate</from_name>
		<from_code>1733690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium metasilicate</to_name>
		<to_code>M0084581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfuryl fluoride</from_name>
		<from_code>2289224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfuryl fluoride</to_name>
		<to_code>M0140442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Senna pod</from_name>
		<from_code>2166041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Senna Pods</to_name>
		<to_code>M000744287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sericin 1</from_name>
		<from_code>1607312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sericin-1</to_name>
		<to_code>M0053773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearamine</from_name>
		<from_code>1313977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearylamine</to_name>
		<to_code>M0053912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sandalore</from_name>
		<from_code>2373965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sandalore</to_name>
		<to_code>M000645421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptodornase</from_name>
		<from_code>10104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptodornase</to_name>
		<to_code>M0006008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sultopride</from_name>
		<from_code>37416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sultopride</to_name>
		<to_code>M0058775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sobrerol</from_name>
		<from_code>36669</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sobrerol</to_name>
		<to_code>M0044341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strychnine</from_name>
		<from_code>66422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Strychnine</to_name>
		<to_code>M0020628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Morrhuate</to_name>
		<to_code>M0020112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Varicose Veins</to_name>
		<to_code>M0022531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium morrhuate</from_name>
		<from_code>9892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esophageal and Gastric Varices</to_name>
		<to_code>M0007742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Varicose Veins</to_name>
		<to_code>M0022531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>polidocanol</from_name>
		<from_code>968170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Varicose Veins</to_name>
		<to_code>M0022531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>laureth-9 phosphate</from_name>
		<from_code>2373964</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Varicose Veins</to_name>
		<to_code>M0022531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esophageal and Gastric Varices</to_name>
		<to_code>M0007742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine oleate</from_name>
		<from_code>24460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esophageal and Gastric Varices</to_name>
		<to_code>M0007742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetradecyl sulfate</from_name>
		<from_code>9913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esophageal and Gastric Varices</to_name>
		<to_code>M0007742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esophageal and Gastric Varices</to_name>
		<to_code>M0007742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasopressin (USP)</from_name>
		<from_code>11149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esophageal and Gastric Varices</to_name>
		<to_code>M0007742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose monolaurate</from_name>
		<from_code>1363647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose monolaurate</to_name>
		<to_code>M0069427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium</from_name>
		<from_code>10122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Strontium</to_name>
		<to_code>M0020618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sisomicin sulfate</from_name>
		<from_code>9807</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sisomicin Sulfate</to_name>
		<to_code>M0019904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower oil</from_name>
		<from_code>37422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sunflower Oil</to_name>
		<to_code>M000625852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium taurodeoxycholate</from_name>
		<from_code>1364852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Taurodeoxycholate</to_name>
		<to_code>M0021071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hexafluorosilicate</from_name>
		<from_code>1862868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium fluorosilicate</to_name>
		<to_code>M0556533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sambucus canadensis flower extract</from_name>
		<from_code>1376215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>American elderberry flower</to_name>
		<to_code>M000744428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samarium</from_name>
		<from_code>9549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Samarium</to_name>
		<to_code>M0019408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>S-adenosylmethionine</from_name>
		<from_code>9504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>S-Adenosylmethionine</to_name>
		<to_code>M0019322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shikimic acid</from_name>
		<from_code>2059172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shikimic Acid</to_name>
		<to_code>M0019775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Staphylococcus aureus</from_name>
		<from_code>1311275</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcus aureus</to_name>
		<to_code>M0020431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sour cherry allergenic extract</from_name>
		<from_code>1012134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon oil</from_name>
		<from_code>41967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salmon oil</to_name>
		<to_code>M0096056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium palmitate</from_name>
		<from_code>1364910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Palmitate</to_name>
		<to_code>M0028752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stem bromelain</from_name>
		<from_code>2373652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stem bromelain</to_name>
		<to_code>M0242372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfaethidole</from_name>
		<from_code>37324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfaethidole</to_name>
		<to_code>M0263388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium cocoyl isethionate</from_name>
		<from_code>1366839</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium cocoyl isethionate</to_name>
		<to_code>M0332850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hydrogen sulfite</from_name>
		<from_code>1366858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium hydrogen sulfite</to_name>
		<to_code>M0569865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous chloride,anhydrous</from_name>
		<from_code>314853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stannous chloride anhydrous</to_name>
		<to_code>M0583141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarcosine</from_name>
		<from_code>1362906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sarcosine</to_name>
		<to_code>M0019445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sanguinarine nitrate</from_name>
		<from_code>1537754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sanguinarine nitrate</to_name>
		<to_code>M0309239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sandalwood oil</from_name>
		<from_code>1309224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sandalwood oil</to_name>
		<to_code>M0206336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Scutellaria baicalensis root extract</from_name>
		<from_code>1307750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ougon</to_name>
		<to_code>M0359562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan monolaurate</from_name>
		<from_code>1363055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan monolaurate</to_name>
		<to_code>M0063643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose</from_name>
		<from_code>10159</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sucrose</to_name>
		<to_code>M0020722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenocysteine</from_name>
		<from_code>1549332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Selenocysteine</to_name>
		<to_code>M0026231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>styrene/isoprene/styrene block copolymer</from_name>
		<from_code>2385109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>styrene-isoprene-styrene block copolymer</to_name>
		<to_code>M0577659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simetone</from_name>
		<from_code>1658655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-methoxy-4-ethylamino-6-ethylamino-1,3,5-triazine</to_name>
		<to_code>M0553714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearalkonium chloride</from_name>
		<from_code>1310555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N,N-dimethyl-N-octadecylbenzylammonium chloride</to_name>
		<to_code>M0321898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samarium Sm153</from_name>
		<from_code>196342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Samarium-153</to_name>
		<to_code>M000627549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver chloride</from_name>
		<from_code>1314846</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver chloride</to_name>
		<to_code>M0113551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serotonin</from_name>
		<from_code>1311214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serotonin</to_name>
		<to_code>M0019683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugammadex</from_name>
		<from_code>1726988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gamma-Cyclodextrins</to_name>
		<to_code>M0081434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugammadex</from_name>
		<from_code>1726988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sugammadex</to_name>
		<to_code>M0497520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serine</from_name>
		<from_code>9671</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Serine</to_name>
		<to_code>M0019675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver sulfide</from_name>
		<from_code>1549110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver sulfide</to_name>
		<to_code>M0060861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hydroxymethylglycinate</from_name>
		<from_code>1367223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium hydroxymethylglycinate</to_name>
		<to_code>M0544173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium copper chlorophyllin</from_name>
		<from_code>1366841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorophyllin, sodium copper complex</to_name>
		<to_code>M000636966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline</from_name>
		<from_code>36437</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sertraline</to_name>
		<to_code>M0029930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sertraline</to_name>
		<to_code>M0029930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium molybdate(VI)</from_name>
		<from_code>36699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium molybdate(VI)</to_name>
		<to_code>M0083179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis</to_name>
		<to_code>M0001741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsalate</from_name>
		<from_code>36108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salicylsalicylic acid</to_name>
		<to_code>M0062507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>devil's claw preparation</from_name>
		<from_code>236279</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis</to_name>
		<to_code>M0001741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyl salicylate</from_name>
		<from_code>29787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arthritis</to_name>
		<to_code>M0001741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium nitrate</from_name>
		<from_code>1356142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>strontium nitrate</to_name>
		<to_code>M0273777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed allergenic extract</from_name>
		<from_code>901203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synthetic beeswax</from_name>
		<from_code>2462009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beeswax, synthetic</to_name>
		<to_code>M0320931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solanine</from_name>
		<from_code>1745416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Solanine</to_name>
		<to_code>M0020136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetate trihydrate</from_name>
		<from_code>237108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Acetate Trihydrate</to_name>
		<to_code>M000638655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulpiride</from_name>
		<from_code>10239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulpiride</to_name>
		<to_code>M0020813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous tartrate</from_name>
		<from_code>56701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stannous tartrate</to_name>
		<to_code>M0094760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>samarium Sm 153 lexidronam</from_name>
		<from_code>177906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>samarium Sm-153 lexidronam</to_name>
		<to_code>M0171702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silk allergenic extract</from_name>
		<from_code>314455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silk</to_name>
		<to_code>M0053814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulbutiamine</from_name>
		<from_code>37317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulbutiamine</to_name>
		<to_code>M0098527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinate</from_name>
		<from_code>1307106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Succinate</to_name>
		<to_code>M0029383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89</from_name>
		<from_code>81638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Strontium-89</to_name>
		<to_code>M000628015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sphinganine</from_name>
		<from_code>1947371</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sphinganine</to_name>
		<to_code>M0047380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean allergenic extract</from_name>
		<from_code>891668</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sertraline hydrochloride</from_name>
		<from_code>155137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sertraline Hydrochloride</to_name>
		<to_code>M0329071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus salivarius</from_name>
		<from_code>2393605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus salivarius</to_name>
		<to_code>M000608853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame oil</from_name>
		<from_code>1309247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sesame Oil</to_name>
		<to_code>M0019701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylsulfathiazole</from_name>
		<from_code>37289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>succinylsulfathiazole</to_name>
		<to_code>M0053950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sunflower seed extract</from_name>
		<from_code>1309391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pyrophosphate</from_name>
		<from_code>1364532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium pyrophosphate</to_name>
		<to_code>M0044345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus agalactiae</from_name>
		<from_code>1363918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus agalactiae</to_name>
		<to_code>M0020570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safflower seed extract</from_name>
		<from_code>1440241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebacic acid</from_name>
		<from_code>1427068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sebacic acid</to_name>
		<to_code>M0057150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenomethionine Se 75</from_name>
		<from_code>9133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Selenomethionine Se 75</to_name>
		<to_code>M0019606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium propionate</from_name>
		<from_code>56513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium propionate</to_name>
		<to_code>M0094460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose cocoate</from_name>
		<from_code>1370728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose cocoate</to_name>
		<to_code>M0543619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium arsenate</from_name>
		<from_code>1364794</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium arsenate</to_name>
		<to_code>M0053853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saccharomyces boulardii</to_name>
		<to_code>M000608778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces boulardii</from_name>
		<from_code>236782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenomethionine</from_name>
		<from_code>9644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Selenomethionine</to_name>
		<to_code>M0019607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose distearate</from_name>
		<from_code>1370303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose distearate</to_name>
		<to_code>M0123240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-COV-2 (COVID-19) vaccine, vector - Ad26</from_name>
		<from_code>2479830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ad26COVS1</to_name>
		<to_code>M000742885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptomycin</to_name>
		<to_code>M0020595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tularemia</to_name>
		<to_code>M0022145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Brucellosis</to_name>
		<to_code>M0002989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin</from_name>
		<from_code>10109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tularemia</to_name>
		<to_code>M0022145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tularemia</to_name>
		<to_code>M0022145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tularemia</to_name>
		<to_code>M0022145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptomycin Sulfate</to_name>
		<to_code>M0329735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aminoglycosides</to_name>
		<to_code>M0000946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Brucellosis</to_name>
		<to_code>M0002989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptomycin sulfate</from_name>
		<from_code>10110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chancroid</to_name>
		<to_code>M0003985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline</from_name>
		<from_code>21272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Brucellosis</to_name>
		<to_code>M0002989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Brucellosis</to_name>
		<to_code>M0002989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomocycline sodium</from_name>
		<from_code>102758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Brucellosis</to_name>
		<to_code>M0002989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Granuloma Inguinale</to_name>
		<to_code>M0009606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline</from_name>
		<from_code>6980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>minocycline hydrochloride</from_name>
		<from_code>6979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Plague</to_name>
		<to_code>M0016945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sanguinarine</from_name>
		<from_code>1537755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sanguinarine</to_name>
		<to_code>M0047429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dehydroacetate</from_name>
		<from_code>1366847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium dehydroacetate</to_name>
		<to_code>M0089315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Shigella sonnei</from_name>
		<from_code>1491872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Shigella sonnei</to_name>
		<to_code>M0019774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sinapultide</from_name>
		<from_code>1440288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sinapultide</to_name>
		<to_code>M0292630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet potato allergenic extract</from_name>
		<from_code>901307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearyl glycyrrhetinate</from_name>
		<from_code>1356147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearyl glycyrrhetinate</to_name>
		<to_code>M0061640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium chloride</from_name>
		<from_code>37175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>strontium chloride</to_name>
		<to_code>M0085394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver acetate</from_name>
		<from_code>137939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver acetate</to_name>
		<to_code>M0269663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver acetate</from_name>
		<from_code>137939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone (K-30) simethicone emulsion</from_name>
		<from_code>1305760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurandrenolide</from_name>
		<from_code>4500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone</from_name>
		<from_code>8610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K30</from_name>
		<from_code>1297406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K90</from_name>
		<from_code>1310497</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>povidone K12</from_name>
		<from_code>1305759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Diseases, Viral</to_name>
		<to_code>M0026098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulthiame</from_name>
		<from_code>10240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulthiame</to_name>
		<to_code>M0224692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sesame seed extract</from_name>
		<from_code>1310046</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salsolinol</from_name>
		<from_code>1311309</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salsolinol</to_name>
		<to_code>M0111390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89 chloride</from_name>
		<from_code>281890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>strontium chloride, 89Sr-labeled</to_name>
		<to_code>M0316540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium-89 chloride</from_name>
		<from_code>281890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibritumomab tiuxetan</from_name>
		<from_code>262323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone sodium sulfate</from_name>
		<from_code>1366962</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dutasteride</from_name>
		<from_code>228790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium propylene glycol solvate</from_name>
		<from_code>1483793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide acetate</from_name>
		<from_code>203217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine hydrochloride</from_name>
		<from_code>1426886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium edetate</from_name>
		<from_code>105745</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leuprolide</from_name>
		<from_code>42375</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine hydrochloride</from_name>
		<from_code>91063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil</from_name>
		<from_code>68149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>goserelin acetate</from_name>
		<from_code>203146</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin</from_name>
		<from_code>861634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin</from_name>
		<from_code>301542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin</from_name>
		<from_code>42463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolic acid</from_name>
		<from_code>7145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium</from_name>
		<from_code>3539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosuvastatin calcium</from_name>
		<from_code>323828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine</from_name>
		<from_code>10847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>yellow fever virus strain 17D-204 live antigen</from_name>
		<from_code>804187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethotoin</from_name>
		<from_code>4136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium trihydrate</from_name>
		<from_code>1297766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pravastatin sodium</from_name>
		<from_code>203144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium anhydrous</from_name>
		<from_code>2569977</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripelennamine citrate</from_name>
		<from_code>71533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin</from_name>
		<from_code>83367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oteseconazole</from_name>
		<from_code>2602577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mycophenolate mofetil hydrochloride</from_name>
		<from_code>237112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine</from_name>
		<from_code>10825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine bitartrate</from_name>
		<from_code>81990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimeprazine tartrate</from_name>
		<from_code>164308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atorvastatin calcium</from_name>
		<from_code>83366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpropamide</from_name>
		<from_code>2404</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin sodium</from_name>
		<from_code>1944734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan hydrochloride</from_name>
		<from_code>266573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin calcium</from_name>
		<from_code>861640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prasterone</from_name>
		<from_code>3143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>topotecan</from_name>
		<from_code>57308</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetate disodium, anhydrous</from_name>
		<from_code>1299924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteamine</from_name>
		<from_code>3022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>danazol</from_name>
		<from_code>3102</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methimazole</from_name>
		<from_code>6835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetic acid</from_name>
		<from_code>3755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pitavastatin magnesium</from_name>
		<from_code>2001252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium disodium EDTA</from_name>
		<from_code>1422486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lactation</to_name>
		<to_code>M0012156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-phenylbutyric acid, sodium salt</to_name>
		<to_code>M0325828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Sickle Cell</to_name>
		<to_code>M0001140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Thalassemia</to_name>
		<to_code>M0025960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylbutyrate</from_name>
		<from_code>214837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myeloproliferative Disorders</to_name>
		<to_code>M0014332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride</from_name>
		<from_code>142424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine amide</from_name>
		<from_code>1591923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dornase alfa</from_name>
		<from_code>337623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride hydrochloride, anhydrous</from_name>
		<from_code>1298837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine zinc</from_name>
		<from_code>1490795</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medium chain triglycerides</from_name>
		<from_code>1310578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine sodium</from_name>
		<from_code>237163</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elexacaftor</from_name>
		<from_code>2256951</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanzacaftor</from_name>
		<from_code>2701431</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine</from_name>
		<from_code>197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylcysteine magnesium</from_name>
		<from_code>1809634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumacaftor</from_name>
		<from_code>1655922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiloride</from_name>
		<from_code>644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ivacaftor</from_name>
		<from_code>1243041</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystic Fibrosis</to_name>
		<to_code>M0005551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella-zoster immune globulin</from_name>
		<from_code>39385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen</from_name>
		<from_code>5640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol</from_name>
		<from_code>8782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone hydrochloride</from_name>
		<from_code>203114</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine</from_name>
		<from_code>1256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>azathioprine sodium</from_name>
		<from_code>267476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amiodarone</from_name>
		<from_code>703</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propofol lipid emulsion</from_name>
		<from_code>2559907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>varicella zoster immune globulin (human)</from_name>
		<from_code>485576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pregnancy, Abdominal</to_name>
		<to_code>M0017497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exagamglogene autotemcel</from_name>
		<from_code>2671667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Sickle Cell</to_name>
		<to_code>M0001140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Sickle Cell</to_name>
		<to_code>M0001140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voxelotor</from_name>
		<from_code>2265678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Anemia, Sickle Cell</to_name>
		<to_code>M0001140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betibeglogene autotemcel</from_name>
		<from_code>2610349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Thalassemia</to_name>
		<to_code>M0025960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clozapine</from_name>
		<from_code>2626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myeloproliferative Disorders</to_name>
		<to_code>M0014332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phenylacetate</from_name>
		<from_code>56510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>phenylacetic acid, sodium salt</to_name>
		<to_code>M0316191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saquinavir mesylate</from_name>
		<from_code>859857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saquinavir Monomethanesulfonate</to_name>
		<to_code>M0329184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium sulfide</from_name>
		<from_code>1293719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium sulfide</to_name>
		<to_code>M0103836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium sulfide anhydrous</from_name>
		<from_code>2692871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium sulfide</to_name>
		<to_code>M0103836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetyltryptophanate</from_name>
		<from_code>1366816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-acetyltryptophanate sodium</to_name>
		<to_code>M0048922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sepiapterin</from_name>
		<from_code>2723056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hyperphenylalaninaemia</to_name>
		<to_code>M0335856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitrate</from_name>
		<from_code>36700</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium nitrate</to_name>
		<to_code>M0099190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>steareth-30</from_name>
		<from_code>1366627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>poly(oxyethylene) (30) stearyl ether</to_name>
		<to_code>M000732368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus oralis</from_name>
		<from_code>2711539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus oralis</to_name>
		<to_code>M0029018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semuloparin</from_name>
		<from_code>2368733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>semuloparin</to_name>
		<to_code>M0570002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bromide</from_name>
		<from_code>1311138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium bromide</to_name>
		<to_code>M0090372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium oleanolate</from_name>
		<from_code>1366853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ursolic Acid Sodium Salt</to_name>
		<to_code>M000758441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sclareolide</from_name>
		<from_code>1426934</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sclareolide</to_name>
		<to_code>M0283904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium isethionate</from_name>
		<from_code>1364895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Isethionate</to_name>
		<to_code>M0011737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium caseinate</from_name>
		<from_code>1366917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Caseinate</to_name>
		<to_code>M0003595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren pivoxil</from_name>
		<from_code>72611</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Caseinate</to_name>
		<to_code>M0003595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefditoren</from_name>
		<from_code>83682</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Caseinate</to_name>
		<to_code>M0003595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ascorbyl phosphate</from_name>
		<from_code>1364501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium ascorbyl phosphate</to_name>
		<to_code>M0551587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfaguanidine</from_name>
		<from_code>10174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfaguanidine</to_name>
		<to_code>M0020744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sambucus nigra flower oil</from_name>
		<from_code>2053443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sambucus nigra flower oil</to_name>
		<to_code>M000757991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan monopalmitate</from_name>
		<from_code>1363701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan monopalmitate</to_name>
		<to_code>M0171039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sultilains</from_name>
		<from_code>227410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sultilains</to_name>
		<to_code>M0080099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium octyl sulfate</from_name>
		<from_code>1438636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium octyl sulfate</to_name>
		<to_code>M0534608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium phytate</from_name>
		<from_code>9903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Phytate</to_name>
		<to_code>M0016821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>steareth-20</from_name>
		<from_code>1367121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polyoxyethylene 20-stearyl ether</to_name>
		<to_code>M0127863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium metabisulfite</from_name>
		<from_code>36696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium metabisulfite</to_name>
		<to_code>M0046576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scandium</from_name>
		<from_code>1311273</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scandium</to_name>
		<to_code>M0019467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbic acid</from_name>
		<from_code>1311139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sorbic Acid</to_name>
		<to_code>M0020168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sangre de grado</from_name>
		<from_code>260039</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sangre de grado</to_name>
		<to_code>M0401063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium polymetaphosphate</from_name>
		<from_code>1364921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium polymetaphosphate</to_name>
		<to_code>M0053862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>symclosene</from_name>
		<from_code>2375531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>symclosene</to_name>
		<to_code>M0147085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfalene</from_name>
		<from_code>10175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfalene</to_name>
		<to_code>M0020745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Staphylococcus haemolyticus</from_name>
		<from_code>1489916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Staphylococcus haemolyticus</to_name>
		<to_code>M0425670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmon gonadotropin releasing hormone D-Arg6 analog ethyl amide</from_name>
		<from_code>1546435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>5-oxo-pro-his-trp-ser-tyr-gly-trp-leu-pro-glynh2</to_name>
		<to_code>M0164268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>S-adenosylmethionine sulfate tosylate</from_name>
		<from_code>9506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>S-Adenosylmethionine Sulfate Tosylate</to_name>
		<to_code>M0019323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadimethoxine</from_name>
		<from_code>10172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfadimethoxine</to_name>
		<to_code>M0020742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiramycin</from_name>
		<from_code>9991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spiramycin</to_name>
		<to_code>M0023923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiramycin</from_name>
		<from_code>9991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>demycarosylturimycin H</to_name>
		<to_code>M0067757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfobromophthalein</from_name>
		<from_code>10212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfobromophthalein</to_name>
		<to_code>M0020785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strychnine nitrate</from_name>
		<from_code>1310185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Strychnine Nitrate</to_name>
		<to_code>M0020629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium oxalate</from_name>
		<from_code>1441659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Oxalate</to_name>
		<to_code>M0329888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamoxole</from_name>
		<from_code>10183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfamoxole</to_name>
		<to_code>M0020753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium laureth sulfate</from_name>
		<from_code>1310569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium laureth sulfate</to_name>
		<to_code>M0362836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sweet cherry allergenic extract</from_name>
		<from_code>901303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sweet Cherries</to_name>
		<to_code>M000602180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfur dioxide</from_name>
		<from_code>1362879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfur Dioxide</to_name>
		<to_code>M0020801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saralasin</from_name>
		<from_code>9556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saralasin</to_name>
		<to_code>M0019423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearyl heptanoate</from_name>
		<from_code>1426355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearyl heptanoate</to_name>
		<to_code>M0582182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicyl alcohol</from_name>
		<from_code>1363054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>salicyl alcohol</to_name>
		<to_code>M0056242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium peroxide</from_name>
		<from_code>1366983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium peroxide</to_name>
		<to_code>M0139196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>85 strontium</from_name>
		<from_code>90613</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Strontium-85</to_name>
		<to_code>M000628014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salvia hispanica seed extract</from_name>
		<from_code>1309460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salvia hispanica seed extract</to_name>
		<to_code>M000745231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chlorate</from_name>
		<from_code>1366921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium chlorate</to_name>
		<to_code>M0101889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>semduramicin</from_name>
		<from_code>1314385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>semduramicin</to_name>
		<to_code>M0197356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearyl alcohol</from_name>
		<from_code>37071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearyl alcohol</to_name>
		<to_code>M0053909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan monooleate</from_name>
		<from_code>1363056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan monooleate</to_name>
		<to_code>M0070418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spinach allergenic extract</from_name>
		<from_code>901317</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium methyl oleoyl taurate</from_name>
		<from_code>1789472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>oleoylmethyltaurine sodium</to_name>
		<to_code>M0315635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>steviol</from_name>
		<from_code>1363645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>steviol</to_name>
		<to_code>M0058753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus uberis</from_name>
		<from_code>1491864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus uberis</to_name>
		<to_code>M000658852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hypophosphite monohydrate</from_name>
		<from_code>1311312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium hypophosphite monohydrate</to_name>
		<to_code>M0310682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>symclosene sodium</from_name>
		<from_code>2375530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>symclosene sodium</to_name>
		<to_code>M0323133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pertechnetate Tc 99m</from_name>
		<from_code>10349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pertechnetate Tc 99m</from_name>
		<from_code>10349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Pertechnetate Tc 99m</to_name>
		<to_code>M0021100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium pertechnetate Tc 99m</from_name>
		<from_code>10349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pertechnetate Sodium</to_name>
		<to_code>M0418362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>skatole</from_name>
		<from_code>1311386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skatole</to_name>
		<to_code>M0019919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>shark cartilage extract</from_name>
		<from_code>81782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>shark cartilage extract</to_name>
		<to_code>M0288651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver carbonate</from_name>
		<from_code>2462152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver carbonate</to_name>
		<to_code>M0103283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stigmasterol</from_name>
		<from_code>10079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Stigmasterol</to_name>
		<to_code>M0020535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silybin</from_name>
		<from_code>155067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silybin</to_name>
		<to_code>M0019880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>santonin</from_name>
		<from_code>1311390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Santonin</to_name>
		<to_code>M0019417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium glutamate</from_name>
		<from_code>1311588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Glutamate</to_name>
		<to_code>M0020104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan trioleate</from_name>
		<from_code>1363643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan trioleate</to_name>
		<to_code>M0047400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sometribove</from_name>
		<from_code>1427014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sometribove</to_name>
		<to_code>M0282067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sambucus nigra seed oil</from_name>
		<from_code>2397121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sambucus nigra seed oil</to_name>
		<to_code>M000757992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sofosbuvir</to_name>
		<to_code>M0551450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofosbuvir</from_name>
		<from_code>1484911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium monofluorophosphate</from_name>
		<from_code>56501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium monofluorophosphate</to_name>
		<to_code>M0060391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sorbitan sesquioleate</from_name>
		<from_code>1363058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sorbitan sesquioleate</to_name>
		<to_code>M0163968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>serratiopeptidase</from_name>
		<from_code>36434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>serratiopeptidase</to_name>
		<to_code>M0078974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethazine</from_name>
		<from_code>10178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfamethazine</to_name>
		<to_code>M0020748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>safrole</from_name>
		<from_code>2383532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Safrole</to_name>
		<to_code>M0019345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy sterol</from_name>
		<from_code>1363446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>soysterol</to_name>
		<to_code>M0104118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suberic acid</from_name>
		<from_code>2044370</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>suberic acid</to_name>
		<to_code>M0047477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebetralstat</from_name>
		<from_code>2717944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sebetralstat</to_name>
		<to_code>M000761589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sebetralstat</from_name>
		<from_code>2717944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garadacimab-gxii</from_name>
		<from_code>2717168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanadelumab</from_name>
		<from_code>2055641</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lanadelumab-flyo</from_name>
		<from_code>2055640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen sodium</from_name>
		<from_code>2724362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icatibant</from_name>
		<from_code>1148138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (human)</from_name>
		<from_code>809864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecallantide</from_name>
		<from_code>658708</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>icatibant acetate</from_name>
		<from_code>1294605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>donidalorsen</from_name>
		<from_code>2724361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>garadacimab</from_name>
		<from_code>2717169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angioedemas, Hereditary</to_name>
		<to_code>M0502559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus viridans group</from_name>
		<from_code>1363919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Viridans Streptococci</to_name>
		<to_code>M0405412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sitosterols</from_name>
		<from_code>9808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sitosterols</to_name>
		<to_code>M0019907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae</from_name>
		<from_code>1363917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>798228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>901631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine</from_name>
		<from_code>2686924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus pneumoniae</to_name>
		<to_code>M0020574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium stearate</from_name>
		<from_code>1366984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium stearate</to_name>
		<to_code>M0537895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soy protein isolate</from_name>
		<from_code>196238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>S-benzoylmercaptoacetyltriglycine</from_name>
		<from_code>194098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>S-benzoylmercaptoacetyltriglycine</to_name>
		<to_code>M0287596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium bisulfite</from_name>
		<from_code>36679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium bisulfite</to_name>
		<to_code>M0053854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selamectin</from_name>
		<from_code>1044269</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>selamectin</to_name>
		<to_code>M0371163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solvent red 27</from_name>
		<from_code>1495079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>oil red O</to_name>
		<to_code>M0057063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>saccharide isomerate</from_name>
		<from_code>1314278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>saccharide isomerate</to_name>
		<to_code>M000752971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silicon dioxide</from_name>
		<from_code>9771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silicon Dioxide</to_name>
		<to_code>M0019851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sambucus nigra flower extract</from_name>
		<from_code>1344643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sambucus nigra flower extract</to_name>
		<to_code>M000744429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sultopride hydrochloride</from_name>
		<from_code>236185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sultopride Hydrochloride</to_name>
		<to_code>M0311708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saccharomyces cerevisiae</to_name>
		<to_code>M0019330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Saccharomyces cerevisiae</from_name>
		<from_code>9511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Salmonella enterica subsp. enterica serovar enteritidis</from_name>
		<from_code>1329877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella enteritidis</to_name>
		<to_code>M0019390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugammadex sodium</from_name>
		<from_code>1726987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sugammadex Sodium</to_name>
		<to_code>M0521536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tetrachloroaurate</from_name>
		<from_code>1366933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>gold tetrachloride, acid, sodium salt</to_name>
		<to_code>M0315827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>strontium chloride hexahydrate</from_name>
		<from_code>1594632</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>strontium chloride hexahydrate</to_name>
		<to_code>M0316535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>solasulfone</from_name>
		<from_code>1551455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>solasulfone</to_name>
		<to_code>M0054811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium glycerophosphate</from_name>
		<from_code>1595589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium glycerophosphate</to_name>
		<to_code>M0094375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silanol</from_name>
		<from_code>1601667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silanol</to_name>
		<to_code>M0219436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium dioxide</from_name>
		<from_code>1309231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Selenium Dioxide</to_name>
		<to_code>M0317736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spermaceti</from_name>
		<from_code>9968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>spermaceti</to_name>
		<to_code>M0053886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Simeprevir</to_name>
		<to_code>M0526124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simeprevir</from_name>
		<from_code>1482790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium thiosulfate</from_name>
		<from_code>36726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium thiosulfate</to_name>
		<to_code>M0068706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silicones</from_name>
		<from_code>9778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Silicones</to_name>
		<to_code>M0019861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose palmitate</from_name>
		<from_code>1367150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose monopalmitate</to_name>
		<to_code>M0123242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Schizandra preparation</from_name>
		<from_code>56084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>schizandrin</to_name>
		<to_code>M0057146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium adipate</from_name>
		<from_code>2627782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium adipate</to_name>
		<to_code>M0095027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium arsenate, dibasic</from_name>
		<from_code>1364793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>disodium arsenate</to_name>
		<to_code>M0310678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulisobenzone</from_name>
		<from_code>1311567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulisobenzone</to_name>
		<to_code>M0053995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium laurate</from_name>
		<from_code>1425357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lauric acid, sodium salt</to_name>
		<to_code>M0318833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Streptococcus mutans</from_name>
		<from_code>1363920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptococcus mutans</to_name>
		<to_code>M0020573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>superoxide dismutase</from_name>
		<from_code>10245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Superoxide Dismutase</to_name>
		<to_code>M0020832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tartrate</from_name>
		<from_code>56524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium tartrate</to_name>
		<to_code>M0094759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scarlet red</from_name>
		<from_code>36224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>C.I. Solvent Red 24</to_name>
		<to_code>M0053724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scarlet red</from_name>
		<from_code>36224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scarlet Red</to_name>
		<to_code>M0053728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silicon nitride</from_name>
		<from_code>1989508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silicon nitride</to_name>
		<to_code>M0101919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver iodide</from_name>
		<from_code>1423914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver iodide</to_name>
		<to_code>M0096626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>St. John's wort extract</from_name>
		<from_code>258326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>herba hyperici</to_name>
		<to_code>M000743974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>St. John's wort extract</from_name>
		<from_code>258326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Saint John's wort extract</to_name>
		<to_code>M000743977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium fumarate</from_name>
		<from_code>56475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium fumarate</to_name>
		<to_code>M0100167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sialyl Lewis A</from_name>
		<from_code>2619423</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>CA-19-9 Antigen</to_name>
		<to_code>M0027621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint allergenic extract</from_name>
		<from_code>901313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chlorite</from_name>
		<from_code>992920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium chlorite</to_name>
		<to_code>M0041846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium ironedetate</from_name>
		<from_code>105673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ferric sodium edetate</to_name>
		<to_code>M0071437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sakuranetin</from_name>
		<from_code>2263158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sakuranetin</to_name>
		<to_code>M0261711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinic anhydride</from_name>
		<from_code>1374803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>succinic anhydride</to_name>
		<to_code>M0099681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver fluoride</from_name>
		<from_code>1544125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>silver fluoride</to_name>
		<to_code>M0274131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium sarcosinate</from_name>
		<from_code>1364526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Sarcosinate</to_name>
		<to_code>M0019446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium lauriminodipropionate</from_name>
		<from_code>1942335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium lauriminodipropionate</to_name>
		<to_code>M0105717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>squalene</from_name>
		<from_code>10014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Squalene</to_name>
		<to_code>M0020400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dithionate</from_name>
		<from_code>1443001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium dithionate</to_name>
		<to_code>M0046061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium sulfate</from_name>
		<from_code>36721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium sulfate</to_name>
		<to_code>M0058743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfate ion</from_name>
		<from_code>1426598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfates</to_name>
		<to_code>M0020761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sarolaner</from_name>
		<from_code>1740360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sarolaner</to_name>
		<to_code>M000636978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stearamidoethyl diethylamine</from_name>
		<from_code>1363699</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearamidoethyl diethylamine</to_name>
		<to_code>M0236680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium chloride, (22)Na</from_name>
		<from_code>1370679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Chloride, (22)Na</to_name>
		<to_code>M0020095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stannous chloride</from_name>
		<from_code>37032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stannous chloride</to_name>
		<to_code>M0081014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium glycolate</from_name>
		<from_code>1356762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>glycolic acid, monosodium salt</to_name>
		<to_code>M0319124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium stearoyl lactylate</from_name>
		<from_code>1366986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stearoyl-2-lactylic acid, sodium salt</to_name>
		<to_code>M0319339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium tripolyphosphate anhydrous</from_name>
		<from_code>1487533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium tripolyphosphate anhydrous</to_name>
		<to_code>M000636954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Sudan III</from_name>
		<from_code>1426472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sudan III</to_name>
		<to_code>M0102605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfobutylether-beta-cyclodextrin</from_name>
		<from_code>1426608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>SBE4-beta-cyclodextrin</to_name>
		<to_code>M0245826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfobutylether-beta-cyclodextrin</from_name>
		<from_code>1426608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>betadex sulfobutyl ether sodium</to_name>
		<to_code>M000645087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sucrose acetate isobutyrate</from_name>
		<from_code>1363646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sucrose acetate isobutyrate</to_name>
		<to_code>M0043686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2</from_name>
		<from_code>2468230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tozinameran</to_name>
		<to_code>M000753666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2</from_name>
		<from_code>2468230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>BNT162 Vaccine</to_name>
		<to_code>M000747629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxypyridazine</from_name>
		<from_code>10181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfamethoxypyridazine</to_name>
		<to_code>M0020751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfobromophthalein sodium</from_name>
		<from_code>203200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfobromophthalein Sodium</to_name>
		<to_code>M0361430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>stepronin</from_name>
		<from_code>2375829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>stepronin</to_name>
		<to_code>M0108093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfuric acid</from_name>
		<from_code>10231</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sulfuric acid</to_name>
		<to_code>M0103037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium dichloroacetate</from_name>
		<from_code>1366930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sodium Dichloroacetate</to_name>
		<to_code>M0006266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>synephrine</from_name>
		<from_code>10288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Synephrine</to_name>
		<to_code>M0020958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfaquinoxaline</from_name>
		<from_code>1306111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sulfaquinoxaline</to_name>
		<to_code>M0020758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraselmis suecica extract</to_name>
		<to_code>2262006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethoxysilylethyl polydimethylsiloxyethyl hexyl dimethicone</to_name>
		<to_code>2566288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsilyl treated diimethiconol-trimethylsiloxysilicate crosspolymer (45-55 WW)</to_name>
		<to_code>2174101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropisetron</to_name>
		<to_code>27392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tecovirimat</to_name>
		<to_code>2055104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrobisdemethoxydiferuloylmethane</to_name>
		<to_code>1376153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tribehenin PEG-20 esters</to_name>
		<to_code>1312647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tinidazole</to_name>
		<to_code>10612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theophylline sodium glycinate</to_name>
		<to_code>155075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymopentin acetate</to_name>
		<to_code>236769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tipiracil</to_name>
		<to_code>1670304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tanacetum coccineum flower extract</to_name>
		<to_code>2283225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia x europaea flower extract</to_name>
		<to_code>1309823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turmeric oil</to_name>
		<to_code>1373037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teniposide</to_name>
		<to_code>10362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triceteareth-4-phosphate</to_name>
		<to_code>1811770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine acetate</to_name>
		<to_code>2360432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triiodide ion</to_name>
		<to_code>1546364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tropaeolum majus flowering top extract</to_name>
		<to_code>1664625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tussilago farfara flower bud extract</to_name>
		<to_code>2540131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talimogene laherparepvec</to_name>
		<to_code>1721264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thallous cation Tl-201</to_name>
		<to_code>1546370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine stearate</to_name>
		<to_code>38625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone undecanoate</to_name>
		<to_code>37864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tuna allergenic extract</to_name>
		<to_code>892503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron pubescens shoot extract</to_name>
		<to_code>1370734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>6-tert-butyl-3-methyl-2,4-dinitroanisole</to_name>
		<to_code>2360131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tripleurospermum inodorum whole extract</to_name>
		<to_code>1866509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>torsemide</to_name>
		<to_code>38413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tea tree extract</to_name>
		<to_code>436163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Torreya nucifera whole extract</to_name>
		<to_code>1312732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tributyl phosphate</to_name>
		<to_code>1314418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tinzaparin</to_name>
		<to_code>69646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisodecyl trimellitate</to_name>
		<to_code>1732390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahexyldecyl ascorbate</to_name>
		<to_code>1309254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimipramine maleate</to_name>
		<to_code>71532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-8</to_name>
		<to_code>1801136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,4,6,8-tetramethyltetraphenylcyclotetrasiloxane, (2.alpha.,4.alpha.,6.beta.,8.beta.)-</to_name>
		<to_code>2550704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiphenamil</to_name>
		<to_code>38150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-dkst</to_name>
		<to_code>2103478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiopronin</to_name>
		<to_code>6765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocainide monohydrochloride</to_name>
		<to_code>142145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tinospora sinensis stem extract</to_name>
		<to_code>2593687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripelennamine hydrochloride</to_name>
		<to_code>91063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tbo-filgrastim</to_name>
		<to_code>1433764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethylene glycoldimethacrylate</to_name>
		<to_code>2472322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioctic acid</to_name>
		<to_code>6417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-3</to_name>
		<to_code>1943166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolmetin</to_name>
		<to_code>10636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talinexomer</to_name>
		<to_code>2670341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyrosine disodium dihydrate</to_name>
		<to_code>2642193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-tert-butylcyclohexyl acetate</to_name>
		<to_code>2289005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin</to_name>
		<to_code>10528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theobromine</to_name>
		<to_code>10437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolperisone</to_name>
		<to_code>10639</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazemetostat hydrobromide</to_name>
		<to_code>2274379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocotrienols</to_name>
		<to_code>578285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrofosmin</to_name>
		<to_code>1311569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trolamine salicylate</to_name>
		<to_code>38866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tanacetum parthenium flower extract</to_name>
		<to_code>1309476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichosanthes kirilowii seed extract</to_name>
		<to_code>2592983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turmeric extract</to_name>
		<to_code>1114883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tixagevimab</to_name>
		<to_code>2587300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiadilon</to_name>
		<to_code>38249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolonium chloride</to_name>
		<to_code>10638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tripterygium wilfordii root extract</to_name>
		<to_code>1360625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolterodine tartrate</to_name>
		<to_code>221174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiotepa</to_name>
		<to_code>10473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tranylcypromine</to_name>
		<to_code>10734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylamine hydrochloride</to_name>
		<to_code>1999993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamine hydrochloride</to_name>
		<to_code>235355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricetin</to_name>
		<to_code>1994358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tussilago farfara flower extract</to_name>
		<to_code>1309480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tovorafenib</to_name>
		<to_code>2682434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane tricaprate</to_name>
		<to_code>1314294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopheryl nicotinate, D-.alpha.</to_name>
		<to_code>1359091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>three-lobe sage extract</to_name>
		<to_code>1534776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taletrectinib</to_name>
		<to_code>2716919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium arvense whole extract</to_name>
		<to_code>2536136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turpentine</to_name>
		<to_code>10938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tebentafusp-tebn</to_name>
		<to_code>2590744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-tert-butylcyclohexanyl acetate, trans-</to_name>
		<to_code>2374918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tigolaner</to_name>
		<to_code>2698199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia tomentosa whole extract</to_name>
		<to_code>2171267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone diacetate</to_name>
		<to_code>10762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichomonas vaginalis preparation</to_name>
		<to_code>1441656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taraxacum officinale whole extract</to_name>
		<to_code>1311305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tormentil</to_name>
		<to_code>237060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turoctocog alfa</to_name>
		<to_code>1737557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiocyanate</to_name>
		<to_code>1427067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tulathromycin A</to_name>
		<to_code>1437806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisopurine</to_name>
		<to_code>38136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tabasco pepper extract</to_name>
		<to_code>1721694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terbutaline sulfate</to_name>
		<to_code>10369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Telopea speciosissima flower extract</to_name>
		<to_code>1807128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafasitamab</to_name>
		<to_code>2387211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telisotuzumab vedotin</to_name>
		<to_code>2721996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trospium chloride</to_name>
		<to_code>38891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tartrate</to_name>
		<to_code>1314221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimipramine</to_name>
		<to_code>10834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilaureth-4 phosphate</to_name>
		<to_code>1370423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine tris(dihydrogen phosphate)</to_name>
		<to_code>1811017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trapa bicornis seed extract</to_name>
		<to_code>1872048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tasimelteon</to_name>
		<to_code>1490468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocophersolan</to_name>
		<to_code>159151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangerine allergenic extract</to_name>
		<to_code>1011412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thuringiensin</to_name>
		<to_code>1648507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsilyl trihydrogen silicate</to_name>
		<to_code>2606512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracycline hydrochloride</to_name>
		<to_code>142446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Terminalia chebula whole extract</to_name>
		<to_code>2048120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temocillin</to_name>
		<to_code>37775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triarachidin</to_name>
		<to_code>1655558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terazosin</to_name>
		<to_code>37798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tungsten</to_name>
		<to_code>1667702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisotumab vedotin</to_name>
		<to_code>2571094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>typha orientalis whole extract</to_name>
		<to_code>2637685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetramethylchromanol glucose</to_name>
		<to_code>2671243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripe preparation</to_name>
		<to_code>1350210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tacrine</to_name>
		<to_code>10318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Teucrium scorodonia whole extract</to_name>
		<to_code>1549111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris(N-hydroxyethyl)hexahydrotriazine</to_name>
		<to_code>2560229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine lauroyl glutamate</to_name>
		<to_code>2690988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tropaeolum majus flower extract</to_name>
		<to_code>1369396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tianeptine</to_name>
		<to_code>38252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trovafloxacin mesylate</to_name>
		<to_code>221177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsiloxysilicate (M-Q 0.8-1.0)</to_name>
		<to_code>1426676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimetrexate glucuronate</to_name>
		<to_code>38725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris(PPG-3 benzyl ether)</to_name>
		<to_code>1649136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripelennamine</to_name>
		<to_code>10847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimipramine mesylate</to_name>
		<to_code>236189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tea leaf oil</to_name>
		<to_code>1309477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium dicarboxymethyl alaninate</to_name>
		<to_code>1598337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Terminalia arjuna whole extract</to_name>
		<to_code>2592072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricyclodecenyl propionate</to_name>
		<to_code>1659916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirilazad mesylate hydrate</to_name>
		<to_code>59827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tellurium tetrachloride</to_name>
		<to_code>1863222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theofibrate</to_name>
		<to_code>236713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telotristat etiprate</to_name>
		<to_code>1872448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopherol</to_name>
		<to_code>1236136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir anhydrous</to_name>
		<to_code>1546017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triazolam</to_name>
		<to_code>10767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir</to_name>
		<to_code>117466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>topiramate</to_name>
		<to_code>38404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamarack pollen extract</to_name>
		<to_code>900131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamoxifen citrate</to_name>
		<to_code>40137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapeptide-21</to_name>
		<to_code>1314296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triphosphoric acid, sodium salt</to_name>
		<to_code>1364528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiotropium</to_name>
		<to_code>69120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thujopsis dolabrata wood oil</to_name>
		<to_code>2174383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane tricaprylate-tricaprate</to_name>
		<to_code>1313271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiapride</to_name>
		<to_code>10588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyme preparation</to_name>
		<to_code>319823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tribulus terrestris fruit extract</to_name>
		<to_code>1311579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telotristat</to_name>
		<to_code>1872382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymine</to_name>
		<to_code>1368871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin, bovine</to_name>
		<to_code>2264114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tebentafusp</to_name>
		<to_code>2590743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiodipropionic acid</to_name>
		<to_code>2046122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone</to_name>
		<to_code>10759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>THALLIUM CATION TL-201 (1+)</to_name>
		<to_code>1546430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoprim lactate</to_name>
		<to_code>235855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thymus vulgaris leaf extract</to_name>
		<to_code>1307658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense pollen extract</to_name>
		<to_code>1340182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisiloxane</to_name>
		<to_code>1368190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-5</to_name>
		<to_code>1371912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine</to_name>
		<to_code>38623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tylophora indica leaf extract</to_name>
		<to_code>1482793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trenbolone acetate</to_name>
		<to_code>1484277</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tabtoxin</to_name>
		<to_code>2590695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetradecamethylhexasiloxane</to_name>
		<to_code>1428858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiagabine</to_name>
		<to_code>31914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tacalcitol</to_name>
		<to_code>291204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tulobuterol hydrochloride</to_name>
		<to_code>235841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecane</to_name>
		<to_code>1811766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetanus immune globulin, human</to_name>
		<to_code>91603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocainide</to_name>
		<to_code>42359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tezepelumab</to_name>
		<to_code>2587789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thaumatococcus daniellii fruit extract</to_name>
		<to_code>1424462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripolyphosphate ion</to_name>
		<to_code>1546409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolvaptan</to_name>
		<to_code>358257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisilane</to_name>
		<to_code>2176729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrolinalool</to_name>
		<to_code>2373947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricalcium phosphate</to_name>
		<to_code>47628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tezepelumab-ekko</to_name>
		<to_code>2587790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiemonium methylsulfate</to_name>
		<to_code>38265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tixocortol pivalate</to_name>
		<to_code>38336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethoxysilane</to_name>
		<to_code>2634293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tipranavir</to_name>
		<to_code>190548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl ethyleneglycol monoether</to_name>
		<to_code>2548930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir disoproxil fumarate</to_name>
		<to_code>322248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine oleate</to_name>
		<to_code>1788982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense pollen extract</to_name>
		<to_code>2102052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirzepatide</to_name>
		<to_code>2601723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tislelizumab-jsgr</to_name>
		<to_code>2677425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoprim hydrochloride</to_name>
		<to_code>259281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiliroside</to_name>
		<to_code>1423792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine phosphate</to_name>
		<to_code>2287550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricaine</to_name>
		<to_code>1370418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talinolol</to_name>
		<to_code>37546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyrotropin-releasing hormone</to_name>
		<to_code>10580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teclistamab-cqyv</to_name>
		<to_code>2619425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiothixene</to_name>
		<to_code>10510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymostimulin</to_name>
		<to_code>38233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tramadol hydrochloride</to_name>
		<to_code>82110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thaumatin</to_name>
		<to_code>1666108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiethylperazine</to_name>
		<to_code>10471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thurfyl salicylate</to_name>
		<to_code>237144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Townsendia exscapa whole extract</to_name>
		<to_code>2590696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylphloroglucinol</to_name>
		<to_code>38716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolbutamide</to_name>
		<to_code>10635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolterodine</to_name>
		<to_code>119565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyme allergenic extract</to_name>
		<to_code>974527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tramazoline</to_name>
		<to_code>38453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thimerosal</to_name>
		<to_code>10472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>timolol</to_name>
		<to_code>10600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethyl citrate</to_name>
		<to_code>1310554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenoxicam</to_name>
		<to_code>37790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tinospora capillipes root extract</to_name>
		<to_code>1546866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tagetes minuta flower oil</to_name>
		<to_code>1366331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triclocarban</to_name>
		<to_code>38609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>threonic acid, L-</to_name>
		<to_code>1549112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolfenamic acid</to_name>
		<to_code>38377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m sestamibi</to_name>
		<to_code>1482913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisocetyl citrate</to_name>
		<to_code>1601596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron diversilobum whole extract</to_name>
		<to_code>2533914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimebutine</to_name>
		<to_code>10819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron radicans leaf extract</to_name>
		<to_code>1309758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine tristearate</to_name>
		<to_code>2391150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tilmicosin</to_name>
		<to_code>38278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-dttb</to_name>
		<to_code>2289225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tivozanib hydrochloride</to_name>
		<to_code>2534245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telaprevir</to_name>
		<to_code>1102261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine 2-cyclohexyl-4,6-dinitrophenolate</to_name>
		<to_code>1552576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>troclosene</to_name>
		<to_code>1537576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichinella britovi</to_name>
		<to_code>1368365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tilbroquinol</to_name>
		<to_code>166718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tadenan</to_name>
		<to_code>37534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoxycaprylylsilane</to_name>
		<to_code>1314293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>timolol hemihydrate</to_name>
		<to_code>221172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethylamine</to_name>
		<to_code>1307097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioctate</to_name>
		<to_code>618060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talactoferrin alfa</to_name>
		<to_code>1425932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tert-butyl methylphenoxy phenol</to_name>
		<to_code>2397690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsiloxysilicate (M-Q 0.66)</to_name>
		<to_code>1426948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilaciclib</to_name>
		<to_code>2479690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taurolidine</to_name>
		<to_code>2670453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripalmitolein</to_name>
		<to_code>2667254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichlormethiazide</to_name>
		<to_code>10772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tilmicosin phosphate</to_name>
		<to_code>1294593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trapidil</to_name>
		<to_code>10735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talampicillin napsylate</to_name>
		<to_code>235836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telisotuzumab vedotin-tllv</to_name>
		<to_code>2714236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsilane</to_name>
		<to_code>1314250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thymus oil</to_name>
		<to_code>1309479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine cocoyl glutamate</to_name>
		<to_code>1653328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toripalimab-tpzi</to_name>
		<to_code>2669407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichloroacetate</to_name>
		<to_code>618564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisotumab</to_name>
		<to_code>2571095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiamulin fumarate</to_name>
		<to_code>1314589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiosalicylate</to_name>
		<to_code>91099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirofiban</to_name>
		<to_code>73137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tribulus terrestris root extract</to_name>
		<to_code>1306058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricaprylyl citrate</to_name>
		<to_code>1314421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trelstar pamoate</to_name>
		<to_code>905060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theophylline</to_name>
		<to_code>10438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Typhonium giganteum whole extract</to_name>
		<to_code>1999320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trofosfamide</to_name>
		<to_code>38865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tussilago petasites</to_name>
		<to_code>350530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron diversilobum leaf extract</to_name>
		<to_code>1310042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teplizumab-mzwv</to_name>
		<to_code>2621881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichlorofluoromethane</to_name>
		<to_code>38578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tradescantia occidentalis whole extract</to_name>
		<to_code>2533915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tizanidine hydrochloride</to_name>
		<to_code>236460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethoxysilylpropyl steardimonium</to_name>
		<to_code>2471303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrozoline hydrochloride</to_name>
		<to_code>57983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tioclomarol</to_name>
		<to_code>163426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichoderma harzianam extract</to_name>
		<to_code>968184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treosulfan</to_name>
		<to_code>38508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium repens pollen extract</to_name>
		<to_code>1363563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taletrectinib adipate</to_name>
		<to_code>2716920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Triticum aestivum extract</to_name>
		<to_code>1311122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopheryl acid succinate,D-alpha</to_name>
		<to_code>314875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichothecium roseum allergenic extract</to_name>
		<to_code>968426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temsirolimus</to_name>
		<to_code>657797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tretinoin</to_name>
		<to_code>10753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tetracoccosporium paxianum allergenic extract</to_name>
		<to_code>968502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine hydrochloride</to_name>
		<to_code>1368178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraethylammonium hydroxide</to_name>
		<to_code>1648695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiotropium bromide, anhydrous</to_name>
		<to_code>2462023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trans-3-isocamphylcyclohexanol</to_name>
		<to_code>2397710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>threonate</to_name>
		<to_code>1547558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tuberculin</to_name>
		<to_code>10908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tofersen</to_name>
		<to_code>2634995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tioconazole</to_name>
		<to_code>38298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone cypionate</to_name>
		<to_code>835827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-tert-butylcyclohexanol, cis-</to_name>
		<to_code>2045941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenapanor hydrochloride</to_name>
		<to_code>2199673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocilizumab-aazg</to_name>
		<to_code>2679427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymidine</to_name>
		<to_code>1372538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tahitian vanilla bean extract</to_name>
		<to_code>2586080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiophene</to_name>
		<to_code>154876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocilizumab-anoh</to_name>
		<to_code>2705421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treponemic skin canker preparation, human</to_name>
		<to_code>1367174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylbenzenepropanol</to_name>
		<to_code>1376097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyrotropin</to_name>
		<to_code>10579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trehalulose</to_name>
		<to_code>1428856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioctic acid amide</to_name>
		<to_code>1597391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazarotene</to_name>
		<to_code>83947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolmetin sodium</to_name>
		<to_code>42935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taurate</to_name>
		<to_code>1431306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolazoline hydrochloride</to_name>
		<to_code>235450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trientine hydrochloride</to_name>
		<to_code>235370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tartaric acid, D-</to_name>
		<to_code>1371315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamarind extract</to_name>
		<to_code>1649129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teprotumumab-trbw</to_name>
		<to_code>2274802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropolone</to_name>
		<to_code>1368873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taraxacum palustre root extract</to_name>
		<to_code>1309985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Theridion curassavicum preparation</to_name>
		<to_code>1311091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talquetamab-tgvs</to_name>
		<to_code>2644448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiadenol</to_name>
		<to_code>38248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Typha angustifolia stem extract</to_name>
		<to_code>2699679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium edetate</to_name>
		<to_code>105745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluperidol</to_name>
		<to_code>10804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisagenlecleucel</to_name>
		<to_code>1986438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theaflavin</to_name>
		<to_code>38021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tulipa kaufmanniana bulb extract</to_name>
		<to_code>1739227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teclistamab</to_name>
		<to_code>2619426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichosporon cutaneum allergenic extract</to_name>
		<to_code>1426665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiotropium bromide</to_name>
		<to_code>393575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taraxacum sinicum whole extract</to_name>
		<to_code>2592981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triheptanoin</to_name>
		<to_code>1313234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tildrakizumab-asmn</to_name>
		<to_code>2053449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m disofenin</to_name>
		<to_code>37665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium citrate anhydrous</to_name>
		<to_code>1310549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron preparation</to_name>
		<to_code>285166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripelennamine citrate</to_name>
		<to_code>71533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,1,1-triethoxyethane</to_name>
		<to_code>2474630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton schoenleinii allergenic extract</to_name>
		<to_code>968422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taxus baccata whole extract</to_name>
		<to_code>1876512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisostearin</to_name>
		<to_code>1426662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocamphyl</to_name>
		<to_code>60906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taxus baccata fruit extract</to_name>
		<to_code>1314222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tralokinumab</to_name>
		<to_code>2589225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tylvalosin tartrate</to_name>
		<to_code>1368468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>troclosene sodium</to_name>
		<to_code>1537575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,1,3-tris(2-chloroethoy)propane</to_name>
		<to_code>2044897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton (fungus)</to_name>
		<to_code>328140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triclofos sodium</to_name>
		<to_code>104696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tantalum carbide</to_name>
		<to_code>1989395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>topotecan hydrochloride</to_name>
		<to_code>266573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilostane</to_name>
		<to_code>38668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tsuga canadensis flower bud extract</to_name>
		<to_code>1309813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tranilast</to_name>
		<to_code>57330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tag alder pollen extract</to_name>
		<to_code>851902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triphenylmethane</to_name>
		<to_code>2287153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripeptide-10 citrulline</to_name>
		<to_code>1664430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triolein</to_name>
		<to_code>1368168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tildrakizumab</to_name>
		<to_code>2053436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trientine</to_name>
		<to_code>10798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichilia emetica seed butter</to_name>
		<to_code>1722377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taurine deoxycholate</to_name>
		<to_code>1364853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tapioca starch allergenic extract</to_name>
		<to_code>901346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-anns</to_name>
		<to_code>2174802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tsuga canadensis whole extract</to_name>
		<to_code>2531132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toceranib phosphate</to_name>
		<to_code>1145944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tin</to_name>
		<to_code>10603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trandolaprilat</to_name>
		<to_code>1546379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triclofos</to_name>
		<to_code>38610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron succedaneum fruit wax</to_name>
		<to_code>2618721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talniflumate</to_name>
		<to_code>236770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron pubescens leaf extract</to_name>
		<to_code>1309673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl lactate</to_name>
		<to_code>1487115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichosanthes kirilowii root extract</to_name>
		<to_code>1310082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrasodium glutamate diacetate</to_name>
		<to_code>1312373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetradecyl hydrogen sulfate (ester)</to_name>
		<to_code>1370424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-strf</to_name>
		<to_code>2700714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris(tetramethylhydroxypiperidinol) citrate</to_name>
		<to_code>1368375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,6,10-trimethyl-9-undecenal</to_name>
		<to_code>2378834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethoxy(3-isocyanatopropyl)silane</to_name>
		<to_code>2371689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trametes versicolor whole extract</to_name>
		<to_code>1435105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taraxacum mongolicum extract</to_name>
		<to_code>1541740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisononanoin</to_name>
		<to_code>1427124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tall oat grass pollen extract</to_name>
		<to_code>1006506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris(trimethylsiloxy)phenylsilane</to_name>
		<to_code>1799152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrasodium diethylenetriaminepentamethylenephosphonate</to_name>
		<to_code>1995243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone 17-phenylpropionate</to_name>
		<to_code>37855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium repens whole extract</to_name>
		<to_code>2001815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirofiban hydrochloride</to_name>
		<to_code>253202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tinzaparin sodium</to_name>
		<to_code>104466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamine</to_name>
		<to_code>10454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolcapone</to_name>
		<to_code>72937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafenoquine succinate</to_name>
		<to_code>2054091</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopheryl glucoside</to_name>
		<to_code>2667746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tylosin tartrate</to_name>
		<to_code>996012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tartrazine</to_name>
		<to_code>1305578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetanus immune globulin</to_name>
		<to_code>1727875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terazosin hydrochloride</to_name>
		<to_code>235224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisostearyl citrate</to_name>
		<to_code>1539636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense leaf extract</to_name>
		<to_code>1364991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terazosin hydrochloride anhydrous</to_name>
		<to_code>1299927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,4,5-T-trolamine</to_name>
		<to_code>1947504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripotassium glycyrrhizinate</to_name>
		<to_code>1359425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tritoqualine</to_name>
		<to_code>38810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja plicata leaf extract</to_name>
		<to_code>1309746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treprostinil sodium</to_name>
		<to_code>342691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluoperazine</to_name>
		<to_code>10800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thymus mastichina flowering top oil</to_name>
		<to_code>1369565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terbinafine</to_name>
		<to_code>37801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-tert-butylcyclohexyloxybutanol</to_name>
		<to_code>1860086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense flower extract</to_name>
		<to_code>1310039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tetradium ruticarpum fruit extract</to_name>
		<to_code>1311684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraxetan</to_name>
		<to_code>2260905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimebutine maleate salt</to_name>
		<to_code>262296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl salicylate</to_name>
		<to_code>1421431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrodiferuloylmethane</to_name>
		<to_code>1362136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioridazine</to_name>
		<to_code>10502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>threonine</to_name>
		<to_code>10524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoprim</to_name>
		<to_code>10829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>transforming growth factor beta 1</to_name>
		<to_code>1426465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangeretin</to_name>
		<to_code>2682551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tanacetum vulgare top extract</to_name>
		<to_code>1311054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine glutamate</to_name>
		<to_code>1743375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tinzaparin sodium,porcine</to_name>
		<to_code>235995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoxybenzylidene pentanedione</to_name>
		<to_code>1925205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrachloroaurate ion</to_name>
		<to_code>1546431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Teucrium marum extract</to_name>
		<to_code>1341385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticovirimat monohydrate</to_name>
		<to_code>2055103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazemetostat</to_name>
		<to_code>2274378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tobramycin</to_name>
		<to_code>10627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tellurium</to_name>
		<to_code>1311384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tragacanth allergenic extract</to_name>
		<to_code>1232630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamoxifen</to_name>
		<to_code>10324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tissue respiratory factor</to_name>
		<to_code>325522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydropiperine</to_name>
		<to_code>1661433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trometamol citrate</to_name>
		<to_code>2166044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>travoprost</to_name>
		<to_code>283809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terpin hydrate</to_name>
		<to_code>89916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamsulosin hydrochloride</to_name>
		<to_code>236495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafamidis meglumine</to_name>
		<to_code>1727003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tanacetum vulgare whole extract</to_name>
		<to_code>1797519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terlipressin</to_name>
		<to_code>57048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theanine</to_name>
		<to_code>38022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris-BHT mesitylene</to_name>
		<to_code>1428857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichoderma viride allergenic extract</to_name>
		<to_code>968401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium ethylenediamine disuccinate</to_name>
		<to_code>1364530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilaurin</to_name>
		<to_code>1368880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triphosphoric acid</to_name>
		<to_code>1364529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tagetes erecta whole extract</to_name>
		<to_code>1539415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Turnera diffusa leaf extract</to_name>
		<to_code>1591919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrozoline</to_name>
		<to_code>37935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>titanium carbide</to_name>
		<to_code>1989495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium nitrilotriacetate</to_name>
		<to_code>1735050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilinolein</to_name>
		<to_code>1655559</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolnaftate</to_name>
		<to_code>10637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trametes versicolor fruiting body extract</to_name>
		<to_code>1370985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyroid (USP)</to_name>
		<to_code>10572</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioguanine anhydrous</to_name>
		<to_code>1546005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tribenoside</to_name>
		<to_code>38557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>threonine, DL-</to_name>
		<to_code>1987478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tepotinib hydrochloride</to_name>
		<to_code>2477104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theobromine sod salicylate</to_name>
		<to_code>236926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropatepine</to_name>
		<to_code>38876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamanu oil</to_name>
		<to_code>1373444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron pubescens whole extract</to_name>
		<to_code>1999726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapetide-4</to_name>
		<to_code>1998745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tartaric acid</to_name>
		<to_code>37578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talampicillin</to_name>
		<to_code>10322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluridine</to_name>
		<to_code>10803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teferrol</to_name>
		<to_code>37744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-6 phosphate</to_name>
		<to_code>1995551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracaine hydrochloride</to_name>
		<to_code>91189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-Trimethylammonioethyl methacrylate</to_name>
		<to_code>2539175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tixocortol</to_name>
		<to_code>57257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m bicisate</to_name>
		<to_code>114918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,2,2-trifluoroacetophenone</to_name>
		<to_code>1371443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trabectedin</to_name>
		<to_code>1716278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir alafenamide fumarate</to_name>
		<to_code>1721604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thonzonium</to_name>
		<to_code>237058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terpinolene</to_name>
		<to_code>2380832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teriparatide</to_name>
		<to_code>32915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tribulus</to_name>
		<to_code>1423345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taenia saginata preparation</to_name>
		<to_code>1426377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tsuga canadensis leaf oil</to_name>
		<to_code>2533916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thenoate lithium</to_name>
		<to_code>236587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toloxatone</to_name>
		<to_code>38382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tulobuterol</to_name>
		<to_code>38967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichloroacetic acid</to_name>
		<to_code>10773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia platyphyllos flower extract</to_name>
		<to_code>1539192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyloxapol</to_name>
		<to_code>38998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thallous acetate</to_name>
		<to_code>2048725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifarotene</to_name>
		<to_code>2205637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanaolamine phenylbenzimidazole sulfonate</to_name>
		<to_code>2000917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirbanibulin</to_name>
		<to_code>2471078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trypan blue</to_name>
		<to_code>10878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-10</to_name>
		<to_code>1314305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teduglutide</to_name>
		<to_code>1364468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyramine</to_name>
		<to_code>10958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracaine</to_name>
		<to_code>10391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toluene</to_name>
		<to_code>1311381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tansy oil</to_name>
		<to_code>1488822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tetragonia tetragonoides whole extract</to_name>
		<to_code>2567332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluperidol hydrochloride</to_name>
		<to_code>236140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone (micronized)</to_name>
		<to_code>221168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tibezonium iodide</to_name>
		<to_code>237141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapropyl orthosilicate</to_name>
		<to_code>1314229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telisotuzumab</to_name>
		<to_code>2714237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,1,1,2-tetrafluorochloroethane</to_name>
		<to_code>2689143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamylal</to_name>
		<to_code>10464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triclosan</to_name>
		<to_code>10795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiothixene hydrochloride</to_name>
		<to_code>91135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trillium erectum root extract</to_name>
		<to_code>1310103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tylophora indica whole extract</to_name>
		<to_code>1361463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxoplasma gondii DNA</to_name>
		<to_code>2530891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafenoquine</to_name>
		<to_code>2054023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapeptide-2</to_name>
		<to_code>2399545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terbium</to_name>
		<to_code>1367186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talquetamab</to_name>
		<to_code>2644447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tybamate</to_name>
		<to_code>62178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tribehenin</to_name>
		<to_code>1426386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethenylmethylsilane</to_name>
		<to_code>2474633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telbivudine</to_name>
		<to_code>474128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teplizumab</to_name>
		<to_code>2621880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telavancin hydrochloride</to_name>
		<to_code>864624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethobenzamide</to_name>
		<to_code>38685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyme oil</to_name>
		<to_code>90950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamarind seed extract</to_name>
		<to_code>1307969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tert-butyl acetate</to_name>
		<to_code>2668412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja occidentalis leaf extract</to_name>
		<to_code>1309810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,1,3-tri(3-tert-butyl-4-hydroxy-6-methylphenyl)butane</to_name>
		<to_code>1872247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrachlorodibenzodioxin</to_name>
		<to_code>2120182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thermus thermophilus lysate</to_name>
		<to_code>1306060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triprolidine tannate</to_name>
		<to_code>1099727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Terminalia catappa leaf extract</to_name>
		<to_code>1860072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trametinib</to_name>
		<to_code>1425099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-terpineol, (+)-</to_name>
		<to_code>1803668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tepraloxydim</to_name>
		<to_code>2549831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thalidomide</to_name>
		<to_code>10432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trospium</to_name>
		<to_code>236778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone isocaproate</to_name>
		<to_code>75806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tioxolone</to_name>
		<to_code>2059173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talazoparib</to_name>
		<to_code>2099704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tromethamine</to_name>
		<to_code>10865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trehalose dihydrate</to_name>
		<to_code>1311372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiratricol</to_name>
		<to_code>13982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiobutabarbital sodium</to_name>
		<to_code>314874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton verrucosum</to_name>
		<to_code>1310905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tryptophan</to_name>
		<to_code>10898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tigecycline</to_name>
		<to_code>384455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab deruxtecan</to_name>
		<to_code>2267582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioglycolate</to_name>
		<to_code>1370627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc-99m sulfur colloid</to_name>
		<to_code>1423270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiletamine hydrochloride</to_name>
		<to_code>1535216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium citrate</to_name>
		<to_code>253204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafamidis</to_name>
		<to_code>1545063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton antigen</to_name>
		<to_code>465118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin, human</to_name>
		<to_code>825006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toremifene citrate</to_name>
		<to_code>49953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoprim sulfate</to_name>
		<to_code>221176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trihexyphenidyl</to_name>
		<to_code>10811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium HEDTA</to_name>
		<to_code>1364567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,4,5-T dimethylammonium</to_name>
		<to_code>2370886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimeprazine tartrate</to_name>
		<to_code>164308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine lactate</to_name>
		<to_code>1312086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tributyl phosphite</to_name>
		<to_code>2399030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetroxoprim</to_name>
		<to_code>37999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxoplasma gondii</to_name>
		<to_code>1432991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiethylperazine maleate</to_name>
		<to_code>71529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trofinetide</to_name>
		<to_code>2632852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja occidentalis leafy twig extract</to_name>
		<to_code>1309754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyrothricin</to_name>
		<to_code>10968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, trans-(+/-)-</to_name>
		<to_code>2570563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temafloxacin hydrochloride</to_name>
		<to_code>295217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temsavir</to_name>
		<to_code>2675620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trolamine stearate</to_name>
		<to_code>1314215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tetrapanax papyrifer stem extract</to_name>
		<to_code>2199294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tobramycin sulfate</to_name>
		<to_code>7276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tremelimumab</to_name>
		<to_code>2619313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,3,3,3-tetrafluoropropene, (1E)-</to_name>
		<to_code>1494198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocol acetate</to_name>
		<to_code>2043280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia tomentosa bud extract</to_name>
		<to_code>1875950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetradecane</to_name>
		<to_code>2167852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangerine juice</to_name>
		<to_code>1747710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrasilane</to_name>
		<to_code>1359283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teicoplanin</to_name>
		<to_code>57021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taraxacum officinale flower extract</to_name>
		<to_code>1649016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terbutaline</to_name>
		<to_code>10368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Torreya nucifera seed oil</to_name>
		<to_code>1874077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triacetoneamine-N-oxyl</to_name>
		<to_code>10757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triceteth-4 phosphate</to_name>
		<to_code>2390629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tabebuia heterophylla bark extract</to_name>
		<to_code>1309796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium pratense whole extract</to_name>
		<to_code>1999194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tanacetum annuum flowering top oil</to_name>
		<to_code>2359269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticlopidine hydrochloride</to_name>
		<to_code>97</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimetrexate</to_name>
		<to_code>42333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thermus thermophilus extract</to_name>
		<to_code>1356714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane triisostearate</to_name>
		<to_code>1539637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracycline trihydrate</to_name>
		<to_code>236873</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talbutal</to_name>
		<to_code>89810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir alafenamide</to_name>
		<to_code>1721603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine dioleate</to_name>
		<to_code>1813434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trypan blue free acid</to_name>
		<to_code>1726081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethylhexanoin</to_name>
		<to_code>1368189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trioxsalen</to_name>
		<to_code>10844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trachelospermum jasminoides stem extract</to_name>
		<to_code>2690788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tisotumab vedotin-tftv</to_name>
		<to_code>2571093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thymus vulgaris whole extract</to_name>
		<to_code>1376349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium phosphide</to_name>
		<to_code>2635085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiropramide hydrochloride</to_name>
		<to_code>236681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyramine hydrochloride</to_name>
		<to_code>236897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tabebuia impetiginosa bark extract</to_name>
		<to_code>1310167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,1,2,2-tetrafluoroethane</to_name>
		<to_code>1487139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridihexethyl chloride</to_name>
		<to_code>54421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talc</to_name>
		<to_code>10323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia americana flower extract</to_name>
		<to_code>1492184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrafluoromethane</to_name>
		<to_code>1368889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiotropium bromide mono</to_name>
		<to_code>1552007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tapentadol</to_name>
		<to_code>787390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-12</to_name>
		<to_code>1313267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiazolylalanine</to_name>
		<to_code>2046121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terpene resin</to_name>
		<to_code>2640032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris(tetramethylhydroxypiperidinol)</to_name>
		<to_code>1368376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymopentin</to_name>
		<to_code>40230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tislelizumab</to_name>
		<to_code>2677426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tribulus terrestris flower extract</to_name>
		<to_code>2636532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-tert-butylcyclohexyl acetate, cis-</to_name>
		<to_code>2604560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethaphan</to_name>
		<to_code>10828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrasodium iminodisuccinate</to_name>
		<to_code>1366937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tartaric acid, DL</to_name>
		<to_code>1803725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3,5,5-trimethylhexanal</to_name>
		<to_code>2367408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiafentanil</to_name>
		<to_code>2691823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tegafur</to_name>
		<to_code>4582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trehalose isostearate esters</to_name>
		<to_code>1541743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temazepam</to_name>
		<to_code>10355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treprostinil diolamine</to_name>
		<to_code>1927409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tristearin</to_name>
		<to_code>1368872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethyl-1,3-pentanediol</to_name>
		<to_code>1607329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripeptide-29</to_name>
		<to_code>2642868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine cocoyl glutaminate</to_name>
		<to_code>2383342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrolinalyl acetate</to_name>
		<to_code>2383940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tasonermin</to_name>
		<to_code>283746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticarcillin disodium</to_name>
		<to_code>142447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-(triethoxysilyl)propylamine</to_name>
		<to_code>1425088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichlorfon</to_name>
		<to_code>1000581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethadione</to_name>
		<to_code>10827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-pkrb</to_name>
		<to_code>2107051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tallow acid, beef</to_name>
		<to_code>1311640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamphenicol glycinate</to_name>
		<to_code>163416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioridazine hydrochloride</to_name>
		<to_code>203165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>topotecan</to_name>
		<to_code>57308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trihydroxystearin</to_name>
		<to_code>1310538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethyl pentaphenyl trisiloxane</to_name>
		<to_code>1539814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tea leaf allergenic extract</to_name>
		<to_code>2588807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricarbaurinium</to_name>
		<to_code>236407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetanus toxoid vaccine, inactivated</to_name>
		<to_code>798306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tylosema esculentum whole extract</to_name>
		<to_code>2388334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tesamorelin</to_name>
		<to_code>1044584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triacetyldithranol</to_name>
		<to_code>38536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tripalmitin</to_name>
		<to_code>1368169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tortoise shell bamboo stem oil</to_name>
		<to_code>2257603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terizidone</to_name>
		<to_code>57047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tofacitinib</to_name>
		<to_code>1357536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>troleandomycin</to_name>
		<to_code>10864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine polypeptide oleate condensate</to_name>
		<to_code>38624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trenbolone</to_name>
		<to_code>1484278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tussilago farfara whole extract</to_name>
		<to_code>1652099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trihexyphenidyl hydrochloride</to_name>
		<to_code>1115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tramadol</to_name>
		<to_code>10689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tasmannia lanceolata leaf extract</to_name>
		<to_code>2596860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium sulfosuccinate</to_name>
		<to_code>1867700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopherol acetate</to_name>
		<to_code>39625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticagrelor</to_name>
		<to_code>1116632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymocyte immunoglobulin</to_name>
		<to_code>1427178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine sulfate</to_name>
		<to_code>1655913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turnip greens extract</to_name>
		<to_code>1799153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terodiline</to_name>
		<to_code>37815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tert-butyl alcohol</to_name>
		<to_code>1363061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium</to_name>
		<to_code>2571856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thallous chloride Tl201</to_name>
		<to_code>91588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trihydroxypalmitamidohydroxypropyl myristyl ether</to_name>
		<to_code>1314292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>troxerutin</to_name>
		<to_code>38893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tadalafil</to_name>
		<to_code>358263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tremelimumab-actl</to_name>
		<to_code>2619312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisopropanolamine</to_name>
		<to_code>1426368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraarsenic tetrasulfide</to_name>
		<to_code>1426938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tinospora cordifolia whole extract</to_name>
		<to_code>2048119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tribulus terrestris extract</to_name>
		<to_code>1370988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolazoline</to_name>
		<to_code>10634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioglycolic acid triethanolamine</to_name>
		<to_code>2360233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichloroacetaldehyde</to_name>
		<to_code>38574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymol</to_name>
		<to_code>10553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toceranib</to_name>
		<to_code>1145945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine isostearate</to_name>
		<to_code>1789185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tribasic potassium phosphate</to_name>
		<to_code>236502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrachloroaurate</to_name>
		<to_code>1370660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine laurylaminopropionate</to_name>
		<to_code>1996998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylamine</to_name>
		<to_code>1999994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toripalimab</to_name>
		<to_code>2669406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenonitrozole</to_name>
		<to_code>236186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylpentanediyl dibenzoate</to_name>
		<to_code>1437987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trillium erectum extract</to_name>
		<to_code>1310282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,3,5,6-tetrafluorophenol</to_name>
		<to_code>2625644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m arcitumomab</to_name>
		<to_code>230435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrodemethoxydiferuloylmethane</to_name>
		<to_code>1376154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichinella spiralis</to_name>
		<to_code>1426916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terconazole</to_name>
		<to_code>37806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangerine extract</to_name>
		<to_code>1426364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tert-butyl methacrylate</to_name>
		<to_code>1489765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tralokinumab-ldrm</to_name>
		<to_code>2589374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tagraxofusp</to_name>
		<to_code>2109055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taiwanofungus camphoratus whole extract</to_name>
		<to_code>2360031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane trioleate</to_name>
		<to_code>2393534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turnip allergenic extract</to_name>
		<to_code>883414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thorium</to_name>
		<to_code>1534769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrofurfuryl oleate</to_name>
		<to_code>1600778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tofacitinib citrate</to_name>
		<to_code>1358492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triazulenone</to_name>
		<to_code>38555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thulium</to_name>
		<to_code>1311496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamine pyrophosphate</to_name>
		<to_code>10459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thrombin alfa</to_name>
		<to_code>1367075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>timolol maleate</to_name>
		<to_code>42933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trillium chloropetalum whole extract</to_name>
		<to_code>2534465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymalfasin</to_name>
		<to_code>38221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamine ion</to_name>
		<to_code>1546268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimyristin</to_name>
		<to_code>1368882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tramiprosate</to_name>
		<to_code>1374845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tildipirosin</to_name>
		<to_code>1306059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracycline</to_name>
		<to_code>10395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiaprofenate</to_name>
		<to_code>618442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triprolidine</to_name>
		<to_code>10849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiopental sodium</to_name>
		<to_code>282416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teriflunomide</to_name>
		<to_code>1310520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taenia solium preparation</to_name>
		<to_code>1348455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiabendazole</to_name>
		<to_code>10450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>troglitazone</to_name>
		<to_code>72610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taurursodiol</to_name>
		<to_code>2613950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane</to_name>
		<to_code>1368881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticarcillin</to_name>
		<to_code>10591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine laurate</to_name>
		<to_code>1552047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taliglucerase alfa</to_name>
		<to_code>1291609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tubocurarine</to_name>
		<to_code>10917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thermomyces lanuginosus allergenic extract</to_name>
		<to_code>1426629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thujopsis dolabrata leafy twig extract</to_name>
		<to_code>1312372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,2,5-trimethylhexane</to_name>
		<to_code>2557376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temoporfin</to_name>
		<to_code>115243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiludronate</to_name>
		<to_code>57230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiamulin</to_name>
		<to_code>1546410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylpentanediol-adipic acid-glycerin crosspolymer (25000 MPA.S)</to_name>
		<to_code>1426831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telmesteine</to_name>
		<to_code>85929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetramethylthiuram monosulfide</to_name>
		<to_code>1363713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tuftsin</to_name>
		<to_code>1534774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyroglobulin</to_name>
		<to_code>10565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3,7,11,15-tetramethyl-1,2,3-hexadecanetriol</to_name>
		<to_code>1368211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temafloxacin</to_name>
		<to_code>37771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrasodium edetate dihydrate</to_name>
		<to_code>2596173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taraxacum officinale leaf extract</to_name>
		<to_code>1309287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc-99m red blood cells</to_name>
		<to_code>1729152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treprostinil</to_name>
		<to_code>343048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyrotropin alfa</to_name>
		<to_code>4952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tropaeolum majus extract</to_name>
		<to_code>1425927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiram</to_name>
		<to_code>10517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichosanthes kirilowii fruit rind</to_name>
		<to_code>2106816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron vernix leafy twig extract</to_name>
		<to_code>1309761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tangerine peel extract</to_name>
		<to_code>1305532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Theobroma grandiflorum seed extract</to_name>
		<to_code>1309260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone acetonide 21-dipotassium phosphate</to_name>
		<to_code>2389302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tagetes erecta flower extract</to_name>
		<to_code>1309474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiafentanil oxalate</to_name>
		<to_code>2691824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Turnera diffusa leafy twig extract</to_name>
		<to_code>1310032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-tetracosanol</to_name>
		<to_code>1314259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Teucrium marum top extract</to_name>
		<to_code>1368325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tannic acid</to_name>
		<to_code>10328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine caproyl glutamate</to_name>
		<to_code>2367430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tourmaline</to_name>
		<to_code>853142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terfenadine</to_name>
		<to_code>42330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triphosphate</to_name>
		<to_code>1487534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Terminalia bellirica fruit extract</to_name>
		<to_code>1368378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja occidentalis root extract</to_name>
		<to_code>1309991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triptorelin pamoate</to_name>
		<to_code>338529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tobacco leaf allergenic extract</to_name>
		<to_code>852062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tricholoma magnivelare whole extract</to_name>
		<to_code>2173921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir disoproxil succinate</to_name>
		<to_code>1928942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium diphosphate</to_name>
		<to_code>2046778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tacrine hydrochloride</to_name>
		<to_code>235972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-tert-butylcyclohexyl acetate</to_name>
		<to_code>2383539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricaprin</to_name>
		<to_code>1314419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia cordata flower extract</to_name>
		<to_code>1307716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triflupromazine hydrochloride</to_name>
		<to_code>91125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thysanotus tuberosus flower extract</to_name>
		<to_code>1807129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tribasic sodium phosphate</to_name>
		<to_code>36710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tsuga canadensis bark extract</to_name>
		<to_code>1310036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tositumomab</to_name>
		<to_code>263010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>titanium dihydride</to_name>
		<to_code>2585535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichlorotrifluoroethane</to_name>
		<to_code>38585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolciclate</to_name>
		<to_code>38372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trandolapril</to_name>
		<to_code>38454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toldimfos</to_name>
		<to_code>2001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(2,3,8,8-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone</to_name>
		<to_code>2396430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton rubrum allergenic extract</to_name>
		<to_code>968413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tigilanol tiglate</to_name>
		<to_code>2478456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triclabendazole</to_name>
		<to_code>2118525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate</to_name>
		<to_code>2180255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluoroacetyl tripeptide-2</to_name>
		<to_code>2645122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taurine</to_name>
		<to_code>10337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain</to_name>
		<to_code>807219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetradecyloctadecyl stearate</to_name>
		<to_code>1858283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricaine methanesulfonate</to_name>
		<to_code>1492443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopherol,DL-alpha</to_name>
		<to_code>402899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tofisopam</to_name>
		<to_code>38365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiostrepton</to_name>
		<to_code>1365970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telavancin</to_name>
		<to_code>473837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-tert-butylcyclohexanol</to_name>
		<to_code>1373206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trigonella foenum-graecum whole extract</to_name>
		<to_code>1593200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane</to_name>
		<to_code>1810870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tripterygium wilfordii whole extract</to_name>
		<to_code>1440289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>totarol</to_name>
		<to_code>1600439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone</to_name>
		<to_code>10379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiemonium</to_name>
		<to_code>236188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyroid, ovine</to_name>
		<to_code>1442996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone decanoate</to_name>
		<to_code>37858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triprolidine hydrochloride</to_name>
		<to_code>71534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocopheryl retinoate</to_name>
		<to_code>1313259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thonzylamine</to_name>
		<to_code>1360721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tin monoarsenide</to_name>
		<to_code>1989396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tabanus nigrovittatus extract</to_name>
		<to_code>2590185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Timothy grass pollen extract</to_name>
		<to_code>851994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trametes versicolor strain CM-101 extract</to_name>
		<to_code>2569483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triolein, 1-C-14</to_name>
		<to_code>2629643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telotristat ethyl</to_name>
		<to_code>1872441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethylene amine</to_name>
		<to_code>2383536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafluprost</to_name>
		<to_code>1244607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trepibutone</to_name>
		<to_code>44532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton mentagrophytes allergenic extract</to_name>
		<to_code>867357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telmisartan</to_name>
		<to_code>73494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine lauryl sulfate</to_name>
		<to_code>1363986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenofovir disoproxil</to_name>
		<to_code>300195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tall oil acid</to_name>
		<to_code>1492942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tanacetum vulgare flower extract</to_name>
		<to_code>2003582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thallium</to_name>
		<to_code>1311633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thenyldiamine</to_name>
		<to_code>38025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron vernicifluum fruit rind wax</to_name>
		<to_code>1314847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapeptide-3</to_name>
		<to_code>2045118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia cordata wood extract</to_name>
		<to_code>1312724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trachyspermum ammi flower extract</to_name>
		<to_code>2601108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m pertechnetate</to_name>
		<to_code>1489762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrahydrocurcumin .beta.-o-glucuronide</to_name>
		<to_code>2670454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trovafloxacin</to_name>
		<to_code>115552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>transforming growth factor beta 2</to_name>
		<to_code>1370419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testolactone</to_name>
		<to_code>10378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioglycerol</to_name>
		<to_code>1363062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3,5,5-trimethylhexyl acetate</to_name>
		<to_code>2395767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymus gland-calf</to_name>
		<to_code>236876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiosalicylic acid</to_name>
		<to_code>322165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Terminalia chebula fruit extract</to_name>
		<to_code>1311683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazobactam sodium</to_name>
		<to_code>221167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theophylline anhydrous</to_name>
		<to_code>91178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethoxybenzene</to_name>
		<to_code>325518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tylosin</to_name>
		<to_code>995505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiropramide</to_name>
		<to_code>38315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tafasitamab-cxix</to_name>
		<to_code>2387334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terodiline hydrochloride</to_name>
		<to_code>235839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilaciclib dihydrochloride</to_name>
		<to_code>2479691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tilidine</to_name>
		<to_code>10597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Typhonium giganteum stem extract</to_name>
		<to_code>2673303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamarind juice</to_name>
		<to_code>2043325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trioctyldodecyl citrate</to_name>
		<to_code>1356150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tea leaf extract</to_name>
		<to_code>968498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocilizumab-bavi</to_name>
		<to_code>2680283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetanus toxin</to_name>
		<to_code>1735049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium uridine 5'-triphosphate dihydrate</to_name>
		<to_code>2642211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamine disulfide</to_name>
		<to_code>38041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trichloroethylene</to_name>
		<to_code>2534464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine benzoate</to_name>
		<to_code>1363997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(4-(trifluoromethoxy)phenyl)urea</to_name>
		<to_code>2169961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tromantadine</to_name>
		<to_code>38868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tragacanth</to_name>
		<to_code>1368197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimetazidine</to_name>
		<to_code>10826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turnip-rooted chervil oil</to_name>
		<to_code>1988422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triacetin</to_name>
		<to_code>10756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Triticum polonicum seed extract</to_name>
		<to_code>1541724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tylosin phosphate</to_name>
		<to_code>1363719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl trimellitate</to_name>
		<to_code>1426289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Torilis japonica whole extract</to_name>
		<to_code>1600750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tetanus Antitoxin</to_name>
		<to_code>10385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tibolone</to_name>
		<to_code>38260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tesamorelin acetate</to_name>
		<to_code>1044583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolbutamide sodium</to_name>
		<to_code>221173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone hexacetonide</to_name>
		<to_code>38546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tegaserod</to_name>
		<to_code>139778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tepotinib</to_name>
		<to_code>2477103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tilidine hydrochloride</to_name>
		<to_code>82109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tea tree oil</to_name>
		<to_code>69627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m tilmanocept</to_name>
		<to_code>1373391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium HEDTA monohydrate</to_name>
		<to_code>2462144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triptorelin acetate</to_name>
		<to_code>236538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraethylammonium hydroxide hexahydrate</to_name>
		<to_code>2173092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Theobroma grandiflorum seed butter extract</to_name>
		<to_code>1307605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m exametazime</to_name>
		<to_code>1431726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tagraxofusp-erzs</to_name>
		<to_code>2109054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triflusal</to_name>
		<to_code>38655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thonzonium bromide</to_name>
		<to_code>221171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja occidentalis whole extract</to_name>
		<to_code>1358891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tecovirimat monohydrate</to_name>
		<to_code>2055677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trazodone</to_name>
		<to_code>10737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tree of heaven pollen extract</to_name>
		<to_code>851890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethobenzamide hydrochloride</to_name>
		<to_code>57227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton mentagrophytes antigen</to_name>
		<to_code>465062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tylvalosin</to_name>
		<to_code>1368469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymus extracts</to_name>
		<to_code>10562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turmeric root extract</to_name>
		<to_code>2695722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thymus citriodorus leaf extract</to_name>
		<to_code>1370676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetradecene</to_name>
		<to_code>1314225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>titanium dioxide</to_name>
		<to_code>38323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tomato juice</to_name>
		<to_code>1307149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toremifene</to_name>
		<to_code>38409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiletamine</to_name>
		<to_code>1535217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tarlatamab</to_name>
		<to_code>2682954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc 99m medronate</to_name>
		<to_code>1488818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiaprofenic acid</to_name>
		<to_code>38253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamylal sodium</to_name>
		<to_code>203201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioproperazine</to_name>
		<to_code>10498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimeprazine</to_name>
		<to_code>10825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-tert-butylhydroquinone</to_name>
		<to_code>1362739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>274786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Theobroma cacao whole extract</to_name>
		<to_code>1429955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropicamide</to_name>
		<to_code>10869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane triethylhexanoate</to_name>
		<to_code>1314295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiobutabarbital</to_name>
		<to_code>38077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiopropazate</to_name>
		<to_code>38133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioguanine</to_name>
		<to_code>10485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsilyl treated diimethiconol-trimethylsiloxysilicate crosspolymer (40-60 WW)</to_name>
		<to_code>1537759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taxillus chinensis top extract</to_name>
		<to_code>2107063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tubocurarine chloride</to_name>
		<to_code>82115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tantalum</to_name>
		<to_code>1311490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymoxamine hydrochloride</to_name>
		<to_code>235778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-qyyp</to_name>
		<to_code>2280730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimetazidine dihydrochloride</to_name>
		<to_code>235779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>threonic acid, DL-</to_name>
		<to_code>1547557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thonzylamine hydrochloride</to_name>
		<to_code>1360720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trifolium repens flower extract</to_name>
		<to_code>1309929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tretinoin microsphere</to_name>
		<to_code>221175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tegaserod maleate</to_name>
		<to_code>339270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-oysk</to_name>
		<to_code>2375543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-9</to_name>
		<to_code>1312368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymocyte immunoglobulin, equine</to_name>
		<to_code>1427177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja occidentalis bark extract</to_name>
		<to_code>1307585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichosanthes cucumerina seed extract</to_name>
		<to_code>1310068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tapinarof</to_name>
		<to_code>2602286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>TEA-dodecylbenzenesulfonate</to_name>
		<to_code>1313771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turkey feather extract</to_name>
		<to_code>1594963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraethyl silicate</to_name>
		<to_code>2594593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium Tc-99m pyrophosphate</to_name>
		<to_code>1488368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tipiracil hydrochloride</to_name>
		<to_code>1670303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>talazoparib tosylate</to_name>
		<to_code>2099703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylolpropane triacrylate</to_name>
		<to_code>1426813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trypsin</to_name>
		<to_code>10890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trientine tetrahydrochloride</to_name>
		<to_code>2611541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trazodone hydrochloride</to_name>
		<to_code>82112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terbinafine hydrochloride</to_name>
		<to_code>235838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ticlopidine</to_name>
		<to_code>10594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone</to_name>
		<to_code>2359257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triflupromazine</to_name>
		<to_code>10805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolu balsam</to_name>
		<to_code>1116238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tuberculin, bovine</to_name>
		<to_code>1648418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tert-butylbenzoic acid (mixed isomers)</to_name>
		<to_code>2671582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropisetron hydrochloride</to_name>
		<to_code>235997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocilizumab</to_name>
		<to_code>612865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,4,5-T-isopropyl</to_name>
		<to_code>2383538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenapanor</to_name>
		<to_code>2199674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tricaprylin</to_name>
		<to_code>1314420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tributyl citrate</to_name>
		<to_code>1314417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl stearate</to_name>
		<to_code>1368187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triptorelin</to_name>
		<to_code>38782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylenediaminetetraacetic acid</to_name>
		<to_code>1789184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolrestat</to_name>
		<to_code>38386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thallium sulfate</to_name>
		<to_code>1309339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tall oil</to_name>
		<to_code>1364132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tylophora indica root extract</to_name>
		<to_code>1309825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tedizolid phosphate</to_name>
		<to_code>1540824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tenecteplase</to_name>
		<to_code>259280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tranexamic acid</to_name>
		<to_code>10691</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrakis(1-isocyano-2-methoxy-2-methyl-propane)-copper(i) tetrafluoroborate</to_name>
		<to_code>1306061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyroid, porcine</to_name>
		<to_code>235479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>turkey allergenic extract</to_name>
		<to_code>975119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triacontanyl PVP (WP-660)</to_name>
		<to_code>1366228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tabebuia impetiginosa whole extract</to_name>
		<to_code>1356705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thuja occidentalis preparation</to_name>
		<to_code>317687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>theodrenaline</to_name>
		<to_code>31958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia cordata, whole extract</to_name>
		<to_code>1432477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tedizolid</to_name>
		<to_code>1540825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethoxysilylpropyl steardimonium chloride</to_name>
		<to_code>2263159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiopental</to_name>
		<to_code>10493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tolazamide</to_name>
		<to_code>10633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine monododecyl ether</to_name>
		<to_code>2276304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetracycline phosphate complex</to_name>
		<to_code>2105975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tamarix gallica whole extract</to_name>
		<to_code>2055742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab</to_name>
		<to_code>224905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine myristate</to_name>
		<to_code>2599619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamcinolone acetonide</to_name>
		<to_code>10761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsiloxysilicate (M-Q 0.6-0.8)</to_name>
		<to_code>1426677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tucatinib</to_name>
		<to_code>2361285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terpinyl acetate</to_name>
		<to_code>1312739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyropanoate</to_name>
		<to_code>10960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichophyton tonsurans allergenic extract</to_name>
		<to_code>1098619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trout allergenic extract</to_name>
		<to_code>882482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>treponema pallidum immunoserum rabbit</to_name>
		<to_code>1367200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiotaurine</to_name>
		<to_code>1368888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thujopsis dolabrata whole extract</to_name>
		<to_code>1312371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tris(PPG-3 benzyl ether) citrate</to_name>
		<to_code>1649135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Thymus serpyllum extract</to_name>
		<to_code>1328313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tulathromycin</to_name>
		<to_code>1309314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toldimfos sodium</to_name>
		<to_code>2001183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>timolol anhydrous</to_name>
		<to_code>1546004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trideceth-6</to_name>
		<to_code>1426365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trifluoperazine hydrochloride</to_name>
		<to_code>91130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisulfapyrimidine</to_name>
		<to_code>38802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethylene glycol</to_name>
		<to_code>1368702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone enanthate</to_name>
		<to_code>37859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine cacodylate</to_name>
		<to_code>2359271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>terpineol</to_name>
		<to_code>1368180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetraselmis chui extract</to_name>
		<to_code>2636731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taurursodiol dihydrate</to_name>
		<to_code>2665620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiludronic acid</to_name>
		<to_code>11476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymomodulin</to_name>
		<to_code>38217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tertatolol hydrochloride</to_name>
		<to_code>236374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trehalose</to_name>
		<to_code>1311373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrazepam</to_name>
		<to_code>37985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamine mononitrate</to_name>
		<to_code>10456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tinospora cordifolia stem extract</to_name>
		<to_code>1806913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiocolchicoside</to_name>
		<to_code>38085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>technetium 99m</to_name>
		<to_code>90650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thyroid (beef)</to_name>
		<to_code>325521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tussilago farfara extract</to_name>
		<to_code>1312369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiagabine hydrochloride</to_name>
		<to_code>236875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triisopropylamine</to_name>
		<to_code>2373440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tamsulosin</to_name>
		<to_code>77492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Teucrium scorodonia flowering top extract</to_name>
		<to_code>1310057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tromethamine hydrochloride</to_name>
		<to_code>1311534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tizanidine</to_name>
		<to_code>57258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tomato allergenic extract</to_name>
		<to_code>892499</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2,4,5-T triethylammonium</to_name>
		<to_code>2608946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapeptide-6</to_name>
		<to_code>1592892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethaphan camsylate</to_name>
		<to_code>38680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tyrosine</to_name>
		<to_code>10962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tranylcypromine sulfate</to_name>
		<to_code>91119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Toxicodendron succedaneum whole extract</to_name>
		<to_code>1491738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiosulfate</to_name>
		<to_code>1546411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tavaborole</to_name>
		<to_code>1543173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triamterene</to_name>
		<to_code>10763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Trichoderma harzianum allergenic extract</to_name>
		<to_code>968197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tromantadine hydrochloride</to_name>
		<to_code>236459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>TICK-BORN ENCEPHALITIS VACC</to_name>
		<to_code>236736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tremella fuciformis fruiting body extract</to_name>
		<to_code>1358890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,2,4-trihydroxybenzene</to_name>
		<to_code>2107302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trisodium dicarboxymethyl alaninate, L-</to_name>
		<to_code>1598336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thioredoxin</to_name>
		<to_code>1314275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>toltrazuril</to_name>
		<to_code>1535930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tarlatamab-dlle</to_name>
		<to_code>2682955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trilinolenin</to_name>
		<to_code>1655560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tremella fuciformis whole extract</to_name>
		<to_code>1539416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>titanium</to_name>
		<to_code>1305547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>taxifolin</to_name>
		<to_code>2700758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiludronate disodium</to_name>
		<to_code>83153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triethanolamine hydriodide</to_name>
		<to_code>1942478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tropatepine hydrochloride</to_name>
		<to_code>236190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tertatolol</to_name>
		<to_code>37840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trastuzumab-zzxf</to_name>
		<to_code>2382599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrabenazine</to_name>
		<to_code>10390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Taiwanofungus camphoratus mycelium extract</to_name>
		<to_code>2593693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,3,5-triethylbenzene</to_name>
		<to_code>2475073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl alcohol</to_name>
		<to_code>1371366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridihexethyl</to_name>
		<to_code>38617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tiotropium bromide monohydrate</to_name>
		<to_code>1298831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tacrolimus monohydrate</to_name>
		<to_code>484288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trametinib dimethyl sulfoxide</to_name>
		<to_code>1425098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>triepoxycyclohexasilane</to_name>
		<to_code>1941993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tivozanib</to_name>
		<to_code>2534233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tacrolimus</to_name>
		<to_code>42316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tezacaftor</to_name>
		<to_code>1999382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thiamphenicol</to_name>
		<to_code>10463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>testosterone propionate</to_name>
		<to_code>10382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tabebuia impetiginosa leaf extract</to_name>
		<to_code>1536454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tuna preparation</to_name>
		<to_code>1651872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>thymol iodide</to_name>
		<to_code>89717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tazobactam</to_name>
		<to_code>37617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tirilazad</to_name>
		<to_code>72467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>trimethylsiloxysilicate (M-Q 1.0-1.2)</to_name>
		<to_code>1370733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>temozolomide</to_name>
		<to_code>37776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tridecyl neopentanoate</to_name>
		<to_code>1368164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tocotrienol, alpha</to_name>
		<to_code>1424648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tetrapeptide-15</to_name>
		<to_code>1986806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tapentadol hydrochloride</to_name>
		<to_code>857492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teprotumumab</to_name>
		<to_code>2274803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Tilia extract</to_name>
		<to_code>236361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>teriparatide acetate</to_name>
		<to_code>114260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tomato seed oil</to_name>
		<to_code>1431285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>T [Preparations]</from_name>
		<from_code>N0000010602</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>tick-borne encephalitis purified antigen</to_name>
		<to_code>2583637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropisetron</from_name>
		<from_code>27392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>(3 alpha-Tropanyl)-1H-indole-3-carboxylic Acid Ester</to_name>
		<to_code>M000640856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropisetron</from_name>
		<from_code>27392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Indole-3-carboxylic Acid Tropine Ester</to_name>
		<to_code>M000640857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropisetron</from_name>
		<from_code>27392</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tropisetron</to_name>
		<to_code>M0132280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tecovirimat</to_name>
		<to_code>M0537233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat</from_name>
		<from_code>2055104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live vaccinia virus</from_name>
		<from_code>833079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ticovirimat monohydrate</from_name>
		<from_code>2055103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brincidofovir</from_name>
		<from_code>2599518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Smallpox Vaccine</from_name>
		<from_code>9835</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smallpox vaccine live, New York City Board of Health vaccinia strain</from_name>
		<from_code>798467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat monohydrate</from_name>
		<from_code>2055677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Smallpox</to_name>
		<to_code>M0019977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tecovirimat monohydrate</from_name>
		<from_code>2055677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tecovirimat monohydrate</to_name>
		<to_code>M000757948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turmeric oil</from_name>
		<from_code>1373037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>turmeric extract</to_name>
		<to_code>M0059721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turmeric extract</from_name>
		<from_code>1114883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>turmeric extract</to_name>
		<to_code>M0059721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turmeric root extract</from_name>
		<from_code>2695722</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>turmeric extract</to_name>
		<to_code>M0059721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triceteareth-4-phosphate</from_name>
		<from_code>1811770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triceteareth-4-phosphate</to_name>
		<to_code>M0574157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tributyl phosphate</from_name>
		<from_code>1314418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tributyl phosphate</to_name>
		<to_code>M0054314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine maleate</from_name>
		<from_code>71532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimipramine Maleate</to_name>
		<to_code>M0329556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimipramine Maleate</to_name>
		<to_code>M0329556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimipramine Maleate</to_name>
		<to_code>M0329556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiphenamil</from_name>
		<from_code>38150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiphenamil</to_name>
		<to_code>M0054234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethylene glycoldimethacrylate</from_name>
		<from_code>2472322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triethylene glycol dimethacrylate</to_name>
		<to_code>M0075276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioctic acid</from_name>
		<from_code>6417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thioctic Acid</to_name>
		<to_code>M0012565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-tert-butylcyclohexyl acetate</from_name>
		<from_code>2289005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-tert-butylcyclohexyl acetate</to_name>
		<to_code>M0581830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolperisone</from_name>
		<from_code>10639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tolperisone</to_name>
		<to_code>M0021637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocotrienols</from_name>
		<from_code>578285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tocotrienols</to_name>
		<to_code>M0370452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixagevimab</from_name>
		<from_code>2587300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tixagevimab</to_name>
		<to_code>M000744508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixagevimab</from_name>
		<from_code>2587300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pre-Exposure Prophylaxis</to_name>
		<to_code>M0587497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilgavimab</from_name>
		<from_code>2587306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pre-Exposure Prophylaxis</to_name>
		<to_code>M0587497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiadilon</from_name>
		<from_code>38249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiadilon</to_name>
		<to_code>M0082147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolonium chloride</from_name>
		<from_code>10638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tolonium Chloride</to_name>
		<to_code>M0021634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tricetin</from_name>
		<from_code>1994358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tricetin</to_name>
		<to_code>M0443939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl nicotinate, D-.alpha.</from_name>
		<from_code>1359091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tocopheryl nicotinate</to_name>
		<to_code>M0059695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl nicotinate, D-.alpha.</from_name>
		<from_code>1359091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>alpha-tocopheryl nicotinate</to_name>
		<to_code>M0059696</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turpentine</from_name>
		<from_code>10938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Turpentine</to_name>
		<to_code>M0022172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turpentine</from_name>
		<from_code>10938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Turpentine, Oil</to_name>
		<to_code>M000629497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiocyanate</from_name>
		<from_code>1427067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiocyanate</to_name>
		<to_code>M0099575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisopurine</from_name>
		<from_code>38136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tisopurine</to_name>
		<to_code>M0047625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tartrate</from_name>
		<from_code>1314221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tartrate</to_name>
		<to_code>M0094761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine</from_name>
		<from_code>10834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimipramine</to_name>
		<to_code>M0021995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocophersolan</from_name>
		<from_code>159151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tocophersolan</to_name>
		<to_code>M0062589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thuringiensin</from_name>
		<from_code>1648507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thuringiensin</to_name>
		<to_code>M0186845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tungsten</from_name>
		<from_code>1667702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tungsten</to_name>
		<to_code>M0022158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tianeptine</from_name>
		<from_code>38252</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tianeptine</to_name>
		<to_code>M0144175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimipramine mesylate</from_name>
		<from_code>236189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimipramine Mesylate</to_name>
		<to_code>M0329557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirilazad mesylate hydrate</from_name>
		<from_code>59827</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tirilazad mesylate hydrate</to_name>
		<to_code>M0323345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tellurium tetrachloride</from_name>
		<from_code>1863222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tellurium tetrachloride</to_name>
		<to_code>M0111366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat etiprate</from_name>
		<from_code>1872448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telotristat etiprate</to_name>
		<to_code>M000599126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat etiprate</from_name>
		<from_code>1872448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malignant Carcinoid Syndrome</to_name>
		<to_code>M0012930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malignant Carcinoid Syndrome</to_name>
		<to_code>M0012930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat</from_name>
		<from_code>1872382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malignant Carcinoid Syndrome</to_name>
		<to_code>M0012930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat ethyl</from_name>
		<from_code>1872441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Malignant Carcinoid Syndrome</to_name>
		<to_code>M0012930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat</from_name>
		<from_code>1872382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telotristat</to_name>
		<to_code>M000599125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telotristat ethyl</from_name>
		<from_code>1872441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telotristat ethyl</to_name>
		<to_code>M000634864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopherol</from_name>
		<from_code>1236136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tocopherols</to_name>
		<to_code>M0022803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triphosphoric acid, sodium salt</from_name>
		<from_code>1364528</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triphosphoric acid, sodium salt</to_name>
		<to_code>M0309226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiapride</from_name>
		<from_code>10588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tiapride</to_name>
		<to_code>M0572218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme preparation</from_name>
		<from_code>319823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tribulus terrestris fruit extract</from_name>
		<from_code>1311579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tribulus terrestris fruit</to_name>
		<to_code>M000744434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymine</from_name>
		<from_code>1368871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thymine</to_name>
		<to_code>M0021455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiodipropionic acid</from_name>
		<from_code>2046122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiodipropionic acid</to_name>
		<to_code>M0060949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim lactate</from_name>
		<from_code>235855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate magnesium</from_name>
		<from_code>1549106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate</from_name>
		<from_code>1592257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate calcium</from_name>
		<from_code>1028454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>folic acid</from_name>
		<from_code>4511</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin calcium</from_name>
		<from_code>225852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium folate</from_name>
		<from_code>1300473</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolate glucosamine</from_name>
		<from_code>1592256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>leucovorin</from_name>
		<from_code>6313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomefolic acid</from_name>
		<from_code>1025342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Folic Acid Deficiency</to_name>
		<to_code>M0008663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim hydrochloride</from_name>
		<from_code>259281</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethoxazole</from_name>
		<from_code>10180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadoxine</from_name>
		<from_code>10173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate</from_name>
		<from_code>42333</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetrexate glucuronate</from_name>
		<from_code>38725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine</from_name>
		<from_code>7994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atovaquone</from_name>
		<from_code>60212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentamidine isethionate</from_name>
		<from_code>7995</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumonia, Pneumocystis</to_name>
		<to_code>M0017073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim sulfate</from_name>
		<from_code>221176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethoprim</from_name>
		<from_code>10829</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimethoprim</to_name>
		<to_code>M0021991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dofetilide</from_name>
		<from_code>49247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimethoprim</to_name>
		<to_code>M0021991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trenbolone acetate</from_name>
		<from_code>1484277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trenbolone Acetate</to_name>
		<to_code>M0021871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tabtoxin</from_name>
		<from_code>2590695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tabtoxin</to_name>
		<to_code>M0044965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacalcitol</from_name>
		<from_code>291204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tacalcitol</to_name>
		<to_code>M0315459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tulobuterol hydrochloride</from_name>
		<from_code>235841</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tulobuterol hydrochloride</to_name>
		<to_code>M0311251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tridecane</from_name>
		<from_code>1811766</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tridecane</to_name>
		<to_code>M0247890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrolinalool</from_name>
		<from_code>2373947</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,6-dimethyl-6-octanol</to_name>
		<to_code>M0528490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tricalcium phosphate</from_name>
		<from_code>47628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tricalcium phosphate</to_name>
		<to_code>M0069864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiemonium methylsulfate</from_name>
		<from_code>38265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiemonium methylsulfate</to_name>
		<to_code>M0074287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixocortol pivalate</from_name>
		<from_code>38336</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tixocortol pivalate</to_name>
		<to_code>M0071279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethoxysilane</from_name>
		<from_code>2634293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triethoxysilane</to_name>
		<to_code>M0513223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiliroside</from_name>
		<from_code>1423792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiliroside</to_name>
		<to_code>M0147990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tricaine</from_name>
		<from_code>1370418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tricaine</to_name>
		<to_code>M0044687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymostimulin</from_name>
		<from_code>38233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thymostimulin</to_name>
		<to_code>M0098698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethylphloroglucinol</from_name>
		<from_code>38716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,3,5-trimethoxybenzene</to_name>
		<to_code>M0064920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme allergenic extract</from_name>
		<from_code>974527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramazoline</from_name>
		<from_code>38453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tramazoline</to_name>
		<to_code>M0046867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thimerosal</from_name>
		<from_code>10472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thimerosal</to_name>
		<to_code>M0021339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethyl citrate</from_name>
		<from_code>1310554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl citrate</to_name>
		<to_code>M0079741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenoxicam</from_name>
		<from_code>37790</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tenoxicam</to_name>
		<to_code>M0102060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclocarban</from_name>
		<from_code>38609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triclocarban</to_name>
		<to_code>M0054336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>threonic acid, L-</from_name>
		<from_code>1549112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>threonic acid, l-</to_name>
		<to_code>M000637065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolfenamic acid</from_name>
		<from_code>38377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tolfenamic acid</to_name>
		<to_code>M0054268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m sestamibi</from_name>
		<from_code>1482913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Sestamibi</to_name>
		<to_code>M0026183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimebutine</from_name>
		<from_code>10819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimebutine</to_name>
		<to_code>M0021980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tilmicosin</from_name>
		<from_code>38278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tilmicosin</to_name>
		<to_code>M0148552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis C</to_name>
		<to_code>M0010234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telaprevir</from_name>
		<from_code>1102261</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telaprevir</to_name>
		<to_code>M0466818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telaprevir</to_name>
		<to_code>M0466818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telaprevir</to_name>
		<to_code>M0466818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troclosene</from_name>
		<from_code>1537576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>troclosene</to_name>
		<to_code>M0058312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tilbroquinol</from_name>
		<from_code>166718</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tilbroquinol</to_name>
		<to_code>M0113814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tadenan</from_name>
		<from_code>37534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tadenan</to_name>
		<to_code>M0521884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethylamine</from_name>
		<from_code>1307097</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triethylamine</to_name>
		<to_code>M0065965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talactoferrin alfa</from_name>
		<from_code>1425932</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>talactoferrin alfa</to_name>
		<to_code>M0504489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taurolidine</from_name>
		<from_code>2670453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catheter-Related Infections</to_name>
		<to_code>M0518001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taurolidine</from_name>
		<from_code>2670453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>taurolidine</to_name>
		<to_code>M0059673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiamulin fumarate</from_name>
		<from_code>1314589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiamulin fumarate</to_name>
		<to_code>M0312444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trofosfamide</from_name>
		<from_code>38865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trofosfamide</to_name>
		<to_code>M0044822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioclomarol</from_name>
		<from_code>163426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tioclomarol</to_name>
		<to_code>M0092428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>treosulfan</from_name>
		<from_code>38508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>treosulfan</to_name>
		<to_code>M0069890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetraethylammonium hydroxide</from_name>
		<from_code>1648695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetraethylammonium Hydroxide</to_name>
		<to_code>M0329102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>threonate</from_name>
		<from_code>1547558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>threonate</to_name>
		<to_code>M0374427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tuberculin</from_name>
		<from_code>10908</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuberculin</to_name>
		<to_code>M0022103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tioconazole</from_name>
		<from_code>38298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tioconazole</to_name>
		<to_code>M0074291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymidine</from_name>
		<from_code>1372538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thymidine</to_name>
		<to_code>M0021446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiophene</from_name>
		<from_code>154876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiophenes</to_name>
		<to_code>M0021371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trehalulose</from_name>
		<from_code>1428856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trehalulose</to_name>
		<to_code>M0124304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioctic acid amide</from_name>
		<from_code>1597391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lipoamide</to_name>
		<to_code>M0060587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Causalgia</to_name>
		<to_code>M0003692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Persistent Fetal Circulation Syndrome</to_name>
		<to_code>M0016380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriosclerosis Obliterans</to_name>
		<to_code>M0001735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thromboangiitis Obliterans</to_name>
		<to_code>M0021426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline hydrochloride</from_name>
		<from_code>235450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tolazoline Hydrochloride</to_name>
		<to_code>M0331290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Causalgia</to_name>
		<to_code>M0003692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thromboangiitis Obliterans</to_name>
		<to_code>M0021426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tolazoline</to_name>
		<to_code>M0021628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriosclerosis Obliterans</to_name>
		<to_code>M0001735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Persistent Fetal Circulation Syndrome</to_name>
		<to_code>M0016380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolazoline</from_name>
		<from_code>10634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine hydrochloride</from_name>
		<from_code>82033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thromboangiitis Obliterans</to_name>
		<to_code>M0021426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine</from_name>
		<from_code>6066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thromboangiitis Obliterans</to_name>
		<to_code>M0021426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thromboangiitis Obliterans</to_name>
		<to_code>M0021426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thromboangiitis Obliterans</to_name>
		<to_code>M0021426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine</from_name>
		<from_code>135056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin hydrochloride</from_name>
		<from_code>203210</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pindolol</from_name>
		<from_code>8332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captopril</from_name>
		<from_code>1998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine hydrochloride</from_name>
		<from_code>203132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine codecarboxylate</from_name>
		<from_code>158387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine hydrochloride</from_name>
		<from_code>82033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lercanidipine hydrochloride</from_name>
		<from_code>153679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaverine</from_name>
		<from_code>7895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prazosin</from_name>
		<from_code>8629</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol hydrochloride</from_name>
		<from_code>82084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoxsuprine</from_name>
		<from_code>6066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raynaud Disease</to_name>
		<to_code>M0018534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine hydrochloride</from_name>
		<from_code>451796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine phosphate</from_name>
		<from_code>20863</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine sulfate</from_name>
		<from_code>203119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium aminobenzoate</from_name>
		<from_code>142141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroquine</from_name>
		<from_code>2393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scleroderma, Systemic</to_name>
		<to_code>M0019543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine</from_name>
		<from_code>4025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacin</from_name>
		<from_code>7393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclandelate</from_name>
		<from_code>2970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc nicotinate</from_name>
		<from_code>236834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol</from_name>
		<from_code>8814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin hydrochloride</from_name>
		<from_code>82060</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid propyl ester</from_name>
		<from_code>236738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nylidrin</from_name>
		<from_code>7595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>niacinamide</from_name>
		<from_code>7405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine</from_name>
		<from_code>4459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunarizine hydrochloride</from_name>
		<from_code>82019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoprostenol sodium</from_name>
		<from_code>104463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilostazol</from_name>
		<from_code>21107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinic acid benzyl ester</from_name>
		<from_code>31767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotinamide hydriodide</from_name>
		<from_code>317251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Peripheral Vascular Diseases</to_name>
		<to_code>M0025176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alprostadil</from_name>
		<from_code>598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Persistent Fetal Circulation Syndrome</to_name>
		<to_code>M0016380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorzoxazone</from_name>
		<from_code>2410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine hydrochloride</from_name>
		<from_code>52101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobenzaprine</from_name>
		<from_code>21949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meprobamate</from_name>
		<from_code>6760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine hydrochloride</from_name>
		<from_code>236460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaxalone</from_name>
		<from_code>59078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tizanidine</from_name>
		<from_code>57258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin</from_name>
		<from_code>2399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>octotropine methylbromide</from_name>
		<from_code>17945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methocarbamol</from_name>
		<from_code>6845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrazepam</from_name>
		<from_code>37985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenesin carbamate</from_name>
		<from_code>20880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisotropine</from_name>
		<from_code>89780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Spasm</to_name>
		<to_code>M0020203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropolone</from_name>
		<from_code>1368873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tropolone</to_name>
		<to_code>M0022040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiadenol</from_name>
		<from_code>38248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiadenol</to_name>
		<to_code>M0045693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tisagenlecleucel</from_name>
		<from_code>1986438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tisagenlecleucel</to_name>
		<to_code>M000641063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theaflavin</from_name>
		<from_code>38021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>theaflavin</to_name>
		<to_code>M0157445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triheptanoin</from_name>
		<from_code>1313234</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triheptanoin</to_name>
		<to_code>M0524318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m disofenin</from_name>
		<from_code>37665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Disofenin</to_name>
		<to_code>M0029352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocamphyl</from_name>
		<from_code>60906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tocamphyl</to_name>
		<to_code>M0201917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troclosene sodium</from_name>
		<from_code>1537575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>troclosene, sodium salt</to_name>
		<to_code>M0311588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton (fungus)</from_name>
		<from_code>328140</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichophyton</to_name>
		<to_code>M0021932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclofos sodium</from_name>
		<from_code>104696</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triclofos, monosodium salt</to_name>
		<to_code>M0308544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilostane</from_name>
		<from_code>38668</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trilostane</to_name>
		<to_code>M0055078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranilast</from_name>
		<from_code>57330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tranilast</to_name>
		<to_code>M0059240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triphenylmethane</from_name>
		<from_code>2287153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triphenylmethane</to_name>
		<to_code>M0135788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triolein</from_name>
		<from_code>1368168</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triolein</to_name>
		<to_code>M0022006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taurine deoxycholate</from_name>
		<from_code>1364853</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Taurine Deoxycholate</to_name>
		<to_code>M0021073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toceranib phosphate</from_name>
		<from_code>1145944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>toceranib phosphate</to_name>
		<to_code>M0538270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tin</from_name>
		<from_code>10603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tin</to_name>
		<to_code>M0021552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclofos</from_name>
		<from_code>38610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triclofos</to_name>
		<to_code>M0045368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talniflumate</from_name>
		<from_code>236770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>talniflumate</to_name>
		<to_code>M0470191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>testosterone 17-phenylpropionate</from_name>
		<from_code>37855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>testosterone 17-phenylpropionate</to_name>
		<to_code>M0108644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine succinate</from_name>
		<from_code>2054091</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tafenoquine succinate</to_name>
		<to_code>M0465286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tafenoquine succinate</to_name>
		<to_code>M0465286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafenoquine</from_name>
		<from_code>2054023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tafenoquine</to_name>
		<to_code>M0355080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tylosin tartrate</from_name>
		<from_code>996012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tylosin Tartrate</to_name>
		<to_code>M0023983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tartrazine</from_name>
		<from_code>1305578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tartrazine</to_name>
		<to_code>M0021053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tritoqualine</from_name>
		<from_code>38810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tritoqualine</to_name>
		<to_code>M0044812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetraxetan</from_name>
		<from_code>2260905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid</to_name>
		<to_code>M0193869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimebutine maleate salt</from_name>
		<from_code>262296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimebutine Maleate Salt</to_name>
		<to_code>M0351710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrahydrodiferuloylmethane</from_name>
		<from_code>1362136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tetrahydrocurcumin</to_name>
		<to_code>M0253320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>threonine</from_name>
		<from_code>10524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Threonine</to_name>
		<to_code>M0021415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>transforming growth factor beta 1</from_name>
		<from_code>1426465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Transforming Growth Factor beta1</to_name>
		<to_code>M0024760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangeretin</from_name>
		<from_code>2682551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tangeretin</to_name>
		<to_code>M0164309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tellurium</from_name>
		<from_code>1311384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tellurium</to_name>
		<to_code>M0021135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terpin hydrate</from_name>
		<from_code>89916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>terpin hydrate</to_name>
		<to_code>M0309295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafamidis meglumine</from_name>
		<from_code>1727003</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tafamidis meglumine</to_name>
		<to_code>M0543570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terlipressin</from_name>
		<from_code>57048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terlipressin</to_name>
		<to_code>M0058831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theanine</from_name>
		<from_code>38022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>theanine</to_name>
		<to_code>M0086236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilaurin</from_name>
		<from_code>1368880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trilaurin</to_name>
		<to_code>M0045681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triphosphoric acid</from_name>
		<from_code>1364529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triphosphoric acid</to_name>
		<to_code>M0047397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>titanium carbide</from_name>
		<from_code>1989495</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>titanium carbide</to_name>
		<to_code>M0253952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium nitrilotriacetate</from_name>
		<from_code>1735050</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trisodium Nitrilotriacetate</to_name>
		<to_code>M0014882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilinolein</from_name>
		<from_code>1655559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trilinolein</to_name>
		<to_code>M0054381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tribenoside</from_name>
		<from_code>38557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tribenoside</to_name>
		<to_code>M0263401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tartaric acid</from_name>
		<from_code>37578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tartaric acid</to_name>
		<to_code>M0094762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teferrol</from_name>
		<from_code>37744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>teferrol</to_name>
		<to_code>M0060902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tixocortol</from_name>
		<from_code>57257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tixocortol</to_name>
		<to_code>M0121683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m bicisate</from_name>
		<from_code>114918</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>technetium Tc 99m bicisate</to_name>
		<to_code>M0165908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terpinolene</from_name>
		<from_code>2380832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>terpinolene</to_name>
		<to_code>M0088126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toloxatone</from_name>
		<from_code>38382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>toloxatone</to_name>
		<to_code>M0056580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tulobuterol</from_name>
		<from_code>38967</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tulobuterol</to_name>
		<to_code>M0056604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichloroacetic acid</from_name>
		<from_code>10773</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichloroacetic Acid</to_name>
		<to_code>M0021920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tyloxapol</from_name>
		<from_code>38998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tyloxapol</to_name>
		<to_code>M0067043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallous acetate</from_name>
		<from_code>2048725</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thallium acetate</to_name>
		<to_code>M0088101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirbanibulin</from_name>
		<from_code>2471078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tirbanibulin</to_name>
		<to_code>M000744224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trypan blue</from_name>
		<from_code>10878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trypan Blue</to_name>
		<to_code>M0022059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toluene</from_name>
		<from_code>1311381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toluene</to_name>
		<to_code>M0021638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbium</from_name>
		<from_code>1367186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Terbium</to_name>
		<to_code>M0021175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tybamate</from_name>
		<from_code>62178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tybamate</to_name>
		<to_code>M0262806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme oil</from_name>
		<from_code>90950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thymus vulgaris oil</to_name>
		<to_code>M000744436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thyme oil</from_name>
		<from_code>90950</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thyme oil</to_name>
		<to_code>M000744309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tert-butyl acetate</from_name>
		<from_code>2668412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tert-butyl acetate</to_name>
		<to_code>M0237478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrachlorodibenzodioxin</from_name>
		<from_code>2120182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetrachlorodibenzodioxin</to_name>
		<to_code>M000617494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrachlorodibenzodioxin</from_name>
		<from_code>2120182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,3,7,8-Tetrachlorodibenzo-p-dioxin</to_name>
		<to_code>M000616959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tepraloxydim</from_name>
		<from_code>2549831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tepraloxydim</to_name>
		<to_code>M0549630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiratricol</from_name>
		<from_code>13982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3,3',5-triiodothyroacetic acid</to_name>
		<to_code>M0056269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichophyton verrucosum</from_name>
		<from_code>1310905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichophyton verrucosum</to_name>
		<to_code>M000704846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tryptophan</from_name>
		<from_code>10898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tryptophan</from_name>
		<from_code>10898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tryptophan</to_name>
		<to_code>M0022088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromazepam</from_name>
		<from_code>1749</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomethiazole edisylate</from_name>
		<from_code>20802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methaqualone</from_name>
		<from_code>6823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormethiazole</from_name>
		<from_code>2372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lormetazepam</from_name>
		<from_code>28894</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tibolone</from_name>
		<from_code>38260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butobarbital</from_name>
		<from_code>19874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrazepam</from_name>
		<from_code>7440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleeplessness</to_name>
		<to_code>M0334961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionellosis</to_name>
		<to_code>M0012292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tigecycline</to_name>
		<to_code>M0305009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tigecycline</from_name>
		<from_code>384455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin</from_name>
		<from_code>2189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoxitin sodium</from_name>
		<from_code>203118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bezlotoxumab</from_name>
		<from_code>1855048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan</from_name>
		<from_code>2187</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nargenicin</from_name>
		<from_code>2668421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurazone</from_name>
		<from_code>7455</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotetan disodium</from_name>
		<from_code>203141</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bezlotoxumab</from_name>
		<from_code>1855048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium Infections</to_name>
		<to_code>M0004637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc-99m sulfur colloid</from_name>
		<from_code>1423270</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Sulfur Colloid</to_name>
		<to_code>M0021107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiletamine hydrochloride</from_name>
		<from_code>1535216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tiletamine Hydrochloride</to_name>
		<to_code>M0351825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisodium citrate</from_name>
		<from_code>253204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trisodium citrate</to_name>
		<to_code>M0443286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tafamidis</from_name>
		<from_code>1545063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tafamidis</to_name>
		<to_code>M0543569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tributyl phosphite</from_name>
		<from_code>2399030</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tributyl phosphite</to_name>
		<to_code>M0495562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetroxoprim</from_name>
		<from_code>37999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tetroxoprim</to_name>
		<to_code>M0080841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Toxoplasma gondii</from_name>
		<from_code>1432991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Toxoplasma gondii</to_name>
		<to_code>M0021731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tyrothricin</from_name>
		<from_code>10968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tyrothricin</to_name>
		<to_code>M0022209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetradecane</from_name>
		<from_code>2167852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>n-tetradecane</to_name>
		<to_code>M0083226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>teicoplanin</from_name>
		<from_code>57021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Teicoplanin</to_name>
		<to_code>M0026325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetoneamine-N-oxyl</from_name>
		<from_code>10757</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triacetoneamine-N-Oxyl</to_name>
		<to_code>M0021889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talbutal</from_name>
		<from_code>89810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>talbutal</to_name>
		<to_code>M0413630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethylhexanoin</from_name>
		<from_code>1368189</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triethylhexanoin</to_name>
		<to_code>M000633768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tridihexethyl chloride</from_name>
		<from_code>54421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tridihexylethyl chloride</to_name>
		<to_code>M0309067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talc</from_name>
		<from_code>10323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talc</from_name>
		<from_code>10323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumothorax</to_name>
		<to_code>M0017083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>talc</from_name>
		<from_code>10323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Talc</to_name>
		<to_code>M0021021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pleural Effusion</to_name>
		<to_code>M0017043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumothorax</to_name>
		<to_code>M0017083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine</from_name>
		<from_code>9061</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumothorax</to_name>
		<to_code>M0017083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumothorax</to_name>
		<to_code>M0017083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinacrine monohydrochloride</from_name>
		<from_code>82092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Pneumothorax</to_name>
		<to_code>M0017083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrafluoromethane</from_name>
		<from_code>1368889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tetrafluoromethane</to_name>
		<to_code>M0533151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymopentin</from_name>
		<from_code>40230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thymopentin</to_name>
		<to_code>M0024918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethaphan</from_name>
		<from_code>10828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimethaphan</to_name>
		<to_code>M0021990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiafentanil</from_name>
		<from_code>2691823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiafentanil</to_name>
		<to_code>M0441707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tegafur</from_name>
		<from_code>4582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tegafur</to_name>
		<to_code>M0008871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tristearin</from_name>
		<from_code>1368872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tristearin</to_name>
		<to_code>M0078926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-(triethoxysilyl)propylamine</from_name>
		<from_code>1425088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>amino-propyl-triethoxysilane</to_name>
		<to_code>M0454360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlorfon</from_name>
		<from_code>1000581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichlorfon</to_name>
		<to_code>M0021916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamphenicol glycinate</from_name>
		<from_code>163416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiamphenicol glycinate</to_name>
		<to_code>M0092383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tripalmitin</from_name>
		<from_code>1368169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tripalmitin</to_name>
		<to_code>M0047681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terizidone</from_name>
		<from_code>57047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>terizidone</to_name>
		<to_code>M0262785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trenbolone</from_name>
		<from_code>1484278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trenbolone</to_name>
		<to_code>M000597834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tert-butyl alcohol</from_name>
		<from_code>1363061</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tert-Butyl Alcohol</to_name>
		<to_code>M0029708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium</from_name>
		<from_code>2571856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium</to_name>
		<to_code>M0021093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallous chloride Tl201</from_name>
		<from_code>91588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallous chloride Tl201</from_name>
		<from_code>91588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thallium chloride, (201)Tl-labeled</to_name>
		<to_code>M0317353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin trifluoroacetate</from_name>
		<from_code>2380556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine mesylate</from_name>
		<from_code>142426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod lauryl sulfate</from_name>
		<from_code>2610292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bivalirudin</from_name>
		<from_code>60819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin</from_name>
		<from_code>67109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eptifibatide</from_name>
		<from_code>75635</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dalteparin sodium</from_name>
		<from_code>82137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod hydrochloride</from_name>
		<from_code>1012891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fingolimod</from_name>
		<from_code>1012892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lepirudin</from_name>
		<from_code>237057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromocriptine</from_name>
		<from_code>1760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myocardial Ischemia</to_name>
		<to_code>M0026104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troxerutin</from_name>
		<from_code>38893</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>troxerutin</to_name>
		<to_code>M0047701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triisopropanolamine</from_name>
		<from_code>1426368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triisopropanolamine</to_name>
		<to_code>M0157846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetraarsenic tetrasulfide</from_name>
		<from_code>1426938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tetraarsenic tetrasulfide</to_name>
		<to_code>M0529020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tinospora cordifolia whole extract</from_name>
		<from_code>2048119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guduchi</to_name>
		<to_code>M000757565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tribulus terrestris extract</from_name>
		<from_code>1370988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tribulus extract</to_name>
		<to_code>M000744328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichloroacetaldehyde</from_name>
		<from_code>38574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trichloroacetaldehyde</to_name>
		<to_code>M0075570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethylamine</from_name>
		<from_code>1999994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trimethylamine</to_name>
		<to_code>M0080511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenonitrozole</from_name>
		<from_code>236186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichomonas Infections</to_name>
		<to_code>M0021928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenonitrozole</from_name>
		<from_code>236186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichomonas Infections</to_name>
		<to_code>M0021928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ornidazole</from_name>
		<from_code>7701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichomonas Infections</to_name>
		<to_code>M0021928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichomonas Infections</to_name>
		<to_code>M0021928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimorazole</from_name>
		<from_code>7427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichomonas Infections</to_name>
		<to_code>M0021928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichomonas Infections</to_name>
		<to_code>M0021928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2,3,5,6-tetrafluorophenol</from_name>
		<from_code>2625644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2,3,5,6-tetrafluorophenol</to_name>
		<to_code>M0132147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m arcitumomab</from_name>
		<from_code>230435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>technetium Tc-99m arcitumomab</to_name>
		<to_code>M0296262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichinella spiralis</from_name>
		<from_code>1426916</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichinella spiralis</to_name>
		<to_code>M0026061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terconazole</from_name>
		<from_code>37806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>terconazole</to_name>
		<to_code>M0114183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>turnip allergenic extract</from_name>
		<from_code>883414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thorium</from_name>
		<from_code>1534769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thorium</to_name>
		<to_code>M0021412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazulenone</from_name>
		<from_code>38555</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triazulenone</to_name>
		<to_code>M0073636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thulium</from_name>
		<from_code>1311496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thulium</to_name>
		<to_code>M0021442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymalfasin</from_name>
		<from_code>38221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thymalfasin</to_name>
		<to_code>M0086869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimyristin</from_name>
		<from_code>1368882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trimyristin</to_name>
		<to_code>M0111540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tramiprosate</from_name>
		<from_code>1374845</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tramiprosate</to_name>
		<to_code>M0041505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tildipirosin</from_name>
		<from_code>1306059</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tildipirosin</to_name>
		<to_code>M0578946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethylolpropane</from_name>
		<from_code>1368881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trimethylolpropane</to_name>
		<to_code>M0069446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temoporfin</from_name>
		<from_code>115243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>temoporfin</to_name>
		<to_code>M0195871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiamulin</from_name>
		<from_code>1546410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiamulin</to_name>
		<to_code>M0062587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telmesteine</from_name>
		<from_code>85929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telmesteine</to_name>
		<to_code>M0241640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetramethylthiuram monosulfide</from_name>
		<from_code>1363713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tetramethylthiuram monosulfide</to_name>
		<to_code>M0105157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tuftsin</from_name>
		<from_code>1534774</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tuftsin</to_name>
		<to_code>M0022144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3,7,11,15-tetramethyl-1,2,3-hexadecanetriol</from_name>
		<from_code>1368211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3,7,11,15-tetramethyl-1,2,3-hexadecanetriol</to_name>
		<to_code>M0496243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiram</from_name>
		<from_code>10517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiram</to_name>
		<to_code>M0021389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiram</to_name>
		<to_code>M0021389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tangerine peel extract</from_name>
		<from_code>1305532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chenpi</to_name>
		<to_code>M0556842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tannic acid</from_name>
		<from_code>10328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tannic acid</to_name>
		<to_code>M000762332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tannic acid</from_name>
		<from_code>10328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tannins</to_name>
		<to_code>M0021034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tourmaline</from_name>
		<from_code>853142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tourmaline</to_name>
		<to_code>M000640732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triphosphate</from_name>
		<from_code>1487534</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triphosphate</to_name>
		<to_code>M0309228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tricaprin</from_name>
		<from_code>1314419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tricaprin</to_name>
		<to_code>M0056583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichlorotrifluoroethane</from_name>
		<from_code>38585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,1,1-trichloro-2,2,2-trifluoroethane</to_name>
		<to_code>M0047666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolciclate</from_name>
		<from_code>38372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tolciclate</to_name>
		<to_code>M0060960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triclabendazole</to_name>
		<to_code>M0117690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triclabendazole</from_name>
		<from_code>2118525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fascioliasis</to_name>
		<to_code>M0008242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taurine</from_name>
		<from_code>10337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Taurine</to_name>
		<to_code>M0021065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiostrepton</from_name>
		<from_code>1365970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiostrepton</to_name>
		<to_code>M0021380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-tert-butylcyclohexanol</from_name>
		<from_code>1373206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-tert-butylcyclohexanol</to_name>
		<to_code>M0557227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>totarol</from_name>
		<from_code>1600439</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>totarol</to_name>
		<to_code>M0210533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocopheryl retinoate</from_name>
		<from_code>1313259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tocopheryl retinoate</to_name>
		<to_code>M0143370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thonzylamine</from_name>
		<from_code>1360721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thonzylamine</to_name>
		<to_code>M0262803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trepibutone</from_name>
		<from_code>44532</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-(2',4',5'-triethoxybenzoyl)propionic acid</to_name>
		<to_code>M0062642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethanolamine lauryl sulfate</from_name>
		<from_code>1363986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triethanolamine lauryl sulfate</to_name>
		<to_code>M0130455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallium</from_name>
		<from_code>1311633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thallium</to_name>
		<to_code>M0021268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thenyldiamine</from_name>
		<from_code>38025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thenyldiamine</to_name>
		<to_code>M0047600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m pertechnetate</from_name>
		<from_code>1489762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Pertechnetate</to_name>
		<to_code>M0021106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trovafloxacin</from_name>
		<from_code>115552</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trovafloxacin</to_name>
		<to_code>M0214301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>transforming growth factor beta 2</from_name>
		<from_code>1370419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Transforming Growth Factor beta2</to_name>
		<to_code>M0024759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioglycerol</from_name>
		<from_code>1363062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thioglycerol</to_name>
		<to_code>M0054190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiosalicylic acid</from_name>
		<from_code>322165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiosalicylic acid</to_name>
		<to_code>M0407663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Terminalia chebula fruit extract</from_name>
		<from_code>1311683</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chebulae fruit</to_name>
		<to_code>M000743816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam sodium</from_name>
		<from_code>221167</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tazobactam Sodium</to_name>
		<to_code>M0589094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tylosin</from_name>
		<from_code>995505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tylosin</to_name>
		<to_code>M0023982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiropramide</from_name>
		<from_code>38315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiropramide</to_name>
		<to_code>M0098137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tilidine</from_name>
		<from_code>10597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tilidine</to_name>
		<to_code>M0021533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetanus toxin</from_name>
		<from_code>1735049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tetanus Toxin</to_name>
		<to_code>M0021202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trichloroethylene</from_name>
		<from_code>2534464</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trichloroethylene</to_name>
		<to_code>M0021923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tromantadine</from_name>
		<from_code>38868</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tromantadine</to_name>
		<to_code>M0045285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetazidine</from_name>
		<from_code>10826</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimetazidine</to_name>
		<to_code>M0021987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triacetin</from_name>
		<from_code>10756</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Triacetin</to_name>
		<to_code>M0021888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tilidine hydrochloride</from_name>
		<from_code>82109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tilidine Hydrochloride</to_name>
		<to_code>M0329667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tea tree oil</from_name>
		<from_code>69627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tea Tree Oil</to_name>
		<to_code>M0328581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m tilmanocept</from_name>
		<from_code>1373391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran</to_name>
		<to_code>M0394765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m exametazime</from_name>
		<from_code>1431726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Exametazime</to_name>
		<to_code>M0029240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflusal</from_name>
		<from_code>38655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triflusal</to_name>
		<to_code>M0065977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thonzonium bromide</from_name>
		<from_code>221171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thonzonium bromide</to_name>
		<to_code>M000619716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trazodone</to_name>
		<to_code>M0021855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone</from_name>
		<from_code>10737</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam</from_name>
		<from_code>4501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valerian root extract</from_name>
		<from_code>253206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine</from_name>
		<from_code>8770</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem tartrate</from_name>
		<from_code>221183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methyprylon</from_name>
		<from_code>6910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine hydrochloride</from_name>
		<from_code>104973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethinamate</from_name>
		<from_code>24474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine hydrochloride</from_name>
		<from_code>103755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital</from_name>
		<from_code>38077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate</from_name>
		<from_code>23665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ramelteon</from_name>
		<from_code>596205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital</from_name>
		<from_code>477631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiobutabarbital sodium</from_name>
		<from_code>314874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lorazepam</from_name>
		<from_code>6470</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quazepam</from_name>
		<from_code>35185</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aprobarbital</from_name>
		<from_code>17381</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone</from_name>
		<from_code>7814</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine</from_name>
		<from_code>3642</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estazolam</from_name>
		<from_code>4077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eszopiclone</from_name>
		<from_code>461016</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine lactate</from_name>
		<from_code>203196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zaleplon</from_name>
		<from_code>74667</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lemborexant</from_name>
		<from_code>2272403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital</from_name>
		<from_code>719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triazolam</from_name>
		<from_code>10767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amobarbital sodium</from_name>
		<from_code>1314242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentazocine</from_name>
		<from_code>8001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolpidem</from_name>
		<from_code>39993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glutethimide</from_name>
		<from_code>4903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>suvorexant</from_name>
		<from_code>1547099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital</from_name>
		<from_code>9624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>temazepam</from_name>
		<from_code>10355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxymorphone hydrochloride</from_name>
		<from_code>82064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flurazepam hydrochloride</from_name>
		<from_code>71484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>secobarbital sodium</from_name>
		<from_code>91110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propiomazine hydrochloride</from_name>
		<from_code>6232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl acetate hydrochloride</from_name>
		<from_code>82043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levomethadyl</from_name>
		<from_code>237005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethchlorvynol</from_name>
		<from_code>4118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meperidine</from_name>
		<from_code>6754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxylamine succinate, (R)-</from_name>
		<from_code>2622915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butabarbital sodium</from_name>
		<from_code>91109</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Sleep Initiation and Maintenance Disorders</to_name>
		<to_code>M0011403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trazodone hydrochloride</from_name>
		<from_code>82112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trazodone Hydrochloride</to_name>
		<to_code>M0021856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>linezolid</from_name>
		<from_code>190376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Linezolid</to_name>
		<to_code>M0257529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine succinate</from_name>
		<from_code>683693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine fumarate monohydrate</from_name>
		<from_code>1487366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desvenlafaxine</from_name>
		<from_code>734064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylene blue</from_name>
		<from_code>6878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Methylene Blue</to_name>
		<to_code>M0013629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tylvalosin</from_name>
		<from_code>1368469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tylvalosin</to_name>
		<to_code>M0541553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymus extracts</from_name>
		<from_code>10562</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thymus Extracts</to_name>
		<to_code>M0021467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>titanium dioxide</from_name>
		<from_code>38323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>titanium dioxide</to_name>
		<to_code>M0054248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiletamine</from_name>
		<from_code>1535217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tiletamine</to_name>
		<to_code>M0021530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc 99m medronate</from_name>
		<from_code>1488818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Medronate</to_name>
		<to_code>M0021098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiaprofenic acid</from_name>
		<from_code>38253</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiaprofenic acid</to_name>
		<to_code>M0075913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thioproperazine</from_name>
		<from_code>10498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thioproperazine</to_name>
		<to_code>M0225304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-tert-butylhydroquinone</from_name>
		<from_code>1362739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-tert-butylhydroquinone</to_name>
		<to_code>M0070836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telithromycin</from_name>
		<from_code>274786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Drug-Induced Liver Injury, Chronic</to_name>
		<to_code>M0527457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium tosylate</from_name>
		<from_code>2052857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine</from_name>
		<from_code>10917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide anhydrous</from_name>
		<from_code>1545988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine</from_name>
		<from_code>153970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine bisulfate</from_name>
		<from_code>55377</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine</from_name>
		<from_code>3008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eculizumab-aeeb</from_name>
		<from_code>2706347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine hydrobromide</from_name>
		<from_code>1047802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine bromide</from_name>
		<from_code>9001</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate</from_name>
		<from_code>1225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine</from_name>
		<from_code>1223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine nitrate</from_name>
		<from_code>857649</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambenonium</from_name>
		<from_code>623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine chloride</from_name>
		<from_code>82115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline</from_name>
		<from_code>8761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl</from_name>
		<from_code>10811</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium chloride</from_name>
		<from_code>3754</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine hydrobromide</from_name>
		<from_code>9603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrronium</from_name>
		<from_code>1546438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zilucoplan sodium</from_name>
		<from_code>2672492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine sulfate</from_name>
		<from_code>9069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin chloride</from_name>
		<from_code>54251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine methylsulfate</from_name>
		<from_code>7316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propantheline bromide</from_name>
		<from_code>8762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine, modified</from_name>
		<from_code>236077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine citrate</from_name>
		<from_code>7716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine hydrochloride</from_name>
		<from_code>53616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclosporine microemulsion</from_name>
		<from_code>484788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine bromide</from_name>
		<from_code>82055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ambenonium chloride</from_name>
		<from_code>624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glycopyrrolate</from_name>
		<from_code>4955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium</from_name>
		<from_code>2689322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine gluconate</from_name>
		<from_code>35220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine hydrochloride</from_name>
		<from_code>202723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxybutynin</from_name>
		<from_code>32675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine bromide</from_name>
		<from_code>56092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine</from_name>
		<from_code>3361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine</from_name>
		<from_code>9068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orphenadrine</from_name>
		<from_code>7715</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trihexyphenidyl hydrochloride</from_name>
		<from_code>1115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methscopolamine</from_name>
		<from_code>89785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>scopolamine</from_name>
		<from_code>9601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyoscyamine sulfate anhydrous</from_name>
		<from_code>1742407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroprocaine</from_name>
		<from_code>20859</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicyclomine hydrochloride</from_name>
		<from_code>152021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine mesylate</from_name>
		<from_code>18927</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eculizumab-aagh</from_name>
		<from_code>2706334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrophonium</from_name>
		<from_code>3752</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benztropine</from_name>
		<from_code>1424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pyridostigmine</from_name>
		<from_code>9000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinidine polygalacturonate</from_name>
		<from_code>41875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium bromide</from_name>
		<from_code>2689321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide lyophilized</from_name>
		<from_code>221085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eculizumab</from_name>
		<from_code>591781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclophosphamide</from_name>
		<from_code>3002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>atropine sulfate</from_name>
		<from_code>153971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zilucoplan</from_name>
		<from_code>2672489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>neostigmine</from_name>
		<from_code>7315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Myasthenia Gravis</to_name>
		<to_code>M0014279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>telithromycin</to_name>
		<to_code>M0333148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopropazate</from_name>
		<from_code>38133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiopropazate</to_name>
		<to_code>M0262950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tantalum</from_name>
		<from_code>1311490</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tantalum</to_name>
		<to_code>M0021035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymoxamine hydrochloride</from_name>
		<from_code>235778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Moxisylyte Hydrochloride</to_name>
		<to_code>M0474459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimetazidine dihydrochloride</from_name>
		<from_code>235779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trimetazidine Dihydrochloride</to_name>
		<to_code>M0476912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>threonic acid, DL-</from_name>
		<from_code>1547557</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>threonic acid, dl-</to_name>
		<to_code>M000637064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thonzylamine hydrochloride</from_name>
		<from_code>1360720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thonzylamine monohydrochloride</to_name>
		<to_code>M0327346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium Tc-99m pyrophosphate</from_name>
		<from_code>1488368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium Tc 99m Pyrophosphate</to_name>
		<to_code>M0025434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trimethylolpropane triacrylate</from_name>
		<from_code>1426813</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trimethylolpropane triacrylate</to_name>
		<to_code>M0090541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolu balsam</from_name>
		<from_code>1116238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tolu balsam</to_name>
		<to_code>M0095759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tropisetron hydrochloride</from_name>
		<from_code>235997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tropisetron Hydrochloride</to_name>
		<to_code>M0443267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tributyl citrate</from_name>
		<from_code>1314417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tributyl citrate</to_name>
		<to_code>M0118881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolrestat</from_name>
		<from_code>38386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tolrestat</to_name>
		<to_code>M0120716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thallium sulfate</from_name>
		<from_code>1309339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thallium sulfate</to_name>
		<to_code>M0061680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tall oil</from_name>
		<from_code>1364132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tall oil</to_name>
		<to_code>M0462250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theodrenaline</from_name>
		<from_code>31958</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>theodrenaline</to_name>
		<to_code>M0043466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terpinyl acetate</from_name>
		<from_code>1312739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>terpinyl acetate</to_name>
		<to_code>M0072101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tyropanoate</from_name>
		<from_code>10960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tyropanoate</to_name>
		<to_code>M0022199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiotaurine</from_name>
		<from_code>1368888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiotaurine</to_name>
		<to_code>M0503106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tulathromycin</from_name>
		<from_code>1309314</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tulathromycin</to_name>
		<to_code>M0466009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trisulfapyrimidine</from_name>
		<from_code>38802</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trisulfapyrimidine</to_name>
		<to_code>M0063702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triethylene glycol</from_name>
		<from_code>1368702</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>triethylene glycol</to_name>
		<to_code>M0092649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tiludronic acid</from_name>
		<from_code>11476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tiludronic acid</to_name>
		<to_code>M0163477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymomodulin</from_name>
		<from_code>38217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thymomodulin</to_name>
		<to_code>M0145377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trehalose</from_name>
		<from_code>1311373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Trehalose</to_name>
		<to_code>M0021860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Tinospora cordifolia stem extract</from_name>
		<from_code>1806913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>guduchi stem extract</to_name>
		<to_code>M000757568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiocolchicoside</from_name>
		<from_code>38085</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>thiocolchicoside</to_name>
		<to_code>M0045288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium 99m</from_name>
		<from_code>90650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>technetium 99m</from_name>
		<from_code>90650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Technetium 99m</to_name>
		<to_code>M0021094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tomato allergenic extract</from_name>
		<from_code>892499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiosulfate</from_name>
		<from_code>1546411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiosulfates</to_name>
		<to_code>M0021382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tromantadine hydrochloride</from_name>
		<from_code>236459</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tromantadine hydrochloride</to_name>
		<to_code>M0308504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,2,4-trihydroxybenzene</from_name>
		<from_code>2107302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hydroxyhydroquinone</to_name>
		<to_code>M0060473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>toltrazuril</from_name>
		<from_code>1535930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>toltrazuril</to_name>
		<to_code>M0111498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trilinolenin</from_name>
		<from_code>1655560</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trilinolenin</to_name>
		<to_code>M0265643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>titanium</from_name>
		<from_code>1305547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Titanium</to_name>
		<to_code>M0021596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>taxifolin</from_name>
		<from_code>2700758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>taxifolin</to_name>
		<to_code>M0044418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,3,5-triethylbenzene</from_name>
		<from_code>2475073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,3,5-triethylbenzene</to_name>
		<to_code>M0506273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tridihexethyl</from_name>
		<from_code>38617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tridihexethyl</to_name>
		<to_code>M0046885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tezacaftor</from_name>
		<from_code>1999382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tezacaftor</to_name>
		<to_code>M000639510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiamphenicol</from_name>
		<from_code>10463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Thiamphenicol</to_name>
		<to_code>M0021328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tazobactam</from_name>
		<from_code>37617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tazobactam</to_name>
		<to_code>M0127405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirilazad</from_name>
		<from_code>72467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tirilazad</to_name>
		<to_code>M0151122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirilazad</from_name>
		<from_code>72467</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methyl-, (16alpha)-, monomethanesulfonate</to_name>
		<to_code>M000645186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tocotrienol, alpha</from_name>
		<from_code>1424648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>tocotrienol, alpha</to_name>
		<to_code>M0218688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetrapeptide-15</from_name>
		<from_code>1986806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>endomorphin 2</to_name>
		<to_code>M0274738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varenicline tartrate</to_name>
		<to_code>636674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verticillium albo-atrum allergenic extract</to_name>
		<to_code>968467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanillyl butyl ether</to_name>
		<to_code>1313189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>verapamil</to_name>
		<to_code>11170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valacyclovir hydrochloride monohydrate</to_name>
		<to_code>2604686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinyl neodecanoate</to_name>
		<to_code>2369641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veronica officinalis flowering top extract</to_name>
		<to_code>1309952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium corymbosum whole extract</to_name>
		<to_code>1859766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium angustifolium leaf extract</to_name>
		<to_code>1307739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vachellia farnesiana whole extract</to_name>
		<to_code>1873116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vindesine sulfate</to_name>
		<to_code>11205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin B complex</to_name>
		<to_code>11251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velaglucerase alfa</to_name>
		<to_code>901805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola odorata extract</to_name>
		<to_code>1370786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinpocetine</to_name>
		<to_code>24506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitex negundo fruit extract</to_name>
		<to_code>2592984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera pollen extract</to_name>
		<to_code>2669695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vildagliptin</to_name>
		<to_code>596554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin E d-alpha</to_name>
		<to_code>220892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venlafaxine besylate monohydrate</to_name>
		<to_code>2605948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veronicastrum virginicum root extract</to_name>
		<to_code>259367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola philippica whole extract</to_name>
		<to_code>2103289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valoctocogene roxaparvovec-rvox</to_name>
		<to_code>2641609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbena officinalis extract</to_name>
		<to_code>1425404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vasicinone</to_name>
		<to_code>2673585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin D</to_name>
		<to_code>11253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vedolizumab</to_name>
		<to_code>1538097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viburnum opulus whole extract</to_name>
		<to_code>2001816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vosoritide</to_name>
		<to_code>2586354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbena officinalis leaf extract</to_name>
		<to_code>2370871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vandetanib</to_name>
		<to_code>1098413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vardenafil hydrochloride</to_name>
		<to_code>307306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin E acetate</to_name>
		<to_code>2531274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viscum album preparation</to_name>
		<to_code>350489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valganciclovir hydrochloride</to_name>
		<to_code>283815</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vasoactive intestinal peptide</to_name>
		<to_code>1942960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valnemulin</to_name>
		<to_code>2604036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K</to_name>
		<to_code>11258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vachellia farnesiana flower extract</to_name>
		<to_code>1363469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinbarbital</to_name>
		<to_code>89811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinorelbine tartrate</to_name>
		<to_code>114527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium myrtillus fruiting top extract</to_name>
		<to_code>1311685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vilazodone hydrochloride</to_name>
		<to_code>1086768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola tricolor extract</to_name>
		<to_code>1371996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitexin</to_name>
		<to_code>2684982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitreoscilla lysate extract</to_name>
		<to_code>2623998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vespa crabro preparation</to_name>
		<to_code>1426670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velvetleaf huckleberry allergenic extract</to_name>
		<to_code>2102487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vindesine</to_name>
		<to_code>11204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanilla bean extract</to_name>
		<to_code>2275721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis extract</to_name>
		<to_code>730907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vaccinia virus strain New York City Board of Health live antigen</to_name>
		<to_code>1492300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valerate</to_name>
		<to_code>1370574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera fruit oil</to_name>
		<to_code>1309486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanillyl-N-nonylamide</to_name>
		<to_code>39371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valley oak pollen extract</to_name>
		<to_code>1111024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venlafaxine</to_name>
		<to_code>39786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>volanesorsen sodium</to_name>
		<to_code>2637346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vespula vulgaris whole extract</to_name>
		<to_code>2709111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbena extract</to_name>
		<to_code>259380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vipera berus venom</to_name>
		<to_code>1310462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum thapsus leaf extract</to_name>
		<to_code>1545042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vasopressin (USP)</to_name>
		<to_code>11149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viloxazine hydrochloride</to_name>
		<to_code>142143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinblastine</to_name>
		<to_code>11198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viltolarsen</to_name>
		<to_code>2389840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vadadustat</to_name>
		<to_code>2679296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voretigene neparvovec-rzyl</to_name>
		<to_code>1995538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vigna radiata extract</to_name>
		<to_code>1428842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vibrio cholerae serotype Ogawa</to_name>
		<to_code>100534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vancomycin hydrochloride</to_name>
		<to_code>66955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vat violet 2</to_name>
		<to_code>2620179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valacyclovir hydrochloride</to_name>
		<to_code>236081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valnemulin hydrochloride</to_name>
		<to_code>2604037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vilanterol</to_name>
		<to_code>1424884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vincetoxicum atratum whole extract</to_name>
		<to_code>2583629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viburnum lantana flower bud extract</to_name>
		<to_code>2055750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vidarabine</to_name>
		<to_code>11194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola odorata flowering top extract</to_name>
		<to_code>1307540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella-zoster immune globulin</to_name>
		<to_code>39385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valproic acid</to_name>
		<to_code>11118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinorelbine</to_name>
		<to_code>39541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>veal allergenic extract</to_name>
		<to_code>1012026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum densiflorum flower extract</to_name>
		<to_code>1495206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vibrio cholerae serotype Inaba</to_name>
		<to_code>100533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>virginiamycin</to_name>
		<to_code>11232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinyl dimethicone/methicone silsesquioxane crosspolymer</to_name>
		<to_code>1855101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viburnum prunifolium bark extract</to_name>
		<to_code>1309955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinyl acetate</to_name>
		<to_code>1368177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valganciclovir</to_name>
		<to_code>275891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vernonia appendiculata leaf extract</to_name>
		<to_code>1433190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum album root extract</to_name>
		<to_code>1309682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vernonia appendiculata whole extract</to_name>
		<to_code>2711361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vatinoxan hydrochloride</to_name>
		<to_code>2601583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voclosporin</to_name>
		<to_code>2475166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valbenazine tosylate</to_name>
		<to_code>1923002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum viride whole extract</to_name>
		<to_code>2168395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>veralipride</to_name>
		<to_code>39468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinyltrimethylsilyloxy silicate</to_name>
		<to_code>2167853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitex rotundifolia fruit extract</to_name>
		<to_code>2390759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velvet grass pollen extract</to_name>
		<to_code>852514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitex trifolia fruit extract</to_name>
		<to_code>1311686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vanilla planifolia leaf extract</to_name>
		<to_code>2284287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum album preparation</to_name>
		<to_code>285168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorasidenib</to_name>
		<to_code>2690647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vetiveria zizanioides root extract</to_name>
		<to_code>1309956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viscum album fruit extract</to_name>
		<to_code>1310131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinylpyrrolidone-hexadecene copolymer</to_name>
		<to_code>1551570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera whole extract</to_name>
		<to_code>1358481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>versetamide</to_name>
		<to_code>1370642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valerian oil</to_name>
		<to_code>2593176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vamorolone</to_name>
		<to_code>2669799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vismodegib</to_name>
		<to_code>1242987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin MK7</to_name>
		<to_code>2001758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum thapsus extract</to_name>
		<to_code>1334750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veronica officinalis whole extract</to_name>
		<to_code>2119174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vericiguat</to_name>
		<to_code>2475830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium vitis-idaea leaf extract</to_name>
		<to_code>1314238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valproate</to_name>
		<to_code>40254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vonoprazan fumarate</to_name>
		<to_code>2604576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velafermin</to_name>
		<to_code>1317116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valencene</to_name>
		<to_code>2569979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voxelotor</to_name>
		<to_code>2265678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinburnine</to_name>
		<to_code>57954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vigabatrin</to_name>
		<to_code>14851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viridiflorol</to_name>
		<to_code>2374348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitex negundo whole extract</to_name>
		<to_code>2601109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vecuronium bromide</to_name>
		<to_code>11153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanadyl sulfate</to_name>
		<to_code>39364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum densiflorum whole extract</to_name>
		<to_code>1546363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venlafaxine hydrochloride</to_name>
		<to_code>235988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vincamine</to_name>
		<to_code>11201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valeric acid</to_name>
		<to_code>1546454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbena officinalis flowering top extract</to_name>
		<to_code>1309829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vilazodone</to_name>
		<to_code>1086769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viscum album fruiting top extract</to_name>
		<to_code>1311096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vidarabine anhydrous</to_name>
		<to_code>2108659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella-zoster virus vaccine live (Oka-Merck) strain</to_name>
		<to_code>1292422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella zoster virus glycoprotein E</to_name>
		<to_code>1986821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium myrtillus whole extract</to_name>
		<to_code>1370109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vilobelimab</to_name>
		<to_code>2639620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K3</to_name>
		<to_code>6728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera root oil</to_name>
		<to_code>1865837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Valeriana officinalis whole extract</to_name>
		<to_code>1537753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera leaf extract</to_name>
		<to_code>1373038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viburnum opulus root</to_name>
		<to_code>1309820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vaborbactam</to_name>
		<to_code>1945213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vibegron</to_name>
		<to_code>2472254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viscum album whole extract</to_name>
		<to_code>1313973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella zoster virus glycoprotein E, recombinant</to_name>
		<to_code>1986820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitex negundo flower extract</to_name>
		<to_code>2360230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velagliflozin</to_name>
		<to_code>2665880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Varicella Virus Vaccine Live (Oka-Merck) strain</to_name>
		<to_code>805486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vibrio cholerae CVD 103-HGR strain live antigen</to_name>
		<to_code>1812935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vigna radiata whole extract</to_name>
		<to_code>2533230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viscum album leaf extract</to_name>
		<to_code>1310003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium vitis-idaea fruit oil</to_name>
		<to_code>2051582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vaccinia virus</to_name>
		<to_code>1668221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>verdinexor</to_name>
		<to_code>2539289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium macrocarpon whole extract</to_name>
		<to_code>1794167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>verteporfin</to_name>
		<to_code>118886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum viride root extract</to_name>
		<to_code>1309737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vonicog alfa</to_name>
		<to_code>1812589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K1</to_name>
		<to_code>8308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera anthocyanins extract</to_name>
		<to_code>1599641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valdecoxib</to_name>
		<to_code>278567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera flowering top extract</to_name>
		<to_code>1309485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-vinyl-2-pyrrolidone</to_name>
		<to_code>1307764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vincristine sulfate</to_name>
		<to_code>11203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola adunca whole extract</to_name>
		<to_code>2641893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorasidenib citrate</to_name>
		<to_code>2690648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorapaxar</to_name>
		<to_code>1537034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vestronidase alfa</to_name>
		<to_code>1989819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>volanesorsen</to_name>
		<to_code>2637345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola odorata leaf extract</to_name>
		<to_code>1364407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinyldimethyl/trimethylsiloxysilicate sterile dimethicone crosspolymer</to_name>
		<to_code>1788822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanilla bean allergenic extract</to_name>
		<to_code>901291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitex agnus-castus whole extract</to_name>
		<to_code>1441400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin A</to_name>
		<to_code>11246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanillin</to_name>
		<to_code>1368176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valine</to_name>
		<to_code>11115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vibrio cholerae</to_name>
		<to_code>1432992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>von Willebrand factor, human</to_name>
		<to_code>826072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vortioxetine hydrobromide</to_name>
		<to_code>1439834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viloxazine</to_name>
		<to_code>11196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium myrtillus anthocyanosides extract</to_name>
		<to_code>1926519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vatinoxan</to_name>
		<to_code>2601584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola mandshurica flower extract</to_name>
		<to_code>2385105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venlafaxine besylate</to_name>
		<to_code>2607741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vecuronium</to_name>
		<to_code>71535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velagliflozin proline</to_name>
		<to_code>2665881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium myrtillus leaf extract</to_name>
		<to_code>1309257</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera fruit rind</to_name>
		<to_code>1992555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>verapamil hydrochloride</to_name>
		<to_code>203138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin A palmitate</to_name>
		<to_code>35406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valsartan</to_name>
		<to_code>69749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veronica beccabunga whole extract</to_name>
		<to_code>2534466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vanilla planifolia seed extract</to_name>
		<to_code>2590916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varenicline</to_name>
		<to_code>591622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viburnum opulus bark extract</to_name>
		<to_code>1809840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanzacaftor</to_name>
		<to_code>2701431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vernicia fordii seed oil</to_name>
		<to_code>1488263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola patrinii whole extract</to_name>
		<to_code>2586083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vancomycin</to_name>
		<to_code>11124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vinca minor extract</to_name>
		<to_code>1318233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanillin 2,3-butanediol acetal, cis-</to_name>
		<to_code>1371314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voxilaprevir</to_name>
		<to_code>1939323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanilla planifolia oil</to_name>
		<to_code>1484502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin D3</to_name>
		<to_code>1244014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vincristine sulfate liposome</to_name>
		<to_code>1304990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valerian root extract</to_name>
		<to_code>253206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venison allergenic extract</to_name>
		<to_code>882488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vincristine liposome</to_name>
		<to_code>1304991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vestronidase alfa-vjbk</to_name>
		<to_code>1989818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valepotriate</to_name>
		<to_code>236857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum phlomoides flower extract</to_name>
		<to_code>1309716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K7</to_name>
		<to_code>2276893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vimseltinib</to_name>
		<to_code>2705378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vonoprazan</to_name>
		<to_code>2604577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velmanase alfa</to_name>
		<to_code>2630725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinyl chloride</to_name>
		<to_code>1995489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum densiflorum leaf extract</to_name>
		<to_code>1307970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum album whole extract</to_name>
		<to_code>1663405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>von Willebrand factor</to_name>
		<to_code>11274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin B12</to_name>
		<to_code>11248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vardenafil</to_name>
		<to_code>306674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinylpyrrolidone-eicosene copolymer</to_name>
		<to_code>1544135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vetiver oil</to_name>
		<to_code>1307788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>venetoclax</to_name>
		<to_code>1747556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vilanterol trifenatate</to_name>
		<to_code>1424883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbena hastata top extract</to_name>
		<to_code>1719248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin K2</to_name>
		<to_code>42781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola odorata flower extract</to_name>
		<to_code>2533917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vecuronium cation</to_name>
		<to_code>1546399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum nigrum flowering top extract</to_name>
		<to_code>1488817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velpatasvir</to_name>
		<to_code>1799206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vanilla planifolia whole extract</to_name>
		<to_code>1921560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin E DL-alpha</to_name>
		<to_code>220893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viola japonica extract</to_name>
		<to_code>2106425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vutrisiran</to_name>
		<to_code>2604578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin MK6</to_name>
		<to_code>2607025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valbenazine</to_name>
		<to_code>1918219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera seed extract</to_name>
		<to_code>1307966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Voacanga africana seed extract</to_name>
		<to_code>1372477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vortioxetine</to_name>
		<to_code>1455099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veronicastrum virginicum whole extract</to_name>
		<to_code>2591819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera leaf oil</to_name>
		<to_code>1742477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>velmanase alfa-tycv</to_name>
		<to_code>2630724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamine E acetate</to_name>
		<to_code>1114513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viquidil hydrochloride</to_name>
		<to_code>236343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valrubicin</to_name>
		<to_code>31435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vinblastine sulfate</to_name>
		<to_code>11199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valacyclovir</to_name>
		<to_code>73645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorapaxar sulfate</to_name>
		<to_code>1537050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vanilla planifolia flower extract</to_name>
		<to_code>1793747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vat yellow 4</to_name>
		<to_code>2621121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voriconazole</to_name>
		<to_code>121243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vorinostat</to_name>
		<to_code>194337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vitis vinifera stem extract</to_name>
		<to_code>2604575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vincristine</to_name>
		<to_code>11202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veratrum viride preparation</to_name>
		<to_code>285240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin B6</to_name>
		<to_code>42954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>valoctocogene roxaparvovec</to_name>
		<to_code>2641610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>viquidil</to_name>
		<to_code>39580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin E</to_name>
		<to_code>11256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanillylamine</to_name>
		<to_code>156075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vaccinium angustifolium whole extract</to_name>
		<to_code>1540240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>voretigene neparvovec</to_name>
		<to_code>1995537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Viscum album stem extract</to_name>
		<to_code>2055749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vipivotide tetraxetan</to_name>
		<to_code>2597054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vardenafil hydrochloride trihydrate</to_name>
		<to_code>1309396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vemurafenib</to_name>
		<to_code>1147220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vanadium</to_name>
		<to_code>11121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Virola sebifera resin</to_name>
		<to_code>1310276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>varicella zoster immune globulin (human)</to_name>
		<to_code>485576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Veronica officinalis leaf extract</to_name>
		<to_code>1801821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vitamin A myristate</to_name>
		<to_code>1813433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>vutrisiran sodium</to_name>
		<to_code>2605574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Vincetoxicum atratum root extract</to_name>
		<to_code>2053444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>V [Preparations]</from_name>
		<from_code>N0000010604</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Verbascum densiflorum flowering top extract</to_name>
		<to_code>1368326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vindesine sulfate</from_name>
		<from_code>11205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vindesine Sulfate</to_name>
		<to_code>M0329487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B complex</from_name>
		<from_code>11251</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>B Vitamins</to_name>
		<to_code>M000642489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinpocetine</from_name>
		<from_code>24506</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vinpocetine</to_name>
		<to_code>M0062184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vildagliptin</from_name>
		<from_code>596554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vildagliptin</to_name>
		<to_code>M0486919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatigue Syndrome, Chronic</to_name>
		<to_code>M0024027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate monohydrate</from_name>
		<from_code>2605948</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fish oils</from_name>
		<from_code>4419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatigue Syndrome, Chronic</to_name>
		<to_code>M0024027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubidecarenone</from_name>
		<from_code>21406</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatigue Syndrome, Chronic</to_name>
		<to_code>M0024027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatigue Syndrome, Chronic</to_name>
		<to_code>M0024027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatigue Syndrome, Chronic</to_name>
		<to_code>M0024027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fatigue Syndrome, Chronic</to_name>
		<to_code>M0024027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Venlafaxine Hydrochloride</to_name>
		<to_code>M0136959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine hydrochloride</from_name>
		<from_code>235988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine besylate</from_name>
		<from_code>2607741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine</from_name>
		<from_code>4328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine</from_name>
		<from_code>51272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fenfluramine hydrochloride</from_name>
		<from_code>82018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quetiapine fumarate</from_name>
		<from_code>221153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Autistic Disorder</to_name>
		<to_code>M0001983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>venlafaxine</from_name>
		<from_code>39786</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Venlafaxine</to_name>
		<to_code>M0136964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasicinone</from_name>
		<from_code>2673585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vasicinone</to_name>
		<to_code>M0149112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vasoactive intestinal peptide</from_name>
		<from_code>1942960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vasoactive Intestinal Peptide</to_name>
		<to_code>M0022549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valnemulin</from_name>
		<from_code>2604036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>valnemulin</to_name>
		<to_code>M0302264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone hydrochloride</from_name>
		<from_code>1086768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vilazodone Hydrochloride</to_name>
		<to_code>M0560395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vindesine</from_name>
		<from_code>11204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vindesine</to_name>
		<to_code>M0022680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean extract</from_name>
		<from_code>2275721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valerate</from_name>
		<from_code>1370574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Valerates</to_name>
		<to_code>M0022494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir hydrochloride</from_name>
		<from_code>236081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Valacyclovir Hydrochloride</to_name>
		<to_code>M0224607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratoconjunctivitis, Infectious</to_name>
		<to_code>M0011967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine</from_name>
		<from_code>11194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vidarabine</to_name>
		<to_code>M0022659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium phosphate</from_name>
		<from_code>55062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone tebutate</from_name>
		<from_code>34376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium succinate</from_name>
		<from_code>55063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone</from_name>
		<from_code>8638</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone phosphate</from_name>
		<from_code>34374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimexolone</from_name>
		<from_code>55681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratitis, Herpetic</to_name>
		<to_code>M0025643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratoconjunctivitis, Infectious</to_name>
		<to_code>M0011967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vidarabine anhydrous</from_name>
		<from_code>2108659</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>trifluridine</from_name>
		<from_code>10803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Keratoconjunctivitis, Infectious</to_name>
		<to_code>M0011967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronic acid</from_name>
		<from_code>5463</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate dihydrate</from_name>
		<from_code>2729665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate monohydrate</from_name>
		<from_code>1309410</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfacon-1</from_name>
		<from_code>59744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet</from_name>
		<from_code>4778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous zinc acetate</from_name>
		<from_code>1299637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate, heptahydrate</from_name>
		<from_code>1311282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>becaplermin</from_name>
		<from_code>115238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hyaluronate</from_name>
		<from_code>62372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium acetylated hyaluronate</from_name>
		<from_code>2198976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>recombinant interferon beta-1b</from_name>
		<from_code>72258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon gamma-1b</from_name>
		<from_code>5882</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc chloride</from_name>
		<from_code>39937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate trihydrate</from_name>
		<from_code>1440975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate anhydrous</from_name>
		<from_code>1299928</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gentian violet cation</from_name>
		<from_code>1546369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium hyaluronate</from_name>
		<from_code>42892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc gluconate</from_name>
		<from_code>58300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc sulfate</from_name>
		<from_code>39954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2b</from_name>
		<from_code>253453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase Clostridium histolyticum</from_name>
		<from_code>898492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-3n,human leukocyte derived</from_name>
		<from_code>314687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagenase</from_name>
		<from_code>58939</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2a</from_name>
		<from_code>5879</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zinc acetate</from_name>
		<from_code>58295</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Skin Ulcer</to_name>
		<to_code>M0019944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>virginiamycin</from_name>
		<from_code>11232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Virginiamycin</to_name>
		<to_code>M0022742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinyl acetate</from_name>
		<from_code>1368177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vinyl acetate</to_name>
		<to_code>M0057943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vatinoxan hydrochloride</from_name>
		<from_code>2601583</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vatinoxan hydrochloride</to_name>
		<to_code>M000655487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>veralipride</from_name>
		<from_code>39468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>veralipride</to_name>
		<to_code>M0089171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valerian oil</from_name>
		<from_code>2593176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>valerian essential oil</to_name>
		<to_code>M000744346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin MK7</from_name>
		<from_code>2001758</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menaquinone 7</to_name>
		<to_code>M0173250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vericiguat</from_name>
		<from_code>2475830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vericiguat</to_name>
		<to_code>M000613267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velafermin</from_name>
		<from_code>1317116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>velafermin</to_name>
		<to_code>M0498699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valencene</from_name>
		<from_code>2569979</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>valencene</to_name>
		<to_code>M0493635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinburnine</from_name>
		<from_code>57954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vinburnine</to_name>
		<to_code>M0066385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viridiflorol</from_name>
		<from_code>2374348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>viridiflorol</to_name>
		<to_code>M0549851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanadyl sulfate</from_name>
		<from_code>39364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vanadyl sulfate</to_name>
		<to_code>M0105150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vincamine</from_name>
		<from_code>11201</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vincamine</to_name>
		<to_code>M0022675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valeric acid</from_name>
		<from_code>1546454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>n-pentanoic acid</to_name>
		<to_code>M0116541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilazodone</from_name>
		<from_code>1086769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vilazodone</to_name>
		<to_code>M0477866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K3</from_name>
		<from_code>6728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin K 3</to_name>
		<to_code>M0022805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaborbactam</from_name>
		<from_code>1945213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vaborbactam</to_name>
		<to_code>M000642916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaborbactam</from_name>
		<from_code>1945213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>velagliflozin</from_name>
		<from_code>2665880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>velagliflozin</to_name>
		<to_code>M000644530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Varicella Virus Vaccine Live (Oka-Merck) strain</from_name>
		<from_code>805486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccines, Attenuated</to_name>
		<to_code>M0022454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vaccinia virus</from_name>
		<from_code>1668221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccinia virus</to_name>
		<to_code>M0022462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verdinexor</from_name>
		<from_code>2539289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>verdinexor</to_name>
		<to_code>M000600782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-vinyl-2-pyrrolidone</from_name>
		<from_code>1307764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-vinyl-2-pyrrolidinone</to_name>
		<to_code>M0125879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vestronidase alfa</from_name>
		<from_code>1989819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vestronidase alfa</to_name>
		<to_code>M000675458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanilla bean allergenic extract</from_name>
		<from_code>901291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanillin</from_name>
		<from_code>1368176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vanillin</to_name>
		<to_code>M0262491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valine</from_name>
		<from_code>11115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Valine</to_name>
		<to_code>M0022497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vibrio cholerae</from_name>
		<from_code>1432992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vibrio cholerae</to_name>
		<to_code>M0022653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine hydrobromide</from_name>
		<from_code>1439834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vortioxetine Hydrobromide</to_name>
		<to_code>M0588225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vatinoxan</from_name>
		<from_code>2601584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vatinoxan</to_name>
		<to_code>M000675753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Vaccinium myrtillus leaf extract</from_name>
		<from_code>1309257</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vaccinium myrtillus leaf</to_name>
		<to_code>M000745828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valerian root extract</from_name>
		<from_code>253206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Valeriana extract</to_name>
		<to_code>M000744345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vestronidase alfa-vjbk</from_name>
		<from_code>1989818</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vestronidase Alfa-Vjbk</to_name>
		<to_code>M000675459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vinyl chloride</from_name>
		<from_code>1995489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vinyl Chloride</to_name>
		<to_code>M0022683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin K2</from_name>
		<from_code>42781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vitamin K 2</to_name>
		<to_code>M0022807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin MK6</from_name>
		<from_code>2607025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>menaquinone 6</to_name>
		<to_code>M0125359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vortioxetine</from_name>
		<from_code>1455099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vortioxetine</to_name>
		<to_code>M0586839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Valacyclovir</to_name>
		<to_code>M0224608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valacyclovir</from_name>
		<from_code>73645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpes Simplex</to_name>
		<to_code>M0010279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vat yellow 4</from_name>
		<from_code>2621121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vat Yellow 4</to_name>
		<to_code>M0178955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viquidil</from_name>
		<from_code>39580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>viquidil</to_name>
		<to_code>M0263200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanillylamine</from_name>
		<from_code>156075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>vanillylamine</to_name>
		<to_code>M0044855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vanadium</from_name>
		<from_code>11121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vanadium</to_name>
		<to_code>M0022516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enilconazole</to_name>
		<to_code>1442172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enrofloxacin</to_name>
		<to_code>24192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (7 MPA.S)</to_name>
		<to_code>1312575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine hydrochloride</to_name>
		<to_code>91165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine</to_name>
		<to_code>4158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eleutherococcus nodiflorus root bark extract</to_name>
		<to_code>1310083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European rabbit hair extract</to_name>
		<to_code>895527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European house dust mite allergenic extract</to_name>
		<to_code>1116979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ecballium elaterium fruit extract</to_name>
		<to_code>1310229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epidermophyton floccosum allergenic extract</to_name>
		<to_code>995707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eurycoma longifolia root extract</to_name>
		<to_code>2001239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efloxate</to_name>
		<to_code>23852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoxazene</to_name>
		<to_code>41078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergotamine tartrate</to_name>
		<to_code>42676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eosine yellowish</to_name>
		<to_code>1310593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl caproate</to_name>
		<to_code>2476631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ephedra distachya flowering twig extract</to_name>
		<to_code>1309669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupolyphaga sinensis preparation</to_name>
		<to_code>1541237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-ethyl-2-pyrrolecarboxaldehyde</to_name>
		<to_code>1368194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptacog alfa activated</to_name>
		<to_code>253149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(ethyltrisulfanyl)propane</to_name>
		<to_code>2603742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea purpurea extract</to_name>
		<to_code>260025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elaeis guineensis fruit extract</to_name>
		<to_code>1432292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethamsylate</to_name>
		<to_code>4112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eschscholzia californica extract</to_name>
		<to_code>265576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eyebright preparation</to_name>
		<to_code>259366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ecamsule ditriethanolamine</to_name>
		<to_code>2359252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etesevimab</to_name>
		<to_code>2477854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalaprilat dihydrate</to_name>
		<to_code>2672730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>embutramide</to_name>
		<to_code>2464539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entacapone</to_name>
		<to_code>60307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus globulus leaf extract</to_name>
		<to_code>1305545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ehrlichia canis</to_name>
		<to_code>1608966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylbenzene</to_name>
		<to_code>1540523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia pekinensis root extract</to_name>
		<to_code>1729316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eurotium herbariorum allergenic extract</to_name>
		<to_code>999450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elosulfase alfa</to_name>
		<to_code>1489914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eribulin mesylate</to_name>
		<to_code>1045452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erbium</to_name>
		<to_code>1311483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epcoritamab</to_name>
		<to_code>2637392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethotoin</to_name>
		<to_code>4136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl macadamiate</to_name>
		<to_code>1314358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European elderberry juice</to_name>
		<to_code>1438112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eremophila scoparia whole extract</to_name>
		<to_code>2395440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erythrina variegata bark extract</to_name>
		<to_code>2106823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine tannate</to_name>
		<to_code>221096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efetozole</to_name>
		<to_code>2691105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupatorium perfoliatum whole extract</to_name>
		<to_code>1649446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanol</to_name>
		<to_code>448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>europium oxide</to_name>
		<to_code>1311116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eletriptan hydrobromide monohydrate</to_name>
		<to_code>2198973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>endothelial growth factor A, vascular</to_name>
		<to_code>2642870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoetin beta</to_name>
		<to_code>105695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylmorphine hydrochloride</to_name>
		<to_code>235782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethisterone</to_name>
		<to_code>4129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etripamil</to_name>
		<to_code>2730302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>encorafenib</to_name>
		<to_code>2049106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucommia ulmoides bark extract</to_name>
		<to_code>1309788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene glycol</to_name>
		<to_code>1314364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edoxudine</to_name>
		<to_code>49428</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eplontersen sodium</to_name>
		<to_code>2671940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus globulus pollen extract</to_name>
		<to_code>852386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ezetimibe</to_name>
		<to_code>341248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erythranthe cardinalis whole extract</to_name>
		<to_code>2534458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ectoine</to_name>
		<to_code>1426644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol 3-benzoate</to_name>
		<to_code>60661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etorphine hydrochloride</to_name>
		<to_code>2728550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl butyrate</to_name>
		<to_code>1314356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus camaldulensis leaf oil</to_name>
		<to_code>1540025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eutanol G</to_name>
		<to_code>1363715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexylglycerin</to_name>
		<to_code>1367134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etilefrine hydrochloride</to_name>
		<to_code>235960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equus caballus whole preparation</to_name>
		<to_code>1552632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eutrema japonicum whole extract</to_name>
		<to_code>1606332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English oak pollen extract</to_name>
		<to_code>1484984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl anthranilate</to_name>
		<to_code>2396756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg extract</to_name>
		<to_code>1315115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin phosphate</to_name>
		<to_code>4058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl oleate</to_name>
		<to_code>1314361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edodekin alfa</to_name>
		<to_code>1371906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estrogenic substances</to_name>
		<to_code>259263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl 2-methylbutyrate</to_name>
		<to_code>1312568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epilobium angustifolium whole extract</to_name>
		<to_code>1539424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflornithine hydrochloride</to_name>
		<to_code>81945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose aqueous dispersion type A</to_name>
		<to_code>2609844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Enterobacter cloacae</to_name>
		<to_code>1491010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etofylline</to_name>
		<to_code>24611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl maltol</to_name>
		<to_code>1314359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergotamine</to_name>
		<to_code>4025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enfuvirtide</to_name>
		<to_code>139896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethaverine hydrochloride</to_name>
		<to_code>235229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl lauroyl arginate hydrochloride</to_name>
		<to_code>1426162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethenzamide</to_name>
		<to_code>24468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl palmitate</to_name>
		<to_code>1306938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ecklonia cava extract</to_name>
		<to_code>1435389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Empetrum nigrum fruit juice</to_name>
		<to_code>1311589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus radiata leaf oil</to_name>
		<to_code>1483423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elamipretide</to_name>
		<to_code>2725600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine hydrate</to_name>
		<to_code>283561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergot alkaloids</to_name>
		<to_code>4023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose aqueous dispersion type B</to_name>
		<to_code>2610401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esculin</to_name>
		<to_code>1314351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine tetraethanol</to_name>
		<to_code>1361654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Evernia prunastri extract</to_name>
		<to_code>1352501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edible rock crab preparation</to_name>
		<to_code>2199490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elacestrant dihydrochloride</to_name>
		<to_code>2628473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elaeis oleifera seed oil</to_name>
		<to_code>1491737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English walnut pollen extract</to_name>
		<to_code>852577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eggplant extract</to_name>
		<to_code>1315116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eculizumab-aeeb</to_name>
		<to_code>2706347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etanercept-szzs</to_name>
		<to_code>2103480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergonovine maleate</to_name>
		<to_code>24313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elaeis guineensis whole extract</to_name>
		<to_code>1425413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg shell preparation</to_name>
		<to_code>2541497</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ecklonia radiata extract</to_name>
		<to_code>2691104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl levulinate</to_name>
		<to_code>1313748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esketamine</to_name>
		<to_code>2119365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg yolk phospholipids</to_name>
		<to_code>314605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eryngium maritimum extract</to_name>
		<to_code>1482536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eszopiclone</to_name>
		<to_code>461016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eichhornia crassipes whole extract</to_name>
		<to_code>1544484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene glycol monobenzyl ether</to_name>
		<to_code>1860420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl methoxycinnamate</to_name>
		<to_code>2468050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epigallocatechin gallate palmitates</to_name>
		<to_code>1536067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>europium</to_name>
		<to_code>1311484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elapegademase</to_name>
		<to_code>2059219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediaminetetraacetate</to_name>
		<to_code>1370600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ertapenem</to_name>
		<to_code>325642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflornithine</to_name>
		<to_code>569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupatorium japonicum whole extract</to_name>
		<to_code>1313690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epstein-Barr virus</to_name>
		<to_code>1316054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine sulfate</to_name>
		<to_code>1249590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erlotinib hydrochloride</to_name>
		<to_code>477320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etilefrine</to_name>
		<to_code>4169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoxiconazole</to_name>
		<to_code>2593180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elderberry fruit</to_name>
		<to_code>260053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ephedra sinica stem extract</to_name>
		<to_code>1551454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emedastine difumarate</to_name>
		<to_code>221094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl glycerin acetal levulinate</to_name>
		<to_code>2370889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg shell membrane</to_name>
		<to_code>1428044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexyl glycidyl ether</to_name>
		<to_code>2369827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium brevicornu whole extract</to_name>
		<to_code>2585537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echium plantagineum seed oil</to_name>
		<to_code>1305635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>exemestane</to_name>
		<to_code>258494</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(ethylenedinitrilo)tetraacetonitrile</to_name>
		<to_code>2286574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum hyemale extract</to_name>
		<to_code>1332872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus gunnii leaf oil</to_name>
		<to_code>1600139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eculizumab</to_name>
		<to_code>591781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etilevodopa</to_name>
		<to_code>1421444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>escargot shell, cooked</to_name>
		<to_code>1540823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalaprilat anhydrous</to_name>
		<to_code>1545989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethenyl</to_name>
		<to_code>2565266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl butylacetylaminopropionate</to_name>
		<to_code>2397705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanethiol</to_name>
		<to_code>1314352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epicatechin</to_name>
		<to_code>2641822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eribulin</to_name>
		<to_code>1045453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European hazelnut oil</to_name>
		<to_code>1307809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>exenatide</to_name>
		<to_code>60548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethinyl estradiol</to_name>
		<to_code>4124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eslicarbazepine</to_name>
		<to_code>1482502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eryngium maritimum root extract</to_name>
		<to_code>2467552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethionamide</to_name>
		<to_code>4127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equus caballus collagen</to_name>
		<to_code>1306187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edotreotide gallium ga-68</to_name>
		<to_code>2199391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalaprilat</to_name>
		<to_code>3829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etretinate</to_name>
		<to_code>4182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl valerate</to_name>
		<to_code>1312574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl sulfate</to_name>
		<to_code>1665664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emtricitabine</to_name>
		<to_code>276237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elsholtzia ciliata whole extract</to_name>
		<to_code>1868197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erenumab</to_name>
		<to_code>2045613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ephedra nevadensis whole extract</to_name>
		<to_code>2590644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evening primrose extract</to_name>
		<to_code>260040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elexacaftor</to_name>
		<to_code>2256951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erechtites hieraciifolius extract</to_name>
		<to_code>1428218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etofamide</to_name>
		<to_code>24607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ebastine</to_name>
		<to_code>23796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethacrynate</to_name>
		<to_code>62349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl salicylate</to_name>
		<to_code>1546423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern white pine extract</to_name>
		<to_code>1372264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elemi extract</to_name>
		<to_code>1426441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptifibatide</to_name>
		<to_code>75635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elastin, human</to_name>
		<to_code>1876396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoxydiglycol oleate</to_name>
		<to_code>2624694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole magnesium</to_name>
		<to_code>283562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol cypionate</to_name>
		<to_code>1000146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Enterococcus faecium</to_name>
		<to_code>1943794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl trisiloxane</to_name>
		<to_code>1607328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine disuccinate</to_name>
		<to_code>1370612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinastine</to_name>
		<to_code>39684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoheptazine citrate</to_name>
		<to_code>235416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>equine diphtheria antitoxin</to_name>
		<to_code>91602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epilobium fleischeri whole extract</to_name>
		<to_code>1788980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epicriptine</to_name>
		<to_code>1546422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ericameria nauseosa whole extract</to_name>
		<to_code>2533857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin</to_name>
		<to_code>4053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European honey bee venom protein</to_name>
		<to_code>854163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl oleate</to_name>
		<to_code>1426862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elotuzumab</to_name>
		<to_code>1726104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Enterobius vermicularis preparation</to_name>
		<to_code>1333420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European flounder preparation</to_name>
		<to_code>1426439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergocalciferol</to_name>
		<to_code>4018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoxyquin</to_name>
		<to_code>1314354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl nitrite</to_name>
		<to_code>1921585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanol, 2-(2-((4-((2-bromo-4,6-dinitrophenyl)azo)-1-naphthalenyl)amino)ethoxy)-, acetate (ester)</to_name>
		<to_code>2376930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emetine</to_name>
		<to_code>3820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epigallocatechin gallatyl glucoside</to_name>
		<to_code>2549747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl lauroyl arginate</to_name>
		<to_code>1426163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enmetazobactam</to_name>
		<to_code>2675985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European beech pollen extract</to_name>
		<to_code>1484981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eriobotrya japonica leaf extract</to_name>
		<to_code>1310088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European elderberry extract</to_name>
		<to_code>1311531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl jojobate</to_name>
		<to_code>1435390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ersofermin</to_name>
		<to_code>1311285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acrylate-methacrylic acid-steareth-20 methacrylate copolymer</to_name>
		<to_code>1433495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esmolol hydrochloride</to_name>
		<to_code>203222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eurycoma longifolia whole extract</to_name>
		<to_code>2585253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elymus repens root extract</to_name>
		<to_code>1310134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine sulfate</to_name>
		<to_code>91166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>econazole nitrate</to_name>
		<to_code>142434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol hemihydrate</to_name>
		<to_code>236859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl glycolate</to_name>
		<to_code>2602133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinococcus granulosus preparation</to_name>
		<to_code>1426375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethybenztropine</to_name>
		<to_code>1358000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl linolenate</to_name>
		<to_code>1483807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elderberry preparation</to_name>
		<to_code>319834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoheptazine</to_name>
		<to_code>24484</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl 10-undecenoate</to_name>
		<to_code>1543079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evinacumab</to_name>
		<to_code>2478335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enoxacin</to_name>
		<to_code>3925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elaeis guineensis fruit butter</to_name>
		<to_code>1307144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoprostenol sodium</to_name>
		<to_code>104463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethiodized oil</to_name>
		<to_code>4125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus globulus whole extract</to_name>
		<to_code>1363729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eremocitrus glauca fruit extract</to_name>
		<to_code>1541718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Enterococcus faecalis</to_name>
		<to_code>10098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erwinia asparaginase</to_name>
		<to_code>235996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole</to_name>
		<to_code>283742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entecavir anhydrous</to_name>
		<to_code>1546027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edrophonium</to_name>
		<to_code>3752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum arvense top extract</to_name>
		<to_code>1306235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium grandiflorum flowering top extract</to_name>
		<to_code>1310141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (10 MPA.S)</to_name>
		<to_code>1313704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl hexyl salicylate</to_name>
		<to_code>236880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin stearate</to_name>
		<to_code>24351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethaverine</to_name>
		<to_code>24464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl isononanoate</to_name>
		<to_code>1367139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entecavir</to_name>
		<to_code>306266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ehrendorferia chrysantha whole extract</to_name>
		<to_code>2533856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epcoritamab-bysp</to_name>
		<to_code>2637395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethacrynate sodium</to_name>
		<to_code>4108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enasidenib mesylate</to_name>
		<to_code>1940331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enoximone</to_name>
		<to_code>49626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>exametazime</to_name>
		<to_code>62153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (50 MPA.S)</to_name>
		<to_code>1739984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epirubicin</to_name>
		<to_code>3995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia amygdaloides extract</to_name>
		<to_code>1547608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elettaria ensal whole extract</to_name>
		<to_code>2592621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoetin alfa</to_name>
		<to_code>105694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl methicone (8 MPA.S)</to_name>
		<to_code>1540870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eravacycline</to_name>
		<to_code>2055906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia sieboldiana root extract</to_name>
		<to_code>2695027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl pyrrolidone</to_name>
		<to_code>1551421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emu oil</to_name>
		<to_code>1309389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elastin</to_name>
		<to_code>1730435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexanol</to_name>
		<to_code>2394645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl isovalerate</to_name>
		<to_code>1314357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acetate</to_name>
		<to_code>1314355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Entamoeba histolytica</to_name>
		<to_code>1316053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emodepside</to_name>
		<to_code>354606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg yolk phosphatides</to_name>
		<to_code>349762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>EGTA disodium</to_name>
		<to_code>1742991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efbemalenograstim alfa-vuxw</to_name>
		<to_code>2670656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium grandiflorum whole extract</to_name>
		<to_code>1358889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-ethyl citrate</to_name>
		<to_code>2587731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edible oyster preparation</to_name>
		<to_code>1426438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidronate</to_name>
		<to_code>42682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elettaria cardamomum whole extract</to_name>
		<to_code>1314853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole magnesium dihydrate</to_name>
		<to_code>1601995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethynodiol</to_name>
		<to_code>24591</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptinezumab-jjmr</to_name>
		<to_code>2283045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>european olive pollen extract</to_name>
		<to_code>852653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esmolol</to_name>
		<to_code>49737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efalizumab</to_name>
		<to_code>356988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl cocoate</to_name>
		<to_code>1484498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eggplant allergenic extract</to_name>
		<to_code>972601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea purpurea root extract</to_name>
		<to_code>259513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylmercurithiosalicylic acid</to_name>
		<to_code>1546427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanethioic acid, S-(1-((1E)-2-hydroxyethenyl)butyl) ester</to_name>
		<to_code>2473844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprinomectin</to_name>
		<to_code>1006619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efgartigimod alfa</to_name>
		<to_code>2587717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl menthane carboxamide, 1R,3R,4S</to_name>
		<to_code>1869726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etrasimod</to_name>
		<to_code>2668045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eschscholzia californica flowering top extract</to_name>
		<to_code>1423921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eleutherococcus senticosus whole extract</to_name>
		<to_code>2001988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethambutol</to_name>
		<to_code>4110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egtazic acid</to_name>
		<to_code>1742992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estrogens, conjugated (USP)</to_name>
		<to_code>4099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estetrol</to_name>
		<to_code>2539031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene-vinyl acetate copolymer (40% vinyl acetate)</to_name>
		<to_code>1312577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Engraulis japonica extract</to_name>
		<to_code>2611454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eliglustat tartrate</to_name>
		<to_code>1547219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene-vinyl acetate copolymer (50% vinyl acetate)</to_name>
		<to_code>1736747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eta-tocopherol</to_name>
		<to_code>2721765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enoxolone dipotassium</to_name>
		<to_code>2043284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esketamine hydrochloride</to_name>
		<to_code>2119366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanolamine oleate</to_name>
		<to_code>24460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etelcalcetide hydrochloride</to_name>
		<to_code>1876122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eutrochium purpureum whole extract</to_name>
		<to_code>1986786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupatorium perfoliatum flowering top extract</to_name>
		<to_code>1309783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elymus violaceus whole extract</to_name>
		<to_code>2668416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate calcium</to_name>
		<to_code>1368950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eliglustat</to_name>
		<to_code>1547220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate</to_name>
		<to_code>42662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethynodiol diacetate</to_name>
		<to_code>4170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythrityl tetranitrate</to_name>
		<to_code>4040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus polybractea leaf oil</to_name>
		<to_code>1307684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus smithii oil</to_name>
		<to_code>2399546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole strontium</to_name>
		<to_code>1435522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern sycamore pollen extract</to_name>
		<to_code>852746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epilobium angustifolium leaf extract</to_name>
		<to_code>1309425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (4 MPA.S)</to_name>
		<to_code>1313698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eruca vesicaria subsp. sativa leaf extract</to_name>
		<to_code>1541728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine dihydriodide</to_name>
		<to_code>1593852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine hydrochloride</to_name>
		<to_code>362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl palmitate</to_name>
		<to_code>1426380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexyl 4-phenylbenzophenone-2'-carboxylate</to_name>
		<to_code>1546353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Evodia rutaecarpa fruit extract, immature</to_name>
		<to_code>2635086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl linoleate</to_name>
		<to_code>24522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl chloride</to_name>
		<to_code>4141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate dipotassium anhydrous</to_name>
		<to_code>1540526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etrasimod arginine</to_name>
		<to_code>2668046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edotreotride</to_name>
		<to_code>2199392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylmorphine</to_name>
		<to_code>4166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethoxyethanol</to_name>
		<to_code>1314365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl 2,2-dimethylhydrocinnamal</to_name>
		<to_code>1649018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl hydroxystearate benzoate</to_name>
		<to_code>1732119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum fluviatile whole extract</to_name>
		<to_code>2287548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus radiata flower top oil</to_name>
		<to_code>1540872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia neriifolia leaf extract</to_name>
		<to_code>2673586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eutrochium purpureum root</to_name>
		<to_code>1309791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethyl-1,6-hexanediol</to_name>
		<to_code>1428859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etofenamate</to_name>
		<to_code>24608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>econazole</to_name>
		<to_code>3743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl menthane carboxamide</to_name>
		<to_code>1358486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus alba leaf extract</to_name>
		<to_code>2122439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg (chicken) allergenic extract</to_name>
		<to_code>904507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprozinol</to_name>
		<to_code>24274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoetin alfa-epbx</to_name>
		<to_code>2047589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl stearate</to_name>
		<to_code>1368181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprazinone HCl</to_name>
		<to_code>236310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etifoxine</to_name>
		<to_code>24441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eryngium yuccifolium root extract</to_name>
		<to_code>1861941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethchlorvynol</to_name>
		<to_code>4118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflapegrastim</to_name>
		<to_code>2612526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etelcalcetide</to_name>
		<to_code>1876119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elagolix sodium</to_name>
		<to_code>2049847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enfortumab</to_name>
		<to_code>2268307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Escherichia coli</to_name>
		<to_code>350202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acetoacetate ethylene glycol ketal</to_name>
		<to_code>2388133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl palmate</to_name>
		<to_code>1440254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl ether</to_name>
		<to_code>1363043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euonymus atropurpureus branch bark-root bark extract</to_name>
		<to_code>1428219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acrylate</to_name>
		<to_code>1859382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephryl borate</to_name>
		<to_code>24255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estriol</to_name>
		<to_code>4094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (20 MPA.S)</to_name>
		<to_code>1313697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea angustifolia root extract</to_name>
		<to_code>259415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexyl benzoate</to_name>
		<to_code>1313732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English sole allergenic extract</to_name>
		<to_code>974140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate disodium, anhydrous</to_name>
		<to_code>1299924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl perfluorobutyl ether</to_name>
		<to_code>1540871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eclipta prostrata leaf extract</to_name>
		<to_code>1307644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enobosarm</to_name>
		<to_code>2168587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estrogens, esterified (USP)</to_name>
		<to_code>214549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estramustine</to_name>
		<to_code>4089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidronate tetrasodium</to_name>
		<to_code>1364894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erysimum preparation</to_name>
		<to_code>319799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl stearate</to_name>
		<to_code>1369682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia fischeriana root extract</to_name>
		<to_code>2631985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eravacycline dihydrochloride</to_name>
		<to_code>2055907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esafoxolaner</to_name>
		<to_code>2636785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etifoxine hydrochloride</to_name>
		<to_code>236215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl lactate</to_name>
		<to_code>1427072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estropipate</to_name>
		<to_code>33747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acrylate and methyl methacrylate copolymer (2:1; 600000 MW)</to_name>
		<to_code>1312573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edrophonium cation</to_name>
		<to_code>1546421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evening primrose oil</to_name>
		<to_code>203219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>endothelial growth factor A, human vascular</to_name>
		<to_code>2642869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidronic acid</to_name>
		<to_code>1356715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium sagittatum leaf extract</to_name>
		<to_code>2540132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Embelia ribes fruit extract</to_name>
		<to_code>2679611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl nitrate</to_name>
		<to_code>1314360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol</to_name>
		<to_code>2589801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eladocagene exuparvovec-tneq</to_name>
		<to_code>2698765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl loflazepate</to_name>
		<to_code>24524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia hirta extract</to_name>
		<to_code>1347564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprozinol hydrochloride</to_name>
		<to_code>402567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl 2,4-decadienoate, (2E,4Z)-</to_name>
		<to_code>1869048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eladocagene exuparvovec</to_name>
		<to_code>2698762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergothioneine</to_name>
		<to_code>1314350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoxazene hydrochloride</to_name>
		<to_code>402538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(2-ethylhexyloxy)ethanol</to_name>
		<to_code>2288811</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine carbamate</to_name>
		<to_code>2375923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efgartigimod alfa-qvfc</to_name>
		<to_code>2639944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia kansui whole extract</to_name>
		<to_code>2699581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ensartinib hydrochloride</to_name>
		<to_code>2712547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elder extract</to_name>
		<to_code>317808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eurotium amstelodami allergenic extract</to_name>
		<to_code>2101329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene glycol allyl ether</to_name>
		<to_code>2389636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English plantain pollen extract</to_name>
		<to_code>852742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern oyster allergenic extract</to_name>
		<to_code>2103250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eryngium maritimum whole extract</to_name>
		<to_code>2563920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edrecolomab</to_name>
		<to_code>80726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium grandiflorum top extract</to_name>
		<to_code>1311044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etonogestrel</to_name>
		<to_code>14584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethacrynic acid</to_name>
		<to_code>4109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evolocumab</to_name>
		<to_code>1665684</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythritol</to_name>
		<to_code>1369563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalapril</to_name>
		<to_code>3827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl acetate</to_name>
		<to_code>1313749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin gluceptate</to_name>
		<to_code>24346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edrophonium chloride</to_name>
		<to_code>3754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erodium cicutarium extract</to_name>
		<to_code>1433760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eicosyl povidone (2 eicosyl branches-repeat)</to_name>
		<to_code>1489921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eutrochium purpureum flowering top extract</to_name>
		<to_code>1813290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphrasia officinalis leaf extract</to_name>
		<to_code>2274241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine bitartrate</to_name>
		<to_code>203180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexylglyceryl behenate</to_name>
		<to_code>1592896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entsufon</to_name>
		<to_code>1366957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European aspen pollen extract</to_name>
		<to_code>2166596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>empagliflozin</to_name>
		<to_code>1545653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erigeron strigosus whole extract</to_name>
		<to_code>2118077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efgartigimod alfa-fcab</to_name>
		<to_code>2587719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ertapenem sodium</to_name>
		<to_code>353107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylenediamine tetra (methylene phosphonic acid) monohydrate</to_name>
		<to_code>1311236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elm extract</to_name>
		<to_code>1372006</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emedastine</to_name>
		<to_code>28144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylparaben sodium</to_name>
		<to_code>1364859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acetoacetate</to_name>
		<to_code>1603474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ensifentrine</to_name>
		<to_code>2687215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etorphine</to_name>
		<to_code>2728549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg white (chicken) allergenic extract</to_name>
		<to_code>892616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eletriptan hydrobromide</to_name>
		<to_code>360288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edaravone</to_name>
		<to_code>1921877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylnorepinephrine hydrochloride</to_name>
		<to_code>289080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern white pine pollen extract</to_name>
		<to_code>852738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl linalool</to_name>
		<to_code>1376096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>8-epi-cyanocobalamin</to_name>
		<to_code>1722234</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupatorium cannabinum whole extract</to_name>
		<to_code>1995487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl ethylhexanoate</to_name>
		<to_code>1313265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphrasia officinalis preparation</to_name>
		<to_code>283679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emapalumab</to_name>
		<to_code>2104604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Entada phaseoloides leaf extract</to_name>
		<to_code>1310085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ellagic acid</to_name>
		<to_code>1043181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entsufon sodium</to_name>
		<to_code>1366956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus cinerea whole extract</to_name>
		<to_code>2059231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>escin</to_name>
		<to_code>4065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea purpurea flowering top extract</to_name>
		<to_code>1307637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elinzanetant</to_name>
		<to_code>2725511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythrulose, D-</to_name>
		<to_code>1862681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English walnut allergenic extract</to_name>
		<to_code>891687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erenumab-aooe</to_name>
		<to_code>2045614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emepronium bromide</to_name>
		<to_code>71481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole sodium</to_name>
		<to_code>1294569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evodiamine</to_name>
		<to_code>2199291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eleutherococcus sessilflorus whole extract</to_name>
		<to_code>1313687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estriol succinate</to_name>
		<to_code>24416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-ethyl-3-oxetanemethanol</to_name>
		<to_code>2285402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eluxadoline</to_name>
		<to_code>1653781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl 2-methylpentanoate</to_name>
		<to_code>2557367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>echothiophate iodide</to_name>
		<to_code>3740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estramustine phosphate</to_name>
		<to_code>105556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epirubicin hydrochloride</to_name>
		<to_code>203213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>escitalopram</to_name>
		<to_code>321988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum hyemale top extract</to_name>
		<to_code>1724425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl laurate</to_name>
		<to_code>1314306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>entrectinib</to_name>
		<to_code>2197862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Entada phaseoloides whole extract</to_name>
		<to_code>1546867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elastin, bovine</to_name>
		<to_code>1730434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanolamine hydrochloride</to_name>
		<to_code>1311530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl dihydroxypropyl PABA</to_name>
		<to_code>314611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg yolk (chicken) allergenic extract</to_name>
		<to_code>892620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia corollata root extract</to_name>
		<to_code>1921561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eucalyptol</to_name>
		<to_code>21116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epifagus virginiana extract</to_name>
		<to_code>1353221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edoxaban tosylate</to_name>
		<to_code>1599564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ertugliflozin pidolate</to_name>
		<to_code>1992674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ehrlichia chaffeensis extract</to_name>
		<to_code>1492326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia resinifera resin</to_name>
		<to_code>1310367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus gum extract</to_name>
		<to_code>1541731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>escitalopram oxalate</to_name>
		<to_code>353108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eucalyptus piperita leaf extract</to_name>
		<to_code>1495155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl thioglycolate</to_name>
		<to_code>2533859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efmoroctocog alfa</to_name>
		<to_code>1543095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>encainide hydrochloride</to_name>
		<to_code>281189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupatorium perfoliatum preparation</to_name>
		<to_code>285152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eupatorium cannabinum extract</to_name>
		<to_code>1309987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ericerus pela polycosanol</to_name>
		<to_code>1313747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ensulizole</to_name>
		<to_code>13714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estramustine phosphate sodium</to_name>
		<to_code>4090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eriobotrya japonica whole extract</to_name>
		<to_code>2533858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia antisyphilitica whole extract</to_name>
		<to_code>2587596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estazolam</to_name>
		<to_code>4077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erodium stephanianum top extract</to_name>
		<to_code>1485538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ebanol</to_name>
		<to_code>2383933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythrosine sodium</to_name>
		<to_code>1366961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eleuthero preparation</to_name>
		<to_code>1368902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epigallocatechin gallate stearates</to_name>
		<to_code>1536068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epigaea repens extract</to_name>
		<to_code>1544392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eugenol</to_name>
		<to_code>4186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euonymus alatus whole extract</to_name>
		<to_code>1358887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>esomeprazole magnesium trihydrate</to_name>
		<to_code>2688630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl pyruvate</to_name>
		<to_code>1539968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Etlingera elatior whole extract</to_name>
		<to_code>2180258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl olivate</to_name>
		<to_code>2266752</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eriastrum filifolium whole extract</to_name>
		<to_code>2289221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylaminoethanol</to_name>
		<to_code>1313220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea purpurea flowering top water</to_name>
		<to_code>2602283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eculizumab-aagh</to_name>
		<to_code>2706334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etranacogene dezaparvovec</to_name>
		<to_code>2626727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Evans blue</to_name>
		<to_code>4191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl glutamate</to_name>
		<to_code>1544275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eperua falcata bark extract</to_name>
		<to_code>1487909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidocaine hydrochloride</to_name>
		<to_code>227221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum arvense branch extract</to_name>
		<to_code>1307596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equus caballus leg callous preparation</to_name>
		<to_code>1488227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>evinacumab-dgnb</to_name>
		<to_code>2478646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epigallocatechin gallate</to_name>
		<to_code>24246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>European rabbit skin extract</to_name>
		<to_code>895195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl ferulate</to_name>
		<to_code>1420983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetic acid dihydrate</to_name>
		<to_code>2465735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (100 MPA S)</to_name>
		<to_code>1305739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergot preparation</to_name>
		<to_code>91405</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elapegademase-lvlr</to_name>
		<to_code>2059218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene oxide</to_name>
		<to_code>1368154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia thymifolia whole extract</to_name>
		<to_code>1371301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-eicosene</to_name>
		<to_code>1313731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene dodecanedioate</to_name>
		<to_code>2604565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>everolimus</to_name>
		<to_code>141704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>everlasting extract</to_name>
		<to_code>1337279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphrasia stricta extract</to_name>
		<to_code>1353885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl sebacate</to_name>
		<to_code>1426475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern yellow jacket venom protein</to_name>
		<to_code>1297529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia hirta flowering top extract</to_name>
		<to_code>1543077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etodolac</to_name>
		<to_code>24605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin lactobionate</to_name>
		<to_code>24347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergoloid mesylates, USP</to_name>
		<to_code>4024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylcellulose (45 MPA.S)</to_name>
		<to_code>1649449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eriodictyon californicum leaf extract</to_name>
		<to_code>1342455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epilobium angustifolium flowering top extract</to_name>
		<to_code>1307564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euterpe oleracea whole extract</to_name>
		<to_code>1358888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprosartan mesylate</to_name>
		<to_code>236878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylparaben potassium</to_name>
		<to_code>2686158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythorbate</to_name>
		<to_code>1356146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea purpurea aerial parts extract</to_name>
		<to_code>477531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>East Indian lemongrass oil</to_name>
		<to_code>1309338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elymus repens whole extract</to_name>
		<to_code>1661742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etanercept</to_name>
		<to_code>214555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eschscholzia californica flower extract</to_name>
		<to_code>2593941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Embelia ribes whole extract</to_name>
		<to_code>2707700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emapalumab-lzsg</to_name>
		<to_code>2104603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efinaconazole</to_name>
		<to_code>1539753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea preparation</to_name>
		<to_code>228041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enzalutamide</to_name>
		<to_code>1307298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylnorepinephrine</to_name>
		<to_code>156240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene distearamide</to_name>
		<to_code>1655222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>equol, (+-)-</to_name>
		<to_code>1492341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eclipta prostrata whole extract</to_name>
		<to_code>1360622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea pallida preparation</to_name>
		<to_code>1364288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ecamsule</to_name>
		<to_code>1544124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ephedra sinica root extract</to_name>
		<to_code>1724424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate sodium tetrahydrate</to_name>
		<to_code>1356152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexyl acrylate</to_name>
		<to_code>1432294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erlotinib</to_name>
		<to_code>337525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eplerenone</to_name>
		<to_code>298869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethinamate</to_name>
		<to_code>24474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etofibrate</to_name>
		<to_code>24609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estrone</to_name>
		<to_code>4103</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprosartan</to_name>
		<to_code>83515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl acrylate and methyl methacrylate copolymer (2:1; 750000 MW)</to_name>
		<to_code>1426457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erythroxylum catuaba bark extract</to_name>
		<to_code>1609189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus extract</to_name>
		<to_code>319781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enflurane</to_name>
		<to_code>3920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elranatamab</to_name>
		<to_code>2644880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl methoxycrylene</to_name>
		<to_code>1311616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucommia ulmoides leaf extract</to_name>
		<to_code>1866521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estetrol monohydrate</to_name>
		<to_code>2539035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl cyanoacrylate</to_name>
		<to_code>1608793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elvitegravir</to_name>
		<to_code>1306286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl-p-hydroxybenzoate</to_name>
		<to_code>1362892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eugenia uniflora whole extract</to_name>
		<to_code>1535488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ensartinib</to_name>
		<to_code>2712546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>English lavender oil</to_name>
		<to_code>2168411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ecothiopate</to_name>
		<to_code>89778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enzacamene</to_name>
		<to_code>1311507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl vanillin</to_name>
		<to_code>1311571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emepronium</to_name>
		<to_code>3816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epidermal growth factor</to_name>
		<to_code>1427158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etoricoxib</to_name>
		<to_code>307296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eriodictyon californicum flowering top extract</to_name>
		<to_code>1371949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etranacogene dezaparvovec-drlb</to_name>
		<to_code>2626768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enoxaparin</to_name>
		<to_code>67108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethopabate</to_name>
		<to_code>1314353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elivaldogene autotemcel</to_name>
		<to_code>2612527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea angustifolia extract</to_name>
		<to_code>236121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylbisiminomethylguaiacol manganese chloride</to_name>
		<to_code>1373152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epsiprantel</to_name>
		<to_code>24285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate calcium disodium anhydrous</to_name>
		<to_code>1371967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>exagamglogene autotemcel</to_name>
		<to_code>2671667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethamivan</to_name>
		<to_code>24453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ESCHERICHIA COLI ANTIGEN</to_name>
		<to_code>237121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eastern cottonwood pollen extract</to_name>
		<to_code>852363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eleutherococcus senticosus root oil</to_name>
		<to_code>2591606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl benzoate</to_name>
		<to_code>1921584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene</to_name>
		<to_code>1314362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epomediol</to_name>
		<to_code>24263</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etravirine</to_name>
		<to_code>475969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexanoic acid</to_name>
		<to_code>1305517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>equol, (-)-</to_name>
		<to_code>1803717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene-vinyl acetate copolymer (28% vinyl acetate)</to_name>
		<to_code>1426456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl pelargonate</to_name>
		<to_code>2587718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eplontersen</to_name>
		<to_code>2671939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethacridine</to_name>
		<to_code>4106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eltrombopag</to_name>
		<to_code>711942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl gallate</to_name>
		<to_code>1596929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl cysteine</to_name>
		<to_code>24513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eltrombopag choline</to_name>
		<to_code>2675185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethambutol hydrochloride</to_name>
		<to_code>142435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erycibe obtusifolia stem extract</to_name>
		<to_code>1788843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate calcium disodium monohydrate</to_name>
		<to_code>2001422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl p-hydroxyhydrocinnamate</to_name>
		<to_code>2642871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetol</to_name>
		<to_code>1314349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emepronium carrageenate</to_name>
		<to_code>23944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elamipretide hydrochloride</to_name>
		<to_code>2725599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythrosine</to_name>
		<to_code>4061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia lathyris extract</to_name>
		<to_code>1337633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eicosenoic acid</to_name>
		<to_code>1374399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eslicarbazepine acetate</to_name>
		<to_code>1482501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eflapegrastim-xnst</to_name>
		<to_code>2612537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erbium sulfate octahydrate</to_name>
		<to_code>2049335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene-vinyl acetate copolymer (9% vinyl acetate)</to_name>
		<to_code>1427045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl perfluoroisobutyl ether</to_name>
		<to_code>1541247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene dicocamide peg-15 disulfate</to_name>
		<to_code>1370603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enoxaparin sodium</to_name>
		<to_code>221095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoglucid</to_name>
		<to_code>4132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efavirenz</to_name>
		<to_code>195085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylnicotinate</to_name>
		<to_code>236122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eprazinone</to_name>
		<to_code>24272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene-vinyl acetate copolymer (19% vinylacetate)</to_name>
		<to_code>1312576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol acetate</to_name>
		<to_code>405416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edoxaban</to_name>
		<to_code>1599538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euphorbia hirta leaf extract</to_name>
		<to_code>2641890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etanercept-ykro</to_name>
		<to_code>2462511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ergonovine</to_name>
		<to_code>4021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eltrombopag olamine</to_name>
		<to_code>735651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene brassylate</to_name>
		<to_code>1314363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum arvense stem oil</to_name>
		<to_code>1864322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emicizumab</to_name>
		<to_code>1989794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucommia ulmoides whole extract</to_name>
		<to_code>1535479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ezogabine</to_name>
		<to_code>1112990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eletriptan</to_name>
		<to_code>231049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl methylphenylglycidate</to_name>
		<to_code>1546209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl olivate</to_name>
		<to_code>2665656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erysimum cheiri seed extract</to_name>
		<to_code>2711783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl methacrylate</to_name>
		<to_code>2373437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Erysimum cheiri extract</to_name>
		<to_code>1810298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elemi oil</to_name>
		<to_code>2588242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin ethylsuccinate</to_name>
		<to_code>4056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epicoccum nigrum allergenic extract</to_name>
		<to_code>852466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erdosteine</to_name>
		<to_code>24305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enasidenib</to_name>
		<to_code>1940332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinephrine</to_name>
		<to_code>3992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>egg shell, cooked</to_name>
		<to_code>1427195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol valerate</to_name>
		<to_code>24395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Equisetum arvense whole extract</to_name>
		<to_code>1535478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>encainide</to_name>
		<to_code>42368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus piperita leaf oil</to_name>
		<to_code>2593181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etoposide phosphate</to_name>
		<to_code>24614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elagolix</to_name>
		<to_code>2049846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl vanillate</to_name>
		<to_code>2588043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elafibranor</to_name>
		<to_code>2684941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ethylhexyl stearate</to_name>
		<to_code>1368886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etoposide</to_name>
		<to_code>4179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea root extract</to_name>
		<to_code>477379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylhexyl hydroxystearate</to_name>
		<to_code>1368707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus oil</to_name>
		<to_code>59087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin estolate</to_name>
		<to_code>4055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emicizumab-kxwh</to_name>
		<to_code>1989795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enalapril maleate</to_name>
		<to_code>203123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanolamine thenoate</to_name>
		<to_code>236213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eptinezumab</to_name>
		<to_code>2282660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium wushanense whole extract</to_name>
		<to_code>2107307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-ethoxyundecane</to_name>
		<to_code>2671359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enfortumab vedotin</to_name>
		<to_code>2277607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium sagittatum top extract</to_name>
		<to_code>1673375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea pallida root extract</to_name>
		<to_code>969119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eicosapentaenoic acid</to_name>
		<to_code>90</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate disodium</to_name>
		<to_code>3539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epoprostenol</to_name>
		<to_code>8814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ecallantide</to_name>
		<to_code>658708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidocaine</to_name>
		<to_code>4171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Elymus repens top extract</to_name>
		<to_code>1344644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl cellulose</to_name>
		<to_code>1310565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eicosapentaenoate</to_name>
		<to_code>618597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Epimedium pubescens whole extract</to_name>
		<to_code>2716393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>epinastine hydrochloride</to_name>
		<to_code>236961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elranatamab-bcmm</to_name>
		<to_code>2644881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>emetine hydrochloride</to_name>
		<to_code>82015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea angustifolia leaf extract</to_name>
		<to_code>1307673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>equol, (+)</to_name>
		<to_code>1648566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethacridine lactate</to_name>
		<to_code>4107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylestrenol</to_name>
		<to_code>4162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>efbemalenograstim alfa</to_name>
		<to_code>2670630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethyl cysteine hydrochloride</to_name>
		<to_code>236634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estradiol</to_name>
		<to_code>4083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etidronate disodium</to_name>
		<to_code>9872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Euonymus europaeus seed extract</to_name>
		<to_code>2386842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ephedrine</to_name>
		<to_code>3966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythromycin stinoprate</to_name>
		<to_code>236847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>enfortumab vedotin-ejfv</to_name>
		<to_code>2268306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethopropazine hydrochloride</to_name>
		<to_code>6541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elbasvir</to_name>
		<to_code>1734628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erdafitinib</to_name>
		<to_code>2123125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethohexadiol</to_name>
		<to_code>1362891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetic acid</to_name>
		<to_code>3755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Echinacea, aerial parts</to_name>
		<to_code>283560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>estrogens</to_name>
		<to_code>4100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethoxydiglycol behenate</to_name>
		<to_code>1794165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ertugliflozin</to_name>
		<to_code>1992672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>eteplirsen</to_name>
		<to_code>1810569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>elacestrant</to_name>
		<to_code>2628469</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethosuximide</to_name>
		<to_code>4135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>edetate calcium disodium</to_name>
		<to_code>1903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>erythrosine sodium anhydrous</to_name>
		<to_code>1736634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethanolamine</to_name>
		<to_code>24457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Eucalyptus dives leafy twig oil</to_name>
		<to_code>1747865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ecklonia kurome extract</to_name>
		<to_code>2261002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>etomidate</to_name>
		<to_code>4177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Enterobacter aerogenes</to_name>
		<to_code>1544929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>E [Preparations]</from_name>
		<from_code>N0000010587</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ethylene-vinyl acetate copolymer (15% vinyl acetate)</to_name>
		<to_code>1313710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enilconazole</from_name>
		<from_code>1442172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>enilconazole</to_name>
		<to_code>M0068167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enrofloxacin</from_name>
		<from_code>24192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enrofloxacin</to_name>
		<to_code>M0150025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>edamine</to_name>
		<to_code>M0098306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylenediamine</to_name>
		<to_code>M0098309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylenediamine</from_name>
		<from_code>4158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethane-1,2-diamine</to_name>
		<to_code>M0521130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efloxate</from_name>
		<from_code>23852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efloxate</to_name>
		<to_code>M0047039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoxazene</from_name>
		<from_code>41078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethoxazene</to_name>
		<to_code>M0066396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eosine yellowish</from_name>
		<from_code>1310593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eosine Yellowish-(YS)</to_name>
		<to_code>M0007531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl caproate</from_name>
		<from_code>2476631</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl hexanoate</to_name>
		<to_code>M0212146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea purpurea extract</from_name>
		<from_code>260025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinacea purpurea extract</to_name>
		<to_code>M000751161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethamsylate</from_name>
		<from_code>4112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethamsylate</to_name>
		<to_code>M0007819</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>embutramide</from_name>
		<from_code>2464539</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>embutramide</to_name>
		<to_code>M0165065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ehrlichia canis</from_name>
		<from_code>1608966</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ehrlichia canis</to_name>
		<to_code>M0425489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylbenzene</from_name>
		<from_code>1540523</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylbenzene</to_name>
		<to_code>M0046113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erbium</from_name>
		<from_code>1311483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erbium</to_name>
		<to_code>M0007649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>endothelial growth factor A, vascular</from_name>
		<from_code>2642870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Vascular Endothelial Growth Factor A</to_name>
		<to_code>M0356369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoetin beta</from_name>
		<from_code>105695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>epoetin beta</to_name>
		<to_code>M0271774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethisterone</from_name>
		<from_code>4129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethisterone</to_name>
		<to_code>M0007872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucommia ulmoides bark extract</from_name>
		<from_code>1309788</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eucommiae cortex</to_name>
		<to_code>M000768111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylene glycol</from_name>
		<from_code>1314364</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethylene Glycol</to_name>
		<to_code>M0029474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edoxudine</from_name>
		<from_code>49428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>edoxudin</to_name>
		<to_code>M0079426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ectoine</from_name>
		<from_code>1426644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ectoine</to_name>
		<to_code>M0132603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl butyrate</from_name>
		<from_code>1314356</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl butyrate</to_name>
		<to_code>M0132450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylhexylglycerin</from_name>
		<from_code>1367134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylhexylglycerin</to_name>
		<to_code>M0516372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etilefrine hydrochloride</from_name>
		<from_code>235960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Etilefrine Hydrochloride</to_name>
		<to_code>M0330371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl anthranilate</from_name>
		<from_code>2396756</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl anthranilate</to_name>
		<to_code>M000617040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythromycin Phosphate</to_name>
		<to_code>M0007717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin phosphate</from_name>
		<from_code>4058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin</from_name>
		<from_code>2551</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin hydrochloride</from_name>
		<from_code>81981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofloxacin lactate</from_name>
		<from_code>235851</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter Infections</to_name>
		<to_code>M0003245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>erythromycin glucoheptonate</to_name>
		<to_code>M0092609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin gluceptate</from_name>
		<from_code>24346</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline hydrochloride</from_name>
		<from_code>81993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acellular pertussis vaccine, inactivated</from_name>
		<from_code>798302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis toxoid vaccine, inactivated</from_name>
		<from_code>1300186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pertussis vaccine</from_name>
		<from_code>8080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis pertactin vaccine, inactivated</from_name>
		<from_code>1300184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>guaifenesin</from_name>
		<from_code>5032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated</from_name>
		<from_code>1300182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated</from_name>
		<from_code>1300180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>demeclocycline</from_name>
		<from_code>3154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>PERTUSSIS VACCINE,ADSORBED</from_name>
		<from_code>402543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Whooping Cough</to_name>
		<to_code>M0022977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythromycin Estolate</to_name>
		<to_code>M0007723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin estolate</from_name>
		<from_code>4055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide</from_name>
		<from_code>89784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>immunoglobulins, intravenous</from_name>
		<from_code>42386</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paraldehyde</from_name>
		<from_code>7909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mefenamic acid</from_name>
		<from_code>6693</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isopropamide iodide</from_name>
		<from_code>6051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gastroenteritis</to_name>
		<to_code>M0009018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stinoprate</from_name>
		<from_code>236847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Legionnaires' Disease</to_name>
		<to_code>M0012293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythromycin Ethylsuccinate</to_name>
		<to_code>M0023980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin ethylsuccinate</from_name>
		<from_code>4056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrasma</to_name>
		<to_code>M0007683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin lactobionate</from_name>
		<from_code>24347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>erythromycin lactobionate</to_name>
		<to_code>M0056871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin</from_name>
		<from_code>4053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline calcium</from_name>
		<from_code>82012</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>troleandomycin</from_name>
		<from_code>10864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hyclate</from_name>
		<from_code>23663</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline</from_name>
		<from_code>3640</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline hydrochloride</from_name>
		<from_code>236647</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline monohydrate</from_name>
		<from_code>203122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxycycline anhydrous</from_name>
		<from_code>1545992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Syphilis</to_name>
		<to_code>M0020966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>erythromycin stearate</to_name>
		<to_code>M0057778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythromycin stearate</from_name>
		<from_code>24351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl oleate</from_name>
		<from_code>1314361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl oleate</to_name>
		<to_code>M0103089</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edodekin alfa</from_name>
		<from_code>1371906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Edodekin Alfa</to_name>
		<to_code>M000642660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Enterobacter cloacae</from_name>
		<from_code>1491010</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterobacter cloacae</to_name>
		<to_code>M0025803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enmetazobactam</from_name>
		<from_code>2675985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterobacter cloacae</to_name>
		<to_code>M0025803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl maltol</from_name>
		<from_code>1314359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl maltol</to_name>
		<to_code>M0148780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl lauroyl arginate hydrochloride</from_name>
		<from_code>1426162</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethyl lauroyl arginate hydrochloride</to_name>
		<to_code>M000737581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethenzamide</from_name>
		<from_code>24468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethenzamide</to_name>
		<to_code>M0070963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl palmitate</from_name>
		<from_code>1306938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl palmitate</to_name>
		<to_code>M0051023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esculin</from_name>
		<from_code>1314351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esculin</to_name>
		<to_code>M0007736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evernia prunastri extract</from_name>
		<from_code>1352501</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>oakmoss, absolute</to_name>
		<to_code>M0130459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant extract</from_name>
		<from_code>1315116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl levulinate</from_name>
		<from_code>1313748</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl levulinate</to_name>
		<to_code>M0538026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder, Treatment-Resistant</to_name>
		<to_code>M0556716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine</from_name>
		<from_code>2119365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Esketamine</to_name>
		<to_code>M000647133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>abciximab</from_name>
		<from_code>83929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenecteplase</from_name>
		<from_code>259280</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reteplase</from_name>
		<from_code>76895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium nitroprusside</from_name>
		<from_code>9895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anistreplase</from_name>
		<from_code>40028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>streptokinase</from_name>
		<from_code>10106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>urokinase</from_name>
		<from_code>11055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Arteriovenous Malformations</to_name>
		<to_code>M0001738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>esketamine hydrochloride</from_name>
		<from_code>2119366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Depressive Disorder, Treatment-Resistant</to_name>
		<to_code>M0556716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide dinitrate</from_name>
		<from_code>6058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentoxifylline</from_name>
		<from_code>8013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dimethyl isosorbide</from_name>
		<from_code>1426599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine</from_name>
		<from_code>4496</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone</from_name>
		<from_code>6691</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide</from_name>
		<from_code>6057</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>medroxyprogesterone acetate</from_name>
		<from_code>1000112</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine decanoate</from_name>
		<from_code>25190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone</from_name>
		<from_code>8727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine enanthate</from_name>
		<from_code>30129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>progesterone, micronized</from_name>
		<from_code>259409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitroglycerin</from_name>
		<from_code>4917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isosorbide mononitrate</from_name>
		<from_code>28004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrityl tetranitrate</from_name>
		<from_code>4040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluphenazine hydrochloride</from_name>
		<from_code>203207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketorolac tromethamine</from_name>
		<from_code>28200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerebral Hemorrhage</to_name>
		<to_code>M0003884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban</from_name>
		<from_code>73137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tirofiban hydrochloride</from_name>
		<from_code>253202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine hydrochloride</from_name>
		<from_code>203184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ketamine</from_name>
		<from_code>6130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Aneurysm</to_name>
		<to_code>M0001174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk phospholipids</from_name>
		<from_code>314605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>europium</from_name>
		<from_code>1311484</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Europium</to_name>
		<to_code>M0007958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Epstein-Barr virus</from_name>
		<from_code>1316054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Herpesvirus 4, Human</to_name>
		<to_code>M0007615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etilefrine</from_name>
		<from_code>4169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Etilefrine</to_name>
		<to_code>M0007916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epoxiconazole</from_name>
		<from_code>2593180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>epoxiconazole</to_name>
		<to_code>M0284102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elderberry fruit</from_name>
		<from_code>260053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elderberry fruit</to_name>
		<to_code>M000744281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etilevodopa</from_name>
		<from_code>1421444</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>etilevodopa</to_name>
		<to_code>M0460318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanethiol</from_name>
		<from_code>1314352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethanethiol</to_name>
		<to_code>M0050959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epicatechin</from_name>
		<from_code>2641822</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epicatechin</to_name>
		<to_code>M0003643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethionamide</to_name>
		<to_code>M0007869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethionamide</from_name>
		<from_code>4127</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edotreotide gallium ga-68</from_name>
		<from_code>2199391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>edotreotide gallium ga-68</to_name>
		<to_code>M000622416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl valerate</from_name>
		<from_code>1312574</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl valerate</to_name>
		<to_code>M000635893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl sulfate</from_name>
		<from_code>1665664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl sulfate</to_name>
		<to_code>M000608460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etofamide</from_name>
		<from_code>24607</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>etofamide</to_name>
		<to_code>M0055455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ebastine</from_name>
		<from_code>23796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ebastine</to_name>
		<to_code>M0162527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl salicylate</from_name>
		<from_code>1546423</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl salicylate</to_name>
		<to_code>M0123872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Enterococcus faecium</from_name>
		<from_code>1943794</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterococcus faecium</to_name>
		<to_code>M0025816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>equine diphtheria antitoxin</from_name>
		<from_code>91602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V benzathine</from_name>
		<from_code>18926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid adsorbed</from_name>
		<from_code>235600</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria antitoxin</from_name>
		<from_code>3510</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V calcium</from_name>
		<from_code>236517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diptheria toxoid absorbed</from_name>
		<from_code>1657601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphtheria toxoid vaccine, inactivated</from_name>
		<from_code>798304</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diphtheria</to_name>
		<to_code>M0006520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoxyquin</from_name>
		<from_code>1314354</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethoxyquin</to_name>
		<to_code>M0007889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl nitrite</from_name>
		<from_code>1921585</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl nitrite</to_name>
		<to_code>M0101894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine</from_name>
		<from_code>3820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Emetine</to_name>
		<to_code>M0007281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine</from_name>
		<from_code>3820</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fascioloidiasis</to_name>
		<to_code>M0008246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine hydrochloride</from_name>
		<from_code>82015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Fascioloidiasis</to_name>
		<to_code>M0008246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emetine hydrochloride</from_name>
		<from_code>82015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Emetine Hydrochloride</to_name>
		<to_code>M0330432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eriobotrya japonica leaf extract</from_name>
		<from_code>1310088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>loquat leaf</to_name>
		<to_code>M000744689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>European elderberry extract</from_name>
		<from_code>1311531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>black elderberry extract</to_name>
		<to_code>M000744426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethybenztropine</from_name>
		<from_code>1358000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethybenztropine</to_name>
		<to_code>M0089667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl linolenate</from_name>
		<from_code>1483807</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl linolenate</to_name>
		<to_code>M0119121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elderberry preparation</from_name>
		<from_code>319834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elderberry extract</to_name>
		<to_code>M000744279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab</from_name>
		<from_code>2478335</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>evinacumab</to_name>
		<to_code>M000634681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoxacin</from_name>
		<from_code>3925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enoxacin</to_name>
		<to_code>M0023652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethiodized oil</from_name>
		<from_code>4125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Administration, Intravenous</to_name>
		<to_code>M0559413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethiodized oil</from_name>
		<from_code>4125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethiodized Oil</to_name>
		<to_code>M0007866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Administration, Intravenous</to_name>
		<to_code>M0559413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Administration, Intravenous</to_name>
		<to_code>M0559413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Enterococcus faecalis</from_name>
		<from_code>10098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterococcus faecalis</to_name>
		<to_code>M0020571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir anhydrous</from_name>
		<from_code>1546027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir anhydrous</from_name>
		<from_code>1546027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>anhydrous entecavir</to_name>
		<to_code>M000758487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide</from_name>
		<from_code>1721603</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir anhydrous</from_name>
		<from_code>1546017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir</from_name>
		<from_code>117466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil fumarate</from_name>
		<from_code>322248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir dipivoxil</from_name>
		<from_code>141400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil</from_name>
		<from_code>300195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir alafenamide fumarate</from_name>
		<from_code>1721604</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tenofovir disoproxil succinate</from_name>
		<from_code>1928942</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>adefovir</from_name>
		<from_code>16521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>interferon alfa-2b</from_name>
		<from_code>5880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>telbivudine</from_name>
		<from_code>474128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hepatitis B, Chronic</to_name>
		<to_code>M0029244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>entecavir</from_name>
		<from_code>306266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>entecavir</to_name>
		<to_code>M0370336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl hexyl salicylate</from_name>
		<from_code>236880</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl hexyl salicylate</to_name>
		<to_code>M0518358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enoximone</from_name>
		<from_code>49626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enoximone</to_name>
		<to_code>M0026327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>exametazime</from_name>
		<from_code>62153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>exametazime</to_name>
		<to_code>M0209364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline</from_name>
		<from_code>2055906</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eravacycline</to_name>
		<to_code>M000606732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emu oil</from_name>
		<from_code>1309389</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>emu Oil</to_name>
		<to_code>M0577244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elastin</from_name>
		<from_code>1730435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Elastin</to_name>
		<to_code>M0007152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-ethylhexanol</from_name>
		<from_code>2394645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-ethylhexanol</to_name>
		<to_code>M0105132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl isovalerate</from_name>
		<from_code>1314357</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl isovalerate</to_name>
		<to_code>M0452046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl acetate</from_name>
		<from_code>1314355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl acetate</to_name>
		<to_code>M0050978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Entamoeba histolytica</from_name>
		<from_code>1316053</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Entamoeba histolytica</to_name>
		<to_code>M0007459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emodepside</from_name>
		<from_code>354606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>emodepside</to_name>
		<to_code>M0443265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eggplant allergenic extract</from_name>
		<from_code>972601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea purpurea root extract</from_name>
		<from_code>259513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinacea purpurea root extract</to_name>
		<to_code>M000751166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprinomectin</from_name>
		<from_code>1006619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eprinomectin</to_name>
		<to_code>M0265917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethambutol</to_name>
		<to_code>M0007814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol</from_name>
		<from_code>4110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine sulfate</from_name>
		<from_code>9075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine salicylate</from_name>
		<from_code>1426899</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin, human</from_name>
		<from_code>1535213</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine hydrochloride</from_name>
		<from_code>9074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine bisulfate</from_name>
		<from_code>9073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine dihydrochloride</from_name>
		<from_code>388472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine ascorbate</from_name>
		<from_code>236327</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin</from_name>
		<from_code>376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinine</from_name>
		<from_code>9071</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Optic Neuritis</to_name>
		<to_code>M0015359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethambutol hydrochloride</from_name>
		<from_code>142435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethambutol Hydrochloride</to_name>
		<to_code>M0007816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egtazic acid</from_name>
		<from_code>1742992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Egtazic Acid</to_name>
		<to_code>M0007133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine oleate</from_name>
		<from_code>24460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethanolamine oleate</to_name>
		<to_code>M0103493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethanolamine oleate</from_name>
		<from_code>24460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>monoethanolamine oleate</to_name>
		<to_code>M0393808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylhexyl palmitate</from_name>
		<from_code>1426380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylhexyl palmitate</to_name>
		<to_code>M0100623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl linoleate</from_name>
		<from_code>24522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl linoleate</to_name>
		<to_code>M0051020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylmorphine</from_name>
		<from_code>4166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethylmorphine</to_name>
		<to_code>M0007912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-ethoxyethanol</from_name>
		<from_code>1314365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-ethoxyethanol</to_name>
		<to_code>M0075980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etofenamate</from_name>
		<from_code>24608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>etofenamate</to_name>
		<to_code>M0064304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg (chicken) allergenic extract</from_name>
		<from_code>904507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Egg Proteins, Dietary</to_name>
		<to_code>M0023708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg (chicken) allergenic extract</from_name>
		<from_code>904507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk (chicken) allergenic extract</from_name>
		<from_code>892620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Egg Proteins, Dietary</to_name>
		<to_code>M0023708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg white (chicken) allergenic extract</from_name>
		<from_code>892616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Egg Proteins, Dietary</to_name>
		<to_code>M0023708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Egg Proteins, Dietary</to_name>
		<to_code>M0023708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg yolk (chicken) allergenic extract</from_name>
		<from_code>892620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg white (chicken) allergenic extract</from_name>
		<from_code>892616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprozinol</from_name>
		<from_code>24274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eprozinol</to_name>
		<to_code>M0065458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl stearate</from_name>
		<from_code>1368181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl stearate</to_name>
		<to_code>M0086603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprazinone HCl</from_name>
		<from_code>236310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eprazinone hydrochloride</to_name>
		<to_code>M0477779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etifoxine</from_name>
		<from_code>24441</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>etifoxine</to_name>
		<to_code>M0042618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Escherichia coli</from_name>
		<from_code>350202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escherichia coli</to_name>
		<to_code>M0007732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Larva Migrans</to_name>
		<to_code>M0012221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Glomus Tumor</to_name>
		<to_code>M0009296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ether</from_name>
		<from_code>1363043</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ether</to_name>
		<to_code>M0007827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol</from_name>
		<from_code>36117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol trifenatate</from_name>
		<from_code>1424883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram hydrochloride</from_name>
		<from_code>82011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doxapram</from_name>
		<from_code>3637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine</from_name>
		<from_code>1767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vilanterol</from_name>
		<from_code>1424884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone</from_name>
		<from_code>1347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone 17-monopropionate</from_name>
		<from_code>1546384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone propionate</from_name>
		<from_code>50121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoflurane</from_name>
		<from_code>6026</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine maleate</from_name>
		<from_code>142427</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide (11.beta.,16.alpha.(S))</from_name>
		<from_code>1367172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halothane</from_name>
		<from_code>5095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enflurane</from_name>
		<from_code>3920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brompheniramine tannate</from_name>
		<from_code>405414</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol xinafoate</from_name>
		<from_code>72616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Status Asthmaticus</to_name>
		<to_code>M0020462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiabendazole</from_name>
		<from_code>10450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Larva Migrans</to_name>
		<to_code>M0012221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine</from_name>
		<from_code>10805</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzonatate</from_name>
		<from_code>18993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triflupromazine hydrochloride</from_name>
		<from_code>91125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>baclofen</from_name>
		<from_code>1292</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hiccup</to_name>
		<to_code>M0010343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl acrylate</from_name>
		<from_code>1859382</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl acrylate</to_name>
		<to_code>M0121381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estriol</from_name>
		<from_code>4094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Estriol</to_name>
		<to_code>M0007788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl perfluorobutyl ether</from_name>
		<from_code>1540871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethoxynonafluorobutane</to_name>
		<to_code>M0404070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enobosarm</from_name>
		<from_code>2168587</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ostarine</to_name>
		<to_code>M0543612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eravacycline dihydrochloride</from_name>
		<from_code>2055907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eravacycline dihydrochloride</to_name>
		<to_code>M000758490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etifoxine hydrochloride</from_name>
		<from_code>236215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>etifoxine hydrochloride</to_name>
		<to_code>M0477832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl lactate</from_name>
		<from_code>1427072</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl lactate</to_name>
		<to_code>M0065477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evening primrose oil</from_name>
		<from_code>203219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>evening primrose oil</to_name>
		<to_code>M0091678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl nitrate</from_name>
		<from_code>1314360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl nitrate</to_name>
		<to_code>M0438845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl loflazepate</from_name>
		<from_code>24524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl loflazepate</to_name>
		<to_code>M0094367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergothioneine</from_name>
		<from_code>1314350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ergothioneine</to_name>
		<to_code>M0007666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elder extract</from_name>
		<from_code>317808</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>elder flower</to_name>
		<to_code>M000744280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrecolomab</from_name>
		<from_code>80726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Edrecolomab</to_name>
		<to_code>M0350230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edrecolomab</from_name>
		<from_code>80726</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>MAb 17-1A</to_name>
		<to_code>M000654645</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Euphrasia officinalis leaf extract</from_name>
		<from_code>2274241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Euphrasia officinalis leaf extract</to_name>
		<to_code>M000744616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl acetoacetate</from_name>
		<from_code>1603474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl acetoacetate</to_name>
		<to_code>M0083486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ellagic acid</from_name>
		<from_code>1043181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ellagic Acid</to_name>
		<to_code>M0007238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escin</from_name>
		<from_code>4065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escin</to_name>
		<to_code>M0007735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea purpurea flowering top extract</from_name>
		<from_code>1307637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinacea purpurea flowering top extract</to_name>
		<to_code>M000751168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea purpurea aerial parts extract</from_name>
		<from_code>477531</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinacea purpurea flowering top extract</to_name>
		<to_code>M000751168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emepronium bromide</from_name>
		<from_code>71481</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Emepronium Bromide</to_name>
		<to_code>M0351160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evodiamine</from_name>
		<from_code>2199291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>evodiamine</to_name>
		<to_code>M0142130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>estriol succinate</from_name>
		<from_code>24416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>estriol succinate</to_name>
		<to_code>M0053947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram</from_name>
		<from_code>321988</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escitalopram</to_name>
		<to_code>M0406596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eucalyptol</from_name>
		<from_code>21116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eucalyptol</to_name>
		<to_code>M0055349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eucalyptol</from_name>
		<from_code>21116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cineole</to_name>
		<to_code>M000641008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>escitalopram oxalate</from_name>
		<from_code>353108</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Escitalopram Oxalate</to_name>
		<to_code>M000643214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ensulizole</from_name>
		<from_code>13714</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ensulizole</to_name>
		<to_code>M0483581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ebanol</from_name>
		<from_code>2383933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ebanol</to_name>
		<to_code>M0496587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl pyruvate</from_name>
		<from_code>1539968</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl pyruvate</to_name>
		<to_code>M0134727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Echinacea purpurea flowering top water</from_name>
		<from_code>2602283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Echinacea purpurea flowering top water</to_name>
		<to_code>M000751169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Evans blue</from_name>
		<from_code>4191</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Evans Blue</to_name>
		<to_code>M0007985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>evinacumab-dgnb</from_name>
		<from_code>2478646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>evinacumab-dgnb</to_name>
		<to_code>M000767487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epigallocatechin gallate</from_name>
		<from_code>24246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>epigallocatechin gallate</to_name>
		<to_code>M0132653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl ferulate</from_name>
		<from_code>1420983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl ferulate</to_name>
		<to_code>M0260162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergot preparation</from_name>
		<from_code>91405</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost tromethamine</from_name>
		<from_code>20259</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin acetate</from_name>
		<from_code>1733680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytocin</from_name>
		<from_code>7824</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboprost</from_name>
		<from_code>2051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine maleate</from_name>
		<from_code>84158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylergonovine</from_name>
		<from_code>6883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Postpartum Hemorrhage</to_name>
		<to_code>M0010156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nelfinavir</from_name>
		<from_code>134527</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Nelfinavir</to_name>
		<to_code>M0029531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine</from_name>
		<from_code>17767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan succinate</from_name>
		<from_code>322249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergoloid mesylates, USP</from_name>
		<from_code>4024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil hydrochloride</from_name>
		<from_code>203138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan</from_name>
		<from_code>141366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem hydrochloride</from_name>
		<from_code>203211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>frovatriptan</from_name>
		<from_code>228783</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zolmitriptan</from_name>
		<from_code>135775</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan malate</from_name>
		<from_code>283792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naratriptan hydrochloride</from_name>
		<from_code>236690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan</from_name>
		<from_code>88014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine</from_name>
		<from_code>7396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine besylate</from_name>
		<from_code>104416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicardipine hydrochloride</from_name>
		<from_code>235230</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>almotriptan</from_name>
		<from_code>279645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rizatriptan benzoate</from_name>
		<from_code>237082</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isradipine</from_name>
		<from_code>33910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem malate</from_name>
		<from_code>81999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem</from_name>
		<from_code>3443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>verapamil</from_name>
		<from_code>11170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>felodipine</from_name>
		<from_code>4316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nisoldipine</from_name>
		<from_code>7435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amlodipine benzoate</from_name>
		<from_code>2184116</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan succinate</from_name>
		<from_code>67158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sumatriptan</from_name>
		<from_code>37418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nifedipine</from_name>
		<from_code>7417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diltiazem maleate</from_name>
		<from_code>314592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Angina Pectoris, Variant</to_name>
		<to_code>M0001181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine mesylate</from_name>
		<from_code>42646</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine monomesylate</from_name>
		<from_code>42645</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine</from_name>
		<from_code>4021</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergonovine maleate</from_name>
		<from_code>24313</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocryptine</from_name>
		<from_code>3417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocristine</from_name>
		<from_code>3416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine mesylate</from_name>
		<from_code>42644</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergocornine</from_name>
		<from_code>3415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ergotamine tartrate</from_name>
		<from_code>42676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotoxine</from_name>
		<from_code>3419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Abortion, Threatened</to_name>
		<to_code>M0000052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylene oxide</from_name>
		<from_code>1368154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethylene Oxide</to_name>
		<to_code>M0007902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylene dodecanedioate</from_name>
		<from_code>2604565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylene dodecanedioate</to_name>
		<to_code>M0573022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl sebacate</from_name>
		<from_code>1426475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl sebacate</to_name>
		<to_code>M0093794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>efinaconazole</to_name>
		<to_code>M0584821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>efinaconazole</from_name>
		<from_code>1539753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolnaftate</from_name>
		<from_code>10637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine hydrochloride</from_name>
		<from_code>235838</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox olamine</from_name>
		<from_code>52172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciclopirox</from_name>
		<from_code>21090</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tavaborole</from_name>
		<from_code>1543173</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>itraconazole</from_name>
		<from_code>28031</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>terbinafine</from_name>
		<from_code>37801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Onychomycosis</to_name>
		<to_code>M0021567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>equol, (+-)-</from_name>
		<from_code>1492341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>(+-)-Isomer of Equol</to_name>
		<to_code>M0310001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ecamsule</from_name>
		<from_code>1544124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ecamsule</to_name>
		<to_code>M0500228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Ephedra sinica root extract</from_name>
		<from_code>1724424</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ephedra root</to_name>
		<to_code>M000758418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-ethylhexyl acrylate</from_name>
		<from_code>1432294</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-ethylhexyl acrylate</to_name>
		<to_code>M0111669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etofibrate</from_name>
		<from_code>24609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>etofibrate</to_name>
		<to_code>M0054708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl cyanoacrylate</from_name>
		<from_code>1608793</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl 2-cyanoacrylate</to_name>
		<to_code>M0092958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl-p-hydroxybenzoate</from_name>
		<from_code>1362892</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl-p-hydroxybenzoate</to_name>
		<to_code>M0059268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>enzacamene</from_name>
		<from_code>1311507</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>enzacamene</to_name>
		<to_code>M0116894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl vanillin</from_name>
		<from_code>1311571</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl vanillin</to_name>
		<to_code>M0133349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emepronium</from_name>
		<from_code>3816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Emepronium</to_name>
		<to_code>M0007264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epidermal growth factor</from_name>
		<from_code>1427158</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Epidermal Growth Factor</to_name>
		<to_code>M0007549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etoricoxib</from_name>
		<from_code>307296</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Etoricoxib</to_name>
		<to_code>M0382298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethopabate</from_name>
		<from_code>1314353</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethopabate</to_name>
		<to_code>M0007886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epsiprantel</from_name>
		<from_code>24285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>epsiprantel</to_name>
		<to_code>M0168955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethamivan</from_name>
		<from_code>24453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethamivan</to_name>
		<to_code>M0263261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylene</from_name>
		<from_code>1314362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylene</to_name>
		<to_code>M0110502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>epomediol</from_name>
		<from_code>24263</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>epomediol</to_name>
		<to_code>M0098590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-ethylhexanoic acid</from_name>
		<from_code>1305517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-ethylhexanoic acid</to_name>
		<to_code>M0120998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacridine</from_name>
		<from_code>4106</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethacridine</to_name>
		<to_code>M0007806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl cysteine</from_name>
		<from_code>24513</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl cysteine</to_name>
		<to_code>M0099558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>edetol</from_name>
		<from_code>1314349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,1',1'',1'''-(ethylenedinitrilo)tetra-2-propanol</to_name>
		<to_code>M0056237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>emepronium carrageenate</from_name>
		<from_code>23944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>emepronium carrageenate</to_name>
		<to_code>M0134066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erythrosine</from_name>
		<from_code>4061</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Erythrosine</to_name>
		<to_code>M0007727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eicosenoic acid</from_name>
		<from_code>1374399</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eicosenoic acid</to_name>
		<to_code>M0573855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethoglucid</from_name>
		<from_code>4132</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethoglucid</to_name>
		<to_code>M0007884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnicotinate</from_name>
		<from_code>236122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylnicotinate</to_name>
		<to_code>M0113050</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eprazinone</from_name>
		<from_code>24272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eprazinone</to_name>
		<to_code>M0050904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylene brassylate</from_name>
		<from_code>1314363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethylene brassylate</to_name>
		<to_code>M0509668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl methylphenylglycidate</from_name>
		<from_code>1546209</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl methylphenylglycidate</to_name>
		<to_code>M0069270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdosteine</from_name>
		<from_code>24305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>erdosteine</to_name>
		<to_code>M0139505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>erdosteine</from_name>
		<from_code>24305</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>S-(2-(N-3-(2-oxo-tetrahydrothienyl)acetamido))thioglycolic acid</to_name>
		<to_code>M000753288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-ethylhexyl stearate</from_name>
		<from_code>1368886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-ethylhexyl stearate</to_name>
		<to_code>M0427563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus oil</from_name>
		<from_code>59087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eucalyptus globulus Oil</to_name>
		<to_code>M000642319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eucalyptus oil</from_name>
		<from_code>59087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eucalyptus Oil</to_name>
		<to_code>M000641009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eicosapentaenoic acid</from_name>
		<from_code>90</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Eicosapentaenoic Acid</to_name>
		<to_code>M0023259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl cellulose</from_name>
		<from_code>1310565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl cellulose</to_name>
		<to_code>M0061318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethacridine lactate</from_name>
		<from_code>4107</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ethacridine Lactate</to_name>
		<to_code>M0007807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethyl cysteine hydrochloride</from_name>
		<from_code>236634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethyl cysteine hydrochloride</to_name>
		<to_code>M0319390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethohexadiol</from_name>
		<from_code>1362891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ethohexadiol</to_name>
		<to_code>M0046120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eteplirsen</from_name>
		<from_code>1810569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eteplirsen</to_name>
		<to_code>M000622394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eteplirsen</from_name>
		<from_code>1810569</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mazindol</from_name>
		<from_code>6664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>deflazacort</from_name>
		<from_code>22396</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>givinostat</from_name>
		<from_code>2678889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>viltolarsen</from_name>
		<from_code>2389840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delandistrogene moxeparvovec</from_name>
		<from_code>2641675</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casimersen</from_name>
		<from_code>2480096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>delandistrogene moxeparvovec-rokl</from_name>
		<from_code>2641674</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vamorolone</from_name>
		<from_code>2669799</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>golodirsen</from_name>
		<from_code>2267207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscular Dystrophy, Duchenne</to_name>
		<to_code>M0014253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Enterobacter aerogenes</from_name>
		<from_code>1544929</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterobacter aerogenes</to_name>
		<to_code>M0355772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrimonium bromide</to_name>
		<to_code>288999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantiifolia flower extract</to_name>
		<to_code>1310117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus horridus horridus venom</to_name>
		<to_code>1310456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coxiella burnetii</to_name>
		<to_code>1432987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvedilol</to_name>
		<to_code>20352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(1-cyanocyclohexyl)acetic acid</to_name>
		<to_code>2058838</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cornsilk</to_name>
		<to_code>579893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroquine sulfate</to_name>
		<to_code>203119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobazam</to_name>
		<to_code>21241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula officinalis seed oil</to_name>
		<to_code>1307790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colesevelam</to_name>
		<to_code>141626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbenicillin</to_name>
		<to_code>2015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa subsp. flowering top extract</to_name>
		<to_code>1484855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canrenone</to_name>
		<to_code>1982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cifenline</to_name>
		<to_code>21099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclophosphamide</to_name>
		<to_code>3002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynanchum paniculatum whole extract</to_name>
		<to_code>2107306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chia seed oil</to_name>
		<to_code>968631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calamus oil</to_name>
		<to_code>1431992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobimetinib</to_name>
		<to_code>1722365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor X, human-lans</to_name>
		<to_code>2643194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftibuten dihydrate</to_name>
		<to_code>1297879</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cordycepin</to_name>
		<to_code>1989289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulose sulfate</to_name>
		<to_code>2642135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbaryl</to_name>
		<to_code>9724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium officinale root extract</to_name>
		<to_code>1307974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cod, unspecified preparation</to_name>
		<to_code>1426437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clostridium botulinum</to_name>
		<to_code>1811178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprolactone</to_name>
		<to_code>1998122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceratostigma willmottianum flowering top extract</to_name>
		<to_code>2591800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coal tar extract</to_name>
		<to_code>90735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlortheophylline</to_name>
		<to_code>1546416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl caprylate</to_name>
		<to_code>1654387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellyl acetate</to_name>
		<to_code>2056062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cevimeline hydrochloride anhydrous</to_name>
		<to_code>2698548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carpinus betulus flowering top extract</to_name>
		<to_code>1309818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticotropin-releasing hormone</to_name>
		<to_code>214461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common cockleburr pollen extract</to_name>
		<to_code>867369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofezone</to_name>
		<to_code>183877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cola acuminata seed extract</to_name>
		<to_code>1307595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis sativus fruit extract</to_name>
		<to_code>2700058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cayaponia tayuya root extract</to_name>
		<to_code>1945470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C13-15 alkane</to_name>
		<to_code>1314336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus officinalis fruit extract</to_name>
		<to_code>1307556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholate</to_name>
		<to_code>1426483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celery seed extract</to_name>
		<to_code>1309989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clascoterone</to_name>
		<to_code>2474340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cicuta virosa whole extract</to_name>
		<to_code>1484856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl stearate</to_name>
		<to_code>1747867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide eop</to_name>
		<to_code>1537211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Codium tomentosum extract</to_name>
		<to_code>1311605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cladribine</to_name>
		<to_code>44157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpheniramine maleate</to_name>
		<to_code>142429</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric oxide</to_name>
		<to_code>21837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn syrup</to_name>
		<to_code>1310576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium versetamide sodium</to_name>
		<to_code>1366881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetromonium methosulfate</to_name>
		<to_code>2056289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicory leaf extract</to_name>
		<to_code>2001615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclophosphamide monohydrate</to_name>
		<to_code>2679071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona officinalis bark extract</to_name>
		<to_code>1309771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove oil</to_name>
		<to_code>7624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cananga odorata leaf oil</to_name>
		<to_code>1793896</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerous oxalate nonahydrate</to_name>
		<to_code>1427054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C9-12 alkane</to_name>
		<to_code>2664491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide 6 II</to_name>
		<to_code>1314307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sodium phosphate</to_name>
		<to_code>2288215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Collinsonia extract</to_name>
		<to_code>1339883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium polycarbophil</to_name>
		<to_code>20063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coumarin</to_name>
		<to_code>2898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoate</to_name>
		<to_code>1370658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl caprylate-caprate</to_name>
		<to_code>1541116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cylindrotheca fusiformis extract</to_name>
		<to_code>2531137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codfish allergenic extract</to_name>
		<to_code>892543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-25</to_name>
		<to_code>1306174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftriaxone sodium</to_name>
		<to_code>203172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic bromide</to_name>
		<to_code>2603281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorhexidine gluconate</to_name>
		<to_code>20791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colchicine</to_name>
		<to_code>2683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Callistemon citrinus pollen extract</to_name>
		<to_code>2171260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carminic acid</to_name>
		<to_code>1368643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistanche deserticola whole extract</to_name>
		<to_code>2633003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citiolone</to_name>
		<to_code>21171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colchicum autumnale flower extract</to_name>
		<to_code>1492385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clothianidin</to_name>
		<to_code>2665345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbonate ion</to_name>
		<to_code>1544139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clinopodium chinense whole extract</to_name>
		<to_code>2046113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>comfrey root extract</to_name>
		<to_code>1343346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carya laciniosa bark extract</to_name>
		<to_code>2590605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cochliobolus lunatus allergenic extract</to_name>
		<to_code>852264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefovecin</to_name>
		<to_code>1591901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyathula officinalis root extract</to_name>
		<to_code>1307735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftizoxime</to_name>
		<to_code>2192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corallium rubrum exoskeleton preparation</to_name>
		<to_code>1311193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric carbonate basic</to_name>
		<to_code>1313321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(C14-C18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine</to_name>
		<to_code>1591921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid, anhydrous</to_name>
		<to_code>221946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canthaxanthin</to_name>
		<to_code>42348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium</to_name>
		<to_code>491498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn oil PEG-6 esters</to_name>
		<to_code>1790130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carteolol</to_name>
		<to_code>2116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceanothus americanus leaf extract</to_name>
		<to_code>1309757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsosiphon fulvescens extract</to_name>
		<to_code>1426908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus maxima seed oil</to_name>
		<to_code>1856268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium 2-ketogluconate</to_name>
		<to_code>1869046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen alpha-1(VII) chain</to_name>
		<to_code>2716574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cephalosporium roseum extract</to_name>
		<to_code>1925834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capromab pendetide</to_name>
		<to_code>136300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camellia sinensis seed extract</to_name>
		<to_code>1742506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cina artemisia preparation</to_name>
		<to_code>283675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carapa guianensis seed oil</to_name>
		<to_code>1306164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common sagebrush pollen extract</to_name>
		<to_code>852020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryloyl glycine</to_name>
		<to_code>1305600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftazidime sodium</to_name>
		<to_code>221071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium bromide</to_name>
		<to_code>195983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramphenicol</to_name>
		<to_code>2348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carzenide</to_name>
		<to_code>20355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotetan disodium</to_name>
		<to_code>203141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid acetate</to_name>
		<to_code>1312366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco-oleamidopropyl betaine</to_name>
		<to_code>2263872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium aluminosilicate</to_name>
		<to_code>1313228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabbage preparation</to_name>
		<to_code>319810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cipaglucosidase alfa-atga</to_name>
		<to_code>2667434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrot allergenic extract</to_name>
		<to_code>892368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl hydroxyethylcellulose (350000 MW)</to_name>
		<to_code>1313703</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium-sodium maleate methyl vinyl ether copolymer (1000000 MW, 1900 MPA.S at 11%)</to_name>
		<to_code>1492944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynodon dactylon extract</to_name>
		<to_code>1428417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonixin</to_name>
		<to_code>2601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chamomile flower oil</to_name>
		<to_code>1309221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citharacanthus spinicrus preparation</to_name>
		<to_code>1311128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboprost tromethamine</to_name>
		<to_code>20259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclohexanepropanol, 2,2,6-trimethyl-.alpha.-propyl-</to_name>
		<to_code>2557362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium oxybate</to_name>
		<to_code>2387307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantiifolia whole extract</to_name>
		<to_code>1541715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calophyllum membranaceum root extract</to_name>
		<to_code>2610400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagenase</to_name>
		<to_code>58939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corchorus olitorius leaf extract</to_name>
		<to_code>1799293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium fruit rind extract</to_name>
		<to_code>1306206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-12</to_name>
		<to_code>1374804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic(capric mono)diglcyerides</to_name>
		<to_code>1307310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clindamycin palmitate</to_name>
		<to_code>21235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein allergenic extract</to_name>
		<to_code>862460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-18</to_name>
		<to_code>2602282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calophyllum membranaceum whole extract</to_name>
		<to_code>2634531</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chocolate allergenic extract</to_name>
		<to_code>1010915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan oligosaccharide</to_name>
		<to_code>1306943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticotropin</to_name>
		<to_code>376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caproamphodipropionate</to_name>
		<to_code>1370602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(cyclohexylamino)ethanesulfonic acid</to_name>
		<to_code>2049985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclobutyrol sodium</to_name>
		<to_code>236180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium stearate</to_name>
		<to_code>47633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus maxima fruit oil</to_name>
		<to_code>1549224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>croscarmellose sodium type A</to_name>
		<to_code>1311609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C30-45 alkyl methicone</to_name>
		<to_code>1313227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caproyl lactate</to_name>
		<to_code>1491980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium monnieri whole extract</to_name>
		<to_code>2632776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrullus colocynthis fruit pulp extract</to_name>
		<to_code>1309772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia oleifera leaf extract</to_name>
		<to_code>1305549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclomethicone 6</to_name>
		<to_code>1307081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cajanius cajan leaf extract</to_name>
		<to_code>1421433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(4-(4-chlorophenyl)-3-phenyl-2-butenyl)-pyrrolidine 1,5-naphthalenedisulfonate</to_name>
		<to_code>1307555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl behenate</to_name>
		<to_code>1487529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalamins</to_name>
		<to_code>42604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut allergenic extract</to_name>
		<to_code>891611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrus sinensis whole extract</to_name>
		<to_code>1437985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucurbitacin B</to_name>
		<to_code>2688460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cajuput oil</to_name>
		<to_code>1309211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceanothus americanus whole extract</to_name>
		<to_code>1358475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium pantothenate</to_name>
		<to_code>1918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus florida bark extract</to_name>
		<to_code>1860605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrimonium</to_name>
		<to_code>20614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl glycol</to_name>
		<to_code>1592894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cereus hildmannianus whole extract</to_name>
		<to_code>2588216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramine-T</to_name>
		<to_code>20762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cluster fig extract</to_name>
		<to_code>1372249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium carbonate, precipitated</to_name>
		<to_code>349908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C1 esterase inhibitor (recombinant)</to_name>
		<to_code>1599831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>candesartan cilexetil</to_name>
		<to_code>135481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorobutanol</to_name>
		<to_code>2378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbenicillin phenyl sodium</to_name>
		<to_code>42580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryl-capramidopropyl betaine</to_name>
		<to_code>1367173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cannabidiol</to_name>
		<to_code>2045371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus rivularis whole extract</to_name>
		<to_code>2727166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbenoxolone sodium</to_name>
		<to_code>2018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citral</to_name>
		<to_code>1362890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetylpyridinium</to_name>
		<to_code>2286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabergoline</to_name>
		<to_code>47579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclohexane</to_name>
		<to_code>1367180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Catalina preparation</to_name>
		<to_code>1372930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosporium herbarum allergenic extract</to_name>
		<to_code>466198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-40 pareth-3</to_name>
		<to_code>1375414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbon disulfide</to_name>
		<to_code>1311478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Comocladia dentata bark-leaf extract</to_name>
		<to_code>1310024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canavalia gladiata whole extract</to_name>
		<to_code>2606483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl acetate</to_name>
		<to_code>1364378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium leafy twig extract</to_name>
		<to_code>2287154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corylus avellana flower bud extract</to_name>
		<to_code>2054215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt titanium oxide</to_name>
		<to_code>2391144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C30-45 olefin</to_name>
		<to_code>1368144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorous acid</to_name>
		<to_code>1543755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 130 MPA.S at 4%)</to_name>
		<to_code>2632123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl phosphate</to_name>
		<to_code>1728295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic-capric-lauric triglyceride</to_name>
		<to_code>1313043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein, Lactococcus lactis cultured</to_name>
		<to_code>1315110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus scutulatus antivenin</to_name>
		<to_code>885189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumaria sea cucumber extract</to_name>
		<to_code>1307561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clostebol</to_name>
		<to_code>61686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclonium</to_name>
		<to_code>21993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium gluconate</to_name>
		<to_code>1311292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein, Lactococcus lactis cultured, aged</to_name>
		<to_code>1315111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cauloside D</to_name>
		<to_code>1542900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromonar hydrochloride</to_name>
		<to_code>81980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloxacillin</to_name>
		<to_code>2625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coceth-7</to_name>
		<to_code>1742990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalexin hydrochloride</to_name>
		<to_code>281942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calotropis procera whole extract</to_name>
		<to_code>2362001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbenicillin disodium</to_name>
		<to_code>258332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladanthus mixtus flower volatile oil</to_name>
		<to_code>1306134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannavis sativa susp. indica top extract</to_name>
		<to_code>1484854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclizine</to_name>
		<to_code>2977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clenbuterol hydrochloride</to_name>
		<to_code>235955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida torresii</to_name>
		<to_code>1343912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetromonium</to_name>
		<to_code>2056290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosporium bruhnei extract</to_name>
		<to_code>2043449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus bergamia whole extract</to_name>
		<to_code>2372087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantiifolia fruit oil</to_name>
		<to_code>1607310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carbo animalis preparation</to_name>
		<to_code>1326501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrus juice</to_name>
		<to_code>2383932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common paper wasp venom protein</to_name>
		<to_code>1294628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-40 pareth-10</to_name>
		<to_code>1307154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camellia reticulata seed oil</to_name>
		<to_code>2383303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorprothixene</to_name>
		<to_code>2406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecyparis obtusa wood extract</to_name>
		<to_code>2376940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-27</to_name>
		<to_code>2695381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium chloride monohydrate</to_name>
		<to_code>2678349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-24</to_name>
		<to_code>1306173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calochortus gunnisonii whole extract</to_name>
		<to_code>2533835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C9-11 pareth-3</to_name>
		<to_code>1437551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper carbonate</to_name>
		<to_code>1427055</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic chloride</to_name>
		<to_code>21009</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-25</to_name>
		<to_code>1311622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Convallaria majalis extract</to_name>
		<to_code>1344641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C9-11 pareth-6</to_name>
		<to_code>1376451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated barley pollen extract</to_name>
		<to_code>1098118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynara scolymus leaf extract</to_name>
		<to_code>1322547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciclopirox</to_name>
		<to_code>21090</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl oleate</to_name>
		<to_code>1306182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrobacter koseri</to_name>
		<to_code>1544937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl dimethicone/bis-vinyldimethicone crosspolymer</to_name>
		<to_code>2275627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon schoenanthus whole extract</to_name>
		<to_code>1992057</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylamidopropyl betaine</to_name>
		<to_code>2584845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsicum oleoresin</to_name>
		<to_code>235787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-1,2-propanediol</to_name>
		<to_code>2058840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coast maple pollen extract</to_name>
		<to_code>851736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl isostearate</to_name>
		<to_code>1541744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centipeda minima whole extract</to_name>
		<to_code>1540874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cesium</to_name>
		<to_code>1310121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cenegermin</to_name>
		<to_code>2104332</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canis lupus familiaris milk preparation</to_name>
		<to_code>1311102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline chloride</to_name>
		<to_code>1425426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cicuta virosa root extract</to_name>
		<to_code>1310043</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colonial bent grass pollen extract</to_name>
		<to_code>1484937</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carapichea ipecacuanha whole extract</to_name>
		<to_code>1740935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chocolate brown HT free acid</to_name>
		<to_code>2000576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium</to_name>
		<to_code>1362694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens fruiting leafy twig extract</to_name>
		<to_code>1438116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofazimine</to_name>
		<to_code>2592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate, bovine</to_name>
		<to_code>1306129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cromoglycate</to_name>
		<to_code>2921</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caolotropis gigantea root extract</to_name>
		<to_code>1673374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordyceps militaris whole extract</to_name>
		<to_code>2170280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinametic acid</to_name>
		<to_code>21113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulose sodium phosphate</to_name>
		<to_code>342965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C9-11 alkane/cycloalkane</to_name>
		<to_code>2396018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cromolyn</to_name>
		<to_code>42612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 isoparaffin</to_name>
		<to_code>1314335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cafedrine</to_name>
		<to_code>47589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclomethycaine</to_name>
		<to_code>21990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer 1342</to_name>
		<to_code>1311163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroacetic acid</to_name>
		<to_code>2374</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistus ladanifer resin</to_name>
		<to_code>1540880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefoperazone sodium</to_name>
		<to_code>227214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan low molecular weight (20-200 MPA.S)</to_name>
		<to_code>1306196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalexin anhydrous</to_name>
		<to_code>1299782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium polysulfide</to_name>
		<to_code>2256949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopentanone</to_name>
		<to_code>2557363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorothiazide sodium</to_name>
		<to_code>91217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclodrine</to_name>
		<to_code>1855092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canavalia gladiata seed pod extract</to_name>
		<to_code>2563144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium cation</to_name>
		<to_code>1546276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canrenoate potassium</to_name>
		<to_code>1981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis melo root extract</to_name>
		<to_code>2465231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum culilaban leaf oil</to_name>
		<to_code>2553101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium pyrophosphate</to_name>
		<to_code>1362901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide 1</to_name>
		<to_code>1364385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium monnieri fruit extract</to_name>
		<to_code>2697463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crisaborole</to_name>
		<to_code>1865953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crambe hispanica subsp. abyssinica seed oil</to_name>
		<to_code>1306138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camelina sativa whole extract</to_name>
		<to_code>1744401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caseins</to_name>
		<to_code>1440974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamedrine</to_name>
		<to_code>21130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida albicans allergenic extract</to_name>
		<to_code>214355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium oxoglurate</to_name>
		<to_code>2667740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calteridol calcium</to_name>
		<to_code>1424675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium propionate</to_name>
		<to_code>1426453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coachwhip stem extract</to_name>
		<to_code>1601989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorthenoxazin</to_name>
		<to_code>20891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cryptomeria japonica leaf extract</to_name>
		<to_code>1918451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colchicum autumnale seed extract</to_name>
		<to_code>1485065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cotton fiber extract</to_name>
		<to_code>1315113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caraway seed allergenic extract</to_name>
		<to_code>899637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefiderocol sulfate tosylate</to_name>
		<to_code>2265863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopidogrel bisulfate</to_name>
		<to_code>236991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cenegermin-bkbj</to_name>
		<to_code>2104331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cananga oil</to_name>
		<to_code>1309214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-5</to_name>
		<to_code>2397687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium bromate</to_name>
		<to_code>2601447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium hydroxide green</to_name>
		<to_code>1312363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium picolinate</to_name>
		<to_code>59308</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Consolida regalis flower extract</to_name>
		<to_code>2533848</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorokojic acid</to_name>
		<to_code>2199653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carya ovata bark extract</to_name>
		<to_code>1739881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Codonopsis pilosula root extract</to_name>
		<to_code>2103292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbamide peroxide</to_name>
		<to_code>47686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-5</to_name>
		<to_code>1987474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobetasone butyrate</to_name>
		<to_code>21246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucurbita pepo flower extract</to_name>
		<to_code>1544634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-13 pareth-6</to_name>
		<to_code>1484500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>castor oil</to_name>
		<to_code>2129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium pyruvate</to_name>
		<to_code>884629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloral betaine</to_name>
		<to_code>89808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida parapsilosis</to_name>
		<to_code>1310914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium officinale whole extract</to_name>
		<to_code>1420959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftazidime pentahydrate</to_name>
		<to_code>235552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistus incanus whole extract</to_name>
		<to_code>1358477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth 20</to_name>
		<to_code>1311619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken fat preparation</to_name>
		<to_code>2002584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamido benzylpiperidinyl ethoxypropylbenzamide</to_name>
		<to_code>2046111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colloid sulfur</to_name>
		<to_code>89767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-10 phosphate</to_name>
		<to_code>1546870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken liver preparation</to_name>
		<to_code>1313217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer interpolymer type C (allyl sucrose crosslinked)</to_name>
		<to_code>2392136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl dimethicone 150</to_name>
		<to_code>1442998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium orotate</to_name>
		<to_code>235786</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic phosphate P32</to_name>
		<to_code>121070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phosphate, dibasic, dihyate</to_name>
		<to_code>1310464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomocycline sodium</to_name>
		<to_code>102758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocaine</to_name>
		<to_code>2653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caryodendron orinocense whole extract</to_name>
		<to_code>2167552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefprozil</to_name>
		<to_code>19552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common wormwood pollen extract</to_name>
		<to_code>896213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium fruit oil</to_name>
		<to_code>1306151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cayenne pepper allergenic extract</to_name>
		<to_code>1006340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chondrus preparation</to_name>
		<to_code>1426885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl glucoside</to_name>
		<to_code>1425219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteamine bitartrate</to_name>
		<to_code>81990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-3</to_name>
		<to_code>1485184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coast sage pollen extract</to_name>
		<to_code>852011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citicoline sodium</to_name>
		<to_code>1099914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis vitalba leaf extract</to_name>
		<to_code>1307839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C9-11 pareth-8</to_name>
		<to_code>1424458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>catalase</to_name>
		<to_code>2133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropyl hydroxysultaine</to_name>
		<to_code>1363593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclomethicone</to_name>
		<to_code>1307080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-3</to_name>
		<to_code>1987473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbinoxamine</to_name>
		<to_code>20220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chorionic gonadotropin</to_name>
		<to_code>4986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curvularia inequalis allergenic extract</to_name>
		<to_code>999438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryl methicone</to_name>
		<to_code>1311638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma zedoria root extract</to_name>
		<to_code>1335893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cardiotoxin III, Naja naja atra</to_name>
		<to_code>2043924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-20 alkyl benzoate</to_name>
		<to_code>1426384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celiprolol</to_name>
		<to_code>20498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coix lacryma-jobi var. ma-yuen seed oil</to_name>
		<to_code>1541732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cirsium japonicum root extract</to_name>
		<to_code>2639345</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centella asiatica root extract</to_name>
		<to_code>2386333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonseed extract</to_name>
		<to_code>853406</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrullus lanatus var. citroides whole extract</to_name>
		<to_code>2118440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cardamom extract</to_name>
		<to_code>1314587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cola nut extract</to_name>
		<to_code>1307946</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroquine diphosphate, (R)-</to_name>
		<to_code>2593903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis yanhusuo tuber extract</to_name>
		<to_code>1313230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caraway oil</to_name>
		<to_code>1309373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline magnesium trisalicylate</to_name>
		<to_code>215799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-16 pareth-9</to_name>
		<to_code>1484852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticotropin, human</to_name>
		<to_code>1535213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-13 pareth-23</to_name>
		<to_code>1368905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clorazepate</to_name>
		<to_code>2353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>croconazole</to_name>
		<to_code>21753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefpirome</to_name>
		<to_code>27130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboplatin</to_name>
		<to_code>40048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia sinensis var. assamica whole extract</to_name>
		<to_code>1442198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crateva magna bark extract</to_name>
		<to_code>2592963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canrenoic acid</to_name>
		<to_code>81971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>castoryl maleate</to_name>
		<to_code>1490683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caplacizumab-yhdp</to_name>
		<to_code>2110604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotiam</to_name>
		<to_code>2188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytosine</to_name>
		<to_code>1372540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium creosotate</to_name>
		<to_code>317206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco-caprylate-caprate</to_name>
		<to_code>1369702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladanthus mixtus whole extract</to_name>
		<to_code>1655982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chondrus crispus extract</to_name>
		<to_code>1311477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clindamycin phosphate</to_name>
		<to_code>797272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 pareth-7</to_name>
		<to_code>1734015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper arsenate</to_name>
		<to_code>1552051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crack willow pollen extract</to_name>
		<to_code>2257289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caspofungin</to_name>
		<to_code>140108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C10-16 pareth-1</to_name>
		<to_code>1437550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-15 sulfonate</to_name>
		<to_code>1370654</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus monogyna fruit extract</to_name>
		<to_code>1311577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cimetidine</to_name>
		<to_code>2541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 50-100 MPA.S at 1% )</to_name>
		<to_code>1597390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftolozane sulfate</to_name>
		<to_code>1597608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium flower wax</to_name>
		<to_code>2540334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyperus rotundus root extract</to_name>
		<to_code>1307777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sulfaloxate</to_name>
		<to_code>102792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbocysteine-lysine</to_name>
		<to_code>1427149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coix lacryma-jobi seed extract</to_name>
		<to_code>1307831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor IX recombinant immunoglobulin G1 fusion protein</to_name>
		<to_code>1535944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrullus lanatus var. lanatus whole extract</to_name>
		<to_code>1747709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephapirin sodium</to_name>
		<to_code>42562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistanche deserticola stem extract</to_name>
		<to_code>1603853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium aspartate</to_name>
		<to_code>253159</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C18 olefin sulfonate</to_name>
		<to_code>1370196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbinoxamine tannate</to_name>
		<to_code>405970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis hexapetala root extract</to_name>
		<to_code>1809897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurea cyanus flower extract</to_name>
		<to_code>1309418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclophosphamide lyophilized</to_name>
		<to_code>221085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-13 alcohols</to_name>
		<to_code>1862973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cashew nut allergenic extract</to_name>
		<to_code>892526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholic acid</to_name>
		<to_code>1440856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryl oligoglucoside</to_name>
		<to_code>2372917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Campylobacter jejuni</to_name>
		<to_code>1435992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma involucrata root extract</to_name>
		<to_code>2619674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camelina sativa seed oil</to_name>
		<to_code>1305631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrullus colocynthis fruit extract</to_name>
		<to_code>1358958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellaburate (MW 65000, 17 % butyryl, 30 % acetyl)</to_name>
		<to_code>2199290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclomethicone 4</to_name>
		<to_code>1363578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco-glycerides</to_name>
		<to_code>1426455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlormadinone</to_name>
		<to_code>78904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>comfrey leaf extract</to_name>
		<to_code>1318235</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabbage allergenic extract</to_name>
		<to_code>899398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium acetate</to_name>
		<to_code>214342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citalopram</to_name>
		<to_code>2556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofibrate</to_name>
		<to_code>2594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan medium molecular weight (200-400 MPA.S)</to_name>
		<to_code>1650610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyperus esculentus leaf extract</to_name>
		<to_code>1433191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C.I. food yellow 3 (free acid)</to_name>
		<to_code>1371306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefatrizine</to_name>
		<to_code>2179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cayenne extract</to_name>
		<to_code>259342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California juniper pollen extract</to_name>
		<to_code>852585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>conivaptan</to_name>
		<to_code>302285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyprodenate</to_name>
		<to_code>22051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chaste tree preparation</to_name>
		<to_code>236664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cifostodine</to_name>
		<to_code>2477852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen, soluble, fish skin</to_name>
		<to_code>1368163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus junos seed extract</to_name>
		<to_code>1310041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coccinella septempunctata preparation</to_name>
		<to_code>1605082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynara scolymus whole extract</to_name>
		<to_code>1809830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl PEG- PPG-10- 1 dimethicone (HLB 3)</to_name>
		<to_code>1376098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistus monspeliensis leaf extract</to_name>
		<to_code>1431225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorproethazine hydrochloride</to_name>
		<to_code>236297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clavulanate potassium</to_name>
		<to_code>831418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide NS dilaurate</to_name>
		<to_code>1655557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium dioxide</to_name>
		<to_code>1312546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capromorelin tartrate</to_name>
		<to_code>1986788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis decumbens root extract</to_name>
		<to_code>1435102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clerodendranthus spicatus leaf extract</to_name>
		<to_code>1309780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl hydroxystearate</to_name>
		<to_code>1370461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chaste berry extract</to_name>
		<to_code>259261</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clospirazine</to_name>
		<to_code>1648693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobamamide</to_name>
		<to_code>21373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cryptomeria japonica bark extract</to_name>
		<to_code>2479553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camylofin bis(noramid-mes)</to_name>
		<to_code>236534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronitrile</to_name>
		<to_code>2383338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteine</to_name>
		<to_code>3024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cercis siliquastrum whole extract</to_name>
		<to_code>2054072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sulfide</to_name>
		<to_code>90521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carmustine</to_name>
		<to_code>2105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cannabigerolic acid</to_name>
		<to_code>2279518</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coccinia grandis whole extract</to_name>
		<to_code>2606066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sulfate, hemihydrate</to_name>
		<to_code>1310466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen alpha-1(II) chain (human)</to_name>
		<to_code>2671625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous nitrate</to_name>
		<to_code>1423923</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cured fat, pork side bacon</to_name>
		<to_code>1357997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine phosphate</to_name>
		<to_code>2672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>certolizumab pegol</to_name>
		<to_code>709271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco-sulfate</to_name>
		<to_code>1370657</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium lactate pentahydrate</to_name>
		<to_code>215834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyproterone</to_name>
		<to_code>3014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphor (natural)</to_name>
		<to_code>1298738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus sanguinea whole extract</to_name>
		<to_code>2054073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caesalpinia spinosa resin</to_name>
		<to_code>1307087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium borogluconate</to_name>
		<to_code>1370420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caffeine</to_name>
		<to_code>1886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlorophytum borivilianum whole extract</to_name>
		<to_code>2531557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creatine ethyl ester</to_name>
		<to_code>2058850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>captodiamine hydrochloride</to_name>
		<to_code>236176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellaburate (MW 12000, 32 &amp; butyryl, 18 % acetyl)</to_name>
		<to_code>2054996</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprooyl phytosphingosine</to_name>
		<to_code>2621643</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl esters wax</to_name>
		<to_code>1311570</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphoric acid 1-methyl ester</to_name>
		<to_code>30193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonseed oil</to_name>
		<to_code>1309243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclohexanone</to_name>
		<to_code>2362166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creosote</to_name>
		<to_code>2915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium monnieri fruit oil</to_name>
		<to_code>2637853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut acid</to_name>
		<to_code>1307562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clodronic acid</to_name>
		<to_code>3350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytisine</to_name>
		<to_code>1723152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciclopirox olamine</to_name>
		<to_code>52172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-15 pareth-12</to_name>
		<to_code>2289008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphor leaf oil</to_name>
		<to_code>1306163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium hydride</to_name>
		<to_code>1428413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium citrate anhydrous</to_name>
		<to_code>2106283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cathine</to_name>
		<to_code>32022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciprofibrate</to_name>
		<to_code>21149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthemum x morifolium whole extract</to_name>
		<to_code>2539791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco/oleamidopopyl betaine</to_name>
		<to_code>2262005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecyparis obtusa leaf extract</to_name>
		<to_code>1305745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthellum indicum flower oil</to_name>
		<to_code>1312365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorate ion</to_name>
		<to_code>1546390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloral hydrate</to_name>
		<to_code>2344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefetamet</to_name>
		<to_code>20482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cullen corylifolium seed extract</to_name>
		<to_code>2048127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Commiphora myrrha top extract</to_name>
		<to_code>1489546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clozapine</to_name>
		<to_code>2626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California sheephead preparation</to_name>
		<to_code>1324595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocotrimonium chloride</to_name>
		<to_code>2391550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken breast preparation</to_name>
		<to_code>1746905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colistimethate</to_name>
		<to_code>2708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chilean hazelnut oil</to_name>
		<to_code>1307679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl nonanoate</to_name>
		<to_code>1539809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellyl methylcrotonate</to_name>
		<to_code>2046112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Castanea crenata shell extract</to_name>
		<to_code>1735509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conyza canadensis extract</to_name>
		<to_code>1331704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chrysin</to_name>
		<to_code>1362888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium sulfate</to_name>
		<to_code>1368145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium amino acid chelate</to_name>
		<to_code>994438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramine-T anhydrous</to_name>
		<to_code>1593148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis solida whole extract</to_name>
		<to_code>2699580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium maculatum flowering top extract</to_name>
		<to_code>1328312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens bark extract</to_name>
		<to_code>2479554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoyl isethionate</to_name>
		<to_code>1366840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-15 pareth-5</to_name>
		<to_code>2103288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefuroxime axetil</to_name>
		<to_code>20493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium iodized</to_name>
		<to_code>317207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centipeda minima flowering top extract</to_name>
		<to_code>2359930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia sinensis root extract</to_name>
		<to_code>1307818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cidofovir anhydrous</to_name>
		<to_code>1546007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese yam extract</to_name>
		<to_code>1372641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cosmos sulphureus flowering top extract</to_name>
		<to_code>2378839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl behenate</to_name>
		<to_code>1312545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium 12</to_name>
		<to_code>2625171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvone, (-)-</to_name>
		<to_code>2048712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium acetate monohydrate</to_name>
		<to_code>1306884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium preparation</to_name>
		<to_code>350344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut juice</to_name>
		<to_code>1420960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Celosia argentea seed extract</to_name>
		<to_code>1482542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrulline malate</to_name>
		<to_code>2707558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnitine chloride</to_name>
		<to_code>1311519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chimonanthus praecox whole extract</to_name>
		<to_code>1733676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrus pectin extract</to_name>
		<to_code>581550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clindamycin</to_name>
		<to_code>2582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cirsium arvense stem extract</to_name>
		<to_code>2592961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium chloride dihydrate</to_name>
		<to_code>221068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>certoparin</to_name>
		<to_code>152610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chaya leaf extract</to_name>
		<to_code>1659210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carob allergenic extract</to_name>
		<to_code>904498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco diethanolamide</to_name>
		<to_code>1305724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium pantothenate, (-)-</to_name>
		<to_code>1792121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoamphoacetate</to_name>
		<to_code>1426830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calochortus tolmiei whole extract</to_name>
		<to_code>2533836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaemelum nobile flower extract</to_name>
		<to_code>1306194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E1</to_name>
		<to_code>2707121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceiba pentandra seed extract</to_name>
		<to_code>2044340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum camphora leaf extract</to_name>
		<to_code>1307754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caldiamide sodium</to_name>
		<to_code>1364943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calvatia gigantea extract</to_name>
		<to_code>1311041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona pubescens whole extract</to_name>
		<to_code>2104343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciclesonide</to_name>
		<to_code>274964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn oil</to_name>
		<to_code>2854</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coptis japonica root extract</to_name>
		<to_code>1307577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl sulfate</to_name>
		<to_code>1366924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C32-36 isoalkyl stearate</to_name>
		<to_code>2665126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caltha palustris extract</to_name>
		<to_code>1346616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium oxide</to_name>
		<to_code>1363045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caesalpinia spinosa fruit pod extract</to_name>
		<to_code>2057801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C15-23 alkane</to_name>
		<to_code>2103200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbon monoxide</to_name>
		<to_code>2037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerivastatin sodium</to_name>
		<to_code>221072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt gluconate</to_name>
		<to_code>235987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 400 MPA.S at 1%)</to_name>
		<to_code>1653793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium hypophosphite</to_name>
		<to_code>1424671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus sinensis flower oil</to_name>
		<to_code>1306133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C30-45 alkyl cetearyl dimethicone crosspolymer</to_name>
		<to_code>2609244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric cation</to_name>
		<to_code>1427198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camelus bactrianus hair extract</to_name>
		<to_code>2590604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(3-chloropropyl)trimethoxysilane</to_name>
		<to_code>2368125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus limon seed oil</to_name>
		<to_code>1425615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose calcium</to_name>
		<to_code>1307734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloperastine</to_name>
		<to_code>2104180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cortisone acetate</to_name>
		<to_code>21655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulase</to_name>
		<to_code>2219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt disodium edetate</to_name>
		<to_code>1722037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-40 pareth-95</to_name>
		<to_code>2109240</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl tallowate</to_name>
		<to_code>2001987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer-934</to_name>
		<to_code>1307830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus officinalis whole extract</to_name>
		<to_code>1795582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corylus americana nut oil</to_name>
		<to_code>1603849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoa extract</to_name>
		<to_code>1373895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecyparis obtusa whole extract</to_name>
		<to_code>1429927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryloamphopropionate</to_name>
		<to_code>1368620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clebopride</to_name>
		<to_code>21224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl diglyceryl tris(trimethylsiloxy)silylethyl dimethicone (3500 MM2/S)</to_name>
		<to_code>2624693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carazolol</to_name>
		<to_code>20192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholecalciferol</to_name>
		<to_code>2418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoyl methyl monoethanolamine</to_name>
		<to_code>2173915</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phenoxide</to_name>
		<to_code>2585538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceratostigma willmottianum whole extract</to_name>
		<to_code>1800659</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramphenicol succinate</to_name>
		<to_code>20769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan high molecular weight (400-800 MPA.S)</to_name>
		<to_code>2053487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Croton tiglium whole extract</to_name>
		<to_code>1546206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C14-18 olefin sulfonate</to_name>
		<to_code>2123367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadexomer iodine</to_name>
		<to_code>20012</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calomel</to_name>
		<to_code>1311098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus laevigata whole extract</to_name>
		<to_code>2198972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinitapride</to_name>
		<to_code>21125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopentolate</to_name>
		<to_code>3001</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen alpha-1(III) (human)</to_name>
		<to_code>1593745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine anhyd</to_name>
		<to_code>236131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken feather extract</to_name>
		<to_code>894934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>catechin</to_name>
		<to_code>1367177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-carbethoxyethyl)diethoxy(methyl)silane</to_name>
		<to_code>1314258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crambe maritima whole extract</to_name>
		<to_code>1487085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrageenan sodium</to_name>
		<to_code>1593445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloropyramine</to_name>
		<to_code>20861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen, hydrolyzed</to_name>
		<to_code>477454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer interpolymer type A (allyl sucrose crosslinked)</to_name>
		<to_code>1305601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chocolate cacao bean allergenic extract</to_name>
		<to_code>2102821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium citrate</to_name>
		<to_code>47613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canada balsam extract</to_name>
		<to_code>1372000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chaenomeles lagenaria fruit extract</to_name>
		<to_code>2107059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen type I</to_name>
		<to_code>1426856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calophyllum tacamahaca seed oil</to_name>
		<to_code>1306160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium formate</to_name>
		<to_code>1362747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynomorium songaricum whole extract</to_name>
		<to_code>2709295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium glubionate</to_name>
		<to_code>25806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsella bursa-pastoris top extract</to_name>
		<to_code>1812326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choriogonadotropin alfa</to_name>
		<to_code>283550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbutamide</to_name>
		<to_code>2068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl laurate</to_name>
		<to_code>2261376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cichorium intybus flower extract</to_name>
		<to_code>1309822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate sodium (shark)</to_name>
		<to_code>1358172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>certeareth-100</to_name>
		<to_code>1543081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabozantinib</to_name>
		<to_code>1363268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynanchum vincetoxicum leaf extract</to_name>
		<to_code>1310023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 38 MPA.S at 2%)</to_name>
		<to_code>2257286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellaburate (MW 20000, 46 % butyryl, 2 % acetyl)</to_name>
		<to_code>2268053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chrysosplenetin</to_name>
		<to_code>1545792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus junos fruit oil</to_name>
		<to_code>2288423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clocortolone</to_name>
		<to_code>21249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistus monspeliensis whole extract</to_name>
		<to_code>1745252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordia dichotoma whole extract</to_name>
		<to_code>2670080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cochliobolus spicifer allergenic extract</to_name>
		<to_code>995699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 olefin sulfonate</to_name>
		<to_code>1370653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus atlantica wood oil</to_name>
		<to_code>1876808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline salicylate</to_name>
		<to_code>20974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefuroxime sodium</to_name>
		<to_code>204144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoyl proline</to_name>
		<to_code>1806680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C.I. direct red 28 parent</to_name>
		<to_code>2391143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corydine</to_name>
		<to_code>2593178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula officinalis extract</to_name>
		<to_code>285222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 2300 mpa.s at 1%)</to_name>
		<to_code>2475182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyanocobalamin Co57</to_name>
		<to_code>91516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus rugosa whole extract</to_name>
		<to_code>2049718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cryptenamine acetates</to_name>
		<to_code>235225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclotetrapeptide-24 aminocyclohexane carboxylate</to_name>
		<to_code>1792312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefonicid monosodium</to_name>
		<to_code>266801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilostazol</to_name>
		<to_code>21107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cladosporium sphaerospermum allergenic extract</to_name>
		<to_code>867202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurium erythraea flower extract</to_name>
		<to_code>1309739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camylofine</to_name>
		<to_code>20136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclododecane</to_name>
		<to_code>2557361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium Cr-51</to_name>
		<to_code>1306065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotaxime sodium</to_name>
		<to_code>203117</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carpipramine</to_name>
		<to_code>20342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium lactate</to_name>
		<to_code>47622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coix lacryma-jobi var. ma-yuen seed extract</to_name>
		<to_code>1307827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crotamiton</to_name>
		<to_code>21766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefadroxil hemihydrate</to_name>
		<to_code>1297878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlorella emersonii extract</to_name>
		<to_code>2382810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crinum asiaticum whole extract</to_name>
		<to_code>1421435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefazolin</to_name>
		<to_code>2180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium levulinate</to_name>
		<to_code>47624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellol acetate, (R)-</to_name>
		<to_code>1432295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese cinnamon leaf oil</to_name>
		<to_code>1306148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefadroxil</to_name>
		<to_code>2177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casirivimab</to_name>
		<to_code>2465242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrus pectin</to_name>
		<to_code>581398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbocysteine</to_name>
		<to_code>2023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capromorelin</to_name>
		<to_code>1986787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobutinol</to_name>
		<to_code>21247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cantaloupe allergenic extract</to_name>
		<to_code>892517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerliponase alfa</to_name>
		<to_code>1922436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula arvensis whole extract</to_name>
		<to_code>1992862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium quinoa flowering top extract</to_name>
		<to_code>1649133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia sinensis whole extract</to_name>
		<to_code>1356680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper gluconate</to_name>
		<to_code>2839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon winterianus whole extract</to_name>
		<to_code>2360889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline citrate</to_name>
		<to_code>2453</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cevimeline</to_name>
		<to_code>44281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celery allergenic extract</to_name>
		<to_code>892372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum loureiroi whole extract</to_name>
		<to_code>2553102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic sulfate</to_name>
		<to_code>90402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline bitartrate</to_name>
		<to_code>2451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor XIII a-subunit (recombinant)</to_name>
		<to_code>1488293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-40 acid</to_name>
		<to_code>1425982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curculigo orchioides whole extract</to_name>
		<to_code>2570477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordyceps militaris fruiting body extract</to_name>
		<to_code>2593690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California black walnut pollen extract</to_name>
		<to_code>852561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceanothus thyrsiflorus whole extract</to_name>
		<to_code>2709116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurea solstitialis whole extract</to_name>
		<to_code>2533846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cosyntropin</to_name>
		<to_code>2890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carthamus tinctorius whole extract</to_name>
		<to_code>1724421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthellum indicum whole extract</to_name>
		<to_code>2106260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cumenesulfonate</to_name>
		<to_code>1370634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceforanide</to_name>
		<to_code>20486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt acetate</to_name>
		<to_code>1369404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide eos</to_name>
		<to_code>1603794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbidium hookerianum flower extract</to_name>
		<to_code>1737791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryloyl glycerin/sebacic acid copolymer (2000 MPA.S)</to_name>
		<to_code>1869798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefepime</to_name>
		<to_code>20481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canada goldenrod pollen extract</to_name>
		<to_code>995743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylaldehyde</to_name>
		<to_code>2396755</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cypripedium parvifolum root extract</to_name>
		<to_code>1343597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caesalpinia sappan bark extract</to_name>
		<to_code>1791061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynomorium songaricum stem extract</to_name>
		<to_code>2592964</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caryophyllene</to_name>
		<to_code>1368148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-9</to_name>
		<to_code>1362144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-16 alcohols</to_name>
		<to_code>1368143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%)</to_name>
		<to_code>1371909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cervus elaphus velvet preparation</to_name>
		<to_code>1441655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorambucil</to_name>
		<to_code>2346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cheat grass pollen extract</to_name>
		<to_code>852225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens whole extract</to_name>
		<to_code>1483424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic-capric diglycerol succinate</to_name>
		<to_code>1425909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlamydia trachomatis</to_name>
		<to_code>1318474</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl-octyldodecyl lauroyl glutamate</to_name>
		<to_code>1435107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotaxime</to_name>
		<to_code>2186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caper berry extract</to_name>
		<to_code>1307590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coxsackieviruses B</to_name>
		<to_code>1668274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloxacillin sodium</to_name>
		<to_code>9864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine hydrochloride</to_name>
		<to_code>1115966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium ambrosioides extract</to_name>
		<to_code>1342490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E2</to_name>
		<to_code>2707122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>catalase (Micrococcus luteus)</to_name>
		<to_code>1648142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capmatinib</to_name>
		<to_code>2362165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorphenesin carbamate</to_name>
		<to_code>20880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis vitalba flower extract</to_name>
		<to_code>1355831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coptis deltoidea root extract</to_name>
		<to_code>2634585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carex humilis root extract</to_name>
		<to_code>1309417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula arvensis leaf extract</to_name>
		<to_code>1729161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn cob extract</to_name>
		<to_code>1440225</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofoctol</to_name>
		<to_code>21264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clostridium perfringens</to_name>
		<to_code>1318475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcobutrol</to_name>
		<to_code>2634452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorocresol</to_name>
		<to_code>20823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cenobamate</to_name>
		<to_code>2265690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus deodara seed oil</to_name>
		<to_code>2359253</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinidon-ethyl</to_name>
		<to_code>2472310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clioquinol</to_name>
		<to_code>5942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat hair extract</to_name>
		<to_code>248123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(C10-C16)alkyldimethylamine oxide</to_name>
		<to_code>1872987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl dimethicone</to_name>
		<to_code>388458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium nicotinic acid complex</to_name>
		<to_code>137732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofexamide</to_name>
		<to_code>21255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clidinium</to_name>
		<to_code>21232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbachol</to_name>
		<to_code>1999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbromal</to_name>
		<to_code>2067</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium maculatum preparation</to_name>
		<to_code>285151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cosibelimab</to_name>
		<to_code>2717511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellic acid</to_name>
		<to_code>2693285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomiphene</to_name>
		<to_code>2596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofexamide hydrochloride</to_name>
		<to_code>236177</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phosphate, monobasic, anhydrous</to_name>
		<to_code>1426444</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyanide</to_name>
		<to_code>1923817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoa shell extract</to_name>
		<to_code>2171268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clinoptilolite</to_name>
		<to_code>2624891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium chloride</to_name>
		<to_code>1863268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clesrovimab</to_name>
		<to_code>2716802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cassia fistula whole extract</to_name>
		<to_code>2589608</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clorazepic acid</to_name>
		<to_code>235408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoyl sarcosinate</to_name>
		<to_code>1370598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid isopropyl ether</to_name>
		<to_code>2560106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium officinale root oil</to_name>
		<to_code>1541883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedar leaf oil</to_name>
		<to_code>1309217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C24-28 olefin</to_name>
		<to_code>1537318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclizine hydrochloride</to_name>
		<to_code>155017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytomegalovirus immune globulin, human</to_name>
		<to_code>1997443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclodextrins</to_name>
		<to_code>1426609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium gluceptate</to_name>
		<to_code>47618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coffee bean allergenic extract</to_name>
		<to_code>891727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous cation</to_name>
		<to_code>1546419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus durissus terrificus venom extract</to_name>
		<to_code>1440287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus atlantica bark oil</to_name>
		<to_code>1306157</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethyl fragment</to_name>
		<to_code>1874892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus laevigata fruit</to_name>
		<to_code>1310259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryloyl sarcosine</to_name>
		<to_code>2109745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cocos nucifera whole extract</to_name>
		<to_code>1367493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calteridol</to_name>
		<to_code>1424676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorothymol</to_name>
		<to_code>1363702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclohexanol</to_name>
		<to_code>2099711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canarium album whole extract</to_name>
		<to_code>2728644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynanchum vincetoxicum root extract</to_name>
		<to_code>1309807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capramidopropyl betaine</to_name>
		<to_code>1541737</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cesium chloride</to_name>
		<to_code>20599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocklebur pollen extract</to_name>
		<to_code>852025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caramiphen edisylate</to_name>
		<to_code>133053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromocarb diethylamine</to_name>
		<to_code>48064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carpinus betulus whole extract</to_name>
		<to_code>2003227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma zedoaria leaf extract</to_name>
		<to_code>1650237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crypthecodinium cohnii DHA oil</to_name>
		<to_code>1307710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cimex lectularius preparation</to_name>
		<to_code>1330092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis ambigua tuber extract</to_name>
		<to_code>1376214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chickpea allergenic extract</to_name>
		<to_code>1011049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crocin</to_name>
		<to_code>2262278</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl octanoate</to_name>
		<to_code>1306181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>californium</to_name>
		<to_code>2571855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxypolymethylene</to_name>
		<to_code>20298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium dihydrogen phosphate</to_name>
		<to_code>236560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>croscarmellose sodium</to_name>
		<to_code>1310573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canary feather extract</to_name>
		<to_code>894961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis virginiana top</to_name>
		<to_code>1309776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cerebral Phospholipids</to_name>
		<to_code>578635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper sulfate</to_name>
		<to_code>21579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calfactant</to_name>
		<to_code>232539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl chloride</to_name>
		<to_code>1606197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis chinensis root extract</to_name>
		<to_code>1358482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum camphora whole extract</to_name>
		<to_code>1487829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cosyntropin hexahydrate</to_name>
		<to_code>1653802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cryptolepis sanguinolenta whole extract</to_name>
		<to_code>2539793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clebopride maleate</to_name>
		<to_code>236701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cotton seed extract</to_name>
		<to_code>1309369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cherry plum extract</to_name>
		<to_code>1358476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbidopa anhydrous</to_name>
		<to_code>1545982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopropanemethanol, 1-methyl-2-((1,2,2-trimethylbicyclo(3.1.0)hex-3-yl)methyl)-</to_name>
		<to_code>2557375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cystamine</to_name>
		<to_code>1426401</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon martini top extract</to_name>
		<to_code>1442507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurium erythraea flowering top extract</to_name>
		<to_code>1544246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa seed extract</to_name>
		<to_code>1429926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-chloro-2-methyl-3-isothiazolone 1-oxide</to_name>
		<to_code>1862282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalexin</to_name>
		<to_code>2231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan</to_name>
		<to_code>59038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cimicifuga simplex root extract</to_name>
		<to_code>1541714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clodronate disodium</to_name>
		<to_code>1546871</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecostus cuspidatus whole extract</to_name>
		<to_code>2711883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciprofloxacin lactate</to_name>
		<to_code>235851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynoglossum lanceolatum whole extract</to_name>
		<to_code>2045731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cotinus coggygria leaf extract</to_name>
		<to_code>2533851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefoxitin</to_name>
		<to_code>2189</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Culex pipiens preparation</to_name>
		<to_code>1345679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chesnut oak pollen extract</to_name>
		<to_code>900995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cochliobolus sativus allergenic extract</to_name>
		<to_code>852398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt</to_name>
		<to_code>1310300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coast live oak pollen extract</to_name>
		<to_code>852302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamate</to_name>
		<to_code>1368650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteamine</to_name>
		<to_code>3022</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cangrelor tetrasodium</to_name>
		<to_code>1656051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C13-14 isoparaffin</to_name>
		<to_code>1311575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Castanea sativa flower extract</to_name>
		<to_code>1309936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric citrate</to_name>
		<to_code>2394040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-20 acid PEG-8 ester</to_name>
		<to_code>1485541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-16 pareth-5</to_name>
		<to_code>1734016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese cinnamon extract</to_name>
		<to_code>1305720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus junos fruit extract</to_name>
		<to_code>1366324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cider vinegar</to_name>
		<to_code>283829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caffeine citrate</to_name>
		<to_code>20033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C8-10 alcohols</to_name>
		<to_code>2462794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn allergenic extract</to_name>
		<to_code>892547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crataegus extract</to_name>
		<to_code>21716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagenase Clostridium histolyticum</to_name>
		<to_code>898492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crizanlizumab</to_name>
		<to_code>2262279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium hydroxide</to_name>
		<to_code>1910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cardamom oil</to_name>
		<to_code>2462493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cycrimine</to_name>
		<to_code>22037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobutinol hydrochloride</to_name>
		<to_code>235956</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>constant albicans extract</to_name>
		<to_code>242874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carthamus tinctorius seedcake extract</to_name>
		<to_code>1314586</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide 5</to_name>
		<to_code>2596172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Concord grape juice</to_name>
		<to_code>1747706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous chloride</to_name>
		<to_code>1426884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canagliflozin anhydrous</to_name>
		<to_code>1546031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cycloserine</to_name>
		<to_code>3007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cariprazine</to_name>
		<to_code>1667655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium chloride anhydrous</to_name>
		<to_code>1667640</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorcyclizine hydrochloride</to_name>
		<to_code>235725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorocitric acid</to_name>
		<to_code>2462207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium lactobionate</to_name>
		<to_code>235784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis melo var. cantalupensis whole extract</to_name>
		<to_code>1356700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen</to_name>
		<to_code>2714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulase (Trichoderma longibrachiatum)</to_name>
		<to_code>2475185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefmetazole</to_name>
		<to_code>2182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carduus marianus preparation</to_name>
		<to_code>350520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carprofen</to_name>
		<to_code>20343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfates</to_name>
		<to_code>2473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clostridioides difficile</to_name>
		<to_code>1534764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl trisiloxane</to_name>
		<to_code>1363431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium saccharate</to_name>
		<to_code>236693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxyethyl siliconate</to_name>
		<to_code>1486524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crizotinib</to_name>
		<to_code>1148495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chaenomeles lagenaria whole extract</to_name>
		<to_code>2533847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellol acetate, (S)-</to_name>
		<to_code>1313269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic-capric-succinic triglyercide</to_name>
		<to_code>1356134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein, emmental cultured</to_name>
		<to_code>1315109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosporium cladosporioides allergenic extract</to_name>
		<to_code>995768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carteolol hydrochloride</to_name>
		<to_code>142132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coleus forskohlii root oil</to_name>
		<to_code>1306135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroquine phosphate</to_name>
		<to_code>20863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carthamus tinctorius (safflower) oleosomes extract</to_name>
		<to_code>1307784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma phaeocaulis root extract</to_name>
		<to_code>2106822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsella bursa-pastoris extract</to_name>
		<to_code>236641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl palmitate</to_name>
		<to_code>1655565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Croton lechleri resin</to_name>
		<to_code>1371038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium monofluorophosphate</to_name>
		<to_code>2463340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinoxate</to_name>
		<to_code>288262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cemiplimab-rwlc</to_name>
		<to_code>2058825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>climbazole</to_name>
		<to_code>191566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>californium Cf-249</to_name>
		<to_code>1794164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl ricinoleate</to_name>
		<to_code>1364381</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticotropin-releasing factor, human</to_name>
		<to_code>1927940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>certoparin sodium</to_name>
		<to_code>152612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cananga odorata flower wax</to_name>
		<to_code>1541726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoamphodipropionate</to_name>
		<to_code>1370641</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged</to_name>
		<to_code>1440973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan PCA</to_name>
		<to_code>1858809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cnidium seed extract</to_name>
		<to_code>1309361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cantharidin</to_name>
		<to_code>1984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium citrate</to_name>
		<to_code>407906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>5-chloro-2-methyl-4-isothiazolin-3-one</to_name>
		<to_code>1367119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens leafy twig extract</to_name>
		<to_code>1442505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cervus elaphus horn oil</to_name>
		<to_code>1309747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbarson</to_name>
		<to_code>20206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclobenzaprine</to_name>
		<to_code>21949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cananga odorata flower extract</to_name>
		<to_code>1309966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese chestnut extract</to_name>
		<to_code>1372271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-chloronaphthalene</to_name>
		<to_code>2673865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida albicans</to_name>
		<to_code>1963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn leaf extract</to_name>
		<to_code>2664059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coal tar</to_name>
		<to_code>2635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C18-C21 alkane</to_name>
		<to_code>1435991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-chloro-2-hydroxypropylcocoalkyldimethylammonium chloride</to_name>
		<to_code>2396890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citicoline</to_name>
		<to_code>997602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cleome gynandra leaf extract</to_name>
		<to_code>2197995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlormethiazole</to_name>
		<to_code>2372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Callitris columellaris wood oil</to_name>
		<to_code>2471084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvone, (+-)-</to_name>
		<to_code>1427074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>CJC-1295</to_name>
		<to_code>1805005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper</to_name>
		<to_code>2837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric nitrate</to_name>
		<to_code>2371954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonazepam</to_name>
		<to_code>2598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus medica var. sarcodactylis whole extract</to_name>
		<to_code>2727163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus reticulata whole extract</to_name>
		<to_code>1724422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein, Streptococcus thermophilus cultured, Propionibacterium freudenreichii subsp. shermanii cultured, aged preparation</to_name>
		<to_code>1421445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper histidinate</to_name>
		<to_code>2732215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chalcone</to_name>
		<to_code>2592960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloprednol</to_name>
		<to_code>21285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phosphate</to_name>
		<to_code>1919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefmetazole sodium</to_name>
		<to_code>203140</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum camphora leafy twig extract</to_name>
		<to_code>2589369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine</to_name>
		<to_code>2670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus maxima leaf extract</to_name>
		<to_code>1306208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma longa leaf extract</to_name>
		<to_code>1307655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber fruit oil</to_name>
		<to_code>1306145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-10</to_name>
		<to_code>1659204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedar elm pollen extract</to_name>
		<to_code>1014191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteine hydrochloride</to_name>
		<to_code>221086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlordiazepoxide hydrochloride</to_name>
		<to_code>203173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cryptomeria japonica whole extract</to_name>
		<to_code>2606482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chikungunya virus antigen, recombinant Senegal strain 37997</to_name>
		<to_code>2707120</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium sulfide</to_name>
		<to_code>1368199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clary sage extract</to_name>
		<to_code>1370470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canarium luzonicum whole extract</to_name>
		<to_code>1487827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-20 phosphate</to_name>
		<to_code>1492340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(C10-C30)alkyl methacrylate ester</to_name>
		<to_code>1312357</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma aromatica root oil</to_name>
		<to_code>1482794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canarium indicum seed oil</to_name>
		<to_code>2398513</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa susp. indica top extract</to_name>
		<to_code>2168435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 pareth-3</to_name>
		<to_code>1426678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer copolymer type C (allyl pentaerythritol crosslinked)</to_name>
		<to_code>2285329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Combretum micranthum leaf extract</to_name>
		<to_code>1597186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia japonica flower oil</to_name>
		<to_code>1739223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephapirin benzathine</to_name>
		<to_code>1294563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus reticulata fruit oil</to_name>
		<to_code>1306131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer-940</to_name>
		<to_code>1362909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistus incanus flowering top extract</to_name>
		<to_code>1482788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Croton lechleri whole extract</to_name>
		<to_code>1727168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cauliflower allergenic extract</to_name>
		<to_code>899661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorfenethazine</to_name>
		<to_code>20785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid, 1-stearyl ester</to_name>
		<to_code>1435636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetiedil citrate</to_name>
		<to_code>236204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celecoxib</to_name>
		<to_code>140587</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>curdlan</to_name>
		<to_code>1313047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C13-16 isoparaffin</to_name>
		<to_code>1314337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth 8</to_name>
		<to_code>1438111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclosporine microemulsion</to_name>
		<to_code>484788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan medium molecular weight (200-800 MPA.S)</to_name>
		<to_code>1368152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cresatin</to_name>
		<to_code>21732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centella asiatica flowering top extract</to_name>
		<to_code>1810985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cascara sagrada</to_name>
		<to_code>66869</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistanche tinctoria stem extract</to_name>
		<to_code>2362245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefovecin sodium</to_name>
		<to_code>1591924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus japonica fruit extract</to_name>
		<to_code>2166039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated mushroom extract</to_name>
		<to_code>1311817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus paradisi whole extract</to_name>
		<to_code>1432296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium quinoa seedcake extract</to_name>
		<to_code>2699307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbetapentane</to_name>
		<to_code>20217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamine oxide</to_name>
		<to_code>1306947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein (cow milk) allergenic extract</to_name>
		<to_code>892604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlophedianol</to_name>
		<to_code>21254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copiba oil</to_name>
		<to_code>1306136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefamandole nafate</to_name>
		<to_code>20473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyperus rotundus whole extract</to_name>
		<to_code>2263064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carya tomentosa bark extract</to_name>
		<to_code>2697732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Convallaria majalis flower top extract</to_name>
		<to_code>1648694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cichorium intybus whole extract</to_name>
		<to_code>1545681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetuximab</to_name>
		<to_code>318341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canis lupus familiaris extract</to_name>
		<to_code>852244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cemiplimab</to_name>
		<to_code>2058826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Copernicia alba whole extract</to_name>
		<to_code>1992522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 1200 MPA.S at 1%)</to_name>
		<to_code>1997244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Commiphora myrrha whole extract</to_name>
		<to_code>1442701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creatinine</to_name>
		<to_code>2913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbocysteine lysine monohydrate</to_name>
		<to_code>1793898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrimide</to_name>
		<to_code>288088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper EDTA</to_name>
		<to_code>1366888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caryocar brasiliense fruit oil</to_name>
		<to_code>1495454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlormadinone acetate</to_name>
		<to_code>2369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefpodoxime proxetil</to_name>
		<to_code>47835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium threonate</to_name>
		<to_code>273888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus adamanteus antivenin</to_name>
		<to_code>885185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creeping bentgrass pollen extract</to_name>
		<to_code>1094116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefonicid</to_name>
		<to_code>2183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilastatin</to_name>
		<to_code>2540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcipotriene</to_name>
		<to_code>29365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyproheptadine pyrid phos</to_name>
		<to_code>236525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carica papaya preparation</to_name>
		<to_code>324031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Claviceps purpurea sclerotium</to_name>
		<to_code>1311077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa subsp. sativa whole extract</to_name>
		<to_code>2177094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline stearate</to_name>
		<to_code>236669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrageenan calcium</to_name>
		<to_code>2001679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper pidolate</to_name>
		<to_code>1306939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cuprous chloride</to_name>
		<to_code>1423796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonitrate</to_name>
		<to_code>2372697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus nuttallii whole extract</to_name>
		<to_code>2533849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clospirazine hydrochloride</to_name>
		<to_code>1648692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Concord grape allergenic extract</to_name>
		<to_code>901191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn silk preparation</to_name>
		<to_code>283677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor IX, human-lans</to_name>
		<to_code>2643192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copanlisib</to_name>
		<to_code>1945077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capreomycin</to_name>
		<to_code>78903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carpinus betulus flower extract</to_name>
		<to_code>1309994</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticorelin human triflutate</to_name>
		<to_code>236900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbetapentane tannate</to_name>
		<to_code>221070</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisapride monohydrate</to_name>
		<to_code>221077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramides</to_name>
		<to_code>2243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrulline</to_name>
		<to_code>2567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber seed extract</to_name>
		<to_code>1307733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cephalanthus occidentalis bark extract</to_name>
		<to_code>1673701</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-13 alkyl lactate</to_name>
		<to_code>1992563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cuprous oxide</to_name>
		<to_code>21842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium quinoa seed extract</to_name>
		<to_code>1306195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyathea medullaris leaf extract</to_name>
		<to_code>1866528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftiofur sodium</to_name>
		<to_code>1370372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cortivazol</to_name>
		<to_code>21660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium carbimide</to_name>
		<to_code>1902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroxylenol</to_name>
		<to_code>20877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(C14-C18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine</to_name>
		<to_code>1591920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cuttlefish preparation</to_name>
		<to_code>1354524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Convolvulus arvensis extract</to_name>
		<to_code>1876510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate A sodium</to_name>
		<to_code>476847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteamine hydrochloride</to_name>
		<to_code>1426886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis sativus whole extract</to_name>
		<to_code>1484279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia oleifera seed extract</to_name>
		<to_code>1307849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens seed extract</to_name>
		<to_code>1309420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phosphate, dibasic, dihydrate</to_name>
		<to_code>1311201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium fluoride</to_name>
		<to_code>1905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chilipepper rockfish, cooked</to_name>
		<to_code>2687239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn grain extract</to_name>
		<to_code>1423924</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon oil</to_name>
		<to_code>1309229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C14-16 olefin sulfonate</to_name>
		<to_code>1370596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corallium rubrum whole extract</to_name>
		<to_code>1999793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat dander allergenic extract</to_name>
		<to_code>465953</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clam allergenic extract</to_name>
		<to_code>892539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondrodendron tomentosum root extract</to_name>
		<to_code>1340183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium carbonate</to_name>
		<to_code>1897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clofarabine</to_name>
		<to_code>44151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia japonica seed extract</to_name>
		<to_code>1309414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer homopolymer type B (allyl pentaerythritol or allyl sucrose crosslinked)</to_name>
		<to_code>1732380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>castorbean seed extract</to_name>
		<to_code>1351789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chymopapain</to_name>
		<to_code>2525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colocasia esculenta root extract</to_name>
		<to_code>1305762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cangrelor</to_name>
		<to_code>1656052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloride hexahydrate</to_name>
		<to_code>314553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codonopsis lanceolata root extract</to_name>
		<to_code>1432472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefditoren pivoxil</to_name>
		<to_code>72611</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cootamundra wattle pollen extract</to_name>
		<to_code>895353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common wasp venom protein</to_name>
		<to_code>1297527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cesium cation</to_name>
		<to_code>1546368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>croscarmellose</to_name>
		<to_code>1310574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric acetate</to_name>
		<to_code>1311216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (1.3 carboxymethyl substitution per saccharide; 600 MPA.S at 2%)</to_name>
		<to_code>2565686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cleome gynandra whole extract</to_name>
		<to_code>2477853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cicletanine hydrochloride</to_name>
		<to_code>235874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate sodium (porcine)</to_name>
		<to_code>1366974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium flower oil</to_name>
		<to_code>1306150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-16 pareth-7</to_name>
		<to_code>2566275</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chamomile flowers</to_name>
		<to_code>221916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry juice</to_name>
		<to_code>1358977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cotton allergenic extract</to_name>
		<to_code>889548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyproheptadine hydrochloride</to_name>
		<to_code>104592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon citratus leaf extract</to_name>
		<to_code>1307549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus sinensis flower wax</to_name>
		<to_code>1663734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Celosia cristata whole extract</to_name>
		<to_code>2289215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytomegalovirus immune globulin</to_name>
		<to_code>22178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorotrianisene</to_name>
		<to_code>2397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlordiazepoxide</to_name>
		<to_code>2356</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cypermethrin</to_name>
		<to_code>2590266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cardiospermum halicacbum whole extract</to_name>
		<to_code>1540827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-chloro-4,5-dimethylphenol</to_name>
		<to_code>2286250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciprofloxacin</to_name>
		<to_code>2551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitutions per saccharide; 600 MPA.S at 2 %)</to_name>
		<to_code>1812763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caplacizumab</to_name>
		<to_code>2110605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coceth-7 carboxylic acid</to_name>
		<to_code>1424644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cherry birch pollen extract</to_name>
		<to_code>852144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous carbonate</to_name>
		<to_code>2606481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clidinium bromide</to_name>
		<to_code>48212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysops vittatus whole allergenic extract</to_name>
		<to_code>2627247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorophyllin</to_name>
		<to_code>20852</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cod liver oil</to_name>
		<to_code>2669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carpipramine dihydrochloride</to_name>
		<to_code>289326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cycloadiphenine</to_name>
		<to_code>21945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C1 esterase inhibitor</to_name>
		<to_code>1599832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopyralid triethanolamine</to_name>
		<to_code>1995247</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantiifolia seed oil</to_name>
		<to_code>1306149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaelirium luteum root extract</to_name>
		<to_code>1322548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cervus nippon velvet preparation</to_name>
		<to_code>1442882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnauba wax</to_name>
		<to_code>1307833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calluna vulgaris whole extract</to_name>
		<to_code>2003323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium aluminum borosilicate</to_name>
		<to_code>1358171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California blackberry extract</to_name>
		<to_code>2590181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclobutyrol</to_name>
		<to_code>21954</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Codonopsis pilosula whole extract</to_name>
		<to_code>2119694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corynoxeine</to_name>
		<to_code>2562545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotetan</to_name>
		<to_code>2187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinoxacin</to_name>
		<to_code>2550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cannabigerol</to_name>
		<to_code>2464938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroprocaine</to_name>
		<to_code>20859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colfosceril palmitate</to_name>
		<to_code>69782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobetasone</to_name>
		<to_code>108074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona pubescens preparation</to_name>
		<to_code>283551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus nobilis extract</to_name>
		<to_code>1372007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma amada whole extract</to_name>
		<to_code>1547578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordyceps sinensis preparation</to_name>
		<to_code>283554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 pareth-9</to_name>
		<to_code>1857735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloticasone</to_name>
		<to_code>2719926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvone</to_name>
		<to_code>1427075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>compound benzoin tincture (USP)</to_name>
		<to_code>215648</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chelone glabra extract</to_name>
		<to_code>1333265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caffeine monohydrate</to_name>
		<to_code>236112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma xanthorrhiza oil</to_name>
		<to_code>1306094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyclamen purpurascens tuber extract</to_name>
		<to_code>1310339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caulophyllum robustum root extract</to_name>
		<to_code>1314321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C14-22 alcohols</to_name>
		<to_code>1307779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorotheophylline</to_name>
		<to_code>236872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine anhydrous</to_name>
		<to_code>1545976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coptis japonica whole extract</to_name>
		<to_code>2050978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline C-11</to_name>
		<to_code>1425419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline hydroxide</to_name>
		<to_code>1311084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common chickweed leaf extract</to_name>
		<to_code>1661436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorthalidone</to_name>
		<to_code>2409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthemum indicum top extract</to_name>
		<to_code>1992280</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Croton tiglium seed extract</to_name>
		<to_code>1309714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula officinalis whole extract</to_name>
		<to_code>1428027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomipramine hydrochloride</to_name>
		<to_code>81984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carglumic acid</to_name>
		<to_code>401713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-2</to_name>
		<to_code>1425220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coffee fruit preparation</to_name>
		<to_code>1009451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerium</to_name>
		<to_code>1367178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cirsium arvense flowering top</to_name>
		<to_code>2359931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-10</to_name>
		<to_code>1600142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caseinate</to_name>
		<to_code>1370656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefepime hydrochloride</to_name>
		<to_code>236058</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cycloastragenol</to_name>
		<to_code>2398144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus bergamia leaf oil</to_name>
		<to_code>2264903</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciltacabtagene autoleucel</to_name>
		<to_code>2594775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium pidolate</to_name>
		<to_code>87393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonidine</to_name>
		<to_code>2599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic sulfate pentadecahydrate</to_name>
		<to_code>1875238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrageenan</to_name>
		<to_code>1368862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Candida tropicalis allergenic extract</to_name>
		<to_code>967033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium ascorbate</to_name>
		<to_code>142407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholestyramine resin</to_name>
		<to_code>2447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C14 olefin sulfonate</to_name>
		<to_code>1370655</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephapirin</to_name>
		<to_code>2238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetylpyridinium chloride</to_name>
		<to_code>2287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus deodara wood extract</to_name>
		<to_code>1486881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clevidipine</to_name>
		<to_code>233603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colistin</to_name>
		<to_code>2709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboprost</to_name>
		<to_code>2051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove allergenic extract</to_name>
		<to_code>899724</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-15</to_name>
		<to_code>1311621</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprooyl tetrapeptide-3</to_name>
		<to_code>1427143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorine dioxide</to_name>
		<to_code>20799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium bromide</to_name>
		<to_code>1874551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium polynicotinate</to_name>
		<to_code>700888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocklebur extract</to_name>
		<to_code>880341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma kwangsiensis root extract</to_name>
		<to_code>2106558</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytarabine liposome</to_name>
		<to_code>968804</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclomethicone 7</to_name>
		<to_code>1862729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline</to_name>
		<to_code>2449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftobiprole</to_name>
		<to_code>2691333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C8-10/propylene glycol/peg-22/decylene glycol ether</to_name>
		<to_code>2392630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capivasertib</to_name>
		<to_code>2669967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canna indica root extract</to_name>
		<to_code>1307727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco monoethanolamide</to_name>
		<to_code>1426393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvacrol</to_name>
		<to_code>1998840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus mexicana whole extract</to_name>
		<to_code>1998612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomiphene citrate</to_name>
		<to_code>142431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorothen</to_name>
		<to_code>59695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cimetidine hydrochloride</to_name>
		<to_code>91251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous phosphate</to_name>
		<to_code>2624688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia sinensis flower extract</to_name>
		<to_code>1309958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chinquapin oak pollen extract</to_name>
		<to_code>2167695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroxine</to_name>
		<to_code>20875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis hexapetala whole extract</to_name>
		<to_code>1594579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroacetate</to_name>
		<to_code>48008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clemizolpenicillin</to_name>
		<to_code>21226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedrol</to_name>
		<to_code>1670019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California mugwort pollen extract</to_name>
		<to_code>892734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetirizine</to_name>
		<to_code>20610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpheniramine polistirex</to_name>
		<to_code>221074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordia dichotoma fruit extract</to_name>
		<to_code>2121054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefotiam hydrochloride</to_name>
		<to_code>236202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic/capric/myristic/stearic triglyceride</to_name>
		<to_code>2669697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis vitalba whole extract</to_name>
		<to_code>1801695</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-15 pareth-20</to_name>
		<to_code>1790285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-60 myristyl glycol</to_name>
		<to_code>2049987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capecitabine</to_name>
		<to_code>194000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cambendazole</to_name>
		<to_code>1951</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroquine hydrochloride</to_name>
		<to_code>451796</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium maculatum root extract</to_name>
		<to_code>1545040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl PEG-PPG-10-1 dimethicone (HLB 1.5)</to_name>
		<to_code>1306940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creatine monohydrate</to_name>
		<to_code>1310467</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cidofovir</to_name>
		<to_code>83171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cochlearia officinalis leaf extract</to_name>
		<to_code>2053437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynanchum otophyllum whole extract</to_name>
		<to_code>2598015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus sinensis leaf extract</to_name>
		<to_code>1856269</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colchiceine</to_name>
		<to_code>2174385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clonostachys rosea f. rosea allergenic extract</to_name>
		<to_code>1426481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate, porcine</to_name>
		<to_code>1306202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens leaf oil</to_name>
		<to_code>1309331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn pollen extract</to_name>
		<to_code>852015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clocortolone pivalate</to_name>
		<to_code>21250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clavulanate</to_name>
		<to_code>48203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefaclor anhydrous</to_name>
		<to_code>1450910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma longa whole extract</to_name>
		<to_code>1428853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>concizumab</to_name>
		<to_code>2708333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>candesartan</to_name>
		<to_code>214354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Collinsonia canadensis root extract</to_name>
		<to_code>1309782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthellum indicum subsp. afroamericanum extract</to_name>
		<to_code>1310162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chiococca alba root extract</to_name>
		<to_code>1655561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caffeic acid</to_name>
		<to_code>1311397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia reticulata whole extract</to_name>
		<to_code>1997243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-6 olivate</to_name>
		<to_code>1733818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Codium fragile extract</to_name>
		<to_code>1735033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen alpha-1(I) chain (bovine)</to_name>
		<to_code>2396784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantiifolia leaf oil</to_name>
		<to_code>1309295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonmouth venom</to_name>
		<to_code>1595881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-coumaric acid</to_name>
		<to_code>1485787</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium gluconate</to_name>
		<to_code>1908</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut oil</to_name>
		<to_code>1309239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceratonia siliqua whole extract</to_name>
		<to_code>1366322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium flower extract</to_name>
		<to_code>1306205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamic aldehyde</to_name>
		<to_code>1368153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftriaxone</to_name>
		<to_code>2193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cresol</to_name>
		<to_code>62130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carpinus betulus flower bud extract</to_name>
		<to_code>2054074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus sinensis seed oil</to_name>
		<to_code>1872040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coffea arabica seed, roasted, extract</to_name>
		<to_code>1310128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clonidine hydrochloride</to_name>
		<to_code>142432</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona bark extract</to_name>
		<to_code>1309666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon martini whole extract</to_name>
		<to_code>1535477</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clavulanic acid</to_name>
		<to_code>21216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen type V</to_name>
		<to_code>2667828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramine-T trihydrate</to_name>
		<to_code>1592902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic fluoride</to_name>
		<to_code>2603282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium silicate</to_name>
		<to_code>1311526</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Castanea sativa whole extract</to_name>
		<to_code>1801151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cassia fistula fruit extract</to_name>
		<to_code>1307589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagenase clostridium histolyticum-aaes</to_name>
		<to_code>2475861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caviar preparation</to_name>
		<to_code>1425214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chitosan succinamide (1300 MPA.S)</to_name>
		<to_code>2399031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl macadamiate</to_name>
		<to_code>2361301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt oxide</to_name>
		<to_code>2606479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulose acetate phthalate</to_name>
		<to_code>1425215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocodimonium hydroxypropyl hydrolyzed keratin (1000 MW)</to_name>
		<to_code>2101718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coix lacryma-jobi whole extract</to_name>
		<to_code>2699765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sulfate</to_name>
		<to_code>1925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Commiphora myrrha stem bark</to_name>
		<to_code>2560107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnosine</to_name>
		<to_code>1362697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl ethylhexanoate</to_name>
		<to_code>1314340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chaenomeles japonica seed extract</to_name>
		<to_code>2592959</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlorella minutissima extract</to_name>
		<to_code>1735032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chenodeoxycholate</to_name>
		<to_code>42588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma longa root powder</to_name>
		<to_code>2705361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroprocaine hydrochloride</to_name>
		<to_code>53616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabotegravir</to_name>
		<to_code>2475077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclic AMP</to_name>
		<to_code>1314330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclomethicone 5</to_name>
		<to_code>1305744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>castor fiber scent gland secretion</to_name>
		<to_code>1375415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>catfish allergenic extract</to_name>
		<to_code>2198979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine sulfate</to_name>
		<to_code>91104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cow milk allergenic extract</to_name>
		<to_code>892665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>captodiamine</to_name>
		<to_code>89812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cistanche salsa stem extract</to_name>
		<to_code>2698552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium picrate</to_name>
		<to_code>1442999</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium disodium pyrophosphate</to_name>
		<to_code>1865167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carthamus tinctorius flower bud extract</to_name>
		<to_code>1376213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclacillin</to_name>
		<to_code>2968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclothiazide</to_name>
		<to_code>22033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholecystokinin</to_name>
		<to_code>2420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryloyl/caproyl methyl glucamide</to_name>
		<to_code>2205481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetalkonium chloride</to_name>
		<to_code>47907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl olivate</to_name>
		<to_code>1435858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cherimoya extract</to_name>
		<to_code>1808538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cymene</to_name>
		<to_code>2584847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium fruit extract</to_name>
		<to_code>1311573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyldimethylethylammonium bromide</to_name>
		<to_code>1427238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>channel catfish allergenic extract</to_name>
		<to_code>2102475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated mushroom allergenic extract</to_name>
		<to_code>901369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclamen aldehyde</to_name>
		<to_code>1376343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citalopram hydrobromide</to_name>
		<to_code>221078</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cashew oil</to_name>
		<to_code>1310044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crocus sativus whole extract</to_name>
		<to_code>2632775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Castor canadensis scent gland secretion preparation</to_name>
		<to_code>1371053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chimaphila maculata extract</to_name>
		<to_code>1336264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium undecylenate</to_name>
		<to_code>89746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbamoylcholine</to_name>
		<to_code>1546387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftaroline</to_name>
		<to_code>1040005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl isononanoate</to_name>
		<to_code>1312361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phosphate dibasic</to_name>
		<to_code>47627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus bergamia leaf extract</to_name>
		<to_code>1310105</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco glucoside</to_name>
		<to_code>1425503</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carmoisine</to_name>
		<to_code>1363916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-15 pareth-7</to_name>
		<to_code>1483735</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis alpigena whole extract</to_name>
		<to_code>1653327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysopogon zizanioides whole extract</to_name>
		<to_code>2048128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerous cation</to_name>
		<to_code>1546388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus limon whole extract</to_name>
		<to_code>1733667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cantharis vesicatoria preparation</to_name>
		<to_code>265758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese rhubarb root exract</to_name>
		<to_code>1489544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cervus elaphus whole preparation</to_name>
		<to_code>1545680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cassia javanica whole extract</to_name>
		<to_code>2536137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber allergenic extract</to_name>
		<to_code>899738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut alcohol</to_name>
		<to_code>1426863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium aspartate</to_name>
		<to_code>287637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated oat pollen extract</to_name>
		<to_code>852114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl stearate</to_name>
		<to_code>1306200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canagliflozin</to_name>
		<to_code>1373458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrate</to_name>
		<to_code>114200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-7</to_name>
		<to_code>1372309</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coenzyme A trilithium dihydrate</to_name>
		<to_code>2642206</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cuscuta australis seed extract</to_name>
		<to_code>1791062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloxazolam</to_name>
		<to_code>21311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopamide</to_name>
		<to_code>2603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>charcoal</to_name>
		<to_code>2296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftaroline fosamil acetate</to_name>
		<to_code>1743286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crassostrea gigas shell extract</to_name>
		<to_code>2369380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C1 esterase inhibitor (human)</to_name>
		<to_code>809864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coenzyme A</to_name>
		<to_code>1314344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Combretum indicum whole extract</to_name>
		<to_code>2592962</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetylhydroxyproline palmitamide</to_name>
		<to_code>1306185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyperus rotundus fruit extract</to_name>
		<to_code>2732340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crab allergenic extract</to_name>
		<to_code>892610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cuminyl acetaldehyde</to_name>
		<to_code>2378840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium glucarate</to_name>
		<to_code>1907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine camsyl</to_name>
		<to_code>236236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl sulfate</to_name>
		<to_code>1366920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium valproate</to_name>
		<to_code>1927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocaine hydrochloride</to_name>
		<to_code>81985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium peroxide</to_name>
		<to_code>1426443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium hexafluorosilicate</to_name>
		<to_code>1311304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coccinia grandis leaf extract</to_name>
		<to_code>2461142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coptis teeta root extract</to_name>
		<to_code>2665346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon citratus whole extract</to_name>
		<to_code>1596767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrot juice</to_name>
		<to_code>1366027</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citraconic acid</to_name>
		<to_code>1435287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorprothixene hydrochloride</to_name>
		<to_code>91133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonseed acid</to_name>
		<to_code>2697172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl lactate</to_name>
		<to_code>1368150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefiderocol</to_name>
		<to_code>2265702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus maxima fruit rind extract</to_name>
		<to_code>1306207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetiedil</to_name>
		<to_code>20609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium alginate</to_name>
		<to_code>47610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colestipol hydrochloride</to_name>
		<to_code>104485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic chloride Cr-51</to_name>
		<to_code>1536069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cicada periostracum extract</to_name>
		<to_code>2390762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl methicone (15000 MW)</to_name>
		<to_code>2056454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlortetracycline</to_name>
		<to_code>2408</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cirsium japonicum flowering top extract</to_name>
		<to_code>2375521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlortetracycline calcium</to_name>
		<to_code>1306093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropyl PG-dimonium chloride phosphate</to_name>
		<to_code>1311528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefdinir monohydrate</to_name>
		<to_code>1306064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclandelate</to_name>
		<to_code>2970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cibotium barometz root extract</to_name>
		<to_code>1793899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coptis chinensis root extract</to_name>
		<to_code>1376211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia sinensis seed oil</to_name>
		<to_code>1364131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calocedrus decurrens pollen extract</to_name>
		<to_code>2670160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbadox</to_name>
		<to_code>1314339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber juice</to_name>
		<to_code>1307563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cottonseed allergenic extract</to_name>
		<to_code>852440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorquinaldol</to_name>
		<to_code>2407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvone, (+)-</to_name>
		<to_code>1747726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 120 MPA.S at 1%)</to_name>
		<to_code>2584311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis ambigua whole extract</to_name>
		<to_code>2585441</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrot seed oil</to_name>
		<to_code>1309293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisatracurium</to_name>
		<to_code>319864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl palmitate</to_name>
		<to_code>1311485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbazochrome</to_name>
		<to_code>2011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat's claw preparation</to_name>
		<to_code>285223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnitine</to_name>
		<to_code>2106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calophyllum inophyllum whole extract</to_name>
		<to_code>2634918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chaste tree fruit oil</to_name>
		<to_code>2716983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisapride</to_name>
		<to_code>35255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ciprofloxacin hydrochloride</to_name>
		<to_code>81981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cardiospermum halicacabum seed extract</to_name>
		<to_code>1923770</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken allergenic extract</to_name>
		<to_code>892653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California black oak pollen extract</to_name>
		<to_code>1014721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric triethanolamine</to_name>
		<to_code>1867699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Commiphora wightii resin</to_name>
		<to_code>2601098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen,activated</to_name>
		<to_code>751543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sulfate, anhydrous</to_name>
		<to_code>1328529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamide</to_name>
		<to_code>1739005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capreomycin sulfate</to_name>
		<to_code>1987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camylofin hydrochloride</to_name>
		<to_code>236175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C10-30 cholesterol-lanosterol esters</to_name>
		<to_code>1368142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrorelix acetate</to_name>
		<to_code>259338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citrus junos fruit rind extract</to_name>
		<to_code>1727719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capryloyl salicylic acid</to_name>
		<to_code>1492035</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-15 pareth-40</to_name>
		<to_code>1927867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carlina vulgaris whole extract</to_name>
		<to_code>1800489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cortisone</to_name>
		<to_code>2878</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus reticulata leaf oil</to_name>
		<to_code>1306132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coccidioidin</to_name>
		<to_code>2660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cryptenamine tannates</to_name>
		<to_code>235226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl PEG-PPG-10-1 dimethicone (HLB 5)</to_name>
		<to_code>1306941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic/capric/palmitic/stearic triglyceride</to_name>
		<to_code>1719259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco diisopropanolamide</to_name>
		<to_code>1421434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorhexidine</to_name>
		<to_code>2358</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl-behenyl-octyldodecyl lauroyl glutamate</to_name>
		<to_code>1424868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlorella pyrenoidosa extract</to_name>
		<to_code>1591911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus monogyna flower extract</to_name>
		<to_code>1310021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorzoxazone</to_name>
		<to_code>2410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crizanlizumab-tmca</to_name>
		<to_code>2262421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefoperazone</to_name>
		<to_code>2184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceritinib</to_name>
		<to_code>1535457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corkwood tree leaf extract</to_name>
		<to_code>1923402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cicletanine</to_name>
		<to_code>21914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clarithromycin</to_name>
		<to_code>21212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium ascorbate anhydrous</to_name>
		<to_code>1307765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cuminum cyminum whole extract</to_name>
		<to_code>2055274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclohexyl cinnamate</to_name>
		<to_code>1601992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilgavimab</to_name>
		<to_code>2587306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisplatin</to_name>
		<to_code>2555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopidogrel</to_name>
		<to_code>32968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carica papaya leaf extract</to_name>
		<to_code>1309415</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium dobesilate</to_name>
		<to_code>1904</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium ion</to_name>
		<to_code>1316581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium oxide</to_name>
		<to_code>28728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramphenicol sodium succinate</to_name>
		<to_code>47998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canakinumab</to_name>
		<to_code>853491</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cytisus scoparius flowering top extract</to_name>
		<to_code>2168418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium chloride</to_name>
		<to_code>1901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry preparation</to_name>
		<to_code>125933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C10-36 olefin</to_name>
		<to_code>1428863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopidol</to_name>
		<to_code>1367179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium album whole extract</to_name>
		<to_code>1421885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbon black</to_name>
		<to_code>2032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calaspargase pegol</to_name>
		<to_code>2121416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-carbethoxyethyl)triethoxysilane</to_name>
		<to_code>2475947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colloidal oatmeal</to_name>
		<to_code>221082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centella asiatica extract</to_name>
		<to_code>1310164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosporium cladosporioides extract</to_name>
		<to_code>867198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurea benedicta extract</to_name>
		<to_code>1320410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-carene</to_name>
		<to_code>2395760</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carnegiea gigantea flower extract</to_name>
		<to_code>2534456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefixime anhydrous</to_name>
		<to_code>1546021</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium cyclamate</to_name>
		<to_code>155015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 600 MPA.S at 2 %)</to_name>
		<to_code>2099296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus horridus horridus whole extract</to_name>
		<to_code>1745412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamyl alcohol</to_name>
		<to_code>1362889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftiofur</to_name>
		<to_code>1311521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrorelix</to_name>
		<to_code>68147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecyparis lawsoniana wood oil</to_name>
		<to_code>2374340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carthamus tinctorius flower oil</to_name>
		<to_code>1495154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomocycline</to_name>
		<to_code>21272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut water</to_name>
		<to_code>1799143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum aromaticum whole extract</to_name>
		<to_code>1489545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coccinia grandis fruit extract</to_name>
		<to_code>1307768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Convallaria majalis bulb extract</to_name>
		<to_code>1312085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crambe maritima leaf extract</to_name>
		<to_code>1371034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceric oxide</to_name>
		<to_code>1673068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calenduladiol</to_name>
		<to_code>2282905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crambe hispanica subsp. abyssinica whole extract</to_name>
		<to_code>2667327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cholera Vaccine</to_name>
		<to_code>2427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia japonica flower extract</to_name>
		<to_code>1307547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorphenoxamine</to_name>
		<to_code>20881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorozotocin</to_name>
		<to_code>1362886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalus atrox antivenin</to_name>
		<to_code>885187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crospovidone (19 MPA.S at 5%)</to_name>
		<to_code>1661326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor VIIa (recombinant)-jncw</to_name>
		<to_code>2386863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-22 alcohols</to_name>
		<to_code>1307780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>castor oil fish whole</to_name>
		<to_code>1371316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcitriol</to_name>
		<to_code>1894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabozantinib s-malate</to_name>
		<to_code>1363267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coxsackievirus A</to_name>
		<to_code>1668272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropylamine oxide</to_name>
		<to_code>1363576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creatine</to_name>
		<to_code>2907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper chloride</to_name>
		<to_code>150596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl-capryl oligoglucoside</to_name>
		<to_code>1368146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coniferyl alcohol</to_name>
		<to_code>1309334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-cymene</to_name>
		<to_code>15002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaemelum nobile extract</to_name>
		<to_code>1311376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloprostenol sodium</to_name>
		<to_code>204179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-carboxyethyl acrylate</to_name>
		<to_code>2286249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula officinalis flowering top extract</to_name>
		<to_code>1309775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl myristate</to_name>
		<to_code>1306180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalothin</to_name>
		<to_code>2236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona officinalis whole extract</to_name>
		<to_code>1591950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coxsackievirus A21</to_name>
		<to_code>2591813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftazidime anhydrous</to_name>
		<to_code>1545984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calendula officinalis flower extract</to_name>
		<to_code>1309289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Callicarpa nudiflora leaf extract</to_name>
		<to_code>2268813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clevidipine butyrate</to_name>
		<to_code>977863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphene</to_name>
		<to_code>2395761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellyl nitrile, (+/-)</to_name>
		<to_code>2388134</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosiphon okamuranus preparation</to_name>
		<to_code>1313229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicory root extract</to_name>
		<to_code>1371300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carbopol 981</to_name>
		<to_code>1311164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurium erythraea preparation</to_name>
		<to_code>1368149</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carminate</to_name>
		<to_code>1368644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine phosphate anhydrous</to_name>
		<to_code>1652891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coix lacryma-jobi seed oil</to_name>
		<to_code>1366325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor IX (recombinant), glycopegylated</to_name>
		<to_code>1990855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate sodium (bovine)</to_name>
		<to_code>1299929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis armandii stem extract</to_name>
		<to_code>1724423</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpheniramine</to_name>
		<to_code>2400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coal tar pitch volatiles</to_name>
		<to_code>90732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlorella vulgaris extract</to_name>
		<to_code>1370784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon allergenic extract</to_name>
		<to_code>899673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorcyclizine</to_name>
		<to_code>2354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorproethazine</to_name>
		<to_code>59860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coumaran</to_name>
		<to_code>1855075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove stem oil</to_name>
		<to_code>1307803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chimaphila umbellata extract</to_name>
		<to_code>1318231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clemastine fumarate</to_name>
		<to_code>142430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cuminaldehyde</to_name>
		<to_code>2177095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftiofur hydrochloride</to_name>
		<to_code>1311520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>codeine polistirex</to_name>
		<to_code>235412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer interpolymer type B (allyl pentaerythritol crosslinked)</to_name>
		<to_code>1366223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cherry juice</to_name>
		<to_code>1307717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove leaf extract</to_name>
		<to_code>1923502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cochineal</to_name>
		<to_code>1425501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyberlindnera jadinii RNA</to_name>
		<to_code>1432976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis viorna whole extract</to_name>
		<to_code>2682734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capparis spinosa whole extract</to_name>
		<to_code>2056925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>creosol</to_name>
		<to_code>1362910</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobimetinib fumarate</to_name>
		<to_code>1722380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefadroxil anhydrous</to_name>
		<to_code>1545975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capsaicin</to_name>
		<to_code>1992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco-caprylate</to_name>
		<to_code>1364293</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramphenicol palmitate</to_name>
		<to_code>20767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordyceps gunnii fruiting body extract</to_name>
		<to_code>1595582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choline fenofibrate</to_name>
		<to_code>1433887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cestrum latifolium leaf extract</to_name>
		<to_code>1376087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbazochrome sodium sulfonate hydrate</to_name>
		<to_code>2469330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus limon flowering top oil</to_name>
		<to_code>2054075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus paradisi fruit oil</to_name>
		<to_code>1310127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetirizine hydrochloride</to_name>
		<to_code>203150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium iodide</to_name>
		<to_code>235273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetostearyl sulfate</to_name>
		<to_code>1370628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulose</to_name>
		<to_code>2221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumaria frondosa preparation</to_name>
		<to_code>1424877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbenoxolone</to_name>
		<to_code>2017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa seed oil</to_name>
		<to_code>1305550</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon flexuosus whole extract</to_name>
		<to_code>1442506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis bungeana whole extract</to_name>
		<to_code>1547472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-20</to_name>
		<to_code>1310709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common cocklebur pollen extract</to_name>
		<to_code>902215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroquine</to_name>
		<to_code>2393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium maculatum leaf extract</to_name>
		<to_code>1994298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcobutrol sodium</to_name>
		<to_code>2634451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cetraria islandica subsp. islandica extract</to_name>
		<to_code>1306351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cuscuta reflexa extract</to_name>
		<to_code>2048126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephaloridine</to_name>
		<to_code>2233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-12</to_name>
		<to_code>1311620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium quinoa whole extract</to_name>
		<to_code>2683194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloride ion</to_name>
		<to_code>153974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen type II</to_name>
		<to_code>2471083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloropropylate</to_name>
		<to_code>1435282</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefprozil anhydrous</to_name>
		<to_code>1546020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cathine hydrochloride</to_name>
		<to_code>236860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clindamycin hydrochloride</to_name>
		<to_code>81982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canrenoate</to_name>
		<to_code>618970</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyproheptadine</to_name>
		<to_code>3013</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoyl glutamate</to_name>
		<to_code>1370631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C30-38 olefin</to_name>
		<to_code>2392135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 sec-pareth-12 sulfosuccinate</to_name>
		<to_code>1370644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-13 pareth-3</to_name>
		<to_code>1368907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut extract</to_name>
		<to_code>1372248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopenthiazide</to_name>
		<to_code>3000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabotegravir sodium</to_name>
		<to_code>2475076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cullen corylifolium fruit extract</to_name>
		<to_code>1311580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cryptosporidium parvum</to_name>
		<to_code>1322778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium</to_name>
		<to_code>2496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl hydroxyethylcellulose (550000 MW)</to_name>
		<to_code>1488054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium glycerophosphate</to_name>
		<to_code>1909</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorphenoxamine hydrochloride</to_name>
		<to_code>235422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis recta flowering top extract</to_name>
		<to_code>1309774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caulophyllum thalictroides root extract</to_name>
		<to_code>1342487</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphor, (-)-</to_name>
		<to_code>1648124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic cation</to_name>
		<to_code>1546418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalidae immune F(ab')2</to_name>
		<to_code>2101271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>3-((3-chlorophenyl)(4-(methylsulfonyl)phenyl)methylene)dihydro-2(3H)-furanone, (3Z)-</to_name>
		<to_code>2099767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefamandole</to_name>
		<to_code>2178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomipramine</to_name>
		<to_code>2597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerium oxalate</to_name>
		<to_code>314546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cola extract</to_name>
		<to_code>283553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-16</to_name>
		<to_code>1306172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>concizumab-mtci</to_name>
		<to_code>2708340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia japonica leaf extract</to_name>
		<to_code>1307826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colestipol</to_name>
		<to_code>2685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefadroxil hydrate</to_name>
		<to_code>407888</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chaenomeles speciosa fruit</to_name>
		<to_code>1310288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cytarabine</to_name>
		<to_code>3041</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoyl glycinate</to_name>
		<to_code>1424461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coriaria ruscifolia fruit extract</to_name>
		<to_code>1925877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl phosphate</to_name>
		<to_code>1306184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium vulvaria extract</to_name>
		<to_code>1428216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calaspargase pegol-mknl</to_name>
		<to_code>2121417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clorsulon</to_name>
		<to_code>28303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chionanthus virginicus bark extract</to_name>
		<to_code>1309759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper oxodotreotide CU-64</to_name>
		<to_code>2396442</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclosporine, modified</to_name>
		<to_code>236077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cumin allergenic extract</to_name>
		<to_code>901365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous nitrate hexahydrate</to_name>
		<to_code>1423922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcifediol anhydrous</to_name>
		<to_code>1855064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl palmitoleate</to_name>
		<to_code>1306183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoamphodiacetate</to_name>
		<to_code>1364462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Commiphora africana resin</to_name>
		<to_code>1537758</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthemum x morifolium flower extract</to_name>
		<to_code>1306204</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cervus elaphus horn preparation</to_name>
		<to_code>1875527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl oleate</to_name>
		<to_code>1368200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colchicum autumnale whole extract</to_name>
		<to_code>1545682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer homopolymer type c</to_name>
		<to_code>1305738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calophyllum tacamahaca whole extract</to_name>
		<to_code>1486507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn dextrin</to_name>
		<to_code>2691826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>curcumin</to_name>
		<to_code>2955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cycrimine hydrochloride</to_name>
		<to_code>235421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clemastine</to_name>
		<to_code>2578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cuscuta chinensis seed extract</to_name>
		<to_code>1310072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefoxitin sodium</to_name>
		<to_code>203118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>California scrub oak pollen extract</to_name>
		<to_code>852802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia oleifera whole extract</to_name>
		<to_code>1650609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carpesium abrotanoides fruit extract</to_name>
		<to_code>1875597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C11-12 isoparaffin</to_name>
		<to_code>1609072</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclophosphamide anhydrous</to_name>
		<to_code>1545988</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 alkyl lactate</to_name>
		<to_code>1356133</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chikungunya virus antigen, live attenuated LR2006 OPY1 strain</to_name>
		<to_code>2673238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Callicarpa japonica fruit extract</to_name>
		<to_code>1809243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbon tetrachloride</to_name>
		<to_code>2383337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caulerpa lentillifera extract</to_name>
		<to_code>1655981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladonia rangiferina whole extract</to_name>
		<to_code>2619241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C.I. acid blue 324</to_name>
		<to_code>1649505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerivastatin</to_name>
		<to_code>596723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C18-36 acid triglyceride</to_name>
		<to_code>1426385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capric diethanolamide</to_name>
		<to_code>1432975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cromolyn sodium</to_name>
		<to_code>3538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casein, Lactococcus lactis cultured, Penicillium camemberti cultured, aged</to_name>
		<to_code>1315112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer-974P</to_name>
		<to_code>1363568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Copernicia prunifera whole extract</to_name>
		<to_code>2587732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove preparation</to_name>
		<to_code>1364295</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide 2</to_name>
		<to_code>1426448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crovalimab-akkz</to_name>
		<to_code>2686620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum cassia twig extract</to_name>
		<to_code>2055273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>conivaptan hydrochloride</to_name>
		<to_code>1294548</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrelopsis grevei bark extract</to_name>
		<to_code>1309997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coconut oil glycereth-8 esters</to_name>
		<to_code>1719252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon oil, leaf</to_name>
		<to_code>1309227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl myristoleate</to_name>
		<to_code>1314343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-17 alkane</to_name>
		<to_code>1541236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbobenzoxycarbonyl-phenylalanyl-alaninyldiazomethane</to_name>
		<to_code>2376939</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyprodenate maleate</to_name>
		<to_code>236532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl betaine</to_name>
		<to_code>1306175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl ethylhexanoate</to_name>
		<to_code>1306178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide 3</to_name>
		<to_code>1362741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloramphenicol stearate</to_name>
		<to_code>20768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylarsonate</to_name>
		<to_code>1744168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon schoenanthus leaf extract</to_name>
		<to_code>1309422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpromazine</to_name>
		<to_code>2403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calamine</to_name>
		<to_code>106212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-33</to_name>
		<to_code>1307783</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Collinsonia canadensis whole extract</to_name>
		<to_code>2123124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobetasol</to_name>
		<to_code>2590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus nobilis whole extract</to_name>
		<to_code>1805272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia kissii seed oil</to_name>
		<to_code>1307800</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chrysarobin</to_name>
		<to_code>1860418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chikungunya virus antigen, recombinant Senegal strain 37997 capsid protein</to_name>
		<to_code>2707119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynanchum paniculatum root extract</to_name>
		<to_code>1546864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cuttle fish ink</to_name>
		<to_code>283555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium arsenate</to_name>
		<to_code>1333425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon schoenanthus top extract</to_name>
		<to_code>1311584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloconazole hydrochloride</to_name>
		<to_code>236864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetylpyridinium acetate</to_name>
		<to_code>1307588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceratostigma willmottianum flower extract</to_name>
		<to_code>1309794</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium, chelated</to_name>
		<to_code>253160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C30-50 alcohols</to_name>
		<to_code>1423780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clopyralid</to_name>
		<to_code>1995248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus medica whole extract</to_name>
		<to_code>2541166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbidopa</to_name>
		<to_code>2019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canary grass pollen extract</to_name>
		<to_code>852697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>capmatinib hydrochloride</to_name>
		<to_code>2362259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clocinizine hydrochloride</to_name>
		<to_code>402584</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl dimethicone 25</to_name>
		<to_code>1373353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticorelin ovine</to_name>
		<to_code>74671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon preparation</to_name>
		<to_code>285245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloprostenol</to_name>
		<to_code>2606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canyon ragweed pollen extract</to_name>
		<to_code>851942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium fructoborate</to_name>
		<to_code>2600351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloropyramine hydrochloride</to_name>
		<to_code>236457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropyl dimethylamine</to_name>
		<to_code>1942697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clary sage oil</to_name>
		<to_code>1309232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clorazepate dipotassium</to_name>
		<to_code>2607</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinacalcet hydrochloride</to_name>
		<to_code>384379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilazapril</to_name>
		<to_code>21102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-chloro-2-methyl-1-propene</to_name>
		<to_code>2469243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis yanhusuo whole extract</to_name>
		<to_code>2665624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrullus colocynthis whole extract</to_name>
		<to_code>1663393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyamopsis tetragonoloba whole extract</to_name>
		<to_code>2480112</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalexin monohydrate</to_name>
		<to_code>215948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cannabichromene</to_name>
		<to_code>2585216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid</to_name>
		<to_code>21183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casanthranol</to_name>
		<to_code>66870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnuba wax</to_name>
		<to_code>1311568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl oleyl carbonate</to_name>
		<to_code>1721620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus limon fruit oil</to_name>
		<to_code>1306152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chimonanthus praecox flower oil</to_name>
		<to_code>2289025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caesalpinia sappan wood extract</to_name>
		<to_code>1806891</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyanomethylacetate</to_name>
		<to_code>2264720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curculigo orchioides root extract</to_name>
		<to_code>2001237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centruroides (scorpion) immune F(ab')2 (equine)</to_name>
		<to_code>1119986</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry seed extract</to_name>
		<to_code>2596443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chenopodium album flower extract</to_name>
		<to_code>1307574</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftizoxime sodium</to_name>
		<to_code>82126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclofenil</to_name>
		<to_code>2983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphor oil</to_name>
		<to_code>1297880</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>choleth-20</to_name>
		<to_code>1306201</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calenduloside E</to_name>
		<to_code>1428039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-6</to_name>
		<to_code>1311624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoa butter</to_name>
		<to_code>21389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis recta whole extract</to_name>
		<to_code>1999995</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbazochrome sodium sulfonate</to_name>
		<to_code>20209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cevimeline hydrochloride</to_name>
		<to_code>260036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clove leaf oil</to_name>
		<to_code>1309233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caldiamide</to_name>
		<to_code>1364944</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1,3-cyclohexadiene</to_name>
		<to_code>2691092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn smut allergenic extract</to_name>
		<to_code>314488</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen type V, human</to_name>
		<to_code>2667827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corn starch</to_name>
		<to_code>1039062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium behenate</to_name>
		<to_code>1312385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium sulfate, dihydrate</to_name>
		<to_code>1310465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cavia porcellus whole extract</to_name>
		<to_code>2590606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chlamydomonas reinhardtii</to_name>
		<to_code>2637877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>(2-chlorophenyl)methyl 4-hydroxybenzoate</to_name>
		<to_code>2104168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceramide 4</to_name>
		<to_code>2389637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chelidonium majus extract</to_name>
		<to_code>285220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corallina officinalis extract</to_name>
		<to_code>1314844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coccidioides immitis spherule</to_name>
		<to_code>1549330</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crocus sativus flower extract</to_name>
		<to_code>1740936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedazuridine</to_name>
		<to_code>2384449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chymotrypsin</to_name>
		<to_code>2530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>canola oil</to_name>
		<to_code>1309202</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium chlorate dihydrate</to_name>
		<to_code>1542454</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcitonin</to_name>
		<to_code>1311287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Celosia cristata flower extract</to_name>
		<to_code>1547471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese elm pollen extract</to_name>
		<to_code>852844</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus medica fruit extract</to_name>
		<to_code>1435099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate (shark)</to_name>
		<to_code>1789516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cysteine, DL-</to_name>
		<to_code>1313188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chondrus crispus carrageenan</to_name>
		<to_code>1540877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celery seed oil</to_name>
		<to_code>2118637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinacalcet</to_name>
		<to_code>407990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate sodium</to_name>
		<to_code>1605114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona officinalis preparation</to_name>
		<to_code>350262</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cabazitaxel</to_name>
		<to_code>996051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cisatracurium besylate</to_name>
		<to_code>136561</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium fluoride</to_name>
		<to_code>2600776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen type I, bovine</to_name>
		<to_code>1426855</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canavalia ensiformis whole extract</to_name>
		<to_code>2624893</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carisoprodol</to_name>
		<to_code>2101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftaroline fosamil</to_name>
		<to_code>1040004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cosibelimab-ipdl</to_name>
		<to_code>2717512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carica papaya whole extract</to_name>
		<to_code>1364987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus pinnatifida whole extract</to_name>
		<to_code>2570730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsicum extract</to_name>
		<to_code>319780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus deodara wood oil</to_name>
		<to_code>1307686</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlophedianol hydrochloride</to_name>
		<to_code>1014329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyamemazine tartrate</to_name>
		<to_code>236251</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl trimethicone</to_name>
		<to_code>1428864</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Costus spicatus root extract</to_name>
		<to_code>2665287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorphenindione</to_name>
		<to_code>402527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor IX, human</to_name>
		<to_code>221099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium galactogluconate bromide</to_name>
		<to_code>47617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-23</to_name>
		<to_code>1427231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefdinir</to_name>
		<to_code>25037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium polystyrene sulfonate product</to_name>
		<to_code>47630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorhexidine diacetate</to_name>
		<to_code>133054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carvedilol phosphate</to_name>
		<to_code>668310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cornus alba whole extract</to_name>
		<to_code>1922524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer copolymer type A</to_name>
		<to_code>1310599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl stearate</to_name>
		<to_code>1425221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canadian bluegrass pollen extract</to_name>
		<to_code>1014731</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carboxymethylcellulose</to_name>
		<to_code>2062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common carp allergenic extract</to_name>
		<to_code>901390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorine</to_name>
		<to_code>1310122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorogenic acid</to_name>
		<to_code>1311387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium gluconate monohydrate</to_name>
		<to_code>1298846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordia sebestena flower extract</to_name>
		<to_code>1482789</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl glucoside</to_name>
		<to_code>1306179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cupressus sempervirens leaf extract</to_name>
		<to_code>1358960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chamomile extract</to_name>
		<to_code>1309226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber extract</to_name>
		<to_code>1305719</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crofelemer</to_name>
		<to_code>1364449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyclopia intermedia leaf extract</to_name>
		<to_code>1435859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colchicum autumnale bulb extract</to_name>
		<to_code>1355184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>corticorelin ovine triflutate</to_name>
		<to_code>74670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia japonica seed oil</to_name>
		<to_code>1306161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cydonia oblonga leaf extract</to_name>
		<to_code>2479551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cherry allergenic extract</to_name>
		<to_code>862461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbamazepine</to_name>
		<to_code>2002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnosine hydrochloride</to_name>
		<to_code>1370593</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 alkyl ethylhexanoate</to_name>
		<to_code>1547713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>4-cresyl acetate</to_name>
		<to_code>14997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcifediol</to_name>
		<to_code>1889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coltsfoot leaf extract</to_name>
		<to_code>1372564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefsulodin</to_name>
		<to_code>2190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloxacillin benzathine</to_name>
		<to_code>1043213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cucumber seed oil</to_name>
		<to_code>1483422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftobiprole medocaril sodium</to_name>
		<to_code>2691334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chrysanthemic acid, (+/-)-</to_name>
		<to_code>2289244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorophyll</to_name>
		<to_code>2388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis bungeana flowering-fruiting top extract</to_name>
		<to_code>1307802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carfilzomib</to_name>
		<to_code>1302966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilantro extract</to_name>
		<to_code>325527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephradine</to_name>
		<to_code>2239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chicken cartilage preparation</to_name>
		<to_code>2359254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-7</to_name>
		<to_code>1428865</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Campsis radicans flower extract</to_name>
		<to_code>2534455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcipotriene hydrate</to_name>
		<to_code>1299898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cotton fiber allergenic extract</to_name>
		<to_code>966925</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecyparis obtusa wood oil</to_name>
		<to_code>1305633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caesalpinia spinosa whole extract</to_name>
		<to_code>2045943</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus maxima seed extract</to_name>
		<to_code>1306209</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamine</to_name>
		<to_code>1598329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-13 pareth-9</to_name>
		<to_code>1991867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coenzyme Q10, (2Z)-</to_name>
		<to_code>1673704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coriandrum sativum whole extract</to_name>
		<to_code>1541716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry allergenic extract</to_name>
		<to_code>899734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper naphthenate</to_name>
		<to_code>1373349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyproterone acetate</to_name>
		<to_code>22054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesteryl nonanoate</to_name>
		<to_code>1362887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus libani whole extract</to_name>
		<to_code>2054069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftazidime</to_name>
		<to_code>2191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellal</to_name>
		<to_code>1424876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calluna vulgaris flowering top extract</to_name>
		<to_code>1309749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobicistat</to_name>
		<to_code>1306284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl glucoside</to_name>
		<to_code>1307766</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetearyl alcohol</to_name>
		<to_code>1425218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium oxalate monohydrate</to_name>
		<to_code>1485047</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coffea arabica seed extract</to_name>
		<to_code>2695791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphor</to_name>
		<to_code>1952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cilastatin sodium</to_name>
		<to_code>82128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftibuten</to_name>
		<to_code>20492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynara preparation</to_name>
		<to_code>235940</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium ipodate</to_name>
		<to_code>1911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crotalidae immune F(ab')2 (equine)</to_name>
		<to_code>2101270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Copaifera officinalis resin</to_name>
		<to_code>1307772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphoric acid, (+)-</to_name>
		<to_code>2264361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamic acid</to_name>
		<to_code>2621720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin 4-sulfate</to_name>
		<to_code>1314214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbinoxamine maleate</to_name>
		<to_code>91066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chocolate hind preparation</to_name>
		<to_code>1994297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobenzorex hydrochloride</to_name>
		<to_code>236205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-19 alkane</to_name>
		<to_code>2050064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromonar</to_name>
		<to_code>2508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedryl acetate</to_name>
		<to_code>2557382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chiro-inositol, (+)-</to_name>
		<to_code>2267019</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centella asiatica leaf extract</to_name>
		<to_code>1307961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carapa procera whole extract</to_name>
		<to_code>2362002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Castanea sative leaf extract</to_name>
		<to_code>1310025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrimonium chloride</to_name>
		<to_code>1311525</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbenicillin indanyl sodium</to_name>
		<to_code>56461</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus sinensis fruit oil</to_name>
		<to_code>1310064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthemum zawadskii whole extract</to_name>
		<to_code>2398514</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citric acid monohydrate</to_name>
		<to_code>221079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromium trioxide</to_name>
		<to_code>1539810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium phosphate, dihydrate</to_name>
		<to_code>1310463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium leafy twig oil</to_name>
		<to_code>1306153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl alcohol</to_name>
		<to_code>20615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobetasol propionate</to_name>
		<to_code>21245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclamate</to_name>
		<to_code>2969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorothiazide</to_name>
		<to_code>2396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clothiapine</to_name>
		<to_code>2620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin sulfate (chicken)</to_name>
		<to_code>1370983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium saccharate anhydrous</to_name>
		<to_code>2636533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>campesterol</to_name>
		<to_code>20129</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colistimethate sodium</to_name>
		<to_code>48305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cissus quadrangularis whole extract</to_name>
		<to_code>1988387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceresin</to_name>
		<to_code>1425217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper sulfate anhydrous</to_name>
		<to_code>1999541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Combretum micranthum whole extract</to_name>
		<to_code>2001173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladonia cristatella whole extract</to_name>
		<to_code>2690254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chenodeoxycholic acid</to_name>
		<to_code>2323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colistin sulfate</to_name>
		<to_code>2710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlortetracycline hydrochloride</to_name>
		<to_code>42545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl dimethicone 45</to_name>
		<to_code>1491002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clocinizine</to_name>
		<to_code>402583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>causticum preparation</to_name>
		<to_code>1311056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colesevelam hydrochloride</to_name>
		<to_code>141625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 pareth-3 sulfate</to_name>
		<to_code>1370606</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carnitine hydrochloride, (+)-</to_name>
		<to_code>1539210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropyl betaine</to_name>
		<to_code>1311576</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cariprazine hydrochloride</to_name>
		<to_code>1721073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Calophyllum inophyllum leaf extract</to_name>
		<to_code>2550707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefadroxil monohydrate</to_name>
		<to_code>204175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloroform</to_name>
		<to_code>1362698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chondroitin 6-sulfate</to_name>
		<to_code>2268212</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefixime</to_name>
		<to_code>25033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopentamine</to_name>
		<to_code>59094</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium stearoyl lactylate</to_name>
		<to_code>1927023</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamic acid preparation</to_name>
		<to_code>1368649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefodizime</to_name>
		<to_code>20485</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric sulfate, basic copper sulfate dibasic</to_name>
		<to_code>2267037</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric glycinate</to_name>
		<to_code>1428217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crinecerfont</to_name>
		<to_code>2701386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnarizine</to_name>
		<to_code>2549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsicum frutescens whole extract</to_name>
		<to_code>1995615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopentolate hydrochloride</to_name>
		<to_code>106029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>colfosceril</to_name>
		<to_code>107784</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cirsium japonicum extract</to_name>
		<to_code>2570729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis melo extract</to_name>
		<to_code>1428847</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C10-18 triglycerides</to_name>
		<to_code>1312360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>camphor oil, white</to_name>
		<to_code>1735333</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caladium bicolor whole extract</to_name>
		<to_code>2533030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Caesalpinia bonduc whole extract</to_name>
		<to_code>2001813</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clesrovimab-cfor</to_name>
		<to_code>2716803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclobenzaprine hydrochloride</to_name>
		<to_code>52101</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C15-19 alkane</to_name>
		<to_code>2560236</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cerliponase</to_name>
		<to_code>1922437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloric acid</to_name>
		<to_code>1546391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>casimersen</to_name>
		<to_code>2480096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor Xa (recombinant), inactivated-zhzo</to_name>
		<to_code>2045125</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chymosin</to_name>
		<to_code>9248</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon flexuosus leaf extract</to_name>
		<to_code>2375828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carrot extract</to_name>
		<to_code>1428866</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clindamycin palmitate hydrochloride</to_name>
		<to_code>91075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocoa bean allergenic extract</to_name>
		<to_code>891721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysanthemum indicum whole extract</to_name>
		<to_code>2531556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cardiospermum halicacabum leaf extract</to_name>
		<to_code>2697963</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-40 alcohols (MP 79C)</to_name>
		<to_code>1650427</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Croton eluteria bark extract</to_name>
		<to_code>1673376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl octacosanoate</to_name>
		<to_code>1992516</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cholesterol</to_name>
		<to_code>2438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbetapentane citrate</to_name>
		<to_code>283547</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chloromethyl methyl ether</to_name>
		<to_code>1312362</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C20-22 alkyl phosphate</to_name>
		<to_code>1424674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylhydroxamic acid</to_name>
		<to_code>1307145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorobutanol hemihydrate</to_name>
		<to_code>1309399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa whole extract</to_name>
		<to_code>2048033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cystoseira tamariscifolia</to_name>
		<to_code>2607150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamedrine hydrochloride</to_name>
		<to_code>314557</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucurbita pepo whole extract</to_name>
		<to_code>1541717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clotrimazole</to_name>
		<to_code>2623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium pangamate</to_name>
		<to_code>1917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus aurantium seed extract</to_name>
		<to_code>2665348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cephaelis ipecacuanha preparation</to_name>
		<to_code>317824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corydalis turtschaninovii whole extract</to_name>
		<to_code>2001180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Colletotrichum coccodes allergenic extract</to_name>
		<to_code>1192729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cytisus scoparius whole extract</to_name>
		<to_code>2046115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaelirium luteum whole extract</to_name>
		<to_code>2712545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-10 phosphate</to_name>
		<to_code>1314342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus sinensis flower extract</to_name>
		<to_code>1373722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citraconate</to_name>
		<to_code>1435288</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylic-capric-linoleic triglyceride</to_name>
		<to_code>1376147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefpirome sulfate</to_name>
		<to_code>236104</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon schoenanthus oil</to_name>
		<to_code>1306146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cortisol succinate</to_name>
		<to_code>21651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-(4-chlorophenyl)-1-phenylethanol</to_name>
		<to_code>1740931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefditoren</to_name>
		<to_code>83682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cucumis sativus leaf extract</to_name>
		<to_code>1600137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium malate</to_name>
		<to_code>1421150</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coriander oil</to_name>
		<to_code>1309241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crovalimab</to_name>
		<to_code>2686619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Commiphora madagascariensis resin</to_name>
		<to_code>1368331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clobenzorex</to_name>
		<to_code>21244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat flea allergenic extract</to_name>
		<to_code>886638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coffea arabica fruit extract</to_name>
		<to_code>1311529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>candelilla wax powder</to_name>
		<to_code>1424679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citral propylene glycol acetal</to_name>
		<to_code>1812465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedrene</to_name>
		<to_code>2632411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronella oil</to_name>
		<to_code>1309376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefazolin sodium</to_name>
		<to_code>203171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Citrus maxima fruit rind oil</to_name>
		<to_code>1306154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clorophene</to_name>
		<to_code>21290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlormezanone</to_name>
		<to_code>2373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cydonia oblonga seed extract</to_name>
		<to_code>1307560</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteth-10</to_name>
		<to_code>1314341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Corymbia citriodora leaf oil</to_name>
		<to_code>1306137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coffea arabica whole extract</to_name>
		<to_code>2534457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia chekiangoleosa seed oil</to_name>
		<to_code>2590603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-15 alcohols</to_name>
		<to_code>1371310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cymbopogon nardus whole extract</to_name>
		<to_code>1797517</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cellulose, oxidized</to_name>
		<to_code>2481135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorhexidine acetate</to_name>
		<to_code>2359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cystine dihydrochloride</to_name>
		<to_code>2642207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chelidonium majus flowering top extract</to_name>
		<to_code>1435388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Carya laciniosa pollen extract</to_name>
		<to_code>1305551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cicloxilic acid</to_name>
		<to_code>21095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clotiazepam</to_name>
		<to_code>2622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium palmitate</to_name>
		<to_code>2637681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>careless weed pollen extract</to_name>
		<to_code>851926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coagulation factor X, human</to_name>
		<to_code>1426166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cathine polistirex</to_name>
		<to_code>236861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco-betaine</to_name>
		<to_code>1367422</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromous chloride</to_name>
		<to_code>21032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cannabinol</to_name>
		<to_code>1976</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chromic sulfate decahydrate</to_name>
		<to_code>2603481</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coniine</to_name>
		<to_code>1313334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centella asiatica leaf homeopathic preparation</to_name>
		<to_code>1307965</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ceanothus integerrimus whole extract</to_name>
		<to_code>2533845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crospovidone (12 MPA.S at 5%)</to_name>
		<to_code>1667764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetrimides</to_name>
		<to_code>2284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium</to_name>
		<to_code>1895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>costus root oil</to_name>
		<to_code>1309387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caspofungin acetate</to_name>
		<to_code>282363</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinchona pubescens bark extract</to_name>
		<to_code>1309667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-22</to_name>
		<to_code>1365710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cryptenamine</to_name>
		<to_code>42618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-2</to_name>
		<to_code>1545169</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cyperus prolifer whole extract</to_name>
		<to_code>2695984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>copper Cu-64</to_name>
		<to_code>2200143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocaine esterase</to_name>
		<to_code>2463110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium maculatum whole extract</to_name>
		<to_code>2001757</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpromazine hydrochloride</to_name>
		<to_code>104728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefpodoxime</to_name>
		<to_code>20489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclizine lactate</to_name>
		<to_code>91071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium chloride, dihydration</to_name>
		<to_code>221069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>collagen hemostat</to_name>
		<to_code>253161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crithmum maritimum extract</to_name>
		<to_code>1372010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chrysonilia sitophila allergenic extract</to_name>
		<to_code>314411</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-20 alkyl glucoside</to_name>
		<to_code>1424672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C18-38 alkyl hydroxystearoyl stearate</to_name>
		<to_code>2586024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Capsicum annuum whole extract</to_name>
		<to_code>1314843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorphenesin</to_name>
		<to_code>2399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalamin concentrate</to_name>
		<to_code>317216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chysanthellum indicum top extract</to_name>
		<to_code>1306203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cairina moshcata heart-liver preparation</to_name>
		<to_code>1311073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorite ion</to_name>
		<to_code>1546392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorhexidine hydrochloride</to_name>
		<to_code>2361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefaclor</to_name>
		<to_code>2176</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclosporine</to_name>
		<to_code>3008</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorophyllin copper complex</to_name>
		<to_code>82242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caprylyl glyceryl ether</to_name>
		<to_code>2382431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon bark</to_name>
		<to_code>477053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium citrate malate</to_name>
		<to_code>73409</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetostearyl alcohol</to_name>
		<to_code>1307840</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cardiospermum halicacabum flowering top extract</to_name>
		<to_code>1309968</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetylpyridinium chloride anhydrous</to_name>
		<to_code>1311527</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbimazole</to_name>
		<to_code>2020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12 olefin sulfonate</to_name>
		<to_code>1370652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cloperastine hydrochloride</to_name>
		<to_code>2104181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crospovidone (15 mpa.s at 5%)</to_name>
		<to_code>2109746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbomer</to_name>
		<to_code>235535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cricket allergenic extract</to_name>
		<to_code>973447</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>candelilla wax</to_name>
		<to_code>1311564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cetyl glyceryl ether</to_name>
		<to_code>2539030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cytisus scoparius flower extract</to_name>
		<to_code>1547555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Centaurea benedicta flowering top extract</to_name>
		<to_code>1435387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cranberry seed oil</to_name>
		<to_code>1306144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cedramber</to_name>
		<to_code>2584846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cullen corylifolium whole extract</to_name>
		<to_code>1808601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-2 phosphate</to_name>
		<to_code>1545168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropyl dimethylamine propionate</to_name>
		<to_code>1812567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cordia boissieri whole extract</to_name>
		<to_code>2562680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpropamide</to_name>
		<to_code>2404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric arsenite</to_name>
		<to_code>1311628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Canis lupus familiaris hair extract</to_name>
		<to_code>854025</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>croton oil</to_name>
		<to_code>1309665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cuscuta japonica seed extract</to_name>
		<to_code>1307742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyamemazine</to_name>
		<to_code>21877</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Coenochloris signiensis extract</to_name>
		<to_code>1947410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cadmium iodide</to_name>
		<to_code>1311081</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobalt sulfate</to_name>
		<to_code>1362742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cedrus atlantica bark extract</to_name>
		<to_code>1307594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chelidonium majus root extract</to_name>
		<to_code>1368151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefuroxime</to_name>
		<to_code>2194</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clomethiazole edisylate</to_name>
		<to_code>20802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cynanchum stauntonii root extract</to_name>
		<to_code>1595583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cannabigerolate</to_name>
		<to_code>2279519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>condoliase</to_name>
		<to_code>1546420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cocamidopropyl propylene glycol-dimonium chloride</to_name>
		<to_code>1595298</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclobarbital</to_name>
		<to_code>2978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crested dogstail pollen extract</to_name>
		<to_code>1484980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclizine tartrate</to_name>
		<to_code>235771</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>C12-14 pareth-12</to_name>
		<to_code>1313736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cipaglucosidase alfa</to_name>
		<to_code>2667433</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>caramiphen</to_name>
		<to_code>20191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cystine</to_name>
		<to_code>3036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum camphora resin</to_name>
		<to_code>1541730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>carbon dioxide</to_name>
		<to_code>2034</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Clematis vitalba top extract</to_name>
		<to_code>1309748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clenbuterol</to_name>
		<to_code>2580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Curcuma aromatica root extract</to_name>
		<to_code>2534440</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium bicarbonate</to_name>
		<to_code>1373352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceftolozane</to_name>
		<to_code>1597609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceruletide diethylamine</to_name>
		<to_code>20024</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cyclopentamine hydrochloride</to_name>
		<to_code>1300303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cat skin extract</to_name>
		<to_code>851949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>celiprolol hydrochloride</to_name>
		<to_code>203145</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>captopril</to_name>
		<to_code>1998</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cladosoprium cladosporioides allergenic extract</to_name>
		<to_code>995720</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chamaecyparis lawsoniana fruiting twig extract</to_name>
		<to_code>1923304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cannabis sativa pollen extract</to_name>
		<to_code>2002575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cefsulodin sodium</to_name>
		<to_code>267417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>citronellene lactone</to_name>
		<to_code>2281672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Camellia oil</to_name>
		<to_code>1306162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chrysanthemin extract</to_name>
		<to_code>1547623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chaetomium globosum allergenic extract</to_name>
		<to_code>466197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cephalothin sodium</to_name>
		<to_code>9860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>common hazel pollen extract</to_name>
		<to_code>1484979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cultivated rye grass pollen extract</to_name>
		<to_code>1014774</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>crospovidone</to_name>
		<to_code>1310706</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ceteareth-30</to_name>
		<to_code>1311623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cryptocarya agathophylla leaf oil</to_name>
		<to_code>1309329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cochlearia officinalis flowering top extract</to_name>
		<to_code>1309738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Cinnamomum verum whole extract</to_name>
		<to_code>1946396</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cycloadiphenine hydrochloride</to_name>
		<to_code>289372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>captan</to_name>
		<to_code>1368147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium lactate anhydrous</to_name>
		<to_code>2697131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cinnamon oil, bark</to_name>
		<to_code>1305634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>coco monoisopropanolamide</to_name>
		<to_code>1435283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>chlorpheniramine tannate</to_name>
		<to_code>221075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Crataegus monogyna leaf extract</to_name>
		<to_code>1745931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Chinese cinnamon oil</to_name>
		<to_code>1309337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cobaltous chloride hexahydrate</to_name>
		<to_code>1426883</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Conium maculatum fruit extract</to_name>
		<to_code>2053438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>cupric chloride</to_name>
		<to_code>21833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>clostebol acetate</to_name>
		<to_code>236522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>C [Preparations]</from_name>
		<from_code>N0000010585</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>calcium oxalate</to_name>
		<to_code>1485048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrimonium bromide</from_name>
		<from_code>288999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetrimonium Bromide</to_name>
		<to_code>M0308521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coxiella burnetii</from_name>
		<from_code>1432987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coxiella burnetii</to_name>
		<to_code>M0025830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canrenone</from_name>
		<from_code>1982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Canrenone</to_name>
		<to_code>M0003283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cifenline</from_name>
		<from_code>21099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cifenline</to_name>
		<to_code>M0100508</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cordycepin</from_name>
		<from_code>1989289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cordycepin</to_name>
		<to_code>M0162242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulose sulfate</from_name>
		<from_code>2642135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cellulose sulfate</to_name>
		<to_code>M0073824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbaryl</from_name>
		<from_code>9724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbaryl</to_name>
		<to_code>M0019707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clostridium botulinum</from_name>
		<from_code>1811178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium botulinum</to_name>
		<to_code>M0004636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caprolactone</from_name>
		<from_code>1998122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>caprolactone</to_name>
		<to_code>M0333785</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citronellyl acetate</from_name>
		<from_code>2056062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citronellyl acetate</to_name>
		<to_code>M0121489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corticotropin-releasing hormone</from_name>
		<from_code>214461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Corticotropin-Releasing Hormone</to_name>
		<to_code>M0005218</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofezone</from_name>
		<from_code>183877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clofezone</to_name>
		<to_code>M0198302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cola acuminata seed extract</from_name>
		<from_code>1307595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cucumis sativus fruit extract</from_name>
		<from_code>2700058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholate</from_name>
		<from_code>1426483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholate</to_name>
		<to_code>M0029992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clascoterone</from_name>
		<from_code>2474340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clascoterone</to_name>
		<to_code>M000675722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetromonium methosulfate</from_name>
		<from_code>2056289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetrimonium Methyl Sulfate</to_name>
		<to_code>M0308522</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clove Oil</to_name>
		<to_code>M0007942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove oil</from_name>
		<from_code>7624</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceramide 6 II</from_name>
		<from_code>1314307</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-(alpha-hydroxyoctadecanoyl)phytosphingosine</to_name>
		<to_code>M0490181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium polycarbophil</to_name>
		<to_code>M0095966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polycarbophil</from_name>
		<from_code>20063</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis, Colonic</to_name>
		<to_code>M0006631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>glucomannan</from_name>
		<from_code>11454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diverticulitis, Colonic</to_name>
		<to_code>M0006631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coumarin</from_name>
		<from_code>2898</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>coumarin</to_name>
		<to_code>M0095579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carminic acid</from_name>
		<from_code>1368643</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carminic Acid</to_name>
		<to_code>M000613705</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citiolone</from_name>
		<from_code>21171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citiolone</to_name>
		<to_code>M0040624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clothianidin</from_name>
		<from_code>2665345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clothianidin</to_name>
		<to_code>M0458704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canthaxanthin</from_name>
		<from_code>42348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Canthaxanthin</to_name>
		<to_code>M0025364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capromab pendetide</from_name>
		<from_code>136300</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Capromab Pendetide</to_name>
		<to_code>M0265650</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium bromide</from_name>
		<from_code>195983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium bromide</to_name>
		<to_code>M0292053</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol</from_name>
		<from_code>2348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin anhydrous</from_name>
		<from_code>1546025</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin</from_name>
		<from_code>139462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G sodium</from_name>
		<from_code>9900</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone</from_name>
		<from_code>2193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G potassium</from_name>
		<from_code>203133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceftriaxone sodium</from_name>
		<from_code>203172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride</from_name>
		<from_code>228750</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin</from_name>
		<from_code>228476</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G</from_name>
		<from_code>7980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nalidixic acid</from_name>
		<from_code>7240</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sparfloxacin</from_name>
		<from_code>18469</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gatifloxacin hemihydrate</from_name>
		<from_code>1999763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Penicillin</from_name>
		<from_code>70618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime</from_name>
		<from_code>2186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hetacillin potassium</from_name>
		<from_code>1299048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin</from_name>
		<from_code>82122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefotaxime sodium</from_name>
		<from_code>203117</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin trihydrate</from_name>
		<from_code>203115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone sodium</from_name>
		<from_code>227214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin sodium</from_name>
		<from_code>81953</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceforanide</from_name>
		<from_code>20486</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ofloxacin</from_name>
		<from_code>7623</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefoperazone</from_name>
		<from_code>2184</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin</from_name>
		<from_code>733</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G benzathine</from_name>
		<from_code>7982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin hydrochloride</from_name>
		<from_code>327584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ampicillin (anhydrous)</from_name>
		<from_code>221058</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin G procaine</from_name>
		<from_code>7983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>moxifloxacin hydrochloride monohydrate</from_name>
		<from_code>1926505</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacampicillin</from_name>
		<from_code>18687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levofloxacin anhydrous</from_name>
		<from_code>1546009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Salmonella Infections</to_name>
		<to_code>M0019393</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramphenicol palmitate</to_name>
		<to_code>M0096609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol palmitate</from_name>
		<from_code>20767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V benzathine</from_name>
		<from_code>18926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V</from_name>
		<from_code>7984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem</from_name>
		<from_code>29561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine</from_name>
		<from_code>10171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V potassium</from_name>
		<from_code>203195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifampin</from_name>
		<from_code>9384</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>penicillin V calcium</from_name>
		<from_code>236517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>meropenem anhydrous</from_name>
		<from_code>1546029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfadiazine sodium</from_name>
		<from_code>220087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Meningitis, Meningococcal</to_name>
		<to_code>M0013369</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramphenicol succinate sodium</to_name>
		<to_code>M0316637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol sodium succinate</from_name>
		<from_code>47998</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline calcium</from_name>
		<from_code>82065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline hydrochloride</from_name>
		<from_code>142446</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline dihydrate</from_name>
		<from_code>266974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline anhydrous</from_name>
		<from_code>1545999</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline trihydrate</from_name>
		<from_code>236873</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline phosphate complex</from_name>
		<from_code>2105975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline</from_name>
		<from_code>7821</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tetracycline</from_name>
		<from_code>10395</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxytetracycline hydrochloride</from_name>
		<from_code>4780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia Infections</to_name>
		<to_code>M0019098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol stearate</from_name>
		<from_code>20768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramphenicol stearate</to_name>
		<to_code>M0100175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramphenicol succinate</from_name>
		<from_code>20769</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramphenicol succinate</to_name>
		<to_code>M0085881</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carzenide</from_name>
		<from_code>20355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carzenide</to_name>
		<to_code>M0042315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium aluminosilicate</from_name>
		<from_code>1313228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Aluminosilicate</to_name>
		<to_code>M000606823</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carrot allergenic extract</from_name>
		<from_code>892368</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clonixin</from_name>
		<from_code>2601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clonixin</to_name>
		<to_code>M0004617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chamomile flower oil</from_name>
		<from_code>1309221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chamomile Oil</to_name>
		<to_code>M0329026</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincomycin</to_name>
		<to_code>M0012521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clindamycin palmitate</to_name>
		<to_code>M0040632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Actinomycetales Infections</to_name>
		<to_code>M0000289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate</from_name>
		<from_code>21235</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincomycin</to_name>
		<to_code>M0012521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincomycin</to_name>
		<to_code>M0012521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincomycin</to_name>
		<to_code>M0012521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lincomycin</from_name>
		<from_code>6398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincomycin</to_name>
		<to_code>M0012521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincomycin</to_name>
		<to_code>M0012521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Actinomycetales Infections</to_name>
		<to_code>M0000289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clindamycin phosphate</to_name>
		<to_code>M0050042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin phosphate</from_name>
		<from_code>797272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincosamides</to_name>
		<to_code>M0515779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Actinomycetales Infections</to_name>
		<to_code>M0000289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Actinomycetales Infections</to_name>
		<to_code>M0000289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Actinomycetales Infections</to_name>
		<to_code>M0000289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincosamides</to_name>
		<to_code>M0515779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin hydrochloride</from_name>
		<from_code>81982</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clindamycin Hydrochloride</to_name>
		<to_code>M0004562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin</from_name>
		<from_code>11124</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin zinc</from_name>
		<from_code>11417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole</from_name>
		<from_code>6922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide hydrochloride</from_name>
		<from_code>82038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin</from_name>
		<from_code>1291</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin hydrochloride</from_name>
		<from_code>235373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate</from_name>
		<from_code>3500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole benzoate</from_name>
		<from_code>103866</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>difenoxin</from_name>
		<from_code>23024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metronidazole hydrochloride</from_name>
		<from_code>82047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>loperamide</from_name>
		<from_code>6468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin</from_name>
		<from_code>2582</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fidaxomicin</from_name>
		<from_code>1111103</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bacitracin A</from_name>
		<from_code>1986366</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenoxylate hydrochloride</from_name>
		<from_code>82005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vancomycin hydrochloride</from_name>
		<from_code>66955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Enterocolitis, Pseudomembranous</to_name>
		<to_code>M0007479</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Lincosamides</to_name>
		<to_code>M0515779</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clindamycin palmitate hydrochloride</from_name>
		<from_code>91075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clindamycin palmitate hydrochloride</to_name>
		<to_code>M0307448</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein allergenic extract</from_name>
		<from_code>862460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>casein allergenic extract</from_name>
		<from_code>862460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Caseins</to_name>
		<to_code>M0003590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caseins</from_name>
		<from_code>1440974</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Caseins</to_name>
		<to_code>M0003590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chocolate allergenic extract</from_name>
		<from_code>1010915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium stearate</from_name>
		<from_code>47633</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium stearate</to_name>
		<to_code>M0098167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cajanius cajan leaf extract</from_name>
		<from_code>1421433</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cajanus cajan leaf</to_name>
		<to_code>M000745616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucurbitacin B</from_name>
		<from_code>2688460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cucurbitacin B</to_name>
		<to_code>M0122413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cajuput oil</from_name>
		<from_code>1309211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cajuput oil</to_name>
		<to_code>M0214200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrimonium</from_name>
		<from_code>20614</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetrimonium</to_name>
		<to_code>M000640323</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramine-T</from_name>
		<from_code>20762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramine-T</to_name>
		<to_code>M0066217</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor (recombinant)</from_name>
		<from_code>1599831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>conestat alfa</to_name>
		<to_code>M0572376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorobutanol</from_name>
		<from_code>2378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlorobutanol</to_name>
		<to_code>M0004163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenoxolone sodium</from_name>
		<from_code>2018</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbenoxolone Sodium</to_name>
		<to_code>M0003343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citral</from_name>
		<from_code>1362890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citral</to_name>
		<to_code>M0050030</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclohexane</from_name>
		<from_code>1367180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclohexane</to_name>
		<to_code>M0005468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon disulfide</from_name>
		<from_code>1311478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbon Disulfide</to_name>
		<to_code>M0003370</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorous acid</from_name>
		<from_code>1543755</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorous acid</to_name>
		<to_code>M0174466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clostebol</from_name>
		<from_code>61686</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clostebol</to_name>
		<to_code>M0206366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclonium</from_name>
		<from_code>21993</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclonium</to_name>
		<to_code>M0092870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromonar hydrochloride</from_name>
		<from_code>81980</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chromonar Hydrochloride</to_name>
		<to_code>M0330662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida torresii</from_name>
		<from_code>1343912</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candida torresii</to_name>
		<to_code>M000691585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper carbonate</from_name>
		<from_code>1427055</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>copper carbonate</to_name>
		<to_code>M0228709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromic chloride</from_name>
		<from_code>21009</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromic chloride</to_name>
		<to_code>M0079730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara scolymus leaf extract</from_name>
		<from_code>1322547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>artichoke leaf</to_name>
		<to_code>M000743826</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyl oleate</from_name>
		<from_code>1306182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>palmityl oleate</to_name>
		<to_code>M0355299</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Citrobacter koseri</from_name>
		<from_code>1544937</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Citrobacter koseri</to_name>
		<to_code>M0425449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cesium</from_name>
		<from_code>1310121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cesium</to_name>
		<to_code>M0003950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline chloride</from_name>
		<from_code>1425426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Choline Chloride</to_name>
		<to_code>M0004285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadmium</from_name>
		<from_code>1362694</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cadmium</to_name>
		<to_code>M0003131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromoglycate</from_name>
		<from_code>2921</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cromoglycate</to_name>
		<to_code>M0006575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinametic acid</from_name>
		<from_code>21113</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinametic acid</to_name>
		<to_code>M0050015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulose sodium phosphate</from_name>
		<from_code>342965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>sodium cellulose phosphate</to_name>
		<to_code>M0442668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cafedrine</from_name>
		<from_code>47589</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cafedrine</to_name>
		<to_code>M0043472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclomethycaine</from_name>
		<from_code>21990</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclomethycaine</to_name>
		<to_code>M0061252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroacetic acid</from_name>
		<from_code>2374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloroacetic acid</to_name>
		<to_code>M0049836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polysulfide</from_name>
		<from_code>2256949</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lime sulfur</to_name>
		<to_code>M0051992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopentanone</from_name>
		<from_code>2557363</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclopentanone</to_name>
		<to_code>M0050237</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclodrine</from_name>
		<from_code>1855092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclodrine</to_name>
		<to_code>M0043660</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canrenoate potassium</from_name>
		<from_code>1981</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Canrenoate Potassium</to_name>
		<to_code>M0003281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pyrophosphate</from_name>
		<from_code>1362901</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Pyrophosphate</to_name>
		<to_code>M0003179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamedrine</from_name>
		<from_code>21130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamedrine</to_name>
		<to_code>M0108580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans allergenic extract</from_name>
		<from_code>214355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium propionate</from_name>
		<from_code>1426453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium propionate</to_name>
		<to_code>M0094456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorthenoxazin</from_name>
		<from_code>20891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorthenoxazin</to_name>
		<to_code>M0049957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway seed allergenic extract</from_name>
		<from_code>899637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorokojic acid</from_name>
		<from_code>2199653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-chloromethyl-5-hydroxy-4-pyranone</to_name>
		<to_code>M0300501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasone butyrate</from_name>
		<from_code>21246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clobetasone butyrate</to_name>
		<to_code>M0056773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>castor oil</from_name>
		<from_code>2129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Castor Oil</to_name>
		<to_code>M0003604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anhydrous tacrolimus</from_name>
		<from_code>235991</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Castor Oil</to_name>
		<to_code>M0003604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus monohydrate</from_name>
		<from_code>484288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Castor Oil</to_name>
		<to_code>M0003604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tacrolimus</from_name>
		<from_code>42316</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Castor Oil</to_name>
		<to_code>M0003604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>valrubicin</from_name>
		<from_code>31435</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Castor Oil</to_name>
		<to_code>M0003604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida parapsilosis</from_name>
		<from_code>1310914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Candida parapsilosis</to_name>
		<to_code>M000626565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceteareth 20</from_name>
		<from_code>1311619</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetomacrogol 1000</to_name>
		<to_code>M0003966</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetearyl glucoside</from_name>
		<from_code>1425219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetearyl glucoside</to_name>
		<to_code>M0537714</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>catalase</from_name>
		<from_code>2133</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catalase</to_name>
		<to_code>M0003613</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocamidopropyl hydroxysultaine</from_name>
		<from_code>1363593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cocamidopropyl hydroxysultaine</to_name>
		<to_code>M0366635</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclomethicone</from_name>
		<from_code>1307080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclomethicone</to_name>
		<to_code>M0468417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cardiotoxin III, Naja naja atra</from_name>
		<from_code>2043924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cardiotoxin III, Naja naja atra</to_name>
		<to_code>M0219088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caraway oil</from_name>
		<from_code>1309373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>caraway oil</to_name>
		<to_code>M0272984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline magnesium trisalicylate</from_name>
		<from_code>215799</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>choline magnesium trisalicylate</to_name>
		<to_code>M0069124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>croconazole</from_name>
		<from_code>21753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>croconazole</to_name>
		<to_code>M0114646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canrenoic acid</from_name>
		<from_code>81971</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Canrenoic Acid</to_name>
		<to_code>M0330907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytosine</from_name>
		<from_code>1372540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytosine</to_name>
		<to_code>M0005618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbocysteine-lysine</from_name>
		<from_code>1427149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbocysteine-lysine</to_name>
		<to_code>M0107349</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coagulation factor IX recombinant immunoglobulin G1 fusion protein</from_name>
		<from_code>1535944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>eftrenonacog alfa</to_name>
		<to_code>M000634510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Campylobacter jejuni</from_name>
		<from_code>1435992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Campylobacter jejuni</to_name>
		<to_code>M0024627</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormadinone</from_name>
		<from_code>78904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlormadinone</to_name>
		<to_code>M0330629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cabbage allergenic extract</from_name>
		<from_code>899398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Citalopram</to_name>
		<to_code>M0023529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram</from_name>
		<from_code>2556</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin acetate</from_name>
		<from_code>236302</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin</from_name>
		<from_code>5514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxocobalamin hydrochloride</from_name>
		<from_code>1947247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vitamin B12</from_name>
		<from_code>11248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>becaplermin</from_name>
		<from_code>115238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capsaicin</from_name>
		<from_code>1992</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine hydrochloride</from_name>
		<from_code>142138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine</from_name>
		<from_code>72625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mecobalamin</from_name>
		<from_code>29421</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum extract</from_name>
		<from_code>319780</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pentoxifylline</from_name>
		<from_code>8013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mexiletine</from_name>
		<from_code>6926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>duloxetine hydrochloride</from_name>
		<from_code>476250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Capsicum oleoresin</from_name>
		<from_code>235787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diabetic Neuropathies</to_name>
		<to_code>M0006162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citalopram hydrobromide</from_name>
		<from_code>221078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Citalopram Hydrobromide</to_name>
		<to_code>M000643213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzgalantamine gluconate</from_name>
		<from_code>2690626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzgalantamine</from_name>
		<from_code>2690627</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benperidol</from_name>
		<from_code>1373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risperidone</from_name>
		<from_code>35636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lecanemab</from_name>
		<from_code>2626143</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lecanemab-irmb</from_name>
		<from_code>2626142</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dementia</to_name>
		<to_code>M0005797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>anisindione</from_name>
		<from_code>17941</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dicumarol</from_name>
		<from_code>1598</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine besylate</from_name>
		<from_code>203186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate</from_name>
		<from_code>82819</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mesoridazine</from_name>
		<from_code>6779</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phenprocoumon</from_name>
		<from_code>8150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride</from_name>
		<from_code>203148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron hydrochloride anhydrous</from_name>
		<from_code>2119176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna alkaloids</from_name>
		<from_code>1359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin sodium</from_name>
		<from_code>114194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin potassium</from_name>
		<from_code>82118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna leaf extract</from_name>
		<from_code>314517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone</from_name>
		<from_code>7243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>warfarin</from_name>
		<from_code>11289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>naltrexone hydrochloride</from_name>
		<from_code>105069</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ondansetron</from_name>
		<from_code>26225</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloserine</from_name>
		<from_code>3007</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>disulfiram</from_name>
		<from_code>3554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eluxadoline</from_name>
		<from_code>1653781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acamprosate calcium</from_name>
		<from_code>152761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Alcoholism</to_name>
		<to_code>M0000661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norelgestromin</from_name>
		<from_code>326374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrochloride</from_name>
		<from_code>203204</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion</from_name>
		<from_code>42347</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>etonogestrel</from_name>
		<from_code>14584</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>norgestimate</from_name>
		<from_code>31994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine</from_name>
		<from_code>7407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>drospirenone</from_name>
		<from_code>11636</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nicotine polacrilex</from_name>
		<from_code>31765</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levonorgestrel</from_name>
		<from_code>6373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bupropion hydrobromide</from_name>
		<from_code>993548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mestranol</from_name>
		<from_code>6782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desogestrel</from_name>
		<from_code>22656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Tobacco Use Disorder</to_name>
		<to_code>M0021604</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyprodenate</from_name>
		<from_code>22051</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyprodenate</to_name>
		<to_code>M0040042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chaste tree preparation</from_name>
		<from_code>236664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chaste tree fruit</to_name>
		<to_code>M000743805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cifostodine</from_name>
		<from_code>2477852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cifostodine</to_name>
		<to_code>M0071682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorproethazine hydrochloride</from_name>
		<from_code>236297</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorproethazine hydrochloride</to_name>
		<to_code>M0323426</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clavulanate Potassium</to_name>
		<to_code>M0329136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Lactams</to_name>
		<to_code>M0012144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate potassium</from_name>
		<from_code>831418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>doripenem</from_name>
		<from_code>119771</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Lactams</to_name>
		<to_code>M0012144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Lactams</to_name>
		<to_code>M0012144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>beta-Lactams</to_name>
		<to_code>M0012144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanate</from_name>
		<from_code>48203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clavulanate</to_name>
		<to_code>M0372713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol</from_name>
		<from_code>2685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholestyramine resin</from_name>
		<from_code>2447</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam</from_name>
		<from_code>141626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colestipol hydrochloride</from_name>
		<from_code>104485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colesevelam hydrochloride</from_name>
		<from_code>141625</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cholestasis, Extrahepatic</to_name>
		<to_code>M0002480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clavulanic acid</from_name>
		<from_code>21216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clavulanic Acid</to_name>
		<to_code>M0029416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium dioxide</from_name>
		<from_code>1312546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromium dioxide</to_name>
		<to_code>M0150875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobamamide</from_name>
		<from_code>21373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cobamamide</to_name>
		<to_code>M0040899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteine</from_name>
		<from_code>3024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cysteine</to_name>
		<to_code>M0005539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfide</from_name>
		<from_code>90521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium sulfide</to_name>
		<to_code>M0104899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabigerolic acid</from_name>
		<from_code>2279518</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cannabigerolic acid</to_name>
		<to_code>M0264172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate, hemihydrate</from_name>
		<from_code>1310466</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Sulfate, Hemihydrate</to_name>
		<to_code>M0003190</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobaltous nitrate</from_name>
		<from_code>1423923</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cobaltous nitrate</to_name>
		<to_code>M0085674</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproterone</from_name>
		<from_code>3014</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyproterone</to_name>
		<to_code>M0005524</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium borogluconate</from_name>
		<from_code>1370420</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>borogluconate, calcium salt</to_name>
		<to_code>M0320063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creatine ethyl ester</from_name>
		<from_code>2058850</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>creatine ethyl ester</to_name>
		<to_code>M0537707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphoric acid 1-methyl ester</from_name>
		<from_code>30193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>camphoric acid 1-methyl ester</to_name>
		<to_code>M0374750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed oil</from_name>
		<from_code>1309243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cottonseed Oil</to_name>
		<to_code>M0005252</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclohexanone</from_name>
		<from_code>2362166</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclohexanone</to_name>
		<to_code>M0111080</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creosote</from_name>
		<from_code>2915</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Creosote</to_name>
		<to_code>M0005306</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clodronic acid</from_name>
		<from_code>3350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clodronic Acid</to_name>
		<to_code>M0006270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cytisine</from_name>
		<from_code>1723152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cytisine</to_name>
		<to_code>M0045860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cathine</from_name>
		<from_code>32022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cathine</to_name>
		<to_code>M000633814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cathine</from_name>
		<from_code>32022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>norpseudoephedrine</to_name>
		<to_code>M0046817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ciprofibrate</from_name>
		<from_code>21149</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ciprofibrate</to_name>
		<to_code>M0071666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chrysin</from_name>
		<from_code>1362888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chrysin</to_name>
		<to_code>M0128116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadmium sulfate</from_name>
		<from_code>1368145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cadmium sulfate</to_name>
		<to_code>M0112534</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramine-T anhydrous</from_name>
		<from_code>1593148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramine-T anhydrous</to_name>
		<to_code>M000620351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoyl isethionate</from_name>
		<from_code>1366840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cocoyl isethionate</to_name>
		<to_code>M0332849</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citrulline malate</from_name>
		<from_code>2707558</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citrulline malate</to_name>
		<to_code>M0193424</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carob allergenic extract</from_name>
		<from_code>904498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coco diethanolamide</from_name>
		<from_code>1305724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>coconut diethanolamide</to_name>
		<to_code>M0114664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chamaemelum nobile flower extract</from_name>
		<from_code>1306194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chamomillae romanae flos</to_name>
		<to_code>M000743814</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn oil</from_name>
		<from_code>2854</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Corn Oil</to_name>
		<to_code>M0005174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesteryl sulfate</from_name>
		<from_code>1366924</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cholesteryl sulfate</to_name>
		<to_code>M0049977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium oxide</from_name>
		<from_code>1363045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromic oxide</to_name>
		<to_code>M0081017</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon monoxide</from_name>
		<from_code>2037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbon Monoxide</to_name>
		<to_code>M0003372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloperastine</from_name>
		<from_code>2104180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cloperastine</to_name>
		<to_code>M0120036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloperastine</from_name>
		<from_code>2104180</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cough</to_name>
		<to_code>M0005255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulase</from_name>
		<from_code>2219</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cellulase</to_name>
		<to_code>M0003782</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbomer-934</from_name>
		<from_code>1307830</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbomer-934</to_name>
		<to_code>M0049742</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clebopride</from_name>
		<from_code>21224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clebopride</to_name>
		<to_code>M0062933</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calomel</from_name>
		<from_code>1311098</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calomel</to_name>
		<to_code>M0065215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinitapride</from_name>
		<from_code>21125</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinitapride</to_name>
		<to_code>M0131853</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>catechin</from_name>
		<from_code>1367177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Catechin</to_name>
		<to_code>M0003638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloropyramine</from_name>
		<from_code>20861</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloropyramine</to_name>
		<to_code>M0045806</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagen type I</from_name>
		<from_code>1426856</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagen Type I</to_name>
		<to_code>M0004788</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium formate</from_name>
		<from_code>1362747</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>formic acid, calcium salt</to_name>
		<to_code>M0318890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbutamide</from_name>
		<from_code>2068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbutamide</to_name>
		<to_code>M0003414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chrysosplenetin</from_name>
		<from_code>1545792</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chrysosplenetin</to_name>
		<to_code>M0571122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corydine</from_name>
		<from_code>2593178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>corydine</to_name>
		<to_code>M0184617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefonicid monosodium</from_name>
		<from_code>266801</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cefonicid Monosodium</to_name>
		<to_code>M0329459</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camylofine</from_name>
		<from_code>20136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>camylofine</to_name>
		<to_code>M0045767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium Cr-51</from_name>
		<from_code>1306065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chromium-51</to_name>
		<to_code>M000627901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carpipramine</from_name>
		<from_code>20342</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carpipramine</to_name>
		<to_code>M0049776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citrus pectin</from_name>
		<from_code>581398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citrus pectin</to_name>
		<to_code>M0592144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbocysteine</from_name>
		<from_code>2023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbocysteine</to_name>
		<to_code>M0003348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capromorelin</from_name>
		<from_code>1986787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Capromorelin</to_name>
		<to_code>M0451668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobutinol</from_name>
		<from_code>21247</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clobutinol</to_name>
		<to_code>M0067642</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline citrate</from_name>
		<from_code>2453</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Choline Citrate</to_name>
		<to_code>M0004286</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>celery allergenic extract</from_name>
		<from_code>892372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline bitartrate</from_name>
		<from_code>2451</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Choline Bitartrate</to_name>
		<to_code>M0004284</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caryophyllene</from_name>
		<from_code>1368148</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>caryophyllene</to_name>
		<to_code>M0083228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chlamydia trachomatis</from_name>
		<from_code>1318474</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydia trachomatis</to_name>
		<to_code>M0004109</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coxsackieviruses B</from_name>
		<from_code>1668274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coxsackieviruses B</to_name>
		<to_code>M0005271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofoctol</from_name>
		<from_code>21264</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clofoctol</to_name>
		<to_code>M0070859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clostridium perfringens</from_name>
		<from_code>1318475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridium perfringens</to_name>
		<to_code>M0004638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorocresol</from_name>
		<from_code>20823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorocresol</to_name>
		<to_code>M0049862</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorocresol</from_name>
		<from_code>20823</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-methyl-4-chlorophenol</to_name>
		<to_code>M0504456</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinidon-ethyl</from_name>
		<from_code>2472310</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinidon-ethyl</to_name>
		<to_code>M0507983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium nicotinic acid complex</from_name>
		<from_code>137732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromium nicotinic acid complex</to_name>
		<to_code>M0269164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clofexamide</from_name>
		<from_code>21255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clofexamide</to_name>
		<to_code>M0045822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbromal</from_name>
		<from_code>2067</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbromal</to_name>
		<to_code>M0225268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citronellic acid</from_name>
		<from_code>2693285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citronellic acid</to_name>
		<to_code>M0523579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clinoptilolite</from_name>
		<from_code>2624891</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clinoptilolite</to_name>
		<to_code>M0221376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadmium chloride</from_name>
		<from_code>1863268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cadmium Chloride</to_name>
		<to_code>M0028677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclodextrins</from_name>
		<from_code>1426609</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclodextrins</to_name>
		<to_code>M0005463</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coffee bean allergenic extract</from_name>
		<from_code>891727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclohexanol</from_name>
		<from_code>2099711</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclohexanol</to_name>
		<to_code>M0005470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cesium chloride</from_name>
		<from_code>20599</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cesium chloride</to_name>
		<to_code>M0090602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromocarb diethylamine</from_name>
		<from_code>48064</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromocarb diethylamine</to_name>
		<to_code>M0098532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chickpea allergenic extract</from_name>
		<from_code>1011049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crocin</from_name>
		<from_code>2262278</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>crocin</to_name>
		<to_code>M0092917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>californium</from_name>
		<from_code>2571855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Californium</to_name>
		<to_code>M0003203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carboxypolymethylene</from_name>
		<from_code>20298</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carboxypolymethylene</to_name>
		<to_code>M0049756</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>croscarmellose sodium</from_name>
		<from_code>1310573</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Croscarmellose Sodium</to_name>
		<to_code>M0545273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper sulfate</from_name>
		<from_code>21579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper Sulfate</to_name>
		<to_code>M0028776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesteryl chloride</from_name>
		<from_code>1606197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-chlorocholest-5-ene</to_name>
		<to_code>M0166975</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clebopride maleate</from_name>
		<from_code>236701</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clebopride maleate</to_name>
		<to_code>M0424314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cystamine</from_name>
		<from_code>1426401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystamine</to_name>
		<to_code>M0005528</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chitosan</from_name>
		<from_code>59038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chitosan</to_name>
		<to_code>M0049825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chitosan medium molecular weight (200-800 MPA.S)</from_name>
		<from_code>1368152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chitosan</to_name>
		<to_code>M0049825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clodronate disodium</from_name>
		<from_code>1546871</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clodronate Disodium</to_name>
		<to_code>M0475707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamate</from_name>
		<from_code>1368650</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cinnamates</to_name>
		<to_code>M0004490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric citrate</from_name>
		<from_code>2394040</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>copper(II) citrate</to_name>
		<to_code>M0289798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crataegus extract</from_name>
		<from_code>21716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crataegus fruit</to_name>
		<to_code>M000744669</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium hydroxide</from_name>
		<from_code>1910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Hydroxide</to_name>
		<to_code>M0003172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycrimine</from_name>
		<from_code>22037</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cycrimine</to_name>
		<to_code>M0059182</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobutinol hydrochloride</from_name>
		<from_code>235956</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clobutinol hydrochloride</to_name>
		<to_code>M0424329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobaltous chloride</from_name>
		<from_code>1426884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cobaltous chloride</to_name>
		<to_code>M0069227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine</from_name>
		<from_code>1667655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cariprazine</to_name>
		<to_code>M0527151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorocitric acid</from_name>
		<from_code>2462207</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorocitric acid</to_name>
		<to_code>M0102439</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagen</from_name>
		<from_code>2714</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagen</to_name>
		<to_code>M0004775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagen type I, bovine</from_name>
		<from_code>1426855</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagen</to_name>
		<to_code>M0004775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clostridioides difficile</from_name>
		<from_code>1534764</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clostridioides difficile</to_name>
		<to_code>M0025018</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium monofluorophosphate</from_name>
		<from_code>2463340</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium monofluorophosphate</to_name>
		<to_code>M0060389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>climbazole</from_name>
		<from_code>191566</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>climbazole</to_name>
		<to_code>M0281379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbarson</from_name>
		<from_code>20206</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbarson</to_name>
		<to_code>M0102609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-chloronaphthalene</from_name>
		<from_code>2673865</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-chloronaphthalene</to_name>
		<to_code>M0098543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citicoline</from_name>
		<from_code>997602</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cytidine Diphosphate Choline</to_name>
		<to_code>M0005571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>CJC-1295</from_name>
		<from_code>1805005</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>CJC 1295</to_name>
		<to_code>M0487015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric nitrate</from_name>
		<from_code>2371954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>copper(II) nitrate</to_name>
		<to_code>M0505839</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chalcone</from_name>
		<from_code>2592960</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chalcone</to_name>
		<to_code>M0003983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cysteine hydrochloride</from_name>
		<from_code>221086</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cysteine Hydrochloride</to_name>
		<to_code>M0333361</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadmium sulfide</from_name>
		<from_code>1368199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cadmium sulfide</to_name>
		<to_code>M0107366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbomer-940</from_name>
		<from_code>1362909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbopol 940</to_name>
		<to_code>M0049747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cauliflower allergenic extract</from_name>
		<from_code>899661</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorfenethazine</from_name>
		<from_code>20785</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorfenethazine</to_name>
		<to_code>M0043566</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>curdlan</from_name>
		<from_code>1313047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>curdlan</to_name>
		<to_code>M0115736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cresatin</from_name>
		<from_code>21732</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cresatin</to_name>
		<to_code>M0064108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cascara sagrada</from_name>
		<from_code>66869</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cascara Sagrada</to_name>
		<to_code>M0003578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Frangula purshiana bark extract</from_name>
		<from_code>1350209</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cascara Sagrada</to_name>
		<to_code>M0003578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlophedianol</from_name>
		<from_code>21254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clofedanol</to_name>
		<to_code>M0055935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creatinine</from_name>
		<from_code>2913</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Creatinine</to_name>
		<to_code>M0005300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrimide</from_name>
		<from_code>288088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetrimide</to_name>
		<to_code>M0045340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper EDTA</from_name>
		<from_code>1366888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Copper EDTA</to_name>
		<to_code>M0007063</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlormadinone acetate</from_name>
		<from_code>2369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlormadinone Acetate</to_name>
		<to_code>M0004147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium threonate</from_name>
		<from_code>273888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium threonate</to_name>
		<to_code>M0350297</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefonicid</from_name>
		<from_code>2183</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cefonicid</to_name>
		<to_code>M0024188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cuprous chloride</from_name>
		<from_code>1423796</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cuprous chloride</to_name>
		<to_code>M0091501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin</from_name>
		<from_code>78903</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Capreomycin</to_name>
		<to_code>M0003304</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citrulline</from_name>
		<from_code>2567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Citrulline</to_name>
		<to_code>M0004523</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cuprous oxide</from_name>
		<from_code>21842</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cuprous oxide</to_name>
		<to_code>M0040693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortivazol</from_name>
		<from_code>21660</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cortivazol</to_name>
		<to_code>M0047799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium carbimide</from_name>
		<from_code>1902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Carbimide</to_name>
		<to_code>M0330580</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium fluoride</from_name>
		<from_code>1905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Fluoride</to_name>
		<to_code>M0003170</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil</from_name>
		<from_code>1309229</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbomer homopolymer type B (allyl pentaerythritol or allyl sucrose crosslinked)</from_name>
		<from_code>1732380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbomer 934p</to_name>
		<to_code>M0049740</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chymopapain</from_name>
		<from_code>2525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chymopapain</to_name>
		<to_code>M0004458</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric acetate</from_name>
		<from_code>1311216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cupric acetate</to_name>
		<to_code>M0064113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cicletanine hydrochloride</from_name>
		<from_code>235874</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cicletanine hydrochloride</to_name>
		<to_code>M0478416</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cypermethrin</from_name>
		<from_code>2590266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cypermethrin</to_name>
		<to_code>M0067698</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyllin</from_name>
		<from_code>20852</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorophyllin</to_name>
		<to_code>M0049930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyllin copper complex</from_name>
		<from_code>82242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorophyllin</to_name>
		<to_code>M0049930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carpipramine dihydrochloride</from_name>
		<from_code>289326</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carpipramine dihydrochloride</to_name>
		<to_code>M0309749</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloadiphenine</from_name>
		<from_code>21945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cycloadiphenine</to_name>
		<to_code>M0050219</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>C1 esterase inhibitor</from_name>
		<from_code>1599832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Complement C1 Inhibitor Protein</to_name>
		<to_code>M0476632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnauba wax</from_name>
		<from_code>1307833</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carnauba wax</to_name>
		<to_code>M0086600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobutyrol</from_name>
		<from_code>21954</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclobutyrol</to_name>
		<to_code>M0041545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corynoxeine</from_name>
		<from_code>2562545</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>corynoxeine</to_name>
		<to_code>M0154563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinoxacin</from_name>
		<from_code>2550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cinoxacin</to_name>
		<to_code>M0004495</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabigerol</from_name>
		<from_code>2464938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cannabigerol</to_name>
		<to_code>M0112336</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril palmitate</from_name>
		<from_code>69782</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>colfosceril palmitate</to_name>
		<to_code>M0217563</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>permethrin</from_name>
		<from_code>33199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine tannate</from_name>
		<from_code>221075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine mesylate</from_name>
		<from_code>235739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine</from_name>
		<from_code>3013</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine</from_name>
		<from_code>2400</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine</from_name>
		<from_code>134615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine hydrochloride</from_name>
		<from_code>91065</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>peginterferon alfa-2a</from_name>
		<from_code>120608</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide sodium</from_name>
		<from_code>82101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine maleate</from_name>
		<from_code>91066</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lindane</from_name>
		<from_code>1388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bromodiphenhydramine</from_name>
		<from_code>19759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine</from_name>
		<from_code>20220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin sodium</from_name>
		<from_code>82806</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine edisylate</from_name>
		<from_code>8705</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>malathion</from_name>
		<from_code>6606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine</from_name>
		<from_code>8704</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine tannate</from_name>
		<from_code>353104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine hydrochloride</from_name>
		<from_code>104592</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine hydrochloride</from_name>
		<from_code>1362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacetamide</from_name>
		<from_code>10169</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine tannate</from_name>
		<from_code>360283</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prochlorperazine maleate</from_name>
		<from_code>8706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine hydrochloride</from_name>
		<from_code>91121</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitric oxide</from_name>
		<from_code>7442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproheptadine pyrid phos</from_name>
		<from_code>236525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine</from_name>
		<from_code>3498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine</from_name>
		<from_code>2578</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosphenytoin</from_name>
		<from_code>72236</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine polistirex</from_name>
		<from_code>221074</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methdilazine</from_name>
		<from_code>29648</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpheniramine maleate</from_name>
		<from_code>142429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>brimonidine tartrate</from_name>
		<from_code>39171</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine diacefyllinate</from_name>
		<from_code>236260</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbinoxamine tannate</from_name>
		<from_code>405970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemastine fumarate</from_name>
		<from_code>142430</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfisoxazole diolamine</from_name>
		<from_code>10208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diphenhydramine citrate</from_name>
		<from_code>82004</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Infant, Newborn</to_name>
		<to_code>M0011285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colfosceril</from_name>
		<from_code>107784</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>colfosceril</to_name>
		<to_code>M0136064</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvone</from_name>
		<from_code>1427075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carvone</to_name>
		<to_code>M0049777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorotheophylline</from_name>
		<from_code>236872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>8-chlorotheophylline</to_name>
		<to_code>M0095498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>choline hydroxide</from_name>
		<from_code>1311084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Choline Hydroxide</to_name>
		<to_code>M000613687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clomipramine Hydrochloride</to_name>
		<to_code>M0004600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine hydrochloride</from_name>
		<from_code>81984</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clomipramine Hydrochloride</to_name>
		<to_code>M0004600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clomipramine Hydrochloride</to_name>
		<to_code>M0004600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin acetate</from_name>
		<from_code>2198943</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antidepressive Agents, Tricyclic</to_name>
		<to_code>M0001387</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clomipramine</from_name>
		<from_code>2597</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clomipramine</to_name>
		<to_code>M0004598</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cerium</from_name>
		<from_code>1367178</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cerium</to_name>
		<to_code>M0003917</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloastragenol</from_name>
		<from_code>2398144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cycloastragenol</to_name>
		<to_code>M0169258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pidolate</from_name>
		<from_code>87393</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium pidolate</to_name>
		<to_code>M0245338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carrageenan</from_name>
		<from_code>1368862</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carrageenan</to_name>
		<to_code>M0003555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ascorbate</from_name>
		<from_code>142407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium ascorbate</to_name>
		<to_code>M0540124</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistin</from_name>
		<from_code>2709</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colistin</to_name>
		<to_code>M0004767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>flos caryophylli</to_name>
		<to_code>M000743005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clove allergenic extract</from_name>
		<from_code>899724</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorine dioxide</from_name>
		<from_code>20799</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorine dioxide</to_name>
		<to_code>M0084108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium polynicotinate</from_name>
		<from_code>700888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromium polynicotinate</to_name>
		<to_code>M000613726</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carvacrol</from_name>
		<from_code>1998840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carvacrol</to_name>
		<to_code>M0198268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thymol</from_name>
		<from_code>10553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carvacrol</to_name>
		<to_code>M0198268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorothen</from_name>
		<from_code>59695</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorothen</to_name>
		<to_code>M0140355</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloroxine</to_name>
		<to_code>M0045392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroxine</from_name>
		<from_code>20875</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium phosphate</from_name>
		<from_code>235482</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone pivalate</from_name>
		<from_code>21250</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate monohydrate</from_name>
		<from_code>153374</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desoximetasone</from_name>
		<from_code>3255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone aceponate</from_name>
		<from_code>41277</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone sodium succinate</from_name>
		<from_code>235483</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone</from_name>
		<from_code>108088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinonide</from_name>
		<from_code>4462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone valerate</from_name>
		<from_code>227897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisol succinate</from_name>
		<from_code>21651</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol</from_name>
		<from_code>2590</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone</from_name>
		<from_code>5492</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone benzoate</from_name>
		<from_code>1517</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tolnaftate</from_name>
		<from_code>10637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone</from_name>
		<from_code>10759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>magnesium salicylate tetrahydrate</from_name>
		<from_code>253186</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobetasol propionate</from_name>
		<from_code>21245</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone</from_name>
		<from_code>108118</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone sodium phosphate</from_name>
		<from_code>203220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone acetate</from_name>
		<from_code>1516</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate, augmented</from_name>
		<from_code>215664</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylate</from_name>
		<from_code>9522</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone cypionate</from_name>
		<from_code>163524</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol</from_name>
		<from_code>41208</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halcinonide</from_name>
		<from_code>5084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone acetate</from_name>
		<from_code>27197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone dipropionate</from_name>
		<from_code>19254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone valerate</from_name>
		<from_code>27199</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mometasone furoate</from_name>
		<from_code>30145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>halobetasol propionate</from_name>
		<from_code>45318</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone hexacetonide</from_name>
		<from_code>38546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>betamethasone</from_name>
		<from_code>1514</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone butyrate</from_name>
		<from_code>103468</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone</from_name>
		<from_code>91311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diflorasone diacetate</from_name>
		<from_code>23033</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clocortolone</from_name>
		<from_code>21249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sodium salicylate</from_name>
		<from_code>9907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone acetonide</from_name>
		<from_code>10761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocortisone probutate</from_name>
		<from_code>27196</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>selenium sulfide</from_name>
		<from_code>36345</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluocinolone acetonide</from_name>
		<from_code>4461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amcinonide</from_name>
		<from_code>17652</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salicylic acid</from_name>
		<from_code>9525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>alclometasone dipropionate</from_name>
		<from_code>17268</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednicarbate</from_name>
		<from_code>34369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>desonide</from_name>
		<from_code>3254</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>potassium salicylate</from_name>
		<from_code>235418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scalp Dermatoses</to_name>
		<to_code>M0019465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Clematis hexapetala whole extract</from_name>
		<from_code>1594579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Radix clematidis whole</to_name>
		<to_code>M000745808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroacetate</from_name>
		<from_code>48008</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloroacetate</to_name>
		<to_code>M000629536</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clemizolpenicillin</from_name>
		<from_code>21226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clemizolpenicillin</to_name>
		<to_code>M0097486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedrol</from_name>
		<from_code>1670019</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cedrol</to_name>
		<to_code>M0210791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cambendazole</from_name>
		<from_code>1951</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cambendazole</to_name>
		<to_code>M0003231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caffeic acid</from_name>
		<from_code>1311397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>caffeic acid</to_name>
		<to_code>M0119464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-coumaric acid</from_name>
		<from_code>1485787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>p-coumaric acid</to_name>
		<to_code>M0479802</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coconut oil</from_name>
		<from_code>1309239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coconut Oil</to_name>
		<to_code>M0110437</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic aldehyde</from_name>
		<from_code>1368153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>trans-cinnamaldehyde</to_name>
		<to_code>M0311985</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic aldehyde</from_name>
		<from_code>1368153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamaldehyde</to_name>
		<to_code>M0060175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cresol</from_name>
		<from_code>62130</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cresol</to_name>
		<to_code>M0209179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagen type V</from_name>
		<from_code>2667828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagen Type V</to_name>
		<to_code>M0004781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloramine-T trihydrate</from_name>
		<from_code>1592902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloramine-T trihydrate</to_name>
		<to_code>M000645156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium silicate</from_name>
		<from_code>1311526</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium silicate</to_name>
		<to_code>M0098430</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt oxide</from_name>
		<from_code>2606479</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cobalt oxide</to_name>
		<to_code>M0168594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulose acetate phthalate</from_name>
		<from_code>1425215</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cellulose acetate phthalate</to_name>
		<to_code>M0058224</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate</from_name>
		<from_code>1925</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Sulfate</to_name>
		<to_code>M0003183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnosine</from_name>
		<from_code>1362697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carnosine</to_name>
		<to_code>M0003535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chenodeoxycholate</from_name>
		<from_code>42588</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chenodeoxycholate</to_name>
		<to_code>M0004031</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclic AMP</from_name>
		<from_code>1314330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclic AMP</to_name>
		<to_code>M0000378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclomethicone 5</from_name>
		<from_code>1305744</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>decamethylcyclopentasiloxane</to_name>
		<to_code>M0295835</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cow milk allergenic extract</from_name>
		<from_code>892665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captodiamine</from_name>
		<from_code>89812</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>captodiamine</to_name>
		<to_code>M0479846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetalkonium chloride</from_name>
		<from_code>47907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetalkonium chloride</to_name>
		<to_code>M0311978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cymene</from_name>
		<from_code>2584847</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cymenes</to_name>
		<to_code>M000649347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyldimethylethylammonium bromide</from_name>
		<from_code>1427238</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetyldimethylethylammonium bromide</to_name>
		<to_code>M0569102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cultivated mushroom allergenic extract</from_name>
		<from_code>901369</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclamen aldehyde</from_name>
		<from_code>1376343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclamen aldehyde</to_name>
		<to_code>M0050214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbamoylcholine</from_name>
		<from_code>1546387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbamylcholine</to_name>
		<to_code>M0003324</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetearyl isononanoate</from_name>
		<from_code>1312361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hexadecyl isononanoate</to_name>
		<to_code>M0465723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber allergenic extract</from_name>
		<from_code>899738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium aspartate</from_name>
		<from_code>287637</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Aspartate</to_name>
		<to_code>M0330805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloxazolam</from_name>
		<from_code>21311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cloxazolam</to_name>
		<to_code>M0047119</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coenzyme A</from_name>
		<from_code>1314344</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coenzyme A</to_name>
		<to_code>M0004712</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium glucarate</from_name>
		<from_code>1907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Saccharate</to_name>
		<to_code>M0009319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyl sulfate</from_name>
		<from_code>1366920</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetyl sulfate</to_name>
		<to_code>M0042717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium peroxide</from_name>
		<from_code>1426443</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium peroxide</to_name>
		<to_code>M0356702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citraconic acid</from_name>
		<from_code>1435287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citraconic acid</to_name>
		<to_code>M0198359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyl lactate</from_name>
		<from_code>1368150</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetyl lactate</to_name>
		<to_code>M0168952</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium alginate</from_name>
		<from_code>47610</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Alginate</to_name>
		<to_code>M0310538</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlortetracycline</from_name>
		<from_code>2408</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlortetracycline</to_name>
		<to_code>M0004211</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclandelate</from_name>
		<from_code>2970</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclandelate</to_name>
		<to_code>M0005451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coptis chinensis root extract</from_name>
		<from_code>1376211</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coptidis rhizoma extract</to_name>
		<to_code>M0279414</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbadox</from_name>
		<from_code>1314339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbadox</to_name>
		<to_code>M0003326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorquinaldol</from_name>
		<from_code>2407</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlorquinaldol</to_name>
		<to_code>M0004208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyl palmitate</from_name>
		<from_code>1311485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetyl palmitate</to_name>
		<to_code>M0049816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbazochrome</from_name>
		<from_code>2011</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbazochrome</to_name>
		<to_code>M0198343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate, anhydrous</from_name>
		<from_code>1328529</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Sulfate, Anhydrous</to_name>
		<to_code>M0003188</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Capreomycin Sulfate</to_name>
		<to_code>M0003303</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capreomycin sulfate</from_name>
		<from_code>1987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Mycobacterium Infections</to_name>
		<to_code>M0014287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camylofin hydrochloride</from_name>
		<from_code>236175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>camylofin hydrochloride</to_name>
		<to_code>M0308658</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>capryloyl salicylic acid</from_name>
		<from_code>1492035</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>capryloyl salicylic acid</to_name>
		<to_code>M000605046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coccidioidin</from_name>
		<from_code>2660</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Coccidioidin</to_name>
		<to_code>M0004675</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cicletanine</from_name>
		<from_code>21914</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cicletanine</to_name>
		<to_code>M0114776</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyria, Acute Intermittent</to_name>
		<to_code>M0026010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ranitidine bismuth citrate</to_name>
		<to_code>M0198352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors</to_name>
		<to_code>M0028567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Protozoan Infections</to_name>
		<to_code>M0017926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clarithromycin</from_name>
		<from_code>21212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone caproate (USP)</from_name>
		<from_code>12488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydroxyprogesterone acetate</from_name>
		<from_code>1101886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin</from_name>
		<from_code>7454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, monohydrate</from_name>
		<from_code>221129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>17-alpha-hydroxyprogesterone</from_name>
		<from_code>5542</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nitrofurantoin, macrocrystals</from_name>
		<from_code>235559</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Jaundice, Obstructive</to_name>
		<to_code>M0004260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride monohydrate</from_name>
		<from_code>221077</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide monohydrate</from_name>
		<from_code>2198973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine mesylate</from_name>
		<from_code>203176</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone</from_name>
		<from_code>233698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine</from_name>
		<from_code>3418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan hydrobromide</from_name>
		<from_code>360288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dihydroergotamine tartrate</from_name>
		<from_code>236680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pimozide</from_name>
		<from_code>8331</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ubrogepant</from_name>
		<from_code>2268216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan hydrochloride</from_name>
		<from_code>1294548</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>conivaptan</from_name>
		<from_code>302285</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisapride</from_name>
		<from_code>35255</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silodosin</from_name>
		<from_code>720825</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>eletriptan</from_name>
		<from_code>231049</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nimodipine</from_name>
		<from_code>7426</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dronedarone hydrochloride</from_name>
		<from_code>736680</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clarithromycin</to_name>
		<to_code>M0026249</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine</from_name>
		<from_code>2403</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyria, Acute Intermittent</to_name>
		<to_code>M0026010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carisoprodol</from_name>
		<from_code>2101</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyria, Acute Intermittent</to_name>
		<to_code>M0026010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hemin</from_name>
		<from_code>5175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyria, Acute Intermittent</to_name>
		<to_code>M0026010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorpromazine hydrochloride</from_name>
		<from_code>104728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyria, Acute Intermittent</to_name>
		<to_code>M0026010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hemin</from_name>
		<from_code>5175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Porphyria, Acute Intermittent</to_name>
		<to_code>M0026010</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ranitidine bismuth citrate</from_name>
		<from_code>55471</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ranitidine bismuth citrate</to_name>
		<to_code>M0198352</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cilgavimab</from_name>
		<from_code>2587306</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cilgavimab</to_name>
		<to_code>M000744506</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium dobesilate</from_name>
		<from_code>1904</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Dobesilate</to_name>
		<to_code>M0003167</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ion</from_name>
		<from_code>1316581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium</to_name>
		<to_code>M0003153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ion</from_name>
		<from_code>1316581</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cations, Divalent</to_name>
		<to_code>M0003682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium</from_name>
		<from_code>1895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium</to_name>
		<to_code>M0003153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium</from_name>
		<from_code>1895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium</to_name>
		<to_code>M0003153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium oxide</from_name>
		<from_code>28728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>lime</to_name>
		<to_code>M0066622</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopidol</from_name>
		<from_code>1367179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clopidol</to_name>
		<to_code>M0004624</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon black</from_name>
		<from_code>2032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbon Black</to_name>
		<to_code>M0003366</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Centella asiatica extract</from_name>
		<from_code>1310164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Centella asiatica extract</to_name>
		<to_code>M0517955</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>3-carene</from_name>
		<from_code>2395760</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-carene</to_name>
		<to_code>M0095767</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium cyclamate</from_name>
		<from_code>155015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Cyclamate</to_name>
		<to_code>M0331213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamyl alcohol</from_name>
		<from_code>1362889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamyl alcohol</to_name>
		<to_code>M0074746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceric oxide</from_name>
		<from_code>1673068</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ceric oxide</to_name>
		<to_code>M0096625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenoxamine</from_name>
		<from_code>20881</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorphenoxamine</to_name>
		<to_code>M0262605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorozotocin</from_name>
		<from_code>1362886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>CHLZ</to_name>
		<to_code>M0176718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorozotocin</from_name>
		<from_code>1362886</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorozotocin</to_name>
		<to_code>M0049947</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocamidopropylamine oxide</from_name>
		<from_code>1363576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cocamidopropylamine oxide</to_name>
		<to_code>M0524413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creatine</from_name>
		<from_code>2907</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Creatine</to_name>
		<to_code>M0005292</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coniferyl alcohol</from_name>
		<from_code>1309334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>coniferyl alcohol</to_name>
		<to_code>M0056128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-cymene</from_name>
		<from_code>15002</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>4-cymene</to_name>
		<to_code>M0050260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloprostenol sodium</from_name>
		<from_code>204179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cloprostenol Sodium</to_name>
		<to_code>M0351575</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-carboxyethyl acrylate</from_name>
		<from_code>2286249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3-acryloyloxypropionic acid</to_name>
		<to_code>M0158088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Calendula officinalis flower extract</from_name>
		<from_code>1309289</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calendula officinalis flower</to_name>
		<to_code>M000742765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>camphene</from_name>
		<from_code>2395761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>camphene</to_name>
		<to_code>M0071632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citronellyl nitrile, (+/-)</from_name>
		<from_code>2388134</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citronellyl nitrile</to_name>
		<to_code>M0078107</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Carbopol 981</from_name>
		<from_code>1311164</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbopol 981</to_name>
		<to_code>M0506419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon allergenic extract</from_name>
		<from_code>899673</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorproethazine</from_name>
		<from_code>59860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorproethazine</to_name>
		<to_code>M0152807</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coumaran</from_name>
		<from_code>1855075</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>coumaran</to_name>
		<to_code>M0127166</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cuminaldehyde</from_name>
		<from_code>2177095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cuminaldehyde</to_name>
		<to_code>M0050179</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cherry juice</from_name>
		<from_code>1307717</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>creosol</from_name>
		<from_code>1362910</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>creosol</to_name>
		<to_code>M0084670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulose</from_name>
		<from_code>2221</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cellulose</to_name>
		<to_code>M0003790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenoxolone</from_name>
		<from_code>2017</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbenoxolone</to_name>
		<to_code>M0003342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cannabis sativa seed oil</from_name>
		<from_code>1305550</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>hempseed oil</to_name>
		<to_code>M000747265</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cephaloridine</from_name>
		<from_code>2233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cephaloridine</to_name>
		<to_code>M0003824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>collagen type II</from_name>
		<from_code>2471083</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Collagen Type II</to_name>
		<to_code>M0004777</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloropropylate</from_name>
		<from_code>1435282</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloropropylate</to_name>
		<to_code>M0045801</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cathine hydrochloride</from_name>
		<from_code>236860</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>norpseudoephedrine hydrochloride</to_name>
		<to_code>M0309038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopenthiazide</from_name>
		<from_code>3000</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclopenthiazide</to_name>
		<to_code>M0005482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cullen corylifolium fruit extract</from_name>
		<from_code>1311580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cullen corylifolium fruit</to_name>
		<to_code>M000745628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cryptosporidium parvum</from_name>
		<from_code>1322778</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cryptosporidium parvum</to_name>
		<to_code>M0025578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorphenoxamine hydrochloride</from_name>
		<from_code>235422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chlorphenoxamine hydrochloride</to_name>
		<to_code>M0327289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorsulon</from_name>
		<from_code>28303</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clorsulon</to_name>
		<to_code>M0065144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper oxodotreotide CU-64</from_name>
		<from_code>2396442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>copper dotatate CU-64</to_name>
		<to_code>M000750673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper oxodotreotide CU-64</from_name>
		<from_code>2396442</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>64Cu-DOTATATE</to_name>
		<to_code>M0578040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cumin allergenic extract</from_name>
		<from_code>901365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobaltous nitrate hexahydrate</from_name>
		<from_code>1423922</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cobaltous nitrate hexahydrate</to_name>
		<to_code>M0316612</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoamphodiacetate</from_name>
		<from_code>1364462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesteryl oleate</from_name>
		<from_code>1368200</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cholesteryl oleate</to_name>
		<to_code>M0062919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>curcumin</from_name>
		<from_code>2955</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Curcumin</to_name>
		<to_code>M0005421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbon tetrachloride</from_name>
		<from_code>2383337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbon Tetrachloride</to_name>
		<to_code>M0003376</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceramide 2</from_name>
		<from_code>1426448</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>N-stearoylsphinganine</to_name>
		<to_code>M0440305</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil, leaf</from_name>
		<from_code>1309227</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamon oil, leaf</to_name>
		<to_code>M0497753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyl myristoleate</from_name>
		<from_code>1314343</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetyl myristoleate</to_name>
		<to_code>M0232077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceramide 3</from_name>
		<from_code>1362741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ceramide 3</to_name>
		<to_code>M0070056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chrysarobin</from_name>
		<from_code>1860418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chrysarobin</to_name>
		<to_code>M0062007</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium arsenate</from_name>
		<from_code>1333425</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium arsenate</to_name>
		<to_code>M0133049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloconazole hydrochloride</from_name>
		<from_code>236864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>croconazole hydrochloride</to_name>
		<to_code>M0320874</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clopyralid</from_name>
		<from_code>1995248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clopyralid</to_name>
		<to_code>M0058315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloprostenol</from_name>
		<from_code>2606</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cloprostenol</to_name>
		<to_code>M0004625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium fructoborate</from_name>
		<from_code>2600351</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium fructoborate</to_name>
		<to_code>M0494123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloropyramine hydrochloride</from_name>
		<from_code>236457</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloropyramine hydrochloride</to_name>
		<to_code>M0424335</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1-chloro-2-methyl-1-propene</from_name>
		<from_code>2469243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1-chloro-2-methylpropene</to_name>
		<to_code>M0147685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabichromene</from_name>
		<from_code>2585216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cannabichromene</to_name>
		<to_code>M0056407</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Centruroides (scorpion) immune F(ab')2 (equine)</from_name>
		<from_code>1119986</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Scorpion Stings</to_name>
		<to_code>M0585473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclofenil</from_name>
		<from_code>2983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclofenil</to_name>
		<to_code>M0005465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calenduloside E</from_name>
		<from_code>1428039</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calenduloside E</to_name>
		<to_code>M0539715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbazochrome sodium sulfonate</from_name>
		<from_code>20209</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbazochrome sodium sulfonate</to_name>
		<to_code>M0424590</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>1,3-cyclohexadiene</from_name>
		<from_code>2691092</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>1,3-cyclohexadiene</to_name>
		<to_code>M0105106</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn starch</from_name>
		<from_code>1039062</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cornstarch</to_name>
		<to_code>M0020434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate, dihydrate</from_name>
		<from_code>1310465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Sulfate Dihydrate</to_name>
		<to_code>M0331331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium sulfate, dihydrate</from_name>
		<from_code>1310465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Sulfate (1:1), Dihydrate</to_name>
		<to_code>M000642843</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chlamydomonas reinhardtii</from_name>
		<from_code>2637877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlamydomonas reinhardtii</to_name>
		<to_code>M0025618</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coccidioides immitis spherule</from_name>
		<from_code>1549330</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Antigens, Fungal</to_name>
		<to_code>M0001418</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedazuridine</from_name>
		<from_code>2384449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cedazuridine</to_name>
		<to_code>M000654977</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedazuridine</from_name>
		<from_code>2384449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>(4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine</to_name>
		<to_code>M000654978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chymotrypsin</from_name>
		<from_code>2530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chymotrypsin</to_name>
		<to_code>M0004462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>canola oil</from_name>
		<from_code>1309202</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Canola Oil</to_name>
		<to_code>M000625875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium chlorate dihydrate</from_name>
		<from_code>1542454</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium chlorate dihydrate</to_name>
		<to_code>M0241285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadmium fluoride</from_name>
		<from_code>2600776</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cadmium fluoride</to_name>
		<to_code>M0526154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlophedianol hydrochloride</from_name>
		<from_code>1014329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clofedanol hydrochloride</to_name>
		<to_code>M0311115</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium galactogluconate bromide</from_name>
		<from_code>47617</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium galactogluconate bromide</to_name>
		<to_code>M0069565</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium polystyrene sulfonate product</from_name>
		<from_code>47630</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>polystyrene sulfonic acid, homopolymer, calcium salt</to_name>
		<to_code>M0308259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorine</from_name>
		<from_code>1310122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlorine</to_name>
		<to_code>M0004144</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorine</from_name>
		<from_code>1310122</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlorine Gas</to_name>
		<to_code>M000638846</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorogenic acid</from_name>
		<from_code>1311387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlorogenic Acid</to_name>
		<to_code>M0004165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chamomile extract</from_name>
		<from_code>1309226</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chamomile extract</to_name>
		<to_code>M000744828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cucumber extract</from_name>
		<from_code>1305719</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crofelemer</from_name>
		<from_code>1364449</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>crofelemer</to_name>
		<to_code>M0543100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carnosine hydrochloride</from_name>
		<from_code>1370593</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carnosine Hydrochloride</to_name>
		<to_code>M0583187</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>4-cresyl acetate</from_name>
		<from_code>14997</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>p-cresyl acetate</to_name>
		<to_code>M0050158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcifediol</from_name>
		<from_code>1889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcifediol</to_name>
		<to_code>M0003141</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin</from_name>
		<from_code>2190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin</from_name>
		<from_code>2190</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cefsulodin</to_name>
		<to_code>M0003727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chrysanthemic acid, (+/-)-</from_name>
		<from_code>2289244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chrysanthemic acid</to_name>
		<to_code>M0049983</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorophyll</from_name>
		<from_code>2388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlorophyll</to_name>
		<to_code>M0004175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>copper naphthenate</from_name>
		<from_code>1373349</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>copper naphthenate</to_name>
		<to_code>M0243911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyproterone acetate</from_name>
		<from_code>22054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyproterone Acetate</to_name>
		<to_code>M0026384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholesteryl nonanoate</from_name>
		<from_code>1362887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cholesteryl nonanoate</to_name>
		<to_code>M0060146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citronellal</from_name>
		<from_code>1424876</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citronellal</to_name>
		<to_code>M0281213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Contraceptives, Oral, Hormonal</to_name>
		<to_code>M0005118</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cobicistat</to_name>
		<to_code>M0558562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>HIV Infections</to_name>
		<to_code>M0023997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobicistat</from_name>
		<from_code>1306284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>drospirenone and ethinyl estradiol combination</to_name>
		<to_code>M0528511</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone hydrochloride</from_name>
		<from_code>1040027</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elbasvir</from_name>
		<from_code>1734628</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>elvitegravir</from_name>
		<from_code>1306286</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>voriconazole</from_name>
		<from_code>121243</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir calcium</from_name>
		<from_code>402365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lurasidone</from_name>
		<from_code>1040028</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fosamprenavir</from_name>
		<from_code>358262</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lumefantrine</from_name>
		<from_code>847728</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Hypericum</to_name>
		<to_code>M0328541</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>simvastatin</from_name>
		<from_code>36567</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cobicistat</to_name>
		<to_code>M0558562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_ChemClass</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lovastatin</from_name>
		<from_code>6472</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cobicistat</to_name>
		<to_code>M0558562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetearyl alcohol</from_name>
		<from_code>1425218</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetearyl alcohol</to_name>
		<to_code>M0377676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium oxalate monohydrate</from_name>
		<from_code>1485047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Oxalate Monohydrate (1:1)</to_name>
		<to_code>M0330902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Coffea arabica seed extract</from_name>
		<from_code>2695791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cynara preparation</from_name>
		<from_code>235940</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium ipodate</from_name>
		<from_code>1911</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Ipodate</to_name>
		<to_code>M0011699</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic acid</from_name>
		<from_code>2621720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamic acid</to_name>
		<to_code>M0318054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamic acid</from_name>
		<from_code>2621720</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-Propenoic acid, 3-phenyl-</to_name>
		<to_code>M000642431</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin 4-sulfate</from_name>
		<from_code>1314214</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chondroitin 4-Sulfate</to_name>
		<to_code>M0330651</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobenzorex hydrochloride</from_name>
		<from_code>236205</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clobenzorex hydrochloride</to_name>
		<to_code>M0307449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromonar</from_name>
		<from_code>2508</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chromonar</to_name>
		<to_code>M0004398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrimonium chloride</from_name>
		<from_code>1311525</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetrimonium Chloride</to_name>
		<to_code>M0308519</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromium trioxide</from_name>
		<from_code>1539810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromium trioxide</to_name>
		<to_code>M0092351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetyl alcohol</from_name>
		<from_code>20615</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetyl alcohol</to_name>
		<to_code>M0046310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclamate</from_name>
		<from_code>2969</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cyclamates</to_name>
		<to_code>M0005446</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clothiapine</from_name>
		<from_code>2620</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clothiapine</to_name>
		<to_code>M0224730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium saccharate anhydrous</from_name>
		<from_code>2636533</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Saccharate Anhydrous</to_name>
		<to_code>M0574147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>campesterol</from_name>
		<from_code>20129</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>campesterol</to_name>
		<to_code>M0075918</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chenodeoxycholic acid</from_name>
		<from_code>2323</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chenodeoxycholic Acid</to_name>
		<to_code>M0004029</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>colistin sulfate</from_name>
		<from_code>2710</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Colistin Sulfate</to_name>
		<to_code>M0004768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlortetracycline hydrochloride</from_name>
		<from_code>42545</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chlortetracycline Hydrochloride</to_name>
		<to_code>M0330638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>causticum preparation</from_name>
		<from_code>1311056</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Causticum</to_name>
		<to_code>M0465982</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocamidopropyl betaine</from_name>
		<from_code>1311576</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cocamidopropyl betaine</to_name>
		<to_code>M0207065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cariprazine hydrochloride</from_name>
		<from_code>1721073</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cariprazine hydrochloride</to_name>
		<to_code>M0527152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloroform</from_name>
		<from_code>1362698</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chloroform</to_name>
		<to_code>M0004164</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chondroitin 6-sulfate</from_name>
		<from_code>2268212</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chondroitin 6-Sulfate</to_name>
		<to_code>M0330652</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclopentamine</from_name>
		<from_code>59094</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclopentamine</to_name>
		<to_code>M0061245</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefodizime</from_name>
		<from_code>20485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cefodizime</to_name>
		<to_code>M0103520</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefodizime</from_name>
		<from_code>20485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefodizime</from_name>
		<from_code>20485</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cupric glycinate</from_name>
		<from_code>1428217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cupric glycinate</to_name>
		<to_code>M0070085</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnarizine</from_name>
		<from_code>2549</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cinnarizine</to_name>
		<to_code>M0004492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloric acid</from_name>
		<from_code>1546391</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloric acid</to_name>
		<to_code>M0079464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chymosin</from_name>
		<from_code>9248</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Chymosin</to_name>
		<to_code>M0018781</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa bean allergenic extract</from_name>
		<from_code>891721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chloromethyl methyl ether</from_name>
		<from_code>1312362</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chloromethyl methyl ether</to_name>
		<to_code>M0198272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>caprylhydroxamic acid</from_name>
		<from_code>1307145</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>octanohydroxamic acid</to_name>
		<to_code>M0049707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium pangamate</from_name>
		<from_code>1917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium pangamate</to_name>
		<to_code>M0275347</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coriander oil</from_name>
		<from_code>1309241</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>coriander oil</to_name>
		<to_code>M000626637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clobenzorex</from_name>
		<from_code>21244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clobenzorex</to_name>
		<to_code>M0040633</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cedrene</from_name>
		<from_code>2632411</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cedrene</to_name>
		<to_code>M0040490</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>citronella oil</from_name>
		<from_code>1309376</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>citronella oil</to_name>
		<to_code>M0206266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clorophene</from_name>
		<from_code>21290</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>clorophene</to_name>
		<to_code>M0045798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Corymbia citriodora leaf oil</from_name>
		<from_code>1306137</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>oil of lemon eucalyptus</to_name>
		<to_code>M000765466</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cellulose, oxidized</from_name>
		<from_code>2481135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cellulose, Oxidized</to_name>
		<to_code>M0003793</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cicloxilic acid</from_name>
		<from_code>21095</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cicloxilic acid</to_name>
		<to_code>M0070857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium palmitate</from_name>
		<from_code>2637681</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Palmitate</to_name>
		<to_code>M0028751</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coco-betaine</from_name>
		<from_code>1367422</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cocobetaine</to_name>
		<to_code>M0114666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chromous chloride</from_name>
		<from_code>21032</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>chromous chloride</to_name>
		<to_code>M0067636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cannabinol</from_name>
		<from_code>1976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cannabinol</to_name>
		<to_code>M0003268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>coniine</from_name>
		<from_code>1313334</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>coniine</to_name>
		<to_code>M0050092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetrimides</from_name>
		<from_code>2284</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cetrimides</to_name>
		<to_code>M0003967</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>costus root oil</from_name>
		<from_code>1309387</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>costus root oil</to_name>
		<to_code>M0050142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cryptenamine</from_name>
		<from_code>42618</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cryptenamine</to_name>
		<to_code>M0017922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocaine esterase</from_name>
		<from_code>2463110</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cocaine esterase</to_name>
		<to_code>M0072960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium citrate malate</from_name>
		<from_code>73409</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium citrate malate</to_name>
		<to_code>M0223270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cetostearyl alcohol</from_name>
		<from_code>1307840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cetostearyl alcohol</to_name>
		<to_code>M0055876</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbimazole</from_name>
		<from_code>2020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Carbimazole</to_name>
		<to_code>M0003346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloperastine hydrochloride</from_name>
		<from_code>2104181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cloperastine hydrochloride</to_name>
		<to_code>M0321360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cloperastine hydrochloride</from_name>
		<from_code>2104181</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cough</to_name>
		<to_code>M0005255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbomer</from_name>
		<from_code>235535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>carbomer</to_name>
		<to_code>M0456569</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cullen corylifolium whole extract</from_name>
		<from_code>1808601</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cullen corylifolium whole</to_name>
		<to_code>M000745629</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>croton oil</from_name>
		<from_code>1309665</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Croton Oil</to_name>
		<to_code>M0005359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyamemazine</from_name>
		<from_code>21877</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyamemazine</to_name>
		<to_code>M0091578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cadmium iodide</from_name>
		<from_code>1311081</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cadmium iodide</to_name>
		<to_code>M0198110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cobalt sulfate</from_name>
		<from_code>1362742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cobalt sulfate</to_name>
		<to_code>M0086545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cyclobarbital</from_name>
		<from_code>2978</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cyclobarbital</to_name>
		<to_code>M0224832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cystine</from_name>
		<from_code>3036</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cystine</to_name>
		<to_code>M0005555</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>clenbuterol</from_name>
		<from_code>2580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Clenbuterol</to_name>
		<to_code>M0004556</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium bicarbonate</from_name>
		<from_code>1373352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>calcium bicarbonate</to_name>
		<to_code>M0099054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ceruletide diethylamine</from_name>
		<from_code>20024</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ceruletide diethylamine</to_name>
		<to_code>M0101746</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin sodium</from_name>
		<from_code>267417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cefsulodin Sodium</to_name>
		<to_code>M0330934</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefsulodin sodium</from_name>
		<from_code>267417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>crospovidone</from_name>
		<from_code>1310706</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Crospovidone</to_name>
		<to_code>M0351816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cycloadiphenine hydrochloride</from_name>
		<from_code>289372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cycloadiphenine hydrochloride</to_name>
		<to_code>M0309856</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>captan</from_name>
		<from_code>1368147</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Captan</to_name>
		<to_code>M0003318</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil, bark</from_name>
		<from_code>1305634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamon oil, bark</to_name>
		<to_code>M0497750</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cinnamon oil, bark</from_name>
		<from_code>1305634</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>cinnamomi corticis aetheroleum</to_name>
		<to_code>M000743822</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>calcium oxalate</from_name>
		<from_code>1485048</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Calcium Oxalate</to_name>
		<to_code>M0003175</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinapril hydrochloride</to_name>
		<to_code>235759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinoline yellow</to_name>
		<to_code>1305564</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus robur whole extract</to_name>
		<to_code>1541242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-18 hectorite</to_name>
		<to_code>1431997</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinethazone</to_name>
		<to_code>59743</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinaprilat</to_name>
		<to_code>1546359</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine bisulfate</to_name>
		<to_code>55377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus robur flower extract</to_name>
		<to_code>1309753</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine bisulfate</to_name>
		<to_code>9073</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus robur nut extract</to_name>
		<to_code>1311052</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-52</to_name>
		<to_code>1363626</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quarternium-15</to_name>
		<to_code>1367171</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus rubra whole extract</to_name>
		<to_code>1863220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-90 bentonite</to_name>
		<to_code>2560230</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine</to_name>
		<to_code>9071</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>queen palm pollen extract</to_name>
		<to_code>867353</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinic acid</to_name>
		<to_code>1427232</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinupramine</to_name>
		<to_code>35242</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinapril</to_name>
		<to_code>35208</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quercetin caprylate</to_name>
		<to_code>1599156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quince extract</to_name>
		<to_code>1370761</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>QS-21</to_name>
		<to_code>2002417</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus alba extract</to_name>
		<to_code>1312383</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine arsenite</to_name>
		<to_code>1426898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-15 trans-form</to_name>
		<to_code>2537630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quizartinib dihydrochloride</to_name>
		<to_code>2643049</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-90</to_name>
		<to_code>2570732</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quadrosilan</to_name>
		<to_code>1313268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-16</to_name>
		<to_code>2274099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-14</to_name>
		<to_code>1312730</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-18</to_name>
		<to_code>1363625</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-33</to_name>
		<to_code>1597389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus spp. whole extract</to_name>
		<to_code>1993213</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-27</to_name>
		<to_code>1732649</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quassia amara wood extract</to_name>
		<to_code>1310168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine dihydrochloride</to_name>
		<to_code>388472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinagolide</to_name>
		<to_code>76887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine sulfate</to_name>
		<to_code>9069</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine salicylate</to_name>
		<to_code>1426899</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinagolide hydrochloride</to_name>
		<to_code>236233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus velutina whole extract</to_name>
		<to_code>2043271</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine gluconate</to_name>
		<to_code>35220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinate</to_name>
		<to_code>1427233</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quillaja saponaria wood extract</to_name>
		<to_code>1438110</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-15</to_name>
		<to_code>283678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quassia amara whole extract</to_name>
		<to_code>1369897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinupristin</to_name>
		<to_code>229367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinacrine</to_name>
		<to_code>9061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinestrol</to_name>
		<to_code>9066</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-53</to_name>
		<to_code>2055747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinhydrone</to_name>
		<to_code>1344799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-90 montmorillonite</to_name>
		<to_code>2537435</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine</to_name>
		<to_code>9068</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-15 cis-form</to_name>
		<to_code>1314289</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-90 sepiolite</to_name>
		<to_code>2537436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quebracho bark extract</to_name>
		<to_code>1309798</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinestradol</to_name>
		<to_code>35215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinoa oil</to_name>
		<to_code>1437504</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus marilandica pollen extract</to_name>
		<to_code>1437222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quetiapine fumarate</to_name>
		<to_code>221153</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-24</to_name>
		<to_code>1539969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quillaja saponaria whole extract</to_name>
		<to_code>2667938</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quercetin</to_name>
		<to_code>9060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-22</to_name>
		<to_code>1426897</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-91</to_name>
		<to_code>1368158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinacrine monohydrochloride</to_name>
		<to_code>82092</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine sulfate</to_name>
		<to_code>9075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus agrifolia whole extract</to_name>
		<to_code>2043272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quazepam</to_name>
		<to_code>35185</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-82</to_name>
		<to_code>1541736</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quaternium-73</to_name>
		<to_code>2667745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus robur twig bark extract</to_name>
		<to_code>1307647</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus suber bark extract</to_name>
		<to_code>1307810</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus petraea whole extract</to_name>
		<to_code>2264602</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine ascorbate</to_name>
		<to_code>236327</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus kelloggii whole extract</to_name>
		<to_code>2043270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus rubra bark extract</to_name>
		<to_code>1312382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine hydrochloride</to_name>
		<to_code>9074</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus garryana whole extract</to_name>
		<to_code>2043268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quizartinib</to_name>
		<to_code>2643048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinine arsenate</to_name>
		<to_code>1309255</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quetiapine</to_name>
		<to_code>51272</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinfamide</to_name>
		<to_code>35216</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quillaja saponaria bark extract</to_name>
		<to_code>1309948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quinidine polygalacturonate</to_name>
		<to_code>41875</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>quackgrass pollen extract</to_name>
		<to_code>852343</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus robur flower bud extract</to_name>
		<to_code>2055000</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>Q [Preparations]</from_name>
		<from_code>N0000010599</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Quercus robur wood extract</to_name>
		<to_code>2479549</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinoline yellow</from_name>
		<from_code>1305564</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinoline yellow</to_name>
		<to_code>M0071662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinic acid</from_name>
		<from_code>1427232</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinic Acid</to_name>
		<to_code>M0018339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupramine</from_name>
		<from_code>35242</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinupramine</to_name>
		<to_code>M0091320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>QS-21</from_name>
		<from_code>2002417</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>QS 21</to_name>
		<to_code>M0211084</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinagolide</from_name>
		<from_code>76887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinagolide</to_name>
		<to_code>M0135075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinagolide hydrochloride</from_name>
		<from_code>236233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinagolide hydrochloride</to_name>
		<to_code>M0389329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinate</from_name>
		<from_code>1427233</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Quinate</to_name>
		<to_code>M0018340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quaternium-15</from_name>
		<from_code>283678</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quaternium-15</to_name>
		<to_code>M0069795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinupristin</to_name>
		<to_code>M0293792</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinupristin</from_name>
		<from_code>229367</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Streptogramins</to_name>
		<to_code>M0022748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinhydrone</from_name>
		<from_code>1344799</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinhydrone</to_name>
		<to_code>M0045716</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quaternium-22</from_name>
		<from_code>1426897</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quaternium-22</to_name>
		<to_code>M0295287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>quinfamide</from_name>
		<from_code>35216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>quinfamide</to_name>
		<to_code>M0087079</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa multiflora flower wax</to_name>
		<to_code>1489920</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubia cordifolia root extract</to_name>
		<to_code>1547468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rickettsia rickettsii</to_name>
		<to_code>1482546</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilonacept</to_name>
		<to_code>763450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reproterol</to_name>
		<to_code>35373</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ranunculus bulbosus root extract</to_name>
		<to_code>2533130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risankizumab-rzaa</to_name>
		<to_code>2166132</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodiola crenulata whole extract</to_name>
		<to_code>2627241</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rutin</to_name>
		<to_code>9500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabies virus vaccine flury-lep strain</to_name>
		<to_code>830457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rituximab-pvvr</to_name>
		<to_code>2273510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>racemethionine</to_name>
		<to_code>9100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimegepant</to_name>
		<to_code>2282307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rickettsia prowazekii</to_name>
		<to_code>1744460</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus coreanus whole extract</to_name>
		<to_code>2570733</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosiglitazone</to_name>
		<to_code>84108</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roxarsone</to_name>
		<to_code>1314413</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relugolix</to_name>
		<to_code>2472778</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revumenib</to_name>
		<to_code>2698325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranitidine hydrochloride</to_name>
		<to_code>203136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus idaeus fruit volatile oil</to_name>
		<to_code>1541710</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rezafungin acetate</to_name>
		<to_code>2639156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remifentanil hydrochloride</to_name>
		<to_code>236540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit skin extract</to_name>
		<to_code>867315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramelteon</to_name>
		<to_code>596205</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropeginterferon alfa-2b</to_name>
		<to_code>2587059</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relatlimab</to_name>
		<to_code>2596773</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranibizumab-nuna</to_name>
		<to_code>2602351</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rye allergenic extract</to_name>
		<to_code>892638</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus chamaemorus seed extract</to_name>
		<to_code>1312378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosuvastatin</to_name>
		<to_code>301542</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reserpine</to_name>
		<to_code>9260</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifamycin SV</to_name>
		<to_code>35616</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retifanlimab</to_name>
		<to_code>2632981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rose bengal sodium</to_name>
		<to_code>1362690</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rehmannia elata root extract</to_name>
		<to_code>1865700</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reductic acid</to_name>
		<to_code>2593372</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regorafenib monohydrate</to_name>
		<to_code>1371319</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramucirumab</to_name>
		<to_code>1535922</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus fruticosus root extract</to_name>
		<to_code>2669455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilmenidine phosphate</to_name>
		<to_code>236379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red clover preparation</to_name>
		<to_code>285193</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ranunculus ficaria extract</to_name>
		<to_code>1355818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raw sugar</to_name>
		<to_code>1483267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice bean extract</to_name>
		<to_code>1941992</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radium bromide</to_name>
		<to_code>1311076</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodiola kirilowii root extract</to_name>
		<to_code>1990882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radium</to_name>
		<to_code>1546450</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rizatriptan</to_name>
		<to_code>88014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranibizumab</to_name>
		<to_code>595060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redberry juniper pollen extract</to_name>
		<to_code>900113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>royal jelly</to_name>
		<to_code>35805</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rolapitant hydrochloride</to_name>
		<to_code>1673367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa centifolia whole extract</to_name>
		<to_code>2621545</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimantadine</to_name>
		<to_code>9386</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa rugosa flower bud extract</to_name>
		<to_code>1483620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rasburicase</to_name>
		<to_code>283821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimiterol hydrobromide</to_name>
		<to_code>203161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosemary extract</to_name>
		<to_code>1314597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remimazolam</to_name>
		<to_code>2383941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redroot pigweed pollen extract</to_name>
		<to_code>851930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice germ oil</to_name>
		<to_code>1307708</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regadenoson</to_name>
		<to_code>640062</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleth-40</to_name>
		<to_code>1868829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rozanolixizumab</to_name>
		<to_code>2642274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red cedar pollen extract</to_name>
		<to_code>852609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruta graveolens flowering top oil</to_name>
		<to_code>1367425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa davurica flower bud extract</to_name>
		<to_code>1799151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin tetrabutyrate</to_name>
		<to_code>2106328</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Robinia pseudoacacia flower extract</to_name>
		<to_code>2050979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roxatidine</to_name>
		<to_code>114817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhizopus stolonifer allergenic extract</to_name>
		<to_code>967721</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>razoxane</to_name>
		<to_code>9154</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa damascena flowering top extract</to_name>
		<to_code>1310016</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosmarinus officinalis whole extract</to_name>
		<to_code>1364990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa californica whole extract</to_name>
		<to_code>2533911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa rubiginosa seed oil</to_name>
		<to_code>1309290</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rehmannia glutinosa root extract</to_name>
		<to_code>1309220</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rose petal extract</to_name>
		<to_code>1322046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romosozumab-aqqg</to_name>
		<to_code>2123180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhizopus arrhizus allergenic extract</to_name>
		<to_code>314443</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruta graveolens whole extract</to_name>
		<to_code>1310215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronate sodium hemi-pentahydrate</to_name>
		<to_code>1356127</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit allergenic extract</to_name>
		<to_code>813859</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin 5'-phosphate sodium anhydrous</to_name>
		<to_code>2279515</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resorcinol monoacetate</to_name>
		<to_code>2106739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubia tinctorum whole extract</to_name>
		<to_code>1370301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rescinnamine</to_name>
		<to_code>9259</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice bran, defatted</to_name>
		<to_code>2531931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex crispus top extract</to_name>
		<to_code>1310183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum pumilum whole extract</to_name>
		<to_code>2683195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romiplostim</to_name>
		<to_code>805452</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raloxifene</to_name>
		<to_code>72143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red oak pollen extract</to_name>
		<to_code>852268</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina flower oil</to_name>
		<to_code>1425900</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum acuminatum root extract</to_name>
		<to_code>2665342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raspberry seed oil</to_name>
		<to_code>1309291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rose bengal sodium I 131</to_name>
		<to_code>82097</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radium chloride Ra-223</to_name>
		<to_code>1424174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redwood pollen extract</to_name>
		<to_code>1014707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosmarinus officinalis flowering top extract</to_name>
		<to_code>1309727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized</to_name>
		<to_code>2642138</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropinirole</to_name>
		<to_code>72302</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rose bengal</to_name>
		<to_code>9471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raxibacumab</to_name>
		<to_code>1366567</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remestemcel-L</to_name>
		<to_code>2700765</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronic acid</to_name>
		<to_code>55685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruthenium tribromide</to_name>
		<to_code>1989389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rituximab-abbs</to_name>
		<to_code>2105824</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa roxburghii fruit extract</to_name>
		<to_code>1311668</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosemary oil</to_name>
		<to_code>90945</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roxithromycin</to_name>
		<to_code>9478</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risdiplam</to_name>
		<to_code>2390935</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rufinamide</to_name>
		<to_code>69036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>repaglinide</to_name>
		<to_code>73044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ribes nigrum flower bud extract</to_name>
		<to_code>1549697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rho(D) immune globulin, human</to_name>
		<to_code>1789837</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin</to_name>
		<to_code>9346</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhynchophylline</to_name>
		<to_code>2562552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ROTAVIRUS VACCINE, LIVE</to_name>
		<to_code>253199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropivacaine</to_name>
		<to_code>35780</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rehmannia glutinosa whole extract</to_name>
		<to_code>1490688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropivacaine hydrochloride anhydrous</to_name>
		<to_code>2198974</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red currant allergenic extract</to_name>
		<to_code>972480</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rapeseed sterol extract</to_name>
		<to_code>1307741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>racepinephrine hydrochloride</to_name>
		<to_code>314610</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimabotulinumtoxinB</to_name>
		<to_code>860178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remdesivir</to_name>
		<to_code>2284718</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retinol acetate</to_name>
		<to_code>35400</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red alder pollen extract</to_name>
		<to_code>851914</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin 5'-phosphate</to_name>
		<to_code>1925821</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reteplase</to_name>
		<to_code>76895</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruta graveolens flowering top extract</to_name>
		<to_code>1309685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radish extract</to_name>
		<to_code>1314656</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranolazine</to_name>
		<to_code>35829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabies virus</to_name>
		<to_code>1648419</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa x damascena flower wax</to_name>
		<to_code>2180552</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhododendron ferrugineum whole extract</to_name>
		<to_code>1922729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regrelor</to_name>
		<to_code>1313722</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex acetosella whole extract</to_name>
		<to_code>1735326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riociguat</to_name>
		<to_code>1439816</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rutin sodium sulfate</to_name>
		<to_code>236445</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus spp whole extract</to_name>
		<to_code>1663402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rinfabate</to_name>
		<to_code>1426631</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus corchorifolius fruit extract</to_name>
		<to_code>1654971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roflumilast</to_name>
		<to_code>1091836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifampin</to_name>
		<to_code>9384</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropinirole hydrochloride</to_name>
		<to_code>236553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rasagiline</to_name>
		<to_code>134748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum officinale root extract</to_name>
		<to_code>1310065</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red king crab preparation</to_name>
		<to_code>1928707</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revakinagene taroretcel-lwey</to_name>
		<to_code>2708831</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rutin sodium propylsulfonate</to_name>
		<to_code>236537</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropivacaine hydrochloride</to_name>
		<to_code>236539</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rocuronium bromide</to_name>
		<to_code>32521</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ripretinib</to_name>
		<to_code>2369389</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relebactam monohydrate</to_name>
		<to_code>2184136</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ricinus communis whole extract</to_name>
		<to_code>1432797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resmethrin</to_name>
		<to_code>35380</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raffinose</to_name>
		<to_code>1362905</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruellia simplex whole extract</to_name>
		<to_code>2590685</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rat skin extract</to_name>
		<to_code>895279</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa moschata oil</to_name>
		<to_code>1305662</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina seed extract</to_name>
		<to_code>1373728</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhopalurus junceus venom</to_name>
		<to_code>2727192</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhamnus cathartica bark extract</to_name>
		<to_code>2714498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ronidazole</to_name>
		<to_code>1535498</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritonavir</to_name>
		<to_code>85762</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>robenacoxib</to_name>
		<to_code>1250203</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubidium fluoride</to_name>
		<to_code>1872046</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remibrutinib</to_name>
		<to_code>2724365</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riluzole</to_name>
		<to_code>35623</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosoxacin</to_name>
		<to_code>35797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice oil</to_name>
		<to_code>1307748</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus ursinus whole extract</to_name>
		<to_code>2118075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rocuronium</to_name>
		<to_code>68139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruscogenin</to_name>
		<to_code>35890</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhizobian gum</to_name>
		<to_code>1869799</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribonucleic acid sodium</to_name>
		<to_code>236790</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhododendron aureum leaf extract</to_name>
		<to_code>1309717</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rofecoxib</to_name>
		<to_code>232158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa multiflora root extract</to_name>
		<to_code>2634354</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimiterol</to_name>
		<to_code>9388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruscus aculeatus root extract</to_name>
		<to_code>1309509</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina fruit extract</to_name>
		<to_code>1311501</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum tanguticum whole extract</to_name>
		<to_code>1541243</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>robenidine</to_name>
		<to_code>1311554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum rhaponticum root extract</to_name>
		<to_code>1996991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina seed oil</to_name>
		<to_code>2567688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimegepant sulfate</to_name>
		<to_code>2282322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ribes nigrum seed oil</to_name>
		<to_code>1305665</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosewood oil</to_name>
		<to_code>1307693</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifapentine</to_name>
		<to_code>35617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus chinensis gall extract</to_name>
		<to_code>1802850</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhubarb preparation</to_name>
		<to_code>91266</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ribes nigrum leaf extract</to_name>
		<to_code>1491860</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ranunculus bulbosus extract</to_name>
		<to_code>1328307</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhubarb allergenic extract</to_name>
		<to_code>1011033</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice bran oil</to_name>
		<to_code>1309223</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosmarinyl glucoside</to_name>
		<to_code>2123048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabeprazole sodium</to_name>
		<to_code>226868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reishi mushroom preparation</to_name>
		<to_code>1313180</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodotorula rubra allergenic extract</to_name>
		<to_code>867321</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>racepinephrine</to_name>
		<to_code>66887</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA</to_name>
		<to_code>2685002</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhododendron caucasicum whole extract</to_name>
		<to_code>2711886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rizatriptan benzoate</to_name>
		<to_code>237082</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubidium</to_name>
		<to_code>1311489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit bush pollen extract</to_name>
		<to_code>851969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus corchorifolius whole extract</to_name>
		<to_code>2399544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa X alba flower oil</to_name>
		<to_code>2471868</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilmenidine</to_name>
		<to_code>55679</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rough marshelder pollen extract</to_name>
		<to_code>852532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rolapitant</to_name>
		<to_code>1665496</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rebaudioside A</to_name>
		<to_code>1667222</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red mulberry whole extract</to_name>
		<to_code>1996984</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rivaroxaban</to_name>
		<to_code>1114195</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhododendron indicum flower extract</to_name>
		<to_code>2588054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus chinensis root extract</to_name>
		<to_code>1373160</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rivastigmine</to_name>
		<to_code>183379</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabacfosadine</to_name>
		<to_code>2003595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilpivirine</to_name>
		<to_code>1102270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus toxicodendron extract</to_name>
		<to_code>283583</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus chamaemorus fruit extract</to_name>
		<to_code>1311671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhaponticum carthamoides root extract</to_name>
		<to_code>1996990</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa centifolia flower oil</to_name>
		<to_code>1305664</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>repotrectinib</to_name>
		<to_code>2670644</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>racementhol</to_name>
		<to_code>1430390</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retinyl linoleate</to_name>
		<to_code>1370677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhamnose</to_name>
		<to_code>1872246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubella virus</to_name>
		<to_code>1365969</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa alba flower extract</to_name>
		<to_code>2371036</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhodamine B</to_name>
		<to_code>1362930</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rocky Mountain juniper pollen extract</to_name>
		<to_code>852601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red yeast rice</to_name>
		<to_code>232540</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex acetosa whole extract</to_name>
		<to_code>1363562</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ranunculus sceleratus extract</to_name>
		<to_code>1862682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa multiflora whole extract</to_name>
		<to_code>2380571</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritodrine hydrochloride</to_name>
		<to_code>105470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Raphanus sativus var. Caudatus root extract</to_name>
		<to_code>2480114</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabbit anti-human T-lymphocyte globulin</to_name>
		<to_code>107044</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribociclib</to_name>
		<to_code>1873916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remimazolam besylate</to_name>
		<to_code>2383942</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rivastigmine tartrate</to_name>
		<to_code>994808</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranitidine</to_name>
		<to_code>9143</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raspberry allergenic extract</to_name>
		<to_code>899906</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhododendron ferrugineum leaf extract</to_name>
		<to_code>1918048</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rancid beef preparation</to_name>
		<to_code>1311083</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronate</to_name>
		<to_code>73056</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ravulizumab</to_name>
		<to_code>2107301</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritlecitinib tosylate</to_name>
		<to_code>2641596</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redtop grass pollen extract</to_name>
		<to_code>851870</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resmetirom</to_name>
		<to_code>2677894</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa luciae flowering top extract</to_name>
		<to_code>2539936</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice (whole grain) allergenic extract</to_name>
		<to_code>892661</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritlecitinib</to_name>
		<to_code>2641595</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ritodrine</to_name>
		<to_code>9392</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rose bengal AT</to_name>
		<to_code>1546378</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa chinensis flower extract</to_name>
		<to_code>2565949</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronate sodium monohydrate</to_name>
		<to_code>1356128</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa damascena flower oil</to_name>
		<to_code>1305663</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosmarinus officinalis preparation</to_name>
		<to_code>317702</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raloxifene hydrochloride</to_name>
		<to_code>166551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa moschata seed oil</to_name>
		<to_code>1310011</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Raphanus sativa extract</to_name>
		<to_code>1311246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifabutin</to_name>
		<to_code>55672</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhodium</to_name>
		<to_code>1311402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum officinale stem extract</to_name>
		<to_code>1373039</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleamidopropyltrimonium chloride</to_name>
		<to_code>1591912</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus idaeus seed extract</to_name>
		<to_code>1431709</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex japonicus root extract</to_name>
		<to_code>1733671</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin sodium</to_name>
		<to_code>2109051</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimantadine hydrochloride</to_name>
		<to_code>82093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retatrutide</to_name>
		<to_code>2722410</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhodinol</to_name>
		<to_code>1986339</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risperidone</to_name>
		<to_code>35636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin 5'-phosphate sodium dihydrate</to_name>
		<to_code>2611697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus chinensis whole extract</to_name>
		<to_code>1372476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa damascena flower wax</to_name>
		<to_code>1539420</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rapacuronium bromide</to_name>
		<to_code>228530</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rimexolone</to_name>
		<to_code>55681</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regenerated cellulose</to_name>
		<to_code>2000577</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raltegravir</to_name>
		<to_code>719872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosmarinus officinalis flowering top oil</to_name>
		<to_code>1376348</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhododendron aureum whole extract</to_name>
		<to_code>1999725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reboxetine mesylate</to_name>
		<to_code>60841</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raspberry juice</to_name>
		<to_code>1307723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rennet</to_name>
		<to_code>35360</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relatlimab-rmbw</to_name>
		<to_code>2596772</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhopalurus princeps venom</to_name>
		<to_code>1812093</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rauwolfia alkaloids</to_name>
		<to_code>9152</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remifentanil</to_name>
		<to_code>73032</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red mulberry pollen extract</to_name>
		<to_code>852680</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabacfosadine succinate</to_name>
		<to_code>2003594</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>river birch pollen extract</to_name>
		<to_code>852148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Raphanus sativus var. sativus seed</to_name>
		<to_code>1652250</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex obtusifolius root extract</to_name>
		<to_code>1997155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribose</to_name>
		<to_code>1314858</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosiglitazone maleate</to_name>
		<to_code>253198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red imported fire ant allergenic extract</to_name>
		<to_code>867341</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodiola sacra root extract</to_name>
		<to_code>1943532</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruthenium</to_name>
		<to_code>1534768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rucaparib</to_name>
		<to_code>1862579</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redroot pigweed whole allergenic extract</to_name>
		<to_code>1306882</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resacetophenone</to_name>
		<to_code>2685741</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>robenidine hydrochloride</to_name>
		<to_code>1311553</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropivacaine hydrochloride monohydrate</to_name>
		<to_code>1298851</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Russula emetica preparation</to_name>
		<to_code>1441399</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revefenacin</to_name>
		<to_code>2102775</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribociclib succinate</to_name>
		<to_code>1873978</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revumenib citrate</to_name>
		<to_code>2698326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubella virus vaccine live (Wistar RA 27-3 strain)</to_name>
		<to_code>762817</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rezafungin</to_name>
		<to_code>2639155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rho(D) immune globulin</to_name>
		<to_code>35465</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romifidine</to_name>
		<to_code>1091919</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa damascena flower extract</to_name>
		<to_code>1307568</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodiola kirilowii whole extract</to_name>
		<to_code>1740941</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabies immune globulin, human</to_name>
		<to_code>89886</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice bran</to_name>
		<to_code>1356151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rasagiline mesylate</to_name>
		<to_code>577300</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosaniline hydrochloride</to_name>
		<to_code>1535512</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilzabrutinib</to_name>
		<to_code>2722398</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosmarinate</to_name>
		<to_code>2531312</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>82 rubidium</to_name>
		<to_code>1546434</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Robinia pseudoacacia bark extract</to_name>
		<to_code>1309971</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosmarinic acid</to_name>
		<to_code>2531311</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus coreanus fruit extract</to_name>
		<to_code>1655991</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruttnera lamellosa oil</to_name>
		<to_code>2281670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reviparin</to_name>
		<to_code>75960</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relebactam anhydrous</to_name>
		<to_code>2268500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleamidopropyltrimonium</to_name>
		<to_code>1591913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raltegravir potassium</to_name>
		<to_code>1235585</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rorippa nasturtium-aquaticum flowering top extract</to_name>
		<to_code>1309500</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>recombinant FVIIa</to_name>
		<to_code>314620</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rough cocklebur pollen extract</to_name>
		<to_code>995600</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruxolitinib phosphate</to_name>
		<to_code>1193325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubia cordifolia whole extract</to_name>
		<to_code>2045734</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Reynoutria multiflora stem extract</to_name>
		<to_code>2669694</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice germ preparation</to_name>
		<to_code>1427015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa arkansana root extract</to_name>
		<to_code>1592898</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhinacanthus nasutus whole extract</to_name>
		<to_code>2565689</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain</to_name>
		<to_code>805573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radium cation</to_name>
		<to_code>1546270</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retapamulin</to_name>
		<to_code>642274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raspberry extract</to_name>
		<to_code>1370769</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roxatidine acetate</to_name>
		<to_code>35803</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retinamide</to_name>
		<to_code>1367161</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rotigotine</to_name>
		<to_code>616739</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubidium chloride Rb-82</to_name>
		<to_code>1367086</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rattus norvegicus hair preparation</to_name>
		<to_code>2471704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina whole extract</to_name>
		<to_code>1739226</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus chamaemorus seed oil</to_name>
		<to_code>1310096</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina leaf extract</to_name>
		<to_code>1438291</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleic acid</to_name>
		<to_code>35605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosin partially dimerized glycerol ester</to_name>
		<to_code>1549331</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronate sodium anhydrous</to_name>
		<to_code>1926958</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex crispus root extract</to_name>
		<to_code>1345677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rituximab-arrx</to_name>
		<to_code>2472325</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rauwolfia serpentina (USP)</to_name>
		<to_code>317836</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa centifolia flower extract</to_name>
		<to_code>1364989</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rozanolixizumab-noli</to_name>
		<to_code>2642273</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhamnus cathartica fruit extract</to_name>
		<to_code>1367391</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifamycins</to_name>
		<to_code>9385</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radium Ra-223 cation</to_name>
		<to_code>1745075</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhinacanthus nasutus leaf extract</to_name>
		<to_code>2632264</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramipril</to_name>
		<to_code>35296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rolitetracycline</to_name>
		<to_code>9462</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ractopamine hydrochloride</to_name>
		<to_code>1311676</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remoxipride</to_name>
		<to_code>35350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabeprazole</to_name>
		<to_code>114979</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ricinus communis leaf extract</to_name>
		<to_code>2682809</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubes nigrum seed extract</to_name>
		<to_code>1307697</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rudbeckia hirta whole extract</to_name>
		<to_code>2539795</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remoxipride hydrochloride</to_name>
		<to_code>235832</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranitidine bismuth citrate</to_name>
		<to_code>55471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa centifolia flower wax</to_name>
		<to_code>2180551</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rituximab</to_name>
		<to_code>121191</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus fruticosus leaf extract</to_name>
		<to_code>1309507</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reslizumab</to_name>
		<to_code>1746889</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>remestemcel-L-rknd</to_name>
		<to_code>2700764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubella virus vaccine</to_name>
		<to_code>9486</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex crispus whole extract</to_name>
		<to_code>1360628</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ramiprilat</to_name>
		<to_code>1546377</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa gallica flower extract</to_name>
		<to_code>1309502</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ractopamine</to_name>
		<to_code>1311677</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus fruticosus whole extract</to_name>
		<to_code>2001178</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ribes rubrum whole extract</to_name>
		<to_code>2394950</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regadenoson anhydrous</to_name>
		<to_code>1546015</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>respiratory syncytial virus immune globulin intravenous</to_name>
		<to_code>119246</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rapacuronium</to_name>
		<to_code>262100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reproterol hydrochloride</to_name>
		<to_code>235833</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosmarinus officinalis flower extract</to_name>
		<to_code>1309505</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>revakinagene taroretcel</to_name>
		<to_code>2708830</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ropeginterferon alfa-2b-njft</to_name>
		<to_code>2587060</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ravulizumab-cwvz</to_name>
		<to_code>2107316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>respiratory syncytial virus pre-fusion F protein, recombinant</to_name>
		<to_code>2636588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosuvastatin calcium</to_name>
		<to_code>323828</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifamycin sodium</to_name>
		<to_code>236475</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rifaximin</to_name>
		<to_code>35619</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa gallica flower oil</to_name>
		<to_code>1307744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodotorula mucilaginosa allergenic extract</to_name>
		<to_code>967529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rice allergenic extract</to_name>
		<to_code>901337</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubidium chloride</to_name>
		<to_code>1367087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>racecadotril</to_name>
		<to_code>16738</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rainbow trout allergenic extract</to_name>
		<to_code>2102483</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>RESPIRATORY VACCINE</to_name>
		<to_code>253196</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romidepsin</to_name>
		<to_code>877510</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>redwood whole extract</to_name>
		<to_code>1996993</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red snapper allergenic extract</to_name>
		<to_code>889646</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleic monoethanolamide sulfosuccinate</to_name>
		<to_code>1370599</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleate</to_name>
		<to_code>618482</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum palmatum whole extract</to_name>
		<to_code>1442704</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red delicious apple allergenic extract</to_name>
		<to_code>895588</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus idaeus subsp. strigosus whole extract</to_name>
		<to_code>2000544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red kidney bean allergenic extract</to_name>
		<to_code>1012183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboprine</to_name>
		<to_code>1376156</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus fruticosus seed extract</to_name>
		<to_code>1600747</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubidium nitrite</to_name>
		<to_code>1658653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>respiratory syncytial virus pre-fusion F protein</to_name>
		<to_code>2636589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa damascena whole extract</to_name>
		<to_code>1543294</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red maple pollen extract</to_name>
		<to_code>851744</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>raltitrexed</to_name>
		<to_code>196239</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Russian olive pollen extract</to_name>
		<to_code>852367</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reviparin sodium</to_name>
		<to_code>75961</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ranibizumab-eqrn</to_name>
		<to_code>2612673</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retifanlimab-dlwr</to_name>
		<to_code>2632980</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red bell pepper allergenic extract</to_name>
		<to_code>901329</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ribavirin</to_name>
		<to_code>9344</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>RNA</to_name>
		<to_code>9394</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rotenone</to_name>
		<to_code>1366666</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>radish allergenic extract</to_name>
		<to_code>974687</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resveratrol</to_name>
		<to_code>1000492</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risankizumab</to_name>
		<to_code>2166040</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosin</to_name>
		<to_code>1362931</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized</to_name>
		<to_code>2642139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus chingii var. suavissimus leaf extract</to_name>
		<to_code>1806682</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated</to_name>
		<to_code>830464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red paper wasp venom protein</to_name>
		<to_code>1294634</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rubidium iodide</to_name>
		<to_code>2634902</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red pine pollen extract</to_name>
		<to_code>900754</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ruxolitinib</to_name>
		<to_code>1193326</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romifidine hydrochloride</to_name>
		<to_code>1091913</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retinyl retinoate</to_name>
		<to_code>1373727</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rumex acetosa whole leaf extract</to_name>
		<to_code>1721436</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rose oil</to_name>
		<to_code>1309371</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>red pepper extract</to_name>
		<to_code>1313692</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Reynoutria multiflora root oil</to_name>
		<to_code>2669403</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubia tinctorum root extract</to_name>
		<to_code>1309973</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rilpivirine hydrochloride</to_name>
		<to_code>1102287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Russian thistle pollen extract</to_name>
		<to_code>852158</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>roxatidine acetate hydrochloride</to_name>
		<to_code>236543</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa alba flower oil extract</to_name>
		<to_code>2002791</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rosa canina fruit oil</to_name>
		<to_code>1305715</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus glabra bark extract</to_name>
		<to_code>1307857</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>risedronate sodium</to_name>
		<to_code>60334</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodomyrtus tomentosa fruit extract</to_name>
		<to_code>1363468</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rhenium</to_name>
		<to_code>1667763</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus chingii whole extract</to_name>
		<to_code>2370872</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>robusta coffee bean extract</to_name>
		<to_code>1307314</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhodiola crenulata root extract</to_name>
		<to_code>1372932</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum palmatum root extract</to_name>
		<to_code>1436168</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>regorafenib</to_name>
		<to_code>1312397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rheum officinale whole extract</to_name>
		<to_code>1435867</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rauwolfia preparation</to_name>
		<to_code>78678</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa multiflora fruit extract</to_name>
		<to_code>1311667</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>romosozumab</to_name>
		<to_code>2123126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rosa canina flower extract</to_name>
		<to_code>1309745</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>recombinant antihemophilic factor VIII</to_name>
		<to_code>253151</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus aromatica root bark extract</to_name>
		<to_code>1353884</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Ruta graveolens preparation</to_name>
		<to_code>285162</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ricinoleamidopropyl ethyldimonium ethosulfate</to_name>
		<to_code>1307142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retinaldehyde</to_name>
		<to_code>2268087</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>retinyl propionate</to_name>
		<to_code>1356759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>rucaparib camsylate</to_name>
		<to_code>1862578</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>resorcinol</to_name>
		<to_code>35382</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus laciniatus whole extract</to_name>
		<to_code>2178088</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>recombinant interferon beta-1b</to_name>
		<to_code>72258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>riboflavin 5'-phosphate sodium</to_name>
		<to_code>1925820</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>reboxetine</to_name>
		<to_code>60842</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rhus glabra top extract</to_name>
		<to_code>1310173</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus chamaemorus whole extract</to_name>
		<to_code>1875603</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Rubus idaeus leaf extract</to_name>
		<to_code>1309981</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>R [Preparations]</from_name>
		<from_code>N0000010600</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>relebactam</to_name>
		<to_code>2184137</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rickettsia rickettsii</from_name>
		<from_code>1482546</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia rickettsii</to_name>
		<to_code>M0019100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reproterol</from_name>
		<from_code>35373</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>reproterol</to_name>
		<to_code>M0063597</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rutin</from_name>
		<from_code>9500</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rutin</to_name>
		<to_code>M0019316</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rickettsia prowazekii</from_name>
		<from_code>1744460</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rickettsia prowazekii</to_name>
		<to_code>M0019099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxarsone</from_name>
		<from_code>1314413</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Roxarsone</to_name>
		<to_code>M0019285</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycin SV</from_name>
		<from_code>35616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rifamycin SV</to_name>
		<to_code>M0081464</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reductic acid</from_name>
		<from_code>2593372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>reductic acid</to_name>
		<to_code>M0177148</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilmenidine phosphate</from_name>
		<from_code>236379</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rilmenidine Phosphate</to_name>
		<to_code>M0100911</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radium</from_name>
		<from_code>1546450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Radium</to_name>
		<to_code>M0018449</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxatidine</from_name>
		<from_code>114817</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>roxatidine</to_name>
		<to_code>M0152121</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>razoxane</from_name>
		<from_code>9154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Razoxane</to_name>
		<to_code>M0018535</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rehmannia glutinosa root extract</from_name>
		<from_code>1309220</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rehmannia root</to_name>
		<to_code>M000744254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resorcinol monoacetate</from_name>
		<from_code>2106739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>resorcinol monoacetate</to_name>
		<to_code>M0163214</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radium chloride Ra-223</from_name>
		<from_code>1424174</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>radium Ra 223 dichloride</to_name>
		<to_code>M0584818</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>risedronic acid</from_name>
		<from_code>55685</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Risedronic Acid</to_name>
		<to_code>M000603388</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosemary oil</from_name>
		<from_code>90945</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rosemary oil</to_name>
		<to_code>M0152210</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Roxithromycin</to_name>
		<to_code>M0023927</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxithromycin</from_name>
		<from_code>9478</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin</from_name>
		<from_code>7337</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin mesylate</from_name>
		<from_code>402429</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin phenyl sodium</from_name>
		<from_code>42580</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>silver nitrate</from_name>
		<from_code>9789</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine hydrochloride</from_name>
		<from_code>2361</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfamethizole</from_name>
		<from_code>10179</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gemifloxacin</from_name>
		<from_code>138099</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>netilmicin sulfate</from_name>
		<from_code>203193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole sodium</from_name>
		<from_code>236084</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine acetate</from_name>
		<from_code>2359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine</from_name>
		<from_code>2358</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine diacetate</from_name>
		<from_code>133054</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin disodium</from_name>
		<from_code>258332</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfacytine</from_name>
		<from_code>78902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin</from_name>
		<from_code>2015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>chlorhexidine gluconate</from_name>
		<from_code>20791</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>amdinocillin</from_name>
		<from_code>626</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sulfathiazole</from_name>
		<from_code>10193</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>carbenicillin indanyl sodium</from_name>
		<from_code>56461</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fleroxacin</from_name>
		<from_code>42322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Gram-Negative Bacterial Infections</to_name>
		<to_code>M0025725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red currant allergenic extract</from_name>
		<from_code>972480</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish extract</from_name>
		<from_code>1314656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabies virus</from_name>
		<from_code>1648419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rabies virus</to_name>
		<to_code>M0018368</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rutin sodium sulfate</from_name>
		<from_code>236445</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rutin sulfate, monosodium salt, monohydrogen</to_name>
		<to_code>M0323725</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resmethrin</from_name>
		<from_code>35380</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>resmethrin</to_name>
		<to_code>M0262438</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raffinose</from_name>
		<from_code>1362905</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Raffinose</to_name>
		<to_code>M0018455</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ronidazole</from_name>
		<from_code>1535498</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ronidazole</to_name>
		<to_code>M0019258</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>robenacoxib</from_name>
		<from_code>1250203</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>robenacoxib</to_name>
		<to_code>M0549130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosoxacin</from_name>
		<from_code>35797</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rosoxacin</to_name>
		<to_code>M0075544</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium</from_name>
		<from_code>68139</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rocuronium</to_name>
		<to_code>M0171457</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ruscogenin</from_name>
		<from_code>35890</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ruscogenin</to_name>
		<to_code>M0059632</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rimiterol</from_name>
		<from_code>9388</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rimiterol</to_name>
		<to_code>M0224688</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>robenidine</from_name>
		<from_code>1311554</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Robenidine</to_name>
		<to_code>M0019227</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rice bran oil</from_name>
		<from_code>1309223</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rice Bran Oil</to_name>
		<to_code>M0145529</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racepinephrine</from_name>
		<from_code>66887</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Racepinephrine</to_name>
		<to_code>M0007589</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubidium</from_name>
		<from_code>1311489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rubidium</to_name>
		<to_code>M0019296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rilmenidine</from_name>
		<from_code>55679</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rilmenidine</to_name>
		<to_code>M0100916</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rebaudioside A</from_name>
		<from_code>1667222</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rebaudioside A</to_name>
		<to_code>M0084861</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabacfosadine</from_name>
		<from_code>2003595</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rabacfosadine</to_name>
		<to_code>M0524829</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinyl linoleate</from_name>
		<from_code>1370677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>retinyl linoleate</to_name>
		<to_code>M0137412</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhamnose</from_name>
		<from_code>1872246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhamnose</to_name>
		<to_code>M0019003</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhodamine B</from_name>
		<from_code>1362930</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rhodamine B</to_name>
		<to_code>M0094768</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red yeast rice</from_name>
		<from_code>232540</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>red yeast rice</to_name>
		<to_code>M0301244</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhodium</from_name>
		<from_code>1311402</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhodium</to_name>
		<to_code>M0019042</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhodinol</from_name>
		<from_code>1986339</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>3,7-dimethyl-7-octen-1-ol</to_name>
		<to_code>M0528489</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium bromide</from_name>
		<from_code>228530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rapacuronium bromide</to_name>
		<to_code>M0220825</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium bromide</from_name>
		<from_code>228530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine</from_name>
		<from_code>10917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium</from_name>
		<from_code>33742</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium</from_name>
		<from_code>262100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pipecuronium bromide</from_name>
		<from_code>66983</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium</from_name>
		<from_code>71535</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rocuronium bromide</from_name>
		<from_code>32521</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine</from_name>
		<from_code>10154</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium</from_name>
		<from_code>319864</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cisatracurium besylate</from_name>
		<from_code>136561</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tubocurarine chloride</from_name>
		<from_code>82115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>vecuronium bromide</from_name>
		<from_code>11153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>gallamine triethiodide</from_name>
		<from_code>4639</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium</from_name>
		<from_code>7883</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>succinylcholine chloride</from_name>
		<from_code>3565</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>induces</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pancuronium bromide</from_name>
		<from_code>7884</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Muscle Hypotonia</to_name>
		<to_code>M0014238</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rapacuronium</from_name>
		<from_code>262100</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rapacuronium</to_name>
		<to_code>M0366636</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>regenerated cellulose</from_name>
		<from_code>2000577</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rayon, purified</to_name>
		<to_code>M0058723</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rennet</from_name>
		<from_code>35360</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rennet</to_name>
		<to_code>M0084582</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rauwolfia alkaloids</from_name>
		<from_code>9152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rauwolfia Alkaloids</to_name>
		<to_code>M0018533</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ribose</from_name>
		<from_code>1314858</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ribose</to_name>
		<to_code>M0019077</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red imported fire ant allergenic extract</from_name>
		<from_code>867341</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ant Venoms</to_name>
		<to_code>M0001287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black imported fire ant allergenic extract</from_name>
		<from_code>995738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ant Venoms</to_name>
		<to_code>M0001287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>black carpenter ant allergenic extract</from_name>
		<from_code>2057909</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ant Venoms</to_name>
		<to_code>M0001287</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ruthenium</from_name>
		<from_code>1534768</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Ruthenium</to_name>
		<to_code>M0019313</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>resacetophenone</from_name>
		<from_code>2685741</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>resacetophenone</to_name>
		<to_code>M0369276</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>robenidine hydrochloride</from_name>
		<from_code>1311553</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Robenidine Hydrochloride</to_name>
		<to_code>M0019229</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rho(D) immune globulin</from_name>
		<from_code>35465</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rho(D) Immune Globulin</to_name>
		<to_code>M0027215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rho(D) immune globulin, human</from_name>
		<from_code>1789837</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rho(D) Immune Globulin</to_name>
		<to_code>M0027215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>romifidine</from_name>
		<from_code>1091919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>romifidine</to_name>
		<to_code>M0205197</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosaniline hydrochloride</from_name>
		<from_code>1535512</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rosaniline hydrochloride</to_name>
		<to_code>M0316395</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosmarinate</from_name>
		<from_code>2531312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosmarinic Acid</to_name>
		<to_code>M000763254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosmarinic acid</from_name>
		<from_code>2531311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rosmarinic Acid</to_name>
		<to_code>M000763254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>82 rubidium</from_name>
		<from_code>1546434</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rubidium-82</to_name>
		<to_code>M000628005</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>retapamulin</to_name>
		<to_code>M0496256</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retapamulin</from_name>
		<from_code>642274</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diterpenes</to_name>
		<to_code>M0006609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime</from_name>
		<from_code>2194</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin</from_name>
		<from_code>42372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hemihydrate</from_name>
		<from_code>1297878</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mupirocin calcium</from_name>
		<from_code>221128</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil monohydrate</from_name>
		<from_code>204175</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime axetil</from_name>
		<from_code>20493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil hydrate</from_name>
		<from_code>407888</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefuroxime sodium</from_name>
		<from_code>204144</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil</from_name>
		<from_code>2177</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ozenoxacin</from_name>
		<from_code>1994739</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cefadroxil anhydrous</from_name>
		<from_code>1545975</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Impetigo</to_name>
		<to_code>M0011174</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lefamulin</from_name>
		<from_code>2198944</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Diterpenes</to_name>
		<to_code>M0006609</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxatidine acetate</from_name>
		<from_code>35803</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>roxatidine acetate</to_name>
		<to_code>M0152123</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinamide</from_name>
		<from_code>1367161</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>retinamide</to_name>
		<to_code>M0153729</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ricinoleic acid</from_name>
		<from_code>35605</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ricinoleic acid</to_name>
		<to_code>M0096472</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycins</from_name>
		<from_code>9385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycins</from_name>
		<from_code>9385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycins</from_name>
		<from_code>9385</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rifamycins</to_name>
		<to_code>M0019113</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rolitetracycline</from_name>
		<from_code>9462</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rolitetracycline</to_name>
		<to_code>M0019254</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ractopamine hydrochloride</from_name>
		<from_code>1311676</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ractopamine hydrochloride</to_name>
		<to_code>M0324340</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remoxipride</from_name>
		<from_code>35350</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Remoxipride</to_name>
		<to_code>M0026320</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>remoxipride hydrochloride</from_name>
		<from_code>235832</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Remoxipride Hydrochloride</to_name>
		<to_code>M0329310</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ractopamine</from_name>
		<from_code>1311677</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>ractopamine</to_name>
		<to_code>M0168987</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>respiratory syncytial virus immune globulin intravenous</from_name>
		<from_code>119246</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>respiratory syncytial virus immune globulin intravenous</to_name>
		<to_code>M0259186</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycin sodium</from_name>
		<from_code>236475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rifamycin sodium</from_name>
		<from_code>236475</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Bacterial Infections</to_name>
		<to_code>M0002126</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubidium chloride</from_name>
		<from_code>1367087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rubidium chloride</to_name>
		<to_code>M0101892</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>racecadotril</from_name>
		<from_code>16738</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>racecadotril</to_name>
		<to_code>M0141397</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>raltitrexed</from_name>
		<from_code>196239</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>raltitrexed</to_name>
		<to_code>M0188215</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red bell pepper allergenic extract</from_name>
		<from_code>901329</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>RNA</from_name>
		<from_code>9394</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>RNA</to_name>
		<to_code>M0019139</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rotenone</from_name>
		<from_code>1366666</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rotenone</to_name>
		<to_code>M0019281</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>radish allergenic extract</from_name>
		<from_code>974687</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rosin</from_name>
		<from_code>1362931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rosin</to_name>
		<to_code>M0062020</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rubidium iodide</from_name>
		<from_code>2634902</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>rubidium iodide</to_name>
		<to_code>M0188630</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinyl retinoate</from_name>
		<from_code>1373727</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>retinyl retinoate</to_name>
		<to_code>M0522845</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>red pepper extract</from_name>
		<from_code>1313692</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FDASPL</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>roxatidine acetate hydrochloride</from_name>
		<from_code>236543</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>roxatidine acetate hydrochloride</to_name>
		<to_code>M0152122</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhenium</from_name>
		<from_code>1667763</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Rhenium</to_name>
		<to_code>M0019004</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinaldehyde</from_name>
		<from_code>2268087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Retinaldehyde</to_name>
		<to_code>M0018957</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinaldehyde</from_name>
		<from_code>2268087</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>11-trans-Retinal</to_name>
		<to_code>M000743797</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>retinyl propionate</from_name>
		<from_code>1356759</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>retinyl propionate</to_name>
		<to_code>M0155948</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kukui nut extract</to_name>
		<to_code>1307863</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketorolac</to_name>
		<to_code>35827</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kaolin light</to_name>
		<to_code>104100</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>2-ketogluconate</to_name>
		<to_code>1869045</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kalanchoe daigremontiana leaf extract</to_name>
		<to_code>1535221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketotifen fumarate</to_name>
		<to_code>11404</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>karaya gum</to_name>
		<to_code>6111</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kiwi seed oil</to_name>
		<to_code>1486759</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kiwi fruit extract</to_name>
		<to_code>1358901</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kiwi juice</to_name>
		<to_code>1747711</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kunzea ambigua whole extract</to_name>
		<to_code>2168267</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kalopanax septemlobus bark extract</to_name>
		<to_code>1307713</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketazolam</to_name>
		<to_code>28181</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketoprofen lysine</to_name>
		<to_code>28199</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kjellmaniella gyrata preparation</to_name>
		<to_code>1314322</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kamala extract</to_name>
		<to_code>28116</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketamine hydrochloride</to_name>
		<to_code>203184</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kebuzone</to_name>
		<to_code>28198</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kojic acid</to_name>
		<to_code>1426451</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kakadu plum extract</to_name>
		<to_code>1598581</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketorolac tromethamine</to_name>
		<to_code>28200</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kaempferia galanga whole extract</to_name>
		<to_code>1606221</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kidney bean allergenic extract</to_name>
		<to_code>891637</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kanamycin</to_name>
		<to_code>6099</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Korean ginseng preparation</to_name>
		<to_code>259470</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kaempferia galanga root extract</to_name>
		<to_code>1310098</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>keratin, type I cytoskeletal 40</to_name>
		<to_code>2606493</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kalmia angustifolia leaf extract</to_name>
		<to_code>1310163</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kale extract</to_name>
		<to_code>1592296</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kalmia latifolia whole extract</to_name>
		<to_code>1998614</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketanserin</to_name>
		<to_code>6131</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketotifen</to_name>
		<to_code>6146</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kappaphycus alvarezii extract</to_name>
		<to_code>1661014</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kanamycin sulfate</to_name>
		<to_code>203183</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kigelia africana fruit extract</to_name>
		<to_code>1311615</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Khuskia oryzae allergenic extract</to_name>
		<to_code>892338</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>1-kestose</to_name>
		<to_code>2590592</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kadsura coccinea whole extract</to_name>
		<to_code>2610402</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kentucky bluegrass pollen extract</to_name>
		<to_code>852834</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>keracyanin</to_name>
		<to_code>28165</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kalimeris indica whole extract</to_name>
		<to_code>2590653</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Korean ginseng root</to_name>
		<to_code>260038</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kava preparation</to_name>
		<to_code>285228</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kukui nut oil</to_name>
		<to_code>1309364</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kluyveromyces marxianus</to_name>
		<to_code>1804172</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kerosene</to_name>
		<to_code>1311375</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kojic dipalmitate</to_name>
		<to_code>1314207</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kininogenase</to_name>
		<to_code>6095</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketamine</to_name>
		<to_code>6130</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kaolin</to_name>
		<to_code>6102</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>keracyanin chloride</to_name>
		<to_code>236274</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>karum seed oil</to_name>
		<to_code>1483231</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kunzea pomifera fruit extract</to_name>
		<to_code>1812670</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Klebsiella pneumoniae</to_name>
		<to_code>1311061</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kiwi fruit allergenic extract</to_name>
		<to_code>1010926</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kalmia latifolia leaf</to_name>
		<to_code>1307972</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kava root</to_name>
		<to_code>259421</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Khaya senegalensis bark extract</to_name>
		<to_code>1307601</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Korean ginseng root extract</to_name>
		<to_code>259471</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kelp preparation</to_name>
		<to_code>285155</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kiwi fruit oil</to_name>
		<to_code>1745929</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kanamycin A sulfate</to_name>
		<to_code>1300476</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>karaya gum extract</to_name>
		<to_code>852617</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>khellin</to_name>
		<to_code>6147</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>krill oil</to_name>
		<to_code>880350</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Kalanchoe pinnata leaf extract</to_name>
		<to_code>1539425</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kinetin</to_name>
		<to_code>16054</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Krameria lappacea whole extract</to_name>
		<to_code>1545683</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Karwinskia humboldtiana seed extract</to_name>
		<to_code>1923812</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketoprofen</to_name>
		<to_code>6142</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kapok tree fiber allergenic extract</to_name>
		<to_code>852315</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Koelers grass pollen extract</to_name>
		<to_code>852605</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>kanamycin A</to_name>
		<to_code>1727573</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>karaya gum allergenic extract</to_name>
		<to_code>904554</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>ketoconazole</to_name>
		<to_code>6135</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Knoxia roxburghii subsp. brunonis root extract</to_name>
		<to_code>2542283</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Parent Of</name>
		<from_namespace>MED-RT</from_namespace>
		<from_name>K [Preparations]</from_name>
		<from_code>N0000010593</from_code>
		<to_namespace>RxNorm</to_namespace>
		<to_name>Krameria lappacea root extract</to_name>
		<to_code>1309764</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>2-ketogluconate</from_name>
		<from_code>1869045</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>2-ketogluconate</to_name>
		<to_code>M0051907</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>has_SC</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Dietary Proteins</to_name>
		<to_code>M0006342</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>FMTSME</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>Synonym Of</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>karaya gum</from_name>
		<from_code>6111</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Karaya Gum</to_name>
		<to_code>M0011928</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>NLMUMLS</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine</from_name>
		<from_code>33272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rhubarb preparation</from_name>
		<from_code>91266</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, pigweed, spiny, pollen</from_name>
		<from_code>314428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate</from_name>
		<from_code>3319</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>redtop grass pollen extract</from_name>
		<from_code>851870</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beech pollen extract</from_name>
		<from_code>852419</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate meglumine</from_name>
		<from_code>3320</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental</from_name>
		<from_code>10493</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>thiopental sodium</from_name>
		<from_code>282416</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine</from_name>
		<from_code>8299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>domestic cow skin extract</from_name>
		<from_code>852256</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>empagliflozin</from_name>
		<from_code>1545653</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>short ragweed pollen extract</from_name>
		<from_code>896135</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_diagnose</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diatrizoate sodium</from_name>
		<from_code>3321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Candida albicans</from_name>
		<from_code>1963</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine hydrochloride</from_name>
		<from_code>297716</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sugar beet allergenic extract</from_name>
		<from_code>899359</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine sulfate</from_name>
		<from_code>3287</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>soybean preparation</from_name>
		<from_code>287515</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium bromide</from_name>
		<from_code>2689321</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine resin</from_name>
		<from_code>221138</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cocoa extract</from_name>
		<from_code>1373895</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Eurotium herbariorum allergenic extract</from_name>
		<from_code>999450</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cholecalciferol</from_name>
		<from_code>2418</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn allergenic extract</from_name>
		<from_code>892547</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flaxseed extract</from_name>
		<from_code>318224</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine sulfate</from_name>
		<from_code>106047</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>rabbit skin extract</from_name>
		<from_code>867315</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine</from_name>
		<from_code>700810</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phendimetrazine tartrate</from_name>
		<from_code>58157</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cottonseed allergenic extract</from_name>
		<from_code>852440</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Timothy grass pollen extract</from_name>
		<from_code>851994</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine</from_name>
		<from_code>10734</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spearmint extract</from_name>
		<from_code>1372258</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine</from_name>
		<from_code>6816</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>papaya extract</from_name>
		<from_code>1992412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Botrytis cinerea allergenic extract</from_name>
		<from_code>466195</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine saccharate</from_name>
		<from_code>221088</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>false ragweed pollen extract</from_name>
		<from_code>851938</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn smut allergenic extract</from_name>
		<from_code>314488</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide</from_name>
		<from_code>2176312</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Kentucky bluegrass pollen extract</from_name>
		<from_code>852834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>lisdexamfetamine dimesylate</from_name>
		<from_code>673579</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus terreus allergenic extract</from_name>
		<from_code>314324</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>whole wheat allergenic extract</from_name>
		<from_code>901299</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>corn pollen extract</from_name>
		<from_code>852015</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dog skin extract</from_name>
		<from_code>894987</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methamphetamine hydrochloride</from_name>
		<from_code>82044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cephalosporium roseum extract</from_name>
		<from_code>1925834</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sofpironium</from_name>
		<from_code>2689322</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>egg extract</from_name>
		<from_code>1315115</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Cochliobolus sativus allergenic extract</from_name>
		<from_code>852398</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>common sagebrush pollen extract</from_name>
		<from_code>852020</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Trichoderma viride allergenic extract</from_name>
		<from_code>968401</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dextroamphetamine</from_name>
		<from_code>3288</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine hydrochloride</from_name>
		<from_code>82078</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tranylcypromine sulfate</from_name>
		<from_code>91119</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Mucor plumbeus allergenic extract</from_name>
		<from_code>314415</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pecan pollen extract</from_name>
		<from_code>852272</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bremelanotide acetate</from_name>
		<from_code>2176311</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Johnson grass pollen extract</from_name>
		<from_code>852136</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>phentermine</from_name>
		<from_code>8152</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus niger allergenic extract</from_name>
		<from_code>1742530</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Curvularia inequalis allergenic extract</from_name>
		<from_code>999438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Cardiovascular Diseases</to_name>
		<to_code>M0003473</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>acetylsalicylate sodium</from_name>
		<from_code>314293</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone acetate</from_name>
		<from_code>34372</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tapentadol</from_name>
		<from_code>787390</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide anhydrous</from_name>
		<from_code>1546428</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>tragacanth</from_name>
		<from_code>1368197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaproterenol</from_name>
		<from_code>7688</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>nedocromil</from_name>
		<from_code>31563</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn</from_name>
		<from_code>42612</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide hemihydrate</from_name>
		<from_code>1298840</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>propranolol</from_name>
		<from_code>8787</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine tannate</from_name>
		<from_code>221096</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>salmeterol xinafoate</from_name>
		<from_code>72616</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>allergenic extract, false ragweed pollen</from_name>
		<from_code>314365</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine nitrate</from_name>
		<from_code>103244</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>iodinated glycerol</from_name>
		<from_code>27723</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ethylnorepinephrine hydrochloride</from_name>
		<from_code>289080</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone</from_name>
		<from_code>5489</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>methylprednisolone sodium phosphate</from_name>
		<from_code>29917</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxycodone</from_name>
		<from_code>7804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Rhizopus stolonifer allergenic extract</from_name>
		<from_code>967721</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>albuterol sulfate</from_name>
		<from_code>142153</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pilocarpine</from_name>
		<from_code>8328</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine hydrochloride</from_name>
		<from_code>102397</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Fusarium oxysporum vasinfectum allergenic extract</from_name>
		<from_code>867228</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine maleate</from_name>
		<from_code>54828</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Chaetomium globosum allergenic extract</from_name>
		<from_code>466197</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bitolterol</from_name>
		<from_code>19499</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate</from_name>
		<from_code>1348</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol</from_name>
		<from_code>6378</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>levorphanol tartrate</from_name>
		<from_code>153973</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pseudoephedrine tannate</from_name>
		<from_code>221151</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate dihydrate</from_name>
		<from_code>998038</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen, sodium salt</from_name>
		<from_code>1429044</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>belladonna extract, USP</from_name>
		<from_code>89781</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>butorphanol tartrate</from_name>
		<from_code>203170</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>metaproterenol sulfate</from_name>
		<from_code>6804</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus allergenic extract</from_name>
		<from_code>466192</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>formoterol fumarate</from_name>
		<from_code>236216</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone</from_name>
		<from_code>41126</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>flunisolide</from_name>
		<from_code>25120</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>mugwort sage pollen extract</from_name>
		<from_code>852029</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>fluticasone furoate</from_name>
		<from_code>705022</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide (11.beta.,16.alpha.(S))</from_name>
		<from_code>1367172</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>parsley extract</from_name>
		<from_code>317857</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ephedrine hydrochloride</from_name>
		<from_code>91165</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>sage extract</from_name>
		<from_code>1354504</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone sodium phosphate</from_name>
		<from_code>48933</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>paregoric</from_name>
		<from_code>32926</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>beclomethasone dipropionate monohydrate</from_name>
		<from_code>253156</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>isoetharine</from_name>
		<from_code>6023</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>reslizumab</from_name>
		<from_code>1746889</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexchlorpheniramine</from_name>
		<from_code>22697</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>ibuprofen lysine</from_name>
		<from_code>36761</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>oxtriphylline</from_name>
		<from_code>20976</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine sulfate</from_name>
		<from_code>91104</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>bambuterol</from_name>
		<from_code>18751</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cortisone acetate</from_name>
		<from_code>21655</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>smooth brome pollen extract</from_name>
		<from_code>852217</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast sodium</from_name>
		<from_code>115713</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>cromolyn sodium</from_name>
		<from_code>3538</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine polistirex</from_name>
		<from_code>235412</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>orris allergenic extract</from_name>
		<from_code>314753</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>physostigmine salicylate</from_name>
		<from_code>33656</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone acetate</from_name>
		<from_code>22690</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>zileuton</from_name>
		<from_code>40575</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>June grass pollen extract</from_name>
		<from_code>851965</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dandelion pollen extract</from_name>
		<from_code>852079</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>dexamethasone isonicotinate</from_name>
		<from_code>3265</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>diclofenac</from_name>
		<from_code>3355</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>codeine phosphate</from_name>
		<from_code>2672</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>spiny pigweed pollen extract</from_name>
		<from_code>895919</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>hydrocodone hydrochloride</from_name>
		<from_code>236931</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>benzhydrocodone</from_name>
		<from_code>2001352</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>prednisolone sodium metasulphobenzoate</from_name>
		<from_code>268872</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>pirbuterol</from_name>
		<from_code>33767</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>theophylline</from_name>
		<from_code>10438</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_prevent</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>triamcinolone diacetate</from_name>
		<from_code>10762</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>western ragweed pollen extract</from_name>
		<from_code>851985</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>Aspergillus fumigatus</from_name>
		<from_code>1182</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>montelukast</from_name>
		<from_code>88249</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>may_treat</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>aminophylline</from_name>
		<from_code>689</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<namespace>MED-RT</namespace>
		<name>CI_with</name>
		<from_namespace>RxNorm</from_namespace>
		<from_name>budesonide</from_name>
		<from_code>19831</from_code>
		<to_namespace>MeSH</to_namespace>
		<to_name>Asthma</to_name>
		<to_code>M0001885</to_code>
		<qualifier>
			<namespace>MED-RT</namespace>
			<name>Authority</name>
			<value>MEDRT</value>
		</qualifier>
	</association>
	<association>
		<names